omim_id	omim_title	omim_description	omim_phenotype	api_lethal_hits	phenotype	section_matched	search_term	gene_symbol	hgnc_id	phenotypes	mode_of_inheritance	needs_date_check	lethal_hit_phenotype_included	lethality_quote	lethality_category_hpo	evidence_from_proband	evidence_from_family_members	disease_gene_lethal	gene_lethal	gene_lethal_summary	all_lethality_categories	earliest_lethality_category	merged_earliest_lethality_category
100100	PRUNE BELLY SYNDROME	Prune belly syndrome, 100100 (3)	Prune belly syndrome	y	PRUNE BELLY SYNDROME; PBS	Clinical Features	died	CHRM3	HGNC:1952	Prune belly syndrome, 100100 (3), Autosomal recessive	Autosomal recessive	y	n	-	-	-	-	ambiguous	ambiguous	ambiguous	-	-	-
100300	ADAMS-OLIVER SYNDROME 1	Adams-Oliver syndrome 1, 100300 (3)	Adams-Oliver syndrome 1	y	ADAMS-OLIVER SYNDROME 1; AOS1	Clinical Features	died|fatal	ARHGAP31	HGNC:29216	Adams-Oliver syndrome 1, 100300 (3), Autosomal dominant	Autosomal dominant	y	y	[Toriello et al. (1988) described cutis marmorata telangiectatica congenita in a child with the Adams-Oliver syndrome. He also had pulmonary hypertension in association with pulmonary vein stenosis and died at age 4 months of cardiopulmonary arrest]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
100800	ACHONDROPLASIA	Achondroplasia, 100800 (3)	Achondroplasia	y	ACHONDROPLASIA; ACH	Clinical Features|Phenotype	death|deaths|died|lethal	FGFR3	HGNC:3690	Achondroplasia, 100800 (3), Autosomal dominant	Autosomal dominant	y	y	[Pauli et al. (1984) focused attention on the risk of sudden unexpected death in infants with achondroplasia. While uncontrolled and retrospective, their study demonstrated an excess of deaths in the first year of life, most or all of which were attributable to abnormalities at the craniocervical junction]	L3	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L2|L3	L2	pre-infant-lethal
101000	SCHWANNOMATOSIS, VESTIBULAR	Schwannomatosis, vestibular, 101000 (3)	Schwannomatosis, vestibular	y	SCHWANNOMATOSIS, VESTIBULAR; SWNV	Clinical Features	death|deaths	NF2	HGNC:7773	Schwannomatosis, vestibular, 101000 (3), Autosomal dominant	Autosomal dominant	y	Y	[The average age at death of affected persons in the second generation was 72, in the third generation 63, in the fourth 42, and in the fifth 28.]	L6	y	-	lethal	lethal	lethal	L6	L6	post-infant-lethal
101200	APERT SYNDROME	Apert syndrome, 101200 (3)	Apert syndrome	y	APERT SYNDROME	Clinical Features	stillborn	FGFR2	HGNC:3689	Apert syndrome, 101200 (3), Autosomal dominant	Autosomal dominant	y	y	[Cohen and Kreiborg (1995) studied 44 pairs of hands and 37 pairs of feet in Apert syndrome, usingclinical, dermatoglyphic, and radiographic methods. They also studied histologic sections of the hand from a 31-week stillborn fetus]	L1	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L1|L2|L3	L1	pre-infant-lethal
101400	SAETHRE-CHOTZEN SYNDROME	Saethre-Chotzen syndrome, 101400 (3)	Saethre-Chotzen syndrome	n	-	-	-	FGFR2	HGNC:3689	Saethre-Chotzen syndrome, 101400 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L1|L2|L3	L1	pre-infant-lethal
101400	SAETHRE-CHOTZEN SYNDROME	Saethre-Chotzen syndrome with or without eyelid anomalies, 101400 (3)	Saethre-Chotzen syndrome with or without eyelid anomalies	n	-	-	-	TWIST1	HGNC:12428	Saethre-Chotzen syndrome with or without eyelid anomalies, 101400 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
101600	PFEIFFER SYNDROME	Pfeiffer syndrome, 101600 (3)	Pfeiffer syndrome	y	PFEIFFER SYNDROME	Description|Clinical Synopsis|Phenotype	demise|death|deaths|died	FGFR1	HGNC:3688	Pfeiffer syndrome, 101600 (3), Autosomal dominant	Autosomal dominant	n	y	[Early demise is characteristic of types 2 and 3 /***Most patients with this form died shortly after birth (in Molecular Genetics field)]	L2	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L2|L3	L2	pre-infant-lethal
101600	PFEIFFER SYNDROME	Craniofacial-skeletal-dermatologic dysplasia, 101600 (3)	Craniofacial-skeletal-dermatologic dysplasia	y	PFEIFFER SYNDROME	Description|Clinical Synopsis|Phenotype	demise|death|deaths|died	FGFR2	HGNC:3689	Craniofacial-skeletal-dermatologic dysplasia, 101600 (3), Autosomal dominant	Autosomal dominant	n	y	[Early demise / died shortly after birth]	L2	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L1|L2|L3	L1	pre-infant-lethal
101600	PFEIFFER SYNDROME	Pfeiffer syndrome, 101600 (3)	Pfeiffer syndrome	y	PFEIFFER SYNDROME	Description|Clinical Synopsis|Phenotype	demise|death|deaths|died	FGFR2	HGNC:3689	Pfeiffer syndrome, 101600 (3), Autosomal dominant	Autosomal dominant	n	y	[Early demise / died shortly after birth]	L2	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L1|L2|L3	L1	pre-infant-lethal
101800	ACRODYSOSTOSIS 1 WITH OR WITHOUT HORMONE RESISTANCE	Acrodysostosis 1, with or without hormone resistance, 101800 (3)	Acrodysostosis 1, with or without hormone resistance	n	-	-	-	PRKAR1A	HGNC:9388	Acrodysostosis 1, with or without hormone resistance, 101800 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L4|L5|LU	L4	post-infant-lethal
101900	ACROKERATOSIS VERRUCIFORMIS	Acrokeratosis verruciformis, 101900 (3)	Acrokeratosis verruciformis	n	-	-	-	ATP2A2	HGNC:812	Acrokeratosis verruciformis, 101900 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
102370	ACROMICRIC DYSPLASIA	Acromicric dysplasia, 102370 (3)	Acromicric dysplasia	y	ACROMICRIC DYSPLASIA; ACMICD	Phenotype	death|deaths	FBN1	HGNC:3603	Acromicric dysplasia, 102370 (3), Autosomal dominant	Autosomal dominant	n	n	-	-	-	-	ambiguous	ambiguous|lethal|nonlethal	lethal|nonlethal	L2|LU	L2	pre-infant-lethal
102500	HAJDU-CHENEY SYNDROME	Hajdu-Cheney syndrome, 102500 (3)	Hajdu-Cheney syndrome	y	HAJDU-CHENEY SYNDROME; HJCYS	Phenotype	died|lethality	NOTCH2	HGNC:7882	Hajdu-Cheney syndrome, 102500 (3), Autosomal dominant	Autosomal dominant	y	n	-	-	-	-	ambiguous	ambiguous|lethal	lethal	L4	L4	post-infant-lethal
102900	ADENOSINE TRIPHOSPHATE, ELEVATED, OF ERYTHROCYTES	Adenosine triphosphate, elevated, of erythrocytes, 102900 (3)	Adenosine triphosphate, elevated, of erythrocytes	n	-	-	-	PKLR	HGNC:9020	Adenosine triphosphate, elevated, of erythrocytes, 102900 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L1	L1	pre-infant-lethal
103050	ADENYLOSUCCINASE DEFICIENCY	Adenylosuccinase deficiency, 103050 (3)	Adenylosuccinase deficiency	y	ADENYLOSUCCINASE DEFICIENCY; ADSLD	Description|Phenotype	fatal	ADSL	HGNC:291	Adenylosuccinase deficiency, 103050 (3), Autosomal recessive	Autosomal recessive	n	y	[There are 3 major phenotypic forms of the disorder that correlate with different values of the S-Ado and SAICAr concentration ratios (S-Ado/SAICAr) in the cerebrospinal fluid. These include the most severe fatal neonatal encephalopathy (S-Ado/SAICAr ratio less than 1) / *** Among 7 unrelated Polish patients with ADSL deficiency, Jurecka et al. (2008) identified 7 biallelic mutations in the ADSL gene, including 5 novel mutations. R426H (608222.0002)was the most common mutation. One patient had a fatal neonatal course (in Molecular Genetics field]	L2	y	-	lethal	lethal	lethal	L2	L2	pre-infant-lethal
103285	ADULT SYNDROME	ADULT syndrome, 103285 (3)	ADULT syndrome	n	-	-	-	TP63	HGNC:15979	ADULT syndrome, 103285 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L2	L2	pre-infant-lethal
103500	TIETZ ALBINISM-DEAFNESS SYNDROME	Tietz albinism-deafness syndrome, 103500 (3)	Tietz albinism-deafness syndrome	n	-	-	-	MITF	HGNC:7105	Tietz albinism-deafness syndrome, 103500 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
103580	PSEUDOHYPOPARATHYROIDISM, TYPE IA	Pseudohypoparathyroidism Ia, 103580 (3)	Pseudohypoparathyroidism Ia	n	-	-	-	GNAS	HGNC:4392	Pseudohypoparathyroidism Ia, 103580 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L3	L3	pre-infant-lethal
103900	HYPERALDOSTERONISM, FAMILIAL, TYPE I	Aldosteronism, glucocorticoid-remediable, 103900 (3)	Aldosteronism, glucocorticoid-remediable	y	HYPERALDOSTERONISM, FAMILIAL, TYPE I; HALD1	Clinical Features	died	CYP11B1	HGNC:2591	Aldosteronism, glucocorticoid-remediable, 103900 (3), Autosomal dominant	Autosomal dominant	n	y	[Of 10 other affected, deceased individuals (7 males and 3 females) from a single family, 6 who died before 60 yearsof age (4 by stroke) were males.]	L6	y	y	lethal	ambiguous|lethal	lethal	L6	L6	post-infant-lethal
104100	PALMOPLANTAR KERATODERMA AND CONGENITAL ALOPECIA 1	Palmoplantar keratoderma with congenital alopecia, 104100 (3)	Palmoplantar keratoderma with congenital alopecia	n	-	-	-	GJA1	HGNC:4274	Palmoplantar keratoderma with congenital alopecia, 104100 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
104200	ALPORT SYNDROME 3A, AUTOSOMAL DOMINANT	Alport syndrome 3A, autosomal dominant, 104200 (3)	Alport syndrome 3A, autosomal dominant	y	ALPORT SYNDROME 3A, AUTOSOMAL DOMINANT; ATS3A	Clinical Features	death|deaths	COL4A3	HGNC:2204	Alport syndrome 3A, autosomal dominant, 104200 (3), Autosomal dominant	Autosomal dominant	y	n	-	-	-	-	ambiguous	ambiguous|nonlethal	ambiguous	-	-	-
104290	ALTERNATING HEMIPLEGIA OF CHILDHOOD 1	Alternating hemiplegia of childhood 1, 104290 (3)	Alternating hemiplegia of childhood 1	n	-	-	-	ATP1A2	HGNC:800	Alternating hemiplegia of childhood 1, 104290 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	ambiguous|nonlethal	ambiguous	-	-	-
104300	ALZHEIMER DISEASE, FAMILIAL, 1	Alzheimer disease 1, familial, 104300 (3)	Alzheimer disease 1, familial	y	ALZHEIMER DISEASE, FAMILIAL, 1; AD1	Clinical Features|Phenotype	death|deaths	APP	HGNC:620	Alzheimer disease 1, familial, 104300 (3), Autosomal dominant	Autosomal dominant	y	y	[Farlow et al. (1994) reviewed the clinical characteristics of the disorder in the AD family reported by Murrell et al. (1991) in which affected members had a mutation in the APP gene (V717F; 104760.0003).The mean age of onset of dementia was 43 years. The earliest cognitive functions affected were recent memory, information-processing speed, sequential tracking, and conceptual reasoning. Language and visuoperceptual skills were largely spared early in the course of the disease. Later, there were progressive cognitive deficits and inability to perform the activities of daily living. Death occurred, on average, 6 years after onse]	L6	y	-	lethal	lethal	lethal	L6	L6	post-infant-lethal
104310	ALZHEIMER DISEASE 2	Alzheimer disease 2, 104310 (3)	Alzheimer disease 2	n	-	-	-	APOE	HGNC:613	Alzheimer disease 2, 104310 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	ambiguous|nonlethal	ambiguous	-	-	-
104500	AMELOGENESIS IMPERFECTA, TYPE IB	Amelogenesis imperfecta, type IB, 104500 (3)	Amelogenesis imperfecta, type IB	n	-	-	-	ENAM	HGNC:3344	Amelogenesis imperfecta, type IB, 104500 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
104510	AMELOGENESIS IMPERFECTA, TYPE IV	Amelogenesis imperfecta, type IV, 104510 (3)	Amelogenesis imperfecta, type IV	n	-	-	-	DLX3	HGNC:2916	Amelogenesis imperfecta, type IV, 104510 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
104530	AMELOGENESIS IMPERFECTA, TYPE IA	Amelogenesis imperfecta, type IA, 104530 (3)	Amelogenesis imperfecta, type IA	n	-	-	-	LAMB3	HGNC:6490	Amelogenesis imperfecta, type IA, 104530 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	ambiguous|lethal|nonlethal	lethal|nonlethal	L2	L2	pre-infant-lethal
105120	AMYLOIDOSIS, FINNISH TYPE	Amyloidosis, Finnish type, 105120 (3)	Amyloidosis, Finnish type	n	-	-	-	GSN	HGNC:4620	Amyloidosis, Finnish type, 105120 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
105150	CEREBRAL AMYLOID ANGIOPATHY, CST3-RELATED	Cerebral amyloid angiopathy, 105150 (3)	Cerebral amyloid angiopathy	y	CEREBRAL AMYLOID ANGIOPATHY, CST3-RELATED	Clinical Features|Clinical Synopsis	died|death|deaths	CST3	HGNC:2475	Cerebral amyloid angiopathy, 105150 (3), Autosomal dominant	Autosomal dominant	y	y	[Onset 3rd to 4th decade of life. Death before age 40]	L6	y	-	lethal	lethal	lethal	L6	L6	post-infant-lethal
105200	AMYLOIDOSIS, FAMILIAL VISCERAL	Amyloidosis, 3 or more types, 105200 (3)	Amyloidosis, 3 or more types	y	AMYLOIDOSIS, FAMILIAL VISCERAL	Clinical Features|Phenotype	death|deaths|died	APOA1	HGNC:600	Amyloidosis, 3 or more types, 105200 (3), Autosomal dominant	Autosomal dominant	y	y	[died of visceral, especially renal, amyloidosis in their 40s]	LU	y	-	lethal	ambiguous|lethal|nonlethal	lethal|nonlethal	LU	LU	post-infant-lethal
105200	AMYLOIDOSIS, FAMILIAL VISCERAL	Amyloidosis, familial visceral, 105200 (3)	Amyloidosis, familial visceral	y	AMYLOIDOSIS, FAMILIAL VISCERAL	Clinical Features|Phenotype	death|deaths|died	FGA	HGNC:3661	Amyloidosis, familial visceral, 105200 (3), Autosomal dominant	Autosomal dominant	y	y	[Systemic amyloidosis is the diagnosis in 2.5% of all renal biopsies, according to Davison (1985), and is the cause of death in more than 1 in 1,500 persons in the United Kingdom annually / In a Peruvian family in which a brother and sister and the son of the brother died from renal amyloidosis, Benson et al. (1993) identified a mutation in the fibrinogen A alpha polypeptide gene (FGA; 134820.0012]	LU	y	-	lethal	ambiguous|lethal	lethal	L2|LU	L2	pre-infant-lethal
105200	AMYLOIDOSIS, FAMILIAL VISCERAL	Amyloidosis, renal, 105200 (3)	Amyloidosis, renal	y	AMYLOIDOSIS, FAMILIAL VISCERAL	Clinical Features|Phenotype	death|deaths|died	LYZ	HGNC:6740	Amyloidosis, renal, 105200 (3), Autosomal dominant	Autosomal dominant	y	y	[died of visceral, especially renal, amyloidosis in their 40s]	LU	y	-	lethal	lethal	lethal	LU	LU	post-infant-lethal
105210	AMYLOIDOSIS, HEREDITARY, TRANSTHYRETIN-RELATED	Amyloidosis, hereditary, transthyretin-related, 105210 (3)	Amyloidosis, hereditary, transthyretin-related	y	AMYLOIDOSIS, HEREDITARY, TRANSTHYRETIN-RELATED	Description|Clinical Features	death|deaths|died	TTR	HGNC:12405	Amyloidosis, hereditary, transthyretin-related, 105210 (3), Autosomal dominant	Autosomal dominant	y	y	[Onset was in the teens or twenties, with death ranging from age 29 to 62 / Age at onset varies greatly; within the ethnically and genetically homogeneous Portuguese population, age at onset was between 17 and 78 in the 1,233 patients examined to 1995 (Hund et al.,2001). Most patients present in the third or fourth decade, but onset of symptoms may be delayed until old age (Benson, 2001). Clinical disease usually progresses over 5 to 15 years and ends with death from cardiac failure, renal failure, or malnutrition. However, in some kindreds heterozygotes with late-onset disease have lived past age 90]	L6	y	-	lethal	ambiguous|lethal	lethal	L6	L6	post-infant-lethal
105250	AMYLOIDOSIS, PRIMARY LOCALIZED CUTANEOUS, 1	Amyloidosis, primary localized cutaneous, 1, 105250 (3)	Amyloidosis, primary localized cutaneous, 1	n	-	-	-	OSMR	HGNC:8507	Amyloidosis, primary localized cutaneous, 1, 105250 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
105400	AMYOTROPHIC LATERAL SCLEROSIS 1	Amyotrophic lateral sclerosis 1, 105400 (3)	Amyotrophic lateral sclerosis 1	y	AMYOTROPHIC LATERAL SCLEROSIS 1; ALS1	Description|Clinical Features|Phenotype	death|deaths|fatal|died	SOD1	HGNC:11179	Amyotrophic lateral sclerosis 1, 105400 (3), Autosomal dominant, Autosomal recessive	Autosomal dominant, Autosomal recessive	y	y	[Powers et al. (1974) reported the first autopsy in a member of the Wetherbee family from Vermont. The patient was a 35-year-old woman who began to experience weakness in the left leg 1 year before her terminal admission / *** reports in other fields]	L6	y	-	lethal	lethal	lethal	L4|L6	L4	post-infant-lethal
105550	FRONTOTEMPORAL DEMENTIA AND/OR AMYOTROPHIC LATERAL SCLEROSIS 1	Frontotemporal dementia and/or amyotrophic lateral sclerosis 1, 105550 (3)	Frontotemporal dementia and/or amyotrophic lateral sclerosis 1	y	FRONTOTEMPORAL DEMENTIA AND/OR AMYOTROPHIC LATERAL SCLEROSIS 1; FTDALS1	Clinical Features	died	C9orf72	HGNC:28337	Frontotemporal dementia and/or amyotrophic lateral sclerosis 1, 105550 (3), Autosomal dominant	Autosomal dominant	y	y	[One female patient presented at age 39 with progressive personality changes and dementia and subsequently developed muscle wasting and fasciculations consistent with ALS. She died of respiratory failure after 31 months, and postmortem examination showed frontal lobe atrophy and shrunken motor neurons]	L6	y	-	lethal	lethal	lethal	L6	L6	post-infant-lethal
105600	ANEMIA, CONGENITAL DYSERYTHROPOIETIC, TYPE IIIa	Anemia, congenital dyserythropoietic, type IIIA, 105600 (3)	Anemia, congenital dyserythropoietic, type IIIA	n	-	-	-	KIF23	HGNC:6392	Anemia, congenital dyserythropoietic, type IIIA, 105600 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
105650	DIAMOND-BLACKFAN ANEMIA 1	Diamond-Blackfan anemia 1, 105650 (3)	Diamond-Blackfan anemia 1	y	DIAMOND-BLACKFAN ANEMIA 1; DBA1	Clinical Features|Diagnosis	died|spontaneous_abortion|spontaneous_abortions	RPS19	HGNC:10402	Diamond-Blackfan anemia 1, 105650 (3), Autosomal dominant	Autosomal dominant	y	y	[Anur et al. (2009) reported a patient with nonclassical Diamond-Blackfan anemia. She presented at age 17 years with progressive pancytopenia and bone marrow hypoplasia diagnosed after nausea and vomiting following outpatient surgery for correction of a flexion contracture of the finger. She became transfusion-dependent and the disorder was steroid-resistant. Erythrocyte adenosine deaminase was increased, consistent with the diagnosis. She underwent bone marrow transplantation, but died of complications]	L5	y	-	lethal	lethal	lethal	L5	L5	post-infant-lethal
105830	ANGELMAN SYNDROME	Angelman syndrome, 105830 (3)	Angelman syndrome	n	-	-	-	UBE3A	HGNC:12496	Angelman syndrome, 105830 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
106100	ANGIOEDEMA, HEREDITARY, 1	Angioedema, hereditary, 1 and 2, 106100 (3)	Angioedema, hereditary, 1 and 2	n	-	-	-	SERPING1	HGNC:1228	Angioedema, hereditary, 1 and 2, 106100 (3), Autosomal dominant, Autosomal recessive	Autosomal dominant, Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
106210	ANIRIDIA 1	Aniridia, 106210 (3)	Aniridia	y	ANIRIDIA 1; AN1	Clinical Features	died	PAX6	HGNC:8620	Aniridia, 106210 (3), Autosomal dominant	Autosomal dominant	n	n	-	-	-	-	ambiguous	ambiguous|lethal|nonlethal	lethal|nonlethal	LU	LU	post-infant-lethal
106210	ANIRIDIA 1	Cataract with late-onset corneal dystrophy, 106210 (3)	Cataract with late-onset corneal dystrophy	y	ANIRIDIA 1; AN1	Clinical Features	died	PAX6	HGNC:8620	Cataract with late-onset corneal dystrophy, 106210 (3), Autosomal dominant	Autosomal dominant	n	n	-	-	-	-	ambiguous	ambiguous|lethal|nonlethal	lethal|nonlethal	LU	LU	post-infant-lethal
106260	ANKYLOBLEPHARON-ECTODERMAL DEFECTS-CLEFT LIP/PALATE	Hay-Wells syndrome, 106260 (3)	Hay-Wells syndrome	n	-	-	-	TP63	HGNC:15979	Hay-Wells syndrome, 106260 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L2	L2	pre-infant-lethal
106600	TOOTH AGENESIS, SELECTIVE, 1	Tooth agenesis, selective, 1, with or without orofacial cleft, 106600 (3)	Tooth agenesis, selective, 1, with or without orofacial cleft	n	-	-	-	MSX1	HGNC:7391	Tooth agenesis, selective, 1, with or without orofacial cleft, 106600 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
107250	ANTERIOR SEGMENT DYSGENESIS 1	Anterior segment dysgenesis 1, multiple subtypes, 107250 (3)	Anterior segment dysgenesis 1, multiple subtypes	n	-	-	-	PITX3	HGNC:9006	Anterior segment dysgenesis 1, multiple subtypes, 107250 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
107480	TOWNES-BROCKS SYNDROME 1	Townes-Brocks branchiootorenal-like syndrome, 107480 (3)	Townes-Brocks branchiootorenal-like syndrome	y	TOWNES-BROCKS SYNDROME 1; TBS1	Clinical Features	died|lethal	SALL1	HGNC:10524	Townes-Brocks branchiootorenal-like syndrome, 107480 (3), Autosomal dominant	Autosomal dominant	y	y	[A severely affected child who died at the age of 3 days from cardiac malformations had bilateral preaxial polydactyly]	L2	y	-	lethal	lethal	lethal	L2	L2	pre-infant-lethal
107480	TOWNES-BROCKS SYNDROME 1	Townes-Brocks syndrome 1, 107480 (3)	Townes-Brocks syndrome 1	y	TOWNES-BROCKS SYNDROME 1; TBS1	Clinical Features	died|lethal	SALL1	HGNC:10524	Townes-Brocks syndrome 1, 107480 (3), Autosomal dominant	Autosomal dominant	y	y	[A severely affected child who died at the age of 3 days from cardiac malformations had bilateral preaxial polydactyly]	L2	y	-	lethal	lethal	lethal	L2	L2	pre-infant-lethal
107970	ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 1	Arrhythmogenic right ventricular dysplasia 1, 107970 (3)	Arrhythmogenic right ventricular dysplasia 1	y	ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 1; ARVD1	Description|Clinical Features|Clinical Synopsis	death|deaths|died	TGFB3	HGNC:11769	Arrhythmogenic right ventricular dysplasia 1, 107970 (3), Autosomal dominant	Autosomal dominant	y	y	[Huhta et al. (2002) discussed the case of a 15-year-old boy with stress-induced arrhythmia and sudden death / Kearney et al. (1995) described 3 sibs with right ventricular dysplasia. A brother died at age 13]	L5	y	y	lethal	lethal	lethal	L5|L6	L5	post-infant-lethal
108120	ARTHROGRYPOSIS, DISTAL, TYPE 1A	Arthrogryposis, distal, type 1A, 108120 (3)	Arthrogryposis, distal, type 1A	y	ARTHROGRYPOSIS, DISTAL, TYPE 1A; DA1A	Description|Clinical Features	lethal|died	TPM2	HGNC:12011	Arthrogryposis, distal, type 1A, 108120 (3), Autosomal dominant	Autosomal dominant	y	y	Ko et al. (2013) reported a Korean mother and daughter with distal arthrogryposis type 2B4. The proband was an infant who at birth showed camptodactyly, overlapping fingers, and adducted thumbs. She had a calcaneovalgus deformity with congenital vertical talus in the right foot and an equinovarus deformity in the left foot. She also displayed subtle facial dysmorphism, including a triangular face, downslanting palpebral fissures, and a small mouth. She had feeding difficulties and died at several months of age, presumably from aspiration pneumonia]	L3	y	-	lethal	lethal	lethal	L3|L6	L3	pre-infant-lethal
108120	ARTHROGRYPOSIS, DISTAL, TYPE 1A	Arthrogryposis, distal, type 2B4, 108120 (3)	Arthrogryposis, distal, type 2B4	y	ARTHROGRYPOSIS, DISTAL, TYPE 1A; DA1A	Description|Clinical Features	lethal|died	TPM2	HGNC:12011	Arthrogryposis, distal, type 2B4, 108120 (3), Autosomal dominant	Autosomal dominant	y	y	Ko et al. (2013) reported a Korean mother and daughter with distal arthrogryposis type 2B4. The proband was an infant who at birth showed camptodactyly, overlapping fingers, and adducted thumbs. She had a calcaneovalgus deformity with congenital vertical talus in the right foot and an equinovarus deformity in the left foot. She also displayed subtle facial dysmorphism, including a triangular face, downslanting palpebral fissures, and a small mouth. She had feeding difficulties and died at several months of age, presumably from aspiration pneumonia]	L3	y	-	lethal	lethal	lethal	L3|L6	L3	pre-infant-lethal
108145	ARTHROGRYPOSIS, DISTAL, TYPE 5	Arthrogryposis, distal, type 5, 108145 (3)	Arthrogryposis, distal, type 5	y	ARTHROGRYPOSIS, DISTAL, TYPE 5; DA5	Clinical Features	died	PIEZO2	HGNC:26270	Arthrogryposis, distal, type 5, 108145 (3), Autosomal dominant	Autosomal dominant	y	n	-	-	-	-	ambiguous	ambiguous|nonlethal	ambiguous	-	-	-
108300	STICKLER SYNDROME, TYPE I	Stickler syndrome, type I, 108300 (3)	Stickler syndrome, type I	y	STICKLER SYNDROME, TYPE I; STL1	Clinical Features	died	COL2A1	HGNC:2200	Stickler syndrome, type I, 108300 (3), Autosomal dominant	Autosomal dominant	y	y	[Hall (1974) described a family in which 1 infant had died of Pierre Robin anomaly]	L3	y	-	lethal	ambiguous|lethal|nonlethal	lethal|nonlethal	L1|L2|L3	L1	pre-infant-lethal
108420	SPERMATOGENIC FAILURE 2	Spermatogenic failure 2, 108420 (3)	Spermatogenic failure 2	n	-	-	-	MSH4	HGNC:7327	Spermatogenic failure 2, 108420 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	ambiguous|nonlethal	ambiguous	-	-	-
108500	EPISODIC ATAXIA, TYPE 2	Episodic ataxia, type 2, 108500 (3)	Episodic ataxia, type 2	y	EPISODIC ATAXIA, TYPE 2; EA2	Clinical Features	died	CACNA1A	HGNC:1388	Episodic ataxia, type 2, 108500 (3), Autosomal dominant	Autosomal dominant	y	y	[He was blind and bedridden with developmental delay, marked muscular atrophy, and rigidity. An older sister had died at age 5 with a similar phenotype.]	L4	n	y	lethal	lethal|nonlethal	lethal|nonlethal	L4|L6	L4	post-infant-lethal
108600	SPASTIC ATAXIA 1, AUTOSOMAL DOMINANT	Spastic ataxia 1, autosomal dominant, 108600 (3)	Spastic ataxia 1, autosomal dominant	n	-	-	-	VAMP1	HGNC:12642	Spastic ataxia 1, autosomal dominant, 108600 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L5	L5	post-infant-lethal
108720	ATELOSTEOGENESIS, TYPE I	Atelosteogenesis, type I, 108720 (3)	Atelosteogenesis, type I	y	ATELOSTEOGENESIS, TYPE I; AO1	Description|Clinical Features|Clinical Synopsis|Phenotype	lethal|die|died|stillborn|death|deaths	FLNB	HGNC:3755	Atelosteogenesis, type I, 108720 (3), Autosomal dominant	Autosomal dominant	y	y	[Maroteaux et al. (1982) pointed to a case reported by Kozlowski et al. (1981). Clubfoot and elbow or knee subluxation may be present. Cleft palate has been observed. The patients are stillborn or die very early of respiratory distress]	L1	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L1|L2|LU	L1	pre-infant-lethal
108721	ATELOSTEOGENESIS, TYPE III	Atelosteogenesis, type III, 108721 (3)	Atelosteogenesis, type III	y	ATELOSTEOGENESIS, TYPE III; AO3	Description	death|deaths	FLNB	HGNC:3755	Atelosteogenesis, type III, 108721 (3), Autosomal dominant	Autosomal dominant	y	y	[Infants with AO3 often have respiratory and feeding difficulties, and respiratory complications and cervical spine instability are the apparent causes of death in reported cases (summary by Schultz et al., 1999)]	LU	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L1|L2|LU	L1	pre-infant-lethal
108770	ATRIAL STANDSTILL 1	Atrial standstill, digenic (GJA5/SCN5A), 108770 (3)	Atrial standstill, digenic (GJA5/SCN5A)	y	ATRIAL STANDSTILL 1; ATRST1	Clinical Features	died	GJA5	HGNC:4279	Atrial standstill, digenic (GJA5/SCN5A), 108770 (3), Autosomal dominant	Autosomal dominant	y	y	Makita et al. (2005) studied a Japanese boy who at 3 years of age presented with severe bradycardia and was diagnosed with sick sinus syndrome (see SSS1, 608567) with paroxysmal atrial fibrillation based on Holter ECG recording... Family history revealed that 2 of the paternal grandfather's sibs died suddenly in the first decade of life]	L4	n	y	lethal	lethal|nonlethal	lethal|nonlethal	L4	L4	post-infant-lethal
108900	ATRIAL SEPTAL DEFECT 7 WITH OR WITHOUT ATRIOVENTRICULAR CONDUCTION DEFECTS	Atrial septal defect 7, with or without AV conduction defects, 108900 (3)	Atrial septal defect 7, with or without AV conduction defects	y	ATRIAL SEPTAL DEFECT 7 WITH OR WITHOUT ATRIOVENTRICULAR CONDUCTION DEFECTS; ASD7	Phenotype	died	NKX2-5	HGNC:2488	Atrial septal defect 7, with or without AV conduction defects, 108900 (3), Autosomal dominant	Autosomal dominant	y	n	-	-	-	-	ambiguous	ambiguous|lethal|nonlethal	lethal|nonlethal	LU	LU	post-infant-lethal
108985	SVEINSSON CHORIORETINAL ATROPHY	Sveinsson chorioretinal atrophy, 108985 (3)	Sveinsson chorioretinal atrophy	n	-	-	-	TEAD1	HGNC:11714	Sveinsson chorioretinal atrophy, 108985 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
109150	MACHADO-JOSEPH DISEASE	Machado-Joseph disease, 109150 (3)	Machado-Joseph disease	y	MACHADO-JOSEPH DISEASE; MJD	Clinical Features	died	ATXN3	HGNC:7106	Machado-Joseph disease, 109150 (3), Autosomal dominant	Autosomal dominant	y	y	[Coutinho et al. (1982) described the presumedly homozygotic son of 2 affected parents; the son had onset at age 8 and died of the disease at age 15]	L5	y	-	lethal	lethal	lethal	L5	L5	post-infant-lethal
109400	BASAL CELL NEVUS SYNDROME 1	Basal cell nevus syndrome 1, 109400 (3)	Basal cell nevus syndrome 1	n	-	-	-	PTCH1	HGNC:9585	Basal cell nevus syndrome 1, 109400 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	ambiguous|nonlethal	ambiguous	-	-	-
109730	AORTIC VALVE DISEASE 1	Aortic valve disease 1, 109730 (3)	Aortic valve disease 1	y	AORTIC VALVE DISEASE 1; AOVD1	Clinical Features	death|deaths	NOTCH1	HGNC:7881	Aortic valve disease 1, 109730 (3), Autosomal dominant	Autosomal dominant	y	y	[Over a 30-year period, Roberts and Roberts (1991) studied 186 patients with aortic dissection at autopsy. Fourteen (7.5%) patients showed a bicuspid aortic valve and 2 (1.1%) showed a unicuspid valve. Among the 16 patients with aortic dissection and congenitally malformed valve, the age at death ranged from 17 to 82 years]	L5	y	-	lethal	lethal	lethal	L4|L5	L4	post-infant-lethal
110100	BLEPHAROPHIMOSIS, PTOSIS, AND EPICANTHUS INVERSUS	Blepharophimosis, epicanthus inversus, and ptosis, type 1, 110100 (3)	Blepharophimosis, epicanthus inversus, and ptosis, type 1	n	-	-	-	FOXL2	HGNC:1092	Blepharophimosis, epicanthus inversus, and ptosis, type 1, 110100 (3), Autosomal dominant, Autosomal recessive	Autosomal dominant, Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
110100	BLEPHAROPHIMOSIS, PTOSIS, AND EPICANTHUS INVERSUS	Blepharophimosis, epicanthus inversus, and ptosis, type 2, 110100 (3)	Blepharophimosis, epicanthus inversus, and ptosis, type 2	n	-	-	-	FOXL2	HGNC:1092	Blepharophimosis, epicanthus inversus, and ptosis, type 2, 110100 (3), Autosomal dominant, Autosomal recessive	Autosomal dominant, Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
110800	BLOOD GROUP, I SYSTEM	Adult i phenotype without cataract, 110800 (3)	Adult i phenotype without cataract	n	-	-	-	GCNT2	HGNC:4204	Adult i phenotype without cataract, 110800 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
111150	BLOOD GROUP--LUTHERAN INHIBITOR	Blood group--Lutheran inhibitor, 111150 (3)	Blood group--Lutheran inhibitor	n	-	-	-	KLF1	HGNC:6345	Blood group--Lutheran inhibitor, 111150 (3)	-	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
111400	BLOOD GROUP, P1PK SYSTEM	NOR polyagglutination syndrome, 111400 (3)	NOR polyagglutination syndrome	y	BLOOD GROUP, P1PK SYSTEM	Clinical Features	spontaneous_abortion|spontaneous_abortions	A4GALT	HGNC:18149	NOR polyagglutination syndrome, 111400 (3)	-	y	n	-	-	-	-	ambiguous	ambiguous	ambiguous	-	-	-
112240	COLE-CARPENTER SYNDROME 1	Cole-Carpenter syndrome 1, 112240 (3)	Cole-Carpenter syndrome 1	n	-	-	-	P4HB	HGNC:8548	Cole-Carpenter syndrome 1, 112240 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
112250	DIAPHYSEAL MEDULLARY STENOSIS WITH MALIGNANT FIBROUS HISTIOCYTOMA	Diaphyseal medullary stenosis with malignant fibrous histiocytoma, 112250 (3)	Diaphyseal medullary stenosis with malignant fibrous histiocytoma	y	DIAPHYSEAL MEDULLARY STENOSIS WITH MALIGNANT FIBROUS HISTIOCYTOMA; DMSMFH	Clinical Features	death|deaths|died	MTAP	HGNC:7413	Diaphyseal medullary stenosis with malignant fibrous histiocytoma, 112250 (3), Autosomal dominant	Autosomal dominant	y	y	[Death had occurred from widespread metastases at ages varying from 23 to 48 years]	L6	y	-	lethal	lethal	lethal	L6	L6	post-infant-lethal
112310	BOOMERANG DYSPLASIA	Boomerang dysplasia, 112310 (3)	Boomerang dysplasia	y	BOOMERANG DYSPLASIA; BOOMD	Description|Clinical Features|Clinical Synopsis	lethal|died|death|deaths	FLNB	HGNC:3755	Boomerang dysplasia, 112310 (3), Autosomal dominant	Autosomal dominant	y	y	[Neonatal death]	L2	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L1|L2|LU	L1	pre-infant-lethal
112410	HYPERTENSION AND BRACHYDACTYLY SYNDROME	Hypertension and brachydactyly syndrome, 112410 (3)	Hypertension and brachydactyly syndrome	y	HYPERTENSION AND BRACHYDACTYLY SYNDROME; HTNB	Description|Clinical Synopsis	death|deaths	PDE3A	HGNC:8778	Hypertension and brachydactyly syndrome, 112410 (3), Autosomal dominant	Autosomal dominant	y	y	[The hypertension and brachydactyly syndrome is characterized by brachydactyly type E, severe salt-independent but age-dependent hypertension, an increased fibroblast growth rate, neurovascular contact at the rostral-ventrolateral medulla, altered baroreflex blood pressure regulation, and death from stroke before age 50 years when untreated]	L6	y	-	lethal	lethal	lethal	L6	L6	post-infant-lethal
112500	BRACHYDACTYLY, TYPE A1	Brachydactyly, type A1, 112500 (3)	Brachydactyly, type A1	n	-	-	-	IHH	HGNC:5956	Brachydactyly, type A1, 112500 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
112600	BRACHYDACTYLY, TYPE A2	Brachydactyly, type A2, 112600 (3)	Brachydactyly, type A2	n	-	-	-	BMP2	HGNC:1069	Brachydactyly, type A2, 112600 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
112600	BRACHYDACTYLY, TYPE A2	Brachydactyly, type A2, 112600 (3)	Brachydactyly, type A2	n	-	-	-	BMPR1B	HGNC:1077	Brachydactyly, type A2, 112600 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
112600	BRACHYDACTYLY, TYPE A2	Brachydactyly, type A2, 112600 (3)	Brachydactyly, type A2	n	-	-	-	GDF5	HGNC:4220	Brachydactyly, type A2, 112600 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L1	L1	pre-infant-lethal
113000	BRACHYDACTYLY, TYPE B1	Brachydactyly, type B1, 113000 (3)	Brachydactyly, type B1	n	-	-	-	ROR2	HGNC:10257	Brachydactyly, type B1, 113000 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	ambiguous|nonlethal	ambiguous	-	-	-
113100	BRACHYDACTYLY, TYPE C	Brachydactyly, type C, 113100 (3)	Brachydactyly, type C	n	-	-	-	GDF5	HGNC:4220	Brachydactyly, type C, 113100 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L1	L1	pre-infant-lethal
113200	BRACHYDACTYLY, TYPE D	Brachydactyly, type D, 113200 (3)	Brachydactyly, type D	n	-	-	-	HOXD13	HGNC:5136	Brachydactyly, type D, 113200 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
113300	BRACHYDACTYLY, TYPE E1	Brachydactyly, type E, 113300 (3)	Brachydactyly, type E	n	-	-	-	HOXD13	HGNC:5136	Brachydactyly, type E, 113300 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
113500	BRACHYOLMIA TYPE 3	Brachyolmia type 3, 113500 (3)	Brachyolmia type 3	n	-	-	-	TRPV4	HGNC:18083	Brachyolmia type 3, 113500 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	ambiguous|lethal|nonlethal	lethal|nonlethal	L1	L1	pre-infant-lethal
113620	BRANCHIOOCULOFACIAL SYNDROME	Branchiooculofacial syndrome, 113620 (3)	Branchiooculofacial syndrome	y	BRANCHIOOCULOFACIAL SYNDROME; BOFS	Clinical Features	died	TFAP2A	HGNC:11742	Branchiooculofacial syndrome, 113620 (3), Autosomal dominant	Autosomal dominant	y	y	[The proband's brother, who was not sequenced, died at 6 hours of life. He had multiple congenital anomalies including contractures of the hands, large low-set ears, left anophthalmia, and left-sided cleft lip]	L2	n	y	lethal	lethal	lethal	L2	L2	pre-infant-lethal
113650	BRANCHIOOTORENAL SYNDROME 1	Branchiootorenal syndrome 1, with or without cataracts, 113650 (3)	Branchiootorenal syndrome 1, with or without cataracts	y	BRANCHIOOTORENAL SYNDROME 1; BOR1	Clinical Features	died	EYA1	HGNC:3519	Branchiootorenal syndrome 1, with or without cataracts, 113650 (3), Autosomal dominant	Autosomal dominant	n	y	[Chitayat et al. (1992) made the diagnosis of BOR syndrome in a woman who had had 2 pregnancies complicated by oligohydramnios due to renal hypoplasia and agenesis. Both babies died neonatally of pulmonary hypoplasia]	L2	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L2	L2	pre-infant-lethal
113750	ALBINISM, OCULOCUTANEOUS, TYPE VI	Albinism, oculocutaneous, type VI, 113750 (3)	Albinism, oculocutaneous, type VI	n	-	-	-	SLC24A5	HGNC:20611	Albinism, oculocutaneous, type VI, 113750 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
113800	EPIDERMOLYTIC HYPERKERATOSIS 1	Epidermolytic hyperkeratosis 1, 113800 (3)	Epidermolytic hyperkeratosis 1	y	EPIDERMOLYTIC HYPERKERATOSIS 1; EHK1	Clinical Features|Diagnosis	death|deaths|died	KRT1	HGNC:6412	Epidermolytic hyperkeratosis 1, 113800 (3), Autosomal dominant, Autosomal recessive	Autosomal dominant, Autosomal recessive	y	y	[died at 6 days of age]	L2	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L2	L2	pre-infant-lethal
113900	PROGRESSIVE FAMILIAL HEART BLOCK, TYPE IA	Heart block, nonprogressive, 113900 (3)	Heart block, nonprogressive	y	PROGRESSIVE FAMILIAL HEART BLOCK, TYPE IA; PFHB1A	Description|Clinical Features|Clinical Synopsis	death|deaths|died	SCN5A	HGNC:10593	Heart block, nonprogressive, 113900 (3), Autosomal dominant	Autosomal dominant	n	y	[Sudden death / Husson et al. (1973) reported a family in which a girl had complete heart block at age 2 years and died at age 10 with ventricular fibrillation]	L4	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L4|L5|L6|LU	L4	post-infant-lethal
113900	PROGRESSIVE FAMILIAL HEART BLOCK, TYPE IA	Heart block, progressive, type IA, 113900 (3)	Heart block, progressive, type IA	y	PROGRESSIVE FAMILIAL HEART BLOCK, TYPE IA; PFHB1A	Description|Clinical Features|Clinical Synopsis	death|deaths|died	SCN5A	HGNC:10593	Heart block, progressive, type IA, 113900 (3), Autosomal dominant	Autosomal dominant	n	y	[Sudden death / Husson et al. (1973) reported a family in which a girl had complete heart block at age 2 years and died at age 10 with ventricular fibrillation]	L4	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L4|L5|L6|LU	L4	post-infant-lethal
114000	CAFFEY DISEASE	Caffey disease, 114000 (3)	Caffey disease	y	CAFFEY DISEASE; CAFYD	Clinical Features	death|deaths|lethal	COL1A1	HGNC:2197	Caffey disease, 114000 (3), Autosomal dominant	Autosomal dominant	y	y	[Perinatal death in 2 sibs with Caffey disease was described by de Jong and Muller (1995)]	L2	y	-	lethal	ambiguous|lethal|nonlethal	lethal|nonlethal	L2|L5|LU	L2	pre-infant-lethal
114290	CAMPOMELIC DYSPLASIA	Acampomelic campomelic dysplasia, 114290 (3)	Acampomelic campomelic dysplasia	y	CAMPOMELIC DYSPLASIA; CMPD	Description|Clinical Features|Clinical Synopsis|Phenotype	lethal|death|deaths|die|died	SOX9	HGNC:11204	Acampomelic campomelic dysplasia, 114290 (3), Autosomal dominant	Autosomal dominant	y	y	[CMPD is often lethal in the first year of life / Smyk et al. (2007) reported 2 sisters with campomelic dysplasia who died within the first days of life]	L2	y	-	lethal	lethal	lethal	L2	L2	pre-infant-lethal
114290	CAMPOMELIC DYSPLASIA	Campomelic dysplasia with autosomal sex reversal, 114290 (3)	Campomelic dysplasia with autosomal sex reversal	y	CAMPOMELIC DYSPLASIA; CMPD	Description|Clinical Features|Clinical Synopsis|Phenotype	lethal|death|deaths|die|died	SOX9	HGNC:11204	Campomelic dysplasia with autosomal sex reversal, 114290 (3), Autosomal dominant	Autosomal dominant	y	y	[CMPD is often lethal in the first year of life / Smyk et al. (2007) reported 2 sisters with campomelic dysplasia who died within the first days of life]	L2	y	-	lethal	lethal	lethal	L2	L2	pre-infant-lethal
114290	CAMPOMELIC DYSPLASIA	Campomelic dysplasia, 114290 (3)	Campomelic dysplasia	y	CAMPOMELIC DYSPLASIA; CMPD	Description|Clinical Features|Clinical Synopsis|Phenotype	lethal|death|deaths|die|died	SOX9	HGNC:11204	Campomelic dysplasia, 114290 (3), Autosomal dominant	Autosomal dominant	y	y	[CMPD is often lethal in the first year of life / Smyk et al. (2007) reported 2 sisters with campomelic dysplasia who died within the first days of life]	L2	y	-	lethal	lethal	lethal	L2	L2	pre-infant-lethal
114300	ARTHROGRYPOSIS, DISTAL, TYPE 3	Arthrogryposis, distal, type 3, 114300 (3)	Arthrogryposis, distal, type 3	n	-	-	-	PIEZO2	HGNC:26270	Arthrogryposis, distal, type 3, 114300 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	ambiguous|nonlethal	ambiguous	-	-	-
115000	VENTRICULAR ARRHYTHMIAS DUE TO CARDIAC RYANODINE RECEPTOR CALCIUM RELEASE DEFICIENCY SYNDROME	Ventricular arrhythmias due to cardiac ryanodine receptor calcium release deficiency syndrome, 115000 (3)	Ventricular arrhythmias due to cardiac ryanodine receptor calcium release deficiency syndrome	y	VENTRICULAR ARRHYTHMIAS DUE TO CARDIAC RYANODINE RECEPTOR CALCIUM RELEASE DEFICIENCY SYNDROME; VACRDS	Description|Clinical Features|Clinical Synopsis|Phenotype	death|deaths|lethal	RYR2	HGNC:10484	Ventricular arrhythmias due to cardiac ryanodine receptor calcium release deficiency syndrome, 115000 (3), Autosomal dominant	Autosomal dominant	y	y	[Sun et al. (2021) reported 17 patients from 6 families with life-threatening ventricular arrhythmias and/or sudden cardiac death (SCD) who had mutations in the RYR2 gene]	LU	y	-	lethal	lethal	lethal	L4|LU	L4	post-infant-lethal
115150	CARDIOFACIOCUTANEOUS SYNDROME 1	Cardiofaciocutaneous syndrome, 115150 (3)	Cardiofaciocutaneous syndrome	y	CARDIOFACIOCUTANEOUS SYNDROME 1; CFC1	Clinical Features	died	BRAF	HGNC:1097	Cardiofaciocutaneous syndrome, 115150 (3), Autosomal dominant	Autosomal dominant	y	y	[Chrzanowska et al. (1989) described an affected girl whose twin brother died shortly after birth and may have had the same malformation syndrome]	L2	n	y	lethal	lethal|nonlethal	lethal|nonlethal	L2	L2	pre-infant-lethal
115195	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 2	Cardiomyopathy, hypertrophic, 2, 115195 (3)	Cardiomyopathy, hypertrophic, 2	y	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 2; CMH2	Clinical Features|Phenotype	died|death|deaths	TNNT2	HGNC:11949	Cardiomyopathy, hypertrophic, 2, 115195 (3), Autosomal dominant	Autosomal dominant	y	y	[A postmortem specimen from 1 individual, who died suddenly at age 15 years, demonstrated left ventricular hypertrophy and myocyte disarray]	L5	y	-	lethal	ambiguous|lethal	lethal	L3|L5	L3	pre-infant-lethal
115196	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 3	Cardiomyopathy, hypertrophic, 3, 115196 (3)	Cardiomyopathy, hypertrophic, 3	y	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 3; CMH3	Phenotype	death|deaths	TPM1	HGNC:12010	Cardiomyopathy, hypertrophic, 3, 115196 (3), Autosomal dominant	Autosomal dominant	y	y	[high incidence of sudden death]	LU	-	-	lethal	lethal	lethal	L4|LU	L4	post-infant-lethal
115197	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 4	Cardiomyopathy, hypertrophic, 4, 115197 (3)	Cardiomyopathy, hypertrophic, 4	y	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 4; CMH4	Clinical Features|Clinical Synopsis|Phenotype	death|deaths|died|fatal	MYBPC3	HGNC:7551	Cardiomyopathy, hypertrophic, 4, 115197 (3), Autosomal dominant, Autosomal recessive	Autosomal dominant, Autosomal recessive	n	y	[Sudden death may occur, particularly during vigorous exercise / Homozygotes are more severely affected, with death in the neonatal period]	L2	y	-	lethal	lethal	lethal	L2|LU	L2	pre-infant-lethal
115200	CARDIOMYOPATHY, DILATED, 1A	Cardiomyopathy, dilated, 1A, 115200 (3)	Cardiomyopathy, dilated, 1A	y	CARDIOMYOPATHY, DILATED, 1A; CMD1A	Clinical Features|Phenotype	death|deaths|died|fatal|lethal	LMNA	HGNC:6636	Cardiomyopathy, dilated, 1A, 115200 (3), Autosomal dominant	Autosomal dominant	y	y	[MacLennan et al. (1987) described 8 affected individuals, 4 of whom were males in 3 generations. Average age at presentation was 39.5 years. Average time to death from onset of symptoms suggestive of cardiomyopathy in 6 affected members was 16 months / Schrader et al. (1961) described 2 sisters with familial idiopathic cardiomegaly. Almost certainly the mother, who died at age 34, and probably 1 brother, who died at age 16, had the same condition]	L6	y	y	lethal	ambiguous|lethal|nonlethal	lethal|nonlethal	L1|L2|L6	L1	pre-infant-lethal
115210	CARDIOMYOPATHY, FAMILIAL RESTRICTIVE, 1	Cardiomyopathy, familial restrictive, 1, 115210 (3)	Cardiomyopathy, familial restrictive, 1	y	CARDIOMYOPATHY, FAMILIAL RESTRICTIVE, 1; RCM1	Clinical Features|Clinical Synopsis	died|death|deaths	TNNI3	HGNC:11947	Cardiomyopathy, familial restrictive, 1, 115210 (3), Autosomal dominant	Autosomal dominant	y	y	[Chen et al. (2001) reviewed the clinical spectrum of restrictive cardiomyopathy in 14 children, 7 of whom had familial cardiomyopathy. The patients were diagnosed from age 4 months to 17.3 years ... The clinical course was variable, although the majority of patients deteriorated rapidly: 5 patients died 1 week to 1.3 years after presentation]	L3	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L3|LU	L3	pre-infant-lethal
115310	PHEOCHROMOCYTOMA/PARAGANGLIOMA SYNDROME 4	Pheochromocytoma/paraganglioma syndrome 4, 115310 (3)	Pheochromocytoma/paraganglioma syndrome 4	y	PHEOCHROMOCYTOMA/PARAGANGLIOMA SYNDROME 4; PPGL4	Clinical Features	died	SDHB	HGNC:10681	Pheochromocytoma/paraganglioma syndrome 4, 115310 (3), Autosomal dominant	Autosomal dominant	y	y	[In the 2 previous generations, pheochromocytoma was suspected in 3 persons, including a hypertensive girl who died suddenly at age 16 years.]	L5	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L3|L5	L3	pre-infant-lethal
115430	CARPAL TUNNEL SYNDROME 1	Carpal tunnel syndrome, familial, 115430 (3)	Carpal tunnel syndrome, familial	y	CARPAL TUNNEL SYNDROME 1; CTS1	Clinical Features|Phenotype	died|lethal|miscarriage|miscarriages	TTR	HGNC:12405	Carpal tunnel syndrome, familial, 115430 (3), Autosomal dominant	Autosomal dominant	y	n	-	-	-	-	ambiguous	ambiguous|lethal	lethal	L6	L6	post-infant-lethal
115700	CATARACT 4, MULTIPLE TYPES	Cataract 4, multiple types, 115700 (3)	Cataract 4, multiple types	n	-	-	-	CRYGD	HGNC:2411	Cataract 4, multiple types, 115700 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
116100	CATARACT 20, MULTIPLE TYPES	Cataract 20, multiple types, 116100 (3)	Cataract 20, multiple types	n	-	-	-	CRYGS	HGNC:2417	Cataract 20, multiple types, 116100 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
116200	CATARACT 1, MULTIPLE TYPES	Cataract 1, multiple types, 116200 (3)	Cataract 1, multiple types	n	-	-	-	GJA8	HGNC:4281	Cataract 1, multiple types, 116200 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
116300	CATARACT 30, MULTIPLE TYPES	Cataract 30, pulverulent, 116300 (3)	Cataract 30, pulverulent	n	-	-	-	VIM	HGNC:12692	Cataract 30, pulverulent, 116300 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
116600	CATARACT 6, MULTIPLE TYPES	Cataract 6, multiple types, 116600 (3)	Cataract 6, multiple types	n	-	-	-	EPHA2	HGNC:3386	Cataract 6, multiple types, 116600 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
116700	CATARACT 13 WITH ADULT i PHENOTYPE	Cataract 13 with adult i phenotype, 116700 (3)	Cataract 13 with adult i phenotype	n	-	-	-	GCNT2	HGNC:4204	Cataract 13 with adult i phenotype, 116700 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
116800	CATARACT 5, MULTIPLE TYPES	Cataract 5, multiple types, 116800 (3)	Cataract 5, multiple types	n	-	-	-	HSF4	HGNC:5227	Cataract 5, multiple types, 116800 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
116860	CEREBRAL CAVERNOUS MALFORMATIONS	Cavernous malformations of CNS and retina, 116860 (3)	Cavernous malformations of CNS and retina	y	CEREBRAL CAVERNOUS MALFORMATIONS; CCM	Clinical Features	death|deaths|died	KRIT1	HGNC:1573	Cavernous malformations of CNS and retina, 116860 (3), Autosomal dominant	Autosomal dominant	y	y	[Bicknell (1989) described cavernous angioma of the brainstem in a 23-year-old Hispanic woman whose mother had died of brain hemorrhage]	L6	y	-	lethal	lethal	lethal	L6	L6	post-infant-lethal
116860	CEREBRAL CAVERNOUS MALFORMATIONS	Cerebral cavernous malformations-1, 116860 (3)	Cerebral cavernous malformations-1	y	CEREBRAL CAVERNOUS MALFORMATIONS; CCM	Clinical Features	death|deaths|died	KRIT1	HGNC:1573	Cerebral cavernous malformations-1, 116860 (3), Autosomal dominant	Autosomal dominant	y	y	[Bicknell (1989) described cavernous angioma of the brainstem in a 23-year-old Hispanic woman whose mother had died of brain hemorrhage]	L6	y	-	lethal	lethal	lethal	L6	L6	post-infant-lethal
116860	CEREBRAL CAVERNOUS MALFORMATIONS	Hyperkeratotic cutaneous capillary-venous malformations associated with cerebral capillary malformations, 116860 (3)	Hyperkeratotic cutaneous capillary-venous malformations associated with cerebral capillary malformations	y	CEREBRAL CAVERNOUS MALFORMATIONS; CCM	Clinical Features	death|deaths|died	KRIT1	HGNC:1573	Hyperkeratotic cutaneous capillary-venous malformations associated with cerebral capillary malformations, 116860 (3), Autosomal dominant	Autosomal dominant	y	y	[Bicknell (1989) described cavernous angioma of the brainstem in a 23-year-old Hispanic woman whose mother had died of brain hemorrhage]	L6	y	-	lethal	lethal	lethal	L6	L6	post-infant-lethal
116920	LEUKOCYTE ADHESION DEFICIENCY, TYPE I	Leukocyte adhesion deficiency, 116920 (3)	Leukocyte adhesion deficiency	n	-	-	-	ITGB2	HGNC:6155	Leukocyte adhesion deficiency, 116920 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
117000	CONGENITAL MYOPATHY 1A, AUTOSOMAL DOMINANT, WITH SUSCEPTIBILITY TO MALIGNANT HYPERTHERMIA	Congenital myopathy 1A, autosomal dominant, with susceptibility to malignant hyperthermia, 117000 (3)	Congenital myopathy 1A, autosomal dominant, with susceptibility to malignant hyperthermia	n	-	-	-	RYR1	HGNC:10483	Congenital myopathy 1A, autosomal dominant, with susceptibility to malignant hyperthermia, 117000 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L1|LU	L1	pre-infant-lethal
117210	SPINOCEREBELLAR ATAXIA 31	Spinocerebellar ataxia 31, 117210 (3)	Spinocerebellar ataxia 31	n	-	-	-	BEAN1	HGNC:24160	Spinocerebellar ataxia 31, 117210 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
117300	CEREBRAL AMYLOID ANGIOPATHY, ITM2B-RELATED, 2	Dementia, familial Danish, 117300 (3)	Dementia, familial Danish	y	CEREBRAL AMYLOID ANGIOPATHY, ITM2B-RELATED, 2	Description|Clinical Features	die	ITM2B	HGNC:6174	Dementia, familial Danish, 117300 (3), Autosomal dominant	Autosomal dominant	y	y	[Most patients die in their fifth to sixth decade of life]	L6	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L6	L6	post-infant-lethal
117360	SPINOCEREBELLAR ATAXIA 29	Spinocerebellar ataxia 29, congenital nonprogressive, 117360 (3)	Spinocerebellar ataxia 29, congenital nonprogressive	n	-	-	-	ITPR1	HGNC:6180	Spinocerebellar ataxia 29, congenital nonprogressive, 117360 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
117550	SOTOS SYNDROME	Sotos syndrome, 117550 (3)	Sotos syndrome	n	-	-	-	NSD1	HGNC:14234	Sotos syndrome, 117550 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
117650	CEREBROCOSTOMANDIBULAR SYNDROME	Cerebrocostomandibular syndrome, 117650 (3)	Cerebrocostomandibular syndrome	y	CEREBROCOSTOMANDIBULAR SYNDROME; CCMS	Clinical Features|Clinical Synopsis	died|die	SNRPB	HGNC:11153	Cerebrocostomandibular syndrome, 117650 (3), Autosomal dominant	Autosomal dominant	y	y	[Forty percent of patients die in the first year / Plotz et al. (1996) described 2 more sporadic cases of this syndrome in males, one of whom died at 12 hours, and the other at 10 months]	L2	y	-	lethal	lethal	lethal	L2	L2	pre-infant-lethal
118100	KLIPPEL-FEIL SYNDROME 1, AUTOSOMAL DOMINANT	Klippel-Feil syndrome 1, autosomal dominant, 118100 (3)	Klippel-Feil syndrome 1, autosomal dominant	n	-	-	-	GDF6	HGNC:4221	Klippel-Feil syndrome 1, autosomal dominant, 118100 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
118200	CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 1B	Charcot-Marie-Tooth disease, type 1B, 118200 (3)	Charcot-Marie-Tooth disease, type 1B	y	CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 1B; CMT1B	Clinical Features	died	MPZ	HGNC:7225	Charcot-Marie-Tooth disease, type 1B, 118200 (3), Autosomal dominant	Autosomal dominant	y	y	[Alajouanine et al. (1967) reported the phenomenal case of a woman who was a patient in La Salpetriere, Paris, for 64 years. The diagnosis was made by Charcot in 1891. She died at age 80 years]	L6	y	-	lethal	ambiguous|lethal|nonlethal	lethal|nonlethal	L6	L6	post-infant-lethal
118210	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2A1	Charcot-Marie-Tooth disease, type 2A1, 118210 (3)	Charcot-Marie-Tooth disease, type 2A1	n	-	-	-	KIF1B	HGNC:16636	Charcot-Marie-Tooth disease, type 2A1, 118210 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
118220	CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 1A	Charcot-Marie-Tooth disease, type 1A, 118220 (3)	Charcot-Marie-Tooth disease, type 1A	n	-	-	-	PMP22	HGNC:9118	Charcot-Marie-Tooth disease, type 1A, 118220 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	ambiguous|nonlethal	ambiguous	-	-	-
118300	CHARCOT-MARIE-TOOTH DISEASE AND DEAFNESS	Charcot-Marie-Tooth disease, type 1E, 118300 (3)	Charcot-Marie-Tooth disease, type 1E	n	-	-	-	PMP22	HGNC:9118	Charcot-Marie-Tooth disease, type 1E, 118300 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	ambiguous|nonlethal	ambiguous	-	-	-
118400	CHERUBISM	Cherubism, 118400 (3)	Cherubism	n	-	-	-	SH3BP2	HGNC:10825	Cherubism, 118400 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
118450	ALAGILLE SYNDROME 1	Alagille syndrome 1, 118450 (3)	Alagille syndrome 1	y	ALAGILLE SYNDROME 1; ALGS1	Clinical Features	death|deaths|died	JAG1	HGNC:6188	Alagille syndrome 1, 118450 (3), Autosomal dominant	Autosomal dominant	y	y	[Mueller et al. (1981) studied 7 patients in 5 families and reviewed 62 reported cases. Of the 69 cases, death from cardiovascular or hepatic complications occurred by age 5 years in 16]	L4	y	-	lethal	ambiguous|lethal|nonlethal	lethal|nonlethal	L4	L4	post-infant-lethal
118600	CHONDROCALCINOSIS 2	Chondrocalcinosis 2, 118600 (3)	Chondrocalcinosis 2	n	-	-	-	ANKH	HGNC:15492	Chondrocalcinosis 2, 118600 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
118700	CHOREA, BENIGN HEREDITARY	Chorea, hereditary benign, 118700 (3)	Chorea, hereditary benign	n	-	-	-	NKX2-1	HGNC:11825	Chorea, hereditary benign, 118700 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L2	L2	pre-infant-lethal
118800	PAROXYSMAL NONKINESIGENIC DYSKINESIA 1	Paroxysmal nonkinesigenic dyskinesia 1, 118800 (3)	Paroxysmal nonkinesigenic dyskinesia 1	n	-	-	-	PNKD	HGNC:9153	Paroxysmal nonkinesigenic dyskinesia 1, 118800 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
119300	VAN DER WOUDE SYNDROME 1	van der Woude syndrome 1, 119300 (3)	van der Woude syndrome 1	y	VAN DER WOUDE SYNDROME 1; VWS1	Phenotype	lethal	IRF6	HGNC:6121	van der Woude syndrome 1, 119300 (3), Autosomal dominant	Autosomal dominant	y	n	-	-	-	-	ambiguous	ambiguous	ambiguous	-	-	-
119500	POPLITEAL PTERYGIUM SYNDROME	Popliteal pterygium syndrome 1, 119500 (3)	Popliteal pterygium syndrome 1	y	POPLITEAL PTERYGIUM SYNDROME; PPS	Phenotype	lethal	IRF6	HGNC:6121	Popliteal pterygium syndrome 1, 119500 (3), Autosomal dominant	Autosomal dominant	y	n	-	-	-	-	ambiguous	ambiguous	ambiguous	-	-	-
119580	BLEPHAROCHEILODONTIC SYNDROME 1	Blepharocheilodontic syndrome 1, 119580 (3)	Blepharocheilodontic syndrome 1	n	-	-	-	CDH1	HGNC:1748	Blepharocheilodontic syndrome 1, 119580 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	LU	LU	post-infant-lethal
119600	CLEIDOCRANIAL DYSPLASIA 1	Cleidocranial dysplasia, 119600 (3)	Cleidocranial dysplasia	n	-	-	-	RUNX2	HGNC:10472	Cleidocranial dysplasia, 119600 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
119600	CLEIDOCRANIAL DYSPLASIA 1	Cleidocranial dysplasia, forme fruste, dental anomalies only, 119600 (3)	Cleidocranial dysplasia, forme fruste, dental anomalies only	n	-	-	-	RUNX2	HGNC:10472	Cleidocranial dysplasia, forme fruste, dental anomalies only, 119600 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
119600	CLEIDOCRANIAL DYSPLASIA 1	Cleidocranial dysplasia, forme fruste, with brachydactyly, 119600 (3)	Cleidocranial dysplasia, forme fruste, with brachydactyly	n	-	-	-	RUNX2	HGNC:10472	Cleidocranial dysplasia, forme fruste, with brachydactyly, 119600 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
119800	CLUBFOOT, CONGENITAL, WITH OR WITHOUT DEFICIENCY OF LONG BONES AND/OR MIRROR-IMAGE POLYDACTYLY	Clubfoot, congenital, with or without deficiency of long bones and/or mirror-image polydactyly, 119800 (3)	Clubfoot, congenital, with or without deficiency of long bones and/or mirror-image polydactyly	y	CLUBFOOT, CONGENITAL, WITH OR WITHOUT DEFICIENCY OF LONG BONES AND/OR MIRROR-IMAGE POLYDACTYLY; CCF	Clinical Features	stillborn	PITX1	HGNC:9004	Clubfoot, congenital, with or without deficiency of long bones and/or mirror-image polydactyly, 119800 (3), Autosomal dominant	Autosomal dominant	n	n	-	-	-	-	ambiguous	ambiguous	ambiguous	-	-	-
120100	FAMILIAL COLD AUTOINFLAMMATORY SYNDROME 1	Familial cold inflammatory syndrome 1, 120100 (3)	Familial cold inflammatory syndrome 1	n	-	-	-	NLRP3	HGNC:16400	Familial cold inflammatory syndrome 1, 120100 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L6	L6	post-infant-lethal
120330	PAPILLORENAL SYNDROME	Papillorenal syndrome, 120330 (3)	Papillorenal syndrome	y	PAPILLORENAL SYNDROME; PAPRS	Clinical Features	died	PAX2	HGNC:8616	Papillorenal syndrome, 120330 (3), Autosomal dominant	Autosomal dominant	y	y	[Rieger (1977) reported a family in which the father showed bilateral optic disc anomalies and died of chronic nephritis]	LU	y	-	lethal	lethal|nonlethal	lethal|nonlethal	LU	LU	post-infant-lethal
120433	COLOBOMA, OCULAR, WITH OR WITHOUT HEARING IMPAIRMENT, CLEFT LIP/PALATE, AND/OR IMPAIRED INTELLECTUAL DEVELOPMENT	Coloboma, ocular, with or without hearing impairment, cleft lip/palate, and/or impaired intellectual development, 120433 (3)	Coloboma, ocular, with or without hearing impairment, cleft lip/palate, and/or impaired intellectual development	n	-	-	-	YAP1	HGNC:16262	Coloboma, ocular, with or without hearing impairment, cleft lip/palate, and/or impaired intellectual development, 120433 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
120435	LYNCH SYNDROME 1	Lynch syndrome 1, 120435 (3)	Lynch syndrome 1	n	-	-	-	MSH2	HGNC:7325	Lynch syndrome 1, 120435 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	ambiguous|lethal|nonlethal	lethal|nonlethal	L3	L3	pre-infant-lethal
120790	COMPLEMENT COMPONENT 4, PARTIAL DEFICIENCY OF	Complement component 4, partial deficiency of, 120790 (3)	Complement component 4, partial deficiency of	n	-	-	-	SERPING1	HGNC:1228	Complement component 4, partial deficiency of, 120790 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
120970	CONE-ROD DYSTROPHY 2	Cone-rod retinal dystrophy-2, 120970 (3)	Cone-rod retinal dystrophy-2	n	-	-	-	CRX	HGNC:2383	Cone-rod retinal dystrophy-2, 120970 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
121050	CONTRACTURAL ARACHNODACTYLY, CONGENITAL	Contractural arachnodactyly, congenital, 121050 (3)	Contractural arachnodactyly, congenital	y	CONTRACTURAL ARACHNODACTYLY, CONGENITAL; CCA	Clinical Features	death|deaths|died|lethal	FBN2	HGNC:3604	Contractural arachnodactyly, congenital, 121050 (3), Autosomal dominant	Autosomal dominant	y	y	[Currarino and Friedman (1986) described 2 unrelated infants with severe CCA, both of whom died in the first year of life]	L3	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L3	L3	pre-infant-lethal
121200	SEIZURES, BENIGN FAMILIAL NEONATAL, 1	Myokymia, 121200 (3)	Myokymia	y	SEIZURES, BENIGN FAMILIAL NEONATAL, 1; BFNS1	Clinical Features	died	KCNQ2	HGNC:6296	Myokymia, 121200 (3), Autosomal dominant	Autosomal dominant	y	y	[Pettit and Fenichel (1980) reported a family with 5 affected members. One patient died during a cyanotic spell, and the remainder were developmentally and neurologically normal, although 3 continued to have seizure disorders as adults]	LU	y	-	lethal	lethal|nonlethal	lethal|nonlethal	LU	LU	post-infant-lethal
121200	SEIZURES, BENIGN FAMILIAL NEONATAL, 1	Seizures, benign neonatal, 1, 121200 (3)	Seizures, benign neonatal, 1	y	SEIZURES, BENIGN FAMILIAL NEONATAL, 1; BFNS1	Clinical Features	died	KCNQ2	HGNC:6296	Seizures, benign neonatal, 1, 121200 (3), Autosomal dominant	Autosomal dominant	y	y	[Pettit and Fenichel (1980) reported a family with 5 affected members. One patient died during a cyanotic spell, and the remainder were developmentally and neurologically normal, although 3 continued to have seizure disorders as adults]	LU	y	-	lethal	lethal|nonlethal	lethal|nonlethal	LU	LU	post-infant-lethal
121201	SEIZURES, BENIGN FAMILIAL NEONATAL, 2	Seizures, benign neonatal, 2, 121201 (3)	Seizures, benign neonatal, 2	n	-	-	-	KCNQ3	HGNC:6297	Seizures, benign neonatal, 2, 121201 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
121300	COPROPORPHYRIA, HEREDITARY	Coproporphyria, 121300 (3)	Coproporphyria	n	-	-	-	CPOX	HGNC:2321	Coproporphyria, 121300 (3), Autosomal dominant, Autosomal recessive	Autosomal dominant, Autosomal recessive	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L3	L3	pre-infant-lethal
121800	SCHNYDER CORNEAL DYSTROPHY	Corneal dystrophy, Schnyder type, 121800 (3)	Corneal dystrophy, Schnyder type	n	-	-	-	UBIAD1	HGNC:30791	Corneal dystrophy, Schnyder type, 121800 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
121820	CORNEAL DYSTROPHY, EPITHELIAL BASEMENT MEMBRANE	Corneal dystrophy, epithelial basement membrane, 121820 (3)	Corneal dystrophy, epithelial basement membrane	n	-	-	-	TGFBI	HGNC:11771	Corneal dystrophy, epithelial basement membrane, 121820 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
121850	CORNEAL DYSTROPHY, FLECK	Corneal fleck dystrophy, 121850 (3)	Corneal fleck dystrophy	n	-	-	-	PIKFYVE	HGNC:23785	Corneal fleck dystrophy, 121850 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
121900	CORNEAL DYSTROPHY, GROENOUW TYPE I	Corneal dystrophy, Groenouw type I, 121900 (3)	Corneal dystrophy, Groenouw type I	n	-	-	-	TGFBI	HGNC:11771	Corneal dystrophy, Groenouw type I, 121900 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
122000	CORNEAL DYSTROPHY, POSTERIOR POLYMORPHOUS, 1	Corneal dystrophy, posterior polymorphous, 1, 122000 (3)	Corneal dystrophy, posterior polymorphous, 1	n	-	-	-	OVOL2	HGNC:15804	Corneal dystrophy, posterior polymorphous, 1, 122000 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
122100	CORNEAL DYSTROPHY, MEESMANN, 1	Meesmann corneal dystrophy 1, 122100 (3)	Meesmann corneal dystrophy 1	n	-	-	-	KRT12	HGNC:6414	Meesmann corneal dystrophy 1, 122100 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
122200	CORNEAL DYSTROPHY, LATTICE TYPE I	Corneal dystrophy, lattice type I, 122200 (3)	Corneal dystrophy, lattice type I	n	-	-	-	TGFBI	HGNC:11771	Corneal dystrophy, lattice type I, 122200 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
122400	EPITHELIAL RECURRENT EROSION DYSTROPHY	Epithelial recurrent erosion dystrophy, 122400 (3)	Epithelial recurrent erosion dystrophy	n	-	-	-	COL17A1	HGNC:2194	Epithelial recurrent erosion dystrophy, 122400 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
122470	CORNELIA DE LANGE SYNDROME 1	Cornelia de Lange syndrome 1, 122470 (3)	Cornelia de Lange syndrome 1	y	CORNELIA DE LANGE SYNDROME 1; CDLS1	Clinical Features|Phenotype	death|deaths|die|died|lethality	NIPBL	HGNC:28862	Cornelia de Lange syndrome 1, 122470 (3), Autosomal dominant	Autosomal dominant	y	y	[Fryns et al. (1987) reported 2 infant brothers with a severe form of the syndrome. They died at the age of 3 months and 3 weeks, respectively]	L2	y	-	lethal	lethal	lethal	L2	L2	pre-infant-lethal
122600	SPONDYLOCOSTAL DYSOSTOSIS 5	Spondylocostal dysostosis 5, 122600 (3)	Spondylocostal dysostosis 5	y	SPONDYLOCOSTAL DYSOSTOSIS 5; SCDO5	Phenotype	lethality	TBX6	HGNC:11605	Spondylocostal dysostosis 5, 122600 (3), Autosomal dominant, Autosomal recessive	Autosomal dominant, Autosomal recessive	y	n	-	-	-	-	ambiguous	ambiguous	ambiguous	-	-	-
122700	COUMARIN RESISTANCE	Coumarin resistance, 122700 (3)	Coumarin resistance	n	-	-	-	CYP2A6	HGNC:2610	Coumarin resistance, 122700 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
122700	COUMARIN RESISTANCE	Warfarin sensitivity, 122700 (3)	Warfarin sensitivity	n	-	-	-	CYP2C9	HGNC:2623	Warfarin sensitivity, 122700 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
122700	COUMARIN RESISTANCE	Warfarin resistance, 122700 (3)	Warfarin resistance	n	-	-	-	VKORC1	HGNC:23663	Warfarin resistance, 122700 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L2	L2	pre-infant-lethal
122860	CRANIODIAPHYSEAL DYSPLASIA, AUTOSOMAL DOMINANT	Craniodiaphyseal dysplasia, autosomal dominant, 122860 (3)	Craniodiaphyseal dysplasia, autosomal dominant	y	CRANIODIAPHYSEAL DYSPLASIA, AUTOSOMAL DOMINANT; CDD	Clinical Features|Clinical Synopsis	died|death|deaths	SOST	HGNC:13771	Craniodiaphyseal dysplasia, autosomal dominant, 122860 (3), Autosomal dominant	Autosomal dominant	y	y	[Often results in death in childhood]	L4	y	-	lethal	lethal	lethal	L4|L6	L4	post-infant-lethal
122880	CRANIOFACIAL-DEAFNESS-HAND SYNDROME	Craniofacial-deafness-hand syndrome, 122880 (3)	Craniofacial-deafness-hand syndrome	n	-	-	-	PAX3	HGNC:8617	Craniofacial-deafness-hand syndrome, 122880 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	ambiguous|nonlethal	ambiguous	-	-	-
123000	CRANIOMETAPHYSEAL DYSPLASIA, AUTOSOMAL DOMINANT	Craniometaphyseal dysplasia, 123000 (3)	Craniometaphyseal dysplasia	n	-	-	-	ANKH	HGNC:15492	Craniometaphyseal dysplasia, 123000 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
123100	CRANIOSYNOSTOSIS 1	Craniosynostosis 1, 123100 (3)	Craniosynostosis 1	n	-	-	-	TWIST1	HGNC:12428	Craniosynostosis 1, 123100 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
123150	JACKSON-WEISS SYNDROME	Jackson-Weiss syndrome, 123150 (3)	Jackson-Weiss syndrome	n	-	-	-	FGFR1	HGNC:3688	Jackson-Weiss syndrome, 123150 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L2|L3	L2	pre-infant-lethal
123150	JACKSON-WEISS SYNDROME	Jackson-Weiss syndrome, 123150 (3)	Jackson-Weiss syndrome	n	-	-	-	FGFR2	HGNC:3689	Jackson-Weiss syndrome, 123150 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L1|L2|L3	L1	pre-infant-lethal
123320	CREATINE PHOSPHOKINASE, ELEVATED SERUM	Creatine phosphokinase, elevated serum, 123320 (3)	Creatine phosphokinase, elevated serum	n	-	-	-	CAV3	HGNC:1529	Creatine phosphokinase, elevated serum, 123320 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	LU	LU	post-infant-lethal
123400	CREUTZFELDT-JAKOB DISEASE	Creutzfeldt-Jakob disease, 123400 (3)	Creutzfeldt-Jakob disease	y	CREUTZFELDT-JAKOB DISEASE; CJD	Clinical Features|Phenotype	death|deaths|died|die	PRNP	HGNC:9449	Creutzfeldt-Jakob disease, 123400 (3), Autosomal dominant	Autosomal dominant	y	y	[Brown et al. (1986) found that men and women were affected about equally with a mean age of onset of 61.5 years ... 90% of patients died within a year of onset]	L6	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L6	L6	post-infant-lethal
123500	CROUZON SYNDROME	Crouzon syndrome, 123500 (3)	Crouzon syndrome	y	CROUZON SYNDROME	Clinical Features	death|deaths	FGFR2	HGNC:3689	Crouzon syndrome, 123500 (3), Autosomal dominant	Autosomal dominant	n	y	[Devine et al. (1984) described a completely cartilaginous trachea without ring formation in a child with Crouzon syndrome who continued to have respiratory distress despite surgical repair of choanal stenosis. Death from respiratory problems occurred at the age of 23 months]	L3	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L1|L2|L3	L1	pre-infant-lethal
123570	CRYPTOPHTHALMOS, UNILATERAL OR BILATERAL, ISOLATED	Cryptophthalmos, unilateral or bilateral, isolated, 123570 (3)	Cryptophthalmos, unilateral or bilateral, isolated	n	-	-	-	FREM2	HGNC:25396	Cryptophthalmos, unilateral or bilateral, isolated, 123570 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L1	L1	pre-infant-lethal
123700	CUTIS LAXA, AUTOSOMAL DOMINANT 1	Cutis laxa, autosomal dominant, 123700 (3)	Cutis laxa, autosomal dominant	y	CUTIS LAXA, AUTOSOMAL DOMINANT 1; ADCL1	Clinical Features	died|fatal	ELN	HGNC:3327	Cutis laxa, autosomal dominant, 123700 (3), Autosomal dominant	Autosomal dominant	y	y	[Szabo et al. (2006) reported a 3-generation family of Japanese and German ancestry and an unrelated Singaporean girl of Chinese descent with cutis laxa and aortic aneurysmal disease...His brother, the proband's uncle, died at age 26 of aortic dissection with no other apparent systemic involvement or skin laxity]	L6	n	y	lethal	lethal	lethal	L3|L6	L3	pre-infant-lethal
123790	BEARE-STEVENSON CUTIS GYRATA SYNDROME	Beare-Stevenson cutis gyrata syndrome, 123790 (3)	Beare-Stevenson cutis gyrata syndrome	y	BEARE-STEVENSON CUTIS GYRATA SYNDROME; BSTVS	Description|Clinical Features|Clinical Synopsis	death|deaths|died	FGFR2	HGNC:3689	Beare-Stevenson cutis gyrata syndrome, 123790 (3), Autosomal dominant	Autosomal dominant	y	y	[Fonseca et al. (2008) reported a girl with Beare-Stevenson syndrome caused by a de novo heterozygous mutation in the FGFR2 gene (S372C; 176943.0016)...She died at age 4 months, after several hospital admissions and surgery]	L3	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L1|L2|L3	L1	pre-infant-lethal
124000	MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 1	Mitochondrial complex III deficiency, nuclear type 1, 124000 (3)	Mitochondrial complex III deficiency, nuclear type 1	y	MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 1; MC3DN1	Description|Clinical Features|Clinical Synopsis	die|died|fatal|death|deaths	BCS1L	HGNC:1020	Mitochondrial complex III deficiency, nuclear type 1, 124000 (3), Autosomal recessive	Autosomal recessive	y	y	[May result in early death / De Meirleir et al. (2003) reported 2 Spanish sibs with fatal infantile complex III deficiency caused by compound heterozygosity for mutation in the BCS1L gene (R45C, 603647.0006; R56X, 603647.0007).... Both had severe liver dysfunction and a renal tubulopathy. One died at age 3 weeks of lactic acidosis]	L2	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L2	L2	pre-infant-lethal
124200	DARIER-WHITE DISEASE	Darier disease, 124200 (3)	Darier disease	n	-	-	-	ATP2A2	HGNC:812	Darier disease, 124200 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
124480	DEAFNESS, CONGENITAL, WITH ONYCHODYSTROPHY, AUTOSOMAL DOMINANT	Deafness, congenital, with onychodystrophy, autosomal dominant, 124480 (3)	Deafness, congenital, with onychodystrophy, autosomal dominant	y	DEAFNESS, CONGENITAL, WITH ONYCHODYSTROPHY, AUTOSOMAL DOMINANT; DDOD	Clinical Features	died	ATP6V1B2	HGNC:854	Deafness, congenital, with onychodystrophy, autosomal dominant, 124480 (3), Autosomal dominant	Autosomal dominant	y	n	-	-	-	-	ambiguous	ambiguous|nonlethal	ambiguous	-	-	-
124500	VOHWINKEL SYNDROME	Vohwinkel syndrome, 124500 (3)	Vohwinkel syndrome	n	-	-	-	GJB2	HGNC:4284	Vohwinkel syndrome, 124500 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	ambiguous|nonlethal	ambiguous	-	-	-
124900	DEAFNESS, AUTOSOMAL DOMINANT 1, WITH OR WITHOUT THROMBOCYTOPENIA	Deafness, autosomal dominant 1, with or without thrombocytopenia, 124900 (3)	Deafness, autosomal dominant 1, with or without thrombocytopenia	n	-	-	-	DIAPH1	HGNC:2876	Deafness, autosomal dominant 1, with or without thrombocytopenia, 124900 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
125250	OPTIC ATROPHY WITH OR WITHOUT DEAFNESS, OPHTHALMOPLEGIA, MYOPATHY, ATAXIA, AND NEUROPATHY	Optic atrophy plus syndrome, 125250 (3)	Optic atrophy plus syndrome	n	-	-	-	OPA1	HGNC:8140	Optic atrophy plus syndrome, 125250 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
125310	CEREBRAL ARTERIOPATHY, AUTOSOMAL DOMINANT, WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY, TYPE 1	Cerebral arteriopathy with subcortical infarcts and leukoencephalopathy 1, 125310 (3)	Cerebral arteriopathy with subcortical infarcts and leukoencephalopathy 1	y	CEREBRAL ARTERIOPATHY, AUTOSOMAL DOMINANT, WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY, TYPE 1; CADASIL1	Clinical Features|Clinical Synopsis	death|deaths|died	NOTCH3	HGNC:7883	Cerebral arteriopathy with subcortical infarcts and leukoencephalopathy 1, 125310 (3), Autosomal dominant	Autosomal dominant	y	y	[Death usually in sixth decade]	L6	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L6	L6	post-infant-lethal
125350	FAILURE OF TOOTH ERUPTION, PRIMARY	Failure of tooth eruption, primary, 125350 (3)	Failure of tooth eruption, primary	n	-	-	-	PTH1R	HGNC:9608	Failure of tooth eruption, primary, 125350 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L1	L1	pre-infant-lethal
125370	DENTATORUBRAL-PALLIDOLUYSIAN ATROPHY	Dentatorubral-pallidoluysian atrophy, 125370 (3)	Dentatorubral-pallidoluysian atrophy	y	DENTATORUBRAL-PALLIDOLUYSIAN ATROPHY; DRPLA	Clinical Features|Phenotype	death|deaths|died	ATN1	HGNC:3033	Dentatorubral-pallidoluysian atrophy, 125370 (3), Autosomal dominant	Autosomal dominant	y	y	[Onset was usually in the twenties and death in the forties]	L6	y	-	lethal	lethal	lethal	L3|L6	L3	pre-infant-lethal
125400	DENTIN DYSPLASIA, TYPE I	Dentin dysplasia, type I, with microdontia and misshapen teeth, 125400 (3)	Dentin dysplasia, type I, with microdontia and misshapen teeth	n	-	-	-	SMOC2	HGNC:20323	Dentin dysplasia, type I, with microdontia and misshapen teeth, 125400 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
125420	DENTIN DYSPLASIA, TYPE II	Dentin dysplasia, type II, 125420 (3)	Dentin dysplasia, type II	n	-	-	-	DSPP	HGNC:3054	Dentin dysplasia, type II, 125420 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
125490	DENTINOGENESIS IMPERFECTA 1	Dentinogenesis imperfecta, Shields type II, 125490 (3)	Dentinogenesis imperfecta, Shields type II	n	-	-	-	DSPP	HGNC:3054	Dentinogenesis imperfecta, Shields type II, 125490 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
125500	DENTINOGENESIS IMPERFECTA, SHIELDS TYPE III	Dentinogenesis imperfecta, Shields type III, 125500 (3)	Dentinogenesis imperfecta, Shields type III	n	-	-	-	DSPP	HGNC:3054	Dentinogenesis imperfecta, Shields type III, 125500 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
125595	DERMATOPATHIA PIGMENTOSA RETICULARIS	Dermatopathia pigmentosa reticularis, 125595 (3)	Dermatopathia pigmentosa reticularis	n	-	-	-	KRT14	HGNC:6416	Dermatopathia pigmentosa reticularis, 125595 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L2	L2	pre-infant-lethal
125630	VIBRATORY URTICARIA	Vibratory urticaria, 125630 (3)	Vibratory urticaria	n	-	-	-	ADGRE2	HGNC:3337	Vibratory urticaria, 125630 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
125700	DIABETES INSIPIDUS, NEUROHYPOPHYSEAL	Diabetes insipidus, neurohypophyseal, 125700 (3)	Diabetes insipidus, neurohypophyseal	n	-	-	-	AVP	HGNC:894	Diabetes insipidus, neurohypophyseal, 125700 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
125800	DIABETES INSIPIDUS, NEPHROGENIC, 2, AUTOSOMAL	Diabetes insipidus, nephrogenic, 2, 125800 (3)	Diabetes insipidus, nephrogenic, 2	n	-	-	-	AQP2	HGNC:634	Diabetes insipidus, nephrogenic, 2, 125800 (3), Autosomal dominant, Autosomal recessive	Autosomal dominant, Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
125850	MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 1	MODY, type I, 125850 (3)	MODY, type I	n	-	-	-	HNF4A	HGNC:5024	MODY, type I, 125850 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
125851	MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 2	MODY, type II, 125851 (3)	MODY, type II	n	-	-	-	GCK	HGNC:4195	MODY, type II, 125851 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L6	L6	post-infant-lethal
125852	TYPE 1 DIABETES MELLITUS 2	Diabetes mellitus, insulin-dependent, 2, 125852 (3)	Diabetes mellitus, insulin-dependent, 2	n	-	-	-	INS	HGNC:6081	Diabetes mellitus, insulin-dependent, 2, 125852 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
125853	TYPE 2 DIABETES MELLITUS	Diabetes mellitus, noninsulin-dependent, 125853 (3)	Diabetes mellitus, noninsulin-dependent	n	-	-	-	ABCC8	HGNC:59	Diabetes mellitus, noninsulin-dependent, 125853 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	ambiguous|nonlethal	ambiguous	-	-	-
125853	TYPE 2 DIABETES MELLITUS	Diabetes mellitus, type II, 125853 (3)	Diabetes mellitus, type II	n	-	-	-	AKT2	HGNC:392	Diabetes mellitus, type II, 125853 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L2	L2	pre-infant-lethal
125853	TYPE 2 DIABETES MELLITUS	Diabetes mellitus, noninsulin-dependent, late onset, 125853 (3)	Diabetes mellitus, noninsulin-dependent, late onset	n	-	-	-	GCK	HGNC:4195	Diabetes mellitus, noninsulin-dependent, late onset, 125853 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L6	L6	post-infant-lethal
125853	TYPE 2 DIABETES MELLITUS	Type 2 diabetes mellitus, 125853 (3)	Type 2 diabetes mellitus	n	-	-	-	HNF1B	HGNC:11630	Type 2 diabetes mellitus, 125853 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L6	L6	post-infant-lethal
125853	TYPE 2 DIABETES MELLITUS	Diabetes mellitus, type 2, 125853 (3)	Diabetes mellitus, type 2	n	-	-	-	PAX4	HGNC:8618	Diabetes mellitus, type 2, 125853 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
125853	TYPE 2 DIABETES MELLITUS	Insulin resistance, severe, digenic, 125853 (3)	Insulin resistance, severe, digenic	n	-	-	-	PPP1R3A	HGNC:9291	Insulin resistance, severe, digenic, 125853 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
126550	CALVARIAL DOUGHNUT LESIONS WITH BONE FRAGILITY	Calvarial doughnut lesions with bone fragility with or without spondylometaphyseal dysplasia, 126550 (3)	Calvarial doughnut lesions with bone fragility with or without spondylometaphyseal dysplasia	n	-	-	-	SGMS2	HGNC:28395	Calvarial doughnut lesions with bone fragility with or without spondylometaphyseal dysplasia, 126550 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
126600	DOYNE HONEYCOMB RETINAL DYSTROPHY	Doyne honeycomb degeneration of retina, 126600 (3)	Doyne honeycomb degeneration of retina	n	-	-	-	EFEMP1	HGNC:3218	Doyne honeycomb degeneration of retina, 126600 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
126700	BASAL LAMINAR DRUSEN	Basal laminar drusen, 126700 (3)	Basal laminar drusen	n	-	-	-	CFH	HGNC:4883	Basal laminar drusen, 126700 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
127000	KENNY-CAFFEY SYNDROME, TYPE 2	Kenny-Caffey syndrome, type 2, 127000 (3)	Kenny-Caffey syndrome, type 2	y	KENNY-CAFFEY SYNDROME, TYPE 2; KCS2	Clinical Features	died	FAM111A	HGNC:24725	Kenny-Caffey syndrome, type 2, 127000 (3), Autosomal dominant	Autosomal dominant	y	y	[Boynton et al. (1979) described a similar finding, with tortuous and dilated retinal vessels. They reported the only known autopsy case in a patient who died at age 19]	L6	y	-	lethal	lethal	lethal	L1|L6	L1	pre-infant-lethal
127300	LERI-WEILL DYSCHONDROSTEOSIS	Leri-Weill dyschondrosteosis, 127300 (3)	Leri-Weill dyschondrosteosis	n	-	-	-	SHOX	HGNC:10853	Leri-Weill dyschondrosteosis, 127300 (3), Pseudoautosomal dominant	Pseudoautosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
127400	DYSCHROMATOSIS SYMMETRICA HEREDITARIA	Dyschromatosis symmetrica hereditaria, 127400 (3)	Dyschromatosis symmetrica hereditaria	n	-	-	-	ADAR	HGNC:225	Dyschromatosis symmetrica hereditaria, 127400 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
127500	DYSCHROMATOSIS UNIVERSALIS HEREDITARIA 1	Dyschromatosis universalis hereditaria 1, 127500 (3)	Dyschromatosis universalis hereditaria 1	n	-	-	-	SASH1	HGNC:19182	Dyschromatosis universalis hereditaria 1, 127500 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
127750	DEMENTIA, LEWY BODY	Dementia, Lewy body, 127750 (3)	Dementia, Lewy body	y	DEMENTIA, LEWY BODY; DLB	Clinical Features|Phenotype	died|death|deaths	SNCA	HGNC:11138	Dementia, Lewy body, 127750 (3), Autosomal dominant	Autosomal dominant	y	y	[Mean age of onset was 62 years / died at the age of 78 years after 7- and 5-year histories of parkinsonism and dementia, respectively]	L6	y	-	lethal	lethal	lethal	L6|LU	L6	post-infant-lethal
127750	DEMENTIA, LEWY BODY	Dementia, Lewy body, 127750 (3)	Dementia, Lewy body	y	DEMENTIA, LEWY BODY; DLB	Clinical Features|Phenotype	died|death|deaths	SNCB	HGNC:11140	Dementia, Lewy body, 127750 (3), Autosomal dominant	Autosomal dominant	y	y	[Mean age of onset was 62 years / died at the age of 78 years after 7- and 5-year histories of parkinsonism and dementia, respectively]	L6	y	-	lethal	lethal	lethal	L6	L6	post-infant-lethal
128100	DYSTONIA 1, TORSION, AUTOSOMAL DOMINANT	Dystonia-1, torsion, 128100 (3)	Dystonia-1, torsion	n	-	-	-	TOR1A	HGNC:3098	Dystonia-1, torsion, 128100 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L3	L3	pre-infant-lethal
128101	DYSTONIA 4, TORSION, AUTOSOMAL DOMINANT	Dystonia 4, torsion, autosomal dominant, 128101 (3)	Dystonia 4, torsion, autosomal dominant	y	DYSTONIA 4, TORSION, AUTOSOMAL DOMINANT; DYT4	Clinical Features	death|deaths	TUBB4A	HGNC:20774	Dystonia 4, torsion, autosomal dominant, 128101 (3), Autosomal dominant	Autosomal dominant	y	n	-	-	-	-	ambiguous	ambiguous|nonlethal	ambiguous	-	-	-
128200	EPISODIC KINESIGENIC DYSKINESIA 1	Episodic kinesigenic dyskinesia 1, 128200 (3)	Episodic kinesigenic dyskinesia 1	n	-	-	-	PRRT2	HGNC:30500	Episodic kinesigenic dyskinesia 1, 128200 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
128230	DYSTONIA, DOPA-RESPONSIVE	Dystonia, DOPA-responsive, 128230 (3)	Dystonia, DOPA-responsive	y	DYSTONIA, DOPA-RESPONSIVE; DRD	Clinical Features	died	GCH1	HGNC:4193	Dystonia, DOPA-responsive, 128230 (3), Autosomal dominant, Autosomal recessive	Autosomal dominant, Autosomal recessive	y	n	-	-	-	-	ambiguous	ambiguous|lethal	lethal	L5	L5	post-infant-lethal
128235	DYSTONIA 12	Dystonia-12, 128235 (3)	Dystonia-12	n	-	-	-	ATP1A3	HGNC:801	Dystonia-12, 128235 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	ambiguous|nonlethal	ambiguous	-	-	-
129200	BASAN SYNDROME	Basan syndrome, 129200 (3)	Basan syndrome	n	-	-	-	SMARCAD1	HGNC:18398	Basan syndrome, 129200 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L6	L6	post-infant-lethal
129400	RAPP-HODGKIN SYNDROME	Rapp-Hodgkin syndrome, 129400 (3)	Rapp-Hodgkin syndrome	y	RAPP-HODGKIN SYNDROME; RHS	Clinical Features	died	TP63	HGNC:15979	Rapp-Hodgkin syndrome, 129400 (3), Autosomal dominant	Autosomal dominant	y	y	[Moerman and Fryns (1996) described a mother with manifestations consistent with the Rapp-Hodgkin type of ectodermal dysplasia and her malformed newborn son with ectrodactyly, ectodermal dysplasia, cleft palate, and bilateral cystic and obstructive ureteroceles with hydroureters and cystic renal dysplasia as described in the EEC syndrome (EEC1; 129900). They suggested that these may be fundamentally the same disorder. The newborn died at 1 day of age]	L2	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L2	L2	pre-infant-lethal
129490	ECTODERMAL DYSPLASIA 10A, HYPOHIDROTIC/HAIR/NAIL TYPE, AUTOSOMAL DOMINANT	Ectodermal dysplasia 10A, hypohidrotic/hair/nail type, autosomal dominant, 129490 (3)	Ectodermal dysplasia 10A, hypohidrotic/hair/nail type, autosomal dominant	y	ECTODERMAL DYSPLASIA 10A, HYPOHIDROTIC/HAIR/NAIL TYPE, AUTOSOMAL DOMINANT; ECTD10A	Clinical Synopsis	death|deaths	EDAR	HGNC:2895	Ectodermal dysplasia 10A, hypohidrotic/hair/nail type, autosomal dominant, 129490 (3), Autosomal dominant	Autosomal dominant	n	n	-	-	-	-	ambiguous	ambiguous	ambiguous	-	-	-
129500	CLOUSTON SYNDROME	Ectodermal dysplasia 2, Clouston type, 129500 (3)	Ectodermal dysplasia 2, Clouston type	n	-	-	-	GJB6	HGNC:4288	Ectodermal dysplasia 2, Clouston type, 129500 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
129600	ECTOPIA LENTIS 1, ISOLATED, AUTOSOMAL DOMINANT	Ectopia lentis, familial, 129600 (3)	Ectopia lentis, familial	n	-	-	-	FBN1	HGNC:3603	Ectopia lentis, familial, 129600 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	ambiguous|lethal|nonlethal	lethal|nonlethal	L2|LU	L2	pre-infant-lethal
130000	EHLERS-DANLOS SYNDROME, CLASSIC TYPE, 1	Ehlers-Danlos syndrome, classic type, 1, 130000 (3)	Ehlers-Danlos syndrome, classic type, 1	y	EHLERS-DANLOS SYNDROME, CLASSIC TYPE, 1; EDSCL1	Clinical Features	died	COL5A1	HGNC:2209	Ehlers-Danlos syndrome, classic type, 1, 130000 (3), Autosomal dominant	Autosomal dominant	n	y	[Friedman and Harrod (1982) described a severe form of EDS. The mother died of dissecting aneurysm of the aorta. Autopsy also showed myxomatous changes in the mitral and tricuspid valves with redundancy of cusps and chordae]	LU	y	-	lethal	lethal|nonlethal	lethal|nonlethal	LU	LU	post-infant-lethal
130010	EHLERS-DANLOS SYNDROME, CLASSIC TYPE, 2	Ehlers-Danlos syndrome, classic type, 2, 130010 (3)	Ehlers-Danlos syndrome, classic type, 2	n	-	-	-	COL5A2	HGNC:2210	Ehlers-Danlos syndrome, classic type, 2, 130010 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
130050	EHLERS-DANLOS SYNDROME, VASCULAR TYPE	Ehlers-Danlos syndrome, vascular type, 130050 (3)	Ehlers-Danlos syndrome, vascular type	y	EHLERS-DANLOS SYNDROME, VASCULAR TYPE; EDSVASC	Clinical Features|Clinical Synopsis|Diagnosis|Phenotype	death|deaths|died|fatal|lethal	COL3A1	HGNC:2201	Ehlers-Danlos syndrome, vascular type, 130050 (3), Autosomal dominant	Autosomal dominant	n	y	[Death usually occurs before 5th decade / Analysis of the COL3A1 gene revealed heterozygosity for a missense mutation (G619R; 120180.0002) that was also found in pathology specimens from her mother and a maternal aunt, who died at age 34 years and 55 years, respectively, of aortic aneurysms]	L6	y	y	lethal	lethal	lethal	L5|L6	L5	post-infant-lethal
130060	EHLERS-DANLOS SYNDROME, ARTHROCHALASIA TYPE, 1	Ehlers-Danlos syndrome, arthrochalasia type, 1, 130060 (3)	Ehlers-Danlos syndrome, arthrochalasia type, 1	n	-	-	-	COL1A1	HGNC:2197	Ehlers-Danlos syndrome, arthrochalasia type, 1, 130060 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	ambiguous|lethal|nonlethal	lethal|nonlethal	L2|L5|LU	L2	pre-infant-lethal
130070	EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 1	Ehlers-Danlos syndrome, spondylodysplastic type, 1, 130070 (3)	Ehlers-Danlos syndrome, spondylodysplastic type, 1	y	EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 1; EDSSPD1	Clinical Features	died	B4GALT7	HGNC:930	Ehlers-Danlos syndrome, spondylodysplastic type, 1, 130070 (3), Autosomal recessive	Autosomal recessive	y	y	[Bonaventure et al. (1992) examined 7 affected children from 3 large consanguineous pedigrees from La Reunion with multiple affected children, 2 of whom were originally described by Payet (1975) and several of whom died in early childhood]	L4	y	-	lethal	lethal	lethal	L4	L4	post-infant-lethal
130080	EHLERS-DANLOS SYNDROME, PERIODONTAL TYPE, 1	Ehlers-Danlos syndrome, periodontal type, 1, 130080 (3)	Ehlers-Danlos syndrome, periodontal type, 1	y	EHLERS-DANLOS SYNDROME, PERIODONTAL TYPE, 1; EDSPD1	Clinical Features	died	C1R	HGNC:1246	Ehlers-Danlos syndrome, periodontal type, 1, 130080 (3), Autosomal dominant	Autosomal dominant	y	y	[Cikla et al. (2014) described a 42-year-old woman with a diagnosis of EDS VIII who died after surgery for an aneurysm of the middle cerebral artery]	L6	y	-	lethal	lethal	lethal	L6	L6	post-infant-lethal
130600	ELLIPTOCYTOSIS 2	Elliptocytosis-2, 130600 (3)	Elliptocytosis-2	n	-	-	-	SPTA1	HGNC:11272	Elliptocytosis-2, 130600 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	ambiguous|nonlethal	ambiguous	-	-	-
130650	BECKWITH-WIEDEMANN SYNDROME	Beckwith-Wiedemann syndrome, 130650 (3)	Beckwith-Wiedemann syndrome	y	BECKWITH-WIEDEMANN SYNDROME; BWS	Clinical Features|Phenotype	died	CDKN1C	HGNC:1786	Beckwith-Wiedemann syndrome, 130650 (3), Autosomal dominant	Autosomal dominant	y	y	[Emery et al. (1983) reported 2 affected sibs, one with thoracic neuroblastoma and the other who died at age 2 months of cardiomyopathy and respiratory failure / *** Gardiner et al. (2012) retrospectively identified 7 unrelated patients with BWS and posterior fossa brain abnormalities from a large cohort of 450 patients... One pregnancy was terminated, 2 patients died within 2 weeks of age, and a third patient died at age 2.5 years (In Other Features)	L2	y	-	lethal	lethal	lethal	L2	L2	pre-infant-lethal
130720	LATERAL MENINGOCELE SYNDROME	Lateral meningocele syndrome, 130720 (3)	Lateral meningocele syndrome	n	-	-	-	NOTCH3	HGNC:7883	Lateral meningocele syndrome, 130720 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L6	L6	post-infant-lethal
130900	AMELOGENESIS IMPERFECTA, TYPE IIIA	Amelogenesis imperfecta, type IIIA, 130900 (3)	Amelogenesis imperfecta, type IIIA	n	-	-	-	FAM83H	HGNC:24797	Amelogenesis imperfecta, type IIIA, 130900 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
131100	MULTIPLE ENDOCRINE NEOPLASIA, TYPE I	Multiple endocrine neoplasia 1, 131100 (3)	Multiple endocrine neoplasia 1	y	MULTIPLE ENDOCRINE NEOPLASIA, TYPE I; MEN1	Clinical Features|Phenotype	death|deaths|died	MEN1	HGNC:7010	Multiple endocrine neoplasia 1, 131100 (3), Autosomal dominant	Autosomal dominant	y	y	[The mean age of death of affected males was 61.1 years versus 65.8 years for unaffected males, and for affected females was 67.2 years versus 67.7 years for unaffected females]	L6	y	-	lethal	lethal	lethal	L6	L6	post-infant-lethal
131300	CAMURATI-ENGELMANN DISEASE	Camurati-Engelmann disease, 131300 (3)	Camurati-Engelmann disease	n	-	-	-	TGFB1	HGNC:11766	Camurati-Engelmann disease, 131300 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L4	L4	post-infant-lethal
131705	TRANSIENT BULLOUS DERMOLYSIS OF THE NEWBORN	Transient bullous of the newborn, 131705 (3)	Transient bullous of the newborn	n	-	-	-	COL7A1	HGNC:2214	Transient bullous of the newborn, 131705 (3), Autosomal dominant, Autosomal recessive	Autosomal dominant, Autosomal recessive	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L6	L6	post-infant-lethal
131750	EPIDERMOLYSIS BULLOSA DYSTROPHICA, AUTOSOMAL DOMINANT	Epidermolysis bullosa dystrophica, autosomal dominant, 131750 (3)	Epidermolysis bullosa dystrophica, autosomal dominant	n	-	-	-	COL7A1	HGNC:2214	Epidermolysis bullosa dystrophica, autosomal dominant, 131750 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L6	L6	post-infant-lethal
131760	EPIDERMOLYSIS BULLOSA SIMPLEX 1A, GENERALIZED SEVERE	Epidermolysis bullosa simplex 1A, generalized severe, 131760 (3)	Epidermolysis bullosa simplex 1A, generalized severe	y	EPIDERMOLYSIS BULLOSA SIMPLEX 1A, GENERALIZED SEVERE; EBS1A	Clinical Features|Clinical Synopsis|Phenotype	died|death|deaths|lethality	KRT14	HGNC:6416	Epidermolysis bullosa simplex 1A, generalized severe, 131760 (3), Autosomal dominant	Autosomal dominant	y	y	Infant death may occur secondary to sepsis / McGrath et al. (1992) reviewed the clinicopathologic features of 22 cases varying in age from 5 days to 46 years. All cases presented clinically within the first 5 days of life. Early blisters were often large (up to 5 cm in diameter), and were mostly acral and particularly periungual. Some patients presented with more widespread erosive skin changes, and 2 neonates with extensive skin involvement died as a result of overwhelming sepsis]	L2	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L2	L2	pre-infant-lethal
131800	EPIDERMOLYSIS BULLOSA SIMPLEX 1C, LOCALIZED	Epidermolysis bullosa simplex 1C, localized, 131800 (3)	Epidermolysis bullosa simplex 1C, localized	n	-	-	-	KRT14	HGNC:6416	Epidermolysis bullosa simplex 1C, localized, 131800 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L2	L2	pre-infant-lethal
131850	EPIDERMOLYSIS BULLOSA DYSTROPHICA, PRETIBIAL	Epidermolysis bullosa, pretibial, 131850 (3)	Epidermolysis bullosa, pretibial	n	-	-	-	COL7A1	HGNC:2214	Epidermolysis bullosa, pretibial, 131850 (3), Autosomal dominant, Autosomal recessive	Autosomal dominant, Autosomal recessive	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L6	L6	post-infant-lethal
131900	EPIDERMOLYSIS BULLOSA SIMPLEX 1B, GENERALIZED INTERMEDIATE	Epidermolysis bullosa simplex 1B, generalized intermediate, 131900 (3)	Epidermolysis bullosa simplex 1B, generalized intermediate	n	-	-	-	KRT14	HGNC:6416	Epidermolysis bullosa simplex 1B, generalized intermediate, 131900 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L2	L2	pre-infant-lethal
131950	EPIDERMOLYSIS BULLOSA SIMPLEX 5A, OGNA TYPE	Epidermolysis bullosa simplex 5A, Ogna type, 131950 (3)	Epidermolysis bullosa simplex 5A, Ogna type	n	-	-	-	PLEC	HGNC:9069	Epidermolysis bullosa simplex 5A, Ogna type, 131950 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L2|L3|L6	L2	pre-infant-lethal
131960	EPIDERMOLYSIS BULLOSA SIMPLEX 2F, WITH MOTTLED PIGMENTATION	Epidermolysis bullosa simplex 2F, with mottled pigmentation, 131960 (3)	Epidermolysis bullosa simplex 2F, with mottled pigmentation	n	-	-	-	KRT5	HGNC:6442	Epidermolysis bullosa simplex 2F, with mottled pigmentation, 131960 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	ambiguous|lethal|nonlethal	lethal|nonlethal	L2	L2	pre-infant-lethal
132000	EPIDERMOLYSIS BULLOSA WITH CONGENITAL LOCALIZED ABSENCE OF SKIN AND DEFORMITY OF NAILS	Epidermolysis bullosa dystrophica, Bart type, 132000 (3)	Epidermolysis bullosa dystrophica, Bart type	n	-	-	-	COL7A1	HGNC:2214	Epidermolysis bullosa dystrophica, Bart type, 132000 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L6	L6	post-infant-lethal
132400	EPIPHYSEAL DYSPLASIA, MULTIPLE, 1	Epiphyseal dysplasia, multiple, 1, 132400 (3)	Epiphyseal dysplasia, multiple, 1	n	-	-	-	COMP	HGNC:2227	Epiphyseal dysplasia, multiple, 1, 132400 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
132700	CYLINDROMATOSIS, FAMILIAL	Cylindromatosis, familial, 132700 (3)	Cylindromatosis, familial	y	CYLINDROMATOSIS, FAMILIAL	Clinical Features	died	CYLD	HGNC:2584	Cylindromatosis, familial, 132700 (3), Autosomal dominant	Autosomal dominant	n	n	-	-	-	-	ambiguous	ambiguous|nonlethal	ambiguous	-	-	-
132900	AORTIC ANEURYSM, FAMILIAL THORACIC 4	Aortic aneurysm, familial thoracic 4, 132900 (3)	Aortic aneurysm, familial thoracic 4	y	AORTIC ANEURYSM, FAMILIAL THORACIC 4; AAT4	Clinical Features|Clinical Synopsis	died|death|deaths	MYH11	HGNC:7569	Aortic aneurysm, familial thoracic 4, 132900 (3), Autosomal dominant	Autosomal dominant	n	y	[Family history of sudden death, as early as fourth decade of life / Glancy et al. (2001) reported 3 generations of a family in which 5 members had aortic dissection and/or patent ductus arteriosus (PDA; 607411)... A daughter of the proband, who had a PDA repaired at age 6, died at age 28 of an extensive dissection of the descending thoracic and abdominal aorta]	L6	y	y	lethal	lethal|nonlethal	lethal|nonlethal	L3|L6	L3	pre-infant-lethal
133020	ERYTHERMALGIA, PRIMARY	Erythermalgia, primary, 133020 (3)	Erythermalgia, primary	n	-	-	-	SCN9A	HGNC:10597	Erythermalgia, primary, 133020 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	ambiguous|nonlethal	ambiguous	-	-	-
133020	ERYTHERMALGIA, PRIMARY	Small fiber neuropathy, 133020 (3)	Small fiber neuropathy	n	-	-	-	SCN9A	HGNC:10597	Small fiber neuropathy, 133020 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	ambiguous|nonlethal	ambiguous	-	-	-
133190	SPINOCEREBELLAR ATAXIA 34	Spinocerebellar ataxia 34, 133190 (3)	Spinocerebellar ataxia 34	n	-	-	-	ELOVL4	HGNC:14415	Spinocerebellar ataxia 34, 133190 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L3	L3	pre-infant-lethal
133200	ERYTHROKERATODERMIA VARIABILIS ET PROGRESSIVA 1	Erythrokeratodermia variabilis et progressiva 1, 133200 (3)	Erythrokeratodermia variabilis et progressiva 1	n	-	-	-	GJB3	HGNC:4285	Erythrokeratodermia variabilis et progressiva 1, 133200 (3), Autosomal dominant, Autosomal recessive	Autosomal dominant, Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
133540	COCKAYNE SYNDROME B	Cockayne syndrome, type B, 133540 (3)	Cockayne syndrome, type B	y	COCKAYNE SYNDROME B; CSB	Clinical Features|Clinical Synopsis	death|deaths|died|fatal	ERCC6	HGNC:3438	Cockayne syndrome, type B, 133540 (3), Autosomal recessive	Autosomal recessive	y	y	[Death by age 6-7 years / Falik-Zaccai et al. (2008) reported a large, highly consanguineous Druze kindred from northern Israel in which 6 members had Cockayne syndrome B...They had sensorineural hearing loss, no language skills, could not sit or walk independently, and died by the age of 5 years]	L4	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L4	L4	post-infant-lethal
133700	EXOSTOSES, MULTIPLE, TYPE I	Exostoses, multiple, type 1, 133700 (3)	Exostoses, multiple, type 1	n	-	-	-	EXT1	HGNC:3512	Exostoses, multiple, type 1, 133700 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
133701	EXOSTOSES, MULTIPLE, TYPE II	Exostoses, multiple, type 2, 133701 (3)	Exostoses, multiple, type 2	n	-	-	-	EXT2	HGNC:3513	Exostoses, multiple, type 2, 133701 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L4	L4	post-infant-lethal
133780	EXUDATIVE VITREORETINOPATHY 1	Exudative vitreoretinopathy 1, 133780 (3)	Exudative vitreoretinopathy 1	n	-	-	-	FZD4	HGNC:4042	Exudative vitreoretinopathy 1, 133780 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
133780	EXUDATIVE VITREORETINOPATHY 1	Retinopathy of prematurity, 133780 (3)	Retinopathy of prematurity	n	-	-	-	FZD4	HGNC:4042	Retinopathy of prematurity, 133780 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
134600	FANCONI RENOTUBULAR SYNDROME 1	Fanconi renotubular syndrome 1, 134600 (3)	Fanconi renotubular syndrome 1	y	FANCONI RENOTUBULAR SYNDROME 1; FRTS1	Clinical Features|Phenotype	died|death|deaths	GATM	HGNC:4175	Fanconi renotubular syndrome 1, 134600 (3), Autosomal dominant	Autosomal dominant	y	n	-	-	-	-	ambiguous	ambiguous|nonlethal	ambiguous	-	-	-
134610	FAMILIAL MEDITERRANEAN FEVER, AUTOSOMAL DOMINANT	Familial Mediterranean fever, AD, 134610 (3)	Familial Mediterranean fever, AD	y	FAMILIAL MEDITERRANEAN FEVER, AUTOSOMAL DOMINANT	Clinical Features	death|deaths|died	MEFV	HGNC:6998	Familial Mediterranean fever, AD, 134610 (3), Autosomal dominant	Autosomal dominant	y	y	[Bergman and Warmenius (1968) described a Swedish family in which 4 individuals had recurrent fever and abdominal pain that persisted for 7 to 14 days. Death from renal failure occurred at ages 19, 21, 33, and 58 years]	L6	y	-	lethal	ambiguous|lethal|nonlethal	lethal|nonlethal	L6	L6	post-infant-lethal
135100	FIBRODYSPLASIA OSSIFICANS PROGRESSIVA	Fibrodysplasia ossificans progressiva, 135100 (3)	Fibrodysplasia ossificans progressiva	y	FIBRODYSPLASIA OSSIFICANS PROGRESSIVA; FOP	Clinical Features	death|deaths|died	ACVR1	HGNC:171	Fibrodysplasia ossificans progressiva, 135100 (3), Autosomal dominant	Autosomal dominant	y	y	[Connor et al. (1993) reported FOP in 5 persons in 3 successive generations. The affected individual in the first generation was a male. He had 2 affected daughters and 2 affected granddaughters. A wide range of phenotypic severity was demonstrated, from disabling ectopic bone formation and premature death to an asymptomatic adult]	LU	y	-	lethal	lethal	lethal	LU	LU	post-infant-lethal
135150	BIRT-HOGG-DUBE SYNDROME 1	Birt-Hogg-Dube syndrome, 135150 (3)	Birt-Hogg-Dube syndrome	n	-	-	-	FLCN	HGNC:27310	Birt-Hogg-Dube syndrome, 135150 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L3	L3	pre-infant-lethal
135290	DESMOID DISEASE, HEREDITARY	Desmoid disease, hereditary, 135290 (3)	Desmoid disease, hereditary	y	DESMOID DISEASE, HEREDITARY; DESMD	Clinical Features	died	APC	HGNC:583	Desmoid disease, hereditary, 135290 (3), Autosomal dominant	Autosomal dominant	y	y	[Maher et al. (1992) described a mother and son with marked infiltrative fibromatosis of the mesentery of the type that had been observed as part of the Gardner syndrome.... She died at 32 years of age of bowel perforation and intractable abdominal sepsis]	L6	y	-	lethal	lethal	lethal	L4|L6	L4	post-infant-lethal
135500	ZIMMERMANN-LABAND SYNDROME 1	Zimmermann-Laband syndrome 1, 135500 (3)	Zimmermann-Laband syndrome 1	n	-	-	-	KCNH1	HGNC:6250	Zimmermann-Laband syndrome 1, 135500 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
135700	FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, 1	Fibrosis of extraocular muscles, congenital, 1, 135700 (3)	Fibrosis of extraocular muscles, congenital, 1	n	-	-	-	KIF21A	HGNC:19349	Fibrosis of extraocular muscles, congenital, 1, 135700 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
135700	FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, 1	Fibrosis of extraocular muscles, congenital, 3B, 135700 (3)	Fibrosis of extraocular muscles, congenital, 3B	n	-	-	-	KIF21A	HGNC:19349	Fibrosis of extraocular muscles, congenital, 3B, 135700 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
135750	LAURIN-SANDROW SYNDROME	Laurin-Sandrow syndrome, 135750 (3)	Laurin-Sandrow syndrome	y	LAURIN-SANDROW SYNDROME; LSS	Clinical Features	died	LMBR1	HGNC:13243	Laurin-Sandrow syndrome, 135750 (3), Autosomal dominant	Autosomal dominant	y	y	[Marino-Enriquez et al. (2008) reported a female infant, born at 33-weeks' gestation with multiple anomalies suggestive of LSS, who died at age 45 minutes]	L2	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L2	L2	pre-infant-lethal
135900	COFFIN-SIRIS SYNDROME 1	Coffin-Siris syndrome 1, 135900 (3)	Coffin-Siris syndrome 1	y	COFFIN-SIRIS SYNDROME 1; CSS1	Phenotype	died	ARID1B	HGNC:18040	Coffin-Siris syndrome 1, 135900 (3), Autosomal dominant	Autosomal dominant	y	y	[Two of the sisters died at 10 days and 1 day of age of cardiac abnormalities]	L2	y	y	lethal	lethal	lethal	L2	L2	pre-infant-lethal
136000	ADERMATOGLYPHIA	Adermatoglyphia, 136000 (3)	Adermatoglyphia	n	-	-	-	SMARCAD1	HGNC:18398	Adermatoglyphia, 136000 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L6	L6	post-infant-lethal
136120	FISH-EYE DISEASE	Fish-eye disease, 136120 (3)	Fish-eye disease	n	-	-	-	LCAT	HGNC:6522	Fish-eye disease, 136120 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	ambiguous|nonlethal	ambiguous	-	-	-
136140	FLOATING-HARBOR SYNDROME	Floating-Harbor syndrome, 136140 (3)	Floating-Harbor syndrome	n	-	-	-	SRCAP	HGNC:16974	Floating-Harbor syndrome, 136140 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
136520	FOVEAL HYPOPLASIA 1	Foveal hypoplasia 1, 136520 (3)	Foveal hypoplasia 1	n	-	-	-	PAX6	HGNC:8620	Foveal hypoplasia 1, 136520 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	ambiguous|lethal|nonlethal	lethal|nonlethal	LU	LU	post-infant-lethal
136630	INTELLECTUAL DEVELOPMENTAL DISORDER, FRA12A TYPE	Intellectual developmental disorder, autosomal dominant, FRA12A type, 136630 (3)	Intellectual developmental disorder, autosomal dominant, FRA12A type	y	INTELLECTUAL DEVELOPMENTAL DISORDER, FRA12A TYPE	Clinical Features	lethal	DIP2B	HGNC:29284	Intellectual developmental disorder, autosomal dominant, FRA12A type, 136630 (3), Autosomal dominant	Autosomal dominant	y	n	-	-	-	-	ambiguous	ambiguous	ambiguous	-	-	-
136760	FRONTONASAL DYSPLASIA 1	Frontonasal dysplasia 1, 136760 (3)	Frontonasal dysplasia 1	n	-	-	-	ALX3	HGNC:449	Frontonasal dysplasia 1, 136760 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
136800	CORNEAL DYSTROPHY, FUCHS ENDOTHELIAL, 1	Corneal dystrophy, Fuchs endothelial, 1, 136800 (3)	Corneal dystrophy, Fuchs endothelial, 1	y	CORNEAL DYSTROPHY, FUCHS ENDOTHELIAL, 1; FECD1	Clinical Synopsis	death|deaths	COL8A2	HGNC:2216	Corneal dystrophy, Fuchs endothelial, 1, 136800 (3), Autosomal dominant	Autosomal dominant	y	n	-	-	-	-	ambiguous	ambiguous|nonlethal	ambiguous	-	-	-
136880	FUNDUS ALBIPUNCTATUS	Retinitis punctata albescens, 136880 (3)	Retinitis punctata albescens	n	-	-	-	PRPH2	HGNC:9942	Retinitis punctata albescens, 136880 (3), Autosomal dominant, Autosomal recessive	Autosomal dominant, Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
136880	FUNDUS ALBIPUNCTATUS	Fundus albipunctatus, 136880 (3)	Fundus albipunctatus	n	-	-	-	RDH5	HGNC:9940	Fundus albipunctatus, 136880 (3), Autosomal dominant, Autosomal recessive	Autosomal dominant, Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
136880	FUNDUS ALBIPUNCTATUS	Retinitis punctata albescens, 136880 (3)	Retinitis punctata albescens	n	-	-	-	RHO	HGNC:10012	Retinitis punctata albescens, 136880 (3), Autosomal dominant, Autosomal recessive	Autosomal dominant, Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
136880	FUNDUS ALBIPUNCTATUS	Fundus albipunctatus, 136880 (3)	Fundus albipunctatus	n	-	-	-	RLBP1	HGNC:10024	Fundus albipunctatus, 136880 (3), Autosomal dominant, Autosomal recessive	Autosomal dominant, Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
136880	FUNDUS ALBIPUNCTATUS	Retinitis punctata albescens, 136880 (3)	Retinitis punctata albescens	n	-	-	-	RLBP1	HGNC:10024	Retinitis punctata albescens, 136880 (3), Autosomal dominant, Autosomal recessive	Autosomal dominant, Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
136900	SORSBY FUNDUS DYSTROPHY	Sorsby fundus dystrophy, 136900 (3)	Sorsby fundus dystrophy	n	-	-	-	TIMP3	HGNC:11822	Sorsby fundus dystrophy, 136900 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
137200	NEUROMYOTONIA AND AXONAL NEUROPATHY, AUTOSOMAL RECESSIVE	Neuromyotonia and axonal neuropathy, autosomal recessive, 137200 (3)	Neuromyotonia and axonal neuropathy, autosomal recessive	n	-	-	-	HINT1	HGNC:4912	Neuromyotonia and axonal neuropathy, autosomal recessive, 137200 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
137215	DIFFUSE GASTRIC AND LOBULAR BREAST CANCER SYNDROME	Diffuse gastric and lobular breast cancer syndrome with or without cleft lip and/or palate, 137215 (3)	Diffuse gastric and lobular breast cancer syndrome with or without cleft lip and/or palate	y	DIFFUSE GASTRIC AND LOBULAR BREAST CANCER SYNDROME; DGLBC	Clinical Features	died	CDH1	HGNC:1748	Diffuse gastric and lobular breast cancer syndrome with or without cleft lip and/or palate, 137215 (3), Autosomal dominant	Autosomal dominant	y	y	[Jones (1964) described 3 multigenerational Maori families from New Zealand segregating early-onset familial gastric cancer. These families were later studied in detail by Guilford et al. (1998). In 1 family, 25 members ranging in age from 14 years upwards had died over 30 years]	LU	y	y	lethal	lethal|nonlethal	lethal|nonlethal	LU	LU	post-infant-lethal
137440	GERSTMANN-STRAUSSLER DISEASE	Cerebral amyloid angiopathy, PRNP-related, 137440 (3)	Cerebral amyloid angiopathy, PRNP-related	y	GERSTMANN-STRAUSSLER DISEASE; GSD	Clinical Features	death|deaths|died	PRNP	HGNC:9449	Cerebral amyloid angiopathy, PRNP-related, 137440 (3), Autosomal dominant	Autosomal dominant	y	y	[Panegyres et al. (2001) reported a man with GSD confirmed by mutation in the PRNP gene (176640.0021)... He died at age 51, 9 years after symptom onset / Jayadev et al. (2011) reported a woman with onset of progressive memory impairment and depression beginning at age 39 years and resulting in death at age 47]	L6	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L6	L6	post-infant-lethal
137440	GERSTMANN-STRAUSSLER DISEASE	Gerstmann-Straussler disease, 137440 (3)	Gerstmann-Straussler disease	y	GERSTMANN-STRAUSSLER DISEASE; GSD	Clinical Features	death|deaths|died	PRNP	HGNC:9449	Gerstmann-Straussler disease, 137440 (3), Autosomal dominant	Autosomal dominant	y	y	[Panegyres et al. (2001) reported a man with GSD confirmed by mutation in the PRNP gene (176640.0021)... He died at age 51, 9 years after symptom onset / Jayadev et al. (2011) reported a woman with onset of progressive memory impairment and depression beginning at age 39 years and resulting in death at age 47]	L6	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L6	L6	post-infant-lethal
137580	GILLES DE LA TOURETTE SYNDROME	Tourette syndrome, 137580 (3)	Tourette syndrome	y	GILLES DE LA TOURETTE SYNDROME; GTS	Clinical Features	miscarriage|miscarriages	SLITRK1	HGNC:20297	Tourette syndrome, 137580 (3), Autosomal dominant	Autosomal dominant	y	n	-	-	-	-	ambiguous	ambiguous	ambiguous	-	-	-
137600	ANTERIOR SEGMENT DYSGENESIS 4	Anterior segment dysgenesis 4, 137600 (3)	Anterior segment dysgenesis 4	n	-	-	-	PITX2	HGNC:9005	Anterior segment dysgenesis 4, 137600 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
137750	GLAUCOMA 1, OPEN ANGLE, A	Glaucoma 1A, primary open angle, 137750 (3)	Glaucoma 1A, primary open angle	n	-	-	-	MYOC	HGNC:7610	Glaucoma 1A, primary open angle, 137750 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
137760	GLAUCOMA, PRIMARY OPEN ANGLE	Glaucoma 1, open angle, E, 137760 (3)	Glaucoma 1, open angle, E	y	GLAUCOMA, PRIMARY OPEN ANGLE; POAG	Phenotype	death|deaths	OPTN	HGNC:17142	Glaucoma 1, open angle, E, 137760 (3), Autosomal dominant	Autosomal dominant	y	n	-	-	-	-	ambiguous	ambiguous|lethal	lethal	L6	L6	post-infant-lethal
137920	RENAL CYSTS AND DIABETES SYNDROME	Renal cysts and diabetes syndrome, 137920 (3)	Renal cysts and diabetes syndrome	y	RENAL CYSTS AND DIABETES SYNDROME; RCAD	Clinical Features	died	HNF1B	HGNC:11630	Renal cysts and diabetes syndrome, 137920 (3), Autosomal dominant	Autosomal dominant	y	y	[Sovik et al. (2002) reported follow-up on the family with MODY5 originally reported by Lindner et al. (1999)...She died at age 27 years]	L6	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L6	L6	post-infant-lethal
137940	HYPOTRICHOSIS-LYMPHEDEMA-TELANGIECTASIA-RENAL DEFECT SYNDROME	Hypotrichosis-lymphedema-telangiectasia-renal defect syndrome, 137940 (3)	Hypotrichosis-lymphedema-telangiectasia-renal defect syndrome	y	HYPOTRICHOSIS-LYMPHEDEMA-TELANGIECTASIA-RENAL DEFECT SYNDROME; HLTRS	Clinical Features	died	SOX18	HGNC:11194	Hypotrichosis-lymphedema-telangiectasia-renal defect syndrome, 137940 (3), Autosomal dominant	Autosomal dominant	n	y	[Irrthum et al. (2003) reported a boy who had sparse hair at birth and presented with swelling of the upper eyelids, scrotal edema, and very large bilateral hydroceles... His brother had died in utero at 30 weeks' gestation. The fetus had nonimmune hydrops fetalis, with chylous effusions in the pleural and peritoneal cavities. The lungs showed generalized vascular congestion and a mild dilatation of lymphatic vessels; postmortem examination showed pulmonary lymphangiectasia]	L1	n	y	lethal	lethal|nonlethal	lethal|nonlethal	L1	L1	pre-infant-lethal
138000	GLOMUVENOUS MALFORMATIONS	Glomuvenous malformations, 138000 (3)	Glomuvenous malformations	n	-	-	-	GLMN	HGNC:14373	Glomuvenous malformations, 138000 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
138800	GOITER, MULTINODULAR 1, WITH OR WITHOUT SERTOLI-LEYDIG CELL TUMORS	Goiter, multinodular 1, with or without Sertoli-Leydig cell tumors, 138800 (3)	Goiter, multinodular 1, with or without Sertoli-Leydig cell tumors	y	GOITER, MULTINODULAR 1, WITH OR WITHOUT SERTOLI-LEYDIG CELL TUMORS; MNG1	Clinical Features	died	DICER1	HGNC:17098	Goiter, multinodular 1, with or without Sertoli-Leydig cell tumors, 138800 (3), Autosomal dominant	Autosomal dominant	n	y	[Druker et al. (1997) reported a family of Ashkenazi Jewish descent in which 7 individuals had benign and/or malignant thyroid tumors... Three of the proband's sibs had thyroid conditions, including 2 with multinodular goiter and 1 with an enlarged thyroid; 1 of the sibs died of an alveolar rhabdomyosarcoma at age 20 years]	L6	n	y	lethal	lethal|nonlethal	lethal|nonlethal	L4|L6	L4	post-infant-lethal
139090	GRAY PLATELET SYNDROME	Gray platelet syndrome, 139090 (3)	Gray platelet syndrome	y	GRAY PLATELET SYNDROME; GPS	Clinical Features	death|deaths	NBEAL2	HGNC:31928	Gray platelet syndrome, 139090 (3), Autosomal recessive	Autosomal recessive	n	y	[Gunay-Aygun et al. (2010) reported 21 patients with GPS from 14 families. Of the 8 patients with severe bleeding, 7 were females in whom menorrhagia and resultant severe anemia required repeated blood transfusions, resulting in death in 2]	LU	y	-	lethal	lethal	lethal	LU	LU	post-infant-lethal
139210	MYHRE SYNDROME	Myhre syndrome, 139210 (3)	Myhre syndrome	y	MYHRE SYNDROME; MYHRS	Clinical Features|Phenotype	death|deaths|died	SMAD4	HGNC:6770	Myhre syndrome, 139210 (3), Autosomal dominant	Autosomal dominant	y	y	[Garavelli et al. (2016) reported a patient with Myhre syndrome who exhibited pericarditis and cardiac tamponade as life-threatening complications / Lin et al. (2016) reported 4 patients with Myhre syndrome and reviewed 50 previously reported patients... Pericarditis and restrictive cardiomyopathy were associated with high mortality (3 patients each among 10 deaths)]	LU	y	-	lethal	lethal	lethal	L6|LU	L6	post-infant-lethal
139300	AROMATASE EXCESS SYNDROME	Aromatase excess syndrome, 139300 (3)	Aromatase excess syndrome	n	-	-	-	CYP19A1	HGNC:2594	Aromatase excess syndrome, 139300 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
140000	HAND-FOOT-GENITAL SYNDROME	Hand-foot-genital syndrome, 140000 (3)	Hand-foot-genital syndrome	n	-	-	-	HOXA13	HGNC:5102	Hand-foot-genital syndrome, 140000 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
140350	HAWKINSINURIA	Hawkinsinuria, 140350 (3)	Hawkinsinuria	y	HAWKINSINURIA; HWKS	Clinical Features	died	HPD	HGNC:5147	Hawkinsinuria, 140350 (3), Autosomal dominant	Autosomal dominant	y	y	[Item et al. (2007) reported a 6-month-old Indian boy with mild hepatomegaly, pedal edema, and mild delay of motor and developmental milestones...The patient's older brother had hepatomegaly and recurrent episodes of metabolic acidosis and died at the age of 15 months of unknown cause]	L3	n	y	lethal	ambiguous|lethal	lethal	L3	L3	pre-infant-lethal
140700	HEINZ BODY ANEMIAS	Heinz body anemias, alpha-, 140700 (3)	Heinz body anemias, alpha-	n	-	-	-	HBA1	HGNC:4823	Heinz body anemias, alpha-, 140700 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L1	L1	pre-infant-lethal
140700	HEINZ BODY ANEMIAS	Heinz body anemia, 140700 (3)	Heinz body anemia	n	-	-	-	HBA2	HGNC:4824	Heinz body anemia, 140700 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L1	L1	pre-infant-lethal
140700	HEINZ BODY ANEMIAS	Heinz body anemia, 140700 (3)	Heinz body anemia	n	-	-	-	HBB	HGNC:4827	Heinz body anemia, 140700 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	ambiguous|lethal|nonlethal	lethal|nonlethal	L3|L6	L3	pre-infant-lethal
141200	HEMATURIA, BENIGN FAMILIAL, 1	Hematuria, familial benign, 1, 141200 (3)	Hematuria, familial benign, 1	n	-	-	-	COL4A4	HGNC:2206	Hematuria, familial benign, 1, 141200 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L4	L4	post-infant-lethal
141500	MIGRAINE, FAMILIAL HEMIPLEGIC, 1	Migraine, familial hemiplegic, 1, 141500 (3)	Migraine, familial hemiplegic, 1	n	-	-	-	CACNA1A	HGNC:1388	Migraine, familial hemiplegic, 1, 141500 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L4|L6	L4	post-infant-lethal
141500	MIGRAINE, FAMILIAL HEMIPLEGIC, 1	Migraine, familial hemiplegic, 1, with progressive cerebellar ataxia, 141500 (3)	Migraine, familial hemiplegic, 1, with progressive cerebellar ataxia	n	-	-	-	CACNA1A	HGNC:1388	Migraine, familial hemiplegic, 1, with progressive cerebellar ataxia, 141500 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L4|L6	L4	post-infant-lethal
141749	FETAL HEMOGLOBIN QUANTITATIVE TRAIT LOCUS 1	Delta-beta thalassemia, 141749 (3)	Delta-beta thalassemia	n	-	-	-	HBB	HGNC:4827	Delta-beta thalassemia, 141749 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	ambiguous|lethal|nonlethal	lethal|nonlethal	L3|L6	L3	pre-infant-lethal
141749	FETAL HEMOGLOBIN QUANTITATIVE TRAIT LOCUS 1	Hereditary persistence of fetal hemoglobin, 141749 (3)	Hereditary persistence of fetal hemoglobin	n	-	-	-	HBB	HGNC:4827	Hereditary persistence of fetal hemoglobin, 141749 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	ambiguous|lethal|nonlethal	lethal|nonlethal	L3|L6	L3	pre-infant-lethal
141749	FETAL HEMOGLOBIN QUANTITATIVE TRAIT LOCUS 1	Fetal hemoglobin quantitative trait locus 1, 141749 (3)	Fetal hemoglobin quantitative trait locus 1	n	-	-	-	HBG1	HGNC:4831	Fetal hemoglobin quantitative trait locus 1, 141749 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
141749	FETAL HEMOGLOBIN QUANTITATIVE TRAIT LOCUS 1	Fetal hemoglobin quantitative trait locus 1, 141749 (3)	Fetal hemoglobin quantitative trait locus 1	n	-	-	-	HBG2	HGNC:4832	Fetal hemoglobin quantitative trait locus 1, 141749 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
142680	PERIODIC FEVER, FAMILIAL, AUTOSOMAL DOMINANT	Periodic fever, familial, 142680 (3)	Periodic fever, familial	n	-	-	-	TNFRSF1A	HGNC:11916	Periodic fever, familial, 142680 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
142690	ACNE INVERSA, FAMILIAL, 1	Acne inversa, familial, 1, 142690 (3)	Acne inversa, familial, 1	y	ACNE INVERSA, FAMILIAL, 1; ACNINV1	Description|Clinical Features	lethal|died	NCSTN	HGNC:17091	Acne inversa, familial, 1, 142690 (3), Autosomal dominant	Autosomal dominant	y	y	[Squamous cell carcinoma is a rare but potentially lethal complication that may develop in affected skin (Nishimori et al., 2020) / Nishimori et al. (2020) reported a 4-generation Japanese family with hidradenitis suppurativa (HS)...The proband developed squamous cell carcinoma (SCC) on his right buttock which, despite treatment, recurred and eventually metastasized to sacral bone and inguinal lymph nodes, and he died of SCC at age 44]	L6	y	-	lethal	lethal	lethal	L6	L6	post-infant-lethal
142900	HOLT-ORAM SYNDROME	Holt-Oram syndrome, 142900 (3)	Holt-Oram syndrome	y	HOLT-ORAM SYNDROME; HOS	Clinical Features	died	TBX5	HGNC:11604	Holt-Oram syndrome, 142900 (3), Autosomal dominant	Autosomal dominant	n	y	[Basson et al. (1994) reported 2 extensively affected kindreds with HOS showing linkage to chromosome 12... One member of the family died of complications related to a complete atrioventricular canal defect]	LU	n	y	lethal	lethal	lethal	LU	LU	post-infant-lethal
142945	HOLOPROSENCEPHALY 3	Holoprosencephaly 3, 142945 (3)	Holoprosencephaly 3	y	HOLOPROSENCEPHALY 3; HPE3	Clinical Synopsis	death|deaths	SHH	HGNC:10848	Holoprosencephaly 3, 142945 (3), Autosomal dominant	Autosomal dominant	n	y	[Severe alobar form may result in death in infancy]	L3	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L3	L3	pre-infant-lethal
142946	HOLOPROSENCEPHALY 4	Holoprosencephaly 4, 142946 (3)	Holoprosencephaly 4	n	-	-	-	TGIF1	HGNC:11776	Holoprosencephaly 4, 142946 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
143095	SPONDYLOEPIPHYSEAL DYSPLASIA WITH CONGENITAL JOINT DISLOCATIONS	Spondyloepiphyseal dysplasia with congenital joint dislocations, 143095 (3)	Spondyloepiphyseal dysplasia with congenital joint dislocations	y	SPONDYLOEPIPHYSEAL DYSPLASIA WITH CONGENITAL JOINT DISLOCATIONS; SEDCJD	Clinical Features	died	CHST3	HGNC:1971	Spondyloepiphyseal dysplasia with congenital joint dislocations, 143095 (3), Autosomal recessive	Autosomal recessive	y	y	[Kozlowski et al. (1974) described 2 half sibs with an unusual skeletal dysplasia of which short humerus with distal bifurcation was one of the more striking features... Both children, brother and sister, had congenital heart disease from which 1 died at the age of 7.5 months]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
143100	HUNTINGTON DISEASE	Huntington disease, 143100 (3)	Huntington disease	y	HUNTINGTON DISEASE; HD	Clinical Features|Diagnosis|Phenotype	death|deaths|died	HTT	HGNC:4851	Huntington disease, 143100 (3), Autosomal dominant	Autosomal dominant	y	y	[Nahhas et al. (2005) reported a girl with a maternal family history of HD who had onset of symptoms at age 3 and died at age 7 due to complications of HD]	L4	y	-	lethal	lethal	lethal	L4	L4	post-infant-lethal
143200	WAGNER VITREORETINOPATHY	Wagner syndrome 1, 143200 (3)	Wagner syndrome 1	n	-	-	-	VCAN	HGNC:2464	Wagner syndrome 1, 143200 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
143400	CONGENITAL ANOMALIES OF KIDNEY AND URINARY TRACT 2	Congenital anomalies of kidney and urinary tract 2, 143400 (3)	Congenital anomalies of kidney and urinary tract 2	y	CONGENITAL ANOMALIES OF KIDNEY AND URINARY TRACT 2; CAKUT2	Clinical Features	died	TBX18	HGNC:11595	Congenital anomalies of kidney and urinary tract 2, 143400 (3), Autosomal dominant	Autosomal dominant	n	y	MacKay (1945) observed congenital megaloureters with hydronephrosis in 3 sibs (bilateral in 2). Two other sibs were said to have died of congenital sarcoma of the kidney]	LU	n	y	lethal	lethal	lethal	LU	LU	post-infant-lethal
143470	HYPERALPHALIPOPROTEINEMIA 1	Hyperalphalipoproteinemia, 143470 (3)	Hyperalphalipoproteinemia	y	HYPERALPHALIPOPROTEINEMIA 1; HALP1	Clinical Features|Phenotype	death|deaths	CETP	HGNC:1869	Hyperalphalipoproteinemia, 143470 (3), Autosomal dominant	Autosomal dominant	n	n	-	-	-	-	ambiguous	ambiguous	ambiguous	-	-	-
143860	HYPERCHLORHIDROSIS, ISOLATED	Hyperchlorhidrosis, isolated, 143860 (3)	Hyperchlorhidrosis, isolated	n	-	-	-	CA12	HGNC:1371	Hyperchlorhidrosis, isolated, 143860 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
143880	HYPERCALCEMIA, INFANTILE, 1	Hypercalcemia, infantile, 1, 143880 (3)	Hypercalcemia, infantile, 1	n	-	-	-	CYP24A1	HGNC:2602	Hypercalcemia, infantile, 1, 143880 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
143890	HYPERCHOLESTEROLEMIA, FAMILIAL, 1	Hypercholesterolemia, familial, 1, 143890 (3)	Hypercholesterolemia, familial, 1	n	-	-	-	LDLR	HGNC:6547	Hypercholesterolemia, familial, 1, 143890 (3), Autosomal dominant, Autosomal recessive	Autosomal dominant, Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
143890	HYPERCHOLESTEROLEMIA, FAMILIAL, 1	LDL cholesterol level QTL2, 143890 (3)	LDL cholesterol level QTL2	n	-	-	-	LDLR	HGNC:6547	LDL cholesterol level QTL2, 143890 (3), Autosomal dominant, Autosomal recessive	Autosomal dominant, Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
144010	HYPERCHOLESTEROLEMIA, FAMILIAL, 2	Hypercholesterolemia, familial, 2, 144010 (3)	Hypercholesterolemia, familial, 2	n	-	-	-	APOB	HGNC:603	Hypercholesterolemia, familial, 2, 144010 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L6	L6	post-infant-lethal
144200	PALMOPLANTAR KERATODERMA, EPIDERMOLYTIC, 1	Palmoplantar keratoderma, epidermolytic, 1, 144200 (3)	Palmoplantar keratoderma, epidermolytic, 1	n	-	-	-	KRT9	HGNC:6447	Palmoplantar keratoderma, epidermolytic, 1, 144200 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
144250	HYPERLIPIDEMIA, FAMILIAL COMBINED, 3	Combined hyperlipidemia, familial, 144250 (3)	Combined hyperlipidemia, familial	n	-	-	-	LPL	HGNC:6677	Combined hyperlipidemia, familial, 144250 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
144650	HYPERLIPOPROTEINEMIA, TYPE V	Hyperchylomicronemia, late-onset, 144650 (3)	Hyperchylomicronemia, late-onset	n	-	-	-	APOA5	HGNC:17288	Hyperchylomicronemia, late-onset, 144650 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
144700	RENAL CELL CARCINOMA, NONPAPILLARY	Renal cell carcinoma, 144700 (3)	Renal cell carcinoma	y	RENAL CELL CARCINOMA, NONPAPILLARY; RCC	Clinical Features	died	HNF1A	HGNC:11621	Renal cell carcinoma, 144700 (3)	-	y	y	[Brinton (1960) described a family in which 2 brothers and a sister had hypernephroma. The father had died of kidney tumor and the mother of cancer, site unstated]	LU	n	y	lethal	lethal|nonlethal	lethal|nonlethal	LU	LU	post-infant-lethal
144700	RENAL CELL CARCINOMA, NONPAPILLARY	Renal cell carcinoma, 144700 (3)	Renal cell carcinoma	y	RENAL CELL CARCINOMA, NONPAPILLARY; RCC	Clinical Features	died	RNF139	HGNC:17023	Renal cell carcinoma, 144700 (3)	-	y	y	[adulthood]	LU	n	y	lethal	lethal	lethal	LU	LU	post-infant-lethal
144750	ENDOSTEAL HYPEROSTOSIS, AUTOSOMAL DOMINANT	Endosteal hyperostosis, 144750 (3)	Endosteal hyperostosis	n	-	-	-	LRP5	HGNC:6697	Endosteal hyperostosis, 144750 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
145000	HYPERPARATHYROIDISM 1	Hyperparathyroidism, familial primary, 145000 (3)	Hyperparathyroidism, familial primary	n	-	-	-	CDC73	HGNC:16783	Hyperparathyroidism, familial primary, 145000 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	LU	LU	post-infant-lethal
145001	HYPERPARATHYROIDISM 2 WITH JAW TUMORS	Hyperparathyroidism-jaw tumor syndrome, 145001 (3)	Hyperparathyroidism-jaw tumor syndrome	y	HYPERPARATHYROIDISM 2 WITH JAW TUMORS; HRPT2	Clinical Features	died	CDC73	HGNC:16783	Hyperparathyroidism-jaw tumor syndrome, 145001 (3), Autosomal dominant	Autosomal dominant	y	y	[Pidwirny et al. (1995) found that the proband in the Canadian family reported by Kennett and Pollick (1971) had died of parathyroid carcinoma]	LU	y	-	lethal	lethal|nonlethal	lethal|nonlethal	LU	LU	post-infant-lethal
145001	HYPERPARATHYROIDISM 2 WITH JAW TUMORS	Parathyroid adenoma with cystic changes, 145001 (3)	Parathyroid adenoma with cystic changes	y	HYPERPARATHYROIDISM 2 WITH JAW TUMORS; HRPT2	Clinical Features	died	CDC73	HGNC:16783	Parathyroid adenoma with cystic changes, 145001 (3), Autosomal dominant	Autosomal dominant	y	y	[Pidwirny et al. (1995) found that the proband in the Canadian family reported by Kennett and Pollick (1971) had died of parathyroid carcinoma]	LU	y	-	lethal	lethal|nonlethal	lethal|nonlethal	LU	LU	post-infant-lethal
145250	HYPERPIGMENTATION WITH OR WITHOUT HYPOPIGMENTATION, FAMILIAL PROGRESSIVE	Hyperpigmentation with or without hypopigmentation, 145250 (3)	Hyperpigmentation with or without hypopigmentation	n	-	-	-	KITLG	HGNC:6343	Hyperpigmentation with or without hypopigmentation, 145250 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	ambiguous|nonlethal	ambiguous	-	-	-
145350	HYPOTAURINEMIC RETINAL DEGENERATION AND CARDIOMYOPATHY	Hypotaurinemic retinal degeneration and cardiomyopathy, 145350 (3)	Hypotaurinemic retinal degeneration and cardiomyopathy	n	-	-	-	SLC6A6	HGNC:11052	Hypotaurinemic retinal degeneration and cardiomyopathy, 145350 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
145420	TEEBI HYPERTELORISM SYNDROME 1	Teebi hypertelorism syndrome 1, 145420 (3)	Teebi hypertelorism syndrome 1	y	TEEBI HYPERTELORISM SYNDROME 1; TBHS1	Clinical Features|Phenotype	died	SPECC1L	HGNC:29022	Teebi hypertelorism syndrome 1, 145420 (3), Autosomal dominant	Autosomal dominant	y	y	[died on day 14 of life]	L2	y	-	lethal	lethal	lethal	L2	L2	pre-infant-lethal
145650	THYROID HORMONE RESISTANCE, SELECTIVE PITUITARY	Thyroid hormone resistance, selective pituitary, 145650 (3)	Thyroid hormone resistance, selective pituitary	n	-	-	-	THRB	HGNC:11799	Thyroid hormone resistance, selective pituitary, 145650 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
145900	HYPERTROPHIC NEUROPATHY OF DEJERINE-SOTTAS	Dejerine-Sottas disease, 145900 (3)	Dejerine-Sottas disease	y	HYPERTROPHIC NEUROPATHY OF DEJERINE-SOTTAS	Clinical Features|Phenotype	died|death|deaths	EGR2	HGNC:3239	Dejerine-Sottas disease, 145900 (3), Autosomal dominant, Autosomal recessive	Autosomal dominant, Autosomal recessive	n	y	[Timmerman et al. (1999) screened 170 unrelated neuropathy patients and identified 2 with Dejerine-Sottas neuropathy who had a heterozygous R359W mutation (129010.0004) in the alpha-helix domain of the first zinc finger of EGR2...The expressivity ranged from that typical for DSN to a more rapidly progressive neuropathy that can cause death by age 6 years (In Inheritance) *** In Molecular Genetics]	L4	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L3|L4	L3	pre-infant-lethal
145900	HYPERTROPHIC NEUROPATHY OF DEJERINE-SOTTAS	Dejerine-Sottas disease, 145900 (3)	Dejerine-Sottas disease	y	HYPERTROPHIC NEUROPATHY OF DEJERINE-SOTTAS	Clinical Features|Phenotype	died|death|deaths	MPZ	HGNC:7225	Dejerine-Sottas disease, 145900 (3), Autosomal dominant, Autosomal recessive	Autosomal dominant, Autosomal recessive	n	n	-	-	-	-	ambiguous	ambiguous|lethal|nonlethal	lethal|nonlethal	L6	L6	post-infant-lethal
145900	HYPERTROPHIC NEUROPATHY OF DEJERINE-SOTTAS	Dejerine-Sottas disease, 145900 (3)	Dejerine-Sottas disease	y	HYPERTROPHIC NEUROPATHY OF DEJERINE-SOTTAS	Clinical Features|Phenotype	died|death|deaths	PMP22	HGNC:9118	Dejerine-Sottas disease, 145900 (3), Autosomal dominant, Autosomal recessive	Autosomal dominant, Autosomal recessive	n	n	-	-	-	-	ambiguous	ambiguous|nonlethal	ambiguous	-	-	-
145900	HYPERTROPHIC NEUROPATHY OF DEJERINE-SOTTAS	Dejerine-Sottas disease, 145900 (3)	Dejerine-Sottas disease	y	HYPERTROPHIC NEUROPATHY OF DEJERINE-SOTTAS	Clinical Features|Phenotype	died|death|deaths	PRX	HGNC:13797	Dejerine-Sottas disease, 145900 (3), Autosomal dominant, Autosomal recessive	Autosomal dominant, Autosomal recessive	n	n	-	-	-	-	ambiguous	ambiguous|nonlethal	ambiguous	-	-	-
145980	HYPOCALCIURIC HYPERCALCEMIA, FAMILIAL, TYPE I	Hypocalciuric hypercalcemia, type I, 145980 (3)	Hypocalciuric hypercalcemia, type I	n	-	-	-	CASR	HGNC:1514	Hypocalciuric hypercalcemia, type I, 145980 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	LU	LU	post-infant-lethal
145981	HYPOCALCIURIC HYPERCALCEMIA, FAMILIAL, TYPE II	Hypocalciuric hypercalcemia, type II, 145981 (3)	Hypocalciuric hypercalcemia, type II	n	-	-	-	GNA11	HGNC:4379	Hypocalciuric hypercalcemia, type II, 145981 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
146000	HYPOCHONDROPLASIA	Hypochondroplasia, 146000 (3)	Hypochondroplasia	n	-	-	-	FGFR3	HGNC:3690	Hypochondroplasia, 146000 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L2|L3	L2	pre-infant-lethal
146110	HYPOGONADOTROPIC HYPOGONADISM 7 WITH OR WITHOUT ANOSMIA	Hypogonadotropic hypogonadism 7 without anosmia, 146110 (3)	Hypogonadotropic hypogonadism 7 without anosmia	n	-	-	-	GNRHR	HGNC:4421	Hypogonadotropic hypogonadism 7 without anosmia, 146110 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
146200	HYPOPARATHYROIDISM, FAMILIAL ISOLATED, 1	Hypoparathyroidism, familial isolated 1, 146200 (3)	Hypoparathyroidism, familial isolated 1	y	HYPOPARATHYROIDISM, FAMILIAL ISOLATED, 1; FIH1	Clinical Features	died	PTH	HGNC:9606	Hypoparathyroidism, familial isolated 1, 146200 (3), Autosomal dominant, Autosomal recessive	Autosomal dominant, Autosomal recessive	y	n	-	-	-	-	ambiguous	ambiguous	ambiguous	-	-	-
146255	HYPOPARATHYROIDISM, SENSORINEURAL DEAFNESS, AND RENAL DYSPLASIA SYNDROME	Hypoparathyroidism, sensorineural deafness, and renal dysplasia, 146255 (3)	Hypoparathyroidism, sensorineural deafness, and renal dysplasia	y	HYPOPARATHYROIDISM, SENSORINEURAL DEAFNESS, AND RENAL DYSPLASIA SYNDROME; HDRS	Clinical Features	death|deaths	GATA3	HGNC:4172	Hypoparathyroidism, sensorineural deafness, and renal dysplasia, 146255 (3), Autosomal dominant	Autosomal dominant	y	y	[Barakat et al. (1977) also described male twins from another family with similar findings and death at age 3 years]	L4	y	-	lethal	lethal	lethal	L4	L4	post-infant-lethal
146300	HYPOPHOSPHATASIA, ADULT	Hypophosphatasia, adult, 146300 (3)	Hypophosphatasia, adult	y	HYPOPHOSPHATASIA, ADULT; HPPA	Clinical Features	died	ALPL	HGNC:438	Hypophosphatasia, adult, 146300 (3), Autosomal dominant, Autosomal recessive	Autosomal dominant, Autosomal recessive	y	y	[Lia-Baldini et al. (2001) reported a 15-month-old girl with a phenotype suggestive of childhood hypophosphatasia, whose father had recurrent dental caries in his third decade despite being raised with fluoridated water, which the authors suggested represented odontohypophosphatasia. A paternal aunt had died at 7 days of apparent neonatal hypophosphatasia]	L2	n	y	lethal	lethal	lethal	L1|L2	L1	pre-infant-lethal
146300	HYPOPHOSPHATASIA, ADULT	Odontohypophosphatasia, 146300 (3)	Odontohypophosphatasia	y	HYPOPHOSPHATASIA, ADULT; HPPA	Clinical Features	died	ALPL	HGNC:438	Odontohypophosphatasia, 146300 (3), Autosomal dominant, Autosomal recessive	Autosomal dominant, Autosomal recessive	y	y	[Lia-Baldini et al. (2001) reported a 15-month-old girl with a phenotype suggestive of childhood hypophosphatasia, whose father had recurrent dental caries in his third decade despite being raised with fluoridated water, which the authors suggested represented odontohypophosphatasia. A paternal aunt had died at 7 days of apparent neonatal hypophosphatasia]	L2	n	y	lethal	lethal	lethal	L1|L2	L1	pre-infant-lethal
146510	PALLISTER-HALL SYNDROME	Pallister-Hall syndrome, 146510 (3)	Pallister-Hall syndrome	y	PALLISTER-HALL SYNDROME; PHS	Clinical Features|Diagnosis|Phenotype	died|lethal|lethality	GLI3	HGNC:4319	Pallister-Hall syndrome, 146510 (3), Autosomal dominant	Autosomal dominant	n	y	[Graham et al. (1983) described an infant with abnormal auricles, short nose with flattened bridge, microglossia, micrognathia, cleft palate, short limbs, dislocated hips, and 4-limb postaxial polydactyly. The infant died at 2 hours of age and autopsy showed hypothalamic hamartoblastoma]	L2	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L2	L2	pre-infant-lethal
146520	HYPOTRICHOSIS 2	Hypotrichosis 2, 146520 (3)	Hypotrichosis 2	n	-	-	-	CDSN	HGNC:1802	Hypotrichosis 2, 146520 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L3	L3	pre-infant-lethal
146550	HYPOTRICHOSIS 4	Hypotrichosis 4, 146550 (3)	Hypotrichosis 4	n	-	-	-	HRURF	HGNC:55085	Hypotrichosis 4, 146550 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
146590	ICHTHYOSIS HYSTRIX, CURTH-MACKLIN TYPE	Ichthyosis histrix, Curth-Macklin type, 146590 (3)	Ichthyosis histrix, Curth-Macklin type	n	-	-	-	KRT1	HGNC:6412	Ichthyosis histrix, Curth-Macklin type, 146590 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L2	L2	pre-infant-lethal
146700	ICHTHYOSIS VULGARIS	Ichthyosis vulgaris, 146700 (3)	Ichthyosis vulgaris	n	-	-	-	FLG	HGNC:3748	Ichthyosis vulgaris, 146700 (3), Autosomal dominant, Autosomal recessive	Autosomal dominant, Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
146750	ICHTHYOSIS, LAMELLAR, AUTOSOMAL DOMINANT	Ichthyosis, lamellar, autosomal dominant, 146750 (3)	Ichthyosis, lamellar, autosomal dominant	n	-	-	-	ASPRV1	HGNC:26321	Ichthyosis, lamellar, autosomal dominant, 146750 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
146800	ICHTHYOSIS BULLOSA OF SIEMENS	Ichthyosis bullosa of Siemens, 146800 (3)	Ichthyosis bullosa of Siemens	n	-	-	-	KRT2	HGNC:6439	Ichthyosis bullosa of Siemens, 146800 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
147060	HYPER-IgE SYNDROME 1, AUTOSOMAL DOMINANT, WITH RECURRENT INFECTIONS	Hyper-IgE syndrome 1, autosomal dominant, with recurrent infections, 147060 (3)	Hyper-IgE syndrome 1, autosomal dominant, with recurrent infections	n	-	-	-	STAT3	HGNC:11364	Hyper-IgE syndrome 1, autosomal dominant, with recurrent infections, 147060 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
147250	SOLITARY MEDIAN MAXILLARY CENTRAL INCISOR	Single median maxillary central incisor, 147250 (3)	Single median maxillary central incisor	n	-	-	-	SHH	HGNC:10848	Single median maxillary central incisor, 147250 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L3	L3	pre-infant-lethal
147480	CHOLESTASIS, INTRAHEPATIC, OF PREGNANCY, 1	Cholestasis, intrahepatic, of pregnancy, 1, 147480 (3)	Cholestasis, intrahepatic, of pregnancy, 1	y	CHOLESTASIS, INTRAHEPATIC, OF PREGNANCY, 1; ICP1	Description|Clinical Features|Clinical Synopsis	death|deaths|fatal	ATP8B1	HGNC:3706	Cholestasis, intrahepatic, of pregnancy, 1, 147480 (3), Autosomal dominant	Autosomal dominant	n	n	-	-	-	-	ambiguous	ambiguous|lethal|nonlethal	lethal|nonlethal	L3	L3	pre-infant-lethal
147630	INSULINOMATOSIS AND DIABETES MELLITUS	Insulinomatosis and diabetes mellitus, 147630 (3)	Insulinomatosis and diabetes mellitus	n	-	-	-	MAFA	HGNC:23145	Insulinomatosis and diabetes mellitus, 147630 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
147891	ISCHIOCOXOPODOPATELLAR SYNDROME WITH OR WITHOUT PULMONARY ARTERIAL HYPERTENSION	Ischiocoxopodopatellar syndrome with or without pulmonary arterial hypertension, 147891 (3)	Ischiocoxopodopatellar syndrome with or without pulmonary arterial hypertension	y	ISCHIOCOXOPODOPATELLAR SYNDROME WITH OR WITHOUT PULMONARY ARTERIAL HYPERTENSION; ICPPS	Clinical Features	died	TBX4	HGNC:11603	Ischiocoxopodopatellar syndrome with or without pulmonary arterial hypertension, 147891 (3), Autosomal dominant	Autosomal dominant	y	y	[Galambos et al. (2019) evaluated a cohort of 19 patients with pulmonary hypertension, including persistent pulmonary hypertension in neonates (PPHN), who had mutations in the TBX4 gene (13 patients) or deletions encompassing TBX4 (6 patients). Ten patients were diagnosed with neonatal hypoxic respiratory failure and PPHN and were subsequently discharged home. These patients were later diagnosed with pulmonary hypertension in infancy or childhood. Half of these patients died or required lung transplantation]	L3	y	-	lethal	lethal	lethal	L1|L3	L1	pre-infant-lethal
147920	KABUKI SYNDROME 1	Kabuki syndrome 1, 147920 (3)	Kabuki syndrome 1	y	KABUKI SYNDROME 1; KABUK1	Clinical Features	died	KMT2D	HGNC:7133	Kabuki syndrome 1, 147920 (3), Autosomal dominant	Autosomal dominant	y	y	[Tsukahara et al. (1997) described 4 individuals with Kabuki syndrome in 2 families. In family 1, the proposita, a 2-year-old girl, and her mother had typical Kabuki syndrome. The proposita also had early breast development. In family 2, the proposita, a 6-month-old girl, and her mother had typical Kabuki syndrome. The proposita died at age 6 months as a result of complications of a cardiac malformation]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
147950	HYPOGONADOTROPIC HYPOGONADISM 2 WITH OR WITHOUT ANOSMIA	Hypogonadotropic hypogonadism 2 with or without anosmia, 147950 (3)	Hypogonadotropic hypogonadism 2 with or without anosmia	y	HYPOGONADOTROPIC HYPOGONADISM 2 WITH OR WITHOUT ANOSMIA; HH2	Clinical Features|Phenotype	died|pregnancy_loss|pregnancy_losses	FGFR1	HGNC:3688	Hypogonadotropic hypogonadism 2 with or without anosmia, 147950 (3), Autosomal dominant	Autosomal dominant	y	y	[Villanueva et al. (2015) studied 7 probands with mutations in the FGFR1 gene (see, e.g., 136350.0026) who exhibited HH as well as split hand/foot malformations (SHFM)... His unaffected parents and an anosmic sister were heterozygous for the mutation; in addition, 3 sibs with reportedly severe skeletal anomalies had died as neonates]	L2	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L2|L3	L2	pre-infant-lethal
148050	KBG SYNDROME	KBG syndrome, 148050 (3)	KBG syndrome	n	-	-	-	ANKRD11	HGNC:21316	KBG syndrome, 148050 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
148190	KERATITIS, HEREDITARY	Keratitis, 148190 (3)	Keratitis	n	-	-	-	PAX6	HGNC:8620	Keratitis, 148190 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	ambiguous|lethal|nonlethal	lethal|nonlethal	LU	LU	post-infant-lethal
148200	KERATOENDOTHELIITIS FUGAX HEREDITARIA	Keratoendothelitis fugax hereditaria, 148200 (3)	Keratoendothelitis fugax hereditaria	n	-	-	-	NLRP3	HGNC:16400	Keratoendothelitis fugax hereditaria, 148200 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L6	L6	post-infant-lethal
148210	KERATITIS-ICHTHYOSIS-DEAFNESS SYNDROME, AUTOSOMAL DOMINANT	Keratitis-ichthyosis-deafness syndrome, 148210 (3)	Keratitis-ichthyosis-deafness syndrome	y	KERATITIS-ICHTHYOSIS-DEAFNESS SYNDROME, AUTOSOMAL DOMINANT; KIDAD	Clinical Features|Diagnosis|Phenotype	died|fatal|lethal	GJB2	HGNC:4284	Keratitis-ichthyosis-deafness syndrome, 148210 (3), Autosomal dominant	Autosomal dominant	y	n	-	-	-	-	ambiguous	ambiguous|nonlethal	ambiguous	-	-	-
148300	KERATOCONUS 1	Keratoconus 1, 148300 (3)	Keratoconus 1	n	-	-	-	VSX1	HGNC:12723	Keratoconus 1, 148300 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
148350	KERATODERMA, PALMOPLANTAR, WITH DEAFNESS	Keratoderma, palmoplantar, with deafness, 148350 (3)	Keratoderma, palmoplantar, with deafness	n	-	-	-	GJB2	HGNC:4284	Keratoderma, palmoplantar, with deafness, 148350 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	ambiguous|nonlethal	ambiguous	-	-	-
148500	TYLOSIS WITH ESOPHAGEAL CANCER	Tylosis with esophageal cancer, 148500 (3)	Tylosis with esophageal cancer	y	TYLOSIS WITH ESOPHAGEAL CANCER; TOC	Clinical Features|Phenotype	died	RHBDF2	HGNC:20788	Tylosis with esophageal cancer, 148500 (3), Autosomal dominant	Autosomal dominant	n	y	[Saarinen et al. (2012) reported a 4-generation Finnish family in which 4 patients had plantar hyperkeratosis from early childhood, 1 of whom also had palmar keratosis and oral leukoplakia, and 2 of whom had thickening of the esophageal epithelium on endoscopy. Three family members had died of esophageal cancer, at ages 31, 48, and 82 years]	L6	n	y	lethal	lethal	lethal	L6	L6	post-infant-lethal
148600	PALMOPLANTAR KERATODERMA, PUNCTATE TYPE IA	Keratoderma, palmoplantar, punctate type IA, 148600 (3)	Keratoderma, palmoplantar, punctate type IA	n	-	-	-	AAGAB	HGNC:25662	Keratoderma, palmoplantar, punctate type IA, 148600 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
148700	PALMOPLANTAR KERATODERMA I, STRIATE, FOCAL, OR DIFFUSE	Keratosis palmoplantaris striata I, AD, 148700 (3)	Keratosis palmoplantaris striata I, AD	y	PALMOPLANTAR KERATODERMA I, STRIATE, FOCAL, OR DIFFUSE; PPKS1	Clinical Features	death|deaths	DSG1	HGNC:3048	Keratosis palmoplantaris striata I, AD, 148700 (3), Autosomal dominant	Autosomal dominant	y	n	-	-	-	-	ambiguous	ambiguous|lethal	lethal	L4	L4	post-infant-lethal
148820	WAARDENBURG SYNDROME, TYPE 3	Waardenburg syndrome, type 3, 148820 (3)	Waardenburg syndrome, type 3	y	WAARDENBURG SYNDROME, TYPE 3; WS3	Phenotype	death|deaths	PAX3	HGNC:8617	Waardenburg syndrome, type 3, 148820 (3), Autosomal dominant, Autosomal recessive	Autosomal dominant, Autosomal recessive	y	n	-	-	-	-	ambiguous	ambiguous|nonlethal	ambiguous	-	-	-
149200	BART-PUMPHREY SYNDROME	Bart-Pumphrey syndrome, 149200 (3)	Bart-Pumphrey syndrome	n	-	-	-	GJB2	HGNC:4284	Bart-Pumphrey syndrome, 149200 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	ambiguous|nonlethal	ambiguous	-	-	-
149400	HYPEREKPLEXIA 1	Hyperekplexia 1, 149400 (3)	Hyperekplexia 1	y	HYPEREKPLEXIA 1; HKPX1	Description|Clinical Features|Clinical Synopsis	death|deaths|died|fatal|die	GLRA1	HGNC:4326	Hyperekplexia 1, 149400 (3), Autosomal dominant, Autosomal recessive	Autosomal dominant, Autosomal recessive	y	y	[Neonates may have prolonged periods of rigidity and are at risk for sudden death from apnea or aspiration / Milani et al. (1996) demonstrated a variable combination of clinical signs of hereditary hyperekplexia in an Italian family...The proband's second cousin died at the age of 45 days from apnea following myoclonic fits, and her father displayed hypertonia and muscle stiffening]	L3	y	y	lethal	lethal	lethal	L3	L3	pre-infant-lethal
149730	LACRIMOAURICULODENTODIGITAL SYNDROME 1	LADD syndrome 1, 149730 (3)	LADD syndrome 1	y	LACRIMOAURICULODENTODIGITAL SYNDROME 1; LADD1	Clinical Features	death|deaths	FGFR2	HGNC:3689	LADD syndrome 1, 149730 (3), Autosomal dominant	Autosomal dominant	y	y	[congenital renal disease causing death in the neonatal period was observed in 2, an uncle and niece]	L2	y	y	lethal	lethal|nonlethal	lethal|nonlethal	L1|L2|L3	L1	pre-infant-lethal
150250	LARSEN SYNDROME	Larsen syndrome, 150250 (3)	Larsen syndrome	n	-	-	-	FLNB	HGNC:3755	Larsen syndrome, 150250 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L1|L2|LU	L1	pre-infant-lethal
150400	TOOTH AGENESIS, SELECTIVE, 4	Tooth agenesis, selective, 4, 150400 (3)	Tooth agenesis, selective, 4	n	-	-	-	WNT10A	HGNC:13829	Tooth agenesis, selective, 4, 150400 (3), Autosomal dominant, Autosomal recessive	Autosomal dominant, Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
150550	PERIODIC FEVER, IMMUNODEFICIENCY, AND THROMBOCYTOPENIA SYNDROME	Periodic fever, immunodeficiency, and thrombocytopenia syndrome, 150550 (3)	Periodic fever, immunodeficiency, and thrombocytopenia syndrome	y	PERIODIC FEVER, IMMUNODEFICIENCY, AND THROMBOCYTOPENIA SYNDROME; PFITS	Description|Clinical Features|Clinical Synopsis	death|deaths|died	WDR1	HGNC:12754	Periodic fever, immunodeficiency, and thrombocytopenia syndrome, 150550 (3), Autosomal recessive	Autosomal recessive	y	y	[Gallin et al. (1978) reported an 8-year-old girl, born of unrelated parents, with a complex primary immunodeficiency... She died of disseminated varicella at age 8.8 years]	L4	y	-	lethal	lethal	lethal	L4	L4	post-infant-lethal
150600	LEGG-CALVE-PERTHES DISEASE	Legg-Calve-Perthes disease, 150600 (3)	Legg-Calve-Perthes disease	n	-	-	-	COL2A1	HGNC:2200	Legg-Calve-Perthes disease, 150600 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	ambiguous|lethal|nonlethal	lethal|nonlethal	L1|L2|L3	L1	pre-infant-lethal
150800	HEREDITARY LEIOMYOMATOSIS AND RENAL CELL CANCER	Leiomyomatosis and renal cell cancer, 150800 (3)	Leiomyomatosis and renal cell cancer	y	HEREDITARY LEIOMYOMATOSIS AND RENAL CELL CANCER; HLRCC	Description|Clinical Features	death|deaths|died	FH	HGNC:3700	Leiomyomatosis and renal cell cancer, 150800 (3), Autosomal dominant	Autosomal dominant	y	y	[As part of the French National Cancer Institute study, Gardie et al. (2011) identified 44 families with genetically-confirmed HLRCC...Twenty (74.1%) of 27 patient died of metastatic renal cell carcinoma / In a retrospective study, Smit et al. (2011) analyzed 14 families from the Netherlands with genetically-confirmed HLRCC... A patient in a third family had reportedly died of metastatic renal cancer at age 21]	L6	y	-	lethal	lethal	lethal	L2|L6	L2	pre-infant-lethal
151050	LENZ-MAJEWSKI HYPEROSTOTIC DWARFISM	Lenz-Majewski hyperostotic dwarfism, 151050 (3)	Lenz-Majewski hyperostotic dwarfism	n	-	-	-	PTDSS1	HGNC:9587	Lenz-Majewski hyperostotic dwarfism, 151050 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
151100	LEOPARD SYNDROME 1	LEOPARD syndrome 1, 151100 (3)	LEOPARD syndrome 1	y	LEOPARD SYNDROME 1; LPRD1	Clinical Features|Phenotype	died|death|deaths	PTPN11	HGNC:9644	LEOPARD syndrome 1, 151100 (3), Autosomal dominant	Autosomal dominant	y	y	[Peter and Kemp (1990) described a 19-year-old woman who died as a result of respiratory insufficiency secondary to thoracic deformities which, together with a congenital heart defect, led to pulmonary hypertension]	L6	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L1|L6	L1	pre-infant-lethal
151210	PLATYSPONDYLIC LETHAL SKELETAL DYSPLASIA, TORRANCE TYPE	Platyspondylic skeletal dysplasia, Torrance type, 151210 (3)	Platyspondylic skeletal dysplasia, Torrance type	y	PLATYSPONDYLIC LETHAL SKELETAL DYSPLASIA, TORRANCE TYPE; PLSDT	Description|Clinical Features|Phenotype	lethal|died|stillborn	COL2A1	HGNC:2200	Platyspondylic skeletal dysplasia, Torrance type, 151210 (3), Autosomal dominant	Autosomal dominant	y	y	[Though generally lethal in the perinatal period, longer survival has been reported (summary by Zankl et al., 2005 / Omran et al. (2000) reported an affected mother who gave birth to an affected daughter who died soon after birth]	L2	y	-	lethal	ambiguous|lethal|nonlethal	lethal|nonlethal	L1|L2|L3	L1	pre-infant-lethal
151600	NAIL DISORDER, NONSYNDROMIC CONGENITAL, 3	Nail disorder, nonsyndromic congenital, 3, (leukonychia), 151600 (3)	Nail disorder, nonsyndromic congenital, 3, (leukonychia)	y	NAIL DISORDER, NONSYNDROMIC CONGENITAL, 3; NDNC3	Clinical Features	death|deaths	PLCD1	HGNC:9060	Nail disorder, nonsyndromic congenital, 3, (leukonychia), 151600 (3), Autosomal dominant, Autosomal recessive	Autosomal dominant, Autosomal recessive	y	n	-	-	-	-	ambiguous	ambiguous	ambiguous	-	-	-
151623	LI-FRAUMENI SYNDROME	Li-Fraumeni syndrome, 151623 (3)	Li-Fraumeni syndrome	y	LI-FRAUMENI SYNDROME; LFS	Clinical Features|Phenotype	death|deaths|died	TP53	HGNC:11998	Li-Fraumeni syndrome, 151623 (3), Autosomal dominant	Autosomal dominant	y	y	[Capponcelli et al. (2005) identified a mutation in the TP53 gene (Y220S; 191170.0039) in a mother and her 3 children with Li-Fraumeni syndrome. All affected family members had a very aggressive clinical phenotype associated with resistance to doxorubicin and early death from cancer]	LU	y	-	lethal	lethal	lethal	L4|LU	L4	post-infant-lethal
151660	LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 2	Lipodystrophy, familial partial, type 2, 151660 (3)	Lipodystrophy, familial partial, type 2	y	LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 2; FPLD2	Clinical Features	death|deaths|lethality|miscarriage|miscarriages	LMNA	HGNC:6636	Lipodystrophy, familial partial, type 2, 151660 (3), Autosomal dominant	Autosomal dominant	n	n	-	-	-	-	ambiguous	ambiguous|lethal|nonlethal	lethal|nonlethal	L1|L2|L6	L1	pre-infant-lethal
151800	LIPOMATOSIS, MULTIPLE SYMMETRIC, WITH OR WITHOUT AXONAL PERIPHERAL NEUROPATHY	Lipomatosis, multiple symmetric, with or without peripheral neuropathy, 151800 (3)	Lipomatosis, multiple symmetric, with or without peripheral neuropathy	y	LIPOMATOSIS, MULTIPLE SYMMETRIC, WITH OR WITHOUT AXONAL PERIPHERAL NEUROPATHY; MSL	Clinical Features	died|fatal	MFN2	HGNC:16877	Lipomatosis, multiple symmetric, with or without peripheral neuropathy, 151800 (3), Autosomal recessive	Autosomal recessive	y	y	[Onset was usually in the fourth or fifth decade. Eight patients (25.8%) died during follow-up, none of whom had signs or symptoms of coronary heart disease.]	L6	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L6	L6	post-infant-lethal
152950	MICROCEPHALY WITH OR WITHOUT CHORIORETINOPATHY, LYMPHEDEMA, OR IMPAIRED INTELLECTUAL DEVELOPMENT	Microcephaly with or without chorioretinopathy, lymphedema, or impaired intellectual development, 152950 (3)	Microcephaly with or without chorioretinopathy, lymphedema, or impaired intellectual development	n	-	-	-	KIF11	HGNC:6388	Microcephaly with or without chorioretinopathy, lymphedema, or impaired intellectual development, 152950 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
153100	LYMPHATIC MALFORMATION 1	Lymphatic malformation 1, 153100 (3)	Lymphatic malformation 1	n	-	-	-	FLT4	HGNC:3767	Lymphatic malformation 1, 153100 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
153400	LYMPHEDEMA-DISTICHIASIS SYNDROME	Lymphedema-distichiasis syndrome with renal disease and diabetes mellitus, 153400 (3)	Lymphedema-distichiasis syndrome with renal disease and diabetes mellitus	y	LYMPHEDEMA-DISTICHIASIS SYNDROME; LPHDST	Clinical Features	died	FOXC2	HGNC:3801	Lymphedema-distichiasis syndrome with renal disease and diabetes mellitus, 153400 (3), Autosomal dominant	Autosomal dominant	y	n	-	-	-	-	ambiguous	ambiguous	ambiguous	-	-	-
153400	LYMPHEDEMA-DISTICHIASIS SYNDROME	Lymphedema-distichiasis syndrome, 153400 (3)	Lymphedema-distichiasis syndrome	y	LYMPHEDEMA-DISTICHIASIS SYNDROME; LPHDST	Clinical Features	died	FOXC2	HGNC:3801	Lymphedema-distichiasis syndrome, 153400 (3), Autosomal dominant	Autosomal dominant	y	n	-	-	-	-	ambiguous	ambiguous	ambiguous	-	-	-
153670	BERNARD-SOULIER SYNDROME, TYPE A2, AUTOSOMAL DOMINANT	Bernard-Soulier syndrome, type A2 (dominant), 153670 (3)	Bernard-Soulier syndrome, type A2 (dominant)	n	-	-	-	GP1BA	HGNC:4439	Bernard-Soulier syndrome, type A2 (dominant), 153670 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
153700	MACULAR DYSTROPHY, VITELLIFORM, 2	Macular dystrophy, vitelliform, 2, 153700 (3)	Macular dystrophy, vitelliform, 2	y	MACULAR DYSTROPHY, VITELLIFORM, 2; VMD2	Clinical Features	died	BEST1	HGNC:12703	Macular dystrophy, vitelliform, 2, 153700 (3), Autosomal dominant	Autosomal dominant	y	n	-	-	-	-	ambiguous	ambiguous|nonlethal	ambiguous	-	-	-
153870	RETINITIS PIGMENTOSA 91	Retinitis pigmentosa 91, 153870 (3)	Retinitis pigmentosa 91	n	-	-	-	IMPG1	HGNC:6055	Retinitis pigmentosa 91, 153870 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	ambiguous|nonlethal	ambiguous	-	-	-
154020	HYPOMAGNESEMIA 2, RENAL	Hypomagnesemia 2, renal, 154020 (3)	Hypomagnesemia 2, renal	n	-	-	-	FXYD2	HGNC:4026	Hypomagnesemia 2, renal, 154020 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
154400	ACROFACIAL DYSOSTOSIS 1, NAGER TYPE	Acrofacial dysostosis 1, Nager type, 154400 (3)	Acrofacial dysostosis 1, Nager type	y	ACROFACIAL DYSOSTOSIS 1, NAGER TYPE; AFD1	Clinical Features	died	SF3B4	HGNC:10771	Acrofacial dysostosis 1, Nager type, 154400 (3), Autosomal dominant	Autosomal dominant	n	y	[Fryns et al. (1996) reported an adult male who, in addition to typical manifestations, had agenesis of the corpus callosum, strabismus, equinovarus position of both feet, cryptorchidism, and blind-ending fistula in the middle of the anoscrotal raphe. The patient died at the age of 50 years from heart failure due to a complete atrioventricular block]	L6	y	-	lethal	lethal	lethal	L6	L6	post-infant-lethal
154500	TREACHER COLLINS SYNDROME 1	Treacher Collins syndrome 1, 154500 (3)	Treacher Collins syndrome 1	n	-	-	-	TCOF1	HGNC:11654	Treacher Collins syndrome 1, 154500 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
154700	MARFAN SYNDROME	Marfan syndrome, 154700 (3)	Marfan syndrome	y	MARFAN SYNDROME; MFS	Clinical Features|Phenotype	death|deaths|died|spontaneous_abortion|spontaneous_abortions|stillborn	FBN1	HGNC:3603	Marfan syndrome, 154700 (3), Autosomal dominant	Autosomal dominant	y	y	[Buntinx et al. (1991) described severe Marfan syndrome in a neonate with aortic dilatation and cardiac valve insufficiency who died from heart failure at 20 hours of age]	L2	y	-	lethal	ambiguous|lethal|nonlethal	lethal|nonlethal	L2|LU	L2	pre-infant-lethal
154780	MARSHALL SYNDROME	Marshall syndrome, 154780 (3)	Marshall syndrome	n	-	-	-	COL11A1	HGNC:2186	Marshall syndrome, 154780 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L1	L1	pre-infant-lethal
154800	MASTOCYTOSIS, CUTANEOUS	Mastocytosis, cutaneous, 154800 (3)	Mastocytosis, cutaneous	y	MASTOCYTOSIS, CUTANEOUS; MASTC	Clinical Features	died	KIT	HGNC:6342	Mastocytosis, cutaneous, 154800 (3), Autosomal dominant	Autosomal dominant	n	y	Pignon et al. (1997) reported a 44-year-old man who presented with a 2-month history of asthenia, gastric pain, and flushes. He was found to have moderate splenomegaly... the patient relapsed 4 months later and died from massive multivisceral involvement of the mastocytosis]	L6	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L6	L6	post-infant-lethal
155100	MACROTHROMBOCYTOPENIA AND GRANULOCYTE INCLUSIONS WITH OR WITHOUT NEPHRITIS OR SENSORINEURAL HEARING LOSS	Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss, 155100 (3)	Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss	n	-	-	-	MYH9	HGNC:7579	Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss, 155100 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
155240	THYROID CARCINOMA, FAMILIAL MEDULLARY	Medullary thyroid carcinoma, 155240 (3)	Medullary thyroid carcinoma	n	-	-	-	RET	HGNC:9967	Medullary thyroid carcinoma, 155240 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	ambiguous|lethal|nonlethal	lethal|nonlethal	L6	L6	post-infant-lethal
155310	VISCERAL MYOPATHY 1	Visceral myopathy 1, 155310 (3)	Visceral myopathy 1	y	VISCERAL MYOPATHY 1; VSCM1	Description|Clinical Features	death|deaths|died|fatal	ACTG2	HGNC:145	Visceral myopathy 1, 155310 (3), Autosomal dominant	Autosomal dominant	y	y	[Guze et al. (1999) described 16 unrelated children, 11 boys and 5 girls, with chronic myopathic intestinal pseudoobstruction, which they designated 'infantile visceral myopathy;' the authors noted that most of their patients would have been diagnosed as having megacystis-microcolon-intestinal hypoperistalsis syndrome (MMIH; see 249210)... Three maternal relatives over 3 generations had symptoms resembling pseudoobstruction, including 2 who died in infancy of 'stomach trouble' and malnutrition, and a maternal cousin who had had constipation, bloating, and problems with urination since childhood]	L3	n	y	lethal	lethal	lethal	L2|L3	L2	pre-infant-lethal
156200	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 1	Intellectual developmental disorder, autosomal dominant 1, 156200 (3)	Intellectual developmental disorder, autosomal dominant 1	n	-	-	-	MBD5	HGNC:20444	Intellectual developmental disorder, autosomal dominant 1, 156200 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
156250	METACHONDROMATOSIS	Metachondromatosis, 156250 (3)	Metachondromatosis	n	-	-	-	PTPN11	HGNC:9644	Metachondromatosis, 156250 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L1|L6	L1	pre-infant-lethal
156400	METAPHYSEAL CHONDRODYSPLASIA, JANSEN TYPE	Metaphyseal chondrodysplasia, Murk Jansen type, 156400 (3)	Metaphyseal chondrodysplasia, Murk Jansen type	n	-	-	-	PTH1R	HGNC:9608	Metaphyseal chondrodysplasia, Murk Jansen type, 156400 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L1	L1	pre-infant-lethal
156500	METAPHYSEAL CHONDRODYSPLASIA, SCHMID TYPE	Metaphyseal chondrodysplasia, Schmid type, 156500 (3)	Metaphyseal chondrodysplasia, Schmid type	n	-	-	-	COL10A1	HGNC:2185	Metaphyseal chondrodysplasia, Schmid type, 156500 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
156510	METAPHYSEAL DYSPLASIA WITH MAXILLARY HYPOPLASIA WITH OR WITHOUT BRACHYDACTYLY	Metaphyseal dysplasia with maxillary hypoplasia with or without brachydactyly, 156510 (3)	Metaphyseal dysplasia with maxillary hypoplasia with or without brachydactyly	n	-	-	-	RUNX2	HGNC:10472	Metaphyseal dysplasia with maxillary hypoplasia with or without brachydactyly, 156510 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
156530	METATROPIC DYSPLASIA	Metatropic dysplasia, 156530 (3)	Metatropic dysplasia	y	METATROPIC DYSPLASIA; MTD	Clinical Features|Phenotype	died|lethal|death|deaths|stillborn	TRPV4	HGNC:18083	Metatropic dysplasia, 156530 (3), Autosomal dominant	Autosomal dominant	y	y	[Genevieve et al. (2008) reported the clinical and radiologic features of 19 novel metatropic patients (5 lethal or terminated pregnancies, and 14 living patients) that had been collected over 40 years]	L1	y	-	lethal	ambiguous|lethal|nonlethal	lethal|nonlethal	L1	L1	pre-infant-lethal
156550	KNIEST DYSPLASIA	Kniest dysplasia, 156550 (3)	Kniest dysplasia	n	-	-	-	COL2A1	HGNC:2200	Kniest dysplasia, 156550 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	ambiguous|lethal|nonlethal	lethal|nonlethal	L1|L2|L3	L1	pre-infant-lethal
156610	SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 1	Symmetric circumferential skin creases, congenital, 1, 156610 (3)	Symmetric circumferential skin creases, congenital, 1	n	-	-	-	TUBB	HGNC:20778	Symmetric circumferential skin creases, congenital, 1, 156610 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
157170	HOLOPROSENCEPHALY 2	Holoprosencephaly 2, 157170 (3)	Holoprosencephaly 2	y	HOLOPROSENCEPHALY 2; HPE2	Clinical Features|Phenotype	died|lethal	SIX3	HGNC:10889	Holoprosencephaly 2, 157170 (3), Autosomal dominant	Autosomal dominant	n	y	[Martin et al. (1977) described a kindred with 7 persons affected with a syndrome manifested by cleft lip and anterior cleft palate, hypotelorism, microcephaly, mental retardation, scoliosis, and chronic constipation. The disorder bore similarities to familial holoprosencephaly. Three of 4 affected males survived past 20 years of age. All 3 affected females died early in infancy]	L3	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L3	L3	pre-infant-lethal
157600	MIRROR MOVEMENTS 1	Mirror movements 1 and/or agenesis of the corpus callosum, 157600 (3)	Mirror movements 1 and/or agenesis of the corpus callosum	n	-	-	-	DCC	HGNC:2701	Mirror movements 1 and/or agenesis of the corpus callosum, 157600 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
157640	PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 1	Progressive external ophthalmoplegia, autosomal dominant 1, 157640 (3)	Progressive external ophthalmoplegia, autosomal dominant 1	n	-	-	-	POLG	HGNC:9179	Progressive external ophthalmoplegia, autosomal dominant 1, 157640 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L2|L3|L5|L6	L2	pre-infant-lethal
157800	CARDIOSPONDYLOCARPOFACIAL SYNDROME	Cardiospondylocarpofacial syndrome, 157800 (3)	Cardiospondylocarpofacial syndrome	n	-	-	-	MAP3K7	HGNC:6859	Cardiospondylocarpofacial syndrome, 157800 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
158000	MONILETHRIX	Monilethrix, 158000 (3)	Monilethrix	n	-	-	-	KRT81	HGNC:6458	Monilethrix, 158000 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
158000	MONILETHRIX	Monilethrix, 158000 (3)	Monilethrix	n	-	-	-	KRT83	HGNC:6460	Monilethrix, 158000 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
158000	MONILETHRIX	Monilethrix, 158000 (3)	Monilethrix	n	-	-	-	KRT86	HGNC:6463	Monilethrix, 158000 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
158300	ARTHROGRYPOSIS, DISTAL, TYPE 7	Trismus-pseudocamptodactyly syndrome, 158300 (3)	Trismus-pseudocamptodactyly syndrome	n	-	-	-	MYH8	HGNC:7578	Trismus-pseudocamptodactyly syndrome, 158300 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
158310	MUCOEPITHELIAL DYSPLASIA, HEREDITARY	Mucoepithelial dysplasia, hereditary, 158310 (3)	Mucoepithelial dysplasia, hereditary	y	MUCOEPITHELIAL DYSPLASIA, HEREDITARY; HMD	Clinical Features	died	SREBF1	HGNC:11289	Mucoepithelial dysplasia, hereditary, 158310 (3), Autosomal dominant	Autosomal dominant	y	n	-	-	-	-	ambiguous	ambiguous|nonlethal	ambiguous	-	-	-
158320	MUIR-TORRE SYNDROME	Muir-Torre syndrome, 158320 (3)	Muir-Torre syndrome	y	MUIR-TORRE SYNDROME; MRTES	Clinical Features	died	MLH1	HGNC:7127	Muir-Torre syndrome, 158320 (3), Autosomal dominant	Autosomal dominant	y	n	-	-	-	-	ambiguous	ambiguous|lethal|nonlethal	lethal|nonlethal	L4	L4	post-infant-lethal
158320	MUIR-TORRE SYNDROME	Muir-Torre syndrome, 158320 (3)	Muir-Torre syndrome	y	MUIR-TORRE SYNDROME; MRTES	Clinical Features	died	MSH2	HGNC:7325	Muir-Torre syndrome, 158320 (3), Autosomal dominant	Autosomal dominant	y	n	-	-	-	-	ambiguous	ambiguous|lethal|nonlethal	lethal|nonlethal	L3	L3	pre-infant-lethal
158330	MULLERIAN APLASIA AND HYPERANDROGENISM	Mullerian aplasia and hyperandrogenism, 158330 (3)	Mullerian aplasia and hyperandrogenism	n	-	-	-	WNT4	HGNC:12783	Mullerian aplasia and hyperandrogenism, 158330 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
158350	COWDEN SYNDROME 1	Cowden syndrome 1, 158350 (3)	Cowden syndrome 1	y	COWDEN SYNDROME 1; CWS1	Clinical Features	death|deaths|died	PTEN	HGNC:9588	Cowden syndrome 1, 158350 (3), Autosomal dominant	Autosomal dominant	n	y	[In the sporadic cases of Bannayan (1971) and of Okumura et al. (1986), death occurred as a result of severe visceral lipomatosis at ages 3.5 years and 5.75 years, respectively]	L4	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L4	L4	post-infant-lethal
158350	COWDEN SYNDROME 1	Lhermitte-Duclos disease, 158350 (3)	Lhermitte-Duclos disease	y	COWDEN SYNDROME 1; CWS1	Clinical Features	death|deaths|died	PTEN	HGNC:9588	Lhermitte-Duclos disease, 158350 (3), Autosomal dominant	Autosomal dominant	n	y	[death occurred as a result of severe visceral lipomatosis at ages 3.5 years and 5.75 years, respectivel]	L4	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L4	L4	post-infant-lethal
158580	NEURONOPATHY, DISTAL HEREDITARY MOTOR, AUTOSOMAL DOMINANT 7	Neuronopathy, distal hereditary motor, autosomal dominant 7, 158580 (3)	Neuronopathy, distal hereditary motor, autosomal dominant 7	n	-	-	-	SLC5A7	HGNC:14025	Neuronopathy, distal hereditary motor, autosomal dominant 7, 158580 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L2	L2	pre-infant-lethal
158590	NEURONOPATHY, DISTAL HEREDITARY MOTOR, AUTOSOMAL DOMINANT 2	Neuronopathy, distal hereditary motor, autosomal dominant 2, 158590 (3)	Neuronopathy, distal hereditary motor, autosomal dominant 2	y	NEURONOPATHY, DISTAL HEREDITARY MOTOR, AUTOSOMAL DOMINANT 2; HMND2	Clinical Features|Phenotype	death|deaths	HSPB8	HGNC:30171	Neuronopathy, distal hereditary motor, autosomal dominant 2, 158590 (3), Autosomal dominant	Autosomal dominant	y	y	[beginning between the end of the fourth and the sixth decade and showing rapid progression without evidence of corticospinal tract dysfunction. Death from respiratory failure occurred within 2 years of onset.]	L6	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L6	L6	post-infant-lethal
158600	SPINAL MUSCULAR ATROPHY, LOWER EXTREMITY-PREDOMINANT, 1, AUTOSOMAL DOMINANT	Spinal muscular atrophy, lower extremity-predominant 1, AD, 158600 (3)	Spinal muscular atrophy, lower extremity-predominant 1, AD	n	-	-	-	DYNC1H1	HGNC:2961	Spinal muscular atrophy, lower extremity-predominant 1, AD, 158600 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
158810	BETHLEM MYOPATHY 1	Bethlem myopathy 1, 158810 (3)	Bethlem myopathy 1	y	BETHLEM MYOPATHY 1; BTHLM1	Clinical Features	die	COL6A1	HGNC:2211	Bethlem myopathy 1, 158810 (3), Autosomal dominant, Autosomal recessive	Autosomal dominant, Autosomal recessive	y	y	[Many patients with Bethlem myopathy need a wheelchair after the age of 50 years, and some die of respiratory failure caused by diaphragmatic paralysis (Haq et al., 1999)]	L6	y	-	lethal	lethal	lethal	L5|L6	L5	post-infant-lethal
158810	BETHLEM MYOPATHY 1	Bethlem myopathy 1, 158810 (3)	Bethlem myopathy 1	y	BETHLEM MYOPATHY 1; BTHLM1	Clinical Features	die	COL6A2	HGNC:2212	Bethlem myopathy 1, 158810 (3), Autosomal dominant, Autosomal recessive	Autosomal dominant, Autosomal recessive	y	y	[Many patients with Bethlem myopathy need a wheelchair after the age of 50 years, and some die of respiratory failure caused by diaphragmatic paralysis (Haq et al., 1999)]	L6	y	-	lethal	lethal	lethal	L5|L6	L5	post-infant-lethal
158810	BETHLEM MYOPATHY 1	Bethlem myopathy 1, 158810 (3)	Bethlem myopathy 1	y	BETHLEM MYOPATHY 1; BTHLM1	Clinical Features	die	COL6A3	HGNC:2213	Bethlem myopathy 1, 158810 (3), Autosomal dominant, Autosomal recessive	Autosomal dominant, Autosomal recessive	y	y	[Many patients with Bethlem myopathy need a wheelchair after the age of 50 years, and some die of respiratory failure caused by diaphragmatic paralysis (Haq et al., 1999)]	L6	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L5|L6	L5	post-infant-lethal
159550	ATAXIA-PANCYTOPENIA SYNDROME	Ataxia-pancytopenia syndrome, 159550 (3)	Ataxia-pancytopenia syndrome	y	ATAXIA-PANCYTOPENIA SYNDROME; ATXPC	Clinical Features	died	SAMD9L	HGNC:1349	Ataxia-pancytopenia syndrome, 159550 (3), Autosomal dominant	Autosomal dominant	y	y	[Li et al. (1978, 1981) described a family with ataxia and pancytopenia. The propositus, the youngest of a sibship of 5, had cerebellar ataxia, developed hypoplastic anemia at age 3 years, and died of acute myelomonocytic leukemia at age 7...Two brothers, including 1 with monosomy 7, died with hypoplastic anemia at ages 5 and 9 years, and a third brother died with acute myelocytic leukemia at age 10 years]	L4	y	y	lethal	lethal|nonlethal	lethal|nonlethal	L4|LU	L4	post-infant-lethal
159900	DYSTONIA 11, MYOCLONIC	Dystonia-11, myoclonic, 159900 (3)	Dystonia-11, myoclonic	n	-	-	-	SGCE	HGNC:10808	Dystonia-11, myoclonic, 159900 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
159950	SPINAL MUSCULAR ATROPHY WITH PROGRESSIVE MYOCLONIC EPILEPSY	Spinal muscular atrophy with progressive myoclonic epilepsy, 159950 (3)	Spinal muscular atrophy with progressive myoclonic epilepsy	y	SPINAL MUSCULAR ATROPHY WITH PROGRESSIVE MYOCLONIC EPILEPSY; SMAPME	Description|Clinical Features	death|deaths|died	ASAH1	HGNC:735	Spinal muscular atrophy with progressive myoclonic epilepsy, 159950 (3), Autosomal recessive	Autosomal recessive	y	y	[Haliloglu et al. (2002) reported a consanguineous Turkish family in which 3 sibs had childhood-onset spinal muscular atrophy and progressive myoclonic epilepsy....The disorder was progressive, and all patients died in their teens]	L5	y	-	lethal	lethal	lethal	L2|L5	L2	pre-infant-lethal
160120	EPISODIC ATAXIA, TYPE 1	Episodic ataxia/myokymia syndrome, 160120 (3)	Episodic ataxia/myokymia syndrome	y	EPISODIC ATAXIA, TYPE 1; EA1	Clinical Features	died	KCNA1	HGNC:6218	Episodic ataxia/myokymia syndrome, 160120 (3), Autosomal dominant	Autosomal dominant	y	y	[Glaudemans et al. (2009) studied a large 5-generation Brazilian family segregating autosomal dominant hypomagnesemia, in which 21 of 46 family members were affected....A younger brother had died in infancy from a severe attack of cramps and tetany, during which time his serum magnesium was as low as 0.28 mmol/l]	L3	n	y	lethal	lethal	lethal	L3	L3	pre-infant-lethal
160150	MYOPATHY, CENTRONUCLEAR, 1	Centronuclear myopathy 1, 160150 (3)	Centronuclear myopathy 1	y	MYOPATHY, CENTRONUCLEAR, 1; CNM1	Clinical Features	died	DNM2	HGNC:2974	Centronuclear myopathy 1, 160150 (3), Autosomal dominant	Autosomal dominant	y	n	-	-	-	-	ambiguous	ambiguous|lethal|nonlethal	lethal|nonlethal	L2	L2	pre-infant-lethal
160500	MYOPATHY, DISTAL, 1	Laing distal myopathy, 160500 (3)	Laing distal myopathy	n	-	-	-	MYH7	HGNC:7577	Laing distal myopathy, 160500 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L1|L6	L1	pre-infant-lethal
160565	MYOPATHY, TUBULAR AGGREGATE, 1	Myopathy, tubular aggregate, 1, 160565 (3)	Myopathy, tubular aggregate, 1	n	-	-	-	STIM1	HGNC:11386	Myopathy, tubular aggregate, 1, 160565 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L3	L3	pre-infant-lethal
160800	MYOTONIA CONGENITA, AUTOSOMAL DOMINANT	Myotonia congenita, dominant, 160800 (3)	Myotonia congenita, dominant	n	-	-	-	CLCN1	HGNC:2019	Myotonia congenita, dominant, 160800 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
160800	MYOTONIA CONGENITA, AUTOSOMAL DOMINANT	Myotonia levior, 160800 (3)	Myotonia levior	n	-	-	-	CLCN1	HGNC:2019	Myotonia levior, 160800 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
160900	MYOTONIC DYSTROPHY 1	Myotonic dystrophy 1, 160900 (3)	Myotonic dystrophy 1	y	MYOTONIC DYSTROPHY 1; DM1	Clinical Features|Phenotype	death|deaths|died|fatal|die	DMPK	HGNC:2933	Myotonic dystrophy 1, 160900 (3), Autosomal dominant	Autosomal dominant	y	y	[Respiratory difficulties are frequent and are often fatal / Bassez et al. (2004) reported 11 DM1 patients under the age of 18 years who had severe cardiac involvement. Two patients died suddenly, 1 patient had cardiac arrest with successful resuscitation, and 1 asymptomatic 13-year-old girl presented with recurrent presyncope]	L5	y	-	lethal	lethal	lethal	L5	L5	post-infant-lethal
160980	CARNEY COMPLEX, TYPE 1	Carney complex, type 1, 160980 (3)	Carney complex, type 1	y	CARNEY COMPLEX, TYPE 1; CNC1	Clinical Features	died	PRKAR1A	HGNC:9388	Carney complex, type 1, 160980 (3), Autosomal dominant	Autosomal dominant	n	y	[Schweizer-Cagianut et al. (1980) reported a brother and sister with Cushing syndrome associated with primary adrenocortical micronodular dysplasia... In a follow-up report of the same family, Schweizer-Cagianut et al. (1982) noted that an older brother had died at age 5 years of atrial myxoma; he had a hemangioma of the right groin. On autopsy at age 36 years, the affected sister was found to have a cardiac myxoma]	L4	y	y	lethal	lethal|nonlethal	lethal|nonlethal	L4|L5|LU	L4	post-infant-lethal
161000	NAEGELI-FRANCESCHETTI-JADASSOHN SYNDROME	Naegeli-Franceschetti-Jadassohn syndrome, 161000 (3)	Naegeli-Franceschetti-Jadassohn syndrome	n	-	-	-	KRT14	HGNC:6416	Naegeli-Franceschetti-Jadassohn syndrome, 161000 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L2	L2	pre-infant-lethal
161050	NAIL DISORDER, NONSYNDROMIC CONGENITAL, 1	Nail disorder, nonsyndromic congenital, 1, 161050 (3)	Nail disorder, nonsyndromic congenital, 1	y	NAIL DISORDER, NONSYNDROMIC CONGENITAL, 1; NDNC1	Clinical Features	died	FZD6	HGNC:4044	Nail disorder, nonsyndromic congenital, 1, 161050 (3), Autosomal recessive	Autosomal recessive	y	n	-	-	-	-	ambiguous	ambiguous	ambiguous	-	-	-
161200	NAIL-PATELLA SYNDROME	Nail-patella syndrome, 161200 (3)	Nail-patella syndrome	y	NAIL-PATELLA SYNDROME; NPS	Clinical Features	died|fatal	LMX1B	HGNC:6654	Nail-patella syndrome, 161200 (3), Autosomal dominant	Autosomal dominant	y	y	[It is relatively benign although fatality at a young age from this complication has been described (Leahy, 1966) / Sabnis et al. (1980) reported 3 patients with collagenation of glomerular basement membrane like that of the nail-patella syndrome... A sister and brother had died of renal disease at ages 6.5 and 9 years, respectively]	L4	n	y	lethal	lethal|nonlethal	lethal|nonlethal	L4	L4	post-infant-lethal
161800	CONGENITAL MYOPATHY 2A, TYPICAL, AUTOSOMAL DOMINANT	Congenital myopathy 2A, typical, autosomal dominant, 161800 (3)	Congenital myopathy 2A, typical, autosomal dominant	y	CONGENITAL MYOPATHY 2A, TYPICAL, AUTOSOMAL DOMINANT; CMYP2A	Description|Clinical Features|Phenotype	death|deaths|died|fatal	ACTA1	HGNC:129	Congenital myopathy 2A, typical, autosomal dominant, 161800 (3), Autosomal dominant	Autosomal dominant	y	y	[Thirty patients died, most of them during the first 12 months of life]	L3	y	-	lethal	lethal	lethal	L2|L3	L2	pre-infant-lethal
162000	TUBULOINTERSTITIAL KIDNEY DISEASE, AUTOSOMAL DOMINANT, 1	Tubulointerstitial kidney disease, autosomal dominant, 1, 162000 (3)	Tubulointerstitial kidney disease, autosomal dominant, 1	y	TUBULOINTERSTITIAL KIDNEY DISEASE, AUTOSOMAL DOMINANT, 1; ADTKD1	Clinical Features|Phenotype	died|lethal	UMOD	HGNC:12559	Tubulointerstitial kidney disease, autosomal dominant, 1, 162000 (3), Autosomal dominant	Autosomal dominant	y	y	[Rosenbloom et al. (1967) described a family in which multiple males in 3 generations died from renal failure at a relatively early age]	LU	y	-	lethal	lethal	lethal	LU	LU	post-infant-lethal
162100	AMYOTROPHY, HEREDITARY NEURALGIC	Amyotrophy, hereditary neuralgic, 162100 (3)	Amyotrophy, hereditary neuralgic	n	-	-	-	SEPTIN9	HGNC:7323	Amyotrophy, hereditary neuralgic, 162100 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
162200	NEUROFIBROMATOSIS, TYPE I	Neurofibromatosis, type 1, 162200 (3)	Neurofibromatosis, type 1	y	NEUROFIBROMATOSIS, TYPE I; NF1	Clinical Features	death|deaths|died|fatal|spontaneous_abortion|spontaneous_abortions	NF1	HGNC:7765	Neurofibromatosis, type 1, 162200 (3), Autosomal dominant	Autosomal dominant	y	y	[Rasmussen et al. (2001) used Multiple-Cause Mortality Files, compiled from U.S. death certificates by the National Center for Health Statistics for 1983-1997, to obtain information on mortality in NF1.. Mean and median ages at death for persons with NF1 were 54.4 and 59 years, respectively, compared with 70.1 and 74 years in the general population]	L6	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L6	L6	post-infant-lethal
162210	NEUROFIBROMATOSIS, FAMILIAL SPINAL	Neurofibromatosis, familial spinal, 162210 (3)	Neurofibromatosis, familial spinal	n	-	-	-	NF1	HGNC:7765	Neurofibromatosis, familial spinal, 162210 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L6	L6	post-infant-lethal
162300	MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIB	Multiple endocrine neoplasia IIB, 162300 (3)	Multiple endocrine neoplasia IIB	y	MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIB; MEN2B	Clinical Features	died	RET	HGNC:9967	Multiple endocrine neoplasia IIB, 162300 (3), Autosomal dominant	Autosomal dominant	n	y	[Williams and Pollock (1966) described 2 unrelated patients with multiple true neuromas, pheochromocytoma and thyroid carcinoma... The father of one of Williams and Pollock's cases had very thick lips and eyelid and tongue lesions as did his daughters. He had a medullary thyroid cancer and died at age 38 after an abdominal operation, having had symptoms suggestive of pheochromocytoma]	L6	n	y	lethal	ambiguous|lethal|nonlethal	lethal|nonlethal	L6	L6	post-infant-lethal
162350	CEROID LIPOFUSCINOSIS, NEURONAL, 4 (KUFS TYPE)	Ceroid lipofuscinosis, neuronal, 4 (Kufs type), autosomal dominant, 162350 (3)	Ceroid lipofuscinosis, neuronal, 4 (Kufs type), autosomal dominant	y	CEROID LIPOFUSCINOSIS, NEURONAL, 4 (KUFS TYPE); CLN4	Clinical Features	death|deaths	DNAJC5	HGNC:16235	Ceroid lipofuscinosis, neuronal, 4 (Kufs type), autosomal dominant, 162350 (3), Autosomal dominant	Autosomal dominant	y	y	[death at age 37 years]	L6	y	-	lethal	lethal	lethal	L6	L6	post-infant-lethal
162400	NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE IA	Neuropathy, hereditary sensory and autonomic, type IA, 162400 (3)	Neuropathy, hereditary sensory and autonomic, type IA	n	-	-	-	SPTLC1	HGNC:11277	Neuropathy, hereditary sensory and autonomic, type IA, 162400 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
162500	NEUROPATHY, HEREDITARY, WITH LIABILITY TO PRESSURE PALSIES	Neuropathy, recurrent, with pressure palsies, 162500 (3)	Neuropathy, recurrent, with pressure palsies	n	-	-	-	PMP22	HGNC:9118	Neuropathy, recurrent, with pressure palsies, 162500 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	ambiguous|nonlethal	ambiguous	-	-	-
162800	CYCLIC NEUTROPENIA	Neutropenia, cyclic, 162800 (3)	Neutropenia, cyclic	y	CYCLIC NEUTROPENIA	Clinical Features|Phenotype	died|death|deaths	ELANE	HGNC:3309	Neutropenia, cyclic, 162800 (3), Autosomal dominant	Autosomal dominant	y	y	[The recurrent severe neutropenia causes patients to experience periodic symptoms of fever, malaise, mucosal ulcers, and, rarely, life-threatening infection / While cyclic hematopoiesis is commonly described as 'benign,' Palmer et al. (1996) found that 4 affected children in 3 of 9 families died of Clostridium or E. coli colitis, documenting the need for urgent evaluation of abdominal pain]	L4	y	-	lethal	lethal	lethal	L4	L4	post-infant-lethal
163500	NIGHT BLINDNESS, CONGENITAL STATIONARY, AUTOSOMAL DOMINANT 2	Night blindness, congenital stationary, autosomal dominant 2, 163500 (3)	Night blindness, congenital stationary, autosomal dominant 2	y	NIGHT BLINDNESS, CONGENITAL STATIONARY, AUTOSOMAL DOMINANT 2; CSNBAD2	Clinical Features	death|deaths	PDE6B	HGNC:8786	Night blindness, congenital stationary, autosomal dominant 2, 163500 (3), Autosomal dominant	Autosomal dominant	y	n	-	-	-	-	ambiguous	ambiguous|nonlethal	ambiguous	-	-	-
163800	SICK SINUS SYNDROME 2	Sick sinus syndrome 2, 163800 (3)	Sick sinus syndrome 2	y	SICK SINUS SYNDROME 2; SSS2	Clinical Features	death|deaths	HCN4	HGNC:16882	Sick sinus syndrome 2, 163800 (3), Autosomal dominant	Autosomal dominant	n	y	[Surawicz and Hariman (1988) found that some members of the third and fourth generations suffered from more symptomatic bradycardia at a younger age than their parents which led, in some cases, to pacemaker implantation. Sudden death, presumably of cardiac origin, had occurred in 1 member of the third generation]	LU	y	-	lethal	lethal	lethal	L6|LU	L6	post-infant-lethal
163950	NOONAN SYNDROME 1	Noonan syndrome 1, 163950 (3)	Noonan syndrome 1	y	NOONAN SYNDROME 1; NS1	Clinical Features|Phenotype	death|deaths|died|lethal|demise|lethality|miscarriage|miscarriages	PTPN11	HGNC:9644	Noonan syndrome 1, 163950 (3), Autosomal dominant	Autosomal dominant	y	y	[artaglia et al. (2003) to speculate that these molecular defects are stronger and associated with embryonic lethality]	L1	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L1|L6	L1	pre-infant-lethal
164200	OCULODENTODIGITAL DYSPLASIA	Oculodentodigital dysplasia, 164200 (3)	Oculodentodigital dysplasia	n	-	-	-	GJA1	HGNC:4274	Oculodentodigital dysplasia, 164200 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
164210	CRANIOFACIAL MICROSOMIA 1	Craniofacial microsomia, 164210 (3)	Craniofacial microsomia	n	-	-	-	SF3B2	HGNC:10769	Craniofacial microsomia, 164210 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
164280	FEINGOLD SYNDROME 1	Feingold syndrome 1, 164280 (3)	Feingold syndrome 1	y	FEINGOLD SYNDROME 1; FGLDS1	Clinical Features	died|miscarriage|miscarriages	MYCN	HGNC:7559	Feingold syndrome 1, 164280 (3), Autosomal dominant	Autosomal dominant	n	y	[Kocak et al. (2009) reported a Turkish boy with Feingold syndrome confirmed by genetic analysis... Family history revealed an older sib with esophageal atresia who died, as well as 3 other miscarriages	L1	n	y	lethal	lethal	lethal	L1	L1	pre-infant-lethal
164300	OCULOPHARYNGEAL MUSCULAR DYSTROPHY 1	Oculopharyngeal muscular dystrophy, 164300 (3)	Oculopharyngeal muscular dystrophy	n	-	-	-	PABPN1	HGNC:8565	Oculopharyngeal muscular dystrophy, 164300 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
164310	OCULOPHARYNGODISTAL MYOPATHY 1	Oculopharyngodistal myopathy 1, 164310 (3)	Oculopharyngodistal myopathy 1	y	OCULOPHARYNGODISTAL MYOPATHY 1; OPDM1	Clinical Features	died	LRP12	HGNC:31708	Oculopharyngodistal myopathy 1, 164310 (3), Autosomal dominant	Autosomal dominant	y	y	[Van der Sluijs et al. (2004) reported 25-year follow-up of 2 Dutch sibs with OPDM....The brother developed pneumonia and died at age 55. At that time, he was wheelchair-bound with hypotonic paralysis of both legs, had paresis of both arms, and complete external ophthalmoplegia]	L6	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L6	L6	post-infant-lethal
164400	SPINOCEREBELLAR ATAXIA 1	Spinocerebellar ataxia 1, 164400 (3)	Spinocerebellar ataxia 1	y	SPINOCEREBELLAR ATAXIA 1; SCA1	Phenotype	death|deaths	ATXN1	HGNC:10548	Spinocerebellar ataxia 1, 164400 (3), Autosomal dominant	Autosomal dominant	y	n	-	-	-	-	ambiguous	ambiguous	ambiguous	-	-	-
164500	SPINOCEREBELLAR ATAXIA 7	Spinocerebellar ataxia 7, 164500 (3)	Spinocerebellar ataxia 7	y	SPINOCEREBELLAR ATAXIA 7; SCA7	Clinical Features|Phenotype	death|deaths|died	ATXN7	HGNC:10560	Spinocerebellar ataxia 7, 164500 (3), Autosomal dominant	Autosomal dominant	n	y	[Foster and Ingram (1962) described a family with at least 7 affected members of 3 generations. Severity varied widely with infant death in at least 1 case and survival to middle age in other affected persons]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
164745	OMODYSPLASIA 2	Omodysplasia 2, 164745 (3)	Omodysplasia 2	n	-	-	-	FZD2	HGNC:4040	Omodysplasia 2, 164745 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
165300	OPTIC ATROPHY 3, AUTOSOMAL DOMINANT	Optic atrophy 3 with cataract, 165300 (3)	Optic atrophy 3 with cataract	n	-	-	-	OPA3	HGNC:8142	Optic atrophy 3 with cataract, 165300 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
165500	OPTIC ATROPHY 1	Optic atrophy 1, 165500 (3)	Optic atrophy 1	n	-	-	-	OPA1	HGNC:8140	Optic atrophy 1, 165500 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
165510	OPTIC ATROPHY 13 WITH RETINAL AND FOVEAL ABNORMALITIES	Optic atrophy 13 with retinal and foveal abnormalities, 165510 (3)	Optic atrophy 13 with retinal and foveal abnormalities	n	-	-	-	SSBP1	HGNC:11317	Optic atrophy 13 with retinal and foveal abnormalities, 165510 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
165550	OPTIC NERVE HYPOPLASIA, BILATERAL	Optic nerve hypoplasia, 165550 (3)	Optic nerve hypoplasia	y	OPTIC NERVE HYPOPLASIA, BILATERAL	Clinical Features	death|deaths	PAX6	HGNC:8620	Optic nerve hypoplasia, 165550 (3), Autosomal dominant	Autosomal dominant	n	y	[Optic nerve hypoplasia is the most common congenital anomaly of the optic disc (Birkebaek et al., 2003)... Hypopituitarism is a serious problem, and failure to recognize it carries a risk of adrenal crisis, hypoglycemia, and death (Brodsky et al., 1997; Cameron et al., 1999)]	LU	y	-	lethal	ambiguous|lethal|nonlethal	lethal|nonlethal	LU	LU	post-infant-lethal
165800	SHORT STATURE AND ADVANCED BONE AGE, WITH OR WITHOUT EARLY-ONSET OSTEOARTHRITIS AND/OR OSTEOCHONDRITIS DISSECANS	Short stature and advanced bone age, with or without early-onset osteoarthritis and/or osteochondritis dissecans, 165800 (3)	Short stature and advanced bone age, with or without early-onset osteoarthritis and/or osteochondritis dissecans	n	-	-	-	ACAN	HGNC:319	Short stature and advanced bone age, with or without early-onset osteoarthritis and/or osteochondritis dissecans, 165800 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
166200	OSTEOGENESIS IMPERFECTA, TYPE I	Osteogenesis imperfecta, type I, 166200 (3)	Osteogenesis imperfecta, type I	y	OSTEOGENESIS IMPERFECTA, TYPE I; OI1	Clinical Features	lethal	COL1A1	HGNC:2197	Osteogenesis imperfecta, type I, 166200 (3), Autosomal dominant	Autosomal dominant	y	y	[In lethal forms of osteogenesis imperfecta caused by mutation in either the COL1A1 gene or the COL1A2 gene, the mutations result in the synthesis of abnormal chains of procollagen that bind to normal chains synthesized by the same cells and destroy their biologic activity in a classic dominant-negative manner *** (In Clinical Management)]	LU	y	-	lethal	ambiguous|lethal|nonlethal	lethal|nonlethal	L2|L5|LU	L2	pre-infant-lethal
166210	OSTEOGENESIS IMPERFECTA, TYPE II	Osteogenesis imperfecta, type II, 166210 (3)	Osteogenesis imperfecta, type II	y	OSTEOGENESIS IMPERFECTA, TYPE II; OI2	Description|Clinical Features|Clinical Synopsis|Phenotype	death|deaths|lethal|died|lethality	COL1A1	HGNC:2197	Osteogenesis imperfecta, type II, 166210 (3), Autosomal dominant	Autosomal dominant	y	y	[Osteogenesis imperfecta type II constitutes a disorder characterized by bone fragility, with many perinatal fractures, severe bowing of long bones, undermineralization, and death in the perinatal period due to respiratory insufficiency (Sillence et al., 1979; Barnes et al., 2006)]	L2	y	-	lethal	ambiguous|lethal|nonlethal	lethal|nonlethal	L2|L5|LU	L2	pre-infant-lethal
166210	OSTEOGENESIS IMPERFECTA, TYPE II	Osteogenesis imperfecta, type II, 166210 (3)	Osteogenesis imperfecta, type II	y	OSTEOGENESIS IMPERFECTA, TYPE II; OI2	Description|Clinical Features|Clinical Synopsis|Phenotype	death|deaths|lethal|died|lethality	COL1A2	HGNC:2198	Osteogenesis imperfecta, type II, 166210 (3), Autosomal dominant	Autosomal dominant	y	y	[Osteogenesis imperfecta type II constitutes a disorder characterized by bone fragility, with many perinatal fractures, severe bowing of long bones, undermineralization, and death in the perinatal period due to respiratory insufficiency (Sillence et al., 1979; Barnes et al., 2006)]	L2	y	-	lethal	ambiguous|lethal|nonlethal	lethal|nonlethal	L2|L4|L5	L2	pre-infant-lethal
166220	OSTEOGENESIS IMPERFECTA, TYPE IV	Osteogenesis imperfecta, type IV, 166220 (3)	Osteogenesis imperfecta, type IV	y	OSTEOGENESIS IMPERFECTA, TYPE IV; OI4	Description	lethal	COL1A1	HGNC:2197	Osteogenesis imperfecta, type IV, 166220 (3), Autosomal dominant	Autosomal dominant	y	n	-	-	-	-	ambiguous	ambiguous|lethal|nonlethal	lethal|nonlethal	L2|L5|LU	L2	pre-infant-lethal
166220	OSTEOGENESIS IMPERFECTA, TYPE IV	Osteogenesis imperfecta, type IV, 166220 (3)	Osteogenesis imperfecta, type IV	y	OSTEOGENESIS IMPERFECTA, TYPE IV; OI4	Description	lethal	COL1A2	HGNC:2198	Osteogenesis imperfecta, type IV, 166220 (3), Autosomal dominant	Autosomal dominant	y	n	-	-	-	-	ambiguous	ambiguous|lethal|nonlethal	lethal|nonlethal	L2|L4|L5	L2	pre-infant-lethal
166250	OSTEOGLOPHONIC DYSPLASIA	Osteoglophonic dysplasia, 166250 (3)	Osteoglophonic dysplasia	y	OSTEOGLOPHONIC DYSPLASIA; OGD	Clinical Features	died	FGFR1	HGNC:3688	Osteoglophonic dysplasia, 166250 (3), Autosomal dominant	Autosomal dominant	y	y	[Santos et al. (1988) described a boy with features typical of osteoglophonic dwarfism who died suddenly at the age of 10 months]	L3	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L2|L3	L2	pre-infant-lethal
166260	GNATHODIAPHYSEAL DYSPLASIA	Gnathodiaphyseal dysplasia, 166260 (3)	Gnathodiaphyseal dysplasia	n	-	-	-	ANO5	HGNC:27337	Gnathodiaphyseal dysplasia, 166260 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
166300	MULTICENTRIC CARPOTARSAL OSTEOLYSIS SYNDROME	Multicentric carpotarsal osteolysis syndrome, 166300 (3)	Multicentric carpotarsal osteolysis syndrome	y	MULTICENTRIC CARPOTARSAL OSTEOLYSIS SYNDROME; MCTO	Clinical Features	died	MAFB	HGNC:6408	Multicentric carpotarsal osteolysis syndrome, 166300 (3), Autosomal dominant	Autosomal dominant	y	y	[Bennett et al. (1980) described a female patient with onset of puffy and tender feet and wrists at age 21 months... At the age of 22, the patient presented with a blood pressure of 240/140; however, hypertensive retinopathy was not seen. The patient died soon afterwards with azotemia.]	L6	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L6	L6	post-infant-lethal
166350	OSSEOUS HETEROPLASIA, PROGRESSIVE	Osseous heteroplasia, progressive, 166350 (3)	Osseous heteroplasia, progressive	y	OSSEOUS HETEROPLASIA, PROGRESSIVE; POH	Clinical Features	died	GNAS	HGNC:4392	Osseous heteroplasia, progressive, 166350 (3), Autosomal dominant	Autosomal dominant	n	y	[Marsden (1983) noted that Peterson and Mandel (1963) had described an affected mother and son. The mother also had multiple pigmented nevi; the son died at 15 months of alveolar sarcoma of the cerebellum]	L3	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L3	L3	pre-infant-lethal
166600	OSTEOPETROSIS, AUTOSOMAL DOMINANT 2	Osteopetrosis, autosomal dominant 2, 166600 (3)	Osteopetrosis, autosomal dominant 2	y	OSTEOPETROSIS, AUTOSOMAL DOMINANT 2; OPTA2	Clinical Features	death|deaths	CLCN7	HGNC:2025	Osteopetrosis, autosomal dominant 2, 166600 (3), Autosomal dominant	Autosomal dominant	n	n	-	-	-	-	ambiguous	ambiguous|lethal|nonlethal	lethal|nonlethal	L3	L3	pre-infant-lethal
166700	BUSCHKE-OLLENDORFF SYNDROME	Buschke-Ollendorff syndrome, 166700 (3)	Buschke-Ollendorff syndrome	n	-	-	-	LEMD3	HGNC:28887	Buschke-Ollendorff syndrome, 166700 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
166700	BUSCHKE-OLLENDORFF SYNDROME	Osteopoikilosis with or without melorheostosis, 166700 (3)	Osteopoikilosis with or without melorheostosis	n	-	-	-	LEMD3	HGNC:28887	Osteopoikilosis with or without melorheostosis, 166700 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
166900	OVALOCYTOSIS, SOUTHEAST ASIAN	Ovalocytosis, SA type, 166900 (3)	Ovalocytosis, SA type	y	OVALOCYTOSIS, SOUTHEAST ASIAN; SAO	Phenotype	lethal|miscarriage|miscarriages	SLC4A1	HGNC:11027	Ovalocytosis, SA type, 166900 (3), Autosomal dominant	Autosomal dominant	n	n	-	-	-	-	ambiguous	ambiguous|lethal|nonlethal	lethal|nonlethal	L6	L6	post-infant-lethal
167100	HYPERTROPHIC OSTEOARTHROPATHY, PRIMARY, AUTOSOMAL DOMINANT	Hypertrophic osteoarthropathy, primary, autosomal dominant, 167100 (3)	Hypertrophic osteoarthropathy, primary, autosomal dominant	n	-	-	-	SLCO2A1	HGNC:10955	Hypertrophic osteoarthropathy, primary, autosomal dominant, 167100 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
167200	PACHYONYCHIA CONGENITA 1	Pachyonychia congenita 1, 167200 (3)	Pachyonychia congenita 1	n	-	-	-	KRT16	HGNC:6423	Pachyonychia congenita 1, 167200 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
167210	PACHYONYCHIA CONGENITA 2	Pachyonychia congenita 2, 167210 (3)	Pachyonychia congenita 2	n	-	-	-	KRT17	HGNC:6427	Pachyonychia congenita 2, 167210 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
167250	PAGET DISEASE OF BONE 3	Paget disease of bone 3, 167250 (3)	Paget disease of bone 3	y	PAGET DISEASE OF BONE 3; PDB3	Clinical Features	died	SQSTM1	HGNC:11280	Paget disease of bone 3, 167250 (3), Autosomal dominant	Autosomal dominant	y	y	[Wu et al. (1991) reported 2 sisters and a brother with longstanding (35 years in 1) polyostotic Paget disease. Two of them developed osteogenic sarcoma at sites unrelated to surgical procedures, one in the sacrum and one in the calvaria. Both died shortly after diagnosis of malignancy because of aggressive spread of the tumor]	LU	y	-	lethal	lethal|nonlethal	lethal|nonlethal	LU	LU	post-infant-lethal
167320	INCLUSION BODY MYOPATHY WITH EARLY-ONSET PAGET DISEASE WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA 1	Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia 1, 167320 (3)	Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia 1	y	INCLUSION BODY MYOPATHY WITH EARLY-ONSET PAGET DISEASE WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA 1; IBMPFD1	Clinical Features	death|deaths|die	VCP	HGNC:12666	Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia 1, 167320 (3), Autosomal dominant	Autosomal dominant	y	y	[Kimonis et al. (2000) described a family in which autosomal dominant limb-girdle muscular dystrophy (LGMD) was associated with early-onset Paget disease of bone PDB and cardiomyopathy... Affected individuals die from progressive muscle weakness and respiratory and cardiac failure in their forties to sixties]	L6	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L6	L6	post-infant-lethal
167400	PAROXYSMAL EXTREME PAIN DISORDER	Paroxysmal extreme pain disorder, 167400 (3)	Paroxysmal extreme pain disorder	n	-	-	-	SCN9A	HGNC:10597	Paroxysmal extreme pain disorder, 167400 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	ambiguous|nonlethal	ambiguous	-	-	-
167800	PANCREATITIS, HEREDITARY	Pancreatitis, hereditary, 167800 (3)	Pancreatitis, hereditary	y	PANCREATITIS, HEREDITARY; PCTT	Clinical Features|Phenotype	death|deaths|died	PRSS1	HGNC:9475	Pancreatitis, hereditary, 167800 (3), Autosomal dominant	Autosomal dominant	y	y	[Lowenfels et al. (1997) assembled records on 246 patients (125 males and 121 females) thought to have hereditary pancreatitis... The mean age at diagnosis of pancreatic cancer was 56.9 +/- 11.2 years. Frequency of other tumors was not increased. Eight of 20 reported deaths in the cohort were from pancreatic cancer]	L6	y	-	lethal	lethal	lethal	L6	L6	post-infant-lethal
167800	PANCREATITIS, HEREDITARY	Pancreatitis, hereditary, 167800 (3)	Pancreatitis, hereditary	y	PANCREATITIS, HEREDITARY; PCTT	Clinical Features|Phenotype	death|deaths|died	SPINK1	HGNC:11244	Pancreatitis, hereditary, 167800 (3), Autosomal dominant	Autosomal dominant	y	y	[In affected members of 2 unrelated families with autosomal dominant chronic pancreatitis, Kiraly et al. (2007) identified a heterozygous mutation in the SPINK1 gene (L14R; 167790.0006). The proband of the Bulgarian family was diagnosed at age 10 years. His father had died of acute pancreatitis, and his paternal grandmother developing pancreatitis at age 59 years]	L6	n	y	lethal	lethal|nonlethal	lethal|nonlethal	L6	L6	post-infant-lethal
168000	PHEOCHROMOCYTOMA/PARAGANGLIOMA SYNDROME 1	Pheochromocytoma/paraganglioma syndrome 1, 168000 (3)	Pheochromocytoma/paraganglioma syndrome 1	y	PHEOCHROMOCYTOMA/PARAGANGLIOMA SYNDROME 1; PPGL1	Clinical Features	died	SDHD	HGNC:10683	Pheochromocytoma/paraganglioma syndrome 1, 168000 (3), Autosomal dominant	Autosomal dominant	y	y	[Family history revealed that the father, who died at age 71 of lung cancer, was diagnosed at age 66 with bilateral paragangliomas in the pericarotid region.]	L6	-	y	lethal	lethal|nonlethal	lethal|nonlethal	L2|L6	L2	pre-infant-lethal
168300	PARAMYOTONIA CONGENITA	Paramyotonia congenita, 168300 (3)	Paramyotonia congenita	y	PARAMYOTONIA CONGENITA; PMC	Clinical Features|Phenotype	died|fatal	SCN4A	HGNC:10591	Paramyotonia congenita, 168300 (3), Autosomal dominant	Autosomal dominant	y	y	[Gay et al. (2008) described a female infant with severe fatal neonatal nondystrophic myotonia who presented with facial dysmorphism, muscle hypertrophy, severe constipation, psychomotor delay, and frequent cold-induced episodes of myotonia and muscle weakness, leading to severe hypoxia and loss of consciousness; she died at 20 months of age following a bronchopulmonary infection]	L3	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L1|L2|L3	L1	pre-infant-lethal
168400	PARASTREMMATIC DWARFISM	Parastremmatic dwarfism, 168400 (3)	Parastremmatic dwarfism	n	-	-	-	TRPV4	HGNC:18083	Parastremmatic dwarfism, 168400 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	ambiguous|lethal|nonlethal	lethal|nonlethal	L1	L1	pre-infant-lethal
168500	PARIETAL FORAMINA 1	Parietal foramina 1, 168500 (3)	Parietal foramina 1	n	-	-	-	MSX2	HGNC:7392	Parietal foramina 1, 168500 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
168550	PARIETAL FORAMINA WITH CLEIDOCRANIAL DYSPLASIA	Parietal foramina with cleidocranial dysplasia, 168550 (3)	Parietal foramina with cleidocranial dysplasia	n	-	-	-	MSX2	HGNC:7392	Parietal foramina with cleidocranial dysplasia, 168550 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
168601	PARKINSON DISEASE 1, AUTOSOMAL DOMINANT	Parkinson disease 1, 168601 (3)	Parkinson disease 1	y	PARKINSON DISEASE 1, AUTOSOMAL DOMINANT; PARK1	Clinical Features|Phenotype	death|deaths|died	SNCA	HGNC:11138	Parkinson disease 1, 168601 (3), Autosomal dominant	Autosomal dominant	n	y	[Lesage et al. (2013) reported a French family in which 4 individuals had a disorder comprising rapidly progressive Parkinson disease, pyramidal signs, and psychiatric features. Three affected individuals had onset at age 31 to 35 years, whereas the fourth had onset at age 60....The disorder was rapidly progressive: all became bedridden within 5 to 7 years, and 3 patients died within 5 to 7 years of onset]	L6	y	-	lethal	lethal	lethal	L6|LU	L6	post-infant-lethal
168605	PERRY SYNDROME	Perry syndrome, 168605 (3)	Perry syndrome	y	PERRY SYNDROME	Clinical Features|Clinical Synopsis	death|deaths|died|fatal	DCTN1	HGNC:2711	Perry syndrome, 168605 (3), Autosomal dominant	Autosomal dominant	y	y	[Caroppo et al. (2014) reported a large 3-generation French family in which 4 individuals had variable manifestations of an adult-onset neurodegenerative disorder associated with a heterozygous missense mutation in the DCTN1 gene (G71E; 601143.0008). The age at symptom onset ranged from 39 to 59 years, and the age of death from 43 to 64 years]	L6	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L6	L6	post-infant-lethal
169100	CHAR SYNDROME	Char syndrome, 169100 (3)	Char syndrome	y	CHAR SYNDROME; CHAR	Clinical Features	died	TFAP2B	HGNC:11743	Char syndrome, 169100 (3), Autosomal dominant	Autosomal dominant	y	y	[Mani et al. (2005) studied a large 3-generation family with Char syndrome (family K144) in which there were 22 affected individuals, including 9 with PDA, facial dysmorphism, and clinodactyly, and 13 who showed dysmorphology and clinodactyly without PDA. In addition, there was 1 obligate carrier who was nonpenetrant for all features, and 1 infant died in the neonatal period from heart failure, with coarctation of the aorta, bicuspid aortic valve, and a large PDA]	L2	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L2	L2	pre-infant-lethal
169150	MACULAR DYSTROPHY, PATTERNED, 1	Macular dystrophy, patterned, 1, 169150 (3)	Macular dystrophy, patterned, 1	n	-	-	-	PRPH2	HGNC:9942	Macular dystrophy, patterned, 1, 169150 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
169400	PELGER-HUET ANOMALY	Pelger-Huet anomaly, 169400 (3)	Pelger-Huet anomaly	n	-	-	-	LBR	HGNC:6518	Pelger-Huet anomaly, 169400 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	ambiguous|lethal|nonlethal	lethal|nonlethal	L1	L1	pre-infant-lethal
169500	LEUKODYSTROPHY, DEMYELINATING, ADULT-ONSET, AUTOSOMAL DOMINANT	Leukodystrophy, adult-onset, autosomal dominant, 169500 (3)	Leukodystrophy, adult-onset, autosomal dominant	y	LEUKODYSTROPHY, DEMYELINATING, ADULT-ONSET, AUTOSOMAL DOMINANT; ADLD	Description|Clinical Features	fatal|death|deaths|died	LMNB1	HGNC:6637	Leukodystrophy, adult-onset, autosomal dominant, 169500 (3), Autosomal dominant	Autosomal dominant	y	y	[Autosomal dominant adult-onset demyelinating leukodystrophy is a slowly progressive and fatal disorder that presents in the fourth or fifth decade of life and is characterized clinically by early autonomic abnormalities, pyramidal and cerebellar dysfunction, and symmetric demyelination of the CNS]	L6	y	-	lethal	ambiguous|lethal	lethal	L6	L6	post-infant-lethal
169600	BENIGN CHRONIC PEMPHIGUS	Hailey-Hailey disease, 169600 (3)	Hailey-Hailey disease	n	-	-	-	ATP2C1	HGNC:13211	Hailey-Hailey disease, 169600 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
170100	PROLIDASE DEFICIENCY	Prolidase deficiency, 170100 (3)	Prolidase deficiency	y	PROLIDASE DEFICIENCY	Description|Clinical Features|Phenotype	fatal|death|deaths|died	PEPD	HGNC:8840	Prolidase deficiency, 170100 (3), Autosomal recessive	Autosomal recessive	n	y	[Mild to severe mental retardation is often a feature, and recurrent respiratory tract infections, sometimes fatal, are common / Falik-Zaccai et al. (2010) reported 20 patients from 10 kindreds with prolidase deficiency in northern Israel... In 1 family, the severity ranged from death in infancy to an essentially asymptomatic adult with minor facial dysmorphism and mental deficits]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
170390	ANDERSEN CARDIODYSRHYTHMIC PERIODIC PARALYSIS	Andersen syndrome, 170390 (3)	Andersen syndrome	y	ANDERSEN CARDIODYSRHYTHMIC PERIODIC PARALYSIS	Clinical Features	death|deaths|died	KCNJ2	HGNC:6263	Andersen syndrome, 170390 (3), Autosomal dominant	Autosomal dominant	n	y	[Sudden death in this syndrome was reported by Levitt et al. (1972) / Kramer et al. (1979) described a 19-year-old man who had episodes of cardiac dysfunction associated with tetraparesis. A brother had died at age 16 from a heart condition and an older surviving brother suffered from a 'heart condition' similar to that in the proband]	L5	y	-	lethal	lethal	lethal	L5|L6|LU	L5	post-infant-lethal
170400	HYPOKALEMIC PERIODIC PARALYSIS, TYPE 1	Hypokalemic periodic paralysis, type 1, 170400 (3)	Hypokalemic periodic paralysis, type 1	n	-	-	-	CACNA1S	HGNC:1397	Hypokalemic periodic paralysis, type 1, 170400 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L2	L2	pre-infant-lethal
170500	HYPERKALEMIC PERIODIC PARALYSIS	Hyperkalemic periodic paralysis, 170500 (3)	Hyperkalemic periodic paralysis	y	HYPERKALEMIC PERIODIC PARALYSIS; HYPP	Clinical Features|Phenotype	death|deaths|died|fatal	SCN4A	HGNC:10591	Hyperkalemic periodic paralysis, 170500 (3), Autosomal dominant	Autosomal dominant	n	y	[ died at 20 months of age]	L3	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L1|L2|L3	L1	pre-infant-lethal
170650	PERIODONTITIS, AGGRESSIVE, 1	Periodontitis 1, juvenile, 170650 (3)	Periodontitis 1, juvenile	n	-	-	-	CTSC	HGNC:2528	Periodontitis 1, juvenile, 170650 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
171300	PHEOCHROMOCYTOMA	Pheochromocytoma, 171300 (3)	Pheochromocytoma	n	-	-	-	RET	HGNC:9967	Pheochromocytoma, 171300 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	ambiguous|lethal|nonlethal	lethal|nonlethal	L6	L6	post-infant-lethal
171300	PHEOCHROMOCYTOMA	Pheochromocytoma, 171300 (3)	Pheochromocytoma	n	-	-	-	VHL	HGNC:12687	Pheochromocytoma, 171300 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L4|L6	L4	post-infant-lethal
171400	MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIA	Multiple endocrine neoplasia IIA, 171400 (3)	Multiple endocrine neoplasia IIA	y	MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIA; MEN2A	Phenotype	death|deaths|died|stillborn	RET	HGNC:9967	Multiple endocrine neoplasia IIA, 171400 (3), Autosomal dominant	Autosomal dominant	y	n	-	-	-	-	ambiguous	ambiguous|lethal|nonlethal	lethal|nonlethal	L6	L6	post-infant-lethal
172700	PICK DISEASE OF BRAIN	Pick disease, 172700 (3)	Pick disease	y	PICK DISEASE OF BRAIN	Clinical Features|Phenotype	death|deaths	MAPT	HGNC:6893	Pick disease, 172700 (3), Autosomal dominant	Autosomal dominant	n	y	[Piguet et al. (2011) retrospectively analyzed the clinical features of 21 patients with a neuropathologic diagnosis of Pick disease. None had a family history of the disorder. The age at onset ranged from 42 to 70 years, with a mean of 60. Duration between symptom onset and death also varied between 2 to 16 years, with a mean of 9 years]	L6	y	-	lethal	lethal	lethal	L6	L6	post-infant-lethal
172700	PICK DISEASE OF BRAIN	Pick disease, 172700 (3)	Pick disease	y	PICK DISEASE OF BRAIN	Clinical Features|Phenotype	death|deaths	PSEN1	HGNC:9508	Pick disease, 172700 (3), Autosomal dominant	Autosomal dominant	n	y	[Piguet et al. (2011) retrospectively analyzed the clinical features of 21 patients with a neuropathologic diagnosis of Pick disease. None had a family history of the disorder. The age at onset ranged from 42 to 70 years, with a mean of 60. Duration between symptom onset and death also varied between 2 to 16 years, with a mean of 9 years]	L6	y	-	lethal	lethal	lethal	L6	L6	post-infant-lethal
172800	PIEBALD TRAIT	Piebaldism, 172800 (3)	Piebaldism	n	-	-	-	KIT	HGNC:6342	Piebaldism, 172800 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L6	L6	post-infant-lethal
172870	PIGMENTED PARAVENOUS CHORIORETINAL ATROPHY	Pigmented paravenous chorioretinal atrophy, 172870 (3)	Pigmented paravenous chorioretinal atrophy	n	-	-	-	CRB1	HGNC:2343	Pigmented paravenous chorioretinal atrophy, 172870 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
173100	ISOLATED GROWTH HORMONE DEFICIENCY, TYPE II	Growth hormone deficiency, isolated, type II, 173100 (3)	Growth hormone deficiency, isolated, type II	n	-	-	-	GH1	HGNC:4261	Growth hormone deficiency, isolated, type II, 173100 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
173200	PITYRIASIS RUBRA PILARIS	Pityriasis rubra pilaris, 173200 (3)	Pityriasis rubra pilaris	n	-	-	-	CARD14	HGNC:16446	Pityriasis rubra pilaris, 173200 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
173600	PNEUMOTHORAX, PRIMARY SPONTANEOUS	Pneumothorax, primary spontaneous, 173600 (3)	Pneumothorax, primary spontaneous	y	PNEUMOTHORAX, PRIMARY SPONTANEOUS; PSP	Clinical Features	died	FLCN	HGNC:27310	Pneumothorax, primary spontaneous, 173600 (3), Autosomal dominant	Autosomal dominant	y	y	[Wilson and Aylsworth (1979) described unilateral pneumothorax in a newborn whose maternal grandmother and 2 maternal uncles had had pneumothorax; 1 maternal uncle died at age 2 months of bilateral pneumothorax]	L3	n	y	lethal	lethal|nonlethal	lethal|nonlethal	L3	L3	pre-infant-lethal
173650	KINDLER SYNDROME	Kindler syndrome, 173650 (3)	Kindler syndrome	n	-	-	-	FERMT1	HGNC:15889	Kindler syndrome, 173650 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
173900	POLYCYSTIC KIDNEY DISEASE 1 WITH OR WITHOUT POLYCYSTIC LIVER DISEASE	Polycystic kidney disease 1, 173900 (3)	Polycystic kidney disease 1	y	POLYCYSTIC KIDNEY DISEASE 1 WITH OR WITHOUT POLYCYSTIC LIVER DISEASE; PKD1	Clinical Features	death|deaths|died	PKD1	HGNC:9008	Polycystic kidney disease 1, 173900 (3), Autosomal dominant	Autosomal dominant	y	y	[Wirth et al. (1987) studied 6 kindreds in which polycystic kidney disease had early onset with cystic enlargement of the kidneys detected by prenatal sonography in some cases and with death soon after birth in several]	L2	y	-	lethal	lethal	lethal	L2	L2	pre-infant-lethal
174000	TUBULOINTERSTITIAL KIDNEY DISEASE, AUTOSOMAL DOMINANT, 2	Tubulointerstitial kidney disease, autosomal dominant, 2, 174000 (3)	Tubulointerstitial kidney disease, autosomal dominant, 2	y	TUBULOINTERSTITIAL KIDNEY DISEASE, AUTOSOMAL DOMINANT, 2; ADTKD2	Clinical Features	died	MUC1	HGNC:7508	Tubulointerstitial kidney disease, autosomal dominant, 2, 174000 (3), Autosomal dominant	Autosomal dominant	y	y	[Goldman et al. (1966) described a kindred with 17 affected members spanning 5 generations. Fifteen had died in the second decade of life with rapid clinical deterioration after the onset of symptoms]	L5	y	-	lethal	lethal	lethal	L5	L5	post-infant-lethal
174050	POLYCYSTIC LIVER DISEASE 1 WITH OR WITHOUT KIDNEY CYSTS	Polycystic liver disease 1, 174050 (3)	Polycystic liver disease 1	n	-	-	-	PRKCSH	HGNC:9411	Polycystic liver disease 1, 174050 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
174200	POLYDACTYLY, POSTAXIAL, TYPE A1	Polydactyly, postaxial, types A1 and B, 174200 (3)	Polydactyly, postaxial, types A1 and B	n	-	-	-	GLI3	HGNC:4319	Polydactyly, postaxial, types A1 and B, 174200 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L2	L2	pre-infant-lethal
174300	OROFACIODIGITAL SYNDROME V	Orofaciodigital syndrome V, 174300 (3)	Orofaciodigital syndrome V	n	-	-	-	DDX59	HGNC:25360	Orofaciodigital syndrome V, 174300 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
174400	POLYDACTYLY, PREAXIAL I	Polydactyly, preaxial I, 174400 (3)	Polydactyly, preaxial I	n	-	-	-	GLI1	HGNC:4317	Polydactyly, preaxial I, 174400 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
174500	POLYDACTYLY, PREAXIAL II	Polydactyly, preaxial type II, 174500 (3)	Polydactyly, preaxial type II	n	-	-	-	LMBR1	HGNC:13243	Polydactyly, preaxial type II, 174500 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L2	L2	pre-infant-lethal
174500	POLYDACTYLY, PREAXIAL II	Triphalangeal thumb, type I, 174500 (3)	Triphalangeal thumb, type I	n	-	-	-	LMBR1	HGNC:13243	Triphalangeal thumb, type I, 174500 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L2	L2	pre-infant-lethal
174700	POLYDACTYLY, PREAXIAL IV	Polydactyly, preaxial, type IV, 174700 (3)	Polydactyly, preaxial, type IV	n	-	-	-	GLI3	HGNC:4319	Polydactyly, preaxial, type IV, 174700 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L2	L2	pre-infant-lethal
174810	FAMILIAL EXPANSILE OSTEOLYSIS	Osteolysis, familial expansile, 174810 (3)	Osteolysis, familial expansile	n	-	-	-	TNFRSF11A	HGNC:11908	Osteolysis, familial expansile, 174810 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L4	L4	post-infant-lethal
174900	JUVENILE POLYPOSIS SYNDROME	Polyposis, juvenile intestinal, 174900 (3)	Polyposis, juvenile intestinal	y	JUVENILE POLYPOSIS SYNDROME; JPS	Clinical Features	death|deaths|died	BMPR1A	HGNC:1076	Polyposis, juvenile intestinal, 174900 (3), Autosomal dominant	Autosomal dominant	y	y	[Walpole and Cullity (1989) described a patient with first presentation of polyposis in the second year of life. The patient had a large head, bilateral inguinal hernias and cryptorchidism, an umbilical hernia, and finger clubbing. Death occurred due to adenocarcinoma of the pancreas at age 19]	L6	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L6	L6	post-infant-lethal
174900	JUVENILE POLYPOSIS SYNDROME	Polyposis, juvenile intestinal, 174900 (3)	Polyposis, juvenile intestinal	y	JUVENILE POLYPOSIS SYNDROME; JPS	Clinical Features	death|deaths|died	SMAD4	HGNC:6770	Polyposis, juvenile intestinal, 174900 (3), Autosomal dominant	Autosomal dominant	y	y	[died of colonic malignancy between ages 30 and 55]	L6	y	-	lethal	lethal	lethal	L6|LU	L6	post-infant-lethal
175050	JUVENILE POLYPOSIS/HEREDITARY HEMORRHAGIC TELANGIECTASIA SYNDROME	Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome, 175050 (3)	Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome	y	JUVENILE POLYPOSIS/HEREDITARY HEMORRHAGIC TELANGIECTASIA SYNDROME; JPHT	Clinical Features	died	SMAD4	HGNC:6770	Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome, 175050 (3), Autosomal dominant	Autosomal dominant	y	y	[Conte et al. (1982) described an autosomal dominant syndrome of juvenile gastrointestinal polyposis, cutaneous telangiectasia, and pulmonary arteriovenous malformations in a father and his son and daughter. The father died from colon cancer at the age of 36]	L6	y	y	lethal	lethal	lethal	L6|LU	L6	post-infant-lethal
175100	FAMILIAL ADENOMATOUS POLYPOSIS 1	Adenomatous polyposis coli, 175100 (3)	Adenomatous polyposis coli	y	FAMILIAL ADENOMATOUS POLYPOSIS 1; FAP1	Clinical Features	death|deaths|died	APC	HGNC:583	Adenomatous polyposis coli, 175100 (3), Autosomal dominant	Autosomal dominant	y	y	[Capps et al. (1968) described a family with 4 generations of polyposis and carcinoma of the colon. A brother of the proband died of brain tumor at age 9 years and had colonic polyposis / Hoffmann and Brooke (1970) described a family in which 6 persons in 3 generations had FAP and a mother and son had sarcoma of bone leading to death from metastases at 28 and 13 years of age, respectively]	L4	y	y	lethal	lethal	lethal	L4|L6	L4	post-infant-lethal
175100	FAMILIAL ADENOMATOUS POLYPOSIS 1	Brain tumor-polyposis syndrome 2, 175100 (3)	Brain tumor-polyposis syndrome 2	y	FAMILIAL ADENOMATOUS POLYPOSIS 1; FAP1	Clinical Features	death|deaths|died	APC	HGNC:583	Brain tumor-polyposis syndrome 2, 175100 (3), Autosomal dominant	Autosomal dominant	y	y	[Capps et al. (1968) described a family with 4 generations of polyposis and carcinoma of the colon. A brother of the proband died of brain tumor at age 9 years and had colonic polyposis / Hoffmann and Brooke (1970) described a family in which 6 persons in 3 generations had FAP and a mother and son had sarcoma of bone leading to death from metastases at 28 and 13 years of age, respectively]	L4	y	y	lethal	lethal	lethal	L4|L6	L4	post-infant-lethal
175100	FAMILIAL ADENOMATOUS POLYPOSIS 1	Gardner syndrome, 175100 (3)	Gardner syndrome	y	FAMILIAL ADENOMATOUS POLYPOSIS 1; FAP1	Clinical Features	death|deaths|died	APC	HGNC:583	Gardner syndrome, 175100 (3), Autosomal dominant	Autosomal dominant	y	y	[Capps et al. (1968) described a family with 4 generations of polyposis and carcinoma of the colon. A brother of the proband died of brain tumor at age 9 years and had colonic polyposis / Hoffmann and Brooke (1970) described a family in which 6 persons in 3 generations had FAP and a mother and son had sarcoma of bone leading to death from metastases at 28 and 13 years of age, respectively]	L4	y	y	lethal	lethal	lethal	L4|L6	L4	post-infant-lethal
175200	PEUTZ-JEGHERS SYNDROME	Peutz-Jeghers syndrome, 175200 (3)	Peutz-Jeghers syndrome	y	PEUTZ-JEGHERS SYNDROME; PJS	Clinical Features|Phenotype	died	STK11	HGNC:11389	Peutz-Jeghers syndrome, 175200 (3), Autosomal dominant	Autosomal dominant	y	y	[Spigelman et al. (1989) found that malignant tumors had developed in 16 (22%), of whom all but 1 had died. There were 9 gastrointestinal and 7 nongastrointestinal tumors. The chance of dying of cancer by age 57 was 48%]	L6	y	-	lethal	lethal	lethal	L6	L6	post-infant-lethal
175700	GREIG CEPHALOPOLYSYNDACTYLY SYNDROME	Greig cephalopolysyndactyly syndrome, 175700 (3)	Greig cephalopolysyndactyly syndrome	n	-	-	-	GLI3	HGNC:4319	Greig cephalopolysyndactyly syndrome, 175700 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L2	L2	pre-infant-lethal
175780	BRAIN SMALL VESSEL DISEASE 1 WITH OR WITHOUT OCULAR ANOMALIES	Brain small vessel disease with or without ocular anomalies, 175780 (3)	Brain small vessel disease with or without ocular anomalies	y	BRAIN SMALL VESSEL DISEASE 1 WITH OR WITHOUT OCULAR ANOMALIES; BSVD1	Clinical Features	died|fatal|miscarriage|miscarriages	COL4A1	HGNC:2202	Brain small vessel disease with or without ocular anomalies, 175780 (3), Autosomal dominant	Autosomal dominant	y	y	[Aguglia et al. (2004) reported a 3-generation Italian family in which 9 individuals had type 1 porencephaly inherited in an autosomal dominant pattern. A high rate of miscarriages was reported. Four patients had a severe phenotype with unilateral porencephalic cyst, pyramidal signs, tetraparesis, limb dystonia, seizures, exotropia, visual field defects, and low IQ.The other affected members manifested some of these features. Three patients had perinatal asphyxia, and 4 patients had mitral valve prolapse. The pattern of brain abnormalities were consistent with in utero insults occurring late in the second trimester]	L1	n	y	lethal	lethal|nonlethal	lethal|nonlethal	L1|L6	L1	pre-infant-lethal
175800	POROKERATOSIS 1, MULTIPLE TYPES	Porokeratosis 1, multiple types, 175800 (3)	Porokeratosis 1, multiple types	y	POROKERATOSIS 1, MULTIPLE TYPES; POROK1	Clinical Features	died	PMVK	HGNC:9141	Porokeratosis 1, multiple types, 175800 (3), Autosomal dominant	Autosomal dominant	n	y	[Machino et al. (1984) described a Japanese patient with porokeratosis of Mibelli who also had features of Werner syndrome (277700), a relatively frequent disorder in Japan. He died of metastatic squamous carcinoma which developed in a lesion on the foot]	LU	y	-	lethal	lethal	lethal	LU	LU	post-infant-lethal
175900	POROKERATOSIS 3, MULTIPLE TYPES	Porokeratosis 3, multiple types, 175900 (3)	Porokeratosis 3, multiple types	n	-	-	-	MVK	HGNC:7530	Porokeratosis 3, multiple types, 175900 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L4|LU	L4	post-infant-lethal
176000	PORPHYRIA, ACUTE INTERMITTENT	Porphyria, acute intermittent, 176000 (3)	Porphyria, acute intermittent	y	PORPHYRIA, ACUTE INTERMITTENT; AIP	Clinical Features|Phenotype	death|deaths|died	HMBS	HGNC:4982	Porphyria, acute intermittent, 176000 (3), Autosomal dominant	Autosomal dominant	y	y	[Abdominal pain is the most common symptom, sometimes with constipation and urinary retention; paraesthesias and paralysis also occur, and death may result from respiratory paralysis / Beukeveld et al. (1990) reported a rare case of a child with presumed homozygous AIP who demonstrated porencephaly and severe developmental retardation... She died at age 8 years]	L4	y	-	lethal	lethal	lethal	L4	L4	post-infant-lethal
176000	PORPHYRIA, ACUTE INTERMITTENT	Porphyria, acute intermittent, nonerythroid variant, 176000 (3)	Porphyria, acute intermittent, nonerythroid variant	y	PORPHYRIA, ACUTE INTERMITTENT; AIP	Clinical Features|Phenotype	death|deaths|died	HMBS	HGNC:4982	Porphyria, acute intermittent, nonerythroid variant, 176000 (3), Autosomal dominant	Autosomal dominant	y	y	[Abdominal pain is the most common symptom, sometimes with constipation and urinary retention; paraesthesias and paralysis also occur, and death may result from respiratory paralysis / Beukeveld et al. (1990) reported a rare case of a child with presumed homozygous AIP who demonstrated porencephaly and severe developmental retardation... She died at age 8 years]	L4	y	-	lethal	lethal	lethal	L4	L4	post-infant-lethal
176100	PORPHYRIA CUTANEA TARDA	Porphyria cutanea tarda, 176100 (3)	Porphyria cutanea tarda	y	PORPHYRIA CUTANEA TARDA	Phenotype	lethal	UROD	HGNC:12591	Porphyria cutanea tarda, 176100 (3), Autosomal dominant, Autosomal recessive	Autosomal dominant, Autosomal recessive	y	n	-	-	-	-	ambiguous	ambiguous	ambiguous	-	-	-
176100	PORPHYRIA CUTANEA TARDA	Porphyria, hepatoerythropoietic, 176100 (3)	Porphyria, hepatoerythropoietic	y	PORPHYRIA CUTANEA TARDA	Phenotype	lethal	UROD	HGNC:12591	Porphyria, hepatoerythropoietic, 176100 (3), Autosomal dominant, Autosomal recessive	Autosomal dominant, Autosomal recessive	y	n	-	-	-	-	ambiguous	ambiguous	ambiguous	-	-	-
176200	VARIEGATE PORPHYRIA	Variegate porphyria, 176200 (3)	Variegate porphyria	n	-	-	-	PPOX	HGNC:9280	Variegate porphyria, 176200 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L5	L5	post-infant-lethal
176410	PRECOCIOUS PUBERTY, MALE-LIMITED	Precocious puberty, male, 176410 (3)	Precocious puberty, male	n	-	-	-	LHCGR	HGNC:6585	Precocious puberty, male, 176410 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
176450	CURRARINO SYNDROME	Currarino syndrome, 176450 (3)	Currarino syndrome	y	CURRARINO SYNDROME	Clinical Features	fatal	MNX1	HGNC:4979	Currarino syndrome, 176450 (3), Autosomal dominant	Autosomal dominant	y	y	[Kim et al. (2007) reported 2 Korean families with Currarino syndrome...In the second family, a 6-month-old infant girl developed fatal polymicrobial cerebritis and arachnoiditis]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
176500	CEREBRAL AMYLOID ANGIOPATHY, ITM2B-RELATED, 1	Dementia, familial British, 176500 (3)	Dementia, familial British	n	-	-	-	ITM2B	HGNC:6174	Dementia, familial British, 176500 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L6	L6	post-infant-lethal
176670	HUTCHINSON-GILFORD PROGERIA SYNDROME	Hutchinson-Gilford progeria, 176670 (3)	Hutchinson-Gilford progeria	y	HUTCHINSON-GILFORD PROGERIA SYNDROME; HGPS	Description|Clinical Features|Phenotype	death|deaths|died	LMNA	HGNC:6636	Hutchinson-Gilford progeria, 176670 (3), Autosomal dominant	Autosomal dominant	n	y	[Three cases of neonatal HGPS were reported in France (De Martinville et al., 1980; Labeille et al., 1987). All 3 patients died early, 2 on the first day of life and the other patient at 20 months of age]	L2	y	-	lethal	ambiguous|lethal|nonlethal	lethal|nonlethal	L1|L2|L6	L1	pre-infant-lethal
176860	THROMBOPHILIA DUE TO PROTEIN C DEFICIENCY, AUTOSOMAL DOMINANT	Thrombophilia 3 due to protein C deficiency, autosomal dominant, 176860 (3)	Thrombophilia 3 due to protein C deficiency, autosomal dominant	y	THROMBOPHILIA DUE TO PROTEIN C DEFICIENCY, AUTOSOMAL DOMINANT; THPH3	Clinical Features|Phenotype	died|fatal|death|deaths	PROC	HGNC:9451	Thrombophilia 3 due to protein C deficiency, autosomal dominant, 176860 (3), Autosomal dominant	Autosomal dominant	n	n	-	-	-	-	ambiguous	ambiguous|lethal	lethal	L2	L2	pre-infant-lethal
177000	PROTOPORPHYRIA, ERYTHROPOIETIC, 1	Protoporphyria, erythropoietic, 1, 177000 (3)	Protoporphyria, erythropoietic, 1	y	PROTOPORPHYRIA, ERYTHROPOIETIC, 1; EPP1	Clinical Features	fatal	FECH	HGNC:3647	Protoporphyria, erythropoietic, 1, 177000 (3), Autosomal recessive	Autosomal recessive	n	y	[Whereas most EPP patients experience only a painful photosensitivity, a small number develop liver complications, including fatal liver damage, due to the accumulation of excessive amounts of protoporphyrin in the liver (Bloomer et al., 1975; Cripps et al., 1977; Bloomer, 1979)]	LU	y	-	lethal	lethal	lethal	LU	LU	post-infant-lethal
177170	PSEUDOACHONDROPLASIA	Pseudoachondroplasia, 177170 (3)	Pseudoachondroplasia	n	-	-	-	COMP	HGNC:2227	Pseudoachondroplasia, 177170 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
177200	LIDDLE SYNDROME 1	Liddle syndrome 1, 177200 (3)	Liddle syndrome 1	y	LIDDLE SYNDROME 1; LIDLS1	Clinical Features	death|deaths|died	SCNN1B	HGNC:10600	Liddle syndrome 1, 177200 (3), Autosomal dominant	Autosomal dominant	n	y	[Jeunemaitre et al. (1997) reported a family in which a mother and her 3 sons had Liddle syndrome and a heterozygous mutation in the SCNN1B gene... Many of the mother's relatives had had stroke or sudden death before age 60 years]	L6	n	y	lethal	lethal|nonlethal	lethal|nonlethal	L4|L6	L4	post-infant-lethal
177735	PSEUDOHYPOALDOSTERONISM, TYPE I, AUTOSOMAL DOMINANT	Pseudohypoaldosteronism type I, autosomal dominant, 177735 (3)	Pseudohypoaldosteronism type I, autosomal dominant	n	-	-	-	NR3C2	HGNC:7979	Pseudohypoaldosteronism type I, autosomal dominant, 177735 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L6	L6	post-infant-lethal
177820	PSEUDO-VON WILLEBRAND DISEASE	von Willebrand disease, platelet-type, 177820 (3)	von Willebrand disease, platelet-type	n	-	-	-	GP1BA	HGNC:4439	von Willebrand disease, platelet-type, 177820 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
177850	PSEUDOXANTHOMA ELASTICUM, FORME FRUSTE	Pseudoxanthoma elasticum, forme fruste, 177850 (3)	Pseudoxanthoma elasticum, forme fruste	y	PSEUDOXANTHOMA ELASTICUM, FORME FRUSTE	Clinical Features	died	ABCC6	HGNC:57	Pseudoxanthoma elasticum, forme fruste, 177850 (3), Autosomal dominant	Autosomal dominant	n	y	[Hausser and Anton-Lamprecht (1991) described a family in which the mother and grandmother died because of major vascular complications of PXE]	LU	n	y	lethal	lethal	lethal	L3|LU	L3	pre-infant-lethal
178110	CONTRACTURES, PTERYGIA, AND SPONDYLOCARPOTARSAL FUSION SYNDROME 1A	Contractures, pterygia, and spondylocarpostarsal fusion syndrome 1A, 178110 (3)	Contractures, pterygia, and spondylocarpostarsal fusion syndrome 1A	n	-	-	-	MYH3	HGNC:7573	Contractures, pterygia, and spondylocarpostarsal fusion syndrome 1A, 178110 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
178500	INTERSTITIAL LUNG DISEASE 2	Interstitial lung disease 2, 178500 (3)	Interstitial lung disease 2	y	INTERSTITIAL LUNG DISEASE 2; ILD2	Clinical Features	died	SFTPA2	HGNC:10799	Interstitial lung disease 2, 178500 (3), Autosomal dominant	Autosomal dominant	y	y	[Wang et al. (2009) reported a large multigenerational family (family F27) with multiple live and deceased individuals with ILD manifest primarily as pulmonary fibrosis...Several affected individuals died between ages 36 and 56 years]	L6	y	-	lethal	lethal	lethal	L6	L6	post-infant-lethal
178600	PULMONARY HYPERTENSION, PRIMARY, 1	Pulmonary hypertension, familial primary, 1, with or without HHT, 178600 (3)	Pulmonary hypertension, familial primary, 1, with or without HHT	y	PULMONARY HYPERTENSION, PRIMARY, 1; PPH1	Description|Clinical Features|Phenotype	fatal|died|death|deaths	BMPR2	HGNC:1078	Pulmonary hypertension, familial primary, 1, with or without HHT, 178600 (3), Autosomal dominant	Autosomal dominant	y	y	[Morse et al. (1992) described a kindred in which 7 members had primary pulmonary hypertension and 2 others had this probable diagnosis. The proband was an 11-year-old girl who had an affected 8-year-old sister. The paternal grandmother died at the age of 21 in severe right heart failure,3 days after delivering her third child/ *** In one family, the gene was apparently transmitted from an affected male through 2 generations of unaffected females to a male who died of the disease at age 6 (in Inheritance field)]	L4	y	y	lethal	lethal	lethal	L3|L4	L3	pre-infant-lethal
178600	PULMONARY HYPERTENSION, PRIMARY, 1	Pulmonary hypertension, primary, fenfluramine or dexfenfluramine-associated, 178600 (3)	Pulmonary hypertension, primary, fenfluramine or dexfenfluramine-associated	y	PULMONARY HYPERTENSION, PRIMARY, 1; PPH1	Description|Clinical Features|Phenotype	fatal|died|death|deaths	BMPR2	HGNC:1078	Pulmonary hypertension, primary, fenfluramine or dexfenfluramine-associated, 178600 (3), Autosomal dominant	Autosomal dominant	y	y	[Morse et al. (1992) described a kindred in which 7 members had primary pulmonary hypertension and 2 others had this probable diagnosis. The proband was an 11-year-old girl who had an affected 8-year-old sister. The paternal grandmother died at the age of 21 in severe right heart failure,3 days after delivering her third child/ *** In one family, the gene was apparently transmitted from an affected male through 2 generations of unaffected females to a male who died of the disease at age 6 (in Inheritance field)]	L4	y	y	lethal	lethal	lethal	L3|L4	L3	pre-infant-lethal
179800	RENAL TUBULAR ACIDOSIS, DISTAL, 1	Distal renal tubular acidosis 1, 179800 (3)	Distal renal tubular acidosis 1	n	-	-	-	SLC4A1	HGNC:11027	Distal renal tubular acidosis 1, 179800 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	ambiguous|lethal|nonlethal	lethal|nonlethal	L6	L6	post-infant-lethal
179850	DOWLING-DEGOS DISEASE 1	Dowling-Degos disease 1, 179850 (3)	Dowling-Degos disease 1	n	-	-	-	KRT5	HGNC:6442	Dowling-Degos disease 1, 179850 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	ambiguous|lethal|nonlethal	lethal|nonlethal	L2	L2	pre-infant-lethal
180100	RETINITIS PIGMENTOSA 1	Retinitis pigmentosa 1, 180100 (3)	Retinitis pigmentosa 1	n	-	-	-	RP1	HGNC:10263	Retinitis pigmentosa 1, 180100 (3), Autosomal dominant, Autosomal recessive	Autosomal dominant, Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
180105	RETINITIS PIGMENTOSA 10	Retinitis pigmentosa 10, 180105 (3)	Retinitis pigmentosa 10	n	-	-	-	IMPDH1	HGNC:6052	Retinitis pigmentosa 10, 180105 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
180295	RHABDOMYOSARCOMA, EMBRYONAL, 2	Rhabdomyosarcoma, embryonal, 2, 180295 (3)	Rhabdomyosarcoma, embryonal, 2	n	-	-	-	DICER1	HGNC:17098	Rhabdomyosarcoma, embryonal, 2, 180295 (3)	-	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L4|L6	L4	post-infant-lethal
180500	AXENFELD-RIEGER SYNDROME, TYPE 1	Axenfeld-Rieger syndrome, type 1, 180500 (3)	Axenfeld-Rieger syndrome, type 1	n	-	-	-	PITX2	HGNC:9005	Axenfeld-Rieger syndrome, type 1, 180500 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
180550	RING DERMOID OF CORNEA	Ring dermoid of cornea, 180550 (3)	Ring dermoid of cornea	n	-	-	-	PITX2	HGNC:9005	Ring dermoid of cornea, 180550 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
180700	ROBINOW SYNDROME, AUTOSOMAL DOMINANT 1	Robinow syndrome, autosomal dominant 1, 180700 (3)	Robinow syndrome, autosomal dominant 1	n	-	-	-	WNT5A	HGNC:12784	Robinow syndrome, autosomal dominant 1, 180700 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
180750	ROBINOW-SORAUF SYNDROME	Robinow-Sorauf syndrome, 180750 (3)	Robinow-Sorauf syndrome	n	-	-	-	TWIST1	HGNC:12428	Robinow-Sorauf syndrome, 180750 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
180800	ROUSSY-LEVY HEREDITARY AREFLEXIC DYSTASIA	Roussy-Levy syndrome, 180800 (3)	Roussy-Levy syndrome	n	-	-	-	MPZ	HGNC:7225	Roussy-Levy syndrome, 180800 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	ambiguous|lethal|nonlethal	lethal|nonlethal	L6	L6	post-infant-lethal
180800	ROUSSY-LEVY HEREDITARY AREFLEXIC DYSTASIA	Roussy-Levy syndrome, 180800 (3)	Roussy-Levy syndrome	n	-	-	-	PMP22	HGNC:9118	Roussy-Levy syndrome, 180800 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	ambiguous|nonlethal	ambiguous	-	-	-
180849	RUBINSTEIN-TAYBI SYNDROME 1	Rubinstein-Taybi syndrome 1, 180849 (3)	Rubinstein-Taybi syndrome 1	y	RUBINSTEIN-TAYBI SYNDROME 1; RSTS1	Diagnosis|Phenotype	died	CREBBP	HGNC:2348	Rubinstein-Taybi syndrome 1, 180849 (3), Autosomal dominant	Autosomal dominant	n	y	[died at 34 days of life]	L2	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L2	L2	pre-infant-lethal
180920	APLASIA OF LACRIMAL AND SALIVARY GLANDS	Aplasia of lacrimal and salivary glands, 180920 (3)	Aplasia of lacrimal and salivary glands	n	-	-	-	FGF10	HGNC:3666	Aplasia of lacrimal and salivary glands, 180920 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
181270	SCALP-EAR-NIPPLE SYNDROME	Scalp-ear-nipple syndrome, 181270 (3)	Scalp-ear-nipple syndrome	n	-	-	-	KCTD1	HGNC:18249	Scalp-ear-nipple syndrome, 181270 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
181350	EMERY-DREIFUSS MUSCULAR DYSTROPHY 2, AUTOSOMAL DOMINANT	Emery-Dreifuss muscular dystrophy 2, autosomal dominant, 181350 (3)	Emery-Dreifuss muscular dystrophy 2, autosomal dominant	y	EMERY-DREIFUSS MUSCULAR DYSTROPHY 2, AUTOSOMAL DOMINANT; EDMD2	Clinical Features|Clinical Synopsis|Phenotype	death|deaths|died|lethal	LMNA	HGNC:6636	Emery-Dreifuss muscular dystrophy 2, autosomal dominant, 181350 (3), Autosomal dominant	Autosomal dominant	n	y	[Witt et al. (1988) described a German family with an autosomal dominant form of the Emery-Dreifuss syndrome. Several affected members died in middle age of sudden cardiac death and at least 2 had a pacemaker implanted]	L6	y	-	lethal	ambiguous|lethal|nonlethal	lethal|nonlethal	L1|L2|L6	L1	pre-infant-lethal
181400	SCAPULOPERONEAL SYNDROME, NEUROGENIC, KAESER TYPE	Scapuloperoneal syndrome, neurogenic, Kaeser type, 181400 (3)	Scapuloperoneal syndrome, neurogenic, Kaeser type	y	SCAPULOPERONEAL SYNDROME, NEUROGENIC, KAESER TYPE; SCPNK	Clinical Features	death|deaths	DES	HGNC:2770	Scapuloperoneal syndrome, neurogenic, Kaeser type, 181400 (3), Autosomal dominant	Autosomal dominant	y	y	[Affected men seemingly carried a higher risk of sudden, cardiac death as compared to affected women]	LU	y	-	lethal	lethal	lethal	L5|L6|LU	L5	post-infant-lethal
181405	SCAPULOPERONEAL SPINAL MUSCULAR ATROPHY	Scapuloperoneal spinal muscular atrophy, 181405 (3)	Scapuloperoneal spinal muscular atrophy	n	-	-	-	TRPV4	HGNC:18083	Scapuloperoneal spinal muscular atrophy, 181405 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	ambiguous|lethal|nonlethal	lethal|nonlethal	L1	L1	pre-infant-lethal
181450	ULNAR-MAMMARY SYNDROME	Ulnar-mammary syndrome, 181450 (3)	Ulnar-mammary syndrome	n	-	-	-	TBX3	HGNC:11602	Ulnar-mammary syndrome, 181450 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
181600	HURIEZ SYNDROME	Huriez syndrome, 181600 (3)	Huriez syndrome	y	HURIEZ SYNDROME; HRZ	Clinical Features	died	SMARCAD1	HGNC:18398	Huriez syndrome, 181600 (3), Autosomal dominant	Autosomal dominant	n	y	[Kavanagh et al. (1997) reported the first family from the U.K. with the scleroatrophic syndrome of Huriez. .. A sister had died at the age of 22 years of metastatic squamous cell carcinoma that developed on scleroatrophic skin on the finger]	L6	n	y	lethal	lethal|nonlethal	lethal|nonlethal	L6	L6	post-infant-lethal
182170	ANEMIA, SIDEROBLASTIC, 4	Anemia, sideroblastic, 4, 182170 (3)	Anemia, sideroblastic, 4	n	-	-	-	HSPA9	HGNC:5244	Anemia, sideroblastic, 4, 182170 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
182212	SHPRINTZEN-GOLDBERG CRANIOSYNOSTOSIS SYNDROME	Shprintzen-Goldberg syndrome, 182212 (3)	Shprintzen-Goldberg syndrome	n	-	-	-	SKI	HGNC:10896	Shprintzen-Goldberg syndrome, 182212 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
182230	SEPTOOPTIC DYSPLASIA	Growth hormone deficiency with pituitary anomalies, 182230 (3)	Growth hormone deficiency with pituitary anomalies	y	SEPTOOPTIC DYSPLASIA	Clinical Features|Phenotype	death|deaths	HESX1	HGNC:4877	Growth hormone deficiency with pituitary anomalies, 182230 (3), Autosomal dominant, Autosomal recessive	Autosomal dominant, Autosomal recessive	n	y	[Sobrier et al. (2006) reported 2 unrelated Italian patients with panhypopituitarism who, at birth, presented with hypoglycemic seizures and respiratory distress complicated by shock, in a familial context of neonatal death in 1 family]	L2	n	y	lethal	lethal	lethal	L2	L2	pre-infant-lethal
182230	SEPTOOPTIC DYSPLASIA	Pituitary hormone deficiency, combined, 5, 182230 (3)	Pituitary hormone deficiency, combined, 5	y	SEPTOOPTIC DYSPLASIA	Clinical Features|Phenotype	death|deaths	HESX1	HGNC:4877	Pituitary hormone deficiency, combined, 5, 182230 (3), Autosomal dominant, Autosomal recessive	Autosomal dominant, Autosomal recessive	n	y	[Sobrier et al. (2006) reported 2 unrelated Italian patients with panhypopituitarism who, at birth, presented with hypoglycemic seizures and respiratory distress complicated by shock, in a familial context of neonatal death in 1 family]	L2	n	y	lethal	lethal	lethal	L2	L2	pre-infant-lethal
182230	SEPTOOPTIC DYSPLASIA	Septooptic dysplasia, 182230 (3)	Septooptic dysplasia	y	SEPTOOPTIC DYSPLASIA	Clinical Features|Phenotype	death|deaths	HESX1	HGNC:4877	Septooptic dysplasia, 182230 (3), Autosomal dominant, Autosomal recessive	Autosomal dominant, Autosomal recessive	n	y	[Sobrier et al. (2006) reported 2 unrelated Italian patients with panhypopituitarism who, at birth, presented with hypoglycemic seizures and respiratory distress complicated by shock, in a familial context of neonatal death in 1 family]	L2	n	y	lethal	lethal	lethal	L2	L2	pre-infant-lethal
182250	SINGLETON-MERTEN SYNDROME 1	Singleton-Merten syndrome 1, 182250 (3)	Singleton-Merten syndrome 1	y	SINGLETON-MERTEN SYNDROME 1; SGMRT1	Description|Clinical Features|Clinical Synopsis	death|deaths	IFIH1	HGNC:18873	Singleton-Merten syndrome 1, 182250 (3), Autosomal dominant	Autosomal dominant	y	y	[Singleton and Merten (1973) and Gay and Kuhn (1976) reported a total of 4 unrelated patients, male and female, with dental dysplasia, progressive calcification of the thoracic aorta, calcific aortic stenosis, osteoporosis, and expansion of the marrow cavities in hand bones like that observed in anemia. In 2 of the 4 patients, there was also generalized muscle weakness and atrophy beginning in the first or second year of life following a febrile illness. Onset was between 4 and 24 months and death between 4 and 18 year]	L4	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L3|L4	L3	pre-infant-lethal
182410	SNEDDON SYNDROME	Sneddon syndrome, 182410 (3)	Sneddon syndrome	y	SNEDDON SYNDROME; SNDNS	Clinical Features	death|deaths|died	ADA2	HGNC:1839	Sneddon syndrome, 182410 (3), Autosomal recessive	Autosomal recessive	y	y	[Hilton and Footitt (2003) described the neuropathologic findings in an isolated case of Sneddon syndrome in a 64-year-old man who died of myocardial infarction]	L6	y	-	lethal	ambiguous|lethal	lethal	L6	L6	post-infant-lethal
182600	SPASTIC PARAPLEGIA 3, AUTOSOMAL DOMINANT	Spastic paraplegia 3A, autosomal dominant, 182600 (3)	Spastic paraplegia 3A, autosomal dominant	y	SPASTIC PARAPLEGIA 3, AUTOSOMAL DOMINANT; SPG3A	Clinical Features	died	ATL1	HGNC:11231	Spastic paraplegia 3A, autosomal dominant, 182600 (3), Autosomal dominant	Autosomal dominant	y	n	-	-	-	-	ambiguous	ambiguous|nonlethal	ambiguous	-	-	-
182601	SPASTIC PARAPLEGIA 4, AUTOSOMAL DOMINANT	Spastic paraplegia 4, autosomal dominant, 182601 (3)	Spastic paraplegia 4, autosomal dominant	n	-	-	-	SPAST	HGNC:11233	Spastic paraplegia 4, autosomal dominant, 182601 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
182900	SPHEROCYTOSIS, TYPE 1	Spherocytosis, type 1, 182900 (3)	Spherocytosis, type 1	y	SPHEROCYTOSIS, TYPE 1; SPH1	Clinical Features	died	ANK1	HGNC:492	Spherocytosis, type 1, 182900 (3), Autosomal dominant, Autosomal recessive	Autosomal dominant, Autosomal recessive	y	n	-	-	-	-	ambiguous	ambiguous	ambiguous	-	-	-
182940	NEURAL TUBE DEFECTS, SUSCEPTIBILITY TO	Neural tube defects, 182940 (3)	Neural tube defects	y	NEURAL TUBE DEFECTS, SUSCEPTIBILITY TO; NTD	Phenotype	lethal|stillborn	VANGL2	HGNC:15511	Neural tube defects, 182940 (3), Autosomal dominant	Autosomal dominant	y	y	[stillborn or miscarried fetuses with neural tube defects, including anencephaly]	L1	y	-	lethal	lethal	lethal	L1	L1	pre-infant-lethal
182980	SPINAL MUSCULAR ATROPHY, LATE-ONSET, FINKEL TYPE	Spinal muscular atrophy, late-onset, Finkel type, 182980 (3)	Spinal muscular atrophy, late-onset, Finkel type	n	-	-	-	VAPB	HGNC:12649	Spinal muscular atrophy, late-onset, Finkel type, 182980 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	ambiguous|nonlethal	ambiguous	-	-	-
183086	SPINOCEREBELLAR ATAXIA 6	Spinocerebellar ataxia 6, 183086 (3)	Spinocerebellar ataxia 6	y	SPINOCEREBELLAR ATAXIA 6; SCA6	Clinical Features	death|deaths|died	CACNA1A	HGNC:1388	Spinocerebellar ataxia 6, 183086 (3), Autosomal dominant	Autosomal dominant	n	y	[Tsuchiya et al. (1998) described a Japanese family with 2 affected sisters and an affected father. The proband developed gait disturbance at age 62 years and died at age 67 years due to subarachnoid hemorrhag]	L6	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L4|L6	L4	post-infant-lethal
183090	SPINOCEREBELLAR ATAXIA 2	Spinocerebellar ataxia 2, 183090 (3)	Spinocerebellar ataxia 2	y	SPINOCEREBELLAR ATAXIA 2; SCA2	Clinical Features	died	ATXN2	HGNC:10555	Spinocerebellar ataxia 2, 183090 (3), Autosomal dominant	Autosomal dominant	y	n	-	-	-	-	ambiguous	ambiguous	ambiguous	-	-	-
183600	SPLIT-HAND/FOOT MALFORMATION 1	Split-hand/foot malformation 1, 183600 (3)	Split-hand/foot malformation 1	n	-	-	-	DLX5	HGNC:2918	Split-hand/foot malformation 1, 183600 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
183900	SPONDYLOEPIPHYSEAL DYSPLASIA CONGENITA	SED congenita, 183900 (3)	SED congenita	y	SPONDYLOEPIPHYSEAL DYSPLASIA CONGENITA; SEDC	Clinical Features|Phenotype	died	COL2A1	HGNC:2200	SED congenita, 183900 (3), Autosomal dominant	Autosomal dominant	y	y	[In an infant with SED congenita who died at age 5 months after an anoxic episode, Murray et al. (1985) found in the eye that the collagen of the vitreous had a smaller-than-normal fiber diameter]	L3	y	-	lethal	ambiguous|lethal|nonlethal	lethal|nonlethal	L1|L2|L3	L1	pre-infant-lethal
184095	SPONDYLOEPIPHYSEAL DYSPLASIA, MAROTEAUX TYPE	SED, Maroteaux type, 184095 (3)	SED, Maroteaux type	n	-	-	-	TRPV4	HGNC:18083	SED, Maroteaux type, 184095 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	ambiguous|lethal|nonlethal	lethal|nonlethal	L1	L1	pre-infant-lethal
184250	SPONDYLOEPIMETAPHYSEAL DYSPLASIA, STRUDWICK TYPE	SMED Strudwick type, 184250 (3)	SMED Strudwick type	n	-	-	-	COL2A1	HGNC:2200	SMED Strudwick type, 184250 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	ambiguous|lethal|nonlethal	lethal|nonlethal	L1|L2|L3	L1	pre-infant-lethal
184252	SPONDYLOMETAPHYSEAL DYSPLASIA, KOZLOWSKI TYPE	Spondylometaphyseal dysplasia, Kozlowski type, 184252 (3)	Spondylometaphyseal dysplasia, Kozlowski type	n	-	-	-	TRPV4	HGNC:18083	Spondylometaphyseal dysplasia, Kozlowski type, 184252 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	ambiguous|lethal|nonlethal	lethal|nonlethal	L1	L1	pre-infant-lethal
184255	SPONDYLOMETAPHYSEAL DYSPLASIA, CORNER FRACTURE TYPE	Spondylometaphyseal dysplasia, corner fracture type, 184255 (3)	Spondylometaphyseal dysplasia, corner fracture type	n	-	-	-	FN1	HGNC:3778	Spondylometaphyseal dysplasia, corner fracture type, 184255 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L6	L6	post-infant-lethal
184260	ODONTOCHONDRODYSPLASIA 1	Odontochondrodysplasia 1, 184260 (3)	Odontochondrodysplasia 1	y	ODONTOCHONDRODYSPLASIA 1; ODCD1	Clinical Features	died|lethal|lethality	TRIP11	HGNC:12305	Odontochondrodysplasia 1, 184260 (3), Autosomal recessive	Autosomal recessive	y	y	[Wehrle et al. (2019) studied 10 patients from 7 families with ODCD, including the 6 patients previously reported by Unger et al. (2008), who were all compound heterozygous for mutations in the TRIP11 gene. The authors observed considerable clinical variability, with early lethality and milder postnatal phenotypes occurring within the same family (family 1), in which a brother died at age 4 months with severe ODCD, whereas his sister was alive at age 16 years with mild disease]	L3	y	-	lethal	lethal	lethal	L1|L3	L1	pre-infant-lethal
184450	STUTTERING, FAMILIAL PERSISTENT, 1	Stuttering, familial persistent, 1, 184450 (3)	Stuttering, familial persistent, 1	n	-	-	-	AP4E1	HGNC:573	Stuttering, familial persistent, 1, 184450 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
184460	STAPES ANKYLOSIS WITH BROAD THUMBS AND TOES	Stapes ankylosis with broad thumbs and toes, 184460 (3)	Stapes ankylosis with broad thumbs and toes	n	-	-	-	NOG	HGNC:7866	Stapes ankylosis with broad thumbs and toes, 184460 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
184500	STEATOCYSTOMA MULTIPLEX	Steatocystoma multiplex, 184500 (3)	Steatocystoma multiplex	n	-	-	-	KRT17	HGNC:6427	Steatocystoma multiplex, 184500 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
184840	OTOSPONDYLOMEGAEPIPHYSEAL DYSPLASIA, AUTOSOMAL DOMINANT	Otospondylomegaepiphyseal dysplasia, autosomal dominant, 184840 (3)	Otospondylomegaepiphyseal dysplasia, autosomal dominant	n	-	-	-	COL11A2	HGNC:2187	Otospondylomegaepiphyseal dysplasia, autosomal dominant, 184840 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L2	L2	pre-infant-lethal
184900	STIFF SKIN SYNDROME	Stiff skin syndrome, 184900 (3)	Stiff skin syndrome	n	-	-	-	FBN1	HGNC:3603	Stiff skin syndrome, 184900 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	ambiguous|lethal|nonlethal	lethal|nonlethal	L2|LU	L2	pre-infant-lethal
185000	OVERHYDRATED HEREDITARY STOMATOCYTOSIS	Overhydrated hereditary stomatocytosis, 185000 (3)	Overhydrated hereditary stomatocytosis	y	OVERHYDRATED HEREDITARY STOMATOCYTOSIS; OHST	Clinical Features	death|deaths|died|stillborn	RHAG	HGNC:10006	Overhydrated hereditary stomatocytosis, 185000 (3), Autosomal dominant	Autosomal dominant	y	y	[Argent et al. (2004) described a boy, born to consanguineous Tunisian parents, who showed a severe multisystem disease... The boy had a total of 5 sibs of both sexes; 2 were stillborn and 2, both born with hydrops fetalis, lived only a short time]	L1	n	y	lethal	lethal|nonlethal	lethal|nonlethal	L1	L1	pre-infant-lethal
185020	CRYOHYDROCYTOSIS	Cryohydrocytosis, 185020 (3)	Cryohydrocytosis	y	CRYOHYDROCYTOSIS; CHC	Clinical Features	died	SLC4A1	HGNC:11027	Cryohydrocytosis, 185020 (3), Autosomal dominant	Autosomal dominant	n	y	[Coles et al. (1999) noted that red cells in this family did show excessive lysis in the cold and as such could be considered to be a form of 'cryohydrocytosis.' The original proband, who was the only member of the pedigree to be splenectomized, died at age 51 of pulmonary hypertension, which the authors stated was likely due to postsplenectomy thrombotic complications that are typical of the hereditary stomatocytoses]	L6	y	-	lethal	ambiguous|lethal|nonlethal	lethal|nonlethal	L6	L6	post-infant-lethal
185070	STORMORKEN SYNDROME	Stormorken syndrome, 185070 (3)	Stormorken syndrome	n	-	-	-	STIM1	HGNC:11386	Stormorken syndrome, 185070 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L3	L3	pre-infant-lethal
185500	SUPRAVALVULAR AORTIC STENOSIS	Supravalvar aortic stenosis, 185500 (3)	Supravalvar aortic stenosis	y	SUPRAVALVULAR AORTIC STENOSIS; SVAS	Clinical Features|Phenotype	death|deaths	ELN	HGNC:3327	Supravalvar aortic stenosis, 185500 (3), Autosomal dominant	Autosomal dominant	n	y	[Metcalfe et al. (2000) described the mutation spectrum of the ELN gene in 35 unrelated patients with SVAS and normal karyotypes without major deletions of the ELN gene as determined by FISH... or sudden infant death / Strong et al. (1970) observed sudden death following premedication for cardiac catheterization in an 11-month-old male]	L3	y	-	lethal	lethal	lethal	L3|L6	L3	pre-infant-lethal
185800	SYMPHALANGISM, PROXIMAL, 1A	Symphalangism, proximal, 1A, 185800 (3)	Symphalangism, proximal, 1A	n	-	-	-	NOG	HGNC:7866	Symphalangism, proximal, 1A, 185800 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
186000	SYNPOLYDACTYLY 1	Synpolydactyly 1, 186000 (3)	Synpolydactyly 1	n	-	-	-	HOXD13	HGNC:5136	Synpolydactyly 1, 186000 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
186100	SYNDACTYLY, TYPE III	Syndactyly, type III, 186100 (3)	Syndactyly, type III	n	-	-	-	GJA1	HGNC:4274	Syndactyly, type III, 186100 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
186200	SYNDACTYLY, TYPE IV	Syndactyly, type IV, 186200 (3)	Syndactyly, type IV	n	-	-	-	LMBR1	HGNC:13243	Syndactyly, type IV, 186200 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L2	L2	pre-infant-lethal
186300	SYNDACTYLY, TYPE V	Syndactyly, type V, 186300 (3)	Syndactyly, type V	n	-	-	-	HOXD13	HGNC:5136	Syndactyly, type V, 186300 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
186500	MULTIPLE SYNOSTOSES SYNDROME 1	Multiple synostoses syndrome 1, 186500 (3)	Multiple synostoses syndrome 1	n	-	-	-	NOG	HGNC:7866	Multiple synostoses syndrome 1, 186500 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
186570	TARSAL-CARPAL COALITION SYNDROME	Tarsal-carpal coalition syndrome, 186570 (3)	Tarsal-carpal coalition syndrome	n	-	-	-	NOG	HGNC:7866	Tarsal-carpal coalition syndrome, 186570 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
186580	BLAU SYNDROME	Blau syndrome, 186580 (3)	Blau syndrome	n	-	-	-	NOD2	HGNC:5331	Blau syndrome, 186580 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
187300	TELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 1	Telangiectasia, hereditary hemorrhagic, type 1, 187300 (3)	Telangiectasia, hereditary hemorrhagic, type 1	y	TELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 1; HHT1	Clinical Features|Phenotype	death|deaths|died|stillborn	ENG	HGNC:3349	Telangiectasia, hereditary hemorrhagic, type 1, 187300 (3), Autosomal dominant	Autosomal dominant	y	y	[Reyes-Mujica et al. (1988) described HHT in a 23-month-old girl who died of massive pulmonary hemorrhage]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
187500	TETRALOGY OF FALLOT	Tetralogy of Fallot, 187500 (3)	Tetralogy of Fallot	n	-	-	-	GATA4	HGNC:4173	Tetralogy of Fallot, 187500 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	LU	LU	post-infant-lethal
187500	TETRALOGY OF FALLOT	Tetralogy of Fallot, 187500 (3)	Tetralogy of Fallot	n	-	-	-	GATA6	HGNC:4174	Tetralogy of Fallot, 187500 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L2	L2	pre-infant-lethal
187500	TETRALOGY OF FALLOT	Tetralogy of Fallot, 187500 (3)	Tetralogy of Fallot	n	-	-	-	JAG1	HGNC:6188	Tetralogy of Fallot, 187500 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	ambiguous|lethal|nonlethal	lethal|nonlethal	L4	L4	post-infant-lethal
187500	TETRALOGY OF FALLOT	Tetralogy of Fallot, 187500 (3)	Tetralogy of Fallot	n	-	-	-	NKX2-5	HGNC:2488	Tetralogy of Fallot, 187500 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	ambiguous|lethal|nonlethal	lethal|nonlethal	LU	LU	post-infant-lethal
187500	TETRALOGY OF FALLOT	Tetralogy of Fallot, 187500 (3)	Tetralogy of Fallot	n	-	-	-	TBX1	HGNC:11592	Tetralogy of Fallot, 187500 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L2	L2	pre-infant-lethal
187500	TETRALOGY OF FALLOT	Tetralogy of Fallot, 187500 (3)	Tetralogy of Fallot	n	-	-	-	ZFPM2	HGNC:16700	Tetralogy of Fallot, 187500 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
187600	THANATOPHORIC DYSPLASIA, TYPE I	Thanatophoric dysplasia, type I, 187600 (3)	Thanatophoric dysplasia, type I	y	THANATOPHORIC DYSPLASIA, TYPE I; TD1	Description|Clinical Features|Clinical Synopsis|Phenotype	lethal|died|death|deaths	FGFR3	HGNC:3690	Thanatophoric dysplasia, type I, 187600 (3), Autosomal dominant	Autosomal dominant	y	y	[Death in majority of infants soon after birth / Maroteaux et al. (1967) referred to patients with micromelic dwarfism who died in the first hours of life as having 'thanatophoric dwarfism.']	L2	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L2|L3	L2	pre-infant-lethal
187601	THANATOPHORIC DYSPLASIA, TYPE II	Thanatophoric dysplasia, type II, 187601 (3)	Thanatophoric dysplasia, type II	y	THANATOPHORIC DYSPLASIA, TYPE II; TD2	Description|Clinical Features|Clinical Synopsis	lethal|death|deaths	FGFR3	HGNC:3690	Thanatophoric dysplasia, type II, 187601 (3), Autosomal dominant	Autosomal dominant	y	y	[Death in majority of infants soon after birth / Thanatophoric dysplasia is a severe short-limb dwarfism syndrome that is usually lethal in the perinatal period]	L2	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L2|L3	L2	pre-infant-lethal
187800	BLEEDING DISORDER, PLATELET-TYPE, 16	Bleeding disorder, platelet-type, 16, autosomal dominant, 187800 (3)	Bleeding disorder, platelet-type, 16, autosomal dominant	n	-	-	-	ITGA2B	HGNC:6138	Bleeding disorder, platelet-type, 16, autosomal dominant, 187800 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
187900	BLEEDING DISORDER, PLATELET-TYPE, 17	Bleeding disorder, platelet-type, 17, 187900 (3)	Bleeding disorder, platelet-type, 17	n	-	-	-	GFI1B	HGNC:4238	Bleeding disorder, platelet-type, 17, 187900 (3), Autosomal dominant, Autosomal recessive	Autosomal dominant, Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
187950	THROMBOCYTHEMIA 1	Thrombocythemia 1, 187950 (3)	Thrombocythemia 1	n	-	-	-	THPO	HGNC:11795	Thrombocythemia 1, 187950 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L4	L4	post-infant-lethal
188000	THROMBOCYTOPENIA 2	Thrombocytopenia 2, 188000 (3)	Thrombocytopenia 2	n	-	-	-	ANKRD26	HGNC:29186	Thrombocytopenia 2, 188000 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
188050	THROMBOPHILIA DUE TO THROMBIN DEFECT	Thrombophilia 1 due to thrombin defect, 188050 (3)	Thrombophilia 1 due to thrombin defect	y	THROMBOPHILIA DUE TO THROMBIN DEFECT; THPH1	Description	pregnancy_loss|pregnancy_losses	F2	HGNC:3535	Thrombophilia 1 due to thrombin defect, 188050 (3), Autosomal dominant	Autosomal dominant	n	n	-	-	-	-	ambiguous	ambiguous|nonlethal	ambiguous	-	-	-
188055	THROMBOPHILIA DUE TO ACTIVATED PROTEIN C RESISTANCE	Thrombophilia 2 due to activated protein C resistance, 188055 (3)	Thrombophilia 2 due to activated protein C resistance	y	THROMBOPHILIA DUE TO ACTIVATED PROTEIN C RESISTANCE; THPH2	Clinical Synopsis|Diagnosis|Phenotype	fetal_loss|fetal_losses|pregnancy_loss|pregnancy_losses|stillbirth|stillbirths	F5	HGNC:3542	Thrombophilia 2 due to activated protein C resistance, 188055 (3), Autosomal dominant	Autosomal dominant	n	n	-	-	-	-	ambiguous	ambiguous|nonlethal	ambiguous	-	-	-
188400	DIGEORGE SYNDROME	DiGeorge syndrome, 188400 (3)	DiGeorge syndrome	y	DIGEORGE SYNDROME; DGS	Clinical Features	died	TBX1	HGNC:11592	DiGeorge syndrome, 188400 (3), Autosomal dominant	Autosomal dominant	y	y	[Forrester et al. (2002) restudied the family reported by Kousseff (1984) and identified a 22q11-q13 deletion in the proband, his deceased brother, and his father... His brother had died at 2 weeks of age with myelomeningocele, hydrocephalus, transposition of the great vessels, and unilateral renal agenesis, and his sister had died at 22 days of age with myelomeningocele, truncus arteriosus, hypocalcemia, and autopsy findings of absent thymus and parathyroid glands, consistent with DiGeorge anomaly]	L2	y	y	lethal	lethal|nonlethal	lethal|nonlethal	L2	L2	pre-infant-lethal
188570	THYROID HORMONE RESISTANCE, GENERALIZED, AUTOSOMAL DOMINANT	Thyroid hormone resistance, 188570 (3)	Thyroid hormone resistance	n	-	-	-	THRB	HGNC:11799	Thyroid hormone resistance, 188570 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
188740	TIBIA, HYPOPLASIA OR APLASIA OF, WITH POLYDACTYLY	Hypoplastic or aplastic tibia with polydactyly, 188740 (3)	Hypoplastic or aplastic tibia with polydactyly	n	-	-	-	LMBR1	HGNC:13243	Hypoplastic or aplastic tibia with polydactyly, 188740 (3), Autosomal dominant, Autosomal recessive	Autosomal dominant, Autosomal recessive	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L2	L2	pre-infant-lethal
189500	WITKOP SYNDROME	Ectodermal dysplasia 3, Witkop type, 189500 (3)	Ectodermal dysplasia 3, Witkop type	n	-	-	-	MSX1	HGNC:7391	Ectodermal dysplasia 3, Witkop type, 189500 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
190320	TRICHODENTOOSSEOUS SYNDROME	Trichodontoosseous syndrome, 190320 (3)	Trichodontoosseous syndrome	n	-	-	-	DLX3	HGNC:2916	Trichodontoosseous syndrome, 190320 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
190330	TRICHOMEGALY	Trichomegaly, 190330 (3)	Trichomegaly	n	-	-	-	FGF5	HGNC:3683	Trichomegaly, 190330 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
190350	TRICHORHINOPHALANGEAL SYNDROME, TYPE I	Trichorhinophalangeal syndrome, type I, 190350 (3)	Trichorhinophalangeal syndrome, type I	y	TRICHORHINOPHALANGEAL SYNDROME, TYPE I; TRPS1	Clinical Features	died	TRPS1	HGNC:12340	Trichorhinophalangeal syndrome, type I, 190350 (3), Autosomal dominant	Autosomal dominant	y	n	-	-	-	-	ambiguous	ambiguous|nonlethal	ambiguous	-	-	-
190351	TRICHORHINOPHALANGEAL SYNDROME, TYPE III	Trichorhinophalangeal syndrome, type III, 190351 (3)	Trichorhinophalangeal syndrome, type III	n	-	-	-	TRPS1	HGNC:12340	Trichorhinophalangeal syndrome, type III, 190351 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	ambiguous|nonlethal	ambiguous	-	-	-
190440	TRIGONOCEPHALY 1	Trigonocephaly 1, 190440 (3)	Trigonocephaly 1	n	-	-	-	FGFR1	HGNC:3688	Trigonocephaly 1, 190440 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L2|L3	L2	pre-infant-lethal
190605	TRIPHALANGEAL THUMB WITH POLYSYNDACTYLY	Triphalangeal thumb-polysyndactyly syndrome, 190605 (3)	Triphalangeal thumb-polysyndactyly syndrome	n	-	-	-	LMBR1	HGNC:13243	Triphalangeal thumb-polysyndactyly syndrome, 190605 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L2	L2	pre-infant-lethal
190900	TRITANOPIA	Colorblindness, tritan, 190900 (3)	Colorblindness, tritan	n	-	-	-	OPN1SW	HGNC:1012	Colorblindness, tritan, 190900 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
191100	TUBEROUS SCLEROSIS 1	Tuberous sclerosis-1, 191100 (3)	Tuberous sclerosis-1	y	TUBEROUS SCLEROSIS 1; TSC1	Clinical Features|Phenotype	death|deaths|died|fatal	TSC1	HGNC:12362	Tuberous sclerosis-1, 191100 (3), Autosomal dominant	Autosomal dominant	y	y	[Ruggieri et al. (1997) described a family in which all 4 sibs, born to consanguineous, healthy, asymptomatic parents, had a severe form of tuberous sclerosis. Three of these infants had a course that was rapidly fatal in the neonatal period; death was attributed to congestive heart failure, with radiographic evidence of cardiomegaly in all of them]	L2	y	y	lethal	lethal	lethal	L2|LU	L2	pre-infant-lethal
191480	UNCOMBABLE HAIR SYNDROME 1	Uncombable hair syndrome, 191480 (3)	Uncombable hair syndrome	n	-	-	-	PADI3	HGNC:18337	Uncombable hair syndrome, 191480 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
191800	BLADDER DYSFUNCTION, AUTONOMIC, WITH IMPAIRED PUPILLARY REFLEX AND SECONDARY CAKUT	Bladder dysfunction, autonomic, with impaired pupillary reflex and secondary CAKUT, 191800 (3)	Bladder dysfunction, autonomic, with impaired pupillary reflex and secondary CAKUT	n	-	-	-	CHRNA3	HGNC:1957	Bladder dysfunction, autonomic, with impaired pupillary reflex and secondary CAKUT, 191800 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
191830	RENAL HYPODYSPLASIA/APLASIA 1	Renal hypodysplasia/aplasia 1, 191830 (3)	Renal hypodysplasia/aplasia 1	y	RENAL HYPODYSPLASIA/APLASIA 1; RHDA1	Description|Clinical Features|Clinical Synopsis|Diagnosis	death|deaths|lethal|died	ITGA8	HGNC:6144	Renal hypodysplasia/aplasia 1, 191830 (3), Autosomal recessive	Autosomal recessive	y	y	[Death in utero or in the perinatal period]	L1	y	-	lethal	lethal	lethal	L1	L1	pre-infant-lethal
191900	MUCKLE-WELLS SYNDROME	Muckle-Wells syndrome, 191900 (3)	Muckle-Wells syndrome	y	MUCKLE-WELLS SYNDROME; MWS	Clinical Features	death|deaths|died	NLRP3	HGNC:16400	Muckle-Wells syndrome, 191900 (3), Autosomal dominant	Autosomal dominant	y	y	[Lieberman et al. (1998) described the histopathologic features of the skin lesions in a sporadic case of MWS.... At age 50, he underwent bilateral corneal transplants for calcific band keratopathy. At age 54, despite antiinflammatory therapy including prednisone, azathioprine, and cyclosporine, his condition progressively deteriorated and he died during a hypotensive episode]	L6	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L6	L6	post-infant-lethal
192315	VASCULOPATHY, RETINAL, WITH CEREBRAL LEUKOENCEPHALOPATHY AND SYSTEMIC MANIFESTATIONS	Vasculopathy, retinal, with cerebral leukoencephalopathy and systemic manifestations, 192315 (3)	Vasculopathy, retinal, with cerebral leukoencephalopathy and systemic manifestations	y	VASCULOPATHY, RETINAL, WITH CEREBRAL LEUKOENCEPHALOPATHY AND SYSTEMIC MANIFESTATIONS; RVCLS	Description|Clinical Features|Clinical Synopsis	death|deaths|died	TREX1	HGNC:12269	Vasculopathy, retinal, with cerebral leukoencephalopathy and systemic manifestations, 192315 (3), Autosomal dominant	Autosomal dominant	y	y	[Onset in adulthood / Death occurs 5 to 10 years after onset / Stam et al. (2016) described 78 individuals from 11 unrelated families with mutations in the TREX1 gene... Thirty-five of the 65 patients had died, primarily from neurologic causes, at an average age of 53.1 years and at an average of 9.0 years after diagnosis]	L6	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L3|L6	L3	pre-infant-lethal
192430	VELOCARDIOFACIAL SYNDROME	Velocardiofacial syndrome, 192430 (3)	Velocardiofacial syndrome	y	VELOCARDIOFACIAL SYNDROME; VCFS	Clinical Features	death|deaths|died	TBX1	HGNC:11592	Velocardiofacial syndrome, 192430 (3), Autosomal dominant	Autosomal dominant	y	y	[Ryan et al. (1997) reported a European collaborative study of 558 patients with deletions of 22q11...Forty-four patients had died, and of the 29 for whom age of death was available, 16 had died within 1 month and 25 within 6 months as a consequence of congenital heart disease]	L2	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L2	L2	pre-infant-lethal
192500	LONG QT SYNDROME 1	Long QT syndrome 1, 192500 (3)	Long QT syndrome 1	y	LONG QT SYNDROME 1; LQT1	Description|Clinical Features|Clinical Synopsis|Phenotype	death|deaths|died|lethal	KCNQ1	HGNC:6294	Long QT syndrome 1, 192500 (3), Autosomal dominant	Autosomal dominant	y	y	[Sudden cardiac death / Priori et al. (2003), risk prediction remained difficult, which he illustrated with several cases. A 13-year-old boy with the LQT1 genotype died suddenly while running, with no prior symptoms]	L5	y	-	lethal	lethal	lethal	L4|L5|L6|LU	L4	post-infant-lethal
192605	VENTRICULAR TACHYCARDIA, FAMILIAL	Ventricular tachycardia, idiopathic, 192605 (3)	Ventricular tachycardia, idiopathic	y	VENTRICULAR TACHYCARDIA, FAMILIAL	Clinical Synopsis	death|deaths	GNAI2	HGNC:4385	Ventricular tachycardia, idiopathic, 192605 (3), Autosomal dominant	Autosomal dominant	n	y	[Sudden cardiac death / Rubin et al. (1992) reported a kindred in which members in 4 successive generations suffered from paroxysmal ventricular tachycardia. They suggested that this is the first report of an autosomal dominant ventricular tachycardia not associated with cardiomyopathy, metabolic disorder, or repolarization abnormality. In generation 2, 4 of 7 sibs sustained sudden cardiac death]	LU	y	-	lethal	lethal	lethal	LU	LU	post-infant-lethal
192950	VERTICAL TALUS, CONGENITAL	Charcot-Marie-Tooth disease, foot deformity of, 192950 (3)	Charcot-Marie-Tooth disease, foot deformity of	n	-	-	-	HOXD10	HGNC:5133	Charcot-Marie-Tooth disease, foot deformity of, 192950 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
192950	VERTICAL TALUS, CONGENITAL	Vertical talus, congenital, 192950 (3)	Vertical talus, congenital	n	-	-	-	HOXD10	HGNC:5133	Vertical talus, congenital, 192950 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
193003	SPINOCEREBELLAR ATAXIA 27A	Spinocerebellar ataxia 27A, 193003 (3)	Spinocerebellar ataxia 27A	n	-	-	-	FGF14	HGNC:3671	Spinocerebellar ataxia 27A, 193003 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
193100	HYPOPHOSPHATEMIC RICKETS, AUTOSOMAL DOMINANT	Hypophosphatemic rickets, autosomal dominant, 193100 (3)	Hypophosphatemic rickets, autosomal dominant	n	-	-	-	FGF23	HGNC:3680	Hypophosphatemic rickets, autosomal dominant, 193100 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
193220	VITREORETINOCHOROIDOPATHY	Vitreoretinochoroidopathy, 193220 (3)	Vitreoretinochoroidopathy	n	-	-	-	BEST1	HGNC:12703	Vitreoretinochoroidopathy, 193220 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	ambiguous|nonlethal	ambiguous	-	-	-
193230	VITREORETINAL DEGENERATION, SNOWFLAKE TYPE	Snowflake vitreoretinal degeneration, 193230 (3)	Snowflake vitreoretinal degeneration	n	-	-	-	KCNJ13	HGNC:6259	Snowflake vitreoretinal degeneration, 193230 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	ambiguous|nonlethal	ambiguous	-	-	-
193235	VITREORETINOPATHY, NEOVASCULAR INFLAMMATORY	Vitreoretinopathy, neovascular inflammatory, 193235 (3)	Vitreoretinopathy, neovascular inflammatory	n	-	-	-	CAPN5	HGNC:1482	Vitreoretinopathy, neovascular inflammatory, 193235 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
193300	VON HIPPEL-LINDAU SYNDROME	von Hippel-Lindau syndrome, 193300 (3)	von Hippel-Lindau syndrome	y	VON HIPPEL-LINDAU SYNDROME; VHLS	Clinical Features	death|deaths|died	VHL	HGNC:12687	von Hippel-Lindau syndrome, 193300 (3), Autosomal dominant	Autosomal dominant	y	y	[Using a VHL register set up in the northwest of England in 1990 containing information on 83 affected persons, Maddock et al. (1996) studied population statistics, clinical features, age at onset, and survival... Mean age at death was 40.9 years with cerebellar hemangioblastoma being the most common cause (47.7% of deaths)]	L6	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L4|L6	L4	post-infant-lethal
193400	VON WILLEBRAND DISEASE, TYPE 1	von Willebrand disease, type 1, 193400 (3)	von Willebrand disease, type 1	n	-	-	-	VWF	HGNC:12726	von Willebrand disease, type 1, 193400 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L4	L4	post-infant-lethal
193500	WAARDENBURG SYNDROME, TYPE 1	Waardenburg syndrome, type 1, 193500 (3)	Waardenburg syndrome, type 1	y	WAARDENBURG SYNDROME, TYPE 1; WS1	Phenotype	death|deaths	PAX3	HGNC:8617	Waardenburg syndrome, type 1, 193500 (3), Autosomal dominant	Autosomal dominant	y	n	-	-	-	-	ambiguous	ambiguous|nonlethal	ambiguous	-	-	-
193510	WAARDENBURG SYNDROME, TYPE 2A	Waardenburg syndrome, type 2A, 193510 (3)	Waardenburg syndrome, type 2A	n	-	-	-	MITF	HGNC:7105	Waardenburg syndrome, type 2A, 193510 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
193520	WATSON SYNDROME	Watson syndrome, 193520 (3)	Watson syndrome	n	-	-	-	NF1	HGNC:7765	Watson syndrome, 193520 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L6	L6	post-infant-lethal
193530	WEYERS ACROFACIAL DYSOSTOSIS	Weyers acrofacial dysostosis, 193530 (3)	Weyers acrofacial dysostosis	n	-	-	-	EVC2	HGNC:19747	Weyers acrofacial dysostosis, 193530 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
193670	WHIM SYNDROME 1	Myelokathexis, isolated, 193670 (3)	Myelokathexis, isolated	y	WHIM SYNDROME 1; WHIMS1	Clinical Features	death|deaths|died	CXCR4	HGNC:2561	Myelokathexis, isolated, 193670 (3), Autosomal dominant	Autosomal dominant	y	y	[Beaussant Cohen et al. (2012) reported 7 patients and 1 affected fetus from 3 unrelated French families with WHIMS... hree patients had died, including a 32-week-old fetus (elective termination) from family 1, and 2 sibs from family 4: a 39.5-year-old woman who died of invasive HPV-related vulvar carcinoma and her 40-year-old brother who died of EBV-negative cutaneous T-cell lymphoma]	L6	y	-	lethal	lethal	lethal	L6	L6	post-infant-lethal
193670	WHIM SYNDROME 1	WHIM syndrome 1, 193670 (3)	WHIM syndrome 1	y	WHIM SYNDROME 1; WHIMS1	Clinical Features	death|deaths|died	CXCR4	HGNC:2561	WHIM syndrome 1, 193670 (3), Autosomal dominant	Autosomal dominant	y	y	[Beaussant Cohen et al. (2012) reported 7 patients and 1 affected fetus from 3 unrelated French families with WHIMS... hree patients had died, including a 32-week-old fetus (elective termination) from family 1, and 2 sibs from family 4: a 39.5-year-old woman who died of invasive HPV-related vulvar carcinoma and her 40-year-old brother who died of EBV-negative cutaneous T-cell lymphoma]	L6	y	-	lethal	lethal	lethal	L6	L6	post-infant-lethal
193700	ARTHROGRYPOSIS, DISTAL, TYPE 2A	Arthrogryposis, distal, type 2A (Freeman-Sheldon), 193700 (3)	Arthrogryposis, distal, type 2A (Freeman-Sheldon)	n	-	-	-	MYH3	HGNC:7573	Arthrogryposis, distal, type 2A (Freeman-Sheldon), 193700 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
193900	WHITE SPONGE NEVUS 1	White sponge nevus 1, 193900 (3)	White sponge nevus 1	n	-	-	-	KRT4	HGNC:6441	White sponge nevus 1, 193900 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
194200	WOLFF-PARKINSON-WHITE SYNDROME	Wolff-Parkinson-White syndrome, 194200 (3)	Wolff-Parkinson-White syndrome	y	WOLFF-PARKINSON-WHITE SYNDROME; WPW	Clinical Features|Clinical Synopsis	death|deaths|died	PRKAG2	HGNC:9386	Wolff-Parkinson-White syndrome, 194200 (3), Autosomal dominant	Autosomal dominant	y	y	[Increased risk of sudden cardiac death (in some patients) / Chia et al. (1982) described a Chinese family in which the WPW syndrome was present in a 21-year-old male (who came to medical attention because of palpitations occasioned by paroxysmal atrial fibrillation) and in his father and 2 of his 5 brothers. One of the brothers died suddenly at age 19 years]	L6	y	-	lethal	lethal	lethal	L2|L6|LU	L2	pre-infant-lethal
194300	WOOLLY HAIR, AUTOSOMAL DOMINANT	Woolly hair, autosomal dominant, 194300 (3)	Woolly hair, autosomal dominant	n	-	-	-	KRT74	HGNC:28929	Woolly hair, autosomal dominant, 194300 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
194380	DEHYDRATED HEREDITARY STOMATOCYTOSIS 1 WITH OR WITHOUT PSEUDOHYPERKALEMIA AND/OR PERINATAL EDEMA	Dehydrated hereditary stomatocytosis with or without pseudohyperkalemia and/or perinatal edema, 194380 (3)	Dehydrated hereditary stomatocytosis with or without pseudohyperkalemia and/or perinatal edema	y	DEHYDRATED HEREDITARY STOMATOCYTOSIS 1 WITH OR WITHOUT PSEUDOHYPERKALEMIA AND/OR PERINATAL EDEMA; DHS1	Clinical Features|Diagnosis	died|lethal	PIEZO1	HGNC:28993	Dehydrated hereditary stomatocytosis with or without pseudohyperkalemia and/or perinatal edema, 194380 (3), Autosomal dominant	Autosomal dominant	y	y	[The mother had had a previous biamniotic twin pregnancy that ended spontaneously at 27 weeks. One twin had died in utero from generalized edema, including ascites and pleural and pericardial effusions / *** Albuisson et al. (2013) noted that DHS is a difficult diagnosis to make because of highly variable clinical expression, ranging from the absence of clinical features to lethal perinatal edema (in Diagnosis field]	L1	n	y	lethal	lethal	lethal	L1	L1	pre-infant-lethal
200100	ABETALIPOPROTEINEMIA	Abetalipoproteinemia, 200100 (3)	Abetalipoproteinemia	n	-	-	-	MTTP	HGNC:7467	Abetalipoproteinemia, 200100 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
200110	ABLEPHARON-MACROSTOMIA SYNDROME	Ablepharon-macrostomia syndrome, 200110 (3)	Ablepharon-macrostomia syndrome	n	-	-	-	TWIST2	HGNC:20670	Ablepharon-macrostomia syndrome, 200110 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
200150	CHOREOACANTHOCYTOSIS	Choreoacanthocytosis, 200150 (3)	Choreoacanthocytosis	y	CHOREOACANTHOCYTOSIS; CHAC	Clinical Features	died	VPS13A	HGNC:1908	Choreoacanthocytosis, 200150 (3), Autosomal recessive	Autosomal recessive	y	y	[The proband was a 41-year-old male, and an affected brother and sister had died at ages 32 and 39 years. Postmortem examination showed marked neuronal loss and gliosis of the caudate and putamen]	L6	n	y	lethal	lethal	lethal	L6	L6	post-infant-lethal
200500	ACHEIROPODY	Acheiropody, 200500 (3)	Acheiropody	n	-	-	-	LMBR1	HGNC:13243	Acheiropody, 200500 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L2	L2	pre-infant-lethal
200600	ACHONDROGENESIS, TYPE IA	Achondrogenesis, type IA, 200600 (3)	Achondrogenesis, type IA	y	ACHONDROGENESIS, TYPE IA; ACG1A	Description|Clinical Features|Clinical Synopsis	death|deaths|lethal|stillbirth|stillbirths|died|stillborn|die	TRIP11	HGNC:12305	Achondrogenesis, type IA, 200600 (3), Autosomal recessive	Autosomal recessive	y	y	[Infants are stillborn or die shortly after birth]	L1	y	-	lethal	lethal	lethal	L1|L3	L1	pre-infant-lethal
200610	ACHONDROGENESIS, TYPE II	Achondrogenesis, type II or hypochondrogenesis, 200610 (3)	Achondrogenesis, type II or hypochondrogenesis	y	ACHONDROGENESIS, TYPE II; ACG2	Clinical Features|Clinical Synopsis|Phenotype	death|deaths|stillbirth|stillbirths|stillborn	COL2A1	HGNC:2200	Achondrogenesis, type II or hypochondrogenesis, 200610 (3), Autosomal dominant	Autosomal dominant	y	y	[Stillborn or death shortly after birth]	L1	y	-	lethal	ambiguous|lethal|nonlethal	lethal|nonlethal	L1|L2|L3	L1	pre-infant-lethal
200700	ACROMESOMELIC DYSPLASIA 2A	Acromesomelic dysplasia 2A, 200700 (3)	Acromesomelic dysplasia 2A	y	ACROMESOMELIC DYSPLASIA 2A; AMD2A	Clinical Synopsis	death|deaths|stillborn	GDF5	HGNC:4220	Acromesomelic dysplasia 2A, 200700 (3), Autosomal recessive	Autosomal recessive	y	y	[Stillborn or death in infancy]	L1	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L1	L1	pre-infant-lethal
200990	ACROCALLOSAL SYNDROME	Acrocallosal syndrome, 200990 (3)	Acrocallosal syndrome	y	ACROCALLOSAL SYNDROME; ACLS	Description|Clinical Features	death|deaths|died|lethal	KIF7	HGNC:30497	Acrocallosal syndrome, 200990 (3), Autosomal recessive	Autosomal recessive	n	y	[Koenig et al. (2002) described 3 patients with ACS demonstrating a spectrum from mild to severe involvement. Two patients had only mild to moderate mental retardation at the age of 2.5 and 4 years, respectively, with surprisingly good speech development. The third patient was severely affected and died at age 7 days because of persistent apnea]	L2	y	-	lethal	lethal	lethal	L2	L2	pre-infant-lethal
200990	ACROCALLOSAL SYNDROME	Joubert syndrome 12, 200990 (3)	Joubert syndrome 12	y	ACROCALLOSAL SYNDROME; ACLS	Description|Clinical Features	death|deaths|died|lethal	KIF7	HGNC:30497	Joubert syndrome 12, 200990 (3), Autosomal recessive	Autosomal recessive	n	y	[Koenig et al. (2002) described 3 patients with ACS demonstrating a spectrum from mild to severe involvement. Two patients had only mild to moderate mental retardation at the age of 2.5 and 4 years, respectively, with surprisingly good speech development. The third patient was severely affected and died at age 7 days because of persistent apnea]	L2	y	-	lethal	lethal	lethal	L2	L2	pre-infant-lethal
201000	CARPENTER SYNDROME 1	Carpenter syndrome, 201000 (3)	Carpenter syndrome	n	-	-	-	RAB23	HGNC:14263	Carpenter syndrome, 201000 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
201100	ACRODERMATITIS ENTEROPATHICA, ZINC-DEFICIENCY TYPE	Acrodermatitis enteropathica, 201100 (3)	Acrodermatitis enteropathica	n	-	-	-	SLC39A4	HGNC:17129	Acrodermatitis enteropathica, 201100 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
201300	NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE IIA	Neuropathy, hereditary sensory and autonomic, type II, 201300 (3)	Neuropathy, hereditary sensory and autonomic, type II	y	NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE IIA; HSAN2A	Phenotype	lethal	WNK1	HGNC:14540	Neuropathy, hereditary sensory and autonomic, type II, 201300 (3), Autosomal recessive	Autosomal recessive	n	y	[Giaccai (1952) reported 'neurogenic acroosteolysis' in 4 children born of an Arab man who married 2 first cousins. By the first wife, 1 of the children was affected, and by the second wife, 3 of 5 children were affected. Since the spinal cord was normal at autopsy, Giaccai (1952) concluded that the abnormality resided in peripheral sensory nerve]	LU	y	-	lethal	lethal|nonlethal	lethal|nonlethal	LU	LU	post-infant-lethal
201400	ACTH DEFICIENCY, ISOLATED	Adrenocorticotropic hormone deficiency, 201400 (3)	Adrenocorticotropic hormone deficiency	y	ACTH DEFICIENCY, ISOLATED; IAD	Clinical Features|Clinical Synopsis	death|deaths|died|die	TBX19	HGNC:11596	Adrenocorticotropic hormone deficiency, 201400 (3), Autosomal recessive	Autosomal recessive	n	y	[Expanding on a previous report by Vallette-Kasic et al. (2005), Couture et al. (2012) reported 37 patients from 29 families with isolated ACTH deficiency...Neonatal death occurred in 25% of the families]	L2	y	-	lethal	lethal	lethal	L2	L2	pre-infant-lethal
201450	ACYL-CoA DEHYDROGENASE, MEDIUM-CHAIN, DEFICIENCY OF	Acyl-CoA dehydrogenase, medium chain, deficiency of, 201450 (3)	Acyl-CoA dehydrogenase, medium chain, deficiency of	y	ACYL-CoA DEHYDROGENASE, MEDIUM-CHAIN, DEFICIENCY OF; ACADMD	Description|Clinical Features|Diagnosis	fatal|death|deaths|died	ACADM	HGNC:89	Acyl-CoA dehydrogenase, medium chain, deficiency of, 201450 (3), Autosomal recessive	Autosomal recessive	y	y	[Inherited deficiency of medium-chain acyl-CoA dehydrogenase is characterized by intolerance to prolonged fasting, recurrent episodes of hypoglycemic coma with medium-chain dicarboxylic aciduria, impaired ketogenesis, and low plasma and tissue carnitine levels. The disorder may be severe, and even fatal, in young patients (Matsubara et al., 1986) / Two of the 5 patients studied by von Dobeln et al. (1990) had elder sibs who had died unexpectedly in early infancy]	L3	y	y	lethal	lethal	lethal	L3	L3	pre-infant-lethal
201470	ACYL-CoA DEHYDROGENASE, SHORT-CHAIN, DEFICIENCY OF	Acyl-CoA dehydrogenase, short-chain, deficiency of, 201470 (3)	Acyl-CoA dehydrogenase, short-chain, deficiency of	n	-	-	-	ACADS	HGNC:90	Acyl-CoA dehydrogenase, short-chain, deficiency of, 201470 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
201475	ACYL-CoA DEHYDROGENASE, VERY LONG-CHAIN, DEFICIENCY OF	VLCAD deficiency, 201475 (3)	VLCAD deficiency	y	ACYL-CoA DEHYDROGENASE, VERY LONG-CHAIN, DEFICIENCY OF; ACADVLD	Clinical Features|Clinical Synopsis|Phenotype	died|death|deaths	ACADVL	HGNC:92	VLCAD deficiency, 201475 (3), Autosomal recessive	Autosomal recessive	y	y	[Six of the 7 patients studied by Aoyama et al. (1995) were North American Caucasians, and 1 was Asian. Clinical onset of abnormality was within 4 months after birth, 75% died within 2 months after onset, and all patients had liver dysfunction and cardiac disease]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
201710	LIPOID CONGENITAL ADRENAL HYPERPLASIA	Lipoid adrenal hyperplasia, 201710 (3)	Lipoid adrenal hyperplasia	y	LIPOID CONGENITAL ADRENAL HYPERPLASIA; LCAH	Description|Clinical Features	fatal|die	STAR	HGNC:11359	Lipoid adrenal hyperplasia, 201710 (3), Autosomal recessive	Autosomal recessive	n	y	[Bose et al. (1996) concluded that the congenital lipoid adrenal hyperplasia phenotype is the result of 2 separate events...The adrenal cortex becomes engorged with cholesterol and cholesterol esters; consequent deficient adrenal steroidogenesis leads to salt wasting, hyponatremia, hypovolemia, hyperkalemia, acidosis, and death in infancy, although patients can survive to adulthood with appropriate mineralocorticoid- and glucocorticoid-replacement therapy]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
201750	ANTLEY-BIXLER SYNDROME WITH GENITAL ANOMALIES AND DISORDERED STEROIDOGENESIS	Antley-Bixler syndrome with genital anomalies and disordered steroidogenesis, 201750 (3)	Antley-Bixler syndrome with genital anomalies and disordered steroidogenesis	y	ANTLEY-BIXLER SYNDROME WITH GENITAL ANOMALIES AND DISORDERED STEROIDOGENESIS; ABS1	Phenotype	lethal	POR	HGNC:9208	Antley-Bixler syndrome with genital anomalies and disordered steroidogenesis, 201750 (3), Autosomal recessive	Autosomal recessive	y	y	[Mortality has been reported to be as high as 80% in the neonatal period, primarily due to airway compromise, and prognosis improves with increasing age (summary by McGlaughlin et al., 2010)]	L2	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L2	L2	pre-infant-lethal
201810	ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 3-BETA-HYDROXYSTEROID DEHYDROGENASE 2 DEFICIENCY	Adrenal hyperplasia, congenital, due to 3-beta-hydroxysteroid dehydrogenase 2 deficiency, 201810 (3)	Adrenal hyperplasia, congenital, due to 3-beta-hydroxysteroid dehydrogenase 2 deficiency	y	ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 3-BETA-HYDROXYSTEROID DEHYDROGENASE 2 DEFICIENCY	Description|Clinical Features	fatal|death|deaths|died	HSD3B2	HGNC:5218	Adrenal hyperplasia, congenital, due to 3-beta-hydroxysteroid dehydrogenase 2 deficiency, 201810 (3), Autosomal recessive	Autosomal recessive	n	y	[Salt loss is a frequent cause of death. Death may occur even with adequate adrenal replacement therapy, perhaps because of the enzyme deficiency in other organ]	LU	y	-	lethal	lethal	lethal	LU	LU	post-infant-lethal
201910	ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 21-HYDROXYLASE DEFICIENCY	Adrenal hyperplasia, congenital, due to 21-hydroxylase deficiency, 201910 (3)	Adrenal hyperplasia, congenital, due to 21-hydroxylase deficiency	n	-	-	-	CYP21A2	HGNC:2600	Adrenal hyperplasia, congenital, due to 21-hydroxylase deficiency, 201910 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
201910	ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 21-HYDROXYLASE DEFICIENCY	Hyperandrogenism, nonclassic type, due to 21-hydroxylase deficiency, 201910 (3)	Hyperandrogenism, nonclassic type, due to 21-hydroxylase deficiency	n	-	-	-	CYP21A2	HGNC:2600	Hyperandrogenism, nonclassic type, due to 21-hydroxylase deficiency, 201910 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
202010	ADRENAL HYPERPLASIA, CONGENITAL, DUE TO STEROID 11-BETA-HYDROXYLASE DEFICIENCY	Adrenal hyperplasia, congenital, due to 11-beta-hydroxylase deficiency, 202010 (3)	Adrenal hyperplasia, congenital, due to 11-beta-hydroxylase deficiency	y	ADRENAL HYPERPLASIA, CONGENITAL, DUE TO STEROID 11-BETA-HYDROXYLASE DEFICIENCY	Clinical Features	died|fatal	CYP11B1	HGNC:2591	Adrenal hyperplasia, congenital, due to 11-beta-hydroxylase deficiency, 202010 (3), Autosomal recessive	Autosomal recessive	n	n	-	-	-	-	ambiguous	ambiguous|lethal	lethal	L6	L6	post-infant-lethal
202110	ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 17-ALPHA-HYDROXYLASE DEFICIENCY	17,20-lyase deficiency, isolated, 202110 (3)	17,20-lyase deficiency, isolated	n	-	-	-	CYP17A1	HGNC:2593	17,20-lyase deficiency, isolated, 202110 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
202110	ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 17-ALPHA-HYDROXYLASE DEFICIENCY	17-alpha-hydroxylase/17,20-lyase deficiency, 202110 (3)	17-alpha-hydroxylase/17,20-lyase deficiency	n	-	-	-	CYP17A1	HGNC:2593	17-alpha-hydroxylase/17,20-lyase deficiency, 202110 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
202370	PEROXISOME BIOGENESIS DISORDER 2B	Peroxisome biogenesis disorder 2B, 202370 (3)	Peroxisome biogenesis disorder 2B	n	-	-	-	PEX5	HGNC:9719	Peroxisome biogenesis disorder 2B, 202370 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L4	L4	post-infant-lethal
202400	AFIBRINOGENEMIA, CONGENITAL	Afibrinogenemia, congenital, 202400 (3)	Afibrinogenemia, congenital	y	AFIBRINOGENEMIA, CONGENITAL	Description|Clinical Features	death|deaths|miscarriage|miscarriages|died	FGA	HGNC:3661	Afibrinogenemia, congenital, 202400 (3), Autosomal recessive	Autosomal recessive	y	y	[Fried and Kaufman (1980) studied an Iraqi Jewish sibship and a Moroccan Jewish kindred in which 10 of 27 sibs had congenital afibrinogenemia. Death occurred in 6 in childhood. Two affected sibs were young women. Two died as neonates from uncontrollable bleeding]	L2	y	-	lethal	ambiguous|lethal	lethal	L2|LU	L2	pre-infant-lethal
202400	AFIBRINOGENEMIA, CONGENITAL	Afibrinogenemia, congenital, 202400 (3)	Afibrinogenemia, congenital	y	AFIBRINOGENEMIA, CONGENITAL	Description|Clinical Features	death|deaths|miscarriage|miscarriages|died	FGB	HGNC:3662	Afibrinogenemia, congenital, 202400 (3), Autosomal recessive	Autosomal recessive	y	y	[Fried and Kaufman (1980) studied an Iraqi Jewish sibship and a Moroccan Jewish kindred in which 10 of 27 sibs had congenital afibrinogenemia. Death occurred in 6 in childhood. Two affected sibs were young women. Two died as neonates from uncontrollable bleeding]	L2	y	-	lethal	ambiguous|lethal	lethal	L2	L2	pre-infant-lethal
202400	AFIBRINOGENEMIA, CONGENITAL	Hypofibrinogenemia, congenital, 202400 (3)	Hypofibrinogenemia, congenital	y	AFIBRINOGENEMIA, CONGENITAL	Description|Clinical Features	death|deaths|miscarriage|miscarriages|died	FGB	HGNC:3662	Hypofibrinogenemia, congenital, 202400 (3), Autosomal recessive	Autosomal recessive	y	y	[Fried and Kaufman (1980) studied an Iraqi Jewish sibship and a Moroccan Jewish kindred in which 10 of 27 sibs had congenital afibrinogenemia. Death occurred in 6 in childhood. Two affected sibs were young women. Two died as neonates from uncontrollable bleeding]	L2	y	-	lethal	ambiguous|lethal	lethal	L2	L2	pre-infant-lethal
202400	AFIBRINOGENEMIA, CONGENITAL	Afibrinogenemia, congenital, 202400 (3)	Afibrinogenemia, congenital	y	AFIBRINOGENEMIA, CONGENITAL	Description|Clinical Features	death|deaths|miscarriage|miscarriages|died	FGG	HGNC:3694	Afibrinogenemia, congenital, 202400 (3), Autosomal recessive	Autosomal recessive	y	y	[Fried and Kaufman (1980) studied an Iraqi Jewish sibship and a Moroccan Jewish kindred in which 10 of 27 sibs had congenital afibrinogenemia. Death occurred in 6 in childhood. Two affected sibs were young women. Two died as neonates from uncontrollable bleeding]	L2	y	-	lethal	ambiguous|lethal	lethal	L2	L2	pre-infant-lethal
202400	AFIBRINOGENEMIA, CONGENITAL	Hypofibrinogenemia, congenital, 202400 (3)	Hypofibrinogenemia, congenital	y	AFIBRINOGENEMIA, CONGENITAL	Description|Clinical Features	death|deaths|miscarriage|miscarriages|died	FGG	HGNC:3694	Hypofibrinogenemia, congenital, 202400 (3), Autosomal recessive	Autosomal recessive	y	y	[Fried and Kaufman (1980) studied an Iraqi Jewish sibship and a Moroccan Jewish kindred in which 10 of 27 sibs had congenital afibrinogenemia. Death occurred in 6 in childhood. Two affected sibs were young women. Two died as neonates from uncontrollable bleeding]	L2	y	-	lethal	ambiguous|lethal	lethal	L2	L2	pre-infant-lethal
202650	AGNATHIA-OTOCEPHALY COMPLEX	Agnathia-otocephaly complex, 202650 (3)	Agnathia-otocephaly complex	y	AGNATHIA-OTOCEPHALY COMPLEX; AGOTC	Description|Clinical Features|Clinical Synopsis	lethal|death|deaths|died|stillborn	PRRX1	HGNC:9142	Agnathia-otocephaly complex, 202650 (3), Autosomal dominant, Autosomal recessive	Autosomal dominant, Autosomal recessive	y	y	[stillborn sisters. Usually lethal in the neonatal period]	L1	y	-	lethal	lethal	lethal	L1	L1	pre-infant-lethal
202700	NEUTROPENIA, SEVERE CONGENITAL, 1, AUTOSOMAL DOMINANT	Neutropenia, severe congenital 1, autosomal dominant, 202700 (3)	Neutropenia, severe congenital 1, autosomal dominant	y	NEUTROPENIA, SEVERE CONGENITAL, 1, AUTOSOMAL DOMINANT; SCN1	Clinical Features	death|deaths|die	ELANE	HGNC:3309	Neutropenia, severe congenital 1, autosomal dominant, 202700 (3), Autosomal dominant	Autosomal dominant	y	y	[Gilman et al. (1970) described prolonged survival and death from acute monocytic leukemia at age 14 years and 10 months. About three-fourths of patients die before age 3 year]	L4	y	-	lethal	lethal	lethal	L4	L4	post-infant-lethal
203100	ALBINISM, OCULOCUTANEOUS, TYPE IA	Albinism, oculocutaneous, type IA, 203100 (3)	Albinism, oculocutaneous, type IA	n	-	-	-	TYR	HGNC:12442	Albinism, oculocutaneous, type IA, 203100 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
203200	ALBINISM, OCULOCUTANEOUS, TYPE II	Albinism, brown oculocutaneous, 203200 (3)	Albinism, brown oculocutaneous	n	-	-	-	OCA2	HGNC:8101	Albinism, brown oculocutaneous, 203200 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
203200	ALBINISM, OCULOCUTANEOUS, TYPE II	Albinism, oculocutaneous, type II, 203200 (3)	Albinism, oculocutaneous, type II	n	-	-	-	OCA2	HGNC:8101	Albinism, oculocutaneous, type II, 203200 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
203290	ALBINISM, OCULOCUTANEOUS, TYPE III	Albinism, oculocutaneous, type III, 203290 (3)	Albinism, oculocutaneous, type III	n	-	-	-	TYRP1	HGNC:12450	Albinism, oculocutaneous, type III, 203290 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
203300	HERMANSKY-PUDLAK SYNDROME 1	Hermansky-Pudlak syndrome 1, 203300 (3)	Hermansky-Pudlak syndrome 1	y	HERMANSKY-PUDLAK SYNDROME 1; HPS1	Clinical Features	death|deaths|fatal	HPS1	HGNC:5163	Hermansky-Pudlak syndrome 1, 203300 (3), Autosomal recessive	Autosomal recessive	y	y	[The proband, a 31-year-old woman with 2 children, had fatal restrictive lung disease, a complication pointed out by others (Davies and Tuddenham, 1976; Garay et al., 1979) / The 2 most common complications associated with ceroid deposition in the usual form of HPS are pulmonary fibrosis and granulomatous colitis; the major cause of death in HPS after 1 year of age is pulmonary fibrosis]	LU	y	-	lethal	lethal	lethal	LU	LU	post-infant-lethal
203400	CORTICOSTERONE METHYLOXIDASE TYPE I DEFICIENCY	Hypoaldosteronism, congenital, due to CMO I deficiency, 203400 (3)	Hypoaldosteronism, congenital, due to CMO I deficiency	y	CORTICOSTERONE METHYLOXIDASE TYPE I DEFICIENCY	Clinical Features	died	CYP11B2	HGNC:2592	Hypoaldosteronism, congenital, due to CMO I deficiency, 203400 (3), Autosomal recessive	Autosomal recessive	n	y	[Postmortem examination of 1 affected infant who died of infection showed grossly normal adrenals, but microscopic examination showed poor development of the zona glomerulosa and hyperplasia of the juxtaglomerular apparatus]	L3	y	-	lethal	lethal	lethal	L3|LU	L3	pre-infant-lethal
203450	ALEXANDER DISEASE	Alexander disease, 203450 (3)	Alexander disease	y	ALEXANDER DISEASE; ALXDRD	Clinical Features|Clinical Synopsis|Phenotype	death|deaths|died	GFAP	HGNC:4235	Alexander disease, 203450 (3), Autosomal dominant	Autosomal dominant	y	y	[Bassuk et al. (2003) reported an infant with Alexander disease who presented with poor feeding on the first day of life, followed by emesis and weight loss... The child died on day 38 from prolonged seizures and respiratory failure / Death by age 5 (infantile form)]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
203500	ALKAPTONURIA	Alkaptonuria, 203500 (3)	Alkaptonuria	n	-	-	-	HGD	HGNC:4892	Alkaptonuria, 203500 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
203655	ALOPECIA UNIVERSALIS CONGENITA	Alopecia universalis, 203655 (3)	Alopecia universalis	n	-	-	-	HR	HGNC:5172	Alopecia universalis, 203655 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
203700	MITOCHONDRIAL DNA DEPLETION SYNDROME 4A (ALPERS TYPE)	Mitochondrial DNA depletion syndrome 4A (Alpers type), 203700 (3)	Mitochondrial DNA depletion syndrome 4A (Alpers type)	y	MITOCHONDRIAL DNA DEPLETION SYNDROME 4A (ALPERS TYPE); MTDPS4A	Description|Clinical Features|Clinical Synopsis|Phenotype	death|deaths|died|fatal	POLG	HGNC:9179	Mitochondrial DNA depletion syndrome 4A (Alpers type), 203700 (3), Autosomal recessive	Autosomal recessive	n	y	[Death usually by age 3 years / Refractory neonatal convulsions, swallowing difficulties, and pneumonia complicated the clinical course of patients in both families, and all of the infants died before age 20 month]	L3	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L2|L3|L5|L6	L2	pre-infant-lethal
203740	OXOGLUTARATE DEHYDROGENASE DEFICIENCY	Oxoglutarate dehydrogenase deficiency, 203740 (3)	Oxoglutarate dehydrogenase deficiency	y	OXOGLUTARATE DEHYDROGENASE DEFICIENCY; OGDHD	Clinical Features|Phenotype	died|lethality	OGDH	HGNC:8124	Oxoglutarate dehydrogenase deficiency, 203740 (3), Autosomal recessive	Autosomal recessive	y	y	[one had died at age 12 months]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
203750	ALPHA-METHYLACETOACETIC ACIDURIA	Alpha-methylacetoacetic aciduria, 203750 (3)	Alpha-methylacetoacetic aciduria	y	ALPHA-METHYLACETOACETIC ACIDURIA	Clinical Features	died	ACAT1	HGNC:93	Alpha-methylacetoacetic aciduria, 203750 (3), Autosomal recessive	Autosomal recessive	y	y	[Grunert et al. (2017) described 32 patients, aged 23 months to 27 years, with MAT deficiency...One patient died at the age of 2 years due to severe infection]	L4	y	-	lethal	lethal	lethal	L4	L4	post-infant-lethal
203780	ALPORT SYNDROME 2, AUTOSOMAL RECESSIVE	Alport syndrome 2, autosomal recessive, 203780 (3)	Alport syndrome 2, autosomal recessive	y	ALPORT SYNDROME 2, AUTOSOMAL RECESSIVE; ATS2	Clinical Features	died	COL4A4	HGNC:2206	Alport syndrome 2, autosomal recessive, 203780 (3), Autosomal recessive	Autosomal recessive	y	y	[The last proband was from a small village in Italy and had 2 affected sisters, both of whom had died of renal failure at age 12 and 8 years]	L4	n	y	lethal	lethal|nonlethal	lethal|nonlethal	L4	L4	post-infant-lethal
203800	ALSTROM SYNDROME	Alstrom syndrome, 203800 (3)	Alstrom syndrome	y	ALSTROM SYNDROME; ALMS	Clinical Features|Phenotype	died	ALMS1	HGNC:428	Alstrom syndrome, 203800 (3), Autosomal recessive	Autosomal recessive	n	y	[Aynaci et al. (1995) described diabetes insipidus in association with Alstrom syndrome in a 16-year-old male patient. One sib who was probably affected died at 3 years of age]	L4	n	y	lethal	lethal	lethal	L4	L4	post-infant-lethal
204000	LEBER CONGENITAL AMAUROSIS 1	Leber congenital amaurosis 1, 204000 (3)	Leber congenital amaurosis 1	y	LEBER CONGENITAL AMAUROSIS 1; LCA1	Phenotype	death|deaths|died	GUCY2D	HGNC:4689	Leber congenital amaurosis 1, 204000 (3), Autosomal recessive	Autosomal recessive	y	n	-	-	-	-	ambiguous	ambiguous|nonlethal	ambiguous	-	-	-
204100	LEBER CONGENITAL AMAUROSIS 2	Leber congenital amaurosis 2, 204100 (3)	Leber congenital amaurosis 2	n	-	-	-	RPE65	HGNC:10294	Leber congenital amaurosis 2, 204100 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	ambiguous|nonlethal	ambiguous	-	-	-
204200	CEROID LIPOFUSCINOSIS, NEURONAL, 3	Ceroid lipofuscinosis, neuronal, 3, 204200 (3)	Ceroid lipofuscinosis, neuronal, 3	y	CEROID LIPOFUSCINOSIS, NEURONAL, 3; CLN3	Clinical Features|Clinical Synopsis	death|deaths|died	CLN3	HGNC:2074	Ceroid lipofuscinosis, neuronal, 3, 204200 (3), Autosomal recessive	Autosomal recessive	y	y	[Wisniewski et al. (1992) reviewed the clinical and pathologic features of 163 patients with juvenile-onset CLN. The disorder was characterized by onset at 4 to 10 years of age of gradual visual loss with macular degeneration, optic atrophy, and/or retinitis pigmentosa. Other features included seizures and gradual mental and motor dysfunction. Ultrastructural examination of neuronal and nonneuronal tissues showed fingerprint inclusions. The youngest age at death was 16 years, and the oldest living patient was 40 years old but had been in a vegetative state for 21 years]	L5	y	-	lethal	lethal	lethal	L5	L5	post-infant-lethal
204300	CEROID LIPOFUSCINOSIS, NEURONAL, 6B (KUFS TYPE)	Ceroid lipofuscinosis, neuronal, 6B (Kufs type), 204300 (3)	Ceroid lipofuscinosis, neuronal, 6B (Kufs type)	y	CEROID LIPOFUSCINOSIS, NEURONAL, 6B (KUFS TYPE); CLN6B	Clinical Features	death|deaths|died	CLN6	HGNC:2077	Ceroid lipofuscinosis, neuronal, 6B (Kufs type), 204300 (3), Autosomal recessive	Autosomal recessive	y	y	[Kufs (1925) reported a case of adult-onset neuronal ceroid lipofuscinosis with onset at age 26 and death at age 38. Fine et al. (1960) found reports of 18 complete histologic descriptions. Chou and Thompson (1970) reported the morphologic changes in a man who was well until age 17 and died at age 32. A sister was said to have died of a similar clinical picture characterized by seizures, intellectual deterioration, lack of motor control, and development of athetoid movements]	L6	y	y	lethal	lethal	lethal	L4|L6	L4	post-infant-lethal
204500	CEROID LIPOFUSCINOSIS, NEURONAL, 2	Ceroid lipofuscinosis, neuronal, 2, 204500 (3)	Ceroid lipofuscinosis, neuronal, 2	y	CEROID LIPOFUSCINOSIS, NEURONAL, 2; CLN2	Clinical Synopsis	death|deaths	TPP1	HGNC:2073	Ceroid lipofuscinosis, neuronal, 2, 204500 (3), Autosomal recessive	Autosomal recessive	y	y	[Death at 10 to 15 years]	L5	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L5	L5	post-infant-lethal
204650	AMELOGENESIS IMPERFECTA, TYPE IC	Amelogenesis imperfecta, type IC, 204650 (3)	Amelogenesis imperfecta, type IC	n	-	-	-	ENAM	HGNC:3344	Amelogenesis imperfecta, type IC, 204650 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
204690	AMELOGENESIS IMPERFECTA, TYPE IG	Amelogenesis imperfecta, type IG (enamel-renal syndrome), 204690 (3)	Amelogenesis imperfecta, type IG (enamel-renal syndrome)	n	-	-	-	FAM20A	HGNC:23015	Amelogenesis imperfecta, type IG (enamel-renal syndrome), 204690 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
204700	AMELOGENESIS IMPERFECTA, HYPOMATURATION TYPE, IIA1	Amelogenesis imperfecta, type IIA1, 204700 (3)	Amelogenesis imperfecta, type IIA1	n	-	-	-	KLK4	HGNC:6365	Amelogenesis imperfecta, type IIA1, 204700 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
204750	ALPHA-AMINOADIPIC AND ALPHA-KETOADIPIC ACIDURIA	Alpha-aminoadipic and alpha-ketoadipic aciduria, 204750 (3)	Alpha-aminoadipic and alpha-ketoadipic aciduria	n	-	-	-	DHTKD1	HGNC:23537	Alpha-aminoadipic and alpha-ketoadipic aciduria, 204750 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
204870	CORNEAL DYSTROPHY, GELATINOUS DROP-LIKE	Corneal dystrophy, gelatinous drop-like, 204870 (3)	Corneal dystrophy, gelatinous drop-like	n	-	-	-	TACSTD2	HGNC:11530	Corneal dystrophy, gelatinous drop-like, 204870 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
205100	AMYOTROPHIC LATERAL SCLEROSIS 2, JUVENILE	Amyotrophic lateral sclerosis 2, juvenile, 205100 (3)	Amyotrophic lateral sclerosis 2, juvenile	n	-	-	-	ALS2	HGNC:443	Amyotrophic lateral sclerosis 2, juvenile, 205100 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L6	L6	post-infant-lethal
205400	TANGIER DISEASE	Tangier disease, 205400 (3)	Tangier disease	n	-	-	-	ABCA1	HGNC:29	Tangier disease, 205400 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
205950	ANEMIA, SIDEROBLASTIC, 2, PYRIDOXINE-REFRACTORY	Anemia, sideroblastic, 2, pyridoxine-refractory, 205950 (3)	Anemia, sideroblastic, 2, pyridoxine-refractory	n	-	-	-	SLC25A38	HGNC:26054	Anemia, sideroblastic, 2, pyridoxine-refractory, 205950 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
206100	ANEMIA, HYPOCHROMIC MICROCYTIC, WITH IRON OVERLOAD 1	Anemia, hypochromic microcytic, with iron overload 1, 206100 (3)	Anemia, hypochromic microcytic, with iron overload 1	n	-	-	-	SLC11A2	HGNC:10908	Anemia, hypochromic microcytic, with iron overload 1, 206100 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
206200	IRON-REFRACTORY IRON DEFICIENCY ANEMIA	Iron-refractory iron deficiency anemia, 206200 (3)	Iron-refractory iron deficiency anemia	n	-	-	-	TMPRSS6	HGNC:16517	Iron-refractory iron deficiency anemia, 206200 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
206700	GILLESPIE SYNDROME	Gillespie syndrome, 206700 (3)	Gillespie syndrome	n	-	-	-	ITPR1	HGNC:6180	Gillespie syndrome, 206700 (3), Autosomal dominant, Autosomal recessive	Autosomal dominant, Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
206800	NAIL DISORDER, NONSYNDROMIC CONGENITAL, 4	Anonychia congenita, 206800 (3)	Anonychia congenita	n	-	-	-	RSPO4	HGNC:16175	Anonychia congenita, 206800 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
206900	MICROPHTHALMIA, SYNDROMIC 3	Microphthalmia, syndromic 3, 206900 (3)	Microphthalmia, syndromic 3	y	MICROPHTHALMIA, SYNDROMIC 3; MCOPS3	Clinical Features|Phenotype	died	SOX2	HGNC:11195	Microphthalmia, syndromic 3, 206900 (3), Autosomal dominant	Autosomal dominant	y	y	[Menetrey et al. (2002) reported a newborn female with bilateral anophthalmia and esophageal atresia, who died shortly after birth]	L2	y	-	lethal	lethal	lethal	L2	L2	pre-infant-lethal
206900	MICROPHTHALMIA, SYNDROMIC 3	Optic nerve hypoplasia and abnormalities of the central nervous system, 206900 (3)	Optic nerve hypoplasia and abnormalities of the central nervous system	y	MICROPHTHALMIA, SYNDROMIC 3; MCOPS3	Clinical Features|Phenotype	died	SOX2	HGNC:11195	Optic nerve hypoplasia and abnormalities of the central nervous system, 206900 (3), Autosomal dominant	Autosomal dominant	y	y	[Menetrey et al. (2002) reported a newborn female with bilateral anophthalmia and esophageal atresia, who died shortly after birth]	L2	y	-	lethal	lethal	lethal	L2	L2	pre-infant-lethal
206920	MICROPHTHALMIA WITH LIMB ANOMALIES	Microphthalmia with limb anomalies, 206920 (3)	Microphthalmia with limb anomalies	n	-	-	-	SMOC1	HGNC:20318	Microphthalmia with limb anomalies, 206920 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
207410	ANTLEY-BIXLER SYNDROME WITHOUT GENITAL ANOMALIES OR DISORDERED STEROIDOGENESIS	Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis, 207410 (3)	Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis	y	ANTLEY-BIXLER SYNDROME WITHOUT GENITAL ANOMALIES OR DISORDERED STEROIDOGENESIS; ABS2	Clinical Features|Clinical Synopsis	death|deaths|died	FGFR2	HGNC:3689	Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis, 207410 (3), Autosomal dominant	Autosomal dominant	n	y	[Early death often due to respiratory complications / Schinzel et al. (1983) described 2 affected sisters: a newborn who died at 14 days of respiratory failure, and a fetus from a subsequent pregnancy in which the diagnosis was made in utero by ultrasonography]	L2	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L1|L2|L3	L1	pre-infant-lethal
207750	APOLIPOPROTEIN C-II DEFICIENCY	Hyperlipoproteinemia, type Ib, 207750 (3)	Hyperlipoproteinemia, type Ib	n	-	-	-	APOC2	HGNC:609	Hyperlipoproteinemia, type Ib, 207750 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
207800	ARGININEMIA	Argininemia, 207800 (3)	Argininemia	y	ARGININEMIA	Clinical Features	died|fatal	ARG1	HGNC:663	Argininemia, 207800 (3), Autosomal recessive	Autosomal recessive	y	y	[Picker et al. (2003) described a rare neonatal and fatal presentation of arginase deficiency in a 2-day-old female with markedly elevated plasma arginine, lactate, and CSF glutamine, and modestly elevated blood ammonia, who developed hypertonia and tachypnea followed by intractable seizures and global cerebral edema]	L2	y	-	lethal	lethal	lethal	L2	L2	pre-infant-lethal
207900	ARGININOSUCCINIC ACIDURIA	Argininosuccinic aciduria, 207900 (3)	Argininosuccinic aciduria	y	ARGININOSUCCINIC ACIDURIA	Clinical Features	died|fatal	ASL	HGNC:746	Argininosuccinic aciduria, 207900 (3), Autosomal recessive	Autosomal recessive	y	y	[Asai et al. (1998) described fatal hyperammonemia in a child with argininosuccinic aciduria following enflurane anesthesia.... At 13 years of age, the patient underwent an inguinal hernioplasty...Despite repeated hemodialysis, she died on the sixth postoperative day]	L5	y	-	lethal	lethal	lethal	L5	L5	post-infant-lethal
208000	ARTERIAL CALCIFICATION, GENERALIZED, OF INFANCY, 1	Arterial calcification, generalized, of infancy, 1, 208000 (3)	Arterial calcification, generalized, of infancy, 1	y	ARTERIAL CALCIFICATION, GENERALIZED, OF INFANCY, 1; GACI1	Description|Clinical Features|Clinical Synopsis|Phenotype	fatal|death|deaths|die|died|stillborn|lethal	ENPP1	HGNC:3356	Arterial calcification, generalized, of infancy, 1, 208000 (3), Autosomal recessive	Autosomal recessive	y	y	[Most patients die in infancy / Dlamini et al. (2009) reported 3 Caucasian sibs with GACI and striking phenotypic variability. ..The proband had 2 deceased younger sibs: a female sib was stillborn, in whom ultrasound at 30 weeks' gestation had shown echogenicity of the myocardium and aortic root suggestive of calcification, and a male sib died 12 hours after birth from myocardial infarction, in whom intracardiac calcification was detected prenatally]	L1	y	y	lethal	lethal|nonlethal	lethal|nonlethal	L1	L1	pre-infant-lethal
208050	ARTERIAL TORTUOSITY SYNDROME	Arterial tortuosity syndrome, 208050 (3)	Arterial tortuosity syndrome	y	ARTERIAL TORTUOSITY SYNDROME; ATORS	Clinical Features|Clinical Synopsis	died|death|deaths	SLC2A10	HGNC:13444	Arterial tortuosity syndrome, 208050 (3), Autosomal recessive	Autosomal recessive	y	y	[ICited paper: Dysplasia of the systemic and pulmonary arterial system with tortuosity and lengthening of the arteries: new entity, diagnosed during life, and leading to coronary death in early childhood.]	L4	y	-	lethal	lethal	lethal	L4	L4	post-infant-lethal
208085	ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 1	Arthrogryposis, renal dysfunction, and cholestasis 1, 208085 (3)	Arthrogryposis, renal dysfunction, and cholestasis 1	y	ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 1; ARCS1	Clinical Features|Clinical Synopsis|Phenotype	death|deaths|died|lethal	VPS33B	HGNC:12712	Arthrogryposis, renal dysfunction, and cholestasis 1, 208085 (3), Autosomal recessive	Autosomal recessive	y	y	[Death in infancy, usually from sepsis, dehydration, or acidosis / Horslen et al. (1994) found that all of the parents were consanguineous and that all of the patients were male except for a single patient reported by Saraiva et al. (1990). All patients died in the first months of life]	L3	y	-	lethal	ambiguous|lethal|nonlethal	lethal|nonlethal	L3	L3	pre-infant-lethal
208150	FETAL AKINESIA DEFORMATION SEQUENCE 1	Fetal akinesia deformation sequence 1, 208150 (3)	Fetal akinesia deformation sequence 1	y	FETAL AKINESIA DEFORMATION SEQUENCE 1; FADS1	Description|Clinical Features|Clinical Synopsis	lethal|died|stillborn	MUSK	HGNC:7525	Fetal akinesia deformation sequence 1, 208150 (3), Autosomal recessive	Autosomal recessive	y	y	[Stillborn (30%)]	L1	y	-	lethal	lethal	lethal	L1|L3	L1	pre-infant-lethal
208230	PROGRESSIVE PSEUDORHEUMATOID DYSPLASIA	Progressive pseudorheumatoid dysplasia, 208230 (3)	Progressive pseudorheumatoid dysplasia	n	-	-	-	CCN6	HGNC:12771	Progressive pseudorheumatoid dysplasia, 208230 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
208250	CAMPTODACTYLY-ARTHROPATHY-COXA VARA-PERICARDITIS SYNDROME	Camptodactyly-arthropathy-coxa vara-pericarditis syndrome, 208250 (3)	Camptodactyly-arthropathy-coxa vara-pericarditis syndrome	n	-	-	-	PRG4	HGNC:9364	Camptodactyly-arthropathy-coxa vara-pericarditis syndrome, 208250 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
208400	ASPARTYLGLUCOSAMINURIA	Aspartylglucosaminuria, 208400 (3)	Aspartylglucosaminuria	y	ASPARTYLGLUCOSAMINURIA; AGU	Clinical Features	died	AGA	HGNC:318	Aspartylglucosaminuria, 208400 (3), Autosomal recessive	Autosomal recessive	y	y	[Gordon et al. (1998) described a Canadian family in which 4 of 12 sibs were affected, 2 brothers and 2 sisters... Three of the sibs had died, at 33, 39, and 44 years of age]	L6	y	-	lethal	lethal	lethal	L6	L6	post-infant-lethal
208530	RIGHT ATRIAL ISOMERISM	Right atrial isomerism (Ivemark), 208530 (3)	Right atrial isomerism (Ivemark)	y	RIGHT ATRIAL ISOMERISM; RAI	Clinical Features	died	GDF1	HGNC:4214	Right atrial isomerism (Ivemark), 208530 (3), Autosomal recessive	Autosomal recessive	y	y	[Eronen et al. (2004) described a nonconsanguineous Finnish family in which 4 consecutive children, 1 female and 3 males, had right atrial isomerism. All 4 succumbed and underwent autopsy... Two sibs had no surgery and died as newborns]	L2	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L2	L2	pre-infant-lethal
208540	RENAL-HEPATIC-PANCREATIC DYSPLASIA 1	Renal-hepatic-pancreatic dysplasia 1, 208540 (3)	Renal-hepatic-pancreatic dysplasia 1	y	RENAL-HEPATIC-PANCREATIC DYSPLASIA 1; RHPD1	Clinical Features|Clinical Synopsis|Phenotype	died|lethal|spontaneous_abortion|spontaneous_abortions|death|deaths	NPHP3	HGNC:7907	Renal-hepatic-pancreatic dysplasia 1, 208540 (3), Autosomal recessive	Autosomal recessive	y	y	[mother had 2 pregnancies that resulted in spontaneous abortion]	L1	y	y	lethal	lethal	lethal	L1|LU	L1	pre-infant-lethal
208550	ASTHMA, NASAL POLYPS, AND ASPIRIN INTOLERANCE	Asthma and nasal polyps, 208550 (3)	Asthma and nasal polyps	n	-	-	-	TBX21	HGNC:11599	Asthma and nasal polyps, 208550 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
208900	ATAXIA-TELANGIECTASIA	Ataxia-telangiectasia, 208900 (3)	Ataxia-telangiectasia	y	ATAXIA-TELANGIECTASIA; AT	Clinical Features	death|deaths|died	ATM	HGNC:795	Ataxia-telangiectasia, 208900 (3), Autosomal recessive	Autosomal recessive	y	y	[Verhagen et al. (2009) provided a retrospective analysis of 13 adult patients with variant AT from 9 families and 6 unrelated patients with classic AT... Five of the 6 died between ages 21 and 27]	L6	y	-	lethal	lethal	lethal	L6	L6	post-infant-lethal
208920	ATAXIA, EARLY-ONSET, WITH OCULOMOTOR APRAXIA AND HYPOALBUMINEMIA	Ataxia, early-onset, with oculomotor apraxia and hypoalbuminemia, 208920 (3)	Ataxia, early-onset, with oculomotor apraxia and hypoalbuminemia	n	-	-	-	APTX	HGNC:15984	Ataxia, early-onset, with oculomotor apraxia and hypoalbuminemia, 208920 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
209300	ATRANSFERRINEMIA	Atransferrinemia, 209300 (3)	Atransferrinemia	y	ATRANSFERRINEMIA	Clinical Features	death|deaths	TF	HGNC:11740	Atransferrinemia, 209300 (3), Autosomal recessive	Autosomal recessive	y	y	[Heilmeyer et al. (1961) described total absence of transferrin in a 7-year-old girl whose presenting complaint was severe hypochromic anemia. Death occurred from heart failure. Severe hemosiderosis of the heart and liver was found at autopsy. About half-normal levels of transferrin in both parents supported recessive inheritance (Goya et al., 1972)]	L4	y	-	lethal	lethal	lethal	L4	L4	post-infant-lethal
209500	ATRICHIA WITH PAPULAR LESIONS	Atrichia with papular lesions, 209500 (3)	Atrichia with papular lesions	n	-	-	-	HR	HGNC:5172	Atrichia with papular lesions, 209500 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
209880	CENTRAL HYPOVENTILATION SYNDROME, CONGENITAL, 1	Central hypoventilation syndrome, congenital, 1, with or without Hirschsprung disease, 209880 (3)	Central hypoventilation syndrome, congenital, 1, with or without Hirschsprung disease	y	CENTRAL HYPOVENTILATION SYNDROME, CONGENITAL, 1; CCHS1	Clinical Features	death|deaths|died|lethal	PHOX2B	HGNC:9143	Central hypoventilation syndrome, congenital, 1, with or without Hirschsprung disease, 209880 (3), Autosomal dominant	Autosomal dominant	y	y	[Haddad et al. (1978) described 3 female patients, 2 of whom were sisters. All 3 died in the first few months of life]	L3	y	-	lethal	lethal	lethal	L3|L4	L3	pre-infant-lethal
209885	BARBER-SAY SYNDROME	Barber-Say syndrome, 209885 (3)	Barber-Say syndrome	n	-	-	-	TWIST2	HGNC:20670	Barber-Say syndrome, 209885 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
209920	BARE LYMPHOCYTE SYNDROME, TYPE II	Bare lymphocyte syndrome, type II, complementation group A, 209920 (3)	Bare lymphocyte syndrome, type II, complementation group A	y	BARE LYMPHOCYTE SYNDROME, TYPE II	Clinical Synopsis	die	CIITA	HGNC:7067	Bare lymphocyte syndrome, type II, complementation group A, 209920 (3), Autosomal recessive	Autosomal recessive	y	y	[Majority of children die between 6 months and 5 yrs]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
209920	BARE LYMPHOCYTE SYNDROME, TYPE II	Bare lymphocyte syndrome, type II, complementation group C, 209920 (3)	Bare lymphocyte syndrome, type II, complementation group C	y	BARE LYMPHOCYTE SYNDROME, TYPE II	Clinical Synopsis	die	RFX5	HGNC:9986	Bare lymphocyte syndrome, type II, complementation group C, 209920 (3), Autosomal recessive	Autosomal recessive	y	y	[Majority of children die between 6 months and 5 yrs]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
209920	BARE LYMPHOCYTE SYNDROME, TYPE II	Bare lymphocyte syndrome, type II, complementation group E, 209920 (3)	Bare lymphocyte syndrome, type II, complementation group E	y	BARE LYMPHOCYTE SYNDROME, TYPE II	Clinical Synopsis	die	RFX5	HGNC:9986	Bare lymphocyte syndrome, type II, complementation group E, 209920 (3), Autosomal recessive	Autosomal recessive	y	y	[Majority of children die between 6 months and 5 yrs]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
209920	BARE LYMPHOCYTE SYNDROME, TYPE II	Bare lymphocyte syndrome, type II, complementation group B, 209920 (3)	Bare lymphocyte syndrome, type II, complementation group B	y	BARE LYMPHOCYTE SYNDROME, TYPE II	Clinical Synopsis	die	RFXANK	HGNC:9987	Bare lymphocyte syndrome, type II, complementation group B, 209920 (3), Autosomal recessive	Autosomal recessive	y	n	-	-	-	-	ambiguous	ambiguous	ambiguous	-	-	-
209920	BARE LYMPHOCYTE SYNDROME, TYPE II	Bare lymphocyte syndrome, type II, complementation group D, 209920 (3)	Bare lymphocyte syndrome, type II, complementation group D	y	BARE LYMPHOCYTE SYNDROME, TYPE II	Clinical Synopsis	die	RFXAP	HGNC:9988	Bare lymphocyte syndrome, type II, complementation group D, 209920 (3), Autosomal recessive	Autosomal recessive	y	y	[Majority of children die between 6 months and 5 yrs]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
209950	IMMUNODEFICIENCY 27A	Immunodeficiency 27A, mycobacteriosis, AR, 209950 (3)	Immunodeficiency 27A, mycobacteriosis, AR	y	IMMUNODEFICIENCY 27A; IMD27A	Description|Clinical Features|Clinical Synopsis	fatal|died	IFNGR1	HGNC:5439	Immunodeficiency 27A, mycobacteriosis, AR, 209950 (3), Autosomal recessive	Autosomal recessive	y	y	[Onset in early childhood / May be fatal / Levin et al. (1995) described 6 children with disseminated atypical mycobacterial infection and no recognized form of immunodeficiency... Three of the children had died and the 3 survivors had chronic infection]	L4	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L4	L4	post-infant-lethal
210000	BEHR SYNDROME	Behr syndrome, 210000 (3)	Behr syndrome	n	-	-	-	OPA1	HGNC:8140	Behr syndrome, 210000 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
210200	3-METHYLCROTONYL-CoA CARBOXYLASE 1 DEFICIENCY	3-Methylcrotonyl-CoA carboxylase 1 deficiency, 210200 (3)	3-Methylcrotonyl-CoA carboxylase 1 deficiency	y	3-METHYLCROTONYL-CoA CARBOXYLASE 1 DEFICIENCY; MCC1D	Clinical Features	died	MCCC1	HGNC:6936	3-Methylcrotonyl-CoA carboxylase 1 deficiency, 210200 (3), Autosomal recessive	Autosomal recessive	y	y	[De Kremer et al. (2002) reported a patient from Argentina with isolated biotin-resistant MCC deficiency diagnosed at 14 months of age. Clinical features included severe psychomotor retardation, hypotonia, areflexia, and failure to thrive. The patient died at age 3 years]	L4	y	-	lethal	lethal	lethal	L4	L4	post-infant-lethal
210210	3-METHYLCROTONYL-CoA CARBOXYLASE 2 DEFICIENCY	3-Methylcrotonyl-CoA carboxylase 2 deficiency, 210210 (3)	3-Methylcrotonyl-CoA carboxylase 2 deficiency	y	3-METHYLCROTONYL-CoA CARBOXYLASE 2 DEFICIENCY; MCC2D	Clinical Features	died	MCCC2	HGNC:6937	3-Methylcrotonyl-CoA carboxylase 2 deficiency, 210210 (3), Autosomal recessive	Autosomal recessive	y	y	[Baykal et al. (2005) reported a child, born of consanguineous Turkish parents, who presented on the second day of life with dehydration, cyanosis, no sucking, generalized muscular hypotonia, encephalopathy, respiratory depression requiring mechanic ventilation, macrocephaly, severe acidosis, and hypoglycemia... Treatment with high-dose biotin and protein-restricted diet was ineffective, and the patient died at the age of 33 days with progressive neurologic deterioration]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
210250	SITOSTEROLEMIA 1	Sitosterolemia 1, 210250 (3)	Sitosterolemia 1	y	SITOSTEROLEMIA 1; STSL1	Phenotype	died	ABCG8	HGNC:13887	Sitosterolemia 1, 210250 (3), Autosomal recessive	Autosomal recessive	y	y	[13-year-old proband who died unexpectedly of advanced coronary atherosclerosis]	L5	y	-	lethal	lethal	lethal	L5	L5	post-infant-lethal
210370	BIETTI CRYSTALLINE CORNEORETINAL DYSTROPHY	Bietti crystalline corneoretinal dystrophy, 210370 (3)	Bietti crystalline corneoretinal dystrophy	n	-	-	-	CYP4V2	HGNC:23198	Bietti crystalline corneoretinal dystrophy, 210370 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
210600	SECKEL SYNDROME 1	Seckel syndrome 1, 210600 (3)	Seckel syndrome 1	y	SECKEL SYNDROME 1; SCKL1	Clinical Features	died	ATR	HGNC:882	Seckel syndrome 1, 210600 (3), Autosomal recessive	Autosomal recessive	y	n	-	-	-	-	ambiguous	ambiguous	ambiguous	-	-	-
210720	MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE II	Microcephalic osteodysplastic primordial dwarfism, type II, 210720 (3)	Microcephalic osteodysplastic primordial dwarfism, type II	y	MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE II; MOPD2	Clinical Features	died	PCNT	HGNC:16068	Microcephalic osteodysplastic primordial dwarfism, type II, 210720 (3), Autosomal recessive	Autosomal recessive	y	n	-	-	-	-	ambiguous	ambiguous	ambiguous	-	-	-
210900	BLOOM SYNDROME	Bloom syndrome, 210900 (3)	Bloom syndrome	y	BLOOM SYNDROME; BLM	Clinical Features	died	BLM	HGNC:1058	Bloom syndrome, 210900 (3), Autosomal recessive	Autosomal recessive	y	y	[Passarge (1991) observed 10 patients in Germany during a 20-year period. One patient died at the age of 5 years of acute leukemia, a second at the age of 18 years of pulmonary fibrosis and bronchiectasis, and a third at the age of 21 years of Hodgkin lymphoma and subsequently leukemia]	L4	y	-	lethal	lethal	lethal	L4	L4	post-infant-lethal
211180	BOWEN-CONRADI SYNDROME	Bowen-Conradi syndrome, 211180 (3)	Bowen-Conradi syndrome	y	BOWEN-CONRADI SYNDROME; BWCNS	Clinical Features|Clinical Synopsis	death|deaths|die	EMG1	HGNC:16912	Bowen-Conradi syndrome, 211180 (3), Autosomal recessive	Autosomal recessive	y	y	[Most children die within the first 2 years of life (range 1 day - 9 years)]	L2	y	-	lethal	lethal	lethal	L2	L2	pre-infant-lethal
211380	ELSAHY-WATERS SYNDROME	Elsahy-Waters syndrome, 211380 (3)	Elsahy-Waters syndrome	y	ELSAHY-WATERS SYNDROME; ESWS	Clinical Features	died	CDH11	HGNC:1750	Elsahy-Waters syndrome, 211380 (3), Autosomal recessive	Autosomal recessive	y	y	[Harms et al. (2018) described a 5.5-year-old Indian girl who exhibited striking phenotypic similarity to the Saudi boy reported by Anazi et al. (2017)... Her first-cousin parents were unaffected; 2 brothers died in the neonatal period of unclear causes]	L2	n	y	lethal	lethal|nonlethal	lethal|nonlethal	L2	L2	pre-infant-lethal
211400	BRONCHIECTASIS WITH OR WITHOUT ELEVATED SWEAT CHLORIDE 1	Bronchiectasis with or without elevated sweat chloride 1, 211400 (3)	Bronchiectasis with or without elevated sweat chloride 1	n	-	-	-	SCNN1B	HGNC:10600	Bronchiectasis with or without elevated sweat chloride 1, 211400 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L4|L6	L4	post-infant-lethal
211530	BROWN-VIALETTO-VAN LAERE SYNDROME 1	Brown-Vialetto-Van Laere syndrome 1, 211530 (3)	Brown-Vialetto-Van Laere syndrome 1	y	BROWN-VIALETTO-VAN LAERE SYNDROME 1; BVVLS1	Clinical Features|Clinical Synopsis	death|deaths|died	SLC52A3	HGNC:16187	Brown-Vialetto-Van Laere syndrome 1, 211530 (3), Autosomal recessive	Autosomal recessive	y	y	[Gallai et al. (1981) described the clinical features of 2 patients and the clinical and postmortem findings in the sib of one of these. One of these patients was a girl who became deaf at age 2 and developed multiple cranial and spinal nerve palsies at age 14. Her brother died of the condition at age 2]	L4	y	-	lethal	lethal	lethal	L4	L4	post-infant-lethal
211600	CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC, 1	Cholestasis, progressive familial intrahepatic 1, 211600 (3)	Cholestasis, progressive familial intrahepatic 1	y	CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC, 1; PFIC1	Clinical Features	death|deaths|died	ATP8B1	HGNC:3706	Cholestasis, progressive familial intrahepatic 1, 211600 (3), Autosomal recessive	Autosomal recessive	y	y	[Nielsen et al. (1986) described Byler disease in 16 Greenland Eskimo children. Typical features included jaundice, pruritus, malnutrition, steatorrhea, osteodystrophy, short stature, and hyperbilirubinemia. Eight patients had died between the ages of 6 weeks and 3 years]	L3	y	-	lethal	ambiguous|lethal|nonlethal	lethal|nonlethal	L3	L3	pre-infant-lethal
211750	C SYNDROME	C syndrome, 211750 (3)	C syndrome	y	C SYNDROME	Clinical Features	die|died	CD96	HGNC:16892	C syndrome, 211750 (3), Autosomal dominant	Autosomal dominant	y	y	[Preus et al. (1975) described 2 similar patients who were unrelated. Oberklaid and Danks (1975) described a patient and suggested that the disorder be called the Opitz trigonocephaly syndrome. They were dubious that the cases of Preus et al. (1975) were the same. The peculiar shape of the skull, the unusual facies, and the bizarre conformation of the palate were illustrated and described. Flexion deformities of the elbows, wrists, and fingers were seen. The child died at 2 weeks of age. About half the patients die in the first year]	L2	y	-	lethal	lethal	lethal	L2	L2	pre-infant-lethal
211800	CALCIFICATION OF JOINTS AND ARTERIES	Calcification of joints and arteries, 211800 (3)	Calcification of joints and arteries	n	-	-	-	NT5E	HGNC:8021	Calcification of joints and arteries, 211800 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
211900	TUMORAL CALCINOSIS, HYPERPHOSPHATEMIC, FAMILIAL, 1	Tumoral calcinosis, hyperphosphatemic, familial, 1, 211900 (3)	Tumoral calcinosis, hyperphosphatemic, familial, 1	y	TUMORAL CALCINOSIS, HYPERPHOSPHATEMIC, FAMILIAL, 1; HFTC1	Clinical Features	died	GALNT3	HGNC:4125	Tumoral calcinosis, hyperphosphatemic, familial, 1, 211900 (3), Autosomal recessive	Autosomal recessive	n	y	[Slavin et al. (1993) reviewed the histopathologic and ultrastructural changes of tumoral calcinosis occurring in 7 affected sibs in a sibship of 15.... One patient, who also had calcinosis cutis involving the antecubital, popliteal, and axillary areas and legs, died at age 19 of pulmonary hypertension. The other sibs varied in age from 20 to 40 years at the time of this report]	L6	y	-	lethal	lethal	lethal	L6	L6	post-infant-lethal
212050	IMMUNODEFICIENCY 103, SUSCEPTIBILITY TO FUNGAL INFECTIONS	Immunodeficiency 103, susceptibility to fungal infection, 212050 (3)	Immunodeficiency 103, susceptibility to fungal infection	y	IMMUNODEFICIENCY 103, SUSCEPTIBILITY TO FUNGAL INFECTIONS; IMD103	Clinical Features	died|fatal	CARD9	HGNC:16391	Immunodeficiency 103, susceptibility to fungal infection, 212050 (3), Autosomal recessive	Autosomal recessive	y	y	[3 of whom died in early adolescence]	L5	y	-	lethal	lethal	lethal	L5	L5	post-infant-lethal
212065	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ia	Congenital disorder of glycosylation, type Ia, 212065 (3)	Congenital disorder of glycosylation, type Ia	y	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ia; CDG1A	Description|Clinical Features|Phenotype	lethality|died|lethal	PMM2	HGNC:9115	Congenital disorder of glycosylation, type Ia, 212065 (3), Autosomal recessive	Autosomal recessive	y	y	[There is a 20% lethality in the first year of life due to severe infections, liver insufficiency, or cardiomyopathy]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
212066	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIa	Congenital disorder of glycosylation, type IIa, 212066 (3)	Congenital disorder of glycosylation, type IIa	y	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIa; CDG2A	Clinical Features	died	MGAT2	HGNC:7045	Congenital disorder of glycosylation, type IIa, 212066 (3), Autosomal recessive	Autosomal recessive	y	y	[De Cock and Jaeken (2009) reported a boy with CDG2A who died at age 18 years]	L5	y	-	lethal	lethal	lethal	L5	L5	post-infant-lethal
212070	CARBOXYPEPTIDASE N DEFICIENCY	Carboxypeptidase N deficiency, 212070 (3)	Carboxypeptidase N deficiency	n	-	-	-	CPN1	HGNC:2312	Carboxypeptidase N deficiency, 212070 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
212093	CARDIAC VALVULAR DYSPLASIA 1	Cardiac valvular dysplasia 1, 212093 (3)	Cardiac valvular dysplasia 1	y	CARDIAC VALVULAR DYSPLASIA 1; CVDP1	Clinical Features	death|deaths|died|spontaneous_abortion|spontaneous_abortions	PLD1	HGNC:9067	Cardiac valvular dysplasia 1, 212093 (3), Autosomal recessive	Autosomal recessive	y	y	[first-trimester spontaneous abortion]	L1	y	y	lethal	lethal	lethal	L1	L1	pre-infant-lethal
212112	CARDIOMYOPATHY, DILATED, WITH HYPERGONADOTROPIC HYPOGONADISM	Malouf syndrome, 212112 (3)	Malouf syndrome	y	CARDIOMYOPATHY, DILATED, WITH HYPERGONADOTROPIC HYPOGONADISM	Clinical Features	death|deaths|died|miscarriage|miscarriages	LMNA	HGNC:6636	Malouf syndrome, 212112 (3), Autosomal dominant	Autosomal dominant	n	y	[Thomas et al. (1993) described 2 brothers with cardiomyopathy and genital anomalies. One brother was born with micropenis and bilateral cryptorchidism but seemed otherwise well until age 5 weeks when he developed congestive heart failure leading to death at age 7 months. The other affected brother was the product of a pregnancy that ended in miscarriage after 17 weeks]	L1	y	-	lethal	ambiguous|lethal|nonlethal	lethal|nonlethal	L1|L2|L6	L1	pre-infant-lethal
212138	CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY	Carnitine-acylcarnitine translocase deficiency, 212138 (3)	Carnitine-acylcarnitine translocase deficiency	y	CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY; CACTD	Clinical Features|Clinical Synopsis|Phenotype	death|deaths|died|fatal	SLC25A20	HGNC:1421	Carnitine-acylcarnitine translocase deficiency, 212138 (3), Autosomal recessive	Autosomal recessive	y	y	[Fukushima et al. (2013) reported 2 unrelated Japanese infants who died of CACT deficiency. One presented at age 2 days with decreased respiratory function, repeated apnea, hypotonia, irritability, oliguria, hypoglycemia, liver dysfunction, and cryptogenic rhabdomyolysis. Plantar blood spots showed an abnormal acylcarnitine profile, consistent with CACT deficiency. The patient died of Reye-like symptoms at age 2 years, 9 months. The other child became cyanotic and flaccid and went into cardiac arrest on day 2 of life; he died the next day]	L2	y	-	lethal	lethal	lethal	L2	L2	pre-infant-lethal
212140	CARNITINE DEFICIENCY, SYSTEMIC PRIMARY	Carnitine deficiency, systemic primary, 212140 (3)	Carnitine deficiency, systemic primary	y	CARNITINE DEFICIENCY, SYSTEMIC PRIMARY; CDSP	Description|Clinical Features|Diagnosis	lethal|death|deaths|died	SLC22A5	HGNC:10969	Carnitine deficiency, systemic primary, 212140 (3), Autosomal recessive	Autosomal recessive	y	y	[If diagnosed early, all clinical manifestations of the disorder can be completely reversed by supplementation of carnitine. However, if left untreated, patients will develop lethal heart failure (summary by Shibbani et al., 2014) / Waber et al. (1982) described a 3.5-year-old boy with cardiomegaly, congestive heart failure, and skeletal muscle weakness. A brother had died of heart failure]	LU	y	y	lethal	lethal	lethal	LU	LU	post-infant-lethal
212350	SENGERS SYNDROME	Sengers syndrome, 212350 (3)	Sengers syndrome	y	SENGERS SYNDROME	Description|Clinical Features|Clinical Synopsis|Phenotype	die|death|deaths|died	AGK	HGNC:21869	Sengers syndrome, 212350 (3), Autosomal recessive	Autosomal recessive	n	y	[Calvo et al. (2012) reported a girl who presented at age 9 months with hypertrophic obstructive cardiomyopathy and cardiac failure associated with metabolic lactic acidosis.... A second unrelated infant, born of consanguineous Pakistani parents, developed respiratory distress and circulatory failure in the first hour of life, associated with severe metabolic lactic acidosis. Studies suggested persistent pulmonary hypertension. Other features included bilateral cataracts and thrombocytopenia. The patient died at age 3 days]	L2	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L2	L2	pre-infant-lethal
212500	CATARACT 46, JUVENILE-ONSET, WITH OR WITHOUT ARRHYTHMIC CARDIOMYOPATHY	Cataract 46, juvenile-onset, 212500 (3)	Cataract 46, juvenile-onset	y	CATARACT 46, JUVENILE-ONSET, WITH OR WITHOUT ARRHYTHMIC CARDIOMYOPATHY; CTRCT46	Description|Clinical Features|Clinical Synopsis|Phenotype	death|deaths|died	LEMD2	HGNC:21244	Cataract 46, juvenile-onset, 212500 (3), Autosomal recessive	Autosomal recessive	y	y	[Sudden unexpected death in patients with arrhythmic cardiomyopathy / Abdelfatah et al. (2019) studied 2 extended Hutterite families: a Lehrerleut kindred (family 600), 3 affected members of which had previously been studied by Shokeir and Lowry (1985) and Boone et al. (2016), and a Schmiedeleut kindred (family 290). Bilateral juvenile cataract was present in 19 family members, and 14 of those patients also exhibited arrhythmic cardiomyopathy, with 5 experiencing sudden unexpected death at ages ranging from 28 to 51 years]	L6	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L6	L6	post-infant-lethal
212550	OPTIC DISC ANOMALIES WITH RETINAL AND/OR MACULAR DYSTROPHY	Optic disc anomalies with retinal and/or macular dystrophy, 212550 (3)	Optic disc anomalies with retinal and/or macular dystrophy	n	-	-	-	SIX6	HGNC:10892	Optic disc anomalies with retinal and/or macular dystrophy, 212550 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
212720	MARTSOLF SYNDROME 1	Martsolf syndrome 1, 212720 (3)	Martsolf syndrome 1	n	-	-	-	RAB3GAP2	HGNC:17168	Martsolf syndrome 1, 212720 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
212780	CENANI-LENZ SYNDACTYLY SYNDROME	Cenani-Lenz syndactyly syndrome, 212780 (3)	Cenani-Lenz syndactyly syndrome	n	-	-	-	LRP4	HGNC:6696	Cenani-Lenz syndactyly syndrome, 212780 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
212840	GORDON HOLMES SYNDROME	Cerebellar ataxia and hypogonadotropic hypogonadism, 212840 (3)	Cerebellar ataxia and hypogonadotropic hypogonadism	y	GORDON HOLMES SYNDROME; GDHS	Clinical Features	died	RNF216	HGNC:21698	Cerebellar ataxia and hypogonadotropic hypogonadism, 212840 (3), Autosomal recessive	Autosomal recessive	y	y	[Santens et al. (2015) reported sibs from 2 unrelated Belgian families with a variant of Gordon Holmes syndrome presenting as a Huntington disease (HD; 143100)-like disorder. In the first family, 2 sibs presented in their thirties with personality changes and inappropriate behavior associated with choreic movements of the face and limbs. They had brisk reflexes and cerebellar signs, including dysmetria, ataxia, unsteady gait, dysdiadochokinesis, and dysarthria. The disorder was progressive, and both patients showed impulsivity and aggressive behavior at times. One sib had significant deterioration, with widespread cognitive dysfunction and loss of speech; she became bedridden and died of aspiration pneumonia in her forties]	L6	y	-	lethal	lethal	lethal	L6	L6	post-infant-lethal
213000	CEREBELLAR HYPOPLASIA/ATROPHY, EPILEPSY, AND GLOBAL DEVELOPMENTAL DELAY	Cerebellar hypoplasia/atrophy, epilepsy, and global developmental delay, 213000 (3)	Cerebellar hypoplasia/atrophy, epilepsy, and global developmental delay	y	CEREBELLAR HYPOPLASIA/ATROPHY, EPILEPSY, AND GLOBAL DEVELOPMENTAL DELAY; CHEGDD	Clinical Features	died|miscarriage|miscarriages	OXR1	HGNC:15822	Cerebellar hypoplasia/atrophy, epilepsy, and global developmental delay, 213000 (3), Autosomal recessive	Autosomal recessive	y	y	[Wang et al. (2019) reported 5 patients from 3 unrelated families with CHEGDD. One patient was 20 years of age, whereas the others ranged from 12 to 15 years; 1 had died at 11 years due to chronic lung disease associated with recurrent aspiration pneumonia. The patients presented in early childhood with hypotonia, global developmental delay, delayed walking at about age 3 years, and severely impaired intellectual development with profound speech delay or even absent language. All also developed epilepsy between 7 and 10 years of age, but the seizures were controlled by medication in most. Subtle nonspecific dysmorphic features seen in some patients included poor overall growth, large forehead, tall face, mild hypertelorism, joint hyperlaxity, and long fingers and toes. Brain imaging in all 5 patients showed cerebellar atrophy and dysplasia. Families 2 and 3 were consanguineous; family history revealed 4 miscarriages in family 3. Additional cerebellar features, such as tremor, ataxia, and nystagmus, were not noted in these patients]	L1	y	y	lethal	lethal	lethal	L1	L1	pre-infant-lethal
213200	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 2	Spinocerebellar ataxia, autosomal recessive 2, 213200 (3)	Spinocerebellar ataxia, autosomal recessive 2	y	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 2; SCAR2	Clinical Features	died	PMPCA	HGNC:18667	Spinocerebellar ataxia, autosomal recessive 2, 213200 (3), Autosomal recessive	Autosomal recessive	n	y	[Jobling et al. (2015) also reported 4 patients from 2 additional families of Lebanese descent. These patients had similar ataxic gait, although in some cases the gait abnormalities appeared between 11 and 15 months of age after normal initial development. Features included truncal and gait ataxia, difficulty in fine motor skills, saccadic smooth pursuit, dysmetria, dysdiadochokinesis, and tremor. All but 1 had intellectual disability and delayed speech with dysarthria. A fourth family, of French descent, contained 2 affected sibs, including 1 living 58-year-old man with gait ataxia, dysmetria, gaze-evoked nystagmus, and dysarthria. He had normal intellectual development and his neurologic status was stable over time. An affected sister died at age 29 years]	L6	n	y	lethal	lethal	lethal	L6	L6	post-infant-lethal
213300	JOUBERT SYNDROME 1	Joubert syndrome 1, 213300 (3)	Joubert syndrome 1	y	JOUBERT SYNDROME 1; JBTS1	Clinical Features	died	INPP5E	HGNC:21474	Joubert syndrome 1, 213300 (3), Autosomal recessive	Autosomal recessive	y	y	[De Haene (1955) collected from the literature 4 cases of total and 7 cases of partial agenesis of the vermis of the cerebellum, and added the only familial example: 3 brothers (1 autopsy) died at ages 4 to 8 years, the illness being characterized by tremor and hypotonia]	L4	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L4	L4	post-infant-lethal
213600	BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 1	Basal ganglia calcification, idiopathic, 1, 213600 (3)	Basal ganglia calcification, idiopathic, 1	y	BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 1; IBGC1	Clinical Features	died	SLC20A2	HGNC:10947	Basal ganglia calcification, idiopathic, 1, 213600 (3), Autosomal dominant	Autosomal dominant	y	y	[Weisman et al. (2007) reported a man with Fahr disease who died 10 years after symptom onset. At age 61 years, he developed slowly progressive memory difficulties, which progressed to fine motor dysfunction and changes in personality consistent with frontotemporal dementia]	L6	y	-	lethal	lethal	lethal	L6	L6	post-infant-lethal
213700	CEREBROTENDINOUS XANTHOMATOSIS	Cerebrotendinous xanthomatosis, 213700 (3)	Cerebrotendinous xanthomatosis	y	CEREBROTENDINOUS XANTHOMATOSIS; CTX	Description|Clinical Features	death|deaths|died	CYP27A1	HGNC:2605	Cerebrotendinous xanthomatosis, 213700 (3), Autosomal recessive	Autosomal recessive	y	y	[Clayton et al. (2002) reviewed the medical histories of a group of patients with CTX and found that prolonged neonatal cholestatic jaundice was common. The family histories also revealed fetal and neonatal deaths among sibs of CTX patients	L1	n	y	lethal	lethal	lethal	L1	L1	pre-infant-lethal
213980	CRANIOFACIAL DYSMORPHISM, SKELETAL ANOMALIES, AND IMPAIRED INTELLECTUAL DEVELOPMENT SYNDROME 1	Craniofacial dysmorphism, skeletal anomalies, and impaired intellectual development 1, 213980 (3)	Craniofacial dysmorphism, skeletal anomalies, and impaired intellectual development 1	y	CRANIOFACIAL DYSMORPHISM, SKELETAL ANOMALIES, AND IMPAIRED INTELLECTUAL DEVELOPMENT SYNDROME 1; CFSMR1	Clinical Features	spontaneous_abortion|spontaneous_abortions	TMCO1	HGNC:18188	Craniofacial dysmorphism, skeletal anomalies, and impaired intellectual development 1, 213980 (3), Autosomal recessive	Autosomal recessive	y	y	[First trimester spontaneous abortions occurred in 22% of pregnancies]	L1	-	-	lethal	lethal	lethal	L1	L1	pre-infant-lethal
214100	PEROXISOME BIOGENESIS DISORDER 1A (ZELLWEGER)	Peroxisome biogenesis disorder 1A (Zellweger), 214100 (3)	Peroxisome biogenesis disorder 1A (Zellweger)	y	PEROXISOME BIOGENESIS DISORDER 1A (ZELLWEGER); PBD1A	Description|Clinical Features|Clinical Synopsis	die|lethal|death|deaths|died	PEX1	HGNC:8850	Peroxisome biogenesis disorder 1A (Zellweger), 214100 (3), Autosomal recessive	Autosomal recessive	y	y	[Death usually in first year of life]	L3	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L3	L3	pre-infant-lethal
214110	PEROXISOME BIOGENESIS DISORDER 2A (ZELLWEGER)	Peroxisome biogenesis disorder 2A (Zellweger), 214110 (3)	Peroxisome biogenesis disorder 2A (Zellweger)	y	PEROXISOME BIOGENESIS DISORDER 2A (ZELLWEGER); PBD2A	Description|Clinical Features|Clinical Synopsis	die|died|death|deaths	PEX5	HGNC:9719	Peroxisome biogenesis disorder 2A (Zellweger), 214110 (3), Autosomal recessive	Autosomal recessive	n	y	[Thomas et al. (1975) described a male patient with hyperpipecolic acidemia. Features were persistent hepatomegaly, severe mental retardation, progressive loss of developmental milestones, and diminished visual acuity associated with nystagmus, abnormal discs, and retinal changes. He died at age 2 years following a progressive loss of neurologic function]	L4	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L4	L4	post-infant-lethal
214150	CEREBROOCULOFACIOSKELETAL SYNDROME 1	Cerebrooculofacioskeletal syndrome 1, 214150 (3)	Cerebrooculofacioskeletal syndrome 1	y	CEREBROOCULOFACIOSKELETAL SYNDROME 1; COFS1	Clinical Features|Clinical Synopsis	died|death|deaths	ERCC6	HGNC:3438	Cerebrooculofacioskeletal syndrome 1, 214150 (3), Autosomal recessive	Autosomal recessive	y	y	[Jaakkola et al. (2010) reported a large multigenerational consanguineous Finnish kindred in which 6 individuals had COFS1. Two deceased patients had originally been reported by Linna et al. (1982) as having COFS, 1 of whom had intracranial calcifications. Two patients, a boy and a girl, were reported in detail. Clinical features included failure to thrive, poor growth, lack of psychomotor development with inability to sit independently or speak, and arthrogryposis. Facial dysmorphism included microcephaly, deep-set eyes, cataracts, prominent nasal bridge, micrognathia, large ear pinna, and upper lip overlapping the lower lip. Both also had hearing loss and nystagmus; 1 developed seizures. Brain MRI showed hypoplasia of the corpus callosum, ventriculomegaly, and delayed myelination. The boy had cryptorchidism. The other family members had a similar phenotype. All patients died between ages 3 and 9 years]	L4	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L4	L4	post-infant-lethal
214300	KLIPPEL-FEIL SYNDROME 2, AUTOSOMAL RECESSIVE	Klippel-Feil syndrome 2, 214300 (3)	Klippel-Feil syndrome 2	n	-	-	-	MEOX1	HGNC:7013	Klippel-Feil syndrome 2, 214300 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
214350	CHAND SYNDROME	CHAND syndrome, 214350 (3)	CHAND syndrome	n	-	-	-	RIPK4	HGNC:496	CHAND syndrome, 214350 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L1	L1	pre-infant-lethal
214400	CHARCOT-MARIE-TOOTH DISEASE, TYPE 4A	Charcot-Marie-Tooth disease, type 4A, 214400 (3)	Charcot-Marie-Tooth disease, type 4A	n	-	-	-	GDAP1	HGNC:15968	Charcot-Marie-Tooth disease, type 4A, 214400 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
214450	GRISCELLI SYNDROME, TYPE 1	Griscelli syndrome, type 1, 214450 (3)	Griscelli syndrome, type 1	n	-	-	-	MYO5A	HGNC:7602	Griscelli syndrome, type 1, 214450 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
214500	CHEDIAK-HIGASHI SYNDROME	Chediak-Higashi syndrome, 214500 (3)	Chediak-Higashi syndrome	y	CHEDIAK-HIGASHI SYNDROME; CHS	Clinical Features	death|deaths|died	LYST	HGNC:1968	Chediak-Higashi syndrome, 214500 (3), Autosomal recessive	Autosomal recessive	y	y	[Siccardi et al. (1978) described a 4-year-old Italian boy with recurrent infections. Both he and his healthy father had a severe isolated defect in bactericidal activity of circulating neutrophils. The parents of the proband were first cousins once removed. The proband had silvery-blond hair, individual hairs showing silver and blond banding, as well as a slate-gray generalized hyperpigmentation of the skin. Generalized lymph node enlargement and hepatosplenomegaly were present. The boy died at age 4 years and 9 months, following cerebral hemorrhage (probably secondary to thrombocytopenia caused by hypersplenism)]	L4	y	-	lethal	lethal	lethal	L4	L4	post-infant-lethal
214700	DIARRHEA 1, SECRETORY CHLORIDE, CONGENITAL	Diarrhea 1, secretory chloride, congenital, 214700 (3)	Diarrhea 1, secretory chloride, congenital	n	-	-	-	SLC26A3	HGNC:3018	Diarrhea 1, secretory chloride, congenital, 214700 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
214800	CHARGE SYNDROME	CHARGE syndrome, 214800 (3)	CHARGE syndrome	y	CHARGE SYNDROME	Clinical Features|Phenotype	died	CHD7	HGNC:20626	CHARGE syndrome, 214800 (3), Autosomal dominant	Autosomal dominant	y	y	[In 3 members of a Finnish family with CHARGE syndrome, Vuorela et al. (2008) identified a nonsense mutation in the CHD7 gene (608892.0017). The male infant proband and a male fetus from a second pregnancy both had absence of the olfactory bulbs in addition to other features consistent with CHARGE syndrome. The male infant, who died at 3 months of age, also had marked isomerism of the liver with significant symmetry of the right side-appearing lobes and a midline gallbladder, as well as extrahepatic bile duct obstruction and significant hyporotation of the intestines / ** In other features Writzl et al. (2007) reported 2 unrelated infants with genetically confirmed CHARGE syndrome who also had lymphopenia with almost absent T cells. Studies in 1 patient showed no proliferative response to phytohemagglutinin. Both patients also had hypocalcemia and hypothyroidism, and 1 had a hypoplastic thymus. Both patients died within the first month of life]	L2	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L2	L2	pre-infant-lethal
214950	BILE ACID SYNTHESIS DEFECT, CONGENITAL, 4	Bile acid synthesis defect, congenital, 4, 214950 (3)	Bile acid synthesis defect, congenital, 4	y	BILE ACID SYNTHESIS DEFECT, CONGENITAL, 4; CBAS4	Clinical Features|Phenotype	died	AMACR	HGNC:451	Bile acid synthesis defect, congenital, 4, 214950 (3), Autosomal recessive	Autosomal recessive	n	y	[Eyssen et al. (1972) reported 2 infant brothers with intrahepatic cholestasis and partial atresia of the intrahepatic bile ducts who died at ages 4 and 6 months, respectively]	L3	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L3	L3	pre-infant-lethal
215045	CHONDRODYSPLASIA, BLOMSTRAND TYPE	Chondrodysplasia, Blomstrand type, 215045 (3)	Chondrodysplasia, Blomstrand type	y	CHONDRODYSPLASIA, BLOMSTRAND TYPE; BOCD	Clinical Features|Clinical Synopsis|Phenotype	died|lethal|die|stillborn	PTH1R	HGNC:9608	Chondrodysplasia, Blomstrand type, 215045 (3), Autosomal recessive	Autosomal recessive	n	y	[Die at birth or shortly after birth / Loshkajian et al. (1997) described 2 sibs, 1 male and 1 female, born to unaffected nonconsanguineous parents. Both had short limbs, polyhydramnios, hydrops fetalis, facial anomalies, preductal aortic coarctation, and remarkably advanced skeletal maturation. The first of these sibs was recognized on ultrasound with extremely short limbs and multiple anomalies; an elective termination was performed. The affected sib died in utero and delivered spontaneously at 33 weeks of gestation. Histologic findings from the male fetus were presented]	L1	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L1	L1	pre-infant-lethal
215100	RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 1	Rhizomelic chondrodysplasia punctata, type 1, 215100 (3)	Rhizomelic chondrodysplasia punctata, type 1	y	RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 1; RCDP1	Description|Clinical Features|Clinical Synopsis	die|death|deaths|died	PEX7	HGNC:8860	Rhizomelic chondrodysplasia punctata, type 1, 215100 (3), Autosomal recessive	Autosomal recessive	y	y	[Dimmick et al. (1991) found de novo deletion del(4)(p14p16) in a newborn male with what they called rhizomelic CDP, but with normal peroxisomes as indicated by electron microscopy and normal plasmalogen synthesis in cultured fibroblasts. Fetal ultrasound demonstrated rhizomelia with epiphyseal stippling and diaphragmatic hernia. Facial anomalies with left cleft lip and bilateral cleft palate were present. The infant died soon after birth]	L2	y	-	lethal	lethal	lethal	L2|L5	L2	pre-infant-lethal
215140	GREENBERG DYSPLASIA	Greenberg skeletal dysplasia, 215140 (3)	Greenberg skeletal dysplasia	y	GREENBERG DYSPLASIA; GRBGD	Description|Clinical Features|Clinical Synopsis|Phenotype	lethal|death|deaths	LBR	HGNC:6518	Greenberg skeletal dysplasia, 215140 (3), Autosomal recessive	Autosomal recessive	y	y	[Fetal death]	L1	y	-	lethal	ambiguous|lethal|nonlethal	lethal|nonlethal	L1	L1	pre-infant-lethal
215150	OTOSPONDYLOMEGAEPIPHYSEAL DYSPLASIA, AUTOSOMAL RECESSIVE	Otospondylomegaepiphyseal dysplasia, autosomal recessive, 215150 (3)	Otospondylomegaepiphyseal dysplasia, autosomal recessive	n	-	-	-	COL11A2	HGNC:2187	Otospondylomegaepiphyseal dysplasia, autosomal recessive, 215150 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L2	L2	pre-infant-lethal
215470	BOUCHER-NEUHAUSER SYNDROME	Boucher-Neuhauser syndrome, 215470 (3)	Boucher-Neuhauser syndrome	n	-	-	-	PNPLA6	HGNC:16268	Boucher-Neuhauser syndrome, 215470 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
215600	CIRRHOSIS, FAMILIAL	Cirrhosis, cryptogenic, 215600 (3)	Cirrhosis, cryptogenic	y	CIRRHOSIS, FAMILIAL	Phenotype	death|deaths|died|lethality	KRT18	HGNC:6430	Cirrhosis, cryptogenic, 215600 (3), Autosomal recessive	Autosomal recessive	y	y	[ died between ages 4.5 and 6 years]	L4	-	-	lethal	lethal	lethal	L4	L4	post-infant-lethal
215700	CITRULLINEMIA, CLASSIC	Citrullinemia, 215700 (3)	Citrullinemia	y	CITRULLINEMIA, CLASSIC	Clinical Features	death|deaths|died	ASS1	HGNC:758	Citrullinemia, 215700 (3), Autosomal recessive	Autosomal recessive	y	y	[Most cases of citrullinemia have pursued a severe course with symptoms from birth and death in the neonatal period in more than half of cases]	L2	y	-	lethal	lethal	lethal	L2	L2	pre-infant-lethal
216100	JUBERG-HAYWARD SYNDROME	Juberg-Hayward syndrome, 216100 (3)	Juberg-Hayward syndrome	n	-	-	-	ESCO2	HGNC:27230	Juberg-Hayward syndrome, 216100 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L1	L1	pre-infant-lethal
216340	YUNIS-VARON SYNDROME	Yunis-Varon syndrome, 216340 (3)	Yunis-Varon syndrome	y	YUNIS-VARON SYNDROME; YVS	Description|Clinical Features|Clinical Synopsis	lethal|died|death|deaths	FIG4	HGNC:16873	Yunis-Varon syndrome, 216340 (3), Autosomal recessive	Autosomal recessive	n	y	[Garrett et al. (1990) described 2 male sibs affected in 1 family and 2 female sibs in a second, both with normal parents. All died before 10 weeks of age]	L3	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L3	L3	pre-infant-lethal
216360	COACH SYNDROME 1	COACH syndrome 1, 216360 (3)	COACH syndrome 1	y	COACH SYNDROME 1; COACH1	Description|Clinical Features	fatal|death|deaths|died	TMEM67	HGNC:28396	COACH syndrome 1, 216360 (3), Autosomal recessive	Autosomal recessive	y	n	-	-	-	-	ambiguous	ambiguous|lethal|nonlethal	lethal|nonlethal	L1|L4	L1	pre-infant-lethal
216400	COCKAYNE SYNDROME A	Cockayne syndrome, type A, 216400 (3)	Cockayne syndrome, type A	y	COCKAYNE SYNDROME A; CSA	Description|Clinical Features|Diagnosis	death|deaths|died|fatal|lethal	ERCC8	HGNC:3439	Cockayne syndrome, type A, 216400 (3), Autosomal recessive	Autosomal recessive	n	y	[Wilson et al. (2016) reviewed the features and made recommendations regarding the evaluation of 102 patients, 44 females and 58 males, with Cockayne syndrome A or B. The mean age of recruited individuals was 11.5 years, with a range of 3 months to 39 years. All patients were microcephalic and had growth failure leading to proportionate short stature. At the time of the analysis, 28 individuals had died, with a mean age of death of 8.4 years with a range of 17 months to 30 years]	L3	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L3	L3	pre-infant-lethal
216550	COHEN SYNDROME	Cohen syndrome, 216550 (3)	Cohen syndrome	y	COHEN SYNDROME; COH1	Clinical Features	fatal	VPS13B	HGNC:2183	Cohen syndrome, 216550 (3), Autosomal recessive	Autosomal recessive	y	n	-	-	-	-	ambiguous	ambiguous	ambiguous	-	-	-
216900	ACHROMATOPSIA 2	Achromatopsia 2, 216900 (3)	Achromatopsia 2	n	-	-	-	CNGA3	HGNC:2150	Achromatopsia 2, 216900 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
217000	COMPLEMENT COMPONENT 2 DEFICIENCY	C2 deficiency, 217000 (3)	C2 deficiency	n	-	-	-	C2	HGNC:1248	C2 deficiency, 217000 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
217080	JALILI SYNDROME	Jalili syndrome, 217080 (3)	Jalili syndrome	n	-	-	-	CNNM4	HGNC:105	Jalili syndrome, 217080 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
217085	CONGENITAL HEART DEFECTS, HAMARTOMAS OF TONGUE, AND POLYSYNDACTYLY	Congenital heart defects, hamartomas of tongue, and polysyndactyly, 217085 (3)	Congenital heart defects, hamartomas of tongue, and polysyndactyly	y	CONGENITAL HEART DEFECTS, HAMARTOMAS OF TONGUE, AND POLYSYNDACTYLY; CHDTHP	Clinical Features	died	WDPCP	HGNC:28027	Congenital heart defects, hamartomas of tongue, and polysyndactyly, 217085 (3), Autosomal recessive	Autosomal recessive	y	y	[Among the children of healthy, unrelated parents, Orstavik et al. (1992) observed a sister and brother with congenital heart defects, hamartomas of the tongue, and polydactyly. Both had coarctation of the aorta, which was repaired in early infancy. In addition, the girl had atrioventricular canal; she died postoperatively at age 4 years. The boy had fibrous subaortic stenosis and died of pneumonia at age 2 years]	L4	y	-	lethal	lethal	lethal	L4	L4	post-infant-lethal
217090	PLASMINOGEN DEFICIENCY, TYPE I	Dysplasminogenemia, 217090 (3)	Dysplasminogenemia	n	-	-	-	PLG	HGNC:9071	Dysplasminogenemia, 217090 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L6	L6	post-infant-lethal
217090	PLASMINOGEN DEFICIENCY, TYPE I	Plasminogen deficiency, type I, 217090 (3)	Plasminogen deficiency, type I	n	-	-	-	PLG	HGNC:9071	Plasminogen deficiency, type I, 217090 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L6	L6	post-infant-lethal
217095	CONOTRUNCAL HEART MALFORMATIONS	Persistent truncus arteriosus, 217095 (3)	Persistent truncus arteriosus	n	-	-	-	GATA6	HGNC:4174	Persistent truncus arteriosus, 217095 (3)	-	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L2	L2	pre-infant-lethal
217095	CONOTRUNCAL HEART MALFORMATIONS	Conotruncal heart malformations, variable, 217095 (3)	Conotruncal heart malformations, variable	n	-	-	-	NKX2-5	HGNC:2488	Conotruncal heart malformations, variable, 217095 (3)	-	-	-	-	-	-	-	nonlethal	ambiguous|lethal|nonlethal	lethal|nonlethal	LU	LU	post-infant-lethal
217095	CONOTRUNCAL HEART MALFORMATIONS	Conotruncal heart malformations, 217095 (3)	Conotruncal heart malformations	n	-	-	-	NKX2-6	HGNC:32940	Conotruncal heart malformations, 217095 (3)	-	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
217095	CONOTRUNCAL HEART MALFORMATIONS	Persistent truncus arteriosus, 217095 (3)	Persistent truncus arteriosus	n	-	-	-	NKX2-6	HGNC:32940	Persistent truncus arteriosus, 217095 (3)	-	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
217095	CONOTRUNCAL HEART MALFORMATIONS	Conotruncal anomaly face syndrome, 217095 (3)	Conotruncal anomaly face syndrome	n	-	-	-	TBX1	HGNC:11592	Conotruncal anomaly face syndrome, 217095 (3)	-	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L2	L2	pre-infant-lethal
217300	CORNEA PLANA 2, AUTOSOMAL RECESSIVE	Cornea plana 2, autosomal recessive, 217300 (3)	Cornea plana 2, autosomal recessive	n	-	-	-	KERA	HGNC:6309	Cornea plana 2, autosomal recessive, 217300 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
217400	CORNEAL DYSTROPHY AND PERCEPTIVE DEAFNESS	Corneal endothelial dystrophy and perceptive deafness, 217400 (3)	Corneal endothelial dystrophy and perceptive deafness	n	-	-	-	SLC4A11	HGNC:16438	Corneal endothelial dystrophy and perceptive deafness, 217400 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
217700	CORNEAL ENDOTHELIAL DYSTROPHY	Corneal endothelial dystrophy, autosomal recessive, 217700 (3)	Corneal endothelial dystrophy, autosomal recessive	n	-	-	-	SLC4A11	HGNC:16438	Corneal endothelial dystrophy, autosomal recessive, 217700 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
217800	MACULAR DYSTROPHY, CORNEAL	Macular corneal dystrophy, 217800 (3)	Macular corneal dystrophy	n	-	-	-	CHST6	HGNC:6938	Macular corneal dystrophy, 217800 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
218000	AGENESIS OF THE CORPUS CALLOSUM WITH PERIPHERAL NEUROPATHY	Agenesis of the corpus callosum with peripheral neuropathy, 218000 (3)	Agenesis of the corpus callosum with peripheral neuropathy	y	AGENESIS OF THE CORPUS CALLOSUM WITH PERIPHERAL NEUROPATHY; ACCPN	Clinical Synopsis	death|deaths	SLC12A6	HGNC:10914	Agenesis of the corpus callosum with peripheral neuropathy, 218000 (3), Autosomal recessive	Autosomal recessive	n	y	[Death in third or fourth decades, usually due to respiratory infection]	L6	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L6	L6	post-infant-lethal
218030	APPARENT MINERALOCORTICOID EXCESS	Apparent mineralocorticoid excess, 218030 (3)	Apparent mineralocorticoid excess	n	-	-	-	HSD11B2	HGNC:5209	Apparent mineralocorticoid excess, 218030 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
218040	COSTELLO SYNDROME	Congenital myopathy with excess of muscle spindles, 218040 (3)	Congenital myopathy with excess of muscle spindles	y	COSTELLO SYNDROME; CSTLO	Clinical Features|Clinical Synopsis|Diagnosis	death|deaths|died	HRAS	HGNC:5173	Congenital myopathy with excess of muscle spindles, 218040 (3), Autosomal dominant	Autosomal dominant	y	y	[Lin et al. (2011) reviewed the cardiac features of 61 patients with Costello syndrome ranging in age from 1 month to 40 years, with 13 patients over age 18 years. Cardiovascular abnormalities were present in 85% of patients. The most common finding was hypertrophic cardiomyopathy (HCM), typically subaortic septal hypertrophy, which was present in 37 (61%) of the 61 patients. Among these patients, HCM was chronic or progressive in 14 (38%), stabilized in 11 (37%), regressed in 4 (11%), and was unknown in 8 (22%). A congenital heart defect was present in 27 (44%) of the 61 patients, most commonly nonprogressive valvar pulmonary stenosis. Arrhythmia occurred in 34 (56%) patients, atrial tachycardia in 15 (25%), and aortic dilation in 4 (7%). The cardiac features of 85 patients with HRAS mutations from the literature were also assessed. Congenital heart disease was present in 22% of patients, HCM in 68%, arrhythmia in 40%, atrial tachycardia in 7%, and aortic dilation in 1 patient. Cardiac tissue showed myocardial fiber disarray in 7 (70%) of 10 specimens, consistent with sarcomeric dysfunction. Ten (43%) of 23 deaths among both cohorts occurred in infants less than 1 year of age, and most of these deaths were cardiac-related / Kuniba et al. (2009) provided a case report of a Japanese fetus with severe Costello syndrome diagnosed using prenatal 3-dimensional ultrasonography at 23 weeks' gestation. Findings at that time included polyhydramnios, severe overgrowth (+5.3 SD using a Japanese fetal growth curve), and dysmorphic craniofacial features, such as large head, pointed chin, broad nasal bridge, and low-set ears. In addition, the wrists showed lateral deviation and flexion. Molecular analysis via amniocentesis identified an uncommon G12D mutation in the HRAS gene (190020.0013). After birth, he developed respiratory failure, severe hypoglycemia, cardiac hypertrophy, and renal failure, and died soon after birth]	L2	y	-	lethal	lethal	lethal	L2	L2	pre-infant-lethal
218040	COSTELLO SYNDROME	Costello syndrome, 218040 (3)	Costello syndrome	y	COSTELLO SYNDROME; CSTLO	Clinical Features|Clinical Synopsis|Diagnosis	death|deaths|died	HRAS	HGNC:5173	Costello syndrome, 218040 (3), Autosomal dominant	Autosomal dominant	y	y	[Lin et al. (2011) reviewed the cardiac features of 61 patients with Costello syndrome ranging in age from 1 month to 40 years, with 13 patients over age 18 years. Cardiovascular abnormalities were present in 85% of patients. The most common finding was hypertrophic cardiomyopathy (HCM), typically subaortic septal hypertrophy, which was present in 37 (61%) of the 61 patients. Among these patients, HCM was chronic or progressive in 14 (38%), stabilized in 11 (37%), regressed in 4 (11%), and was unknown in 8 (22%). A congenital heart defect was present in 27 (44%) of the 61 patients, most commonly nonprogressive valvar pulmonary stenosis. Arrhythmia occurred in 34 (56%) patients, atrial tachycardia in 15 (25%), and aortic dilation in 4 (7%). The cardiac features of 85 patients with HRAS mutations from the literature were also assessed. Congenital heart disease was present in 22% of patients, HCM in 68%, arrhythmia in 40%, atrial tachycardia in 7%, and aortic dilation in 1 patient. Cardiac tissue showed myocardial fiber disarray in 7 (70%) of 10 specimens, consistent with sarcomeric dysfunction. Ten (43%) of 23 deaths among both cohorts occurred in infants less than 1 year of age, and most of these deaths were cardiac-related / Kuniba et al. (2009) provided a case report of a Japanese fetus with severe Costello syndrome diagnosed using prenatal 3-dimensional ultrasonography at 23 weeks' gestation. Findings at that time included polyhydramnios, severe overgrowth (+5.3 SD using a Japanese fetal growth curve), and dysmorphic craniofacial features, such as large head, pointed chin, broad nasal bridge, and low-set ears. In addition, the wrists showed lateral deviation and flexion. Molecular analysis via amniocentesis identified an uncommon G12D mutation in the HRAS gene (190020.0013). After birth, he developed respiratory failure, severe hypoglycemia, cardiac hypertrophy, and renal failure, and died soon after birth]	L2	y	-	lethal	lethal	lethal	L2	L2	pre-infant-lethal
218330	CRANIOECTODERMAL DYSPLASIA 1	Cranioectodermal dysplasia 1, 218330 (3)	Cranioectodermal dysplasia 1	y	CRANIOECTODERMAL DYSPLASIA 1; CED1	Clinical Features|Clinical Synopsis|Phenotype	death|deaths|died|lethal|miscarriage|miscarriages|die|spontaneous_abortion|spontaneous_abortions	IFT122	HGNC:13556	Cranioectodermal dysplasia 1, 218330 (3), Autosomal recessive	Autosomal recessive	y	y	[Tsurusaki et al. (2014) reported a family in which the mother had 4 miscarriages that occurred between 6 weeks' and 8 weeks' gestation (II-3 to II-6), 1 intrauterine death with hydrops at 13 weeks' gestation (II-7), and 2 terminated pregnancies (II-1 and II-8), due to hydrops at 13 weeks' gestation and skeletal anomalies at 21 weeks' gestation, respectively]	L1	y	-	lethal	lethal	lethal	L1	L1	pre-infant-lethal
218340	TEMTAMY SYNDROME	Temtamy syndrome, 218340 (3)	Temtamy syndrome	y	TEMTAMY SYNDROME; TEMTYS	Clinical Features	died	C12orf57	HGNC:29521	Temtamy syndrome, 218340 (3), Autosomal recessive	Autosomal recessive	n	y	[Among the 6 children of a first-cousin marriage, Temtamy et al. (1991) observed a boy and 2 girls with a syndrome consisting of craniofacial dysmorphism, absent corpus callosum, and iris coloboma. Two of the 3 sibs had aortic dilatation with aortic regurgitation, and one had moderate mental retardation. The craniofacial anomalies consisted of macrodolichocephaly, arched eyebrows, antimongoloid slant of the eyes, beaked nose, low-set and simple lop ears, long philtrum, short upper lip, and micrognathia. In conjunction with the 'keyhole' coloboma of the iris, retina, and choroid, the lenses were dislocated upward and there was myopia and hypertelorism. Electron microscopy of the gingiva showed widening of the intercellular space, thickness of collagen fibers, and lack of periodicity. The sister, who died at age 22 years from heart failure, had moderate dilatation of the aorta, myocardial impairment, and bulbous thumbs]	L6	y	-	lethal	lethal	lethal	L6	L6	post-infant-lethal
218400	CRANIOMETAPHYSEAL DYSPLASIA, AUTOSOMAL RECESSIVE	Craniometaphyseal dysplasia, autosomal recessive, 218400 (3)	Craniometaphyseal dysplasia, autosomal recessive	n	-	-	-	GJA1	HGNC:4274	Craniometaphyseal dysplasia, autosomal recessive, 218400 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
218600	BALLER-GEROLD SYNDROME	Baller-Gerold syndrome, 218600 (3)	Baller-Gerold syndrome	n	-	-	-	RECQL4	HGNC:9949	Baller-Gerold syndrome, 218600 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L4	L4	post-infant-lethal
218700	HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 2	Hypothyroidism, congenital, due to thyroid dysgenesis or hypoplasia, 218700 (3)	Hypothyroidism, congenital, due to thyroid dysgenesis or hypoplasia	n	-	-	-	PAX8	HGNC:8622	Hypothyroidism, congenital, due to thyroid dysgenesis or hypoplasia, 218700 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
219000	FRASER SYNDROME 1	Fraser syndrome 1, 219000 (3)	Fraser syndrome 1	y	FRASER SYNDROME 1; FRASRS1	Clinical Features|Clinical Synopsis|Phenotype	death|deaths|stillbirth|stillbirths|stillborn|die|lethal	FRAS1	HGNC:19185	Fraser syndrome 1, 219000 (3), Autosomal recessive	Autosomal recessive	n	y	[Twenty-five percent of affected babies are stillborn]	L1	y	-	lethal	lethal	lethal	L1	L1	pre-infant-lethal
219050	CRYPTORCHIDISM, UNILATERAL OR BILATERAL	Cryptorchidism, 219050 (3)	Cryptorchidism	n	-	-	-	INSL3	HGNC:6086	Cryptorchidism, 219050 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
219100	CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IA	Cutis laxa, autosomal recessive, type IA, 219100 (3)	Cutis laxa, autosomal recessive, type IA	y	CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IA; ARCL1A	Clinical Features	death|deaths|died	FBLN5	HGNC:3602	Cutis laxa, autosomal recessive, type IA, 219100 (3), Autosomal recessive	Autosomal recessive	y	y	[Dallaire et al. (1976) reported a leprechaunoid disorder in 3 male infants from 2 related and consanguineous pairs of parents of Italian origin. Many of the features suggested cutis laxa. All 3 boys died in the first year of life of severe cardiopulmonary complications]	L3	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L3	L3	pre-infant-lethal
219150	CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIIA	Cutis laxa, autosomal recessive, type IIIA, 219150 (3)	Cutis laxa, autosomal recessive, type IIIA	y	CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIIA; ARCL3A	Clinical Features	died	ALDH18A1	HGNC:9722	Cutis laxa, autosomal recessive, type IIIA, 219150 (3), Autosomal recessive	Autosomal recessive	y	y	[Fischer et al. (2014) reported 2 patients with classic features of de Barsy syndrome. The female patient was the first child of a consanguineous Tunisian couple. She exhibited intrauterine growth restriction, and at age 18 months had disseminated tremors. She had no structural brain abnormalities. Craniofacial dysmorphic features included a triangular face, malar hypoplasia, prognathism, and prominent ears, leading to a prematurely aged appearance. She had mild cataract as well as thin, lax, and wrinkled skin at the abdomen and the dorsum of hands and feet. Visibility of veins was also observed. She had hand and foot contractures, hypotonia, kyphosis, bilateral hearing loss, and cardiovascular problems, including ventricular septal defect, atrial septal defect (ostium secundum type), patent ductus arteriosus, and persistence of superior left vena cava. The second patient was the male offspring of a consanguineous Turkish couple. He had intrauterine growth restriction and agenesis of the corpus callosum. He presented with seizures and had a typical facial gestalt, prominent ears, and corneal clouding. He had remarkably thin, translucent, lax, and wrinkled skin as well as a narrow aortic arch without a clear stenosis. He died at 3 months of age due to progressive respiratory failure and urosepsis]	L3	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L3|L4	L3	pre-infant-lethal
219200	CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIA	Cutis laxa, autosomal recessive, type IIA, 219200 (3)	Cutis laxa, autosomal recessive, type IIA	y	CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIA; ARCL2A	Clinical Features	lethal	ATP6V0A2	HGNC:18481	Cutis laxa, autosomal recessive, type IIA, 219200 (3), Autosomal recessive	Autosomal recessive	y	n	-	-	-	-	ambiguous	ambiguous|nonlethal	ambiguous	-	-	-
219500	CYSTATHIONINURIA	Cystathioninuria, 219500 (3)	Cystathioninuria	n	-	-	-	CTH	HGNC:2501	Cystathioninuria, 219500 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
219700	CYSTIC FIBROSIS	Cystic fibrosis, 219700 (3)	Cystic fibrosis	y	CYSTIC FIBROSIS; CF	Clinical Features|Diagnosis	death|deaths|lethal	CFTR	HGNC:1884	Cystic fibrosis, 219700 (3), Autosomal recessive	Autosomal recessive	y	y	[In 149 CF patients, different MBL genotypes were compared with respect to lung function, microbiology, and survival to end-stage CF (death or lung transplantation)]	LU	y	-	lethal	lethal|nonlethal	lethal|nonlethal	LU	LU	post-infant-lethal
219730	VENTRICULOMEGALY WITH CYSTIC KIDNEY DISEASE	Ventriculomegaly with cystic kidney disease, 219730 (3)	Ventriculomegaly with cystic kidney disease	y	VENTRICULOMEGALY WITH CYSTIC KIDNEY DISEASE; VMCKD	Clinical Features	died|stillborn	CRB2	HGNC:18688	Ventriculomegaly with cystic kidney disease, 219730 (3), Autosomal recessive	Autosomal recessive	n	y	[Reuss et al. (1989) described a family in which in 2 consanguineous relationships a Cape Verdean man fathered 2 normal children and 6 infants or fetuses with hydrocephaly and cystic disease of the corticomedullary areas of the kidneys. All 6 affected infants were detected prenatally. The first was found at 32 weeks' gestation to have ventriculomegaly, normal-sized but echodense kidneys, and increased amniotic fluid, and was born stillborn at 32 weeks' gestation]	L1	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L1	L1	pre-infant-lethal
219750	CYSTINOSIS, ADULT NONNEPHROPATHIC	Cystinosis, ocular nonnephropathic, 219750 (3)	Cystinosis, ocular nonnephropathic	n	-	-	-	CTNS	HGNC:2518	Cystinosis, ocular nonnephropathic, 219750 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
219800	CYSTINOSIS, NEPHROPATHIC	Cystinosis, atypical nephropathic, 219800 (3)	Cystinosis, atypical nephropathic	n	-	-	-	CTNS	HGNC:2518	Cystinosis, atypical nephropathic, 219800 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
219800	CYSTINOSIS, NEPHROPATHIC	Cystinosis, nephropathic, 219800 (3)	Cystinosis, nephropathic	n	-	-	-	CTNS	HGNC:2518	Cystinosis, nephropathic, 219800 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
219900	CYSTINOSIS, LATE-ONSET JUVENILE OR ADOLESCENT NEPHROPATHIC TYPE	Cystinosis, late-onset juvenile or adolescent nephropathic, 219900 (3)	Cystinosis, late-onset juvenile or adolescent nephropathic	n	-	-	-	CTNS	HGNC:2518	Cystinosis, late-onset juvenile or adolescent nephropathic, 219900 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
220100	CYSTINURIA	Cystinuria, 220100 (3)	Cystinuria	y	CYSTINURIA	Clinical Features	died	SLC3A1	HGNC:11025	Cystinuria, 220100 (3), Autosomal dominant, Autosomal recessive	Autosomal dominant, Autosomal recessive	n	n	-	-	-	-	ambiguous	ambiguous	ambiguous	-	-	-
220100	CYSTINURIA	Cystinuria, 220100 (3)	Cystinuria	y	CYSTINURIA	Clinical Features	died	SLC7A9	HGNC:11067	Cystinuria, 220100 (3), Autosomal dominant, Autosomal recessive	Autosomal dominant, Autosomal recessive	n	n	-	-	-	-	ambiguous	ambiguous	ambiguous	-	-	-
220110	MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 1	Mitochondrial complex IV deficiency, nuclear type 1, 220110 (3)	Mitochondrial complex IV deficiency, nuclear type 1	y	MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 1; MC4DN1	Description|Clinical Features|Clinical Synopsis|Phenotype	death|deaths|died|fatal	SURF1	HGNC:11474	Mitochondrial complex IV deficiency, nuclear type 1, 220110 (3), Autosomal recessive	Autosomal recessive	y	y	[Muller-Hocker et al. (1983) studied 2 Turkish sisters who developed apathy, failure of suckling, and generalized progressive muscular hypotonia in the newborn period and died at age 7 weeks]	L3	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L1|L3	L1	pre-infant-lethal
220110	MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 1	Mitochondrial complex IV deficiency, nuclear type 1, 220110 (3)	Mitochondrial complex IV deficiency, nuclear type 1	y	MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 1; MC4DN1	Description|Clinical Features|Clinical Synopsis|Phenotype	death|deaths|died|fatal	SURF1	HGNC:11474	Mitochondrial complex IV deficiency, nuclear type 1, 220110 (3), Autosomal recessive	Autosomal recessive	y	y	[Muller-Hocker et al. (1983) studied 2 Turkish sisters who developed apathy, failure of suckling, and generalized progressive muscular hypotonia in the newborn period and died at age 7 weeks / Bakker et al. (1996) reported a boy, the second child of nonconsanguineous parents, who was born after a term pregnancy and normal delivery. It was the third pregnancy of the mother: the first ended at 19 weeks with death in utero of twins; the second ended at term with the birth of a healthy boy]	L1	y	y	lethal	lethal|nonlethal	lethal|nonlethal	L1|L3	L1	pre-infant-lethal
220111	MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 5	Mitochondrial complex IV deficiency, nuclear type 5, (French-Canadian), 220111 (3)	Mitochondrial complex IV deficiency, nuclear type 5, (French-Canadian)	y	MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 5; MC4DN5	Description|Clinical Features|Clinical Synopsis	death|deaths|died	LRPPRC	HGNC:15714	Mitochondrial complex IV deficiency, nuclear type 5, (French-Canadian), 220111 (3), Autosomal recessive	Autosomal recessive	y	y	[Debray et al. (2011) retrospectively reviewed the clinical course of 56 patients with genetically confirmed French Canadian Leigh syndrome. The median age at onset was 5 months, and patients presented with neonatal distress, psychomotor delay, failure to thrive, ataxia, and acute metabolic acidosis. Other features during the neonatal period included hypotonia (58%), transient tachypnea of the newborn (47%), poor sucking (44%), tremor (28%), and hypoglycemia (17%). There were mild craniofacial features such as prominent forehead, midfacial hypoplasia, broad nasal bridge, hypertelorism, hirsutism, and arched eyebrows. All had developmental and language delay. Older ambulatory patients had truncal ataxia with wide-based gait and mild intention tremor. Most (90%) had 1 or more episodes of acute metabolic and/or neurologic decompensation, most of which (82%) resulted in death at a median age of 1.6 years]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
220120	D-GLYCERIC ACIDURIA	D-glyceric aciduria, 220120 (3)	D-glyceric aciduria	y	D-GLYCERIC ACIDURIA	Description|Clinical Features	death|deaths|died	GLYCTK	HGNC:24247	D-glyceric aciduria, 220120 (3), Autosomal recessive	Autosomal recessive	n	y	[In the son of nonconsanguineous Serbian parents, Brandt et al. (1974, 1976) described nonketotic hyperglycinemia with the excretion of D-glyceric acid in the urine and the presence of this substance in the serum. Clinical features included neonatal hypotonia, delayed psychomotor development, mental retardation, and seizures. He died at age 3.5 years (Duran et al., 1987; Sass et al., 2010)]	L4	y	-	lethal	lethal	lethal	L4	L4	post-infant-lethal
220150	HYPOURICEMIA, RENAL, 1	Hypouricemia, renal, 220150 (3)	Hypouricemia, renal	y	HYPOURICEMIA, RENAL, 1; RHUC1	Description	lethal	SLC22A12	HGNC:17989	Hypouricemia, renal, 220150 (3), Autosomal recessive	Autosomal recessive	n	n	-	-	-	-	ambiguous	ambiguous	ambiguous	-	-	-
220210	RITSCHER-SCHINZEL SYNDROME 1	Ritscher-Schinzel syndrome 1, 220210 (3)	Ritscher-Schinzel syndrome 1	y	RITSCHER-SCHINZEL SYNDROME 1; RTSC1	Clinical Features	died|lethal|stillborn	WASHC5	HGNC:28984	Ritscher-Schinzel syndrome 1, 220210 (3), Autosomal recessive	Autosomal recessive	y	y	[Stevens and Lachman (2010) described 2 sibs, a stillborn male born at 27 weeks' gestation and a female born at 31 weeks' gestation who died at 7 days of age, with a phenotype characterized by Dandy-Walker malformation, congenital heart defects, joint contractures, genital hypoplasia, distinctive facial features, rhizomelic and mesomelic limb shortening, hooked clavicles, dumbbell femurs, and absent talus and calcaneus ossification]	L1	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L1	L1	pre-infant-lethal
220400	JERVELL AND LANGE-NIELSEN SYNDROME 1	Jervell and Lange-Nielsen syndrome, 220400 (3)	Jervell and Lange-Nielsen syndrome	y	JERVELL AND LANGE-NIELSEN SYNDROME 1; JLNS1	Description|Clinical Features|Clinical Synopsis	death|deaths|died	KCNQ1	HGNC:6294	Jervell and Lange-Nielsen syndrome, 220400 (3), Autosomal recessive	Autosomal recessive	y	y	[Jervell and Lange-Nielsen (1957) reported a family in which 4 of 6 children, born to unrelated parents, had congenital deafness and prolonged QT interval and died suddenly in childhood]	L4	y	-	lethal	lethal	lethal	L4|L5|L6|LU	L4	post-infant-lethal
220500	DEAFNESS, ONYCHODYSTROPHY, OSTEODYSTROPHY, IMPAIRED INTELLECTUAL DEVELOPMENT, AND SEIZURES SYNDROME	DOORS syndrome, 220500 (3)	DOORS syndrome	y	DEAFNESS, ONYCHODYSTROPHY, OSTEODYSTROPHY, IMPAIRED INTELLECTUAL DEVELOPMENT, AND SEIZURES SYNDROME; DOORS	Clinical Features	death|deaths|die|died|lethal	TBC1D24	HGNC:29203	DOORS syndrome, 220500 (3), Autosomal recessive	Autosomal recessive	y	y	[Eronen et al. (1985) reported a constellation of features in a male infant who had 2 double first cousins, females, who had died with the same disorder. The patients had absence of the distal phalanges and nails of all 10 digits, cystic dysplasia of the kidneys, and dilated right cerebral ventricle. The 2 cousins died at age 2 years and 2 hours, respectively / Le Merrer et al. (1992) described this syndrome in 2 unrelated children. Absence or hypoplasia of the distal phalanges of the toes and fingers was a particularly striking feature. Expression of the renal and cerebral manifestations was variable. One patient had seizures with abnormal EEG and a double kidney with 2 ureters and 2 renal arteries; he died at the age of 6 months. Both patients showed a large nose with wide nasal tip]	L2	n	y	lethal	lethal|nonlethal	lethal|nonlethal	L2|L3	L2	pre-infant-lethal
221200	DEAFNESS AND MYOPIA	Deafness and myopia, 221200 (3)	Deafness and myopia	n	-	-	-	SLITRK6	HGNC:23503	Deafness and myopia, 221200 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
221750	PITUITARY HORMONE DEFICIENCY, COMBINED, 3	Pituitary hormone deficiency, combined, 3, 221750 (3)	Pituitary hormone deficiency, combined, 3	n	-	-	-	LHX3	HGNC:6595	Pituitary hormone deficiency, combined, 3, 221750 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
221770	POLYCYSTIC LIPOMEMBRANOUS OSTEODYSPLASIA WITH SCLEROSING LEUKOENCEPHALOPATHY 1	Polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy 1, 221770 (3)	Polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy 1	y	POLYCYSTIC LIPOMEMBRANOUS OSTEODYSPLASIA WITH SCLEROSING LEUKOENCEPHALOPATHY 1; PLOSL1	Description|Clinical Features|Clinical Synopsis	death|deaths|die	TYROBP	HGNC:12449	Polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy 1, 221770 (3), Autosomal recessive	Autosomal recessive	y	y	[The disorder usuallly leads to death in the fifth decade of life (summary by Kondo et al., 2002)]	L6	y	-	lethal	lethal	lethal	L6	L6	post-infant-lethal
221820	LEUKOENCEPHALOPATHY, HEREDITARY DIFFUSE, WITH SPHEROIDS 1	Leukoencephalopathy, diffuse hereditary, with spheroids 1, 221820 (3)	Leukoencephalopathy, diffuse hereditary, with spheroids 1	y	LEUKOENCEPHALOPATHY, HEREDITARY DIFFUSE, WITH SPHEROIDS 1; HDLS1	Description|Clinical Features|Clinical Synopsis	die|death|deaths|died	CSF1R	HGNC:2433	Leukoencephalopathy, diffuse hereditary, with spheroids 1, 221820 (3), Autosomal dominant	Autosomal dominant	y	y	[Rademakers et al. (2012) reported 14 families with HDLS, including those reported previously by Swerdlow et al. (2009) and Baba et al. (2006). Clinical features of 24 affected individuals showed that the mean age at onset was 47.2 years (range, 18-78 years), with a mean age of death at 57.2 years (range, 40-84 years]	L6	y	-	lethal	lethal	lethal	L3|L6	L3	pre-infant-lethal
221900	PERSISTENT HYPERPLASTIC PRIMARY VITREOUS, AUTOSOMAL RECESSIVE	Persistent hyperplastic primary vitreous, autosomal recessive, 221900 (3)	Persistent hyperplastic primary vitreous, autosomal recessive	n	-	-	-	ATOH7	HGNC:13907	Persistent hyperplastic primary vitreous, autosomal recessive, 221900 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
222300	WOLFRAM SYNDROME 1	Wolfram syndrome 1, 222300 (3)	Wolfram syndrome 1	y	WOLFRAM SYNDROME 1; WFS1	Clinical Features|Phenotype	died|death|deaths	WFS1	HGNC:12762	Wolfram syndrome 1, 222300 (3), Autosomal recessive	Autosomal recessive	y	y	[Hardy et al. (1999) and Sam et al. (2001) described Wolfram syndrome with a distinctive phenotype, namely, central respiratory failure. All of the patients were homozygous for a 4-bp deletion at position 2648-2651 in exon 8 of the WFS1 gene (606201.0012). In the patient with the 4-bp deletion reported by Hardy et al. (1999), there was severe brainstem atrophy and central respiratory failure requiring tracheostomy. Her affected sister had died at age 28 from brainstem atrophy and central respiratory failure]	L6	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L6	L6	post-infant-lethal
222448	DONNAI-BARROW SYNDROME	Donnai-Barrow syndrome, 222448 (3)	Donnai-Barrow syndrome	y	DONNAI-BARROW SYNDROME; DBS	Clinical Features	death|deaths|died	LRP2	HGNC:6694	Donnai-Barrow syndrome, 222448 (3), Autosomal recessive	Autosomal recessive	y	y	[Gripp et al. (1997) described a male infant, the offspring of first-cousin parents from Saudi Arabia, who had wide anterior fontanel and metopic suture with frontal bossing, hypertelorism, downslanting palpebral fissures, bilateral iris coloboma, omphalocele, and bilateral absence of the diaphragm with herniation of internal organs causing pulmonary hypoplasia and death]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
222470	TRICHOHEPATOENTERIC SYNDROME 1	Trichohepatoenteric syndrome 1, 222470 (3)	Trichohepatoenteric syndrome 1	y	TRICHOHEPATOENTERIC SYNDROME 1; THES1	Clinical Features|Clinical Synopsis|Phenotype	death|deaths|died|fatal	SKIC3	HGNC:23639	Trichohepatoenteric syndrome 1, 222470 (3), Autosomal recessive	Autosomal recessive	y	y	[Often fatal due in infancy due to intractable diarrhea / Stankler et al. (1982) reported a seemingly 'new,' presumably autosomal recessive disorder in a sister and brother who died at 33 and 87 days of age, respectively, with severe unexplained diarrhea]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
222600	DIASTROPHIC DYSPLASIA	Diastrophic dysplasia, 222600 (3)	Diastrophic dysplasia	y	DIASTROPHIC DYSPLASIA; DTD	Clinical Features	death|deaths|died|lethal	SLC26A2	HGNC:10994	Diastrophic dysplasia, 222600 (3), Autosomal recessive	Autosomal recessive	n	y	[Gustavson et al. (1985) studied 14 cases of DTD, including 3 pairs of sibs. Six died shortly after birth of respiratory and circulatory insufficiency]	L2	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L1|L2	L1	pre-infant-lethal
222600	DIASTROPHIC DYSPLASIA	Diastrophic dysplasia, broad bone-platyspondylic variant, 222600 (3)	Diastrophic dysplasia, broad bone-platyspondylic variant	y	DIASTROPHIC DYSPLASIA; DTD	Clinical Features	death|deaths|died|lethal	SLC26A2	HGNC:10994	Diastrophic dysplasia, broad bone-platyspondylic variant, 222600 (3), Autosomal recessive	Autosomal recessive	n	y	[Gustavson et al. (1985) studied 14 cases of DTD, including 3 pairs of sibs. Six died shortly after birth of respiratory and circulatory insufficiency]	L2	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L1|L2	L1	pre-infant-lethal
222700	LYSINURIC PROTEIN INTOLERANCE	Lysinuric protein intolerance, 222700 (3)	Lysinuric protein intolerance	y	LYSINURIC PROTEIN INTOLERANCE; LPI	Clinical Features	death|deaths|died	SLC7A7	HGNC:11065	Lysinuric protein intolerance, 222700 (3), Autosomal recessive	Autosomal recessive	n	y	[McManus et al. (1996) reported a 21-year-old woman who had presented at 8 months of age with persistent vomiting and failure to thrive.... She died despite intensive therapy, including intravenous arginine for the hyperammonemia. Postmortem examination revealed hepatic micronodular cirrhosis with extensive fatty changes]	LU	y	-	lethal	lethal	lethal	LU	LU	post-infant-lethal
222730	DICARBOXYLIC AMINOACIDURIA	Dicarboxylic aminoaciduria, 222730 (3)	Dicarboxylic aminoaciduria	n	-	-	-	SLC1A1	HGNC:10939	Dicarboxylic aminoaciduria, 222730 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
222748	DIHYDROPYRIMIDINASE DEFICIENCY	Dihydropyrimidinuria, 222748 (3)	Dihydropyrimidinuria	y	DIHYDROPYRIMIDINASE DEFICIENCY; DPYSD	Clinical Features	died	DPYS	HGNC:3013	Dihydropyrimidinuria, 222748 (3), Autosomal recessive	Autosomal recessive	y	y	[Assmann et al. (1997) described a boy, born of consanguineous Turkish parents, who suffered from intractable diarrhea due to congenital microvillus atrophy (251850). He developed severe cholestasis starting at 2 weeks of age and leading to liver cirrhosis. He died of septicemia at the age of 7 months]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
222765	RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 2	Rhizomelic chondrodysplasia punctata, type 2, 222765 (3)	Rhizomelic chondrodysplasia punctata, type 2	y	RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 2; RCDP2	Description|Clinical Features	die|died	GNPAT	HGNC:4416	Rhizomelic chondrodysplasia punctata, type 2, 222765 (3), Autosomal recessive	Autosomal recessive	y	y	[Wanders et al. (1992) described a patient showing all the clinical features of rhizomelic chondrodysplasia punctata but lacking the classic tetrad of biochemical abnormalities: impairment of plasmalogen biosynthesis, elevated phytanic acid, deficiency of alkyl-dihydroxyacetonephosphate synthase, and an abnormal molecular form of peroxisomal thiolase. Instead the patient was found to have an isolated deficiency of dihydroxyacetonephosphate acyltransferase (DHAPAT). The patient (sex not stated) had a low/broad nasal bridge and anteverted nostrils, cataracts, and pronounced rhizomelic shortening, especially of the arms. The patient died at 6 months after a course complicated by frequent infections]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
222800	ERYTHROCYTOSIS, FAMILIAL, 8	Erythrocytosis, familial, 8, 222800 (3)	Erythrocytosis, familial, 8	n	-	-	-	BPGM	HGNC:1093	Erythrocytosis, familial, 8, 222800 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
222900	SUCRASE-ISOMALTASE DEFICIENCY, CONGENITAL	Sucrase-isomaltase deficiency, congenital, 222900 (3)	Sucrase-isomaltase deficiency, congenital	n	-	-	-	SI	HGNC:10856	Sucrase-isomaltase deficiency, congenital, 222900 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
223000	LACTASE DEFICIENCY, CONGENITAL	Lactase deficiency, congenital, 223000 (3)	Lactase deficiency, congenital	y	LACTASE DEFICIENCY, CONGENITAL	Clinical Features	death|deaths	LCT	HGNC:6530	Lactase deficiency, congenital, 223000 (3), Autosomal recessive	Autosomal recessive	y	n	-	-	-	-	ambiguous	ambiguous	ambiguous	-	-	-
223100	LACTOSE INTOLERANCE, ADULT TYPE	Lactase persistence/nonpersistence, 223100 (3)	Lactase persistence/nonpersistence	y	LACTOSE INTOLERANCE, ADULT TYPE	Phenotype	death|deaths	MCM6	HGNC:6949	Lactase persistence/nonpersistence, 223100 (3), Autosomal dominant	Autosomal dominant	y	n	-	-	-	-	ambiguous	ambiguous	ambiguous	-	-	-
223360	ORTHOSTATIC HYPOTENSION 1	Orthostatic hypotension 1, due to DBH deficiency, 223360 (3)	Orthostatic hypotension 1, due to DBH deficiency	n	-	-	-	DBH	HGNC:2689	Orthostatic hypotension 1, due to DBH deficiency, 223360 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
223800	DYGGVE-MELCHIOR-CLAUSEN DISEASE	Dyggve-Melchior-Clausen disease, 223800 (3)	Dyggve-Melchior-Clausen disease	n	-	-	-	DYM	HGNC:21317	Dyggve-Melchior-Clausen disease, 223800 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
223900	NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE III	Dysautonomia, familial, 223900 (3)	Dysautonomia, familial	y	NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE III; HSAN3	Description	fatal	ELP1	HGNC:5959	Dysautonomia, familial, 223900 (3), Autosomal recessive	Autosomal recessive	y	y	[The disorder is inevitably fatal, with only 50% of patients reaching 40 years of age]	LU	y	-	lethal	lethal	lethal	LU	LU	post-infant-lethal
224050	CEREBELLAR ATAXIA, IMPAIRED INTELLECTUAL DEVELOPMENT, AND DYSEQUILIBRIUM SYNDROME 1	Cerebellar hypoplasia, impaired intellectual development, and dysequilibrium syndrome 1, 224050 (3)	Cerebellar hypoplasia, impaired intellectual development, and dysequilibrium syndrome 1	n	-	-	-	VLDLR	HGNC:12698	Cerebellar hypoplasia, impaired intellectual development, and dysequilibrium syndrome 1, 224050 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
224100	ANEMIA, CONGENITAL DYSERYTHROPOIETIC, TYPE II	Dyserythropoietic anemia, congenital, type II, 224100 (3)	Dyserythropoietic anemia, congenital, type II	n	-	-	-	SEC23B	HGNC:10702	Dyserythropoietic anemia, congenital, type II, 224100 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
224120	ANEMIA, CONGENITAL DYSERYTHROPOIETIC, TYPE Ia	Dyserythropoietic anemia, congenital, type Ia, 224120 (3)	Dyserythropoietic anemia, congenital, type Ia	n	-	-	-	CDAN1	HGNC:1713	Dyserythropoietic anemia, congenital, type Ia, 224120 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
224410	DYSSEGMENTAL DYSPLASIA, SILVERMAN-HANDMAKER TYPE	Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3)	Dyssegmental dysplasia, Silverman-Handmaker type	y	DYSSEGMENTAL DYSPLASIA, SILVERMAN-HANDMAKER TYPE; DDSH	Description|Clinical Features|Clinical Synopsis	lethal	HSPG2	HGNC:5273	Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive	Autosomal recessive	y	y	[Neonatal lethal]	L2	y	-	lethal	ambiguous|lethal	lethal	L2	L2	pre-infant-lethal
224500	DYSTONIA 2, TORSION, AUTOSOMAL RECESSIVE	Dystonia 2, torsion, autosomal recessive, 224500 (3)	Dystonia 2, torsion, autosomal recessive	n	-	-	-	HPCA	HGNC:5144	Dystonia 2, torsion, autosomal recessive, 224500 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
224690	MEIER-GORLIN SYNDROME 1	Meier-Gorlin syndrome 1, 224690 (3)	Meier-Gorlin syndrome 1	y	MEIER-GORLIN SYNDROME 1; MGORS1	Phenotype	lethal	ORC1	HGNC:8487	Meier-Gorlin syndrome 1, 224690 (3), Autosomal recessive	Autosomal recessive	n	y	[a lethal phenotype was observed in 4 compound heterozygous individuals, 2 with mutations in ORC1 and 2 with mutations in CDT1]	LU	y	-	lethal	lethal	lethal	LU	LU	post-infant-lethal
224750	SCHOPF-SCHULZ-PASSARGE SYNDROME	Schopf-Schulz-Passarge syndrome, 224750 (3)	Schopf-Schulz-Passarge syndrome	n	-	-	-	WNT10A	HGNC:13829	Schopf-Schulz-Passarge syndrome, 224750 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
224900	ECTODERMAL DYSPLASIA 10B, HYPOHIDROTIC/HAIR/TOOTH TYPE, AUTOSOMAL RECESSIVE	Ectodermal dysplasia 10B, hypohidrotic/hair/tooth type, autosomal recessive, 224900 (3)	Ectodermal dysplasia 10B, hypohidrotic/hair/tooth type, autosomal recessive	y	ECTODERMAL DYSPLASIA 10B, HYPOHIDROTIC/HAIR/TOOTH TYPE, AUTOSOMAL RECESSIVE; ECTD10B	Clinical Synopsis	death|deaths	EDAR	HGNC:2895	Ectodermal dysplasia 10B, hypohidrotic/hair/tooth type, autosomal recessive, 224900 (3), Autosomal recessive	Autosomal recessive	n	n	-	-	-	-	ambiguous	ambiguous	ambiguous	-	-	-
225060	CLEFT LIP/PALATE-ECTODERMAL DYSPLASIA SYNDROME	Cleft lip/palate-ectodermal dysplasia syndrome, 225060 (3)	Cleft lip/palate-ectodermal dysplasia syndrome	n	-	-	-	NECTIN1	HGNC:9706	Cleft lip/palate-ectodermal dysplasia syndrome, 225060 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
225060	CLEFT LIP/PALATE-ECTODERMAL DYSPLASIA SYNDROME	Orofacial cleft 7, 225060 (3)	Orofacial cleft 7	n	-	-	-	NECTIN1	HGNC:9706	Orofacial cleft 7, 225060 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
225100	ECTOPIA LENTIS 2, ISOLATED, AUTOSOMAL RECESSIVE	Ectopia lentis, isolated, autosomal recessive, 225100 (3)	Ectopia lentis, isolated, autosomal recessive	n	-	-	-	ADAMTSL4	HGNC:19706	Ectopia lentis, isolated, autosomal recessive, 225100 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
225200	ECTOPIA LENTIS ET PUPILLAE	Ectopia lentis et pupillae, 225200 (3)	Ectopia lentis et pupillae	n	-	-	-	ADAMTSL4	HGNC:19706	Ectopia lentis et pupillae, 225200 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
225250	HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 5	Hypothyroidism, congenital nongoitrous, 5, 225250 (3)	Hypothyroidism, congenital nongoitrous, 5	n	-	-	-	NKX2-5	HGNC:2488	Hypothyroidism, congenital nongoitrous, 5, 225250 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	ambiguous|lethal|nonlethal	lethal|nonlethal	LU	LU	post-infant-lethal
225280	ECTODERMAL DYSPLASIA, ECTRODACTYLY, AND MACULAR DYSTROPHY SYNDROME	Ectodermal dysplasia, ectrodactyly, and macular dystrophy, 225280 (3)	Ectodermal dysplasia, ectrodactyly, and macular dystrophy	n	-	-	-	CDH3	HGNC:1762	Ectodermal dysplasia, ectrodactyly, and macular dystrophy, 225280 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
225300	SPLIT-HAND/FOOT MALFORMATION 6	Split-hand/foot malformation 6, 225300 (3)	Split-hand/foot malformation 6	n	-	-	-	WNT10B	HGNC:12775	Split-hand/foot malformation 6, 225300 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
225320	EHLERS-DANLOS SYNDROME, CARDIAC VALVULAR TYPE	Ehlers-Danlos syndrome, cardiac valvular type, 225320 (3)	Ehlers-Danlos syndrome, cardiac valvular type	y	EHLERS-DANLOS SYNDROME, CARDIAC VALVULAR TYPE; EDSCV	Clinical Features	died|fatal	COL1A2	HGNC:2198	Ehlers-Danlos syndrome, cardiac valvular type, 225320 (3), Autosomal recessive	Autosomal recessive	y	y	[Shohet et al. (1987) reported 2 unrelated patients, aged 10 and 11 years, who had minor signs of Ehlers-Danlos syndrome but severe changes in the aorta requiring surgical repair with fatal complications in 1 patient. One of the patients had a similarly affected sister and brother who died at ages 4 and 7.5 years, respectively]	L4	n	y	lethal	ambiguous|lethal|nonlethal	lethal|nonlethal	L2|L4|L5	L2	pre-infant-lethal
225400	EHLERS-DANLOS SYNDROME, KYPHOSCOLIOTIC TYPE, 1	Ehlers-Danlos syndrome, kyphoscoliotic type, 1, 225400 (3)	Ehlers-Danlos syndrome, kyphoscoliotic type, 1	y	EHLERS-DANLOS SYNDROME, KYPHOSCOLIOTIC TYPE, 1; EDSKSCL1	Clinical Features	died	PLOD1	HGNC:9081	Ehlers-Danlos syndrome, kyphoscoliotic type, 1, 225400 (3), Autosomal recessive	Autosomal recessive	y	y	[McKusick (1966) had a patient who appeared to have the same defect; the distinctive clinical features suggested the mnemonic designation ocular-scoliotic form of EDS.... The brother had 4 unaffected children. The affected female died at the age of 50 years with symptoms typical of acute dissecting aneurysm of the aorta (autopsy was not performed)	L6	y	-	lethal	lethal	lethal	L6	L6	post-infant-lethal
225410	EHLERS-DANLOS SYNDROME, DERMATOSPARAXIS TYPE	Ehlers-Danlos syndrome, dermatosparaxis type, 225410 (3)	Ehlers-Danlos syndrome, dermatosparaxis type	y	EHLERS-DANLOS SYNDROME, DERMATOSPARAXIS TYPE; EDSDERMS	Clinical Features	died	ADAMTS2	HGNC:218	Ehlers-Danlos syndrome, dermatosparaxis type, 225410 (3), Autosomal recessive	Autosomal recessive	n	y	[Bar-Yosef et al. (2008) reported an infant of Ashkenazi Jewish origin with EDS dermatosparaxis type confirmed by genetic analysis (604539.0001). He was delivered preterm by cesarean due to fetal heart decelerations and with multiple congenital nontraumatic skull fractures and intracranial hemorrhage. Eight days prior to delivery the mother was admitted to the hospital with premature rupture of the membranes. He died at age 145 days due to sepsis]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
225500	ELLIS-VAN CREVELD SYNDROME	Ellis-van Creveld syndrome, 225500 (3)	Ellis-van Creveld syndrome	n	-	-	-	EVC	HGNC:3497	Ellis-van Creveld syndrome, 225500 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
225500	ELLIS-VAN CREVELD SYNDROME	Ellis-van Creveld syndrome, 225500 (3)	Ellis-van Creveld syndrome	n	-	-	-	EVC2	HGNC:19747	Ellis-van Creveld syndrome, 225500 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
225750	AICARDI-GOUTIERES SYNDROME 1	Aicardi-Goutieres syndrome 1, dominant and recessive, 225750 (3)	Aicardi-Goutieres syndrome 1, dominant and recessive	y	AICARDI-GOUTIERES SYNDROME 1; AGS1	Description|Clinical Features|Clinical Synopsis|Phenotype	death|deaths|died	TREX1	HGNC:12269	Aicardi-Goutieres syndrome 1, dominant and recessive, 225750 (3), Autosomal dominant, Autosomal recessive	Autosomal dominant, Autosomal recessive	y	y	[Death within first year of life in 25%]	L3	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L3|L6	L3	pre-infant-lethal
225753	PONTOCEREBELLAR HYPOPLASIA, TYPE 4	Pontocerebellar hypoplasia type 4, 225753 (3)	Pontocerebellar hypoplasia type 4	y	PONTOCEREBELLAR HYPOPLASIA, TYPE 4; PCH4	Description|Clinical Features|Clinical Synopsis|Phenotype	lethality|died|lethal|death|deaths	TSEN54	HGNC:27561	Pontocerebellar hypoplasia type 4, 225753 (3), Autosomal recessive	Autosomal recessive	n	y	[Cassandrini et al. (2010) reported an Italian infant girl with lethal PCH4. She presented at birth with hypertonia, congenital contractures, and seizures, and died at age 1 month]	L3	y	-	lethal	lethal	lethal	L2|L3	L2	pre-infant-lethal
225790	PROLIFERATIVE VASCULOPATHY AND HYDRANENCEPHALY-HYDROCEPHALY SYNDROME	Proliferative vasculopathy and hydranencephaly-hydrocephaly syndrome, 225790 (3)	Proliferative vasculopathy and hydranencephaly-hydrocephaly syndrome	y	PROLIFERATIVE VASCULOPATHY AND HYDRANENCEPHALY-HYDROCEPHALY SYNDROME; PVHH	Description|Clinical Features|Clinical Synopsis	lethal|died|death|deaths|stillborn	FLVCR2	HGNC:20105	Proliferative vasculopathy and hydranencephaly-hydrocephaly syndrome, 225790 (3), Autosomal recessive	Autosomal recessive	y	y	[Stillborn or neonatal death]	L1	y	-	lethal	lethal	lethal	L1	L1	pre-infant-lethal
226200	ENTEROKINASE DEFICIENCY	Enterokinase deficiency, 226200 (3)	Enterokinase deficiency	n	-	-	-	TMPRSS15	HGNC:9490	Enterokinase deficiency, 226200 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
226300	COMPLEMENT HYPERACTIVATION, ANGIOPATHIC THROMBOSIS, AND PROTEIN-LOSING ENTEROPATHY	Complement hyperactivation, angiopathic thrombosis, and protein-losing enteropathy, 226300 (3)	Complement hyperactivation, angiopathic thrombosis, and protein-losing enteropathy	y	COMPLEMENT HYPERACTIVATION, ANGIOPATHIC THROMBOSIS, AND PROTEIN-LOSING ENTEROPATHY; CHAPLE	Clinical Features	death|deaths|died	CD55	HGNC:2665	Complement hyperactivation, angiopathic thrombosis, and protein-losing enteropathy, 226300 (3), Autosomal recessive	Autosomal recessive	y	y	[Kurolap et al. (2017) reported a large consanguineous Muslim-Arab family in which 6 individuals had protein-losing enteropathy associated with hypercoagulability. Disease onset was between 10 months and 3 years of age, and patients presented with generalized edema, severe hypoalbuminemia, diarrhea, and abdominal complications, with repeated thrombotic events in 3 of the patients; 2 of the patients died from disease complications]	LU	y	-	lethal	lethal	lethal	LU	LU	post-infant-lethal
226400	EPIDERMODYSPLASIA VERRUCIFORMIS, SUSCEPTIBILITY TO, 1	Epidermodysplasia verruciformis, 226400 (3)	Epidermodysplasia verruciformis	n	-	-	-	TMC6	HGNC:18021	Epidermodysplasia verruciformis, 226400 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
226600	EPIDERMOLYSIS BULLOSA DYSTROPHICA, AUTOSOMAL RECESSIVE	Epidermolysis bullosa dystrophica inversa, 226600 (3)	Epidermolysis bullosa dystrophica inversa	y	EPIDERMOLYSIS BULLOSA DYSTROPHICA, AUTOSOMAL RECESSIVE; RDEB	Clinical Features|Phenotype	death|deaths|died|fatal	COL7A1	HGNC:2214	Epidermolysis bullosa dystrophica inversa, 226600 (3), Autosomal recessive	Autosomal recessive	y	y	[led to death in the oldest brother at age 21 years]	L6	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L6	L6	post-infant-lethal
226600	EPIDERMOLYSIS BULLOSA DYSTROPHICA, AUTOSOMAL RECESSIVE	Epidermolysis bullosa dystrophica, autosomal recessive, 226600 (3)	Epidermolysis bullosa dystrophica, autosomal recessive	y	EPIDERMOLYSIS BULLOSA DYSTROPHICA, AUTOSOMAL RECESSIVE; RDEB	Clinical Features|Phenotype	death|deaths|died|fatal	COL7A1	HGNC:2214	Epidermolysis bullosa dystrophica, autosomal recessive, 226600 (3), Autosomal recessive	Autosomal recessive	y	y	[led to death in the oldest brother at age 21 years]	L6	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L6	L6	post-infant-lethal
226600	EPIDERMOLYSIS BULLOSA DYSTROPHICA, AUTOSOMAL RECESSIVE	Epidermolysis bullosa dystrophica, localisata variant, 226600 (3)	Epidermolysis bullosa dystrophica, localisata variant	y	EPIDERMOLYSIS BULLOSA DYSTROPHICA, AUTOSOMAL RECESSIVE; RDEB	Clinical Features|Phenotype	death|deaths|died|fatal	COL7A1	HGNC:2214	Epidermolysis bullosa dystrophica, localisata variant, 226600 (3), Autosomal recessive	Autosomal recessive	y	y	[led to death in the oldest brother at age 21 years]	L6	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L6	L6	post-infant-lethal
226650	EPIDERMOLYSIS BULLOSA, JUNCTIONAL 1A, INTERMEDIATE	Epidermolysis bullosa, junctional 1A, intermediate, 226650 (3)	Epidermolysis bullosa, junctional 1A, intermediate	y	EPIDERMOLYSIS BULLOSA, JUNCTIONAL 1A, INTERMEDIATE; JEB1A	Clinical Features|Phenotype	died|lethal	LAMB3	HGNC:6490	Epidermolysis bullosa, junctional 1A, intermediate, 226650 (3), Autosomal recessive	Autosomal recessive	y	n	-	-	-	-	ambiguous	ambiguous|lethal|nonlethal	lethal|nonlethal	L2	L2	pre-infant-lethal
226670	EPIDERMOLYSIS BULLOSA SIMPLEX 5B, WITH MUSCULAR DYSTROPHY	Epidermolysis bullosa simplex 5B, with muscular dystrophy, 226670 (3)	Epidermolysis bullosa simplex 5B, with muscular dystrophy	y	EPIDERMOLYSIS BULLOSA SIMPLEX 5B, WITH MUSCULAR DYSTROPHY; EBS5B	Clinical Features	died|fatal	PLEC	HGNC:9069	Epidermolysis bullosa simplex 5B, with muscular dystrophy, 226670 (3), Autosomal recessive	Autosomal recessive	y	y	[Variable survival (some neonatal lethality)]	L2	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L2|L3|L6	L2	pre-infant-lethal
226700	EPIDERMOLYSIS BULLOSA, JUNCTIONAL 1B, SEVERE	Epidermolysis bullosa, junctional 1B, severe, 226700 (3)	Epidermolysis bullosa, junctional 1B, severe	y	EPIDERMOLYSIS BULLOSA, JUNCTIONAL 1B, SEVERE; JEB1B	Description|Clinical Features|Clinical Synopsis|Phenotype	die|death|deaths|died|lethal	LAMB3	HGNC:6490	Epidermolysis bullosa, junctional 1B, severe, 226700 (3), Autosomal recessive	Autosomal recessive	y	y	[died at 20, 24, and 42 days, respectively]	L2	-	-	lethal	ambiguous|lethal|nonlethal	lethal|nonlethal	L2	L2	pre-infant-lethal
226730	EPIDERMOLYSIS BULLOSA, JUNCTIONAL 5B, WITH PYLORIC ATRESIA	Epidermolysis bullosa, junctional 5B, with pyloric atresia, 226730 (3)	Epidermolysis bullosa, junctional 5B, with pyloric atresia	y	EPIDERMOLYSIS BULLOSA, JUNCTIONAL 5B, WITH PYLORIC ATRESIA; JEB5B	Description|Clinical Features|Clinical Synopsis|Diagnosis|Phenotype	lethal|death|deaths|died|stillborn	ITGB4	HGNC:6158	Epidermolysis bullosa, junctional 5B, with pyloric atresia, 226730 (3), Autosomal recessive	Autosomal recessive	y	y	[early infancy of complications related to the skin disorder. An older stillborn sister was probably affected]	L2	y	y	lethal	lethal|nonlethal	lethal|nonlethal	L2	L2	pre-infant-lethal
226750	KOHLSCHUTTER-TONZ SYNDROME	Kohlschutter-Tonz syndrome, 226750 (3)	Kohlschutter-Tonz syndrome	y	KOHLSCHUTTER-TONZ SYNDROME; KTZS	Clinical Features	died	ROGDI	HGNC:29478	Kohlschutter-Tonz syndrome, 226750 (3), Autosomal recessive	Autosomal recessive	y	y	[Mory et al. (2012) reported 14 patients from 5 Druze families with KTZS. Three of the families were part of a large consanguineous kindred, and all the families originated from the same small village in northern Israel. Although the phenotype was consistent, it was variable. All patients had early-onset seizures, severe global developmental delay, spasticity and amelogenesis imperfecta. Age at onset of seizures ranged from birth to 3 years, although most had onset before 12 months of age. Treatment response varied, and about half had intractable seizures. Most patients were ambulant, but almost all had no speech development. The most severely affected individual had failure to thrive, microcephaly, and refractory convulsions. She was vegetative and died at age 2 years]	L4	y	-	lethal	lethal	lethal	L4	L4	post-infant-lethal
226900	EPIPHYSEAL DYSPLASIA, MULTIPLE, 4	Epiphyseal dysplasia, multiple, 4, 226900 (3)	Epiphyseal dysplasia, multiple, 4	n	-	-	-	SLC26A2	HGNC:10994	Epiphyseal dysplasia, multiple, 4, 226900 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L1|L2	L1	pre-infant-lethal
226980	EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH EARLY-ONSET DIABETES MELLITUS	Wolcott-Rallison syndrome, 226980 (3)	Wolcott-Rallison syndrome	y	EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH EARLY-ONSET DIABETES MELLITUS	Clinical Features	died	EIF2AK3	HGNC:3255	Wolcott-Rallison syndrome, 226980 (3), Autosomal recessive	Autosomal recessive	n	y	[Al-Gazali et al. (1995) described this syndrome in 2 brothers born to consanguineous Omani parents. Both children presented with diabetes, which was diagnosed at the age of 2 months in 1 brother and at the age of 2 weeks in the other. The radiologic abnormalities in 1 brother (osteoporosis, mild platyspondyly, small flattened epiphyses, bilateral coxa valga with narrow iliac wings) were evident from the age of 6 months. The first child of this couple, a female infant, died at the age of 2 months after weight loss, irritability and diarrhea. None of these sibs had hepatomegaly / Bonthron et al. (1998) described a family in which the proband, born to first-cousin parents, died at 2 years of age from the sequelae of poorly controlled diabetes]	L3	y	y	lethal	lethal	lethal	L3	L3	pre-infant-lethal
226990	IMMUNODEFICIENCY 32B	Immunodeficiency 32B, monocyte and dendritic cell deficiency, autosomal recessive, 226990 (3)	Immunodeficiency 32B, monocyte and dendritic cell deficiency, autosomal recessive	y	IMMUNODEFICIENCY 32B; IMD32B	Clinical Features	died	IRF8	HGNC:5358	Immunodeficiency 32B, monocyte and dendritic cell deficiency, autosomal recessive, 226990 (3), Autosomal recessive	Autosomal recessive	n	y	[Fleisher et al. (1982) reported a family in which 3 sibs had an immunodeficiency syndrome characterized by susceptibility to Epstein-Barr virus (EBV). One patient was a 16-year-old boy with a history of recurrent sinusitis, otitis, and pneumonia, followed by progressive bronchiectasis; he developed infectious mononucleosis at age 16 and died on the 26th day of illness from 'uncontrollable hemorrhage and multiple organ failure]	L5	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L5	L5	post-infant-lethal
227260	FOCAL FACIAL DERMAL DYSPLASIA 3, SETLEIS TYPE	Focal facial dermal dysplasia 3, Setleis type, 227260 (3)	Focal facial dermal dysplasia 3, Setleis type	n	-	-	-	TWIST2	HGNC:20670	Focal facial dermal dysplasia 3, Setleis type, 227260 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
227300	FACTOR V AND FACTOR VIII, COMBINED DEFICIENCY OF, 1	Combined factor V and VIII deficiency, 227300 (3)	Combined factor V and VIII deficiency	n	-	-	-	LMAN1	HGNC:6631	Combined factor V and VIII deficiency, 227300 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
227400	FACTOR V DEFICIENCY	Factor V deficiency, 227400 (3)	Factor V deficiency	n	-	-	-	F5	HGNC:3542	Factor V deficiency, 227400 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	ambiguous|nonlethal	ambiguous	-	-	-
227500	FACTOR VII DEFICIENCY	Factor VII deficiency, 227500 (3)	Factor VII deficiency	y	FACTOR VII DEFICIENCY	Clinical Features|Phenotype	die|died|death|deaths	F7	HGNC:3544	Factor VII deficiency, 227500 (3), Autosomal recessive	Autosomal recessive	n	y	[McVey et al. (2001) noted that complete absence of factor VII in plasma is usually incompatible with life, and individuals die shortly after birth due to severe hemorrhage / McVey et al. (1998) reported infant brother and sister, born of consanguineous parents, who died at 10 days and 1 month of age, respectively, of intracranial hemorrhage related to severe factor VII deficiency]	L2	y	-	lethal	lethal	lethal	L2	L2	pre-infant-lethal
227600	FACTOR X DEFICIENCY	Factor X deficiency, 227600 (3)	Factor X deficiency	y	FACTOR X DEFICIENCY	Phenotype	died|spontaneous_abortion|spontaneous_abortions	F10	HGNC:3528	Factor X deficiency, 227600 (3), Autosomal recessive	Autosomal recessive	n	n	-	-	-	-	ambiguous	ambiguous	ambiguous	-	-	-
227645	FANCONI ANEMIA, COMPLEMENTATION GROUP C	Fanconi anemia, complementation group C, 227645 (3)	Fanconi anemia, complementation group C	n	-	-	-	FANCC	HGNC:3584	Fanconi anemia, complementation group C, 227645 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
227646	FANCONI ANEMIA, COMPLEMENTATION GROUP D2	Fanconi anemia, complementation group D2, 227646 (3)	Fanconi anemia, complementation group D2	n	-	-	-	FANCD2	HGNC:3585	Fanconi anemia, complementation group D2, 227646 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
227650	FANCONI ANEMIA, COMPLEMENTATION GROUP A	Fanconi anemia, complementation group A, 227650 (3)	Fanconi anemia, complementation group A	y	FANCONI ANEMIA, COMPLEMENTATION GROUP A; FANCA	Clinical Features	death|deaths|died|fatal	FANCA	HGNC:3582	Fanconi anemia, complementation group A, 227650 (3), Autosomal recessive	Autosomal recessive	n	y	[Macdougall et al. (1990) described FA in 25 black African children seen in Johannesburg over an 11-year period. Seventeen (68%) of the children died during the period of observation. Leukemia was the terminal event in 2. Response to androgens was poor and most patients required regular transfusion. Mean age of death was 9.8 years and the mean time between diagnosis and death 2.3 years]	L4	y	-	lethal	lethal	lethal	L4	L4	post-infant-lethal
227810	FANCONI-BICKEL SYNDROME	Fanconi-Bickel syndrome, 227810 (3)	Fanconi-Bickel syndrome	n	-	-	-	SLC2A2	HGNC:11006	Fanconi-Bickel syndrome, 227810 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
228000	FARBER LIPOGRANULOMATOSIS	Farber lipogranulomatosis, 228000 (3)	Farber lipogranulomatosis	y	FARBER LIPOGRANULOMATOSIS; FRBRL	Description|Clinical Features|Clinical Synopsis|Phenotype	death|deaths|die|died|spontaneous_abortion|spontaneous_abortions	ASAH1	HGNC:735	Farber lipogranulomatosis, 228000 (3), Autosomal recessive	Autosomal recessive	y	y	[In a patient with severe Farber disease resulting in hydrops fetalis and death at age 3 days (Kattner et al., 1997), Alves et al. (2013) identified compound heterozygosity for 2 null mutations in the ASAH1 gene (613468.0008 and 613468.0009). The severe phenotype correlated with a complete loss of the full-length protein]	L2	y	-	lethal	lethal	lethal	L2|L5	L2	pre-infant-lethal
228300	HYPOGONADOTROPIC HYPOGONADISM 23 WITH OR WITHOUT ANOSMIA	Hypogonadotropic hypogonadism 23 with or without anosmia, 228300 (3)	Hypogonadotropic hypogonadism 23 with or without anosmia	n	-	-	-	LHB	HGNC:6584	Hypogonadotropic hypogonadism 23 with or without anosmia, 228300 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
228520	FIBROCHONDROGENESIS 1	Fibrochondrogenesis 1, 228520 (3)	Fibrochondrogenesis 1	y	FIBROCHONDROGENESIS 1; FBCG1	Clinical Features|Clinical Synopsis	lethal|stillborn|died	COL11A1	HGNC:2186	Fibrochondrogenesis 1, 228520 (3), Autosomal recessive	Autosomal recessive	n	y	[Tompson et al. (2010) reported 3 patients, 2 of whom were sibs, with fibrochondrogenesis. The proband from one family was the first child of parents of European descent and was stillborn at 32 weeks of gestation]	L1	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L1	L1	pre-infant-lethal
228550	MYOFIBROMATOSIS, INFANTILE, 1	Myofibromatosis, infantile, 1, 228550 (3)	Myofibromatosis, infantile, 1	y	MYOFIBROMATOSIS, INFANTILE, 1; IMF1	Clinical Features	die	PDGFRB	HGNC:8804	Myofibromatosis, infantile, 1, 228550 (3), Autosomal dominant	Autosomal dominant	y	y	[Chung and Enzinger (1981) preferred the term juvenile myofibromatosis because of the presumed myofibroblastic origin of the cells. The prognosis is poor when several internal organs are affected; 80% of such infants are said to die in the first 4 months of life]	L3	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L3|L6	L3	pre-infant-lethal
228600	HYALINE FIBROMATOSIS SYNDROME	Hyaline fibromatosis syndrome, 228600 (3)	Hyaline fibromatosis syndrome	y	HYALINE FIBROMATOSIS SYNDROME; HFS	Description|Clinical Features	death|deaths|died	ANTXR2	HGNC:21732	Hyaline fibromatosis syndrome, 228600 (3), Autosomal recessive	Autosomal recessive	y	y	[El-Kamah et al. (2010) reported 3 Egyptian sibs, born of consanguineous parents, with severe infantile-onset hyaline fibromatosis. The first child died of respiratory distress at age 3 days]	L2	y	-	lethal	lethal	lethal	L2	L2	pre-infant-lethal
228900	ACROMESOMELIC DYSPLASIA 2B	Acromesomelic dysplasia 2B, 228900 (3)	Acromesomelic dysplasia 2B	n	-	-	-	GDF5	HGNC:4220	Acromesomelic dysplasia 2B, 228900 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L1	L1	pre-infant-lethal
228930	FIBULAR APLASIA OR HYPOPLASIA, FEMORAL BOWING AND POLY-, SYN-, AND OLIGODACTYLY	Fuhrmann syndrome, 228930 (3)	Fuhrmann syndrome	y	FIBULAR APLASIA OR HYPOPLASIA, FEMORAL BOWING AND POLY-, SYN-, AND OLIGODACTYLY	Clinical Features	lethal	WNT7A	HGNC:12786	Fuhrmann syndrome, 228930 (3), Autosomal recessive	Autosomal recessive	n	y	[In a male and female offspring of Turkish parents related as cousins once removed, Pfeiffer et al. (1988) observed a lethal syndrome consisting of absence of the fibula and ulna with oligodactyly, joint contractures, right-angle bowing of the femurs, cleft lip and palate, and, in the sib examined, an Arnold-Chiari anomaly with communicating hydrocephalus, caudally displaced cerebellum with absence of the velum medullare and of the posterior vermis, and focal microgyria in the frontal area. The first infant was delivered at 28 weeks by cesarean section because of premature labor and lived only a short period. The upper lip appeared attached to the nose because the tongue was squeezed into the cleft lip. The abnormalities in the second affected child were detected at 20 weeks of the pregnancy by ultrasonography and the pregnancy was terminated]	L2	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L2	L2	pre-infant-lethal
229050	FOLATE MALABSORPTION, HEREDITARY	Folate malabsorption, hereditary, 229050 (3)	Folate malabsorption, hereditary	y	FOLATE MALABSORPTION, HEREDITARY	Clinical Features	died	SLC46A1	HGNC:30521	Folate malabsorption, hereditary, 229050 (3), Autosomal recessive	Autosomal recessive	n	y	[Jebnoun et al. (2001) reported a large family of 8 children (6 males and 2 females) affected by congenital folate malabsorption. The first 5 children (4 boys and 1 girl) died within the first few months of life with diarrhea, vomiting, drowsiness, pallor, and glossitis]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
229070	HYPOGONADOTROPIC HYPOGONADISM 24 WITH OR WITHOUT ANOSMIA	Hypogonadotropic hypogonadism 24 without anosmia, 229070 (3)	Hypogonadotropic hypogonadism 24 without anosmia	n	-	-	-	FSHB	HGNC:3964	Hypogonadotropic hypogonadism 24 without anosmia, 229070 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
229100	GLUTAMATE FORMIMINOTRANSFERASE DEFICIENCY	Glutamate formiminotransferase deficiency, 229100 (3)	Glutamate formiminotransferase deficiency	n	-	-	-	FTCD	HGNC:3974	Glutamate formiminotransferase deficiency, 229100 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
229200	BRITTLE CORNEA SYNDROME 1	Brittle cornea syndrome 1, 229200 (3)	Brittle cornea syndrome 1	n	-	-	-	ZNF469	HGNC:23216	Brittle cornea syndrome 1, 229200 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
229300	FRIEDREICH ATAXIA	Friedreich ataxia with retained reflexes, 229300 (3)	Friedreich ataxia with retained reflexes	y	FRIEDREICH ATAXIA; FRDA	Clinical Features|Clinical Synopsis	death|deaths|died|fatal	FXN	HGNC:3951	Friedreich ataxia with retained reflexes, 229300 (3), Autosomal recessive	Autosomal recessive	y	y	[Cardiac manifestations are conspicuous in some cases (Boyer et al., 1962). Hewer (1968) found that one-half of 82 fatal cases of Friedreich ataxia died of heart failure and nearly three-quarters had evidence of cardiac dysfunction in life. Twenty-three percent had diabetes and 4 developed diabetic ketosis terminally. One case had an affected parent. Age at death varied from the first (3 cases) to the eighth (1 case) decade with a mean of 36.6 years]	L4	y	-	lethal	lethal	lethal	L4	L4	post-infant-lethal
229300	FRIEDREICH ATAXIA	Friedreich ataxia, 229300 (3)	Friedreich ataxia	y	FRIEDREICH ATAXIA; FRDA	Clinical Features|Clinical Synopsis	death|deaths|died|fatal	FXN	HGNC:3951	Friedreich ataxia, 229300 (3), Autosomal recessive	Autosomal recessive	y	y	[Cardiac manifestations are conspicuous in some cases (Boyer et al., 1962). Hewer (1968) found that one-half of 82 fatal cases of Friedreich ataxia died of heart failure and nearly three-quarters had evidence of cardiac dysfunction in life. Twenty-three percent had diabetes and 4 developed diabetic ketosis terminally. One case had an affected parent. Age at death varied from the first (3 cases) to the eighth (1 case) decade with a mean of 36.6 years]	L4	y	-	lethal	lethal	lethal	L4	L4	post-infant-lethal
229600	FRUCTOSE INTOLERANCE, HEREDITARY	Fructose intolerance, hereditary, 229600 (3)	Fructose intolerance, hereditary	y	FRUCTOSE INTOLERANCE, HEREDITARY; HFI	Description|Clinical Features	fatal|died	ALDOB	HGNC:417	Fructose intolerance, hereditary, 229600 (3), Autosomal recessive	Autosomal recessive	y	y	[Esposito et al. (2010) reported 2 unrelated patients with fructose intolerance who were determined to be heterozygous for a mutation in the ALDOB gene. One patient with an R46W substitution (612724.0014) had mild hypoglycemia and ketosis after ingestion of fructose and a marked aversion to sweets and fruit. The second patient with a Y343H substitution (612724.0015) was hospitalized for a series of febrile episodes associated with sever liver dysfunction at age 8 months. She died 1 month later from unknown causes]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
229700	FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY	Fructose-1,6-bisphosphatase deficiency, 229700 (3)	Fructose-1,6-bisphosphatase deficiency	y	FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY; FBP1D	Description|Clinical Features	lethal|died	FBP1	HGNC:3606	Fructose-1,6-bisphosphatase deficiency, 229700 (3), Autosomal recessive	Autosomal recessive	y	y	[Although the disorder may be lethal in the newborn period, proper treatment yields an excellent prognosis (Kikawa et al., 1997; Matsuura et al., 2002)]	L2	y	-	lethal	lethal	lethal	L2	L2	pre-infant-lethal
230000	FUCOSIDOSIS	Fucosidosis, 230000 (3)	Fucosidosis	y	FUCOSIDOSIS	Description|Clinical Features	death|deaths|died	FUCA1	HGNC:4006	Fucosidosis, 230000 (3), Autosomal recessive	Autosomal recessive	n	y	[Fucosidosis has been classified into 2 major types. Type 1 is characterized by rapid psychomotor regression and severe neurologic deterioration beginning at about 6 months of age, elevated sweat sodium chloride, and death within the first decade of life]	L4	y	-	lethal	lethal	lethal	L4	L4	post-infant-lethal
230200	GALACTOSEMIA II	Galactokinase deficiency with cataracts, 230200 (3)	Galactokinase deficiency with cataracts	n	-	-	-	GALK1	HGNC:4118	Galactokinase deficiency with cataracts, 230200 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
230350	GALACTOSEMIA III	Galactose epimerase deficiency, 230350 (3)	Galactose epimerase deficiency	n	-	-	-	GALE	HGNC:4116	Galactose epimerase deficiency, 230350 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
230400	GALACTOSEMIA I	Galactosemia, 230400 (3)	Galactosemia	y	GALACTOSEMIA I; GALAC1	Clinical Features|Diagnosis	death|deaths|died	GALT	HGNC:4135	Galactosemia, 230400 (3), Autosomal recessive	Autosomal recessive	y	y	[There appears to be a high frequency of neonatal death due to E. coli sepsis, with a fulminant course (Levy et al., 1977)]	L2	y	-	lethal	lethal	lethal	L2	L2	pre-infant-lethal
230450	GAMMA-GLUTAMYLCYSTEINE SYNTHETASE DEFICIENCY, HEMOLYTIC ANEMIA DUE TO	Hemolytic anemia due to gamma-glutamylcysteine synthetase deficiency, 230450 (3)	Hemolytic anemia due to gamma-glutamylcysteine synthetase deficiency	n	-	-	-	GCLC	HGNC:4311	Hemolytic anemia due to gamma-glutamylcysteine synthetase deficiency, 230450 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
230500	GM1-GANGLIOSIDOSIS, TYPE I	GM1-gangliosidosis, type I, 230500 (3)	GM1-gangliosidosis, type I	y	GM1-GANGLIOSIDOSIS, TYPE I; GM1G1	Description|Clinical Features|Clinical Synopsis	death|deaths|died|fetal_loss|fetal_losses	GLB1	HGNC:4298	GM1-gangliosidosis, type I, 230500 (3), Autosomal recessive	Autosomal recessive	y	y	[Giugliani et al. (1985) found that GM1-gangliosidosis was the inborn error of metabolism most often diagnosed on the Pediatrics Service in Porto Alegre, Brazil. From a study of 8 families, they suggested that increased fetal loss and macrosomy are features and that vacuolated lymphocytes are a useful diagnostic clue / Kohlschutter et al. (1982) reported cardiomyopathy in an infant with beta-glucosidase deficiency who died of heart failure at age 8 months]	L1	y	y	lethal	lethal|nonlethal	lethal|nonlethal	L1|L4	L1	pre-infant-lethal
230600	GM1-GANGLIOSIDOSIS, TYPE II	GM1-gangliosidosis, type II, 230600 (3)	GM1-gangliosidosis, type II	y	GM1-GANGLIOSIDOSIS, TYPE II; GM1G2	Description	death|deaths	GLB1	HGNC:4298	GM1-gangliosidosis, type II, 230600 (3), Autosomal recessive	Autosomal recessive	y	y	[Onset of disease 7 months to 3 years - Survival to 10 years / Within type II, those with somewhat earlier onset and earlier death are considered to have the 'late-infantile' form, whereas those with slightly later onset and survival into late childhood are referred to as having the 'juvenile' form (Caciotti et al., 2003)]	L4	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L1|L4	L1	pre-infant-lethal
230650	GM1-GANGLIOSIDOSIS, TYPE III	GM1-gangliosidosis, type III, 230650 (3)	GM1-gangliosidosis, type III	n	-	-	-	GLB1	HGNC:4298	GM1-gangliosidosis, type III, 230650 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L1|L4	L1	pre-infant-lethal
230740	GAPO SYNDROME	GAPO syndrome, 230740 (3)	GAPO syndrome	y	GAPO SYNDROME; GAPOS	Clinical Features	died	ANTXR1	HGNC:21014	GAPO syndrome, 230740 (3), Autosomal recessive	Autosomal recessive	n	y	[Gagliardi et al. (1984) reported 3 affected brothers with consanguineous parents. They found information on 9 cases (4 males, 5 females). One of the patients died at age 39 years and another at age 37 years]	L6	y	-	lethal	lethal	lethal	L6	L6	post-infant-lethal
230800	GAUCHER DISEASE, TYPE I	Gaucher disease, type I, 230800 (3)	Gaucher disease, type I	y	GAUCHER DISEASE, TYPE I; GD1	Description	lethal	GBA1	HGNC:4177	Gaucher disease, type I, 230800 (3), Autosomal recessive	Autosomal recessive	y	n	-	-	-	-	ambiguous	ambiguous|lethal|nonlethal	lethal|nonlethal	L1|L3|L5	L1	pre-infant-lethal
230900	GAUCHER DISEASE, TYPE II	Gaucher disease, type II, 230900 (3)	Gaucher disease, type II	y	GAUCHER DISEASE, TYPE II; GD2	Description|Clinical Features|Clinical Synopsis|Phenotype	death|deaths|died|lethal	GBA1	HGNC:4177	Gaucher disease, type II, 230900 (3), Autosomal recessive	Autosomal recessive	y	y	[Death often by age 2 years / Gornati et al. (2002) examined the lipid composition of the liver, spleen, brain, cerebellum, and cerebrospinal fluid of a type II Gaucher patient who died at age 5 months]	L3	y	-	lethal	ambiguous|lethal|nonlethal	lethal|nonlethal	L1|L3|L5	L1	pre-infant-lethal
231000	GAUCHER DISEASE, TYPE III	Gaucher disease, type III, 231000 (3)	Gaucher disease, type III	n	-	-	-	GBA1	HGNC:4177	Gaucher disease, type III, 231000 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	ambiguous|lethal|nonlethal	lethal|nonlethal	L1|L3|L5	L1	pre-infant-lethal
231005	GAUCHER DISEASE, TYPE IIIC	Gaucher disease, type IIIC, 231005 (3)	Gaucher disease, type IIIC	y	GAUCHER DISEASE, TYPE IIIC; GD3C	Clinical Features|Clinical Synopsis	died|fatal	GBA1	HGNC:4177	Gaucher disease, type IIIC, 231005 (3), Autosomal recessive	Autosomal recessive	y	y	[Cardiac manifestations are often fatal / Chabas et al. (1995) reported 3 Spanish sisters with Gaucher disease type IIIc.... The 3 sisters died at ages 16, 15, and 13, 2 of them having undergone aortic valve replacement	L5	y	y	lethal	ambiguous|lethal|nonlethal	lethal|nonlethal	L1|L3|L5	L1	pre-infant-lethal
231050	GELEOPHYSIC DYSPLASIA 1	Geleophysic dysplasia 1, 231050 (3)	Geleophysic dysplasia 1	y	GELEOPHYSIC DYSPLASIA 1; GPHYSD1	Description|Clinical Features	death|deaths|died|stillborn	ADAMTSL2	HGNC:14631	Geleophysic dysplasia 1, 231050 (3), Autosomal recessive	Autosomal recessive	n	y	[Wraith et al. (1990) described 2 patients, one of whom was the offspring of consanguineous parents. One died of heart failure at the age of 5 months / Spranger et al. (1984) gave a follow-up of the male patient described by Spranger et al. (1971) and described the same disorder in of his sibs. The original patient had progressive joint contractures; he walked on his toes and stood bent forward, flexed at the hips and knees. By age 12 he had extensive disease of the aortic and mitral valves. A sister developed heart failure soon after birth and was found to have right ventricular hypertrophy. She was found to have severe mitral stenosis with aortic regurgitation; she died at age 7.5 years during preparation for surgical repair of the valvular lesions. At autopsy all 4 heart valves were strikingly abnormal. The liver and heart as well as the growth plates showed cells with lysosomal inclusions with the staining properties of a neutral glycoprotein. Radiographic changes were most striking in the hands and feet where the tubular bones were short and plump. The other sib was stillborn and was probably affected]	L1	y	y	lethal	lethal	lethal	L1	L1	pre-infant-lethal
231070	GERODERMA OSTEODYSPLASTICUM	Geroderma osteodysplasticum, 231070 (3)	Geroderma osteodysplasticum	n	-	-	-	GORAB	HGNC:25676	Geroderma osteodysplasticum, 231070 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
231090	HYDATIDIFORM MOLE, RECURRENT, 1	Hydatidiform mole, recurrent, 1, 231090 (3)	Hydatidiform mole, recurrent, 1	y	HYDATIDIFORM MOLE, RECURRENT, 1; HYDM1	Description|Phenotype	death|deaths|miscarriage|miscarriages|pregnancy_loss|pregnancy_losses|stillbirth|stillbirths|spontaneous_abortion|spontaneous_abortions	NLRP7	HGNC:22947	Hydatidiform mole, recurrent, 1, 231090 (3), Autosomal recessive	Autosomal recessive	y	n	-	-	-	-	ambiguous	ambiguous	ambiguous	-	-	-
231095	GHOSAL HEMATODIAPHYSEAL DYSPLASIA	Ghosal hematodiaphyseal syndrome, 231095 (3)	Ghosal hematodiaphyseal syndrome	n	-	-	-	TBXAS1	HGNC:11609	Ghosal hematodiaphyseal syndrome, 231095 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
231200	BERNARD-SOULIER SYNDROME	Bernard-Soulier syndrome, type A1 (recessive), 231200 (3)	Bernard-Soulier syndrome, type A1 (recessive)	n	-	-	-	GP1BA	HGNC:4439	Bernard-Soulier syndrome, type A1 (recessive), 231200 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
231200	BERNARD-SOULIER SYNDROME	Bernard-Soulier syndrome, type B, 231200 (3)	Bernard-Soulier syndrome, type B	n	-	-	-	GP1BB	HGNC:4440	Bernard-Soulier syndrome, type B, 231200 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
231200	BERNARD-SOULIER SYNDROME	Giant platelet disorder, isolated, 231200 (3)	Giant platelet disorder, isolated	n	-	-	-	GP1BB	HGNC:4440	Giant platelet disorder, isolated, 231200 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
231200	BERNARD-SOULIER SYNDROME	Bernard-Soulier syndrome, type C, 231200 (3)	Bernard-Soulier syndrome, type C	n	-	-	-	GP9	HGNC:4444	Bernard-Soulier syndrome, type C, 231200 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
231300	GLAUCOMA 3, PRIMARY CONGENITAL, A	Glaucoma 3A, primary open angle, congenital, juvenile, or adult onset, 231300 (3)	Glaucoma 3A, primary open angle, congenital, juvenile, or adult onset	n	-	-	-	CYP1B1	HGNC:2597	Glaucoma 3A, primary open angle, congenital, juvenile, or adult onset, 231300 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
231530	3-HYDROXYACYL-CoA DEHYDROGENASE DEFICIENCY	3-hydroxyacyl-CoA dehydrogenase deficiency, 231530 (3)	3-hydroxyacyl-CoA dehydrogenase deficiency	y	3-HYDROXYACYL-CoA DEHYDROGENASE DEFICIENCY	Clinical Features|Clinical Synopsis	death|deaths	HADH	HGNC:4799	3-hydroxyacyl-CoA dehydrogenase deficiency, 231530 (3), Autosomal recessive	Autosomal recessive	n	y	[Sudden infant death may occur]	L3	y	-	lethal	lethal	lethal	L3|LU	L3	pre-infant-lethal
231550	ACHALASIA-ADDISONIANISM-ALACRIMA SYNDROME	Achalasia-addisonianism-alacrimia syndrome, 231550 (3)	Achalasia-addisonianism-alacrimia syndrome	y	ACHALASIA-ADDISONIANISM-ALACRIMA SYNDROME; AAAS	Clinical Features	died	AAAS	HGNC:13666	Achalasia-addisonianism-alacrimia syndrome, 231550 (3), Autosomal recessive	Autosomal recessive	y	y	[Grant et al. (1992) provided follow-up on the patients originally described by Allgrove et al. (1978) and documented that they had developed neurologic manifestations, including polyneuropathy with sensory, motor, and autonomic components, long-tract degeneration, parkinsonism, and mild dementia. Tsao et al. (1994) reported the cases of 2 first cousins, a 17-year-old girl and a 9-year-old boy, with adrenal insufficiency and microcephaly who also developed peripheral neuropathy, achalasia, and alacrima. In this kindred, 2 brothers had married 2 sisters. A sister of the 9-year-old boy had died at the age of 18 months of the same disorder]	L3	n	y	lethal	lethal	lethal	L3	L3	pre-infant-lethal
231670	GLUTARIC ACIDEMIA I	Glutaricaciduria, type I, 231670 (3)	Glutaricaciduria, type I	y	GLUTARIC ACIDEMIA I; GA1	Clinical Features	death|deaths|died	GCDH	HGNC:4189	Glutaricaciduria, type I, 231670 (3), Autosomal recessive	Autosomal recessive	y	y	[In 14 children with type I glutaric aciduria from the Old Order Amish community in Lancaster County, Pennsylvania, Morton et al. (1991) noted a remarkably variable clinical picture ranging from acute infantile encephalopathy and sudden death to static extrapyramidal cerebral palsy. In 10 patients, the disorder was first manifest between 3 and 18 months during an acute infectious illness. Four of these children died in early childhood, also during acute illnesses]	L4	y	-	lethal	lethal	lethal	L4	L4	post-infant-lethal
231680	MULTIPLE ACYL-CoA DEHYDROGENASE DEFICIENCY	Glutaric acidemia IIA, 231680 (3)	Glutaric acidemia IIA	y	MULTIPLE ACYL-CoA DEHYDROGENASE DEFICIENCY; MADD	Description|Clinical Features|Clinical Synopsis|Phenotype	fatal|death|deaths|died	ETFA	HGNC:3481	Glutaric acidemia IIA, 231680 (3), Autosomal recessive	Autosomal recessive	y	y	[Neonatal death frequent]	L2	y	-	lethal	lethal	lethal	L2	L2	pre-infant-lethal
231680	MULTIPLE ACYL-CoA DEHYDROGENASE DEFICIENCY	Glutaric acidemia IIB, 231680 (3)	Glutaric acidemia IIB	y	MULTIPLE ACYL-CoA DEHYDROGENASE DEFICIENCY; MADD	Description|Clinical Features|Clinical Synopsis|Phenotype	fatal|death|deaths|died	ETFB	HGNC:3482	Glutaric acidemia IIB, 231680 (3), Autosomal recessive	Autosomal recessive	y	y	[Neonatal death frequent]	L2	y	-	lethal	lethal	lethal	L2	L2	pre-infant-lethal
231680	MULTIPLE ACYL-CoA DEHYDROGENASE DEFICIENCY	Glutaric acidemia IIC, 231680 (3)	Glutaric acidemia IIC	y	MULTIPLE ACYL-CoA DEHYDROGENASE DEFICIENCY; MADD	Description|Clinical Features|Clinical Synopsis|Phenotype	fatal|death|deaths|died	ETFDH	HGNC:3483	Glutaric acidemia IIC, 231680 (3), Autosomal recessive	Autosomal recessive	y	y	[Neonatal death frequent]	L2	y	-	lethal	lethal	lethal	L2	L2	pre-infant-lethal
231690	GLUTARIC ACIDURIA III	Glutaric aciduria III, 231690 (3)	Glutaric aciduria III	n	-	-	-	SUGCT	HGNC:16001	Glutaric aciduria III, 231690 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
231900	GLUTATHIONE SYNTHETASE DEFICIENCY OF ERYTHROCYTES, HEMOLYTIC ANEMIA DUE TO	Hemolytic anemia due to glutathione synthetase deficiency, 231900 (3)	Hemolytic anemia due to glutathione synthetase deficiency	n	-	-	-	GSS	HGNC:4624	Hemolytic anemia due to glutathione synthetase deficiency, 231900 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L2	L2	pre-infant-lethal
232200	GLYCOGEN STORAGE DISEASE Ia	Glycogen storage disease Ia, 232200 (3)	Glycogen storage disease Ia	y	GLYCOGEN STORAGE DISEASE Ia; GSD1A	Clinical Features	death|deaths	G6PC1	HGNC:4056	Glycogen storage disease Ia, 232200 (3), Autosomal recessive	Autosomal recessive	y	y	[Chen et al. (1988) found that of the 38 patients with type I glycogen storage disease under their care, the 18 children under age 10 years had normal renal function. Fourteen of the 20 older patients (aged 13 to 47 years) had disturbed renal function manifested by persistent proteinuria; many also had hypertension, hematuria, or altered creatinine clearance. Progressive renal insufficiency developed in 6 of these 14 patients, leading to death from renal failure in 3]	LU	y	-	lethal	lethal	lethal	LU	LU	post-infant-lethal
232220	GLYCOGEN STORAGE DISEASE Ib	Glycogen storage disease Ib, 232220 (3)	Glycogen storage disease Ib	n	-	-	-	SLC37A4	HGNC:4061	Glycogen storage disease Ib, 232220 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
232240	GLYCOGEN STORAGE DISEASE Ic	Glycogen storage disease Ic, 232240 (3)	Glycogen storage disease Ic	n	-	-	-	SLC37A4	HGNC:4061	Glycogen storage disease Ic, 232240 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
232300	GLYCOGEN STORAGE DISEASE II	Glycogen storage disease II, 232300 (3)	Glycogen storage disease II	y	GLYCOGEN STORAGE DISEASE II; GSD2	Clinical Features|Clinical Synopsis|Diagnosis|Phenotype	death|deaths|died|fatal	GAA	HGNC:4065	Glycogen storage disease II, 232300 (3), Autosomal recessive	Autosomal recessive	y	y	[In classic cases of Pompe disease, affected children are prostrate and markedly hypotonic with large hearts. The tongue may be enlarged. Although the enzyme is deficient in all tissues, muscle weakness and heart involvement are the most common features. The liver is rarely enlarged, except as a result of heart failure, and hypoglycemia and acidosis do not occur as they do in glycogen storage disease I (232200). Death usually occurs in the first year of life in the classic form of the disorder and cardiac involvement is striking]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
232400	GLYCOGEN STORAGE DISEASE III	Glycogen storage disease IIIa, 232400 (3)	Glycogen storage disease IIIa	y	GLYCOGEN STORAGE DISEASE III; GSD3	Clinical Features	died|fatal	AGL	HGNC:321	Glycogen storage disease IIIa, 232400 (3), Autosomal recessive	Autosomal recessive	y	y	[Schoser et al. (2008) reported a family with variable presentation of GSD III. The 49-year-old female proband presented with hepatomegaly, cardiomyopathy, and moderate progressive proximal limb myopathy. She developed proximal muscle weakness at age 10 and signs and symptoms of cardiomyopathy at age 30. She also had progressive hearing impairment beginning at age 30. Skeletal muscle biopsy showed severe vacuolar myopathy with PAS-positive glycogen storage material that altered the contractile apparatus. Two brothers had died of severe infantile liver cirrhosis, and a sister died with cardiomyopathy, hepatomegaly, and myopathy at age 33 / Schoser et al. (2008) concluded that, with the exception of early infantile fatal cirrhosis, patients with GSD III may stay ambulatory until adulthood]	L3	n	y	lethal	lethal	lethal	L3	L3	pre-infant-lethal
232400	GLYCOGEN STORAGE DISEASE III	Glycogen storage disease IIIb, 232400 (3)	Glycogen storage disease IIIb	y	GLYCOGEN STORAGE DISEASE III; GSD3	Clinical Features	died|fatal	AGL	HGNC:321	Glycogen storage disease IIIb, 232400 (3), Autosomal recessive	Autosomal recessive	y	y	[Schoser et al. (2008) reported a family with variable presentation of GSD III. The 49-year-old female proband presented with hepatomegaly, cardiomyopathy, and moderate progressive proximal limb myopathy. She developed proximal muscle weakness at age 10 and signs and symptoms of cardiomyopathy at age 30. She also had progressive hearing impairment beginning at age 30. Skeletal muscle biopsy showed severe vacuolar myopathy with PAS-positive glycogen storage material that altered the contractile apparatus. Two brothers had died of severe infantile liver cirrhosis, and a sister died with cardiomyopathy, hepatomegaly, and myopathy at age 33 / Schoser et al. (2008) concluded that, with the exception of early infantile fatal cirrhosis, patients with GSD III may stay ambulatory until adulthood]	L3	n	y	lethal	lethal	lethal	L3	L3	pre-infant-lethal
232500	GLYCOGEN STORAGE DISEASE IV	Glycogen storage disease IV, 232500 (3)	Glycogen storage disease IV	y	GLYCOGEN STORAGE DISEASE IV; GSD4	Description|Clinical Features|Clinical Synopsis|Phenotype	death|deaths|lethal|died|fatal	GBE1	HGNC:4180	Glycogen storage disease IV, 232500 (3), Autosomal recessive	Autosomal recessive	y	y	[Glycogen storage disease type IV is a clinically heterogeneous disorder. The typical 'classic' hepatic presentation is liver disease of childhood, progressing to lethal cirrhosis. The neuromuscular presentation of GSD IV is distinguished by age at onset into 4 groups: perinatal, presenting as fetal akinesia deformation sequence (FADS) and perinatal death]	L2	y	-	lethal	ambiguous|lethal	lethal	L2	L2	pre-infant-lethal
232600	GLYCOGEN STORAGE DISEASE V	McArdle disease, 232600 (3)	McArdle disease	y	GLYCOGEN STORAGE DISEASE V; GSD5	Clinical Features|Phenotype	died	PYGM	HGNC:9726	McArdle disease, 232600 (3), Autosomal recessive	Autosomal recessive	y	y	[DiMauro and Hartlage (1978) described an infant with severe McArdle disease. She developed generalized, rapidly progressive weakness at age 4 weeks and died at age 13 weeks of respiratory failure]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
232700	GLYCOGEN STORAGE DISEASE VI	Glycogen storage disease VI, 232700 (3)	Glycogen storage disease VI	n	-	-	-	PYGL	HGNC:9725	Glycogen storage disease VI, 232700 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
232800	GLYCOGEN STORAGE DISEASE VII	Glycogen storage disease VII, 232800 (3)	Glycogen storage disease VII	y	GLYCOGEN STORAGE DISEASE VII; GSD7	Clinical Features	death|deaths|died|fatal	PFKM	HGNC:8877	Glycogen storage disease VII, 232800 (3), Autosomal recessive	Autosomal recessive	n	y	[There are rare reports of a rapidly progressive fatal infantile form of PFKM deficiency. Servidei et al. (1986) reported an unusually severe case of PFKM deficiency. An affected girl had onset in infancy of limb weakness, seizures, cortical blindness, and corneal clouding, with death at age 7 months of respiratory failure]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
233100	RENAL GLUCOSURIA	Renal glucosuria, 233100 (3)	Renal glucosuria	n	-	-	-	SLC5A2	HGNC:11037	Renal glucosuria, 233100 (3), Autosomal dominant, Autosomal recessive	Autosomal dominant, Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
233300	OVARIAN DYSGENESIS 1	Ovarian dysgenesis 1, 233300 (3)	Ovarian dysgenesis 1	n	-	-	-	FSHR	HGNC:3969	Ovarian dysgenesis 1, 233300 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
233400	PERRAULT SYNDROME 1	Perrault syndrome 1, 233400 (3)	Perrault syndrome 1	y	PERRAULT SYNDROME 1; PRLTS1	Phenotype	fatal	HSD17B4	HGNC:5213	Perrault syndrome 1, 233400 (3), Autosomal recessive	Autosomal recessive	y	n	-	-	-	-	ambiguous	ambiguous|lethal	lethal	L3	L3	pre-infant-lethal
233420	46,XY SEX REVERSAL 7	46XY sex reversal 7, 233420 (3)	46XY sex reversal 7	n	-	-	-	DHH	HGNC:2865	46XY sex reversal 7, 233420 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
233650	COMBINED CELLULAR AND HUMORAL IMMUNE DEFECTS WITH GRANULOMAS	Combined cellular and humoral immune defects with granulomas, 233650 (3)	Combined cellular and humoral immune defects with granulomas	y	COMBINED CELLULAR AND HUMORAL IMMUNE DEFECTS WITH GRANULOMAS; CCHIDG	Clinical Features	death|deaths|died	RAG1	HGNC:9831	Combined cellular and humoral immune defects with granulomas, 233650 (3), Autosomal recessive	Autosomal recessive	n	y	[De Ravin et al. (2010) reported a 14-year-old boy who presented with destructive midline granulomatous disease of the head and neck. The patient had a complicated medical history. He had a history of myasthenia gravis with thymectomy at age 10 years, and a history of recurrent ear and sinus infections. The thymus showed dysplastic features and absence of autoimmune regulator, indicating a defect in thymocyte maturation. Laboratory studies showed a decrease of IgG subclasses 2 and 4 and mild CD8+ T cell lymphopenia, whereas CD3+ T cells, CD19+ B cells, and NK cells were normal. He was treated for Wegener granulomatosis with chemotherapeutic agents, but developed severe lymphopenia and continued to have relapses of noninfectious granulomas. In vitro studies showed dysregulated cellular inflammatory responses to various stimuli, including increased production of IL1B (147720) and IL8 (146930). An older sister had autoimmune cytopenias and antinuclear antibody-positive collagen vascular disease, with death at age 5 years. Molecular analysis of the proband identified compound heterozygous mutations in the RAG1 gene: W522C (179615.0024), which retained about 50% residual activity, and a null mutation (1621delC; 179615.0025)]	L4	n	y	lethal	lethal|nonlethal	lethal|nonlethal	L3|L4	L3	pre-infant-lethal
233650	COMBINED CELLULAR AND HUMORAL IMMUNE DEFECTS WITH GRANULOMAS	Combined cellular and humoral immune defects with granulomas, 233650 (3)	Combined cellular and humoral immune defects with granulomas	y	COMBINED CELLULAR AND HUMORAL IMMUNE DEFECTS WITH GRANULOMAS; CCHIDG	Clinical Features	death|deaths|died	RAG2	HGNC:9832	Combined cellular and humoral immune defects with granulomas, 233650 (3), Autosomal recessive	Autosomal recessive	n	n	-	-	-	-	ambiguous	ambiguous|lethal	lethal	L3	L3	pre-infant-lethal
233690	GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, 4	Chronic granulomatous disease 4, autosomal recessive, 233690 (3)	Chronic granulomatous disease 4, autosomal recessive	n	-	-	-	CYBA	HGNC:2577	Chronic granulomatous disease 4, autosomal recessive, 233690 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
233700	GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, 1	Chronic granulomatous disease 1, autosomal recessive, 233700 (3)	Chronic granulomatous disease 1, autosomal recessive	y	GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, 1; CGD1	Clinical Features	died	NCF1	HGNC:7660	Chronic granulomatous disease 1, autosomal recessive, 233700 (3), Autosomal recessive	Autosomal recessive	y	y	A patient who had the highest level of cytosol factor activity had been healthy and was diagnosed only after her brother died of Aspergillus pneumonitis	LU	n	y	lethal	lethal	lethal	LU	LU	post-infant-lethal
233710	GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, 2	Chronic granulomatous disease 2, autosomal recessive, 233710 (3)	Chronic granulomatous disease 2, autosomal recessive	y	GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, 2; CGD2	Clinical Features	death|deaths	NCF2	HGNC:7661	Chronic granulomatous disease 2, autosomal recessive, 233710 (3), Autosomal recessive	Autosomal recessive	y	y	[Patino et al. (1999) reported several girls with p67-phox-deficient CGD confirmed by molecular analysis. In an 8-year-old Hispanic girl, the diagnosis of CGD had been made at age 8 months when the patient presented with a right upper lobe pneumonia caused by Serratia marcescens. A 10-year-old girl, born of first-cousin parents native to Jordan, had recurrent abscesses caused by gram-negative bacteria in the first year of life. At the age of 5 years, she had developed inflammatory bowel disease. The diagnosis of CGD was made on the basis of absent NBT reduction and O2(-) production by her PMA-stimulated neutrophils. Deficiency of p67-phox was demonstrated by Western blot analysis. Her sister, aged 2 years, also showed the genetic defect but had not yet developed serious illness or required hospitalization. In a girl with p67-phox-deficient CGD who was 4 years old at the time of her death in Mexico]	L4	y	-	lethal	lethal	lethal	L4	L4	post-infant-lethal
233910	HYPERPHENYLALANINEMIA, BH4-DEFICIENT, B	Hyperphenylalaninemia, BH4-deficient, B, 233910 (3)	Hyperphenylalaninemia, BH4-deficient, B	y	HYPERPHENYLALANINEMIA, BH4-DEFICIENT, B; HPABH4B	Clinical Features	died	GCH1	HGNC:4193	Hyperphenylalaninemia, BH4-deficient, B, 233910 (3), Autosomal recessive	Autosomal recessive	n	y	[Ichinose et al. (1995) reported a female infant with BH4-dependent hyperphenylalaninemia due to GTP1 deficiency. She developed feeding problems, poor sucking, and poor muscle tone in the first week of life, and later showed delayed development. By the age of 2 years, she was unable to walk and developed seizures and choreoathetosis. Urinary pterins showed a profound deficiency in neopterin and biopterin. She died at age 10 years]	L5	y	-	lethal	ambiguous|lethal	lethal	L5	L5	post-infant-lethal
234000	FACTOR XII DEFICIENCY	Factor XII deficiency, 234000 (3)	Factor XII deficiency	y	FACTOR XII DEFICIENCY	Clinical Features	spontaneous_abortion|spontaneous_abortions	F12	HGNC:3530	Factor XII deficiency, 234000 (3), Autosomal recessive	Autosomal recessive	y	n	-	-	-	-	ambiguous	ambiguous|nonlethal	ambiguous	-	-	-
234050	TRICHOTHIODYSTROPHY 4, NONPHOTOSENSITIVE	Trichothiodystrophy 4, nonphotosensitive, 234050 (3)	Trichothiodystrophy 4, nonphotosensitive	n	-	-	-	MPLKIP	HGNC:16002	Trichothiodystrophy 4, nonphotosensitive, 234050 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
234200	NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 1	Neurodegeneration with brain iron accumulation 1, 234200 (3)	Neurodegeneration with brain iron accumulation 1	y	NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 1; NBIA1	Clinical Features	death|deaths|died	PANK2	HGNC:15894	Neurodegeneration with brain iron accumulation 1, 234200 (3), Autosomal recessive	Autosomal recessive	y	y	[Malmstrom-Groth and Kristensson (1982) reported the cases of 2 second cousins who developed clinical signs of a progressive extrapyramidal motor disorder and mental retardation and died at ages 8 and 11 years]	L4	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L4	L4	post-infant-lethal
234500	HARTNUP DISORDER	Hartnup disorder, 234500 (3)	Hartnup disorder	y	HARTNUP DISORDER; HND	Clinical Features	died	SLC6A19	HGNC:27960	Hartnup disorder, 234500 (3), Autosomal recessive	Autosomal recessive	y	y	[Nozaki et al. (2001) studied 2 Japanese families with first-cousin parents. The proband in the first family died of cirrhosis of the liver at the age of 42 years. Hartnup disorder was diagnosed on the basis of consistent patterns of monoamino-monocarboxylic aciduria and defects in the intestinal absorption of monoamino-monocarboxylic acids as determined by oral loading. He periodically had psychologic symptoms, ataxia, and diplopia. Niacin administration resolved these clinical symptoms. The patient was reported by Mori et al. (1989) as having no skin lesions. An older brother died at the age of 32 years of a progressive neurologic disease of unexplored pathogenesis]	L6	y	y	lethal	lethal	lethal	L6	L6	post-infant-lethal
234580	HEIMLER SYNDROME 1	Heimler syndrome 1, 234580 (3)	Heimler syndrome 1	n	-	-	-	PEX1	HGNC:8850	Heimler syndrome 1, 234580 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L3	L3	pre-infant-lethal
234810	PULMONARY VENOOCCLUSIVE DISEASE 2, AUTOSOMAL RECESSIVE	Pulmonary venoocclusive disease 2, 234810 (3)	Pulmonary venoocclusive disease 2	y	PULMONARY VENOOCCLUSIVE DISEASE 2, AUTOSOMAL RECESSIVE; PVOD2	Clinical Features|Clinical Synopsis	died|fatal	EIF2AK4	HGNC:19687	Pulmonary venoocclusive disease 2, 234810 (3), Autosomal recessive	Autosomal recessive	n	y	[Fatal without lung transplant / Langleben et al. (1988) reported cases of familial pulmonary capillary hemangiomatosis. They described 3 sibs, 2 brothers and a sister in a French Canadian family, who died from primary pulmonary hypertension]	LU	y	-	lethal	lethal	lethal	LU	LU	post-infant-lethal
235200	HEMOCHROMATOSIS, TYPE 1	Hemochromatosis, type 1, 235200 (3)	Hemochromatosis, type 1	y	HEMOCHROMATOSIS, TYPE 1; HFE1	Phenotype	fatal	HFE	HGNC:4886	Hemochromatosis, type 1, 235200 (3), Autosomal recessive	Autosomal recessive	y	n	-	-	-	-	ambiguous	ambiguous	ambiguous	-	-	-
235510	HENNEKAM LYMPHANGIECTASIA-LYMPHEDEMA SYNDROME 1	Hennekam lymphangiectasia-lymphedema syndrome 1, 235510 (3)	Hennekam lymphangiectasia-lymphedema syndrome 1	y	HENNEKAM LYMPHANGIECTASIA-LYMPHEDEMA SYNDROME 1; HKLLS1	Clinical Features	died|fatal	CCBE1	HGNC:29426	Hennekam lymphangiectasia-lymphedema syndrome 1, 235510 (3), Autosomal recessive	Autosomal recessive	y	y	[Scarcella et al. (2000) described 2 sisters with facial anomalies, protein-losing enteropathy, and intestinal lymphangiectasia consistent with the diagnosis of Hennekam syndrome. Both had a number of other anomalies not previously described in this disorder: primary hypothyroidism, hypertrophic pyloric stenosis, and an early fatal outcome at 8 and 3 months, respectively]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
235550	HEPATIC VENOOCCLUSIVE DISEASE WITH IMMUNODEFICIENCY	Hepatic venoocclusive disease with immunodeficiency, 235550 (3)	Hepatic venoocclusive disease with immunodeficiency	y	HEPATIC VENOOCCLUSIVE DISEASE WITH IMMUNODEFICIENCY; VODI	Clinical Features	died	SP110	HGNC:5401	Hepatic venoocclusive disease with immunodeficiency, 235550 (3), Autosomal recessive	Autosomal recessive	n	y	[In Australia, Mellis and Bale (1976) described 5 infants in 3 families who died between ages 2 and 7 months with venoocclusive disease of the liver]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
235555	BILE ACID SYNTHESIS DEFECT, CONGENITAL, 2	Bile acid synthesis defect, congenital, 2, 235555 (3)	Bile acid synthesis defect, congenital, 2	y	BILE ACID SYNTHESIS DEFECT, CONGENITAL, 2; CBAS2	Clinical Features	died	AKR1D1	HGNC:388	Bile acid synthesis defect, congenital, 2, 235555 (3), Autosomal recessive	Autosomal recessive	y	y	[Setchell et al. (1988) reported monozygotic male twins who presented at birth with cholestatic jaundice due to severe intrahepatic cholestasis. A previously born sib had died at the age of 4 months of hepatic failure following an identical course]	L3	n	y	lethal	lethal	lethal	L3	L3	pre-infant-lethal
235700	HEMOLYTIC ANEMIA, NONSPHEROCYTIC, DUE TO HEXOKINASE DEFICIENCY	Hemolytic anemia due to hexokinase deficiency, 235700 (3)	Hemolytic anemia due to hexokinase deficiency	n	-	-	-	HK1	HGNC:4922	Hemolytic anemia due to hexokinase deficiency, 235700 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L3	L3	pre-infant-lethal
235730	MOWAT-WILSON SYNDROME	Mowat-Wilson syndrome, 235730 (3)	Mowat-Wilson syndrome	y	MOWAT-WILSON SYNDROME; MOWS	Clinical Features	lethal	ZEB2	HGNC:14881	Mowat-Wilson syndrome, 235730 (3), Autosomal dominant	Autosomal dominant	y	n	-	-	-	-	ambiguous	ambiguous	ambiguous	-	-	-
236200	HOMOCYSTINURIA DUE TO CYSTATHIONINE BETA-SYNTHASE DEFICIENCY	Homocystinuria, B6-responsive and nonresponsive types, 236200 (3)	Homocystinuria, B6-responsive and nonresponsive types	y	HOMOCYSTINURIA DUE TO CYSTATHIONINE BETA-SYNTHASE DEFICIENCY	Clinical Features|Clinical Synopsis|Phenotype	death|deaths|fatal|fetal_loss|fetal_losses|spontaneous_abortion|spontaneous_abortions	CBS	HGNC:1550	Homocystinuria, B6-responsive and nonresponsive types, 236200 (3), Autosomal recessive	Autosomal recessive	n	y	[In a review, Testai and Gorelick (2010) noted that thromboembolic events are the most common cause of death in patients with classic homocystinuria and can manifest as peripheral vein thrombosis, pulmonary embolism, stroke, peripheral artery occlusion, and myocardial infarction. The risk of having a vascular event is 25% before age 16 years and 50% by age 30 years]	LU	y	-	lethal	lethal	lethal	LU	LU	post-infant-lethal
236200	HOMOCYSTINURIA DUE TO CYSTATHIONINE BETA-SYNTHASE DEFICIENCY	Thrombosis, hyperhomocysteinemic, 236200 (3)	Thrombosis, hyperhomocysteinemic	y	HOMOCYSTINURIA DUE TO CYSTATHIONINE BETA-SYNTHASE DEFICIENCY	Clinical Features|Clinical Synopsis|Phenotype	death|deaths|fatal|fetal_loss|fetal_losses|spontaneous_abortion|spontaneous_abortions	CBS	HGNC:1550	Thrombosis, hyperhomocysteinemic, 236200 (3), Autosomal recessive	Autosomal recessive	n	y	[In a review, Testai and Gorelick (2010) noted that thromboembolic events are the most common cause of death in patients with classic homocystinuria and can manifest as peripheral vein thrombosis, pulmonary embolism, stroke, peripheral artery occlusion, and myocardial infarction. The risk of having a vascular event is 25% before age 16 years and 50% by age 30 years]	LU	y	-	lethal	lethal	lethal	LU	LU	post-infant-lethal
236250	HOMOCYSTINURIA DUE TO DEFICIENCY OF N(5,10)-METHYLENETETRAHYDROFOLATE REDUCTASE ACTIVITY	Homocystinuria due to MTHFR deficiency, 236250 (3)	Homocystinuria due to MTHFR deficiency	y	HOMOCYSTINURIA DUE TO DEFICIENCY OF N(5,10)-METHYLENETETRAHYDROFOLATE REDUCTASE ACTIVITY	Description|Clinical Features|Phenotype	death|deaths|died|spontaneous_abortion|spontaneous_abortions	MTHFR	HGNC:7436	Homocystinuria due to MTHFR deficiency, 236250 (3), Autosomal recessive	Autosomal recessive	n	y	[Cappuccio et al. (2014) reported 2 sibs and a first cousin with MTHFR deficiency presenting as early infantile epileptic encephalopathy. All showed poor sucking, hypotonia, microcephaly, and lethargy in the newborn period. The most severely affected patient had onset of intractable seizures at age 1 month and died at age 7 months]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
236270	HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, cblE COMPLEMENTATION TYPE	Homocystinuria-megaloblastic anemia, cbl E type, 236270 (3)	Homocystinuria-megaloblastic anemia, cbl E type	n	-	-	-	MTRR	HGNC:7473	Homocystinuria-megaloblastic anemia, cbl E type, 236270 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
236500	MULTINUCLEATED NEURONS, ANHYDRAMNIOS, RENAL DYSPLASIA, CEREBELLAR HYPOPLASIA, AND HYDRANENCEPHALY	Multinucleated neurons, anhydramnios, renal dysplasia, cerebellar hypoplasia, and hydranencephaly, 236500 (3)	Multinucleated neurons, anhydramnios, renal dysplasia, cerebellar hypoplasia, and hydranencephaly	y	MULTINUCLEATED NEURONS, ANHYDRAMNIOS, RENAL DYSPLASIA, CEREBELLAR HYPOPLASIA, AND HYDRANENCEPHALY; MARCH	Description|Clinical Features|Clinical Synopsis|Phenotype	die|lethal|death|deaths|died|stillborn	CEP55	HGNC:1161	Multinucleated neurons, anhydramnios, renal dysplasia, cerebellar hypoplasia, and hydranencephaly, 236500 (3), Autosomal recessive	Autosomal recessive	y	y	[Death in utero or within minutes after birth]	L1	y	-	lethal	lethal	lethal	L1	L1	pre-infant-lethal
236600	HYDROCEPHALUS, CONGENITAL, 1	Hydrocephalus, congenital, 1, 236600 (3)	Hydrocephalus, congenital, 1	y	HYDROCEPHALUS, CONGENITAL, 1; HYC1	Clinical Features	miscarriage|miscarriages	CCDC88C	HGNC:19967	Hydrocephalus, congenital, 1, 236600 (3), Autosomal recessive	Autosomal recessive	y	n	-	-	-	-	ambiguous	ambiguous	ambiguous	-	-	-
236670	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 1	Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 1, 236670 (3)	Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 1	y	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 1; MDDGA1	Description|Clinical Features|Clinical Synopsis	death|deaths|die|died|spontaneous_abortion|spontaneous_abortions	POMT1	HGNC:9202	Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 1, 236670 (3), Autosomal recessive	Autosomal recessive	y	y	[Cormand et al. (2001) reported 7 patients and 8 fetuses from 8 families who were classified as having WWS based mainly on MRI studies. All of the liveborn probands had cobblestone complex; 3 patients and 2 fetuses had encephaloceles. In 1 family, 3 fetuses with hydrocephalus, severe cobblestone complex, and retinal dysplasia were aborted at 20 to 27 weeks' gestation. Among all patients, ocular changes included microphthalmia, buphthalmos, congenital glaucoma, congenital cataract, corneal clouding, anterior chamber dysgenesis, and retinal dysplasia. Serum creatine kinase was elevated, and muscle biopsies available in 3 infants showed myopathic changes. In 1 patient, the presence of a cobblestone cortex could not be evaluated due to severe hydrocephalus. However, other findings including vermis hypoplasia, flat pons, cerebellar hypoplasia, and a Dandy-Walker malformation together with death in early infancy and high serum creatine kinase, were considered sufficient for a WWS diagnosis. Of the liveborn children with WWS, 1 was living at age 6 months, 2 died at 3 years, and 4 died before age 9 months]	L3	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L3	L3	pre-infant-lethal
236680	HYDROLETHALUS SYNDROME 1	Hydrolethalus syndrome, 236680 (3)	Hydrolethalus syndrome	y	HYDROLETHALUS SYNDROME 1; HLS1	Clinical Features|Clinical Synopsis	death|deaths|lethal|stillbirth|stillbirths|die|stillborn	HYLS1	HGNC:26558	Hydrolethalus syndrome, 236680 (3), Autosomal recessive	Autosomal recessive	n	y	[Seventy percent of cases are stillborn / Live born infants die within few hours of birth]	L1	y	-	lethal	lethal	lethal	L1	L1	pre-infant-lethal
236690	HYDROCEPHALUS, NORMAL-PRESSURE, 1	Hydrocephalus, normal pressure, 1, 236690 (3)	Hydrocephalus, normal pressure, 1	n	-	-	-	CFAP43	HGNC:26684	Hydrocephalus, normal pressure, 1, 236690 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
236700	MCKUSICK-KAUFMAN SYNDROME	McKusick-Kaufman syndrome, 236700 (3)	McKusick-Kaufman syndrome	y	MCKUSICK-KAUFMAN SYNDROME; MKKS	Clinical Features	death|deaths	MKKS	HGNC:7108	McKusick-Kaufman syndrome, 236700 (3), Autosomal recessive	Autosomal recessive	y	y	Davenport et al. (1989) described a male infant with polydactyly, consisting of partial duplication of the third metacarpal and a postaxial accessory digit on both hands and postaxial accessory digits on the feet, as well as penoscrotal hypospadias with chordee. There was no evidence of congenital heart disease. Hirschsprung disease (142623) was established by rectal biopsy. A previous pregnancy had resulted in the intrauterine death of a female fetus with typical features of the Kaufman-McKusick syndrome]	L1	n	y	lethal	lethal	lethal	L1|L3	L1	pre-infant-lethal
236730	UROFACIAL SYNDROME 1	Urofacial syndrome 1, 236730 (3)	Urofacial syndrome 1	y	UROFACIAL SYNDROME 1; UFS1	Clinical Features	died	HPSE2	HGNC:18374	Urofacial syndrome 1, 236730 (3), Autosomal recessive	Autosomal recessive	y	n	-	-	-	-	ambiguous	ambiguous	ambiguous	-	-	-
236792	L-2-HYDROXYGLUTARIC ACIDURIA	L-2-hydroxyglutaric aciduria, 236792 (3)	L-2-hydroxyglutaric aciduria	y	L-2-HYDROXYGLUTARIC ACIDURIA; L2HGA	Clinical Features	died	L2HGDH	HGNC:20499	L-2-hydroxyglutaric aciduria, 236792 (3), Autosomal recessive	Autosomal recessive	y	y	[Seijo-Martinez et al. (2005) reported a 15-year-old Spanish boy with L-2-hydroxyglutaric aciduria. He was wheelchair-bound and had severe mental retardation, epilepsy, bilateral optic atrophy, strabismus, hypoacusis, spastic tetraparesis, and choreodystonia of the upper limbs. He died suddenly of massive mesenteric thrombosis]	L5	y	-	lethal	lethal	lethal	L5	L5	post-infant-lethal
237300	CARBAMOYL PHOSPHATE SYNTHETASE I DEFICIENCY, HYPERAMMONEMIA DUE TO	Carbamoylphosphate synthetase I deficiency, 237300 (3)	Carbamoylphosphate synthetase I deficiency	y	CARBAMOYL PHOSPHATE SYNTHETASE I DEFICIENCY, HYPERAMMONEMIA DUE TO	Description|Clinical Features|Clinical Synopsis|Phenotype	lethal|died	CPS1	HGNC:2323	Carbamoylphosphate synthetase I deficiency, 237300 (3), Autosomal recessive	Autosomal recessive	y	y	[Two types - lethal neonatal and less severe, late onset / Finckh et al. (1998) reported a male infant with severe CPS I deficiency who died at 11 days of age]	L2	y	-	lethal	lethal	lethal	L2	L2	pre-infant-lethal
237310	N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY	N-acetylglutamate synthase deficiency, 237310 (3)	N-acetylglutamate synthase deficiency	y	N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY; NAGSD	Clinical Features	died	NAGS	HGNC:17996	N-acetylglutamate synthase deficiency, 237310 (3), Autosomal recessive	Autosomal recessive	y	y	[Bachmann et al. (1988) reported an additional patient who presented at the age of 6 days with somnolence, tachypnea, and feeding difficulties. Hyperammonemia with high plasma concentrations of alanine and glutamine was present. Organic acid and orotic acid excretion was normal. Therapy with sodium benzoate, arginine hydrochloride, glucose, and insulin as well as peritoneal dialysis initially improved the hyperammonemia. Nonetheless, the child died at 8 days of age]	L2	y	-	lethal	lethal	lethal	L2	L2	pre-infant-lethal
237500	DUBIN-JOHNSON SYNDROME	Dubin-Johnson syndrome, 237500 (3)	Dubin-Johnson syndrome	n	-	-	-	ABCC2	HGNC:53	Dubin-Johnson syndrome, 237500 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
238320	LEYDIG CELL HYPOPLASIA, TYPE I	Leydig cell hypoplasia with hypergonadotropic hypogonadism, 238320 (3)	Leydig cell hypoplasia with hypergonadotropic hypogonadism	n	-	-	-	LHCGR	HGNC:6585	Leydig cell hypoplasia with hypergonadotropic hypogonadism, 238320 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
238320	LEYDIG CELL HYPOPLASIA, TYPE I	Leydig cell hypoplasia with pseudohermaphroditism, 238320 (3)	Leydig cell hypoplasia with pseudohermaphroditism	n	-	-	-	LHCGR	HGNC:6585	Leydig cell hypoplasia with pseudohermaphroditism, 238320 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
238320	LEYDIG CELL HYPOPLASIA, TYPE I	Luteinizing hormone resistance, female, 238320 (3)	Luteinizing hormone resistance, female	n	-	-	-	LHCGR	HGNC:6585	Luteinizing hormone resistance, female, 238320 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
238600	HYPERLIPOPROTEINEMIA, TYPE I	Lipoprotein lipase deficiency, 238600 (3)	Lipoprotein lipase deficiency	n	-	-	-	LPL	HGNC:6677	Lipoprotein lipase deficiency, 238600 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
238700	HYPERLYSINEMIA, TYPE I	Hyperlysinemia, 238700 (3)	Hyperlysinemia	n	-	-	-	AASS	HGNC:17366	Hyperlysinemia, 238700 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
238970	HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME	Hyperornithinemia-hyperammonemia-homocitrullinemia syndrome, 238970 (3)	Hyperornithinemia-hyperammonemia-homocitrullinemia syndrome	y	HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME; HHHS	Diagnosis|Phenotype	death|deaths|died	SLC25A15	HGNC:10985	Hyperornithinemia-hyperammonemia-homocitrullinemia syndrome, 238970 (3), Autosomal recessive	Autosomal recessive	y	y	[neonatal death]	L2	-	-	lethal	lethal	lethal	L2	L2	pre-infant-lethal
239000	PAGET DISEASE OF BONE 5, JUVENILE-ONSET	Paget disease of bone 5, juvenile-onset, 239000 (3)	Paget disease of bone 5, juvenile-onset	y	PAGET DISEASE OF BONE 5, JUVENILE-ONSET; PDB5	Clinical Features	died	TNFRSF11B	HGNC:11909	Paget disease of bone 5, juvenile-onset, 239000 (3), Autosomal recessive	Autosomal recessive	y	y	[Singer et al. (1994) provided a 20-year follow-up of the same family. Of 8 sibs, 3 were affected. One brother, at the age of 36, had roentgenographic signs only. The second affected brother suffered from recurrent renal colic from calcium-containing stones. The affected sister had died at the age of 30 from pneumonia and respiratory failure]	L6	n	y	lethal	lethal	lethal	L6	L6	post-infant-lethal
239200	HYPERPARATHYROIDISM, NEONATAL SEVERE	Hyperparathyroidism, neonatal, 239200 (3)	Hyperparathyroidism, neonatal	y	HYPERPARATHYROIDISM, NEONATAL SEVERE; NSHPT	Description	lethal	CASR	HGNC:1514	Hyperparathyroidism, neonatal, 239200 (3), Autosomal dominant, Autosomal recessive	Autosomal dominant, Autosomal recessive	n	y	[Neonatal severe hyperparathyroidism usually manifests in the first 6 months of life with severe hypercalcemia, bone demineralization, and failure to thrive. Early diagnosis is critical because untreated NSHPT can be a devastating neurodevelopmental disorder, which in some cases is lethal without parathyroidectomy]	LU	y	-	lethal	lethal|nonlethal	lethal|nonlethal	LU	LU	post-infant-lethal
239300	HYPERPHOSPHATASIA WITH IMPAIRED INTELLECTUAL DEVELOPMENT SYNDROME 1	Hyperphosphatasia with impaired intellectual development syndrome 1, 239300 (3)	Hyperphosphatasia with impaired intellectual development syndrome 1	y	HYPERPHOSPHATASIA WITH IMPAIRED INTELLECTUAL DEVELOPMENT SYNDROME 1; HPMRS1	Clinical Features	died	PIGV	HGNC:26031	Hyperphosphatasia with impaired intellectual development syndrome 1, 239300 (3), Autosomal recessive	Autosomal recessive	y	n	-	-	-	-	ambiguous	ambiguous	ambiguous	-	-	-
239500	HYPERPROLINEMIA, TYPE I	Hyperprolinemia, type I, 239500 (3)	Hyperprolinemia, type I	n	-	-	-	PRODH	HGNC:9453	Hyperprolinemia, type I, 239500 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
239510	HYPERPROLINEMIA, TYPE II	Hyperprolinemia, type II, 239510 (3)	Hyperprolinemia, type II	y	HYPERPROLINEMIA, TYPE II; HYRPRO2	Clinical Features	died	ALDH4A1	HGNC:406	Hyperprolinemia, type II, 239510 (3), Autosomal recessive	Autosomal recessive	y	n	-	-	-	-	ambiguous	ambiguous	ambiguous	-	-	-
239850	CANTU SYNDROME	Hypertrichotic osteochondrodysplasia (Cantu syndrome), 239850 (3)	Hypertrichotic osteochondrodysplasia (Cantu syndrome)	n	-	-	-	ABCC9	HGNC:60	Hypertrichotic osteochondrodysplasia (Cantu syndrome), 239850 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L6	L6	post-infant-lethal
240300	AUTOIMMUNE POLYENDOCRINE SYNDROME, TYPE I, WITH OR WITHOUT REVERSIBLE METAPHYSEAL DYSPLASIA	Autoimmune polyendocrinopathy syndrome , type I, with or without reversible metaphyseal dysplasia, 240300 (3)	Autoimmune polyendocrinopathy syndrome , type I, with or without reversible metaphyseal dysplasia	y	AUTOIMMUNE POLYENDOCRINE SYNDROME, TYPE I, WITH OR WITHOUT REVERSIBLE METAPHYSEAL DYSPLASIA; APS1	Clinical Features|Phenotype	died	AIRE	HGNC:360	Autoimmune polyendocrinopathy syndrome , type I, with or without reversible metaphyseal dysplasia, 240300 (3), Autosomal dominant, Autosomal recessive	Autosomal dominant, Autosomal recessive	y	y	[Zaidi et al. (2009) reported 9 Indian patients with APS1 from 8 families, 3 of whom had unusual manifestations, including presentation with type 1 diabetes, chronic sinusitis and otitis media, and facial dysmorphism. Two patients died of septicemia]	LU	y	-	lethal	lethal	lethal	LU	LU	post-infant-lethal
240500	IMMUNODEFICIENCY, COMMON VARIABLE, 2	Immunodeficiency, common variable, 2, 240500 (3)	Immunodeficiency, common variable, 2	y	IMMUNODEFICIENCY, COMMON VARIABLE, 2; CVID2	Clinical Features	died	TNFRSF13B	HGNC:18153	Immunodeficiency, common variable, 2, 240500 (3), Autosomal dominant, Autosomal recessive	Autosomal dominant, Autosomal recessive	n	y	[Castigli et al. (2005) reported 4 unrelated individuals with antibody deficiency due to mutation in the TNFRSF13B gene. All presented with recurrent sinopulmonary infections requiring intravenous Ig therapy. Serum IgG and IgA were low, and serum antibody response to immunization with pneumococcal vaccine was decreased, although T cell-dependent response to tetanus toxin was normal. One proband developed a B-cell non-Hodkgin lymphoma, and her mother, who had recurrent infections, died of lymphoma. An affected sister died of gastrointestinal carcinoma]	LU	y	y	lethal	lethal|nonlethal	lethal|nonlethal	LU	LU	post-infant-lethal
240600	GLYCOGEN STORAGE DISEASE 0, LIVER	Glycogen storage disease 0, liver, 240600 (3)	Glycogen storage disease 0, liver	n	-	-	-	GYS2	HGNC:4707	Glycogen storage disease 0, liver, 240600 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
240800	HYPOGLYCEMIA, LEUCINE-INDUCED	Hypoglycemia of infancy, leucine-sensitive, 240800 (3)	Hypoglycemia of infancy, leucine-sensitive	n	-	-	-	ABCC8	HGNC:59	Hypoglycemia of infancy, leucine-sensitive, 240800 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	ambiguous|nonlethal	ambiguous	-	-	-
240900	HYPOINSULINEMIC HYPOGLYCEMIA WITH HEMIHYPERTROPHY	Hypoinsulinemic hypoglycemia with hemihypertrophy, 240900 (3)	Hypoinsulinemic hypoglycemia with hemihypertrophy	y	HYPOINSULINEMIC HYPOGLYCEMIA WITH HEMIHYPERTROPHY; HIHGHH	Clinical Features	death|deaths|died	AKT2	HGNC:392	Hypoinsulinemic hypoglycemia with hemihypertrophy, 240900 (3), Autosomal dominant	Autosomal dominant	n	y	[Hansson and Redin (1963) reported 2 sisters, born of healthy first-cousin parents, who were macrosomic at birth, developed seizures, and died at 35 hours and 65 hours of life]	L2	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L2	L2	pre-infant-lethal
241080	WOODHOUSE-SAKATI SYNDROME	Woodhouse-Sakati syndrome, 241080 (3)	Woodhouse-Sakati syndrome	y	WOODHOUSE-SAKATI SYNDROME; WDSKS	Clinical Features	died	DCAF17	HGNC:25784	Woodhouse-Sakati syndrome, 241080 (3), Autosomal recessive	Autosomal recessive	y	y	[Devriendt et al. (1996) reported a brother and sister with a progressive extrapyramidal movement disorder with onset in adolescence associated with progressive alopecia and primary hypogonadism. The parents were first cousins once removed. Of 9 children total, 2 were affected and 1 died immediately after birth with severe arthrogryposis]	L2	y	-	lethal	lethal	lethal	L2	L2	pre-infant-lethal
241200	BARTTER SYNDROME, TYPE 2, ANTENATAL	Bartter syndrome, type 2, 241200 (3)	Bartter syndrome, type 2	y	BARTTER SYNDROME, TYPE 2, ANTENATAL; BARTS2	Clinical Features	died	KCNJ1	HGNC:6255	Bartter syndrome, type 2, 241200 (3), Autosomal recessive	Autosomal recessive	n	y	[Finer et al. (2003) reported 12 infants with mutations in the ROMK gene, affecting all 3 protein isoforms, who showed transient hyperkalemia as high as 9.0 mmol/L without acidosis within the first few weeks of life. Two patients developed ventricular arrhythmias and 1 patient died while hyperkalemic at age 8 days]	L2	y	-	lethal	lethal	lethal	L2	L2	pre-infant-lethal
241410	HYPOPARATHYROIDISM-RETARDATION-DYSMORPHISM SYNDROME	Hypoparathyroidism-retardation-dysmorphism syndrome, 241410 (3)	Hypoparathyroidism-retardation-dysmorphism syndrome	y	HYPOPARATHYROIDISM-RETARDATION-DYSMORPHISM SYNDROME; HRDS	Clinical Features	died	TBCE	HGNC:11582	Hypoparathyroidism-retardation-dysmorphism syndrome, 241410 (3), Autosomal recessive	Autosomal recessive	y	y	[Ratbi et al. (2015) reported a female infant, born of consanguineous Moroccan parents, with HRDS. She had intrauterine growth retardation, axial hypotonia, and developed seizures associated with hypocalcemia on the second day of life. Phosphate was increased and parathyroid hormone was severely decreased. Dysmorphic features included deep-set small eyes, depressed nasal bridge with a beaked nose, long philtrum, thin upper lip, micrognathia, and large floppy earlobes. She had no cardiac or skeletal manifestations and died at age 3 months from complications of hypoparathyroidism]	L3	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L2|L3	L2	pre-infant-lethal
241500	HYPOPHOSPHATASIA, INFANTILE	Hypophosphatasia, infantile, 241500 (3)	Hypophosphatasia, infantile	y	HYPOPHOSPHATASIA, INFANTILE; HPPI	Clinical Features|Clinical Synopsis|Diagnosis|Phenotype	death|deaths|died|fatal|lethal|stillborn|lethality	ALPL	HGNC:438	Hypophosphatasia, infantile, 241500 (3), Autosomal recessive	Autosomal recessive	y	y	[Stillborn or infantile death usual in prenatal form]	L1	y	-	lethal	lethal	lethal	L1|L2	L1	pre-infant-lethal
241510	HYPOPHOSPHATASIA, CHILDHOOD	Hypophosphatasia, childhood, 241510 (3)	Hypophosphatasia, childhood	y	HYPOPHOSPHATASIA, CHILDHOOD; HPPC	Clinical Features	died	ALPL	HGNC:438	Hypophosphatasia, childhood, 241510 (3), Autosomal recessive	Autosomal recessive	y	y	[Lia-Baldini et al. (2001) reported a 15-month-old girl with a phenotype suggestive of childhood hypophosphatasia, whose father had recurrent dental caries in his third decade despite being raised with fluoridated water, which the authors suggested represented odontohypophosphatasia. A paternal aunt had died at 7 days of apparent neonatal hypophosphatasia, with x-rays showing poorly mineralized ribs and skull, and the paternal grandmother lost all her permanent teeth in her third decade and subsequently developed osteoporosis]	L2	n	y	lethal	lethal	lethal	L1|L2	L1	pre-infant-lethal
241520	HYPOPHOSPHATEMIC RICKETS, AUTOSOMAL RECESSIVE, 1	Hypophosphatemic rickets, AR, 241520 (3)	Hypophosphatemic rickets, AR	n	-	-	-	DMP1	HGNC:2932	Hypophosphatemic rickets, AR, 241520 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
241530	HYPOPHOSPHATEMIC RICKETS WITH HYPERCALCIURIA, HEREDITARY	Hypophosphatemic rickets with hypercalciuria, 241530 (3)	Hypophosphatemic rickets with hypercalciuria	n	-	-	-	SLC34A3	HGNC:20305	Hypophosphatemic rickets with hypercalciuria, 241530 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
241600	IMMUNODEFICIENCY 43	Immunodeficiency 43, 241600 (3)	Immunodeficiency 43	y	IMMUNODEFICIENCY 43; IMD43	Clinical Features	died	B2M	HGNC:914	Immunodeficiency 43, 241600 (3), Autosomal recessive	Autosomal recessive	n	y	[Ardeniz et al. (2015) reported 2 sibs, born of consanguineous parents, with B2M deficiency... Family history included 3 sibs who died early in life and a sister who died at age 22 years with a diagnosis of 'cutaneous tuberculosis]	L6	n	y	lethal	lethal	lethal	L6	L6	post-infant-lethal
241800	PALLISTER-HALL-LIKE SYNDROME	Pallister-Hall-like syndrome, 241800 (3)	Pallister-Hall-like syndrome	y	PALLISTER-HALL-LIKE SYNDROME; PHLS	Clinical Features	died	SMO	HGNC:11119	Pallister-Hall-like syndrome, 241800 (3), Autosomal recessive	Autosomal recessive	y	y	[Encha-Razavi et al. (1992) described 3 unrelated fetuses (one was actually a term neonate who had died a few minutes after birth) in whom, at autopsy, congenital hypothalamic hamartomas were found.]	L2	y	-	lethal	lethal	lethal	L2	L2	pre-infant-lethal
241850	BAMFORTH-LAZARUS SYNDROME	Bamforth-Lazarus syndrome, 241850 (3)	Bamforth-Lazarus syndrome	n	-	-	-	FOXE1	HGNC:3806	Bamforth-Lazarus syndrome, 241850 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
242100	ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 2	Ichthyosis, congenital, autosomal recessive 2, 242100 (3)	Ichthyosis, congenital, autosomal recessive 2	n	-	-	-	ALOX12B	HGNC:430	Ichthyosis, congenital, autosomal recessive 2, 242100 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
242150	KERATITIS-ICHTHYOSIS-DEAFNESS SYNDROME, AUTOSOMAL RECESSIVE	Keratitis-ichthyosis-deafness syndrome, autosomal recessive, 242150 (3)	Keratitis-ichthyosis-deafness syndrome, autosomal recessive	n	-	-	-	AP1B1	HGNC:554	Keratitis-ichthyosis-deafness syndrome, autosomal recessive, 242150 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
242300	ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 1	Ichthyosis, congenital, autosomal recessive 1, 242300 (3)	Ichthyosis, congenital, autosomal recessive 1	y	ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 1; ARCI1	Clinical Features|Phenotype	died|lethal	TGM1	HGNC:11777	Ichthyosis, congenital, autosomal recessive 1, 242300 (3), Autosomal recessive	Autosomal recessive	y	n	-	-	-	-	ambiguous	ambiguous	ambiguous	-	-	-
242500	ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 4B	Ichthyosis, congenital, autosomal recessive 4B (harlequin), 242500 (3)	Ichthyosis, congenital, autosomal recessive 4B (harlequin)	y	ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 4B; ARCI4B	Description|Clinical Features|Clinical Synopsis|Diagnosis	fatal|died	ABCA12	HGNC:14637	Ichthyosis, congenital, autosomal recessive 4B (harlequin), 242500 (3), Autosomal recessive	Autosomal recessive	y	y	[Usually fatal within the first few weeks of life / Unamuno et al. (1987) described 3 affected males and 1 affected female from a consanguineous mating. The infants were covered with an enormous horny shell, similar to armor, with deep creases which fragmented the hard surface into large polygonal plates. The limbs remained in rigid semiflexion. The nose and external ear were hidden in the keratotic layer. Severe ectropion and eclabion were present. All 4 sibs were born prematurely. Two were alive at birth but 1 died soon after delivery and the other 4 days after delivery]	L2	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L2	L2	pre-infant-lethal
242840	VICI SYNDROME	Vici syndrome, 242840 (3)	Vici syndrome	y	VICI SYNDROME; VICIS	Clinical Features|Clinical Synopsis|Phenotype	death|deaths|died	EPG5	HGNC:29331	Vici syndrome, 242840 (3), Autosomal recessive	Autosomal recessive	n	y	[McClelland et al. (2010) reported an infant with Vici syndrome who presented at birth with hypotonia, feeble cry, and feeding difficulties. Examination showed microcephaly, hypertrophic cardiomyopathy, hypopigmentation, and dysmorphic facial features, such as broad nose, full lips, and long philtrum. He also had nystagmus, cataracts, profound sensorineural hearing loss, decreased lymphocytes, and recurrent infections. He died at age 3 months of cardiac failure]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
242860	IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 1	Immunodeficiency-centromeric instability-facial anomalies syndrome 1, 242860 (3)	Immunodeficiency-centromeric instability-facial anomalies syndrome 1	y	IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 1; ICF1	Clinical Features	died	DNMT3B	HGNC:2979	Immunodeficiency-centromeric instability-facial anomalies syndrome 1, 242860 (3), Autosomal recessive	Autosomal recessive	y	y	[Hagleitner et al. (2008) reviewed the clinical features of 45 patients with ICF syndrome. Facial dysmorphism, including epicanthic folds, hypertelorism, flat nasal bridge, and low-set ears, was commonly present. Hypo- or agammaglobulinaemia was demonstrated in nearly all patients (39 of 44), and opportunistic infections were seen in several patients, indicating T-cell dysfunction. However, there was phenotypic variability in that not all patients had obvious facial dysmorphism, and 39% had normal intelligence. Life expectancy was poor: 17 (40.5%) patients died at a mean age of 8 years, predominantly due to severe respiratory tract infections, sepsis, and failure to thrive]	L4	y	-	lethal	lethal	lethal	L4	L4	post-infant-lethal
242900	SCHIMKE IMMUNOOSSEOUS DYSPLASIA	Schimke immunoosseous dysplasia, 242900 (3)	Schimke immunoosseous dysplasia	y	SCHIMKE IMMUNOOSSEOUS DYSPLASIA; SIOD	Clinical Features	death|deaths|died	SMARCAL1	HGNC:11102	Schimke immunoosseous dysplasia, 242900 (3), Autosomal recessive	Autosomal recessive	y	y	[Taha et al. (2004) reported a case of a 5-year-old Saudi Arabian boy with SIOD who presented with fever of unknown origin secondary to B-cell lymphoma. They suggested that this was the first report of an SIOD patient with a primary lymphoproliferative disorder. The parents were first cousins. A male sib, who died at the age 3 years, was short with facies similar to that of the patient]	L4	y	-	lethal	lethal	lethal	L4	L4	post-infant-lethal
243000	INDIFFERENCE TO PAIN, CONGENITAL, AUTOSOMAL RECESSIVE	Insensitivity to pain, congenital, 243000 (3)	Insensitivity to pain, congenital	y	INDIFFERENCE TO PAIN, CONGENITAL, AUTOSOMAL RECESSIVE; CIP	Clinical Features	died	SCN9A	HGNC:10597	Insensitivity to pain, congenital, 243000 (3), Autosomal recessive	Autosomal recessive	y	n	-	-	-	-	ambiguous	ambiguous|nonlethal	ambiguous	-	-	-
243000	INDIFFERENCE TO PAIN, CONGENITAL, AUTOSOMAL RECESSIVE	Neuropathy, hereditary sensory and autonomic, type IID, 243000 (3)	Neuropathy, hereditary sensory and autonomic, type IID	y	INDIFFERENCE TO PAIN, CONGENITAL, AUTOSOMAL RECESSIVE; CIP	Clinical Features	died	SCN9A	HGNC:10597	Neuropathy, hereditary sensory and autonomic, type IID, 243000 (3), Autosomal recessive	Autosomal recessive	y	n	-	-	-	-	ambiguous	ambiguous|nonlethal	ambiguous	-	-	-
243060	SPERMATOGENIC FAILURE 5	Spermatogenic failure 5, 243060 (3)	Spermatogenic failure 5	n	-	-	-	AURKC	HGNC:11391	Spermatogenic failure 5, 243060 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
243150	GASTROINTESTINAL DEFECTS AND IMMUNODEFICIENCY SYNDROME 1	Gastrointestinal defects and immunodeficiency syndrome, 243150 (3)	Gastrointestinal defects and immunodeficiency syndrome	y	GASTROINTESTINAL DEFECTS AND IMMUNODEFICIENCY SYNDROME 1; GIDID1	Description|Clinical Features|Clinical Synopsis|Phenotype	fatal|died|death|deaths	TTC7A	HGNC:19750	Gastrointestinal defects and immunodeficiency syndrome, 243150 (3), Autosomal recessive	Autosomal recessive	y	y	[Fatal in first few months of life in most cases]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
243180	VISCERAL NEUROPATHY, FAMILIAL, 1, AUTOSOMAL RECESSIVE	Visceral neuropathy, familial, 1, autosomal recessive, 243180 (3)	Visceral neuropathy, familial, 1, autosomal recessive	y	VISCERAL NEUROPATHY, FAMILIAL, 1, AUTOSOMAL RECESSIVE; VSCN1	Clinical Features	died	ERBB3	HGNC:3431	Visceral neuropathy, familial, 1, autosomal recessive, 243180 (3), Autosomal recessive	Autosomal recessive	y	y	[Schuffler et al. (1978) described brother and sister who for 40 years had had intermittent abdominal pain, distention and vomiting as well as ataxia of gait, small, irregular, poorly reactive pupils, dysarthria, absent deep tendon reflexes, and impaired vibratory and position senses. They had inappropriate blood pressure responses to phenylephrine, Valsalva maneuver, and upright posture. They also showed lack of sweating on warming and denervation hypersensitivity of the pupils. Radiographic studies showed hyperactive, nonpropulsive contractions of a dilated esophagus and small intestine, as well as extensive colonic diverticulosis. Both died at age 65 years]	L6	y	-	lethal	lethal	lethal	L6	L6	post-infant-lethal
243300	CHOLESTASIS, BENIGN RECURRENT INTRAHEPATIC, 1	Cholestasis, benign recurrent intrahepatic, 243300 (3)	Cholestasis, benign recurrent intrahepatic	n	-	-	-	ATP8B1	HGNC:3706	Cholestasis, benign recurrent intrahepatic, 243300 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	ambiguous|lethal|nonlethal	lethal|nonlethal	L3	L3	pre-infant-lethal
243310	BARAITSER-WINTER SYNDROME 1	Baraitser-Winter syndrome 1, 243310 (3)	Baraitser-Winter syndrome 1	y	BARAITSER-WINTER SYNDROME 1; BRWS1	Clinical Features	spontaneous_abortion|spontaneous_abortions	ACTB	HGNC:132	Baraitser-Winter syndrome 1, 243310 (3), Autosomal dominant	Autosomal dominant	y	y	[Valente et al. (2005) reported an 18-year-old boy with what they termed 'Fryns-Aftimos syndrome.' The distinct facial phenotype included facial edema, ptosis, hypertelorism, and temporal flattening. Other features included webbed neck, hypoplastic thorax with inverted nipples, limited extension of the elbows and knees, epilepsy, and severe mental retardation. MRI showed diffuse pachygyria and an unusual skull base presentation with a small posterior fossa and narrowed foramen magnum. Notably, the unaffected mother had subsequent spontaneous abortion of an anencephalic male fetus with limb abnormalities, suggesting X-linked inheritance]	L1	n	y	lethal	lethal	lethal	L1|L5|L6	L1	pre-infant-lethal
243500	ISOVALERIC ACIDEMIA	Isovaleric acidemia, 243500 (3)	Isovaleric acidemia	y	ISOVALERIC ACIDEMIA; IVA	Description|Clinical Features|Clinical Synopsis	death|deaths|died	IVD	HGNC:6186	Isovaleric acidemia, 243500 (3), Autosomal recessive	Autosomal recessive	y	y	[Approximately 50% of cases are acute, severe neonatal illness often with rapid death and 50% are chronic episodic with asymptomatic intervals / Sidbury et al. (1967) observed that 3 of 4 children of a second-cousin marriage died in the first 2 weeks of life with the following symptoms after the first 3 days]	L2	y	-	lethal	lethal	lethal	L2	L2	pre-infant-lethal
243605	STROMME SYNDROME	Stromme syndrome, 243605 (3)	Stromme syndrome	y	STROMME SYNDROME; STROMS	Description|Clinical Features|Clinical Synopsis|Phenotype	lethal|died|lethality	CENPF	HGNC:1857	Stromme syndrome, 243605 (3), Autosomal recessive	Autosomal recessive	n	y	[Waters et al. (2015) reported a Caucasian family in which 4 fetuses had an embryonic lethal phenotype reminiscent of a ciliopathy. The fetuses died in midgestation, and autopsy showed hydrocephalus, cerebellar hypoplasia, agenesis of the corpus callosum, duodenal atresia, gastrointestinal malrotation, and renal hypodysplasia. Abnormal craniofacial features included microcephaly, cleft palate, micrognathia, hypertelorism, low-set ears, prominent nose, broad nasal root, and high nasal bridge]	L1	y	-	lethal	lethal	lethal	L1	L1	pre-infant-lethal
243700	HYPER-IgE SYNDROME 2, AUTOSOMAL RECESSIVE, WITH RECURRENT INFECTIONS	Hyper-IgE syndrome 2, autosomal recessive, with recurrent infections, 243700 (3)	Hyper-IgE syndrome 2, autosomal recessive, with recurrent infections	y	HYPER-IgE SYNDROME 2, AUTOSOMAL RECESSIVE, WITH RECURRENT INFECTIONS; HIES2	Clinical Features|Clinical Synopsis	died|death|deaths	DOCK8	HGNC:19191	Hyper-IgE syndrome 2, autosomal recessive, with recurrent infections, 243700 (3), Autosomal recessive	Autosomal recessive	y	y	[Eight patients died between 6 months and 12 years of age]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
243800	JOHANSON-BLIZZARD SYNDROME	Johanson-Blizzard syndrome, 243800 (3)	Johanson-Blizzard syndrome	y	JOHANSON-BLIZZARD SYNDROME; JBS	Clinical Features|Clinical Synopsis|Phenotype	died|lethal|death|deaths	UBR1	HGNC:16808	Johanson-Blizzard syndrome, 243800 (3), Autosomal recessive	Autosomal recessive	n	y	[Gould et al. (1989) described a family with 2 affected sibs and possibly a third who had died shortly after birth. One of the 2 sibs reported in detail (surprisingly, the sex was not given) died 3 days after birth, colostomy having been performed at age 36 hours for imperforate anus]	L2	y	-	lethal	lethal	lethal	L2	L2	pre-infant-lethal
244200	HYPOGONADOTROPIC HYPOGONADISM 3 WITH OR WITHOUT ANOSMIA	Hypogonadotropic hypogonadism 3 with or without anosmia, 244200 (3)	Hypogonadotropic hypogonadism 3 with or without anosmia	n	-	-	-	PROKR2	HGNC:15836	Hypogonadotropic hypogonadism 3 with or without anosmia, 244200 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
244400	CILIARY DYSKINESIA, PRIMARY, 1	Ciliary dyskinesia, primary, 1, with or without situs inversus, 244400 (3)	Ciliary dyskinesia, primary, 1, with or without situs inversus	y	CILIARY DYSKINESIA, PRIMARY, 1; CILD1	Clinical Features	died	DNAI1	HGNC:2954	Ciliary dyskinesia, primary, 1, with or without situs inversus, 244400 (3), Autosomal recessive	Autosomal recessive	y	y	[Macchiarini et al. (1994) reported en bloc double lung transplantation with bilateral bronchial anastomoses in 3 patients with complete situs inversus and end-stage lung disease. One patient died of obliterative bronchiolitis 36 months after the operation. The remaining 2 were alive and doing well after 48 months. The patients were a 41-year-old woman, a 38-year-old man, and a 49-year-old man]	L6	y	-	lethal	lethal	lethal	L6	L6	post-infant-lethal
244450	KAUFMAN OCULOCEREBROFACIAL SYNDROME	Kaufman oculocerebrofacial syndrome, 244450 (3)	Kaufman oculocerebrofacial syndrome	n	-	-	-	UBE3B	HGNC:13478	Kaufman oculocerebrofacial syndrome, 244450 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
244460	KENNY-CAFFEY SYNDROME, TYPE 1	Kenny-Caffey syndrome, type 1, 244460 (3)	Kenny-Caffey syndrome, type 1	y	KENNY-CAFFEY SYNDROME, TYPE 1; KCS1	Clinical Features	died	TBCE	HGNC:11582	Kenny-Caffey syndrome, type 1, 244460 (3), Autosomal recessive	Autosomal recessive	y	y	[Franceschini et al. (1992) suggested autosomal recessive inheritance of Kenny-Caffey syndrome in female and male sibs, born of normal consanguineous parents. The sister died at 10 days of age with generalized hypertonic seizures associated with hypocalcemia]	L2	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L2|L3	L2	pre-infant-lethal
245000	PAPILLON-LEFEVRE SYNDROME	Papillon-Lefevre syndrome, 245000 (3)	Papillon-Lefevre syndrome	n	-	-	-	CTSC	HGNC:2528	Papillon-Lefevre syndrome, 245000 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
245010	HAIM-MUNK SYNDROME	Haim-Munk syndrome, 245010 (3)	Haim-Munk syndrome	n	-	-	-	CTSC	HGNC:2528	Haim-Munk syndrome, 245010 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
245050	SUCCINYL-CoA:3-OXOACID-CoA TRANSFERASE DEFICIENCY	Succinyl CoA:3-oxoacid CoA transferase deficiency, 245050 (3)	Succinyl CoA:3-oxoacid CoA transferase deficiency	y	SUCCINYL-CoA:3-OXOACID-CoA TRANSFERASE DEFICIENCY; SCOTD	Clinical Features	died	OXCT1	HGNC:8527	Succinyl CoA:3-oxoacid CoA transferase deficiency, 245050 (3), Autosomal recessive	Autosomal recessive	n	y	[By study of cultured fibroblasts and postmortem tissue from a black male infant who died at age 6 months from severe intermittent ketoacidosis, Tildon and Cornblath (1972) found no measurable succinyl-CoA:3-ketoacid CoA-transferase activity]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
245150	KEUTEL SYNDROME	Keutel syndrome, 245150 (3)	Keutel syndrome	y	KEUTEL SYNDROME; KTLS	Clinical Features|Clinical Synopsis	died|spontaneous_abortion|spontaneous_abortions	MGP	HGNC:7060	Keutel syndrome, 245150 (3), Autosomal recessive	Autosomal recessive	y	n	-	-	-	-	ambiguous	ambiguous	ambiguous	-	-	-
245200	KRABBE DISEASE	Krabbe disease, 245200 (3)	Krabbe disease	y	KRABBE DISEASE; KRB	Description|Clinical Features|Clinical Synopsis	death|deaths|died	GALC	HGNC:4115	Krabbe disease, 245200 (3), Autosomal recessive	Autosomal recessive	y	y	[In a retrospective analysis of 26 Italian or Tunisian patients with Krabbe disease, Fiumara et al. (2011) found that 9 (34%) had the classic early infantile form with onset before age 6 months. All but 1 were born of consanguineous parents; family history of another child adopted from Brazil was not available. All presented between 2 and 5 months of age with unprovoked inconsolable crying, opisthotonus, and hemiplegia. There was rapid progressive motor deterioration with generalized hypertonia and hyperreflexia. Four patients had horizontal nystagmus, 7 had optic nerve atrophy, and 4 had seizures. Brain MRI showed symmetric cerebral and cerebellar demyelination, as well as changes in the basal nuclei and corpus callosum. Generalized brain atrophy with dilatation of the ventricles and subarachnoideal spaces was evident later over the course of the disease. GALC activity levels ranged between 0.39 and 5.8% of normal. Death occurred between 6 and 29 months of age]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
245340	ERYTHROCYTE LACTATE TRANSPORTER DEFECT	Erythrocyte lactate transporter defect, 245340 (3)	Erythrocyte lactate transporter defect	n	-	-	-	SLC16A1	HGNC:10922	Erythrocyte lactate transporter defect, 245340 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
245348	PYRUVATE DEHYDROGENASE E2 DEFICIENCY	Pyruvate dehydrogenase E2 deficiency, 245348 (3)	Pyruvate dehydrogenase E2 deficiency	n	-	-	-	DLAT	HGNC:2896	Pyruvate dehydrogenase E2 deficiency, 245348 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
245349	PYRUVATE DEHYDROGENASE E3-BINDING PROTEIN DEFICIENCY	Lacticacidemia due to PDX1 deficiency, 245349 (3)	Lacticacidemia due to PDX1 deficiency	y	PYRUVATE DEHYDROGENASE E3-BINDING PROTEIN DEFICIENCY; PDHXD	Clinical Features	died	PDHX	HGNC:21350	Lacticacidemia due to PDX1 deficiency, 245349 (3), Autosomal recessive	Autosomal recessive	y	y	[Dey et al. (2003) reported an affected infant born to related parents. The child had severe hypotonia, respiratory distress, and abnormal ocular movements. Brain MRI showed large subependymal cysts and a thin corpus callosum. Activity of the pyruvate dehydrogenase complex was reduced to 23% of control. She died at 35 days of age]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
245400	MITOCHONDRIAL DNA DEPLETION SYNDROME 9 (ENCEPHALOMYOPATHIC TYPE WITH METHYLMALONIC ACIDURIA)	Mitochondrial DNA depletion syndrome 9 (encephalomyopathic type with methylmalonic aciduria), 245400 (3)	Mitochondrial DNA depletion syndrome 9 (encephalomyopathic type with methylmalonic aciduria)	y	MITOCHONDRIAL DNA DEPLETION SYNDROME 9 (ENCEPHALOMYOPATHIC TYPE WITH METHYLMALONIC ACIDURIA); MTDPS9	Description|Clinical Features|Clinical Synopsis|Phenotype	die|death|deaths|died|fatal|lethal	SUCLG1	HGNC:11449	Mitochondrial DNA depletion syndrome 9 (encephalomyopathic type with methylmalonic aciduria), 245400 (3), Autosomal recessive	Autosomal recessive	y	y	[Ostergaard et al. (2007) described patients with fatal infantile lactic acidosis resulting from mutation in the SUCLG1 gene (611224.0001). The patients had an exceedingly severe phenotype with antenatal manifestations and severe lactic acidosis in the first day of life and death within 2 to 4 days]	L2	y	-	lethal	lethal	lethal	L2	L2	pre-infant-lethal
245450	D-LACTIC ACIDURIA WITH GOUT	D-lactic aciduria with susceptibility to gout, 245450 (3)	D-lactic aciduria with susceptibility to gout	n	-	-	-	LDHD	HGNC:19708	D-lactic aciduria with susceptibility to gout, 245450 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
245480	SPECIFIC GRANULE DEFICIENCY 1	Specific granule deficiency, 245480 (3)	Specific granule deficiency	y	SPECIFIC GRANULE DEFICIENCY 1; SGD1	Clinical Features	died	CEBPE	HGNC:1836	Specific granule deficiency, 245480 (3), Autosomal dominant, Autosomal recessive	Autosomal dominant, Autosomal recessive	y	y	[Breton-Gorius et al. (1980) found total lack of specific granules (and lactoferrin) in a 6-year-old boy with recurrent infections. Neutrophils also exhibited abnormal nuclear segmentation, nuclear clefts, abnormally weak cytochemical reaction for alkaline phosphatase, and an increased number of mitochondria and ribosomes. Degranulation of azurophil granules occurred normally following phagocytosis. Neutrophil count was normal. The parents were first cousins; a sister had died at the age of 1 year of an infection]	L3	n	y	lethal	lethal	lethal	L3	L3	pre-infant-lethal
245570	EPILEPSY, FOCAL, WITH SPEECH DISORDER AND WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT	Epilepsy, focal, with speech disorder and with or without impaired intellectual development, 245570 (3)	Epilepsy, focal, with speech disorder and with or without impaired intellectual development	n	-	-	-	GRIN2A	HGNC:4585	Epilepsy, focal, with speech disorder and with or without impaired intellectual development, 245570 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
245590	GROWTH HORMONE INSENSITIVITY SYNDROME WITH IMMUNE DYSREGULATION 1, AUTOSOMAL RECESSIVE	Growth hormone insensitivity with immune dysregulation 1, autosomal recessive, 245590 (3)	Growth hormone insensitivity with immune dysregulation 1, autosomal recessive	n	-	-	-	STAT5B	HGNC:11367	Growth hormone insensitivity with immune dysregulation 1, autosomal recessive, 245590 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
245600	MULTIPLE JOINT DISLOCATIONS, SHORT STATURE, AND CRANIOFACIAL DYSMORPHISM WITH OR WITHOUT CONGENITAL HEART DEFECTS	Multiple joint dislocations, short stature, craniofacial dysmorphism, with or without congenital heart defects, 245600 (3)	Multiple joint dislocations, short stature, craniofacial dysmorphism, with or without congenital heart defects	y	MULTIPLE JOINT DISLOCATIONS, SHORT STATURE, AND CRANIOFACIAL DYSMORPHISM WITH OR WITHOUT CONGENITAL HEART DEFECTS; JDSCD	Clinical Features	died	B3GAT3	HGNC:923	Multiple joint dislocations, short stature, craniofacial dysmorphism, with or without congenital heart defects, 245600 (3), Autosomal recessive	Autosomal recessive	y	y	[Yap et al. (2016) reported 2 sibs, clinically diagnosed with pseudodiastrophic dysplasia (PDD; see 264180), whose healthy, unrelated Caucasian parents also had 2 healthy sons. The first sib was a male fetus (patient 1A) that died in utero at 16 weeks' gestation]	L1	y	-	lethal	lethal	lethal	L1	L1	pre-infant-lethal
245660	EPIDERMOLYSIS BULLOSA, JUNCTIONAL 2C, LARYNGOONYCHOCUTANEOUS	Epidermolysis bullosa, junctional 2C, laryngoonychocutaneous, 245660 (3)	Epidermolysis bullosa, junctional 2C, laryngoonychocutaneous	y	EPIDERMOLYSIS BULLOSA, JUNCTIONAL 2C, LARYNGOONYCHOCUTANEOUS; JEB2C	Description|Clinical Features|Clinical Synopsis|Phenotype	die|death|deaths|fatal|lethal	LAMA3	HGNC:6483	Epidermolysis bullosa, junctional 2C, laryngoonychocutaneous, 245660 (3), Autosomal recessive	Autosomal recessive	y	y	[Patients may die in childhood]	L4	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L3|L4	L3	pre-infant-lethal
245900	LECITHIN:CHOLESTEROL ACYLTRANSFERASE DEFICIENCY	Norum disease, 245900 (3)	Norum disease	y	LECITHIN:CHOLESTEROL ACYLTRANSFERASE DEFICIENCY	Clinical Features	died	LCAT	HGNC:6522	Norum disease, 245900 (3), Autosomal recessive	Autosomal recessive	y	n	-	-	-	-	ambiguous	ambiguous|nonlethal	ambiguous	-	-	-
246200	DONOHUE SYNDROME	Donohue syndrome, 246200 (3)	Donohue syndrome	y	DONOHUE SYNDROME	Clinical Features|Clinical Synopsis	death|deaths|die|died	INSR	HGNC:6091	Donohue syndrome, 246200 (3), Autosomal recessive	Autosomal recessive	y	y	[died at 4 months of age]	L3	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L3|L4	L3	pre-infant-lethal
246450	3-HYDROXY-3-METHYLGLUTARYL-CoA LYASE DEFICIENCY	HMG-CoA lyase deficiency, 246450 (3)	HMG-CoA lyase deficiency	y	3-HYDROXY-3-METHYLGLUTARYL-CoA LYASE DEFICIENCY; HMGCLD	Clinical Features	death|deaths|died	HMGCL	HGNC:5005	HMG-CoA lyase deficiency, 246450 (3), Autosomal recessive	Autosomal recessive	y	y	[Grunert et al. (2017) reviewed the clinical presentation and outcome in a series of 37 patients with HMGCLD, including 30 from Turkey and the rest from Belgium, Germany, The Netherlands, and Switzerland... Six of the patients had died at a mean age of 11 years (range, 4 months to 40 years)]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
246650	LIPASE DEFICIENCY, COMBINED	Lipase deficiency, combined, 246650 (3)	Lipase deficiency, combined	y	LIPASE DEFICIENCY, COMBINED	Clinical Features|Clinical Synopsis	died|lethal	LMF1	HGNC:14154	Lipase deficiency, combined, 246650 (3), Autosomal recessive	Autosomal recessive	y	n	-	-	-	-	ambiguous	ambiguous	ambiguous	-	-	-
246700	CHYLOMICRON RETENTION DISEASE	Chylomicron retention disease, 246700 (3)	Chylomicron retention disease	n	-	-	-	SAR1B	HGNC:10535	Chylomicron retention disease, 246700 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
246900	DIHYDROLIPOAMIDE DEHYDROGENASE DEFICIENCY	Dihydrolipoamide dehydrogenase deficiency, 246900 (3)	Dihydrolipoamide dehydrogenase deficiency	y	DIHYDROLIPOAMIDE DEHYDROGENASE DEFICIENCY; DLDD	Clinical Features	death|deaths|died	DLD	HGNC:2898	Dihydrolipoamide dehydrogenase deficiency, 246900 (3), Autosomal recessive	Autosomal recessive	n	y	[Robinson et al. (1977) reported a male child, born of Caucasian first-cousin parents, who died at age 7 months with progressive neurologic deterioration and persistent metabolic acidosis]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
247100	LIPOID PROTEINOSIS OF URBACH AND WIETHE	Urbach-Wiethe disease, 247100 (3)	Urbach-Wiethe disease	n	-	-	-	ECM1	HGNC:3153	Urbach-Wiethe disease, 247100 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
248000	MACROCEPHALY/MEGALENCEPHALY SYNDROME, AUTOSOMAL RECESSIVE	Macrocephaly/megalencephaly syndrome, autosomal recessive, 248000 (3)	Macrocephaly/megalencephaly syndrome, autosomal recessive	n	-	-	-	TBC1D7	HGNC:21066	Macrocephaly/megalencephaly syndrome, autosomal recessive, 248000 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
248190	HYPOMAGNESEMIA 5, RENAL, WITH OR WITHOUT OCULAR INVOLVEMENT	Hypomagnesemia 5, renal, with ocular involvement, 248190 (3)	Hypomagnesemia 5, renal, with ocular involvement	n	-	-	-	CLDN19	HGNC:2040	Hypomagnesemia 5, renal, with ocular involvement, 248190 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
248200	STARGARDT DISEASE 1	Fundus flavimaculatus, 248200 (3)	Fundus flavimaculatus	y	STARGARDT DISEASE 1; STGD1	Clinical Features	death|deaths	ABCA4	HGNC:34	Fundus flavimaculatus, 248200 (3), Autosomal recessive	Autosomal recessive	y	n	-	-	-	-	ambiguous	ambiguous|nonlethal	ambiguous	-	-	-
248200	STARGARDT DISEASE 1	Retinal dystrophy, early-onset severe, 248200 (3)	Retinal dystrophy, early-onset severe	y	STARGARDT DISEASE 1; STGD1	Clinical Features	death|deaths	ABCA4	HGNC:34	Retinal dystrophy, early-onset severe, 248200 (3), Autosomal recessive	Autosomal recessive	y	n	-	-	-	-	ambiguous	ambiguous|nonlethal	ambiguous	-	-	-
248200	STARGARDT DISEASE 1	Stargardt disease 1, 248200 (3)	Stargardt disease 1	y	STARGARDT DISEASE 1; STGD1	Clinical Features	death|deaths	ABCA4	HGNC:34	Stargardt disease 1, 248200 (3), Autosomal recessive	Autosomal recessive	y	n	-	-	-	-	ambiguous	ambiguous|nonlethal	ambiguous	-	-	-
248250	HYPOMAGNESEMIA 3, RENAL	Hypomagnesemia 3, renal, 248250 (3)	Hypomagnesemia 3, renal	y	HYPOMAGNESEMIA 3, RENAL; HOMG3	Clinical Features	death|deaths	CLDN16	HGNC:2037	Hypomagnesemia 3, renal, 248250 (3), Autosomal recessive	Autosomal recessive	y	n	-	-	-	-	ambiguous	ambiguous	ambiguous	-	-	-
248300	MAL DE MELEDA	Meleda disease, 248300 (3)	Meleda disease	n	-	-	-	SLURP1	HGNC:18746	Meleda disease, 248300 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
248340	3MC SYNDROME 3	3MC syndrome 3, 248340 (3)	3MC syndrome 3	y	3MC SYNDROME 3; 3MC3	Clinical Features	died|miscarriage|miscarriages	COLEC10	HGNC:2220	3MC syndrome 3, 248340 (3), Autosomal recessive	Autosomal recessive	n	y	[Reardon et al. (2001) reported a 9-year-old boy whose clinical presentation resembled Malpuech syndrome, but who had radiologic features similar to those seen in patients with Juberg-Hayward syndrome (216100). At birth, the patient was noted to have left-sided cleft lip/palate, hypertelorism, micrognathia, right diaphragmatic hernia, left renal agenesis with an enlarged and downwardly displaced right kidney, bilateral undescended testes, and bilateral talipes. At age 2 he had surgery to repair a large umbilical hernia. The parents were nonconsanguineous; a second pregnancy ended in miscarriage of a fetus with a large abdominal herniation / Chinen and Naritomi (1995) reported this disorder in the sixth child of healthy parents. The first child, a male, had died at age 2 months of congenital heart disease]	L1	y	y	lethal	lethal	lethal	L1	L1	pre-infant-lethal
248360	MALONYL-CoA DECARBOXYLASE DEFICIENCY	Malonyl-CoA decarboxylase deficiency, 248360 (3)	Malonyl-CoA decarboxylase deficiency	y	MALONYL-CoA DECARBOXYLASE DEFICIENCY	Clinical Features	death|deaths|died|miscarriage|miscarriages	MLYCD	HGNC:7150	Malonyl-CoA decarboxylase deficiency, 248360 (3), Autosomal recessive	Autosomal recessive	y	y	[De Wit et al. (2006) reported a 4.5-year-old girl, born of consanguineous Moroccan parents, with MCD deficiency. Family history revealed 2 neonatal deaths and several miscarriages]	L1	n	y	lethal	lethal	lethal	L1	L1	pre-infant-lethal
248370	MANDIBULOACRAL DYSPLASIA WITH TYPE A LIPODYSTROPHY	Mandibuloacral dysplasia, 248370 (3)	Mandibuloacral dysplasia	y	MANDIBULOACRAL DYSPLASIA WITH TYPE A LIPODYSTROPHY; MADA	Clinical Features	died|lethal	LMNA	HGNC:6636	Mandibuloacral dysplasia, 248370 (3), Autosomal recessive	Autosomal recessive	y	y	[Seftel et al. (1996) reported a male newborn from South Africa (non-Italian descent) with confluent fontanels, sparse hair and eyebrows, severe micrognathia, bulbar digits, and short clavicles. These manifestations were consistent with mandibuloacral dysplasia. He also had glanular hypospadias and died at 8 days of age]	L2	y	-	lethal	ambiguous|lethal|nonlethal	lethal|nonlethal	L1|L2|L6	L1	pre-infant-lethal
248390	TREACHER COLLINS SYNDROME 3	Treacher Collins syndrome 3, 248390 (3)	Treacher Collins syndrome 3	n	-	-	-	POLR1C	HGNC:20194	Treacher Collins syndrome 3, 248390 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
248450	MANITOBA OCULOTRICHOANAL SYNDROME	Manitoba oculotrichoanal syndrome, 248450 (3)	Manitoba oculotrichoanal syndrome	n	-	-	-	FREM1	HGNC:23399	Manitoba oculotrichoanal syndrome, 248450 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L2	L2	pre-infant-lethal
248500	MANNOSIDOSIS, ALPHA B, LYSOSOMAL	Mannosidosis, alpha-, types I and II, 248500 (3)	Mannosidosis, alpha-, types I and II	y	MANNOSIDOSIS, ALPHA B, LYSOSOMAL; MANSA	Description|Clinical Features	death|deaths|died	MAN2B1	HGNC:6826	Mannosidosis, alpha-, types I and II, 248500 (3), Autosomal recessive	Autosomal recessive	y	y	[Ockerman (1967, 1969) reported a boy with a generalized lysosomal storage disorder resembling Hurler syndrome (607014), but the storage material was not acid mucopolysaccharide. The patient had coarse features, macroglossia, flat nose, large clumsy ears, widely spaced teeth, large head, big hands and feet, tall stature, lenticular opacities, muscular hypotonia, lumbar gibbus, and radiographic skeletal abnormalities. He also had mild hepatosplenomegaly, dilated cerebral ventricles, hypogammaglobulinemia, and susceptibility to infection. Vacuolated lymphocytes were present in the bone marrow and blood. The patient died at age 4.5 years during an episode of increased intracranial pressure]	L4	y	-	lethal	lethal	lethal	L4	L4	post-infant-lethal
248510	MANNOSIDOSIS, BETA A, LYSOSOMAL	Mannosidosis, beta, 248510 (3)	Mannosidosis, beta	y	MANNOSIDOSIS, BETA A, LYSOSOMAL; MANSB	Clinical Features	died	MANBA	HGNC:6831	Mannosidosis, beta, 248510 (3), Autosomal recessive	Autosomal recessive	n	y	[Cooper et al. (1991) reported a female infant with severe beta-mannosidosis. She had no dysmorphic features except brachycephaly. She showed moderate developmental delay, developed refractive seizures at age 12 months, and died at age 15 months]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
248600	MAPLE SYRUP URINE DISEASE	Maple syrup urine disease, type Ia, 248600 (3)	Maple syrup urine disease, type Ia	y	MAPLE SYRUP URINE DISEASE; MSUD	Clinical Features|Clinical Synopsis	death|deaths|died	BCKDHA	HGNC:986	Maple syrup urine disease, type Ia, 248600 (3), Autosomal recessive	Autosomal recessive	n	y	[Death in untreated children]	L4	y	-	lethal	lethal	lethal	L4	L4	post-infant-lethal
248600	MAPLE SYRUP URINE DISEASE	Maple syrup urine disease, type Ib, 248600 (3)	Maple syrup urine disease, type Ib	y	MAPLE SYRUP URINE DISEASE; MSUD	Clinical Features|Clinical Synopsis	death|deaths|died	BCKDHB	HGNC:987	Maple syrup urine disease, type Ib, 248600 (3), Autosomal recessive	Autosomal recessive	n	y	[Death in untreated children]	L4	y	-	lethal	lethal	lethal	L4	L4	post-infant-lethal
248600	MAPLE SYRUP URINE DISEASE	Maple syrup urine disease, type II, 248600 (3)	Maple syrup urine disease, type II	y	MAPLE SYRUP URINE DISEASE; MSUD	Clinical Features|Clinical Synopsis	death|deaths|died	DBT	HGNC:2698	Maple syrup urine disease, type II, 248600 (3), Autosomal recessive	Autosomal recessive	n	y	[Death in untreated children]	L4	y	-	lethal	lethal	lethal	L4	L4	post-infant-lethal
248800	MARINESCO-SJOGREN SYNDROME	Marinesco-Sjogren syndrome, 248800 (3)	Marinesco-Sjogren syndrome	n	-	-	-	SIL1	HGNC:24624	Marinesco-Sjogren syndrome, 248800 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
248900	MAST SYNDROME	Mast syndrome, 248900 (3)	Mast syndrome	y	MAST SYNDROME; MASTS	Clinical Features	died	SPG21	HGNC:20373	Mast syndrome, 248900 (3), Autosomal recessive	Autosomal recessive	y	y	[2 died in their fifties]	L6	y	-	lethal	lethal	lethal	L6	L6	post-infant-lethal
249000	MECKEL SYNDROME, TYPE 1	Meckel syndrome 1, 249000 (3)	Meckel syndrome 1	y	MECKEL SYNDROME, TYPE 1; MKS1	Clinical Features|Clinical Synopsis	death|deaths|stillborn	MKS1	HGNC:7121	Meckel syndrome 1, 249000 (3), Autosomal recessive	Autosomal recessive	y	y	[Perinatal death / Wright et al. (1994) described 2 sibs, the first of whom presented the classic Meckel syndrome triad, which they defined as encephalocele, postaxial polydactyly, and characteristic cystic changes in the kidney. The second sib showed none of these abnormalities but did show urethral atresia and preaxial polydactyly, 2 features previously described in some patients with Meckel syndrome. For example, 4 of the cases reviewed by Salonen (1984) had urethral atresia. The second sib showed features overlapping those of the entity reported as distal obstructive uropathy with polydactyly by Halal (1986); 2 unrelated stillborn infants had hydronephrosis, hydroureter, and bladder dilatation secondary to urethral obstruction, together with postaxial polydactyly.]	L1	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L1	L1	pre-infant-lethal
249100	FAMILIAL MEDITERRANEAN FEVER	Familial Mediterranean fever, AR, 249100 (3)	Familial Mediterranean fever, AR	n	-	-	-	MEFV	HGNC:6998	Familial Mediterranean fever, AR, 249100 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	ambiguous|lethal|nonlethal	lethal|nonlethal	L6	L6	post-infant-lethal
249210	MEGACYSTIS-MICROCOLON-INTESTINAL HYPOPERISTALSIS SYNDROME 1	Megacystis-microcolon-intestinal hypoperistalsis syndrome 1, 249210 (3)	Megacystis-microcolon-intestinal hypoperistalsis syndrome 1	y	MEGACYSTIS-MICROCOLON-INTESTINAL HYPOPERISTALSIS SYNDROME 1; MMIHS1	Clinical Features|Clinical Synopsis|Diagnosis|Phenotype	death|deaths|died	MYLK	HGNC:7590	Megacystis-microcolon-intestinal hypoperistalsis syndrome 1, 249210 (3), Autosomal recessive	Autosomal recessive	y	y	[Intrauterine or neonatal death]	L1	y	-	lethal	lethal	lethal	L1|LU	L1	pre-infant-lethal
249270	THIAMINE-RESPONSIVE MEGALOBLASTIC ANEMIA SYNDROME	Thiamine-responsive megaloblastic anemia syndrome, 249270 (3)	Thiamine-responsive megaloblastic anemia syndrome	n	-	-	-	SLC19A2	HGNC:10938	Thiamine-responsive megaloblastic anemia syndrome, 249270 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
249420	FRANK-TER HAAR SYNDROME	Frank-ter Haar syndrome, 249420 (3)	Frank-ter Haar syndrome	y	FRANK-TER HAAR SYNDROME; FTHS	Clinical Features	death|deaths|died	SH3PXD2B	HGNC:29242	Frank-ter Haar syndrome, 249420 (3), Autosomal recessive	Autosomal recessive	y	y	[Billette de Villemeur et al. (1992) reported a girl, the child of consanguineous parents, with congenital glaucoma, hypertelorism, short saddle nose, micrognathia, flexion deformity of fingers, unilateral clubfoot, widely open fontanels, ventricular septal defect, and motor retardation. She died at 21 months. A brother, who died at 1 year, had the same condition]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
249500	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 1	Intellectual developmental disorder, autosomal recessive 1, 249500 (3)	Intellectual developmental disorder, autosomal recessive 1	n	-	-	-	PRSS12	HGNC:9477	Intellectual developmental disorder, autosomal recessive 1, 249500 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
249700	LANGER MESOMELIC DYSPLASIA	Langer mesomelic dysplasia, 249700 (3)	Langer mesomelic dysplasia	n	-	-	-	SHOX	HGNC:10853	Langer mesomelic dysplasia, 249700 (3), Pseudoautosomal recessive	Pseudoautosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
249900	METACHROMATIC LEUKODYSTROPHY DUE TO SAPOSIN B DEFICIENCY	Metachromatic leukodystrophy due to SAP-b deficiency, 249900 (3)	Metachromatic leukodystrophy due to SAP-b deficiency	y	METACHROMATIC LEUKODYSTROPHY DUE TO SAPOSIN B DEFICIENCY; MLDSAPB	Clinical Features	died	PSAP	HGNC:9498	Metachromatic leukodystrophy due to SAP-b deficiency, 249900 (3), Autosomal recessive	Autosomal recessive	y	y	[Wrobe et al. (2000) reported a 4-year-old girl of Spanish ancestry with saposin B deficiency. At the age of 2 years, she showed severe motor deterioration, hypotonia, weakness, and signs of CNS demyelination and polyneuropathy. At 4 years of age, nerve conduction was severely decreased, and sural nerve biopsy showed active demyelination and metachromatic deposits in macrophages. A bone marrow transplant (BMT) was attempted at the age of 4 years 9 months, but the child died 2 months postengraftment]	L4	y	-	lethal	lethal	lethal	L3|L4|L5	L3	pre-infant-lethal
250100	METACHROMATIC LEUKODYSTROPHY	Metachromatic leukodystrophy, 250100 (3)	Metachromatic leukodystrophy	y	METACHROMATIC LEUKODYSTROPHY; MLD	Clinical Features|Phenotype	death|deaths|died|fatal	ARSA	HGNC:713	Metachromatic leukodystrophy, 250100 (3), Autosomal recessive	Autosomal recessive	y	y	[This condition was described by Greenfield (1933). In the late infantile form, onset is usually in the second year of life and death occurs before 5 years in most]	L4	y	-	lethal	lethal	lethal	L4	L4	post-infant-lethal
250220	SPONDYLOMETAPHYSEAL DYSPLASIA, SEDAGHATIAN TYPE	Spondylometaphyseal dysplasia, Sedaghatian type, 250220 (3)	Spondylometaphyseal dysplasia, Sedaghatian type	y	SPONDYLOMETAPHYSEAL DYSPLASIA, SEDAGHATIAN TYPE; SMDS	Description|Clinical Features|Clinical Synopsis	die|lethal|died|death|deaths	GPX4	HGNC:4556	Spondylometaphyseal dysplasia, Sedaghatian type, 250220 (3), Autosomal recessive	Autosomal recessive	n	y	[Death in perinatal period / Sedaghatian-type spondylometaphyseal dysplasia (SMDS) is a rare lethal disorder characterized by severe metaphyseal chondrodysplasia with mild limb shortening, platyspondyly, delayed epiphyseal ossification, irregular iliac crests, and pulmonary hemorrhage. Affected infants present with severe hypotonia and cardiorespiratory problems; most die within days of birth due to respiratory failure]	L2	y	-	lethal	lethal	lethal	L2	L2	pre-infant-lethal
250400	METAPHYSEAL DYSPLASIA, SPAHR TYPE	Metaphyseal dysplasia, Spahr type, 250400 (3)	Metaphyseal dysplasia, Spahr type	n	-	-	-	MMP13	HGNC:7159	Metaphyseal dysplasia, Spahr type, 250400 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
250410	RETINITIS PIGMENTOSA WITH OR WITHOUT SKELETAL ANOMALIES	Retinitis pigmentosa with or without skeletal anomalies, 250410 (3)	Retinitis pigmentosa with or without skeletal anomalies	n	-	-	-	CWC27	HGNC:10664	Retinitis pigmentosa with or without skeletal anomalies, 250410 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
250620	3-HYDROXYISOBUTYRYL-CoA HYDROLASE DEFICIENCY	3-hydroxyisobutryl-CoA hydrolase deficiency, 250620 (3)	3-hydroxyisobutryl-CoA hydrolase deficiency	y	3-HYDROXYISOBUTYRYL-CoA HYDROLASE DEFICIENCY; HIBCHD	Clinical Features	death|deaths|died	HIBCH	HGNC:4908	3-hydroxyisobutryl-CoA hydrolase deficiency, 250620 (3), Autosomal recessive	Autosomal recessive	y	y	[Brown et al. (1982) found deficiency of beta-hydroxyisobutyryl-CoA deacylase, an enzyme unique to valine metabolism, in a male infant who was born to first-cousin parents and died at age 3 months with multiple physical malformations (dysmorphic facies, multiple vertebral anomalies, tetralogy of Fallot, and, at autopsy, agenesis of the cingulate gyrus and corpus callosum).]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
250790	METHEMOGLOBINEMIA AND AMBIGUOUS GENITALIA	Methemoglobinemia and ambiguous genitalia, 250790 (3)	Methemoglobinemia and ambiguous genitalia	n	-	-	-	CYB5A	HGNC:2570	Methemoglobinemia and ambiguous genitalia, 250790 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
250800	METHEMOGLOBINEMIA DUE TO DEFICIENCY OF METHEMOGLOBIN REDUCTASE	Methemoglobinemia, type I, 250800 (3)	Methemoglobinemia, type I	y	METHEMOGLOBINEMIA DUE TO DEFICIENCY OF METHEMOGLOBIN REDUCTASE	Clinical Features	death|deaths|died|fatal	CYB5R3	HGNC:2873	Methemoglobinemia, type I, 250800 (3), Autosomal recessive	Autosomal recessive	n	y	[Aalfs et al. (2000) reported a child, born of healthy, unrelated Hindustani Suriname parents, with type II methemoglobinemia. She was born small for gestational age. Central cyanosis was noted shortly after birth. She had severe psychomotor retardation and microcephaly. Neurologic features included athetoid movements, generalized hypertonia, epilepsy, and a complete head lag. At 6 years of age, MRI of the brain demonstrated frontal and bitemporal cortical atrophy, cerebellar atrophy, retarded myelinization, and hypoplasia of the basal ganglia. There was almost no psychomotor development and she developed spastic tetraplegia with scoliosis. The patient died at the age of 8 years. Genetic analysis identified compound heterozygosity for 2 nonsense mutations in the CYB5R3 gene (Q77X; 613213.0014 and R160X; 613213.0015]	L4	y	-	lethal	lethal	lethal	L4	L4	post-infant-lethal
250800	METHEMOGLOBINEMIA DUE TO DEFICIENCY OF METHEMOGLOBIN REDUCTASE	Methemoglobinemia, type II, 250800 (3)	Methemoglobinemia, type II	y	METHEMOGLOBINEMIA DUE TO DEFICIENCY OF METHEMOGLOBIN REDUCTASE	Clinical Features	death|deaths|died|fatal	CYB5R3	HGNC:2873	Methemoglobinemia, type II, 250800 (3), Autosomal recessive	Autosomal recessive	n	y	[Aalfs et al. (2000) reported a child, born of healthy, unrelated Hindustani Suriname parents, with type II methemoglobinemia. She was born small for gestational age. Central cyanosis was noted shortly after birth. She had severe psychomotor retardation and microcephaly. Neurologic features included athetoid movements, generalized hypertonia, epilepsy, and a complete head lag. At 6 years of age, MRI of the brain demonstrated frontal and bitemporal cortical atrophy, cerebellar atrophy, retarded myelinization, and hypoplasia of the basal ganglia. There was almost no psychomotor development and she developed spastic tetraplegia with scoliosis. The patient died at the age of 8 years. Genetic analysis identified compound heterozygosity for 2 nonsense mutations in the CYB5R3 gene (Q77X; 613213.0014 and R160X; 613213.0015]	L4	y	-	lethal	lethal	lethal	L4	L4	post-infant-lethal
250850	METHIONINE ADENOSYLTRANSFERASE I/III DEFICIENCY	Hypermethioninemia, persistent, autosomal dominant, due to methionine adenosyltransferase I/III deficiency, 250850 (3)	Hypermethioninemia, persistent, autosomal dominant, due to methionine adenosyltransferase I/III deficiency	n	-	-	-	MAT1A	HGNC:6903	Hypermethioninemia, persistent, autosomal dominant, due to methionine adenosyltransferase I/III deficiency, 250850 (3), Autosomal dominant, Autosomal recessive	Autosomal dominant, Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
250850	METHIONINE ADENOSYLTRANSFERASE I/III DEFICIENCY	Methionine adenosyltransferase deficiency, autosomal recessive, 250850 (3)	Methionine adenosyltransferase deficiency, autosomal recessive	n	-	-	-	MAT1A	HGNC:6903	Methionine adenosyltransferase deficiency, autosomal recessive, 250850 (3), Autosomal dominant, Autosomal recessive	Autosomal dominant, Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
250940	HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, cblG COMPLEMENTATION TYPE	Homocystinuria-megaloblastic anemia, cblG complementation type, 250940 (3)	Homocystinuria-megaloblastic anemia, cblG complementation type	n	-	-	-	MTR	HGNC:7468	Homocystinuria-megaloblastic anemia, cblG complementation type, 250940 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
250950	3-METHYLGLUTACONIC ACIDURIA, TYPE I	3-methylglutaconic aciduria, type I, 250950 (3)	3-methylglutaconic aciduria, type I	n	-	-	-	AUH	HGNC:890	3-methylglutaconic aciduria, type I, 250950 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
251000	METHYLMALONIC ACIDURIA DUE TO METHYLMALONYL-CoA MUTASE DEFICIENCY	Methylmalonic aciduria, mut(0) type, 251000 (3)	Methylmalonic aciduria, mut(0) type	y	METHYLMALONIC ACIDURIA DUE TO METHYLMALONYL-CoA MUTASE DEFICIENCY	Clinical Features	death|deaths|died|fatal	MMUT	HGNC:7526	Methylmalonic aciduria, mut(0) type, 251000 (3), Autosomal recessive	Autosomal recessive	y	y	[The clinical spectrum of methylmalonic aciduria is wide, ranging from a benign condition (Ledley et al., 1984) to fatal neonatal disease (Matsui et al., 1983)]	L2	y	-	lethal	lethal	lethal	L2	L2	pre-infant-lethal
251100	METHYLMALONIC ACIDURIA, cblA TYPE	Methylmalonic aciduria, vitamin B12-responsive, cblA type, 251100 (3)	Methylmalonic aciduria, vitamin B12-responsive, cblA type	y	METHYLMALONIC ACIDURIA, cblA TYPE	Clinical Features	died	MMAA	HGNC:18871	Methylmalonic aciduria, vitamin B12-responsive, cblA type, 251100 (3), Autosomal recessive	Autosomal recessive	y	y	[Matsui et al. (1983) collected detailed information on 45 patients with MMA: 15 with mut(0) type, 5 with mut(-), 14 with cblA, and 11 with cblB. The most common presenting symptoms at onset were lethargy, failure to thrive, recurrent vomiting, dehydration, respiratory distress, and hypotonia. Other common features included hepatomegaly, developmental delay, and coma. Mut(0) patients presented earlier in infancy than the 3 other groups. All patients had methylmalonic acidemia and normal serum cobalamin, and most had metabolic acidosis, ketonuria, hyperammonemia, and hyperglycinemia. Approximately half of all the patients had pancytopenia. Most cblA and nearly half of cblB patients showed a decrease in urine and blood concentrations of methylmalonic acid in response to vitamin B12 supplementation, whereas none of the mut(0) or mut(-) responded. Most cblA, cblB, and mut(-) patients were still living at the time of the report; most mut(0) patients died during the first few months of life]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
251110	METHYLMALONIC ACIDURIA, cblB TYPE	Methylmalonic aciduria, vitamin B12-responsive, cblB type, 251110 (3)	Methylmalonic aciduria, vitamin B12-responsive, cblB type	y	METHYLMALONIC ACIDURIA, cblB TYPE	Clinical Features|Phenotype	died	MMAB	HGNC:19331	Methylmalonic aciduria, vitamin B12-responsive, cblB type, 251110 (3), Autosomal recessive	Autosomal recessive	y	y	[Jorge-Finnigan et al. (2010) reported 4 patients, including 2 sibs, with MMA type cblB. Two unrelated patients had onset as neonates with vastly different outcomes: 1 had severe encephalopathy at age 7 years, whereas the other was asymptomatic at age 12 years. Of the 2 sibs, 1 had late onset at age 4 years and died at age 4 years, whereas the younger sib was diagnosed at age 3 months and was asymptomatic at age 5 years]	L4	y	-	lethal	lethal	lethal	L4	L4	post-infant-lethal
251120	METHYLMALONYL-CoA EPIMERASE DEFICIENCY	Methylmalonyl-CoA epimerase deficiency, 251120 (3)	Methylmalonyl-CoA epimerase deficiency	n	-	-	-	MCEE	HGNC:16732	Methylmalonyl-CoA epimerase deficiency, 251120 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
251200	MICROCEPHALY 1, PRIMARY, AUTOSOMAL RECESSIVE	Microcephaly 1, primary, autosomal recessive, 251200 (3)	Microcephaly 1, primary, autosomal recessive	y	MICROCEPHALY 1, PRIMARY, AUTOSOMAL RECESSIVE; MCPH1	Clinical Features	death|deaths	MCPH1	HGNC:6954	Microcephaly 1, primary, autosomal recessive, 251200 (3), Autosomal recessive	Autosomal recessive	y	y	[Hofman (1984) found that micrencephalics have a significantly lower brain weight in adolescence than in early childhood, and that this cerebral dystrophy continues throughout adulthood, leading to death in more than 85% of males and 78% of females before age 30 years]	L6	y	-	lethal	lethal	lethal	L6	L6	post-infant-lethal
251230	MICROCEPHALY-MICROMELIA SYNDROME	Microcephaly-micromelia syndrome, 251230 (3)	Microcephaly-micromelia syndrome	y	MICROCEPHALY-MICROMELIA SYNDROME; MIMIS	Description|Clinical Features|Clinical Synopsis	death|deaths|died|stillborn	DONSON	HGNC:2993	Microcephaly-micromelia syndrome, 251230 (3), Autosomal recessive	Autosomal recessive	n	y	[Death in utero or in the perinatal period due to respiratory failure]	L1	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L1	L1	pre-infant-lethal
251255	JAWAD SYNDROME	Jawad syndrome, 251255 (3)	Jawad syndrome	n	-	-	-	RBBP8	HGNC:9891	Jawad syndrome, 251255 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
251260	NIJMEGEN BREAKAGE SYNDROME	Nijmegen breakage syndrome, 251260 (3)	Nijmegen breakage syndrome	y	NIJMEGEN BREAKAGE SYNDROME; NBS	Clinical Features|Clinical Synopsis	death|deaths|died	NBN	HGNC:7652	Nijmegen breakage syndrome, 251260 (3), Autosomal recessive	Autosomal recessive	y	y	[Premature death / Maraschio et al. (1986) described the case of a 31-year-old woman with primary amenorrhea, microcephaly and immunodeficiency. Her healthy parents were related as first cousins once removed. A younger sister, who also had primary amenorrhea, had died at age 20 years with a malignant lymphoma]	L6	y	y	lethal	lethal|nonlethal	lethal|nonlethal	L6	L6	post-infant-lethal
251270	MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 1	Microcephaly and chorioretinopathy, autosomal recessive, 1, 251270 (3)	Microcephaly and chorioretinopathy, autosomal recessive, 1	n	-	-	-	TUBGCP6	HGNC:18127	Microcephaly and chorioretinopathy, autosomal recessive, 1, 251270 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
251280	DIENCEPHALIC-MESENCEPHALIC JUNCTION DYSPLASIA SYNDROME 1	Diencephalic-mesencephalic junction dysplasia syndrome 1, 251280 (3)	Diencephalic-mesencephalic junction dysplasia syndrome 1	y	DIENCEPHALIC-MESENCEPHALIC JUNCTION DYSPLASIA SYNDROME 1; DMJDS1	Clinical Features	died	PCDH12	HGNC:8657	Diencephalic-mesencephalic junction dysplasia syndrome 1, 251280 (3), Autosomal recessive	Autosomal recessive	n	y	[Aran et al. (2016) reported 10 patients from 4 consanguineous Palestinian families originating from the same small town with MISSBC. Three of the 10 were affected fetuses, each from a different family, who were terminated after prenatal ultrasound showed microcephaly and hyperechogenic foci in the perithalamic and/or periventricular regions. One fetus had midbrain dysplasia. Postmortem examinations were not performed on the fetuses. Two of the other patients were children, 1 of whom died at age 3 (family A) and the other who was alive but severely disabled at age 5 (family B)]	L4	y	-	lethal	lethal	lethal	L4	L4	post-infant-lethal
251290	PSEUDO-TORCH SYNDROME 1	Pseudo-TORCH syndrome 1, 251290 (3)	Pseudo-TORCH syndrome 1	y	PSEUDO-TORCH SYNDROME 1; PTORCH1	Clinical Features|Clinical Synopsis	died|death|deaths	OCLN	HGNC:8104	Pseudo-TORCH syndrome 1, 251290 (3), Autosomal recessive	Autosomal recessive	y	y	[Abdel-Salam et al. (2008) reported a consanguineous family from Egypt in which 5 sibs had congenital microcephaly, growth retardation, and generalized tonic-clonic seizures. There were multiple structural brain anomalies, including cortical band-like calcification, calcifications of the basal ganglia and brainstem, polymicrogyria, loss of white matter, dysplastic ventricles, and hypogenesis of the corpus callosum and cerebellum. Some of the patients had dysmorphic facial features, such as anteverted nostrils, high-arched palate, low-set ears, and sloping forehead. Other features included nystagmus and spasticity. Three died within the first years of life, whereas 2 died within days after birth with high fever and status epilepticus]	L2	y	-	lethal	lethal	lethal	L2	L2	pre-infant-lethal
251300	GALLOWAY-MOWAT SYNDROME 1	Galloway-Mowat syndrome 1, 251300 (3)	Galloway-Mowat syndrome 1	y	GALLOWAY-MOWAT SYNDROME 1; GAMOS1	Clinical Features|Clinical Synopsis	death|deaths|died	WDR73	HGNC:25928	Galloway-Mowat syndrome 1, 251300 (3), Autosomal recessive	Autosomal recessive	y	y	[died at 14 days and 3 years of age]	L2	y	-	lethal	lethal	lethal	L2	L2	pre-infant-lethal
251450	DESBUQUOIS DYSPLASIA 1	Desbuquois dysplasia 1, 251450 (3)	Desbuquois dysplasia 1	y	DESBUQUOIS DYSPLASIA 1; DBQD1	Clinical Features|Clinical Synopsis|Phenotype	died|lethal|death|deaths	CANT1	HGNC:19721	Desbuquois dysplasia 1, 251450 (3), Autosomal recessive	Autosomal recessive	y	y	[Highly variable severity, ranging from death in utero to survival to adulthood with normal intelligence]	L1	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L1	L1	pre-infant-lethal
251750	MICROSPHEROPHAKIA AND/OR MEGALOCORNEA, WITH ECTOPIA LENTIS AND WITH OR WITHOUT SECONDARY GLAUCOMA	Microspherophakia and/or megalocornea, with ectopia lentis and with or without secondary glaucoma, 251750 (3)	Microspherophakia and/or megalocornea, with ectopia lentis and with or without secondary glaucoma	n	-	-	-	LTBP2	HGNC:6715	Microspherophakia and/or megalocornea, with ectopia lentis and with or without secondary glaucoma, 251750 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
251850	DIARRHEA 2, WITH MICROVILLUS ATROPHY, WITH OR WITHOUT CHOLESTASIS	Diarrhea 2, with microvillus atrophy, with or without cholestasis, 251850 (3)	Diarrhea 2, with microvillus atrophy, with or without cholestasis	y	DIARRHEA 2, WITH MICROVILLUS ATROPHY, WITH OR WITHOUT CHOLESTASIS; DIAR2	Description|Clinical Features|Clinical Synopsis	fatal|died|death|deaths	MYO5B	HGNC:7603	Diarrhea 2, with microvillus atrophy, with or without cholestasis, 251850 (3), Autosomal recessive	Autosomal recessive	y	y	[Fifteen infants (75%) died between 3 and 9 months]	L3	y	-	lethal	lethal	lethal	L3|LU	L3	pre-infant-lethal
251880	MITOCHONDRIAL DNA DEPLETION SYNDROME 3 (HEPATOCEREBRAL TYPE)	Mitochondrial DNA depletion syndrome 3 (hepatocerebral type), 251880 (3)	Mitochondrial DNA depletion syndrome 3 (hepatocerebral type)	y	MITOCHONDRIAL DNA DEPLETION SYNDROME 3 (HEPATOCEREBRAL TYPE); MTDPS3	Clinical Features|Clinical Synopsis	death|deaths|died|fatal|die	DGUOK	HGNC:2858	Mitochondrial DNA depletion syndrome 3 (hepatocerebral type), 251880 (3), Autosomal recessive	Autosomal recessive	n	y	[Mandel et al. (2001) reported 19 affected members from 3 unrelated Israeli-Druze families with the hepatocerebral form of mtDNA depletion syndrome. Affected individuals presented between birth and 6 months of age with hepatic failure, severe failure to thrive, oscillating eye movements, and neurologic abnormalities, accompanied by lactic acidosis, hypoglycemia, and markedly elevated amounts of alpha-fetoprotein in plasma. Death usually occurred before 1 year of age]	L3	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L3	L3	pre-infant-lethal
251900	MITOCHONDRIAL MYOPATHY, EPISODIC, WITH OR WITHOUT OPTIC ATROPHY AND REVERSIBLE LEUKOENCEPHALOPATHY	Mitochondrial myopathy, episodic, with optic atrophy and reversible leukoencephalopathy, 251900 (3)	Mitochondrial myopathy, episodic, with optic atrophy and reversible leukoencephalopathy	n	-	-	-	FDX2	HGNC:30546	Mitochondrial myopathy, episodic, with optic atrophy and reversible leukoencephalopathy, 251900 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
252010	MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 1	Mitochondrial complex I deficiency, nuclear type 1, 252010 (3)	Mitochondrial complex I deficiency, nuclear type 1	y	MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 1; MC1DN1	Description|Clinical Features|Clinical Synopsis	lethal|death|deaths|died|fatal	NDUFS4	HGNC:7711	Mitochondrial complex I deficiency, nuclear type 1, 252010 (3), Autosomal recessive	Autosomal recessive	y	y	[Budde et al. (2000) reported 2 unrelated patients, born to consanguineous parents, with complex I deficiency and decreased activity of complex III. The female patient showed, within 1 week of age, hypotonia, absent eye contact, lethargy, and failure to thrive. At 3 months of age, microcephaly was present and lactic acidemia with an increased lactate/pyruvate ratio was found. CT and MRI showed bilateral basal ganglia hypodensities. The child died at 3 months of age]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
252011	MITOCHONDRIAL COMPLEX II DEFICIENCY, NUCLEAR TYPE 1	Mitochondrial complex II deficiency, nuclear type 1, 252011 (3)	Mitochondrial complex II deficiency, nuclear type 1	y	MITOCHONDRIAL COMPLEX II DEFICIENCY, NUCLEAR TYPE 1; MC2DN1	Clinical Features|Phenotype	death|deaths|died	SDHA	HGNC:10680	Mitochondrial complex II deficiency, nuclear type 1, 252011 (3), Autosomal recessive	Autosomal recessive	y	y	[Jain-Ghai et al. (2013) reviewed 36 published cases of complex II deficiency. The phenotype was highly variable: some patients had multisystem involvement of the brain, heart, and muscle, sometimes resulting in death in infancy, whereas others had only isolated cardiac or muscle involvement with onset in adulthood and normal cognition]	L3	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L3	L3	pre-infant-lethal
252150	MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP A	Molybdenum cofactor deficiency A, 252150 (3)	Molybdenum cofactor deficiency A	y	MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP A; MOCODA	Description|Clinical Features|Clinical Synopsis	die|death|deaths|died	MOCS1	HGNC:7190	Molybdenum cofactor deficiency A, 252150 (3), Autosomal recessive	Autosomal recessive	n	y	[Slot et al. (1993) reported 2 unrelated patients with MOCOD who presented with neonatal convulsions. The parents in one case were second cousins. One infant died at the age of 10 days and was found to have severe loss of neocortical neurons, predominantly affecting the deeper layers, well-established gliosis of the white matter, and areas of cystic lysis in the white matter]	L2	y	-	lethal	lethal	lethal	L2	L2	pre-infant-lethal
252160	MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP B	Molybdenum cofactor deficiency B, 252160 (3)	Molybdenum cofactor deficiency B	y	MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP B; MOCODB	Description|Clinical Features|Clinical Synopsis	die|died	MOCS2	HGNC:7193	Molybdenum cofactor deficiency B, 252160 (3), Autosomal recessive	Autosomal recessive	n	y	[Hahnewald et al. (2006) reported a Senegalese male infant with molybdenum cofactor deficiency. The child was born to a nonconsanguineous couple and appeared healthy at birth. From the third day of life, he developed feeding difficulties, hypotonia, and drug-resistant tonic and clonic seizures, and he had elevated sulfite and diminished uric acid in urine. He died 21 days after birth from cardiorespiratory arrest]	L2	y	-	lethal	lethal	lethal	L2	L2	pre-infant-lethal
252270	MONOSOMY 7 MYELODYSPLASIA AND LEUKEMIA SYNDROME 1	Monosomy 7 myelodysplasia and leukemia syndrome 1, 252270 (3)	Monosomy 7 myelodysplasia and leukemia syndrome 1	y	MONOSOMY 7 MYELODYSPLASIA AND LEUKEMIA SYNDROME 1; M7MLS1	Clinical Features|Phenotype	died|death|deaths	SAMD9L	HGNC:1349	Monosomy 7 myelodysplasia and leukemia syndrome 1, 252270 (3), Autosomal dominant	Autosomal dominant	y	y	[Minelli et al. (2001) described 2 sisters with a myelodysplastic syndrome associated with partial monosomy 7. Trisomy 8 was also present in 1 of the sisters, who later developed acute myeloid leukemia of the M0 FAB-type and died, whereas the other sister died with no evolution into AML]	LU	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L4|LU	L4	post-infant-lethal
252500	MUCOLIPIDOSIS II ALPHA/BETA	Mucolipidosis II alpha/beta, 252500 (3)	Mucolipidosis II alpha/beta	y	MUCOLIPIDOSIS II ALPHA/BETA	Clinical Features|Clinical Synopsis	died|death|deaths	GNPTAB	HGNC:29670	Mucolipidosis II alpha/beta, 252500 (3), Autosomal recessive	Autosomal recessive	n	y	[Beck et al. (1995) analyzed the inter- and intrafamilial variability in I-cell disease based on 9 patients. Although they all had disproportionate dwarfism, coarse facial features, and mental retardation, there was remarkable variability in age of onset, organ manifestation, and radiologic findings. Some had unusual clinical symptoms, including pericardial effusion and profound brain atrophy. Differences were seen even in 2 affected sibs: a brother survived to the age of 8 years, dying of bronchial pneumonia, whereas a sister died from cardiac failure at the age of 2 months, and another sister died at 29 days following a similar course]	L2	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L2	L2	pre-infant-lethal
252600	MUCOLIPIDOSIS III ALPHA/BETA	Mucolipidosis III alpha/beta, 252600 (3)	Mucolipidosis III alpha/beta	n	-	-	-	GNPTAB	HGNC:29670	Mucolipidosis III alpha/beta, 252600 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L2	L2	pre-infant-lethal
252605	MUCOLIPIDOSIS III GAMMA	Mucolipidosis III gamma, 252605 (3)	Mucolipidosis III gamma	n	-	-	-	GNPTG	HGNC:23026	Mucolipidosis III gamma, 252605 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
252650	MUCOLIPIDOSIS IV	Mucolipidosis IV, 252650 (3)	Mucolipidosis IV	y	MUCOLIPIDOSIS IV; ML4	Clinical Features	death|deaths	MCOLN1	HGNC:13356	Mucolipidosis IV, 252650 (3), Autosomal recessive	Autosomal recessive	n	y	[Chitayat et al. (1991) reported 5 patients with ML IV from 3 Ashkenazi Jewish families. The presenting symptoms were hypotonia, developmental delay, corneal clouding, and puffy eyelids. Four of the patients had convergent strabismus. None progressed beyond the developmental age of 15 months. In 1 patient, death was due to aspiration at age 17 years; the oldest patient entered puberty at 20 years, developed a coarse face at 30 years, and was 32 years old at the time of report]	L5	y	-	lethal	lethal	lethal	L5	L5	post-infant-lethal
252900	MUCOPOLYSACCHARIDOSIS, TYPE IIIA	Mucopolysaccharidosis type IIIA (Sanfilippo A), 252900 (3)	Mucopolysaccharidosis type IIIA (Sanfilippo A)	y	MUCOPOLYSACCHARIDOSIS, TYPE IIIA; MPS3A	Description|Clinical Features	death|deaths|died	SGSH	HGNC:10818	Mucopolysaccharidosis type IIIA (Sanfilippo A), 252900 (3), Autosomal recessive	Autosomal recessive	y	y	[The Sanfilippo syndrome, or mucopolysaccharidosis III, is an autosomal recessive lysosomal storage disease due to impaired degradation of heparan sulfate (Esposito et al., 2000). The disorder is characterized by severe central nervous system degeneration, but only mild somatic disease. Onset of clinical features usually occurs between 2 and 6 years; severe neurologic degeneration occurs in most patients between 6 and 10 years of age, and death occurs typically during the second or third decade of life]	L5	y	-	lethal	lethal	lethal	L5	L5	post-infant-lethal
252920	MUCOPOLYSACCHARIDOSIS, TYPE IIIB	Mucopolysaccharidosis type IIIB (Sanfilippo B), 252920 (3)	Mucopolysaccharidosis type IIIB (Sanfilippo B)	y	MUCOPOLYSACCHARIDOSIS, TYPE IIIB; MPS3B	Clinical Synopsis	death|deaths	NAGLU	HGNC:7632	Mucopolysaccharidosis type IIIB (Sanfilippo B), 252920 (3), Autosomal recessive	Autosomal recessive	y	y	[Death occurs in second or third decade]	L5	y	-	lethal	lethal	lethal	L5	L5	post-infant-lethal
252930	MUCOPOLYSACCHARIDOSIS, TYPE IIIC	Mucopolysaccharidosis type IIIC (Sanfilippo C), 252930 (3)	Mucopolysaccharidosis type IIIC (Sanfilippo C)	y	MUCOPOLYSACCHARIDOSIS, TYPE IIIC; MPS3C	Clinical Features|Clinical Synopsis	death|deaths	HGSNAT	HGNC:26527	Mucopolysaccharidosis type IIIC (Sanfilippo C), 252930 (3), Autosomal recessive	Autosomal recessive	y	y	[Mean age of death is 34 years]	L6	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L6	L6	post-infant-lethal
252940	MUCOPOLYSACCHARIDOSIS, TYPE IIID	Mucopolysaccharidosis type IIID, 252940 (3)	Mucopolysaccharidosis type IIID	n	-	-	-	GNS	HGNC:4422	Mucopolysaccharidosis type IIID, 252940 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
253000	MUCOPOLYSACCHARIDOSIS, TYPE IVA	Mucopolysaccharidosis IVA, 253000 (3)	Mucopolysaccharidosis IVA	n	-	-	-	GALNS	HGNC:4122	Mucopolysaccharidosis IVA, 253000 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
253010	MUCOPOLYSACCHARIDOSIS, TYPE IVB	Mucopolysaccharidosis type IVB (Morquio), 253010 (3)	Mucopolysaccharidosis type IVB (Morquio)	n	-	-	-	GLB1	HGNC:4298	Mucopolysaccharidosis type IVB (Morquio), 253010 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L1|L4	L1	pre-infant-lethal
253200	MUCOPOLYSACCHARIDOSIS, TYPE VI	Mucopolysaccharidosis type VI (Maroteaux-Lamy), 253200 (3)	Mucopolysaccharidosis type VI (Maroteaux-Lamy)	y	MUCOPOLYSACCHARIDOSIS, TYPE VI; MPS6	Clinical Features	died	ARSB	HGNC:714	Mucopolysaccharidosis type VI (Maroteaux-Lamy), 253200 (3), Autosomal recessive	Autosomal recessive	y	y	[Horovitz et al. (2021) reported long-term outcomes in 34 Brazilian patients with MPS VI who started treatment with galsulfase enzyme replacement therapy before 5 years of age (range, 0-59 months). During follow-up, 4 patients died, 3 from respiratory events and 1 during anesthesia for an MRI]	LU	y	-	lethal	lethal	lethal	LU	LU	post-infant-lethal
253220	MUCOPOLYSACCHARIDOSIS, TYPE VII	Mucopolysaccharidosis VII, 253220 (3)	Mucopolysaccharidosis VII	y	MUCOPOLYSACCHARIDOSIS, TYPE VII; MPS7	Description|Clinical Features	lethal|death|deaths|died|spontaneous_abortion|spontaneous_abortions	GUSB	HGNC:4696	Mucopolysaccharidosis VII, 253220 (3), Autosomal recessive	Autosomal recessive	y	y	[Mucopolysaccharidosis type VII is an autosomal recessive lysosomal storage disease characterized by the inability to degrade glucuronic acid-containing glycosaminoglycans. The phenotype is highly variable, ranging from severe lethal hydrops fetalis to mild forms with survival into adulthood]	L1	y	-	lethal	lethal	lethal	L1	L1	pre-infant-lethal
253250	MULIBREY NANISM	Mulibrey nanism, 253250 (3)	Mulibrey nanism	n	-	-	-	TRIM37	HGNC:7523	Mulibrey nanism, 253250 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
253260	BIOTINIDASE DEFICIENCY	Biotinidase deficiency, 253260 (3)	Biotinidase deficiency	y	BIOTINIDASE DEFICIENCY	Clinical Features	death|deaths	BTD	HGNC:1122	Biotinidase deficiency, 253260 (3), Autosomal recessive	Autosomal recessive	y	y	[Wolf et al. (1985) reviewed the clinical presentation of 31 children with late-onset multiple carboxylase deficiency due to biotinidase deficiency. Symptoms usually appeared by about 3 months of age with seizures as the most frequent initial symptom. Other main features included hypotonia, ataxia, hearing loss, optic atrophy, skin rash, and alopecia. Metabolic abnormalities included ketolactic acidosis and organic aciduria. If untreated, symptoms became progressively worse, resulting in coma and death]	LU	y	-	lethal	lethal	lethal	LU	LU	post-infant-lethal
253270	HOLOCARBOXYLASE SYNTHETASE DEFICIENCY	Holocarboxylase synthetase deficiency, 253270 (3)	Holocarboxylase synthetase deficiency	y	HOLOCARBOXYLASE SYNTHETASE DEFICIENCY	Clinical Features	died	HLCS	HGNC:4976	Holocarboxylase synthetase deficiency, 253270 (3), Autosomal recessive	Autosomal recessive	n	y	[Yang et al. (2001) reported multiple Japanese and non-Japanese patients with neonatal MCD. Three patients developed severe acidosis in the first few days of life and died soon after]	L2	y	-	lethal	lethal	lethal	L2	L2	pre-infant-lethal
253280	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 3	Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 3, 253280 (3)	Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 3	y	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 3; MDDGA3	Description|Clinical Features|Clinical Synopsis	death|deaths|die	POMGNT1	HGNC:19139	Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 3, 253280 (3), Autosomal recessive	Autosomal recessive	y	y	[Majority of WWS patients die within the first year of life]	L3	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L3	L3	pre-infant-lethal
253290	MULTIPLE PTERYGIUM SYNDROME, LETHAL TYPE	Multiple pterygium syndrome, lethal type, 253290 (3)	Multiple pterygium syndrome, lethal type	y	MULTIPLE PTERYGIUM SYNDROME, LETHAL TYPE; LMPS	Clinical Features|Clinical Synopsis|Phenotype	death|deaths|lethal	CHRNA1	HGNC:1955	Multiple pterygium syndrome, lethal type, 253290 (3), Autosomal recessive	Autosomal recessive	n	y	[Van Regemorter et al. (1984) documented the lethal multiple pterygium syndrome in 2 spontaneously aborted fetuses from first-cousin parents of Moroccan origin. They had had 3 additional pregnancies that resulted in intrauterine death in the first trimester but information on the concepti was not available]	L1	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L1	L1	pre-infant-lethal
253290	MULTIPLE PTERYGIUM SYNDROME, LETHAL TYPE	Multiple pterygium syndrome, lethal type, 253290 (3)	Multiple pterygium syndrome, lethal type	y	MULTIPLE PTERYGIUM SYNDROME, LETHAL TYPE; LMPS	Clinical Features|Clinical Synopsis|Phenotype	death|deaths|lethal	CHRND	HGNC:1965	Multiple pterygium syndrome, lethal type, 253290 (3), Autosomal recessive	Autosomal recessive	n	y	[Van Regemorter et al. (1984) documented the lethal multiple pterygium syndrome in 2 spontaneously aborted fetuses from first-cousin parents of Moroccan origin. They had had 3 additional pregnancies that resulted in intrauterine death in the first trimester but information on the concepti was not available]	L1	y	-	lethal	lethal	lethal	L1|L3	L1	pre-infant-lethal
253290	MULTIPLE PTERYGIUM SYNDROME, LETHAL TYPE	Multiple pterygium syndrome, lethal type, 253290 (3)	Multiple pterygium syndrome, lethal type	y	MULTIPLE PTERYGIUM SYNDROME, LETHAL TYPE; LMPS	Clinical Features|Clinical Synopsis|Phenotype	death|deaths|lethal	CHRNG	HGNC:1967	Multiple pterygium syndrome, lethal type, 253290 (3), Autosomal recessive	Autosomal recessive	n	y	[Van Regemorter et al. (1984) documented the lethal multiple pterygium syndrome in 2 spontaneously aborted fetuses from first-cousin parents of Moroccan origin. They had had 3 additional pregnancies that resulted in intrauterine death in the first trimester but information on the concepti was not available]	L1	y	-	lethal	lethal	lethal	L1	L1	pre-infant-lethal
253300	SPINAL MUSCULAR ATROPHY, TYPE I	Spinal muscular atrophy-1, 253300 (3)	Spinal muscular atrophy-1	y	SPINAL MUSCULAR ATROPHY, TYPE I; SMA1	Clinical Features|Clinical Synopsis|Phenotype	death|deaths|died	SMN1	HGNC:11117	Spinal muscular atrophy-1, 253300 (3), Autosomal recessive	Autosomal recessive	y	y	[Rudnik-Schoneborn et al. (2009) reviewed the clinical features of 66 German patients with SMA type 1 caused by homozygous deletion of the SMN1 gene. Reduced fetal movements were recorded in 33% of pregnancies. Sixteen (24%) patients showed onset of weakness in the first week of life; the overall mean age at death was 9 months. Four (6.1%) patients with 1 SMN2 gene copy had severe SMA type '0' with joint contractures and respiratory distress from birth. All died within a few months of age]	L3	y	-	lethal	ambiguous|lethal	lethal	L3|L4	L3	pre-infant-lethal
253310	LETHAL CONGENITAL CONTRACTURE SYNDROME 1	Lethal congenital contracture syndrome 1, 253310 (3)	Lethal congenital contracture syndrome 1	y	LETHAL CONGENITAL CONTRACTURE SYNDROME 1; LCCS1	Description|Clinical Features|Clinical Synopsis	lethal|death|deaths|died|stillborn	GLE1	HGNC:4315	Lethal congenital contracture syndrome 1, 253310 (3), Autosomal recessive	Autosomal recessive	n	y	[Neonatal death / Makela-Bengs et al. (1997) noted that LCCS leads to prenatal death of the fetus before the thirty-second week of gestation]	L1	y	-	lethal	lethal	lethal	L1	L1	pre-infant-lethal
253400	SPINAL MUSCULAR ATROPHY, TYPE III	Spinal muscular atrophy-3, 253400 (3)	Spinal muscular atrophy-3	y	SPINAL MUSCULAR ATROPHY, TYPE III; SMA3	Description|Phenotype	death|deaths|lethality	SMN1	HGNC:11117	Spinal muscular atrophy-3, 253400 (3), Autosomal recessive	Autosomal recessive	y	n	-	-	-	-	ambiguous	ambiguous|lethal	lethal	L3|L4	L3	pre-infant-lethal
253550	SPINAL MUSCULAR ATROPHY, TYPE II	Spinal muscular atrophy-2, 253550 (3)	Spinal muscular atrophy-2	y	SPINAL MUSCULAR ATROPHY, TYPE II; SMA2	Clinical Synopsis	death|deaths	SMN1	HGNC:11117	Spinal muscular atrophy-2, 253550 (3), Autosomal recessive	Autosomal recessive	y	y	[Death between 2 years of age and young adulthood]	L4	y	-	lethal	ambiguous|lethal	lethal	L3|L4	L3	pre-infant-lethal
253600	MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 1	Muscular dystrophy, limb-girdle, autosomal recessive 1, 253600 (3)	Muscular dystrophy, limb-girdle, autosomal recessive 1	y	MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 1; LGMDR1	Clinical Features	death|deaths	CAPN3	HGNC:1480	Muscular dystrophy, limb-girdle, autosomal recessive 1, 253600 (3), Autosomal recessive	Autosomal recessive	y	y	[In a large study of patients with different forms of muscular dystrophy, Chung and Morton (1959) delineated the common features of limb-girdle muscular dystrophy. Onset usually occurred in childhood, but sometimes in maturity or middle age. Involvement was first evident in either the pelvic or, less frequently, the shoulder girdle, often with asymmetry of wasting when the upper limbs were first involved. Spread from the lower to the upper limbs or vice versa occurred within 20 years. Pseudohypertrophy of the calves was uncommon, but may have been counterfeited by a stocky build or wasting of the vasti. The rate of progression was variable, but severe disability with inability to walk was seen within 20 to 30 years of onset. Contractures and facial weakness occurred in some in late stages. Age at death was variable with the largest number of patients dying in middle age]	LU	y	-	lethal	lethal|nonlethal	lethal|nonlethal	LU	LU	post-infant-lethal
253601	MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 2	Muscular dystrophy, limb-girdle, autosomal recessive 2, 253601 (3)	Muscular dystrophy, limb-girdle, autosomal recessive 2	n	-	-	-	DYSF	HGNC:3097	Muscular dystrophy, limb-girdle, autosomal recessive 2, 253601 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
253700	MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 5	Muscular dystrophy, limb-girdle, autosomal recessive 5, 253700 (3)	Muscular dystrophy, limb-girdle, autosomal recessive 5	y	MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 5; LGMDR5	Clinical Features	death|deaths	SGCG	HGNC:10809	Muscular dystrophy, limb-girdle, autosomal recessive 5, 253700 (3), Autosomal recessive	Autosomal recessive	y	y	[Autosomal recessive inheritance of a muscular dystrophy resembling X-linked Duchenne muscular dystrophy (DMD; 310200) was reported by Kloepfer and Talley (1958), Dubowitz (1960), and Skyring and McKusick (1961), among others. The clinical course was characterized by onset before age 5 years, confinement to wheelchair by 12 years, and death usually before age 20 years]	L5	y	-	lethal	lethal	lethal	L5	L5	post-infant-lethal
253800	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 4	Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 4, 253800 (3)	Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 4	y	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 4; MDDGA4	Description|Clinical Features|Phenotype	death|deaths|died|lethal	FKTN	HGNC:3622	Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 4, 253800 (3), Autosomal recessive	Autosomal recessive	y	y	[Cotarelo et al. (2008) described a Spanish female infant, born of nonconsanguineous parents, who was diagnosed with Walker-Warburg syndrome and died on day 5 of life after suffering respiratory apnea and bradycardia]	L2	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L2|L5	L2	pre-infant-lethal
254090	ULLRICH CONGENITAL MUSCULAR DYSTROPHY 1	Ullrich congenital muscular dystrophy 1, 254090 (3)	Ullrich congenital muscular dystrophy 1	y	ULLRICH CONGENITAL MUSCULAR DYSTROPHY 1; UCMD1	Clinical Features	died	COL6A1	HGNC:2211	Ullrich congenital muscular dystrophy 1, 254090 (3), Autosomal dominant, Autosomal recessive	Autosomal dominant, Autosomal recessive	y	y	[Nadeau et al. (2009) reported the natural history of 13 patients with UCMD. The mean age at symptom onset was 12 months, with delayed motor development and proximal weakness, but 6 patients had a congenital presentation with variable combinations of congenital hip dislocation (2), hypotonia (3), contractures (4), torticollis (2), scoliosis (1), and feeding difficulties (2). Eight patients (61.5%) acquired independent ambulation, none ever ran, and 9 were wheelchair-dependent at a mean age of 11 years. All patients developed multiple joint contractures in the first decade of life, including of the long finger flexors. Twelve patients had scoliosis, 6 had kyphosis, and many had rigid spine. All patients developed progressive respiratory insufficiency from age 6 years on, and most required nocturnal ventilation; 2 died of respiratory failure at ages 10.8 and 15.1 years]	L5	y	-	lethal	lethal	lethal	L5|L6	L5	post-infant-lethal
254090	ULLRICH CONGENITAL MUSCULAR DYSTROPHY 1	Ullrich congenital muscular dystrophy 1, 254090 (3)	Ullrich congenital muscular dystrophy 1	y	ULLRICH CONGENITAL MUSCULAR DYSTROPHY 1; UCMD1	Clinical Features	died	COL6A2	HGNC:2212	Ullrich congenital muscular dystrophy 1, 254090 (3), Autosomal dominant, Autosomal recessive	Autosomal dominant, Autosomal recessive	y	y	[Nadeau et al. (2009) reported the natural history of 13 patients with UCMD. The mean age at symptom onset was 12 months, with delayed motor development and proximal weakness, but 6 patients had a congenital presentation with variable combinations of congenital hip dislocation (2), hypotonia (3), contractures (4), torticollis (2), scoliosis (1), and feeding difficulties (2). Eight patients (61.5%) acquired independent ambulation, none ever ran, and 9 were wheelchair-dependent at a mean age of 11 years. All patients developed multiple joint contractures in the first decade of life, including of the long finger flexors. Twelve patients had scoliosis, 6 had kyphosis, and many had rigid spine. All patients developed progressive respiratory insufficiency from age 6 years on, and most required nocturnal ventilation; 2 died of respiratory failure at ages 10.8 and 15.1 years]	L5	y	-	lethal	lethal	lethal	L5|L6	L5	post-infant-lethal
254090	ULLRICH CONGENITAL MUSCULAR DYSTROPHY 1	Ullrich congenital muscular dystrophy 1, 254090 (3)	Ullrich congenital muscular dystrophy 1	y	ULLRICH CONGENITAL MUSCULAR DYSTROPHY 1; UCMD1	Clinical Features	died	COL6A3	HGNC:2213	Ullrich congenital muscular dystrophy 1, 254090 (3), Autosomal dominant, Autosomal recessive	Autosomal dominant, Autosomal recessive	y	y	[Nadeau et al. (2009) reported the natural history of 13 patients with UCMD. The mean age at symptom onset was 12 months, with delayed motor development and proximal weakness, but 6 patients had a congenital presentation with variable combinations of congenital hip dislocation (2), hypotonia (3), contractures (4), torticollis (2), scoliosis (1), and feeding difficulties (2). Eight patients (61.5%) acquired independent ambulation, none ever ran, and 9 were wheelchair-dependent at a mean age of 11 years. All patients developed multiple joint contractures in the first decade of life, including of the long finger flexors. Twelve patients had scoliosis, 6 had kyphosis, and many had rigid spine. All patients developed progressive respiratory insufficiency from age 6 years on, and most required nocturnal ventilation; 2 died of respiratory failure at ages 10.8 and 15.1 years]	L5	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L5|L6	L5	post-infant-lethal
254110	MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 8	Muscular dystrophy, limb-girdle, autosomal recessive 8, 254110 (3)	Muscular dystrophy, limb-girdle, autosomal recessive 8	n	-	-	-	TRIM32	HGNC:16380	Muscular dystrophy, limb-girdle, autosomal recessive 8, 254110 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
254130	MIYOSHI MUSCULAR DYSTROPHY 1	Miyoshi muscular dystrophy 1, 254130 (3)	Miyoshi muscular dystrophy 1	n	-	-	-	DYSF	HGNC:3097	Miyoshi muscular dystrophy 1, 254130 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
254210	MYASTHENIC SYNDROME, CONGENITAL, 6, PRESYNAPTIC	Myasthenic syndrome, congenital, 6, presynaptic, 254210 (3)	Myasthenic syndrome, congenital, 6, presynaptic	y	MYASTHENIC SYNDROME, CONGENITAL, 6, PRESYNAPTIC; CMS6	Clinical Features|Clinical Synopsis	died|death|deaths	CHAT	HGNC:1912	Myasthenic syndrome, congenital, 6, presynaptic, 254210 (3), Autosomal recessive	Autosomal recessive	n	y	[Zammarchi et al. (1994) described an affected infant who showed decreased intrauterine fetal movements and had closed fists and polyhydramnios by ultrasonography at 16 weeks' gestation. At birth, she had distal articular rigidity, flexion of the hands, long and tapering fingers, and hypotonia. Episodes of apnea occurred in association with an upper respiratory infection at the age of 13 months. Treatment with pyridostigmine bromide was effective. Palpebral ptosis occurred on one occasion and was controlled by medication. A younger brother, who died at 15 hours of life from respiratory failure, had arthrogryposis and presumably was also affected by congenital myasthenia]	L2	n	y	lethal	lethal	lethal	L2	L2	pre-infant-lethal
254300	MYASTHENIC SYNDROME, CONGENITAL, 10	Myasthenic syndrome, congenital, 10, 254300 (3)	Myasthenic syndrome, congenital, 10	y	MYASTHENIC SYNDROME, CONGENITAL, 10; CMS10	Clinical Features	died	DOK7	HGNC:26594	Myasthenic syndrome, congenital, 10, 254300 (3), Autosomal recessive	Autosomal recessive	y	n	-	-	-	-	ambiguous	ambiguous|lethal	lethal	L1	L1	pre-infant-lethal
254600	MYELOPEROXIDASE DEFICIENCY	Myeloperoxidase deficiency, 254600 (3)	Myeloperoxidase deficiency	n	-	-	-	MPO	HGNC:7218	Myeloperoxidase deficiency, 254600 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
254780	MYOCLONIC EPILEPSY OF LAFORA	Epilepsy, progressive myoclonic 2A (Lafora), 254780 (3)	Epilepsy, progressive myoclonic 2A (Lafora)	y	MYOCLONIC EPILEPSY OF LAFORA	Clinical Features|Phenotype	death|deaths	EPM2A	HGNC:3413	Epilepsy, progressive myoclonic 2A (Lafora), 254780 (3), Autosomal recessive	Autosomal recessive	y	y	[Schwarz and Yanoff (1965) described a brother and sister, offspring of a one-and-one-half cousin marriage, with this disease. Seizures began at age 15 in the boy with slowly progressive motor and mental deterioration leading to death at age 23.5 years. The sister's seizures began at age 14 years and progression to dementia and blindness occurred, with death at age 19]	L6	y	y	lethal	lethal	lethal	L6	L6	post-infant-lethal
254780	MYOCLONIC EPILEPSY OF LAFORA	Epilepsy, progressive myoclonic 2B (Lafora), 254780 (3)	Epilepsy, progressive myoclonic 2B (Lafora)	y	MYOCLONIC EPILEPSY OF LAFORA	Clinical Features|Phenotype	death|deaths	NHLRC1	HGNC:21576	Epilepsy, progressive myoclonic 2B (Lafora), 254780 (3), Autosomal recessive	Autosomal recessive	y	y	[Schwarz and Yanoff (1965) described a brother and sister, offspring of a one-and-one-half cousin marriage, with this disease. Seizures began at age 15 in the boy with slowly progressive motor and mental deterioration leading to death at age 23.5 years. The sister's seizures began at age 14 years and progression to dementia and blindness occurred, with death at age 19]	L6	y	y	lethal	lethal	lethal	L6	L6	post-infant-lethal
254800	MYOCLONIC EPILEPSY OF UNVERRICHT AND LUNDBORG	Epilepsy, progressive myoclonic 1A (Unverricht and Lundborg), 254800 (3)	Epilepsy, progressive myoclonic 1A (Unverricht and Lundborg)	y	MYOCLONIC EPILEPSY OF UNVERRICHT AND LUNDBORG	Clinical Features	death|deaths|died|fatal	CSTB	HGNC:2482	Epilepsy, progressive myoclonic 1A (Unverricht and Lundborg), 254800 (3), Autosomal recessive	Autosomal recessive	y	y	[Carr et al. (2007) reported 2 large families from the Western Cape province of South Africa with generalized tonic-clonic seizures and myoclonus. The mean age at onset was 20 years (range 13 to 31). Myoclonus predominantly affected the trunk and upper limbs but was also observed in the lower limbs. Hand tremor became apparent on posture holding. Additional features included nystagmus, abnormal pursuit, dysarthria, hyperreflexia, cerebellar ataxia, and cerebellar atrophy. A number of patients also had progressive cognitive impairment, resulting in dementia in some. EEG studies were abnormal in the majority of patients, with polyspike and wave activity and/or clear epileptogenic activity. Postmortem examination of 1 patient showed cerebellar atrophy and cerebellar neuronal loss. Several patients died in their thirties and forties]	L6	y	-	lethal	lethal	lethal	L6	L6	post-infant-lethal
254900	EPILEPSY, PROGRESSIVE MYOCLONIC, 4, WITH OR WITHOUT RENAL FAILURE	Epilepsy, progressive myoclonic 4, with or without renal failure, 254900 (3)	Epilepsy, progressive myoclonic 4, with or without renal failure	y	EPILEPSY, PROGRESSIVE MYOCLONIC, 4, WITH OR WITHOUT RENAL FAILURE; EPM4	Clinical Features|Clinical Synopsis	died|death|deaths	SCARB2	HGNC:1665	Epilepsy, progressive myoclonic 4, with or without renal failure, 254900 (3), Autosomal recessive	Autosomal recessive	n	y	[Onset in teens to 20's / Death occurs 10 to 20 years after onset]	L6	y	-	lethal	lethal	lethal	L6	L6	post-infant-lethal
254940	CAREY-FINEMAN-ZITER SYNDROME 1	Carey-Fineman-Ziter syndrome, 254940 (3)	Carey-Fineman-Ziter syndrome	y	CAREY-FINEMAN-ZITER SYNDROME 1; CFZS1	Clinical Features	died	MYMK	HGNC:33778	Carey-Fineman-Ziter syndrome, 254940 (3), Autosomal recessive	Autosomal recessive	y	y	[Di Gioia et al. (2017) provided follow-up of the sibs with CFZS originally reported by Carey et al. (1982). Both had nocturnal hypoventilation and developed restrictive pulmonary disease and pulmonary hypertension after 35 years of age; 1 died at age 37]	L6	y	-	lethal	lethal	lethal	L6	L6	post-infant-lethal
255100	LIPID STORAGE MYOPATHY DUE TO FLAVIN ADENINE DINUCLEOTIDE SYNTHETASE DEFICIENCY	Lipid storage myopathy due to flavin adenine dinucleotide synthetase deficiency, 255100 (3)	Lipid storage myopathy due to flavin adenine dinucleotide synthetase deficiency	y	LIPID STORAGE MYOPATHY DUE TO FLAVIN ADENINE DINUCLEOTIDE SYNTHETASE DEFICIENCY; LSMFLAD	Description|Clinical Features|Clinical Synopsis|Phenotype	death|deaths|died|miscarriage|miscarriages	FLAD1	HGNC:24671	Lipid storage myopathy due to flavin adenine dinucleotide synthetase deficiency, 255100 (3), Autosomal recessive	Autosomal recessive	n	y	[Olsen et al. (2016) reported 9 patients from 7 unrelated families, recruited from metabolic centers in 6 countries, with a metabolic myopathy variably associated with mitochondrial respiratory chain deficiencies... Four patients died within the first year of life. In 1 consanguineous family, a boy died at age 3 days, whereas his sister was still alive at age 22 years... One consanguineous family experienced 4 miscarriages]	L1	y	y	lethal	lethal	lethal	L1	L1	pre-infant-lethal
255110	CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, MYOPATHIC, STRESS-INDUCED	CPT II deficiency, myopathic, stress-induced, 255110 (3)	CPT II deficiency, myopathic, stress-induced	y	CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, MYOPATHIC, STRESS-INDUCED	Description|Clinical Features|Clinical Synopsis	death|deaths|lethal|died	CPT2	HGNC:2330	CPT II deficiency, myopathic, stress-induced, 255110 (3), Autosomal dominant, Autosomal recessive	Autosomal dominant, Autosomal recessive	y	y	[Carnitine palmitoyltransferase II deficiency is an inherited disorder of mitochondrial long-chain fatty acid oxidation. The myopathic form presents most frequently in children or young adults with muscle pain with or, in most cases, without myoglobinuria with elevation of serum creatine kinase precipitated by strenuous exercise, cold, fever, or prolonged fasting. Severity of attacks is highly variable. Myoglobinuria can cause kidney failure and death / Handig et al. (1996) reported a consanguineous CPT II deficient-family with 3 affected members who showed phenotypic variability. The proband, a male, suffered from a classic form of adult CPT II deficiency with recurrent rhabdomyolysis with myoglobinuria and serum creatine kinase levels up to more than 100,000 U/l. By contrast, a female cousin was almost asymptomatic and had never had episodes of acute muscular injury with rhabdomyolysis and myoglobinuria, although her affected sister had died at the age of 16 years during a severe attack of muscle injury]	L5	y	y	lethal	lethal	lethal	L2|L3|L5	L2	pre-infant-lethal
255120	CARNITINE PALMITOYLTRANSFERASE I DEFICIENCY	CPT deficiency, hepatic, type IA, 255120 (3)	CPT deficiency, hepatic, type IA	y	CARNITINE PALMITOYLTRANSFERASE I DEFICIENCY	Clinical Features	death|deaths	CPT1A	HGNC:2328	CPT deficiency, hepatic, type IA, 255120 (3), Autosomal recessive	Autosomal recessive	n	y	[Bougneres et al. (1981) reported 2 sisters who developed severe hypoketotic hypoglycemia at age 8 months, resulting in death in 1 of them]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
255125	MYOPATHY WITH LACTIC ACIDOSIS, HEREDITARY	Myopathy with lactic acidosis, hereditary, 255125 (3)	Myopathy with lactic acidosis, hereditary	n	-	-	-	ISCU	HGNC:29882	Myopathy with lactic acidosis, hereditary, 255125 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
255160	CONGENITAL MYOPATHY 7B, MYOSIN STORAGE, AUTOSOMAL RECESSIVE	Congenital myopathy 7B, myosin storage, autosomal recessive, 255160 (3)	Congenital myopathy 7B, myosin storage, autosomal recessive	y	CONGENITAL MYOPATHY 7B, MYOSIN STORAGE, AUTOSOMAL RECESSIVE; CMYP7B	Clinical Features|Phenotype	died	MYH7	HGNC:7577	Congenital myopathy 7B, myosin storage, autosomal recessive, 255160 (3), Autosomal recessive	Autosomal recessive	y	y	[ died of cardiac failure at age 32]	L6	n	y	lethal	lethal|nonlethal	lethal|nonlethal	L1|L6	L1	pre-infant-lethal
255200	MYOPATHY, CENTRONUCLEAR, 2	Centronuclear myopathy 2, 255200 (3)	Centronuclear myopathy 2	y	MYOPATHY, CENTRONUCLEAR, 2; CNM2	Clinical Features	death|deaths|died	BIN1	HGNC:1052	Centronuclear myopathy 2, 255200 (3), Autosomal recessive	Autosomal recessive	y	y	[Pavone et al. (1980) observed a girl with typical clinical and histologic features of centronuclear myopathy. The electromyogram was of myopathic type. The parents were first cousins once removed. A paternal aunt and uncle and a maternal aunt, all dead, were thought to have also been affected. Curiously, the authors concluded that the pedigree 'suggests autosomal dominant inheritance with low penetrance.' Difficulty walking, noted at the 'end of the third semester of life,' was the first manifestation. She showed severe hypotonia, bilateral ptosis and absence of deep tendon reflexes. At age 10 years, external ophthalmoplegia and facial weakness were also present. Death in the affected relatives had been at ages 2, 5, and 12 years]	L4	n	y	lethal	lethal	lethal	L4	L4	post-infant-lethal
255310	CONGENITAL MYOPATHY 4A, AUTOSOMAL DOMINANT	Congenital myopathy 4A, autosomal dominant, 255310 (3)	Congenital myopathy 4A, autosomal dominant	y	CONGENITAL MYOPATHY 4A, AUTOSOMAL DOMINANT; CMYP4A	Clinical Features	died	TPM3	HGNC:12012	Congenital myopathy 4A, autosomal dominant, 255310 (3), Autosomal dominant	Autosomal dominant	y	n	-	-	-	-	ambiguous	ambiguous|lethal	lethal	L3	L3	pre-infant-lethal
255320	CONGENITAL MYOPATHY 1B, AUTOSOMAL RECESSIVE	Congenital myopathy 1B, autosomal recessive, 255320 (3)	Congenital myopathy 1B, autosomal recessive	y	CONGENITAL MYOPATHY 1B, AUTOSOMAL RECESSIVE; CMYP1B	Description|Clinical Features|Clinical Synopsis|Phenotype	death|deaths|died|lethal|lethality	RYR1	HGNC:10483	Congenital myopathy 1B, autosomal recessive, 255320 (3), Autosomal recessive	Autosomal recessive	y	y	[Some patients have lethal fetal akinesia with death in utero]	L1	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L1|LU	L1	pre-infant-lethal
255700	MYOTONIA CONGENITA, AUTOSOMAL RECESSIVE	Myotonia congenita, recessive, 255700 (3)	Myotonia congenita, recessive	n	-	-	-	CLCN1	HGNC:2019	Myotonia congenita, recessive, 255700 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
255800	SCHWARTZ-JAMPEL SYNDROME, TYPE 1	Schwartz-Jampel syndrome, type 1, 255800 (3)	Schwartz-Jampel syndrome, type 1	y	SCHWARTZ-JAMPEL SYNDROME, TYPE 1; SJS1	Phenotype	lethal	HSPG2	HGNC:5273	Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive	Autosomal recessive	y	n	-	-	-	-	ambiguous	ambiguous|lethal	lethal	L2	L2	pre-infant-lethal
255960	MYXOMA, INTRACARDIAC	Myxoma, intracardiac, 255960 (3)	Myxoma, intracardiac	y	MYXOMA, INTRACARDIAC	Clinical Features	died	PRKAR1A	HGNC:9388	Myxoma, intracardiac, 255960 (3), Autosomal dominant	Autosomal dominant	n	y	[Dandolu et al. (1995) described a family in which the mother had biatrial myxoma with stalks growing from either side of the interatrial septum. A son and a daughter of hers had atrial myxoma and a 12-year-old son had died suddenly after having cardiac symptoms consistent with myxoma]	L5	n	y	lethal	lethal|nonlethal	lethal|nonlethal	L4|L5|LU	L4	post-infant-lethal
255995	CONGENITAL MYOPATHY 13	Congenital myopathy 13, 255995 (3)	Congenital myopathy 13	y	CONGENITAL MYOPATHY 13; CMYP13	Clinical Features	died	STAC3	HGNC:28423	Congenital myopathy 13, 255995 (3), Autosomal recessive	Autosomal recessive	y	y	[died within the first year of life]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
256020	FOCAL SEGMENTAL GLOMERULOSCLEROSIS 10	Focal segmental glomerulosclerosis 10, 256020 (3)	Focal segmental glomerulosclerosis 10	n	-	-	-	LMX1B	HGNC:6654	Focal segmental glomerulosclerosis 10, 256020 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L4	L4	post-infant-lethal
256030	NEMALINE MYOPATHY 2	Nemaline myopathy 2, autosomal recessive, 256030 (3)	Nemaline myopathy 2, autosomal recessive	y	NEMALINE MYOPATHY 2; NEM2	Clinical Features	death|deaths|lethal	NEB	HGNC:7720	Nemaline myopathy 2, autosomal recessive, 256030 (3), Autosomal recessive	Autosomal recessive	y	y	[Death at birth or within first 2 years of life (severe form)]	L2	y	-	lethal	lethal	lethal	L1|L2	L1	pre-infant-lethal
256040	PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 1	Proteasome-associated autoinflammatory syndrome 1 and digenic forms, 256040 (3)	Proteasome-associated autoinflammatory syndrome 1 and digenic forms	y	PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 1; PRAAS1	Clinical Features	died	PSMB8	HGNC:9545	Proteasome-associated autoinflammatory syndrome 1 and digenic forms, 256040 (3), Autosomal recessive	Autosomal recessive	y	y	[Torrelo et al. (2010) proposed the acronym chronic atypical neutrophilic dermatosis with lipodystrophy and elevated temperature syndrome (CANDLE) to refer to this presumably autosomal recessive disorder. In 3 of the patients reported by Torrelo et al. (2010), Liu et al. (2012) identified the same homozygous mutation in the PSMB8 gene (T75M; 177046.0001); the fourth patient, who had died at age 14 years, was presumed to carry the same mutation as her sister]	L5	n	y	lethal	lethal	lethal	L5	L5	post-infant-lethal
256050	ATELOSTEOGENESIS, TYPE II	Atelosteogenesis, type II, 256050 (3)	Atelosteogenesis, type II	y	ATELOSTEOGENESIS, TYPE II; AO2	Clinical Features|Clinical Synopsis	death|deaths|die|stillborn	SLC26A2	HGNC:10994	Atelosteogenesis, type II, 256050 (3), Autosomal recessive	Autosomal recessive	n	y	[Stillborn or death shortly after birth]	L1	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L1|L2	L1	pre-infant-lethal
256050	ATELOSTEOGENESIS, TYPE II	De la Chapelle dysplasia, 256050 (3)	De la Chapelle dysplasia	y	ATELOSTEOGENESIS, TYPE II; AO2	Clinical Features|Clinical Synopsis	death|deaths|die|stillborn	SLC26A2	HGNC:10994	De la Chapelle dysplasia, 256050 (3), Autosomal recessive	Autosomal recessive	n	y	[Stillborn or death shortly after birth]	L1	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L1|L2	L1	pre-infant-lethal
256100	NEPHRONOPHTHISIS 1	Nephronophthisis 1, juvenile, 256100 (3)	Nephronophthisis 1, juvenile	y	NEPHRONOPHTHISIS 1; NPHP1	Description|Clinical Features	death|deaths|died	NPHP1	HGNC:7905	Nephronophthisis 1, juvenile, 256100 (3), Autosomal recessive	Autosomal recessive	y	y	[Like several other mendelizing disorders, this one was first described by Fanconi et al. (1951). In the various reports, anemia, polyuria, polydipsia, isosthenuria, and death in uremia have been features. Hypertension and proteinuria are conspicuous in their absence. Symmetrical destruction of the kidneys involving both tubules and glomeruli (which were hyalinized) are observed. The age at death ranges from about 4 to 15 years]	L4	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L4	L4	post-infant-lethal
256300	NEPHROTIC SYNDROME, TYPE 1	Nephrotic syndrome, type 1, 256300 (3)	Nephrotic syndrome, type 1	y	NEPHROTIC SYNDROME, TYPE 1; NPHS1	Clinical Features|Clinical Synopsis|Phenotype	lethal|death|deaths|stillborn	NPHS1	HGNC:7908	Nephrotic syndrome, type 1, 256300 (3), Autosomal recessive	Autosomal recessive	y	y	[Early death without kidney transplant / In a review of Finnish congenital nephrosis, Tryggvason et al. (2006) noted that affected persons have massive proteinuria in utero and the nephrotic syndrome develops soon after birth. Affected children are usually born prematurely, and the weight of the placenta is almost invariably more than 25% of the weight of the child at birth. Hypoalbuminemia, hyperlipidemia, abdominal distention, and edema appear soon after birth. Electron microscopic studies of the kidney show effacement of the podocytes, a narrow slit, and absence of the slit diaphragm. The disorder is lethal; immunosuppressive therapy does not induce a remission]	LU	y	-	lethal	lethal	lethal	LU	LU	post-infant-lethal
256370	NEPHROTIC SYNDROME, TYPE 4	Nephrotic syndrome, type 4, 256370 (3)	Nephrotic syndrome, type 4	y	NEPHROTIC SYNDROME, TYPE 4; NPHS4	Clinical Features	death|deaths|died	WT1	HGNC:12796	Nephrotic syndrome, type 4, 256370 (3), Autosomal dominant	Autosomal dominant	y	y	[Jeanpierre et al. (1998) also reported 10 other patients with diffuse mesangial sclerosis on renal biopsy in the context of DDS. Nine of the patients had the 46,XY karyotype and genital abnormalities ranging from testicular ectopia to female phenotype. One patient had the 46,XX karyotype and streaked ovaries. Unilateral WT was diagnosed in 2 patients, and gonadoblastoma was diagnosed in 2 other patients. For all 20 patients, the age at which the first symptoms of nephrotic syndrome were observed varied from birth to 4.3 years. The age at end-stage renal disease was 18 days to 4.5 years, except for 1 patient who developed ESRD at age 11 years 6 months. Two patients died of ESRD during the first month of life]	L2	y	-	lethal	lethal	lethal	L2|LU	L2	pre-infant-lethal
256450	HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 1	Hyperinsulinemic hypoglycemia, familial, 1, 256450 (3)	Hyperinsulinemic hypoglycemia, familial, 1	y	HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 1; HHF1	Clinical Features	death|deaths|died|stillborn	ABCC8	HGNC:59	Hyperinsulinemic hypoglycemia, familial, 1, 256450 (3), Autosomal dominant, Autosomal recessive	Autosomal dominant, Autosomal recessive	y	n	-	-	-	-	ambiguous	ambiguous|nonlethal	ambiguous	-	-	-
256500	NETHERTON SYNDROME	Netherton syndrome, 256500 (3)	Netherton syndrome	y	NETHERTON SYNDROME; NETH	Clinical Features|Clinical Synopsis|Phenotype	died|fatal|die|death|deaths|lethal	SPINK5	HGNC:15464	Netherton syndrome, 256500 (3), Autosomal recessive	Autosomal recessive	y	y	[Some severely affected infants die in the neonatal period]	L2	y	-	lethal	lethal	lethal	L2	L2	pre-infant-lethal
256520	NEU-LAXOVA SYNDROME 1	Neu-Laxova syndrome 1, 256520 (3)	Neu-Laxova syndrome 1	y	NEU-LAXOVA SYNDROME 1; NLS1	Description|Clinical Features|Clinical Synopsis	lethal|died|lethality|stillborn|die	PHGDH	HGNC:8923	Neu-Laxova syndrome 1, 256520 (3), Autosomal recessive	Autosomal recessive	n	y	[Most patients are stillborn or die in immediate neonatal period]	L1	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L1	L1	pre-infant-lethal
256540	GALACTOSIALIDOSIS	Galactosialidosis, 256540 (3)	Galactosialidosis	y	GALACTOSIALIDOSIS; GSL	Description|Clinical Features	death|deaths|died	CTSA	HGNC:9251	Galactosialidosis, 256540 (3), Autosomal recessive	Autosomal recessive	y	y	[Landau et al. (1995) added galactosialidosis to the list of conditions that can cause nonimmune hydrops fetalis. Four pregnancies of a 22-year-old Bedouin woman produced a severely hydropic fetus in 1 case; her husband was a first cousin. The second pregnancy was terminated in the second trimester after ultrasound diagnosis of hydrops fetalis. The placenta showed marked accumulation of a mucoid material. The first and third pregnancies resulted in delivery of a preterm hydropic baby who died a few days after birth]	L2	y	-	lethal	lethal	lethal	L2	L2	pre-infant-lethal
256550	NEURAMINIDASE DEFICIENCY	Sialidosis, type I, 256550 (3)	Sialidosis, type I	y	NEURAMINIDASE DEFICIENCY	Clinical Features|Diagnosis	death|deaths|died	NEU1	HGNC:7758	Sialidosis, type I, 256550 (3), Autosomal recessive	Autosomal recessive	y	y	[Laver et al. (1983) reported a case of the type II early infantile sialidosis with onset at birth and death at 4 months. The patient's fibroblasts showed neuraminidase deficiency, and reduced levels of enzyme activity were found in the lymphocytes of both parents. A previously born sister was apparently affected; born prematurely, she died 6 hours after birth and showed hepatosplenomegaly as well as foam cells in the placenta]	L2	y	y	lethal	lethal	lethal	L2	L2	pre-infant-lethal
256550	NEURAMINIDASE DEFICIENCY	Sialidosis, type II, 256550 (3)	Sialidosis, type II	y	NEURAMINIDASE DEFICIENCY	Clinical Features|Diagnosis	death|deaths|died	NEU1	HGNC:7758	Sialidosis, type II, 256550 (3), Autosomal recessive	Autosomal recessive	y	y	[Laver et al. (1983) reported a case of the type II early infantile sialidosis with onset at birth and death at 4 months. The patient's fibroblasts showed neuraminidase deficiency, and reduced levels of enzyme activity were found in the lymphocytes of both parents. A previously born sister was apparently affected; born prematurely, she died 6 hours after birth and showed hepatosplenomegaly as well as foam cells in the placenta]	L2	y	y	lethal	lethal	lethal	L2	L2	pre-infant-lethal
256600	NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2A	Infantile neuroaxonal dystrophy 1, 256600 (3)	Infantile neuroaxonal dystrophy 1	y	NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2A; NBIA2A	Clinical Features|Clinical Synopsis	death|deaths|died	PLA2G6	HGNC:9039	Infantile neuroaxonal dystrophy 1, 256600 (3), Autosomal recessive	Autosomal recessive	y	y	[Hunter et al. (1987) described 2 brothers who had a remarkably similar history of prenatal onset of neurologic deterioration, gangrene of the distal limbs leading to autoamputation of digits, pathologic changes of axonal dystrophy, and minor anomalies. They died at 9 months and 14.5 months of age]	L3	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L3|L6	L3	pre-infant-lethal
256730	CEROID LIPOFUSCINOSIS, NEURONAL, 1	Ceroid lipofuscinosis, neuronal, 1, 256730 (3)	Ceroid lipofuscinosis, neuronal, 1	n	-	-	-	PPT1	HGNC:9325	Ceroid lipofuscinosis, neuronal, 1, 256730 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
256731	CEROID LIPOFUSCINOSIS, NEURONAL, 5	Ceroid lipofuscinosis, neuronal, 5, 256731 (3)	Ceroid lipofuscinosis, neuronal, 5	y	CEROID LIPOFUSCINOSIS, NEURONAL, 5; CLN5	Clinical Synopsis	death|deaths	CLN5	HGNC:2076	Ceroid lipofuscinosis, neuronal, 5, 256731 (3), Autosomal recessive	Autosomal recessive	n	y	[Death at 13 to 30 years]	L5	y	-	lethal	lethal	lethal	L5	L5	post-infant-lethal
256800	INSENSITIVITY TO PAIN, CONGENITAL, WITH ANHIDROSIS	Insensitivity to pain, congenital, with anhidrosis, 256800 (3)	Insensitivity to pain, congenital, with anhidrosis	y	INSENSITIVITY TO PAIN, CONGENITAL, WITH ANHIDROSIS; CIPA	Clinical Features	died	NTRK1	HGNC:8031	Insensitivity to pain, congenital, with anhidrosis, 256800 (3), Autosomal recessive	Autosomal recessive	n	y	[Ishii et al. (1988) described a Japanese girl with CIPA who died at the age of 21 months]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
256810	MITOCHONDRIAL DNA DEPLETION SYNDROME 6 (HEPATOCEREBRAL TYPE)	Mitochondrial DNA depletion syndrome 6 (hepatocerebral type), 256810 (3)	Mitochondrial DNA depletion syndrome 6 (hepatocerebral type)	y	MITOCHONDRIAL DNA DEPLETION SYNDROME 6 (HEPATOCEREBRAL TYPE); MTDPS6	Description|Clinical Features|Clinical Synopsis|Diagnosis	death|deaths|died|miscarriage|miscarriages	MPV17	HGNC:7224	Mitochondrial DNA depletion syndrome 6 (hepatocerebral type), 256810 (3), Autosomal recessive	Autosomal recessive	n	y	[Spinazzola et al. (2008) reported 2 sisters, born of Iraqi consanguineous parents, with a hepatocerebral form of MTDPS confirmed by genetic analysis (137960.0005). The family history was positive for 2 miscarriages. At age 2 months, the older sister developed jaundice and hepatomegaly associated with clinical liver failure that progressed rapidly over the next few months. Initial MRI at age 3 months was normal but later showed edema of the white matter. She developed dystonic movements and deteriorating neurologic status and died from liver failure at age 11 months. The younger sister showed hypotonia and died of rapidly progressive liver failure at age 5 months. A third unrelated girl, conceived by artificial insemination because of a history of endometriosis in the mother, cried immediately after birth, fed poorly, and was jittery. At age 2 weeks, she was lethargic and had abnormal liver function tests. Brain MRI showed bilateral subdural hemorrhages with an area of periventricular leukomalacia in the right parietal region. Physical examination at age 5 months showed poor growth, hypotonia, roving eye movements, and nystagmus. She died of liver failure at 9 months of age]	L1	y	y	lethal	ambiguous|lethal	lethal	L1	L1	pre-infant-lethal
256840	NEUROPATHY, HEREDITARY SENSORY, WITH SPASTIC PARAPLEGIA, AUTOSOMAL RECESSIVE	Neuropathy, hereditary sensory, with spastic paraplegia, 256840 (3)	Neuropathy, hereditary sensory, with spastic paraplegia	n	-	-	-	CCT5	HGNC:1618	Neuropathy, hereditary sensory, with spastic paraplegia, 256840 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
256850	GIANT AXONAL NEUROPATHY 1, AUTOSOMAL RECESSIVE	Giant axonal neuropathy-1, 256850 (3)	Giant axonal neuropathy-1	n	-	-	-	GAN	HGNC:4137	Giant axonal neuropathy-1, 256850 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
257200	NIEMANN-PICK DISEASE, TYPE A	Niemann-Pick disease, type A, 257200 (3)	Niemann-Pick disease, type A	y	NIEMANN-PICK DISEASE, TYPE A	Description|Clinical Features|Clinical Synopsis	death|deaths|died|fatal	SMPD1	HGNC:11120	Niemann-Pick disease, type A, 257200 (3), Autosomal recessive	Autosomal recessive	y	y	[Death by age 3 years]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
257220	NIEMANN-PICK DISEASE, TYPE C1	Niemann-Pick disease, type C1, 257220 (3)	Niemann-Pick disease, type C1	y	NIEMANN-PICK DISEASE, TYPE C1; NPC1	Clinical Features|Clinical Synopsis	death|deaths|died|lethal|fatal	NPC1	HGNC:7897	Niemann-Pick disease, type C1, 257220 (3), Autosomal recessive	Autosomal recessive	y	y	[Death usually in teenage years]	L5	y	-	lethal	lethal	lethal	L5	L5	post-infant-lethal
257220	NIEMANN-PICK DISEASE, TYPE C1	Niemann-Pick disease, type D, 257220 (3)	Niemann-Pick disease, type D	y	NIEMANN-PICK DISEASE, TYPE C1; NPC1	Clinical Features|Clinical Synopsis	death|deaths|died|lethal|fatal	NPC1	HGNC:7897	Niemann-Pick disease, type D, 257220 (3), Autosomal recessive	Autosomal recessive	y	y	[Death usually in teenage years]	L5	y	-	lethal	lethal	lethal	L5	L5	post-infant-lethal
257270	NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1B	Night blindness, congenital stationary (complete), 1B, autosomal recessive, 257270 (3)	Night blindness, congenital stationary (complete), 1B, autosomal recessive	n	-	-	-	GRM6	HGNC:4598	Night blindness, congenital stationary (complete), 1B, autosomal recessive, 257270 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
257300	MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 1	Mosaic variegated aneuploidy syndrome 1, 257300 (3)	Mosaic variegated aneuploidy syndrome 1	y	MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 1; MVA1	Clinical Features	died	BUB1B	HGNC:1149	Mosaic variegated aneuploidy syndrome 1, 257300 (3), Autosomal recessive	Autosomal recessive	y	y	[Matsuura et al. (2000) analyzed skin fibroblast cells from 2 unrelated Japanese male infants with MVA and chromosome instability. One of the patients had been reported by Kawame et al. (1999). Both infants had severe growth and developmental retardation, microcephaly, and Dandy-Walker anomaly, and both developed Wilms tumor. One died at age 5 months and the other at age 3 years]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
257320	LISSENCEPHALY 2	Lissencephaly 2 (Norman-Roberts type), 257320 (3)	Lissencephaly 2 (Norman-Roberts type)	n	-	-	-	RELN	HGNC:9957	Lissencephaly 2 (Norman-Roberts type), 257320 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
257850	OCULODENTODIGITAL DYSPLASIA, AUTOSOMAL RECESSIVE	Oculodentodigital dysplasia, autosomal recessive, 257850 (3)	Oculodentodigital dysplasia, autosomal recessive	n	-	-	-	GJA1	HGNC:4274	Oculodentodigital dysplasia, autosomal recessive, 257850 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
257920	3MC SYNDROME 1	3MC syndrome 1, 257920 (3)	3MC syndrome 1	y	3MC SYNDROME 1; 3MC1	Clinical Features	died	MASP1	HGNC:6901	3MC syndrome 1, 257920 (3), Autosomal recessive	Autosomal recessive	y	y	[Leal and Baptista (2007) reported 3 additional Brazilian cases of Michels syndrome: 2 brothers, aged 23 and 17 years, respectively, born to first-cousin parents, and an unrelated 11-year-old girl. The younger affected brother had a normal twin brother, and a fourth brother, who had died at 2 years of age from diarrhea, was reported to have had the same facial appearance as the 2 affected brothers]	L4	n	y	lethal	lethal	lethal	L4	L4	post-infant-lethal
257980	ODONTOONYCHODERMAL DYSPLASIA	Ectodermal dysplasia 16 (odontoonychodermal dysplasia), 257980 (3)	Ectodermal dysplasia 16 (odontoonychodermal dysplasia)	n	-	-	-	WNT10A	HGNC:13829	Ectodermal dysplasia 16 (odontoonychodermal dysplasia), 257980 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
258100	OGUCHI DISEASE 1	Oguchi disease-1, 258100 (3)	Oguchi disease-1	n	-	-	-	SAG	HGNC:10521	Oguchi disease-1, 258100 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	ambiguous|nonlethal	ambiguous	-	-	-
258150	SPERMATOGENIC FAILURE 1	Spermatogenic failure 1, 258150 (3)	Spermatogenic failure 1	n	-	-	-	SYCP2	HGNC:11490	Spermatogenic failure 1, 258150 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
258315	OMODYSPLASIA 1	Omodysplasia 1, 258315 (3)	Omodysplasia 1	y	OMODYSPLASIA 1; OMOD1	Clinical Features	died	GPC6	HGNC:4454	Omodysplasia 1, 258315 (3), Autosomal recessive	Autosomal recessive	y	y	[Stoll et al. (1995) reported a girl with very short limbs whose parents were first cousins. A paternal aunt of the proposita, who was also the product of first-cousin parents, had very short limbs; she was not available for physical or radiologic examination as she had died at age 3 years]	L4	n	y	lethal	lethal	lethal	L4	L4	post-infant-lethal
258450	PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 1	Progressive external ophthalmoplegia, autosomal recessive 1, 258450 (3)	Progressive external ophthalmoplegia, autosomal recessive 1	y	PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 1; PEOB1	Clinical Features	death|deaths|died	POLG	HGNC:9179	Progressive external ophthalmoplegia, autosomal recessive 1, 258450 (3), Autosomal recessive	Autosomal recessive	y	y	[Van Goethem et al. (1997) reported 2 Belgian families in which 5 individuals had arPEO... Two patients had sudden unexplained death in their late thirties]	L6	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L2|L3|L5|L6	L2	pre-infant-lethal
258480	OPSISMODYSPLASIA	Opsismodysplasia, 258480 (3)	Opsismodysplasia	y	OPSISMODYSPLASIA; OPSMD	Description|Clinical Features|Clinical Synopsis|Phenotype	death|deaths|died|lethal|stillborn	INPPL1	HGNC:6080	Opsismodysplasia, 258480 (3), Autosomal recessive	Autosomal recessive	y	y	[May result in death in neonatal period or early childhood / Death in utero or secondary to respiratory failure during the first few years of life has been reported, but there can be long-term survival]	L1	y	-	lethal	lethal	lethal	L1	L1	pre-infant-lethal
258501	3-METHYLGLUTACONIC ACIDURIA, TYPE III	3-methylglutaconic aciduria, type III, 258501 (3)	3-methylglutaconic aciduria, type III	n	-	-	-	OPA3	HGNC:8142	3-methylglutaconic aciduria, type III, 258501 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
258860	OROFACIODIGITAL SYNDROME IV	Orofaciodigital syndrome IV, 258860 (3)	Orofaciodigital syndrome IV	y	OROFACIODIGITAL SYNDROME IV; OFD4	Clinical Features|Phenotype	stillborn|lethal	TCTN3	HGNC:24519	Orofaciodigital syndrome IV, 258860 (3), Autosomal recessive	Autosomal recessive	n	y	[s et al. (1994) entertained a severe form of OFD IV as the diagnosis in a child of first-cousin Lebanese parents who was spontaneously delivered stillborn at 27 weeks' gestation]	L1	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L1	L1	pre-infant-lethal
258870	GYRATE ATROPHY OF CHOROID AND RETINA	Gyrate atrophy of choroid and retina with or without ornithinemia, 258870 (3)	Gyrate atrophy of choroid and retina with or without ornithinemia	n	-	-	-	OAT	HGNC:8091	Gyrate atrophy of choroid and retina with or without ornithinemia, 258870 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
258900	OROTIC ACIDURIA	Orotic aciduria, 258900 (3)	Orotic aciduria	y	OROTIC ACIDURIA	Clinical Features	died	UMPS	HGNC:12563	Orotic aciduria, 258900 (3), Autosomal recessive	Autosomal recessive	n	n	-	-	-	-	ambiguous	ambiguous	ambiguous	-	-	-
259050	PRIMROSE SYNDROME	Primrose syndrome, 259050 (3)	Primrose syndrome	n	-	-	-	ZBTB20	HGNC:13503	Primrose syndrome, 259050 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
259100	HYPERTROPHIC OSTEOARTHROPATHY, PRIMARY, AUTOSOMAL RECESSIVE, 1	Cranioosteoarthropathy, 259100 (3)	Cranioosteoarthropathy	n	-	-	-	HPGD	HGNC:5154	Cranioosteoarthropathy, 259100 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
259100	HYPERTROPHIC OSTEOARTHROPATHY, PRIMARY, AUTOSOMAL RECESSIVE, 1	Hypertrophic osteoarthropathy, primary, autosomal recessive 1, 259100 (3)	Hypertrophic osteoarthropathy, primary, autosomal recessive 1	n	-	-	-	HPGD	HGNC:5154	Hypertrophic osteoarthropathy, primary, autosomal recessive 1, 259100 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
259420	OSTEOGENESIS IMPERFECTA, TYPE III	Osteogenesis imperfecta, type III, 259420 (3)	Osteogenesis imperfecta, type III	y	OSTEOGENESIS IMPERFECTA, TYPE III; OI3	Clinical Features	died	COL1A1	HGNC:2197	Osteogenesis imperfecta, type III, 259420 (3), Autosomal dominant	Autosomal dominant	n	y	[Peltonen et al. (1980) studied procollagen synthesis by fibroblasts from a male patient who died at age 18 years after a fall from his wheelchair. He was born with multiple fractures. He had blue sclerae, but normal dentition]	L5	y	-	lethal	ambiguous|lethal|nonlethal	lethal|nonlethal	L2|L5|LU	L2	pre-infant-lethal
259420	OSTEOGENESIS IMPERFECTA, TYPE III	Osteogenesis imperfecta, type III, 259420 (3)	Osteogenesis imperfecta, type III	y	OSTEOGENESIS IMPERFECTA, TYPE III; OI3	Clinical Features	died	COL1A2	HGNC:2198	Osteogenesis imperfecta, type III, 259420 (3), Autosomal dominant	Autosomal dominant	n	y	[Peltonen et al. (1980) studied procollagen synthesis by fibroblasts from a male patient who died at age 18 years after a fall from his wheelchair. He was born with multiple fractures. He had blue sclerae, but normal dentition]	L5	y	-	lethal	ambiguous|lethal|nonlethal	lethal|nonlethal	L2|L4|L5	L2	pre-infant-lethal
259440	OSTEOGENESIS IMPERFECTA, TYPE IX	Osteogenesis imperfecta, type IX, 259440 (3)	Osteogenesis imperfecta, type IX	y	OSTEOGENESIS IMPERFECTA, TYPE IX; OI9	Clinical Features|Phenotype	died|lethal	PPIB	HGNC:9255	Osteogenesis imperfecta, type IX, 259440 (3), Autosomal recessive	Autosomal recessive	n	y	[Pyott et al. (2011) identified mutations in the PPIB gene in 3 families with OI9; one family had a lethal OI type II phenotype, another had a severe OI type III phenotype, and the last had a moderately severe deforming OI type III/IV phenotype]	L2	y	-	lethal	lethal	lethal	L2	L2	pre-infant-lethal
259450	BRUCK SYNDROME 1	Bruck syndrome 1, 259450 (3)	Bruck syndrome 1	y	BRUCK SYNDROME 1; BRKS1	Clinical Features	died	FKBP10	HGNC:18169	Bruck syndrome 1, 259450 (3), Autosomal recessive	Autosomal recessive	y	y	[McPherson and Clemens (1997) described a male patient who was born with flexion contractures and pterygia at the elbows, clubfeet, torticollis, and several rib fractures... He died at age 21 of restrictive lung disease]	L6	y	-	lethal	ambiguous|lethal	lethal	L6	L6	post-infant-lethal
259600	MULTICENTRIC OSTEOLYSIS, NODULOSIS, AND ARTHROPATHY	Multicentric osteolysis, nodulosis, and arthropathy, 259600 (3)	Multicentric osteolysis, nodulosis, and arthropathy	n	-	-	-	MMP2	HGNC:7166	Multicentric osteolysis, nodulosis, and arthropathy, 259600 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
259700	OSTEOPETROSIS, AUTOSOMAL RECESSIVE 1	Osteopetrosis, autosomal recessive 1, 259700 (3)	Osteopetrosis, autosomal recessive 1	y	OSTEOPETROSIS, AUTOSOMAL RECESSIVE 1; OPTB1	Clinical Features	lethal	TCIRG1	HGNC:11647	Osteopetrosis, autosomal recessive 1, 259700 (3), Autosomal recessive	Autosomal recessive	y	y	[Dudin and Rambaud-Cousson (1993) found 7 cases of lethal infantile osteopetrosis]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
259710	OSTEOPETROSIS, AUTOSOMAL RECESSIVE 2	Osteopetrosis, autosomal recessive 2, 259710 (3)	Osteopetrosis, autosomal recessive 2	y	OSTEOPETROSIS, AUTOSOMAL RECESSIVE 2; OPTB2	Clinical Features|Clinical Synopsis	died|lethal	TNFSF11	HGNC:11926	Osteopetrosis, autosomal recessive 2, 259710 (3), Autosomal recessive	Autosomal recessive	n	y	[also a mild dominant form and a lethal recessive form / McClure (1978) reported a relatively mild form of recessive osteopetrosis in 3 sibs. One died at age 17; the 2 others were surviving at ages 20 and 16]	L5	y	-	lethal	lethal	lethal	L5	L5	post-infant-lethal
259720	OSTEOPETROSIS, AUTOSOMAL RECESSIVE 5	Osteopetrosis, autosomal recessive 5, 259720 (3)	Osteopetrosis, autosomal recessive 5	y	OSTEOPETROSIS, AUTOSOMAL RECESSIVE 5; OPTB5	Clinical Features|Clinical Synopsis|Phenotype	died|stillborn|death|deaths|lethal	OSTM1	HGNC:21652	Osteopetrosis, autosomal recessive 5, 259720 (3), Autosomal recessive	Autosomal recessive	n	y	[El Khazen et al. (1986) reported severe osteopetrosis with in utero fractures in 2 successive offspring, a male and a female, born of first-cousin Moroccan parents. They suggested that this was a distinct entity because osteoclasts were markedly reduced (they are usually increased in severe recessive osteopetrosis) and clinical expression occurred very early. Hydrocephaly and skeletal hyperdensity were detected at 18 weeks of gestation and fractures at 24 weeks. The female was stillborn, and the pregnancy with the male was terminated at 25 weeks]	L1	y	-	lethal	lethal	lethal	L1	L1	pre-infant-lethal
259730	OSTEOPETROSIS, AUTOSOMAL RECESSIVE 3	Osteopetrosis, autosomal recessive 3, with renal tubular acidosis, 259730 (3)	Osteopetrosis, autosomal recessive 3, with renal tubular acidosis	n	-	-	-	CA2	HGNC:1373	Osteopetrosis, autosomal recessive 3, with renal tubular acidosis, 259730 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
259770	OSTEOPOROSIS-PSEUDOGLIOMA SYNDROME	Osteoporosis-pseudoglioma syndrome, 259770 (3)	Osteoporosis-pseudoglioma syndrome	n	-	-	-	LRP5	HGNC:6697	Osteoporosis-pseudoglioma syndrome, 259770 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
259775	RAINE SYNDROME	Raine syndrome, 259775 (3)	Raine syndrome	y	RAINE SYNDROME; RNS	Description|Clinical Features|Phenotype	death|deaths|lethal|died|stillborn	FAM20C	HGNC:22140	Raine syndrome, 259775 (3), Autosomal recessive	Autosomal recessive	y	y	[Chitayat et al. (2007) described prenatal ultrasound, autopsy, and neuropathologic findings in a stillborn infant with Raine syndrome, the offspring of nonconsanguineous parents / Raine syndrome is a neonatal osteosclerotic bone dysplasia of early and aggressive onset that usually results in death within the first few weeks of life, although there have been some reports of survival into childhood]	L1	y	-	lethal	lethal	lethal	L1	L1	pre-infant-lethal
259900	HYPEROXALURIA, PRIMARY, TYPE I	Hyperoxaluria, primary, type 1, 259900 (3)	Hyperoxaluria, primary, type 1	y	HYPEROXALURIA, PRIMARY, TYPE I; HP1	Clinical Features|Clinical Synopsis	died|fatal|die	AGXT	HGNC:341	Hyperoxaluria, primary, type 1, 259900 (3), Autosomal recessive	Autosomal recessive	y	y	[Boquist et al. (1973) reported a 46-year-old man with primary oxalosis who had onset of symptoms as an adult characterized by elevated levels of serum and urinary oxalic acid, as well as increased urinary excretion of glycolic and glyoxylic acid... He died in uremia after 14 months of hemodialysis]	L6	y	-	lethal	lethal	lethal	L6	L6	post-infant-lethal
260000	HYPEROXALURIA, PRIMARY, TYPE II	Hyperoxaluria, primary, type II, 260000 (3)	Hyperoxaluria, primary, type II	n	-	-	-	GRHPR	HGNC:4570	Hyperoxaluria, primary, type II, 260000 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
260005	5-OXOPROLINASE DEFICIENCY	5-oxoprolinase deficiency, 260005 (3)	5-oxoprolinase deficiency	n	-	-	-	OPLAH	HGNC:8149	5-oxoprolinase deficiency, 260005 (3), Autosomal dominant, Autosomal recessive	Autosomal dominant, Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
260300	PARKINSON DISEASE 15, AUTOSOMAL RECESSIVE EARLY-ONSET	Parkinson disease 15, autosomal recessive, 260300 (3)	Parkinson disease 15, autosomal recessive	n	-	-	-	FBXO7	HGNC:13586	Parkinson disease 15, autosomal recessive, 260300 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
260370	PANCREATIC AGENESIS 1	Pancreatic agenesis 1, 260370 (3)	Pancreatic agenesis 1	n	-	-	-	PDX1	HGNC:6107	Pancreatic agenesis 1, 260370 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
260400	SHWACHMAN-DIAMOND SYNDROME 1	Shwachman-Diamond syndrome 1, 260400 (3)	Shwachman-Diamond syndrome 1	y	SHWACHMAN-DIAMOND SYNDROME 1; SDS1	Clinical Features	death|deaths|died	SBDS	HGNC:19440	Shwachman-Diamond syndrome 1, 260400 (3), Autosomal recessive	Autosomal recessive	y	y	[One patient died in infancy of respiratory infection]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
260540	PARKINSON-DEMENTIA SYNDROME	Supranuclear palsy, progressive atypical, 260540 (3)	Supranuclear palsy, progressive atypical	y	PARKINSON-DEMENTIA SYNDROME	Clinical Features	died	MAPT	HGNC:6893	Supranuclear palsy, progressive atypical, 260540 (3), Autosomal recessive	Autosomal recessive	n	y	[Mata et al. (1983) described 2 brothers and a sister with a 'new' Parkinson-dementia syndrome. The disorder, characterized also by ophthalmoparesis and pyramidal signs, came on in the third decade and progressed for several years. Kyphoscoliosis was present in all 3 sibs. Examination of the brain in the sister, who died at age 31 years, showed neurofibrillary degeneration of the hippocampus, basal ganglia and brainstem nuclei]	L6	n	y	lethal	lethal	lethal	L6	L6	post-infant-lethal
260565	PEHO SYNDROME	PEHO syndrome, 260565 (3)	PEHO syndrome	y	PEHO SYNDROME; PEHO	Clinical Features|Phenotype	died|death|deaths	ZNHIT3	HGNC:12309	PEHO syndrome, 260565 (3), Autosomal recessive	Autosomal recessive	n	y	[Chitty et al. (1996) described 2 female sibs and 2 unrelated infants (a boy and a girl) with progressive encephalopathy, seizures, which started between 3 days and 13 months of age, characteristic facies, edema of the hands and feet, tapering fingers, and optic atrophy. All 4 patients died between 10 weeks and 34 months of age]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
260600	LEUKODYSTROPHY, HYPOMYELINATING, 3	Leukodystrophy, hypomyelinating, 3, 260600 (3)	Leukodystrophy, hypomyelinating, 3	y	LEUKODYSTROPHY, HYPOMYELINATING, 3; HLD3	Clinical Features|Phenotype	death|deaths|died	AIMP1	HGNC:10648	Leukodystrophy, hypomyelinating, 3, 260600 (3), Autosomal recessive	Autosomal recessive	n	y	[Yokoi et al. (1985) reported 2 affected sisters and reviewed reports of other cases. Novotny (1988) reported a case with associated arthrogryposis multiplex congenita and death at age 19 days]	L2	y	-	lethal	lethal	lethal	L2	L2	pre-infant-lethal
260660	COUSIN SYNDROME	Cousin syndrome, 260660 (3)	Cousin syndrome	n	-	-	-	TBX15	HGNC:11594	Cousin syndrome, 260660 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
260920	HYPER-IgD SYNDROME	Hyper-IgD syndrome, 260920 (3)	Hyper-IgD syndrome	y	HYPER-IgD SYNDROME; HIDS	Clinical Features	died	MVK	HGNC:7530	Hyper-IgD syndrome, 260920 (3), Autosomal recessive	Autosomal recessive	y	y	[Van der Meer et al. (1984) described a possibly distinct syndrome on the basis of 6 patients of Dutch ancestry with a long history of recurrent attacks of fever of unknown origin.... In case 5 the mother had the same disorder and died of amyloidosis, and 2 of her brothers had periodic fever, 1 of them with amyloidosis for which renal transplantation was performed]	LU	n	y	lethal	lethal|nonlethal	lethal|nonlethal	L4|LU	L4	post-infant-lethal
261000	INTRINSIC FACTOR DEFICIENCY	Intrinsic factor deficiency, 261000 (3)	Intrinsic factor deficiency	n	-	-	-	CBLIF	HGNC:4268	Intrinsic factor deficiency, 261000 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
261100	IMERSLUND-GRASBECK SYNDROME 1	Imerslund-Grasbeck syndrome 1, 261100 (3)	Imerslund-Grasbeck syndrome 1	n	-	-	-	CUBN	HGNC:2548	Imerslund-Grasbeck syndrome 1, 261100 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
261515	D-BIFUNCTIONAL PROTEIN DEFICIENCY	D-bifunctional protein deficiency, 261515 (3)	D-bifunctional protein deficiency	y	D-BIFUNCTIONAL PROTEIN DEFICIENCY	Description|Clinical Features|Clinical Synopsis|Diagnosis	die|death|deaths|died	HSD17B4	HGNC:5213	D-bifunctional protein deficiency, 261515 (3), Autosomal recessive	Autosomal recessive	n	y	[Watkins et al. (1989) reported a black male infant with neonatal hypotonia and macrocephaly who developed seizures and required ventilatory support for the first 4 days of life. By 6 weeks of age, he had made no developmental progress, seizures continued, and the fontanels were large. Brain biopsy at 6 weeks of age showed polymicrogyria. He also had generalized osteopenia with delayed bone maturation. He died at 5.5 months as a result of an acute necrotizing enterocolitis]	L3	y	-	lethal	ambiguous|lethal	lethal	L3	L3	pre-infant-lethal
261540	PETERS-PLUS SYNDROME	Peters-plus syndrome, 261540 (3)	Peters-plus syndrome	y	PETERS-PLUS SYNDROME; PTRPLS	Clinical Features	died	B3GLCT	HGNC:20207	Peters-plus syndrome, 261540 (3), Autosomal recessive	Autosomal recessive	n	y	[De Almeida et al. (1991) reported the cases of a brother and sister with similar features and consanguineous parents. They thought that the disorder in these sibs was the same as that described by van Schooneveld et al. (1984) as the Peters-plus syndrome. The first-born child in the family reported by de Almeida et al. (1991), who died soon after birth, had cleft]	L2	y	-	lethal	lethal	lethal	L2	L2	pre-infant-lethal
261550	PERSISTENT MULLERIAN DUCT SYNDROME, TYPES I AND II	Persistent Mullerian duct syndrome, type I, 261550 (3)	Persistent Mullerian duct syndrome, type I	n	-	-	-	AMH	HGNC:464	Persistent Mullerian duct syndrome, type I, 261550 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
261550	PERSISTENT MULLERIAN DUCT SYNDROME, TYPES I AND II	Persistent Mullerian duct syndrome, type II, 261550 (3)	Persistent Mullerian duct syndrome, type II	n	-	-	-	AMHR2	HGNC:465	Persistent Mullerian duct syndrome, type II, 261550 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
261600	PHENYLKETONURIA	Phenylketonuria, 261600 (3)	Phenylketonuria	y	PHENYLKETONURIA; PKU	Clinical Features|Diagnosis	died	PAH	HGNC:8582	Phenylketonuria, 261600 (3), Autosomal recessive	Autosomal recessive	y	y	[ Riess et al. (1987) described experience with prenatal diagnosis of PKU by RFLP analysis. They pointed out that in those cases in which the affected child had died but a phenotypically normal brother or sister is available for investigation, full genetic predictability could be obtained only if this child proved to be homozygously healthy in the phenylalanine-loading heterozygote test]	L4	y	y	lethal	lethal	lethal	L4	L4	post-infant-lethal
261630	HYPERPHENYLALANINEMIA, BH4-DEFICIENT, C	Hyperphenylalaninemia, BH4-deficient, C, 261630 (3)	Hyperphenylalaninemia, BH4-deficient, C	n	-	-	-	QDPR	HGNC:9752	Hyperphenylalaninemia, BH4-deficient, C, 261630 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
261640	HYPERPHENYLALANINEMIA, BH4-DEFICIENT, A	Hyperphenylalaninemia, BH4-deficient, A, 261640 (3)	Hyperphenylalaninemia, BH4-deficient, A	n	-	-	-	PTS	HGNC:9689	Hyperphenylalaninemia, BH4-deficient, A, 261640 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
261670	GLYCOGEN STORAGE DISEASE X	Glycogen storage disease X, 261670 (3)	Glycogen storage disease X	n	-	-	-	PGAM2	HGNC:8889	Glycogen storage disease X, 261670 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
261680	PHOSPHOENOLPYRUVATE CARBOXYKINASE DEFICIENCY, CYTOSOLIC	Phosphoenolpyruvate carboxykinase deficiency, cytosolic, 261680 (3)	Phosphoenolpyruvate carboxykinase deficiency, cytosolic	y	PHOSPHOENOLPYRUVATE CARBOXYKINASE DEFICIENCY, CYTOSOLIC; PCKDC	Clinical Features	died	PCK1	HGNC:8724	Phosphoenolpyruvate carboxykinase deficiency, cytosolic, 261680 (3), Autosomal recessive	Autosomal recessive	y	y	[died at age 2 years, 10 months]	L4	y	-	lethal	lethal	lethal	L4	L4	post-infant-lethal
261740	GLYCOGEN STORAGE DISEASE OF HEART, LETHAL CONGENITAL	Glycogen storage disease of heart, lethal congenital, 261740 (3)	Glycogen storage disease of heart, lethal congenital	y	GLYCOGEN STORAGE DISEASE OF HEART, LETHAL CONGENITAL	Clinical Features|Clinical Synopsis|Phenotype	death|deaths|died|fatal	PRKAG2	HGNC:9386	Glycogen storage disease of heart, lethal congenital, 261740 (3), Autosomal dominant	Autosomal dominant	n	y	[Death in neonatal period / Burwinkel et al. (2005) described 5 sporadic, unrelated patients with fatal congenital nonlysosomal cardiac glycogenosis and noted the similarities between these patients and those previously described with so-called phosphorylase kinase deficiency of the heart. All but 1 had extreme cardiomegaly, onset of cardiac or respiratory distress in the neonatal period, and death at 3 weeks to 5 months of age]	L2	y	-	lethal	lethal	lethal	L2|L6|LU	L2	pre-infant-lethal
261750	GLYCOGEN STORAGE DISEASE IXb	Phosphorylase kinase deficiency of liver and muscle, autosomal recessive, 261750 (3)	Phosphorylase kinase deficiency of liver and muscle, autosomal recessive	n	-	-	-	PHKB	HGNC:8927	Phosphorylase kinase deficiency of liver and muscle, autosomal recessive, 261750 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
262000	BJORNSTAD SYNDROME	Bjornstad syndrome, 262000 (3)	Bjornstad syndrome	n	-	-	-	BCS1L	HGNC:1020	Bjornstad syndrome, 262000 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L2	L2	pre-infant-lethal
262190	PINEAL HYPERPLASIA, INSULIN-RESISTANT DIABETES MELLITUS, AND SOMATIC ABNORMALITIES	Rabson-Mendenhall syndrome, 262190 (3)	Rabson-Mendenhall syndrome	y	PINEAL HYPERPLASIA, INSULIN-RESISTANT DIABETES MELLITUS, AND SOMATIC ABNORMALITIES	Clinical Features	died	INSR	HGNC:6091	Rabson-Mendenhall syndrome, 262190 (3), Autosomal recessive	Autosomal recessive	y	y	[Rabson and Mendenhall (1956) described 3 sibs (2 girls, 1 boy) who initially presented with dental and skin abnormalities, abdominal distention, and phallic enlargement. The children demonstrated early dentition, a coarse, senile-appearing facies, and striking hirsutism. An 'adult growth of hair of head' at 5 years of age was pictured in the case of one of the girls. In the older girl the genitalia were large enough at the age of 6 months to permit vaginal examination for diagnosis of a left ovarian tumor which was removed soon afterward. The children were mentally precocious. Prognathism and very thick fingernails as well as acanthosis nigricans were also described. Insulin-resistant diabetes developed, and the patients died during childhood of ketoacidosis and intercurrent infections. At necropsy pineal hyperplasia was found in all 3. Rabson and Mendenhall (1956) stated that 'the histories...gain in value because the family physician (E.N.M.) brought them and their siblings into the world, and cared for them until they died...' Cases probably of the same condition in 2 sisters, offspring of first-cousin parents, were described by Barnes et al. (1974). They did not have abnormality of the teeth and nails and were living at ages 23 and 11 years, when reported. (Accili et al. (1989) demonstrated that these 2 sisters had a point mutation of the insulin receptor gene (147670.0011).) West et al. (1975) described brother and sister with the syndrome. They showed unusual facies, dry skin, acanthosis nigricans, thickened nails, hirsutism, dental precocity and dysplasia, abdominal protuberance, and phallic enlargement. Both had diabetic ketoacidosis with insulin resistance. The elder, a girl, had recurrent sepsis and died at the age of 7.8 years.]	L4	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L3|L4	L3	pre-infant-lethal
262300	ACHROMATOPSIA 3	Achromatopsia 3, 262300 (3)	Achromatopsia 3	y	ACHROMATOPSIA 3; ACHM3	Clinical Features	miscarriage|miscarriages	CNGB3	HGNC:2153	Achromatopsia 3, 262300 (3), Autosomal recessive	Autosomal recessive	n	n	-	-	-	-	ambiguous	ambiguous	ambiguous	-	-	-
262400	ISOLATED GROWTH HORMONE DEFICIENCY, TYPE IA	Growth hormone deficiency, isolated, type IA, 262400 (3)	Growth hormone deficiency, isolated, type IA	n	-	-	-	GH1	HGNC:4261	Growth hormone deficiency, isolated, type IA, 262400 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
262500	LARON SYNDROME	Laron dwarfism, 262500 (3)	Laron dwarfism	n	-	-	-	GHR	HGNC:4263	Laron dwarfism, 262500 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
262600	PITUITARY HORMONE DEFICIENCY, COMBINED, 2	Pituitary hormone deficiency, combined, 2, 262600 (3)	Pituitary hormone deficiency, combined, 2	y	PITUITARY HORMONE DEFICIENCY, COMBINED, 2; CPHD2	Clinical Features	died	PROP1	HGNC:9455	Pituitary hormone deficiency, combined, 2, 262600 (3), Autosomal recessive	Autosomal recessive	y	y	[Steiner and Boggs (1965) described brother and sister, offspring of first-cousin parents, with congenital absence of the pituitary, leading to hypothyroidism, hypoadrenalism, and hypogonadism. A third sib was probably also affected and died, presumably of hypoglycemia, in the newborn period. The sella turcica was normal in size. The disorder reported by Sadeghi-Nejad and Senior (1974) may be the same or an allelic disorder. A male newborn developed hypoglycemic convulsions. Diagnostic studies showed evidence of deficiency of thyrotropin, growth hormone, and prolactin (176760). The child thrived on replacement therapy. A female sib died in the first day of life with similar clinical findings and at autopsy showed absence of the anterior pituitary and atrophic adrenal glands]	L2	n	y	lethal	lethal	lethal	L2	L2	pre-infant-lethal
262650	KOWARSKI SYNDROME	Kowarski syndrome, 262650 (3)	Kowarski syndrome	n	-	-	-	GH1	HGNC:4261	Kowarski syndrome, 262650 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
262700	PITUITARY HORMONE DEFICIENCY, COMBINED, 4	Pituitary hormone deficiency, combined, 4, 262700 (3)	Pituitary hormone deficiency, combined, 4	n	-	-	-	LHX4	HGNC:21734	Pituitary hormone deficiency, combined, 4, 262700 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
262850	ALPHA-2-PLASMIN INHIBITOR DEFICIENCY	Alpha-2-plasmin inhibitor deficiency, 262850 (3)	Alpha-2-plasmin inhibitor deficiency	n	-	-	-	SERPINF2	HGNC:9075	Alpha-2-plasmin inhibitor deficiency, 262850 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
262890	SCOTT SYNDROME	Scott syndrome, 262890 (3)	Scott syndrome	y	SCOTT SYNDROME; SCTS	Clinical Features	death|deaths|miscarriage|miscarriages	ANO6	HGNC:25240	Scott syndrome, 262890 (3), Autosomal recessive	Autosomal recessive	y	y	[experienced a miscarriage at 2 months in a pregnancy that was complicated by prolonged uterine bleeding]	L1	-	y	lethal	lethal	lethal	L1	L1	pre-infant-lethal
263200	POLYCYSTIC KIDNEY DISEASE 4 WITH OR WITHOUT POLYCYSTIC LIVER DISEASE	Polycystic kidney disease 4, with or without hepatic disease, 263200 (3)	Polycystic kidney disease 4, with or without hepatic disease	y	POLYCYSTIC KIDNEY DISEASE 4 WITH OR WITHOUT POLYCYSTIC LIVER DISEASE; PKD4	Description|Clinical Features|Clinical Synopsis|Phenotype	death|deaths|demise|died|lethal|stillbirth|stillbirths	PKHD1	HGNC:9016	Polycystic kidney disease 4, with or without hepatic disease, 263200 (3), Autosomal recessive	Autosomal recessive	y	y	[Deget et al. (1995) observed 42 children from 20 sibships with ARPKD, pro- and retrospectively, over a mean period of 3.7 years. Using the subclassification of Blyth and Ockenden (1971), they assigned 12 patients to the perinatal, 9 to the neonatal, 13 to the infantile, and 8 to the juvenile category. In 11 of the 20 families, different subtypes were observed among affected sibs; in 7 families, affected sibs belonged to adjacent subgroups, while major intrafamilial differences were observed in 4 families. The phenotypic manifestations ranged from stillbirths to mildly affected adults]	L1	y	-	lethal	lethal	lethal	L1	L1	pre-infant-lethal
263210	GILLESSEN-KAESBACH-NISHIMURA SYNDROME	Gillessen-Kaesbach-Nishimura syndrome, 263210 (3)	Gillessen-Kaesbach-Nishimura syndrome	y	GILLESSEN-KAESBACH-NISHIMURA SYNDROME; GIKANIS	Description|Clinical Features|Clinical Synopsis|Phenotype	lethal|died|stillborn	ALG9	HGNC:15672	Gillessen-Kaesbach-Nishimura syndrome, 263210 (3), Autosomal recessive	Autosomal recessive	n	y	[May be lethal in utero]	L1	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L1	L1	pre-infant-lethal
263400	ERYTHROCYTOSIS, FAMILIAL, 2	Erythrocytosis, familial, 2, 263400 (3)	Erythrocytosis, familial, 2	y	ERYTHROCYTOSIS, FAMILIAL, 2; ECYT2	Clinical Features|Phenotype	death|deaths|fatal	VHL	HGNC:12687	Erythrocytosis, familial, 2, 263400 (3), Autosomal recessive	Autosomal recessive	y	y	[Sarangi et al. (2014) reported a 7-month-old infant, born of consanguineous Bangladeshi parents, with congenital ECYT2. He had failure to thrive, developmental delay, and polycythemia with dramatically increased erythropoietin levels. Imaging of the abdomen showed multiple hepatic hemangiomas. He was treated with phlebotomy, but developed pulmonary hypertension and recurrent respiratory infections, resulting in death at age 2]	L4	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L4|L6	L4	post-infant-lethal
263570	POLYGLUCOSAN BODY NEUROPATHY, ADULT FORM	Polyglucosan body disease, adult form, 263570 (3)	Polyglucosan body disease, adult form	y	POLYGLUCOSAN BODY NEUROPATHY, ADULT FORM; APBN	Clinical Features	died	GBE1	HGNC:4180	Polyglucosan body disease, adult form, 263570 (3), Autosomal recessive	Autosomal recessive	y	n	-	-	-	-	ambiguous	ambiguous|lethal	lethal	L2	L2	pre-infant-lethal
263650	BARTSOCAS-PAPAS SYNDROME 1	Popliteal pterygium syndrome, Bartsocas-Papas type 1, 263650 (3)	Popliteal pterygium syndrome, Bartsocas-Papas type 1	y	BARTSOCAS-PAPAS SYNDROME 1; BPS1	Description|Clinical Features|Clinical Synopsis|Phenotype	lethality|demise|died|lethal|stillborn|death|deaths	RIPK4	HGNC:496	Popliteal pterygium syndrome, Bartsocas-Papas type 1, 263650 (3), Autosomal recessive	Autosomal recessive	y	y	[Massoud et al. (1998) described BPS in 4 sibs in an Arab family. The phenotypically normal parents were unrelated; the father and mother were from Qatar and United Arab Emirates, respectively. The patients showed oral cleft, filiform bands between the jaws, ankyloblepharon, popliteal pterygium, syndactyly of fingers and toes, phalangeal anomalies with synostosis, clubfeet, nail hypoplasia, and genital anomalies. Additional traits included cutis aplasia, widely spaced nipples, low-set umbilicus, and unilateral renal hypoplasia. One of the sibs were stillborn; the other 3 children lived 10 to 17 months]	L1	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L1	L1	pre-infant-lethal
263700	PORPHYRIA, CONGENITAL ERYTHROPOIETIC	Porphyria, congenital erythropoietic, 263700 (3)	Porphyria, congenital erythropoietic	n	-	-	-	UROS	HGNC:12592	Porphyria, congenital erythropoietic, 263700 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
263750	POSTAXIAL ACROFACIAL DYSOSTOSIS	Miller syndrome, 263750 (3)	Miller syndrome	y	POSTAXIAL ACROFACIAL DYSOSTOSIS; POADS	Clinical Features	died	DHODH	HGNC:2867	Miller syndrome, 263750 (3), Autosomal recessive	Autosomal recessive	y	y	[Chrzanowska and Fryns (1993) provided follow-up on the second patient reported by Chrzanowska et al. (1989) and his family. Growth and intellectual development had been normal in the proband. The second pregnancy of his parents ended spontaneously in preterm delivery at 31 weeks' gestation, with the birth of twin boys, both of whom had the same postaxial limb deficiency in the form of absence of the fifth digital rays of all 4 limbs. Both died in the neonatal period]	L2	y	y	lethal	lethal	lethal	L2	L2	pre-infant-lethal
263800	GITELMAN SYNDROME	Gitelman syndrome, 263800 (3)	Gitelman syndrome	n	-	-	-	SLC12A3	HGNC:10912	Gitelman syndrome, 263800 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
264070	HYPERPHENYLALANINEMIA, BH4-DEFICIENT, D	Hyperphenylalaninemia, BH4-deficient, D, 264070 (3)	Hyperphenylalaninemia, BH4-deficient, D	n	-	-	-	PCBD1	HGNC:8646	Hyperphenylalaninemia, BH4-deficient, D, 264070 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
264090	WIEDEMANN-RAUTENSTRAUCH SYNDROME	Wiedemann-Rautenstrauch syndrome, 264090 (3)	Wiedemann-Rautenstrauch syndrome	y	WIEDEMANN-RAUTENSTRAUCH SYNDROME; WDRTS	Clinical Features|Clinical Synopsis|Phenotype	death|deaths|died	POLR3A	HGNC:30074	Wiedemann-Rautenstrauch syndrome, 264090 (3), Autosomal recessive	Autosomal recessive	n	y	[Arboleda et al. (2011) reported 3 sibs, born of unrelated Colombian parents, with neonatal progeroid syndrome. The parents were flower cultivators with possible exposure to herbicides. At birth, all sibs appeared emaciated with senile facies, wrinkled thin skin, and hypertonia. The frontal and parietal bones were prominent, with scant hair and visible scalp veins. The face was triangular and facial bones were hypoplastic, with pointed chin, prominent supraorbital ridges, and small nose with anteverted nares. Limbs were thin, joints rigid, and hands in a paw-like position. Two patients died within the first week of life, whereas the third survived until day 43]	L2	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L2	L2	pre-infant-lethal
264300	17-BETA HYDROXYSTEROID DEHYDROGENASE III DEFICIENCY	Pseudohermaphroditism, male, with gynecomastia, 264300 (3)	Pseudohermaphroditism, male, with gynecomastia	n	-	-	-	HSD17B3	HGNC:5212	Pseudohermaphroditism, male, with gynecomastia, 264300 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
264350	PSEUDOHYPOALDOSTERONISM, TYPE IB1, AUTOSOMAL RECESSIVE	Pseudohypoaldosteronism, type IB1, autosomal recessive, 264350 (3)	Pseudohypoaldosteronism, type IB1, autosomal recessive	y	PSEUDOHYPOALDOSTERONISM, TYPE IB1, AUTOSOMAL RECESSIVE; PHA1B1	Clinical Features	died	SCNN1A	HGNC:10599	Pseudohypoaldosteronism, type IB1, autosomal recessive, 264350 (3), Autosomal recessive	Autosomal recessive	y	y	[died in the first days of life]	L2	y	y	lethal	lethal|nonlethal	lethal|nonlethal	L2	L2	pre-infant-lethal
264470	PEROXISOMAL ACYL-CoA OXIDASE DEFICIENCY	Peroxisomal acyl-CoA oxidase deficiency, 264470 (3)	Peroxisomal acyl-CoA oxidase deficiency	y	PEROXISOMAL ACYL-CoA OXIDASE DEFICIENCY	Clinical Features	death|deaths|died|miscarriage|miscarriages	ACOX1	HGNC:119	Peroxisomal acyl-CoA oxidase deficiency, 264470 (3), Autosomal recessive	Autosomal recessive	y	y	[Carrozzo et al. (2008) reported a patient with severe acyl-CoA oxidase deficiency, born of consanguineous parents of Italian ancestry. Two previous pregnancies had resulted in miscarriages / Suzuki et al. (2002) provided follow-up of the patients reported by Suzuki et al. (1994) and reported a third unrelated affected Japanese child. The 2 sibs showed neurologic regression at ages 34 and 26 months, respectively... The child died of respiratory failure at 42 months of age]	L1	y	y	lethal	lethal	lethal	L1|L6	L1	pre-infant-lethal
264600	PSEUDOVAGINAL PERINEOSCROTAL HYPOSPADIAS	Pseudovaginal perineoscrotal hypospadias, 264600 (3)	Pseudovaginal perineoscrotal hypospadias	n	-	-	-	SRD5A2	HGNC:11285	Pseudovaginal perineoscrotal hypospadias, 264600 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
264700	VITAMIN D HYDROXYLATION-DEFICIENT RICKETS, TYPE 1A	Vitamin D-dependent rickets, type I, 264700 (3)	Vitamin D-dependent rickets, type I	n	-	-	-	CYP27B1	HGNC:2606	Vitamin D-dependent rickets, type I, 264700 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
264800	PSEUDOXANTHOMA ELASTICUM	Pseudoxanthoma elasticum, 264800 (3)	Pseudoxanthoma elasticum	y	PSEUDOXANTHOMA ELASTICUM; PXE	Clinical Features|Phenotype	died|fatal	ABCC6	HGNC:57	Pseudoxanthoma elasticum, 264800 (3), Autosomal recessive	Autosomal recessive	n	y	[Le Boulanger et al. (2010) studied a nonconsanguineous French family in which an older brother developed uncomplicated PXE in adolescence, whereas a younger brother died of a condition 'strikingly reminiscent' of generalized arterial calcification of infancy (GACI2; 614473) at 15 months of age. The younger brother had a myocardial infarction complicated by heart failure at 6 months of age, and skin biopsy at 1 year of age for evaluation of a possible connective tissue disorder showed elastic fiber dystrophy, with clumped and fragmented fibers in the mid dermis, as well as calcifications on the elastic fibers and sporadically in vessel walls of the subcutis. At 15 months of age, he had a second, fatal MI, and autopsy showed fibrosis of the coronary arteries with calcifications involving the intima, internal elastic lamina, and media]	L3	y	-	lethal	lethal	lethal	L3|LU	L3	pre-infant-lethal
265000	MULTIPLE PTERYGIUM SYNDROME, ESCOBAR VARIANT	Escobar syndrome, 265000 (3)	Escobar syndrome	y	MULTIPLE PTERYGIUM SYNDROME, ESCOBAR VARIANT; EVMPS	Description|Clinical Features|Clinical Synopsis|Phenotype	lethal|died|death|deaths	CHRNG	HGNC:1967	Escobar syndrome, 265000 (3), Autosomal recessive	Autosomal recessive	y	y	[Intrauterine death]	L1	y	-	lethal	lethal	lethal	L1	L1	pre-infant-lethal
265050	3MC SYNDROME 2	3MC syndrome 2, 265050 (3)	3MC syndrome 2	n	-	-	-	COLEC11	HGNC:17213	3MC syndrome 2, 265050 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
265100	PULMONARY ALVEOLAR MICROLITHIASIS	Pulmonary alveolar microlithiasis, 265100 (3)	Pulmonary alveolar microlithiasis	y	PULMONARY ALVEOLAR MICROLITHIASIS; PULAM	Description|Phenotype	lethal|died	SLC34A2	HGNC:11020	Pulmonary alveolar microlithiasis, 265100 (3), Autosomal recessive	Autosomal recessive	n	y	[The onset of this potentially lethal disease varies from the neonatal period to old age, and the disease follows a long-term progressive course, resulting in a slow deterioration of lung functions. About one-third of the reported cases are said to be familial (summary by Corut et al., 2006)]	LU	y	-	lethal	lethal	lethal	LU	LU	post-infant-lethal
265120	SURFACTANT METABOLISM DYSFUNCTION, PULMONARY, 1	Surfactant metabolism dysfunction, pulmonary, 1, 265120 (3)	Surfactant metabolism dysfunction, pulmonary, 1	y	SURFACTANT METABOLISM DYSFUNCTION, PULMONARY, 1; SMDP1	Clinical Features|Clinical Synopsis|Diagnosis|Phenotype	died|fatal|death|deaths	SFTPB	HGNC:10801	Surfactant metabolism dysfunction, pulmonary, 1, 265120 (3), Autosomal recessive	Autosomal recessive	y	y	[Death usually occurs in the first weeks to months of life / Moulton et al. (1992) reported 2 pairs of sibs from 2 unrelated families with neonatal respiratory distress associated with pulmonary alveolar proteinosis beginning within hours of birth. All were full-term infants and 3 had mature lung profiles. Radiographic studies showed an early granular pattern followed by lung opacification. All died within 16 to 190 days]	L2	y	-	lethal	lethal	lethal	L2	L2	pre-infant-lethal
265380	ALVEOLAR CAPILLARY DYSPLASIA WITH MISALIGNMENT OF PULMONARY VEINS	Alveolar capillary dysplasia with misalignment of pulmonary veins, 265380 (3)	Alveolar capillary dysplasia with misalignment of pulmonary veins	y	ALVEOLAR CAPILLARY DYSPLASIA WITH MISALIGNMENT OF PULMONARY VEINS; ACDMPV	Description|Clinical Features|Clinical Synopsis|Phenotype	fatal|died|lethal|death|deaths	FOXF1	HGNC:3809	Alveolar capillary dysplasia with misalignment of pulmonary veins, 265380 (3), Autosomal dominant	Autosomal dominant	y	y	[Lethal in the neonatal period / Shohet et al. (1984) reported 2 brothers and a sister with persistent pulmonary hypertension of the newborn who died at 4, 11, and 15 days of age]	L2	y	y	lethal	lethal	lethal	L2	L2	pre-infant-lethal
265400	PULMONARY HYPERTENSION, PRIMARY, 5	Pulmonary hypertension, primary, 5, 265400 (3)	Pulmonary hypertension, primary, 5	y	PULMONARY HYPERTENSION, PRIMARY, 5; PPH5	Description|Clinical Features|Clinical Synopsis|Phenotype	death|deaths|died	ATP13A3	HGNC:24113	Pulmonary hypertension, primary, 5, 265400 (3), Autosomal recessive	Autosomal recessive	y	y	[Four of the patients died between 11 months and 8 years]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
265450	PULMONARY VENOOCCLUSIVE DISEASE 1, AUTOSOMAL DOMINANT	Pulmonary venoocclusive disease 1, 265450 (3)	Pulmonary venoocclusive disease 1	y	PULMONARY VENOOCCLUSIVE DISEASE 1, AUTOSOMAL DOMINANT; PVOD1	Description|Clinical Features|Phenotype	death|deaths|died	BMPR2	HGNC:1078	Pulmonary venoocclusive disease 1, 265450 (3), Autosomal dominant	Autosomal dominant	n	y	[Voordes et al. (1977) reported pulmonary venoocclusive disease in a male infant who died at the age of 3 months]	L3	y	-	lethal	lethal	lethal	L3|L4	L3	pre-infant-lethal
265800	PYCNODYSOSTOSIS	Pycnodysostosis, 265800 (3)	Pycnodysostosis	n	-	-	-	CTSK	HGNC:2536	Pycnodysostosis, 265800 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
265900	PYLE DISEASE	Pyle disease, 265900 (3)	Pyle disease	n	-	-	-	SFRP4	HGNC:10778	Pyle disease, 265900 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
266100	EPILEPSY, EARLY-ONSET, 4, VITAMIN B6-DEPENDENT	Epilepsy, early-onset, 4, vitamin B6-dependent, 266100 (3)	Epilepsy, early-onset, 4, vitamin B6-dependent	y	EPILEPSY, EARLY-ONSET, 4, VITAMIN B6-DEPENDENT; EPEO4	Clinical Features	died	ALDH7A1	HGNC:877	Epilepsy, early-onset, 4, vitamin B6-dependent, 266100 (3), Autosomal recessive	Autosomal recessive	y	y	[Autosomal recessive inheritance was supported by parental consanguinity in the case of an affected female infant whose elder brother died at 8 months of age of unexplained status epilepticus.]	L3	-	y	lethal	lethal	lethal	L3	L3	pre-infant-lethal
266120	URIDINE 5-PRIME MONOPHOSPHATE HYDROLASE DEFICIENCY, HEMOLYTIC ANEMIA DUE TO	Anemia, hemolytic, due to UMPH1 deficiency, 266120 (3)	Anemia, hemolytic, due to UMPH1 deficiency	n	-	-	-	NT5C3A	HGNC:17820	Anemia, hemolytic, due to UMPH1 deficiency, 266120 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
266130	GLUTATHIONE SYNTHETASE DEFICIENCY	Glutathione synthetase deficiency, 266130 (3)	Glutathione synthetase deficiency	y	GLUTATHIONE SYNTHETASE DEFICIENCY; GSSD	Clinical Features|Diagnosis	fatal|died	GSS	HGNC:4624	Glutathione synthetase deficiency, 266130 (3), Autosomal recessive	Autosomal recessive	n	y	[Divry et al. (1991) described a patient with a very severe neurologic presentation leading to fatal outcome in the first hours of life]	L2	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L2	L2	pre-infant-lethal
266140	PYROPOIKILOCYTOSIS, HEREDITARY	Pyropoikilocytosis, 266140 (3)	Pyropoikilocytosis	n	-	-	-	SPTA1	HGNC:11272	Pyropoikilocytosis, 266140 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	ambiguous|nonlethal	ambiguous	-	-	-
266150	PYRUVATE CARBOXYLASE DEFICIENCY	Pyruvate carboxylase deficiency, 266150 (3)	Pyruvate carboxylase deficiency	y	PYRUVATE CARBOXYLASE DEFICIENCY	Clinical Features|Clinical Synopsis	died|fatal|die	PC	HGNC:8636	Pyruvate carboxylase deficiency, 266150 (3), Autosomal recessive	Autosomal recessive	y	y	[Brun et al. (1999) reported brother and sister with the severe form of PC deficiency. Both had macrocephaly and severe ischemia-like brain lesions at birth and died in the first week of life with intractable lactic acidemia]	L2	y	-	lethal	lethal	lethal	L2	L2	pre-infant-lethal
266200	PYRUVATE KINASE DEFICIENCY OF RED CELLS	Pyruvate kinase deficiency, 266200 (3)	Pyruvate kinase deficiency	y	PYRUVATE KINASE DEFICIENCY OF RED CELLS	Clinical Features|Phenotype	death|deaths|stillbirth|stillbirths|lethal	PKLR	HGNC:9020	Pyruvate kinase deficiency, 266200 (3), Autosomal recessive	Autosomal recessive	y	y	[Gilsanz et al. (1993) reported PK deficiency as a cause of fetal anemia and nonimmune hydrops fetalis. They described a woman in whom 3 previous pregnancies had resulted in stillbirth or early neonatal death due to anemic hydrops fetalis; PK deficiency was diagnosed in a later pregnancy by umbilical vessel sampling at 30 weeks' gestation. The infant survived with transfusion-dependent hemolytic anemia / Bowman and Procopio (1963) observed a severe form of hemolytic anemia in the Old Order Amish of Mifflin Co., Pennsylvania. The disorder was much more severe than that reported by Tanaka et al. (1962), leading to death in the first years of life if not treated by transfusions and splenectomy]	L1	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L1	L1	pre-infant-lethal
266265	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIc	Congenital disorder of glycosylation, type IIc, 266265 (3)	Congenital disorder of glycosylation, type IIc	n	-	-	-	SLC35C1	HGNC:20197	Congenital disorder of glycosylation, type IIc, 266265 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
266280	RAPADILINO SYNDROME	RAPADILINO syndrome, 266280 (3)	RAPADILINO syndrome	n	-	-	-	RECQL4	HGNC:9949	RAPADILINO syndrome, 266280 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L4	L4	post-infant-lethal
266500	REFSUM DISEASE, CLASSIC	Refsum disease, 266500 (3)	Refsum disease	y	REFSUM DISEASE, CLASSIC	Clinical Synopsis	death|deaths	PHYH	HGNC:8940	Refsum disease, 266500 (3), Autosomal recessive	Autosomal recessive	n	y	[Cardiac failure (sudden death has been reported)]	LU	y	-	lethal	lethal	lethal	LU	LU	post-infant-lethal
266510	PEROXISOME BIOGENESIS DISORDER 3B	Peroxisome biogenesis disorder 3B, 266510 (3)	Peroxisome biogenesis disorder 3B	n	-	-	-	PEX12	HGNC:8854	Peroxisome biogenesis disorder 3B, 266510 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L2	L2	pre-infant-lethal
266900	SENIOR-LOKEN SYNDROME 1	Senior-Loken syndrome-1, 266900 (3)	Senior-Loken syndrome-1	y	SENIOR-LOKEN SYNDROME 1; SLSN1	Clinical Features	died	NPHP1	HGNC:7905	Senior-Loken syndrome-1, 266900 (3), Autosomal recessive	Autosomal recessive	n	y	[Diekmann et al. (1977) described retinitis pigmentosa and nephronophthisis in 2 young sisters, one of whom died at age 7 years]	L4	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L4	L4	post-infant-lethal
266920	SHORT-RIB THORACIC DYSPLASIA 9 WITH OR WITHOUT POLYDACTYLY	Short-rib thoracic dysplasia 9 with or without polydactyly, 266920 (3)	Short-rib thoracic dysplasia 9 with or without polydactyly	y	SHORT-RIB THORACIC DYSPLASIA 9 WITH OR WITHOUT POLYDACTYLY; SRTD9	Description|Clinical Features|Phenotype	lethal|died	IFT140	HGNC:29077	Short-rib thoracic dysplasia 9 with or without polydactyly, 266920 (3), Autosomal recessive	Autosomal recessive	y	y	[Some forms of SRTD are lethal in the neonatal period due to respiratory insufficiency secondary to a severely restricted thoracic cage, whereas others are compatible with life (summary by Huber and Cormier-Daire, 2012 and Schmidts et al., 2013)]	L2	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L2	L2	pre-infant-lethal
267000	PERLMAN SYNDROME	Perlman syndrome, 267000 (3)	Perlman syndrome	y	PERLMAN SYNDROME; PRLMNS	Clinical Features|Clinical Synopsis	death|deaths|died|fatal	DIS3L2	HGNC:28648	Perlman syndrome, 267000 (3), Autosomal recessive	Autosomal recessive	y	y	[Fatal in the neonatal period (in some patients) / Alessandri et al. (2008) reported an infant with Perlman syndrome who died at 2 days of age]	L2	y	-	lethal	lethal	lethal	L2	L2	pre-infant-lethal
267010	MECKEL SYNDROME, TYPE 7	Meckel syndrome 7, 267010 (3)	Meckel syndrome 7	y	MECKEL SYNDROME, TYPE 7; MKS7	Clinical Features|Clinical Synopsis	died|lethal	NPHP3	HGNC:7907	Meckel syndrome 7, 267010 (3), Autosomal recessive	Autosomal recessive	y	y	[died at age 23 weeks' gestation and the other in the perinatal perio]	L1	y	y	lethal	lethal	lethal	L1|LU	L1	pre-infant-lethal
267300	RENAL TUBULAR ACIDOSIS, DISTAL, 2, WITH PROGRESSIVE SENSORINEURAL HEARING LOSS	Distal renal tubular acidosis 2 with progressive sensorineural hearing loss, 267300 (3)	Distal renal tubular acidosis 2 with progressive sensorineural hearing loss	y	RENAL TUBULAR ACIDOSIS, DISTAL, 2, WITH PROGRESSIVE SENSORINEURAL HEARING LOSS; DRTA2	Clinical Features	death|deaths	ATP6V1B1	HGNC:853	Distal renal tubular acidosis 2 with progressive sensorineural hearing loss, 267300 (3), Autosomal recessive	Autosomal recessive	y	y	[In 2 Greek Cypriot families with autosomal recessive dRTA and homozygosity and compound heterozygosity for mutations in the ATP6V1B1 gene, respectively, Feldman et al. (2006) reported long-term clinical findings in 4 of 5 affected members. The 5 patients demonstrated the entire clinical spectrum of the disease including death in infancy, failure to thrive, rickets, nephrocalcinosis, nephrolithiasis, and episodes of hypokalemic paralysis]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
267430	RENAL TUBULAR DYSGENESIS	Renal tubular dysgenesis, 267430 (3)	Renal tubular dysgenesis	y	RENAL TUBULAR DYSGENESIS; RTD	Description|Clinical Features|Clinical Synopsis	death|deaths|died|lethal|miscarriage|miscarriages|stillborn|die	ACE	HGNC:2707	Renal tubular dysgenesis, 267430 (3), Autosomal recessive	Autosomal recessive	n	y	[Affected infants often die in utero or in the postnatal period]	L1	y	-	lethal	lethal	lethal	L1	L1	pre-infant-lethal
267430	RENAL TUBULAR DYSGENESIS	Renal tubular dysgenesis, 267430 (3)	Renal tubular dysgenesis	y	RENAL TUBULAR DYSGENESIS; RTD	Description|Clinical Features|Clinical Synopsis	death|deaths|died|lethal|miscarriage|miscarriages|stillborn|die	AGT	HGNC:333	Renal tubular dysgenesis, 267430 (3), Autosomal recessive	Autosomal recessive	n	y	[Affected infants often die in utero or in the postnatal period]	L1	y	-	lethal	lethal	lethal	L1	L1	pre-infant-lethal
267430	RENAL TUBULAR DYSGENESIS	Renal tubular dysgenesis, 267430 (3)	Renal tubular dysgenesis	y	RENAL TUBULAR DYSGENESIS; RTD	Description|Clinical Features|Clinical Synopsis	death|deaths|died|lethal|miscarriage|miscarriages|stillborn|die	AGTR1	HGNC:336	Renal tubular dysgenesis, 267430 (3), Autosomal recessive	Autosomal recessive	n	y	[Affected infants often die in utero or in the postnatal period]	L1	y	-	lethal	lethal	lethal	L1	L1	pre-infant-lethal
267430	RENAL TUBULAR DYSGENESIS	Renal tubular dysgenesis, 267430 (3)	Renal tubular dysgenesis	y	RENAL TUBULAR DYSGENESIS; RTD	Description|Clinical Features|Clinical Synopsis	death|deaths|died|lethal|miscarriage|miscarriages|stillborn|die	REN	HGNC:9958	Renal tubular dysgenesis, 267430 (3), Autosomal recessive	Autosomal recessive	n	y	[Affected infants often die in utero or in the postnatal period]	L1	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L1	L1	pre-infant-lethal
267500	RETICULAR DYSGENESIS	Reticular dysgenesis, 267500 (3)	Reticular dysgenesis	y	RETICULAR DYSGENESIS	Description|Clinical Features|Clinical Synopsis	fatal|died|death|deaths	AK2	HGNC:362	Reticular dysgenesis, 267500 (3), Autosomal recessive	Autosomal recessive	y	y	[Early death in the first few weeks of life / De Vaal and Seynhaeve (1959) described newborn male twins who had normal numbers of erythrocytes and platelets but no blood leukocytes. They died at 5 and 8 days of age of sepsis]	L2	y	-	lethal	lethal	lethal	L2	L2	pre-infant-lethal
267750	KNOBLOCH SYNDROME 1	Knobloch syndrome, type 1, 267750 (3)	Knobloch syndrome, type 1	n	-	-	-	COL18A1	HGNC:2195	Knobloch syndrome, type 1, 267750 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	ambiguous|nonlethal	ambiguous	-	-	-
268100	ENHANCED S-CONE SYNDROME	Enhanced S-cone syndrome, 268100 (3)	Enhanced S-cone syndrome	n	-	-	-	NR2E3	HGNC:7974	Enhanced S-cone syndrome, 268100 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
268130	REVESZ SYNDROME	Revesz syndrome, 268130 (3)	Revesz syndrome	y	REVESZ SYNDROME	Clinical Features	death|deaths|died	TINF2	HGNC:11824	Revesz syndrome, 268130 (3), Autosomal dominant	Autosomal dominant	y	y	[Revesz et al. (1992) reported the case of a Sudanese male infant who was found to have bilateral exudative retinopathy at 6 months of age. A month later, severe aplastic anemia was found, which led to the child's death at the age of 19 months]	L3	y	-	lethal	lethal	lethal	L3|L5	L3	pre-infant-lethal
268150	RH-NULL, REGULATOR TYPE	Anemia, hemolytic, Rh-null, regulator type, 268150 (3)	Anemia, hemolytic, Rh-null, regulator type	n	-	-	-	RHAG	HGNC:10006	Anemia, hemolytic, Rh-null, regulator type, 268150 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L1	L1	pre-infant-lethal
268200	MYOGLOBINURIA, ACUTE RECURRENT, AUTOSOMAL RECESSIVE	Myoglobinuria, acute recurrent, autosomal recessive, 268200 (3)	Myoglobinuria, acute recurrent, autosomal recessive	y	MYOGLOBINURIA, ACUTE RECURRENT, AUTOSOMAL RECESSIVE	Clinical Features	died	LPIN1	HGNC:13345	Myoglobinuria, acute recurrent, autosomal recessive, 268200 (3), Autosomal recessive	Autosomal recessive	y	y	[Ramesh and Gardner-Medwin (1992) described 2 families with familial paroxysmal rhabdomyolysis unrelated to exercise. In 1 family, a 3-month-old girl had a single attack of rhabdomyolysis. Her older brother died suddenly at the age of 4 years following a day-long illness. The parents were not consanguineous. The second family had 4 affected girls who were born of a Kuwaiti, Bedouin, first-cousin couple. The 2 oldest sisters died at the age of about 5 years with acute generalized muscle weakness and myoglobinuria]	L4	y	-	lethal	lethal	lethal	L4	L4	post-infant-lethal
268300	ROBERTS-SC PHOCOMELIA SYNDROME	Roberts-SC phocomelia syndrome, 268300 (3)	Roberts-SC phocomelia syndrome	y	ROBERTS-SC PHOCOMELIA SYNDROME; RBS	Description|Clinical Features|Clinical Synopsis	die|death|deaths|died|stillborn	ESCO2	HGNC:27230	Roberts-SC phocomelia syndrome, 268300 (3), Autosomal recessive	Autosomal recessive	y	y	[Presence of severe midfacial and limb defects and birth length less than 37cm associated with stillborn or early infant death]	L1	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L1	L1	pre-infant-lethal
268305	ROBIN SEQUENCE WITH CLEFT MANDIBLE AND LIMB ANOMALIES	Robin sequence with cleft mandible and limb anomalies, 268305 (3)	Robin sequence with cleft mandible and limb anomalies	y	ROBIN SEQUENCE WITH CLEFT MANDIBLE AND LIMB ANOMALIES	Clinical Features	died|stillborn	EIF4A3	HGNC:18683	Robin sequence with cleft mandible and limb anomalies, 268305 (3), Autosomal recessive	Autosomal recessive	n	y	[Richieri-Costa and Pereira (1992) described a seemingly distinct entity in 5 unrelated Brazilian patients. The features were short stature, Robin sequence, cleft mandible, and limb defects... Affected males were either stillborn or died within 1 week of birth; more severe defects, including apodia, were noted in 1]	L1	y	-	lethal	lethal	lethal	L1	L1	pre-infant-lethal
268310	ROBINOW SYNDROME, AUTOSOMAL RECESSIVE 1	Robinow syndrome, autosomal recessive, 268310 (3)	Robinow syndrome, autosomal recessive	y	ROBINOW SYNDROME, AUTOSOMAL RECESSIVE 1; RRS1	Phenotype	died	ROR2	HGNC:10257	Robinow syndrome, autosomal recessive, 268310 (3), Autosomal recessive	Autosomal recessive	y	n	-	-	-	-	ambiguous	ambiguous|nonlethal	ambiguous	-	-	-
268315	ROD-CONE DYSTROPHY, SENSORINEURAL DEAFNESS, AND FANCONI-TYPE RENAL DYSFUNCTION	Rod-cone dystrophy, sensorineural deafness, and Fanconi-type renal dysfunction, 268315 (3)	Rod-cone dystrophy, sensorineural deafness, and Fanconi-type renal dysfunction	y	ROD-CONE DYSTROPHY, SENSORINEURAL DEAFNESS, AND FANCONI-TYPE RENAL DYSFUNCTION; RCDFRD	Description|Clinical Features|Clinical Synopsis	death|deaths|died	RRM2B	HGNC:17296	Rod-cone dystrophy, sensorineural deafness, and Fanconi-type renal dysfunction, 268315 (3), Autosomal recessive	Autosomal recessive	y	y	[died between the ages of 3 and 20 years]	L4	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L3|L4	L3	pre-infant-lethal
268400	ROTHMUND-THOMSON SYNDROME, TYPE 2	Rothmund-Thomson syndrome, type 2, 268400 (3)	Rothmund-Thomson syndrome, type 2	y	ROTHMUND-THOMSON SYNDROME, TYPE 2; RTS2	Phenotype	died	RECQL4	HGNC:9949	Rothmund-Thomson syndrome, type 2, 268400 (3), Autosomal recessive	Autosomal recessive	y	y	[died at age 9 years]	L4	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L4	L4	post-infant-lethal
268800	SANDHOFF DISEASE	Sandhoff disease, infantile, juvenile, and adult forms, 268800 (3)	Sandhoff disease, infantile, juvenile, and adult forms	y	SANDHOFF DISEASE	Clinical Features|Clinical Synopsis|Phenotype	death|deaths|lethal|died	HEXB	HGNC:4879	Sandhoff disease, infantile, juvenile, and adult forms, 268800 (3), Autosomal recessive	Autosomal recessive	y	y	[Sandhoff et al. (1968) gave the initial description of the disorder that bears his name. O'Brien (1971) studied 2 Mexican-American sisters and a boy of Anglo-Saxon extraction. Most patients have been non-Jewish; however, the clinical and pathologic picture is very similar to Tay-Sachs disease (272800). Weakness begins in the first 6 months of life. Startle reaction, early blindness, progressive mental and motor deterioration, doll-like face, cherry red spots, and macrocephaly are all present as in Tay-Sachs disease. Death usually occurs by age 3 years]	L4	y	-	lethal	lethal	lethal	L4	L4	post-infant-lethal
269150	SCHINZEL-GIEDION MIDFACE RETRACTION SYNDROME	Schinzel-Giedion midface retraction syndrome, 269150 (3)	Schinzel-Giedion midface retraction syndrome	y	SCHINZEL-GIEDION MIDFACE RETRACTION SYNDROME	Clinical Features	died	SETBP1	HGNC:15573	Schinzel-Giedion midface retraction syndrome, 269150 (3), Autosomal dominant	Autosomal dominant	y	y	[Al-Gazali et al. (1988) reported 3 cases. Hypoplasia of dermal ridges and genital anomalies were mentioned as abnormalities. The skeletal abnormalities also included broad ribs and hypoplasia of the distal phalanges. Two of the 7 children reported in the literature died in the neonatal period, and the remainder developed intractable epilepsy and spasticity along with profound growth and developmental retardation]	L2	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L2	L2	pre-infant-lethal
269160	SCHIZENCEPHALY	Schizencephaly, 269160 (3)	Schizencephaly	n	-	-	-	EMX2	HGNC:3341	Schizencephaly, 269160 (3)	-	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
269160	SCHIZENCEPHALY	Schizencephaly, 269160 (3)	Schizencephaly	n	-	-	-	SHH	HGNC:10848	Schizencephaly, 269160 (3)	-	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L3	L3	pre-infant-lethal
269160	SCHIZENCEPHALY	Schizencephaly, 269160 (3)	Schizencephaly	n	-	-	-	SIX3	HGNC:10889	Schizencephaly, 269160 (3)	-	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L3	L3	pre-infant-lethal
269250	SCHNECKENBECKEN DYSPLASIA	Schneckenbecken dysplasia, 269250 (3)	Schneckenbecken dysplasia	y	SCHNECKENBECKEN DYSPLASIA; SHNKND	Description|Clinical Features|Clinical Synopsis	lethal|miscarriage|miscarriages|stillborn	SLC35D1	HGNC:20800	Schneckenbecken dysplasia, 269250 (3), Autosomal recessive	Autosomal recessive	y	y	[Stillborn or lethal in the neonatal period]	L1	y	-	lethal	lethal	lethal	L1	L1	pre-infant-lethal
269400	ANTERIOR SEGMENT DYSGENESIS 7	Anterior segment dysgenesis 7, with sclerocornea, 269400 (3)	Anterior segment dysgenesis 7, with sclerocornea	n	-	-	-	PXDN	HGNC:14966	Anterior segment dysgenesis 7, with sclerocornea, 269400 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
269500	SCLEROSTEOSIS 1	Sclerosteosis 1, 269500 (3)	Sclerosteosis 1	y	SCLEROSTEOSIS 1; SOST1	Clinical Features|Clinical Synopsis	death|deaths|died	SOST	HGNC:13771	Sclerosteosis 1, 269500 (3), Autosomal recessive	Autosomal recessive	n	y	[Sudden death secondary to impaction of medulla oblongata / Hamersma et al. (2003) analyzed the course and complications of 63 individuals with sclerosteosis in South Africa who were seen over a 38-year period. Of these, 34 had died during the course of the survey, 24 from complications related to elevation of intracranial pressure as a result of calvarial overgrowth. The mean age of death was 33 years, with an even gender distribution]	L6	y	-	lethal	lethal	lethal	L4|L6	L4	post-infant-lethal
269600	SEA-BLUE HISTIOCYTE DISEASE	Sea-blue histiocyte disease, 269600 (3)	Sea-blue histiocyte disease	n	-	-	-	APOE	HGNC:613	Sea-blue histiocyte disease, 269600 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	ambiguous|nonlethal	ambiguous	-	-	-
269700	LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 2	Lipodystrophy, congenital generalized, type 2, 269700 (3)	Lipodystrophy, congenital generalized, type 2	y	LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 2; CGL2	Clinical Features	death|deaths|died	BSCL2	HGNC:15832	Lipodystrophy, congenital generalized, type 2, 269700 (3), Autosomal recessive	Autosomal recessive	y	y	[Van Maldergem et al. (2002) studied 70 affected individuals from 44 unrelated families with congenital generalized lipodystrophy. Forty-five patients from 24 families had BSCL2 and 21 patients from 17 families had BSCL1 (608594). Two European families had no BSCL2 mutations and did not show linkage to chromosome 9q34, indicating the existence of an additional locus, which the authors termed BSCLX. All subjects of African ancestry (35%) were in the BSCL1 group. Congenital lipoatrophy occurred in 79.5% of patients with BSCL2 compared to 61% of other cases. Onset of diabetes was the same in all patients. All patients had skeletal muscle hypertrophy, and the prevalence of hypertrophic cardiomyopathy was approximately 20% in all groups. Seven of 45 (15%) BSCL2 patients died prematurely (range, 4 months to 35 years of age), compared to no premature deaths in patients with BSCL1]	L3	y	-	lethal	ambiguous|lethal|nonlethal	lethal|nonlethal	L3|L4	L3	pre-infant-lethal
269840	IMMUNODEFICIENCY 48	Immunodeficiency 48, 269840 (3)	Immunodeficiency 48	n	-	-	-	ZAP70	HGNC:12858	Immunodeficiency 48, 269840 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
269880	SHORT SYNDROME	SHORT syndrome, 269880 (3)	SHORT syndrome	n	-	-	-	PIK3R1	HGNC:8979	SHORT syndrome, 269880 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	LU	LU	post-infant-lethal
269920	INFANTILE SIALIC ACID STORAGE DISEASE	Sialic acid storage disorder, infantile, 269920 (3)	Sialic acid storage disorder, infantile	y	INFANTILE SIALIC ACID STORAGE DISEASE; ISSD	Clinical Features|Clinical Synopsis|Diagnosis	death|deaths|died	SLC17A5	HGNC:10933	Sialic acid storage disorder, infantile, 269920 (3), Autosomal recessive	Autosomal recessive	n	y	[Hancock et al. (1982) reported a patient with extensive accumulation of free NeuAc in tissues and abnormal storage lysosomes who pursued a fulminant clinical course ending in death at 5 months]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
269921	SIALURIA	Sialuria, 269921 (3)	Sialuria	n	-	-	-	GNE	HGNC:23657	Sialuria, 269921 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
270100	HETEROTAXY, VISCERAL, 5, AUTOSOMAL	Heterotaxy, visceral, 5, 270100 (3)	Heterotaxy, visceral, 5	n	-	-	-	NODAL	HGNC:7865	Heterotaxy, visceral, 5, 270100 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
270200	SJOGREN-LARSSON SYNDROME	Sjogren-Larsson syndrome, 270200 (3)	Sjogren-Larsson syndrome	n	-	-	-	ALDH3A2	HGNC:403	Sjogren-Larsson syndrome, 270200 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
270300	PEELING SKIN SYNDROME 1	Peeling skin syndrome 1, 270300 (3)	Peeling skin syndrome 1	y	PEELING SKIN SYNDROME 1; PSS1	Clinical Features	died	CDSN	HGNC:1802	Peeling skin syndrome 1, 270300 (3), Autosomal recessive	Autosomal recessive	n	y	[Mevorah et al. (1987) reported a 28-year-old Caucasian woman with variably pruritic ichthyosiform dermatosis. At birth her skin was diffusely red and became generally encrusted; there was no ectropion. The universal erythema was later replaced by migratory erythematous scaling patches that spared the palms and soles and evolved on a background of diffusely thickened dirty-grayish skin. There was persistent diffuse erythema of the face, but no blisters or mucous membrane lesions. The typical pattern of lesion development, which occurred over 6 to 8 days and could be induced by moderate rubbing of the skin, began with a reddish spot that expanded with a thin horny collarette at its border; the surface was initially smooth, but later became covered with large grayish scales which flaked off, leaving regenerated background skin. The grayish thickening of her skin progressively diminished after puberty, but the erythematous peeling lesions showed no improvement, although they regressed markedly every summer. The pruritis showed reverse seasonal periodicity, becoming worse in summer. The patient also exhibited moderate uniform palmoplantar keratoderma with chapping, and she had slightly dystrophic fingernails, with some showing definite koilonychia. Her hair appeared grossly normal, and microscopic examination of hair shafts showed no significant changes. A brother who was reported to have exhibited a similar dermatosis died at 8 months of age; no medical records were available]	L3	n	y	lethal	lethal|nonlethal	lethal|nonlethal	L3	L3	pre-infant-lethal
270400	SMITH-LEMLI-OPITZ SYNDROME	Smith-Lemli-Opitz syndrome, 270400 (3)	Smith-Lemli-Opitz syndrome	y	SMITH-LEMLI-OPITZ SYNDROME; SLOS	Clinical Features|Diagnosis|Phenotype	death|deaths|died|lethal|lethality|stillbirth|stillbirths|die	DHCR7	HGNC:2860	Smith-Lemli-Opitz syndrome, 270400 (3), Autosomal recessive	Autosomal recessive	y	y	[Ryan et al. (1998) reported a review of all known cases of SLOS in the U. K. A total of 86 cases were initially identified with a diagnosis of SLOS, and a group of 49 with proven 7-dehydrocholesterol reductase deficiency were studied. Thirty-five (71%) were male. Twenty-four individuals were alive at the time of study; 20 had died, including 1 stillbirth, and 5 fetuses had been terminated]	L1	y	-	lethal	lethal	lethal	L1	L1	pre-infant-lethal
270420	DIARRHEA 3, SECRETORY SODIUM, CONGENITAL, WITH OR WITHOUT OTHER CONGENITAL ANOMALIES	Diarrhea 3, secretory sodium, congenital, syndromic, 270420 (3)	Diarrhea 3, secretory sodium, congenital, syndromic	y	DIARRHEA 3, SECRETORY SODIUM, CONGENITAL, WITH OR WITHOUT OTHER CONGENITAL ANOMALIES; DIAR3	Clinical Features|Phenotype	death|deaths|died|fatal|lethal	SPINT2	HGNC:11247	Diarrhea 3, secretory sodium, congenital, syndromic, 270420 (3), Autosomal recessive	Autosomal recessive	n	y	[Keller et al. (1990) reported a boy, born of nonconsanguineous parents, who had protracted and ultimately lethal diarrhea from the third day of life]	L2	y	-	lethal	lethal	lethal	L2	L2	pre-infant-lethal
270450	INSULIN-LIKE GROWTH FACTOR I, RESISTANCE TO	Insulin-like growth factor I, resistance to, 270450 (3)	Insulin-like growth factor I, resistance to	n	-	-	-	IGF1R	HGNC:5465	Insulin-like growth factor I, resistance to, 270450 (3), Autosomal dominant, Autosomal recessive	Autosomal dominant, Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
270550	SPASTIC ATAXIA, CHARLEVOIX-SAGUENAY TYPE	Spastic ataxia, Charlevoix-Saguenay type, 270550 (3)	Spastic ataxia, Charlevoix-Saguenay type	n	-	-	-	SACS	HGNC:10519	Spastic ataxia, Charlevoix-Saguenay type, 270550 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
270685	SPASTIC PARAPLEGIA 17, AUTOSOMAL DOMINANT	Silver spastic paraplegia syndrome, 270685 (3)	Silver spastic paraplegia syndrome	n	-	-	-	BSCL2	HGNC:15832	Silver spastic paraplegia syndrome, 270685 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	ambiguous|lethal|nonlethal	lethal|nonlethal	L3|L4	L3	pre-infant-lethal
270700	SPASTIC PARAPLEGIA 15, AUTOSOMAL RECESSIVE	Spastic paraplegia 15, autosomal recessive, 270700 (3)	Spastic paraplegia 15, autosomal recessive	n	-	-	-	ZFYVE26	HGNC:20761	Spastic paraplegia 15, autosomal recessive, 270700 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
270750	SPASTIC PARAPLEGIA 23, AUTOSOMAL RECESSIVE	Spastic paraplegia 23, autosomal recessive, 270750 (3)	Spastic paraplegia 23, autosomal recessive	y	SPASTIC PARAPLEGIA 23, AUTOSOMAL RECESSIVE; SPG23	Clinical Features|Phenotype	died|death|deaths	DSTYK	HGNC:29043	Spastic paraplegia 23, autosomal recessive, 270750 (3), Autosomal recessive	Autosomal recessive	y	y	[In an inbred Arab family in Israel, Mukamel et al. (1985) observed 4 affected sibs. All 4 sibs had severe incapacitating spastic paraparesis from early childhood, combined with abnormalities of skin and hair pigmentation. Two other sibs with similar dermatologic findings died at the ages of 3 and 4 months of sepsis.]	L3	-	y	lethal	lethal	lethal	L2|L3	L2	pre-infant-lethal
270800	SPASTIC PARAPLEGIA 5A, AUTOSOMAL RECESSIVE	Spastic paraplegia 5A, autosomal recessive, 270800 (3)	Spastic paraplegia 5A, autosomal recessive	n	-	-	-	CYP7B1	HGNC:2652	Spastic paraplegia 5A, autosomal recessive, 270800 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L1	L1	pre-infant-lethal
270960	SPERMATOGENIC FAILURE 4	Pregnancy loss, recurrent, 4, 270960 (3)	Pregnancy loss, recurrent, 4	y	SPERMATOGENIC FAILURE 4; SPGF4	Description|Clinical Features|Clinical Synopsis|Phenotype	fetal_loss|fetal_losses|miscarriage|miscarriages|pregnancy_loss|pregnancy_losses|spontaneous_abortion|spontaneous_abortions|stillbirth|stillbirths	SYCP3	HGNC:18130	Pregnancy loss, recurrent, 4, 270960 (3), Autosomal dominant	Autosomal dominant	n	n	-	-	-	-	ambiguous	ambiguous	ambiguous	-	-	-
270960	SPERMATOGENIC FAILURE 4	Spermatogenic failure 4, 270960 (3)	Spermatogenic failure 4	y	SPERMATOGENIC FAILURE 4; SPGF4	Description|Clinical Features|Clinical Synopsis|Phenotype	fetal_loss|fetal_losses|miscarriage|miscarriages|pregnancy_loss|pregnancy_losses|spontaneous_abortion|spontaneous_abortions|stillbirth|stillbirths	SYCP3	HGNC:18130	Spermatogenic failure 4, 270960 (3), Autosomal dominant	Autosomal dominant	n	n	-	-	-	-	ambiguous	ambiguous	ambiguous	-	-	-
270970	SPHEROCYTOSIS, TYPE 3	Spherocytosis, type 3, 270970 (3)	Spherocytosis, type 3	y	SPHEROCYTOSIS, TYPE 3; SPH3	Clinical Features	fatal	SPTA1	HGNC:11272	Spherocytosis, type 3, 270970 (3), Autosomal recessive	Autosomal recessive	n	n	-	-	-	-	ambiguous	ambiguous|nonlethal	ambiguous	-	-	-
271150	SPINAL MUSCULAR ATROPHY, TYPE IV	Spinal muscular atrophy-4, 271150 (3)	Spinal muscular atrophy-4	y	SPINAL MUSCULAR ATROPHY, TYPE IV; SMA4	Clinical Features	died	SMN1	HGNC:11117	Spinal muscular atrophy-4, 271150 (3), Autosomal recessive	Autosomal recessive	y	n	-	-	-	-	ambiguous	ambiguous|lethal	lethal	L3|L4	L3	pre-infant-lethal
271245	MITOCHONDRIAL DNA DEPLETION SYNDROME 7 (HEPATOCEREBRAL TYPE)	Mitochondrial DNA depletion syndrome 7 (hepatocerebral type), 271245 (3)	Mitochondrial DNA depletion syndrome 7 (hepatocerebral type)	y	MITOCHONDRIAL DNA DEPLETION SYNDROME 7 (HEPATOCEREBRAL TYPE); MTDPS7	Clinical Features|Clinical Synopsis	died|death|deaths	TWNK	HGNC:1160	Mitochondrial DNA depletion syndrome 7 (hepatocerebral type), 271245 (3), Autosomal recessive	Autosomal recessive	n	y	[Lonnqvist et al. (2009) reported long-term follow-up of 21 patients with IOSCA who were homozygous for the Y508C (606075.0012) mutation. Age at the time of study ranged from 14 to 48 years. There were 2 patients with compound heterozygosity for C10ORF2 mutations (reported by Hakonen et al., 2007) who showed consistently earlier onset of all features and died at age 4.5 years]	L4	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L4|L6	L4	post-infant-lethal
271400	ASPLENIA, ISOLATED CONGENITAL	Asplenia, isolated congenital, 271400 (3)	Asplenia, isolated congenital	y	ASPLENIA, ISOLATED CONGENITAL; ICAS	Description|Clinical Features	die|death|deaths|died|fatal	RPSA	HGNC:6502	Asplenia, isolated congenital, 271400 (3), Autosomal dominant	Autosomal dominant	n	y	[Koss et al. (2012) reported detailed features of a family of African descent with congenital asplenia (family E in Mahlaoui et al., 2011). In this family, 3 children died of fulminant infection within the first year of life; they were not further studied]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
271510	SPONDYLOEPIMETAPHYSEAL DYSPLASIA, SPONASTRIME TYPE	Spondyloepimetaphyseal dysplasia, sponastrime type, 271510 (3)	Spondyloepimetaphyseal dysplasia, sponastrime type	n	-	-	-	TONSL	HGNC:7801	Spondyloepimetaphyseal dysplasia, sponastrime type, 271510 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
271640	SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY, TYPE 1, WITH OR WITHOUT FRACTURES	Spondyloepimetaphyseal dysplasia with joint laxity, type 1, with or without fractures, 271640 (3)	Spondyloepimetaphyseal dysplasia with joint laxity, type 1, with or without fractures	y	SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY, TYPE 1, WITH OR WITHOUT FRACTURES; SEMDJL1	Description|Clinical Features|Clinical Synopsis	death|deaths|die|died|lethal	B3GALT6	HGNC:17978	Spondyloepimetaphyseal dysplasia with joint laxity, type 1, with or without fractures, 271640 (3), Autosomal recessive	Autosomal recessive	y	y	[Death in first-second decade of life secondary to cardio-respiratory compromise]	L4	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L1|L4	L1	pre-infant-lethal
271665	SPONDYLOMETAEPIPHYSEAL DYSPLASIA, SHORT LIMB-HAND TYPE	Spondylometaepiphyseal dysplasia, short limb-hand type, 271665 (3)	Spondylometaepiphyseal dysplasia, short limb-hand type	y	SPONDYLOMETAEPIPHYSEAL DYSPLASIA, SHORT LIMB-HAND TYPE	Clinical Features	death|deaths|died	DDR2	HGNC:2731	Spondylometaepiphyseal dysplasia, short limb-hand type, 271665 (3), Autosomal recessive	Autosomal recessive	y	y	[Dias et al. (2009) described 2 female sibs with clinical and radiographic features consistent with SMED-SL, who died suddenly in infancy from cord compression because of foramen magnum stenosis]	L3	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L3	L3	pre-infant-lethal
271700	SPONDYLOPERIPHERAL DYSPLASIA	Spondyloperipheral dysplasia, 271700 (3)	Spondyloperipheral dysplasia	n	-	-	-	COL2A1	HGNC:2200	Spondyloperipheral dysplasia, 271700 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	ambiguous|lethal|nonlethal	lethal|nonlethal	L1|L2|L3	L1	pre-infant-lethal
271900	CANAVAN DISEASE	Canavan disease, 271900 (3)	Canavan disease	y	CANAVAN DISEASE	Clinical Features|Clinical Synopsis|Phenotype	death|deaths|died	ASPA	HGNC:756	Canavan disease, 271900 (3), Autosomal recessive	Autosomal recessive	n	y	[The salient clinical features of Canavan disease are onset in early infancy, atonia of neck muscles, hypotonia, hyperextension of legs and flexion of arms, blindness, severe mental defect, megalocephaly, and death by 18 months on the average]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
271930	STRIATONIGRAL DEGENERATION, INFANTILE	Striatonigral degeneration, infantile, 271930 (3)	Striatonigral degeneration, infantile	y	STRIATONIGRAL DEGENERATION, INFANTILE; SNDI	Clinical Features	died	NUP62	HGNC:8066	Striatonigral degeneration, infantile, 271930 (3), Autosomal recessive	Autosomal recessive	y	y	[Holtzman and Hedley-Whyte (1992) reviewed the case of a boy who died at 56 months of age of a progressive neurodegenerative disorder characterized by gradual loss of motor and verbal skills with generalized seizures, myoclonus, and final deterioration to a nonverbal, quadriparetic state]	L4	y	-	lethal	lethal	lethal	L4	L4	post-infant-lethal
271980	SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	Succinic semialdehyde dehydrogenase deficiency, 271980 (3)	Succinic semialdehyde dehydrogenase deficiency	n	-	-	-	ALDH5A1	HGNC:408	Succinic semialdehyde dehydrogenase deficiency, 271980 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
272200	MULTIPLE SULFATASE DEFICIENCY	Multiple sulfatase deficiency, 272200 (3)	Multiple sulfatase deficiency	y	MULTIPLE SULFATASE DEFICIENCY; MSD	Description	death|deaths	SUMF1	HGNC:20376	Multiple sulfatase deficiency, 272200 (3), Autosomal recessive	Autosomal recessive	y	y	[Neonatal MSD is the most severe form with a broad range of mucopolysaccharidosis-like symptoms and death within the first year of life]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
272300	SULFITE OXIDASE DEFICIENCY, ISOLATED	Sulfite oxidase deficiency, 272300 (3)	Sulfite oxidase deficiency	y	SULFITE OXIDASE DEFICIENCY, ISOLATED; ISOD	Clinical Features|Clinical Synopsis|Phenotype	died|fatal|death|deaths	SUOX	HGNC:11460	Sulfite oxidase deficiency, 272300 (3), Autosomal recessive	Autosomal recessive	y	y	[ Sulfocysteinuria is an autosomal recessive disorder. Vianey-Liaud et al. (1988) reported an affected child of a consanguineous Algerian couple. The proband, a boy, died at 9 days of life. Two older sibs, a boy and a girl, had died in the first days of life, apparently of the same disorder ***(In Inheritance)]	L2	y	-	lethal	lethal	lethal	L2	L2	pre-infant-lethal
272430	CRISPONI/COLD-INDUCED SWEATING SYNDROME 1	Cold-induced sweating syndrome 1, 272430 (3)	Cold-induced sweating syndrome 1	y	CRISPONI/COLD-INDUCED SWEATING SYNDROME 1; CISS1	Description|Clinical Features	death|deaths|died	CRLF1	HGNC:2364	Cold-induced sweating syndrome 1, 272430 (3), Autosomal recessive	Autosomal recessive	y	y	[Accorsi et al. (2003) reported a patient with features consistent with Crisponi syndrome. The patient was born of unrelated parents, but both parents came from a small village in a geographically isolated area in northern Italy with a high rate of inbreeding. The pregnancy was complicated by polyhydramnios, and unspecified fetal hand abnormalities were noted by ultrasound.... The child died at age 4 months of cardiorespiratory failure following a hyperthermic crisis]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
272440	FILIPPI SYNDROME	Filippi syndrome, 272440 (3)	Filippi syndrome	n	-	-	-	CKAP2L	HGNC:26877	Filippi syndrome, 272440 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
272460	SPONDYLOCARPOTARSAL SYNOSTOSIS SYNDROME	Spondylocarpotarsal synostosis syndrome, 272460 (3)	Spondylocarpotarsal synostosis syndrome	n	-	-	-	FLNB	HGNC:3755	Spondylocarpotarsal synostosis syndrome, 272460 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L1|L2|LU	L1	pre-infant-lethal
272750	GM2-GANGLIOSIDOSIS, AB VARIANT	GM2-gangliosidosis, AB variant, 272750 (3)	GM2-gangliosidosis, AB variant	n	-	-	-	GM2A	HGNC:4367	GM2-gangliosidosis, AB variant, 272750 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
272800	TAY-SACHS DISEASE	GM2-gangliosidosis, several forms, 272800 (3)	GM2-gangliosidosis, several forms	y	TAY-SACHS DISEASE; TSD	Description|Clinical Features|Clinical Synopsis|Phenotype	fatal|death|deaths|died|die	HEXA	HGNC:4878	GM2-gangliosidosis, several forms, 272800 (3), Autosomal recessive	Autosomal recessive	y	y	[Kolodny (1972), who studied the proband described by Okada et al. (1971), stated that visual function was retained and optic atrophy was not present at age 20 months. At death at 32 months, microscopic findings in the central nervous system were similar to those in Tay-Sachs disease]	L4	y	-	lethal	lethal	lethal	L4	L4	post-infant-lethal
272800	TAY-SACHS DISEASE	Tay-Sachs disease, 272800 (3)	Tay-Sachs disease	y	TAY-SACHS DISEASE; TSD	Description|Clinical Features|Clinical Synopsis|Phenotype	fatal|death|deaths|died|die	HEXA	HGNC:4878	Tay-Sachs disease, 272800 (3), Autosomal recessive	Autosomal recessive	y	y	[Kolodny (1972), who studied the proband described by Okada et al. (1971), stated that visual function was retained and optic atrophy was not present at age 20 months. At death at 32 months, microscopic findings in the central nervous system were similar to those in Tay-Sachs disease]	L4	y	-	lethal	lethal	lethal	L4	L4	post-infant-lethal
273250	46,XY SEX REVERSAL 11	46XY sex reversal 11, 273250 (3)	46XY sex reversal 11	n	-	-	-	DHX37	HGNC:17210	46XY sex reversal 11, 273250 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
273750	THREE M SYNDROME 1	3-M syndrome 1, 273750 (3)	3-M syndrome 1	y	THREE M SYNDROME 1; 3M1	Clinical Features	died	CUL7	HGNC:21024	3-M syndrome 1, 273750 (3), Autosomal recessive	Autosomal recessive	y	y	[Maksimova et al. (2007) identified 43 patients from 37 Yakut families with a short stature syndrome similar to 3M syndrome... In 5 families (11.6%), affected newborns died shortly after birth of unknown causes]	L2	y	-	lethal	lethal	lethal	L2	L2	pre-infant-lethal
273800	GLANZMANN THROMBASTHENIA 1	Glanzmann thrombasthenia 1, 273800 (3)	Glanzmann thrombasthenia 1	n	-	-	-	ITGA2B	HGNC:6138	Glanzmann thrombasthenia 1, 273800 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
273900	THROMBOCYTOPENIA 3	Thrombocytopenia 3, 273900 (3)	Thrombocytopenia 3	n	-	-	-	FYB1	HGNC:4036	Thrombocytopenia 3, 273900 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
274000	THROMBOCYTOPENIA-ABSENT RADIUS SYNDROME	Thrombocytopenia-absent radius syndrome, 274000 (3)	Thrombocytopenia-absent radius syndrome	y	THROMBOCYTOPENIA-ABSENT RADIUS SYNDROME; TAR	Clinical Features|Clinical Synopsis	died|die	RBM8A	HGNC:9905	Thrombocytopenia-absent radius syndrome, 274000 (3), Autosomal recessive	Autosomal recessive	y	y	[Approximately 40% of patients die within newborn period / Menghsol et al. (2003) reported a patient with TAR syndrome who also had coarctation of the aorta and axial rotation of the kidney. He died at approximately 3 weeks of age from cardiorespiratory arrest due to pneumonia and sepsis]	L2	y	-	lethal	lethal	lethal	L2	L2	pre-infant-lethal
274150	THROMBOTIC THROMBOCYTOPENIC PURPURA, HEREDITARY	Thrombotic thrombocytopenic purpura, hereditary, 274150 (3)	Thrombotic thrombocytopenic purpura, hereditary	y	THROMBOTIC THROMBOCYTOPENIC PURPURA, HEREDITARY; TTP	Clinical Features	died|fatal|stillborn	ADAMTS13	HGNC:1366	Thrombotic thrombocytopenic purpura, hereditary, 274150 (3), Autosomal recessive	Autosomal recessive	y	y	[Fujimura et al. (2008) reported 9 Japanese women from 6 families with genetically confirmed USS who were diagnosed with the disorder during their first pregnancy. Six of the 9 had episodes of thrombocytopenia during childhood misdiagnosed as autoimmune idiopathic thrombocytopenic purpura (AITP; 188030).Thrombocytopenia occurred during the second to third trimesters in eachof their 15 pregnancies, often followed by TTP. Of 15 pregnancies, 8 babies were stillborn or died soon after birth]	L1	y	-	lethal	lethal	lethal	L1	L1	pre-infant-lethal
274270	DIHYDROPYRIMIDINE DEHYDROGENASE DEFICIENCY	5-fluorouracil toxicity, 274270 (3)	5-fluorouracil toxicity	y	DIHYDROPYRIMIDINE DEHYDROGENASE DEFICIENCY; DPYDD	Clinical Features	died	DPYD	HGNC:3012	5-fluorouracil toxicity, 274270 (3), Autosomal recessive	Autosomal recessive	y	y	[Vreken et al. (1997) reported a child with DPD deficiency who showed febrile convulsions, severe neuromotor retardation, and spastic tetraplegia at age 9 months. Cerebral MRI showed ventriculomegaly with white matter hypodensity. At the age of 6 years, thymine-uraciluria was noted and DPD deficiency was demonstrated in fibroblasts. An earlier-born child had died before her first birthday with severe neuromotor retardation and febrile convulsions. Genetic analysis identified a homozygous truncating mutation in the DPYD gene (611779.0005)]	L3	n	y	lethal	lethal	lethal	L3	L3	pre-infant-lethal
274270	DIHYDROPYRIMIDINE DEHYDROGENASE DEFICIENCY	Dihydropyrimidine dehydrogenase deficiency, 274270 (3)	Dihydropyrimidine dehydrogenase deficiency	y	DIHYDROPYRIMIDINE DEHYDROGENASE DEFICIENCY; DPYDD	Clinical Features	died	DPYD	HGNC:3012	Dihydropyrimidine dehydrogenase deficiency, 274270 (3), Autosomal recessive	Autosomal recessive	y	y	[Vreken et al. (1997) reported a child with DPD deficiency who showed febrile convulsions, severe neuromotor retardation, and spastic tetraplegia at age 9 months. Cerebral MRI showed ventriculomegaly with white matter hypodensity. At the age of 6 years, thymine-uraciluria was noted and DPD deficiency was demonstrated in fibroblasts. An earlier-born child had died before her first birthday with severe neuromotor retardation and febrile convulsions. Genetic analysis identified a homozygous truncating mutation in the DPYD gene (611779.0005)]	L3	n	y	lethal	lethal	lethal	L3	L3	pre-infant-lethal
274300	THYROID HORMONE RESISTANCE, GENERALIZED, AUTOSOMAL RECESSIVE	Thyroid hormone resistance, autosomal recessive, 274300 (3)	Thyroid hormone resistance, autosomal recessive	n	-	-	-	THRB	HGNC:11799	Thyroid hormone resistance, autosomal recessive, 274300 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
274400	THYROID DYSHORMONOGENESIS 1	Thyroid dyshormonogenesis 1, 274400 (3)	Thyroid dyshormonogenesis 1	n	-	-	-	SLC5A5	HGNC:11040	Thyroid dyshormonogenesis 1, 274400 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
274500	THYROID DYSHORMONOGENESIS 2A	Thyroid dyshormonogenesis 2A, 274500 (3)	Thyroid dyshormonogenesis 2A	n	-	-	-	TPO	HGNC:12015	Thyroid dyshormonogenesis 2A, 274500 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
274600	PENDRED SYNDROME	Pendred syndrome, 274600 (3)	Pendred syndrome	n	-	-	-	SLC26A4	HGNC:8818	Pendred syndrome, 274600 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
274700	THYROID DYSHORMONOGENESIS 3	Thyroid dyshormonogenesis 3, 274700 (3)	Thyroid dyshormonogenesis 3	n	-	-	-	TG	HGNC:11764	Thyroid dyshormonogenesis 3, 274700 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
274800	THYROID DYSHORMONOGENESIS 4	Thyroid dyshormonogenesis 4, 274800 (3)	Thyroid dyshormonogenesis 4	n	-	-	-	IYD	HGNC:21071	Thyroid dyshormonogenesis 4, 274800 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
274900	THYROID DYSHORMONOGENESIS 5	Thyroid dyshormonogenesis 5, 274900 (3)	Thyroid dyshormonogenesis 5	n	-	-	-	DUOXA2	HGNC:32698	Thyroid dyshormonogenesis 5, 274900 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
275100	HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 4	Hypothyroidism, congenital, nongoitrous 4, 275100 (3)	Hypothyroidism, congenital, nongoitrous 4	y	HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 4; CHNG4	Clinical Features	died	TSHB	HGNC:12372	Hypothyroidism, congenital, nongoitrous 4, 275100 (3), Autosomal recessive	Autosomal recessive	n	y	[The first familial incidence of isolated thyrotropin deficiency was reported by Miyai et al. (1971), who observed 2 affected sisters. Synthetic thyrotropin-releasing hormone (TRH) resulted in no rise in serum TSH levels. (Thyrotropin is more generally known as TSH (thyroid-stimulating hormone).) The parents were second cousins. A male sib, who died at age 3 years, may also have been affected]	L4	n	y	lethal	lethal	lethal	L4	L4	post-infant-lethal
275210	RESTRICTIVE DERMOPATHY 1	Restrictive dermopathy 1, 275210 (3)	Restrictive dermopathy 1	y	RESTRICTIVE DERMOPATHY 1; RSDM1	Description|Clinical Features|Clinical Synopsis|Phenotype	die|lethal|death|deaths|died|fatal|stillborn|stillbirth|stillbirths	ZMPSTE24	HGNC:12877	Restrictive dermopathy 1, 275210 (3), Autosomal recessive	Autosomal recessive	y	y	[Stillbirth]	L1	y	y	lethal	lethal	lethal	L1|L6	L1	pre-infant-lethal
275350	TRANSCOBALAMIN II DEFICIENCY	Transcobalamin II deficiency, 275350 (3)	Transcobalamin II deficiency	y	TRANSCOBALAMIN II DEFICIENCY	Clinical Features	died	TCN2	HGNC:11653	Transcobalamin II deficiency, 275350 (3), Autosomal recessive	Autosomal recessive	n	y	[The patient with TC deficiency reported by Hitzig et al. (1974) came from a Moroccan family in which 2 sons had died of severe infections in early infancy]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
275355	SQUAMOUS CELL CARCINOMA, HEAD AND NECK	Squamous cell carcinoma, head and neck, 275355 (3)	Squamous cell carcinoma, head and neck	y	SQUAMOUS CELL CARCINOMA, HEAD AND NECK; HNSCC	Phenotype	death|deaths	TNFRSF10B	HGNC:11905	Squamous cell carcinoma, head and neck, 275355 (3), Autosomal recessive	Autosomal recessive	y	n	-	-	-	-	ambiguous	ambiguous	ambiguous	-	-	-
275400	OLIVER-MCFARLANE SYNDROME	Oliver-McFarlane syndrome, 275400 (3)	Oliver-McFarlane syndrome	n	-	-	-	PNPLA6	HGNC:16268	Oliver-McFarlane syndrome, 275400 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
275630	CHANARIN-DORFMAN SYNDROME	Chanarin-Dorfman syndrome, 275630 (3)	Chanarin-Dorfman syndrome	n	-	-	-	ABHD5	HGNC:21396	Chanarin-Dorfman syndrome, 275630 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
275900	SPASTIC PARAPLEGIA 20, AUTOSOMAL RECESSIVE	Troyer syndrome, 275900 (3)	Troyer syndrome	n	-	-	-	SPART	HGNC:18514	Troyer syndrome, 275900 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
276300	MISMATCH REPAIR CANCER SYNDROME 1	Mismatch repair cancer syndrome 1, 276300 (3)	Mismatch repair cancer syndrome 1	y	MISMATCH REPAIR CANCER SYNDROME 1; MMRCS1	Clinical Features|Phenotype	died	MLH1	HGNC:7127	Mismatch repair cancer syndrome 1, 276300 (3), Autosomal recessive	Autosomal recessive	y	y	[Michels and Stevens (1982) reported a 22-year-old female with multiple polyposis of the colon requiring colectomy at age 17, multiple basal cell carcinoma in the scalp first presenting at age 18, pontine glioma presenting at age 19, and a tumor of the left posterior parietal region, either a second primary tumor or metastatic adenocarcinoma of the colon; invasive adenocarcinoma had been found in the colon specimen. She also had multiple pigmented lesions on the back and arms. A sister died of cerebral glioma at age 8 / Itoh et al. (1979) described 2 sisters, born of first-cousin parents, with malignant cerebral neoplasms and colonic polyposis. One sister presented at age 19 with multiple colonic polyps for which colectomy was performed. At the age of 22, she presented with a grade 3 astrocytoma of the left frontal lobe, from which she eventually died]	L4	y	y	lethal	ambiguous|lethal|nonlethal	lethal|nonlethal	L4	L4	post-infant-lethal
276600	TYROSINEMIA, TYPE II	Tyrosinemia, type II, 276600 (3)	Tyrosinemia, type II	n	-	-	-	TAT	HGNC:11573	Tyrosinemia, type II, 276600 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
276700	TYROSINEMIA, TYPE I	Tyrosinemia, type I, 276700 (3)	Tyrosinemia, type I	y	TYROSINEMIA, TYPE I; TYRSN1	Description|Clinical Features	die|death|deaths|died	FAH	HGNC:3579	Tyrosinemia, type I, 276700 (3), Autosomal recessive	Autosomal recessive	y	y	[Perry et al. (1965) described 3 sibs (2 females and a male) in 1 sibship who died in the third month after an illness characterized by irritability and progressive somnolence, and terminally by a tendency to bleed and hypoglycemia]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
276710	TYROSINEMIA, TYPE III	Tyrosinemia, type III, 276710 (3)	Tyrosinemia, type III	y	TYROSINEMIA, TYPE III; TYRSN3	Clinical Features	died	HPD	HGNC:5147	Tyrosinemia, type III, 276710 (3), Autosomal recessive	Autosomal recessive	y	n	-	-	-	-	ambiguous	ambiguous|lethal	lethal	L3	L3	pre-infant-lethal
276820	ULNA AND FIBULA, ABSENCE OF, WITH SEVERE LIMB DEFICIENCY	Ulna and fibula, absence of, with severe limb deficiency, 276820 (3)	Ulna and fibula, absence of, with severe limb deficiency	n	-	-	-	WNT7A	HGNC:12786	Ulna and fibula, absence of, with severe limb deficiency, 276820 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L2	L2	pre-infant-lethal
276900	USHER SYNDROME, TYPE I	Usher syndrome, type 1B, 276900 (3)	Usher syndrome, type 1B	n	-	-	-	MYO7A	HGNC:7606	Usher syndrome, type 1B, 276900 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
276901	USHER SYNDROME, TYPE IIA	Usher syndrome, type 2A, 276901 (3)	Usher syndrome, type 2A	n	-	-	-	USH2A	HGNC:12601	Usher syndrome, type 2A, 276901 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
276902	USHER SYNDROME, TYPE IIIA	Usher syndrome, type 3A, 276902 (3)	Usher syndrome, type 3A	y	USHER SYNDROME, TYPE IIIA; USH3A	Clinical Features	died	CLRN1	HGNC:12605	Usher syndrome, type 3A, 276902 (3), Autosomal recessive	Autosomal recessive	n	n	-	-	-	-	ambiguous	ambiguous|nonlethal	ambiguous	-	-	-
276904	USHER SYNDROME, TYPE IC	Usher syndrome, type 1C, 276904 (3)	Usher syndrome, type 1C	n	-	-	-	USH1C	HGNC:12597	Usher syndrome, type 1C, 276904 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
277170	OROFACIODIGITAL SYNDROME VI	Orofaciodigital syndrome VI, 277170 (3)	Orofaciodigital syndrome VI	y	OROFACIODIGITAL SYNDROME VI; OFD6	Clinical Features	died|stillborn	CPLANE1	HGNC:25801	Orofaciodigital syndrome VI, 277170 (3), Autosomal recessive	Autosomal recessive	y	y	[Doss et al. (1998) described the neuropathologic findings in a stillborn, 21-week estimated gestational age, male fetus diagnosed antenatally]	L1	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L1	L1	pre-infant-lethal
277180	VAS DEFERENS, CONGENITAL BILATERAL APLASIA OF	Congenital bilateral absence of vas deferens, 277180 (3)	Congenital bilateral absence of vas deferens	n	-	-	-	CFTR	HGNC:1884	Congenital bilateral absence of vas deferens, 277180 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	LU	LU	post-infant-lethal
277300	SPONDYLOCOSTAL DYSOSTOSIS 1, AUTOSOMAL RECESSIVE	Spondylocostal dysostosis 1, autosomal recessive, 277300 (3)	Spondylocostal dysostosis 1, autosomal recessive	y	SPONDYLOCOSTAL DYSOSTOSIS 1, AUTOSOMAL RECESSIVE; SCDO1	Clinical Features|Clinical Synopsis	die|died|lethal|death|deaths	DLL3	HGNC:2909	Spondylocostal dysostosis 1, autosomal recessive, 277300 (3), Autosomal recessive	Autosomal recessive	y	y	[Gassner and Grabs (1982) described 8 affected persons in 4 interrelated families. One also had Down syndrome and died at the age of 7 days]	L2	y	-	lethal	lethal	lethal	L2	L2	pre-infant-lethal
277380	METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, cblF TYPE	Methylmalonic aciduria and homocystinuria, cblF type, 277380 (3)	Methylmalonic aciduria and homocystinuria, cblF type	y	METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, cblF TYPE; MAHCF	Clinical Features	death|deaths	LMBRD1	HGNC:23038	Methylmalonic aciduria and homocystinuria, cblF type, 277380 (3), Autosomal recessive	Autosomal recessive	n	y	[Shih et al. (1987, 1989) reported a female infant with failure to thrive, developmental delay, minor facial anomalies, stomatitis, skin rashes, macrocytosis, homocystinuria, and methylmalonic acidemia. In vitro studies showed decreased synthesis of AdoCbl and MeCbl, and accumulation of unmetabolized free cobalamin. Treatment with hydroxocobalamin resulted in clinical and biochemical improvement, but sudden death occurred at 5 months of age]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
277400	METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, cblC TYPE	Methylmalonic aciduria and homocystinuria, cblC type, 277400 (3)	Methylmalonic aciduria and homocystinuria, cblC type	y	METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, cblC TYPE; MAHCC	Clinical Features|Clinical Synopsis	died|death|deaths	MMACHC	HGNC:24525	Methylmalonic aciduria and homocystinuria, cblC type, 277400 (3), Autosomal recessive	Autosomal recessive	y	y	[Russo et al. (1992) described 3 infants with cblC disease characterized by metabolic acidosis, methylmalonic aciduria, and homocystinuria. In the first weeks of life, all showed failure to thrive, hypotonia, and lethargy associated with pancytopenia and hepatic dysfunction, which progressed to severe respiratory insufficiency and renal failure consistent with hemolytic-uremic syndrome. The infants died at 40, 45, and 75 days of age]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
277400	METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, cblC TYPE	Methylmalonic aciduria and homocystinuria, cblC type, digenic, 277400 (3)	Methylmalonic aciduria and homocystinuria, cblC type, digenic	y	METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, cblC TYPE; MAHCC	Clinical Features|Clinical Synopsis	died|death|deaths	PRDX1	HGNC:9352	Methylmalonic aciduria and homocystinuria, cblC type, digenic, 277400 (3), Autosomal recessive	Autosomal recessive	y	n	-	-	-	-	ambiguous	ambiguous	ambiguous	-	-	-
277410	METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, cblD TYPE	Homocystinuria, cblD type, variant 1, 277410 (3)	Homocystinuria, cblD type, variant 1	n	-	-	-	MMADHC	HGNC:25221	Homocystinuria, cblD type, variant 1, 277410 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
277410	METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, cblD TYPE	Methylmalonic aciduria and homocystinuria, cblD type, 277410 (3)	Methylmalonic aciduria and homocystinuria, cblD type	n	-	-	-	MMADHC	HGNC:25221	Methylmalonic aciduria and homocystinuria, cblD type, 277410 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
277410	METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, cblD TYPE	Methylmalonic aciduria, cblD type, variant 2, 277410 (3)	Methylmalonic aciduria, cblD type, variant 2	n	-	-	-	MMADHC	HGNC:25221	Methylmalonic aciduria, cblD type, variant 2, 277410 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
277440	VITAMIN D-DEPENDENT RICKETS, TYPE 2A	Rickets, vitamin D-resistant, type IIA, 277440 (3)	Rickets, vitamin D-resistant, type IIA	y	VITAMIN D-DEPENDENT RICKETS, TYPE 2A; VDDR2A	Clinical Features	died	VDR	HGNC:12679	Rickets, vitamin D-resistant, type IIA, 277440 (3), Autosomal recessive	Autosomal recessive	y	y	[Liberman et al. (1980) described a 13-year-old girl with total alopecia and rickets unresponsive to large doses of vitamin D2. She had profound hypocalcemia, which was unresponsive to several agents including 1,25-dihydroxycholecalciferol. Serum concentrations of 25-hydroxyvitamin D were normal, but those of 1,25-(OH)2-cholecalciferol were markedly raised. In addition, 24,25-dihydroxyvitamin D was undetectable in the serum. Administration of synthetic 24,25-dihydroxycholecalciferol was followed by normocalcemia which persisted long after treatment was stopped. Her sister, who died at age 10 months, also had total alopecia, rickets, and hypocalcemia resistant to vitamin D2 treatment / Fraher et al. (1986) reported a 3-year-old boy with extreme end-organ resistance to vitamin D. Although he had classic features of the disease and did not respond to treatment with vitamin D metabolites, he nevertheless had normal hair growth. In vitro studies of skin fibroblasts from the patient showed an absence of hormone binding. He died at 39 months of age]	L3	y	y	lethal	lethal	lethal	L3	L3	pre-infant-lethal
277450	VITAMIN K-DEPENDENT CLOTTING FACTORS, COMBINED DEFICIENCY OF, 1	Vitamin K-dependent clotting factors, combined deficiency of, 1, 277450 (3)	Vitamin K-dependent clotting factors, combined deficiency of, 1	y	VITAMIN K-DEPENDENT CLOTTING FACTORS, COMBINED DEFICIENCY OF, 1; VKCFD1	Description|Clinical Features	fatal|died	GGCX	HGNC:4247	Vitamin K-dependent clotting factors, combined deficiency of, 1, 277450 (3), Autosomal recessive	Autosomal recessive	n	y	[Brenner et al. (1990) described a case of this disorder in a 7-year-old Arab girl who was the tenth offspring of a first-cousin marriage. The child showed deficiency of the procoagulant factors II, VII, IX, and X and also the natural anticoagulant proteins C and S. The child presented at 6 weeks of age with spontaneous intracerebral hemorrhage. A sib had died at 5 days from uncontrollable umbilical bleeding.]	L2	n	y	lethal	lethal|nonlethal	lethal|nonlethal	L2	L2	pre-infant-lethal
277460	ATAXIA WITH VITAMIN E DEFICIENCY	Ataxia with isolated vitamin E deficiency, 277460 (3)	Ataxia with isolated vitamin E deficiency	n	-	-	-	TTPA	HGNC:12404	Ataxia with isolated vitamin E deficiency, 277460 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
277470	PONTOCEREBELLAR HYPOPLASIA, TYPE 2A	Pontocerebellar hypoplasia type 2A, 277470 (3)	Pontocerebellar hypoplasia type 2A	y	PONTOCEREBELLAR HYPOPLASIA, TYPE 2A; PCH2A	Clinical Features|Clinical Synopsis	death|deaths|died|lethal	TSEN54	HGNC:27561	Pontocerebellar hypoplasia type 2A, 277470 (3), Autosomal recessive	Autosomal recessive	y	y	[Namavar et al. (2011) reviewed the clinical features of 88 patients with PCH2A who were homozygous for the common TSEN54 A307S mutation (608755.0001). The patients had neonatal irritability with jitteriness and/or clonus as well as dyskinesia and/or dystonia; most had impaired swallowing leading to failure to thrive. Progressive microcephaly became more apparent with age. Other features included impaired head and hand control, central visual impairment in the absence of primary optic atrophy, and seizures. Pre- and perinatal complications, such as polyhydramnios and contractures, were rare in these patients. Brain imaging showed pontocerebellar hypoplasia with a 'dragonfly-like' pattern characterized by flattened cerebellar hemispheres and a relatively preserved vermis. There was a wide range of life expectancy: 1 patient died at age 2.5 weeks, whereas another was alive at age 31 years]	L2	y	-	lethal	lethal	lethal	L2|L3	L2	pre-infant-lethal
277480	VON WILLEBRAND DISEASE, TYPE 3	von Willebrand disease, type 3, 277480 (3)	von Willebrand disease, type 3	y	VON WILLEBRAND DISEASE, TYPE 3; VWD3	Clinical Features	death|deaths|died	VWF	HGNC:12726	von Willebrand disease, type 3, 277480 (3), Autosomal recessive	Autosomal recessive	n	y	[Von Willebrand (1926, 1931) discovered a hemorrhagic condition in persons living on the Aland Islands in the Sea of Bothnia between Sweden and Finland and called it 'pseudohemophilia.' (See 300600 for another Aland Island disease.) The main difference from classic hemophilia was prolonged bleeding time. Major clinical problems were gastrointestinal, urinary, and uterine bleeding; hemarthroses were rare, but present. Nyman et al. (1981) followed up on the kindred originally reported by von Willebrand (1926). Zhang et al. (1993) described patients descended from the original family reported by von Willebrand (1926). Only heterozygotes were found surviving. The proposita was a 5-year-old girl, who later bled to death during her fourth menstrual period... Four of the proband's sisters had died of uncontrolled bleeding in early childhood]	L4	y	y	lethal	lethal|nonlethal	lethal|nonlethal	L4	L4	post-infant-lethal
277580	WAARDENBURG SYNDROME, TYPE 4A	Waardenburg syndrome, type 4A, 277580 (3)	Waardenburg syndrome, type 4A	y	WAARDENBURG SYNDROME, TYPE 4A; WS4A	Clinical Features	died	EDNRB	HGNC:3180	Waardenburg syndrome, type 4A, 277580 (3), Autosomal dominant, Autosomal recessive	Autosomal dominant, Autosomal recessive	y	y	[Shah et al. (1981) reported studies of 5 families in which a total of 12 babies (7 male; 5 female) with white forelock and white eyebrows and eyelashes presented in the neonatal period with intestinal obstruction.. The 12 infants died 3 to 38 days after birth because of failure of the ileostomy to function]	L2	y	-	lethal	lethal	lethal	L2	L2	pre-infant-lethal
277590	WEAVER SYNDROME	Weaver syndrome, 277590 (3)	Weaver syndrome	n	-	-	-	EZH2	HGNC:3527	Weaver syndrome, 277590 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
277600	WEILL-MARCHESANI SYNDROME 1	Weill-Marchesani syndrome 1, recessive, 277600 (3)	Weill-Marchesani syndrome 1, recessive	n	-	-	-	ADAMTS10	HGNC:13201	Weill-Marchesani syndrome 1, recessive, 277600 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
277700	WERNER SYNDROME	Werner syndrome, 277700 (3)	Werner syndrome	n	-	-	-	WRN	HGNC:12791	Werner syndrome, 277700 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
277900	WILSON DISEASE	Wilson disease, 277900 (3)	Wilson disease	y	WILSON DISEASE; WND	Clinical Features|Diagnosis	death|deaths|died	ATP7B	HGNC:870	Wilson disease, 277900 (3), Autosomal recessive	Autosomal recessive	y	y	[From Slovenia, Ferlan-Marolt and Stepec (1999) reported a 24-year-old woman with fulminant Wilsonian hepatitis accompanied by hemolytic anemia and leading to death in a few weeks]	L6	y	-	lethal	lethal	lethal	L6	L6	post-infant-lethal
278000	CHOLESTERYL ESTER STORAGE DISEASE	Cholesteryl ester storage disease, 278000 (3)	Cholesteryl ester storage disease	y	CHOLESTERYL ESTER STORAGE DISEASE; CESD	Description|Clinical Features	death|deaths|died	LIPA	HGNC:6617	Cholesteryl ester storage disease, 278000 (3), Autosomal recessive	Autosomal recessive	y	y	[Wolman et al. (1961) described 3 sibs in whom involvement of the viscera was an important feature and death occurred at the age of about 3 months]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
278150	HYPOTRICHOSIS 8	Hypotrichosis 8, 278150 (3)	Hypotrichosis 8	n	-	-	-	LPAR6	HGNC:15520	Hypotrichosis 8, 278150 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
278150	HYPOTRICHOSIS 8	Woolly hair, autosomal recessive 1, with or without hypotrichosis, 278150 (3)	Woolly hair, autosomal recessive 1, with or without hypotrichosis	n	-	-	-	LPAR6	HGNC:15520	Woolly hair, autosomal recessive 1, with or without hypotrichosis, 278150 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
278250	WRINKLY SKIN SYNDROME	Wrinkly skin syndrome, 278250 (3)	Wrinkly skin syndrome	n	-	-	-	ATP6V0A2	HGNC:18481	Wrinkly skin syndrome, 278250 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	ambiguous|nonlethal	ambiguous	-	-	-
278300	XANTHINURIA, TYPE I	Xanthinuria, type I, 278300 (3)	Xanthinuria, type I	n	-	-	-	XDH	HGNC:12805	Xanthinuria, type I, 278300 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
278700	XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP A	Xeroderma pigmentosum, group A, 278700 (3)	Xeroderma pigmentosum, group A	n	-	-	-	XPA	HGNC:12814	Xeroderma pigmentosum, group A, 278700 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
278720	XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP C	Xeroderma pigmentosum, group C, 278720 (3)	Xeroderma pigmentosum, group C	y	XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP C; XPC	Clinical Features	died	XPC	HGNC:12816	Xeroderma pigmentosum, group C, 278720 (3), Autosomal recessive	Autosomal recessive	n	y	[Gozukara et al. (2001) reported a Turkish family with severe XPC confirmed by genetic analysis (R579X; 613208.0007). The 8-year-old boy had abnormal skin lesions by 1 year of age, and developed typical freckling on sun-exposed areas with atrophy, telangiectasia, hypopigmentation, and actinic keratoses. He had multiple skin cancers and died at age 10 years]	L5	y	-	lethal	lethal	lethal	L5	L5	post-infant-lethal
278730	XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP D	Xeroderma pigmentosum, group D, 278730 (3)	Xeroderma pigmentosum, group D	n	-	-	-	ERCC2	HGNC:3434	Xeroderma pigmentosum, group D, 278730 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L3	L3	pre-infant-lethal
278740	XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP E	Xeroderma pigmentosum, group E, DDB-negative subtype, 278740 (3)	Xeroderma pigmentosum, group E, DDB-negative subtype	n	-	-	-	DDB2	HGNC:2718	Xeroderma pigmentosum, group E, DDB-negative subtype, 278740 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
278750	XERODERMA PIGMENTOSUM, VARIANT TYPE	Xeroderma pigmentosum, variant type, 278750 (3)	Xeroderma pigmentosum, variant type	n	-	-	-	POLH	HGNC:9181	Xeroderma pigmentosum, variant type, 278750 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
278760	XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP F	Xeroderma pigmentosum, group F, 278760 (3)	Xeroderma pigmentosum, group F	y	XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP F; XPF	Clinical Features	died|lethal	ERCC4	HGNC:3436	Xeroderma pigmentosum, group F, 278760 (3), Autosomal recessive	Autosomal recessive	n	y	[Kashiyama et al. (2013) reported a 16-year-old boy (CS1USAU) with Cockayne syndrome. He developed normally for the first year without obvious abnormalities, except for the microcephaly.... A second unrelated patient (XPCS1CD) had a more complex phenotype comprising XPF, Cockayne syndrome, and Fanconi anemia (see FANCQ; 615272).... She died of renal failure at age 12 years]	L5	y	-	lethal	lethal	lethal	L4|L5	L4	post-infant-lethal
278760	XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP F	Xeroderma pigmentosum, type F/Cockayne syndrome, 278760 (3)	Xeroderma pigmentosum, type F/Cockayne syndrome	y	XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP F; XPF	Clinical Features	died|lethal	ERCC4	HGNC:3436	Xeroderma pigmentosum, type F/Cockayne syndrome, 278760 (3), Autosomal recessive	Autosomal recessive	n	y	[Kashiyama et al. (2013) reported a 16-year-old boy (CS1USAU) with Cockayne syndrome. He developed normally for the first year without obvious abnormalities, except for the microcephaly.... A second unrelated patient (XPCS1CD) had a more complex phenotype comprising XPF, Cockayne syndrome, and Fanconi anemia (see FANCQ; 615272).... She died of renal failure at age 12 years]	L5	y	-	lethal	lethal	lethal	L4|L5	L4	post-infant-lethal
278780	XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP G	Xeroderma pigmentosum, group G, 278780 (3)	Xeroderma pigmentosum, group G	n	-	-	-	ERCC5	HGNC:3437	Xeroderma pigmentosum, group G, 278780 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L3	L3	pre-infant-lethal
278780	XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP G	Xeroderma pigmentosum, group G/Cockayne syndrome, 278780 (3)	Xeroderma pigmentosum, group G/Cockayne syndrome	n	-	-	-	ERCC5	HGNC:3437	Xeroderma pigmentosum, group G/Cockayne syndrome, 278780 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L3	L3	pre-infant-lethal
280000	COLOBOMA, CONGENITAL HEART DISEASE, ICHTHYOSIFORM DERMATOSIS, IMPAIRED INTELLECTUAL DEVELOPMENT, AND EAR ANOMALIES SYNDROME	CHIME syndrome, 280000 (3)	CHIME syndrome	n	-	-	-	PIGL	HGNC:8966	CHIME syndrome, 280000 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
300004	CORPUS CALLOSUM, AGENESIS OF, WITH ABNORMAL GENITALIA	Proud syndrome, 300004 (3)	Proud syndrome	y	CORPUS CALLOSUM, AGENESIS OF, WITH ABNORMAL GENITALIA	Clinical Features	died	ARX	HGNC:18060	Proud syndrome, 300004 (3), X-linked	X-linked	y	y	[Proud et al. (1992) reported on 4 generations in a family in which 3 living males, 3 males who died in infancy, and 3 females had neurologic impairment and agenesis of the corpus callosum]	L3	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L2|L3	L2	pre-infant-lethal
300009	DENT DISEASE 1	Dent disease 1, 300009 (3)	Dent disease 1	y	DENT DISEASE 1; DENT1	Clinical Features	died	CLCN5	HGNC:2023	Dent disease 1, 300009 (3), X-linked recessive	X-linked recessive	y	y	[Wrong et al. (1992) also reported affected women: one died of nephrocalcinosis and renal failure, and another was asymptomatic but had microglobulinuria, suggesting that carrier females may manifest some symptoms]	LU	y	-	lethal	lethal|nonlethal	lethal|nonlethal	LU	LU	post-infant-lethal
300018	46,XY SEX REVERSAL 2	46XY sex reversal 2, dosage-sensitive, 300018 (3)	46XY sex reversal 2, dosage-sensitive	n	-	-	-	NR0B1	HGNC:7960	46XY sex reversal 2, dosage-sensitive, 300018 (3), X-linked	X-linked	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L2	L2	pre-infant-lethal
300029	RETINITIS PIGMENTOSA 3	Retinitis pigmentosa 3, 300029 (3)	Retinitis pigmentosa 3	n	-	-	-	RPGR	HGNC:10295	Retinitis pigmentosa 3, 300029 (3), X-linked	X-linked	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
300048	INTESTINAL PSEUDOOBSTRUCTION, NEURONAL, CHRONIC IDIOPATHIC, X-LINKED	Congenital short bowel syndrome, 300048 (3)	Congenital short bowel syndrome	y	INTESTINAL PSEUDOOBSTRUCTION, NEURONAL, CHRONIC IDIOPATHIC, X-LINKED	Clinical Features|Phenotype	died|lethal|lethality	FLNA	HGNC:3754	Congenital short bowel syndrome, 300048 (3), X-linked recessive	X-linked recessive	n	y	[Gargiulo et al. (2007) described an affected male in the Italian family with X-linked chronic idiopathic intestinal pseudoobstruction reported by Auricchio et al. (1996).... Of the 10 affected males in 4 generations in this family, all except this patient died in the first months of life]	L3	y	-	lethal	lethal	lethal	L1|L2|L3	L1	pre-infant-lethal
300048	INTESTINAL PSEUDOOBSTRUCTION, NEURONAL, CHRONIC IDIOPATHIC, X-LINKED	Intestinal pseudoobstruction, neuronal, 300048 (3)	Intestinal pseudoobstruction, neuronal	y	INTESTINAL PSEUDOOBSTRUCTION, NEURONAL, CHRONIC IDIOPATHIC, X-LINKED	Clinical Features|Phenotype	died|lethal|lethality	FLNA	HGNC:3754	Intestinal pseudoobstruction, neuronal, 300048 (3), X-linked recessive	X-linked recessive	n	y	[Gargiulo et al. (2007) described an affected male in the Italian family with X-linked chronic idiopathic intestinal pseudoobstruction reported by Auricchio et al. (1996).... Of the 10 affected males in 4 generations in this family, all except this patient died in the first months of life]	L3	y	-	lethal	lethal	lethal	L1|L2|L3	L1	pre-infant-lethal
300049	PERIVENTRICULAR NODULAR HETEROTOPIA 1	Heterotopia, periventricular, 1, 300049 (3)	Heterotopia, periventricular, 1	y	PERIVENTRICULAR NODULAR HETEROTOPIA 1; PVNH1	Description|Clinical Features|Clinical Synopsis|Phenotype	die|death|deaths|died|lethality|spontaneous_abortion|spontaneous_abortions	FLNA	HGNC:3754	Heterotopia, periventricular, 1, 300049 (3), X-linked dominant	X-linked dominant	y	y	[Prenatal or perinatal lethality in hemizygous males]	L1	y	-	lethal	lethal	lethal	L1|L2|L3	L1	pre-infant-lethal
300055	INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC 13	Intellectual developmental disorder, X-linked syndromic 13, 300055 (3)	Intellectual developmental disorder, X-linked syndromic 13	y	INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC 13; MRXS13	Description|Clinical Features	lethal|died	MECP2	HGNC:6990	Intellectual developmental disorder, X-linked syndromic 13, 300055 (3), X-linked recessive	X-linked recessive	y	n	-	-	-	-	ambiguous	ambiguous|lethal	lethal	L1|L3|L4	L1	pre-infant-lethal
300066	DEAFNESS, X-LINKED 4	Deafness, X-linked 4, 300066 (3)	Deafness, X-linked 4	n	-	-	-	SMPX	HGNC:11122	Deafness, X-linked 4, 300066 (3), X-linked dominant	X-linked dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
300067	LISSENCEPHALY, X-LINKED, 1	Lissencephaly, X-linked, 300067 (3)	Lissencephaly, X-linked	y	LISSENCEPHALY, X-LINKED, 1; LISX1	Clinical Features	died|spontaneous_abortion|spontaneous_abortions	DCX	HGNC:2714	Lissencephaly, X-linked, 300067 (3), X-linked	X-linked	y	y	[Huttenlocher et al. (1994) reported a family in which 6 females spanning 4 generations had nodular subependymal masses of heterotopic gray matter and seizures. Cognitive function was normal. There was a high rate of spontaneous abortion, consistent with X-linked dominant inheritance and lack of viability in affected males /Berry-Kravis and Israel (1994) reported a family in which 5 male infants in 2 generations had lissencephaly inherited in an X-linked pattern. All the affected infants had intractable seizures, severe retardation, growth failure, and microphallus, and died during infancy]	L1	y	y	lethal	lethal	lethal	L1	L1	pre-infant-lethal
300067	LISSENCEPHALY, X-LINKED, 1	Subcortical laminal heterotopia, X-linked, 300067 (3)	Subcortical laminal heterotopia, X-linked	y	LISSENCEPHALY, X-LINKED, 1; LISX1	Clinical Features	died|spontaneous_abortion|spontaneous_abortions	DCX	HGNC:2714	Subcortical laminal heterotopia, X-linked, 300067 (3), X-linked	X-linked	y	y	[Huttenlocher et al. (1994) reported a family in which 6 females spanning 4 generations had nodular subependymal masses of heterotopic gray matter and seizures. Cognitive function was normal. There was a high rate of spontaneous abortion, consistent with X-linked dominant inheritance and lack of viability in affected males /Berry-Kravis and Israel (1994) reported a family in which 5 male infants in 2 generations had lissencephaly inherited in an X-linked pattern. All the affected infants had intractable seizures, severe retardation, growth failure, and microphallus, and died during infancy]	L1	y	y	lethal	lethal	lethal	L1	L1	pre-infant-lethal
300068	ANDROGEN INSENSITIVITY SYNDROME	Androgen insensitivity, 300068 (3)	Androgen insensitivity	n	-	-	-	AR	HGNC:644	Androgen insensitivity, 300068 (3), X-linked recessive	X-linked recessive	-	-	-	-	-	-	nonlethal	ambiguous|nonlethal	ambiguous	-	-	-
300071	NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 2A	Night blindness, congenital stationary (incomplete), 2A, X-linked, 300071 (3)	Night blindness, congenital stationary (incomplete), 2A, X-linked	n	-	-	-	CACNA1F	HGNC:1393	Night blindness, congenital stationary (incomplete), 2A, X-linked, 300071 (3), X-linked	X-linked	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
300088	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 9	Developmental and epileptic encephalopathy 9, 300088 (3)	Developmental and epileptic encephalopathy 9	n	-	-	-	PCDH19	HGNC:14270	Developmental and epileptic encephalopathy 9, 300088 (3), X-linked	X-linked	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
300100	ADRENOLEUKODYSTROPHY	Adrenoleukodystrophy, 300100 (3)	Adrenoleukodystrophy	y	ADRENOLEUKODYSTROPHY; ALD	Clinical Features|Clinical Synopsis	death|deaths|died|stillborn	ABCD1	HGNC:61	Adrenoleukodystrophy, 300100 (3), X-linked recessive	X-linked recessive	y	y	[Highly variable phenotype, ranging from asymptomatic to death by age 3 years]	L4	y	-	lethal	lethal	lethal	L4	L4	post-infant-lethal
300100	ADRENOLEUKODYSTROPHY	Adrenomyeloneuropathy, adult, 300100 (3)	Adrenomyeloneuropathy, adult	y	ADRENOLEUKODYSTROPHY; ALD	Clinical Features|Clinical Synopsis	death|deaths|died|stillborn	ABCD1	HGNC:61	Adrenomyeloneuropathy, adult, 300100 (3), X-linked recessive	X-linked recessive	y	y	[Highly variable phenotype, ranging from asymptomatic to death by age 3 years]	L4	y	-	lethal	lethal	lethal	L4	L4	post-infant-lethal
300106	SPONDYLOEPIMETAPHYSEAL DYSPLASIA, X-LINKED	Spondyloepimetaphyseal dysplasia, X-linked, 300106 (3)	Spondyloepimetaphyseal dysplasia, X-linked	n	-	-	-	BGN	HGNC:1044	Spondyloepimetaphyseal dysplasia, X-linked, 300106 (3), X-linked recessive	X-linked recessive	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	LU	LU	post-infant-lethal
300114	RAYNAUD-CLAES SYNDROME	Raynaud-Claes syndrome, 300114 (3)	Raynaud-Claes syndrome	y	RAYNAUD-CLAES SYNDROME; MRXSRC	Clinical Features	death|deaths	CLCN4	HGNC:2022	Raynaud-Claes syndrome, 300114 (3), X-linked dominant	X-linked dominant	n	y	[All affected males had a seizure disorder, including 4 with an infantile-onset epileptic encephalopathy phenotype associated with seizure-related death and mild to severe intellectual disability]	LU	y	-	lethal	lethal	lethal	LU	LU	post-infant-lethal
300115	INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 50	Intellectual developmental disorder, X-linked 50, 300115 (3)	Intellectual developmental disorder, X-linked 50	y	INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 50; XLID50	Clinical Features	died	SYN1	HGNC:11494	Intellectual developmental disorder, X-linked 50, 300115 (3), X-linked	X-linked	y	n	-	-	-	-	ambiguous	ambiguous|nonlethal	ambiguous	-	-	-
300123	INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, WITH PANHYPOPITUITARISM	Intellectual developmental disorder, X-linked, with isolated growth hormone deficiency, 300123 (3)	Intellectual developmental disorder, X-linked, with isolated growth hormone deficiency	y	INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, WITH PANHYPOPITUITARISM	Clinical Features	died	SOX3	HGNC:11199	Intellectual developmental disorder, X-linked, with isolated growth hormone deficiency, 300123 (3)	-	y	y	[Phelan et al. (1971) reported 4 cases of X-linked recessive panhypopituitary dwarfism in 3 sibships connected through females. Lagerstrom-Fermer et al. (1997) reinvestigated the family reported by Phelan et al. (1971), which included affected males with variable degrees of hypopituitarism. Some affected males had died during the first day of life and exhibited postmortem findings of hypoadrenalism, presumably due to hypopituitarism]	L2	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L2	L2	pre-infant-lethal
300143	INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 21	Intellectual developmental disorder, X-linked 21, 300143 (3)	Intellectual developmental disorder, X-linked 21	n	-	-	-	IL1RAPL1	HGNC:5996	Intellectual developmental disorder, X-linked 21, 300143 (3), X-linked recessive	X-linked recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
300148	MEHMO SYNDROME	MEHMO syndrome, 300148 (3)	MEHMO syndrome	y	MEHMO SYNDROME; MEHMO	Clinical Features|Phenotype	death|deaths|died	EIF2S3	HGNC:3267	MEHMO syndrome, 300148 (3), X-linked recessive	X-linked recessive	y	y	[Leshinsky-Silver et al. (2002) provided evidence that MEHMO is an X-linked mitochondrial disorder. They described an Ethiopian Jewish boy with MEHMO and lactic acidosis, whose muscle biopsy revealed markedly reduced activities of respiratory chain enzymes of complex I (see 602694), III (see 516020), and IV (see 516030), whereas complex II (see 600857) (exclusively encoded by nuclear DNA) was not affected. The skeletal muscle histology showed abundant fatty infiltration and mitochondrial proliferation. Electron microscopy showed concentric arrangement of the cristae in huge mitochondria, irregular lamellar arrangement, and electron dense bodies. The family history of 2 male sibs of the mother who died in the first year of life suggested X-linked MEHMO syndrome]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
300166	MICROPHTHALMIA, SYNDROMIC 2	Microphthalmia, syndromic 2, 300166 (3)	Microphthalmia, syndromic 2	y	MICROPHTHALMIA, SYNDROMIC 2; MCOPS2	Clinical Features|Phenotype	lethal|lethality|died|miscarriage|miscarriages	BCOR	HGNC:20893	Microphthalmia, syndromic 2, 300166 (3), X-linked dominant	X-linked dominant	y	y	[Gorlin et al. (1996) reviewed all reported cases and concluded that the OFCD syndrome consists of (1) eye anomalies (congenital cataract, microphthalmia, or secondary glaucoma); (2) facial abnormalities (long narrow face, high nasal bridge, pointed nose with cartilages separated at the tip, cleft palate, or submucous cleft palate); (3) cardiac anomalies (atrial septal defect, ventricular septal defect, or floppy mitral valve); and (4) dental abnormalities (canine radiculomegaly, delayed dentition, oligodontia, persistent primary teeth, or variable root length). They suggested that inheritance might be X-linked dominant, lethal in the male. The syndrome had been observed in 2 generations and in 7 females but not in males]	L1	y	-	lethal	lethal	lethal	L1	L1	pre-infant-lethal
300200	ADRENAL HYPOPLASIA, CONGENITAL	Adrenal hypoplasia, congenital, 300200 (3)	Adrenal hypoplasia, congenital	y	ADRENAL HYPOPLASIA, CONGENITAL; AHC	Clinical Features	died	NR0B1	HGNC:7960	Adrenal hypoplasia, congenital, 300200 (3), X-linked recessive	X-linked recessive	n	y	[An extensive Greenlandic pedigree was reported by Petersen et al. (1982). Over 5 generations, 11 boys had died with a clinical picture of adrenocortical insufficiency within 3 weeks of birth]	L2	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L2	L2	pre-infant-lethal
300209	SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 2	Simpson-Golabi-Behmel syndrome, type 2, 300209 (3)	Simpson-Golabi-Behmel syndrome, type 2	y	SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 2; SGBS2	Clinical Features|Clinical Synopsis	died|death|deaths	OFD1	HGNC:2567	Simpson-Golabi-Behmel syndrome, type 2, 300209 (3), X-linked recessive	X-linked recessive	y	y	[Death in infancy may occur]	L3	y	-	lethal	lethal	lethal	L1|L3|LU	L1	pre-infant-lethal
300210	INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 58	Intellectual developmental disorder, X-linked 58, 300210 (3)	Intellectual developmental disorder, X-linked 58	n	-	-	-	TSPAN7	HGNC:11854	Intellectual developmental disorder, X-linked 58, 300210 (3), X-linked recessive	X-linked recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
300215	LISSENCEPHALY, X-LINKED, 2	Hydranencephaly with abnormal genitalia, 300215 (3)	Hydranencephaly with abnormal genitalia	y	LISSENCEPHALY, X-LINKED, 2; LISX2	Description|Clinical Features|Clinical Synopsis	die|died|death|deaths	ARX	HGNC:18060	Hydranencephaly with abnormal genitalia, 300215 (3), X-linked	X-linked	y	y	[Early death in males / Ogata et al. (2000) reported an additional infant with this condition. The infant had lissencephaly, agenesis of the corpus callosum, intractable epilepsy of neonatal onset, hypothalamic dysfunction including temperature instability, ambiguous genitalia, and a 46,XY karyotype. The infant died at 6 weeks of age and an autopsy showed ventricular septal defect, patent ductus arteriosus (see 607411), mild left lung hypoplasia, megacolon, and small dysgenetic testes, in addition to the brain anomalies. The nonconsanguineous parents had 2 previous pregnancies, both recorded as males, in whom fetal ultrasound studies showed a hydrocephalic appearance. The first resulted in a neonate at 32 weeks of gestation who died of respiratory failure shortly after birth]	L2	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L2|L3	L2	pre-infant-lethal
300215	LISSENCEPHALY, X-LINKED, 2	Lissencephaly, X-linked 2, 300215 (3)	Lissencephaly, X-linked 2	y	LISSENCEPHALY, X-LINKED, 2; LISX2	Description|Clinical Features|Clinical Synopsis	die|died|death|deaths	ARX	HGNC:18060	Lissencephaly, X-linked 2, 300215 (3), X-linked	X-linked	y	y	[Early death in males / Ogata et al. (2000) reported an additional infant with this condition. The infant had lissencephaly, agenesis of the corpus callosum, intractable epilepsy of neonatal onset, hypothalamic dysfunction including temperature instability, ambiguous genitalia, and a 46,XY karyotype. The infant died at 6 weeks of age and an autopsy showed ventricular septal defect, patent ductus arteriosus (see 607411), mild left lung hypoplasia, megacolon, and small dysgenetic testes, in addition to the brain anomalies. The nonconsanguineous parents had 2 previous pregnancies, both recorded as males, in whom fetal ultrasound studies showed a hydrocephalic appearance. The first resulted in a neonate at 32 weeks of gestation who died of respiratory failure shortly after birth]	L2	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L2|L3	L2	pre-infant-lethal
300232	SPONDYLOEPIMETAPHYSEAL DYSPLASIA, X-LINKED, WITH HYPOMYELINATING LEUKODYSTROPHY	Spondyloepimetaphyseal dysplasia, X-linked, with hypomyelinating leukodystrophy, 300232 (3)	Spondyloepimetaphyseal dysplasia, X-linked, with hypomyelinating leukodystrophy	y	SPONDYLOEPIMETAPHYSEAL DYSPLASIA, X-LINKED, WITH HYPOMYELINATING LEUKODYSTROPHY; SEMDHL	Clinical Features|Clinical Synopsis	died|death|deaths	AIFM1	HGNC:8768	Spondyloepimetaphyseal dysplasia, X-linked, with hypomyelinating leukodystrophy, 300232 (3), X-linked recessive	X-linked recessive	n	y	[Mierzewska et al. (2017) reported 4 Polish brothers (family 2) with SEMDHL, all of whom died at 17 to 18 years of age]	L5	y	-	lethal	ambiguous|lethal|nonlethal	lethal|nonlethal	L3|L5	L3	pre-infant-lethal
300243	INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC, CHRISTIANSON TYPE	Intellectual developmental disorder, X-linked syndromic, Christianson type, 300243 (3)	Intellectual developmental disorder, X-linked syndromic, Christianson type	n	-	-	-	SLC9A6	HGNC:11079	Intellectual developmental disorder, X-linked syndromic, Christianson type, 300243 (3), X-linked	X-linked	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
300244	TERMINAL OSSEOUS DYSPLASIA	Terminal osseous dysplasia, 300244 (3)	Terminal osseous dysplasia	y	TERMINAL OSSEOUS DYSPLASIA; TOD	Description|Clinical Features	lethal|miscarriage|miscarriages|spontaneous_abortion|spontaneous_abortions	FLNA	HGNC:3754	Terminal osseous dysplasia, 300244 (3), X-linked dominant	X-linked dominant	y	y	[Bacino et al. (2000) gave a full description of the family reported by Zhang et al. (2000). The syndrome was present in 10 females in 4 generations...The lack of affected males, decreased number of male progeny in the pedigree, and the number of spontaneous abortions in the family supported a male-lethal X-linked dominant etiology.]	L1	y	-	lethal	lethal	lethal	L1|L2|L3	L1	pre-infant-lethal
300257	DANON DISEASE	Danon disease, 300257 (3)	Danon disease	y	DANON DISEASE	Clinical Features|Clinical Synopsis|Phenotype	death|deaths|died|lethal	LAMP2	HGNC:6501	Danon disease, 300257 (3), X-linked dominant	X-linked dominant	y	y	[Sudden death in affected males occurs in teens / Sudden death in affected females occurs in the forties]	L5	y	-	lethal	lethal	lethal	L5	L5	post-infant-lethal
300260	INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC, LUBS TYPE	Intellectual developmental disorder, X-linked syndromic, Lubs type, 300260 (3)	Intellectual developmental disorder, X-linked syndromic, Lubs type	y	INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC, LUBS TYPE; MRXSL	Clinical Features	died	MECP2	HGNC:6990	Intellectual developmental disorder, X-linked syndromic, Lubs type, 300260 (3), X-linked recessive	X-linked recessive	y	y	[Lubs et al. (1999) reported a family in which 5 males had severe X-linked mental retardation and progressive, severe central nervous system deterioration. The patients also had hypotonia, mild myopathy, and a characteristic facies with downslanting palpebral fissures, hypertelorism, and a short nose with a low nasal bridge. Three of the 5 affected males died of secondary complications before the age of 10 years, and no affected males had survived beyond the age of 10 years]	L4	y	-	lethal	ambiguous|lethal	lethal	L1|L3|L4	L1	pre-infant-lethal
300261	INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC, ARMFIELD TYPE	Intellectual developmental disorder, X-linked syndromic, Armfield type, 300261 (3)	Intellectual developmental disorder, X-linked syndromic, Armfield type	n	-	-	-	FAM50A	HGNC:18786	Intellectual developmental disorder, X-linked syndromic, Armfield type, 300261 (3), X-linked recessive	X-linked recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
300263	INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC, SIDERIUS TYPE	Intellectual developmental disorder, X-linked syndromic, Siderius type, 300263 (3)	Intellectual developmental disorder, X-linked syndromic, Siderius type	y	INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC, SIDERIUS TYPE; MRXSSD	Clinical Features	died	PHF8	HGNC:20672	Intellectual developmental disorder, X-linked syndromic, Siderius type, 300263 (3), X-linked recessive	X-linked recessive	y	y	[2 maternal uncles who had died in infancy and reportedly had bilateral cleft lip and palate]	L3	n	y	lethal	lethal	lethal	L3	L3	pre-infant-lethal
300271	INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 72	Intellectual developmental disorder, X-linked 72, 300271 (3)	Intellectual developmental disorder, X-linked 72	n	-	-	-	RAB39B	HGNC:16499	Intellectual developmental disorder, X-linked 72, 300271 (3), X-linked recessive	X-linked recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
300291	ECTODERMAL DYSPLASIA AND IMMUNODEFICIENCY 1	Ectodermal dysplasia and immunodeficiency 1, 300291 (3)	Ectodermal dysplasia and immunodeficiency 1	y	ECTODERMAL DYSPLASIA AND IMMUNODEFICIENCY 1; EDAID1	Description|Clinical Features|Phenotype	fatal|death|deaths|died|lethal|stillborn	IKBKG	HGNC:5961	Ectodermal dysplasia and immunodeficiency 1, 300291 (3), X-linked recessive	X-linked recessive	y	y	[Johnston et al. (2016) reported a male infant who presented with systemic Staphylococcus aureus infection associated with multiple brain infarcts, microabscesses, and white matter abnormalities. He was noted to have features of ectodermal dysplasia, such as sparse hair and absent eyelashes and eyebrows. He also had edema of the scalp, hands, scrotum, and lower extremities. Laboratory studies showed dysgammaglobulinemia with mostly low Ig levels, whereas T, B, and NK cells were normal. The infection persisted despite treatment, and he died at 18 days of age]	L2	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L1|L2|L3	L1	pre-infant-lethal
300299	NEUTROPENIA, SEVERE CONGENITAL, X-LINKED	Neutropenia, severe congenital, X-linked, 300299 (3)	Neutropenia, severe congenital, X-linked	n	-	-	-	WAS	HGNC:12731	Neutropenia, severe congenital, X-linked, 300299 (3), X-linked recessive	X-linked recessive	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L4|L6	L4	post-infant-lethal
300322	LESCH-NYHAN SYNDROME	Lesch-Nyhan syndrome, 300322 (3)	Lesch-Nyhan syndrome	n	-	-	-	HPRT1	HGNC:5157	Lesch-Nyhan syndrome, 300322 (3), X-linked recessive	X-linked recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
300323	HYPERURICEMIA, HPRT-RELATED	Hyperuricemia, HRPT-related, 300323 (3)	Hyperuricemia, HRPT-related	n	-	-	-	HPRT1	HGNC:5157	Hyperuricemia, HRPT-related, 300323 (3), X-linked recessive	X-linked recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
300352	CEREBRAL CREATINE DEFICIENCY SYNDROME 1	Cerebral creatine deficiency syndrome 1, 300352 (3)	Cerebral creatine deficiency syndrome 1	y	CEREBRAL CREATINE DEFICIENCY SYNDROME 1; CCDS1	Clinical Features	death|deaths	SLC6A8	HGNC:11055	Cerebral creatine deficiency syndrome 1, 300352 (3), X-linked recessive	X-linked recessive	y	n	-	-	-	-	ambiguous	ambiguous	ambiguous	-	-	-
300354	INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC, CABEZAS TYPE	Intellectual developmental disorder, X-linked syndromic, Cabezas type, 300354 (3)	Intellectual developmental disorder, X-linked syndromic, Cabezas type	n	-	-	-	CUL4B	HGNC:2555	Intellectual developmental disorder, X-linked syndromic, Cabezas type, 300354 (3), X-linked recessive	X-linked recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
300367	THROMBOCYTOPENIA, X-LINKED, WITH OR WITHOUT DYSERYTHROPOIETIC ANEMIA	Thrombocytopenia, X-linked, with or without dyserythropoietic anemia, 300367 (3)	Thrombocytopenia, X-linked, with or without dyserythropoietic anemia	y	THROMBOCYTOPENIA, X-LINKED, WITH OR WITHOUT DYSERYTHROPOIETIC ANEMIA; XLTDA	Clinical Features	died	GATA1	HGNC:4170	Thrombocytopenia, X-linked, with or without dyserythropoietic anemia, 300367 (3), X-linked recessive	X-linked recessive	n	y	[Freson et al. (2002) reported a family with X-linked thrombocytopenia and dyserythropoietic anemia in which 6 boys died of the disorder before age 2 years]	L3	y	-	lethal	ambiguous|lethal	lethal	L3	L3	pre-infant-lethal
300373	OSTEOPATHIA STRIATA WITH CRANIAL SCLEROSIS	Osteopathia striata with cranial sclerosis, 300373 (3)	Osteopathia striata with cranial sclerosis	y	OSTEOPATHIA STRIATA WITH CRANIAL SCLEROSIS; OSCS	Description|Clinical Features|Phenotype	lethality|died|spontaneous_abortion|spontaneous_abortions|stillborn	AMER1	HGNC:26837	Osteopathia striata with cranial sclerosis, 300373 (3), X-linked dominant	X-linked dominant	y	y	[Winter et al. (1980) observed osteopathia striata with cranial sclerosis in 4 persons spanning 3 generations of a family. The proband was a 29-year-old woman with large head, broad nasal bridge, wide-set eyes, cranial sclerosis, and spina bifida occulta. Osteopathia striata was present since childhood. She also had conductive hearing loss. Her first pregnancy ended in spontaneous abortion; her second pregnancy resulted in a severely affected son who died at 6 days of age / Bueno et al. (1998) likewise reported a family in which an affected male was stillborn with multiple congenital anomalies, whereas a sister and the mother and maternal grandfather had mild features]	L1	y	-	lethal	lethal	lethal	L1	L1	pre-infant-lethal
300376	MUSCULAR DYSTROPHY, BECKER TYPE	Becker muscular dystrophy, 300376 (3)	Becker muscular dystrophy	y	MUSCULAR DYSTROPHY, BECKER TYPE; BMD	Description|Clinical Features	death|deaths|fatal	DMD	HGNC:2928	Becker muscular dystrophy, 300376 (3), X-linked recessive	X-linked recessive	n	y	[Loss of ambulation also varies from adolescence onward, with death usually in the fourth or fifth decade]	L6	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L5|L6	L5	post-infant-lethal
300387	INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 63	Intellectual developmental disorder, X-linked 63, 300387 (3)	Intellectual developmental disorder, X-linked 63	n	-	-	-	ACSL4	HGNC:3571	Intellectual developmental disorder, X-linked 63, 300387 (3), X-linked dominant	X-linked dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
300400	SEVERE COMBINED IMMUNODEFICIENCY, X-LINKED	Severe combined immunodeficiency, X-linked, 300400 (3)	Severe combined immunodeficiency, X-linked	y	SEVERE COMBINED IMMUNODEFICIENCY, X-LINKED; SCIDX1	Clinical Features|Clinical Synopsis	death|deaths|died|fatal	IL2RG	HGNC:6010	Severe combined immunodeficiency, X-linked, 300400 (3), X-linked recessive	X-linked recessive	n	y	[Death within first year of life]	L3	y	-	lethal	lethal	lethal	L3|L4	L3	pre-infant-lethal
300419	INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 29	Intellectual developmental disorder, X-linked 29, 300419 (3)	Intellectual developmental disorder, X-linked 29	n	-	-	-	ARX	HGNC:18060	Intellectual developmental disorder, X-linked 29, 300419 (3), X-linked recessive	X-linked recessive	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L2|L3	L2	pre-infant-lethal
300422	FG SYNDROME 4	FG syndrome 4, 300422 (3)	FG syndrome 4	n	-	-	-	CASK	HGNC:1497	FG syndrome 4, 300422 (3), X-linked recessive	X-linked recessive	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L2	L2	pre-infant-lethal
300422	FG SYNDROME 4	Intellectual developmental disorder, with or without nystagmus, 300422 (3)	Intellectual developmental disorder, with or without nystagmus	n	-	-	-	CASK	HGNC:1497	Intellectual developmental disorder, with or without nystagmus, 300422 (3), X-linked recessive	X-linked recessive	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L2	L2	pre-infant-lethal
300423	INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC, HEDERA TYPE	Intellectual developmental disorder, X-linked syndromic, Hedera type, 300423 (3)	Intellectual developmental disorder, X-linked syndromic, Hedera type	y	INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC, HEDERA TYPE; MRXSH	Phenotype	death|deaths	ATP6AP2	HGNC:18305	Intellectual developmental disorder, X-linked syndromic, Hedera type, 300423 (3), X-linked recessive	X-linked recessive	y	n	-	-	-	-	ambiguous	ambiguous	ambiguous	-	-	-
300438	HSD10 MITOCHONDRIAL DISEASE	HSD10 mitochondrial disease, 300438 (3)	HSD10 mitochondrial disease	y	HSD10 MITOCHONDRIAL DISEASE; HSD10MD	Description|Clinical Features	death|deaths|died	HSD17B10	HGNC:4800	HSD10 mitochondrial disease, 300438 (3), X-linked dominant	X-linked dominant	y	y	[Perez-Cerda et al. (2005) reported 3 patients with MHBD deficiency from 2 unrelated Spanish families. In the first family, a girl presented with psychomotor delay from the first months of life and later showed ataxic gait, speech delay, and sensorineural deafness. She also showed episodes of myoclonus during stress. Cultured fibroblasts showed intermediate MHBD activity at 3.8 nmol/min/mg protein (control value of 7.1). She was started on a low-protein, isoleucine-restricted diet and showed moderate psychomotor retardation at age 10 years. A younger affected brother died during the neonatal period from lactic acidosis / Rauschenberger et al. (2010) found that development and severity of symptoms in HSD10 disease are unrelated to residual enzymatic activity. They reported a male infant with a severe form of the disorder who had absent neurologic development and died of progressive hypertrophic cardiomyopathy at age 7 months]	L2	y	y	lethal	lethal	lethal	L2	L2	pre-infant-lethal
300455	RETINITIS PIGMENTOSA, X-LINKED, AND SINORESPIRATORY INFECTIONS WITH OR WITHOUT DEAFNESS	Retinitis pigmentosa, X-linked, and sinorespiratory infections, with or without deafness, 300455 (3)	Retinitis pigmentosa, X-linked, and sinorespiratory infections, with or without deafness	n	-	-	-	RPGR	HGNC:10295	Retinitis pigmentosa, X-linked, and sinorespiratory infections, with or without deafness, 300455 (3), X-linked	X-linked	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
300475	DEAFNESS, DYSTONIA, AND CEREBRAL HYPOMYELINATION	Deafness, dystonia, and cerebral hypomyelination, 300475 (3)	Deafness, dystonia, and cerebral hypomyelination	y	DEAFNESS, DYSTONIA, AND CEREBRAL HYPOMYELINATION; DDCH	Clinical Features|Clinical Synopsis	died|death|deaths	BCAP31	HGNC:16695	Deafness, dystonia, and cerebral hypomyelination, 300475 (3), X-linked recessive	X-linked recessive	n	y	[Cacciagli et al. (2013) reported 7 males from 3 unrelated families with severe syndromic X-linked mental retardation apparent at birth or in the first years of life and almost no apparent motor or cognitive development. The oldest patients died at 13 and 24 years of age. The other patients died suddenly or during a febrile illness between 7 months and 3 years of age]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
300476	CONE-ROD DYSTROPHY, X-LINKED, 3	Cone-rod dystrophy, X-linked, 3, 300476 (3)	Cone-rod dystrophy, X-linked, 3	n	-	-	-	CACNA1F	HGNC:1393	Cone-rod dystrophy, X-linked, 3, 300476 (3), X-linked recessive	X-linked recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
300486	INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC, BILLUART TYPE	Intellectual developmental disorder, X-linked syndromic, Billuart type, 300486 (3)	Intellectual developmental disorder, X-linked syndromic, Billuart type	n	-	-	-	OPHN1	HGNC:8148	Intellectual developmental disorder, X-linked syndromic, Billuart type, 300486 (3), X-linked recessive	X-linked recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
300489	NEURONOPATHY, DISTAL HEREDITARY MOTOR, X-LINKED	Neuronopathy, distal hereditary motor, X-linked, 300489 (3)	Neuronopathy, distal hereditary motor, X-linked	n	-	-	-	ATP7A	HGNC:869	Neuronopathy, distal hereditary motor, X-linked, 300489 (3), X-linked recessive	X-linked recessive	-	-	-	-	-	-	nonlethal	ambiguous|lethal|nonlethal	lethal|nonlethal	L2	L2	pre-infant-lethal
300491	EPILEPSY, X-LINKED 1, WITH VARIABLE LEARNING DISABILITIES AND BEHAVIOR DISORDERS	Epilepsy, X-linked 1, with variable learning disabilities and behavior disorders, 300491 (3)	Epilepsy, X-linked 1, with variable learning disabilities and behavior disorders	n	-	-	-	SYN1	HGNC:11494	Epilepsy, X-linked 1, with variable learning disabilities and behavior disorders, 300491 (3), X-linked	X-linked	-	-	-	-	-	-	nonlethal	ambiguous|nonlethal	ambiguous	-	-	-
300495	AUTISM, SUSCEPTIBILITY TO, X-LINKED 2	Intellectual developmental disorder, X-linked, 300495 (3)	Intellectual developmental disorder, X-linked	n	-	-	-	NLGN4X	HGNC:14287	Intellectual developmental disorder, X-linked, 300495 (3), X-linked	X-linked	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
300500	ALBINISM, OCULAR, TYPE I	Ocular albinism, type I, Nettleship-Falls type, 300500 (3)	Ocular albinism, type I, Nettleship-Falls type	n	-	-	-	GPR143	HGNC:20145	Ocular albinism, type I, Nettleship-Falls type, 300500 (3), X-linked	X-linked	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
300510	OVARIAN DYSGENESIS 2	Ovarian dysgenesis 2, 300510 (3)	Ovarian dysgenesis 2	n	-	-	-	BMP15	HGNC:1068	Ovarian dysgenesis 2, 300510 (3), X-linked	X-linked	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
300510	OVARIAN DYSGENESIS 2	Premature ovarian failure 4, 300510 (3)	Premature ovarian failure 4	n	-	-	-	BMP15	HGNC:1068	Premature ovarian failure 4, 300510 (3), X-linked	X-linked	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
300514	FANCONI ANEMIA, COMPLEMENTATION GROUP B	Fanconi anemia, complementation group B, 300514 (3)	Fanconi anemia, complementation group B	y	FANCONI ANEMIA, COMPLEMENTATION GROUP B; FANCB	Description|Clinical Features	die|died	FANCB	HGNC:3583	Fanconi anemia, complementation group B, 300514 (3), X-linked recessive	X-linked recessive	y	y	[McCauley et al. (2011) reported 4 unrelated males with variable manifestations of VACTERL-H associated with mutations in the FANCB gene. Two of the affected pregnancies were terminated at 20 weeks' gestation, 1 proband died at age 15 weeks, and 1 died at age 2 years, 10 months. All presented in utero or at birth with multiple variable congenital anomalies including intrauterine growth retardation, dysmorphic ears, vertebral anomalies, esophageal, duodenal, or anal atresia, ventriculomegaly, renal agenesis, and radial agenesis. Two had cardiac defects, 2 had tracheoesophageal fistula, and 2 had small genitalia. Only the patient who lived beyond infancy developed anemia. Three patients studied had evidence of chromosome breakage. Two of the patients had male family members with a similar phenotype, both of whom died within the first month of life]	L2	y	y	lethal	lethal	lethal	L2	L2	pre-infant-lethal
300523	ALLAN-HERNDON-DUDLEY SYNDROME	Allan-Herndon-Dudley syndrome, 300523 (3)	Allan-Herndon-Dudley syndrome	y	ALLAN-HERNDON-DUDLEY SYNDROME; AHDS	Clinical Features	death|deaths	SLC16A2	HGNC:10923	Allan-Herndon-Dudley syndrome, 300523 (3), X-linked	X-linked	y	y	[Papadimitriou et al. (2008) reported an 11-month-old boy referred for severe hypotonia and global developmental delay. He had decreased muscle strength, hyperactive deep tendon reflexes, severe head lag, was unable to sit independently. Although he showed no signs of thyroid dysfunction, and thyrotropin was within the reference range, laboratory studies showed high serum triiodothyronine (T3), low thyroxine (T4), and mildly increased serum lactate. The increased serum lactate was considered to be consistent with peripheral thyrotoxicosis. Brain MRI showed decreased myelination of the subcortical tissue and thalamus. Family history was significant for a maternal uncle with an unidentified neurologic disorder leading to death at age of 8 years, and a brother with muscular hypotonia since birth and death at age 9 months]	L3	n	y	lethal	lethal	lethal	L3	L3	pre-infant-lethal
300534	INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC, CLAES-JENSEN TYPE	Intellectual developmental disorder, X-linked syndromic, Claes-Jensen type, 300534 (3)	Intellectual developmental disorder, X-linked syndromic, Claes-Jensen type	n	-	-	-	KDM5C	HGNC:11114	Intellectual developmental disorder, X-linked syndromic, Claes-Jensen type, 300534 (3), X-linked recessive	X-linked recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
300539	NEPHROGENIC SYNDROME OF INAPPROPRIATE ANTIDIURESIS	Nephrogenic syndrome of inappropriate antidiuresis, 300539 (3)	Nephrogenic syndrome of inappropriate antidiuresis	n	-	-	-	AVPR2	HGNC:897	Nephrogenic syndrome of inappropriate antidiuresis, 300539 (3), X-linked recessive	X-linked recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
300554	HYPOPHOSPHATEMIC RICKETS, X-LINKED RECESSIVE	Hypophosphatemic rickets, 300554 (3)	Hypophosphatemic rickets	n	-	-	-	CLCN5	HGNC:2023	Hypophosphatemic rickets, 300554 (3), X-linked recessive	X-linked recessive	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	LU	LU	post-infant-lethal
300555	DENT DISEASE 2	Dent disease 2, 300555 (3)	Dent disease 2	n	-	-	-	OCRL	HGNC:8108	Dent disease 2, 300555 (3), X-linked recessive	X-linked recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
300558	INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 30	Intellectual developmental disorder, X-linked 30, 300558 (3)	Intellectual developmental disorder, X-linked 30	n	-	-	-	PAK3	HGNC:8592	Intellectual developmental disorder, X-linked 30, 300558 (3), X-linked recessive	X-linked recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
300559	GLYCOGEN STORAGE DISEASE IXd	Muscle glycogenosis, 300559 (3)	Muscle glycogenosis	y	GLYCOGEN STORAGE DISEASE IXd; GSD9D	Clinical Features	died	PHKA1	HGNC:8925	Muscle glycogenosis, 300559 (3), X-linked recessive	X-linked recessive	y	n	-	-	-	-	ambiguous	ambiguous	ambiguous	-	-	-
300582	SHORT STATURE, IDIOPATHIC, X-LINKED	Short stature, idiopathic familial, 300582 (3)	Short stature, idiopathic familial	n	-	-	-	SHOX	HGNC:10853	Short stature, idiopathic familial, 300582 (3)	-	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
300590	CORNELIA DE LANGE SYNDROME 2	Cornelia de Lange syndrome 2, 300590 (3)	Cornelia de Lange syndrome 2	n	-	-	-	SMC1A	HGNC:11111	Cornelia de Lange syndrome 2, 300590 (3), X-linked dominant	X-linked dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L3	L3	pre-infant-lethal
300600	ALAND ISLAND EYE DISEASE	Aland Island eye disease, 300600 (3)	Aland Island eye disease	n	-	-	-	CACNA1F	HGNC:1393	Aland Island eye disease, 300600 (3), X-linked	X-linked	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
300607	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 8	Developmental and epileptic encephalopathy 8, 300607 (3)	Developmental and epileptic encephalopathy 8	y	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 8; DEE8	Clinical Features	death|deaths	ARHGEF9	HGNC:14561	Developmental and epileptic encephalopathy 8, 300607 (3), X-linked	X-linked	y	y	[Harvey et al. (2004) reported a patient with clinical symptoms of both hyperekplexia and early-onset epileptic encephalopathy. The child was the first-born of a 32-year-old woman, delivered at 36 weeks' gestation. Cyanosis and muscular stiffness were noted immediately after delivery, and the child appeared to stare. During the following weeks, the child developed tonic seizures that were provoked by tactile stimulation. Although the treatment of seizures was initially effective, after 3.5 months of age the seizures recurred and were often precipitated by extreme emotion. At 4 months of age, a diagnosis for hyperekplexia was made, but therapy with clonazepam was unsuccessful. EEG monitoring coupled with ambulatory video demonstrated that the seizures were both hyperekplectic and epileptic in origin. During the following years, the child suffered from frequent long-lasting seizures accompanied by the arrest and later decline of psychomotor development. Eventually, a progressive epileptic encephalopathy as well as hyperekplexia became evident, and poly-drug treatment failed to provide adequate long-term seizure control. At 4 years of age, the subject was severely retarded and suffered almost daily severe long-lasting fits, both epileptic and nonepileptic in origin, eventually leading to death at the age of 4 years and 4 months]	L4	y	-	lethal	lethal	lethal	L4	L4	post-infant-lethal
300614	DEAFNESS, X-LINKED 5, WITH PERIPHERAL NEUROPATHY	Deafness, X-linked 5, 300614 (3)	Deafness, X-linked 5	n	-	-	-	AIFM1	HGNC:8768	Deafness, X-linked 5, 300614 (3), X-linked recessive	X-linked recessive	-	-	-	-	-	-	nonlethal	ambiguous|lethal|nonlethal	lethal|nonlethal	L3|L5	L3	pre-infant-lethal
300615	BRUNNER SYNDROME	Brunner syndrome, 300615 (3)	Brunner syndrome	n	-	-	-	MAOA	HGNC:6833	Brunner syndrome, 300615 (3), X-linked recessive	X-linked recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
300623	FRAGILE X TREMOR/ATAXIA SYNDROME	Fragile X tremor/ataxia syndrome, 300623 (3)	Fragile X tremor/ataxia syndrome	y	FRAGILE X TREMOR/ATAXIA SYNDROME; FXTAS	Clinical Features	died	FMR1	HGNC:3775	Fragile X tremor/ataxia syndrome, 300623 (3), X-linked dominant	X-linked dominant	y	y	[Greco et al. (2008) reported a woman diagnosed with relapsing-remitting multiple sclerosis (MS; see 126200) at age 38 who was found to have a 75-repeat FMR1 premutation allele. Clinical features included distal sensory loss, intention tremor, gait ataxia, spastic paraparesis, short-term memory deficits, progressive dysarthria, disinhibition, and depression. She died at the age of 52 years after progressive memory impairment and loss of motor control]	L6	y	-	lethal	ambiguous|lethal|nonlethal	lethal|nonlethal	L6	L6	post-infant-lethal
300624	FRAGILE X SYNDROME	Fragile X syndrome, 300624 (3)	Fragile X syndrome	y	FRAGILE X SYNDROME; FXS	Clinical Features	died|miscarriage|miscarriages	FMR1	HGNC:3775	Fragile X syndrome, 300624 (3), X-linked dominant	X-linked dominant	y	n	-	-	-	-	ambiguous	ambiguous|lethal|nonlethal	lethal|nonlethal	L6	L6	post-infant-lethal
300633	HYPOSPADIAS 1, X-LINKED	Hypospadias 1, X-linked, 300633 (3)	Hypospadias 1, X-linked	n	-	-	-	AR	HGNC:644	Hypospadias 1, X-linked, 300633 (3), X-linked recessive	X-linked recessive	-	-	-	-	-	-	nonlethal	ambiguous|nonlethal	ambiguous	-	-	-
300635	LYMPHOPROLIFERATIVE SYNDROME, X-LINKED, 2	Lymphoproliferative syndrome, X-linked, 2, 300635 (3)	Lymphoproliferative syndrome, X-linked, 2	y	LYMPHOPROLIFERATIVE SYNDROME, X-LINKED, 2; XLP2	Description|Clinical Features|Clinical Synopsis	death|deaths|die|died|fatal	XIAP	HGNC:592	Lymphoproliferative syndrome, X-linked, 2, 300635 (3), X-linked recessive	X-linked recessive	n	y	[Rigaud et al. (2006) reported 12 male patients from 3 unrelated families with XLP2. Eight patients from 2 unrelated families were diagnosed in the first years of life. In the third family, 2 brothers were diagnosed at ages 20 years and 0.5 years, and they both died of HLH at diagnosis; their nephew was diagnosed at age 22 years]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
300636	IMMUNODEFICIENCY 33	Immunodeficiency 33, 300636 (3)	Immunodeficiency 33	y	IMMUNODEFICIENCY 33; IMD33	Clinical Features|Phenotype	died	IKBKG	HGNC:5961	Immunodeficiency 33, 300636 (3), X-linked recessive	X-linked recessive	y	y	[Boisson et al. (2019) reported 2 brothers from a European family (family A) and a boy from a Japanese family (family B) with severe IMD33. The patients presented in infancy with severe systemic infections, including Klebsiella, respiratory syncytial virus, Enterobacter, E. coli, fungal infections, and HHV6. Although immunologic parameters were basically normal, 1 patient had no IgA and developed hypogammaglobulinemia with poor response to tetanus and H. influenzae vaccination. Two patients had other variable abnormalities, including low IgG levels, high white cells, transient neutropenia, lymphopenia, and low NK cell levels. TNFA production in response to LPS and IFNG was impaired in the 1 patient studied. None of the patients had features of ectodermal dysplasia; all died by 9 months of age]	L3	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L1|L2|L3	L1	pre-infant-lethal
300645	IMMUNODEFICIENCY 34	Immunodeficiency 34, mycobacteriosis, X-linked, 300645 (3)	Immunodeficiency 34, mycobacteriosis, X-linked	n	-	-	-	CYBB	HGNC:2578	Immunodeficiency 34, mycobacteriosis, X-linked, 300645 (3), X-linked recessive	X-linked recessive	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	LU	LU	post-infant-lethal
300653	PHOSPHOGLYCERATE KINASE 1 DEFICIENCY	Phosphoglycerate kinase 1 deficiency, 300653 (3)	Phosphoglycerate kinase 1 deficiency	y	PHOSPHOGLYCERATE KINASE 1 DEFICIENCY	Clinical Features	died	PGK1	HGNC:8896	Phosphoglycerate kinase 1 deficiency, 300653 (3), X-linked recessive	X-linked recessive	n	y	[Noel et al. (2005) reported 2 unrelated boys of Spanish origin with PGK1 deficiency... He died of severe encephalopathy at 7 years of age]	L4	y	-	lethal	lethal	lethal	L4	L4	post-infant-lethal
300659	INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 93	Intellectual developmental disorder, X-linked 93, 300659 (3)	Intellectual developmental disorder, X-linked 93	n	-	-	-	BRWD3	HGNC:17342	Intellectual developmental disorder, X-linked 93, 300659 (3), X-linked recessive	X-linked recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
300661	PHOSPHORIBOSYLPYROPHOSPHATE SYNTHETASE SUPERACTIVITY	Gout, PRPS-related, 300661 (3)	Gout, PRPS-related	y	PHOSPHORIBOSYLPYROPHOSPHATE SYNTHETASE SUPERACTIVITY	Clinical Features	death|deaths|died	PRPS1	HGNC:9462	Gout, PRPS-related, 300661 (3), X-linked recessive	X-linked recessive	y	y	[Moran et al. (2012) described a patient with PRPS1 superactivity as well as features of Arts syndrome (301835), a developmental disorder also caused by mutations in the PRPS1 gene. Laboratory studies showed increased serum uric acid and increased urinary hypoxanthine consistent with PRPS1 superactivity, but he did not have gout. He had developmental delay, hypotonia, areflexia, motor neuropathy, sensorineural hearing loss, and a Chiari I malformation. In addition, he had recurrent infections and early death at age 27 months from infection, consistent with Arts syndrome. A maternal uncle with similar symptoms had died of pneumonia at age 2]	L4	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L4	L4	post-infant-lethal
300661	PHOSPHORIBOSYLPYROPHOSPHATE SYNTHETASE SUPERACTIVITY	Phosphoribosylpyrophosphate synthetase superactivity, 300661 (3)	Phosphoribosylpyrophosphate synthetase superactivity	y	PHOSPHORIBOSYLPYROPHOSPHATE SYNTHETASE SUPERACTIVITY	Clinical Features	death|deaths|died	PRPS1	HGNC:9462	Phosphoribosylpyrophosphate synthetase superactivity, 300661 (3), X-linked recessive	X-linked recessive	y	y	[Moran et al. (2012) described a patient with PRPS1 superactivity as well as features of Arts syndrome (301835), a developmental disorder also caused by mutations in the PRPS1 gene. Laboratory studies showed increased serum uric acid and increased urinary hypoxanthine consistent with PRPS1 superactivity, but he did not have gout. He had developmental delay, hypotonia, areflexia, motor neuropathy, sensorineural hearing loss, and a Chiari I malformation. In addition, he had recurrent infections and early death at age 27 months from infection, consistent with Arts syndrome. A maternal uncle with similar symptoms had died of pneumonia at age 2]	L4	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L4	L4	post-infant-lethal
300672	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 2	Developmental and epileptic encephalopathy 2, 300672 (3)	Developmental and epileptic encephalopathy 2	y	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 2; DEE2	Clinical Features	died	CDKL5	HGNC:11411	Developmental and epileptic encephalopathy 2, 300672 (3), X-linked dominant	X-linked dominant	y	y	[Weaving et al. (2004) reported a family with infantile spasms and severe mental retardation... A brother of the girls was profoundly affected, with infantile seizures, a mixed seizure disorder, severe global developmental delay with no visual or social responses, spastic quadriparesis, cortical blindness, episodes of hyperventilation, and marked kyphoscoliosis. He died of respiratory failure at the age of 16 years]	L5	y	-	lethal	lethal	lethal	L5	L5	post-infant-lethal
300673	ENCEPHALOPATHY, NEONATAL SEVERE, DUE TO MECP2 MUTATIONS	Encephalopathy, neonatal severe, 300673 (3)	Encephalopathy, neonatal severe	y	ENCEPHALOPATHY, NEONATAL SEVERE, DUE TO MECP2 MUTATIONS	Description|Clinical Features|Clinical Synopsis|Phenotype	lethal|death|deaths|died|spontaneous_abortion|spontaneous_abortions	MECP2	HGNC:6990	Encephalopathy, neonatal severe, 300673 (3), X-linked recessive	X-linked recessive	y	y	[Two of the patients' mothers had had previous spontaneous abortions OR died at age 11 months]	L1	y	y	lethal	ambiguous|lethal	lethal	L1|L3|L4	L1	pre-infant-lethal
300676	INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC 14	Intellectual developmental disorder, X-linked syndromic 14, 300676 (3)	Intellectual developmental disorder, X-linked syndromic 14	n	-	-	-	UPF3B	HGNC:20439	Intellectual developmental disorder, X-linked syndromic 14, 300676 (3), X-linked recessive	X-linked recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
300696	MYOPATHY, X-LINKED, WITH POSTURAL MUSCLE ATROPHY	Emery-Dreifuss muscular dystrophy 6, X-linked, 300696 (3)	Emery-Dreifuss muscular dystrophy 6, X-linked	y	MYOPATHY, X-LINKED, WITH POSTURAL MUSCLE ATROPHY; XMPMA	Clinical Features	death|deaths|died	FHL1	HGNC:3702	Emery-Dreifuss muscular dystrophy 6, X-linked, 300696 (3), X-linked recessive	X-linked recessive	n	y	[Gueneau et al. (2009) reported 6 unrelated families and an isolated patient with a form of Emery-Dreifuss muscular dystrophy consistent with X-linked inheritance, but without mutations in the emerin gene (EMD; 300384).... Cardiac involvement became apparent between ages 10 to 48, and included arrhythmias and cardiac chamber hypertrophy; 2 patient had sudden death at ages 31 and 51 years, respectively.]	L6	y	-	lethal	lethal	lethal	L3|L6|LU	L3	pre-infant-lethal
300696	MYOPATHY, X-LINKED, WITH POSTURAL MUSCLE ATROPHY	Myopathy, X-linked, with postural muscle atrophy, 300696 (3)	Myopathy, X-linked, with postural muscle atrophy	y	MYOPATHY, X-LINKED, WITH POSTURAL MUSCLE ATROPHY; XMPMA	Clinical Features	death|deaths|died	FHL1	HGNC:3702	Myopathy, X-linked, with postural muscle atrophy, 300696 (3), X-linked recessive	X-linked recessive	n	y	[Gueneau et al. (2009) reported 6 unrelated families and an isolated patient with a form of Emery-Dreifuss muscular dystrophy consistent with X-linked inheritance, but without mutations in the emerin gene (EMD; 300384).... Cardiac involvement became apparent between ages 10 to 48, and included arrhythmias and cardiac chamber hypertrophy; 2 patient had sudden death at ages 31 and 51 years, respectively.]	L6	y	-	lethal	lethal	lethal	L3|L6|LU	L3	pre-infant-lethal
300699	INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC, WU TYPE	Intellectual developmental disorder, X-linked syndromic, Wu type, 300699 (3)	Intellectual developmental disorder, X-linked syndromic, Wu type	n	-	-	-	GRIA3	HGNC:4573	Intellectual developmental disorder, X-linked syndromic, Wu type, 300699 (3), X-linked recessive	X-linked recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
300707	TOE SYNDACTYLY, TELECANTHUS, AND ANOGENITAL AND RENAL MALFORMATIONS	STAR syndrome, 300707 (3)	STAR syndrome	n	-	-	-	CCNQ	HGNC:28434	STAR syndrome, 300707 (3), X-linked dominant	X-linked dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
300717	REDUCING BODY MYOPATHY, X-LINKED 1A, SEVERE, WITH INFANTILE OR EARLY CHILDHOOD ONSET	Reducing body myopathy, X-linked 1a, severe, infantile or early childhood onset, 300717 (3)	Reducing body myopathy, X-linked 1a, severe, infantile or early childhood onset	y	REDUCING BODY MYOPATHY, X-LINKED 1A, SEVERE, WITH INFANTILE OR EARLY CHILDHOOD ONSET; RBMX1A	Description|Clinical Features|Clinical Synopsis	death|deaths|died|fatal	FHL1	HGNC:3702	Reducing body myopathy, X-linked 1a, severe, infantile or early childhood onset, 300717 (3), X-linked dominant	X-linked dominant	n	y	[Brooke and Neville (1972) reported 2 unrelated girls with a severe, progressive, fatal muscle disorder. One girl had onset before age 8 weeks of hypotonia, contractures, and respiratory muscle weakness. She died at age 2.5 years. The second child had onset of hypotonia a few days after birth and died at age 9 months]	L3	y	-	lethal	lethal	lethal	L3|L6|LU	L3	pre-infant-lethal
300718	REDUCING BODY MYOPATHY, X-LINKED 1B, WITH LATE CHILDHOOD OR ADULT ONSET	Reducing body myopathy, X-linked 1b, with late childhood or adult onset, 300718 (3)	Reducing body myopathy, X-linked 1b, with late childhood or adult onset	y	REDUCING BODY MYOPATHY, X-LINKED 1B, WITH LATE CHILDHOOD OR ADULT ONSET; RBMX1B	Description	death|deaths	FHL1	HGNC:3702	Reducing body myopathy, X-linked 1b, with late childhood or adult onset, 300718 (3), X-linked	X-linked	y	y	[The clinical features of RBM are variable; a severe form has onset in infancy or early childhood and results in severe disability or early death]	LU	y	-	lethal	lethal	lethal	L3|L6|LU	L3	pre-infant-lethal
300749	INTELLECTUAL DEVELOPMENTAL DISORDER WITH MICROCEPHALY AND PONTINE AND CEREBELLAR HYPOPLASIA	Intellectual developmental disorder and microcephaly with pontine and cerebellar hypoplasia, 300749 (3)	Intellectual developmental disorder and microcephaly with pontine and cerebellar hypoplasia	y	INTELLECTUAL DEVELOPMENTAL DISORDER WITH MICROCEPHALY AND PONTINE AND CEREBELLAR HYPOPLASIA; MICPCH	Clinical Features|Phenotype	died|lethality	CASK	HGNC:1497	Intellectual developmental disorder and microcephaly with pontine and cerebellar hypoplasia, 300749 (3), X-linked dominant	X-linked dominant	y	y	[Najm et al. (2008) reported several patients with a phenotype of congenital and marked postnatal microcephaly, severe mental retardation, and disproportionate pontine and cerebellar hypoplasia. Four were female and 1 was male. The first girl was referred at 4 years of age because of congenital and marked postnatal microcephaly, severe mental retardation, and sensorineural hearing loss. Her brain MRI showed reduced number and complexity of gyri, thin brainstem, and severe cerebellar hypoplasia. The male was severely affected and died at 2 weeks of age]	L2	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L2	L2	pre-infant-lethal
300751	ANEMIA, SIDEROBLASTIC, 1	Anemia, sideroblastic, 1, 300751 (3)	Anemia, sideroblastic, 1	y	ANEMIA, SIDEROBLASTIC, 1; SIDBA1	Clinical Features	death|deaths	ALAS2	HGNC:397	Anemia, sideroblastic, 1, 300751 (3), X-linked recessive	X-linked recessive	y	y	[Peto et al. (1983) focused attention on iron overload in mild sideroblastic anemia after the death from cardiac iron loading of a middle-aged woman with a very mild form of familial sideroblastic anemia]	L6	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L6	L6	post-infant-lethal
300752	PROTOPORPHYRIA, ERYTHROPOIETIC, X-LINKED	Protoporphyria, erythropoietic, X-linked, 300752 (3)	Protoporphyria, erythropoietic, X-linked	n	-	-	-	ALAS2	HGNC:397	Protoporphyria, erythropoietic, X-linked, 300752 (3), X-linked	X-linked	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L6	L6	post-infant-lethal
300755	AGAMMAGLOBULINEMIA, X-LINKED	Agammaglobulinemia, X-linked 1, 300755 (3)	Agammaglobulinemia, X-linked 1	y	AGAMMAGLOBULINEMIA, X-LINKED; XLA	Clinical Features	death|deaths|died|fatal	BTK	HGNC:1133	Agammaglobulinemia, X-linked 1, 300755 (3), X-linked recessive	X-linked recessive	y	y	[X-linked agammaglobulinemia, the first genetic immunodeficiency to be specifically identified, was described by Bruton (1952). Patients are unusually prone to bacterial infection but not to viral infection. A clinical picture resembling rheumatoid arthritis develops in many. Before antibiotics, death occurred in the first decade]	L4	y	-	lethal	lethal	lethal	L4	L4	post-infant-lethal
300758	HYPOSPADIAS 2, X-LINKED	Hypospadias 2, X-linked, 300758 (3)	Hypospadias 2, X-linked	n	-	-	-	MAMLD1	HGNC:2568	Hypospadias 2, X-linked, 300758 (3), X-linked recessive	X-linked recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
300770	SURFACTANT METABOLISM DYSFUNCTION, PULMONARY, 4	Surfactant metabolism dysfunction, pulmonary, 4, 300770 (3)	Surfactant metabolism dysfunction, pulmonary, 4	n	-	-	-	CSF2RA	HGNC:2435	Surfactant metabolism dysfunction, pulmonary, 4, 300770 (3)	-	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
300799	INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC, RAYMOND TYPE	Intellectual developmental disorder, X-linked syndromic, Raymond type, 300799 (3)	Intellectual developmental disorder, X-linked syndromic, Raymond type	n	-	-	-	ZDHHC9	HGNC:18475	Intellectual developmental disorder, X-linked syndromic, Raymond type, 300799 (3), X-linked	X-linked	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
300802	INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 96	Intellectual developmental disorder, X-linked 96, 300802 (3)	Intellectual developmental disorder, X-linked 96	n	-	-	-	SYP	HGNC:11506	Intellectual developmental disorder, X-linked 96, 300802 (3), X-linked recessive	X-linked recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
300803	INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 97	Intellectual developmental disorder, X-linked 97, 300803 (3)	Intellectual developmental disorder, X-linked 97	n	-	-	-	ZNF711	HGNC:13128	Intellectual developmental disorder, X-linked 97, 300803 (3), X-linked	X-linked	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
300804	JOUBERT SYNDROME 10	Joubert syndrome 10, 300804 (3)	Joubert syndrome 10	y	JOUBERT SYNDROME 10; JBTS10	Clinical Features|Phenotype	died|lethality	OFD1	HGNC:2567	Joubert syndrome 10, 300804 (3), X-linked recessive	X-linked recessive	n	y	[Coene et al. (2009) reported a large kindred in which 8 males had severe to profound mental retardation and findings consistent with Joubert syndrome segregating in an X-linked recessive pattern. Three had died of recurrent infections]	LU	y	-	lethal	lethal	lethal	L1|L3|LU	L1	pre-infant-lethal
300807	THROMBOPHILIA, X-LINKED, DUE TO FACTOR IX DEFECT	Thrombophilia 8, X-linked, due to factor IX defect, 300807 (3)	Thrombophilia 8, X-linked, due to factor IX defect	n	-	-	-	F9	HGNC:3551	Thrombophilia 8, X-linked, due to factor IX defect, 300807 (3), X-linked recessive	X-linked recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
300814	NYSTAGMUS 6, CONGENITAL, X-LINKED	Nystagmus 6, congenital, X-linked, 300814 (3)	Nystagmus 6, congenital, X-linked	n	-	-	-	GPR143	HGNC:20145	Nystagmus 6, congenital, X-linked, 300814 (3), X-linked recessive	X-linked recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
300816	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 6	Combined oxidative phosphorylation deficiency 6, 300816 (3)	Combined oxidative phosphorylation deficiency 6	y	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 6; COXPD6	Description|Clinical Features|Phenotype	death|deaths|died	AIFM1	HGNC:8768	Combined oxidative phosphorylation deficiency 6, 300816 (3), X-linked recessive	X-linked recessive	n	y	[Berger et al. (2011) reported 2 male infants, born of unrelated Palestinian parents, with COXPD6. During prenatal ultrasound at 13 to 14 weeks' gestation, the patients were noted to have enlarged ventricles, enlarged cisterna magna, and bilateral septated choroid plexus cysts. At birth, the patients had marked hypotonia with few spontaneous movements and swallowing difficulties; both required tube-feeding and occasional mechanical ventilation. They also developed neonatal seizures that could be controlled. Brain imaging of 1 patient at 2 months of age showed abnormal T2-weighted hyperintense lesions in the basal ganglia. This patient had lack of developmental progress and recurrent respiratory insufficiency resulting in death at 4 years of age, whereas the other brother died of aspiration pneumonia and hypertrophic cardiomyopathy at 3 months of age]	L3	y	-	lethal	ambiguous|lethal|nonlethal	lethal|nonlethal	L3|L5	L3	pre-infant-lethal
300831	CK SYNDROME	CK syndrome, 300831 (3)	CK syndrome	n	-	-	-	NSDHL	HGNC:13398	CK syndrome, 300831 (3), X-linked recessive	X-linked recessive	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L1	L1	pre-infant-lethal
300834	MACULAR DEGENERATION, ATROPHIC, X-LINKED	Macular degeneration, X-linked atrophic, 300834 (3)	Macular degeneration, X-linked atrophic	n	-	-	-	RPGR	HGNC:10295	Macular degeneration, X-linked atrophic, 300834 (3), X-linked recessive	X-linked recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
300835	ANEMIA, X-LINKED, WITH OR WITHOUT NEUTROPENIA AND/OR PLATELET ABNORMALITIES	Anemia, X-linked, with/without neutropenia and/or platelet abnormalities, 300835 (3)	Anemia, X-linked, with/without neutropenia and/or platelet abnormalities	y	ANEMIA, X-LINKED, WITH OR WITHOUT NEUTROPENIA AND/OR PLATELET ABNORMALITIES; XLANP	Clinical Features	died	GATA1	HGNC:4170	Anemia, X-linked, with/without neutropenia and/or platelet abnormalities, 300835 (3), X-linked recessive	X-linked recessive	y	n	-	-	-	-	ambiguous	ambiguous|lethal	lethal	L3	L3	pre-infant-lethal
300842	MCLEOD SYNDROME	McLeod syndrome with or without chronic granulomatous disease, 300842 (3)	McLeod syndrome with or without chronic granulomatous disease	y	MCLEOD SYNDROME; MCLDS	Clinical Features	death|deaths|died	XK	HGNC:12811	McLeod syndrome with or without chronic granulomatous disease, 300842 (3), X-linked	X-linked	y	y	[Jung et al. (2007) remarked that patients with McLeod syndrome usually show a slow progression of disease, with a mean onset between 30 and 40 years of age. A review of the literature found that disease duration ranged from 7 to 51 years, and mean age at death was 53 years, ranging from 31 to 69 years]	L6	y	-	lethal	lethal	lethal	L6	L6	post-infant-lethal
300844	INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 19	Intellectual developmental disorder, X-linked 19, 300844 (3)	Intellectual developmental disorder, X-linked 19	n	-	-	-	RPS6KA3	HGNC:10432	Intellectual developmental disorder, X-linked 19, 300844 (3), X-linked dominant	X-linked dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L6	L6	post-infant-lethal
300849	INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 41	Intellectual developmental disorder, X-linked 41, 300849 (3)	Intellectual developmental disorder, X-linked 41	n	-	-	-	GDI1	HGNC:4226	Intellectual developmental disorder, X-linked 41, 300849 (3), X-linked dominant	X-linked dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
300850	INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 90	Intellectual developmental disorder, X-linked 90, 300850 (3)	Intellectual developmental disorder, X-linked 90	n	-	-	-	DLG3	HGNC:2902	Intellectual developmental disorder, X-linked 90, 300850 (3), X-linked recessive	X-linked recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
300853	IMMUNODEFICIENCY, X-LINKED, WITH MAGNESIUM DEFECT, EPSTEIN-BARR VIRUS INFECTION, AND NEOPLASIA	Immunodeficiency, X-linked, with magnesium defect, Epstein-Barr virus infection and neoplasia, 300853 (3)	Immunodeficiency, X-linked, with magnesium defect, Epstein-Barr virus infection and neoplasia	y	IMMUNODEFICIENCY, X-LINKED, WITH MAGNESIUM DEFECT, EPSTEIN-BARR VIRUS INFECTION, AND NEOPLASIA; XMEN	Clinical Features|Phenotype	death|deaths|died	MAGT1	HGNC:28880	Immunodeficiency, X-linked, with magnesium defect, Epstein-Barr virus infection and neoplasia, 300853 (3), X-linked recessive	X-linked recessive	y	y	[Li et al. (2014) reported 4 additional unrelated patients, ranging in age from 4 to 23 years, with XMEN. All patients had chronic EBV infection with persistent EBV detectable in the blood. Other features included splenomegaly and variable recurrent infections, mainly of the respiratory tract. Three patients developed EBV-associated B-cell lymphoproliferative disorders, including the 23-year-old patient who died after hematopoietic stem cell transplantation]	L6	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L6	L6	post-infant-lethal
300854	RENAL CELL CARCINOMA, Xp11-ASSOCIATED	Renal cell carcinoma, papillary, 1, 300854 (3)	Renal cell carcinoma, papillary, 1	n	-	-	-	TFE3	HGNC:11752	Renal cell carcinoma, papillary, 1, 300854 (3)	-	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
300855	OGDEN SYNDROME	Ogden syndrome, 300855 (3)	Ogden syndrome	y	OGDEN SYNDROME; OGDNS	Clinical Features|Clinical Synopsis	death|deaths|died	NAA10	HGNC:18704	Ogden syndrome, 300855 (3), X-linked dominant, X-linked recessive	X-linked dominant, X-linked recessive	y	y	[Rope et al. (2011) reported 2 families segregating an X-linked recessive condition characterized by postnatal growth failure with severe delays and dysmorphic features characterized by wrinkled forehead, prominent eyes, widely opened anterior and posterior fontanels, downsloping palpebral fissures, thickened lids, large ears, flared nares, hypoplastic alae, short columella, protruding upper lip, and microretrognathia. ... Death occurred prior to 2 years in all cases and prior to 1 year in the majority]	L3	y	-	lethal	lethal	lethal	L1|L3	L1	pre-infant-lethal
300857	AMYOTROPHIC LATERAL SCLEROSIS 15 WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA	Amyotrophic lateral sclerosis 15, with or without frontotemporal dementia, 300857 (3)	Amyotrophic lateral sclerosis 15, with or without frontotemporal dementia	y	AMYOTROPHIC LATERAL SCLEROSIS 15 WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA; ALS15	Clinical Features	death|deaths	UBQLN2	HGNC:12509	Amyotrophic lateral sclerosis 15, with or without frontotemporal dementia, 300857 (3), X-linked dominant	X-linked dominant	y	y	[Fahed et al. (2014) reported a 5-generation family in which 6 individuals presented before 30 years of age with a severe neurodegenerative disorder. The family had previously been reported by DeMyer et al. (1964). Disease onset occurred before age 10 years in 3 males, whereas it began between 20 and 30 years of age in 3 females. Initial symptoms included dysarthria and decreased fine motor dexterity. Speech deficits progressively worsened, and drooling, dysphagia, and abnormal involuntary movements developed, followed by spastic paralysis in all limbs and behavioral dementia. Death occurred in both males and females within 17 years after symptom onset]	L6	y	-	lethal	lethal	lethal	L6	L6	post-infant-lethal
300860	INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC, NASCIMENTO TYPE	Intellectual developmental disorder, X-linked syndromic, Nascimento type, 300860 (3)	Intellectual developmental disorder, X-linked syndromic, Nascimento type	n	-	-	-	UBE2A	HGNC:12472	Intellectual developmental disorder, X-linked syndromic, Nascimento type, 300860 (3), X-linked recessive	X-linked recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
300867	KABUKI SYNDROME 2	Kabuki syndrome 2, 300867 (3)	Kabuki syndrome 2	n	-	-	-	KDM6A	HGNC:12637	Kabuki syndrome 2, 300867 (3), X-linked dominant	X-linked dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
300868	MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 2	Multiple congenital anomalies-hypotonia-seizures syndrome 2, 300868 (3)	Multiple congenital anomalies-hypotonia-seizures syndrome 2	y	MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 2; MCAHS2	Description|Clinical Features|Clinical Synopsis	die|died|lethal	PIGA	HGNC:8957	Multiple congenital anomalies-hypotonia-seizures syndrome 2, 300868 (3), X-linked recessive	X-linked recessive	y	y	[Johnston et al. (2012) reported a family in which 2 brothers had a lethal multiple congenital anomaly disorder. Both infants were born by cesarean section due to breech presentation and were noted to have large size at birth. Both infants developed severe myoclonic seizures associated with a burst-suppression pattern on EEG in the first weeks of life; they died at 10 and 11 weeks of age]	L3	y	-	lethal	lethal	lethal	L3|L4	L3	pre-infant-lethal
300882	CORNELIA DE LANGE SYNDROME 5	Cornelia de Lange syndrome 5, 300882 (3)	Cornelia de Lange syndrome 5	n	-	-	-	HDAC8	HGNC:13315	Cornelia de Lange syndrome 5, 300882 (3), X-linked dominant	X-linked dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
300884	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 36	Developmental and epileptic encephalopathy 36, 300884 (3)	Developmental and epileptic encephalopathy 36	y	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 36; DEE36	Clinical Features|Clinical Synopsis	death|deaths|died	ALG13	HGNC:30881	Developmental and epileptic encephalopathy 36, 300884 (3), X-linked	X-linked	y	y	[Timal et al. (2012) reported a Caucasian boy with a severe multisystem disorder resulting in death at 1 year of age]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
300887	LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 2	Linear skin defects with multiple congenital anomalies 2, 300887 (3)	Linear skin defects with multiple congenital anomalies 2	y	LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 2; LSDMCA2	Clinical Features	spontaneous_abortion|spontaneous_abortions	COX7B	HGNC:2291	Linear skin defects with multiple congenital anomalies 2, 300887 (3), X-linked dominant	X-linked dominant	n	y	[Based on 4 reported patients (last curated April 2013) Repeated first-trimester abortions in mothers of 2 probands]	L1	n	y	lethal	lethal	lethal	L1	L1	pre-infant-lethal
300888	HYPOTHYROIDISM, CENTRAL, WITH TESTICULAR ENLARGEMENT	Hypothyroidism, central, and testicular enlargement, 300888 (3)	Hypothyroidism, central, and testicular enlargement	n	-	-	-	IGSF1	HGNC:5948	Hypothyroidism, central, and testicular enlargement, 300888 (3), X-linked recessive	X-linked recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
300894	NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 5	Neurodegeneration with brain iron accumulation 5, 300894 (3)	Neurodegeneration with brain iron accumulation 5	n	-	-	-	WDR45	HGNC:28912	Neurodegeneration with brain iron accumulation 5, 300894 (3), X-linked dominant	X-linked dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
300895	OHDO SYNDROME, X-LINKED	Ohdo syndrome, X-linked, 300895 (3)	Ohdo syndrome, X-linked	y	OHDO SYNDROME, X-LINKED; OHDOX	Clinical Features	died	MED12	HGNC:11957	Ohdo syndrome, X-linked, 300895 (3), X-linked recessive	X-linked recessive	y	n	-	-	-	-	ambiguous	ambiguous|lethal|nonlethal	lethal|nonlethal	L2	L2	pre-infant-lethal
300908	ANEMIA, NONSPHEROCYTIC HEMOLYTIC, DUE TO G6PD DEFICIENCY	Hemolytic anemia, G6PD deficient (favism), 300908 (3)	Hemolytic anemia, G6PD deficient (favism)	y	ANEMIA, NONSPHEROCYTIC HEMOLYTIC, DUE TO G6PD DEFICIENCY	Clinical Features|Phenotype	death|deaths|lethal	G6PD	HGNC:4057	Hemolytic anemia, G6PD deficient (favism), 300908 (3), X-linked	X-linked	n	n	-	-	-	-	ambiguous	ambiguous	ambiguous	-	-	-
300910	BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 18	Bone mineral density QTL18, osteoporosis, 300910 (3)	Bone mineral density QTL18, osteoporosis	n	-	-	-	PLS3	HGNC:9091	Bone mineral density QTL18, osteoporosis, 300910 (3), X-linked dominant	X-linked dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L2	L2	pre-infant-lethal
300912	INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 98	Intellectual developmental disorder, X-linked 98, 300912 (3)	Intellectual developmental disorder, X-linked 98	n	-	-	-	NEXMIF	HGNC:29433	Intellectual developmental disorder, X-linked 98, 300912 (3), X-linked dominant	X-linked dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
300919	INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 99	Intellectual developmental disorder, X-linked 99, 300919 (3)	Intellectual developmental disorder, X-linked 99	n	-	-	-	USP9X	HGNC:12632	Intellectual developmental disorder, X-linked 99, 300919 (3), X-linked recessive	X-linked recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
300923	INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 100	Intellectual developmental disorder, X-linked 100, 300923 (3)	Intellectual developmental disorder, X-linked 100	y	INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 100; XLID100	Clinical Features	died	KIF4A	HGNC:13339	Intellectual developmental disorder, X-linked 100, 300923 (3), X-linked recessive	X-linked recessive	y	y	[Patient 2 had a prenatal history of oligohydramnios and died at 1 hour of life]	L2	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L2	L2	pre-infant-lethal
300934	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Iy	Congenital disorder of glycosylation, type Iy, 300934 (3)	Congenital disorder of glycosylation, type Iy	n	-	-	-	SSR4	HGNC:11326	Congenital disorder of glycosylation, type Iy, 300934 (3), X-linked recessive	X-linked recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
300943	PITUITARY ADENOMA 2, GROWTH HORMONE-SECRETING	Pituitary adenoma 2, GH-secreting, 300943 (3)	Pituitary adenoma 2, GH-secreting	n	-	-	-	GPR101	HGNC:14963	Pituitary adenoma 2, GH-secreting, 300943 (3), X-linked	X-linked	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
300952	LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 3	Linear skin defects with multiple congenital anomalies 3, 300952 (3)	Linear skin defects with multiple congenital anomalies 3	y	LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 3; LSDMCA3	Clinical Features	died	NDUFB11	HGNC:20372	Linear skin defects with multiple congenital anomalies 3, 300952 (3), X-linked dominant	X-linked dominant	n	y	[Van Rahden et al. (2015) reported 2 unrelated girls with linear skin defects of the face and neck at birth, cardiomyopathy, and various other congenital anomalies. In 1 patient, the skin defects disappeared within the first few months of life; she also exhibited axial hypotonia and failure to thrive. Ocular examination showed lacrimal duct atresia. At 6 months of age, she was hospitalized after cardiac arrest and underwent repeated treatment of ventricular fibrillation and tachycardia, but died within a few weeks]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
300953	TRICHOTHIODYSTROPHY 5, NONPHOTOSENSITIVE	Trichothiodystrophy 5, nonphotosensitive, 300953 (3)	Trichothiodystrophy 5, nonphotosensitive	n	-	-	-	RNF113A	HGNC:12974	Trichothiodystrophy 5, nonphotosensitive, 300953 (3), X-linked	X-linked	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
300957	INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 12	Intellectual developmental disorder, X-linked 12, 300957 (3)	Intellectual developmental disorder, X-linked 12	n	-	-	-	THOC2	HGNC:19073	Intellectual developmental disorder, X-linked 12, 300957 (3), X-linked recessive	X-linked recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
300958	INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC, SNIJDERS BLOK TYPE	Intellectual developmental disorder, X-linked syndromic, Snijders Blok type, 300958 (3)	Intellectual developmental disorder, X-linked syndromic, Snijders Blok type	y	INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC, SNIJDERS BLOK TYPE; MRXSSB	Phenotype	lethal	DDX3X	HGNC:2745	Intellectual developmental disorder, X-linked syndromic, Snijders Blok type, 300958 (3), X-linked dominant, X-linked recessive	X-linked dominant, X-linked recessive	y	n	-	-	-	-	ambiguous	ambiguous	ambiguous	-	-	-
300960	MEND SYNDROME	MEND syndrome, 300960 (3)	MEND syndrome	y	MEND SYNDROME; MEND	Clinical Features	death|deaths|died	EBP	HGNC:3133	MEND syndrome, 300960 (3), X-linked recessive	X-linked recessive	y	y	[Furtado et al. (2010) reported a male infant with multiple congenital anomalies first detected in utero, including polyhydramnios, agenesis of the corpus callosum, Dandy-Walker malformation, and cardiac malformations such as aortic stenosis, ventricular septal defect, and hypoplastic aortic arch... The patient died of cardiac failure at 24 days of age]	L2	y	-	lethal	lethal	lethal	L2	L2	pre-infant-lethal
300963	RITSCHER-SCHINZEL SYNDROME 2	Ritscher-Schinzel syndrome 2, 300963 (3)	Ritscher-Schinzel syndrome 2	n	-	-	-	CCDC22	HGNC:28909	Ritscher-Schinzel syndrome 2, 300963 (3), X-linked recessive	X-linked recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
300966	INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC 33	Intellectual developmental disorder, X-linked syndromic 33, 300966 (3)	Intellectual developmental disorder, X-linked syndromic 33	n	-	-	-	TAF1	HGNC:11535	Intellectual developmental disorder, X-linked syndromic 33, 300966 (3), X-linked recessive	X-linked recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
300967	INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC 34	Intellectual developmental disorder, X-linked syndromic 34, 300967 (3)	Intellectual developmental disorder, X-linked syndromic 34	n	-	-	-	NONO	HGNC:7871	Intellectual developmental disorder, X-linked syndromic 34, 300967 (3), X-linked	X-linked	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
300968	INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 99, SYNDROMIC, FEMALE-RESTRICTED	Intellectual developmental disorder, X-linked 99, syndromic, female-restricted, 300968 (3)	Intellectual developmental disorder, X-linked 99, syndromic, female-restricted	n	-	-	-	USP9X	HGNC:12632	Intellectual developmental disorder, X-linked 99, syndromic, female-restricted, 300968 (3), X-linked dominant	X-linked dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
300971	BARTTER SYNDROME, TYPE 5, ANTENATAL, TRANSIENT	Bartter syndrome, type 5, antenatal, transient, 300971 (3)	Bartter syndrome, type 5, antenatal, transient	y	BARTTER SYNDROME, TYPE 5, ANTENATAL, TRANSIENT; BARTS5	Clinical Features|Phenotype	died|stillborn	MAGED2	HGNC:16353	Bartter syndrome, type 5, antenatal, transient, 300971 (3), X-linked recessive	X-linked recessive	y	y	[Laghmani et al. (2016) reported a family in which the mother's first pregnancy was complicated by severe polyhydramnios at 19 weeks' gestation and preterm delivery of a stillborn male at 22 weeks / Reinalter et al. (1998) reported a 6-year-old Flemish boy who was born after a pregnancy complicated by severe polyhydramnios at a gestational age of 28 weeks ...Family history revealed that mother's first pregnancy also had been complicated by polyhydramnios, resulting in premature delivery at 25 weeks' gestation of a male infant who died at 7 hours of life]	L1	n	y	lethal	lethal	lethal	L1	L1	pre-infant-lethal
300972	IMMUNODEFICIENCY 47	Immunodeficiency 47, 300972 (3)	Immunodeficiency 47	y	IMMUNODEFICIENCY 47; IMD47	Clinical Features	died	ATP6AP1	HGNC:868	Immunodeficiency 47, 300972 (3), X-linked recessive	X-linked recessive	y	y	[Ondruskova et al. (2020) reported 2 sibs with IMD47, both of whom had hyperbilirubinemia, hepatosplenomegaly, and cutis laxa. Both died before one year of age from liver failure]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
300978	TONNE-KALSCHEUER SYNDROME	Tonne-Kalscheuer syndrome, 300978 (3)	Tonne-Kalscheuer syndrome	y	TONNE-KALSCHEUER SYNDROME; TOKAS	Description|Clinical Features|Clinical Synopsis	death|deaths|died|die	RLIM	HGNC:13429	Tonne-Kalscheuer syndrome, 300978 (3), X-linked	X-linked	n	y	[Tonne-Kalscheuer syndrome (TOKAS) is an X-linked recessive multiple congenital anomaly disorder with 2 main presentations. Most patients exhibit global developmental delay apparent from early infancy, impaired intellectual development, speech delay, behavioral abnormalities, and abnormal gait. Affected individuals also have dysmorphic facial features that evolve with age, anomalies of the hands, feet, and nails, and urogenital abnormalities with hypogenitalism. A subset of more severely affected males develop congenital diaphragmatic hernia in utero, which may result in perinatal or premature death]	L2	y	-	lethal	lethal	lethal	L2	L2	pre-infant-lethal
300982	INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 103	Intellectual developmental disorder, X-linked 103, 300982 (3)	Intellectual developmental disorder, X-linked 103	n	-	-	-	KLHL15	HGNC:29347	Intellectual developmental disorder, X-linked 103, 300982 (3), X-linked recessive	X-linked recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
300983	INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 104	Intellectual developmental disorder, X-linked 104, 300983 (3)	Intellectual developmental disorder, X-linked 104	n	-	-	-	FRMPD4	HGNC:29007	Intellectual developmental disorder, X-linked 104, 300983 (3), X-linked	X-linked	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
300984	INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 105	Intellectual developmental disorder, X-linked 105, 300984 (3)	Intellectual developmental disorder, X-linked 105	n	-	-	-	USP27X	HGNC:13486	Intellectual developmental disorder, X-linked 105, 300984 (3), X-linked recessive	X-linked recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
300985	VAS DEFERENS, CONGENITAL BILATERAL APLASIA OF, X-LINKED	Congenital bilateral absence of vas deferens, X-linked, 300985 (3)	Congenital bilateral absence of vas deferens, X-linked	n	-	-	-	ADGRG2	HGNC:4516	Congenital bilateral absence of vas deferens, X-linked, 300985 (3), X-linked	X-linked	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
300986	INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC, BAIN TYPE	Intellectual developmental disorder, X-linked syndromic, Bain type, 300986 (3)	Intellectual developmental disorder, X-linked syndromic, Bain type	y	INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC, BAIN TYPE; MRXSB	Phenotype	lethal	HNRNPH2	HGNC:5042	Intellectual developmental disorder, X-linked syndromic, Bain type, 300986 (3), X-linked dominant	X-linked dominant	y	n	-	-	-	-	ambiguous	ambiguous	ambiguous	-	-	-
300988	IMMUNODEFICIENCY 50	Immunodeficiency 50, 300988 (3)	Immunodeficiency 50	n	-	-	-	MSN	HGNC:7373	Immunodeficiency 50, 300988 (3), X-linked recessive	X-linked recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
300989	MEESTER-LOEYS SYNDROME	Meester-Loeys syndrome, 300989 (3)	Meester-Loeys syndrome	y	MEESTER-LOEYS SYNDROME; MRLS	Clinical Features|Clinical Synopsis	fatal	BGN	HGNC:1044	Meester-Loeys syndrome, 300989 (3), X-linked	X-linked	n	y	[Meester et al. (2017) studied 5 families in which affected males had early-onset aortic aneurysm and dissection, with the earliest occurrences at age 1 year and 15 years, respectively. The aneurysms involved the aortic root or more distal ascending aorta in all families. There was mild mitral or aortic insufficiency in some families. Cardiovascular phenotypes of carrier females ranged from unaffected to fatal aortic dissection]	LU	y	-	lethal	lethal|nonlethal	lethal|nonlethal	LU	LU	post-infant-lethal
300990	MIDFACE HYPOPLASIA, HEARING IMPAIRMENT, ELLIPTOCYTOSIS, AND NEPHROCALCINOSIS	Midface hypoplasia, hearing impairment, elliptocytosis, and nephrocalcinosis, 300990 (3)	Midface hypoplasia, hearing impairment, elliptocytosis, and nephrocalcinosis	n	-	-	-	AMMECR1	HGNC:467	Midface hypoplasia, hearing impairment, elliptocytosis, and nephrocalcinosis, 300990 (3), X-linked recessive	X-linked recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
300991	CILIARY DYSKINESIA, PRIMARY, 36, X-LINKED	Ciliary dyskinesia, primary, 36, X-linked, 300991 (3)	Ciliary dyskinesia, primary, 36, X-linked	n	-	-	-	DNAAF6	HGNC:28570	Ciliary dyskinesia, primary, 36, X-linked, 300991 (3), X-linked recessive	X-linked recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
300997	INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 106	Intellectual developmental disorder, X-linked 106, 300997 (3)	Intellectual developmental disorder, X-linked 106	n	-	-	-	OGT	HGNC:8127	Intellectual developmental disorder, X-linked 106, 300997 (3), X-linked recessive	X-linked recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
300998	INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC, 35	Intellectual developmental disorder, X-linked syndromic 35, 300998 (3)	Intellectual developmental disorder, X-linked syndromic 35	n	-	-	-	RPL10	HGNC:10298	Intellectual developmental disorder, X-linked syndromic 35, 300998 (3), X-linked recessive	X-linked recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
301000	WISKOTT-ALDRICH SYNDROME	Wiskott-Aldrich syndrome, 301000 (3)	Wiskott-Aldrich syndrome	y	WISKOTT-ALDRICH SYNDROME; WAS	Clinical Features|Phenotype	death|deaths	WAS	HGNC:12731	Wiskott-Aldrich syndrome, 301000 (3), X-linked recessive	X-linked recessive	y	y	[The manifestations of Wiskott-Aldrich syndrome are eczema, thrombocytopenia, proneness to infection, and bloody diarrhea. Death usually occurs before age 10 years]	L4	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L4|L6	L4	post-infant-lethal
301006	GALLOWAY-MOWAT SYNDROME 2, X-LINKED	Galloway-Mowat syndrome 2, X-linked, 301006 (3)	Galloway-Mowat syndrome 2, X-linked	y	GALLOWAY-MOWAT SYNDROME 2, X-LINKED; GAMOS2	Description|Clinical Features|Clinical Synopsis	die|death|deaths|died	LAGE3	HGNC:26058	Galloway-Mowat syndrome 2, X-linked, 301006 (3), X-linked recessive	X-linked recessive	n	y	[Death may occur / The patients presented with nephrotic syndrome with proteinuria between 3 months and 2 years of age. One had end-stage renal disease resulting in death at 8 months, whereas 2 sibs had a more protracted course and died at ages 8 and 25 years, respectively]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
301008	INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC, HOUGE TYPE	Intellectual developmental disorder, X-linked syndromic, Houge type, 301008 (3)	Intellectual developmental disorder, X-linked syndromic, Houge type	n	-	-	-	CNKSR2	HGNC:19701	Intellectual developmental disorder, X-linked syndromic, Houge type, 301008 (3), X-linked	X-linked	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
301010	MYOPIA 26, X-LINKED, FEMALE-LIMITED	Myopia 26, X-linked, female-limited, 301010 (3)	Myopia 26, X-linked, female-limited	n	-	-	-	ARR3	HGNC:710	Myopia 26, X-linked, female-limited, 301010 (3), X-linked	X-linked	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
301014	OSTEOGENESIS IMPERFECTA, TYPE XIX	Osteogenesis imperfecta, type XIX, 301014 (3)	Osteogenesis imperfecta, type XIX	n	-	-	-	MBTPS2	HGNC:15455	Osteogenesis imperfecta, type XIX, 301014 (3), X-linked recessive	X-linked recessive	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L2	L2	pre-infant-lethal
301020	MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 12	Mitochondrial complex I deficiency, nuclear type 12, 301020 (3)	Mitochondrial complex I deficiency, nuclear type 12	y	MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 12; MC1DN12	Clinical Features|Clinical Synopsis|Phenotype	death|deaths|died	NDUFA1	HGNC:7683	Mitochondrial complex I deficiency, nuclear type 12, 301020 (3), X-linked recessive	X-linked recessive	y	y	[Fernandez-Moreira et al. (2007) reported 2 unrelated Spanish male patients with complex I deficiency nuclear type 12. The first patient was conceived via in vitro fertilization with an anonymous donor from a sperm bank. Developmental delay was noted at 4 months, and he later developed axial hypotonia, nystagmus, generalized choreoathetosis, and decreased reflexes. MRI showed bilateral lesions within the brain consistent with Leigh syndrome (see 256000). He developed an abnormal breathing pattern and died at age 14 months]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
301022	MULLEGAMA-KLEIN-MARTINEZ SYNDROME	Mullegama-Klein-Martinez syndrome, 301022 (3)	Mullegama-Klein-Martinez syndrome	y	MULLEGAMA-KLEIN-MARTINEZ SYNDROME; MKMS	Phenotype	lethality	STAG2	HGNC:11355	Mullegama-Klein-Martinez syndrome, 301022 (3), X-linked	X-linked	y	y	[early embryonic lethality]	L1	-	-	lethal	lethal	lethal	L1	L1	pre-infant-lethal
301024	INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 108	Intellectual developmental disorder, X-linked 108, 301024 (3)	Intellectual developmental disorder, X-linked 108	n	-	-	-	SLC9A7	HGNC:17123	Intellectual developmental disorder, X-linked 108, 301024 (3), X-linked recessive	X-linked recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
301026	KEIPERT SYNDROME	Keipert syndrome, 301026 (3)	Keipert syndrome	n	-	-	-	GPC4	HGNC:4452	Keipert syndrome, 301026 (3), X-linked recessive	X-linked recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
301028	NEPHROTIC SYNDROME, TYPE 20	Nephrotic syndrome, type 20, 301028 (3)	Nephrotic syndrome, type 20	y	NEPHROTIC SYNDROME, TYPE 20; NPHS20	Description|Clinical Features	die|died	TBC1D8B	HGNC:24715	Nephrotic syndrome, type 20, 301028 (3), X-linked	X-linked	y	y	[Dorval et al. (2019) reported 3 brothers, born of unrelated parents from Ecuador (family A), with congenital steroid-resistant nephrotic syndrome. Two of the affected brothers died in the first years of life; the remaining brother reached end-stage kidney disease at age 2.8 years and underwent successful renal transplantation with no disease recurrence]	L4	y	-	lethal	lethal	lethal	L4	L4	post-infant-lethal
301029	SHUKLA-VERNON SYNDROME	Shukla-Vernon syndrome, 301029 (3)	Shukla-Vernon syndrome	n	-	-	-	BCORL1	HGNC:25657	Shukla-Vernon syndrome, 301029 (3), X-linked recessive	X-linked recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
301030	VAN ESCH-O'DRISCOLL SYNDROME	Van Esch-O'Driscoll syndrome, 301030 (3)	Van Esch-O'Driscoll syndrome	n	-	-	-	POLA1	HGNC:9173	Van Esch-O'Driscoll syndrome, 301030 (3), X-linked recessive	X-linked recessive	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L3	L3	pre-infant-lethal
301031	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Icc	Congenital disorder of glycosylation, type Icc, 301031 (3)	Congenital disorder of glycosylation, type Icc	n	-	-	-	MAGT1	HGNC:28880	Congenital disorder of glycosylation, type Icc, 301031 (3), X-linked recessive	X-linked recessive	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L6	L6	post-infant-lethal
301032	BASILICATA-AKHTAR SYNDROME	Basilicata-Akhtar syndrome, 301032 (3)	Basilicata-Akhtar syndrome	y	BASILICATA-AKHTAR SYNDROME; MRXSBA	Clinical Synopsis	lethal	MSL3	HGNC:7370	Basilicata-Akhtar syndrome, 301032 (3), X-linked dominant	X-linked dominant	y	n	-	-	-	-	ambiguous	ambiguous	ambiguous	-	-	-
301033	HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 8	Hypothyroidism, congenital, nongoitrous, 8, 301033 (3)	Hypothyroidism, congenital, nongoitrous, 8	n	-	-	-	TBL1X	HGNC:11585	Hypothyroidism, congenital, nongoitrous, 8, 301033 (3), X-linked	X-linked	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
301035	HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 9	Hypothyroidism, congenital, nongoitrous, 9, 301035 (3)	Hypothyroidism, congenital, nongoitrous, 9	n	-	-	-	IRS4	HGNC:6128	Hypothyroidism, congenital, nongoitrous, 9, 301035 (3), X-linked recessive	X-linked recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
301039	INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC, HACKMANN-DI DONATO TYPE	Intellectual developmental disorder, X-linked syndromic, Hackman-Di Donato type, 301039 (3)	Intellectual developmental disorder, X-linked syndromic, Hackman-Di Donato type	n	-	-	-	NKAP	HGNC:29873	Intellectual developmental disorder, X-linked syndromic, Hackman-Di Donato type, 301039 (3), X-linked recessive	X-linked recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
301040	ALPHA-THALASSEMIA/IMPAIRED INTELLECTUAL DEVELOPMENT SYNDROME, X-LINKED	Alpha-thalassemia/impaired intellectual development syndrome, 301040 (3)	Alpha-thalassemia/impaired intellectual development syndrome	y	ALPHA-THALASSEMIA/IMPAIRED INTELLECTUAL DEVELOPMENT SYNDROME, X-LINKED; ATRX	Clinical Features|Phenotype	died|fatal|lethal	ATRX	HGNC:886	Alpha-thalassemia/impaired intellectual development syndrome, 301040 (3), X-linked dominant	X-linked dominant	y	y	[The authors noted that complete loss of ATRX is most likely lethal, suggesting that the mutation was likely hypomorphic and associated with some residual protein function]	LU	y	-	lethal	lethal	lethal	L3|LU	L3	pre-infant-lethal
301041	WIEACKER-WOLFF SYNDROME, FEMALE-RESTRICTED	Wieacker-Wolff syndrome, female-restricted, 301041 (3)	Wieacker-Wolff syndrome, female-restricted	y	WIEACKER-WOLFF SYNDROME, FEMALE-RESTRICTED; WRWFFR	Clinical Features|Phenotype	died|lethal|miscarriage|miscarriages	ZC4H2	HGNC:24931	Wieacker-Wolff syndrome, female-restricted, 301041 (3), X-linked dominant	X-linked dominant	y	y	[Frints et al. (2019) also reported a family (family 3) in which 2 sibs, male and female, had a severe neonatal lethal form of the disorder. The proband was a female fetus who showed fetal akinesia and severe congenital malformations with diffuse contractures, dysmorphic facial features, and enlarged brain ventricles on prenatal ultrasound. The pregnancy, which was also complicated by polyhydramnios, was electively terminated, and postmortem examination confirmed the prenatal findings. An earlier pregnancy in the family was an affected male infant with AMC and cleft palate who died of respiratory distress 10 hours after birth, and a subsequent pregnancy resulted in early spontaneous miscarriage at 12 weeks' gestation]	L1	y	y	lethal	lethal	lethal	L1|L2	L1	pre-infant-lethal
301043	HOLOPROSENCEPHALY 13, X-LINKED	Holoprosencephaly 13, X-linked, 301043 (3)	Holoprosencephaly 13, X-linked	y	HOLOPROSENCEPHALY 13, X-LINKED; HPE13	Description|Clinical Features|Clinical Synopsis|Phenotype	die|died|lethal	STAG2	HGNC:11355	Holoprosencephaly 13, X-linked, 301043 (3), X-linked dominant, X-linked recessive	X-linked dominant, X-linked recessive	y	y	[Males usually die in utero]	L1	y	-	lethal	lethal	lethal	L1	L1	pre-infant-lethal
301044	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 85 WITH OR WITHOUT MIDLINE BRAIN DEFECTS	Developmental and epileptic encephalopathy 85, with or without midline brain defects, 301044 (3)	Developmental and epileptic encephalopathy 85, with or without midline brain defects	y	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 85 WITH OR WITHOUT MIDLINE BRAIN DEFECTS; DEE85	Clinical Features|Phenotype	died|lethal	SMC1A	HGNC:11111	Developmental and epileptic encephalopathy 85, with or without midline brain defects, 301044 (3), X-linked dominant	X-linked dominant	y	y	[Symonds et al. (2017) reported 10 unrelated girls with early-onset refractory seizures, 8 of whom were probands identified through the DDD cohort based on exome sequencing. A ninth patient was a sister of one of the 8 probands, and a tenth patient was identified through analysis of a custom gene pane... Of 2 affected sisters, one (patient 9) had semilobar HPE and died at 11 months of age]	L3	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L3	L3	pre-infant-lethal
301045	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIr	Congenital disorder of glycosylation, type IIr, 301045 (3)	Congenital disorder of glycosylation, type IIr	y	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIr; CDG2R	Phenotype	death|deaths	ATP6AP2	HGNC:18305	Congenital disorder of glycosylation, type IIr, 301045 (3), X-linked recessive	X-linked recessive	y	n	-	-	-	-	ambiguous	ambiguous	ambiguous	-	-	-
301050	ALPORT SYNDROME 1, X-LINKED	Alport syndrome 1, X-linked, 301050 (3)	Alport syndrome 1, X-linked	y	ALPORT SYNDROME 1, X-LINKED; ATS1	Clinical Features	die|died	COL4A5	HGNC:2207	Alport syndrome 1, X-linked, 301050 (3), X-linked dominant	X-linked dominant	y	y	[Most boys with this disease die from uraemia during adolescence]	L5	y	-	lethal	lethal	lethal	L5	L5	post-infant-lethal
301051	IMMUNODEFICIENCY 74, COVID19-RELATED, X-LINKED	Immunodeficiency 74, COVID19-related, X-linked, 301051 (3)	Immunodeficiency 74, COVID19-related, X-linked	y	IMMUNODEFICIENCY 74, COVID19-RELATED, X-LINKED; IMD74	Clinical Features|Clinical Synopsis	died|death|deaths	TLR7	HGNC:15631	Immunodeficiency 74, COVID19-related, X-linked, 301051 (3), X-linked recessive	X-linked recessive	y	y	[Death from respiratory failure may occur / Van der Made et al. (2020) reported 2 pairs of adult brothers from 2 unrelated families (family 1 of Dutch ancestry and family 2 of African ancestry) who developed severe respiratory insufficiency associated with proven COVID19 (SARS-CoV-2) infection... One patient died at age 29 years after developing a concurrent bacterial superinfection, whereas the others survived]	L6	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L6	L6	post-infant-lethal
301056	MULTIPLE CONGENITAL ANOMALIES-NEURODEVELOPMENTAL SYNDROME, X-LINKED	Multiple congenital anomalies-neurodevelopmental syndrome, X-linked, 301056 (3)	Multiple congenital anomalies-neurodevelopmental syndrome, X-linked	y	MULTIPLE CONGENITAL ANOMALIES-NEURODEVELOPMENTAL SYNDROME, X-LINKED; MCAND	Description|Clinical Features|Clinical Synopsis|Phenotype	death|deaths|died|lethality	OTUD5	HGNC:25402	Multiple congenital anomalies-neurodevelopmental syndrome, X-linked, 301056 (3), X-linked recessive	X-linked recessive	y	y	[The severity of the disorder is highly variable, ranging from death in early infancy to survival into the second or third decade ' Tripolszki et al. (2021) reported a large family in which 13 males spanning 3 generations were affected with a severe multisystemic developmental disorder. All but one were deceased: most died in utero, infancy, or early childhood, although 1 patient died at age 37 years]	L1	y	-	lethal	lethal	lethal	L1	L1	pre-infant-lethal
301058	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 90	Developmental and epileptic encephalopathy 90, 301058 (3)	Developmental and epileptic encephalopathy 90	n	-	-	-	FGF13	HGNC:3670	Developmental and epileptic encephalopathy 90, 301058 (3), X-linked dominant, X-linked recessive	X-linked dominant, X-linked recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
301059	SPERMATOGENIC FAILURE, X-LINKED, 3	Spermatogenic failure, X-linked 3, 301059 (3)	Spermatogenic failure, X-linked 3	n	-	-	-	CFAP47	HGNC:26708	Spermatogenic failure, X-linked 3, 301059 (3), X-linked recessive	X-linked recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
301066	INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC, WITH PIGMENTARY MOSAICISM AND COARSE FACIES	Intellectual developmental disorder, X-linked syndromic, with pigmentary mosaicism and coarse facies, 301066 (3)	Intellectual developmental disorder, X-linked syndromic, with pigmentary mosaicism and coarse facies	n	-	-	-	TFE3	HGNC:11752	Intellectual developmental disorder, X-linked syndromic, with pigmentary mosaicism and coarse facies, 301066 (3), X-linked	X-linked	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
301068	HARDIKAR SYNDROME	Hardikar syndrome, 301068 (3)	Hardikar syndrome	y	HARDIKAR SYNDROME; HDKR	Clinical Features|Phenotype	died|lethal	MED12	HGNC:11957	Hardikar syndrome, 301068 (3), X-linked dominant	X-linked dominant	y	n	-	-	-	-	ambiguous	ambiguous|lethal|nonlethal	lethal|nonlethal	L2	L2	pre-infant-lethal
301071	THROMBOPHILIA, X-LINKED, DUE TO FACTOR VIII DEFECT	Thrombophilia 13, X-linked, due to factor VIII defect, 301071 (3)	Thrombophilia 13, X-linked, due to factor VIII defect	y	THROMBOPHILIA, X-LINKED, DUE TO FACTOR VIII DEFECT; THPH13	Clinical Features	died	F8	HGNC:3546	Thrombophilia 13, X-linked, due to factor VIII defect, 301071 (3)	-	y	y	[died from a PE at age 48 years]	L6	y	-	lethal	lethal	lethal	L6|LU	L6	post-infant-lethal
301072	NEURODEVELOPMENTAL DISORDER WITH EPILEPSY AND HEMOCHROMATOSIS	Neurodevelopmental disorder with epilepsy and hemochromatosis, 301072 (3)	Neurodevelopmental disorder with epilepsy and hemochromatosis	y	NEURODEVELOPMENTAL DISORDER WITH EPILEPSY AND HEMOCHROMATOSIS; NEDEPH	Clinical Features|Phenotype	died|lethal	PIGA	HGNC:8957	Neurodevelopmental disorder with epilepsy and hemochromatosis, 301072 (3)	-	y	y	[died at age 7 years]	L4	y	-	lethal	lethal	lethal	L3|L4	L3	pre-infant-lethal
301074	AUTOINFLAMMATORY SYNDROME, FAMILIAL, X-LINKED, BEHCET-LIKE 2	Autoinflammatory syndrome, familial, X-linked, Behcet-like 2, 301074 (3)	Autoinflammatory syndrome, familial, X-linked, Behcet-like 2	n	-	-	-	ELF4	HGNC:3319	Autoinflammatory syndrome, familial, X-linked, Behcet-like 2, 301074 (3), X-linked recessive	X-linked recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
301075	MYOPATHY, DISTAL, 7, ADULT-ONSET, X-LINKED	Myopathy, distal, 7, adult-onset, X-linked, 301075 (3)	Myopathy, distal, 7, adult-onset, X-linked	n	-	-	-	SMPX	HGNC:11122	Myopathy, distal, 7, adult-onset, X-linked, 301075 (3), X-linked recessive	X-linked recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
301076	INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC, PILORGE TYPE	Intellectual developmental disorder, X-linked syndromic, Pilorge type, 301076 (3)	Intellectual developmental disorder, X-linked syndromic, Pilorge type	y	INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC, PILORGE TYPE; MRXSP	Clinical Features|Phenotype	died|lethality	GLRA2	HGNC:4327	Intellectual developmental disorder, X-linked syndromic, Pilorge type, 301076 (3), X-linked	X-linked	y	n	-	-	-	-	ambiguous	ambiguous	ambiguous	-	-	-
301077	SPERMATOGENIC FAILURE, X-LINKED, 4	Spermatogenic failure, X-linked, 4, 301077 (3)	Spermatogenic failure, X-linked, 4	n	-	-	-	GCNA	HGNC:15805	Spermatogenic failure, X-linked, 4, 301077 (3), X-linked	X-linked	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
301080	SYSTEMIC LUPUS ERYTHEMATOSUS 17	Systemic lupus erythematosus 17, 301080 (3)	Systemic lupus erythematosus 17	n	-	-	-	TLR7	HGNC:15631	Systemic lupus erythematosus 17, 301080 (3), X-linked dominant	X-linked dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L6	L6	post-infant-lethal
301081	AUTOINFLAMMATORY DISEASE, SYSTEMIC, X-LINKED	Autoinflammatory disease, systemic, X-linked, 301081 (3)	Autoinflammatory disease, systemic, X-linked	n	-	-	-	IKBKG	HGNC:5961	Autoinflammatory disease, systemic, X-linked, 301081 (3), X-linked	X-linked	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L1|L2|L3	L1	pre-infant-lethal
301082	IMMUNODEFICIENCY 102	Immunodeficiency 102, 301082 (3)	Immunodeficiency 102	y	IMMUNODEFICIENCY 102; IMD102	Clinical Features	died	SASH3	HGNC:15975	Immunodeficiency 102, 301082 (3), X-linked recessive	X-linked recessive	y	y	[ died of multiple strokes and neurologic decline at age 27 years]	L6	y	-	lethal	lethal	lethal	L6	L6	post-infant-lethal
301083	ADENOSINE DEAMINASE, ELEVATED, HEMOLYTIC ANEMIA DUE TO	Hemolytic anemia due to elevated adenosine deaminase, 301083 (3)	Hemolytic anemia due to elevated adenosine deaminase	y	ADENOSINE DEAMINASE, ELEVATED, HEMOLYTIC ANEMIA DUE TO; HAEADA	Clinical Features	died	GATA1	HGNC:4170	Hemolytic anemia due to elevated adenosine deaminase, 301083 (3), X-linked recessive	X-linked recessive	y	n	-	-	-	-	ambiguous	ambiguous|lethal	lethal	L3	L3	pre-infant-lethal
301091	EPILEPSY, X-LINKED 2, WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT AND DYSMORPHIC FEATURES	Epilepsy, X-linked 2, with or without impaired intellectual development and dysmorphic features, 301091 (3)	Epilepsy, X-linked 2, with or without impaired intellectual development and dysmorphic features	y	EPILEPSY, X-LINKED 2, WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT AND DYSMORPHIC FEATURES; EPILX2	Clinical Features	died	GABRA3	HGNC:4077	Epilepsy, X-linked 2, with or without impaired intellectual development and dysmorphic features, 301091 (3), X-linked	X-linked	y	y	[died of choking during a seizure at 10 years of age]	L4	y	-	lethal	lethal	lethal	L4	L4	post-infant-lethal
301094	HIJAZI-REIS SYNDROME	Hijazi-Reis syndrome, 301094 (3)	Hijazi-Reis syndrome	n	-	-	-	TCEAL1	HGNC:11616	Hijazi-Reis syndrome, 301094 (3), X-linked dominant	X-linked dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
301095	INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 110	Intellectual developmental disorder, X-linked 110, 301095 (3)	Intellectual developmental disorder, X-linked 110	n	-	-	-	FGF13	HGNC:3670	Intellectual developmental disorder, X-linked 110, 301095 (3), X-linked recessive	X-linked recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
301099	SPERMATOGENIC FAILURE, X-LINKED, 5	Spermatogenic failure, X-linked, 5, 301099 (3)	Spermatogenic failure, X-linked, 5	n	-	-	-	SSX1	HGNC:11335	Spermatogenic failure, X-linked, 5, 301099 (3), X-linked	X-linked	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
301101	SPERMATOGENIC FAILURE, X-LINKED, 6	Spermatogenic failure, X-linked, 6, 301101 (3)	Spermatogenic failure, X-linked, 6	n	-	-	-	USP26	HGNC:13485	Spermatogenic failure, X-linked, 6, 301101 (3), X-linked	X-linked	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
301107	INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 111	Intellectual developmental disorder, X-linked 111, 301107 (3)	Intellectual developmental disorder, X-linked 111	n	-	-	-	SLITRK2	HGNC:13449	Intellectual developmental disorder, X-linked 111, 301107 (3), X-linked	X-linked	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
301109	AUTOINFLAMMATORY DISEASE, MULTISYSTEM, WITH IMMUNE DYSREGULATION, X-LINKED	Autoinflammatory disease, multisystem, with immune dysregulation, X-linked, 301109 (3)	Autoinflammatory disease, multisystem, with immune dysregulation, X-linked	y	AUTOINFLAMMATORY DISEASE, MULTISYSTEM, WITH IMMUNE DYSREGULATION, X-LINKED; ADMIDX	Description|Clinical Features|Clinical Synopsis	death|deaths|died	DOCK11	HGNC:23483	Autoinflammatory disease, multisystem, with immune dysregulation, X-linked, 301109 (3), X-linked recessive	X-linked recessive	y	y	[Three patients had failure to thrive and died of complications of the disease between 3 and 6 years of age]	L4	y	-	lethal	lethal	lethal	L4	L4	post-infant-lethal
301110	HEMOLYTIC UREMIC SYNDROME, ATYPICAL, 8, WITH RHIZOMELIC SHORT STATURE	Hemolytic uremic syndrome, atypical, 8, with rhizomelic short stature, 301110 (3)	Hemolytic uremic syndrome, atypical, 8, with rhizomelic short stature	y	HEMOLYTIC UREMIC SYNDROME, ATYPICAL, 8, WITH RHIZOMELIC SHORT STATURE; AHUS8	Clinical Features	died	C1GALT1C1	HGNC:24338	Hemolytic uremic syndrome, atypical, 8, with rhizomelic short stature, 301110 (3), X-linked recessive	X-linked recessive	y	y	[Family history revealed that a maternal half brother from a third partnership developed renal failure and died 3 days after birth, but autopsy was not performed and tissue was not available for study.]	L2	-	y	lethal	lethal	lethal	L2	L2	pre-infant-lethal
301111	INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 112	Intellectual developmental disorder, X-linked 112, 301111 (3)	Intellectual developmental disorder, X-linked 112	n	-	-	-	ZMYM3	HGNC:13054	Intellectual developmental disorder, X-linked 112, 301111 (3), X-linked recessive	X-linked recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
301200	AMELOGENESIS IMPERFECTA, TYPE IE	Amelogenesis imperfecta, type 1E, 301200 (3)	Amelogenesis imperfecta, type 1E	n	-	-	-	AMELX	HGNC:461	Amelogenesis imperfecta, type 1E, 301200 (3), X-linked dominant	X-linked dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
301220	PIGMENTARY DISORDER, RETICULATE, WITH SYSTEMIC MANIFESTATIONS, X-LINKED	Pigmentary disorder, reticulate, with systemic manifestations, X-linked, 301220 (3)	Pigmentary disorder, reticulate, with systemic manifestations, X-linked	y	PIGMENTARY DISORDER, RETICULATE, WITH SYSTEMIC MANIFESTATIONS, X-LINKED; PDR	Clinical Features|Clinical Synopsis	died|die	POLA1	HGNC:9173	Pigmentary disorder, reticulate, with systemic manifestations, X-linked, 301220 (3), X-linked recessive	X-linked recessive	n	y	[Males may die early from systemic disease / Partington et al. (1981) described a large Canadian family in which 2 males and 7 females had brown pigmentation of the skin...Two died of pneumonia by age 3 months. One died at 3 months of colitis. Two had colitis as infants, failed to thrive, and developed recurrent pneumonia from which 1 died at age 3 years]	L3	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L3	L3	pre-infant-lethal
301310	ANEMIA, SIDEROBLASTIC, AND SPINOCEREBELLAR ATAXIA	Anemia, sideroblastic, with ataxia, 301310 (3)	Anemia, sideroblastic, with ataxia	n	-	-	-	ABCB7	HGNC:48	Anemia, sideroblastic, with ataxia, 301310 (3), X-linked recessive	X-linked recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
301500	FABRY DISEASE	Fabry disease, 301500 (3)	Fabry disease	y	FABRY DISEASE	Clinical Features|Clinical Synopsis|Phenotype	death|deaths|died|miscarriage|miscarriages	GLA	HGNC:4296	Fabry disease, 301500 (3), X-linked	X-linked	y	y	[Death secondary to renal failure, cardiac or cerebrovascular disease / MacDermot et al. (2001) reported clinical manifestations and impact of disease in 60 females with Fabry disease. The median cumulative survival was 70 years, representing an approximate reduction of 15 years from the general population]	L6	y	-	lethal	lethal	lethal	L6	L6	post-infant-lethal
301500	FABRY DISEASE	Fabry disease, cardiac variant, 301500 (3)	Fabry disease, cardiac variant	y	FABRY DISEASE	Clinical Features|Clinical Synopsis|Phenotype	death|deaths|died|miscarriage|miscarriages	GLA	HGNC:4296	Fabry disease, cardiac variant, 301500 (3), X-linked	X-linked	y	y	[Death secondary to renal failure, cardiac or cerebrovascular disease / MacDermot et al. (2001) reported clinical manifestations and impact of disease in 60 females with Fabry disease. The median cumulative survival was 70 years, representing an approximate reduction of 15 years from the general population]	L6	y	-	lethal	lethal	lethal	L6	L6	post-infant-lethal
301830	SPINAL MUSCULAR ATROPHY, X-LINKED 2	Spinal muscular atrophy, X-linked 2, infantile, 301830 (3)	Spinal muscular atrophy, X-linked 2, infantile	y	SPINAL MUSCULAR ATROPHY, X-LINKED 2; SMAX2	Description|Clinical Features|Clinical Synopsis	death|deaths|lethal|died|spontaneous_abortion|spontaneous_abortions	UBA1	HGNC:12469	Spinal muscular atrophy, X-linked 2, infantile, 301830 (3), X-linked recessive	X-linked recessive	y	y	[Death usually in infancy due to respiratory failure]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
301835	ARTS SYNDROME	Arts syndrome, 301835 (3)	Arts syndrome	y	ARTS SYNDROME; ARTS	Description|Clinical Features|Clinical Synopsis	death|deaths|died	PRPS1	HGNC:9462	Arts syndrome, 301835 (3), X-linked recessive	X-linked recessive	n	y	[Moran et al. (2012) reported a young boy with a complex phenotype comprising Arts syndrome and PRPS1 superactivity. He had developmental delay, hypotonia, areflexia, motor neuropathy, sensorineural hearing loss, and a Chiari I malformation. Laboratory studies showed increased serum uric acid and increased urinary hypoxanthine consistent with PRPS1 superactivity, but he did not have gout. In addition, he had recurrent infections and early death at age 27 months from infection, consistent with Arts syndrome. A maternal uncle with similar symptoms had died of pneumonia at age 2]	L4	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L4	L4	post-infant-lethal
301835	ARTS SYNDROME	Arts syndrome, 301835 (3)	Arts syndrome	y	ARTS SYNDROME; ARTS	Description|Clinical Features|Clinical Synopsis	death|deaths|died	PRPS1	HGNC:9462	Arts syndrome, 301835 (3), X-linked recessive	X-linked recessive	n	y	[Susceptibility to infections, especially of the upper respiratory tract, can result in early death / Moran et al. (2012) reported a young boy with a complex phenotype comprising Arts syndrome and PRPS1 superactivity. He had developmental delay, hypotonia, areflexia, motor neuropathy, sensorineural hearing loss, and a Chiari I malformation. Laboratory studies showed increased serum uric acid and increased urinary hypoxanthine consistent with PRPS1 superactivity, but he did not have gout. In addition, he had recurrent infections and early death at age 27 months from infection, consistent with Arts syndrome]	L4	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L4	L4	post-infant-lethal
301900	BORJESON-FORSSMAN-LEHMANN SYNDROME	Borjeson-Forssman-Lehmann syndrome, 301900 (3)	Borjeson-Forssman-Lehmann syndrome	y	BORJESON-FORSSMAN-LEHMANN SYNDROME; BFLS	Clinical Features	death|deaths	PHF6	HGNC:18145	Borjeson-Forssman-Lehmann syndrome, 301900 (3), X-linked recessive	X-linked recessive	y	y	[Dereymaeker et al. (1986) described a typical case. The mother had suggestive features, and a first cousin, the daughter of a maternal male (who was himself 'feeble-minded,' but with a normal somatic phenotype), had hyperkyphosis that increased with age, no menarche at age 17, and sudden death at age 17 due probably to epileptic seizures]	L5	y	-	lethal	lethal	lethal	L5	L5	post-infant-lethal
302045	CARDIOMYOPATHY, DILATED, 3B	Cardiomyopathy, dilated, 3B, 302045 (3)	Cardiomyopathy, dilated, 3B	n	-	-	-	DMD	HGNC:2928	Cardiomyopathy, dilated, 3B, 302045 (3), X-linked	X-linked	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L5|L6	L5	post-infant-lethal
302060	BARTH SYNDROME	Barth syndrome, 302060 (3)	Barth syndrome	y	BARTH SYNDROME; BTHS	Clinical Features|Clinical Synopsis|Phenotype	death|deaths|demise|died|lethal|fetal_loss|fetal_losses|miscarriage|miscarriages|stillbirth|stillbirths|stillborn|fatal	TAFAZZIN	HGNC:11577	Barth syndrome, 302060 (3), X-linked recessive	X-linked recessive	y	y	[male fetal loss and stillbirths	L1	-	-	lethal	lethal	lethal	L1	L1	pre-infant-lethal
302200	CATARACT 40	Cataract 40, X-linked, 302200 (3)	Cataract 40, X-linked	y	CATARACT 40; CTRCT40	Clinical Features	lethality	NHS	HGNC:7820	Cataract 40, X-linked, 302200 (3), X-linked	X-linked	n	n	-	-	-	-	ambiguous	ambiguous|nonlethal	ambiguous	-	-	-
302350	NANCE-HORAN SYNDROME	Nance-Horan syndrome, 302350 (3)	Nance-Horan syndrome	n	-	-	-	NHS	HGNC:7820	Nance-Horan syndrome, 302350 (3), X-linked dominant	X-linked dominant	-	-	-	-	-	-	nonlethal	ambiguous|nonlethal	ambiguous	-	-	-
303100	CHOROIDEREMIA	Choroideremia, 303100 (3)	Choroideremia	n	-	-	-	CHM	HGNC:1940	Choroideremia, 303100 (3), X-linked	X-linked	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
303350	MASA SYNDROME	MASA syndrome, 303350 (3)	MASA syndrome	y	MASA SYNDROME	Clinical Features	death|deaths|died	L1CAM	HGNC:6470	MASA syndrome, 303350 (3), X-linked recessive	X-linked recessive	n	y	[Kaepernick et al. (1994) described a family with expressing females. Adducted thumbs were present in 2 obligate carriers, learning problems or mild mental retardation in 3 females, 2 of whom were obligate carriers, and hydrocephalus with neonatal death in 3 females born to obligate carriers]	L2	y	-	lethal	lethal	lethal	L2	L2	pre-infant-lethal
303400	CLEFT PALATE WITH OR WITHOUT ANKYLOGLOSSIA, X-LINKED	Cleft palate with ankyloglossia, 303400 (3)	Cleft palate with ankyloglossia	n	-	-	-	TBX22	HGNC:11600	Cleft palate with ankyloglossia, 303400 (3), X-linked	X-linked	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
303600	COFFIN-LOWRY SYNDROME	Coffin-Lowry syndrome, 303600 (3)	Coffin-Lowry syndrome	y	COFFIN-LOWRY SYNDROME; CLS	Clinical Features	death|deaths|died	RPS6KA3	HGNC:10432	Coffin-Lowry syndrome, 303600 (3), X-linked dominant	X-linked dominant	n	y	[Hunter (2002) also summarized the clinically important complications that have been reported in patients with Coffin-Lowry syndrome: premature death / Machin et al. (1987) reported the pathologic findings in a sister and brother who died at ages 28 and 22, respectively]	L6	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L6	L6	post-infant-lethal
303700	BLUE CONE MONOCHROMACY	Blue cone monochromacy, 303700 (3)	Blue cone monochromacy	n	-	-	-	OPN1LW	HGNC:9936	Blue cone monochromacy, 303700 (3), X-linked recessive	X-linked recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
303700	BLUE CONE MONOCHROMACY	Blue cone monochromacy, 303700 (3)	Blue cone monochromacy	n	-	-	-	OPN1MW	HGNC:4206	Blue cone monochromacy, 303700 (3), X-linked recessive	X-linked recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
303800	COLORBLINDNESS, PARTIAL, DEUTAN SERIES	Colorblindness, deutan, 303800 (3)	Colorblindness, deutan	n	-	-	-	OPN1MW	HGNC:4206	Colorblindness, deutan, 303800 (3), X-linked	X-linked	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
303900	COLORBLINDNESS, PARTIAL, PROTAN SERIES	Colorblindness, protan, 303900 (3)	Colorblindness, protan	n	-	-	-	OPN1LW	HGNC:9936	Colorblindness, protan, 303900 (3), X-linked	X-linked	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
304020	CONE-ROD DYSTROPHY, X-LINKED, 1	Cone-rod dystrophy, X-linked, 1, 304020 (3)	Cone-rod dystrophy, X-linked, 1	n	-	-	-	RPGR	HGNC:10295	Cone-rod dystrophy, X-linked, 1, 304020 (3), X-linked recessive	X-linked recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
304110	CRANIOFRONTONASAL SYNDROME	Craniofrontonasal dysplasia, 304110 (3)	Craniofrontonasal dysplasia	y	CRANIOFRONTONASAL SYNDROME; CFNS	Clinical Features|Phenotype	miscarriage|miscarriages|lethal	EFNB1	HGNC:3226	Craniofrontonasal dysplasia, 304110 (3), X-linked dominant	X-linked dominant	n	n	-	-	-	-	ambiguous	ambiguous	ambiguous	-	-	-
304120	OTOPALATODIGITAL SYNDROME, TYPE II	Otopalatodigital syndrome, type II, 304120 (3)	Otopalatodigital syndrome, type II	y	OTOPALATODIGITAL SYNDROME, TYPE II; OPD2	Description|Clinical Features|Clinical Synopsis|Phenotype	death|deaths|lethality|died|lethal|die|stillborn|stillbirth|stillbirths	FLNA	HGNC:3754	Otopalatodigital syndrome, type II, 304120 (3), X-linked dominant	X-linked dominant	y	y	[Majority of patients are stillborn or die before 5 months of age]	L1	y	-	lethal	lethal	lethal	L1|L2|L3	L1	pre-infant-lethal
304150	OCCIPITAL HORN SYNDROME	Occipital horn syndrome, 304150 (3)	Occipital horn syndrome	y	OCCIPITAL HORN SYNDROME; OHS	Clinical Features	death|deaths	ATP7A	HGNC:869	Occipital horn syndrome, 304150 (3), X-linked recessive	X-linked recessive	n	n	-	-	-	-	ambiguous	ambiguous|lethal|nonlethal	lethal|nonlethal	L2	L2	pre-infant-lethal
304340	PETTIGREW SYNDROME	Pettigrew syndrome, 304340 (3)	Pettigrew syndrome	n	-	-	-	AP1S2	HGNC:560	Pettigrew syndrome, 304340 (3), X-linked recessive	X-linked recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
304400	DEAFNESS, X-LINKED 2	Deafness, X-linked 2, 304400 (3)	Deafness, X-linked 2	n	-	-	-	POU3F4	HGNC:9217	Deafness, X-linked 2, 304400 (3), X-linked recessive	X-linked recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
304500	DEAFNESS, X-LINKED 1	Deafness, X-linked 1, 304500 (3)	Deafness, X-linked 1	n	-	-	-	PRPS1	HGNC:9462	Deafness, X-linked 1, 304500 (3), X-linked	X-linked	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L4	L4	post-infant-lethal
304700	MOHR-TRANEBJAERG SYNDROME	Mohr-Tranebjaerg syndrome, 304700 (3)	Mohr-Tranebjaerg syndrome	y	MOHR-TRANEBJAERG SYNDROME; MTS	Clinical Features	died	TIMM8A	HGNC:11817	Mohr-Tranebjaerg syndrome, 304700 (3), X-linked recessive	X-linked recessive	y	y	[In 2 and perhaps 3 males in 3 successive generations, connected through possible carrier females, Scribanu and Kennedy (1976) observed dystonia and deafness. Deafness, first recognized at age 2 years in the affected member most fully studied, was progressive. Severe dysarthria, striking deterioration of handwriting, occasional bizarre posturing of head and neck, and hyperactivity were evident by age 8, and he died at age 11]	L5	y	-	lethal	lethal	lethal	L5	L5	post-infant-lethal
304790	IMMUNODYSREGULATION, POLYENDOCRINOPATHY, AND ENTEROPATHY, X-LINKED	Immunodysregulation, polyendocrinopathy, and enteropathy, X-linked, 304790 (3)	Immunodysregulation, polyendocrinopathy, and enteropathy, X-linked	y	IMMUNODYSREGULATION, POLYENDOCRINOPATHY, AND ENTEROPATHY, X-LINKED; IPEX	Description|Clinical Features|Clinical Synopsis	fatal|death|deaths|died	FOXP3	HGNC:6106	Immunodysregulation, polyendocrinopathy, and enteropathy, X-linked, 304790 (3), X-linked recessive	X-linked recessive	y	y	[Patel (2001) discussed the escape from tolerance in XLAAD and in the 'scurfy' mouse. Options for treatment of the disorder are limited to immunosuppressive agents and supportive care, with death usually occurring within the first year of life]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
304800	DIABETES INSIPIDUS, NEPHROGENIC, 1, X-LINKED	Diabetes insipidus, nephrogenic, 1, 304800 (3)	Diabetes insipidus, nephrogenic, 1	n	-	-	-	AVPR2	HGNC:897	Diabetes insipidus, nephrogenic, 1, 304800 (3), X-linked recessive	X-linked recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
305000	DYSKERATOSIS CONGENITA, X-LINKED	Dyskeratosis congenita, X-linked, 305000 (3)	Dyskeratosis congenita, X-linked	y	DYSKERATOSIS CONGENITA, X-LINKED; DKCX	Description|Clinical Features|Clinical Synopsis|Phenotype	death|deaths|died|die	DKC1	HGNC:2890	Dyskeratosis congenita, X-linked, 305000 (3), X-linked recessive	X-linked recessive	y	y	[Pearson et al. (2008) reported a 9-month-old Italian boy with HHS. The pregnancy was complicated by decreased fetal movements, intrauterine growth retardation, and oligohydramnios. He had microcephaly, neonatal respiratory distress, and transient thrombocytopenia and leukopenia. At age 4 months, he presented with seizures and axial hypotonia. Brain MRI showed cerebellar hypoplasia, and other radiographs showed distal metaphyseal flaring of the long bones. Although most hematologic indices remained relatively normal, his platelet counts continued to fall below normal, requiring transfusions. He died at age 2 years]	L4	y	-	lethal	lethal	lethal	L4	L4	post-infant-lethal
305100	ECTODERMAL DYSPLASIA 1, HYPOHIDROTIC, X-LINKED	Ectodermal dysplasia 1, hypohidrotic, X-linked, 305100 (3)	Ectodermal dysplasia 1, hypohidrotic, X-linked	y	ECTODERMAL DYSPLASIA 1, HYPOHIDROTIC, X-LINKED; XHED	Clinical Features	death|deaths|died	EDA	HGNC:3157	Ectodermal dysplasia 1, hypohidrotic, X-linked, 305100 (3), X-linked recessive	X-linked recessive	y	y	[Nakata et al. (1980) reported the clinical findings in 23 affected males from 15 families as well as 21 mothers. All affected males had the characteristic clinical findings of HED, including very sparse hair, small, misshapen, and missing teeth, diminished sweating with a history of frequent hospitalization for high fevers during infancy, and symptoms of atrophic rhinitis and decreased salivary secretions. All affected males had normal nails. Seven other male family members were reported to be affected, including 6 who died before 1 year of age with high fevers]	L3	n	y	lethal	lethal|nonlethal	lethal|nonlethal	L3	L3	pre-infant-lethal
305390	EXUDATIVE VITREORETINOPATHY 2, X-LINKED	Exudative vitreoretinopathy 2, X-linked, 305390 (3)	Exudative vitreoretinopathy 2, X-linked	n	-	-	-	NDP	HGNC:7678	Exudative vitreoretinopathy 2, X-linked, 305390 (3), X-linked dominant, X-linked recessive	X-linked dominant, X-linked recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
305400	AARSKOG-SCOTT SYNDROME	Aarskog-Scott syndrome, 305400 (3)	Aarskog-Scott syndrome	n	-	-	-	FGD1	HGNC:3663	Aarskog-Scott syndrome, 305400 (3), X-linked recessive	X-linked recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
305400	AARSKOG-SCOTT SYNDROME	Intellectual developmental disorder, X-linked syndromic 16, 305400 (3)	Intellectual developmental disorder, X-linked syndromic 16	n	-	-	-	FGD1	HGNC:3663	Intellectual developmental disorder, X-linked syndromic 16, 305400 (3), X-linked recessive	X-linked recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
305450	OPITZ-KAVEGGIA SYNDROME	Opitz-Kaveggia syndrome, 305450 (3)	Opitz-Kaveggia syndrome	y	OPITZ-KAVEGGIA SYNDROME; OKS	Clinical Features|Diagnosis	died|fetal_loss|fetal_losses	MED12	HGNC:11957	Opitz-Kaveggia syndrome, 305450 (3), X-linked recessive	X-linked recessive	y	y	[In a nonconsanguineous family, Keller et al. (1976) observed 3 brothers with an apparently 'new' syndrome manifested by mental retardation, short stature, frontal upsweep of the hair, laterally displaced inner canthi, small simplified ears, and broad great toes. Three additional brothers died in infancy from what was thought to be a similar pattern of abnormality. Two of these had imperforate anus and died in the first days of life]	L2	y	-	lethal	ambiguous|lethal|nonlethal	lethal|nonlethal	L2	L2	pre-infant-lethal
305600	FOCAL DERMAL HYPOPLASIA	Focal dermal hypoplasia, 305600 (3)	Focal dermal hypoplasia	y	FOCAL DERMAL HYPOPLASIA; FDH	Description|Clinical Features|Phenotype	lethality|died|lethal|miscarriage|miscarriages	PORCN	HGNC:17652	Focal dermal hypoplasia, 305600 (3), X-linked dominant	X-linked dominant	y	y	[Focal dermal hypoplasia is inherited as an X-linked dominant with in utero lethality in males]	L1	y	-	lethal	lethal	lethal	L1	L1	pre-infant-lethal
305620	FRONTOMETAPHYSEAL DYSPLASIA 1	Frontometaphyseal dysplasia 1, 305620 (3)	Frontometaphyseal dysplasia 1	y	FRONTOMETAPHYSEAL DYSPLASIA 1; FMD1	Description|Clinical Features	death|deaths|lethality|died	FLNA	HGNC:3754	Frontometaphyseal dysplasia 1, 305620 (3), X-linked recessive	X-linked recessive	y	y	[Affected males exhibit severe malformations similar to those observed in individuals with OPD2, resulting in prenatal lethality or death in the first few months of life (review by Robertson, 2005). Verloes et al. (2000)]	L1	y	-	lethal	lethal	lethal	L1|L2|L3	L1	pre-infant-lethal
306000	GLYCOGEN STORAGE DISEASE IXa1	Glycogen storage disease, type IXa1, 306000 (3)	Glycogen storage disease, type IXa1	n	-	-	-	PHKA2	HGNC:8926	Glycogen storage disease, type IXa1, 306000 (3), X-linked recessive	X-linked recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
306000	GLYCOGEN STORAGE DISEASE IXa1	Glycogen storage disease, type IXa2, 306000 (3)	Glycogen storage disease, type IXa2	n	-	-	-	PHKA2	HGNC:8926	Glycogen storage disease, type IXa2, 306000 (3), X-linked recessive	X-linked recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
306400	GRANULOMATOUS DISEASE, CHRONIC, X-LINKED	Chronic granulomatous disease, X-linked, 306400 (3)	Chronic granulomatous disease, X-linked	y	GRANULOMATOUS DISEASE, CHRONIC, X-LINKED; CGDX	Clinical Features	died|fatal	CYBB	HGNC:2578	Chronic granulomatous disease, X-linked, 306400 (3), X-linked recessive	X-linked recessive	y	y	[Carson et al. (1965) reported 16 males in 8 families with a syndrome of chronic suppurative lymphadenitis, chronic dermatitis, chronic pulmonary disease and hepatosplenomegaly with subsequent fatal outcome]	LU	y	-	lethal	lethal|nonlethal	lethal|nonlethal	LU	LU	post-infant-lethal
306700	HEMOPHILIA A	Hemophilia A, 306700 (3)	Hemophilia A	y	HEMOPHILIA A; HEMA	Clinical Features	death|deaths|fatal	F8	HGNC:3546	Hemophilia A, 306700 (3), X-linked recessive	X-linked recessive	y	y	[Women in the cohort had an increased risk of deaths from extra cranial hemorrhage; however, the number of deaths from this cause was much lower than that for ischemic heart disease]	LU	y	-	lethal	lethal	lethal	L6|LU	L6	post-infant-lethal
306900	HEMOPHILIA B	Hemophilia B, 306900 (3)	Hemophilia B	n	-	-	-	F9	HGNC:3551	Hemophilia B, 306900 (3), X-linked recessive	X-linked recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
306950	DIAPHRAGMATIC HERNIA 5, X-LINKED	Diaphragmatic hernia 5, X-linked, 306950 (3)	Diaphragmatic hernia 5, X-linked	y	DIAPHRAGMATIC HERNIA 5, X-LINKED; DIH5	Description|Clinical Features|Clinical Synopsis	die|died|death|deaths	PLS3	HGNC:9091	Diaphragmatic hernia 5, X-linked, 306950 (3), X-linked	X-linked	y	y	[The disorder is usually transmitted in an X-linked recessive pattern with males being severely affected; many die in early childhood. Frequent neonatal death]	L2	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L2	L2	pre-infant-lethal
306955	HETEROTAXY, VISCERAL, 1, X-LINKED	Congenital heart defects, nonsyndromic, 1, X-linked, 306955 (3)	Congenital heart defects, nonsyndromic, 1, X-linked	y	HETEROTAXY, VISCERAL, 1, X-LINKED; HTX1	Clinical Features|Phenotype	died	ZIC3	HGNC:12874	Congenital heart defects, nonsyndromic, 1, X-linked, 306955 (3), X-linked recessive	X-linked recessive	y	y	[In an Italian family in which affected males had a clinical phenotype ranging from VACTERL-H (314390) to X-linked visceral heterotaxy, Chung et al. (2011) identified a 1.3-Mb deletion of chromosome Xq26.3 including the ZIC3 gene. One male fetus had complex cardiac anomalies, including atrial isomerism, atrioventricular septal defect, double-outlet right ventricle, transposition of the great arteries, and subvalvular pulmonary stenosis. He also had enlarged kidneys, imperforate anus, right-sided stomach and pancreas, bilateral trilobed lungs, and asplenia, consistent with heterotaxy. Neuropathology was normal. Family history revealed 2 additional male family members who had died soon after birth/ ** In cytogenetics / Mikkila et al. (1994) described X-linked laterality defects in 2 male cousins. One infant had a large atrial septal defect, anomalous inferior vena cava, and atresia of the extrahepatic bile ducts. He died at age 7.5 months due to cardiac and hepatic insufficiency]	L2	y	y	lethal	lethal	lethal	L2	L2	pre-infant-lethal
307000	HYDROCEPHALUS, CONGENITAL, X-LINKED	Hydrocephalus, congenital, X-linked, 307000 (3)	Hydrocephalus, congenital, X-linked	y	HYDROCEPHALUS, CONGENITAL, X-LINKED; HYCX	Description|Clinical Features|Clinical Synopsis	die|died|death|deaths	L1CAM	HGNC:6470	Hydrocephalus, congenital, X-linked, 307000 (3), X-linked recessive	X-linked recessive	y	y	[died at or within 10 days of birth]	L2	-	-	lethal	lethal	lethal	L2	L2	pre-infant-lethal
307030	GLYCEROL KINASE DEFICIENCY	Glycerol kinase deficiency, 307030 (3)	Glycerol kinase deficiency	n	-	-	-	GK	HGNC:4289	Glycerol kinase deficiency, 307030 (3), X-linked recessive	X-linked recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
307200	ISOLATED GROWTH HORMONE DEFICIENCY, TYPE III, WITH AGAMMAGLOBULINEMIA	Isolated growth hormone deficiency, type III, with agammaglobulinemia, 307200 (3)	Isolated growth hormone deficiency, type III, with agammaglobulinemia	y	ISOLATED GROWTH HORMONE DEFICIENCY, TYPE III, WITH AGAMMAGLOBULINEMIA; IGHD3	Clinical Features	died	BTK	HGNC:1133	Isolated growth hormone deficiency, type III, with agammaglobulinemia, 307200 (3), X-linked recessive	X-linked recessive	n	y	[Monafo et al. (1991) described this syndrome in a 13-year-old boy. An earlier born agammaglobulinemic brother, who died at 6 years of age, was below the third percentile for height]	L4	y	-	lethal	lethal	lethal	L4	L4	post-infant-lethal
308050	CONGENITAL HEMIDYSPLASIA WITH ICHTHYOSIFORM ERYTHRODERMA AND LIMB DEFECTS	CHILD syndrome, 308050 (3)	CHILD syndrome	y	CONGENITAL HEMIDYSPLASIA WITH ICHTHYOSIFORM ERYTHRODERMA AND LIMB DEFECTS	Description|Clinical Features	lethal|lethality|miscarriage|miscarriages|stillbirth|stillbirths	NSDHL	HGNC:13398	CHILD syndrome, 308050 (3), X-linked dominant	X-linked dominant	y	y	[They suggested that the syndrome may be inherited as an X-linked dominant trait with lethality in hemizygous males (Wettke-Schafer and Kantner, 1983). The basis for the suggestion was: sex ratio of 19 females to 1 male, an 11:3 ratio of unaffected sisters to unaffected brothers, and the observation of 5 miscarriages and 1 male stillbirth in the affected sibships]	L1	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L1	L1	pre-infant-lethal
308100	ICHTHYOSIS, X-LINKED	Ichthyosis, X-linked, 308100 (3)	Ichthyosis, X-linked	n	-	-	-	STS	HGNC:11425	Ichthyosis, X-linked, 308100 (3), X-linked recessive	X-linked recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
308205	IFAP SYNDROME 1, WITH OR WITHOUT BRESHECK SYNDROME	IFAP syndrome with or without BRESHECK syndrome, 308205 (3)	IFAP syndrome with or without BRESHECK syndrome	y	IFAP SYNDROME 1, WITH OR WITHOUT BRESHECK SYNDROME; IFAP1	Clinical Features|Phenotype	died|death|deaths	MBTPS2	HGNC:15455	IFAP syndrome with or without BRESHECK syndrome, 308205 (3), X-linked recessive	X-linked recessive	y	y	[The first half brother was born at 32 weeks' gestation after a pregnancy complicated by intrauterine growth retardation and oligohydramnios. Multiple congenital anomalies were noted, including acrocephaly, right microphthalmia, lamellar desquamation and generalized alopecia of the scalp/eyebrows/eyelashes, scoliosis and hypoplasia of the right chest, bilateral talipes calcaneus, unilateral postaxial polydactyly, and multiple flexion contractures with a dislocated hip. He died of respiratory distress 6 hours after delivery / Family history was remarkable for the mother having a brother who died a few hours after delivery of undefined cause but with a reported failure of growth, further suggesting an X-linked disorder]	L2	y	y	lethal	lethal|nonlethal	lethal|nonlethal	L2	L2	pre-infant-lethal
308230	IMMUNODEFICIENCY WITH HYPER-IgM, TYPE 1	Immunodeficiency, X-linked, with hyper-IgM, 308230 (3)	Immunodeficiency, X-linked, with hyper-IgM	y	IMMUNODEFICIENCY WITH HYPER-IgM, TYPE 1; HIGM1	Clinical Features	died	CD40LG	HGNC:11935	Immunodeficiency, X-linked, with hyper-IgM, 308230 (3), X-linked recessive	X-linked recessive	y	y	[Thomas et al. (1995) performed successful allogeneic bone marrow transplantation in a boy with hyper-IgM syndrome 1 using his carrier sister as the donor. Full engraftment was shown by several means, including changes in red cell antigens, the results of fluorescence in situ hybridization for X and Y chromosomes, polymorphism of the CD40LG gene, and expression of the CD40 ligand by activated T cells. Transplantation was considered indicated because the patient had had P. carinii pneumonitis and came from a family in which 2 maternal uncles had died of protracted diarrhea at the ages of 6 months and 2 years, respectively]	L3	n	y	lethal	lethal	lethal	L3	L3	pre-infant-lethal
308240	LYMPHOPROLIFERATIVE SYNDROME, X-LINKED, 1	Lymphoproliferative syndrome, X-linked, 1, 308240 (3)	Lymphoproliferative syndrome, X-linked, 1	y	LYMPHOPROLIFERATIVE SYNDROME, X-LINKED, 1; XLP1	Description|Clinical Features|Clinical Synopsis|Diagnosis|Phenotype	fatal|death|deaths|died	SH2D1A	HGNC:10820	Lymphoproliferative syndrome, X-linked, 1, 308240 (3), X-linked recessive	X-linked recessive	y	y	[Purtilo and Grierson (1991) reported that during the previous decade 240 males with XLP within 59 unrelated kindreds had been identified worldwide. One-half of the patients had developed fatal infectious mononucleosis at an average age of about 2.5 years, and death occurred on average only 33 days following onset of illness]	L4	y	-	lethal	lethal	lethal	L4	L4	post-infant-lethal
308300	INCONTINENTIA PIGMENTI	Incontinentia pigmenti, 308300 (3)	Incontinentia pigmenti	y	INCONTINENTIA PIGMENTI; IP	Description|Clinical Features|Diagnosis|Phenotype	lethal|died|death|deaths|miscarriage|miscarriages|lethality	IKBKG	HGNC:5961	Incontinentia pigmenti, 308300 (3), X-linked dominant	X-linked dominant	y	y	[Familial incontinentia pigmenti (IP) is a genodermatosis that segregates as an X-linked dominant disorder and is usually lethal prenatally in males (The International Incontinentia Pigmenti Consortium, 2000)]	L1	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L1|L2|L3	L1	pre-infant-lethal
308350	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 1	Developmental and epileptic encephalopathy 1, 308350 (3)	Developmental and epileptic encephalopathy 1	y	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 1; DEE1	Clinical Features	died	ARX	HGNC:18060	Developmental and epileptic encephalopathy 1, 308350 (3), X-linked recessive	X-linked recessive	y	y	[Feinberg and Leahy (1977) reported X-linked recessive inheritance of infantile seizures in a family in which 5 males in 4 sibships spanning 3 generations were affected. Although the 13-month-old proband was still living at the time of the report, the 4 other affected children died between 9 months and 6 years of age]	L3	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L2|L3	L2	pre-infant-lethal
308700	HYPOGONADOTROPIC HYPOGONADISM 1 WITH OR WITHOUT ANOSMIA	Hypogonadotropic hypogonadism 1 with or without anosmia (Kallmann syndrome 1), 308700 (3)	Hypogonadotropic hypogonadism 1 with or without anosmia (Kallmann syndrome 1)	y	HYPOGONADOTROPIC HYPOGONADISM 1 WITH OR WITHOUT ANOSMIA; HH1	Clinical Features	died	ANOS1	HGNC:6211	Hypogonadotropic hypogonadism 1 with or without anosmia (Kallmann syndrome 1), 308700 (3), X-linked recessive	X-linked recessive	y	n	-	-	-	-	ambiguous	ambiguous	ambiguous	-	-	-
308800	KERATOSIS FOLLICULARIS SPINULOSA DECALVANS, X-LINKED	Keratosis follicularis spinulosa decalvans, X-linked, 308800 (3)	Keratosis follicularis spinulosa decalvans, X-linked	n	-	-	-	MBTPS2	HGNC:15455	Keratosis follicularis spinulosa decalvans, X-linked, 308800 (3), X-linked recessive	X-linked recessive	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L2	L2	pre-infant-lethal
308990	PROTEINURIA, LOW MOLECULAR WEIGHT, WITH HYPERCALCIURIA AND NEPHROCALCINOSIS	Proteinuria, low molecular weight, with hypercalciuric nephrocalcinosis, 308990 (3)	Proteinuria, low molecular weight, with hypercalciuric nephrocalcinosis	n	-	-	-	CLCN5	HGNC:2023	Proteinuria, low molecular weight, with hypercalciuric nephrocalcinosis, 308990 (3), X-linked recessive	X-linked recessive	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	LU	LU	post-infant-lethal
309000	LOWE OCULOCEREBRORENAL SYNDROME	Lowe syndrome, 309000 (3)	Lowe syndrome	n	-	-	-	OCRL	HGNC:8108	Lowe syndrome, 309000 (3), X-linked recessive	X-linked recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
309120	SPERMATOGENIC FAILURE, X-LINKED, 2	Spermatogenic failure, X-linked 2, 309120 (3)	Spermatogenic failure, X-linked 2	n	-	-	-	TEX11	HGNC:11733	Spermatogenic failure, X-linked 2, 309120 (3), X-linked recessive	X-linked recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
309350	MELNICK-NEEDLES SYNDROME	Melnick-Needles syndrome, 309350 (3)	Melnick-Needles syndrome	y	MELNICK-NEEDLES SYNDROME; MNS	Description|Clinical Features|Clinical Synopsis	death|deaths|lethality|died|lethal|stillborn	FLNA	HGNC:3754	Melnick-Needles syndrome, 309350 (3), X-linked dominant	X-linked dominant	n	y	[Affected males exhibit severe malformations similar to those observed in individuals with OPD2, resulting in prenatal lethality or death in the first few months of life (review by Robertson, 2005)]	L1	y	-	lethal	lethal	lethal	L1|L2|L3	L1	pre-infant-lethal
309400	MENKES DISEASE	Menkes disease, 309400 (3)	Menkes disease	y	MENKES DISEASE; MNK	Clinical Features|Clinical Synopsis|Phenotype	death|deaths|died|fatal	ATP7A	HGNC:869	Menkes disease, 309400 (3), X-linked recessive	X-linked recessive	y	y	[Jankov et al. (1998) described a newborn male who presented with acute onset of severe intraabdominal bleeding, hemorrhagic shock, and multiple fractures leading to death on day 27]	L2	y	-	lethal	ambiguous|lethal|nonlethal	lethal|nonlethal	L2	L2	pre-infant-lethal
309500	RENPENNING SYNDROME 1	Renpenning syndrome, 309500 (3)	Renpenning syndrome	y	RENPENNING SYNDROME 1; RENS1	Clinical Features	died	PQBP1	HGNC:9330	Renpenning syndrome, 309500 (3), X-linked recessive	X-linked recessive	n	y	[Hamel et al. (1994) reported a family in which 2 brothers and their 2 maternal uncles had a syndromic form of X-linked severe mental retardation. Other features included short stature, severe congenital heart defects, and craniofacial abnormalities consisting of cleft or highly arched palate, microcephaly, abnormal ears, bulbous nose, broad nasal bridge, malar hypoplasia, small mouth, and micrognathia. Spasticity was also present. Three of the 4 patients died at an early age]	LU	y	-	lethal	lethal	lethal	LU	LU	post-infant-lethal
309510	PARTINGTON SYNDROME	Partington syndrome, 309510 (3)	Partington syndrome	n	-	-	-	ARX	HGNC:18060	Partington syndrome, 309510 (3), X-linked recessive	X-linked recessive	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L2|L3	L2	pre-infant-lethal
309520	INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC, LUJAN-FRYNS TYPE	Lujan-Fryns syndrome, 309520 (3)	Lujan-Fryns syndrome	n	-	-	-	MED12	HGNC:11957	Lujan-Fryns syndrome, 309520 (3), X-linked recessive	X-linked recessive	-	-	-	-	-	-	nonlethal	ambiguous|lethal|nonlethal	lethal|nonlethal	L2	L2	pre-infant-lethal
309530	INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 1	Intellectual developmental disorder, X-linked 1, 309530 (3)	Intellectual developmental disorder, X-linked 1	n	-	-	-	IQSEC2	HGNC:29059	Intellectual developmental disorder, X-linked 1, 309530 (3), X-linked dominant	X-linked dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
309541	METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, cblX TYPE	Methylmalonic aciduria and homocysteinemia, cblX type, 309541 (3)	Methylmalonic aciduria and homocysteinemia, cblX type	y	METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, cblX TYPE; MAHCX	Phenotype	death|deaths	HCFC1	HGNC:4839	Methylmalonic aciduria and homocysteinemia, cblX type, 309541 (3), X-linked recessive	X-linked recessive	y	n	-	-	-	-	ambiguous	ambiguous	ambiguous	-	-	-
309548	INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 109	Intellectual developmental disorder, X-linked 109, 309548 (3)	Intellectual developmental disorder, X-linked 109	n	-	-	-	AFF2	HGNC:3776	Intellectual developmental disorder, X-linked 109, 309548 (3), X-linked recessive	X-linked recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
309549	INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 9	Intellectual developmental disorder, X-linked 9, 309549 (3)	Intellectual developmental disorder, X-linked 9	n	-	-	-	FTSJ1	HGNC:13254	Intellectual developmental disorder, X-linked 9, 309549 (3), X-linked recessive	X-linked recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
309580	INTELLECTUAL DISABILITY-HYPOTONIC FACIES SYNDROME, X-LINKED, 1	Intellectual disability-hypotonic facies syndrome, X-linked, 309580 (3)	Intellectual disability-hypotonic facies syndrome, X-linked	y	INTELLECTUAL DISABILITY-HYPOTONIC FACIES SYNDROME, X-LINKED, 1; MRXHF1	Clinical Features	died	ATRX	HGNC:886	Intellectual disability-hypotonic facies syndrome, X-linked, 309580 (3), X-linked recessive	X-linked recessive	y	y	[died in infancy or early childhood]	L3	y	y	lethal	lethal	lethal	L3|LU	L3	pre-infant-lethal
309583	INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC, SNYDER-ROBINSON TYPE	Intellectual developmental disorder, X-linked syndromic, Snyder-Robinson type, 309583 (3)	Intellectual developmental disorder, X-linked syndromic, Snyder-Robinson type	y	INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC, SNYDER-ROBINSON TYPE; MRXSSR	Clinical Features	spontaneous_abortion|spontaneous_abortions	SMS	HGNC:11123	Intellectual developmental disorder, X-linked syndromic, Snyder-Robinson type, 309583 (3), X-linked recessive	X-linked recessive	y	y	[Becerra-Solano et al. (2009) reported 2 adult Mexican brothers with Snyder-Robinson syndrome. Clinical features included mental retardation, multiple childhood fractures associated with decreased bone density, thin body habitus with poor muscle bulk and long thin limbs, pectus excavatum with widely-spaced nipples, and kyphoscoliosis... Family history was notable for a spontaneous abortion in the mother during the first trimester]	L1	n	y	lethal	lethal	lethal	L1	L1	pre-infant-lethal
309585	INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC, WILSON-TURNER TYPE	Wilson-Turner syndrome, 309585 (3)	Wilson-Turner syndrome	n	-	-	-	LAS1L	HGNC:25726	Wilson-Turner syndrome, 309585 (3), X-linked recessive	X-linked recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
309590	INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC, TURNER TYPE	Intellectual developmental disorder, X-linked syndromic, Turner type, 309590 (3)	Intellectual developmental disorder, X-linked syndromic, Turner type	y	INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC, TURNER TYPE; MRXST	Clinical Features	death|deaths|died	HUWE1	HGNC:30892	Intellectual developmental disorder, X-linked syndromic, Turner type, 309590 (3), X-linked	X-linked	y	n	-	-	-	-	ambiguous	ambiguous	ambiguous	-	-	-
309630	METACARPAL 4-5 FUSION	Metacarpal 4-5 fusion, 309630 (3)	Metacarpal 4-5 fusion	n	-	-	-	FGF16	HGNC:3672	Metacarpal 4-5 fusion, 309630 (3), X-linked recessive	X-linked recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
309800	MICROPHTHALMIA, SYNDROMIC 1	Microphthalmia, syndromic 1, 309800 (3)	Microphthalmia, syndromic 1	y	MICROPHTHALMIA, SYNDROMIC 1; MCOPS1	Clinical Features|Clinical Synopsis	stillborn|spontaneous_abortion|spontaneous_abortions	NAA10	HGNC:18704	Microphthalmia, syndromic 1, 309800 (3), X-linked	X-linked	y	y	[Multiple spontaneous abortions in obligate carriers]	L1	n	y	lethal	lethal	lethal	L1|L3	L1	pre-infant-lethal
309801	LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 1	Linear skin defects with multiple congenital anomalies 1, 309801 (3)	Linear skin defects with multiple congenital anomalies 1	y	LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 1; LSDMCA1	Description|Clinical Features|Phenotype	lethality|death|deaths|died|lethal|miscarriage|miscarriages	HCCS	HGNC:4837	Linear skin defects with multiple congenital anomalies 1, 309801 (3), X-linked dominant	X-linked dominant	y	y	[The microphthalmia with linear skin defects syndrome (MLS) is an X-linked dominant disorder characterized by unilateral or bilateral microphthalmia and linear skin defects--which are limited to the face and neck, consisting of areas of aplastic skin that heal with age to form hyperpigmented areas--in affected females and in utero lethality for males (Wimplinger et al., 2006)]	L1	y	-	lethal	lethal	lethal	L1	L1	pre-infant-lethal
309900	MUCOPOLYSACCHARIDOSIS, TYPE II	Mucopolysaccharidosis II, 309900 (3)	Mucopolysaccharidosis II	y	MUCOPOLYSACCHARIDOSIS, TYPE II; MPS2	Clinical Features|Clinical Synopsis|Phenotype	death|deaths|lethal	IDS	HGNC:5389	Mucopolysaccharidosis II, 309900 (3), X-linked recessive	X-linked recessive	y	y	[MPS II is a multisystem disorder. Clinical manifestations include severe airway obstruction, skeletal deformities, cardiomyopathy, and, in most patients, neurologic decline. Death usually occurs in the second decade of life, although some patients with less severe disease have survived into their fifth or sixth decade (summary by Wraith et al., 2008)]	L5	y	-	lethal	lethal	lethal	L5	L5	post-infant-lethal
310200	MUSCULAR DYSTROPHY, DUCHENNE TYPE	Duchenne muscular dystrophy, 310200 (3)	Duchenne muscular dystrophy	y	MUSCULAR DYSTROPHY, DUCHENNE TYPE; DMD	Description|Clinical Features|Clinical Synopsis|Phenotype	death|deaths|fatal|died|lethal|stillbirth|stillbirths	DMD	HGNC:2928	Duchenne muscular dystrophy, 310200 (3), X-linked recessive	X-linked recessive	y	y	[Usual onset before age 6 years and death by age 20 / Dystrophin-associated muscular dystrophies range from the severe Duchenne muscular dystrophy (DMD) to the milder Becker muscular dystrophy (BMD; 300376). Mapping and molecular genetic studies showed that both are the result of mutations in the huge gene that encodes dystrophin, also symbolized DMD. Approximately two-thirds of the mutations in both forms are deletions of one or many exons in the dystrophin gene. Although there is no clear correlation found between the extent of the deletion and the severity of the disorder, DMD deletions usually result in frameshift. Boland et al. (1996) studied a retrospective cohort of 33 male patients born between 1953 and 1983. The mean age at DMD diagnosis was 4.6 years; wheelchair dependency had a median age of 10 years; cardiac muscle failure developed in 15% of patients with a median age of 21.5 years; smooth muscle dysfunction in the digestive or urinary tract occurred in 21% and 6% of the patients, respectively, at a median age of 15 years. In this cohort, death occurred at a median age of 17 years]	L5	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L5|L6	L5	post-infant-lethal
310300	EMERY-DREIFUSS MUSCULAR DYSTROPHY 1, X-LINKED	Emery-Dreifuss muscular dystrophy 1, X-linked, 310300 (3)	Emery-Dreifuss muscular dystrophy 1, X-linked	y	EMERY-DREIFUSS MUSCULAR DYSTROPHY 1, X-LINKED; EDMD1	Clinical Features|Clinical Synopsis|Diagnosis	death|deaths|lethal	EMD	HGNC:3331	Emery-Dreifuss muscular dystrophy 1, X-linked, 310300 (3), X-linked recessive	X-linked recessive	y	y	[The authors stressed that emerin staining should be part of the work-up of every unexplained muscular dystrophy, because the early diagnosis of EDMD is very important, especially to avoid cardiac complications that may cause sudden death]	LU	y	-	lethal	lethal	lethal	LU	LU	post-infant-lethal
310440	MYOPATHY, X-LINKED, WITH EXCESSIVE AUTOPHAGY	Myopathy, X-linked, with excessive autophagy, 310440 (3)	Myopathy, X-linked, with excessive autophagy	y	MYOPATHY, X-LINKED, WITH EXCESSIVE AUTOPHAGY; MEAX	Clinical Features	died	VMA21	HGNC:22082	Myopathy, X-linked, with excessive autophagy, 310440 (3), X-linked recessive	X-linked recessive	n	y	[Yan et al. (2005) reported a Chinese American family in which 2 male sibs had a severe congenital form of XMEA. The proband was a 7-year-old boy with congenital hypotonia, neonatal hypoventilation requiring mechanical ventilation, and poor suckling requiring nasogastric feeding until 2.5 years of age. He had delayed motor milestones, progressive generalized muscle weakness involving facial and neck muscles, increased serum creatine kinase, and a high-arched palate. Mentation was normal. In addition, he had incomplete cardiac right bundle branch block and left ventricular hypertrophy. His older brother had a similar phenotype but without cardiac involvement. Family history showed that 3 maternal uncles and 2 maternal granduncles died in infancy with a similar phenotype]	L3	n	y	lethal	lethal	lethal	L3	L3	pre-infant-lethal
310468	NEPHROLITHIASIS, X-LINKED RECESSIVE, WITH RENAL FAILURE	Nephrolithiasis, type I, 310468 (3)	Nephrolithiasis, type I	n	-	-	-	CLCN5	HGNC:2023	Nephrolithiasis, type I, 310468 (3), X-linked recessive	X-linked recessive	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	LU	LU	post-infant-lethal
310490	CHARCOT-MARIE-TOOTH DISEASE, X-LINKED RECESSIVE, 4, WITH OR WITHOUT CEREBELLAR ATAXIA	Cowchock syndrome, 310490 (3)	Cowchock syndrome	y	CHARCOT-MARIE-TOOTH DISEASE, X-LINKED RECESSIVE, 4, WITH OR WITHOUT CEREBELLAR ATAXIA; CMTX4	Phenotype	death|deaths	AIFM1	HGNC:8768	Cowchock syndrome, 310490 (3), X-linked recessive	X-linked recessive	y	n	-	-	-	-	ambiguous	ambiguous|lethal|nonlethal	lethal|nonlethal	L3|L5	L3	pre-infant-lethal
310500	NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1A	Night blindness, congenital stationary (complete), 1A, X-linked, 310500 (3)	Night blindness, congenital stationary (complete), 1A, X-linked	n	-	-	-	NYX	HGNC:8082	Night blindness, congenital stationary (complete), 1A, X-linked, 310500 (3), X-linked recessive	X-linked recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
310600	NORRIE DISEASE	Norrie disease, 310600 (3)	Norrie disease	n	-	-	-	NDP	HGNC:7678	Norrie disease, 310600 (3), X-linked recessive	X-linked recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
310700	NYSTAGMUS 1, CONGENITAL, X-LINKED	Nystagmus 1, congenital, X-linked, 310700 (3)	Nystagmus 1, congenital, X-linked	n	-	-	-	FRMD7	HGNC:8079	Nystagmus 1, congenital, X-linked, 310700 (3), X-linked	X-linked	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
310700	NYSTAGMUS 1, CONGENITAL, X-LINKED	Nystagmus, infantile periodic alternating, X-linked, 310700 (3)	Nystagmus, infantile periodic alternating, X-linked	n	-	-	-	FRMD7	HGNC:8079	Nystagmus, infantile periodic alternating, X-linked, 310700 (3), X-linked	X-linked	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
311200	OROFACIODIGITAL SYNDROME I	Orofaciodigital syndrome I, 311200 (3)	Orofaciodigital syndrome I	y	OROFACIODIGITAL SYNDROME I; OFD1	Description|Clinical Synopsis|Phenotype	lethality|lethal	OFD1	HGNC:2567	Orofaciodigital syndrome I, 311200 (3), X-linked dominant	X-linked dominant	n	y	[Lethal in males]	L1	y	-	lethal	lethal	lethal	L1|L3|LU	L1	pre-infant-lethal
311250	ORNITHINE TRANSCARBAMYLASE DEFICIENCY, HYPERAMMONEMIA DUE TO	Ornithine transcarbamylase deficiency, 311250 (3)	Ornithine transcarbamylase deficiency	y	ORNITHINE TRANSCARBAMYLASE DEFICIENCY, HYPERAMMONEMIA DUE TO	Clinical Features|Clinical Synopsis	death|deaths|died|lethal	OTC	HGNC:8512	Ornithine transcarbamylase deficiency, 311250 (3), X-linked	X-linked	y	y	[Two types - lethal neonatal and less severe, late onset]	L2	y	-	lethal	lethal	lethal	L2	L2	pre-infant-lethal
311300	OTOPALATODIGITAL SYNDROME, TYPE I	Otopalatodigital syndrome, type I, 311300 (3)	Otopalatodigital syndrome, type I	y	OTOPALATODIGITAL SYNDROME, TYPE I; OPD1	Description|Clinical Features|Clinical Synopsis|Phenotype	death|deaths|lethality|lethal|died	FLNA	HGNC:3754	Otopalatodigital syndrome, type I, 311300 (3), X-linked dominant	X-linked dominant	y	y	[Affected males exhibit severe malformations similar to those observed in individuals with OPD2, resulting in prenatal lethality or death in the first few months of life (review by Robertson, 2005)]	L1	y	-	lethal	lethal	lethal	L1|L2|L3	L1	pre-infant-lethal
311360	PREMATURE OVARIAN FAILURE 1	Premature ovarian failure 1, 311360 (3)	Premature ovarian failure 1	n	-	-	-	FMR1	HGNC:3775	Premature ovarian failure 1, 311360 (3), X-linked	X-linked	-	-	-	-	-	-	nonlethal	ambiguous|lethal|nonlethal	lethal|nonlethal	L6	L6	post-infant-lethal
311510	WAISMAN SYNDROME	Waisman syndrome, 311510 (3)	Waisman syndrome	n	-	-	-	RAB39B	HGNC:16499	Waisman syndrome, 311510 (3), X-linked recessive	X-linked recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
311900	TARP SYNDROME	TARP syndrome, 311900 (3)	TARP syndrome	y	TARP SYNDROME; TARPS	Description|Clinical Features	die|death|deaths|died|lethal|miscarriage|miscarriages|pregnancy_loss|pregnancy_losses|stillborn	RBM10	HGNC:9896	TARP syndrome, 311900 (3), X-linked recessive	X-linked recessive	y	y	[Most patients die in late prenatal or early postnatal stages (summary by Kaeppler et al., 2018)]	L1	y	-	lethal	lethal	lethal	L1	L1	pre-infant-lethal
312000	PANHYPOPITUITARISM, X-LINKED	Panhypopituitarism, X-linked, 312000 (3)	Panhypopituitarism, X-linked	n	-	-	-	SOX3	HGNC:11199	Panhypopituitarism, X-linked, 312000 (3), X-linked	X-linked	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L2	L2	pre-infant-lethal
312060	PROPERDIN DEFICIENCY, X-LINKED	Properdin deficiency, X-linked, 312060 (3)	Properdin deficiency, X-linked	y	PROPERDIN DEFICIENCY, X-LINKED; CFPD	Clinical Features|Phenotype	died|fatal	CFP	HGNC:8864	Properdin deficiency, X-linked, 312060 (3), X-linked recessive	X-linked recessive	n	y	[Some of the patients had fulminant and often fatal meningitis with Neisseria meningitidis / Densen et al. (1987) reported a large family in which properdin deficiency was associated with meningococcal infection. The proband was a previously healthy 30-year-old man who worked as a logger and died with fulminant group Y meningococcal meningitis. A brother had died of fulminant group B meningococcal disease 16 years earlier at age 18]	L5	y	y	lethal	lethal	lethal	L5	L5	post-infant-lethal
312080	PELIZAEUS-MERZBACHER DISEASE	Pelizaeus-Merzbacher disease, 312080 (3)	Pelizaeus-Merzbacher disease	y	PELIZAEUS-MERZBACHER DISEASE; PMD	Clinical Features|Clinical Synopsis	death|deaths|died|fatal	PLP1	HGNC:9086	Pelizaeus-Merzbacher disease, 312080 (3), X-linked recessive	X-linked recessive	y	y	[Connatal form (type II), most severe with death in first decade]	L4	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L4	L4	post-infant-lethal
312170	PYRUVATE DEHYDROGENASE E1-ALPHA DEFICIENCY	Pyruvate dehydrogenase E1-alpha deficiency, 312170 (3)	Pyruvate dehydrogenase E1-alpha deficiency	y	PYRUVATE DEHYDROGENASE E1-ALPHA DEFICIENCY; PDHAD	Description|Clinical Features|Clinical Synopsis|Phenotype	fatal|death|deaths|died|die	PDHA1	HGNC:8806	Pyruvate dehydrogenase E1-alpha deficiency, 312170 (3), X-linked dominant	X-linked dominant	y	y	[Severe infantile cases usually die by 6 months]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
312300	ANDROGEN INSENSITIVITY, PARTIAL	Androgen insensitivity, partial, with or without breast cancer, 312300 (3)	Androgen insensitivity, partial, with or without breast cancer	n	-	-	-	AR	HGNC:644	Androgen insensitivity, partial, with or without breast cancer, 312300 (3), X-linked recessive	X-linked recessive	-	-	-	-	-	-	nonlethal	ambiguous|nonlethal	ambiguous	-	-	-
312600	RETINITIS PIGMENTOSA 2	Retinitis pigmentosa 2, 312600 (3)	Retinitis pigmentosa 2	n	-	-	-	RP2	HGNC:10274	Retinitis pigmentosa 2, 312600 (3), X-linked	X-linked	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
312700	RETINOSCHISIS 1, X-LINKED, JUVENILE	Retinoschisis, 312700 (3)	Retinoschisis	n	-	-	-	RS1	HGNC:10457	Retinoschisis, 312700 (3), X-linked recessive	X-linked recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
312750	RETT SYNDROME	Rett syndrome, 312750 (3)	Rett syndrome	y	RETT SYNDROME; RTT	Clinical Features|Phenotype	death|deaths|lethality|spontaneous_abortion|spontaneous_abortions|died	MECP2	HGNC:6990	Rett syndrome, 312750 (3), X-linked dominant	X-linked dominant	y	y	[Kerr et al. (1997) found an annual mortality rate in Rett syndrome of 1.2%; a high proportion (26%) of these deaths were sudden and unexplained / The authors suggested that in children with Rett syndrome, loss of physiologic heart rate variability associated with an increase of adrenergic tone, represents the electrophysiologic basis of cardiac instability and sudden death]	L3	y	-	lethal	ambiguous|lethal	lethal	L1|L3|L4	L1	pre-infant-lethal
312750	RETT SYNDROME	Rett syndrome, atypical, 312750 (3)	Rett syndrome, atypical	y	RETT SYNDROME; RTT	Clinical Features|Phenotype	death|deaths|lethality|spontaneous_abortion|spontaneous_abortions|died	MECP2	HGNC:6990	Rett syndrome, atypical, 312750 (3), X-linked dominant	X-linked dominant	y	y	[Kerr et al. (1997) found an annual mortality rate in Rett syndrome of 1.2%; a high proportion (26%) of these deaths were sudden and unexplained / The authors suggested that in children with Rett syndrome, loss of physiologic heart rate variability associated with an increase of adrenergic tone, represents the electrophysiologic basis of cardiac instability and sudden death]	L3	y	-	lethal	ambiguous|lethal	lethal	L1|L3|L4	L1	pre-infant-lethal
312750	RETT SYNDROME	Rett syndrome, preserved speech variant, 312750 (3)	Rett syndrome, preserved speech variant	y	RETT SYNDROME; RTT	Clinical Features|Phenotype	death|deaths|lethality|spontaneous_abortion|spontaneous_abortions|died	MECP2	HGNC:6990	Rett syndrome, preserved speech variant, 312750 (3), X-linked dominant	X-linked dominant	y	y	[Kerr et al. (1997) found an annual mortality rate in Rett syndrome of 1.2%; a high proportion (26%) of these deaths were sudden and unexplained / The authors suggested that in children with Rett syndrome, loss of physiologic heart rate variability associated with an increase of adrenergic tone, represents the electrophysiologic basis of cardiac instability and sudden death]	L3	y	-	lethal	ambiguous|lethal	lethal	L1|L3|L4	L1	pre-infant-lethal
312863	COMBINED IMMUNODEFICIENCY, X-LINKED	Combined immunodeficiency, X-linked, moderate, 312863 (3)	Combined immunodeficiency, X-linked, moderate	y	COMBINED IMMUNODEFICIENCY, X-LINKED; CIDX	Clinical Features	died	IL2RG	HGNC:6010	Combined immunodeficiency, X-linked, moderate, 312863 (3), X-linked recessive	X-linked recessive	n	y	[Sharfe et al. (1997) reported a child who was normal until the age of 9 months when he developed progressive respiratory symptoms caused by Pneumocystis carinii, which was treated successfully with trimethoprim-sulfamethazole. Physical examination was normal, with normal numbers of peripheral T and B cells, normal cervical lymph nodes, and a normal thymus gland viewed by ultrasonography and biopsy. Although immunoglobulin subtypes were normal, the patient had defective humoral immunity. T cells showed an unusual lack of response to exogenous IL2 The patient received a matched unrelated bone marrow transplantation and was doing well at the time of report. A maternal male cousin had previously been diagnosed with an unusual combined immunodeficiency with normal numbers of both B and T peripheral lymphocytes and normal levels of immunoglobulins and specific antibodies. That patient died at the age of 2 years after a mismatched bone marrow transplant following lectin T-cell depletion]	L4	y	-	lethal	lethal	lethal	L3|L4	L3	pre-infant-lethal
312870	SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 1	Simpson-Golabi-Behmel syndrome, type 1, 312870 (3)	Simpson-Golabi-Behmel syndrome, type 1	y	SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 1; SGBS1	Clinical Features	death|deaths|died|lethal	GPC3	HGNC:4451	Simpson-Golabi-Behmel syndrome, type 1, 312870 (3), X-linked recessive	X-linked recessive	y	y	[Terespolsky et al. (1995) commented on the wide clinical range in reported cases of SGBS, ranging from a mild form associated with long-term survival to an early lethal form with multiple congenital anomalies and severe mental retardation. They found 8 reported families in which affected individuals died in infancy]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
312920	SPASTIC PARAPLEGIA 2, X-LINKED	Spastic paraplegia 2, X-linked, 312920 (3)	Spastic paraplegia 2, X-linked	n	-	-	-	PLP1	HGNC:9086	Spastic paraplegia 2, X-linked, 312920 (3), X-linked recessive	X-linked recessive	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L4	L4	post-infant-lethal
313200	SPINAL AND BULBAR MUSCULAR ATROPHY, X-LINKED 1	Spinal and bulbar muscular atrophy of Kennedy, 313200 (3)	Spinal and bulbar muscular atrophy of Kennedy	y	SPINAL AND BULBAR MUSCULAR ATROPHY, X-LINKED 1; SMAX1	Phenotype	died	AR	HGNC:644	Spinal and bulbar muscular atrophy of Kennedy, 313200 (3), X-linked recessive	X-linked recessive	n	n	-	-	-	-	ambiguous	ambiguous|nonlethal	ambiguous	-	-	-
313400	SPONDYLOEPIPHYSEAL DYSPLASIA TARDA, X-LINKED	Spondyloepiphyseal dysplasia tarda, 313400 (3)	Spondyloepiphyseal dysplasia tarda	n	-	-	-	TRAPPC2	HGNC:23068	Spondyloepiphyseal dysplasia tarda, 313400 (3), X-linked recessive	X-linked recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
313490	TAURODONTISM, MICRODONTIA, AND DENS INVAGINATUS	Taurodontism, microdontia, and dens invaginatus, 313490 (3)	Taurodontism, microdontia, and dens invaginatus	n	-	-	-	KIF4A	HGNC:13339	Taurodontism, microdontia, and dens invaginatus, 313490 (3), X-linked recessive	X-linked recessive	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L2	L2	pre-infant-lethal
313500	TOOTH AGENESIS, SELECTIVE, X-LINKED, 1	Tooth agenesis, selective, X-linked 1, 313500 (3)	Tooth agenesis, selective, X-linked 1	n	-	-	-	EDA	HGNC:3157	Tooth agenesis, selective, X-linked 1, 313500 (3), X-linked dominant	X-linked dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L3	L3	pre-infant-lethal
313900	THROMBOCYTOPENIA 1	Thrombocytopenia, X-linked, 313900 (3)	Thrombocytopenia, X-linked	y	THROMBOCYTOPENIA 1; THC1	Clinical Features	died	WAS	HGNC:12731	Thrombocytopenia, X-linked, 313900 (3), X-linked recessive	X-linked recessive	y	y	[Vestermark and Vestermark (1964) found X-linked 'essential' thrombocytopenia in 2 generations of a family. One affected male became symptom-free spontaneously after puberty and one became symptom-free after splenectomy at the age of 18 years but died later of adrenal hemorrhage.]	L6	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L4|L6	L4	post-infant-lethal
313900	THROMBOCYTOPENIA 1	Thrombocytopenia, X-linked, intermittent, 313900 (3)	Thrombocytopenia, X-linked, intermittent	y	THROMBOCYTOPENIA 1; THC1	Clinical Features	died	WAS	HGNC:12731	Thrombocytopenia, X-linked, intermittent, 313900 (3), X-linked recessive	X-linked recessive	y	y	[Vestermark and Vestermark (1964) found X-linked 'essential' thrombocytopenia in 2 generations of a family. One affected male became symptom-free spontaneously after puberty and one became symptom-free after splenectomy at the age of 18 years but died later of adrenal hemorrhage.]	L6	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L4|L6	L4	post-infant-lethal
314050	THROMBOCYTOPENIA WITH BETA-THALASSEMIA, X-LINKED	Thrombocytopenia with beta-thalassemia, X-linked, 314050 (3)	Thrombocytopenia with beta-thalassemia, X-linked	y	THROMBOCYTOPENIA WITH BETA-THALASSEMIA, X-LINKED; XLTT	Clinical Features	spontaneous_abortion|spontaneous_abortions	GATA1	HGNC:4170	Thrombocytopenia with beta-thalassemia, X-linked, 314050 (3), X-linked recessive	X-linked recessive	n	n	-	-	-	-	ambiguous	ambiguous|lethal	lethal	L3	L3	pre-infant-lethal
314250	DYSTONIA 3, TORSION, X-LINKED	Dystonia-Parkinsonism, X-linked, 314250 (3)	Dystonia-Parkinsonism, X-linked	n	-	-	-	TAF1	HGNC:11535	Dystonia-Parkinsonism, X-linked, 314250 (3), X-linked recessive	X-linked recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
314390	VACTERL ASSOCIATION, X-LINKED, WITH OR WITHOUT HYDROCEPHALUS	VACTERL association, X-linked, 314390 (3)	VACTERL association, X-linked	y	VACTERL ASSOCIATION, X-LINKED, WITH OR WITHOUT HYDROCEPHALUS; VACTERLX	Clinical Features	died	ZIC3	HGNC:12874	VACTERL association, X-linked, 314390 (3), X-linked recessive	X-linked recessive	n	y	[Wessels et al. (2010) reported a male infant with VACTERL association. He was born with anal atresia, laryngeal and esophageal atresia with tracheoesophageal fistula, dextroposition of the heart with persistent left superior vena cava, and unilateral multicystic kidney. Limb defects and hydrocephalus were not noted. He died 1 hour after birth]	L2	y	-	lethal	lethal	lethal	L2	L2	pre-infant-lethal
314400	CARDIAC VALVULAR DYSPLASIA, X-LINKED	Cardiac valvular dysplasia, X-linked, 314400 (3)	Cardiac valvular dysplasia, X-linked	y	CARDIAC VALVULAR DYSPLASIA, X-LINKED; CVDPX	Description|Clinical Features|Phenotype	lethal|died	FLNA	HGNC:3754	Cardiac valvular dysplasia, X-linked, 314400 (3), X-linked	X-linked	y	y	[X-linked cardiac valvular dysplasia is a rare form of heart disease characterized by multivalvular dysplasia and regurgitation, which can lead to lethal heart failure in some patients / Newbury-Ecob et al. (1993) described a British family in which 2 brothers and the son of a daughter of one of them had valvular dysplasia. The grandson died in severe heart failure in the first day of life]	L2	y	y	lethal	lethal	lethal	L1|L2|L3	L1	pre-infant-lethal
314580	WIEACKER-WOLFF SYNDROME	Wieacker-Wolff syndrome, 314580 (3)	Wieacker-Wolff syndrome	y	WIEACKER-WOLFF SYNDROME; WRWF	Clinical Features	death|deaths	ZC4H2	HGNC:24931	Wieacker-Wolff syndrome, 314580 (3), X-linked recessive	X-linked recessive	y	y	[A third family identified by Hirata et al. (2013) had previously been reported by Hennekam et al. (1991). That family had 5 affected males in 3 sibships connected through females. Affected males had severe arthrogryposis and muscle weakness in the pre- and postnatal periods, resulting in death within the first weeks or months of life]	L2	y	-	lethal	lethal	lethal	L1|L2	L1	pre-infant-lethal
400044	46,XY SEX REVERSAL 1	46XY sex reversal 1, 400044 (3)	46XY sex reversal 1	y	46,XY SEX REVERSAL 1; SRXY1	Clinical Features	miscarriage|miscarriages	SRY	HGNC:11311	46XY sex reversal 1, 400044 (3), Y-linked	Y-linked	y	n	-	-	-	-	ambiguous	ambiguous	ambiguous	-	-	-
415000	SPERMATOGENIC FAILURE, Y-LINKED, 2	Spermatogenic failure, Y-linked, 2, 415000 (3)	Spermatogenic failure, Y-linked, 2	y	SPERMATOGENIC FAILURE, Y-LINKED, 2; SPGFY2	Phenotype	miscarriage|miscarriages	USP9Y	HGNC:12633	Spermatogenic failure, Y-linked, 2, 415000 (3), Y-linked	Y-linked	y	n	-	-	-	-	ambiguous	ambiguous	ambiguous	-	-	-
600001	HEART DEFECTS, CONGENITAL, AND OTHER CONGENITAL ANOMALIES	Pancreatic agenesis and congenital heart defects, 600001 (3)	Pancreatic agenesis and congenital heart defects	y	HEART DEFECTS, CONGENITAL, AND OTHER CONGENITAL ANOMALIES; HDCA	Clinical Features|Phenotype	died|lethal	GATA6	HGNC:4174	Pancreatic agenesis and congenital heart defects, 600001 (3), Autosomal dominant	Autosomal dominant	n	y	[Yorifuji et al. (1994) described a nonconsanguineous Japanese family in which the mother had undergone cardiac surgery at 19 years of age for patent ductus arteriosus and atrial septal defect. She developed diabetes mellitus after her third pregnancy at the age of 28 years. After 2 offspring were found to have hypoplasia of the pancreas, she was reexamined; abdominal CT scan showed hypoplasia of the pancreas. Only the head and the uncus of the pancreas were present; most of the body and tail were absent. The first 2 offspring of this woman had died soon after birth from unknown causes. The third child had diabetes and cyanotic congenital heart disease and died at 2 years and 8 months]	L2	y	y	lethal	lethal|nonlethal	lethal|nonlethal	L2	L2	pre-infant-lethal
600002	EIKEN SYNDROME	Eiken syndrome, 600002 (3)	Eiken syndrome	n	-	-	-	PTH1R	HGNC:9608	Eiken syndrome, 600002 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L1	L1	pre-infant-lethal
600059	RETINITIS PIGMENTOSA 13	Retinitis pigmentosa 13, 600059 (3)	Retinitis pigmentosa 13	n	-	-	-	PRPF8	HGNC:17340	Retinitis pigmentosa 13, 600059 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
600060	DEAFNESS, AUTOSOMAL RECESSIVE 2	Deafness, autosomal recessive 2, 600060 (3)	Deafness, autosomal recessive 2	n	-	-	-	MYO7A	HGNC:7606	Deafness, autosomal recessive 2, 600060 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
600072	FATAL FAMILIAL INSOMNIA	Insomnia, fatal familial, 600072 (3)	Insomnia, fatal familial	y	FATAL FAMILIAL INSOMNIA; FFI	Description|Clinical Features|Clinical Synopsis|Phenotype	fatal|death|deaths|died	PRNP	HGNC:9449	Insomnia, fatal familial, 600072 (3), Autosomal dominant	Autosomal dominant	n	y	[Onset in adulthood / Death within 12 months]	L6	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L6	L6	post-infant-lethal
600081	VITAMIN D HYDROXYLATION-DEFICIENT RICKETS, TYPE 1B	Rickets due to defect in vitamin D 25-hydroxylation deficiency, 600081 (3)	Rickets due to defect in vitamin D 25-hydroxylation deficiency	n	-	-	-	CYP2R1	HGNC:20580	Rickets due to defect in vitamin D 25-hydroxylation deficiency, 600081 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
600092	NIVELON-NIVELON-MABILLE SYNDROME	Nivelon-Nivelon-Mabille syndrome, 600092 (3)	Nivelon-Nivelon-Mabille syndrome	n	-	-	-	HHAT	HGNC:18270	Nivelon-Nivelon-Mabille syndrome, 600092 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
600101	DEAFNESS, AUTOSOMAL DOMINANT 2A	Deafness, autosomal dominant 2A, 600101 (3)	Deafness, autosomal dominant 2A	n	-	-	-	KCNQ4	HGNC:6298	Deafness, autosomal dominant 2A, 600101 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
600105	RETINITIS PIGMENTOSA 12	Retinitis pigmentosa-12, 600105 (3)	Retinitis pigmentosa-12	n	-	-	-	CRB1	HGNC:2343	Retinitis pigmentosa-12, 600105 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
600110	STARGARDT DISEASE 3	Stargardt disease 3, 600110 (3)	Stargardt disease 3	n	-	-	-	ELOVL4	HGNC:14415	Stargardt disease 3, 600110 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L3	L3	pre-infant-lethal
600116	PARKINSON DISEASE 2, AUTOSOMAL RECESSIVE JUVENILE	Parkinson disease, juvenile, type 2, 600116 (3)	Parkinson disease, juvenile, type 2	y	PARKINSON DISEASE 2, AUTOSOMAL RECESSIVE JUVENILE; PARK2	Clinical Features	died	PRKN	HGNC:8607	Parkinson disease, juvenile, type 2, 600116 (3), Autosomal recessive	Autosomal recessive	y	y	An autosomal recessive form of familial juvenile parkinsonism, defined as onset before age 40 years, was described in a Japanese family by Takahashi et al. (1994). Juvenile-onset Parkinson disease is symptomatically different in several aspects from classic late-onset Parkinson disease (PD; 168600), although classic symptoms of PD, such as bradykinesia, rigidity, and tremor, are present... One sister had died at age 42 years and a brother at the age of 27 years, both in a bedridden state]	L6	y	-	lethal	lethal	lethal	L6	L6	post-infant-lethal
600118	WARBURG MICRO SYNDROME 1	Warburg micro syndrome 1, 600118 (3)	Warburg micro syndrome 1	y	WARBURG MICRO SYNDROME 1; WARBM1	Clinical Features|Phenotype	lethal|died	RAB3GAP1	HGNC:17063	Warburg micro syndrome 1, 600118 (3), Autosomal recessive	Autosomal recessive	y	n	-	-	-	-	ambiguous	ambiguous|nonlethal	ambiguous	-	-	-
600121	RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 3	Rhizomelic chondrodysplasia punctata, type 3, 600121 (3)	Rhizomelic chondrodysplasia punctata, type 3	y	RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 3; RCDP3	Description	die	AGPS	HGNC:327	Rhizomelic chondrodysplasia punctata, type 3, 600121 (3), Autosomal recessive	Autosomal recessive	y	y	[Most patients die in the first decade of life]	L4	y	-	lethal	lethal	lethal	L4	L4	post-infant-lethal
600132	RETINITIS PIGMENTOSA 14	Retinitis pigmentosa 14, 600132 (3)	Retinitis pigmentosa 14	n	-	-	-	TULP1	HGNC:12423	Retinitis pigmentosa 14, 600132 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
600138	RETINITIS PIGMENTOSA 11	Retinitis pigmentosa 11, 600138 (3)	Retinitis pigmentosa 11	n	-	-	-	PRPF31	HGNC:15446	Retinitis pigmentosa 11, 600138 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
600142	CEREBRAL ARTERIOPATHY, AUTOSOMAL RECESSIVE, WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY	CARASIL syndrome, 600142 (3)	CARASIL syndrome	y	CEREBRAL ARTERIOPATHY, AUTOSOMAL RECESSIVE, WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY; CARASIL	Clinical Features	death|deaths|died	HTRA1	HGNC:9476	CARASIL syndrome, 600142 (3), Autosomal recessive	Autosomal recessive	y	y	[Maeda et al. (1976) reported 2 Japanese brothers, born of consanguineous parents, with young adult-onset progressive encephalopathy characterized by extrapyramidal features and dementia. Clinical features included generalized rigidity, spastic ataxia, hyperreflexia, extensor plantar responses, pseudobulbar symptoms, and dementia. The encephalopathy resembled Binswanger encephalopathy, but blood pressure was normal. Both brothers had alopecia, and 1 brother had back pain with lumbar disc herniation. Onset was in the third decade and death occurred within 10 years after a rapidly progressive course]	L6	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L6	L6	post-infant-lethal
600143	CEROID LIPOFUSCINOSIS, NEURONAL, 8	Ceroid lipofuscinosis, neuronal, 8, 600143 (3)	Ceroid lipofuscinosis, neuronal, 8	n	-	-	-	CLN8	HGNC:2079	Ceroid lipofuscinosis, neuronal, 8, 600143 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
600145	SACRAL DEFECT WITH ANTERIOR MENINGOCELE	Caudal regression syndrome, 600145 (3)	Caudal regression syndrome	y	SACRAL DEFECT WITH ANTERIOR MENINGOCELE	Clinical Features	stillbirth|stillbirths	VANGL1	HGNC:15512	Caudal regression syndrome, 600145 (3), Autosomal dominant	Autosomal dominant	y	n	-	-	-	-	ambiguous	ambiguous	ambiguous	-	-	-
600151	BARDET-BIEDL SYNDROME 3	Bardet-Biedl syndrome 3, 600151 (3)	Bardet-Biedl syndrome 3	n	-	-	-	ARL6	HGNC:13210	Bardet-Biedl syndrome 3, 600151 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
600175	NEURONOPATHY, DISTAL HEREDITARY MOTOR, AUTOSOMAL DOMINANT 8	Neuronopathy, distal hereditary motor, autosomal dominant 8, 600175 (3)	Neuronopathy, distal hereditary motor, autosomal dominant 8	n	-	-	-	TRPV4	HGNC:18083	Neuronopathy, distal hereditary motor, autosomal dominant 8, 600175 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	ambiguous|lethal|nonlethal	lethal|nonlethal	L1	L1	pre-infant-lethal
600195	VENOUS MALFORMATIONS, MULTIPLE CUTANEOUS AND MUCOSAL	Venous malformations, multiple cutaneous and mucosal, 600195 (3)	Venous malformations, multiple cutaneous and mucosal	y	VENOUS MALFORMATIONS, MULTIPLE CUTANEOUS AND MUCOSAL; VMCM	Clinical Features	death|deaths|died	TEK	HGNC:11724	Venous malformations, multiple cutaneous and mucosal, 600195 (3), Autosomal dominant	Autosomal dominant	y	y	[Gallione et al. (1995) restudied the large family with multiple vascular malformations originally described by Pasyk et al. (1984), noting that of 337 members over 7 generations, 56 individuals were affected. The location of the venous malformations was almost identical for several family members. In most cases, the lesions were small, enlarged with time, and were asymptomatic. A few of the females observed an increase in size of the vascular lesions approximately 1 week before menstruation and a subsequent decrease in size during menstruation. The lesions were present on the face and mucous membranes, including the lips, tongue, cheeks, tonsils, and larynx. Some members had venous malformations within internal organs. One developed 2 vascular tumors in the large intestine and required blood transfusions because of excessive bleeding. Two members of the family died from complications of these vascular abnormalities]	LU	n	y	lethal	lethal|nonlethal	lethal|nonlethal	LU	LU	post-infant-lethal
600204	EPIPHYSEAL DYSPLASIA, MULTIPLE, 2	Epiphyseal dysplasia, multiple, 2, 600204 (3)	Epiphyseal dysplasia, multiple, 2	n	-	-	-	COL9A2	HGNC:2218	Epiphyseal dysplasia, multiple, 2, 600204 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
600224	SPINOCEREBELLAR ATAXIA 5	Spinocerebellar ataxia 5, 600224 (3)	Spinocerebellar ataxia 5	n	-	-	-	SPTBN2	HGNC:11276	Spinocerebellar ataxia 5, 600224 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
600231	PALMOPLANTAR KERATODERMA, BOTHNIAN TYPE	Palmoplantar keratoderma, Bothnian type, 600231 (3)	Palmoplantar keratoderma, Bothnian type	n	-	-	-	AQP5	HGNC:638	Palmoplantar keratoderma, Bothnian type, 600231 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
600274	FRONTOTEMPORAL DEMENTIA	Dementia, frontotemporal, with or without parkinsonism, 600274 (3)	Dementia, frontotemporal, with or without parkinsonism	y	FRONTOTEMPORAL DEMENTIA; FTD	Clinical Features	death|deaths|died	MAPT	HGNC:6893	Dementia, frontotemporal, with or without parkinsonism, 600274 (3), Autosomal dominant	Autosomal dominant	y	y	[Wszolek et al. (1992) reported a large kindred in which 32 members in 8 generations had a neurodegenerative disorder characterized by progressive parkinsonism with dystonia, dementia, ocular motility abnormalities, pyramidal tract dysfunction, frontal lobe release signs, perseverative vocalizations, and urinary incontinence. The course was exceptionally 'aggressive'; onset of symptoms and death consistently occurred in the fifth decade]	L6	y	-	lethal	lethal	lethal	L6	L6	post-infant-lethal
600274	FRONTOTEMPORAL DEMENTIA	Dementia, frontotemporal, 600274 (3)	Dementia, frontotemporal	y	FRONTOTEMPORAL DEMENTIA; FTD	Clinical Features	death|deaths|died	PSEN1	HGNC:9508	Dementia, frontotemporal, 600274 (3), Autosomal dominant	Autosomal dominant	y	y	[Wszolek et al. (1992) reported a large kindred in which 32 members in 8 generations had a neurodegenerative disorder characterized by progressive parkinsonism with dystonia, dementia, ocular motility abnormalities, pyramidal tract dysfunction, frontal lobe release signs, perseverative vocalizations, and urinary incontinence. The course was exceptionally 'aggressive'; onset of symptoms and death consistently occurred in the fifth decade]	L6	y	-	lethal	lethal	lethal	L6	L6	post-infant-lethal
600316	DEAFNESS, AUTOSOMAL RECESSIVE 3	Deafness, autosomal recessive 3, 600316 (3)	Deafness, autosomal recessive 3	n	-	-	-	MYO15A	HGNC:7594	Deafness, autosomal recessive 3, 600316 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
600334	TIBIAL MUSCULAR DYSTROPHY, TARDIVE	Tibial muscular dystrophy, tardive, 600334 (3)	Tibial muscular dystrophy, tardive	n	-	-	-	TTN	HGNC:12403	Tibial muscular dystrophy, tardive, 600334 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L6|LU	L6	post-infant-lethal
600348	BAND HETEROTOPIA	Band heterotopia, 600348 (3)	Band heterotopia	y	BAND HETEROTOPIA; BH	Clinical Synopsis	death|deaths	EML1	HGNC:3330	Band heterotopia, 600348 (3), Autosomal recessive	Autosomal recessive	y	y	[May result in early death]	LU	y	-	lethal	lethal	lethal	LU	LU	post-infant-lethal
600363	SPASTIC PARAPLEGIA 6, AUTOSOMAL DOMINANT	Spastic paraplegia 6, autosomal dominant, 600363 (3)	Spastic paraplegia 6, autosomal dominant	n	-	-	-	NIPA1	HGNC:17043	Spastic paraplegia 6, autosomal dominant, 600363 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
600373	CODAS SYNDROME	CODAS syndrome, 600373 (3)	CODAS syndrome	y	CODAS SYNDROME	Clinical Features	died|lethality|stillborn	LONP1	HGNC:9479	CODAS syndrome, 600373 (3), Autosomal recessive	Autosomal recessive	n	y	[Other features present in the Amish children included omphalocele, imperforate anus, rectovaginal fistula, and cryptorchidism. In addition, features observed on prenatal ultrasound of a stillborn female infant with CODAS included polyhydramnios, 2-vessel umbilical cord, balanced atrioventricular canal, and absence of left lower long bones, with a relatively well-formed foot attached directly to the hip]	L1	y	-	lethal	lethal	lethal	L1	L1	pre-infant-lethal
600376	TELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 2	Telangiectasia, hereditary hemorrhagic, type 2, 600376 (3)	Telangiectasia, hereditary hemorrhagic, type 2	n	-	-	-	ACVRL1	HGNC:175	Telangiectasia, hereditary hemorrhagic, type 2, 600376 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
600462	MYOPATHY, LACTIC ACIDOSIS, AND SIDEROBLASTIC ANEMIA 1	Myopathy, lactic acidosis, and sideroblastic anemia 1, 600462 (3)	Myopathy, lactic acidosis, and sideroblastic anemia 1	y	MYOPATHY, LACTIC ACIDOSIS, AND SIDEROBLASTIC ANEMIA 1; MLASA1	Phenotype	died	PUS1	HGNC:15508	Myopathy, lactic acidosis, and sideroblastic anemia 1, 600462 (3), Autosomal recessive	Autosomal recessive	n	y	[died of respiratory failure at 12 years of age]	L5	y	-	lethal	lethal	lethal	L5	L5	post-infant-lethal
600496	MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 3	MODY, type III, 600496 (3)	MODY, type III	n	-	-	-	HNF1A	HGNC:11621	MODY, type III, 600496 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	LU	LU	post-infant-lethal
600512	EPILEPSY, FAMILIAL TEMPORAL LOBE, 1	Epilepsy, familial temporal lobe, 1, 600512 (3)	Epilepsy, familial temporal lobe, 1	y	EPILEPSY, FAMILIAL TEMPORAL LOBE, 1; ETL1	Clinical Features	died	LGI1	HGNC:6572	Epilepsy, familial temporal lobe, 1, 600512 (3), Autosomal dominant	Autosomal dominant	y	y	[Brodtkorb et al. (2002) reported a large Norwegian family in which 20 members over 5 generations had seizures in an autosomal dominant pattern. Twelve affected members were studied: mean age of onset was 18 years (range 4-42); 11 had simple partial seizures, 8 of which were characterized by aphasic features, and many experienced auditory hallucinations; all had secondary generalized tonic-clonic seizures that improved with age. EEG recordings in 4 patients showed temporal lobe activity and the symptoms suggested localization to the lateral neocortical temporal lobe. Two patients died unexpectedly in their twenties]	L6	y	-	lethal	lethal	lethal	L6	L6	post-infant-lethal
600513	EPILEPSY, NOCTURNAL FRONTAL LOBE, 1	Epilepsy, nocturnal frontal lobe, 1, 600513 (3)	Epilepsy, nocturnal frontal lobe, 1	n	-	-	-	CHRNA4	HGNC:1958	Epilepsy, nocturnal frontal lobe, 1, 600513 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
600625	OROFACIAL CLEFT 11	Orofacial cleft 11, 600625 (3)	Orofacial cleft 11	n	-	-	-	BMP4	HGNC:1071	Orofacial cleft 11, 600625 (3)	-	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
600630	UV-SENSITIVE SYNDROME 1	UV-sensitive syndrome 1, 600630 (3)	UV-sensitive syndrome 1	n	-	-	-	ERCC6	HGNC:3438	UV-sensitive syndrome 1, 600630 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L4	L4	post-infant-lethal
600638	FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, 3A, WITH OR WITHOUT EXTRAOCULAR INVOLVEMENT	Fibrosis of extraocular muscles, congenital, 3A, 600638 (3)	Fibrosis of extraocular muscles, congenital, 3A	n	-	-	-	TUBB3	HGNC:20772	Fibrosis of extraocular muscles, congenital, 3A, 600638 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
600649	CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, INFANTILE	CPT II deficiency, infantile, 600649 (3)	CPT II deficiency, infantile	y	CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, INFANTILE	Description|Clinical Features|Clinical Synopsis	lethal|death|deaths|died	CPT2	HGNC:2330	CPT II deficiency, infantile, 600649 (3), Autosomal recessive	Autosomal recessive	y	y	[Illsinger et al. (2008) noted that the phenotype of CPT2 deficiency can range from normal to early death in infancy, but concluded that all patients with abnormal neonatal screening should be followed for possible decompensation under certain circumstances]	L3	y	-	lethal	lethal	lethal	L2|L3|L5	L2	pre-infant-lethal
600652	DEAFNESS, AUTOSOMAL DOMINANT 4A	Deafness, autosomal dominant 4A, 600652 (3)	Deafness, autosomal dominant 4A	n	-	-	-	MYH14	HGNC:23212	Deafness, autosomal dominant 4A, 600652 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
600666	POLYCYSTIC KIDNEY DISEASE 3 WITH OR WITHOUT POLYCYSTIC LIVER DISEASE	Polycystic kidney disease 3, 600666 (3)	Polycystic kidney disease 3	n	-	-	-	GANAB	HGNC:4138	Polycystic kidney disease 3, 600666 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
600721	D-2-HYDROXYGLUTARIC ACIDURIA 1	D-2-hydroxyglutaric aciduria, 600721 (3)	D-2-hydroxyglutaric aciduria	y	D-2-HYDROXYGLUTARIC ACIDURIA 1; D2HGA1	Clinical Features	died	D2HGDH	HGNC:28358	D-2-hydroxyglutaric aciduria, 600721 (3), Autosomal recessive	Autosomal recessive	y	y	[Wajner et al. (2002) reported an infant with intermittent urinary excretion of D-2-hydroxyglutaric (D-2-OHG) acid who died at the age of 10 months from cardiogenic shock due to cardiomyopathy]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
600740	HYPOCALCIURIC HYPERCALCEMIA, FAMILIAL, TYPE III	Hypocalciuric hypercalcemia, type III, 600740 (3)	Hypocalciuric hypercalcemia, type III	n	-	-	-	AP2S1	HGNC:565	Hypocalciuric hypercalcemia, type III, 600740 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
600775	CRANIOSYNOSTOSIS 4	Craniosynostosis 4, 600775 (3)	Craniosynostosis 4	n	-	-	-	ERF	HGNC:3444	Craniosynostosis 4, 600775 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
600791	DEAFNESS, AUTOSOMAL RECESSIVE 4, WITH ENLARGED VESTIBULAR AQUEDUCT	Enlarged vestibular aqueduct, 600791 (3)	Enlarged vestibular aqueduct	n	-	-	-	FOXI1	HGNC:3815	Enlarged vestibular aqueduct, 600791 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
600791	DEAFNESS, AUTOSOMAL RECESSIVE 4, WITH ENLARGED VESTIBULAR AQUEDUCT	Enlarged vestibular aqueduct, digenic, 600791 (3)	Enlarged vestibular aqueduct, digenic	n	-	-	-	KCNJ10	HGNC:6256	Enlarged vestibular aqueduct, digenic, 600791 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L3	L3	pre-infant-lethal
600791	DEAFNESS, AUTOSOMAL RECESSIVE 4, WITH ENLARGED VESTIBULAR AQUEDUCT	Deafness, autosomal recessive 4, with enlarged vestibular aqueduct, 600791 (3)	Deafness, autosomal recessive 4, with enlarged vestibular aqueduct	n	-	-	-	SLC26A4	HGNC:8818	Deafness, autosomal recessive 4, with enlarged vestibular aqueduct, 600791 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
600794	NEURONOPATHY, DISTAL HEREDITARY MOTOR, AUTOSOMAL DOMINANT 5	Neuronopathy, distal hereditary motor, autosomal dominant 5, 600794 (3)	Neuronopathy, distal hereditary motor, autosomal dominant 5	n	-	-	-	GARS1	HGNC:4162	Neuronopathy, distal hereditary motor, autosomal dominant 5, 600794 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
600795	FRONTOTEMPORAL DEMENTIA AND/OR AMYOTROPHIC LATERAL SCLEROSIS 7	Frontotemporal dementia and/or amyotrophic lateral sclerosis 7, 600795 (3)	Frontotemporal dementia and/or amyotrophic lateral sclerosis 7	y	FRONTOTEMPORAL DEMENTIA AND/OR AMYOTROPHIC LATERAL SCLEROSIS 7; FTDALS7	Clinical Features	died	CHMP2B	HGNC:24537	Frontotemporal dementia and/or amyotrophic lateral sclerosis 7, 600795 (3), Autosomal dominant	Autosomal dominant	y	y	[Parkinson et al. (2006) reported a 75-year-old man with rapidly progressive ALS. At age 74 years, the patient developed bulbar-onset weakness with flaccid dysarthria and tongue fasciculations. He later developed weakness and wasting of the intrinsic hand muscles and respiratory weakness. Although he had a previous right leg amputation from trauma, neurophysiologic testing showed neurogenic changes in all 4 limbs. Deep tendon reflexes were depressed and plantar responses were flexor. The patient died of respiratory failure 15 months after symptom onset.]	L6	y	-	lethal	lethal	lethal	L6	L6	post-infant-lethal
600802	SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-POSITIVE, NK CELL-NEGATIVE	SCID, autosomal recessive, T-negative/B-positive type, 600802 (3)	SCID, autosomal recessive, T-negative/B-positive type	n	-	-	-	JAK3	HGNC:6193	SCID, autosomal recessive, T-negative/B-positive type, 600802 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
600803	GALLBLADDER DISEASE 1	Gallbladder disease 1, 600803 (3)	Gallbladder disease 1	y	GALLBLADDER DISEASE 1; GBD1	Clinical Features	stillborn	ABCB4	HGNC:45	Gallbladder disease 1, 600803 (3), Autosomal dominant, Autosomal recessive	Autosomal dominant, Autosomal recessive	y	n	-	-	-	-	ambiguous	ambiguous|nonlethal	ambiguous	-	-	-
600858	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 6	Cardiomyopathy, hypertrophic 6, 600858 (3)	Cardiomyopathy, hypertrophic 6	y	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 6; CMH6	Description|Clinical Features|Phenotype	death|deaths|died|lethal	PRKAG2	HGNC:9386	Cardiomyopathy, hypertrophic 6, 600858 (3), Autosomal dominant	Autosomal dominant	y	y	[Mutations in the PRKAG2 gene (602743) give rise to a moderate, essentially heart-specific, nonlysosomal glycogenosis with clinical onset typically in late adolescence or in the third decade of life, ventricular pre-excitation predisposing to supraventricular arrhythmias, mild to severe cardiac hypertrophy, enhanced risk of sudden cardiac death in midlife, and autosomal dominant inheritance with full penetrance (summary by Burwinkel et al., 2005)]	LU	y	-	lethal	lethal	lethal	L2|L6|LU	L2	pre-infant-lethal
600881	CATARACT 10, MULTIPLE TYPES	Cataract 10, multiple types, 600881 (3)	Cataract 10, multiple types	n	-	-	-	CRYBA1	HGNC:2394	Cataract 10, multiple types, 600881 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
600882	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2B	Charcot-Marie-Tooth disease, type 2B, 600882 (3)	Charcot-Marie-Tooth disease, type 2B	n	-	-	-	RAB7A	HGNC:9788	Charcot-Marie-Tooth disease, type 2B, 600882 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
600886	HYPERFERRITINEMIA WITH OR WITHOUT CATARACT	Hyperferritinemia-cataract syndrome, 600886 (3)	Hyperferritinemia-cataract syndrome	n	-	-	-	FTL	HGNC:3999	Hyperferritinemia-cataract syndrome, 600886 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L6	L6	post-infant-lethal
600901	FANCONI ANEMIA, COMPLEMENTATION GROUP E	Fanconi anemia, complementation group E, 600901 (3)	Fanconi anemia, complementation group E	n	-	-	-	FANCE	HGNC:3586	Fanconi anemia, complementation group E, 600901 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
600919	CARDIAC ARRHYTHMIA, ANKYRIN-B-RELATED	Cardiac arrhythmia, ankyrin-B-related, 600919 (3)	Cardiac arrhythmia, ankyrin-B-related	y	CARDIAC ARRHYTHMIA, ANKYRIN-B-RELATED	Description|Clinical Features|Clinical Synopsis	death|deaths	ANK2	HGNC:493	Cardiac arrhythmia, ankyrin-B-related, 600919 (3), Autosomal dominant	Autosomal dominant	n	y	[Sudden cardiac death]	LU	y	-	lethal	lethal	lethal	LU	LU	post-infant-lethal
600919	CARDIAC ARRHYTHMIA, ANKYRIN-B-RELATED	Long QT syndrome 4, 600919 (3)	Long QT syndrome 4	y	CARDIAC ARRHYTHMIA, ANKYRIN-B-RELATED	Description|Clinical Features|Clinical Synopsis	death|deaths	ANK2	HGNC:493	Long QT syndrome 4, 600919 (3), Autosomal dominant	Autosomal dominant	n	y	[Sudden cardiac death]	LU	y	-	lethal	lethal	lethal	LU	LU	post-infant-lethal
600920	VAN DEN ENDE-GUPTA SYNDROME	Van den Ende-Gupta syndrome, 600920 (3)	Van den Ende-Gupta syndrome	y	VAN DEN ENDE-GUPTA SYNDROME; VDEGS	Clinical Features	death|deaths	SCARF2	HGNC:19869	Van den Ende-Gupta syndrome, 600920 (3), Autosomal recessive	Autosomal recessive	y	n	-	-	-	-	ambiguous	ambiguous	ambiguous	-	-	-
600955	PROPROTEIN CONVERTASE 1/3 DEFICIENCY	Endocrinopathy due to proprotein convertase 1/3 deficiency, 600955 (3)	Endocrinopathy due to proprotein convertase 1/3 deficiency	y	PROPROTEIN CONVERTASE 1/3 DEFICIENCY	Clinical Features	died|fatal	PCSK1	HGNC:8743	Endocrinopathy due to proprotein convertase 1/3 deficiency, 600955 (3), Autosomal recessive	Autosomal recessive	y	y	[died at 9 days and 5 months of age]	L2	y	y	lethal	lethal	lethal	L2	L2	pre-infant-lethal
600962	PALMOPLANTAR KERATODERMA, NONEPIDERMOLYTIC	Palmoplantar keratoderma, nonepidermolytic, 600962 (3)	Palmoplantar keratoderma, nonepidermolytic	n	-	-	-	KRT1	HGNC:6412	Palmoplantar keratoderma, nonepidermolytic, 600962 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L2	L2	pre-infant-lethal
600965	DEAFNESS, AUTOSOMAL DOMINANT 6	Deafness, autosomal dominant 6/14/38, 600965 (3)	Deafness, autosomal dominant 6/14/38	n	-	-	-	WFS1	HGNC:12762	Deafness, autosomal dominant 6/14/38, 600965 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L6	L6	post-infant-lethal
600969	EPIPHYSEAL DYSPLASIA, MULTIPLE, 3	Epiphyseal dysplasia, multiple, 3, with or without myopathy, 600969 (3)	Epiphyseal dysplasia, multiple, 3, with or without myopathy	n	-	-	-	COL9A3	HGNC:2219	Epiphyseal dysplasia, multiple, 3, with or without myopathy, 600969 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
600971	DEAFNESS, AUTOSOMAL RECESSIVE 6	Deafness, autosomal recessive 6, 600971 (3)	Deafness, autosomal recessive 6	n	-	-	-	TMIE	HGNC:30800	Deafness, autosomal recessive 6, 600971 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
600972	ACHONDROGENESIS, TYPE IB	Achondrogenesis Ib, 600972 (3)	Achondrogenesis Ib	y	ACHONDROGENESIS, TYPE IB; ACG1B	Description|Clinical Synopsis	death|deaths|lethal|stillbirth|stillbirths|stillborn	SLC26A2	HGNC:10994	Achondrogenesis Ib, 600972 (3), Autosomal recessive	Autosomal recessive	n	y	[Often stillborn]	L1	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L1|L2	L1	pre-infant-lethal
600974	DEAFNESS, AUTOSOMAL RECESSIVE 7	Deafness, autosomal recessive 7, 600974 (3)	Deafness, autosomal recessive 7	n	-	-	-	TMC1	HGNC:16513	Deafness, autosomal recessive 7, 600974 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
600977	CONE-ROD DYSTROPHY 5	Cone-rod dystrophy 5, 600977 (3)	Cone-rod dystrophy 5	n	-	-	-	PITPNM3	HGNC:21043	Cone-rod dystrophy 5, 600977 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
600987	CLEFT PALATE, CARDIAC DEFECTS, AND IMPAIRED INTELLECTUAL DEVELOPMENT	Cleft palate, cardiac defects, and impaired intellectual development, 600987 (3)	Cleft palate, cardiac defects, and impaired intellectual development	n	-	-	-	MEIS2	HGNC:7001	Cleft palate, cardiac defects, and impaired intellectual development, 600987 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
600994	DEAFNESS, AUTOSOMAL DOMINANT 5	Deafness, autosomal dominant 5, 600994 (3)	Deafness, autosomal dominant 5	n	-	-	-	GSDME	HGNC:2810	Deafness, autosomal dominant 5, 600994 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
600995	NEPHROTIC SYNDROME, TYPE 2	Nephrotic syndrome, type 2, 600995 (3)	Nephrotic syndrome, type 2	n	-	-	-	NPHS2	HGNC:13394	Nephrotic syndrome, type 2, 600995 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
601001	EPIDERMOLYSIS BULLOSA SIMPLEX 1D, GENERALIZED, INTERMEDIATE OR SEVERE, AUTOSOMAL RECESSIVE	Epidermolysis bullosa simplex 1D, generalized, intermediate or severe, autosomal recessive, 601001 (3)	Epidermolysis bullosa simplex 1D, generalized, intermediate or severe, autosomal recessive	n	-	-	-	KRT14	HGNC:6416	Epidermolysis bullosa simplex 1D, generalized, intermediate or severe, autosomal recessive, 601001 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L2	L2	pre-infant-lethal
601003	BRODY DISEASE	Brody myopathy, 601003 (3)	Brody myopathy	n	-	-	-	ATP2A1	HGNC:811	Brody myopathy, 601003 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
601005	TIMOTHY SYNDROME	Timothy syndrome, 601005 (3)	Timothy syndrome	y	TIMOTHY SYNDROME; TS	Description|Clinical Features|Clinical Synopsis|Phenotype	lethal|death|deaths|died	CACNA1C	HGNC:1390	Timothy syndrome, 601005 (3), Autosomal dominant	Autosomal dominant	y	y	[Splawski et al. (2004) referred to the disorder reported by Reichenbach et al. (1992) and Marks et al. (1995) as Timothy syndrome (TS) and described 17 affected children. Inheritance was sporadic in all but 1 family in which 2 of 3 sibs were affected. None of the parents was affected. Ten of the 17 children with TS died, and the average age of death was 2.5 years]	L4	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L4|L5	L4	post-infant-lethal
601042	DYSTONIA 9	Dystonia 9, 601042 (3)	Dystonia 9	n	-	-	-	SLC2A1	HGNC:11005	Dystonia 9, 601042 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
601068	EPILEPSY, FAMILIAL ADULT MYOCLONIC, 1	Epilepsy, familial adult myoclonic, 1, 601068 (3)	Epilepsy, familial adult myoclonic, 1	n	-	-	-	SAMD12	HGNC:31750	Epilepsy, familial adult myoclonic, 1, 601068 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
601071	DEAFNESS, AUTOSOMAL RECESSIVE 9	Auditory neuropathy, autosomal recessive, 1, 601071 (3)	Auditory neuropathy, autosomal recessive, 1	n	-	-	-	OTOF	HGNC:8515	Auditory neuropathy, autosomal recessive, 1, 601071 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
601071	DEAFNESS, AUTOSOMAL RECESSIVE 9	Deafness, autosomal recessive 9, 601071 (3)	Deafness, autosomal recessive 9	n	-	-	-	OTOF	HGNC:8515	Deafness, autosomal recessive 9, 601071 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
601072	DEAFNESS, AUTOSOMAL RECESSIVE 8	Deafness, autosomal recessive 8/10, 601072 (3)	Deafness, autosomal recessive 8/10	n	-	-	-	TMPRSS3	HGNC:11877	Deafness, autosomal recessive 8/10, 601072 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
601088	AYME-GRIPP SYNDROME	Ayme-Gripp syndrome, 601088 (3)	Ayme-Gripp syndrome	n	-	-	-	MAF	HGNC:6776	Ayme-Gripp syndrome, 601088 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
601098	CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 1C	Charcot-Marie-Tooth disease, type 1C, 601098 (3)	Charcot-Marie-Tooth disease, type 1C	n	-	-	-	LITAF	HGNC:16841	Charcot-Marie-Tooth disease, type 1C, 601098 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
601104	SUPRANUCLEAR PALSY, PROGRESSIVE, 1	Supranuclear palsy, progressive, 601104 (3)	Supranuclear palsy, progressive	y	SUPRANUCLEAR PALSY, PROGRESSIVE, 1; PSNP1	Clinical Features	death|deaths|died|fatal	MAPT	HGNC:6893	Supranuclear palsy, progressive, 601104 (3), Autosomal dominant	Autosomal dominant	n	y	Nicholl et al. (2003) described a form of PSP characterized by fatal respiratory hypoventilation in 2 sibs from a consanguineous marriage. The authors called the disorder 'tauopathy and respiratory failure.' The 29-year-old pregnant sister developed dyspnea with stridor, and later had a generalized seizure that left her unconscious. Despite therapy, she died after 9 days. Her 30-year-old brother developed cough syncope, dyspnea, and central apnea, which progressed over 40 months, leading to death at age 34 years]	L6	y	-	lethal	lethal	lethal	L6	L6	post-infant-lethal
601110	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Id	Congenital disorder of glycosylation, type Id, 601110 (3)	Congenital disorder of glycosylation, type Id	n	-	-	-	ALG3	HGNC:23056	Congenital disorder of glycosylation, type Id, 601110 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
601144	BRUGADA SYNDROME 1	Brugada syndrome 1, 601144 (3)	Brugada syndrome 1	y	BRUGADA SYNDROME 1; BRGDA1	Description|Clinical Features|Clinical Synopsis|Diagnosis|Phenotype	death|deaths|died	SCN5A	HGNC:10593	Brugada syndrome 1, 601144 (3), Autosomal dominant	Autosomal dominant	y	y	[Brugada syndrome is characterized by an ST segment elevation in the right precordial electrocardiogram leads (so-called type 1 ECG) and a high incidence of sudden death in patients with structurally normal hearts. The syndrome typically manifests during adulthood, with a mean age of sudden death of 41 +/- 15 years, but also occurs in infants and children (summary by Antzelevitch et al., 2005)]	L6	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L4|L5|L6|LU	L4	post-infant-lethal
601152	NEUROPATHY, HEREDITARY MOTOR AND SENSORY, TYPE VIA, WITH OPTIC ATROPHY	Hereditary motor and sensory neuropathy VIA, 601152 (3)	Hereditary motor and sensory neuropathy VIA	n	-	-	-	MFN2	HGNC:16877	Hereditary motor and sensory neuropathy VIA, 601152 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L6	L6	post-infant-lethal
601154	CARDIOMYOPATHY, DILATED, 1E	Cardiomyopathy, dilated, 1E, 601154 (3)	Cardiomyopathy, dilated, 1E	y	CARDIOMYOPATHY, DILATED, 1E; CMD1E	Clinical Features|Clinical Synopsis	death|deaths|died	SCN5A	HGNC:10593	Cardiomyopathy, dilated, 1E, 601154 (3), Autosomal dominant	Autosomal dominant	y	y	[May result in sudden death / Hershberger et al. (2008) (family C.7), in which the asymptomatic proband was diagnosed with CMD at 31 years of age after a screening echocardiogram showed left ventricular enlargement and low-normal ejection fraction... An ICD was placed 1 year later, and he died suddenly at 42 years of age]	L6	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L4|L5|L6|LU	L4	post-infant-lethal
601162	SPASTIC PARAPLEGIA 9A, AUTOSOMAL DOMINANT	Spastic paraplegia 9A, autosomal dominant, 601162 (3)	Spastic paraplegia 9A, autosomal dominant	n	-	-	-	ALDH18A1	HGNC:9722	Spastic paraplegia 9A, autosomal dominant, 601162 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L3|L4	L3	pre-infant-lethal
601186	MICROPHTHALMIA, SYNDROMIC 9	Microphthalmia, isolated, with coloboma 8, 601186 (3)	Microphthalmia, isolated, with coloboma 8	y	MICROPHTHALMIA, SYNDROMIC 9; MCOPS9	Description|Clinical Features|Clinical Synopsis	die|died|lethality|stillborn	STRA6	HGNC:30650	Microphthalmia, isolated, with coloboma 8, 601186 (3), Autosomal recessive	Autosomal recessive	n	y	[The phenotype is variable, ranging from isolated clinical anophthalmia or microphthalmia to complex presentations involving the cardiac, pulmonary, diaphragmatic, and renal systems. At its most severe, infants are born without pulmonary structures and die soon after birth (Marcadier et al., 2015) / Lee et al. (2006) reported a female infant, the only child of a nonconsanguineous Pakistani couple, who was born at term weighing 2,125 g but died 4 hours after birth from respiratory failure]	L2	y	-	lethal	lethal	lethal	L2	L2	pre-infant-lethal
601186	MICROPHTHALMIA, SYNDROMIC 9	Microphthalmia, syndromic 9, 601186 (3)	Microphthalmia, syndromic 9	y	MICROPHTHALMIA, SYNDROMIC 9; MCOPS9	Description|Clinical Features|Clinical Synopsis	die|died|lethality|stillborn	STRA6	HGNC:30650	Microphthalmia, syndromic 9, 601186 (3), Autosomal recessive	Autosomal recessive	n	y	[The phenotype is variable, ranging from isolated clinical anophthalmia or microphthalmia to complex presentations involving the cardiac, pulmonary, diaphragmatic, and renal systems. At its most severe, infants are born without pulmonary structures and die soon after birth (Marcadier et al., 2015) / Lee et al. (2006) reported a female infant, the only child of a nonconsanguineous Pakistani couple, who was born at term weighing 2,125 g but died 4 hours after birth from respiratory failure]	L2	y	-	lethal	lethal	lethal	L2	L2	pre-infant-lethal
601198	HYPOCALCEMIA, AUTOSOMAL DOMINANT 1	Hypocalcemia, autosomal dominant, 601198 (3)	Hypocalcemia, autosomal dominant	n	-	-	-	CASR	HGNC:1514	Hypocalcemia, autosomal dominant, 601198 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	LU	LU	post-infant-lethal
601198	HYPOCALCEMIA, AUTOSOMAL DOMINANT 1	Hypocalcemia, autosomal dominant, with Bartter syndrome, 601198 (3)	Hypocalcemia, autosomal dominant, with Bartter syndrome	n	-	-	-	CASR	HGNC:1514	Hypocalcemia, autosomal dominant, with Bartter syndrome, 601198 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	LU	LU	post-infant-lethal
601200	PLEUROPULMONARY BLASTOMA	Pleuropulmonary blastoma, 601200 (3)	Pleuropulmonary blastoma	y	PLEUROPULMONARY BLASTOMA; PPB	Clinical Features	died	DICER1	HGNC:17098	Pleuropulmonary blastoma, 601200 (3), Autosomal dominant	Autosomal dominant	n	y	[Delahunt et al. (1993) reported a family in which a 27-month-old girl and a 31-month-old boy underwent nephrectomy for cystic nephroma and were free of disease in the contralateral kidney 16 and 14 years later, respectively. Their 28-month-old sister underwent pleuropneumonectomy with postoperative chemotherapy for PPB and died of recurrent disease 9 months later]	L4	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L4|L6	L4	post-infant-lethal
601214	NAXOS DISEASE	Naxos disease, 601214 (3)	Naxos disease	y	NAXOS DISEASE; NXD	Description|Clinical Features|Clinical Synopsis|Phenotype	lethal|death|deaths|died	JUP	HGNC:6207	Naxos disease, 601214 (3), Autosomal recessive	Autosomal recessive	y	y	[Sudden death / In a female infant with generalized epidermolysis, alopecia, and onycholysis who died at day 12 of life due to sepsis and respiratory failure, in whom mutation in 6 genes encoding desmosomal or adherens junction components had been excluded, Pigors et al. (2011) sequenced the candidate gene JUP and identified a homozygous nonsense mutation (Q539X; 173325.0005) for which her unaffected first-cousin parents were heterozygous]	L2	y	-	lethal	lethal	lethal	L2	L2	pre-infant-lethal
601216	DENTAL ANOMALIES AND SHORT STATURE	Dental anomalies and short stature, 601216 (3)	Dental anomalies and short stature	y	DENTAL ANOMALIES AND SHORT STATURE; DASS	Clinical Features	died	LTBP3	HGNC:6716	Dental anomalies and short stature, 601216 (3), Autosomal recessive	Autosomal recessive	n	n	-	-	-	-	ambiguous	ambiguous|lethal	lethal	L4	L4	post-infant-lethal
601238	CEREBELLAR ATAXIA, CAYMAN TYPE	Ataxia, cerebellar, Cayman type, 601238 (3)	Ataxia, cerebellar, Cayman type	n	-	-	-	ATCAY	HGNC:779	Ataxia, cerebellar, Cayman type, 601238 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
601277	ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 4A	Ichthyosis, congenital, autosomal recessive 4A, 601277 (3)	Ichthyosis, congenital, autosomal recessive 4A	n	-	-	-	ABCA12	HGNC:14637	Ichthyosis, congenital, autosomal recessive 4A, 601277 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L2	L2	pre-infant-lethal
601287	MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 6	Muscular dystrophy, limb-girdle, autosomal recessive 6, 601287 (3)	Muscular dystrophy, limb-girdle, autosomal recessive 6	n	-	-	-	SGCD	HGNC:10807	Muscular dystrophy, limb-girdle, autosomal recessive 6, 601287 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
601316	DEAFNESS, AUTOSOMAL DOMINANT 10	Deafness, autosomal dominant 10, 601316 (3)	Deafness, autosomal dominant 10	n	-	-	-	EYA4	HGNC:3522	Deafness, autosomal dominant 10, 601316 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
601317	DEAFNESS, AUTOSOMAL DOMINANT 11	Deafness, autosomal dominant 11, 601317 (3)	Deafness, autosomal dominant 11	n	-	-	-	MYO7A	HGNC:7606	Deafness, autosomal dominant 11, 601317 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
601321	NEUROFIBROMATOSIS-NOONAN SYNDROME	Neurofibromatosis-Noonan syndrome, 601321 (3)	Neurofibromatosis-Noonan syndrome	n	-	-	-	NF1	HGNC:7765	Neurofibromatosis-Noonan syndrome, 601321 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L6	L6	post-infant-lethal
601338	CEREBELLAR ATAXIA, AREFLEXIA, PES CAVUS, OPTIC ATROPHY, AND SENSORINEURAL HEARING LOSS	CAPOS syndrome, 601338 (3)	CAPOS syndrome	n	-	-	-	ATP1A3	HGNC:801	CAPOS syndrome, 601338 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	ambiguous|nonlethal	ambiguous	-	-	-
601358	NICOLAIDES-BARAITSER SYNDROME	Nicolaides-Baraitser syndrome, 601358 (3)	Nicolaides-Baraitser syndrome	n	-	-	-	SMARCA2	HGNC:11098	Nicolaides-Baraitser syndrome, 601358 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
601360	AMELIA, POSTERIOR, WITH PELVIC AND PULMONARY HYPOPLASIA SYNDROME	Amelia, posterior, with pelvic and pulmonary hypoplasia syndrome, 601360 (3)	Amelia, posterior, with pelvic and pulmonary hypoplasia syndrome	y	AMELIA, POSTERIOR, WITH PELVIC AND PULMONARY HYPOPLASIA SYNDROME; PAPPAS	Clinical Features|Clinical Synopsis	miscarriage|miscarriages|stillborn|stillbirth|stillbirths	TBX4	HGNC:11603	Amelia, posterior, with pelvic and pulmonary hypoplasia syndrome, 601360 (3), Autosomal recessive	Autosomal recessive	y	y	[Stillbirth (in some patients)]	L1	y	-	lethal	lethal	lethal	L1|L3	L1	pre-infant-lethal
601369	DEAFNESS, AUTOSOMAL DOMINANT 9	Deafness, autosomal dominant 9, 601369 (3)	Deafness, autosomal dominant 9	n	-	-	-	COCH	HGNC:2180	Deafness, autosomal dominant 9, 601369 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
601382	CHARCOT-MARIE-TOOTH DISEASE, TYPE 4B1	Charcot-Marie-Tooth disease, type 4B1, 601382 (3)	Charcot-Marie-Tooth disease, type 4B1	y	CHARCOT-MARIE-TOOTH DISEASE, TYPE 4B1; CMT4B1	Clinical Synopsis	death|deaths	MTMR2	HGNC:7450	Charcot-Marie-Tooth disease, type 4B1, 601382 (3), Autosomal recessive	Autosomal recessive	n	y	[Death in fourth to fifth decade]	L6	y	-	lethal	lethal	lethal	L6	L6	post-infant-lethal
601386	DEAFNESS, AUTOSOMAL RECESSIVE 12	Deafness, autosomal recessive 12, 601386 (3)	Deafness, autosomal recessive 12	n	-	-	-	CDH23	HGNC:13733	Deafness, autosomal recessive 12, 601386 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
601390	VAN MALDERGEM SYNDROME 1	Van Maldergem syndrome 1, 601390 (3)	Van Maldergem syndrome 1	n	-	-	-	DCHS1	HGNC:13681	Van Maldergem syndrome 1, 601390 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
601399	PLATELET DISORDER, FAMILIAL, WITH ASSOCIATED MYELOID MALIGNANCY	Platelet disorder, familial, with associated myeloid malignancy, 601399 (3)	Platelet disorder, familial, with associated myeloid malignancy	y	PLATELET DISORDER, FAMILIAL, WITH ASSOCIATED MYELOID MALIGNANCY; FPDMM	Clinical Features	died	RUNX1	HGNC:10471	Platelet disorder, familial, with associated myeloid malignancy, 601399 (3), Autosomal dominant	Autosomal dominant	n	y	[Preudhomme et al. (2009) reported 16 individuals with familial platelet disorder from 4 unrelated French families associated with heterozygous mutation in or deletion of the RUNX1 gene (see, e.g., 151385.0010). Among these patients, 7 developed AML, 1 had a T-acute lymphoblastic leukemia, 1 had T-ALL followed by AML, and 1 died of an uncharacterized leukemia]	LU	y	-	lethal	lethal	lethal	LU	LU	post-infant-lethal
601410	DIABETES MELLITUS, TRANSIENT NEONATAL, 1	Diabetes mellitus, transient neonatal 1, 601410 (3)	Diabetes mellitus, transient neonatal 1	n	-	-	-	ZFP57	HGNC:18791	Diabetes mellitus, transient neonatal 1, 601410 (3), Autosomal dominant, Autosomal recessive	Autosomal dominant, Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
601412	DEAFNESS, AUTOSOMAL DOMINANT 7	Deafness, autosomal dominant 7, 601412 (3)	Deafness, autosomal dominant 7	n	-	-	-	LMX1A	HGNC:6653	Deafness, autosomal dominant 7, 601412 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
601414	RETINITIS PIGMENTOSA 18	Retinitis pigmentosa 18, 601414 (3)	Retinitis pigmentosa 18	n	-	-	-	PRPF3	HGNC:17348	Retinitis pigmentosa 18, 601414 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
601419	MYOPATHY, MYOFIBRILLAR, 1	Myopathy, myofibrillar, 1, 601419 (3)	Myopathy, myofibrillar, 1	y	MYOPATHY, MYOFIBRILLAR, 1; MFM1	Clinical Features|Phenotype	death|deaths|died	DES	HGNC:2770	Myopathy, myofibrillar, 1, 601419 (3), Autosomal dominant, Autosomal recessive	Autosomal dominant, Autosomal recessive	y	y	[In a female patient who had recurrent episodes of syncope from infancy and an aggressive course leading to the devastation of cardiac, skeletal, and smooth musculature, and death from cardiac failure at age 20 years, Pinol-Ripoll et al. (2009) identified homozygosity for the same 21-bp deletion in the DES gene that was previously found by Munoz-Marmol et al. (1998)]	L6	y	-	lethal	lethal	lethal	L5|L6|LU	L5	post-infant-lethal
601455	CHARCOT-MARIE-TOOTH DISEASE, TYPE 4D	Charcot-Marie-Tooth disease, type 4D, 601455 (3)	Charcot-Marie-Tooth disease, type 4D	n	-	-	-	NDRG1	HGNC:7679	Charcot-Marie-Tooth disease, type 4D, 601455 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
601457	SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-NEGATIVE, NK CELL-POSITIVE	Severe combined immunodeficiency, B cell-negative, 601457 (3)	Severe combined immunodeficiency, B cell-negative	y	SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-NEGATIVE, NK CELL-POSITIVE	Description|Clinical Features|Clinical Synopsis	die|died|fatal|death|deaths	RAG1	HGNC:9831	Severe combined immunodeficiency, B cell-negative, 601457 (3), Autosomal recessive	Autosomal recessive	y	y	[Presents at 2 to 3 months of age / Death within several months if untreated]	L3	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L3|L4	L3	pre-infant-lethal
601457	SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-NEGATIVE, NK CELL-POSITIVE	Severe combined immunodeficiency, B cell-negative, 601457 (3)	Severe combined immunodeficiency, B cell-negative	y	SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-NEGATIVE, NK CELL-POSITIVE	Description|Clinical Features|Clinical Synopsis	die|died|fatal|death|deaths	RAG2	HGNC:9832	Severe combined immunodeficiency, B cell-negative, 601457 (3), Autosomal recessive	Autosomal recessive	y	y	[Presents at 2 to 3 months of age / Death within several months if untreated]	L3	y	-	lethal	ambiguous|lethal	lethal	L3	L3	pre-infant-lethal
601462	MYASTHENIC SYNDROME, CONGENITAL, 1A, SLOW-CHANNEL	Myasthenic syndrome, congenital, 1A, slow-channel, 601462 (3)	Myasthenic syndrome, congenital, 1A, slow-channel	n	-	-	-	CHRNA1	HGNC:1955	Myasthenic syndrome, congenital, 1A, slow-channel, 601462 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L1	L1	pre-infant-lethal
601472	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2D	Charcot-Marie-Tooth disease, type 2D, 601472 (3)	Charcot-Marie-Tooth disease, type 2D	n	-	-	-	GARS1	HGNC:4162	Charcot-Marie-Tooth disease, type 2D, 601472 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
601492	MUCOPOLYSACCHARIDOSIS, TYPE IX	Mucopolysaccharidosis type IX, 601492 (3)	Mucopolysaccharidosis type IX	n	-	-	-	HYAL1	HGNC:5320	Mucopolysaccharidosis type IX, 601492 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
601493	CARDIOMYOPATHY, DILATED, 1C, WITH OR WITHOUT LEFT VENTRICULAR NONCOMPACTION	Cardiomyopathy, dilated, 1C, with or without LVNC, 601493 (3)	Cardiomyopathy, dilated, 1C, with or without LVNC	y	CARDIOMYOPATHY, DILATED, 1C, WITH OR WITHOUT LEFT VENTRICULAR NONCOMPACTION; CMD1C	Clinical Features|Clinical Synopsis|Phenotype	death|deaths|died	LDB3	HGNC:15710	Cardiomyopathy, dilated, 1C, with or without LVNC, 601493 (3), Autosomal dominant	Autosomal dominant	y	y	[Sudden cardiac death (in some patients).A maternal aunt died at 10 years of age of indistinct cardiac disease ]	L4	y	y	lethal	lethal|nonlethal	lethal|nonlethal	L4|LU	L4	post-infant-lethal
601493	CARDIOMYOPATHY, DILATED, 1C, WITH OR WITHOUT LEFT VENTRICULAR NONCOMPACTION	Cardiomyopathy, hypertrophic, 24, 601493 (3)	Cardiomyopathy, hypertrophic, 24	y	CARDIOMYOPATHY, DILATED, 1C, WITH OR WITHOUT LEFT VENTRICULAR NONCOMPACTION; CMD1C	Clinical Features|Clinical Synopsis|Phenotype	death|deaths|died	LDB3	HGNC:15710	Cardiomyopathy, hypertrophic, 24, 601493 (3), Autosomal dominant	Autosomal dominant	y	y	[Sudden cardiac death (in some patients)]	LU	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L4|LU	L4	post-infant-lethal
601493	CARDIOMYOPATHY, DILATED, 1C, WITH OR WITHOUT LEFT VENTRICULAR NONCOMPACTION	Left ventricular noncompaction 3, 601493 (3)	Left ventricular noncompaction 3	y	CARDIOMYOPATHY, DILATED, 1C, WITH OR WITHOUT LEFT VENTRICULAR NONCOMPACTION; CMD1C	Clinical Features|Clinical Synopsis|Phenotype	death|deaths|died	LDB3	HGNC:15710	Left ventricular noncompaction 3, 601493 (3), Autosomal dominant	Autosomal dominant	y	y	[Sudden cardiac death (in some patients)]	LU	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L4|LU	L4	post-infant-lethal
601494	CARDIOMYOPATHY, DILATED, 1D	Cardiomyopathy, dilated, 1D, 601494 (3)	Cardiomyopathy, dilated, 1D	y	CARDIOMYOPATHY, DILATED, 1D; CMD1D	Clinical Features|Clinical Synopsis|Phenotype	death|deaths|died	TNNT2	HGNC:11949	Cardiomyopathy, dilated, 1D, 601494 (3), Autosomal dominant	Autosomal dominant	n	y	[Kamisago et al. (2000) studied families with dilated cardiomyopathy. In 1 family (family C), sudden death occurred in a 26- and a 27-year-old as well as in a 1- and an 8-month-old, both of whom had a diagnosis of infantile cardiomyopathy]	L3	y	-	lethal	ambiguous|lethal	lethal	L3|L5	L3	pre-infant-lethal
601494	CARDIOMYOPATHY, DILATED, 1D	Left ventricular noncompaction 6, 601494 (3)	Left ventricular noncompaction 6	y	CARDIOMYOPATHY, DILATED, 1D; CMD1D	Clinical Features|Clinical Synopsis|Phenotype	death|deaths|died	TNNT2	HGNC:11949	Left ventricular noncompaction 6, 601494 (3), Autosomal dominant	Autosomal dominant	n	y	[Kamisago et al. (2000) studied families with dilated cardiomyopathy. In 1 family (family C), sudden death occurred in a 26- and a 27-year-old as well as in a 1- and an 8-month-old, both of whom had a diagnosis of infantile cardiomyopathy]	L3	y	-	lethal	ambiguous|lethal	lethal	L3|L5	L3	pre-infant-lethal
601518	PROSTATE CANCER, HEREDITARY, 1	Prostate cancer 1, 601518 (3)	Prostate cancer 1	n	-	-	-	RNASEL	HGNC:10050	Prostate cancer 1, 601518 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
601536	ATHABASKAN BRAINSTEM DYSGENESIS SYNDROME	Athabaskan brainstem dysgenesis syndrome, 601536 (3)	Athabaskan brainstem dysgenesis syndrome	y	ATHABASKAN BRAINSTEM DYSGENESIS SYNDROME; ABDS	Description|Clinical Features	death|deaths|fatal	HOXA1	HGNC:5099	Athabaskan brainstem dysgenesis syndrome, 601536 (3), Autosomal recessive	Autosomal recessive	y	y	[Unique to ABDS are central hypoventilation, often resulting in early death, facial weakness, and more severe cognitive deficits / In another family, a sib's death was attributed to sudden infant death syndrome (SIDS), suggesting that the death was probably caused by the central hypoventilation of Athabaskan brainstem dysgenesis]	LU	y	y	lethal	lethal	lethal	LU	LU	post-infant-lethal
601536	ATHABASKAN BRAINSTEM DYSGENESIS SYNDROME	Bosley-Salih-Alorainy syndrome, 601536 (3)	Bosley-Salih-Alorainy syndrome	y	ATHABASKAN BRAINSTEM DYSGENESIS SYNDROME; ABDS	Description|Clinical Features	death|deaths|fatal	HOXA1	HGNC:5099	Bosley-Salih-Alorainy syndrome, 601536 (3), Autosomal recessive	Autosomal recessive	y	y	[Unique to ABDS are central hypoventilation, often resulting in early death, facial weakness, and more severe cognitive deficits / In another family, a sib's death was attributed to sudden infant death syndrome (SIDS), suggesting that the death was probably caused by the central hypoventilation of Athabaskan brainstem dysgenesis]	LU	y	y	lethal	lethal	lethal	LU	LU	post-infant-lethal
601539	PEROXISOME BIOGENESIS DISORDER 1B	Peroxisome biogenesis disorder 1B (NALD/IRD), 601539 (3)	Peroxisome biogenesis disorder 1B (NALD/IRD)	y	PEROXISOME BIOGENESIS DISORDER 1B; PBD1B	Description|Clinical Features	death|deaths|fatal	PEX1	HGNC:8850	Peroxisome biogenesis disorder 1B (NALD/IRD), 601539 (3), Autosomal recessive	Autosomal recessive	y	y	[results in death in the first year of life]	L3	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L3	L3	pre-infant-lethal
601543	DEAFNESS, AUTOSOMAL DOMINANT 12	Deafness, autosomal dominant 8/12, 601543 (3)	Deafness, autosomal dominant 8/12	n	-	-	-	TECTA	HGNC:11720	Deafness, autosomal dominant 8/12, 601543 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
601544	DEAFNESS, AUTOSOMAL DOMINANT 3A	Deafness, autosomal dominant 3A, 601544 (3)	Deafness, autosomal dominant 3A	n	-	-	-	GJB2	HGNC:4284	Deafness, autosomal dominant 3A, 601544 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	ambiguous|nonlethal	ambiguous	-	-	-
601547	CATARACT 3, MULTIPLE TYPES	Cataract 3, multiple types, 601547 (3)	Cataract 3, multiple types	n	-	-	-	CRYBB2	HGNC:2398	Cataract 3, multiple types, 601547 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
601552	FACIAL DYSMORPHISM, LENS DISLOCATION, ANTERIOR SEGMENT ABNORMALITIES, AND SPONTANEOUS FILTERING BLEBS	Traboulsi syndrome, 601552 (3)	Traboulsi syndrome	n	-	-	-	ASPH	HGNC:757	Traboulsi syndrome, 601552 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
601553	HYPOTRICHOSIS, CONGENITAL, WITH JUVENILE MACULAR DYSTROPHY	Hypotrichosis, congenital, with juvenile macular dystrophy, 601553 (3)	Hypotrichosis, congenital, with juvenile macular dystrophy	n	-	-	-	CDH3	HGNC:1762	Hypotrichosis, congenital, with juvenile macular dystrophy, 601553 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
601559	STUVE-WIEDEMANN SYNDROME 1	Stuve-Wiedemann syndrome/Schwartz-Jampel type 2 syndrome, 601559 (3)	Stuve-Wiedemann syndrome/Schwartz-Jampel type 2 syndrome	y	STUVE-WIEDEMANN SYNDROME 1; STWS1	Description|Clinical Features|Clinical Synopsis	death|deaths|died|lethal	LIFR	HGNC:6597	Stuve-Wiedemann syndrome/Schwartz-Jampel type 2 syndrome, 601559 (3), Autosomal recessive	Autosomal recessive	y	y	[Stuve and Wiedemann (1971) reported 2 sisters and a first-cousin male with congenital bowing of the long bones. Other features included short stature, camptodactyly with ulnar deviation, and contractures of the elbows and fingers. Radiographically, the long bones were short and thick with large metaphyses. Although the clavicles were normal, there was a broad coracoid process bilaterally, long scapulae, and relatively thin ribs. The pubic and ischial bones were broad and the ilia relatively small. One patient died after 10 days of life from respiratory insufficiency with apnea; her sister developed hyperthermia with temperatures as high as 41 degrees centigrade and died on day 5 of life]	L2	y	-	lethal	lethal	lethal	L2	L2	pre-infant-lethal
601596	CHARCOT-MARIE-TOOTH DISEASE, TYPE 4C	Charcot-Marie-Tooth disease, type 4C, 601596 (3)	Charcot-Marie-Tooth disease, type 4C	y	CHARCOT-MARIE-TOOTH DISEASE, TYPE 4C; CMT4C	Clinical Features	died	SH3TC2	HGNC:29427	Charcot-Marie-Tooth disease, type 4C, 601596 (3), Autosomal recessive	Autosomal recessive	y	y	[Colomer et al. (2006) reported detailed clinical features of 15 individuals from European Gypsy families with CMT4C and homozygous for the R1109X mutation (608206.0006)... Two boys were hypotonic from birth, never achieved ambulation, had severe scoliosis, and remained wheelchair-bound and totally disabled with generalized muscle weakness and wasting. One died at age 22 years]	L6	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L6	L6	post-infant-lethal
601606	TRICHOEPITHELIOMA, MULTIPLE FAMILIAL, 1	Trichoepithelioma, multiple familial, 1, 601606 (3)	Trichoepithelioma, multiple familial, 1	n	-	-	-	CYLD	HGNC:2584	Trichoepithelioma, multiple familial, 1, 601606 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	ambiguous|nonlethal	ambiguous	-	-	-
601631	ANTERIOR SEGMENT DYSGENESIS 3	Anterior segment dysgenesis 3, multiple subtypes, 601631 (3)	Anterior segment dysgenesis 3, multiple subtypes	n	-	-	-	FOXC1	HGNC:3800	Anterior segment dysgenesis 3, multiple subtypes, 601631 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
601650	PHEOCHROMOCYTOMA/PARAGANGLIOMA SYNDROME 2	Pheochromocytoma/paraganglioma syndrome 2, 601650 (3)	Pheochromocytoma/paraganglioma syndrome 2	n	-	-	-	SDHAF2	HGNC:26034	Pheochromocytoma/paraganglioma syndrome 2, 601650 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
601675	TRICHOTHIODYSTROPHY 1, PHOTOSENSITIVE	Trichothiodystrophy 1, photosensitive, 601675 (3)	Trichothiodystrophy 1, photosensitive	y	TRICHOTHIODYSTROPHY 1, PHOTOSENSITIVE; TTD1	Clinical Features|Phenotype	death|deaths|died	ERCC2	HGNC:3434	Trichothiodystrophy 1, photosensitive, 601675 (3), Autosomal recessive	Autosomal recessive	y	y	[Botta et al. (1998) determined the mutations and the pattern of inheritance of the XPD alleles in 11 cases of trichothiodystrophy identified in Italy... Seven patients were still alive at ages 4 to 30 years; the 4 patients who died during early infancy showed severe physical and mental retardation and suffered from frequent respiratory infections.]	L3	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L3	L3	pre-infant-lethal
601678	BARTTER SYNDROME, TYPE 1, ANTENATAL	Bartter syndrome, type 1, 601678 (3)	Bartter syndrome, type 1	y	BARTTER SYNDROME, TYPE 1, ANTENATAL; BARTS1	Clinical Features	died	SLC12A1	HGNC:10910	Bartter syndrome, type 1, 601678 (3), Autosomal recessive	Autosomal recessive	y	y	[Li et al. (2016) reported 2 African American brothers with BARTS1 associated with hyperparathyroidism, hypercalcemia, hypercalciuria, and nephrocalcinosis. Both pregnancies were complicated by polyhydramnios and premature delivery. The proband's brother died of multiorgan failure at 9 weeks, and postmortem examination showed multigland parathyroid hyperplasia]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
601680	ARTHROGRYPOSIS, DISTAL, TYPE 2B1	Arthrogryposis, distal, type 2B1, 601680 (3)	Arthrogryposis, distal, type 2B1	n	-	-	-	TNNI2	HGNC:11946	Arthrogryposis, distal, type 2B1, 601680 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
601705	T-CELL IMMUNODEFICIENCY, CONGENITAL ALOPECIA, AND NAIL DYSTROPHY	T-cell immunodeficiency, congenital alopecia, and nail dystrophy, 601705 (3)	T-cell immunodeficiency, congenital alopecia, and nail dystrophy	y	T-CELL IMMUNODEFICIENCY, CONGENITAL ALOPECIA, AND NAIL DYSTROPHY; TIDAND	Clinical Features|Clinical Synopsis	died|death|deaths	FOXN1	HGNC:12765	T-cell immunodeficiency, congenital alopecia, and nail dystrophy, 601705 (3), Autosomal recessive	Autosomal recessive	y	y	[Chou et al. (2014) reported an infant, born of consanguineous Lebanese parents, with TIDAND. She presented at 1 month of age with a diffuse eczematous rash, erythroderma, alopecia, and severe diarrhea. Laboratory studies showed CD3+ T-cell lymphopenia with most cells having a CD45RO+ memory phenotype and decreased numbers of CD45RA+ recent thymic emigrants. Total B and NK cell numbers were normal, but B cell memory cells were severely decreased. Lymphocyte proliferation to anti-CD3 and PHA was absent, but response to PMA and ionomycin was normal. Prior to the genetic diagnosis, she was treated with hematopoietic stem cell transplantation at age 5 months, but she died from complications]	L3	y	-	lethal	lethal	lethal	L3|L4	L3	pre-infant-lethal
601709	QUEBEC PLATELET DISORDER	Quebec platelet disorder, 601709 (3)	Quebec platelet disorder	n	-	-	-	PLAU	HGNC:9052	Quebec platelet disorder, 601709 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
601718	RETINITIS PIGMENTOSA 19	Retinitis pigmentosa 19, 601718 (3)	Retinitis pigmentosa 19	n	-	-	-	ABCA4	HGNC:34	Retinitis pigmentosa 19, 601718 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	ambiguous|nonlethal	ambiguous	-	-	-
601776	EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE, 1	Ehlers-Danlos syndrome, musculocontractural type 1, 601776 (3)	Ehlers-Danlos syndrome, musculocontractural type 1	y	EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE, 1; EDSMC1	Clinical Features	died	CHST14	HGNC:24464	Ehlers-Danlos syndrome, musculocontractural type 1, 601776 (3), Autosomal recessive	Autosomal recessive	y	y	[Janecke et al. (2001) described 2 male sibs, born to fourth-cousin Austrian parents, with dysmorphic facies.... One child had an atrial septal defect, mild coarctation of the aorta, and a horseshoe kidney. This child died shortly after birth from respiratory failure]	L2	y	-	lethal	lethal	lethal	L2	L2	pre-infant-lethal
601777	CONE-ROD DYSTROPHY 6	Cone-rod dystrophy 6, 601777 (3)	Cone-rod dystrophy 6	n	-	-	-	GUCY2D	HGNC:4689	Cone-rod dystrophy 6, 601777 (3), Autosomal dominant, Autosomal recessive	Autosomal dominant, Autosomal recessive	-	-	-	-	-	-	nonlethal	ambiguous|nonlethal	ambiguous	-	-	-
601780	CEROID LIPOFUSCINOSIS, NEURONAL, 6A	Ceroid lipofuscinosis, neuronal, 6A, 601780 (3)	Ceroid lipofuscinosis, neuronal, 6A	y	CEROID LIPOFUSCINOSIS, NEURONAL, 6A; CLN6A	Clinical Features|Clinical Synopsis	death|deaths	CLN6	HGNC:2077	Ceroid lipofuscinosis, neuronal, 6A, 601780 (3), Autosomal recessive	Autosomal recessive	y	y	[Early death / Sharp et al. (2003) reported the clinical features of 26 families from 9 different countries with CLN6A confirmed by genetic analysis. Some of the patients and mutations had previously been reported. Disease onset ranged from 1.5 to 5 years of age. Seizures occurred between 3 and 6 years of age, although some had later onset. Progressive visual failure was observed between 3 and 6 years, loss of ambulation between 2 and 8 years, and death between 9 and 16.8 years]	L4	y	-	lethal	lethal	lethal	L4|L6	L4	post-infant-lethal
601812	PREMATURE AGING SYNDROME, PENTTINEN TYPE	Premature aging syndrome, Penttinen type, 601812 (3)	Premature aging syndrome, Penttinen type	y	PREMATURE AGING SYNDROME, PENTTINEN TYPE; PENTT	Clinical Features	died	PDGFRB	HGNC:8804	Premature aging syndrome, Penttinen type, 601812 (3), Autosomal dominant	Autosomal dominant	y	y	[Zufferey et al. (2013) reported 2 unrelated patients, a 15-year-old girl of North Vietnamese and Chinese ancestry and a 20-year-old French man, who exhibited a progeroid syndrome of the Penttinen type.... Skin retraction and joint contractures developed during adolescence, and the French patient died at age 20 years due to restrictive respiratory insufficiency and cachexia]	L6	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L3|L6	L3	pre-infant-lethal
601813	EXUDATIVE VITREORETINOPATHY 4	Exudative vitreoretinopathy 4, 601813 (3)	Exudative vitreoretinopathy 4	n	-	-	-	LRP5	HGNC:6697	Exudative vitreoretinopathy 4, 601813 (3), Autosomal dominant, Autosomal recessive	Autosomal dominant, Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
601815	PHOSPHOGLYCERATE DEHYDROGENASE DEFICIENCY	Phosphoglycerate dehydrogenase deficiency, 601815 (3)	Phosphoglycerate dehydrogenase deficiency	n	-	-	-	PHGDH	HGNC:8923	Phosphoglycerate dehydrogenase deficiency, 601815 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L1	L1	pre-infant-lethal
601820	HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 2	Hyperinsulinemic hypoglycemia, familial, 2, 601820 (3)	Hyperinsulinemic hypoglycemia, familial, 2	n	-	-	-	KCNJ11	HGNC:6257	Hyperinsulinemic hypoglycemia, familial, 2, 601820 (3), Autosomal dominant, Autosomal recessive	Autosomal dominant, Autosomal recessive	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L3	L3	pre-infant-lethal
601846	MYOPATHY WITH RIMMED UBIQUITIN-POSITIVE AUTOPHAGIC VACUOLATION, AUTOSOMAL DOMINANT	Myopathy with rimmed ubiquitin-positive autophagic vacuolation, autosomal dominant, 601846 (3)	Myopathy with rimmed ubiquitin-positive autophagic vacuolation, autosomal dominant	y	MYOPATHY WITH RIMMED UBIQUITIN-POSITIVE AUTOPHAGIC VACUOLATION, AUTOSOMAL DOMINANT; MRUPAV	Clinical Features	death|deaths|died	PLIN4	HGNC:29393	Myopathy with rimmed ubiquitin-positive autophagic vacuolation, autosomal dominant, 601846 (3), Autosomal dominant	Autosomal dominant	y	y	[Five patients died at a median age of 74 years,]	L6	y	-	lethal	lethal	lethal	L6	L6	post-infant-lethal
601847	CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC, 2	Cholestasis, progressive familial intrahepatic 2, 601847 (3)	Cholestasis, progressive familial intrahepatic 2	y	CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC, 2; PFIC2	Clinical Features	died	ABCB11	HGNC:42	Cholestasis, progressive familial intrahepatic 2, 601847 (3), Autosomal recessive	Autosomal recessive	y	y	[Sandor et al. (1976) described brother and sister with 'giant cell hepatitis' in infancy. The male died of a rare primary hepatic cancer; the female died of cirrhosis and hepatic coma]	LU	y	-	lethal	lethal|nonlethal	lethal|nonlethal	LU	LU	post-infant-lethal
601859	AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME	Autoimmune lymphoproliferative syndrome, type IA, 601859 (3)	Autoimmune lymphoproliferative syndrome, type IA	y	AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME; ALPS	Clinical Features|Phenotype	died|death|deaths	FAS	HGNC:11920	Autoimmune lymphoproliferative syndrome, type IA, 601859 (3), Autosomal dominant	Autosomal dominant	n	y	[Drappa et al. (1996) provided follow-up on 2 patients reported by Canale and Smith (1967). One patient was a 43-year-old woman who had continued lymphadenopathy and hypergammaglobulinemia throughout her life. She also had several neoplastic lesions, including a breast adenoma, 3 thyroid adenomas, and 2 basal cell carcinomas. Another patient was a 43-year-old man whose lymphadenopathy had gradually diminished during adolescence and was mild during adulthood. He died of hepatocellular carcinoma associated with hepatitis C infection.]	L6	y	-	lethal	lethal	lethal	L6	L6	post-infant-lethal
601859	AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME	Autoimmune lymphoproliferative syndrome, type IB, 601859 (3)	Autoimmune lymphoproliferative syndrome, type IB	y	AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME; ALPS	Clinical Features|Phenotype	died|death|deaths	FASLG	HGNC:11936	Autoimmune lymphoproliferative syndrome, type IB, 601859 (3), Autosomal dominant	Autosomal dominant	n	y	[Drappa et al. (1996) provided follow-up on 2 patients reported by Canale and Smith (1967). One patient was a 43-year-old woman who had continued lymphadenopathy and hypergammaglobulinemia throughout her life. She also had several neoplastic lesions, including a breast adenoma, 3 thyroid adenomas, and 2 basal cell carcinomas. Another patient was a 43-year-old man whose lymphadenopathy had gradually diminished during adolescence and was mild during adulthood. He died of hepatocellular carcinoma associated with hepatitis C infection.]	L6	y	-	lethal	lethal	lethal	L6	L6	post-infant-lethal
601868	DEAFNESS, AUTOSOMAL DOMINANT 13	Deafness, autosomal dominant 13, 601868 (3)	Deafness, autosomal dominant 13	n	-	-	-	COL11A2	HGNC:2187	Deafness, autosomal dominant 13, 601868 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L2	L2	pre-infant-lethal
601869	DEAFNESS, AUTOSOMAL RECESSIVE 15	Deafness, autosomal recessive 15, 601869 (3)	Deafness, autosomal recessive 15	n	-	-	-	GIPC3	HGNC:18183	Deafness, autosomal recessive 15, 601869 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
601885	CATARACT 14, MULTIPLE TYPES	Cataract 14, multiple types, 601885 (3)	Cataract 14, multiple types	n	-	-	-	GJA3	HGNC:4277	Cataract 14, multiple types, 601885 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
601894	GLOMERULOPATHY WITH FIBRONECTIN DEPOSITS 2	Glomerulopathy with fibronectin deposits 2, 601894 (3)	Glomerulopathy with fibronectin deposits 2	y	GLOMERULOPATHY WITH FIBRONECTIN DEPOSITS 2; GFND2	Clinical Features	died	FN1	HGNC:3778	Glomerulopathy with fibronectin deposits 2, 601894 (3), Autosomal dominant	Autosomal dominant	y	y	[Mazzucco et al. (1992) described an Italian mother and daughter with slowly progressive nephrotic syndrome. Proteinuria was first detected at ages 25 and 11 years, respectively.... A paternal aunt of the mother died at 37 years of nephropathy]	L6	n	y	lethal	lethal|nonlethal	lethal|nonlethal	L6	L6	post-infant-lethal
601952	KERATOSIS LINEARIS WITH ICHTHYOSIS CONGENITA AND SCLEROSING KERATODERMA	Keratosis linearis with ichthyosis congenita and sclerosing keratoderma, 601952 (3)	Keratosis linearis with ichthyosis congenita and sclerosing keratoderma	n	-	-	-	POMP	HGNC:20330	Keratosis linearis with ichthyosis congenita and sclerosing keratoderma, 601952 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
601954	MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 7	Muscular dystrophy, limb-girdle, autosomal recessive 7, 601954 (3)	Muscular dystrophy, limb-girdle, autosomal recessive 7	n	-	-	-	TCAP	HGNC:11610	Muscular dystrophy, limb-girdle, autosomal recessive 7, 601954 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L6	L6	post-infant-lethal
602014	HYPOMAGNESEMIA 1, INTESTINAL	Hypomagnesemia 1, intestinal, 602014 (3)	Hypomagnesemia 1, intestinal	y	HYPOMAGNESEMIA 1, INTESTINAL; HOMG1	Description|Clinical Features|Phenotype	fatal|died	TRPM6	HGNC:17995	Hypomagnesemia 1, intestinal, 602014 (3), Autosomal recessive	Autosomal recessive	y	y	[Untreated, the disease may be fatal or lead to severe neurologic damage / Vainsel et al. (1970) described a 5-month-old boy who had convulsions and persistent tetany, associated with hypomagnesemia and hypocalcemia... Two brothers of the proband had died of a clinically similar disorder and 3 of 4 surviving brothers had convulsions]	LU	y	y	lethal	lethal	lethal	LU	LU	post-infant-lethal
602032	ECTODERMAL DYSPLASIA 4, HAIR/NAIL TYPE	Ectodermal dysplasia 4, hair/nail type, 602032 (3)	Ectodermal dysplasia 4, hair/nail type	n	-	-	-	KRT85	HGNC:6462	Ectodermal dysplasia 4, hair/nail type, 602032 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
602066	CONVULSIONS, FAMILIAL INFANTILE, WITH PAROXYSMAL CHOREOATHETOSIS	Convulsions, familial infantile, with paroxysmal choreoathetosis, 602066 (3)	Convulsions, familial infantile, with paroxysmal choreoathetosis	n	-	-	-	PRRT2	HGNC:30500	Convulsions, familial infantile, with paroxysmal choreoathetosis, 602066 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
602078	FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, 2	Fibrosis of extraocular muscles, congenital, 2, 602078 (3)	Fibrosis of extraocular muscles, congenital, 2	n	-	-	-	PHOX2A	HGNC:691	Fibrosis of extraocular muscles, congenital, 2, 602078 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
602079	TRIMETHYLAMINURIA	Trimethylaminuria, 602079 (3)	Trimethylaminuria	n	-	-	-	FMO3	HGNC:3771	Trimethylaminuria, 602079 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
602081	SPEECH-LANGUAGE DISORDER 1	Speech-language disorder-1, 602081 (3)	Speech-language disorder-1	n	-	-	-	FOXP2	HGNC:13875	Speech-language disorder-1, 602081 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
602082	CORNEAL DYSTROPHY, THIEL-BEHNKE TYPE	Corneal dystrophy, Thiel-Behnke type, 602082 (3)	Corneal dystrophy, Thiel-Behnke type	n	-	-	-	TGFBI	HGNC:11771	Corneal dystrophy, Thiel-Behnke type, 602082 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
602083	USHER SYNDROME, TYPE IF	Usher syndrome, type 1F, 602083 (3)	Usher syndrome, type 1F	n	-	-	-	PCDH15	HGNC:14674	Usher syndrome, type 1F, 602083 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
602088	NEPHRONOPHTHISIS 2	Nephronophthisis 2, infantile, 602088 (3)	Nephronophthisis 2, infantile	y	NEPHRONOPHTHISIS 2; NPHP2	Clinical Features|Clinical Synopsis	death|deaths|died	INVS	HGNC:17870	Nephronophthisis 2, infantile, 602088 (3), Autosomal recessive	Autosomal recessive	y	y	[Neonatal death secondary to pulmonary insufficiency]	L2	y	-	lethal	lethal	lethal	L2	L2	pre-infant-lethal
602092	DEAFNESS, AUTOSOMAL RECESSIVE 18A	Deafness, autosomal recessive 18A, 602092 (3)	Deafness, autosomal recessive 18A	n	-	-	-	USH1C	HGNC:12597	Deafness, autosomal recessive 18A, 602092 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
602093	CONE DYSTROPHY 3	Cone dystrophy-3, 602093 (3)	Cone dystrophy-3	n	-	-	-	GUCA1A	HGNC:4678	Cone dystrophy-3, 602093 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
602093	CONE DYSTROPHY 3	Cone-rod dystrophy 14, 602093 (3)	Cone-rod dystrophy 14	n	-	-	-	GUCA1A	HGNC:4678	Cone-rod dystrophy 14, 602093 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
602099	AMYOTROPHIC LATERAL SCLEROSIS 5, JUVENILE	Amyotrophic lateral sclerosis 5, juvenile, 602099 (3)	Amyotrophic lateral sclerosis 5, juvenile	n	-	-	-	SPG11	HGNC:11226	Amyotrophic lateral sclerosis 5, juvenile, 602099 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
602111	SPONDYLOEPIMETAPHYSEAL DYSPLASIA, MISSOURI TYPE	Metaphyseal anadysplasia 1, 602111 (3)	Metaphyseal anadysplasia 1	n	-	-	-	MMP13	HGNC:7159	Metaphyseal anadysplasia 1, 602111 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
602271	SPONDYLOMETAPHYSEAL DYSPLASIA, AXIAL	Spondylometaphyseal dysplasia, axial, 602271 (3)	Spondylometaphyseal dysplasia, axial	n	-	-	-	CFAP410	HGNC:1260	Spondylometaphyseal dysplasia, axial, 602271 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
602342	PIERPONT SYNDROME	Pierpont syndrome, 602342 (3)	Pierpont syndrome	n	-	-	-	TBL1XR1	HGNC:29529	Pierpont syndrome, 602342 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
602347	CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC, 3	Cholestasis, progressive familial intrahepatic 3, 602347 (3)	Cholestasis, progressive familial intrahepatic 3	n	-	-	-	ABCB4	HGNC:45	Cholestasis, progressive familial intrahepatic 3, 602347 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	ambiguous|nonlethal	ambiguous	-	-	-
602361	GRACILE BONE DYSPLASIA	Gracile bone dysplasia, 602361 (3)	Gracile bone dysplasia	y	GRACILE BONE DYSPLASIA; GCLEB	Description|Clinical Features|Clinical Synopsis	lethal|death|deaths|died|fatal|stillborn	FAM111A	HGNC:24725	Gracile bone dysplasia, 602361 (3), Autosomal dominant	Autosomal dominant	y	y	[Death in utero or in early infancy is common]	L1	y	-	lethal	lethal	lethal	L1|L6	L1	pre-infant-lethal
602390	HEMOCHROMATOSIS, TYPE 2A	Hemochromatosis, type 2A, 602390 (3)	Hemochromatosis, type 2A	y	HEMOCHROMATOSIS, TYPE 2A; HFE2A	Description|Clinical Features|Phenotype	death|deaths|died|fatal	HJV	HGNC:4887	Hemochromatosis, type 2A, 602390 (3), Autosomal recessive	Autosomal recessive	y	y	[Cazzola et al. (1998) reported molecular studies in 2 Italian families with juvenile hemochromatosis, 1 of which was reported by Cazzola et al. (1983). Both families had an affected brother and sister. Of the 4 affected individuals, 3 presented with hypogonadotropic hypogonadism at 14 to 21 years of age. The affected male of 1 family presented with cardiac failure at 20 years of age and died at 21 years of age with congestive cardiomyopathy]	L6	y	-	lethal	lethal	lethal	L6	L6	post-infant-lethal
602398	DESMOSTEROLOSIS	Desmosterolosis, 602398 (3)	Desmosterolosis	y	DESMOSTEROLOSIS	Clinical Features	lethal	DHCR24	HGNC:2859	Desmosterolosis, 602398 (3), Autosomal recessive	Autosomal recessive	y	y	[FitzPatrick et al. (1998) reported the case of an infant with multiple lethal congenital malformations and osteosclerosis in whom there was generalized accumulation of an abnormal neutral sterol and a relative deficiency of cholesterol]	LU	y	-	lethal	lethal	lethal	LU	LU	post-infant-lethal
602400	ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 11	Ichthyosis, congenital, autosomal recessive 11, 602400 (3)	Ichthyosis, congenital, autosomal recessive 11	n	-	-	-	ST14	HGNC:11344	Ichthyosis, congenital, autosomal recessive 11, 602400 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
602433	AMYOTROPHIC LATERAL SCLEROSIS 4, JUVENILE	Amyotrophic lateral sclerosis 4, juvenile, 602433 (3)	Amyotrophic lateral sclerosis 4, juvenile	n	-	-	-	SETX	HGNC:445	Amyotrophic lateral sclerosis 4, juvenile, 602433 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	ambiguous|nonlethal	ambiguous	-	-	-
602450	SEVERE COMBINED IMMUNODEFICIENCY WITH SENSITIVITY TO IONIZING RADIATION	Severe combined immunodeficiency, Athabascan type, 602450 (3)	Severe combined immunodeficiency, Athabascan type	y	SEVERE COMBINED IMMUNODEFICIENCY WITH SENSITIVITY TO IONIZING RADIATION	Clinical Features	died	DCLRE1C	HGNC:17642	Severe combined immunodeficiency, Athabascan type, 602450 (3), Autosomal recessive	Autosomal recessive	y	y	[Moshous et al. (2003) also reported an unrelated patient with partial SCID who died at the age of 16 years of liver cirrhosis]	L5	y	-	lethal	lethal	lethal	L3|L5	L3	pre-infant-lethal
602459	DEAFNESS, AUTOSOMAL DOMINANT 15	Deafness, autosomal dominant 15, 602459 (3)	Deafness, autosomal dominant 15	n	-	-	-	POU4F3	HGNC:9220	Deafness, autosomal dominant 15, 602459 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
602471	SHORT STATURE, AUDITORY CANAL ATRESIA, MANDIBULAR HYPOPLASIA, AND SKELETAL ABNORMALITIES	Short stature, auditory canal atresia, mandibular hypoplasia, skeletal abnormalities, 602471 (3)	Short stature, auditory canal atresia, mandibular hypoplasia, skeletal abnormalities	n	-	-	-	GSC	HGNC:4612	Short stature, auditory canal atresia, mandibular hypoplasia, skeletal abnormalities, 602471 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
602473	ENCEPHALOPATHY, ETHYLMALONIC	Ethylmalonic encephalopathy, 602473 (3)	Ethylmalonic encephalopathy	y	ENCEPHALOPATHY, ETHYLMALONIC; EE	Description|Clinical Features|Clinical Synopsis|Phenotype	death|deaths|died	ETHE1	HGNC:23287	Ethylmalonic encephalopathy, 602473 (3), Autosomal recessive	Autosomal recessive	y	y	[Drousiotou et al. (2011) reported 3 patients from 2 unrelated families of Greek Cypriot origin with ethylmalonic encephalopathy. The first patient presented at age 2.5 months with feeding difficulties, failure to thrive, petechiae, and ecchymosis. She was floppy with severe head lag and microcephaly, and showed poor responses to auditory and visual stimuli. Deep tendon reflexes were exaggerated, and there was sustained clonus and bilateral Babinski sign. She subsequently developed chronic diarrhea and seizures. Brain MRI revealed multiple bilateral loci of high intensity in the basal ganglia on T2-weighted images. She showed neurologic regression and was 5.5 years old at the time of the report. Her older brother died at age 6 months of a presumably similar disorder. Ultrasound of the brain showed hyperechogenicity of gyri and sulci. No tissues were available for confirmation of diagnosis. A girl from a second family was born prematurely at 36 weeks' gestation and presented at age 6 months with feeding difficulties, hypotonia, and global developmental delay. She later developed diarrhea, petechiae, ecchymosis, and seizures, and brain MRI showed abnormal signals in the basal ganglia and thinning of the corpus callosum. She died at age 8 months from cardiopulmonary arrest]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
602477	EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 17	Febrile seizures, familial, 2, 602477 (3)	Febrile seizures, familial, 2	n	-	-	-	HCN2	HGNC:4846	Febrile seizures, familial, 2, 602477 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
602477	EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 17	Generalized epilepsy with febrile seizures plus, type 11, 602477 (3)	Generalized epilepsy with febrile seizures plus, type 11	n	-	-	-	HCN2	HGNC:4846	Generalized epilepsy with febrile seizures plus, type 11, 602477 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
602481	MIGRAINE, FAMILIAL HEMIPLEGIC, 2	Migraine, familial basilar, 602481 (3)	Migraine, familial basilar	n	-	-	-	ATP1A2	HGNC:800	Migraine, familial basilar, 602481 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	ambiguous|nonlethal	ambiguous	-	-	-
602481	MIGRAINE, FAMILIAL HEMIPLEGIC, 2	Migraine, familial hemiplegic, 2, 602481 (3)	Migraine, familial hemiplegic, 2	n	-	-	-	ATP1A2	HGNC:800	Migraine, familial hemiplegic, 2, 602481 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	ambiguous|nonlethal	ambiguous	-	-	-
602482	AXENFELD-RIEGER SYNDROME, TYPE 3	Axenfeld-Rieger syndrome, type 3, 602482 (3)	Axenfeld-Rieger syndrome, type 3	n	-	-	-	FOXC1	HGNC:3800	Axenfeld-Rieger syndrome, type 3, 602482 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
602483	AURICULOCONDYLAR SYNDROME 1	Auriculocondylar syndrome 1, 602483 (3)	Auriculocondylar syndrome 1	n	-	-	-	GNAI3	HGNC:4387	Auriculocondylar syndrome 1, 602483 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
602485	HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 3	Hyperinsulinemic hypoglycemia, familial, 3, 602485 (3)	Hyperinsulinemic hypoglycemia, familial, 3	y	HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 3; HHF3	Clinical Features	death|deaths	GCK	HGNC:4195	Hyperinsulinemic hypoglycemia, familial, 3, 602485 (3), Autosomal dominant	Autosomal dominant	y	y	[Cuesta-Munoz et al. (2004) reported a Finnish woman who had hypoglycemic seizures from birth and inappropriate hyperinsulinemia. Despite a leucine-free diet, high-dose glucose infusion, hydrocortisone, and glucagon, hypoglycemia persisted. She underwent subtotal pancreatectomy at the age of 6 months with no resolution of hypoglycemia; treatment with diazoxide, which continued for 22 years, was also unsuccessful. She was severely mentally retarded, and had seizures until her death at age 29]	L6	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L6	L6	post-infant-lethal
602522	BARTTER SYNDROME, TYPE 4A, NEONATAL, WITH SENSORINEURAL DEAFNESS	Bartter syndrome, type 4a, 602522 (3)	Bartter syndrome, type 4a	n	-	-	-	BSND	HGNC:16512	Bartter syndrome, type 4a, 602522 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
602522	BARTTER SYNDROME, TYPE 4A, NEONATAL, WITH SENSORINEURAL DEAFNESS	Sensorineural deafness with mild renal dysfunction, 602522 (3)	Sensorineural deafness with mild renal dysfunction	n	-	-	-	BSND	HGNC:16512	Sensorineural deafness with mild renal dysfunction, 602522 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
602531	GRANGE SYNDROME	Grange syndrome, 602531 (3)	Grange syndrome	y	GRANGE SYNDROME; GRNG	Clinical Features	died	YY1AP1	HGNC:30935	Grange syndrome, 602531 (3), Autosomal recessive	Autosomal recessive	y	n	-	-	-	-	ambiguous	ambiguous	ambiguous	-	-	-
602535	MARSHALL-SMITH SYNDROME	Marshall-Smith syndrome, 602535 (3)	Marshall-Smith syndrome	y	MARSHALL-SMITH SYNDROME; MRSHSS	Clinical Features|Clinical Synopsis	death|deaths|died	NFIX	HGNC:7788	Marshall-Smith syndrome, 602535 (3), Autosomal dominant	Autosomal dominant	y	y	[Adam et al. (2005) noted that most patients with Marshall-Smith syndrome reported in the literature to that time had died in the neonatal period or early infancy, most commonly from respiratory compromise]	L2	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L2	L2	pre-infant-lethal
602540	ICHTHYOSIS, HYSTRIX-LIKE, WITH DEAFNESS	Hystrix-like ichthyosis with deafness, 602540 (3)	Hystrix-like ichthyosis with deafness	n	-	-	-	GJB2	HGNC:4284	Hystrix-like ichthyosis with deafness, 602540 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	ambiguous|nonlethal	ambiguous	-	-	-
602541	MUSCULAR DYSTROPHY, CONGENITAL, MEGACONIAL TYPE	Muscular dystrophy, congenital, megaconial type, 602541 (3)	Muscular dystrophy, congenital, megaconial type	y	MUSCULAR DYSTROPHY, CONGENITAL, MEGACONIAL TYPE; MDCMC	Description|Clinical Features|Clinical Synopsis	fatal|died|die	CHKB	HGNC:1938	Muscular dystrophy, congenital, megaconial type, 602541 (3), Autosomal recessive	Autosomal recessive	y	y	[Mitsuhashi et al. (2011) reported 11 unrelated patients, including 10 of Turkish origin and 1 of British origin, with congenital muscular dystrophy and mental retardation similar to that reported by Nishino et al. (1998). All affected individuals had early-onset muscle weakness, and about half had infantile hypotonia. Some had delayed walking, whereas others never achieved independent ambulation. Most never acquired meaningful language. Most had microcephaly, but brain imaging showed no developmental defects. Four had cardiomyopathy, 1 had an atrial septal defect, and 1 had mitral valve prolapse. Two died of cardiomyopathy in the first decade of life]	L4	y	-	lethal	lethal	lethal	L4	L4	post-infant-lethal
602557	SPONDYLOEPIMETAPHYSEAL DYSPLASIA, SHOHAT TYPE	Spondyloepimetaphyseal dysplasia, Shohat type, 602557 (3)	Spondyloepimetaphyseal dysplasia, Shohat type	y	SPONDYLOEPIMETAPHYSEAL DYSPLASIA, SHOHAT TYPE; SEMDSH	Clinical Features|Clinical Synopsis	died|fatal	DDRGK1	HGNC:16110	Spondyloepimetaphyseal dysplasia, Shohat type, 602557 (3), Autosomal recessive	Autosomal recessive	n	y	[Tracheal narrowing may result in fatal upper airway obstruction]	LU	y	-	lethal	lethal	lethal	LU	LU	post-infant-lethal
602579	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ib	Congenital disorder of glycosylation, type Ib, 602579 (3)	Congenital disorder of glycosylation, type Ib	y	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ib; CDG1B	Description|Clinical Features	fatal|died	MPI	HGNC:7216	Congenital disorder of glycosylation, type Ib, 602579 (3), Autosomal recessive	Autosomal recessive	y	y	[Pelletier et al. (1986) first described CDG Ib clinically. They observed secretory diarrhea with protein-losing enteropathy, enterocolitis cystica superficialis, intestinal lymphangiectasia, and congenital hepatic fibrosis in 4 children whose parents originated from the same northeastern province of Quebec. Jaeken et al. (1998) suggested that the patients reported by Pelletier et al. (1986) had CDG Ib. The infants, who died between the ages of 4 and 21 months, also had antithrombin III deficiency (613118), a typical feature of CDG syndromes]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
602588	BRANCHIOOTIC SYNDROME 1	Anterior segment anomalies with or without cataract, 602588 (3)	Anterior segment anomalies with or without cataract	n	-	-	-	EYA1	HGNC:3519	Anterior segment anomalies with or without cataract, 602588 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L2	L2	pre-infant-lethal
602588	BRANCHIOOTIC SYNDROME 1	Branchiootic syndrome 1, 602588 (3)	Branchiootic syndrome 1	n	-	-	-	EYA1	HGNC:3519	Branchiootic syndrome 1, 602588 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L2	L2	pre-infant-lethal
602629	DYSTONIA 6, TORSION	Dystonia 6, torsion, 602629 (3)	Dystonia 6, torsion	n	-	-	-	THAP1	HGNC:20856	Dystonia 6, torsion, 602629 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
602668	MYOTONIC DYSTROPHY 2	Myotonic dystrophy 2, 602668 (3)	Myotonic dystrophy 2	y	MYOTONIC DYSTROPHY 2; DM2	Clinical Features	death|deaths|died|miscarriage|miscarriages	CNBP	HGNC:13164	Myotonic dystrophy 2, 602668 (3), Autosomal dominant	Autosomal dominant	y	y	[Schoser et al. (2004) reported 4 DM2 patients from 3 families who died of sudden cardiac death between ages 31 and 44 years]	L6	y	-	lethal	lethal	lethal	L6	L6	post-infant-lethal
602722	RENAL TUBULAR ACIDOSIS, DISTAL, 3, WITH OR WITHOUT SENSORINEURAL HEARING LOSS	Distal renal tubular acidosis 3, with or without sensorineural hearing loss, 602722 (3)	Distal renal tubular acidosis 3, with or without sensorineural hearing loss	n	-	-	-	ATP6V0A4	HGNC:866	Distal renal tubular acidosis 3, with or without sensorineural hearing loss, 602722 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
602723	PSORIASIS 2	Psoriasis 2, 602723 (3)	Psoriasis 2	n	-	-	-	CARD14	HGNC:16446	Psoriasis 2, 602723 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
602771	CONGENITAL MYOPATHY 3 WITH RIGID SPINE	Congenital myopathy 3 with rigid spine, 602771 (3)	Congenital myopathy 3 with rigid spine	y	CONGENITAL MYOPATHY 3 WITH RIGID SPINE; CMYP3	Clinical Features|Clinical Synopsis	died|death|deaths	SELENON	HGNC:15999	Congenital myopathy 3 with rigid spine, 602771 (3), Autosomal recessive	Autosomal recessive	y	y	[died from respiratory failure at 10 and 22 years/died of pneumonia at age 8 years]	L4	y	-	lethal	lethal	lethal	L4	L4	post-infant-lethal
602772	RETINITIS PIGMENTOSA 25	Retinitis pigmentosa 25, 602772 (3)	Retinitis pigmentosa 25	n	-	-	-	EYS	HGNC:21555	Retinitis pigmentosa 25, 602772 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
602782	HISTIOCYTOSIS-LYMPHADENOPATHY PLUS SYNDROME	Histiocytosis-lymphadenopathy plus syndrome, 602782 (3)	Histiocytosis-lymphadenopathy plus syndrome	y	HISTIOCYTOSIS-LYMPHADENOPATHY PLUS SYNDROME	Phenotype	died	SLC29A3	HGNC:23096	Histiocytosis-lymphadenopathy plus syndrome, 602782 (3), Autosomal recessive	Autosomal recessive	y	n	-	-	-	-	ambiguous	ambiguous	ambiguous	-	-	-
602849	MUENKE SYNDROME	Muenke syndrome, 602849 (3)	Muenke syndrome	y	MUENKE SYNDROME; MNKES	Clinical Features	died	FGFR3	HGNC:3690	Muenke syndrome, 602849 (3), Autosomal dominant	Autosomal dominant	y	y	[Shah et al. (2006) reported a family in which a female infant with Muenke syndrome due to the P250R mutation died suddenly on day 3 of life, most likely due to respiratory insufficiency resulting from upper airway obstruction associated with craniosynostosis]	L2	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L2|L3	L2	pre-infant-lethal
602875	ACROMESOMELIC DYSPLASIA 1	Acromesomelic dysplasia 1, Maroteaux type, 602875 (3)	Acromesomelic dysplasia 1, Maroteaux type	n	-	-	-	NPR2	HGNC:7944	Acromesomelic dysplasia 1, Maroteaux type, 602875 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
603034	MYASTHENIC SYNDROME, CONGENITAL, 5	Myasthenic syndrome, congenital, 5, 603034 (3)	Myasthenic syndrome, congenital, 5	n	-	-	-	COLQ	HGNC:2226	Myasthenic syndrome, congenital, 5, 603034 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
603041	MITOCHONDRIAL DNA DEPLETION SYNDROME 1 (MNGIE TYPE)	Mitochondrial DNA depletion syndrome 1 (MNGIE type), 603041 (3)	Mitochondrial DNA depletion syndrome 1 (MNGIE type)	y	MITOCHONDRIAL DNA DEPLETION SYNDROME 1 (MNGIE TYPE); MTDPS1	Clinical Features|Clinical Synopsis	death|deaths|die|died|fatal	TYMP	HGNC:3148	Mitochondrial DNA depletion syndrome 1 (MNGIE type), 603041 (3), Autosomal recessive	Autosomal recessive	y	y	[Early death in early adulthood often associated with diverticulitis and intestinal perforation / Giordano et al. (2008) reported 5 unrelated patients with TYMP-related MNGIE.. Death occurred between ages 28 and 39 years, suggesting that decreased life span is associated with this disorder.	L6	y	-	lethal	lethal	lethal	L6	L6	post-infant-lethal
603147	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ic	Congenital disorder of glycosylation, type Ic, 603147 (3)	Congenital disorder of glycosylation, type Ic	n	-	-	-	ALG6	HGNC:23157	Congenital disorder of glycosylation, type Ic, 603147 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
603194	MECKEL SYNDROME, TYPE 2	Meckel syndrome 2, 603194 (3)	Meckel syndrome 2	y	MECKEL SYNDROME, TYPE 2; MKS2	Description|Clinical Synopsis	lethal	TMEM216	HGNC:25018	Meckel syndrome 2, 603194 (3), Autosomal recessive	Autosomal recessive	y	y	[Lethal in utero or perinatal lethal]	L1	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L1	L1	pre-infant-lethal
603218	HUNTINGTON DISEASE-LIKE 1	Huntington disease-like 1, 603218 (3)	Huntington disease-like 1	n	-	-	-	PRNP	HGNC:9449	Huntington disease-like 1, 603218 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L6	L6	post-infant-lethal
603233	PSEUDOHYPOPARATHYROIDISM, TYPE IB	Pseudohypoparathyroidism Ib, 603233 (3)	Pseudohypoparathyroidism Ib	n	-	-	-	GNAS	HGNC:4392	Pseudohypoparathyroidism Ib, 603233 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L3	L3	pre-infant-lethal
603233	PSEUDOHYPOPARATHYROIDISM, TYPE IB	Pseudohypoparathyroidism Ib, 603233 (3)	Pseudohypoparathyroidism Ib	n	-	-	-	STX16	HGNC:11431	Pseudohypoparathyroidism Ib, 603233 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
603278	FOCAL SEGMENTAL GLOMERULOSCLEROSIS 1	Glomerulosclerosis, focal segmental, 1, 603278 (3)	Glomerulosclerosis, focal segmental, 1	n	-	-	-	ACTN4	HGNC:166	Glomerulosclerosis, focal segmental, 1, 603278 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
603284	CEREBRAL CAVERNOUS MALFORMATIONS 2	Cerebral cavernous malformations-2, 603284 (3)	Cerebral cavernous malformations-2	n	-	-	-	CCM2	HGNC:21708	Cerebral cavernous malformations-2, 603284 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
603285	CEREBRAL CAVERNOUS MALFORMATIONS 3	Cerebral cavernous malformations-3, 603285 (3)	Cerebral cavernous malformations-3	y	CEREBRAL CAVERNOUS MALFORMATIONS 3; CCM3	Clinical Synopsis	death|deaths	PDCD10	HGNC:8761	Cerebral cavernous malformations-3, 603285 (3), Autosomal dominant	Autosomal dominant	y	n	-	-	-	-	ambiguous	ambiguous	ambiguous	-	-	-
603358	GRACILE SYNDROME	GRACILE syndrome, 603358 (3)	GRACILE syndrome	y	GRACILE SYNDROME	Description|Clinical Features|Clinical Synopsis	die|lethal|died|death|deaths	BCS1L	HGNC:1020	GRACILE syndrome, 603358 (3), Autosomal recessive	Autosomal recessive	y	y	[Fellman et al. (1998) described a neonatal metabolic disorder characterized by severe intrauterine growth retardation, fulminant lactic acidosis during the first days of life, Fanconi-type amino aciduria, and abnormalities in iron metabolism, including liver hemosiderosis. Affected infants failed to thrive, and they died neonatally or in early infancy]	L2	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L2	L2	pre-infant-lethal
603373	HYPERTHYROIDISM, FAMILIAL GESTATIONAL	Hyperthyroidism, familial gestational, 603373 (3)	Hyperthyroidism, familial gestational	y	HYPERTHYROIDISM, FAMILIAL GESTATIONAL	Clinical Features|Clinical Synopsis	miscarriage|miscarriages|spontaneous_abortion|spontaneous_abortions	TSHR	HGNC:12373	Hyperthyroidism, familial gestational, 603373 (3), Autosomal dominant	Autosomal dominant	y	n	-	-	-	-	ambiguous	ambiguous|nonlethal	ambiguous	-	-	-
603383	GLAUCOMA 1, OPEN ANGLE, F	Glaucoma 1, open angle, F, 603383 (3)	Glaucoma 1, open angle, F	n	-	-	-	ASB10	HGNC:17185	Glaucoma 1, open angle, F, 603383 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
603387	MEGALENCEPHALY-POLYMICROGYRIA-POLYDACTYLY-HYDROCEPHALUS SYNDROME 1	Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 1, 603387 (3)	Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 1	y	MEGALENCEPHALY-POLYMICROGYRIA-POLYDACTYLY-HYDROCEPHALUS SYNDROME 1; MPPH1	Clinical Features	died	PIK3R2	HGNC:8980	Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 1, 603387 (3), Autosomal dominant	Autosomal dominant	y	y	[Dagli et al. (2008) reported a female infant with a phenotype similar to that described by Gohlich-Ratmann et al. (1998). At birth, she had macrocephaly, hypotonia, frontal bossing, depressed nasal bridge, and normal brain MRI. Features noted later included open anterior fontanel, wide palpebral fissures, ptosis, and profound mental retardation with no psychomotor development. Brain MRI at age 15 months showed bilateral megalencephaly with generalized thickening of the cortex, severe enlargement of the corpus callosum, and a cavum septum pellucidum. There was abnormal sulcation, which may be seen with polymicrogyria. The ventricles were normal in size, and the Sylvian fissures were not wide. The patient died at home at 21 months of age from respiratory complications associated with a flu-like illness]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
603457	BOSMA ARHINIA MICROPHTHALMIA SYNDROME	Bosma arhinia microphthalmia syndrome, 603457 (3)	Bosma arhinia microphthalmia syndrome	y	BOSMA ARHINIA MICROPHTHALMIA SYNDROME; BAMS	Clinical Features	died	SMCHD1	HGNC:29090	Bosma arhinia microphthalmia syndrome, 603457 (3), Autosomal dominant	Autosomal dominant	y	y	[Thiele et al. (1996) reported a 3-generation German family in which a 5-year-old girl with complete absence of the nose and nostrils had hypertelorism, microphthalmia of the left eye and right-sided clinical anophthalmia, high palate, choanal atresia, preauricular pits, and bilateral absence of the twelfth ribs. She had normal motor and mental development. A similarly affected maternal aunt had died 2 hours after birth]	L2	n	y	lethal	lethal	lethal	L2	L2	pre-infant-lethal
603467	FANCONI ANEMIA, COMPLEMENTATION GROUP F	Fanconi anemia, complementation group F, 603467 (3)	Fanconi anemia, complementation group F	y	FANCONI ANEMIA, COMPLEMENTATION GROUP F; FANCF	Clinical Features	death|deaths	FANCF	HGNC:3587	Fanconi anemia, complementation group F, 603467 (3), Autosomal recessive	Autosomal recessive	y	y	[Tryon et al. (2017) investigated 3 patients with Fanconi anemia complementation group F who demonstrated the clinical variability within this group. Patient 1 was a female born at 34 weeks' gestation following a pregnancy complicated by polyhydramnios and IUGR. Fanconi anemia was suspected on the basis of multiple congenital anomalies including single umbilical artery, microcephaly, microphthalmia, microtia, bilateral radial hypoplasia, absent thumbs, atrial septal defect, duodenal atresia, and left pelvic kidney. Chromosomal breakage testing with diepoxybutane (DEB) revealed 11.5 breaks/cell, confirming the diagnosis of Fanconi anemia. Complementation group analysis determined group F. Single lineage marrow failure (severe neutropenia) led to hematopoietic cell transplant (HCT) at 3 years 7 months and then death 144 days after HCT secondary to severe hemorrhagic cystitis and hemolytic anemia]	L4	y	-	lethal	lethal	lethal	L4	L4	post-infant-lethal
603471	CITRULLINEMIA, TYPE II, ADULT-ONSET	Citrullinemia, adult-onset type II, 603471 (3)	Citrullinemia, adult-onset type II	y	CITRULLINEMIA, TYPE II, ADULT-ONSET; CTLN2	Description|Clinical Features|Phenotype	death|deaths|died|fatal	SLC25A13	HGNC:10983	Citrullinemia, adult-onset type II, 603471 (3), Autosomal recessive	Autosomal recessive	n	y	[In some cases, rapid progression can lead to brain edema and death if liver transplantation is not possible / Yasuda et al. (2000) found that the onset of serious and recurring symptoms in CTLN2 varied from age 11 to age 79, with a mean of 34.4 years. Almost all patients suffered from a sudden disturbance of consciousness associated with disorientation, restlessness, drowsiness, and coma, and most died mainly of cerebral edema within a few years of onset]	L5	y	-	lethal	ambiguous|lethal	lethal	L5	L5	post-infant-lethal
603472	NEURONAL INTRANUCLEAR INCLUSION DISEASE	Neuronal intranuclear inclusion disease, 603472 (3)	Neuronal intranuclear inclusion disease	y	NEURONAL INTRANUCLEAR INCLUSION DISEASE; NIID	Clinical Features	death|deaths|died	NOTCH2NLC	HGNC:53924	Neuronal intranuclear inclusion disease, 603472 (3), Autosomal dominant	Autosomal dominant	y	y	[Kimber et al. (1998) described female monozygotic twins who developed upper and lower limb neurogenic weakness in their thirties, followed by cerebellar ataxia, dysarthria, and death after an illness of about 20 years' duration]	L6	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L6|LU	L6	post-infant-lethal
603511	MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL DOMINANT 1	Muscular dystrophy, limb-girdle, autosomal dominant 1, 603511 (3)	Muscular dystrophy, limb-girdle, autosomal dominant 1	n	-	-	-	DNAJB6	HGNC:14888	Muscular dystrophy, limb-girdle, autosomal dominant 1, 603511 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
603516	SPINOCEREBELLAR ATAXIA 10	Spinocerebellar ataxia 10, 603516 (3)	Spinocerebellar ataxia 10	n	-	-	-	ATXN10	HGNC:10549	Spinocerebellar ataxia 10, 603516 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
603543	LIMB-MAMMARY SYNDROME	Limb-mammary syndrome, 603543 (3)	Limb-mammary syndrome	n	-	-	-	TP63	HGNC:15979	Limb-mammary syndrome, 603543 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L2	L2	pre-infant-lethal
603546	SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY, TYPE 2	Spondyloepimetaphyseal dysplasia with joint laxity, type 2, 603546 (3)	Spondyloepimetaphyseal dysplasia with joint laxity, type 2	n	-	-	-	KIF22	HGNC:6391	Spondyloepimetaphyseal dysplasia with joint laxity, type 2, 603546 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
603552	HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 4	Hemophagocytic lymphohistiocytosis, familial, 4, 603552 (3)	Hemophagocytic lymphohistiocytosis, familial, 4	y	HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 4; FHL4	Clinical Synopsis	fatal	STX11	HGNC:11429	Hemophagocytic lymphohistiocytosis, familial, 4, 603552 (3), Autosomal recessive	Autosomal recessive	y	y	[Fatal without hematopoietic stem cell transplantation	LU	y	-	lethal	lethal	lethal	LU	LU	post-infant-lethal
603553	HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 2	Hemophagocytic lymphohistiocytosis, familial, 2, 603553 (3)	Hemophagocytic lymphohistiocytosis, familial, 2	y	HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 2; FHL2	Description|Clinical Features	fatal|died	PRF1	HGNC:9360	Hemophagocytic lymphohistiocytosis, familial, 2, 603553 (3), Autosomal recessive	Autosomal recessive	y	y	[Chemotherapy and/or immunosuppressant therapy may result in symptomatic remission, but the disorder is fatal without bone marrow transplantation / Goransdotter Ericson et al. (2001) reported 7 unrelated families with FHL2 confirmed by genetic analysis. Four of the families were consanguineous: 3 from Turkey and 1 from Sweden. The patients presented between ages 1 and 58 months with fever, splenomegaly, cytopenia affecting at least 2 lineages, and hypertriglyceridemia and/or hypofibrinogenemia. All had hemophagocytosis on bone marrow, splenic, or lymph node biopsy. Five patients died without bone marrow transplant]	L4	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L4	L4	post-infant-lethal
603554	OMENN SYNDROME	Omenn syndrome, 603554 (3)	Omenn syndrome	y	OMENN SYNDROME	Clinical Features|Phenotype	died	DCLRE1C	HGNC:17642	Omenn syndrome, 603554 (3), Autosomal recessive	Autosomal recessive	y	y	[Omenn (1965) described reticuloendotheliosis with eosinophilia in several individuals in related sibships from an inbred American family of Irish extraction. Barth et al. (1972) concluded that the familial reticuloendotheliosis with eosinophilia described by Omenn is a distinct entity. Pneumocystis carinii, responsible for eosinophilia in other immune deficiency disorders, was not detected in any of Omenn's cases. Velders et al. (1983) described an 18-month-old child with a widespread pruritic skin disorder and fever, lymphadenopathy, anemia, eosinophilia, and chronic diarrhea. The child had sharply demarcated erythematosquamous disseminated lesions on the head, trunk, and limbs. Biopsy of a nodule from one of his extremities revealed a dense infiltrate in the deep dermis consisting of histiocytes, lymphocytes, eosinophils, and mast cells. Ecto-5-nucleotidase was markedly reduced in the patient's lymph node tissue and peripheral blood lymphocytes compared to a control. The patient died of toxic shock syndrome at the age of 20 months]	L3	y	-	lethal	lethal	lethal	L3|L5	L3	pre-infant-lethal
603554	OMENN SYNDROME	Omenn syndrome, 603554 (3)	Omenn syndrome	y	OMENN SYNDROME	Clinical Features|Phenotype	died	RAG1	HGNC:9831	Omenn syndrome, 603554 (3), Autosomal recessive	Autosomal recessive	y	y	[Omenn (1965) described reticuloendotheliosis with eosinophilia in several individuals in related sibships from an inbred American family of Irish extraction. Barth et al. (1972) concluded that the familial reticuloendotheliosis with eosinophilia described by Omenn is a distinct entity. Pneumocystis carinii, responsible for eosinophilia in other immune deficiency disorders, was not detected in any of Omenn's cases. Velders et al. (1983) described an 18-month-old child with a widespread pruritic skin disorder and fever, lymphadenopathy, anemia, eosinophilia, and chronic diarrhea. The child had sharply demarcated erythematosquamous disseminated lesions on the head, trunk, and limbs. Biopsy of a nodule from one of his extremities revealed a dense infiltrate in the deep dermis consisting of histiocytes, lymphocytes, eosinophils, and mast cells. Ecto-5-nucleotidase was markedly reduced in the patient's lymph node tissue and peripheral blood lymphocytes compared to a control. The patient died of toxic shock syndrome at the age of 20 months]	L3	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L3|L4	L3	pre-infant-lethal
603554	OMENN SYNDROME	Omenn syndrome, 603554 (3)	Omenn syndrome	y	OMENN SYNDROME	Clinical Features|Phenotype	died	RAG2	HGNC:9832	Omenn syndrome, 603554 (3), Autosomal recessive	Autosomal recessive	y	y	[Omenn (1965) described reticuloendotheliosis with eosinophilia in several individuals in related sibships from an inbred American family of Irish extraction. Barth et al. (1972) concluded that the familial reticuloendotheliosis with eosinophilia described by Omenn is a distinct entity. Pneumocystis carinii, responsible for eosinophilia in other immune deficiency disorders, was not detected in any of Omenn's cases. Velders et al. (1983) described an 18-month-old child with a widespread pruritic skin disorder and fever, lymphadenopathy, anemia, eosinophilia, and chronic diarrhea. The child had sharply demarcated erythematosquamous disseminated lesions on the head, trunk, and limbs. Biopsy of a nodule from one of his extremities revealed a dense infiltrate in the deep dermis consisting of histiocytes, lymphocytes, eosinophils, and mast cells. Ecto-5-nucleotidase was markedly reduced in the patient's lymph node tissue and peripheral blood lymphocytes compared to a control. The patient died of toxic shock syndrome at the age of 20 months]	L3	y	-	lethal	ambiguous|lethal	lethal	L3	L3	pre-infant-lethal
603563	SPASTIC PARAPLEGIA 8, AUTOSOMAL DOMINANT	Spastic paraplegia 8, autosomal dominant, 603563 (3)	Spastic paraplegia 8, autosomal dominant	n	-	-	-	WASHC5	HGNC:28984	Spastic paraplegia 8, autosomal dominant, 603563 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L1	L1	pre-infant-lethal
603585	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIf	Congenital disorder of glycosylation, type IIf, 603585 (3)	Congenital disorder of glycosylation, type IIf	y	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIf; CDG2F	Clinical Features|Clinical Synopsis	died	SLC35A1	HGNC:11021	Congenital disorder of glycosylation, type IIf, 603585 (3), Autosomal recessive	Autosomal recessive	y	y	[Willig et al. (2001) reported a 4-month-old boy who presented with a spontaneous massive bleed in the posterior chamber of the right eye along with cutaneous hemorrhages. Laboratory studies showed marked thrombocytopenia and neutropenia. The patient experienced multiple episodes of bleeding over the next 30 months, including severe pulmonary hemorrhage. He also had multiple recurrent bacterial infections. Bone marrow transplantation was performed at age 34 months, but the patient died of complications at age 37 months]	L4	y	-	lethal	lethal	lethal	L4	L4	post-infant-lethal
603592	XANTHINURIA, TYPE II	Xanthinuria, type II, 603592 (3)	Xanthinuria, type II	n	-	-	-	MOCOS	HGNC:18234	Xanthinuria, type II, 603592 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
603622	DEAFNESS, AUTOSOMAL DOMINANT 17	Deafness, autosomal dominant 17, 603622 (3)	Deafness, autosomal dominant 17	n	-	-	-	MYH9	HGNC:7579	Deafness, autosomal dominant 17, 603622 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
603629	DEAFNESS, AUTOSOMAL RECESSIVE 21	Deafness, autosomal recessive 21, 603629 (3)	Deafness, autosomal recessive 21	n	-	-	-	TECTA	HGNC:11720	Deafness, autosomal recessive 21, 603629 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
603671	ACROMELIC FRONTONASAL DYSOSTOSIS	Acromelic frontonasal dysostosis, 603671 (3)	Acromelic frontonasal dysostosis	y	ACROMELIC FRONTONASAL DYSOSTOSIS; AFND	Clinical Features	died	ZSWIM6	HGNC:29316	Acromelic frontonasal dysostosis, 603671 (3), Autosomal dominant	Autosomal dominant	y	y	[Hing et al. (2004) reported 2 unrelated boys, aged 8 and 9, with classic features of AFND in whom CT studies showed strikingly similar findings of brachycephaly, orbital hypertelorism, midline maxillary cleft, large anterior fontanel with an interfrontal bone, and posterior parietal foramina... A paternal uncle died in the newborn period with clinical features similar to the proband, whereas the paternal grandmother was clinically unaffected]	L2	n	y	lethal	lethal|nonlethal	lethal|nonlethal	L2	L2	pre-infant-lethal
603689	MYOPATHY, MYOFIBRILLAR, 9, WITH EARLY RESPIRATORY FAILURE	Myopathy, myofibrillar, 9, with early respiratory failure, 603689 (3)	Myopathy, myofibrillar, 9, with early respiratory failure	n	-	-	-	TTN	HGNC:12403	Myopathy, myofibrillar, 9, with early respiratory failure, 603689 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L6|LU	L6	post-infant-lethal
603720	DEAFNESS, AUTOSOMAL RECESSIVE 16	Deafness, autosomal recessive 16, 603720 (3)	Deafness, autosomal recessive 16	n	-	-	-	STRC	HGNC:16035	Deafness, autosomal recessive 16, 603720 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
603736	OHDO SYNDROME, SBBYS VARIANT	SBBYSS syndrome, 603736 (3)	SBBYSS syndrome	n	-	-	-	KAT6B	HGNC:17582	SBBYSS syndrome, 603736 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L3	L3	pre-infant-lethal
603776	HYPERCHOLESTEROLEMIA, FAMILIAL, 3	Hypercholesterolemia, familial, 3, 603776 (3)	Hypercholesterolemia, familial, 3	n	-	-	-	PCSK9	HGNC:20001	Hypercholesterolemia, familial, 3, 603776 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
603786	STARGARDT DISEASE 4	Stargardt disease 4, 603786 (3)	Stargardt disease 4	n	-	-	-	PROM1	HGNC:9454	Stargardt disease 4, 603786 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	ambiguous|nonlethal	ambiguous	-	-	-
603813	HYPERCHOLESTEROLEMIA, FAMILIAL, 4	Hypercholesterolemia, familial, 4, 603813 (3)	Hypercholesterolemia, familial, 4	n	-	-	-	LDLRAP1	HGNC:18640	Hypercholesterolemia, familial, 4, 603813 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
603829	VENTRICULAR FIBRILLATION, PAROXYSMAL FAMILIAL, 1	Ventricular fibrillation, familial, 1, 603829 (3)	Ventricular fibrillation, familial, 1	y	VENTRICULAR FIBRILLATION, PAROXYSMAL FAMILIAL, 1; VF1	Description|Clinical Features|Phenotype	death|deaths|died	SCN5A	HGNC:10593	Ventricular fibrillation, familial, 1, 603829 (3)	-	n	y	[McRae et al. (1974) described a family in which 3 brothers had syncopal attacks and died suddenly at ages 17, 12, and 12 years]	L5	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L4|L5|L6|LU	L4	post-infant-lethal
603830	LONG QT SYNDROME 3	Long QT syndrome 3, 603830 (3)	Long QT syndrome 3	y	LONG QT SYNDROME 3; LQT3	Description|Clinical Synopsis|Phenotype	death|deaths|lethal|fetal_loss|fetal_losses|stillbirth|stillbirths	SCN5A	HGNC:10593	Long QT syndrome 3, 603830 (3), Autosomal dominant	Autosomal dominant	n	y	[Sudden cardiac death]	LU	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L4|L5|L6|LU	L4	post-infant-lethal
603896	LEUKOENCEPHALOPATHY WITH VANISHING WHITE MATTER 1	Leukoencephalopathy with vanishing white matter 1, with or without ovarian failure, 603896 (3)	Leukoencephalopathy with vanishing white matter 1, with or without ovarian failure	y	LEUKOENCEPHALOPATHY WITH VANISHING WHITE MATTER 1; VWM1	Clinical Features|Clinical Synopsis|Phenotype	died|death|deaths	EIF2B1	HGNC:3257	Leukoencephalopathy with vanishing white matter 1, with or without ovarian failure, 603896 (3), Autosomal recessive	Autosomal recessive	y	y	[Early death occurs in affected infants (days to months after disease onset)]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
603902	BETA-THALASSEMIA, DOMINANT INCLUSION BODY TYPE	Thalassemia-beta, dominant inclusion-body, 603902 (3)	Thalassemia-beta, dominant inclusion-body	y	BETA-THALASSEMIA, DOMINANT INCLUSION BODY TYPE	Clinical Features	died	HBB	HGNC:4827	Thalassemia-beta, dominant inclusion-body, 603902 (3), Autosomal dominant	Autosomal dominant	y	n	-	-	-	-	ambiguous	ambiguous|lethal|nonlethal	lethal|nonlethal	L3|L6	L3	pre-infant-lethal
603903	SICKLE CELL DISEASE	Sickle cell disease, 603903 (3)	Sickle cell disease	y	SICKLE CELL DISEASE	Clinical Features	death|deaths|died|fatal	HBB	HGNC:4827	Sickle cell disease, 603903 (3), Autosomal recessive	Autosomal recessive	y	y	[The earliest death occurred in a 1-year-old child who had cyanotic congenital heart; the other children were aged 3.5 to 15 years.]	L3	y	-	lethal	ambiguous|lethal|nonlethal	lethal|nonlethal	L3|L6	L3	pre-infant-lethal
603909	AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME, TYPE IIA	Autoimmune lymphoproliferative syndrome, type II, 603909 (3)	Autoimmune lymphoproliferative syndrome, type II	n	-	-	-	CASP10	HGNC:1500	Autoimmune lymphoproliferative syndrome, type II, 603909 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
603965	FOCAL SEGMENTAL GLOMERULOSCLEROSIS 2	Glomerulosclerosis, focal segmental, 2, 603965 (3)	Glomerulosclerosis, focal segmental, 2	n	-	-	-	TRPC6	HGNC:12338	Glomerulosclerosis, focal segmental, 2, 603965 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
604004	MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 1	Megalencephalic leukoencephalopathy with subcortical cysts 1, 604004 (3)	Megalencephalic leukoencephalopathy with subcortical cysts 1	y	MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 1; MLC1	Clinical Features	died	MLC1	HGNC:17082	Megalencephalic leukoencephalopathy with subcortical cysts 1, 604004 (3), Autosomal recessive	Autosomal recessive	y	n	-	-	-	-	ambiguous	ambiguous	ambiguous	-	-	-
604091	HYPOALPHALIPOPROTEINEMIA, PRIMARY, 1	HDL deficiency, familial, 1, 604091 (3)	HDL deficiency, familial, 1	n	-	-	-	ABCA1	HGNC:29	HDL deficiency, familial, 1, 604091 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
604116	CONE-ROD DYSTROPHY 3	Cone-rod dystrophy 3, 604116 (3)	Cone-rod dystrophy 3	n	-	-	-	ABCA4	HGNC:34	Cone-rod dystrophy 3, 604116 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	ambiguous|nonlethal	ambiguous	-	-	-
604117	VOHWINKEL SYNDROME, VARIANT FORM	Vohwinkel syndrome with ichthyosis, 604117 (3)	Vohwinkel syndrome with ichthyosis	n	-	-	-	LORICRIN	HGNC:6663	Vohwinkel syndrome with ichthyosis, 604117 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
604121	CEREBELLAR ATAXIA, DEAFNESS, AND NARCOLEPSY, AUTOSOMAL DOMINANT	Cerebellar ataxia, deafness, and narcolepsy, autosomal dominant, 604121 (3)	Cerebellar ataxia, deafness, and narcolepsy, autosomal dominant	n	-	-	-	DNMT1	HGNC:2976	Cerebellar ataxia, deafness, and narcolepsy, autosomal dominant, 604121 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L6	L6	post-infant-lethal
604129	EPIDERMOLYSIS BULLOSA PRURIGINOSA	Epidermolysis bullosa pruriginosa, 604129 (3)	Epidermolysis bullosa pruriginosa	n	-	-	-	COL7A1	HGNC:2214	Epidermolysis bullosa pruriginosa, 604129 (3), Autosomal dominant, Autosomal recessive	Autosomal dominant, Autosomal recessive	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L6	L6	post-infant-lethal
604131	ALPHA-THALASSEMIA	Thalassemias, alpha-, 604131 (3)	Thalassemias, alpha-	y	ALPHA-THALASSEMIA	Description|Clinical Features	death|deaths|die|lethal	HBA1	HGNC:4823	Thalassemias, alpha-, 604131 (3)	-	y	y	[These fetuses almost always succumb in utero during the second or third trimester of gestation, or die within hours after birth]	L1	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L1	L1	pre-infant-lethal
604131	ALPHA-THALASSEMIA	Thalassemia, alpha-, 604131 (3)	Thalassemia, alpha-	y	ALPHA-THALASSEMIA	Description|Clinical Features	death|deaths|die|lethal	HBA2	HGNC:4824	Thalassemia, alpha-, 604131 (3)	-	y	y	[These fetuses almost always succumb in utero during the second or third trimester of gestation, or die within hours after birth]	L1	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L1	L1	pre-infant-lethal
604145	CARDIOMYOPATHY, DILATED, 1G	Cardiomyopathy, dilated, 1G, 604145 (3)	Cardiomyopathy, dilated, 1G	y	CARDIOMYOPATHY, DILATED, 1G; CMD1G	Clinical Features|Clinical Synopsis	death|deaths|died	TTN	HGNC:12403	Cardiomyopathy, dilated, 1G, 604145 (3), Autosomal dominant	Autosomal dominant	y	y	[Premature deaths, in the third to sixth decade of life]	L6	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L6|LU	L6	post-infant-lethal
604168	CONGENITAL CATARACTS, FACIAL DYSMORPHISM, AND NEUROPATHY	Congenital cataracts, facial dysmorphism, and neuropathy, 604168 (3)	Congenital cataracts, facial dysmorphism, and neuropathy	n	-	-	-	CTDP1	HGNC:2498	Congenital cataracts, facial dysmorphism, and neuropathy, 604168 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
604169	LEFT VENTRICULAR NONCOMPACTION 1	Left ventricular noncompaction 1, with or without congenital heart defects, 604169 (3)	Left ventricular noncompaction 1, with or without congenital heart defects	y	LEFT VENTRICULAR NONCOMPACTION 1; LVNC1	Clinical Features|Clinical Synopsis|Phenotype	death|deaths|died	DTNA	HGNC:3057	Left ventricular noncompaction 1, with or without congenital heart defects, 604169 (3), Autosomal dominant	Autosomal dominant	n	y	[Sudden cardiac death / Kurosaki et al. (1999) described a possibly autosomal dominant form of isolated noncompaction of the left ventricular myocardium....He died of progressive congestive heart failure at the age of 59 years. Autopsy showed trabeculations at the apex of the left ventricle]	L6	y	-	lethal	lethal	lethal	L6	L6	post-infant-lethal
604173	POIKILODERMA WITH NEUTROPENIA	Poikiloderma with neutropenia, 604173 (3)	Poikiloderma with neutropenia	y	POIKILODERMA WITH NEUTROPENIA; PN	Clinical Features	died	USB1	HGNC:25792	Poikiloderma with neutropenia, 604173 (3), Autosomal recessive	Autosomal recessive	y	y	[Van Hove et al. (2005) reported 2 sibs from a consanguineous Turkish family with poikiloderma of the limbs and face, plantar keratoderma, toenail pachyonychia, and neutropenia and neutrophil dysfunction resulting in frequent respiratory infections. The proband died at 2 years of age from respiratory failure due to a bronchocentric granulomatous pneumonia]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
604187	SPASTIC PARAPLEGIA 10, AUTOSOMAL DOMINANT	Spastic paraplegia 10, autosomal dominant, 604187 (3)	Spastic paraplegia 10, autosomal dominant	n	-	-	-	KIF5A	HGNC:6323	Spastic paraplegia 10, autosomal dominant, 604187 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L3	L3	pre-infant-lethal
604213	CHUDLEY-MCCULLOUGH SYNDROME	Chudley-McCullough syndrome, 604213 (3)	Chudley-McCullough syndrome	n	-	-	-	GPSM2	HGNC:29501	Chudley-McCullough syndrome, 604213 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
604218	ENCEPHALOPATHY, FAMILIAL, WITH NEUROSERPIN INCLUSION BODIES	Encephalopathy, familial, with neuroserpin inclusion bodies, 604218 (3)	Encephalopathy, familial, with neuroserpin inclusion bodies	y	ENCEPHALOPATHY, FAMILIAL, WITH NEUROSERPIN INCLUSION BODIES; FENIB	Clinical Features	died	SERPINI1	HGNC:8943	Encephalopathy, familial, with neuroserpin inclusion bodies, 604218 (3), Autosomal dominant	Autosomal dominant	y	y	[Davis et al. (2002) reported additional patients with the disorder. A 23-year-old man had an 8-year history of progressive myoclonic epilepsy, dementia, tremor, and dysarthria. The second patient was a 13-year-old girl with progressive myoclonus epilepsy with intractable seizures, myoclonus, and dementia. She died at age 19 years during status epilepticus. Her father was said to be mentally deficient, and a paternal uncle had died from epilepsy at 18 years of age]	L5	y	y	lethal	lethal	lethal	L5	L5	post-infant-lethal
604219	CATARACT 9, MULTIPLE TYPES	Cataract 9, multiple types, 604219 (3)	Cataract 9, multiple types	n	-	-	-	CRYAA	HGNC:2388	Cataract 9, multiple types, 604219 (3), Autosomal dominant, Autosomal recessive	Autosomal dominant, Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
604229	ANTERIOR SEGMENT DYSGENESIS 5	Anterior segment dysgenesis 5, multiple subtypes, 604229 (3)	Anterior segment dysgenesis 5, multiple subtypes	n	-	-	-	PAX6	HGNC:8620	Anterior segment dysgenesis 5, multiple subtypes, 604229 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	ambiguous|lethal|nonlethal	lethal|nonlethal	LU	LU	post-infant-lethal
604232	LEBER CONGENITAL AMAUROSIS 3	Leber congenital amaurosis 3, 604232 (3)	Leber congenital amaurosis 3	n	-	-	-	SPATA7	HGNC:20423	Leber congenital amaurosis 3, 604232 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
604232	LEBER CONGENITAL AMAUROSIS 3	Retinitis pigmentosa 94, variable age at onset, autosomal recessive, 604232 (3)	Retinitis pigmentosa 94, variable age at onset, autosomal recessive	n	-	-	-	SPATA7	HGNC:20423	Retinitis pigmentosa 94, variable age at onset, autosomal recessive, 604232 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
604233	GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 1	Generalized epilepsy with febrile seizures plus, type 1, 604233 (3)	Generalized epilepsy with febrile seizures plus, type 1	n	-	-	-	SCN1B	HGNC:10586	Generalized epilepsy with febrile seizures plus, type 1, 604233 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L3|L6	L3	pre-infant-lethal
604250	HEMOCHROMATOSIS, TYPE 3	Hemochromatosis, type 3, 604250 (3)	Hemochromatosis, type 3	n	-	-	-	TFR2	HGNC:11762	Hemochromatosis, type 3, 604250 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
604271	GROWTH HORMONE INSENSITIVITY, PARTIAL	Growth hormone insensitivity, partial, 604271 (3)	Growth hormone insensitivity, partial	n	-	-	-	GHR	HGNC:4263	Growth hormone insensitivity, partial, 604271 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
604278	RENAL TUBULAR ACIDOSIS, PROXIMAL, WITH OCULAR ABNORMALITIES AND IMPAIRED INTELLECTUAL DEVELOPMENT	Renal tubular acidosis, proximal, with ocular abnormalities, 604278 (3)	Renal tubular acidosis, proximal, with ocular abnormalities	n	-	-	-	SLC4A4	HGNC:11030	Renal tubular acidosis, proximal, with ocular abnormalities, 604278 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
604286	MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 4	Muscular dystrophy, limb-girdle, autosomal recessive 4, 604286 (3)	Muscular dystrophy, limb-girdle, autosomal recessive 4	y	MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 4; LGMDR4	Clinical Features	died|fatal	SGCB	HGNC:10806	Muscular dystrophy, limb-girdle, autosomal recessive 4, 604286 (3), Autosomal recessive	Autosomal recessive	y	y	[Barresi et al. (2000) reported 2 unrelated males with LGMD2E who developed fatal dilated cardiomyopathy and died at ages 27 and 18 years, respectively]	L5	y	-	lethal	lethal	lethal	L5	L5	post-infant-lethal
604290	ACERULOPLASMINEMIA	Cerebellar ataxia, 604290 (3)	Cerebellar ataxia	n	-	-	-	CP	HGNC:2295	Cerebellar ataxia, 604290 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
604290	ACERULOPLASMINEMIA	Hemosiderosis, systemic, due to aceruloplasminemia, 604290 (3)	Hemosiderosis, systemic, due to aceruloplasminemia	n	-	-	-	CP	HGNC:2295	Hemosiderosis, systemic, due to aceruloplasminemia, 604290 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
604292	ECTRODACTYLY, ECTODERMAL DYSPLASIA, AND CLEFT LIP/PALATE SYNDROME 3	Ectrodactyly, ectodermal dysplasia, and cleft lip/palate syndrome 3, 604292 (3)	Ectrodactyly, ectodermal dysplasia, and cleft lip/palate syndrome 3	n	-	-	-	TP63	HGNC:15979	Ectrodactyly, ectodermal dysplasia, and cleft lip/palate syndrome 3, 604292 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L2	L2	pre-infant-lethal
604307	CATARACT 2, MULTIPLE TYPES	Cataract 2, multiple types, 604307 (3)	Cataract 2, multiple types	n	-	-	-	CRYGC	HGNC:2410	Cataract 2, multiple types, 604307 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
604308	MASS SYNDROME	MASS syndrome, 604308 (3)	MASS syndrome	n	-	-	-	FBN1	HGNC:3603	MASS syndrome, 604308 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	ambiguous|lethal|nonlethal	lethal|nonlethal	L2|LU	L2	pre-infant-lethal
604317	MICROCEPHALY 2, PRIMARY, AUTOSOMAL RECESSIVE, WITH OR WITHOUT CORTICAL MALFORMATIONS	Microcephaly 2, primary, autosomal recessive, with or without cortical malformations, 604317 (3)	Microcephaly 2, primary, autosomal recessive, with or without cortical malformations	n	-	-	-	WDR62	HGNC:24502	Microcephaly 2, primary, autosomal recessive, with or without cortical malformations, 604317 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
604320	NEURONOPATHY, DISTAL HEREDITARY MOTOR, AUTOSOMAL RECESSIVE 1	Neuronopathy, distal hereditary motor, autosomal recessive 1, 604320 (3)	Neuronopathy, distal hereditary motor, autosomal recessive 1	y	NEURONOPATHY, DISTAL HEREDITARY MOTOR, AUTOSOMAL RECESSIVE 1; HMNR1	Description|Clinical Features|Clinical Synopsis	die|death|deaths|died	IGHMBP2	HGNC:5542	Neuronopathy, distal hereditary motor, autosomal recessive 1, 604320 (3), Autosomal recessive	Autosomal recessive	y	y	[The first affected son died at the age of 10 weeks of suspected sudden infant death syndrome (SIDS; 272120).]	L3	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L3	L3	pre-infant-lethal
604321	MICROCEPHALY 4, PRIMARY, AUTOSOMAL RECESSIVE	Microcephaly 4, primary, autosomal recessive, 604321 (3)	Microcephaly 4, primary, autosomal recessive	n	-	-	-	KNL1	HGNC:24054	Microcephaly 4, primary, autosomal recessive, 604321 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
604326	SPINOCEREBELLAR ATAXIA 12	Spinocerebellar ataxia 12, 604326 (3)	Spinocerebellar ataxia 12	n	-	-	-	PPP2R2B	HGNC:9305	Spinocerebellar ataxia 12, 604326 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
604356	DUANE RETRACTION SYNDROME 2	Duane retraction syndrome 2, 604356 (3)	Duane retraction syndrome 2	n	-	-	-	CHN1	HGNC:1943	Duane retraction syndrome 2, 604356 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
604360	SPASTIC PARAPLEGIA 11, AUTOSOMAL RECESSIVE	Spastic paraplegia 11, autosomal recessive, 604360 (3)	Spastic paraplegia 11, autosomal recessive	n	-	-	-	SPG11	HGNC:11226	Spastic paraplegia 11, autosomal recessive, 604360 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
604364	EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 1	Epilepsy, familial focal, with variable foci 1, 604364 (3)	Epilepsy, familial focal, with variable foci 1	y	EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 1; FFEVF1	Description|Clinical Features|Clinical Synopsis	death|deaths|died	DEPDC5	HGNC:18423	Epilepsy, familial focal, with variable foci 1, 604364 (3), Autosomal dominant	Autosomal dominant	y	y	[Two affected individuals died of sudden unexplained death in epilepsy (SUDEP) at 58 and 50 years of age.]	L6	y	-	lethal	lethal	lethal	L3|L6	L3	pre-infant-lethal
604367	LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 3	Insulin resistance, severe, digenic, 604367 (3)	Insulin resistance, severe, digenic	n	-	-	-	PPARG	HGNC:9236	Insulin resistance, severe, digenic, 604367 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
604367	LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 3	Lipodystrophy, familial partial, type 3, 604367 (3)	Lipodystrophy, familial partial, type 3	n	-	-	-	PPARG	HGNC:9236	Lipodystrophy, familial partial, type 3, 604367 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
604369	SALLA DISEASE	Salla disease, 604369 (3)	Salla disease	y	SALLA DISEASE; SD	Clinical Features	death|deaths|died	SLC17A5	HGNC:10933	Salla disease, 604369 (3), Autosomal recessive	Autosomal recessive	n	y	[No precisely similar patients with urinary excretion of free sialic acid had, it seemed, been reported outside Finland. However, Hancock et al. (1982) reported a patient with extensive accumulation of free NeuAc in tissues and abnormal storage lysosomes who pursued a fulminant clinical course ending in death at 5 months]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
604377	MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 2	Mitochondrial complex IV deficiency, nuclear type 2, 604377 (3)	Mitochondrial complex IV deficiency, nuclear type 2	y	MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 2; MC4DN2	Description|Clinical Features|Clinical Synopsis|Phenotype	death|deaths|die|died|fatal|spontaneous_abortion|spontaneous_abortions	SCO2	HGNC:10604	Mitochondrial complex IV deficiency, nuclear type 2, 604377 (3), Autosomal recessive	Autosomal recessive	y	y	[Tay et al. (2004) reported a woman whose first pregnancy resulted in spontaneous abortion at 11 weeks' gestation and whose second child died at age 53 days from fatal infantile cardioencephalomyopathy with compound heterozygosity for 2 mutations in the SCO2 gene (604272.0001; 604272.0002; Papadopoulou et al., 1999) / Verdijk et al. (2008) reported 2 sibs with fatal infantile cardioencephalomyopathy. The proband presented at birth with hypotonia and respiratory insufficiency. He later developed seizures and inspiratory stridor thought to be partly due to brainstem abnormalities. Laboratory studies revealed increased lactate and pyruvate. He died at age 25 days from hypertrophic cardiomyopathy]	L1	y	y	lethal	ambiguous|lethal	lethal	L1	L1	pre-infant-lethal
604379	HYPOTRICHOSIS 7	Hypotrichosis 7, 604379 (3)	Hypotrichosis 7	n	-	-	-	LIPH	HGNC:18483	Hypotrichosis 7, 604379 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
604379	HYPOTRICHOSIS 7	Woolly hair, autosomal recessive 2 with or without hypotrichosis, 604379 (3)	Woolly hair, autosomal recessive 2 with or without hypotrichosis	n	-	-	-	LIPH	HGNC:18483	Woolly hair, autosomal recessive 2 with or without hypotrichosis, 604379 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
604387	NEPHRONOPHTHISIS 3	Nephronophthisis 3, 604387 (3)	Nephronophthisis 3	y	NEPHRONOPHTHISIS 3; NPHP3	Clinical Features|Phenotype	lethal	NPHP3	HGNC:7907	Nephronophthisis 3, 604387 (3), Autosomal recessive	Autosomal recessive	n	y	[lethal neonatal nephronophthisis]	LU	y	-	lethal	lethal	lethal	L1|LU	L1	pre-infant-lethal
604391	ATAXIA-TELANGIECTASIA-LIKE DISORDER 1	Ataxia-telangiectasia-like disorder 1, 604391 (3)	Ataxia-telangiectasia-like disorder 1	n	-	-	-	MRE11	HGNC:7230	Ataxia-telangiectasia-like disorder 1, 604391 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
604393	LEBER CONGENITAL AMAUROSIS 4	Cone-rod dystrophy, 604393 (3)	Cone-rod dystrophy	n	-	-	-	AIPL1	HGNC:359	Cone-rod dystrophy, 604393 (3), Autosomal dominant, Autosomal recessive	Autosomal dominant, Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
604393	LEBER CONGENITAL AMAUROSIS 4	Leber congenital amaurosis 4, 604393 (3)	Leber congenital amaurosis 4	n	-	-	-	AIPL1	HGNC:359	Leber congenital amaurosis 4, 604393 (3), Autosomal dominant, Autosomal recessive	Autosomal dominant, Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
604393	LEBER CONGENITAL AMAUROSIS 4	Retinitis pigmentosa, juvenile, 604393 (3)	Retinitis pigmentosa, juvenile	n	-	-	-	AIPL1	HGNC:359	Retinitis pigmentosa, juvenile, 604393 (3), Autosomal dominant, Autosomal recessive	Autosomal dominant, Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
604400	ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 5	Arrhythmogenic right ventricular dysplasia 5, 604400 (3)	Arrhythmogenic right ventricular dysplasia 5	y	ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 5; ARVD5	Clinical Features|Clinical Synopsis	death|deaths|died|lethal	TMEM43	HGNC:28472	Arrhythmogenic right ventricular dysplasia 5, 604400 (3), Autosomal dominant	Autosomal dominant	n	y	[Sudden cardiac death frequent in affected families]	LU	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L6|LU	L6	post-infant-lethal
604403	GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 2	Febrile seizures, familial, 3A, 604403 (3)	Febrile seizures, familial, 3A	n	-	-	-	SCN1A	HGNC:10585	Febrile seizures, familial, 3A, 604403 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L3|L5	L3	pre-infant-lethal
604403	GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 2	Generalized epilepsy with febrile seizures plus, type 2, 604403 (3)	Generalized epilepsy with febrile seizures plus, type 2	n	-	-	-	SCN1A	HGNC:10585	Generalized epilepsy with febrile seizures plus, type 2, 604403 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L3|L5	L3	pre-infant-lethal
604416	PYOGENIC STERILE ARTHRITIS, PYODERMA GANGRENOSUM, AND ACNE	Pyogenic sterile arthritis, pyoderma gangrenosum, and acne, 604416 (3)	Pyogenic sterile arthritis, pyoderma gangrenosum, and acne	n	-	-	-	PSTPIP1	HGNC:9580	Pyogenic sterile arthritis, pyoderma gangrenosum, and acne, 604416 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
604432	SPINOCEREBELLAR ATAXIA 11	Spinocerebellar ataxia 11, 604432 (3)	Spinocerebellar ataxia 11	n	-	-	-	TTBK2	HGNC:19141	Spinocerebellar ataxia 11, 604432 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
604454	WELANDER DISTAL MYOPATHY	Welander distal myopathy, 604454 (3)	Welander distal myopathy	n	-	-	-	TIA1	HGNC:11802	Welander distal myopathy, 604454 (3), Autosomal dominant, Autosomal recessive	Autosomal dominant, Autosomal recessive	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L6	L6	post-infant-lethal
604484	NEUROPATHY, HEREDITARY MOTOR AND SENSORY, OKINAWA TYPE	Hereditary motor and sensory neuropathy, Okinawa type, 604484 (3)	Hereditary motor and sensory neuropathy, Okinawa type	y	NEUROPATHY, HEREDITARY MOTOR AND SENSORY, OKINAWA TYPE; HMSNO	Clinical Features	died	TFG	HGNC:11758	Hereditary motor and sensory neuropathy, Okinawa type, 604484 (3), Autosomal dominant	Autosomal dominant	y	n	-	-	-	-	ambiguous	ambiguous	ambiguous	-	-	-
604498	AMEGAKARYOCYTIC THROMBOCYTOPENIA, CONGENITAL, 1	Thrombocytopenia, congenital amegakaryocytic, 604498 (3)	Thrombocytopenia, congenital amegakaryocytic	y	AMEGAKARYOCYTIC THROMBOCYTOPENIA, CONGENITAL, 1; CAMT1	Clinical Features	died	MPL	HGNC:7217	Thrombocytopenia, congenital amegakaryocytic, 604498 (3), Autosomal recessive	Autosomal recessive	y	y	[King et al. (2005) studied 20 children with CAMT, including 7 previously analyzed for TPO reactivity and MPL mutations by Ballmaier et al. (2001). Six (30%) of the 20 children died]	L4	y	-	lethal	lethal	lethal	L4	L4	post-infant-lethal
604536	ECTODERMAL DYSPLASIA/SKIN FRAGILITY SYNDROME	Ectodermal dysplasia/skin fragility syndrome, 604536 (3)	Ectodermal dysplasia/skin fragility syndrome	n	-	-	-	PKP1	HGNC:9023	Ectodermal dysplasia/skin fragility syndrome, 604536 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
604537	LEBER CONGENITAL AMAUROSIS 5	Leber congenital amaurosis 5, 604537 (3)	Leber congenital amaurosis 5	n	-	-	-	LCA5	HGNC:31923	Leber congenital amaurosis 5, 604537 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
604559	PROGRESSIVE FAMILIAL HEART BLOCK, TYPE IB	Progressive familial heart block, type IB, 604559 (3)	Progressive familial heart block, type IB	y	PROGRESSIVE FAMILIAL HEART BLOCK, TYPE IB; PFHB1B	Clinical Features	death|deaths	TRPM4	HGNC:17993	Progressive familial heart block, type IB, 604559 (3), Autosomal dominant	Autosomal dominant	n	y	[Brink and Torrington (1977) reported a 6-generation South African family of Portuguese and French ancestry with 261 known relatives, in which conduction defects segregated in an autosomal dominant pattern... Sudden cardiac death occurred in 22 individuals over the 3 generations, also at increasingly younger ages, dropping from an average of 50.7 years to 44.7 years to 12.3 years in the fourth, fifth, and sixth generations, respectively]	L5	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L5	L5	post-infant-lethal
604563	CHARCOT-MARIE-TOOTH DISEASE, TYPE 4B2	Charcot-Marie-Tooth disease, type 4B2, 604563 (3)	Charcot-Marie-Tooth disease, type 4B2	n	-	-	-	SBF2	HGNC:2135	Charcot-Marie-Tooth disease, type 4B2, 604563 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
604571	BARE LYMPHOCYTE SYNDROME, TYPE I	Bare lymphocyte syndrome, type I, 604571 (3)	Bare lymphocyte syndrome, type I	n	-	-	-	TAP1	HGNC:43	Bare lymphocyte syndrome, type I, 604571 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
604571	BARE LYMPHOCYTE SYNDROME, TYPE I	Bare lymphocyte syndrome, type I, due to TAP2 deficiency, 604571 (3)	Bare lymphocyte syndrome, type I, due to TAP2 deficiency	n	-	-	-	TAP2	HGNC:44	Bare lymphocyte syndrome, type I, due to TAP2 deficiency, 604571 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
604571	BARE LYMPHOCYTE SYNDROME, TYPE I	Bare lymphocyte syndrome, type I, 604571 (3)	Bare lymphocyte syndrome, type I	n	-	-	-	TAPBP	HGNC:11566	Bare lymphocyte syndrome, type I, 604571 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
604625	TOOTH AGENESIS, SELECTIVE, 3	Tooth agenesis, selective, 3, 604625 (3)	Tooth agenesis, selective, 3	n	-	-	-	PAX9	HGNC:8623	Tooth agenesis, selective, 3, 604625 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
604717	DEAFNESS, AUTOSOMAL DOMINANT 20	Deafness, autosomal dominant 20/26, 604717 (3)	Deafness, autosomal dominant 20/26	n	-	-	-	ACTG1	HGNC:144	Deafness, autosomal dominant 20/26, 604717 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
604757	CRANIOSYNOSTOSIS 2	Craniosynostosis 2, 604757 (3)	Craniosynostosis 2	n	-	-	-	MSX2	HGNC:7392	Craniosynostosis 2, 604757 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
604765	CARDIOMYOPATHY, DILATED, 1I	Cardiomyopathy, dilated, 1I, 604765 (3)	Cardiomyopathy, dilated, 1I	y	CARDIOMYOPATHY, DILATED, 1I; CMD1I	Clinical Features|Clinical Synopsis|Phenotype	death|deaths|died	DES	HGNC:2770	Cardiomyopathy, dilated, 1I, 604765 (3), Autosomal dominant	Autosomal dominant	y	y	[Sudden death (in some patients) / Brodehl et al. (2013) studied a large 4-generation family segregating autosomal dominant cardiomyopathy and sudden cardiac death (SCD). The 34-year-old female proband presented with atrial flutter, variable AV conduction, and biatrial dilation. Echocardiography showed normal left ventricular systolic function with an ejection fraction of 67% and borderline concentric left ventricular hypertrophy. Her family history was remarkable for 10 instances of SCD, including 1 sister and 2 brothers who all died in their teens; 2 paternal cousins who died at ages 13 and 30 years; 2 paternal second cousins who died at 13 years; and 3 paternal aunts who died in the fourth and fifth decades of life]	L5	y	y	lethal	lethal	lethal	L5|L6|LU	L5	post-infant-lethal
604772	VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 1, WITH OR WITHOUT ATRIAL DYSFUNCTION AND/OR DILATED CARDIOMYOPATHY	Ventricular tachycardia, catecholaminergic polymorphic, 1, 604772 (3)	Ventricular tachycardia, catecholaminergic polymorphic, 1	y	VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 1, WITH OR WITHOUT ATRIAL DYSFUNCTION AND/OR DILATED CARDIOMYOPATHY; CPVT1	Description|Clinical Features|Clinical Synopsis|Phenotype	death|deaths|died	RYR2	HGNC:10484	Ventricular tachycardia, catecholaminergic polymorphic, 1, 604772 (3), Autosomal dominant	Autosomal dominant	y	y	[Tester et al. (2020) reported 2 large multiply consanguineous Amish families in which a phenotype consistent with CPVT1 segregated with homozygosity for a large tandem duplication involving 26,000 basepairs of intergenic sequence, the RYR2 5-prime UTR/promoter region, and exons 1 through 4 of the RYR2 gene (see CYTOGENETICS). Multiple young members experienced exercise-associated syncope, cardiac arrest, and/or sudden unexplained death. The proband of family 1, who had a normal electrocardiogram (ECG) and exercise stress test after an episode of exercise-associated syncope, died suddenly several years later at age 12 during physical exertion. She had 3 sisters who also experienced exercise-associated sudden cardiac death, at 10, 9, and 3 years of age.]	L4	n	y	lethal	lethal	lethal	L4|LU	L4	post-infant-lethal
604777	ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 5	Ichthyosis, congenital, autosomal recessive 5, 604777 (3)	Ichthyosis, congenital, autosomal recessive 5	n	-	-	-	CYP4F22	HGNC:26820	Ichthyosis, congenital, autosomal recessive 5, 604777 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
604804	MICROCEPHALY 3, PRIMARY, AUTOSOMAL RECESSIVE	Microcephaly 3, primary, autosomal recessive, 604804 (3)	Microcephaly 3, primary, autosomal recessive	n	-	-	-	CDK5RAP2	HGNC:18672	Microcephaly 3, primary, autosomal recessive, 604804 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
604805	SPASTIC PARAPLEGIA 12, AUTOSOMAL DOMINANT	Spastic paraplegia 12, autosomal dominant, 604805 (3)	Spastic paraplegia 12, autosomal dominant	n	-	-	-	RTN2	HGNC:10468	Spastic paraplegia 12, autosomal dominant, 604805 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
604841	STICKLER SYNDROME, TYPE II	Stickler syndrome, type II, 604841 (3)	Stickler syndrome, type II	n	-	-	-	COL11A1	HGNC:2186	Stickler syndrome, type II, 604841 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L1	L1	pre-infant-lethal
604864	OSTEOARTHRITIS WITH MILD CHONDRODYSPLASIA	Osteoarthritis with mild chondrodysplasia, 604864 (3)	Osteoarthritis with mild chondrodysplasia	y	OSTEOARTHRITIS WITH MILD CHONDRODYSPLASIA; OSCDP	Clinical Features	died	COL2A1	HGNC:2200	Osteoarthritis with mild chondrodysplasia, 604864 (3), Autosomal dominant	Autosomal dominant	n	n	-	-	-	-	ambiguous	ambiguous|lethal|nonlethal	lethal|nonlethal	L1|L2|L3	L1	pre-infant-lethal
604928	WOLFRAM SYNDROME 2	Wolfram syndrome 2, 604928 (3)	Wolfram syndrome 2	n	-	-	-	CISD2	HGNC:24212	Wolfram syndrome 2, 604928 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
604931	CORTISONE REDUCTASE DEFICIENCY 1	Cortisone reductase deficiency 1, 604931 (3)	Cortisone reductase deficiency 1	n	-	-	-	H6PD	HGNC:4795	Cortisone reductase deficiency 1, 604931 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
605013	MICROHYDRANENCEPHALY	Microhydranencephaly, 605013 (3)	Microhydranencephaly	y	MICROHYDRANENCEPHALY; MHAC	Clinical Features|Phenotype	died	NDE1	HGNC:17619	Microhydranencephaly, 605013 (3), Autosomal recessive	Autosomal recessive	y	y	[died at age 7 year]	L4	n	y	lethal	lethal	lethal	L4	L4	post-infant-lethal
605019	HYPOBETALIPOPROTEINEMIA, FAMILIAL, 2	Hypobetalipoproteinemia, familial, 2, 605019 (3)	Hypobetalipoproteinemia, familial, 2	y	HYPOBETALIPOPROTEINEMIA, FAMILIAL, 2; FHBL2	Clinical Features	died	ANGPTL3	HGNC:491	Hypobetalipoproteinemia, familial, 2, 605019 (3), Autosomal recessive	Autosomal recessive	n	y	[Pisciotta et al. (2012) studied 3 kindreds from northern Italy in which affected members had absence of plasma ANGPTL3 and mutations in the ANGPTL3 gene (see MOLECULAR GENETICS)... There was a family history of premature coronary artery disease; his father had died of a myocardial infarction at 40 years of age.]	L6	n	y	lethal	lethal	lethal	L6	L6	post-infant-lethal
605021	MYOCLONIC EPILEPSY, FAMILIAL INFANTILE	Myoclonic epilepsy, infantile, familial, 605021 (3)	Myoclonic epilepsy, infantile, familial	n	-	-	-	TBC1D24	HGNC:29203	Myoclonic epilepsy, infantile, familial, 605021 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L2|L3	L2	pre-infant-lethal
605027	LYMPHOMA, NON-HODGKIN, FAMILIAL	Lymphoma, non-Hodgkin, 605027 (3)	Lymphoma, non-Hodgkin	n	-	-	-	PRF1	HGNC:9360	Lymphoma, non-Hodgkin, 605027 (3)	-	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L4	L4	post-infant-lethal
605039	BOHRING-OPITZ SYNDROME	Bohring-Opitz syndrome, 605039 (3)	Bohring-Opitz syndrome	y	BOHRING-OPITZ SYNDROME; BOPS	Clinical Features|Clinical Synopsis	died|death|deaths	ASXL1	HGNC:18318	Bohring-Opitz syndrome, 605039 (3), Autosomal dominant	Autosomal dominant	y	y	[Hoischen et al. (2011) reported 7 unrelated patients with Bohring-Opitz syndrome due to de novo heterozygous mutations in the ASXL1 gene (see MOLECULAR GENETICS). All patients fulfilled the main criteria proposed by Bohring et al. (2006). There were 6 females and 1 male, ranging in age from 2.5 to 24 years, although 2 died at ages 6 years and 23 hours after birth, respectively]	L2	y	-	lethal	lethal	lethal	L2	L2	pre-infant-lethal
605041	BROOKE-SPIEGLER SYNDROME	Brooke-Spiegler syndrome, 605041 (3)	Brooke-Spiegler syndrome	n	-	-	-	CYLD	HGNC:2584	Brooke-Spiegler syndrome, 605041 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	ambiguous|nonlethal	ambiguous	-	-	-
605074	RENAL CELL CARCINOMA, PAPILLARY, 1	Renal cell carcinoma, papillary, 605074 (3)	Renal cell carcinoma, papillary	n	-	-	-	PRCC	HGNC:9343	Renal cell carcinoma, papillary, 605074 (3)	-	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
605115	HYPERTENSION, EARLY-ONSET, AUTOSOMAL DOMINANT, WITH SEVERE EXACERBATION IN PREGNANCY	Hypertension, early-onset, autosomal dominant, with exacerbation in pregnancy, 605115 (3)	Hypertension, early-onset, autosomal dominant, with exacerbation in pregnancy	y	HYPERTENSION, EARLY-ONSET, AUTOSOMAL DOMINANT, WITH SEVERE EXACERBATION IN PREGNANCY	Clinical Features	died	NR3C2	HGNC:7979	Hypertension, early-onset, autosomal dominant, with exacerbation in pregnancy, 605115 (3)	-	y	y	[Of note, 3 deceased family members with early-onset hypertension died of heart failure before age 50.]	L6	-	y	lethal	lethal|nonlethal	lethal|nonlethal	L6	L6	post-infant-lethal
605130	WIEDEMANN-STEINER SYNDROME	Wiedemann-Steiner syndrome, 605130 (3)	Wiedemann-Steiner syndrome	n	-	-	-	KMT2A	HGNC:7132	Wiedemann-Steiner syndrome, 605130 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
605192	DEAFNESS, AUTOSOMAL DOMINANT 23	Deafness, autosomal dominant 23, 605192 (3)	Deafness, autosomal dominant 23	n	-	-	-	SIX1	HGNC:10887	Deafness, autosomal dominant 23, 605192 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
605231	BARDET-BIEDL SYNDROME 6	Bardet-Biedl syndrome 6, 605231 (3)	Bardet-Biedl syndrome 6	y	BARDET-BIEDL SYNDROME 6; BBS6	Clinical Features	died	MKKS	HGNC:7108	Bardet-Biedl syndrome 6, 605231 (3), Autosomal recessive	Autosomal recessive	y	y	[Slavotinek et al. (2000) described patients from 4 families with BBS6. The first was a 13-year-old Hispanic girl with severe retinitis pigmentosa, postaxial polydactyly, mental retardation, and obesity (BMI greater than 40). A second proband and her affected brother had retinitis pigmentosa, postaxial polydactyly, mild mental retardation, morbid obesity (BMI greater than 50 and 37, respectively), lobulated kidneys with prominent calyces, and diabetes mellitus. A deceased sister had similar phenotypic features and also had vaginal atresia and syndactyly of both feet. A third family included a 4-year-old male proband with reduced visual acuity, postaxial polydactyly, obesity, and cystic kidneys, and a sib with hypospadias, postaxial polydactyly, obesity, and lobular cystic kidneys who died at age 18 months]	L3	y	-	lethal	lethal	lethal	L1|L3	L1	pre-infant-lethal
605253	NEUROPATHY, CONGENITAL HYPOMYELINATING, 1, AUTOSOMAL RECESSIVE	Hypomyelinating neuropathy, congenital, 1, 605253 (3)	Hypomyelinating neuropathy, congenital, 1	y	NEUROPATHY, CONGENITAL HYPOMYELINATING, 1, AUTOSOMAL RECESSIVE; CHN1	Description	died	EGR2	HGNC:3239	Hypomyelinating neuropathy, congenital, 1, 605253 (3), Autosomal dominant, Autosomal recessive	Autosomal dominant, Autosomal recessive	n	y	[Cormier-Daire et al. (2000) reported the association of absent patellae, genital and renal anomalies, dysmorphic features, and mental retardation in 6 boys and 1 girl belonging to 5 unrelated families. Flexion deformities of the knees and hips with clubfeet and absent patellae were consistently observed, and scrotal hypoplasia and cryptorchidism were present in all boys. Dysmorphic features included coarse facies, prominent nose with a high nasal bridge, and microcephaly. Multicystic kidneys or hydronephrosis were present in all cases. Agenesis of the corpus callosum was present in 4 cases. Micrognathia was found in 4 cases and pulmonary hypoplasia in 3. Other radiographic features included bilateral hypoplasia of the ischia and brachydactyly. Two of the 7 cases were detected by prenatal ultrasound and resulted in termination of pregnancy. Three of the remaining 5 children died within the first 3 years of life; 2 died within the first 6 montha]	L3	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L3|L4	L3	pre-infant-lethal
605258	IMMUNODEFICIENCY WITH HYPER-IgM, TYPE 2	Immunodeficiency with hyper-IgM, type 2, 605258 (3)	Immunodeficiency with hyper-IgM, type 2	n	-	-	-	AICDA	HGNC:13203	Immunodeficiency with hyper-IgM, type 2, 605258 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
605259	SPINOCEREBELLAR ATAXIA 13	Spinocerebellar ataxia 13, 605259 (3)	Spinocerebellar ataxia 13	n	-	-	-	KCNC3	HGNC:6235	Spinocerebellar ataxia 13, 605259 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
605275	NOONAN SYNDROME 2	Noonan syndrome 2, 605275 (3)	Noonan syndrome 2	y	NOONAN SYNDROME 2; NS2	Clinical Features	died	LZTR1	HGNC:6742	Noonan syndrome 2, 605275 (3), Autosomal recessive	Autosomal recessive	y	y	[Johnston et al. (2018) reported 23 patients (21 of whom underwent molecular analysis) from 12 families with autosomal recessive Noonan syndrome... Several patients died in the neonatal period]	L2	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L2	L2	pre-infant-lethal
605280	SPASTIC PARAPLEGIA 13, AUTOSOMAL DOMINANT	Spastic paraplegia 13, autosomal dominant, 605280 (3)	Spastic paraplegia 13, autosomal dominant	n	-	-	-	HSPD1	HGNC:5261	Spastic paraplegia 13, autosomal dominant, 605280 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L3	L3	pre-infant-lethal
605282	TEMTAMY PREAXIAL BRACHYDACTYLY SYNDROME	Temtamy preaxial brachydactyly syndrome, 605282 (3)	Temtamy preaxial brachydactyly syndrome	n	-	-	-	CHSY1	HGNC:17198	Temtamy preaxial brachydactyly syndrome, 605282 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
605285	NEUROPATHY, HEREDITARY MOTOR AND SENSORY, RUSSE TYPE	Neuropathy, hereditary motor and sensory, Russe type, 605285 (3)	Neuropathy, hereditary motor and sensory, Russe type	n	-	-	-	HK1	HGNC:4922	Neuropathy, hereditary motor and sensory, Russe type, 605285 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L3	L3	pre-infant-lethal
605289	SPLIT-HAND/FOOT MALFORMATION 4	Split-hand/foot malformation 4, 605289 (3)	Split-hand/foot malformation 4	n	-	-	-	TP63	HGNC:15979	Split-hand/foot malformation 4, 605289 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L2	L2	pre-infant-lethal
605309	MACROCEPHALY/AUTISM SYNDROME	Macrocephaly/autism syndrome, 605309 (3)	Macrocephaly/autism syndrome	n	-	-	-	PTEN	HGNC:9588	Macrocephaly/autism syndrome, 605309 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L4	L4	post-infant-lethal
605355	NEMALINE MYOPATHY 5A, AUTOSOMAL RECESSIVE, SEVERE INFANTILE	Nemaline myopathy 5A, autosomal recessive, severe infantile, 605355 (3)	Nemaline myopathy 5A, autosomal recessive, severe infantile	y	NEMALINE MYOPATHY 5A, AUTOSOMAL RECESSIVE, SEVERE INFANTILE; NEM5A	Description|Clinical Features|Clinical Synopsis|Phenotype	death|deaths|died	TNNT1	HGNC:11948	Nemaline myopathy 5A, autosomal recessive, severe infantile, 605355 (3), Autosomal recessive	Autosomal recessive	y	y	[Geraud et al. (2021) reported 3 unrelated patients with NEM5A resulting in death from respiratory failure between 6 and 29 months of age.]	L3	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L3|L6 	L3	pre-infant-lethal
605361	SPINOCEREBELLAR ATAXIA 14	Spinocerebellar ataxia 14, 605361 (3)	Spinocerebellar ataxia 14	n	-	-	-	PRKCG	HGNC:9402	Spinocerebellar ataxia 14, 605361 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
605373	PHEOCHROMOCYTOMA/PARAGANGLIOMA SYNDROME 3	Pheochromocytoma/paraganglioma syndrome 3, 605373 (3)	Pheochromocytoma/paraganglioma syndrome 3	n	-	-	-	SDHC	HGNC:10682	Pheochromocytoma/paraganglioma syndrome 3, 605373 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
605375	EPILEPSY, NOCTURNAL FRONTAL LOBE, 3	Epilepsy, nocturnal frontal lobe, 3, 605375 (3)	Epilepsy, nocturnal frontal lobe, 3	n	-	-	-	CHRNB2	HGNC:1962	Epilepsy, nocturnal frontal lobe, 3, 605375 (3)	-	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
605376	HETEROTAXY, VISCERAL, 2, AUTOSOMAL	Heterotaxy, visceral, 2, autosomal, 605376 (3)	Heterotaxy, visceral, 2, autosomal	n	-	-	-	CFC1	HGNC:18292	Heterotaxy, visceral, 2, autosomal, 605376 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
605387	CATARACT 31, MULTIPLE TYPES	Cataract 31, multiple types, 605387 (3)	Cataract 31, multiple types	n	-	-	-	CHMP4B	HGNC:16171	Cataract 31, multiple types, 605387 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
605389	HYPOTRICHOSIS 1	Hypotrichosis 1, 605389 (3)	Hypotrichosis 1	n	-	-	-	APCDD1	HGNC:15718	Hypotrichosis 1, 605389 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
605407	SEGAWA SYNDROME, AUTOSOMAL RECESSIVE	Segawa syndrome, recessive, 605407 (3)	Segawa syndrome, recessive	n	-	-	-	TH	HGNC:11782	Segawa syndrome, recessive, 605407 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
605432	RADIOULNAR SYNOSTOSIS WITH AMEGAKARYOCYTIC THROMBOCYTOPENIA 1	Radioulnar synostosis with amegakaryocytic thrombocytopenia 1, 605432 (3)	Radioulnar synostosis with amegakaryocytic thrombocytopenia 1	n	-	-	-	HOXA11	HGNC:5101	Radioulnar synostosis with amegakaryocytic thrombocytopenia 1, 605432 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
605479	CHOLESTASIS, BENIGN RECURRENT INTRAHEPATIC, 2	Cholestasis, benign recurrent intrahepatic, 2, 605479 (3)	Cholestasis, benign recurrent intrahepatic, 2	n	-	-	-	ABCB11	HGNC:42	Cholestasis, benign recurrent intrahepatic, 2, 605479 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	LU	LU	post-infant-lethal
605543	PARKINSON DISEASE 4, AUTOSOMAL DOMINANT	Parkinson disease 4, 605543 (3)	Parkinson disease 4	y	PARKINSON DISEASE 4, AUTOSOMAL DOMINANT; PARK4	Clinical Features	death|deaths|died	SNCA	HGNC:11138	Parkinson disease 4, 605543 (3), Autosomal dominant	Autosomal dominant	n	y	[Spellman (1962) described a family in which multiple members in 4 generations had autosomal dominant parkinsonism beginning in their thirties and progressing rapidly to death in 2 to 12 years]	LU	y	-	lethal	lethal	lethal	L6|LU	L6	post-infant-lethal
605583	DEAFNESS, AUTOSOMAL DOMINANT 25	Deafness, autosomal dominant 25, 605583 (3)	Deafness, autosomal dominant 25	n	-	-	-	SLC17A8	HGNC:20151	Deafness, autosomal dominant 25, 605583 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
605588	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2B1	Charcot-Marie-Tooth disease, type 2B1, 605588 (3)	Charcot-Marie-Tooth disease, type 2B1	n	-	-	-	LMNA	HGNC:6636	Charcot-Marie-Tooth disease, type 2B1, 605588 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	ambiguous|lethal|nonlethal	lethal|nonlethal	L1|L2|L6	L1	pre-infant-lethal
605594	DEAFNESS, AUTOSOMAL DOMINANT 39, WITH DENTINOGENESIS IMPERFECTA 1	Deafness, autosomal dominant 39, with dentinogenesis, 605594 (3)	Deafness, autosomal dominant 39, with dentinogenesis	n	-	-	-	DSPP	HGNC:3054	Deafness, autosomal dominant 39, with dentinogenesis, 605594 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
605635	HYPERALDOSTERONISM, FAMILIAL, TYPE II	Hyperaldosteronism, familial, type II, 605635 (3)	Hyperaldosteronism, familial, type II	n	-	-	-	CLCN2	HGNC:2020	Hyperaldosteronism, familial, type II, 605635 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
605637	CONGENITAL MYOPATHY 6 WITH OPHTHALMOPLEGIA	Congenital myopathy 6 with ophthalmoplegia, 605637 (3)	Congenital myopathy 6 with ophthalmoplegia	n	-	-	-	MYH2	HGNC:7572	Congenital myopathy 6 with ophthalmoplegia, 605637 (3), Autosomal dominant, Autosomal recessive	Autosomal dominant, Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
605670	LATE-ONSET RETINAL DEGENERATION	Retinal degeneration, late-onset, autosomal dominant, 605670 (3)	Retinal degeneration, late-onset, autosomal dominant	n	-	-	-	C1QTNF5	HGNC:14344	Retinal degeneration, late-onset, autosomal dominant, 605670 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
605676	CARDIOMYOPATHY, DILATED, WITH WOOLLY HAIR AND KERATODERMA	Cardiomyopathy, dilated, with woolly hair and keratoderma, 605676 (3)	Cardiomyopathy, dilated, with woolly hair and keratoderma	y	CARDIOMYOPATHY, DILATED, WITH WOOLLY HAIR AND KERATODERMA; DCWHK	Description|Clinical Features|Clinical Synopsis|Phenotype	death|deaths|died|die|lethal	DSP	HGNC:3052	Cardiomyopathy, dilated, with woolly hair and keratoderma, 605676 (3), Autosomal recessive	Autosomal recessive	y	y	[Risk of death due to cardiac dysfunction / The dilated cardiomyopathy sometimes led to congestive heart failure and death]	LU	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L2|L4|L5|LU	L2	pre-infant-lethal
605711	MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 1	Multiple mitochondrial dysfunctions syndrome 1, 605711 (3)	Multiple mitochondrial dysfunctions syndrome 1	y	MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 1; MMDS1	Description|Clinical Features|Clinical Synopsis|Phenotype	death|deaths|died|fatal	NFU1	HGNC:16287	Multiple mitochondrial dysfunctions syndrome 1, 605711 (3), Autosomal recessive	Autosomal recessive	y	y	[Death by age 15 months / Seyda et al. (2001) reported 3 sibs, 1 male and 2 females, born to unrelated Mexican parents, with a fatal mitochondrial disease. The sibs presented with feeding difficulty, weakness, lethargy, and decreasing responsiveness within a few days after birth. Laboratory investigations showed metabolic acidosis with elevated blood lactate levels. Assisted ventilation was necessary because of respiratory failure. All 3 sibs died under 1 month of age]	L2	y	y	lethal	lethal	lethal	L2	L2	pre-infant-lethal
605714	CEREBRAL AMYLOID ANGIOPATHY, APP-RELATED	Cerebral amyloid angiopathy, Dutch, Italian, Iowa, Flemish, Arctic variants, 605714 (3)	Cerebral amyloid angiopathy, Dutch, Italian, Iowa, Flemish, Arctic variants	y	CEREBRAL AMYLOID ANGIOPATHY, APP-RELATED	Clinical Features	death|deaths|died	APP	HGNC:620	Cerebral amyloid angiopathy, Dutch, Italian, Iowa, Flemish, Arctic variants, 605714 (3), Autosomal dominant	Autosomal dominant	n	y	[Bugiani et al. (2010) reported 4 unrelated Italian families with autosomal dominant hereditary cerebral hemorrhage with amyloidosis caused by a heterozygous mutation in the APP gene (E693K; 104760.0014). Affected individuals presented with recurrent headache and multiple hemorrhagic strokes between age 44 and 63, followed by epilepsy and cognitive decline in most of them. Several affected individuals became comatose or bedridden, and some died as a result of cerebral hemorrhage]	L6	y	-	lethal	lethal	lethal	L6	L6	post-infant-lethal
605724	FANCONI ANEMIA, COMPLEMENTATION GROUP D1	Fanconi anemia, complementation group D1, 605724 (3)	Fanconi anemia, complementation group D1	y	FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1	Clinical Features|Phenotype	died	BRCA2	HGNC:1101	Fanconi anemia, complementation group D1, 605724 (3), Autosomal recessive	Autosomal recessive	y	y	[Weinberg-Shukron et al. (2018) reported 2 sisters with Fanconi anemia, aged 20 and 15 years, from a nonconsanguineous family of Ethiopian ancestry, who presented with short stature, primary amenorrhea, and absence of spontaneous pubertal development. Both sisters had a normal female karyotype and hypergonadotrophic hypogonadism, and had no detectable uterus or ovaries on initial imaging studies, findings consistent with complete XX ovarian dysgenesis. Thyroid, adrenal, and ovarian antibodies and serum antimullerian hormone were undetectable. Cortisol levels and findings from adrenal imaging were normal. After 18 months of receiving oral estradiol, in doses that were increased gradually, followed by ongoing treatment with a combined estrogen-progesterone oral contraceptive, both sisters had grown to mean familial height and had secondary sexual characteristics, adult-sized uteri, and regular menstrual periods. Physical examination revealed microcephaly and a few small cafe-au-lait spots in both sisters. The sisters had normal intelligence. The older sister was in a long-term (more than 14 years) remission from acute myelocytic leukemia which had been diagnosed when she was 5 years of age. An older brother of the sisters had died from acute promyelocytic leukemia at 13 years of age]	L5	n	y	lethal	lethal	lethal	L5	L5	post-infant-lethal
605751	SEIZURES, BENIGN FAMILIAL INFANTILE, 2	Seizures, benign familial infantile, 2, 605751 (3)	Seizures, benign familial infantile, 2	n	-	-	-	PRRT2	HGNC:30500	Seizures, benign familial infantile, 2, 605751 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
605809	MYASTHENIC SYNDROME, CONGENITAL, 4A, SLOW-CHANNEL	Myasthenic syndrome, congenital, 4A, slow-channel, 605809 (3)	Myasthenic syndrome, congenital, 4A, slow-channel	n	-	-	-	CHRNE	HGNC:1966	Myasthenic syndrome, congenital, 4A, slow-channel, 605809 (3), Autosomal dominant, Autosomal recessive	Autosomal dominant, Autosomal recessive	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L3	L3	pre-infant-lethal
605814	CITRULLINEMIA, TYPE II, NEONATAL-ONSET	Citrullinemia, type II, neonatal-onset, 605814 (3)	Citrullinemia, type II, neonatal-onset	y	CITRULLINEMIA, TYPE II, NEONATAL-ONSET	Description	fatal	SLC25A13	HGNC:10983	Citrullinemia, type II, neonatal-onset, 605814 (3), Autosomal recessive	Autosomal recessive	y	n	-	-	-	-	ambiguous	ambiguous|lethal	lethal	L5	L5	post-infant-lethal
605820	NONAKA MYOPATHY	Nonaka myopathy, 605820 (3)	Nonaka myopathy	n	-	-	-	GNE	HGNC:23657	Nonaka myopathy, 605820 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
605822	SPONDYLOOCULAR SYNDROME	Spondyloocular syndrome, 605822 (3)	Spondyloocular syndrome	n	-	-	-	XYLT2	HGNC:15517	Spondyloocular syndrome, 605822 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
605850	DIMETHYLGLYCINE DEHYDROGENASE DEFICIENCY	Dimethylglycine dehydrogenase deficiency, 605850 (3)	Dimethylglycine dehydrogenase deficiency	n	-	-	-	DMGDH	HGNC:24475	Dimethylglycine dehydrogenase deficiency, 605850 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
605899	GLYCINE ENCEPHALOPATHY 1	Glycine encephalopathy1, 605899 (3)	Glycine encephalopathy1	y	GLYCINE ENCEPHALOPATHY 1; GCE1	Clinical Features|Clinical Synopsis	death|deaths|died	GLDC	HGNC:4313	Glycine encephalopathy1, 605899 (3), Autosomal recessive	Autosomal recessive	y	y	[had mildly elevated blood ammonia and markedly elevated glycine in blood and cerebrospinal fluid, and died at age 12 days.]	L2	y	-	lethal	lethal	lethal	L2	L2	pre-infant-lethal
605909	PARKINSON DISEASE 6, AUTOSOMAL RECESSIVE EARLY-ONSET	Parkinson disease 6, early onset, 605909 (3)	Parkinson disease 6, early onset	y	PARKINSON DISEASE 6, AUTOSOMAL RECESSIVE EARLY-ONSET; PARK6	Clinical Features|Phenotype	died|death|deaths	PINK1	HGNC:14581	Parkinson disease 6, early onset, 605909 (3), Autosomal recessive	Autosomal recessive	n	n	-	-	-	-	ambiguous	ambiguous	ambiguous	-	-	-
605911	3-HYDROXY-3-METHYLGLUTARYL-CoA SYNTHASE-2 DEFICIENCY	HMG-CoA synthase-2 deficiency, 605911 (3)	HMG-CoA synthase-2 deficiency	y	3-HYDROXY-3-METHYLGLUTARYL-CoA SYNTHASE-2 DEFICIENCY; HMGCS2D	Clinical Features|Phenotype	died	HMGCS2	HGNC:5008	HMG-CoA synthase-2 deficiency, 605911 (3), Autosomal recessive	Autosomal recessive	y	y	[Kilic et al. (2020) reported a 6-month-old female (family 1, patient 37) who presented with fever, vomiting, diarrhea, Kussmaul breathing, hepatomegaly and encephalopathy. Laboratory testing showed hypoglycemia, metabolic and lactic acidosis, hyperammonemia, hyperuricemia, hypertriglyceridemia, low HDL-cholesterol, hypertransaminasemia, coagulopathy, and elevated creatine kinase. She required intubation and ventilation, and was treated with hydration, glucose, and hemodialysis for refractory metabolic acidosis. She had improvement in clinical status and laboratory abnormalities, but then developed refractory hyperglycemia, pneumothorax, pneumoperitonium, and seizures. She died despite supportive care]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
606002	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE, WITH AXONAL NEUROPATHY 2	Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2, 606002 (3)	Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2	y	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE, WITH AXONAL NEUROPATHY 2; SCAN2	Clinical Features	died	SETX	HGNC:445	Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2, 606002 (3), Autosomal recessive	Autosomal recessive	y	n	-	-	-	-	ambiguous	ambiguous|nonlethal	ambiguous	-	-	-
606003	TRANSALDOLASE DEFICIENCY	Transaldolase deficiency, 606003 (3)	Transaldolase deficiency	y	TRANSALDOLASE DEFICIENCY; TALDOD	Clinical Features	died	TALDO1	HGNC:11559	Transaldolase deficiency, 606003 (3), Autosomal recessive	Autosomal recessive	y	y	[Banne et al. (2016) reported a male infant with prenatal diagnosis of hyperechogenic bowel on an ultrasound at almost 22 weeks' gestation. At 2 days of life, a meconium plug was diagnosed, which led to a small bowel resection and ileostomy placement. He had hypertrichosis and cutis laxa. He was found to have thrombocytopenia without leukopenia or anemia. He also had hypothyroidism that required treatment with both T4 and T3 to achieve euthyroidism. He died at age 2 months after he developed liver failure following a second surgery to repair the ileostomy complicated by peritonitis]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
606053	INTELLECTUAL DEVELOPMENTAL DISORDER WITH AUTISM AND SPEECH DELAY	Intellectual developmental disorder with autism and speech delay, 606053 (3)	Intellectual developmental disorder with autism and speech delay	n	-	-	-	TBR1	HGNC:11590	Intellectual developmental disorder with autism and speech delay, 606053 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
606054	PROPIONIC ACIDEMIA	Propionicacidemia, 606054 (3)	Propionicacidemia	y	PROPIONIC ACIDEMIA	Description|Clinical Features	death|deaths|died	PCCA	HGNC:8653	Propionicacidemia, 606054 (3), Autosomal recessive	Autosomal recessive	y	y	[In a male Pakistani offspring of first-cousin parents, Gompertz et al. (1970) described acidosis and ketosis due to propionic acidemia, leading to death at 8 days of age. A sib had died at 2 weeks of age with metabolic acidosis and ketonuria]	L2	y	y	lethal	lethal	lethal	L2	L2	pre-infant-lethal
606054	PROPIONIC ACIDEMIA	Propionicacidemia, 606054 (3)	Propionicacidemia	y	PROPIONIC ACIDEMIA	Description|Clinical Features	death|deaths|died	PCCB	HGNC:8654	Propionicacidemia, 606054 (3), Autosomal recessive	Autosomal recessive	y	y	[In a male Pakistani offspring of first-cousin parents, Gompertz et al. (1970) described acidosis and ketosis due to propionic acidemia, leading to death at 8 days of age. A sib had died at 2 weeks of age with metabolic acidosis and ketonuria]	L2	y	y	lethal	lethal	lethal	L2	L2	pre-infant-lethal
606056	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIb	Congenital disorder of glycosylation, type IIb, 606056 (3)	Congenital disorder of glycosylation, type IIb	y	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIb; CDG2B	Clinical Features	fatal	MOGS	HGNC:24862	Congenital disorder of glycosylation, type IIb, 606056 (3), Autosomal recessive	Autosomal recessive	y	y	[De Praeter et al. (2000) reported a neonate with severe generalized hypotonia and dysmorphic features. The patient was born at 36 weeks' gestation after an uneventful pregnancy and delivery. Marked generalized hypotonia and hypomotility were noticed, as were dysmorphic features, including a prominent occiput, short palpebral fissures, long eyelashes, broad nose, retrognathia, high-arched palate, generalized edema, and hypoplastic genitalia. Her hands were clenched and her fingers overlapped, second over third and fifth over fourth. A band of alopecia was seen on both parietal areas of the skull. A thoracic scoliosis was present. The clinical course was progressive and was characterized by the occurrence of hepatomegaly, hypoventilation, feeding problems, seizures, and fatal outcome at age 74 days]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
606068	RETINITIS PIGMENTOSA 28	Retinitis pigmentosa 28, 606068 (3)	Retinitis pigmentosa 28	n	-	-	-	FAM161A	HGNC:25808	Retinitis pigmentosa 28, 606068 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
606069	HEMOCHROMATOSIS, TYPE 4	Hemochromatosis, type 4, 606069 (3)	Hemochromatosis, type 4	n	-	-	-	SLC40A1	HGNC:10909	Hemochromatosis, type 4, 606069 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
606070	AMYOTROPHIC LATERAL SCLEROSIS 21	Amyotrophic lateral sclerosis 21, 606070 (3)	Amyotrophic lateral sclerosis 21	y	AMYOTROPHIC LATERAL SCLEROSIS 21; ALS21	Clinical Features	death|deaths|died	MATR3	HGNC:6912	Amyotrophic lateral sclerosis 21, 606070 (3), Autosomal dominant	Autosomal dominant	y	y	[Johnson et al. (2014) reported a large family of European origin segregating ALS and dementia in an autosomal dominant pattern of inheritance.. Two affected individuals from an unrelated Sardinian family had onset of distal muscle weakness at ages 60 and 62 years, respectively. Imaging of 1 patient showed bilateral corticospinal tract damage. The other patient developed upper motor neuron signs and died of respiratory failure 33 months after onsett]	L6	y	-	lethal	lethal	lethal	L6	L6	post-infant-lethal
606071	HEREDITARY MOTOR AND SENSORY NEUROPATHY, TYPE IIC	Hereditary motor and sensory neuropathy, type IIc, 606071 (3)	Hereditary motor and sensory neuropathy, type IIc	y	HEREDITARY MOTOR AND SENSORY NEUROPATHY, TYPE IIC; HMSN2C	Phenotype	death|deaths	TRPV4	HGNC:18083	Hereditary motor and sensory neuropathy, type IIc, 606071 (3), Autosomal dominant	Autosomal dominant	y	n	-	-	-	-	ambiguous	ambiguous|lethal|nonlethal	lethal|nonlethal	L1	L1	pre-infant-lethal
606072	RIPPLING MUSCLE DISEASE 2	Rippling muscle disease 2, 606072 (3)	Rippling muscle disease 2	n	-	-	-	CAV3	HGNC:1529	Rippling muscle disease 2, 606072 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	LU	LU	post-infant-lethal
606159	NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 3	Neurodegeneration with brain iron accumulation 3, 606159 (3)	Neurodegeneration with brain iron accumulation 3	y	NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 3; NBIA3	Clinical Features	died	FTL	HGNC:3999	Neurodegeneration with brain iron accumulation 3, 606159 (3), Autosomal dominant	Autosomal dominant	y	y	Ohta et al. (2008) reported a Japanese mother and son with neuroferritinopathy confirmed by genetic analysis (134790.0015). The son developed hand tremors in his mid-teens and foot dragging at age 35. By age 42, he had generalized hypotonia, hyperextensibility, unsteady gait, aphonia, micrographia, hyperreflexia, and cognitive impairment. Rigidity, spasticity, dystonia, and chorea were not observed. His mother had hand tremors at age 10, difficulty walking at age 35, developed cognitive impairment and akinetic mutism, and died at age 64]	L6	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L6	L6	post-infant-lethal
606164	DIAMOND-BLACKFAN ANEMIA 15 WITH MANDIBULOFACIAL DYSOSTOSIS	Diamond Blackfan anemia 15 with mandibulofacial dysostosis, 606164 (3)	Diamond Blackfan anemia 15 with mandibulofacial dysostosis	n	-	-	-	RPS28	HGNC:10418	Diamond Blackfan anemia 15 with mandibulofacial dysostosis, 606164 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
606170	GENITOPATELLAR SYNDROME	Genitopatellar syndrome, 606170 (3)	Genitopatellar syndrome	y	GENITOPATELLAR SYNDROME; GTPTS	Clinical Features	died	KAT6B	HGNC:17582	Genitopatellar syndrome, 606170 (3), Autosomal dominant	Autosomal dominant	y	y	[There is also variation in the prognosis of patients diagnosed with CHN. In patients with CHN, Harati and Butler (1985) showed correlation of morbidity and mortality with the presence/absence of onion bulbs: patients with few onion bulbs died in early infancy, usually because of difficulty in swallowing and respiration after birth]	L3	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L3	L3	pre-infant-lethal
606176	DIABETES MELLITUS, PERMANENT NEONATAL, 1	Diabetes mellitus, permanent neonatal 1, 606176 (3)	Diabetes mellitus, permanent neonatal 1	n	-	-	-	GCK	HGNC:4195	Diabetes mellitus, permanent neonatal 1, 606176 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L6	L6	post-infant-lethal
606217	ATRIOVENTRICULAR SEPTAL DEFECT, SUSCEPTIBILITY TO, 2	Atrioventricular septal defect, partial, with heterotaxy syndrome, 606217 (3)	Atrioventricular septal defect, partial, with heterotaxy syndrome	n	-	-	-	CRELD1	HGNC:14630	Atrioventricular septal defect, partial, with heterotaxy syndrome, 606217 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
606220	INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE, FACIAL ANOMALIES, AND SPEECH DEFECTS	Intellectual developmental disorder with short stature, facial anomalies, and speech defects, 606220 (3)	Intellectual developmental disorder with short stature, facial anomalies, and speech defects	n	-	-	-	FBXL3	HGNC:13599	Intellectual developmental disorder with short stature, facial anomalies, and speech defects, 606220 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
606232	PHELAN-MCDERMID SYNDROME	Phelan-McDermid syndrome, 606232 (3)	Phelan-McDermid syndrome	y	PHELAN-MCDERMID SYNDROME; PHMDS	Phenotype	died	SHANK3	HGNC:14294	Phelan-McDermid syndrome, 606232 (3), Autosomal dominant	Autosomal dominant	y	n	-	-	-	-	ambiguous	ambiguous	ambiguous	-	-	-
606243	ALVEOLAR SOFT PART SARCOMA	Alveolar soft-part sarcoma, 606243 (3)	Alveolar soft-part sarcoma	n	-	-	-	ASPSCR1	HGNC:13825	Alveolar soft-part sarcoma, 606243 (3)	-	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
606324	PARKINSON DISEASE 7, AUTOSOMAL RECESSIVE EARLY-ONSET	Parkinson disease 7, autosomal recessive early-onset, 606324 (3)	Parkinson disease 7, autosomal recessive early-onset	y	PARKINSON DISEASE 7, AUTOSOMAL RECESSIVE EARLY-ONSET; PARK7	Clinical Features	died	PARK7	HGNC:16369	Parkinson disease 7, autosomal recessive early-onset, 606324 (3), Autosomal recessive	Autosomal recessive	n	n	-	-	-	-	ambiguous	ambiguous	ambiguous	-	-	-
606346	DEAFNESS, AUTOSOMAL DOMINANT 22	Deafness, autosomal dominant 22, 606346 (3)	Deafness, autosomal dominant 22	n	-	-	-	MYO6	HGNC:7605	Deafness, autosomal dominant 22, 606346 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
606346	DEAFNESS, AUTOSOMAL DOMINANT 22	Deafness, autosomal dominant 22, with hypertrophic cardiomyopathy, 606346 (3)	Deafness, autosomal dominant 22, with hypertrophic cardiomyopathy	n	-	-	-	MYO6	HGNC:7605	Deafness, autosomal dominant 22, with hypertrophic cardiomyopathy, 606346 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
606353	PRIMARY LATERAL SCLEROSIS, JUVENILE	Primary lateral sclerosis, juvenile, 606353 (3)	Primary lateral sclerosis, juvenile	n	-	-	-	ALS2	HGNC:443	Primary lateral sclerosis, juvenile, 606353 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L6	L6	post-infant-lethal
606367	IMMUNODEFICIENCY 41 WITH LYMPHOPROLIFERATION AND AUTOIMMUNITY	Immunodeficiency 41 with lymphoproliferation and autoimmunity, 606367 (3)	Immunodeficiency 41 with lymphoproliferation and autoimmunity	n	-	-	-	IL2RA	HGNC:6008	Immunodeficiency 41 with lymphoproliferation and autoimmunity, 606367 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
606392	MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 4	MODY, type IV, 606392 (3)	MODY, type IV	n	-	-	-	PDX1	HGNC:6107	MODY, type IV, 606392 (3)	-	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
606394	MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 6	Maturity-onset diabetes of the young 6, 606394 (3)	Maturity-onset diabetes of the young 6	n	-	-	-	NEUROD1	HGNC:7762	Maturity-onset diabetes of the young 6, 606394 (3)	-	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
606438	HUNTINGTON DISEASE-LIKE 2	Huntington disease-like 2, 606438 (3)	Huntington disease-like 2	y	HUNTINGTON DISEASE-LIKE 2; HDL2	Clinical Features	death|deaths	JPH3	HGNC:14203	Huntington disease-like 2, 606438 (3), Autosomal dominant	Autosomal dominant	y	y	[Margolis et al. (2001) described a large kindred with an autosomal dominant disorder that is clinically similar to Huntington disease (143100) but arose from a CAG expansion in a different gene. The disorder is characterized by onset in the fourth decade, involuntary movements and abnormalities of voluntary movements, psychiatric symptoms, weight loss, dementia, and relentless course with death about 20 years after disease onsett]	L6	y	-	lethal	lethal	lethal	L6	L6	post-infant-lethal
606482	CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE B	Charcot-Marie-Tooth disease, axonal type 2M, 606482 (3)	Charcot-Marie-Tooth disease, axonal type 2M	n	-	-	-	DNM2	HGNC:2974	Charcot-Marie-Tooth disease, axonal type 2M, 606482 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	ambiguous|lethal|nonlethal	lethal|nonlethal	L2	L2	pre-infant-lethal
606482	CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE B	Charcot-Marie-Tooth disease, dominant intermediate B, 606482 (3)	Charcot-Marie-Tooth disease, dominant intermediate B	n	-	-	-	DNM2	HGNC:2974	Charcot-Marie-Tooth disease, dominant intermediate B, 606482 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	ambiguous|lethal|nonlethal	lethal|nonlethal	L2	L2	pre-infant-lethal
606483	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2GG	Charcot-Marie-Tooth disease, axonal, type 2GG, 606483 (3)	Charcot-Marie-Tooth disease, axonal, type 2GG	n	-	-	-	GBF1	HGNC:4181	Charcot-Marie-Tooth disease, axonal, type 2GG, 606483 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
606545	ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 3	Ichthyosis, congenital, autosomal recessive 3, 606545 (3)	Ichthyosis, congenital, autosomal recessive 3	n	-	-	-	ALOXE3	HGNC:13743	Ichthyosis, congenital, autosomal recessive 3, 606545 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
606574	ALBINISM, OCULOCUTANEOUS, TYPE IV	Albinism, oculocutaneous, type IV, 606574 (3)	Albinism, oculocutaneous, type IV	n	-	-	-	SLC45A2	HGNC:16472	Albinism, oculocutaneous, type IV, 606574 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
606593	LIG4 SYNDROME	LIG4 syndrome, 606593 (3)	LIG4 syndrome	n	-	-	-	LIG4	HGNC:6601	LIG4 syndrome, 606593 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
606595	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2F	Charcot-Marie-Tooth disease, axonal, type 2F, 606595 (3)	Charcot-Marie-Tooth disease, axonal, type 2F	n	-	-	-	HSPB1	HGNC:5246	Charcot-Marie-Tooth disease, axonal, type 2F, 606595 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
606612	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT), TYPE B, 5	Muscular dystrophy-dystroglycanopathy (congenital with or without impaired intellectual development), type B, 5, 606612 (3)	Muscular dystrophy-dystroglycanopathy (congenital with or without impaired intellectual development), type B, 5	n	-	-	-	FKRP	HGNC:17997	Muscular dystrophy-dystroglycanopathy (congenital with or without impaired intellectual development), type B, 5, 606612 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L2	L2	pre-infant-lethal
606658	SPINOCEREBELLAR ATAXIA 15	Spinocerebellar ataxia 15, 606658 (3)	Spinocerebellar ataxia 15	n	-	-	-	ITPR1	HGNC:6180	Spinocerebellar ataxia 15, 606658 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
606664	GLYCINE N-METHYLTRANSFERASE DEFICIENCY	Glycine N-methyltransferase deficiency, 606664 (3)	Glycine N-methyltransferase deficiency	n	-	-	-	GNMT	HGNC:4415	Glycine N-methyltransferase deficiency, 606664 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
606685	CARDIOMYOPATHY, DILATED, 1L	Cardiomyopathy, dilated, 1L, 606685 (3)	Cardiomyopathy, dilated, 1L	n	-	-	-	SGCD	HGNC:10807	Cardiomyopathy, dilated, 1L, 606685 (3)	-	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
606688	SPONGIFORM ENCEPHALOPATHY WITH NEUROPSYCHIATRIC FEATURES	Spongiform encephalopathy with neuropsychiatric features, 606688 (3)	Spongiform encephalopathy with neuropsychiatric features	n	-	-	-	PRNP	HGNC:9449	Spongiform encephalopathy with neuropsychiatric features, 606688 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L6	L6	post-infant-lethal
606690	LYMPHANGIOLEIOMYOMATOSIS	Lymphangioleiomyomatosis, 606690 (3)	Lymphangioleiomyomatosis	y	LYMPHANGIOLEIOMYOMATOSIS; LAM	Clinical Features	death|deaths	TSC1	HGNC:12362	Lymphangioleiomyomatosis, 606690 (3)	-	n	y	[Lymphangiomyomatosis can occur as an isolated disorder or in association with TSC. Among patients with TSC, it is said to be the third most frequent cause of TSC-related death, after renal disease and brain tumors]	LU	y	-	lethal	lethal	lethal	L2|LU	L2	pre-infant-lethal
606693	KUFOR-RAKEB SYNDROME	Kufor-Rakeb syndrome, 606693 (3)	Kufor-Rakeb syndrome	y	KUFOR-RAKEB SYNDROME; KRS	Clinical Features	died	ATP13A2	HGNC:30213	Kufor-Rakeb syndrome, 606693 (3), Autosomal recessive	Autosomal recessive	n	y	[Bras et al. (2012) noted that the patients in the Belgian family developed dyskinesias following L-DOPA treatment. The oldest patient became wheelchair-bound at age 25 years and died of pulmonary embolism at age 36]	L6	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L6	L6	post-infant-lethal
606703	DYSKINESIA WITH OROFACIAL INVOLVEMENT, AUTOSOMAL DOMINANT	Dyskinesia with orofacial involvement, autosomal dominant, 606703 (3)	Dyskinesia with orofacial involvement, autosomal dominant	n	-	-	-	ADCY5	HGNC:236	Dyskinesia with orofacial involvement, autosomal dominant, 606703 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	ambiguous|nonlethal	ambiguous	-	-	-
606705	DEAFNESS, AUTOSOMAL DOMINANT 36	Deafness, autosomal dominant 36, 606705 (3)	Deafness, autosomal dominant 36	n	-	-	-	TMC1	HGNC:16513	Deafness, autosomal dominant 36, 606705 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
606713	VAN DER WOUDE SYNDROME 2	van der Woude syndrome 2, 606713 (3)	van der Woude syndrome 2	n	-	-	-	GRHL3	HGNC:25839	van der Woude syndrome 2, 606713 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
606721	LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 7	Lipodystrophy, familial partial, type 7, 606721 (3)	Lipodystrophy, familial partial, type 7	y	LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 7; FPLD7	Clinical Features	death|deaths|died	CAV1	HGNC:1527	Lipodystrophy, familial partial, type 7, 606721 (3), Autosomal dominant	Autosomal dominant	n	y	[Berger et al. (2002) described familial lipodystrophy associated with congenital cataracts and cerebellar and spinal cord dysfunction. The proposita, a 28-year-old woman with congenital atypical partial lipodystrophy and cataracts, presented with a spastic-ataxic gait and lower extremity paresthesias at age 18 years. Laboratory investigation demonstrated a type V hyperlipidemia pattern, insulin resistance, and high alpha-tocopherol levels. Lack of fat in the face and upper body was noted at birth, and a small jaw necessitated multiple teeth extractions. In addition to congenital cataracts, she was said to have pigmentary retinopathy, lack of breast development, and pancreatitis complicating hyperlipidemia. She had symptomatic orthostatic hypotension and mild acanthosis nigricans. Her legs were spastic with spontaneous clonus, brisk reflexes, and bilateral Babinski signs. MRI of the cervical spine showed a signal abnormality in the spinal cord. Peroxisomal function panels were normal, and muscle biopsy showed no features suggestive of a mitochondrial disorder. Her father and his sister, 2 of 5 children, were similarly affected. The father had congenital cataracts, retinitis pigmentosa, and mild hyperlipidemia. Absence of facial, neck, and extremity fat was noted. Neurologic manifestations appeared to be minimal. The affected paternal aunt died from a neurologic condition at approximately age 40]	L6	n	y	lethal	ambiguous|lethal	lethal	L4|L6	L4	post-infant-lethal
606744	SECKEL SYNDROME 2	Seckel syndrome 2, 606744 (3)	Seckel syndrome 2	n	-	-	-	RBBP8	HGNC:9891	Seckel syndrome 2, 606744 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
606762	HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 6	Hyperinsulinism-hyperammonemia syndrome, 606762 (3)	Hyperinsulinism-hyperammonemia syndrome	n	-	-	-	GLUD1	HGNC:4335	Hyperinsulinism-hyperammonemia syndrome, 606762 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
606763	CILIARY DYSKINESIA, PRIMARY, 2	Ciliary dyskinesia, primary, 2, 606763 (3)	Ciliary dyskinesia, primary, 2	n	-	-	-	DNAAF3	HGNC:30492	Ciliary dyskinesia, primary, 2, 606763 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
606766	SPERMATOGENIC FAILURE 3	Spermatogenic failure 3, 606766 (3)	Spermatogenic failure 3	n	-	-	-	SLC26A8	HGNC:14468	Spermatogenic failure 3, 606766 (3), Autosomal dominant, Autosomal recessive	Autosomal dominant, Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
606768	MYOPATHY, DISTAL, WITH ANTERIOR TIBIAL ONSET	Myopathy, distal, with anterior tibial onset, 606768 (3)	Myopathy, distal, with anterior tibial onset	n	-	-	-	DYSF	HGNC:3097	Myopathy, distal, with anterior tibial onset, 606768 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
606777	GLUT1 DEFICIENCY SYNDROME 1	GLUT1 deficiency syndrome 1, infantile onset, severe, 606777 (3)	GLUT1 deficiency syndrome 1, infantile onset, severe	n	-	-	-	SLC2A1	HGNC:11005	GLUT1 deficiency syndrome 1, infantile onset, severe, 606777 (3), Autosomal dominant, Autosomal recessive	Autosomal dominant, Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
606812	FUMARASE DEFICIENCY	Fumarase deficiency, 606812 (3)	Fumarase deficiency	y	FUMARASE DEFICIENCY; FMRD	Clinical Features|Phenotype	death|deaths|died|lethal	FH	HGNC:3700	Fumarase deficiency, 606812 (3), Autosomal recessive	Autosomal recessive	y	y	[Mroch et al. (2012) reported 2 brothers, born of unrelated parents, with genetically confirmed FH deficiency resulting in death in infancy... He developed severe metabolic acidosis, necrotizing enterocolitis, liver failure associated with coagulopathy and hyperbilirubinemia, and encephalopathy, resulting in death at age 22 days]	L2	y	-	lethal	lethal	lethal	L2|L6	L2	pre-infant-lethal
606824	GLUCOSE/GALACTOSE MALABSORPTION	Glucose/galactose malabsorption, 606824 (3)	Glucose/galactose malabsorption	y	GLUCOSE/GALACTOSE MALABSORPTION; GGM	Clinical Features|Clinical Synopsis	fatal|lethal	SLC5A1	HGNC:11036	Glucose/galactose malabsorption, 606824 (3), Autosomal recessive	Autosomal recessive	n	y	[Onset in first days of life; May be lethal if untreated / Glucose/galactose malabsorption (GGM) is a rare autosomal recessive disorder caused by a defect in glucose and galactose transport across the intestinal brush border. Patients with GGM present with neonatal onset of severe life-threatening watery diarrhea and dehydration]	L2	y	-	lethal	lethal	lethal	L2	L2	pre-infant-lethal
606835	DIGITAL ARTHROPATHY-BRACHYDACTYLY, FAMILIAL	Digital arthropathy-brachydactyly, familial, 606835 (3)	Digital arthropathy-brachydactyly, familial	n	-	-	-	TRPV4	HGNC:18083	Digital arthropathy-brachydactyly, familial, 606835 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	ambiguous|lethal|nonlethal	lethal|nonlethal	L1	L1	pre-infant-lethal
606843	IMMUNODEFICIENCY WITH HYPER-IgM, TYPE 3	Immunodeficiency with hyper-IgM, type 3, 606843 (3)	Immunodeficiency with hyper-IgM, type 3	n	-	-	-	CD40	HGNC:11919	Immunodeficiency with hyper-IgM, type 3, 606843 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
606854	CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 14A (BILATERAL FRONTOPARIETAL)	Cortical dysplasia, complex, with other brain malformations 14A, (bilateral frontoparietal), 606854 (3)	Cortical dysplasia, complex, with other brain malformations 14A, (bilateral frontoparietal)	n	-	-	-	ADGRG1	HGNC:4512	Cortical dysplasia, complex, with other brain malformations 14A, (bilateral frontoparietal), 606854 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
606864	PARAGANGLIOMA AND GASTRIC STROMAL SARCOMA	Paraganglioma and gastric stromal sarcoma, 606864 (3)	Paraganglioma and gastric stromal sarcoma	n	-	-	-	SDHB	HGNC:10681	Paraganglioma and gastric stromal sarcoma, 606864 (3)	-	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L3|L5	L3	pre-infant-lethal
606864	PARAGANGLIOMA AND GASTRIC STROMAL SARCOMA	Paraganglioma and gastric stromal sarcoma, 606864 (3)	Paraganglioma and gastric stromal sarcoma	n	-	-	-	SDHC	HGNC:10682	Paraganglioma and gastric stromal sarcoma, 606864 (3)	-	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
606864	PARAGANGLIOMA AND GASTRIC STROMAL SARCOMA	Paraganglioma and gastric stromal sarcoma, 606864 (3)	Paraganglioma and gastric stromal sarcoma	n	-	-	-	SDHD	HGNC:10683	Paraganglioma and gastric stromal sarcoma, 606864 (3)	-	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L2|L6	L2	pre-infant-lethal
606889	ALZHEIMER DISEASE 4	Alzheimer disease-4, 606889 (3)	Alzheimer disease-4	y	ALZHEIMER DISEASE 4; AD4	Clinical Features	death|deaths|died	PSEN2	HGNC:9509	Alzheimer disease-4, 606889 (3), Autosomal dominant	Autosomal dominant	y	y	[Bird et al. (1996) reported that the mean age at onset in the Volga Germans is 54.9 years, mean age at death is 65.9 years, and mean disease duration is 11.3 years]	L6	y	-	lethal	ambiguous|lethal	lethal	L6	L6	post-infant-lethal
606893	VASCULAR MALFORMATION, PRIMARY INTRAOSSEOUS	Vascular malformation, primary intraosseous, 606893 (3)	Vascular malformation, primary intraosseous	y	VASCULAR MALFORMATION, PRIMARY INTRAOSSEOUS; VMPI	Clinical Features	death|deaths|died	ELMO2	HGNC:17233	Vascular malformation, primary intraosseous, 606893 (3), Autosomal recessive	Autosomal recessive	y	y	[All patients also exhibited gingival bleeding, requiring endovascular embolization and/or percutaneous sclerotherapy, and 5 of them had chronic anemia due to repeated bleeding episodes. One of the Turkish patients died at age 27 due to spontaneous massive bleeding]	L6	y	-	lethal	lethal	lethal	L6	L6	post-infant-lethal
606943	USHER SYNDROME, TYPE IG	Usher syndrome, type 1G, 606943 (3)	Usher syndrome, type 1G	n	-	-	-	USH1G	HGNC:16356	Usher syndrome, type 1G, 606943 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
606952	ALBINISM, OCULOCUTANEOUS, TYPE IB	Albinism, oculocutaneous, type IB, 606952 (3)	Albinism, oculocutaneous, type IB	n	-	-	-	TYR	HGNC:12442	Albinism, oculocutaneous, type IB, 606952 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
606966	NEPHRONOPHTHISIS 4	Nephronophthisis 4, 606966 (3)	Nephronophthisis 4	n	-	-	-	NPHP4	HGNC:19104	Nephronophthisis 4, 606966 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
606996	SENIOR-LOKEN SYNDROME 4	Senior-Loken syndrome 4, 606996 (3)	Senior-Loken syndrome 4	n	-	-	-	NPHP4	HGNC:19104	Senior-Loken syndrome 4, 606996 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
607014	HURLER SYNDROME	Mucopolysaccharidosis Ih, 607014 (3)	Mucopolysaccharidosis Ih	y	HURLER SYNDROME	Clinical Features	death|deaths|died	IDUA	HGNC:5391	Mucopolysaccharidosis Ih, 607014 (3), Autosomal recessive	Autosomal recessive	y	y	The average age at death was 6.25 years in their series of 27 patients with a range of 1.3 to 10.9 years ]	L4	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L4|L6	L4	post-infant-lethal
607015	HURLER-SCHEIE SYNDROME	Mucopolysaccharidosis Ih/s, 607015 (3)	Mucopolysaccharidosis Ih/s	y	HURLER-SCHEIE SYNDROME	Clinical Features	died	IDUA	HGNC:5391	Mucopolysaccharidosis Ih/s, 607015 (3), Autosomal recessive	Autosomal recessive	n	y	[Winters et al. (1976) described a case of alpha-L-iduronidase deficiency that differed from the Hurler and Scheie syndromes and may represent the Hurler-Scheie compound. The female patient died at age 25 years]	L6	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L4|L6	L4	post-infant-lethal
607016	SCHEIE SYNDROME	Mucopolysaccharidosis Is, 607016 (3)	Mucopolysaccharidosis Is	n	-	-	-	IDUA	HGNC:5391	Mucopolysaccharidosis Is, 607016 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L4|L6	L4	post-infant-lethal
607017	DEAFNESS, AUTOSOMAL DOMINANT 21	Deafness, autosomal dominant 21, 607017 (3)	Deafness, autosomal dominant 21	n	-	-	-	RIPOR2	HGNC:13872	Deafness, autosomal dominant 21, 607017 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
607039	DEAFNESS, AUTOSOMAL RECESSIVE 22	Deafness, autosomal recessive 22, 607039 (3)	Deafness, autosomal recessive 22	n	-	-	-	OTOA	HGNC:16378	Deafness, autosomal recessive 22, 607039 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
607078	EPIPHYSEAL DYSPLASIA, MULTIPLE, 5	Epiphyseal dysplasia, multiple, 5, 607078 (3)	Epiphyseal dysplasia, multiple, 5	y	EPIPHYSEAL DYSPLASIA, MULTIPLE, 5; EDM5	Clinical Features	died	MATN3	HGNC:6909	Epiphyseal dysplasia, multiple, 5, 607078 (3), Autosomal dominant	Autosomal dominant	y	y	[Elsbach (1959) described a 4-generation Delft family with what they called bilateral microepiphyseal dysplasia. Mostert et al. (2003) provided follow-up on this family. The index case had died before reevaluation but his affected younger brother was available for study]	LU	y	-	lethal	lethal|nonlethal	lethal|nonlethal	LU	LU	post-infant-lethal
607080	46,XY GONADAL DYSGENESIS WITH MINIFASCICULAR NEUROPATHY	46XY gonadal dysgenesis with minifascicular neuropathy, 607080 (3)	46XY gonadal dysgenesis with minifascicular neuropathy	n	-	-	-	DHH	HGNC:2865	46XY gonadal dysgenesis with minifascicular neuropathy, 607080 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
607084	DEAFNESS, AUTOSOMAL RECESSIVE 31	Deafness, autosomal recessive 31, 607084 (3)	Deafness, autosomal recessive 31	n	-	-	-	WHRN	HGNC:16361	Deafness, autosomal recessive 31, 607084 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
607091	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IId	Congenital disorder of glycosylation, type IId, 607091 (3)	Congenital disorder of glycosylation, type IId	n	-	-	-	B4GALT1	HGNC:924	Congenital disorder of glycosylation, type IId, 607091 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
607101	DEAFNESS, AUTOSOMAL RECESSIVE 30	Deafness, autosomal recessive 30, 607101 (3)	Deafness, autosomal recessive 30	n	-	-	-	MYO3A	HGNC:7601	Deafness, autosomal recessive 30, 607101 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
607115	CINCA SYNDROME	CINCA syndrome, 607115 (3)	CINCA syndrome	n	-	-	-	NLRP3	HGNC:16400	CINCA syndrome, 607115 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L6	L6	post-infant-lethal
607136	SPINOCEREBELLAR ATAXIA 17	Spinocerebellar ataxia 17, 607136 (3)	Spinocerebellar ataxia 17	y	SPINOCEREBELLAR ATAXIA 17; SCA17	Clinical Features|Phenotype	death|deaths|died	TBP	HGNC:11588	Spinocerebellar ataxia 17, 607136 (3), Autosomal dominant	Autosomal dominant	y	y	[Bruni et al. (2004) reported neuropathologic findings of a patient from the family reported by Filla et al. (2002).She had onset of behavioral and frontal lobe impairment at age 17 years and followed a progressive course until death at age 48 years]	L6	y	-	lethal	lethal	lethal	L6	L6	post-infant-lethal
607143	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ig	Congenital disorder of glycosylation, type Ig, 607143 (3)	Congenital disorder of glycosylation, type Ig	y	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ig; CDG1G	Description|Clinical Features|Clinical Synopsis	die|died|death|deaths	ALG12	HGNC:19358	Congenital disorder of glycosylation, type Ig, 607143 (3), Autosomal recessive	Autosomal recessive	y	y	[Death in neonatal period or infancy]	L2	y	-	lethal	lethal	lethal	L2	L2	pre-infant-lethal
607155	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 5	Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 5, 607155 (3)	Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 5	n	-	-	-	FKRP	HGNC:17997	Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 5, 607155 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L2	L2	pre-infant-lethal
607174	MENINGIOMA, FAMILIAL, SUSCEPTIBILITY TO	Meningioma, 607174 (3)	Meningioma	y	MENINGIOMA, FAMILIAL, SUSCEPTIBILITY TO	Phenotype	died	MN1	HGNC:7180	Meningioma, 607174 (3), Autosomal dominant	Autosomal dominant	n	n	-	-	-	-	ambiguous	ambiguous|nonlethal	ambiguous	-	-	-
607174	MENINGIOMA, FAMILIAL, SUSCEPTIBILITY TO	Meningioma, SIS-related, 607174 (3)	Meningioma, SIS-related	y	MENINGIOMA, FAMILIAL, SUSCEPTIBILITY TO	Phenotype	died	PDGFB	HGNC:8800	Meningioma, SIS-related, 607174 (3), Autosomal dominant	Autosomal dominant	n	n	-	-	-	-	ambiguous	ambiguous|nonlethal	ambiguous	-	-	-
607196	MICROCEPHALY, AMISH TYPE	Microcephaly, Amish type, 607196 (3)	Microcephaly, Amish type	y	MICROCEPHALY, AMISH TYPE; MCPHA	Clinical Features|Clinical Synopsis	death|deaths|lethal	SLC25A19	HGNC:14409	Microcephaly, Amish type, 607196 (3), Autosomal recessive	Autosomal recessive	y	y	[Death usually within first year of life/ Kelley et al. (2002) described a metabolic disorder among the Old Order Amish of Lancaster County, Pennsylvania, characterized by severe congenital microcephaly, death within the first year, and severe 2-ketoglutaric aciduria]	L3	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L3	L3	pre-infant-lethal
607200	THYROID DYSHORMONOGENESIS 6	Thyroid dyshormonogenesis 6, 607200 (3)	Thyroid dyshormonogenesis 6	n	-	-	-	DUOX2	HGNC:13273	Thyroid dyshormonogenesis 6, 607200 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
607208	DRAVET SYNDROME	Dravet syndrome, 607208 (3)	Dravet syndrome	y	DRAVET SYNDROME; DRVT	Clinical Features	death|deaths|died	SCN1A	HGNC:10585	Dravet syndrome, 607208 (3), Autosomal dominant	Autosomal dominant	y	y	[Freilich et al. (2011) reported a female infant who presented clinically with MPSI associated with a heterozygous mutation in the SCN1A gene (A1669E; 182389.0023). She had a severe phenotype, with onset of seizures at age 10 weeks, progression to refractory recurrent seizures by age 5 months, status epilepticus, EEG evidence of migrating focal onset progressing to multifocal seizures, progressive microcephaly, and profound psychomotor delay. She died at age 9 months]	L3	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L3|L5	L3	pre-infant-lethal
607225	SPASTIC PARALYSIS, INFANTILE-ONSET ASCENDING	Spastic paralysis, infantile onset ascending, 607225 (3)	Spastic paralysis, infantile onset ascending	y	SPASTIC PARALYSIS, INFANTILE-ONSET ASCENDING; IAHSP	Clinical Features	death|deaths	ALS2	HGNC:443	Spastic paralysis, infantile onset ascending, 607225 (3), Autosomal recessive	Autosomal recessive	y	y	[Gros-Louis et al. (2003) reported a large consanguineous Pakistani family with infantile-onset complicated spastic paraparesis. The proband presented with gait disturbance and hyperreflexia at 18 months and was anarthric and wheelchair-bound by age 12 years. Family history indicated that the disease slowly progressed to tetraplegia and death by the fourth decade, with relatively preserved intellect]	L6	n	y	lethal	lethal|nonlethal	lethal|nonlethal	L6	L6	post-infant-lethal
607236	HYPOPREBETALIPOPROTEINEMIA, ACANTHOCYTOSIS, RETINITIS PIGMENTOSA, AND PALLIDAL DEGENERATION	HARP syndrome, 607236 (3)	HARP syndrome	n	-	-	-	PANK2	HGNC:15894	HARP syndrome, 607236 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L4	L4	post-infant-lethal
607259	SPASTIC PARAPLEGIA 7, AUTOSOMAL RECESSIVE	Spastic paraplegia 7, autosomal recessive, 607259 (3)	Spastic paraplegia 7, autosomal recessive	n	-	-	-	SPG7	HGNC:11237	Spastic paraplegia 7, autosomal recessive, 607259 (3), Autosomal dominant, Autosomal recessive	Autosomal dominant, Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
607313	GAZE PALSY, FAMILIAL HORIZONTAL, WITH PROGRESSIVE SCOLIOSIS 1	Gaze palsy, familial horizontal, with progressive scoliosis, 1, 607313 (3)	Gaze palsy, familial horizontal, with progressive scoliosis, 1	n	-	-	-	ROBO3	HGNC:13433	Gaze palsy, familial horizontal, with progressive scoliosis, 1, 607313 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
607317	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 4	Spinocerebellar ataxia, autosomal recessive 4, 607317 (3)	Spinocerebellar ataxia, autosomal recessive 4	n	-	-	-	VPS13D	HGNC:23595	Spinocerebellar ataxia, autosomal recessive 4, 607317 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
607323	DUANE-RADIAL RAY SYNDROME	Duane-radial ray syndrome, 607323 (3)	Duane-radial ray syndrome	n	-	-	-	SALL4	HGNC:15924	Duane-radial ray syndrome, 607323 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
607326	SMITH-MCCORT DYSPLASIA 1	Smith-McCort dysplasia, 607326 (3)	Smith-McCort dysplasia	n	-	-	-	DYM	HGNC:21317	Smith-McCort dysplasia, 607326 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
607330	LATHOSTEROLOSIS	Lathosterolosis, 607330 (3)	Lathosterolosis	y	LATHOSTEROLOSIS; LATHOS	Clinical Features	died	SC5D	HGNC:10547	Lathosterolosis, 607330 (3), Autosomal recessive	Autosomal recessive	y	y	[Parnes et al. (1990) described a patient who was hypotonic at birth with height, weight, and head circumference below the 3rd percentile. He had ptosis, microcorneae, and bilateral cataracts. He also had hypospadias, bilateral 2-3 toe syndactyly, and bilateral hexadactyly of his feet. At 2 months of age, he developed myoclonus and pathologic hyperreflexia. He developed progressive hepatosplenomegaly, corneal clouding, and gingival hypertrophy. He died of respiratory failure at 18 weeks of age. Liver biopsy studies showed focal vacuolated hepatocytes, swollen and vacuolated Kupffer cells, and foamy granular histiocytes. Krakowiak et al. (2003) reported further on this patient and determined by molecular analysis that he had lathosterolosis]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
607346	SPINOCEREBELLAR ATAXIA 19	Spinocerebellar ataxia 19, 607346 (3)	Spinocerebellar ataxia 19	n	-	-	-	KCND3	HGNC:6239	Spinocerebellar ataxia 19, 607346 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L6	L6	post-infant-lethal
607361	MECKEL SYNDROME, TYPE 3	Meckel syndrome 3, 607361 (3)	Meckel syndrome 3	y	MECKEL SYNDROME, TYPE 3; MKS3	Description|Clinical Synopsis	lethal	TMEM67	HGNC:28396	Meckel syndrome 3, 607361 (3), Autosomal recessive	Autosomal recessive	n	y	[Lethal in utero or in the perinatal period]	L1	y	-	lethal	ambiguous|lethal|nonlethal	lethal|nonlethal	L1|L4	L1	pre-infant-lethal
607364	BARTTER SYNDROME, TYPE 3	Bartter syndrome, type 3, 607364 (3)	Bartter syndrome, type 3	y	BARTTER SYNDROME, TYPE 3; BARTS3	Clinical Features	fatal	CLCNKB	HGNC:2027	Bartter syndrome, type 3, 607364 (3), Autosomal recessive	Autosomal recessive	n	y	[Patients with antenatal (or neonatal) forms of Bartter syndrome (e.g., BARTS1, 601678) typically present with premature birth associated with polyhydramnios and low birth weight and may develop life-threatening dehydration in the neonatal period]	L2	y	-	lethal	lethal	lethal	L2	L2	pre-infant-lethal
607371	DYSTONIA-DEAFNESS SYNDROME 1	Dystonia-deafness syndrome 1, 607371 (3)	Dystonia-deafness syndrome 1	y	DYSTONIA-DEAFNESS SYNDROME 1; DDS1	Description|Clinical Features	death|deaths	ACTB	HGNC:132	Dystonia-deafness syndrome 1, 607371 (3), Autosomal dominant	Autosomal dominant	y	y	[Death occurred at ages 21 and 22 years.]	L6	y	-	lethal	lethal	lethal	L1|L5|L6	L1	pre-infant-lethal
607398	GLUCOCORTICOID DEFICIENCY 2	Glucocorticoid deficiency 2, 607398 (3)	Glucocorticoid deficiency 2	n	-	-	-	MRAP	HGNC:1304	Glucocorticoid deficiency 2, 607398 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
607417	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 2	Intellectual developmental disorder, autosomal recessive 2, 607417 (3)	Intellectual developmental disorder, autosomal recessive 2	n	-	-	-	CRBN	HGNC:30185	Intellectual developmental disorder, autosomal recessive 2, 607417 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
607426	COENZYME Q10 DEFICIENCY, PRIMARY, 1	Coenzyme Q10 deficiency, primary, 1, 607426 (3)	Coenzyme Q10 deficiency, primary, 1	y	COENZYME Q10 DEFICIENCY, PRIMARY, 1; COQ10D1	Clinical Features|Phenotype	death|deaths|died|fatal	COQ2	HGNC:25223	Coenzyme Q10 deficiency, primary, 1, 607426 (3), Autosomal recessive	Autosomal recessive	y	y	[Diomedi-Camassei et al. (2007) reported 2 unrelated children with CoQ10 deficiency who manifested with severe early-onset nephrotic syndrome... At age 3 months, he developed drug-resistant seizures, status epilepticus, and encephalopathy, leading to an unresponsive state, respiratory failure, and death at age 6 months. Brain MRI showed stroke-like lesions and cerebral atrophy. He also had increased CSF lactate. An older sister had died at age 18 hours of metabolic acidosis and respiratory distress]	L2	y	y	lethal	lethal	lethal	L2	L2	pre-infant-lethal
607432	LISSENCEPHALY 1	Lissencephaly 1, 607432 (3)	Lissencephaly 1	y	LISSENCEPHALY 1; LIS1	Clinical Features	died	PAFAH1B1	HGNC:8574	Lissencephaly 1, 607432 (3), Autosomal dominant	Autosomal dominant	y	y	[Leventer et al. (2001) described the patient reported by Chong et al. (1996) in greater detail. From infancy, the patient showed developmental delay, myoclonic jerks and spasms, seizures, generalized hypotonia, microcephaly, and dysmorphic facies. Brain MRI revealed moderate agyria in the occipital lobes transitioning to pachygyria anteriorly as well as flattening of the corpus callosum and mild dilation of the posterior horns of the lateral ventricles. The patient developed progressive spasticity and died of sepsis at age 4 years]	L4	y	-	lethal	lethal	lethal	L4	L4	post-infant-lethal
607432	LISSENCEPHALY 1	Subcortical laminar heterotopia, 607432 (3)	Subcortical laminar heterotopia	y	LISSENCEPHALY 1; LIS1	Clinical Features	died	PAFAH1B1	HGNC:8574	Subcortical laminar heterotopia, 607432 (3), Autosomal dominant	Autosomal dominant	y	y	[Leventer et al. (2001) described the patient reported by Chong et al. (1996) in greater detail. From infancy, the patient showed developmental delay, myoclonic jerks and spasms, seizures, generalized hypotonia, microcephaly, and dysmorphic facies. Brain MRI revealed moderate agyria in the occipital lobes transitioning to pachygyria anteriorly as well as flattening of the corpus callosum and mild dilation of the posterior horns of the lateral ventricles. The patient developed progressive spasticity and died of sepsis at age 4 years]	L4	y	-	lethal	lethal	lethal	L4	L4	post-infant-lethal
607450	ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 8	Arrhythmogenic right ventricular dysplasia 8, 607450 (3)	Arrhythmogenic right ventricular dysplasia 8	y	ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 8; ARVD8	Clinical Features|Clinical Synopsis	death|deaths|died	DSP	HGNC:3052	Arrhythmogenic right ventricular dysplasia 8, 607450 (3), Autosomal dominant	Autosomal dominant	y	y	[Sudden cardiac death / Rampazzo et al. (2002) reported a 4-generation Italian family in which the proband experienced cardiac arrest at age 18 due to ventricular fibrillation during physical effort....Familial analysis revealed 10 additional family members who all exhibited repolarization abnormalities as well as various other cardiac abnormalities, including sustained ventricular tachycardia in 2 patients.Cardiac symptoms ranged from mild to severe among the family members; there were 2 sudden deaths, at ages 15 and 65 years, and 1 patient died of heart failure at age 68 year]	L5	y	y	lethal	lethal|nonlethal	lethal|nonlethal	L2|L4|L5|LU	L2	pre-infant-lethal
607454	SPINOCEREBELLAR ATAXIA 21	Spinocerebellar ataxia 21, 607454 (3)	Spinocerebellar ataxia 21	y	SPINOCEREBELLAR ATAXIA 21; SCA21	Clinical Features	died	TMEM240	HGNC:25186	Spinocerebellar ataxia 21, 607454 (3), Autosomal dominant	Autosomal dominant	n	n	-	-	-	-	ambiguous	ambiguous	ambiguous	-	-	-
607459	SENSORY ATAXIC NEUROPATHY, DYSARTHRIA, AND OPHTHALMOPARESIS	Mitochondrial recessive ataxia syndrome (includes SANDO and SCAE), 607459 (3)	Mitochondrial recessive ataxia syndrome (includes SANDO and SCAE)	y	SENSORY ATAXIC NEUROPATHY, DYSARTHRIA, AND OPHTHALMOPARESIS; SANDO	Clinical Features	death|deaths|died|fatal	POLG	HGNC:9179	Mitochondrial recessive ataxia syndrome (includes SANDO and SCAE), 607459 (3), Autosomal recessive	Autosomal recessive	y	y	[Van Goethem et al. (2004) reported 8 patients from 5 European families who presented with sensory ataxia without apparent muscle involvement;... The patient's sister had acute encephalopathy, myoclonus, partial seizures, cortical blindness, stupor, and sudden death at age 17 years]	L5	n	y	lethal	lethal|nonlethal	lethal|nonlethal	L2|L3|L5|L6	L2	pre-infant-lethal
607473	VITAMIN K-DEPENDENT CLOTTING FACTORS, COMBINED DEFICIENCY OF, 2	Vitamin K-dependent clotting factors, combined deficiency of, 2, 607473 (3)	Vitamin K-dependent clotting factors, combined deficiency of, 2	y	VITAMIN K-DEPENDENT CLOTTING FACTORS, COMBINED DEFICIENCY OF, 2; VKCFD2	Description|Clinical Features	fatal|died	VKORC1	HGNC:23663	Vitamin K-dependent clotting factors, combined deficiency of, 2, 607473 (3), Autosomal recessive	Autosomal recessive	y	y	[Clinical symptoms of the disease include episodes of intracranial hemorrhage in the first weeks of life, sometimes leading to a fatal outcome / Oldenburg et al. (2000) described 2 pedigrees showing an autosomal recessive transmission of familial multiple coagulation factor deficiency. The first pedigree was a consanguineous kindred of Lebanese origin with 8 children alive. There were 2 further children who died, one on day 3 after birth from intracranial hemorrhage, and the other during the first year of life. Four sibs had experienced severe bleeding previously]	L2	y	y	lethal	lethal|nonlethal	lethal|nonlethal	L2	L2	pre-infant-lethal
607475	BOTHNIA RETINAL DYSTROPHY	Bothnia retinal dystrophy, 607475 (3)	Bothnia retinal dystrophy	n	-	-	-	RLBP1	HGNC:10024	Bothnia retinal dystrophy, 607475 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
607476	NEWFOUNDLAND ROD-CONE DYSTROPHY	Newfoundland rod-cone dystrophy, 607476 (3)	Newfoundland rod-cone dystrophy	n	-	-	-	RLBP1	HGNC:10024	Newfoundland rod-cone dystrophy, 607476 (3)	-	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
607483	THIAMINE METABOLISM DYSFUNCTION SYNDROME 2 (BIOTIN- OR THIAMINE-RESPONSIVE TYPE)	Thiamine metabolism dysfunction syndrome 2 (biotin- or thiamine-responsive encephalopathy type 2), 607483 (3)	Thiamine metabolism dysfunction syndrome 2 (biotin- or thiamine-responsive encephalopathy type 2)	y	THIAMINE METABOLISM DYSFUNCTION SYNDROME 2 (BIOTIN- OR THIAMINE-RESPONSIVE TYPE); THMD2	Description|Clinical Features	death|deaths|died|lethal	SLC19A3	HGNC:16266	Thiamine metabolism dysfunction syndrome 2 (biotin- or thiamine-responsive encephalopathy type 2), 607483 (3), Autosomal recessive	Autosomal recessive	y	y	[Kevelam et al. (2013) identified a group of 7 patients from 5 unrelated families with an early-infantile lethal encephalopathy / All 5 patients died of respiratory insufficiency about 1 month after birth]	L3	y	y	lethal	lethal	lethal	L3	L3	pre-infant-lethal
607485	FRONTOTEMPORAL LOBAR DEGENERATION WITH TDP43 INCLUSIONS, GRN-RELATED	Aphasia, primary progressive, 607485 (3)	Aphasia, primary progressive	y	FRONTOTEMPORAL LOBAR DEGENERATION WITH TDP43 INCLUSIONS, GRN-RELATED	Clinical Features|Phenotype	death|deaths|died	GRN	HGNC:4601	Aphasia, primary progressive, 607485 (3), Autosomal dominant	Autosomal dominant	y	y	[In an international collaborative study comparing clinical features of 97 unrelated patients with FTLD due to GRN mutations and 453 patients with FTLD who did not have GRN mutations, Chen-Plotkin et al. (2011) found clinical differences between the 2 groups. Those with GRN mutations had a younger age at disease onset (median age 58.0 vs 61.0 years), younger age at death (median age 65.5 vs 69.0 years), and less motor neuron disease (5.4% vs 26.3%)]	L6	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L6	L6	post-infant-lethal
607485	FRONTOTEMPORAL LOBAR DEGENERATION WITH TDP43 INCLUSIONS, GRN-RELATED	Frontotemporal lobar degeneration with ubiquitin-positive inclusions, 607485 (3)	Frontotemporal lobar degeneration with ubiquitin-positive inclusions	y	FRONTOTEMPORAL LOBAR DEGENERATION WITH TDP43 INCLUSIONS, GRN-RELATED	Clinical Features|Phenotype	death|deaths|died	GRN	HGNC:4601	Frontotemporal lobar degeneration with ubiquitin-positive inclusions, 607485 (3), Autosomal dominant	Autosomal dominant	y	y	[In an international collaborative study comparing clinical features of 97 unrelated patients with FTLD due to GRN mutations and 453 patients with FTLD who did not have GRN mutations, Chen-Plotkin et al. (2011) found clinical differences between the 2 groups. Those with GRN mutations had a younger age at disease onset (median age 58.0 vs 61.0 years), younger age at death (median age 65.5 vs 69.0 years), and less motor neuron disease (5.4% vs 26.3%)]	L6	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L6	L6	post-infant-lethal
607487	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 25	Cardiomyopathy, hypertrophic, 25, 607487 (3)	Cardiomyopathy, hypertrophic, 25	y	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 25; CMH25	Clinical Features|Clinical Synopsis	death|deaths|died	TCAP	HGNC:11610	Cardiomyopathy, hypertrophic, 25, 607487 (3), Autosomal dominant	Autosomal dominant	y	y	[Sudden cardiac death after exercise (in some patients) / Hayashi et al. (2004) studied 2 Japanese families with hypertrophic cardiomyopathy. In the first family, an affected mother and son both showed left ventricular hypertrophy (LVH) on electrocardiography (ECG), and the 62-year-old mother also exhibited Wolff-Parkinson-White syndrome (see 194200) whereas her 29-year-old son had abnormal Q-waves. The mother's father had died suddenly after exercise at 34 years of age]	L6	n	y	lethal	lethal|nonlethal	lethal|nonlethal	L6	L6	post-infant-lethal
607523	NAIL DISORDER, NONSYNDROMIC CONGENITAL, 8	Nail disorder, nonsyndromic congenital, 8, 607523 (3)	Nail disorder, nonsyndromic congenital, 8	n	-	-	-	COL7A1	HGNC:2214	Nail disorder, nonsyndromic congenital, 8, 607523 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L6	L6	post-infant-lethal
607541	CORNEAL DYSTROPHY, AVELLINO TYPE	Corneal dystrophy, Avellino type, 607541 (3)	Corneal dystrophy, Avellino type	n	-	-	-	TGFBI	HGNC:11771	Corneal dystrophy, Avellino type, 607541 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
607554	ATRIAL FIBRILLATION, FAMILIAL, 3	Atrial fibrillation, familial, 3, 607554 (3)	Atrial fibrillation, familial, 3	y	ATRIAL FIBRILLATION, FAMILIAL, 3; ATFB3	Clinical Features	death|deaths|died	KCNQ1	HGNC:6294	Atrial fibrillation, familial, 3, 607554 (3), Autosomal dominant	Autosomal dominant	y	y	[Bartos et al. (2013) studied 4 families with early-onset AF (less than 40 years of age) in which a missense mutation in the KCNQ1 gene (R231H; 607542.0043) was identified in affected individuals (see MOLECULAR GENETICS)....Their mother and a maternal aunt were both diagnosed with early-onset AF and died suddenly during sleep at 60 and 55 years of age]	L6	n	y	lethal	lethal	lethal	L4|L5|L6|LU	L4	post-infant-lethal
607594	IMMUNODEFICIENCY, COMMON VARIABLE, 1	Immunodeficiency, common variable, 1, 607594 (3)	Immunodeficiency, common variable, 1	n	-	-	-	ICOS	HGNC:5351	Immunodeficiency, common variable, 1, 607594 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
607596	PONTOCEREBELLAR HYPOPLASIA, TYPE 1A	Pontocerebellar hypoplasia type 1A, 607596 (3)	Pontocerebellar hypoplasia type 1A	y	PONTOCEREBELLAR HYPOPLASIA, TYPE 1A; PCH1A	Description|Clinical Features|Clinical Synopsis	death|deaths|died	VRK1	HGNC:12718	Pontocerebellar hypoplasia type 1A, 607596 (3), Autosomal recessive	Autosomal recessive	y	y	[Renbaum et al. (2009) reported a consanguineous family of Ashkenazi Jewish origin in which 3 children had SMA-PCH. Early features included microcephaly, poor sucking, and developmental delay. In the first 2 years, the proband developed upper limb ataxia, brisk reflexes, and bilateral equinovarus. She was found to have motor and sensory neuropathy due to chronic denervation. Brain MRI showed a small cerebellar vermis and a large cisterna magna, compatible with cerebellar hypoplasia; she had mild mental retardation. Disease progression led to severe weakness, and the child became wheelchair-bound and incontinent, with sleep disturbance, increasing swallowing difficulties, severe ataxia, and progressive intercostal muscle weakness. She died at age 11.5 years. A previously deceased older sister had a similar phenotype, with tongue fasciculations, hypotonia with brisk reflexes, ataxia, and equinovarus deformities. She died at age 9.5 years. Their cousin, also the product of a consanguineous marriage within the extended family, reportedly had a similar phenotype and died at age 8 years]	L4	y	y	lethal	lethal|nonlethal	lethal|nonlethal	L4	L4	post-infant-lethal
607602	ICHTHYOSIS, ANNULAR EPIDERMOLYTIC, 1	Ichthyosis, annular epidermolytic 1, 607602 (3)	Ichthyosis, annular epidermolytic 1	n	-	-	-	KRT10	HGNC:6413	Ichthyosis, annular epidermolytic 1, 607602 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L2|L6	L2	pre-infant-lethal
607616	NIEMANN-PICK DISEASE, TYPE B	Niemann-Pick disease, type B, 607616 (3)	Niemann-Pick disease, type B	y	NIEMANN-PICK DISEASE, TYPE B	Description|Clinical Features	death|deaths|died|fatal	SMPD1	HGNC:11120	Niemann-Pick disease, type B, 607616 (3), Autosomal recessive	Autosomal recessive	y	y	[Median age of death was 15.5 years (range 1-72). Causes of death included pneumonia, liver failure, and hemorrhage. The majority of deaths (12 of the 18) occurred in patients younger than 21 years, yielding a mortality rate of 19% in the pediatric population]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
607624	GRISCELLI SYNDROME, TYPE 2	Griscelli syndrome, type 2, 607624 (3)	Griscelli syndrome, type 2	y	GRISCELLI SYNDROME, TYPE 2; GS2	Clinical Features|Clinical Synopsis	death|deaths|died|fatal	RAB27A	HGNC:9766	Griscelli syndrome, type 2, 607624 (3), Autosomal recessive	Autosomal recessive	y	y	[Hurvitz et al. (1993) reported studies of 4 members of a highly consanguineous kindred with pigmentation and histologic findings consistent with Griscelli syndrome but without recurrent infections. These patients exhibited a range of neurologic involvement from mild cognitive delay with a convulsive disorder in one patient to a fatal degenerative course in 3 others. Anikster et al. (2002) restudied this family, a Muslim Arab kindred whose members had highly variable neurologic involvement, along with the hemophagocytic syndrome and immunologic abnormalities. This family included 4 affected children: a brother (the proband) and sister in one family, and their 2 female first cousins. All 4 individuals died in childhood, at ages 11.5 years, 10 months, 6 years, and 2 years, respectively]	L4	y	-	lethal	lethal	lethal	L4	L4	post-infant-lethal
607625	NIEMANN-PICK DISEASE, TYPE C2	Niemann-pick disease, type C2, 607625 (3)	Niemann-pick disease, type C2	y	NIEMANN-PICK DISEASE, TYPE C2; NPC2	Clinical Features|Clinical Synopsis	death|deaths	NPC2	HGNC:14537	Niemann-pick disease, type C2, 607625 (3), Autosomal recessive	Autosomal recessive	n	y	[Millat et al. (2001) reported the first comprehensive study of 8 unrelated families with NPC2, originating from France, Algeria, Italy, Germany, the Czech Republic, and Turkey. These cases represented essentially all patients with NPC2 who had been reported, as well as those known to the authors. Seven families demonstrated severe and rapid disease course, with age at death being 6 months to 4 years]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
607626	ICHTHYOSIS, LEUKOCYTE VACUOLES, ALOPECIA, AND SCLEROSING CHOLANGITIS	Ichthyosis, leukocyte vacuoles, alopecia, and sclerosing cholangitis, 607626 (3)	Ichthyosis, leukocyte vacuoles, alopecia, and sclerosing cholangitis	n	-	-	-	CLDN1	HGNC:2032	Ichthyosis, leukocyte vacuoles, alopecia, and sclerosing cholangitis, 607626 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
607634	OSTEOPETROSIS, AUTOSOMAL DOMINANT 1	Osteopetrosis, autosomal dominant 1, 607634 (3)	Osteopetrosis, autosomal dominant 1	n	-	-	-	LRP5	HGNC:6697	Osteopetrosis, autosomal dominant 1, 607634 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
607641	NEURONOPATHY, DISTAL HEREDITARY MOTOR, AUTOSOMAL DOMINANT 14	Neuronopathy, distal hereditary motor, autosomal dominant 14, 607641 (3)	Neuronopathy, distal hereditary motor, autosomal dominant 14	n	-	-	-	DCTN1	HGNC:2711	Neuronopathy, distal hereditary motor, autosomal dominant 14, 607641 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L6	L6	post-infant-lethal
607654	KERATOSIS PALMOPLANTARIS STRIATA III	Keratosis palmoplantaris striata III, 607654 (3)	Keratosis palmoplantaris striata III	n	-	-	-	KRT1	HGNC:6412	Keratosis palmoplantaris striata III, 607654 (3)	-	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L2	L2	pre-infant-lethal
607676	IMMUNODEFICIENCY 67	Immunodeficiency 67, 607676 (3)	Immunodeficiency 67	y	IMMUNODEFICIENCY 67; IMD67	Description|Clinical Features|Clinical Synopsis|Phenotype	death|deaths|died|fatal	IRAK4	HGNC:17967	Immunodeficiency 67, 607676 (3), Autosomal recessive	Autosomal recessive	y	y	[Enders et al. (2004) reported 2 sibs, born of consanguineous Turkish parents, with IMD67. They presented in infancy with recurrent infections, including bronchitis, gastroenteritis, osteomyelitis, and pneumococcal meningitis. Despite treatment, both died, at 14 and 2 months of age. During the infections, both children had a poor inflammatory response without fever, suggesting a deficiency in NFKB-mediated immunity]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
607677	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2I	Charcot-Marie-Tooth disease, type 2I, 607677 (3)	Charcot-Marie-Tooth disease, type 2I	n	-	-	-	MPZ	HGNC:7225	Charcot-Marie-Tooth disease, type 2I, 607677 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	ambiguous|lethal|nonlethal	lethal|nonlethal	L6	L6	post-infant-lethal
607678	CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 1D	Charcot-Marie-Tooth disease, type 1D, 607678 (3)	Charcot-Marie-Tooth disease, type 1D	n	-	-	-	EGR2	HGNC:3239	Charcot-Marie-Tooth disease, type 1D, 607678 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L3|L4	L3	pre-infant-lethal
607681	FEBRILE SEIZURES, FAMILIAL, 8	Febrile seizures, familial, 8, 607681 (3)	Febrile seizures, familial, 8	n	-	-	-	GABRG2	HGNC:4087	Febrile seizures, familial, 8, 607681 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
607681	FEBRILE SEIZURES, FAMILIAL, 8	Generalized epilepsy with febrile seizures plus, type 3, 607681 (3)	Generalized epilepsy with febrile seizures plus, type 3	n	-	-	-	GABRG2	HGNC:4087	Generalized epilepsy with febrile seizures plus, type 3, 607681 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
607684	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2E	Charcot-Marie-Tooth disease, type 2E, 607684 (3)	Charcot-Marie-Tooth disease, type 2E	n	-	-	-	NEFL	HGNC:7739	Charcot-Marie-Tooth disease, type 2E, 607684 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
607694	LEUKODYSTROPHY, HYPOMYELINATING, 7, WITH OR WITHOUT OLIGODONTIA AND/OR HYPOGONADOTROPIC HYPOGONADISM	Leukodystrophy, hypomyelinating, 7, with or without oligodontia and/or hypogonadotropic hypogonadism, 607694 (3)	Leukodystrophy, hypomyelinating, 7, with or without oligodontia and/or hypogonadotropic hypogonadism	n	-	-	-	POLR3A	HGNC:30074	Leukodystrophy, hypomyelinating, 7, with or without oligodontia and/or hypogonadotropic hypogonadism, 607694 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L2	L2	pre-infant-lethal
607706	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, WITH VOCAL CORD PARESIS, AUTOSOMAL RECESSIVE	Charcot-Marie-Tooth disease, axonal, with vocal cord paresis, 607706 (3)	Charcot-Marie-Tooth disease, axonal, with vocal cord paresis	n	-	-	-	GDAP1	HGNC:15968	Charcot-Marie-Tooth disease, axonal, with vocal cord paresis, 607706 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
607721	NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 1	Noonan syndrome-like with loose anagen hair 1, 607721 (3)	Noonan syndrome-like with loose anagen hair 1	y	NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 1; NSLH1	Phenotype	died	SHOC2	HGNC:15454	Noonan syndrome-like with loose anagen hair 1, 607721 (3), Autosomal dominant	Autosomal dominant	y	y	[died of congestive heart failure at 4 months of age]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
607734	CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 1F	Charcot-Marie-Tooth disease, type 1F, 607734 (3)	Charcot-Marie-Tooth disease, type 1F	n	-	-	-	NEFL	HGNC:7739	Charcot-Marie-Tooth disease, type 1F, 607734 (3), Autosomal dominant, Autosomal recessive	Autosomal dominant, Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
607736	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2J	Charcot-Marie-Tooth disease, type 2J, 607736 (3)	Charcot-Marie-Tooth disease, type 2J	n	-	-	-	MPZ	HGNC:7225	Charcot-Marie-Tooth disease, type 2J, 607736 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	ambiguous|lethal|nonlethal	lethal|nonlethal	L6	L6	post-infant-lethal
607745	SEIZURES, BENIGN FAMILIAL INFANTILE, 3	Seizures, benign familial infantile, 3, 607745 (3)	Seizures, benign familial infantile, 3	n	-	-	-	SCN2A	HGNC:10588	Seizures, benign familial infantile, 3, 607745 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L2	L2	pre-infant-lethal
607748	HYPERCHOLANEMIA, FAMILIAL 1	Hypercholanemia, familial 1, 607748 (3)	Hypercholanemia, familial 1	n	-	-	-	TJP2	HGNC:11828	Hypercholanemia, familial 1, 607748 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L3	L3	pre-infant-lethal
607765	BILE ACID SYNTHESIS DEFECT, CONGENITAL, 1	Bile acid synthesis defect, congenital, 1, 607765 (3)	Bile acid synthesis defect, congenital, 1	y	BILE ACID SYNTHESIS DEFECT, CONGENITAL, 1; CBAS1	Clinical Features	died	HSD3B7	HGNC:18324	Bile acid synthesis defect, congenital, 1, 607765 (3), Autosomal recessive	Autosomal recessive	n	y	[Schwarz et al. (2000) studied the fifth child, a boy, from the sibship described by Clayton et al. (1987). An older sister and brother had died of complications of progressive liver disease]	LU	n	y	lethal	lethal	lethal	LU	LU	post-infant-lethal
607778	ACROCAPITOFEMORAL DYSPLASIA	Acrocapitofemoral dysplasia, 607778 (3)	Acrocapitofemoral dysplasia	n	-	-	-	IHH	HGNC:5956	Acrocapitofemoral dysplasia, 607778 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
607791	CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE D	Charcot-Marie-Tooth disease, dominant intermediate D, 607791 (3)	Charcot-Marie-Tooth disease, dominant intermediate D	n	-	-	-	MPZ	HGNC:7225	Charcot-Marie-Tooth disease, dominant intermediate D, 607791 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	ambiguous|lethal|nonlethal	lethal|nonlethal	L6	L6	post-infant-lethal
607812	CRANIOLENTICULOSUTURAL DYSPLASIA	Craniolenticulosutural dysplasia, 607812 (3)	Craniolenticulosutural dysplasia	n	-	-	-	SEC23A	HGNC:10701	Craniolenticulosutural dysplasia, 607812 (3), Autosomal dominant, Autosomal recessive	Autosomal dominant, Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
607821	DEAFNESS, AUTOSOMAL RECESSIVE 37	Deafness, autosomal recessive 37, 607821 (3)	Deafness, autosomal recessive 37	n	-	-	-	MYO6	HGNC:7605	Deafness, autosomal recessive 37, 607821 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
607822	ALZHEIMER DISEASE 3	Alzheimer disease, type 3, 607822 (3)	Alzheimer disease, type 3	y	ALZHEIMER DISEASE 3; AD3	Clinical Features|Phenotype	death|deaths|died	PSEN1	HGNC:9508	Alzheimer disease, type 3, 607822 (3), Autosomal dominant	Autosomal dominant	y	y	[Campion et al. (1995) studied a large pedigree that included 34 subjects with early-onset progressive dementia with mean age at onset at 46 plus or minus 3.5 years and mean age at death at 52.6]	L6	y	-	lethal	lethal	lethal	L6	L6	post-infant-lethal
607822	ALZHEIMER DISEASE 3	Alzheimer disease, type 3, with spastic paraparesis and apraxia, 607822 (3)	Alzheimer disease, type 3, with spastic paraparesis and apraxia	y	ALZHEIMER DISEASE 3; AD3	Clinical Features|Phenotype	death|deaths|died	PSEN1	HGNC:9508	Alzheimer disease, type 3, with spastic paraparesis and apraxia, 607822 (3), Autosomal dominant	Autosomal dominant	y	y	[Campion et al. (1995) studied a large pedigree that included 34 subjects with early-onset progressive dementia with mean age at onset at 46 plus or minus 3.5 years and mean age at death at 52.6]	L6	y	-	lethal	lethal	lethal	L6	L6	post-infant-lethal
607822	ALZHEIMER DISEASE 3	Alzheimer disease, type 3, with spastic paraparesis and unusual plaques, 607822 (3)	Alzheimer disease, type 3, with spastic paraparesis and unusual plaques	y	ALZHEIMER DISEASE 3; AD3	Clinical Features|Phenotype	death|deaths|died	PSEN1	HGNC:9508	Alzheimer disease, type 3, with spastic paraparesis and unusual plaques, 607822 (3), Autosomal dominant	Autosomal dominant	y	y	[Campion et al. (1995) studied a large pedigree that included 34 subjects with early-onset progressive dementia with mean age at onset at 46 plus or minus 3.5 years and mean age at death at 52.6]	L6	y	-	lethal	lethal	lethal	L6	L6	post-infant-lethal
607823	HYPOTRICHOSIS-LYMPHEDEMA-TELANGIECTASIA SYNDROME	Hypotrichosis-lymphedema-telangiectasia syndrome, 607823 (3)	Hypotrichosis-lymphedema-telangiectasia syndrome	n	-	-	-	SOX18	HGNC:11194	Hypotrichosis-lymphedema-telangiectasia syndrome, 607823 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L1	L1	pre-infant-lethal
607829	MITRAL VALVE PROLAPSE 2	Mitral valve prolapse 2, 607829 (3)	Mitral valve prolapse 2	n	-	-	-	DCHS1	HGNC:13681	Mitral valve prolapse 2, 607829 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
607831	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2K	Charcot-Marie-Tooth disease, axonal, type 2K, 607831 (3)	Charcot-Marie-Tooth disease, axonal, type 2K	n	-	-	-	GDAP1	HGNC:15968	Charcot-Marie-Tooth disease, axonal, type 2K, 607831 (3), Autosomal dominant, Autosomal recessive	Autosomal dominant, Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
607832	FOCAL SEGMENTAL GLOMERULOSCLEROSIS 3, SUSCEPTIBILITY TO	Glomerulosclerosis, focal segmental, 3, 607832 (3)	Glomerulosclerosis, focal segmental, 3	n	-	-	-	CD2AP	HGNC:14258	Glomerulosclerosis, focal segmental, 3, 607832 (3)	-	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
607842	AURAL ATRESIA, CONGENITAL	Aural atresia, congenital, 607842 (3)	Aural atresia, congenital	n	-	-	-	TSHZ1	HGNC:10669	Aural atresia, congenital, 607842 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
607855	MUSCULAR DYSTROPHY, CONGENITAL MEROSIN-DEFICIENT, 1A	Muscular dystrophy, congenital, merosin deficient or partially deficient, 607855 (3)	Muscular dystrophy, congenital, merosin deficient or partially deficient	n	-	-	-	LAMA2	HGNC:6482	Muscular dystrophy, congenital, merosin deficient or partially deficient, 607855 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
607876	EPILEPSY, FAMILIAL ADULT MYOCLONIC, 2	Epilepsy, familial adult myoclonic, 2, 607876 (3)	Epilepsy, familial adult myoclonic, 2	n	-	-	-	STARD7	HGNC:18063	Epilepsy, familial adult myoclonic, 2, 607876 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
607903	HYPOTRICHOSIS 6	Hypotrichosis 6, 607903 (3)	Hypotrichosis 6	n	-	-	-	DSG4	HGNC:21307	Hypotrichosis 6, 607903 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
607906	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ii	Congenital disorder of glycosylation, type Ii, 607906 (3)	Congenital disorder of glycosylation, type Ii	n	-	-	-	ALG2	HGNC:23159	Congenital disorder of glycosylation, type Ii, 607906 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
607907	DERMATOFIBROSARCOMA PROTUBERANS	Dermatofibrosarcoma protuberans, 607907 (3)	Dermatofibrosarcoma protuberans	n	-	-	-	PDGFB	HGNC:8800	Dermatofibrosarcoma protuberans, 607907 (3)	-	-	-	-	-	-	-	nonlethal	ambiguous|nonlethal	ambiguous	-	-	-
607921	RETINITIS PIGMENTOSA 30	Retinitis pigmentosa 30, 607921 (3)	Retinitis pigmentosa 30	n	-	-	-	FSCN2	HGNC:3960	Retinitis pigmentosa 30, 607921 (3)	-	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
607932	MICROPHTHALMIA, SYNDROMIC 6	Microphthalmia, syndromic 6, 607932 (3)	Microphthalmia, syndromic 6	n	-	-	-	BMP4	HGNC:1071	Microphthalmia, syndromic 6, 607932 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
607936	PEELING SKIN SYNDROME 4	Peeling skin syndrome 4, 607936 (3)	Peeling skin syndrome 4	n	-	-	-	CSTA	HGNC:2481	Peeling skin syndrome 4, 607936 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
607941	ATRIAL SEPTAL DEFECT 2	Atrial septal defect 2, 607941 (3)	Atrial septal defect 2	n	-	-	-	GATA4	HGNC:4173	Atrial septal defect 2, 607941 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	LU	LU	post-infant-lethal
607944	SPONDYLOENCHONDRODYSPLASIA WITH IMMUNE DYSREGULATION	Spondyloenchondrodysplasia with immune dysregulation, 607944 (3)	Spondyloenchondrodysplasia with immune dysregulation	y	SPONDYLOENCHONDRODYSPLASIA WITH IMMUNE DYSREGULATION; SPENCDI	Clinical Features|Clinical Synopsis|Phenotype	fatal|death|deaths	ACP5	HGNC:124	Spondyloenchondrodysplasia with immune dysregulation, 607944 (3), Autosomal recessive	Autosomal recessive	y	y	[Variable severity, from infantile death due to autoimmune thrombocytopenia to isolated skeletal dysplasia in adult patient]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
608013	GAUCHER DISEASE, PERINATAL LETHAL	Gaucher disease, perinatal lethal, 608013 (3)	Gaucher disease, perinatal lethal	y	GAUCHER DISEASE, PERINATAL LETHAL	Description|Clinical Features|Clinical Synopsis|Phenotype	lethal|death|deaths|died|lethality	GBA1	HGNC:4177	Gaucher disease, perinatal lethal, 608013 (3), Autosomal recessive	Autosomal recessive	y	y	[Death in utero (30%)]	L1	y	-	lethal	ambiguous|lethal|nonlethal	lethal|nonlethal	L1|L3|L5	L1	pre-infant-lethal
608022	DIAPHANOSPONDYLODYSOSTOSIS	Diaphanospondylodysostosis, 608022 (3)	Diaphanospondylodysostosis	y	DIAPHANOSPONDYLODYSOSTOSIS	Description|Clinical Features|Clinical Synopsis	lethal|died|stillborn|die	BMPER	HGNC:24154	Diaphanospondylodysostosis, 608022 (3), Autosomal recessive	Autosomal recessive	y	y	[Diaphanospondylodysostosis is a rare, recessively inherited, perinatal lethal skeletal disorder / Majority of patients die in neonatal period secondary to respiratory insufficiency /Gonzales et al. (2005) reported 4 patients from 3 families with similar radiologic findings comprising absent or severely delayed ossification of vertebral bodies. Other manifestations included a short neck, short and wide thorax, normally shaped limbs, hypoplastic nails, and nephroblastomatosis. The babies were stillborn or died soon after birth of respiratory insufficiency]	L1	y	-	lethal	lethal	lethal	L1	L1	pre-infant-lethal
608030	AMYOTROPHIC LATERAL SCLEROSIS 6 WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA	Amyotrophic lateral sclerosis 6, with or without frontotemporal dementia, 608030 (3)	Amyotrophic lateral sclerosis 6, with or without frontotemporal dementia	y	AMYOTROPHIC LATERAL SCLEROSIS 6 WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA; ALS6	Clinical Features	died	FUS	HGNC:4010	Amyotrophic lateral sclerosis 6, with or without frontotemporal dementia, 608030 (3)	-	y	y	[Hewitt et al. (2010) reported a 69-year-old man who presented with predominantly lower motor neuron ALS involving both the lower and upper limbs. He had marked proximal muscle wasting with fasciculations around the shoulder girdle and depressed reflexes. The lower limbs showed distal weakness, proximal fasciculations, and decreased reflexes. He had no family history of neurologic disease, and died of respiratory failure 42 months after symptom onset]	L6	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L6	L6	post-infant-lethal
608051	MACULAR DYSTROPHY, RETINAL, 2	Macular dystrophy, retinal, 2, 608051 (3)	Macular dystrophy, retinal, 2	y	MACULAR DYSTROPHY, RETINAL, 2; MCDR2	Clinical Features	miscarriage|miscarriages	PROM1	HGNC:9454	Macular dystrophy, retinal, 2, 608051 (3), Autosomal dominant	Autosomal dominant	n	n	-	-	-	-	ambiguous	ambiguous|nonlethal	ambiguous	-	-	-
608068	NEUTROPHILIC DERMATOSIS, ACUTE FEBRILE	Neutrophilic dermatosis, acute febrile, 608068 (3)	Neutrophilic dermatosis, acute febrile	y	NEUTROPHILIC DERMATOSIS, ACUTE FEBRILE; AFND	Phenotype	death|deaths	MEFV	HGNC:6998	Neutrophilic dermatosis, acute febrile, 608068 (3), Autosomal dominant	Autosomal dominant	y	n	-	-	-	-	ambiguous	ambiguous|lethal|nonlethal	lethal|nonlethal	L6	L6	post-infant-lethal
608091	JOUBERT SYNDROME 2	Joubert syndrome 2, 608091 (3)	Joubert syndrome 2	n	-	-	-	TMEM216	HGNC:25018	Joubert syndrome 2, 608091 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L1	L1	pre-infant-lethal
608093	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ij	Congenital disorder of glycosylation, type Ij, 608093 (3)	Congenital disorder of glycosylation, type Ij	y	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ij; CDG1J	Clinical Features	death|deaths|died	DPAGT1	HGNC:2995	Congenital disorder of glycosylation, type Ij, 608093 (3), Autosomal recessive	Autosomal recessive	n	y	[Wurde et al. (2012) reported 2 sibs, born of consanguineous Turkish parents, with a severe form of CDG Ij resulting in death in the first year of life]	L3	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L3	L3	pre-infant-lethal
608097	PERIVENTRICULAR HETEROTOPIA WITH MICROCEPHALY, AUTOSOMAL RECESSIVE	Periventricular heterotopia with microcephaly, 608097 (3)	Periventricular heterotopia with microcephaly	n	-	-	-	ARFGEF2	HGNC:15853	Periventricular heterotopia with microcephaly, 608097 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
608099	MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 3	Muscular dystrophy, limb-girdle, autosomal recessive 3, 608099 (3)	Muscular dystrophy, limb-girdle, autosomal recessive 3	n	-	-	-	SGCA	HGNC:10805	Muscular dystrophy, limb-girdle, autosomal recessive 3, 608099 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
608104	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ih	Congenital disorder of glycosylation, type Ih, 608104 (3)	Congenital disorder of glycosylation, type Ih	y	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ih; CDG1H	Description|Clinical Features|Clinical Synopsis	die|death|deaths|died	ALG8	HGNC:23161	Congenital disorder of glycosylation, type Ih, 608104 (3), Autosomal recessive	Autosomal recessive	y	y	[Schollen et al. (2004) described 3 patients from 2 families with CDG Ih associated with a severe clinical phenotype and early infant death. A brother and sister displayed antenatal symptoms, including intrauterine growth retardation and reduced fetal movements. Postnatally, the boy was lethargic and difficult to feed, and subsequently developed diarrhea, vomiting, and massive ascites, and died at 3 months of age]	L3	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L3	L3	pre-infant-lethal
608105	EPILEPSY, ROLANDIC, WITH PAROXYSMAL EXERCISE-INDUCED DYSTONIA AND WRITER'S CRAMP	Epilepsy, rolandic, with paroxysmal exercise-induce dystonia and writer's cramp, 608105 (3)	Epilepsy, rolandic, with paroxysmal exercise-induce dystonia and writer's cramp	n	-	-	-	TBC1D24	HGNC:29203	Epilepsy, rolandic, with paroxysmal exercise-induce dystonia and writer's cramp, 608105 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L2|L3	L2	pre-infant-lethal
608106	IMMUNODEFICIENCY WITH HYPER-IgM, TYPE 5	Immunodeficiency with hyper IgM, type 5, 608106 (3)	Immunodeficiency with hyper IgM, type 5	n	-	-	-	UNG	HGNC:12572	Immunodeficiency with hyper IgM, type 5, 608106 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
608115	OVARIAN HYPERSTIMULATION SYNDROME	Ovarian hyperstimulation syndrome, 608115 (3)	Ovarian hyperstimulation syndrome	n	-	-	-	FSHR	HGNC:3969	Ovarian hyperstimulation syndrome, 608115 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
608118	ZINC DEFICIENCY, TRANSIENT NEONATAL	Zinc deficiency, transient neonatal, 608118 (3)	Zinc deficiency, transient neonatal	n	-	-	-	SLC30A2	HGNC:11013	Zinc deficiency, transient neonatal, 608118 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
608161	MACULAR DYSTROPHY, VITELLIFORM, 3	Macular dystrophy, vitelliform, 3, 608161 (3)	Macular dystrophy, vitelliform, 3	n	-	-	-	PRPH2	HGNC:9942	Macular dystrophy, vitelliform, 3, 608161 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
608189	TROPICAL CALCIFIC PANCREATITIS	Tropical calcific pancreatitis, 608189 (3)	Tropical calcific pancreatitis	n	-	-	-	SPINK1	HGNC:11244	Tropical calcific pancreatitis, 608189 (3), Autosomal dominant, Autosomal recessive	Autosomal dominant, Autosomal recessive	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L6	L6	post-infant-lethal
608194	CONE-ROD DYSTROPHY 13	Cone-rod dystrophy 13, 608194 (3)	Cone-rod dystrophy 13	n	-	-	-	RPGRIP1	HGNC:13436	Cone-rod dystrophy 13, 608194 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
608203	IMMUNODEFICIENCY 73A WITH DEFECTIVE NEUTROPHIL CHEMOTAXIS AND LEUKOCYTOSIS	Immunodeficiency 73A with defective neutrophil chemotaxix and leukocytosis, 608203 (3)	Immunodeficiency 73A with defective neutrophil chemotaxix and leukocytosis	n	-	-	-	RAC2	HGNC:9802	Immunodeficiency 73A with defective neutrophil chemotaxix and leukocytosis, 608203 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L5	L5	post-infant-lethal
608224	DEAFNESS, AUTOSOMAL DOMINANT 41	Deafness, autosomal dominant 41, 608224 (3)	Deafness, autosomal dominant 41	n	-	-	-	P2RX2	HGNC:15459	Deafness, autosomal dominant 41, 608224 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
608233	HERMANSKY-PUDLAK SYNDROME 2	Hermansky-Pudlak syndrome 2, 608233 (3)	Hermansky-Pudlak syndrome 2	n	-	-	-	AP3B1	HGNC:566	Hermansky-Pudlak syndrome 2, 608233 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
608265	DEAFNESS, AUTOSOMAL RECESSIVE 39	Deafness, autosomal recessive 39, 608265 (3)	Deafness, autosomal recessive 39	n	-	-	-	HGF	HGNC:4893	Deafness, autosomal recessive 39, 608265 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
608266	PARATHYROID CARCINOMA	Parathyroid carcinoma, 608266 (3)	Parathyroid carcinoma	n	-	-	-	CDC73	HGNC:16783	Parathyroid carcinoma, 608266 (3)	-	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	LU	LU	post-infant-lethal
608323	CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE C	Charcot-Marie-Tooth disease, dominant intermediate C, 608323 (3)	Charcot-Marie-Tooth disease, dominant intermediate C	n	-	-	-	YARS1	HGNC:12840	Charcot-Marie-Tooth disease, dominant intermediate C, 608323 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L3	L3	pre-infant-lethal
608328	WEILL-MARCHESANI SYNDROME 2	Weill-Marchesani syndrome 2, dominant, 608328 (3)	Weill-Marchesani syndrome 2, dominant	n	-	-	-	FBN1	HGNC:3603	Weill-Marchesani syndrome 2, dominant, 608328 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	ambiguous|lethal|nonlethal	lethal|nonlethal	L2|LU	L2	pre-infant-lethal
608340	CHARCOT-MARIE-TOOTH DISEASE, RECESSIVE INTERMEDIATE A	Charcot-Marie-Tooth disease, recessive intermediate, A, 608340 (3)	Charcot-Marie-Tooth disease, recessive intermediate, A	n	-	-	-	GDAP1	HGNC:15968	Charcot-Marie-Tooth disease, recessive intermediate, A, 608340 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
608354	CAPILLARY MALFORMATION-ARTERIOVENOUS MALFORMATION 1	Capillary malformation-arteriovenous malformation 1, 608354 (3)	Capillary malformation-arteriovenous malformation 1	n	-	-	-	RASA1	HGNC:9871	Capillary malformation-arteriovenous malformation 1, 608354 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
608358	CONGENITAL MYOPATHY 7A, MYOSIN STORAGE, AUTOSOMAL DOMINANT	Congenital myopathy 7A, myosin storage, autosomal dominant, 608358 (3)	Congenital myopathy 7A, myosin storage, autosomal dominant	y	CONGENITAL MYOPATHY 7A, MYOSIN STORAGE, AUTOSOMAL DOMINANT; CMYP7A	Clinical Features|Phenotype	died	MYH7	HGNC:7577	Congenital myopathy 7A, myosin storage, autosomal dominant, 608358 (3), Autosomal dominant	Autosomal dominant	y	y	[affected sister who died at age 25 years]	L6	n	y	lethal	lethal|nonlethal	lethal|nonlethal	L1|L6	L1	pre-infant-lethal
608380	RETINITIS PIGMENTOSA 26	Retinitis pigmentosa 26, 608380 (3)	Retinitis pigmentosa 26	n	-	-	-	CERKL	HGNC:21699	Retinitis pigmentosa 26, 608380 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
608389	BRANCHIOOTIC SYNDROME 3	Branchiootic syndrome 3, 608389 (3)	Branchiootic syndrome 3	n	-	-	-	SIX1	HGNC:10887	Branchiootic syndrome 3, 608389 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
608390	MYOTONIA, POTASSIUM-AGGRAVATED	Myotonia congenita, atypical, acetazolamide-responsive, 608390 (3)	Myotonia congenita, atypical, acetazolamide-responsive	y	MYOTONIA, POTASSIUM-AGGRAVATED	Clinical Features	died	SCN4A	HGNC:10591	Myotonia congenita, atypical, acetazolamide-responsive, 608390 (3), Autosomal dominant	Autosomal dominant	y	y	[Lion-Francois et al. (2010) reported 3 unrelated neonates with sodium channel myotonias who each experienced recurrent life-threatening episodic apnea due to laryngospasm. The attacks were associated with stridor and generalized stiffness, followed by hypotonia, cyanosis, and bradycardia. There were no apparent triggering factors, and examinations between episodes were normal in 2, although all showed feeding difficulties. EMG in all 3 children showed continuous myotonic discharges. One child died of respiratory arrest at age 2.5 months]	L3	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L1|L2|L3	L1	pre-infant-lethal
608393	MICROCEPHALY 6, PRIMARY, AUTOSOMAL RECESSIVE	Microcephaly 6, primary, autosomal recessive, 608393 (3)	Microcephaly 6, primary, autosomal recessive	n	-	-	-	CENPJ	HGNC:17272	Microcephaly 6, primary, autosomal recessive, 608393 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
608404	PLATELET GLYCOPROTEIN IV DEFICIENCY	Platelet glycoprotein IV deficiency, 608404 (3)	Platelet glycoprotein IV deficiency	n	-	-	-	CD36	HGNC:1663	Platelet glycoprotein IV deficiency, 608404 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
608415	PROLONGED ELECTRORETINAL RESPONSE SUPPRESSION 1	Bradyopsia 1, 608415 (3)	Bradyopsia 1	n	-	-	-	RGS9	HGNC:10004	Bradyopsia 1, 608415 (3)	-	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
608423	MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL DOMINANT 2	Muscular dystrophy, limb-girdle, autosomal dominant 2, 608423 (3)	Muscular dystrophy, limb-girdle, autosomal dominant 2	n	-	-	-	TNPO3	HGNC:17103	Muscular dystrophy, limb-girdle, autosomal dominant 2, 608423 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
608443	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 3	Intellectual developmental disorder, autosomal recessive 3, 608443 (3)	Intellectual developmental disorder, autosomal recessive 3	n	-	-	-	CC2D1A	HGNC:30237	Intellectual developmental disorder, autosomal recessive 3, 608443 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
608456	FAMILIAL ADENOMATOUS POLYPOSIS 2	Adenomas, multiple colorectal, 608456 (3)	Adenomas, multiple colorectal	n	-	-	-	MUTYH	HGNC:7527	Adenomas, multiple colorectal, 608456 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
608470	CORNEAL DYSTROPHY, REIS-BUCKLERS TYPE	Corneal dystrophy, Reis-Bucklers type, 608470 (3)	Corneal dystrophy, Reis-Bucklers type	n	-	-	-	TGFBI	HGNC:11771	Corneal dystrophy, Reis-Bucklers type, 608470 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
608471	CORNEAL DYSTROPHY, LATTICE TYPE IIIA	Corneal dystrophy, lattice type IIIA, 608471 (3)	Corneal dystrophy, lattice type IIIA	n	-	-	-	TGFBI	HGNC:11771	Corneal dystrophy, lattice type IIIA, 608471 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
608540	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ik	Congenital disorder of glycosylation, type Ik, 608540 (3)	Congenital disorder of glycosylation, type Ik	y	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ik; CDG1K	Clinical Features|Clinical Synopsis	death|deaths|died|lethal	ALG1	HGNC:18294	Congenital disorder of glycosylation, type Ik, 608540 (3), Autosomal recessive	Autosomal recessive	n	y	[Schwarz et al. (2004) described a patient with type I CDG, which they designated CDG Ik. The patient had previously been reported by de Koning et al. (1998). Ultrasound analysis at the thirtieth week of pregnancy revealed nonimmune fetal hydrops and hepatosplenomegaly. After birth at 35 weeks, the boy showed multiple dysmorphic features, with a large fontanel, hypertelorism, micrognathia, hypogonadism, contractures, areflexia, cardiomyopathy, and multifocal epileptic activity. The patient died at 2 weeks of age]	L2	y	-	lethal	lethal	lethal	L2	L2	pre-infant-lethal
608553	LEBER CONGENITAL AMAUROSIS 9	Leber congenital amaurosis 9, 608553 (3)	Leber congenital amaurosis 9	n	-	-	-	NMNAT1	HGNC:17877	Leber congenital amaurosis 9, 608553 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
608565	DEAFNESS, AUTOSOMAL RECESSIVE 35	Deafness, autosomal recessive 35, 608565 (3)	Deafness, autosomal recessive 35	n	-	-	-	ESRRB	HGNC:3473	Deafness, autosomal recessive 35, 608565 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
608567	SICK SINUS SYNDROME 1	Sick sinus syndrome 1, 608567 (3)	Sick sinus syndrome 1	n	-	-	-	SCN5A	HGNC:10593	Sick sinus syndrome 1, 608567 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L4|L5|L6|LU	L4	post-infant-lethal
608569	CARDIOMYOPATHY, DILATED, 1O	Cardiomyopathy, dilated, 1O, 608569 (3)	Cardiomyopathy, dilated, 1O	y	CARDIOMYOPATHY, DILATED, 1O; CMD1O	Clinical Features	died	ABCC9	HGNC:60	Cardiomyopathy, dilated, 1O, 608569 (3), Autosomal dominant	Autosomal dominant	y	y	[Bienengraeber et al. (2004) reported 2 unrelated patients with idiopathic cardiomyopathy and mutation in the ABCC9 gene. Both patients had severely dilated hearts with compromised contractile function and rhythm disturbances. The first patient, a male with no family history of dilated cardiomyopathy, was diagnosed at age 55 and died from heart failure at age 60. The second patient was a female diagnosed at age 40. Her father was diagnosed at age 54 and died at age 55 from heart failure]	L6	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L6	L6	post-infant-lethal
608572	BURN-MCKEOWN SYNDROME	Burn-McKeown syndrome, 608572 (3)	Burn-McKeown syndrome	n	-	-	-	TXNL4A	HGNC:30551	Burn-McKeown syndrome, 608572 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
608594	LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 1	Lipodystrophy, congenital generalized, type 1, 608594 (3)	Lipodystrophy, congenital generalized, type 1	y	LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 1; CGL1	Clinical Features	death|deaths|died|lethal	AGPAT2	HGNC:325	Lipodystrophy, congenital generalized, type 1, 608594 (3), Autosomal recessive	Autosomal recessive	y	y	[Growth velocity is increased in preschool age children, and organomegaly is observed with hypertrophic cardiomyopathy that can be lethal in early adulthood / Three patients of Seip and Trygstad (1996) died at the ages of 24, 32, and 37 years]	L6	y	-	lethal	lethal	lethal	L6	L6	post-infant-lethal
608611	RIBOSE 5-PHOSPHATE ISOMERASE DEFICIENCY	Ribose 5-phosphate isomerase deficiency, 608611 (3)	Ribose 5-phosphate isomerase deficiency	n	-	-	-	RPIA	HGNC:10297	Ribose 5-phosphate isomerase deficiency, 608611 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
608612	MANDIBULOACRAL DYSPLASIA WITH TYPE B LIPODYSTROPHY	Mandibuloacral dysplasia with type B lipodystrophy, 608612 (3)	Mandibuloacral dysplasia with type B lipodystrophy	y	MANDIBULOACRAL DYSPLASIA WITH TYPE B LIPODYSTROPHY; MADB	Clinical Features|Phenotype	died|death|deaths	ZMPSTE24	HGNC:12877	Mandibuloacral dysplasia with type B lipodystrophy, 608612 (3), Autosomal recessive	Autosomal recessive	y	y	[died at age 27.5 years]	L6	-	-	lethal	lethal	lethal	L1|L6	L1	pre-infant-lethal
608615	OLIGODONTIA-COLORECTAL CANCER SYNDROME	Oligodontia-colorectal cancer syndrome, 608615 (3)	Oligodontia-colorectal cancer syndrome	y	OLIGODONTIA-COLORECTAL CANCER SYNDROME; ODCRCS	Phenotype	died	AXIN2	HGNC:904	Oligodontia-colorectal cancer syndrome, 608615 (3), Autosomal dominant	Autosomal dominant	y	n	-	-	-	-	ambiguous	ambiguous	ambiguous	-	-	-
608627	AMYOTROPHIC LATERAL SCLEROSIS 8	Amyotrophic lateral sclerosis 8, 608627 (3)	Amyotrophic lateral sclerosis 8	y	AMYOTROPHIC LATERAL SCLEROSIS 8; ALS8	Clinical Features|Phenotype	death|deaths|died	VAPB	HGNC:12649	Amyotrophic lateral sclerosis 8, 608627 (3), Autosomal dominant	Autosomal dominant	y	n	-	-	-	-	ambiguous	ambiguous|nonlethal	ambiguous	-	-	-
608629	JOUBERT SYNDROME 3	Joubert syndrome 3, 608629 (3)	Joubert syndrome 3	n	-	-	-	AHI1	HGNC:21575	Joubert syndrome 3, 608629 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
608634	NEURONOPATHY, DISTAL HEREDITARY MOTOR, AUTOSOMAL DOMINANT 3	Neuronopathy, distal hereditary motor, autosomal dominant 3, 608634 (3)	Neuronopathy, distal hereditary motor, autosomal dominant 3	n	-	-	-	HSPB1	HGNC:5246	Neuronopathy, distal hereditary motor, autosomal dominant 3, 608634 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
608641	DEAFNESS, AUTOSOMAL DOMINANT 28	Deafness, autosomal dominant 28, 608641 (3)	Deafness, autosomal dominant 28	n	-	-	-	GRHL2	HGNC:2799	Deafness, autosomal dominant 28, 608641 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
608643	AROMATIC L-AMINO ACID DECARBOXYLASE DEFICIENCY	Aromatic L-amino acid decarboxylase deficiency, 608643 (3)	Aromatic L-amino acid decarboxylase deficiency	n	-	-	-	DDC	HGNC:2719	Aromatic L-amino acid decarboxylase deficiency, 608643 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
608644	CILIARY DYSKINESIA, PRIMARY, 3	Ciliary dyskinesia, primary, 3, with or without situs inversus, 608644 (3)	Ciliary dyskinesia, primary, 3, with or without situs inversus	n	-	-	-	DNAH5	HGNC:2950	Ciliary dyskinesia, primary, 3, with or without situs inversus, 608644 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
608647	CILIARY DYSKINESIA, PRIMARY, 5	Ciliary dyskinesia, primary, 5, 608647 (3)	Ciliary dyskinesia, primary, 5	n	-	-	-	HYDIN	HGNC:19368	Ciliary dyskinesia, primary, 5, 608647 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
608649	ICHTHYOSIS PREMATURITY SYNDROME	Ichthyosis prematurity syndrome, 608649 (3)	Ichthyosis prematurity syndrome	y	ICHTHYOSIS PREMATURITY SYNDROME; IPS	Clinical Features	died	SLC27A4	HGNC:10998	Ichthyosis prematurity syndrome, 608649 (3), Autosomal recessive	Autosomal recessive	y	y	[All patients were born prematurely between 29 and 35 weeks' gestation with sometimes life-threatening neonatal asphyxia requiring prolonged hospitalization in the neonatal intensive care unit. Two patients died within 24 hours of delivery]	L2	y	-	lethal	lethal	lethal	L2	L2	pre-infant-lethal
608653	DEAFNESS, AUTOSOMAL RECESSIVE 32, WITH OR WITHOUT IMMOTILE SPERM	Deafness, autosomal recessive 32, with or without immotile sperm, 608653 (3)	Deafness, autosomal recessive 32, with or without immotile sperm	n	-	-	-	CDC14A	HGNC:1718	Deafness, autosomal recessive 32, with or without immotile sperm, 608653 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
608654	NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE V	Neuropathy, hereditary sensory and autonomic, type V, 608654 (3)	Neuropathy, hereditary sensory and autonomic, type V	n	-	-	-	NGF	HGNC:7808	Neuropathy, hereditary sensory and autonomic, type V, 608654 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
608673	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2L	Charcot-Marie-Tooth disease, axonal, type 2L, 608673 (3)	Charcot-Marie-Tooth disease, axonal, type 2L	n	-	-	-	HSPB8	HGNC:30171	Charcot-Marie-Tooth disease, axonal, type 2L, 608673 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L6	L6	post-infant-lethal
608681	SPONDYLOCOSTAL DYSOSTOSIS 2, AUTOSOMAL RECESSIVE	Spondylocostal dysostosis 2, autosomal recessive, 608681 (3)	Spondylocostal dysostosis 2, autosomal recessive	y	SPONDYLOCOSTAL DYSOSTOSIS 2, AUTOSOMAL RECESSIVE; SCDO2	Clinical Features	died	MESP2	HGNC:29659	Spondylocostal dysostosis 2, autosomal recessive, 608681 (3), Autosomal recessive	Autosomal recessive	y	y	[Cornier et al. (2004) described a detailed phenotype for SCDO based on a series of 27 Puerto Rican patients. Eight of 18 prospectively followed patients (44%) died within 6 months from respiratory failure due to pneumonia and pulmonary restriction; the ages of the remaining patients ranged from 4 months to 47 years]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
608688	AICA-RIBOSURIA DUE TO ATIC DEFICIENCY	AICA-ribosiduria due to ATIC deficiency, 608688 (3)	AICA-ribosiduria due to ATIC deficiency	n	-	-	-	ATIC	HGNC:794	AICA-ribosiduria due to ATIC deficiency, 608688 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
608703	SPINOCEREBELLAR ATAXIA 25	Spinocerebellar ataxia 25, 608703 (3)	Spinocerebellar ataxia 25	n	-	-	-	PNPT1	HGNC:23166	Spinocerebellar ataxia 25, 608703 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L3	L3	pre-infant-lethal
608716	MICROCEPHALY 5, PRIMARY, AUTOSOMAL RECESSIVE	Microcephaly 5, primary, autosomal recessive, 608716 (3)	Microcephaly 5, primary, autosomal recessive	n	-	-	-	ASPM	HGNC:19048	Microcephaly 5, primary, autosomal recessive, 608716 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
608728	SPONDYLOEPIMETAPHYSEAL DYSPLASIA, BOROCHOWITZ-CORMIER-DAIRE TYPE	Spondyloepimetaphyseal dysplasia, Borochowitz-Cormier-Daire type, 608728 (3)	Spondyloepimetaphyseal dysplasia, Borochowitz-Cormier-Daire type	n	-	-	-	MATN3	HGNC:6909	Spondyloepimetaphyseal dysplasia, Borochowitz-Cormier-Daire type, 608728 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	LU	LU	post-infant-lethal
608747	INSULIN-LIKE GROWTH FACTOR I DEFICIENCY	Insulin-like growth factor I deficiency, 608747 (3)	Insulin-like growth factor I deficiency	n	-	-	-	IGF1	HGNC:5464	Insulin-like growth factor I deficiency, 608747 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
608751	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 8	Cardiomyopathy, hypertrophic, 8, 608751 (3)	Cardiomyopathy, hypertrophic, 8	y	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 8; CMH8	Clinical Features|Clinical Synopsis	died|death|deaths	MYL3	HGNC:7584	Cardiomyopathy, hypertrophic, 8, 608751 (3), Autosomal dominant, Autosomal recessive	Autosomal dominant, Autosomal recessive	n	y	[Sudden cardiac death in some patients / Autosomal recessive inheritance of CMH8 was suspected in a 5-generation consanguineous family reported by Olson et al. (2002). Three male sibs, the products of a second-cousin marriage, developed a cardiomyopathy in the second decade of life. Two died within 2 years of diagnosis]	L5	y	-	lethal	lethal	lethal	L5	L5	post-infant-lethal
608758	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 10	Cardiomyopathy, hypertrophic, 10, 608758 (3)	Cardiomyopathy, hypertrophic, 10	y	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 10; CMH10	Clinical Features|Clinical Synopsis	died|death|deaths	MYL2	HGNC:7583	Cardiomyopathy, hypertrophic, 10, 608758 (3), Autosomal dominant	Autosomal dominant	y	y	[Sudden cardiac death (in some patients) / Kabaeva et al. (2002) described 2 unrelated families with CMH, each having a different heterozygous missense mutation in MYL2 and a distinct phenotype. Affected members of 1 family had mild to moderate septal hypertrophy, a late onset of clinical manifestations, and a benign disease course and prognosis. The proband from the other family had first been diagnosed at age 7 years with nonobstructive myocardial hypertrophy and underwent implantation of a cardioverter defibrillator at age 25 years after ventricular tachycardia degenerating into ventricular fibrillation was observed. She had recurrent episodes of supraventricular tachycardia, and echocardiography revealed asymmetric septal hypertrophy. DNA was not available from her sister, who had asymmetric obstructive myocardial hypertrophy and died suddenly at the age of 21 years, or from her father, who died unexpectedly at a young age and was found to have myocardial hypertrophy on autopsy]	L6	y	y	lethal	lethal	lethal	L3|L6	L3	pre-infant-lethal
608768	SPINOCEREBELLAR ATAXIA 8	Spinocerebellar ataxia 8, 608768 (3)	Spinocerebellar ataxia 8	y	SPINOCEREBELLAR ATAXIA 8; SCA8	Clinical Features	died	ATXN8	HGNC:32925	Spinocerebellar ataxia 8, 608768 (3), Autosomal dominant	Autosomal dominant	n	y	[Ito et al. (2006) reported a Japanese father and son with heterozygous expanded SCA8 CAG repeats of 240 and 221, respectively. The father developed progressive gait unsteadiness at age 41 years. Other features included ataxic dysarthria, limb and trunk ataxia, limited upward gaze, and later onset of bradykinesia, rigidity, and difficulty swallowing. The son presented at age 14 with dysarthria and later developed cerebellar ataxia, facial grimacing, hyperreflexia, rigidity, spasticity, dystonia, and bradykinesia. His verbal IQ was 63. The father died suddenly at age 45 from accidental suffocation by sputum while hiking]	L6	n	y	lethal	lethal	lethal	L6	L6	post-infant-lethal
608776	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Il	Congenital disorder of glycosylation, type Il, 608776 (3)	Congenital disorder of glycosylation, type Il	n	-	-	-	ALG9	HGNC:15672	Congenital disorder of glycosylation, type Il, 608776 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L1	L1	pre-infant-lethal
608779	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIe	Congenital disorder of glycosylation, type IIe, 608779 (3)	Congenital disorder of glycosylation, type IIe	y	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIe; CDG2E	Clinical Features|Clinical Synopsis|Phenotype	died|death|deaths|fatal	COG7	HGNC:18622	Congenital disorder of glycosylation, type IIe, 608779 (3), Autosomal recessive	Autosomal recessive	n	y	[In 2 sibs with manifestations consistent with a congenital disorder of glycosylation, Wu et al. (2004) confirmed abnormal glycosylation on IEF analysis of their serum transferrin. The patients had perinatal asphyxia and dysmorphia, including low-set dysplastic ears, micrognathia, short neck, and loose, wrinkled skin. Generalized hypotonia, hepatosplenomegaly, and progressive jaundice developed shortly after birth. X-ray examination revealed that the male sib lacked humeral and tibial epiphyses, whereas the female had short extremities. The male also had a large space at the cisterna cerebelli superior on CT scan. Both sibs developed severe epilepsy and died from recurrent infections and cardiac insufficiency, the male at age 5 weeks and the female at age 10 weeks]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
608782	PYRUVATE DEHYDROGENASE PHOSPHATASE DEFICIENCY	Pyruvate dehydrogenase phosphatase deficiency, 608782 (3)	Pyruvate dehydrogenase phosphatase deficiency	y	PYRUVATE DEHYDROGENASE PHOSPHATASE DEFICIENCY; PDHPD	Clinical Features	died	PDP1	HGNC:9279	Pyruvate dehydrogenase phosphatase deficiency, 608782 (3), Autosomal recessive	Autosomal recessive	y	n	-	-	-	-	ambiguous	ambiguous	ambiguous	-	-	-
608799	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ie	Congenital disorder of glycosylation, type Ie, 608799 (3)	Congenital disorder of glycosylation, type Ie	n	-	-	-	DPM1	HGNC:3005	Congenital disorder of glycosylation, type Ie, 608799 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
608800	SUDDEN INFANT DEATH WITH DYSGENESIS OF THE TESTES SYNDROME	Sudden infant death with dysgenesis of the testes syndrome, 608800 (3)	Sudden infant death with dysgenesis of the testes syndrome	y	SUDDEN INFANT DEATH WITH DYSGENESIS OF THE TESTES SYNDROME; SIDDT	Description|Clinical Features|Clinical Synopsis	death|deaths|fatal|died	TSPYL1	HGNC:12382	Sudden infant death with dysgenesis of the testes syndrome, 608800 (3), Autosomal recessive	Autosomal recessive	y	y	[Death occurs before 12 months of age due to cardiorespiratory arrest]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
608804	LEUKODYSTROPHY, HYPOMYELINATING, 2	Leukodystrophy, hypomyelinating, 2, 608804 (3)	Leukodystrophy, hypomyelinating, 2	n	-	-	-	GJC2	HGNC:17494	Leukodystrophy, hypomyelinating, 2, 608804 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
608805	AVASCULAR NECROSIS OF FEMORAL HEAD, PRIMARY, 1	Avascular necrosis of the femoral head, 608805 (3)	Avascular necrosis of the femoral head	n	-	-	-	COL2A1	HGNC:2200	Avascular necrosis of the femoral head, 608805 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	ambiguous|lethal|nonlethal	lethal|nonlethal	L1|L2|L3	L1	pre-infant-lethal
608807	MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 10	Muscular dystrophy, limb-girdle, autosomal recessive 10, 608807 (3)	Muscular dystrophy, limb-girdle, autosomal recessive 10	n	-	-	-	TTN	HGNC:12403	Muscular dystrophy, limb-girdle, autosomal recessive 10, 608807 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L6|LU	L6	post-infant-lethal
608810	MYOPATHY, MYOFIBRILLAR, 2	Myopathy, myofibrillar, 2, 608810 (3)	Myopathy, myofibrillar, 2	y	MYOPATHY, MYOFIBRILLAR, 2; MFM2	Description|Clinical Features	fatal|died	CRYAB	HGNC:2389	Myopathy, myofibrillar, 2, 608810 (3), Autosomal dominant	Autosomal dominant	n	n	-	-	-	-	ambiguous	ambiguous|lethal|nonlethal	lethal|nonlethal	L3|L6	L3	pre-infant-lethal
608836	CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, LETHAL NEONATAL	CPT II deficiency, lethal neonatal, 608836 (3)	CPT II deficiency, lethal neonatal	y	CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, LETHAL NEONATAL	Description|Clinical Features|Clinical Synopsis|Diagnosis|Phenotype	fatal|death|deaths|died|lethal	CPT2	HGNC:2330	CPT II deficiency, lethal neonatal, 608836 (3), Autosomal recessive	Autosomal recessive	y	y	[Sudden death within first days of life]	L2	y	-	lethal	lethal	lethal	L2|L3|L5	L2	pre-infant-lethal
608837	CARNEY COMPLEX VARIANT	Carney complex variant, 608837 (3)	Carney complex variant	n	-	-	-	MYH8	HGNC:7578	Carney complex variant, 608837 (3)	-	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
608840	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH IMPAIRED INTELLECTUAL DEVELOPMENT), TYPE B, 6	Muscular dystrophy-dystroglycanopathy (congenital with impaired intellectual development), type B, 6, 608840 (3)	Muscular dystrophy-dystroglycanopathy (congenital with impaired intellectual development), type B, 6	n	-	-	-	LARGE1	HGNC:6511	Muscular dystrophy-dystroglycanopathy (congenital with impaired intellectual development), type B, 6, 608840 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L3	L3	pre-infant-lethal
608874	OROFACIAL CLEFT 5	Orofacial cleft 5, 608874 (3)	Orofacial cleft 5	n	-	-	-	MSX1	HGNC:7391	Orofacial cleft 5, 608874 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
608885	STOMATIN-DEFICIENT CRYOHYDROCYTOSIS WITH NEUROLOGIC DEFECTS	Stomatin-deficient cryohydrocytosis with neurologic defects, 608885 (3)	Stomatin-deficient cryohydrocytosis with neurologic defects	n	-	-	-	SLC2A1	HGNC:11005	Stomatin-deficient cryohydrocytosis with neurologic defects, 608885 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
608895	MACULAR DEGENERATION, AGE-RELATED, 3	Macular degeneration, age-related, 3, 608895 (3)	Macular degeneration, age-related, 3	n	-	-	-	FBLN5	HGNC:3602	Macular degeneration, age-related, 3, 608895 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L3	L3	pre-infant-lethal
608895	MACULAR DEGENERATION, AGE-RELATED, 3	Neuropathy, hereditary, with or without age-related macular degeneration, 608895 (3)	Neuropathy, hereditary, with or without age-related macular degeneration	n	-	-	-	FBLN5	HGNC:3602	Neuropathy, hereditary, with or without age-related macular degeneration, 608895 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L3	L3	pre-infant-lethal
608898	HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 3	Hemophagocytic lymphohistiocytosis, familial, 3, 608898 (3)	Hemophagocytic lymphohistiocytosis, familial, 3	y	HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 3; FHL3	Clinical Features	died	UNC13D	HGNC:23147	Hemophagocytic lymphohistiocytosis, familial, 3, 608898 (3), Autosomal recessive	Autosomal recessive	y	n	-	-	-	-	ambiguous	ambiguous	ambiguous	-	-	-
608908	MYOPIA 6	Myopia 6, 608908 (3)	Myopia 6	y	MYOPIA 6; MYP6	Phenotype	death|deaths|fatal	SCO2	HGNC:10604	Myopia 6, 608908 (3), Autosomal dominant	Autosomal dominant	n	n	-	-	-	-	ambiguous	ambiguous|lethal	lethal	L1	L1	pre-infant-lethal
608930	MYASTHENIC SYNDROME, CONGENITAL, 1B, FAST-CHANNEL	Myasthenic syndrome, congenital, 1B, fast-channel, 608930 (3)	Myasthenic syndrome, congenital, 1B, fast-channel	n	-	-	-	CHRNA1	HGNC:1955	Myasthenic syndrome, congenital, 1B, fast-channel, 608930 (3), Autosomal dominant, Autosomal recessive	Autosomal dominant, Autosomal recessive	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L1	L1	pre-infant-lethal
608931	MYASTHENIC SYNDROME, CONGENITAL, 4C, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY	Myasthenic syndrome, congenital, 4C, associated with acetylcholine receptor deficiency, 608931 (3)	Myasthenic syndrome, congenital, 4C, associated with acetylcholine receptor deficiency	n	-	-	-	CHRNE	HGNC:1966	Myasthenic syndrome, congenital, 4C, associated with acetylcholine receptor deficiency, 608931 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L3	L3	pre-infant-lethal
608940	SPONDYLOMETAPHYSEAL DYSPLASIA WITH CONE-ROD DYSTROPHY	Spondylometaphyseal dysplasia with cone-rod dystrophy, 608940 (3)	Spondylometaphyseal dysplasia with cone-rod dystrophy	y	SPONDYLOMETAPHYSEAL DYSPLASIA WITH CONE-ROD DYSTROPHY; SMDCRD	Clinical Features	died	PCYT1A	HGNC:8754	Spondylometaphyseal dysplasia with cone-rod dystrophy, 608940 (3), Autosomal recessive	Autosomal recessive	n	y	[Hoover-Fong et al. (2014) described 2 previously unreported patients with SMDCRD....She had an affected brother who died at 45 years of age with short stature and confirmed CRD]	L6	y	-	lethal	lethal	lethal	L6	L6	post-infant-lethal
608957	CD8 DEFICIENCY, FAMILIAL	CD8 deficiency, familial, 608957 (3)	CD8 deficiency, familial	n	-	-	-	CD8A	HGNC:1706	CD8 deficiency, familial, 608957 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
608970	MACULAR DYSTROPHY, PATTERNED, 2	Macular dystrophy, patterned, 2, 608970 (3)	Macular dystrophy, patterned, 2	n	-	-	-	CTNNA1	HGNC:2509	Macular dystrophy, patterned, 2, 608970 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
608971	IMMUNODEFICIENCY 104	Immunodeficiency 104, severe combined, 608971 (3)	Immunodeficiency 104, severe combined	y	IMMUNODEFICIENCY 104; IMD104	Clinical Features	died	IL7R	HGNC:6024	Immunodeficiency 104, severe combined, 608971 (3), Autosomal recessive	Autosomal recessive	y	y	[Both died, presumably in infancy]	L3	y	y	lethal	lethal	lethal	L3	L3	pre-infant-lethal
608978	MEACHAM SYNDROME	Meacham syndrome, 608978 (3)	Meacham syndrome	y	MEACHAM SYNDROME	Clinical Features|Clinical Synopsis	died|death|deaths	WT1	HGNC:12796	Meacham syndrome, 608978 (3), Autosomal dominant	Autosomal dominant	y	y	[Suri et al. (2007) reported detailed clinical features of 8 patients, including 2 half-sibs, with Meacham syndrome. All had a normal male karyotype, 46,XY, with complex sex reversal or ambiguous genitalia, and congenital diaphragmatic hernia. Other symptoms, including heart, pulmonary, and genital defects, were variable. All patients died early in life]	LU	y	-	lethal	lethal	lethal	L2|LU	L2	pre-infant-lethal
608980	BIFID NOSE WITH OR WITHOUT ANORECTAL AND RENAL ANOMALIES	Bifid nose with or without anorectal and renal anomalies, 608980 (3)	Bifid nose with or without anorectal and renal anomalies	y	BIFID NOSE WITH OR WITHOUT ANORECTAL AND RENAL ANOMALIES; BNAR	Clinical Features	died	FREM1	HGNC:23399	Bifid nose with or without anorectal and renal anomalies, 608980 (3), Autosomal recessive	Autosomal recessive	y	y	[Al-Gazali et al. (2002) reported a consanguineous Egyptian Arab family in which 4 sibs had bifid nose associated with renal and anorectal malformations. All had median nose clefts, wide bulbous nasal tip, short philtrum, but no hypertelorism. All had renal agenesis, which was unilateral in 3 and bilateral in 1. One of the children, born at 28 weeks' gestation, died during the first hour of life]	L2	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L2	L2	pre-infant-lethal
608984	ATAXIA, SENSORY, 1, AUTOSOMAL DOMINANT	Ataxia, sensory, 1, autosomal dominant, 608984 (3)	Ataxia, sensory, 1, autosomal dominant	y	ATAXIA, SENSORY, 1, AUTOSOMAL DOMINANT; SNAX1	Clinical Features|Phenotype	died|death|deaths	RNF170	HGNC:25358	Ataxia, sensory, 1, autosomal dominant, 608984 (3), Autosomal dominant	Autosomal dominant	y	n	-	-	-	-	ambiguous	ambiguous|nonlethal	ambiguous	-	-	-
608996	PREMATURE OVARIAN FAILURE 3	Premature ovarian failure 3, 608996 (3)	Premature ovarian failure 3	n	-	-	-	FOXL2	HGNC:1092	Premature ovarian failure 3, 608996 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
609006	DEAFNESS, AUTOSOMAL RECESSIVE 36, WITH OR WITHOUT VESTIBULAR INVOLVEMENT	Deafness, autosomal recessive 36, 609006 (3)	Deafness, autosomal recessive 36	n	-	-	-	ESPN	HGNC:13281	Deafness, autosomal recessive 36, 609006 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
609006	DEAFNESS, AUTOSOMAL RECESSIVE 36, WITH OR WITHOUT VESTIBULAR INVOLVEMENT	Deafness, neurosensory, without vestibular involvement, autosomal dominant, 609006 (3)	Deafness, neurosensory, without vestibular involvement, autosomal dominant	n	-	-	-	ESPN	HGNC:13281	Deafness, neurosensory, without vestibular involvement, autosomal dominant, 609006 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
609015	MITOCHONDRIAL TRIFUNCTIONAL PROTEIN DEFICIENCY 1	Mitochondrial trifunctional protein deficiency 1, 609015 (3)	Mitochondrial trifunctional protein deficiency 1	y	MITOCHONDRIAL TRIFUNCTIONAL PROTEIN DEFICIENCY 1; MTPD1	Description|Clinical Features|Clinical Synopsis|Phenotype	death|deaths|lethal|died|die	HADHA	HGNC:4801	Mitochondrial trifunctional protein deficiency 1, 609015 (3), Autosomal recessive	Autosomal recessive	y	y	[infant death]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
609016	LONG-CHAIN 3-HYDROXYACYL-CoA DEHYDROGENASE DEFICIENCY	Fatty liver, acute, of pregnancy, 609016 (3)	Fatty liver, acute, of pregnancy	y	LONG-CHAIN 3-HYDROXYACYL-CoA DEHYDROGENASE DEFICIENCY	Description|Clinical Features|Clinical Synopsis	death|deaths|died|fatal	HADHA	HGNC:4801	Fatty liver, acute, of pregnancy, 609016 (3), Autosomal recessive	Autosomal recessive	y	y	[Hagenfeldt et al. (1990) described 5 patients with a suspected defect in the beta-oxidation of fatty acids characterized by massive excretion of 3-hydroxydicarboxylic acids in the urine and accumulation of 3-hydroxy fatty acids in serum during acute illness. Long-chain and medium-chain acyl-coenzyme A dehydrogenases in fibroblasts were normal in all patients. Death due to cardiomyopathy and liver failure occurred in 4 of the 5 at 3 to 14 months of age]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
609016	LONG-CHAIN 3-HYDROXYACYL-CoA DEHYDROGENASE DEFICIENCY	HELLP syndrome, maternal, of pregnancy, 609016 (3)	HELLP syndrome, maternal, of pregnancy	y	LONG-CHAIN 3-HYDROXYACYL-CoA DEHYDROGENASE DEFICIENCY	Description|Clinical Features|Clinical Synopsis	death|deaths|died|fatal	HADHA	HGNC:4801	HELLP syndrome, maternal, of pregnancy, 609016 (3), Autosomal recessive	Autosomal recessive	y	y	[Hagenfeldt et al. (1990) described 5 patients with a suspected defect in the beta-oxidation of fatty acids characterized by massive excretion of 3-hydroxydicarboxylic acids in the urine and accumulation of 3-hydroxy fatty acids in serum during acute illness. Long-chain and medium-chain acyl-coenzyme A dehydrogenases in fibroblasts were normal in all patients. Death due to cardiomyopathy and liver failure occurred in 4 of the 5 at 3 to 14 months of age]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
609016	LONG-CHAIN 3-HYDROXYACYL-CoA DEHYDROGENASE DEFICIENCY	LCHAD deficiency, 609016 (3)	LCHAD deficiency	y	LONG-CHAIN 3-HYDROXYACYL-CoA DEHYDROGENASE DEFICIENCY	Description|Clinical Features|Clinical Synopsis	death|deaths|died|fatal	HADHA	HGNC:4801	LCHAD deficiency, 609016 (3), Autosomal recessive	Autosomal recessive	y	y	[Hagenfeldt et al. (1990) described 5 patients with a suspected defect in the beta-oxidation of fatty acids characterized by massive excretion of 3-hydroxydicarboxylic acids in the urine and accumulation of 3-hydroxy fatty acids in serum during acute illness. Long-chain and medium-chain acyl-coenzyme A dehydrogenases in fibroblasts were normal in all patients. Death due to cardiomyopathy and liver failure occurred in 4 of the 5 at 3 to 14 months of age]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
609033	POSTERIOR COLUMN ATAXIA WITH RETINITIS PIGMENTOSA	Ataxia, posterior column, with retinitis pigmentosa, 609033 (3)	Ataxia, posterior column, with retinitis pigmentosa	n	-	-	-	FLVCR1	HGNC:24682	Ataxia, posterior column, with retinitis pigmentosa, 609033 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
609040	ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 9	Arrhythmogenic right ventricular dysplasia 9, 609040 (3)	Arrhythmogenic right ventricular dysplasia 9	y	ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 9; ARVD9	Clinical Synopsis|Phenotype	death|deaths|lethal	PKP2	HGNC:9024	Arrhythmogenic right ventricular dysplasia 9, 609040 (3), Autosomal dominant	Autosomal dominant	y	y	[Sudden cardiac death]	LU	y	-	lethal	lethal	lethal	LU	LU	post-infant-lethal
609049	PIERSON SYNDROME	Pierson syndrome, 609049 (3)	Pierson syndrome	y	PIERSON SYNDROME; PIERS	Description|Clinical Features|Clinical Synopsis	die|death|deaths|died	LAMB2	HGNC:6487	Pierson syndrome, 609049 (3), Autosomal recessive	Autosomal recessive	y	y	[Death usually within first weeks of life / Pierson et al. (1963) reported 2 sisters with congenital nephrotic syndrome and peculiar eye abnormalities. The renal disorder manifested in the newborn period with severe nephrotic syndrome followed by early-onset end-stage renal disease; both sisters died in the first 2 weeks of life]	L2	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L2	L2	pre-infant-lethal
609053	FANCONI ANEMIA, COMPLEMENTATION GROUP I	Fanconi anemia, complementation group I, 609053 (3)	Fanconi anemia, complementation group I	y	FANCONI ANEMIA, COMPLEMENTATION GROUP I; FANCI	Clinical Features	died	FANCI	HGNC:25568	Fanconi anemia, complementation group I, 609053 (3), Autosomal recessive	Autosomal recessive	n	y	[Savage et al. (2015) reported 3 patients with molecularly confirmed FANCI who also had features of VACTERL/VACTERL-H association (see 192350, 276950, 314390)... She died at age 11.5 years from complications of hematopoietic stem cell transplantation]	L5	y	-	lethal	lethal	lethal	L5	L5	post-infant-lethal
609054	FANCONI ANEMIA, COMPLEMENTATION GROUP J	Fanconi anemia, complementation group J, 609054 (3)	Fanconi anemia, complementation group J	n	-	-	-	BRIP1	HGNC:20473	Fanconi anemia, complementation group J, 609054 (3)	-	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
609056	SALT AND PEPPER DEVELOPMENTAL REGRESSION SYNDROME	Salt and pepper developmental regression syndrome, 609056 (3)	Salt and pepper developmental regression syndrome	y	SALT AND PEPPER DEVELOPMENTAL REGRESSION SYNDROME; SPDRS	Clinical Features|Phenotype	died|death|deaths	ST3GAL5	HGNC:10872	Salt and pepper developmental regression syndrome, 609056 (3), Autosomal recessive	Autosomal recessive	y	y	[The 2 sibships with this disorder reported by Simpson et al. (2004), related as double fifth cousins, contained a total of 9 affected individuals. Only 1 had died (aged 27 months)]	L4	y	-	lethal	lethal	lethal	L4	L4	post-infant-lethal
609057	EPIDERMOLYSIS BULLOSA SIMPLEX 7, WITH NEPHROPATHY AND DEAFNESS	Epidermolysis bullosa simplex 7, with nephropathy and deafness, 609057 (3)	Epidermolysis bullosa simplex 7, with nephropathy and deafness	n	-	-	-	CD151	HGNC:1630	Epidermolysis bullosa simplex 7, with nephropathy and deafness, 609057 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
609060	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 1	Combined oxidative phosphorylation deficiency 1, 609060 (3)	Combined oxidative phosphorylation deficiency 1	y	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 1; COXPD1	Description|Clinical Features|Clinical Synopsis	death|deaths|died	GFM1	HGNC:13780	Combined oxidative phosphorylation deficiency 1, 609060 (3), Autosomal recessive	Autosomal recessive	y	y	[Coenen et al. (2004) described 2 sibs, born of consanguineous Lebanese parents, who died at age 27 days and 5 months and were found to have a severe defect in mitochondrial translation, reduced levels of oxidative phosphorylation complexes containing mitochondrial DNA (mtDNA)-encoded subunits, and progressive hepatoencephalopathy. Postmortem examination showed extensive necrosis of the liver, hypoplasia of the corpus callosum, and generalized atrophy of the brain]	L2	y	-	lethal	lethal	lethal	L2	L2	pre-infant-lethal
609069	PANCREATIC AND CEREBELLAR AGENESIS	Pancreatic and cerebellar agenesis, 609069 (3)	Pancreatic and cerebellar agenesis	y	PANCREATIC AND CEREBELLAR AGENESIS; PACA	Clinical Features|Clinical Synopsis|Phenotype	died|death|deaths	PTF1A	HGNC:23734	Pancreatic and cerebellar agenesis, 609069 (3), Autosomal recessive	Autosomal recessive	y	y	[Al-Shammari et al. (2011) described a male infant, the first child of healthy first-cousin Saudi parents, with this syndrome. Antenatal ultrasound showed intrauterine growth retardation and atrophic cerebellum. At birth, his growth parameters were below the third percentile. Dysmorphic features included triangular face, small chin, generalized joint stiffness, and bilateral talipes equinovarus. He had meconium ileus and was found to have diabetes mellitus. Brain MRI showed cerebellar agenesis. Ophthalmologic examination showed bilateral optic atrophy. The pancreas could not be visualized on abdominal ultrasound. The infant died at 4 months of age]	L3	y	-	lethal	lethal	lethal	L3|LU	L3	pre-infant-lethal
609115	MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL DOMINANT 3	Muscular dystrophy, limb-girdle, autosomal dominant 3, 609115 (3)	Muscular dystrophy, limb-girdle, autosomal dominant 3	n	-	-	-	HNRNPDL	HGNC:5037	Muscular dystrophy, limb-girdle, autosomal dominant 3, 609115 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
609129	AUDITORY NEUROPATHY, AUTOSOMAL DOMINANT 1	Auditory neuropathy, autosomal dominant 1, 609129 (3)	Auditory neuropathy, autosomal dominant 1	n	-	-	-	DIAPH3	HGNC:15480	Auditory neuropathy, autosomal dominant 1, 609129 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
609135	APLASTIC ANEMIA	Aplastic anemia, 609135 (3)	Aplastic anemia	n	-	-	-	NBN	HGNC:7652	Aplastic anemia, 609135 (3)	-	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L6	L6	post-infant-lethal
609135	APLASTIC ANEMIA	Aplastic anemia, 609135 (3)	Aplastic anemia	n	-	-	-	PRF1	HGNC:9360	Aplastic anemia, 609135 (3)	-	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L4	L4	post-infant-lethal
609136	PERIPHERAL DEMYELINATING NEUROPATHY, CENTRAL DYSMYELINATION, WAARDENBURG SYNDROME, AND HIRSCHSPRUNG DISEASE	PCWH syndrome, 609136 (3)	PCWH syndrome	y	PERIPHERAL DEMYELINATING NEUROPATHY, CENTRAL DYSMYELINATION, WAARDENBURG SYNDROME, AND HIRSCHSPRUNG DISEASE; PCWH	Clinical Features	died	SOX10	HGNC:11190	PCWH syndrome, 609136 (3), Autosomal dominant	Autosomal dominant	n	y	[Touraine et al. (2000) reported 3 unrelated patients from Europe with a neurologic variant of Waardenburg-Shah syndrome... Three other boys who were members of his family had died during the first week of life.... The child died on day 11 of life]	L2	y	y	lethal	lethal|nonlethal	lethal|nonlethal	L2	L2	pre-infant-lethal
609140	CORNEAL DYSTROPHY, POSTERIOR POLYMORPHOUS, 2	Corneal dystrophy, posterior polymorphous 2, 609140 (3)	Corneal dystrophy, posterior polymorphous 2	n	-	-	-	COL8A2	HGNC:2216	Corneal dystrophy, posterior polymorphous 2, 609140 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	ambiguous|nonlethal	ambiguous	-	-	-
609141	CORNEAL DYSTROPHY, POSTERIOR POLYMORPHOUS, 3	Corneal dystrophy, posterior polymorphous, 3, 609141 (3)	Corneal dystrophy, posterior polymorphous, 3	n	-	-	-	ZEB1	HGNC:11642	Corneal dystrophy, posterior polymorphous, 3, 609141 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
609152	HYPERTHYROIDISM, NONAUTOIMMUNE	Hyperthyroidism, nonautoimmune, 609152 (3)	Hyperthyroidism, nonautoimmune	n	-	-	-	TSHR	HGNC:12373	Hyperthyroidism, nonautoimmune, 609152 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	ambiguous|nonlethal	ambiguous	-	-	-
609153	PSEUDOHYPERKALEMIA, FAMILIAL, 2, DUE TO RED CELL LEAK	Pseudohyperkalemia, familial, 2, due to red cell leak, 609153 (3)	Pseudohyperkalemia, familial, 2, due to red cell leak	n	-	-	-	ABCB6	HGNC:47	Pseudohyperkalemia, familial, 2, due to red cell leak, 609153 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
609161	STRIATAL DEGENERATION, AUTOSOMAL DOMINANT 1	Striatal degeneration, autosomal dominant, 609161 (3)	Striatal degeneration, autosomal dominant	n	-	-	-	PDE8B	HGNC:8794	Striatal degeneration, autosomal dominant, 609161 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
609162	CZECH DYSPLASIA	Czech dysplasia, 609162 (3)	Czech dysplasia	n	-	-	-	COL2A1	HGNC:2200	Czech dysplasia, 609162 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	ambiguous|lethal|nonlethal	lethal|nonlethal	L1|L2|L3	L1	pre-infant-lethal
609165	ICHTHYOSIS WITH CONFETTI	Ichthyosis with confetti, 609165 (3)	Ichthyosis with confetti	y	ICHTHYOSIS WITH CONFETTI; IWC	Clinical Features	died	KRT10	HGNC:6413	Ichthyosis with confetti, 609165 (3), Autosomal dominant	Autosomal dominant	y	y	[Burger et al. (2020) provided follow-up on the 2 patients with MAUIE syndrome originally reported by Elbaum et al. (1995) and Hendrix et al. (1997). Both patients developed numerous cutaneous squamous cell carcinomas, and both died from aggressive SCC, the boy at age 23 and the woman at age 36]	L6	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L2|L6	L2	pre-infant-lethal
609180	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE If	Congenital disorder of glycosylation, type If, 609180 (3)	Congenital disorder of glycosylation, type If	y	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE If; CDG1F	Clinical Features	death|deaths	MPDU1	HGNC:7207	Congenital disorder of glycosylation, type If, 609180 (3), Autosomal recessive	Autosomal recessive	n	y	[Schenk et al. (2001) described 3 unrelated patients with clinical features consistent with a congenital disorder of glycosylation. Patient 'S' had intractable seizures from birth, severe feeding difficulties, no psychomotor development, and patchy desquamation over his entire body. His seizures worsened, accompanied by recurrent apnea leading to his death at age 10 months]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
609192	LOEYS-DIETZ SYNDROME 1	Loeys-Dietz syndrome 1, 609192 (3)	Loeys-Dietz syndrome 1	y	LOEYS-DIETZ SYNDROME 1; LDS1	Clinical Features	death|deaths|died|fatal	TGFBR1	HGNC:11772	Loeys-Dietz syndrome 1, 609192 (3), Autosomal dominant	Autosomal dominant	y	y	[Loeys et al. (2006) noted that the natural history of both types of LDS among 52 probands was characterized by aggressive arterial aneurysms (mean age at death, 26.0 years / Nicod et al. (1989) described a family in which 9 members over 2 generations had aortic dissecting aneurysm or aortic or arterial dilatation at a young age. Three died of ruptured aortic dissecting aneurysms at ages 14, 18, and 24 years, respectively]	L5	y	-	lethal	lethal	lethal	L5	L5	post-infant-lethal
609195	SPASTIC PARAPLEGIA 26, AUTOSOMAL RECESSIVE	Spastic paraplegia 26, autosomal recessive, 609195 (3)	Spastic paraplegia 26, autosomal recessive	n	-	-	-	B4GALNT1	HGNC:4117	Spastic paraplegia 26, autosomal recessive, 609195 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
609200	MYOPATHY, MYOFIBRILLAR, 3	Myopathy, myofibrillar, 3, 609200 (3)	Myopathy, myofibrillar, 3	y	MYOPATHY, MYOFIBRILLAR, 3; MFM3	Clinical Features	death|deaths	MYOT	HGNC:12399	Myopathy, myofibrillar, 3, 609200 (3), Autosomal dominant	Autosomal dominant	y	y	[Reilich et al. (2011) reported a Turkish woman with a rapidly progressive disease course of LGMD1A. She developed progressive proximal weakness of the lower limbs at age 40 years followed by proximal upper limb weakness, and subsequently developed mild distal muscle weakness. She was wheelchair-dependent at age 50. Within the next 3 years, she developed respiratory insufficiency and dysphagia, resulting in death from pneumonia at age 55]	L6	y	-	lethal	lethal	lethal	L6	L6	post-infant-lethal
609218	FOVEAL HYPOPLASIA 2	Foveal hypoplasia 2, with or without optic nerve misrouting and/or anterior segment dysgenesis, 609218 (3)	Foveal hypoplasia 2, with or without optic nerve misrouting and/or anterior segment dysgenesis	n	-	-	-	SLC38A8	HGNC:32434	Foveal hypoplasia 2, with or without optic nerve misrouting and/or anterior segment dysgenesis, 609218 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
609220	BRUCK SYNDROME 2	Bruck syndrome 2, 609220 (3)	Bruck syndrome 2	n	-	-	-	PLOD2	HGNC:9082	Bruck syndrome 2, 609220 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
609227	GRISCELLI SYNDROME, TYPE 3	Griscelli syndrome, type 3, 609227 (3)	Griscelli syndrome, type 3	y	GRISCELLI SYNDROME, TYPE 3; GS3	Clinical Features	died|miscarriage|miscarriages	MLPH	HGNC:29643	Griscelli syndrome, type 3, 609227 (3), Autosomal recessive	Autosomal recessive	y	n	-	-	-	-	ambiguous	ambiguous	ambiguous	-	-	-
609241	SCHINDLER DISEASE, TYPE I	Schindler disease, type I, 609241 (3)	Schindler disease, type I	y	SCHINDLER DISEASE, TYPE I	Clinical Features	died	NAGA	HGNC:7631	Schindler disease, type I, 609241 (3), Autosomal recessive	Autosomal recessive	n	y	[Keulemans et al. (1996) reported a distant affected relative of the boys described by van Diggelen et al. (1987). He had normal development until age 7 months, when he developed convulsions. He died at 18 months of hypoxia during a prolonged convulsion causing apnea]	L3	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L3	L3	pre-infant-lethal
609241	SCHINDLER DISEASE, TYPE I	Schindler disease, type III, 609241 (3)	Schindler disease, type III	y	SCHINDLER DISEASE, TYPE I	Clinical Features	died	NAGA	HGNC:7631	Schindler disease, type III, 609241 (3), Autosomal recessive	Autosomal recessive	n	y	[Keulemans et al. (1996) reported a distant affected relative of the boys described by van Diggelen et al. (1987). He had normal development until age 7 months, when he developed convulsions. He died at 18 months of hypoxia during a prolonged convulsion causing apnea]	L3	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L3	L3	pre-infant-lethal
609242	KANZAKI DISEASE	Kanzaki disease, 609242 (3)	Kanzaki disease	n	-	-	-	NAGA	HGNC:7631	Kanzaki disease, 609242 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L3	L3	pre-infant-lethal
609254	SENIOR-LOKEN SYNDROME 5	Senior-Loken syndrome 5, 609254 (3)	Senior-Loken syndrome 5	n	-	-	-	IQCB1	HGNC:28949	Senior-Loken syndrome 5, 609254 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
609260	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, AUTOSOMAL DOMINANT, TYPE 2A2A	Charcot-Marie-Tooth disease, axonal, type 2A2A, 609260 (3)	Charcot-Marie-Tooth disease, axonal, type 2A2A	y	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, AUTOSOMAL DOMINANT, TYPE 2A2A; CMT2A2A	Clinical Features|Clinical Synopsis	died|fatal	MFN2	HGNC:16877	Charcot-Marie-Tooth disease, axonal, type 2A2A, 609260 (3), Autosomal dominant	Autosomal dominant	y	y	[Boaretto et al. (2010) reported 2 sisters and a brother with a severe form of adult-onset axonal CMT associated with a fatal subacute encephalopathy characterized by vomiting, nystagmus, chorea, clouded consciousness, and dysautonomia. At age 50, after colectomy, 1 sister developed encephalopathy. Postmortem examination of this patient showed vasculonecrotic lesions in the upper brainstem and periaqueductal gray matter. Their father had a similar course and died at age 61]	L6	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L6	L6	post-infant-lethal
609265	TUMOR PREDISPOSITION SYNDROME 4	Tumor predisposition syndrome 4, breast/prostate/colorectal, 609265 (3)	Tumor predisposition syndrome 4, breast/prostate/colorectal	n	-	-	-	CHEK2	HGNC:16627	Tumor predisposition syndrome 4, breast/prostate/colorectal, 609265 (3)	-	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
609270	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 7	Spinocerebellar ataxia, autosomal recessive 7, 609270 (3)	Spinocerebellar ataxia, autosomal recessive 7	n	-	-	-	TPP1	HGNC:2073	Spinocerebellar ataxia, autosomal recessive 7, 609270 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L5	L5	post-infant-lethal
609273	NEMALINE MYOPATHY 6	Nemaline myopathy 6, autosomal dominant, 609273 (3)	Nemaline myopathy 6, autosomal dominant	n	-	-	-	KBTBD13	HGNC:37227	Nemaline myopathy 6, autosomal dominant, 609273 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
609283	PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 2	Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 2, 609283 (3)	Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 2	n	-	-	-	SLC25A4	HGNC:10990	Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 2, 609283 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L2	L2	pre-infant-lethal
609284	CONGENITAL MYOPATHY 4B, AUTOSOMAL RECESSIVE	Congenital myopathy 4B, autosomal recessive, 609284 (3)	Congenital myopathy 4B, autosomal recessive	y	CONGENITAL MYOPATHY 4B, AUTOSOMAL RECESSIVE; CMYP4B	Clinical Features|Phenotype	died	TPM3	HGNC:12012	Congenital myopathy 4B, autosomal recessive, 609284 (3), Autosomal recessive	Autosomal recessive	y	y	[died at age 21 months]	L3	y	-	lethal	ambiguous|lethal	lethal	L3	L3	pre-infant-lethal
609285	CONGENITAL MYOPATHY 23	Congenital myopathy 23, 609285 (3)	Congenital myopathy 23	y	CONGENITAL MYOPATHY 23; CMYP23	Clinical Features	died	TPM2	HGNC:12011	Congenital myopathy 23, 609285 (3), Autosomal dominant	Autosomal dominant	y	y	[and died of respiratory causes at age 51. I]	L6	y	-	lethal	lethal	lethal	L3|L6	L3	pre-infant-lethal
609286	PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 3	Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 3, 609286 (3)	Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 3	y	PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 3; PEOA3	Clinical Features	died	TWNK	HGNC:1160	Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 3, 609286 (3), Autosomal dominant	Autosomal dominant	y	y	[Hudson et al. (2005) identified a heterozygous mutation in the C10ORF2 gene (K319E; 606075.0010) in 2 sibs with PEO. The mutation was not identified in the parents' blood, hair follicles, buccal mucosa, or urinary epithelium, indicating germline mosaicism... At age 41 she developed status epilepticus and died]	L6	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L4|L6	L4	post-infant-lethal
609296	B-CELL IMMUNODEFICIENCY, DISTAL LIMB ANOMALIES, AND UROGENITAL MALFORMATIONS	B-cell immunodeficiency, distal limb anomalies, and urogenital malformations, 609296 (3)	B-cell immunodeficiency, distal limb anomalies, and urogenital malformations	n	-	-	-	TOP2B	HGNC:11990	B-cell immunodeficiency, distal limb anomalies, and urogenital malformations, 609296 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
609304	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 3	Developmental and epileptic encephalopathy 3, 609304 (3)	Developmental and epileptic encephalopathy 3	y	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 3; DEE3	Description|Clinical Features|Clinical Synopsis	die|died|death|deaths	SLC25A22	HGNC:19954	Developmental and epileptic encephalopathy 3, 609304 (3), Autosomal recessive	Autosomal recessive	y	y	[Poduri et al. (2013) reported 2 sibs, born of consanguineous Saudi Arabian parents, with DEE3 presenting as migrating partial clonic seizures within the first 2 weeks of life. EEG showed abnormal spikes in various brain regions. Other features included hypotonia and brisk tendon reflexes. Brain MRI was normal in 1 child, but showed delayed myelination and diffuse thinning of the corpus callosum in the other child. The seizures in both children were refractory to treatment, and psychomotor development was delayed and subsequently arrested. The children died at 14 months and 47 months of age]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
609308	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 1	Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 1, 609308 (3)	Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 1	n	-	-	-	POMT1	HGNC:9202	Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 1, 609308 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L3	L3	pre-infant-lethal
609310	LYNCH SYNDROME 2	Lynch syndrome 2, 609310 (3)	Lynch syndrome 2	n	-	-	-	MLH1	HGNC:7127	Lynch syndrome 2, 609310 (3)	-	-	-	-	-	-	-	nonlethal	ambiguous|lethal|nonlethal	lethal|nonlethal	L4	L4	post-infant-lethal
609311	CHARCOT-MARIE-TOOTH DISEASE, TYPE 4H	Charcot-Marie-Tooth disease, type 4H, 609311 (3)	Charcot-Marie-Tooth disease, type 4H	n	-	-	-	FGD4	HGNC:19125	Charcot-Marie-Tooth disease, type 4H, 609311 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
609313	MEDNIK SYNDROME	MEDNIK syndrome, 609313 (3)	MEDNIK syndrome	y	MEDNIK SYNDROME; MEDNIK	Clinical Features|Clinical Synopsis	death|deaths|died	AP1S1	HGNC:559	MEDNIK syndrome, 609313 (3), Autosomal recessive	Autosomal recessive	y	y	[Montpetit et al. (2008) restudied the patients reported by Saba et al. (2005) and identified another family from Quebec with the disorder. Features included high forehead with upslanting palpebral fissures, congenital sensorineural deafness, psychomotor retardation and mental retardation, peripheral neuropathy, hypotonia, and ichthyosiform erythroderma. Gastrointestinal problems included severe diarrhea, resulting in death in infancy in 4 patients, hepatic fibrosis, cirrhosis, and cholestasis]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
609338	CAROTID INTIMAL MEDIAL THICKNESS 1	Carotid intimal medial thickness 1, 609338 (3)	Carotid intimal medial thickness 1	n	-	-	-	PPARG	HGNC:9236	Carotid intimal medial thickness 1, 609338 (3)	-	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
609340	SPASTIC PARAPLEGIA 28, AUTOSOMAL RECESSIVE	Spastic paraplegia 28, autosomal recessive, 609340 (3)	Spastic paraplegia 28, autosomal recessive	n	-	-	-	DDHD1	HGNC:19714	Spastic paraplegia 28, autosomal recessive, 609340 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
609352	EPIDERMOLYSIS BULLOSA SIMPLEX 2E, WITH MIGRATORY CIRCINATE ERYTHEMA	Epidermolysis bullosa simplex 2E, with migratory circinate erythema, 609352 (3)	Epidermolysis bullosa simplex 2E, with migratory circinate erythema	n	-	-	-	KRT5	HGNC:6442	Epidermolysis bullosa simplex 2E, with migratory circinate erythema, 609352 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	ambiguous|lethal|nonlethal	lethal|nonlethal	L2	L2	pre-infant-lethal
609404	PREECLAMPSIA/ECLAMPSIA 4	Preeclampsia/eclampsia 4, 609404 (3)	Preeclampsia/eclampsia 4	n	-	-	-	STOX1	HGNC:23508	Preeclampsia/eclampsia 4, 609404 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
609432	SYNDACTYLY, MESOAXIAL SYNOSTOTIC, WITH PHALANGEAL REDUCTION	Syndactyly, mesoaxial synostotic, with phalangeal reduction, 609432 (3)	Syndactyly, mesoaxial synostotic, with phalangeal reduction	n	-	-	-	BHLHA9	HGNC:35126	Syndactyly, mesoaxial synostotic, with phalangeal reduction, 609432 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
609439	DEAFNESS, AUTOSOMAL RECESSIVE 48	Deafness, autosomal recessive 48, 609439 (3)	Deafness, autosomal recessive 48	n	-	-	-	CIB2	HGNC:24579	Deafness, autosomal recessive 48, 609439 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
609441	ACROMESOMELIC DYSPLASIA 3	Acromesomelic dysplasia 3, 609441 (3)	Acromesomelic dysplasia 3	n	-	-	-	BMPR1B	HGNC:1077	Acromesomelic dysplasia 3, 609441 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
609446	PAROXYSMAL NONKINESIGENIC DYSKINESIA, 3, WITH OR WITHOUT GENERALIZED EPILEPSY	Paroxysmal nonkinesigenic dyskinesia, 3, with or without generalized epilepsy, 609446 (3)	Paroxysmal nonkinesigenic dyskinesia, 3, with or without generalized epilepsy	n	-	-	-	KCNMA1	HGNC:6284	Paroxysmal nonkinesigenic dyskinesia, 3, with or without generalized epilepsy, 609446 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
609452	MYOPATHY, MYOFIBRILLAR, 4	Myopathy, myofibrillar, 4, 609452 (3)	Myopathy, myofibrillar, 4	n	-	-	-	LDB3	HGNC:15710	Myopathy, myofibrillar, 4, 609452 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L4|LU	L4	post-infant-lethal
609460	GOLDBERG-SHPRINTZEN SYNDROME	Goldberg-Shprintzen megacolon syndrome, 609460 (3)	Goldberg-Shprintzen megacolon syndrome	n	-	-	-	KIFBP	HGNC:23419	Goldberg-Shprintzen megacolon syndrome, 609460 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
609465	AL-GAZALI SYNDROME	Al-Gazali syndrome, 609465 (3)	Al-Gazali syndrome	y	AL-GAZALI SYNDROME; ALGAZ	Description|Clinical Features|Clinical Synopsis	lethality|died|spontaneous_abortion|spontaneous_abortions|stillbirth|stillbirths|death|deaths	B3GALT6	HGNC:17978	Al-Gazali syndrome, 609465 (3), Autosomal recessive	Autosomal recessive	y	y	[Thong et al. (2005) reported 2 sibs, born of second-cousin Malaysian parents, with multiple skeletal abnormalities, anterior segment anomalies of the eye, and early lethality. The parents' reproductive history included 3 spontaneous abortions, 1 male stillbirth, and 4 male live births. Of the 4 live births, only 2 were affected with clinical features of al-Gazali syndrome. The affected boys had intrauterine growth retardation, bilateral talipes equinovarus, contractures of the large joints, camptodactyly, multiple fractures, and abnormalities of the anterior segment of the eyes. Each died within the first year of life, one at 7 months and the second at 1 month]	L1	y	y	lethal	lethal|nonlethal	lethal|nonlethal	L1|L4	L1	pre-infant-lethal
609508	STICKLER SYNDROME, TYPE I, NONSYNDROMIC OCULAR	Stickler syndrome, type I, nonsyndromic ocular, 609508 (3)	Stickler syndrome, type I, nonsyndromic ocular	n	-	-	-	COL2A1	HGNC:2200	Stickler syndrome, type I, nonsyndromic ocular, 609508 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	ambiguous|lethal|nonlethal	lethal|nonlethal	L1|L2|L3	L1	pre-infant-lethal
609524	MYOPATHY, MYOFIBRILLAR, 5	Myopathy, myofibrillar, 5, 609524 (3)	Myopathy, myofibrillar, 5	y	MYOPATHY, MYOFIBRILLAR, 5; MFM5	Clinical Features	died	FLNC	HGNC:3756	Myopathy, myofibrillar, 5, 609524 (3), Autosomal dominant	Autosomal dominant	y	y	[Lee et al. (2020) reported 34 individuals from 9 apparently unrelated Chinese families segregating MFM5. Eight of the individuals, aged 26 to 47 years, were asymptomatic at the time of molecular analysis. The other 26 individuals presented with clinical manifestations between ages 45 and 62 years. Four of the 26 patients had died from pulmonary causes (pneumonia or respiratory failure)]	L6	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L6	L6	post-infant-lethal
609528	CEREBRAL DYSGENESIS, NEUROPATHY, ICHTHYOSIS, AND PALMOPLANTAR KERATODERMA SYNDROME	Cerebral dysgenesis, neuropathy, ichthyosis, and palmoplantar keratoderma syndrome, 609528 (3)	Cerebral dysgenesis, neuropathy, ichthyosis, and palmoplantar keratoderma syndrome	y	CEREBRAL DYSGENESIS, NEUROPATHY, ICHTHYOSIS, AND PALMOPLANTAR KERATODERMA SYNDROME; CEDNIK	Description|Clinical Features|Clinical Synopsis	die|died|death|deaths	SNAP29	HGNC:11133	Cerebral dysgenesis, neuropathy, ichthyosis, and palmoplantar keratoderma syndrome, 609528 (3), Autosomal recessive	Autosomal recessive	y	y	[Abdollahi et al. (2009) reported 2 unrelated consanguineous Pakistani families in which 4 children had severe developmental delay, hypotonia, and seizures. All had optic nerve hypoplasia and extensive polymicrogyria, with a dysplastic or absent corpus callosum and colpocephaly. There was also a distinctive abnormality of the brainstem with loss of demarcation between the pons and medulla. There were no dysmorphic features. One child died at age 2 years from an overwhelming respiratory infection, whereas the others survived with profound neurologic impairment]	L4	y	-	lethal	lethal	lethal	L4	L4	post-infant-lethal
609529	IMMUNOGLOBULIN A DEFICIENCY 2	Immunoglobulin A deficiency 2, 609529 (3)	Immunoglobulin A deficiency 2	n	-	-	-	TNFRSF13B	HGNC:18153	Immunoglobulin A deficiency 2, 609529 (3)	-	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	LU	LU	post-infant-lethal
609533	DEAFNESS, AUTOSOMAL RECESSIVE 23	Deafness, autosomal recessive 23, 609533 (3)	Deafness, autosomal recessive 23	n	-	-	-	PCDH15	HGNC:14674	Deafness, autosomal recessive 23, 609533 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
609536	COMPLEMENT COMPONENT 5 DEFICIENCY	C5 deficiency, 609536 (3)	C5 deficiency	n	-	-	-	C5	HGNC:1331	C5 deficiency, 609536 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
609541	SPASTIC PARAPLEGIA, OPTIC ATROPHY, AND NEUROPATHY	Spastic paraplegia, optic atrophy, and neuropathy, 609541 (3)	Spastic paraplegia, optic atrophy, and neuropathy	n	-	-	-	KLC2	HGNC:20716	Spastic paraplegia, optic atrophy, and neuropathy, 609541 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
609549	NANOPHTHALMOS 2	Nanophthalmos 2, 609549 (3)	Nanophthalmos 2	n	-	-	-	MFRP	HGNC:18121	Nanophthalmos 2, 609549 (3)	-	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
609560	MITOCHONDRIAL DNA DEPLETION SYNDROME 2 (MYOPATHIC TYPE)	Mitochondrial DNA depletion syndrome 2 (myopathic type), 609560 (3)	Mitochondrial DNA depletion syndrome 2 (myopathic type)	y	MITOCHONDRIAL DNA DEPLETION SYNDROME 2 (MYOPATHIC TYPE); MTDPS2	Description|Clinical Features|Phenotype	death|deaths|died|fatal	TK2	HGNC:11831	Mitochondrial DNA depletion syndrome 2 (myopathic type), 609560 (3), Autosomal recessive	Autosomal recessive	y	y	[Boustany et al. (1983) reported a female infant with a fatal mitochondrial myopathy characterized by progressive generalized hypotonia, progressive external ophthalmoplegia, and severe lactic acidosis. Electron microscopy of skeletal muscle in the proband showed marked proliferation of enlarged mitochondria, many containing concentric rings of cristae, and biochemical studies showed severely decreased cytochrome c oxidase activity (less than 1% of normal). Mitochondria from kidney, liver, heart, lung, and brain examined postmortem had normal cytochromes and preserved cytochrome c oxidase activity. A second cousin, related through the maternal grandfather, died at 9 months of hepatic failure with generalized aminoaciduria, but without lactic acidosis or muscle involvement, consistent with the hepatocerebral form of the disorder / Oskoui et al. (2006) reported 4 unrelated patients with the myopathic form of mtDNA depletion syndrome due to TK2 mutations. There was significant clinical variability: 1 patient had a rapidly progressive course with death at age 19 months, whereas the others showed a more protracted course. One died at age 6 years and another at age 16 years]	L3	y	y	lethal	lethal	lethal	L3	L3	pre-infant-lethal
609583	JOUBERT SYNDROME 4	Joubert syndrome 4, 609583 (3)	Joubert syndrome 4	n	-	-	-	NPHP1	HGNC:7905	Joubert syndrome 4, 609583 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L4	L4	post-infant-lethal
609597	PARIETAL FORAMINA 2	Parietal foramina 2, 609597 (3)	Parietal foramina 2	n	-	-	-	ALX4	HGNC:450	Parietal foramina 2, 609597 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
609620	SHORT QT SYNDROME 1	Short QT syndrome 1, 609620 (3)	Short QT syndrome 1	y	SHORT QT SYNDROME 1; SQT1	Description|Clinical Features|Phenotype	death|deaths	KCNH2	HGNC:6251	Short QT syndrome 1, 609620 (3)	-	y	y	[Short QT syndrome is a cardiac channelopathy associated with a predisposition to atrial fibrillation and sudden cardiac death]	LU	y	-	lethal	lethal	lethal	LU	LU	post-infant-lethal
609621	SHORT QT SYNDROME 2	Short QT syndrome 2, 609621 (3)	Short QT syndrome 2	y	SHORT QT SYNDROME 2; SQT2	Description|Clinical Features|Phenotype	death|deaths|died	KCNQ1	HGNC:6294	Short QT syndrome 2, 609621 (3), Autosomal dominant	Autosomal dominant	n	y	[Short QT syndrome is a cardiac channelopathy associated with a predisposition to atrial fibrillation and sudden cardiac death]	LU	y	-	lethal	lethal	lethal	L4|L5|L6|LU	L4	post-infant-lethal
609621	SHORT QT SYNDROME 2	Short QT syndrome 2, 609621 (3)	Short QT syndrome 2	y	SHORT QT SYNDROME 2; SQT2	Description|Clinical Features|Phenotype	death|deaths|died	KCNQ1	HGNC:6294	Short QT syndrome 2, 609621 (3), Autosomal dominant	Autosomal dominant	n	y	[Short QT syndrome is a cardiac channelopathy associated with a predisposition to atrial fibrillation and sudden cardiac death / Moreno et al. (2015) studied a 23-year-old man whose father died unexpectedly at age 37 years while working as a postman]	L6	n	y	lethal	lethal	lethal	L4|L5|L6|LU	L4	post-infant-lethal
609622	SHORT QT SYNDROME 3	Short QT syndrome 3, 609622 (3)	Short QT syndrome 3	y	SHORT QT SYNDROME 3; SQT3	Description|Clinical Features	death|deaths	KCNJ2	HGNC:6263	Short QT syndrome 3, 609622 (3)	-	n	y	[Short QT syndrome is a cardiac channelopathy associated with a predisposition to atrial fibrillation and sudden cardiac death]	LU	y	-	lethal	lethal	lethal	L5|L6|LU	L5	post-infant-lethal
609628	MAJEED SYNDROME	Majeed syndrome, 609628 (3)	Majeed syndrome	n	-	-	-	LPIN2	HGNC:14450	Majeed syndrome, 609628 (3)	-	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
609634	MIGRAINE, FAMILIAL HEMIPLEGIC, 3	Migraine, familial hemiplegic, 3, 609634 (3)	Migraine, familial hemiplegic, 3	n	-	-	-	SCN1A	HGNC:10585	Migraine, familial hemiplegic, 3, 609634 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L3|L5	L3	pre-infant-lethal
609637	HOLOPROSENCEPHALY 5	Holoprosencephaly 5, 609637 (3)	Holoprosencephaly 5	y	HOLOPROSENCEPHALY 5; HPE5	Phenotype	lethal	ZIC2	HGNC:12873	Holoprosencephaly 5, 609637 (3), Autosomal dominant	Autosomal dominant	y	n	-	-	-	-	ambiguous	ambiguous	ambiguous	-	-	-
609638	EPIDERMOLYSIS BULLOSA, LETHAL ACANTHOLYTIC	Epidermolysis bullosa, lethal acantholytic, 609638 (3)	Epidermolysis bullosa, lethal acantholytic	y	EPIDERMOLYSIS BULLOSA, LETHAL ACANTHOLYTIC; EBLA	Description|Clinical Features|Clinical Synopsis|Phenotype	death|deaths|lethal|died	DSP	HGNC:3052	Epidermolysis bullosa, lethal acantholytic, 609638 (3), Autosomal recessive	Autosomal recessive	y	y	[Neonatal death / Bolling et al. (2010) reported a consanguineous Yemeni family in which the first child, a boy, died at 3 days of age from an erosive skin condition consistent with a lethal form of epidermolysis bullosa]	L2	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L2|L4|L5|LU	L2	pre-infant-lethal
609646	DEAFNESS, AUTOSOMAL RECESSIVE 42	Deafness, autosomal recessive 42, 609646 (3)	Deafness, autosomal recessive 42	n	-	-	-	ILDR1	HGNC:28741	Deafness, autosomal recessive 42, 609646 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
609698	THYROID HORMONE METABOLISM, ABNORMAL, 1	Thyroid hormone metabolism, abnormal, 1, 609698 (3)	Thyroid hormone metabolism, abnormal, 1	n	-	-	-	SECISBP2	HGNC:30972	Thyroid hormone metabolism, abnormal, 1, 609698 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
609706	DEAFNESS, AUTOSOMAL RECESSIVE 53	Deafness, autosomal recessive 53, 609706 (3)	Deafness, autosomal recessive 53	n	-	-	-	COL11A2	HGNC:2187	Deafness, autosomal recessive 53, 609706 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L2	L2	pre-infant-lethal
609734	OBESITY, EARLY-ONSET, WITH ADRENAL INSUFFICIENCY AND RED HAIR	Obesity, adrenal insufficiency, and red hair due to POMC deficiency, 609734 (3)	Obesity, adrenal insufficiency, and red hair due to POMC deficiency	y	OBESITY, EARLY-ONSET, WITH ADRENAL INSUFFICIENCY AND RED HAIR; OBAIRH	Description|Clinical Features	death|deaths|died	POMC	HGNC:9201	Obesity, adrenal insufficiency, and red hair due to POMC deficiency, 609734 (3), Autosomal recessive	Autosomal recessive	n	y	[Clement et al. (2008) reported an 18-year-old woman, born of consanguineous parents of North African descent, with OBAIRH. She presented in infancy with obesity and hypothalamic endocrine abnormalities, including ACTH deficiency. At 4 weeks of age, she had persistent hypoglycemia associated with undetectable levels of plasma cortisol, ACTH, and lipotropin hormone. Brain imaging showed a normal pituitary gland and agenesis of the corpus callosum. She did not develop signs of puberty, and laboratory studies showed gonadotropin deficiency. Additional features included growth hormone deficiency and TSH deficiency that developed during the teenage years, both requiring hormone replacement treatment. Her brother died at age 3 months from hepatomegaly, hepatic insufficiency, hypoglycemia, and acidosis]	L3	n	y	lethal	lethal	lethal	L3	L3	pre-infant-lethal
609741	CATARACT 22, MULTIPLE TYPES	Cataract 22, 609741 (3)	Cataract 22	n	-	-	-	CRYBB3	HGNC:2400	Cataract 22, 609741 (3), Autosomal dominant, Autosomal recessive	Autosomal dominant, Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
609796	PEELING SKIN SYNDROME 2	Peeling skin syndrome 2, 609796 (3)	Peeling skin syndrome 2	n	-	-	-	TGM5	HGNC:11781	Peeling skin syndrome 2, 609796 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
609812	MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 8, WITH EXOCRINE DYSFUNCTION	Maturity-onset diabetes of the young, type VIII, 609812 (3)	Maturity-onset diabetes of the young, type VIII	n	-	-	-	CEL	HGNC:1848	Maturity-onset diabetes of the young, type VIII, 609812 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
609813	SPONDYLOCOSTAL DYSOSTOSIS 3, AUTOSOMAL RECESSIVE	Spondylocostal dysostosis 3, autosomal recessive, 609813 (3)	Spondylocostal dysostosis 3, autosomal recessive	n	-	-	-	LFNG	HGNC:6560	Spondylocostal dysostosis 3, autosomal recessive, 609813 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
609814	COMPLEMENT FACTOR H DEFICIENCY	Complement factor H deficiency, 609814 (3)	Complement factor H deficiency	n	-	-	-	CFH	HGNC:4883	Complement factor H deficiency, 609814 (3), Autosomal dominant, Autosomal recessive	Autosomal dominant, Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
609820	ERYTHROCYTOSIS, FAMILIAL, 3	Erythrocytosis, familial, 3, 609820 (3)	Erythrocytosis, familial, 3	n	-	-	-	EGLN1	HGNC:1232	Erythrocytosis, familial, 3, 609820 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
609821	BLEEDING DISORDER, PLATELET-TYPE, 8	Bleeding disorder, platelet-type, 8, 609821 (3)	Bleeding disorder, platelet-type, 8	y	BLEEDING DISORDER, PLATELET-TYPE, 8; BDPLT8	Clinical Features	died	P2RY12	HGNC:18124	Bleeding disorder, platelet-type, 8, 609821 (3), Autosomal recessive	Autosomal recessive	n	y	[The proband in the family reported by Nurden et al. (1995) was a 61-year-old Caucasian man with a history of episodes of excessive bleeding... Other affected family members included a father, who died from bleeding after a motor accident, an uncle who died as a result of severe epistaxis, and a sister]	LU	n	y	lethal	lethal	lethal	LU	LU	post-infant-lethal
609823	DEAFNESS, AUTOSOMAL RECESSIVE 28	Deafness, autosomal recessive 28, 609823 (3)	Deafness, autosomal recessive 28	n	-	-	-	TRIOBP	HGNC:17009	Deafness, autosomal recessive 28, 609823 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
609887	GLAUCOMA 1, OPEN ANGLE, G	Glaucoma 1, open angle, G, 609887 (3)	Glaucoma 1, open angle, G	n	-	-	-	WDR36	HGNC:30696	Glaucoma 1, open angle, G, 609887 (3)	-	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
609889	ALPHA/BETA T-CELL LYMPHOPENIA WITH GAMMA/DELTA T-CELL EXPANSION, SEVERE CYTOMEGALOVIRUS INFECTION, AND AUTOIMMUNITY	Alpha/beta T-cell lymphopenia with gamma/delta T-cell expansion, severe cytomegalovirus infection, and autoimmunity, 609889 (3)	Alpha/beta T-cell lymphopenia with gamma/delta T-cell expansion, severe cytomegalovirus infection, and autoimmunity	n	-	-	-	RAG1	HGNC:9831	Alpha/beta T-cell lymphopenia with gamma/delta T-cell expansion, severe cytomegalovirus infection, and autoimmunity, 609889 (3)	-	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L3|L4	L3	pre-infant-lethal
609909	CARDIOMYOPATHY, DILATED, 1P	Cardiomyopathy, dilated, 1P, 609909 (3)	Cardiomyopathy, dilated, 1P	y	CARDIOMYOPATHY, DILATED, 1P; CMD1P	Clinical Features|Phenotype	death|deaths|died	PLN	HGNC:9080	Cardiomyopathy, dilated, 1P, 609909 (3)	-	n	y	[Schmitt et al. (2003) reported a 4-generation family with dilated cardiomyopathy (CMD) and heart failure inherited in an autosomal dominant fashion. Affected individuals had increased chamber dimensions and decreased contractile function at age 20 to 30 years, with progression to heart failure within 5 to 10 years after symptom onset. Congestive heart failure was severe in 12 individuals, necessitating cardiac transplantation in 4. The average age at death of affected individuals was 25.1 +/- 12.7 years]	L5	y	-	lethal	lethal	lethal	L5|L6	L5	post-infant-lethal
609913	RETINITIS PIGMENTOSA 32	Retinitis pigmentosa 32, 609913 (3)	Retinitis pigmentosa 32	n	-	-	-	CLCC1	HGNC:29675	Retinitis pigmentosa 32, 609913 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
609923	RETINITIS PIGMENTOSA 31	Retinitis pigmentosa 31, 609923 (3)	Retinitis pigmentosa 31	n	-	-	-	TOPORS	HGNC:21653	Retinitis pigmentosa 31, 609923 (3)	-	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
609924	AMINOACYLASE 1 DEFICIENCY	Aminoacylase 1 deficiency, 609924 (3)	Aminoacylase 1 deficiency	n	-	-	-	ACY1	HGNC:177	Aminoacylase 1 deficiency, 609924 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
609942	NOONAN SYNDROME 3	Noonan syndrome 3, 609942 (3)	Noonan syndrome 3	n	-	-	-	KRAS	HGNC:6407	Noonan syndrome 3, 609942 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L5	L5	post-infant-lethal
609968	HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 5	Hyperinsulinemic hypoglycemia, familial, 5, 609968 (3)	Hyperinsulinemic hypoglycemia, familial, 5	n	-	-	-	INSR	HGNC:6091	Hyperinsulinemic hypoglycemia, familial, 5, 609968 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L3|L4	L3	pre-infant-lethal
609975	HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 4	Hyperinsulinemic hypoglycemia, familial, 4, 609975 (3)	Hyperinsulinemic hypoglycemia, familial, 4	y	HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 4; HHF4	Clinical Features	died	HADH	HGNC:4799	Hyperinsulinemic hypoglycemia, familial, 4, 609975 (3), Autosomal recessive	Autosomal recessive	n	y	[Vidnes (1976) was the first to document glucagon deficiency in a case of persistent hereditary neonatal hypoglycemia. Vidnes and Oyasaeter (1977) described an inbred Pakistani family in which 2 brothers and a sister appear to have had hypoglycemia due to isolated glucagon deficiency. Two of the 3 had died before the nature of the problem was identified]	LU	y	-	lethal	lethal	lethal	L3|LU	L3	pre-infant-lethal
609981	IMMUNODEFICIENCY 54	Immunodeficiency 54, 609981 (3)	Immunodeficiency 54	n	-	-	-	MCM4	HGNC:6947	Immunodeficiency 54, 609981 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
610003	CEROID LIPOFUSCINOSIS, NEURONAL, 8, NORTHERN EPILEPSY VARIANT	Ceroid lipofuscinosis, neuronal, 8, Northern epilepsy variant, 610003 (3)	Ceroid lipofuscinosis, neuronal, 8, Northern epilepsy variant	n	-	-	-	CLN8	HGNC:2079	Ceroid lipofuscinosis, neuronal, 8, Northern epilepsy variant, 610003 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
610006	2-METHYLBUTYRYL-CoA DEHYDROGENASE DEFICIENCY	2-methylbutyrylglycinuria, 610006 (3)	2-methylbutyrylglycinuria	n	-	-	-	ACADSB	HGNC:91	2-methylbutyrylglycinuria, 610006 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
610015	GLUTAMINE DEFICIENCY, CONGENITAL	Glutamine deficiency, congenital, 610015 (3)	Glutamine deficiency, congenital	y	GLUTAMINE DEFICIENCY, CONGENITAL	Clinical Features|Clinical Synopsis	death|deaths|died	GLUL	HGNC:4341	Glutamine deficiency, congenital, 610015 (3), Autosomal recessive	Autosomal recessive	n	y	[Haberle et al. (2005) described 2 presumably unrelated newborns of consanguineous Turkish ancestry who had congenital glutamine synthetase deficiency with severe brain malformations resulting in multiorgan failure and neonatal death. Glutamine was largely absent from their serum, urine, and cerebrospinal fluid. The first infant died on day 2]	L2	y	-	lethal	lethal	lethal	L2	L2	pre-infant-lethal
610017	MULTIPLE SYNOSTOSES SYNDROME 2	Multiple synostoses syndrome 2, 610017 (3)	Multiple synostoses syndrome 2	n	-	-	-	GDF5	HGNC:4220	Multiple synostoses syndrome 2, 610017 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L1	L1	pre-infant-lethal
610019	CATARACT 18	Cataract 18, autosomal recessive, 610019 (3)	Cataract 18, autosomal recessive	n	-	-	-	FYCO1	HGNC:14673	Cataract 18, autosomal recessive, 610019 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
610021	HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 7	Hyperinsulinemic hypoglycemia, familial, 7, 610021 (3)	Hyperinsulinemic hypoglycemia, familial, 7	n	-	-	-	SLC16A1	HGNC:10922	Hyperinsulinemic hypoglycemia, familial, 7, 610021 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
610024	RETINAL CONE DYSTROPHY 3A	Achromatopsia 6, 610024 (3)	Achromatopsia 6	n	-	-	-	PDE6H	HGNC:8790	Achromatopsia 6, 610024 (3), Autosomal dominant, Autosomal recessive	Autosomal dominant, Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
610024	RETINAL CONE DYSTROPHY 3A	Retinal cone dystrophy 3, 610024 (3)	Retinal cone dystrophy 3	n	-	-	-	PDE6H	HGNC:8790	Retinal cone dystrophy 3, 610024 (3), Autosomal dominant, Autosomal recessive	Autosomal dominant, Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
610031	CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 7	Cortical dysplasia, complex, with other brain malformations 7, 610031 (3)	Cortical dysplasia, complex, with other brain malformations 7	y	CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 7; CDCBM7	Clinical Synopsis	death|deaths	TUBB2B	HGNC:30829	Cortical dysplasia, complex, with other brain malformations 7, 610031 (3), Autosomal dominant	Autosomal dominant	y	y	[May result in death in utero in severe cases]	L1	y	-	lethal	lethal	lethal	L1	L1	pre-infant-lethal
610042	PITT-HOPKINS-LIKE SYNDROME 1	Pitt-Hopkins like syndrome 1, 610042 (3)	Pitt-Hopkins like syndrome 1	n	-	-	-	CNTNAP2	HGNC:13830	Pitt-Hopkins like syndrome 1, 610042 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
610048	CORNEAL DYSTROPHY, CONGENITAL STROMAL	Corneal dystrophy, congenital stromal, 610048 (3)	Corneal dystrophy, congenital stromal	n	-	-	-	DCN	HGNC:2705	Corneal dystrophy, congenital stromal, 610048 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
610069	POLYPOSIS SYNDROME, HEREDITARY MIXED, 2	Polyposis syndrome, hereditary mixed, 2, 610069 (3)	Polyposis syndrome, hereditary mixed, 2	n	-	-	-	BMPR1A	HGNC:1076	Polyposis syndrome, hereditary mixed, 2, 610069 (3)	-	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L6	L6	post-infant-lethal
610090	PYRIDOXAMINE 5-PRIME-PHOSPHATE OXIDASE DEFICIENCY	Pyridoxamine 5'-phosphate oxidase deficiency, 610090 (3)	Pyridoxamine 5'-phosphate oxidase deficiency	y	PYRIDOXAMINE 5-PRIME-PHOSPHATE OXIDASE DEFICIENCY; PNPOD	Clinical Features	died	PNPO	HGNC:30260	Pyridoxamine 5'-phosphate oxidase deficiency, 610090 (3), Autosomal recessive	Autosomal recessive	n	y	[Brautigam et al. (2002) described twins, born of first-cousin parents, who were born at 29 weeks' gestation and suffered from birth from severe convulsions, myoclonus, rotatory eye movements, sudden clonic contractions, burst suppression electroencephalogram (EEG), hypoglycemia, and acidosis. The patients showed an improvement of the clonic contractions with vitamin B6 supplementation, but died in the third week of life]	L2	y	-	lethal	lethal	lethal	L2	L2	pre-infant-lethal
610092	MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 3	Microphthalmia with coloboma 3, 610092 (3)	Microphthalmia with coloboma 3	n	-	-	-	VSX2	HGNC:1975	Microphthalmia with coloboma 3, 610092 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
610093	MICROPHTHALMIA, ISOLATED 2	Microphthalmia, isolated 2, 610093 (3)	Microphthalmia, isolated 2	n	-	-	-	VSX2	HGNC:1975	Microphthalmia, isolated 2, 610093 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
610102	COMPLEMENT COMPONENT 7 DEFICIENCY	C7 deficiency, 610102 (3)	C7 deficiency	y	COMPLEMENT COMPONENT 7 DEFICIENCY; C7D	Clinical Features	fatal	C7	HGNC:1346	C7 deficiency, 610102 (3)	-	y	y	[Friduss et al. (1992) described a severe, aggressive, and ultimately fatal pyoderma gangrenosum in a patient with congenital C7 deficiency]	LU	y	-	lethal	lethal	lethal	LU	LU	post-infant-lethal
610125	MICROPHTHALMIA, SYNDROMIC 5	Microphthalmia, syndromic 5, 610125 (3)	Microphthalmia, syndromic 5	y	MICROPHTHALMIA, SYNDROMIC 5; MCOPS5	Clinical Features|Phenotype	died|miscarriage|miscarriages	OTX2	HGNC:8522	Microphthalmia, syndromic 5, 610125 (3), Autosomal dominant	Autosomal dominant	y	y	[Chassaing et al. (2012) studied a large 4-generation French family in which 17 individuals had microphthalmia or clinical anophthalmia, 3 were diagnosed with otocephaly-dysgnathia complex (see 202650), and 2 exhibited an intermediate, overlapping phenotype. One affected woman had 2 sons with otocephaly, 1 of whom died soon after birth from respiratory distress and unsuccessful intubation; the second pregnancy was electively terminated after ultrasonography showed recurrence of facial malformations consistent with otocephaly. An affected male cousin also had a son who died soon after birth from respiratory distress with a probable diagnosis of otocephaly]	L2	n	y	lethal	lethal|nonlethal	lethal|nonlethal	L2	L2	pre-infant-lethal
610125	MICROPHTHALMIA, SYNDROMIC 5	Retinal dystrophy, early-onset, with or without pituitary dysfunction, 610125 (3)	Retinal dystrophy, early-onset, with or without pituitary dysfunction	y	MICROPHTHALMIA, SYNDROMIC 5; MCOPS5	Clinical Features|Phenotype	died|miscarriage|miscarriages	OTX2	HGNC:8522	Retinal dystrophy, early-onset, with or without pituitary dysfunction, 610125 (3), Autosomal dominant	Autosomal dominant	y	y	[Chassaing et al. (2012) studied a large 4-generation French family in which 17 individuals had microphthalmia or clinical anophthalmia, 3 were diagnosed with otocephaly-dysgnathia complex (see 202650), and 2 exhibited an intermediate, overlapping phenotype. One affected woman had 2 sons with otocephaly, 1 of whom died soon after birth from respiratory distress and unsuccessful intubation; the second pregnancy was electively terminated after ultrasonography showed recurrence of facial malformations consistent with otocephaly. An affected male cousin also had a son who died soon after birth from respiratory distress with a probable diagnosis of otocephaly]	L2	n	y	lethal	lethal|nonlethal	lethal|nonlethal	L2	L2	pre-infant-lethal
610127	CEROID LIPOFUSCINOSIS, NEURONAL, 10	Ceroid lipofuscinosis, neuronal, 10, 610127 (3)	Ceroid lipofuscinosis, neuronal, 10	y	CEROID LIPOFUSCINOSIS, NEURONAL, 10; CLN10	Clinical Features|Clinical Synopsis|Phenotype	died|death|deaths	CTSD	HGNC:2529	Ceroid lipofuscinosis, neuronal, 10, 610127 (3), Autosomal recessive	Autosomal recessive	n	y	[Patients with null mutations in (CTSD) show a more severe phenotype with onset at birth ('congenital NCL') and early death within days]	L2	y	-	lethal	lethal	lethal	L2	L2	pre-infant-lethal
610131	PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 4	Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 4, 610131 (3)	Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 4	n	-	-	-	POLG2	HGNC:9180	Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 4, 610131 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
610140	HEART-HAND SYNDROME, SLOVENIAN TYPE	Heart-hand syndrome, Slovenian type, 610140 (3)	Heart-hand syndrome, Slovenian type	y	HEART-HAND SYNDROME, SLOVENIAN TYPE	Clinical Features|Clinical Synopsis	death|deaths|died	LMNA	HGNC:6636	Heart-hand syndrome, Slovenian type, 610140 (3), Autosomal dominant	Autosomal dominant	n	y	[Ventricular tachyarrhythmia (can result in sudden death) / Zaragoza et al. (2017) reported a family with German and Irish ancestry in which 11 members were born with 'small hands' and later developed heart disease. Photographs of the hands of the proband and his affected first cousin showed small hands with short digital rays. Hand radiographs showed shortened digital rays with no carpal anomalies, and metacarpophalangeal pattern profile analysis revealed a consistent wavy pattern with brachydactyly of all tubular bones with marked shortening of the first and third distal phalanges, second middle phalanx, and first proximal phalanx. The feet in both patients were normal. The proband had dilated cardiomyopathy and died at age 57. His daughter had syncope at age 12, his nephew had cardiogenic shock at age 27, and his sister had sudden death at age 23]	L6	y	y	lethal	ambiguous|lethal|nonlethal	lethal|nonlethal	L1|L2|L6	L1	pre-infant-lethal
610153	DEAFNESS, AUTOSOMAL RECESSIVE 49	Deafness, autosomal recessive 49, 610153 (3)	Deafness, autosomal recessive 49	n	-	-	-	MARVELD2	HGNC:26401	Deafness, autosomal recessive 49, 610153 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
610156	IMPAIRED INTELLECTUAL DEVELOPMENT, TRUNCAL OBESITY, RETINAL DYSTROPHY, AND MICROPENIS SYNDROME	Mental retardation, truncal obesity, retinal dystrophy, and micropenis, 610156 (3)	Mental retardation, truncal obesity, retinal dystrophy, and micropenis	n	-	-	-	INPP5E	HGNC:21474	Mental retardation, truncal obesity, retinal dystrophy, and micropenis, 610156 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L4	L4	post-infant-lethal
610168	LOEYS-DIETZ SYNDROME 2	Loeys-Dietz syndrome 2, 610168 (3)	Loeys-Dietz syndrome 2	y	LOEYS-DIETZ SYNDROME 2; LDS2	Clinical Features|Phenotype	died|death|deaths	TGFBR2	HGNC:11773	Loeys-Dietz syndrome 2, 610168 (3), Autosomal dominant	Autosomal dominant	y	y	[Boileau et al. (1990) described a large French family in which multiple members in an autosomal dominant pedigree pattern exhibited some of the skeletal and cardiovascular features of the Marfan syndrome (154700) but lacked ocular abnormalities. Boileau et al. (1993) considered that the patients fulfilled criteria for the MASS (mitral valve, aortic, skeleton, and skin) phenotype (see 157700), but might represent a distinct clinical entity. The proband was a man who died at age 39 years from aortic dissection. Necropsy showed dilatation of the ascending aorta at the level of the sinuses of Valsalva. Other members demonstrated aortic dilatation on echocardiograms as well as mitral valve prolapse. The father of one of these patients died suddenly at the age of 35 years. Another member of the family died suddenly of aortic dissection at age 29 years. One girl died at the age of 9 years after complaining of chest pain]	L4	y	y	lethal	lethal|nonlethal	lethal|nonlethal	L4	L4	post-infant-lethal
610181	AICARDI-GOUTIERES SYNDROME 2	Aicardi-Goutieres syndrome 2, 610181 (3)	Aicardi-Goutieres syndrome 2	n	-	-	-	RNASEH2B	HGNC:25671	Aicardi-Goutieres syndrome 2, 610181 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
610185	CEREBELLAR ATAXIA, IMPAIRED INTELLECTUAL DEVELOPMENT, AND DYSEQUILIBRIUM SYNDROME 2	Cerebellar ataxia, impaired intellectual development, and dysquilibrium syndrome 2, 610185 (3)	Cerebellar ataxia, impaired intellectual development, and dysquilibrium syndrome 2	y	CEREBELLAR ATAXIA, IMPAIRED INTELLECTUAL DEVELOPMENT, AND DYSEQUILIBRIUM SYNDROME 2; CAMRQ2	Clinical Features|Phenotype	died|death|deaths	WDR81	HGNC:26600	Cerebellar ataxia, impaired intellectual development, and dysquilibrium syndrome 2, 610185 (3), Autosomal recessive	Autosomal recessive	y	y	[neonatal death]	L2	y	-	lethal	lethal	lethal	L1|L2	L1	pre-infant-lethal
610187	DIAPHRAGMATIC HERNIA 3	Diaphragmatic hernia 3, 610187 (3)	Diaphragmatic hernia 3	n	-	-	-	ZFPM2	HGNC:16700	Diaphragmatic hernia 3, 610187 (3)	-	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
610188	JOUBERT SYNDROME 5	Joubert syndrome 5, 610188 (3)	Joubert syndrome 5	n	-	-	-	CEP290	HGNC:29021	Joubert syndrome 5, 610188 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	ambiguous|lethal|nonlethal	lethal|nonlethal	L1	L1	pre-infant-lethal
610189	SENIOR-LOKEN SYNDROME 6	Senior-Loken syndrome 6, 610189 (3)	Senior-Loken syndrome 6	n	-	-	-	CEP290	HGNC:29021	Senior-Loken syndrome 6, 610189 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	ambiguous|lethal|nonlethal	lethal|nonlethal	L1	L1	pre-infant-lethal
610193	ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 10	Arrhythmogenic right ventricular dysplasia 10, 610193 (3)	Arrhythmogenic right ventricular dysplasia 10	y	ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 10; ARVD10	Clinical Synopsis|Phenotype	death|deaths	DSG2	HGNC:3049	Arrhythmogenic right ventricular dysplasia 10, 610193 (3), Autosomal dominant	Autosomal dominant	y	y	[Sudden cardiac death]	LU	y	-	lethal	ambiguous|lethal	lethal	LU	LU	post-infant-lethal
610198	3-METHYLGLUTACONIC ACIDURIA, TYPE V	3-methylglutaconic aciduria, type V, 610198 (3)	3-methylglutaconic aciduria, type V	y	3-METHYLGLUTACONIC ACIDURIA, TYPE V; MGCA5	Description|Clinical Features|Clinical Synopsis	die|death|deaths|died	DNAJC19	HGNC:30528	3-methylglutaconic aciduria, type V, 610198 (3), Autosomal recessive	Autosomal recessive	y	n	-	-	-	-	ambiguous	ambiguous	ambiguous	-	-	-
610199	DIABETES MELLITUS, NEONATAL, WITH CONGENITAL HYPOTHYROIDISM	Diabetes mellitus, neonatal, with congenital hypothyroidism, 610199 (3)	Diabetes mellitus, neonatal, with congenital hypothyroidism	y	DIABETES MELLITUS, NEONATAL, WITH CONGENITAL HYPOTHYROIDISM; NDH	Clinical Features	died	GLIS3	HGNC:28510	Diabetes mellitus, neonatal, with congenital hypothyroidism, 610199 (3), Autosomal recessive	Autosomal recessive	n	y	[Senee et al. (2006) studied the original NDH family described by Taha et al. (2003) as well as a second Saudi Arabian family and a consanguineous French family. They reported that a third affected child was born in the original Saudi family, bearing the same clinical features with the exception of cystic kidney disease; he died at 10 days of life from sepsis]	L2	y	-	lethal	lethal	lethal	L2	L2	pre-infant-lethal
610202	CATARACT 21, MULTIPLE TYPES	Cataract 21, multiple types, 610202 (3)	Cataract 21, multiple types	n	-	-	-	MAF	HGNC:6776	Cataract 21, multiple types, 610202 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
610205	ALAGILLE SYNDROME 2	Alagille syndrome 2, 610205 (3)	Alagille syndrome 2	y	ALAGILLE SYNDROME 2; ALGS2	Clinical Features	died	NOTCH2	HGNC:7882	Alagille syndrome 2, 610205 (3), Autosomal dominant	Autosomal dominant	n	y	[Alagille syndrome is an autosomal dominant multisystem disorder defined clinically by hepatic bile duct paucity and cholestasis in association with cardiac, skeletal, and ophthalmologic manifestations. There are characteristic facial features and less frequent clinical involvement of the renal and vascular systems. McDaniell et al. (2006) identified 2 probands with mutation in the NOTCH2 gene who, in addition to meeting the diagnostic criteria for ALGS, had severe renal disease. The first proband had cholestatic liver disease, cardiac disease (peripheral pulmonic stenosis and a small atrial septal defect), characteristic facial features, and severe infantile renal disease (small kidneys with cysts bilaterally, renal tubular acidosis, and renal insufficiency). He died of cardiopulmonary arrest at age 2 years]	L4	y	-	lethal	ambiguous|lethal	lethal	L4	L4	post-infant-lethal
610217	NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2B	Neurodegeneration with brain iron accumulation 2B, 610217 (3)	Neurodegeneration with brain iron accumulation 2B	y	NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2B; NBIA2B	Clinical Features	died	PLA2G6	HGNC:9039	Neurodegeneration with brain iron accumulation 2B, 610217 (3), Autosomal recessive	Autosomal recessive	n	y	[One of the patients reported by Gregory et al. (2008) was compound heterozygous for 2 mutations in the PLA2G6 gene (603604.0007 and 603604.0008). She presented at 3 years of age with toe walking and lower extremity spasticity. She developed optic atrophy and became nonambulatory by 5 years of age with dystonia and dysarthria, progressing to profound sensorimotor impairment by age 9 years. She died at age 23 years]	L6	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L3|L6	L3	pre-infant-lethal
610220	DEAFNESS, AUTOSOMAL RECESSIVE 59	Deafness, autosomal recessive 59, 610220 (3)	Deafness, autosomal recessive 59	n	-	-	-	PJVK	HGNC:29502	Deafness, autosomal recessive 59, 610220 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
610244	SPASTIC PARAPLEGIA 33, AUTOSOMAL DOMINANT	Spastic paraplegia 33, autosomal dominant, 610244 (3)	Spastic paraplegia 33, autosomal dominant	n	-	-	-	ZFYVE27	HGNC:26559	Spastic paraplegia 33, autosomal dominant, 610244 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
610245	SPINOCEREBELLAR ATAXIA 23	Spinocerebellar ataxia 23, 610245 (3)	Spinocerebellar ataxia 23	n	-	-	-	PDYN	HGNC:8820	Spinocerebellar ataxia 23, 610245 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
610246	SPINOCEREBELLAR ATAXIA 28	Spinocerebellar ataxia 28, 610246 (3)	Spinocerebellar ataxia 28	n	-	-	-	AFG3L2	HGNC:315	Spinocerebellar ataxia 28, 610246 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L5	L5	post-infant-lethal
610250	SPASTIC PARAPLEGIA 31, AUTOSOMAL DOMINANT	Spastic paraplegia 31, autosomal dominant, 610250 (3)	Spastic paraplegia 31, autosomal dominant	n	-	-	-	REEP1	HGNC:25786	Spastic paraplegia 31, autosomal dominant, 610250 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
610251	ALCOHOL SENSITIVITY, ACUTE	Alcohol sensitivity, acute, 610251 (3)	Alcohol sensitivity, acute	n	-	-	-	ALDH2	HGNC:404	Alcohol sensitivity, acute, 610251 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
610253	KLEEFSTRA SYNDROME 1	Kleefstra syndrome 1, 610253 (3)	Kleefstra syndrome 1	n	-	-	-	EHMT1	HGNC:24650	Kleefstra syndrome 1, 610253 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
610256	ANTERIOR SEGMENT DYSGENESIS 2	Anterior segment dysgenesis 2, multiple subtypes, 610256 (3)	Anterior segment dysgenesis 2, multiple subtypes	n	-	-	-	FOXE3	HGNC:3808	Anterior segment dysgenesis 2, multiple subtypes, 610256 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
610265	DEAFNESS, AUTOSOMAL RECESSIVE 67	Deafness, autosomal recessive 67, 610265 (3)	Deafness, autosomal recessive 67	n	-	-	-	LHFPL5	HGNC:21253	Deafness, autosomal recessive 67, 610265 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
610282	RETINITIS PIGMENTOSA 35	Retinitis pigmentosa 35, 610282 (3)	Retinitis pigmentosa 35	n	-	-	-	SEMA4A	HGNC:10729	Retinitis pigmentosa 35, 610282 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
610283	CONE-ROD DYSTROPHY 10	Cone-rod dystrophy 10, 610283 (3)	Cone-rod dystrophy 10	n	-	-	-	SEMA4A	HGNC:10729	Cone-rod dystrophy 10, 610283 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
610293	GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 1	Glycosylphosphatidylinositol deficiency, 610293 (3)	Glycosylphosphatidylinositol deficiency	y	GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 1; GPIBD1	Clinical Features	died	PIGM	HGNC:18858	Glycosylphosphatidylinositol deficiency, 610293 (3), Autosomal recessive	Autosomal recessive	y	y	[Pode-Shakked et al. (2019) reported 4 patients from 2 unrelated Arab families with glycosylphosphatidylinositol deficiency and mutations in the PIGM gene. Three sibs in family A had cerebral and portal vein thrombosis, macrocephaly, prominent superficial facial/abdominal veins, and hepato- or splenomegaly. The 2 oldest sibs, a brother and sister, had persistent atypical absence seizures beginning at age 3 to 4 years. The brother died at age 7 due to complications of cirrhosis]	L4	y	-	lethal	lethal	lethal	L4	L4	post-infant-lethal
610313	CRISPONI/COLD-INDUCED SWEATING SYNDROME 2	Cold-induced sweating syndrome 2, 610313 (3)	Cold-induced sweating syndrome 2	y	CRISPONI/COLD-INDUCED SWEATING SYNDROME 2; CISS2	Description	death|deaths	CLCF1	HGNC:17412	Cold-induced sweating syndrome 2, 610313 (3), Autosomal recessive	Autosomal recessive	y	y	[Crisponi/cold-induced sweating syndrome is an autosomal recessive disorder characterized in the neonatal period by orofacial weakness with impaired sucking and swallowing resulting in poor feeding necessitating medical intervention. Affected infants show a tendency to startle, with contractions of the facial muscles in response to tactile stimuli or during crying, trismus, abundant salivation, and opisthotonus. During the first year, most infants have spiking fevers. These features, referred to as 'Crisponi syndrome' in infancy, can result in early death without advanced care]	LU	y	-	lethal	lethal	lethal	LU	LU	post-infant-lethal
610329	AICARDI-GOUTIERES SYNDROME 3	Aicardi-Goutieres syndrome 3, 610329 (3)	Aicardi-Goutieres syndrome 3	y	AICARDI-GOUTIERES SYNDROME 3; AGS3	Description	die	RNASEH2C	HGNC:24116	Aicardi-Goutieres syndrome 3, 610329 (3), Autosomal recessive	Autosomal recessive	n	y	[Aicardi-Goutieres syndrome is an autosomal recessive disorder characterized by onset of encephalopathy in the first year of life following normal early development. Affected infants typically show extreme irritability, intermittent unexplained fever, chilblains, progressive microcephaly, spasticity, dystonia, and profound psychomotor retardation. Laboratory studies show lymphocytosis and raised titers of alpha-interferon in the cerebrospinal fluid. Brain imaging may show white matter abnormalities, intracerebral calcifications, and cerebral atrophy. Many patients die in childhood (summary by Vogt et al., 2013)]	L4	y	-	lethal	lethal	lethal	L4	L4	post-infant-lethal
610333	AICARDI-GOUTIERES SYNDROME 4	Aicardi-Goutieres syndrome 4, 610333 (3)	Aicardi-Goutieres syndrome 4	y	AICARDI-GOUTIERES SYNDROME 4; AGS4	Clinical Features|Phenotype	died	RNASEH2A	HGNC:18518	Aicardi-Goutieres syndrome 4, 610333 (3), Autosomal recessive	Autosomal recessive	n	y	[Sanchis et al. (2005) described 2 brothers, born of second-cousin parents of white Spanish ancestry, who had intrauterine growth retardation and clinical features suggestive of intrauterine infection but with negative bacteriologic and serologic investigations... He was unable to sit and had no speech. He died of pneumonia at 7 years of age]	L4	y	-	lethal	lethal	lethal	L4	L4	post-infant-lethal
610353	EPILEPSY, NOCTURNAL FRONTAL LOBE, 4	Epilepsy, nocturnal frontal lobe, type 4, 610353 (3)	Epilepsy, nocturnal frontal lobe, type 4	n	-	-	-	CHRNA2	HGNC:1956	Epilepsy, nocturnal frontal lobe, type 4, 610353 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
610356	RETINAL CONE DYSTROPHY 3B	Retinal cone dystrophy 3B, 610356 (3)	Retinal cone dystrophy 3B	n	-	-	-	KCNV2	HGNC:19698	Retinal cone dystrophy 3B, 610356 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
610357	SPASTIC PARAPLEGIA 30, AUTOSOMAL DOMINANT	Spastic paraplegia 30, autosomal dominant, 610357 (3)	Spastic paraplegia 30, autosomal dominant	n	-	-	-	KIF1A	HGNC:888	Spastic paraplegia 30, autosomal dominant, 610357 (3), Autosomal dominant, Autosomal recessive	Autosomal dominant, Autosomal recessive	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L3	L3	pre-infant-lethal
610357	SPASTIC PARAPLEGIA 30, AUTOSOMAL DOMINANT	Spastic paraplegia 30, autosomal recessive, 610357 (3)	Spastic paraplegia 30, autosomal recessive	n	-	-	-	KIF1A	HGNC:888	Spastic paraplegia 30, autosomal recessive, 610357 (3), Autosomal dominant, Autosomal recessive	Autosomal dominant, Autosomal recessive	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L3	L3	pre-infant-lethal
610359	RETINITIS PIGMENTOSA 33	Retinitis pigmentosa 33, 610359 (3)	Retinitis pigmentosa 33	n	-	-	-	SNRNP200	HGNC:30859	Retinitis pigmentosa 33, 610359 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
610370	DIARRHEA 4, MALABSORPTIVE, CONGENITAL	Diarrhea 4, malabsorptive, congenital, 610370 (3)	Diarrhea 4, malabsorptive, congenital	y	DIARRHEA 4, MALABSORPTIVE, CONGENITAL; DIAR4	Clinical Features	died	NEUROG3	HGNC:13806	Diarrhea 4, malabsorptive, congenital, 610370 (3), Autosomal recessive	Autosomal recessive	n	y	[Wang et al. (2006) reported 3 unrelated boys who presented with chronic unremitting malabsorptive diarrhea in the first weeks of life. Accompanying features included vomiting, dehydration, and severe hyperchloremic metabolic acidosis after the ingestion of standard cows-milk-based formula. The diarrhea ceased during periods of fasting, but returned with glucose- or amino acid-based oral solutions. All studies were negative for allergic, immunologic, infectious, and metabolic causes of diarrhea; pancreatic exocrine function was also normal. The children were discharged on parenteral nutrition and limited enteral feeding. One child died of sepsis at about 3 years of age; the other 2 continued to have large-volume loose stools daily and low weight]	L4	y	-	lethal	lethal	lethal	L4	L4	post-infant-lethal
610374	DIABETES MELLITUS, TRANSIENT NEONATAL, 2	Diabetes mellitus, transient neonatal 2, 610374 (3)	Diabetes mellitus, transient neonatal 2	n	-	-	-	ABCC8	HGNC:59	Diabetes mellitus, transient neonatal 2, 610374 (3)	-	-	-	-	-	-	-	nonlethal	ambiguous|nonlethal	ambiguous	-	-	-
610377	MEVALONIC ACIDURIA	Mevalonic aciduria, 610377 (3)	Mevalonic aciduria	y	MEVALONIC ACIDURIA; MEVA	Clinical Features	die|died	MVK	HGNC:7530	Mevalonic aciduria, 610377 (3), Autosomal recessive	Autosomal recessive	y	y	[Hoffmann et al. (1986) delineated this inborn error of metabolism in a boy who came to their attention at age 2 years and in an unborn female sib.. The proband died at 24.5 months]	L4	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L4|LU	L4	post-infant-lethal
610381	CONE-ROD DYSTROPHY 11	Cone-rod dystrophy 11, 610381 (3)	Cone-rod dystrophy 11	n	-	-	-	RAX2	HGNC:18286	Cone-rod dystrophy 11, 610381 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
610419	DEAFNESS, AUTOSOMAL RECESSIVE 68	Deafness, autosomal recessive 68, 610419 (3)	Deafness, autosomal recessive 68	n	-	-	-	S1PR2	HGNC:3169	Deafness, autosomal recessive 68, 610419 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
610425	CATARACT 23, MULTIPLE TYPES	Cataract 23, 610425 (3)	Cataract 23	n	-	-	-	CRYBA4	HGNC:2396	Cataract 23, 610425 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
610427	CONE-ROD SYNAPTIC DISORDER, CONGENITAL NONPROGRESSIVE	Cone-rod synaptic disorder, congenital nonprogressive, 610427 (3)	Cone-rod synaptic disorder, congenital nonprogressive	n	-	-	-	CABP4	HGNC:1386	Cone-rod synaptic disorder, congenital nonprogressive, 610427 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
610442	SPONDYLOEPIMETAPHYSEAL DYSPLASIA, GENEVIEVE TYPE	Spondyloepimetaphyseal dysplasia, Camera-Genevieve type, 610442 (3)	Spondyloepimetaphyseal dysplasia, Camera-Genevieve type	n	-	-	-	NANS	HGNC:19237	Spondyloepimetaphyseal dysplasia, Camera-Genevieve type, 610442 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
610443	KOOLEN-DE VRIES SYNDROME	Koolen-De Vries syndrome, 610443 (3)	Koolen-De Vries syndrome	n	-	-	-	KANSL1	HGNC:24565	Koolen-De Vries syndrome, 610443 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
610444	NIGHT BLINDNESS, CONGENITAL STATIONARY, AUTOSOMAL DOMINANT 3	Night blindness, congenital stationary, autosomal dominant 3, 610444 (3)	Night blindness, congenital stationary, autosomal dominant 3	n	-	-	-	GNAT1	HGNC:4393	Night blindness, congenital stationary, autosomal dominant 3, 610444 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
610445	NIGHT BLINDNESS, CONGENITAL STATIONARY, AUTOSOMAL DOMINANT 1	Night blindness, congenital stationary, autosomal dominant 1, 610445 (3)	Night blindness, congenital stationary, autosomal dominant 1	n	-	-	-	RHO	HGNC:10012	Night blindness, congenital stationary, autosomal dominant 1, 610445 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
610448	CHILBLAIN LUPUS 1	Chilblain lupus, 610448 (3)	Chilblain lupus	n	-	-	-	TREX1	HGNC:12269	Chilblain lupus, 610448 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L3|L6	L3	pre-infant-lethal
610455	TUMORAL CALCINOSIS, NORMOPHOSPHATEMIC, FAMILIAL	Tumoral calcinosis, familial, normophosphatemic, 610455 (3)	Tumoral calcinosis, familial, normophosphatemic	n	-	-	-	SAMD9	HGNC:1348	Tumoral calcinosis, familial, normophosphatemic, 610455 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L3|L4	L3	pre-infant-lethal
610474	CAMPTODACTYLY, TALL STATURE, AND HEARING LOSS SYNDROME	CATSHL syndrome, 610474 (3)	CATSHL syndrome	n	-	-	-	FGFR3	HGNC:3690	CATSHL syndrome, 610474 (3), Autosomal dominant, Autosomal recessive	Autosomal dominant, Autosomal recessive	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L2|L3	L2	pre-infant-lethal
610475	PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 2	Pigmented nodular adrenocortical disease, primary, 2, 610475 (3)	Pigmented nodular adrenocortical disease, primary, 2	n	-	-	-	PDE11A	HGNC:8773	Pigmented nodular adrenocortical disease, primary, 2, 610475 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
610476	ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 11	Arrhythmogenic right ventricular dysplasia 11 with mild palmoplantar keratoderma and woolly hair, 610476 (3)	Arrhythmogenic right ventricular dysplasia 11 with mild palmoplantar keratoderma and woolly hair	y	ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 11; ARVD11	Clinical Features|Clinical Synopsis	death|deaths|died	DSC2	HGNC:3036	Arrhythmogenic right ventricular dysplasia 11 with mild palmoplantar keratoderma and woolly hair, 610476 (3), Autosomal dominant, Autosomal recessive	Autosomal dominant, Autosomal recessive	y	y	[Premature sudden cardiac death / Gerull et al. (2013) studied 8 patients from 2 Canadian Hutterite kindreds segregating autosomal recessive sudden cardiac death, 1 from the Dariusleut branch (family D) and 1 from the Lehrerleut branch (family L). Autopsies in 2 individuals, 1 from each family, who both died suddenly at 14 years of age while exercising, showed marked dilation of the left ventricle and fibrofatty replacement of myocardial tissue in the right ventricle]	L5	y	-	lethal	lethal	lethal	L5	L5	post-infant-lethal
610476	ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 11	Arrhythmogenic right ventricular dysplasia 11, 610476 (3)	Arrhythmogenic right ventricular dysplasia 11	y	ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 11; ARVD11	Clinical Features|Clinical Synopsis	death|deaths|died	DSC2	HGNC:3036	Arrhythmogenic right ventricular dysplasia 11, 610476 (3), Autosomal dominant, Autosomal recessive	Autosomal dominant, Autosomal recessive	y	y	[Premature sudden cardiac death / Gerull et al. (2013) studied 8 patients from 2 Canadian Hutterite kindreds segregating autosomal recessive sudden cardiac death, 1 from the Dariusleut branch (family D) and 1 from the Lehrerleut branch (family L). Autopsies in 2 individuals, 1 from each family, who both died suddenly at 14 years of age while exercising, showed marked dilation of the left ventricle and fibrofatty replacement of myocardial tissue in the right ventricle]	L5	y	-	lethal	lethal	lethal	L5	L5	post-infant-lethal
610478	RETINAL CONE DYSTROPHY 4	Retinal cone dystrophy 4, 610478 (3)	Retinal cone dystrophy 4	n	-	-	-	CACNA2D4	HGNC:20202	Retinal cone dystrophy 4, 610478 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
610489	PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 1	Pigmented nodular adrenocortical disease, primary, 1, 610489 (3)	Pigmented nodular adrenocortical disease, primary, 1	y	PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 1; PPNAD1	Clinical Features	died	PRKAR1A	HGNC:9388	Pigmented nodular adrenocortical disease, primary, 1, 610489 (3), Autosomal dominant	Autosomal dominant	y	y	[Arce et al. (1978) reported 4 sibs with 'familial Cushing syndrome.' Three sibs had onset around adolescence of moon facies, obesity, hypertrichosis, purple striae, and osteoporosis. Skull radiographs showed no enlargement of the sella turcica, and dexamethasone suppression resulted in no change of circulating steroid levels. Measurement of serum ACTH was not available. Functional studies showed adrenal autonomy. Adrenalectomy resulted in complete remission in 3 sibs; the fourth died from a presumed virilizing adrenal carcinoma. Histology of the 3 sibs demonstrated enlarged adrenal glands containing numerous yellow cortical nodules ranging in size from 0.3 to 1.5 cm. Lipochromic pigment was reported. Although data were lacking, this family may have had PPNAD]	LU	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L4|L5|LU	L4	post-infant-lethal
610498	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 2	Combined oxidative phosphorylation deficiency 2, 610498 (3)	Combined oxidative phosphorylation deficiency 2	y	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 2; COXPD2	Clinical Features	died|fatal	MRPS16	HGNC:14048	Combined oxidative phosphorylation deficiency 2, 610498 (3), Autosomal recessive	Autosomal recessive	n	y	[Miller et al. (2004) reported an infant, born of consanguineous parents, with agenesis of the corpus callosum, dysmorphism, and fatal neonatal lactic acidosis. The patient was small at birth, with dysmorphic facies, low-set ears, nonpitting edema of the limbs, brachydactyly, and redundant skin over the neck. She died of intractable metabolic acidosis at age 3 days]	L2	y	-	lethal	lethal	lethal	L2	L2	pre-infant-lethal
610505	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 3	Combined oxidative phosphorylation deficiency 3, 610505 (3)	Combined oxidative phosphorylation deficiency 3	y	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 3; COXPD3	Clinical Features|Phenotype	death|deaths|died|lethal	TSFM	HGNC:12367	Combined oxidative phosphorylation deficiency 3, 610505 (3), Autosomal recessive	Autosomal recessive	n	y	[Smeitink et al. (2006) reported 2 unrelated patients with COXPD3. The first proband was the child of consanguineous Turkish parents. Muscular hypotonia, sucking weakness, and severe lactic acidosis were the initial clinical signs and symptoms, followed by rhabdomyolysis with elevated creatine kinase values. Generalized convulsions began on the third day of life. Despite intensive treatment, the patient died of progressive encephalomyopathy and respiratory failure at age 7 weeks]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
610508	MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 7	Maturity-onset diabetes of the young, type VII, 610508 (3)	Maturity-onset diabetes of the young, type VII	n	-	-	-	KLF11	HGNC:11811	Maturity-onset diabetes of the young, type VII, 610508 (3)	-	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
610532	LEUKODYSTROPHY, HYPOMYELINATING, 5	Leukodystrophy, hypomyelinating, 5, 610532 (3)	Leukodystrophy, hypomyelinating, 5	y	LEUKODYSTROPHY, HYPOMYELINATING, 5; HLD5	Clinical Features	died	HYCC1	HGNC:24587	Leukodystrophy, hypomyelinating, 5, 610532 (3), Autosomal recessive	Autosomal recessive	y	y	[Ugur and Tolun (2008) reported a large consanguineous Turkish family in which 5 individuals had hypomyelination and congenital cataracts associated with an intragenic deletion in the FAM126A gene (610531.0004). Clinical details of the 10-year-old male proband included congenital bilateral cataract, psychomotor regression beginning around 1 year of age, moderate mental retardation, and white matter changes in supratentorial structures and paraventricular regions. He also had a sensorimotor peripheral demyelinating neuropathy and never achieved walking. Two other affected individuals died at ages 2 and 12 years, respectively]	L4	y	-	lethal	lethal	lethal	L4	L4	post-infant-lethal
610536	MANDIBULOFACIAL DYSOSTOSIS, GUION-ALMEIDA TYPE	Mandibulofacial dysostosis, Guion-Almeida type, 610536 (3)	Mandibulofacial dysostosis, Guion-Almeida type	n	-	-	-	EFTUD2	HGNC:30858	Mandibulofacial dysostosis, Guion-Almeida type, 610536 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
610539	GAUCHER DISEASE, ATYPICAL, DUE TO SAPOSIN C DEFICIENCY	Gaucher disease, atypical, 610539 (3)	Gaucher disease, atypical	y	GAUCHER DISEASE, ATYPICAL, DUE TO SAPOSIN C DEFICIENCY; GDSAPC	Clinical Features	died	PSAP	HGNC:9498	Gaucher disease, atypical, 610539 (3)	-	y	y	[Christomanou et al. (1986) reported a patient with an atypical form of Gaucher disease associated with normal beta-glucosidase activity and deficiency of saposin C, an activator protein that enhances beta-glucosidase activity. The patient had neurologic onset at about 4 years of age and died at age 14 (Tylki-Szymanska et al., 2007]	L5	y	-	lethal	lethal	lethal	L3|L4|L5	L3	pre-infant-lethal
610542	MYASTHENIC SYNDROME, CONGENITAL, 12	Myasthenia, congenital, 12, with tubular aggregates, 610542 (3)	Myasthenia, congenital, 12, with tubular aggregates	n	-	-	-	GFPT1	HGNC:4241	Myasthenia, congenital, 12, with tubular aggregates, 610542 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
610549	DIABETES MELLITUS, INSULIN-RESISTANT, WITH ACANTHOSIS NIGRICANS	Diabetes mellitus, insulin-resistant, with acanthosis nigricans, 610549 (3)	Diabetes mellitus, insulin-resistant, with acanthosis nigricans	n	-	-	-	INSR	HGNC:6091	Diabetes mellitus, insulin-resistant, with acanthosis nigricans, 610549 (3)	-	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L3|L4	L3	pre-infant-lethal
610582	DIABETES MELLITUS, TRANSIENT NEONATAL, 3	Diabetes mellitus, transient neonatal 3, 610582 (3)	Diabetes mellitus, transient neonatal 3	n	-	-	-	KCNJ11	HGNC:6257	Diabetes mellitus, transient neonatal 3, 610582 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L3	L3	pre-infant-lethal
610599	RETINITIS PIGMENTOSA 36	Retinitis pigmentosa 36, 610599 (3)	Retinitis pigmentosa 36	n	-	-	-	PRCD	HGNC:32528	Retinitis pigmentosa 36, 610599 (3)	-	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
610600	CORTICOSTERONE METHYLOXIDASE TYPE II DEFICIENCY	Hypoaldosteronism, congenital, due to CMO II deficiency, 610600 (3)	Hypoaldosteronism, congenital, due to CMO II deficiency	y	CORTICOSTERONE METHYLOXIDASE TYPE II DEFICIENCY	Clinical Features	lethal	CYP11B2	HGNC:2592	Hypoaldosteronism, congenital, due to CMO II deficiency, 610600 (3), Autosomal recessive	Autosomal recessive	n	y	[Unexplained hyperkalemia may be the main diagnostic clue in adults; lethal hyperkalemia may occur with salt depletion]	LU	y	-	lethal	lethal	lethal	L3|LU	L3	pre-infant-lethal
610612	LEBER CONGENITAL AMAUROSIS 12	Leber congenital amaurosis 12, 610612 (3)	Leber congenital amaurosis 12	n	-	-	-	RD3	HGNC:19689	Leber congenital amaurosis 12, 610612 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
610618	ANGIOEDEMA, HEREDITARY, 3	Angioedema, hereditary, 3, 610618 (3)	Angioedema, hereditary, 3	n	-	-	-	F12	HGNC:3530	Angioedema, hereditary, 3, 610618 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	ambiguous|nonlethal	ambiguous	-	-	-
610623	CATARACT 11, MULTIPLE TYPES	Cataract 11, multiple types, 610623 (3)	Cataract 11, multiple types	n	-	-	-	PITX3	HGNC:9006	Cataract 11, multiple types, 610623 (3), Autosomal dominant, Autosomal recessive	Autosomal dominant, Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
610623	CATARACT 11, MULTIPLE TYPES	Cataract 11, syndromic, autosomal recessive, 610623 (3)	Cataract 11, syndromic, autosomal recessive	n	-	-	-	PITX3	HGNC:9006	Cataract 11, syndromic, autosomal recessive, 610623 (3), Autosomal dominant, Autosomal recessive	Autosomal dominant, Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
610628	HYPOGONADOTROPIC HYPOGONADISM 4 WITH OR WITHOUT ANOSMIA	Hypogonadotropic hypogonadism 4 with or without anosmia, 610628 (3)	Hypogonadotropic hypogonadism 4 with or without anosmia	n	-	-	-	PROK2	HGNC:18455	Hypogonadotropic hypogonadism 4 with or without anosmia, 610628 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
610629	DIAMOND-BLACKFAN ANEMIA 3	Diamond-blackfan anemia 3, 610629 (3)	Diamond-blackfan anemia 3	n	-	-	-	RPS24	HGNC:10411	Diamond-blackfan anemia 3, 610629 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
610644	PALMOPLANTAR HYPERKERATOSIS WITH SQUAMOUS CELL CARCINOMA OF SKIN AND 46,XX SEX REVERSAL	Palmoplantar hyperkeratosis and true hermaphroditism, 610644 (3)	Palmoplantar hyperkeratosis and true hermaphroditism	n	-	-	-	RSPO1	HGNC:21679	Palmoplantar hyperkeratosis and true hermaphroditism, 610644 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
610644	PALMOPLANTAR HYPERKERATOSIS WITH SQUAMOUS CELL CARCINOMA OF SKIN AND 46,XX SEX REVERSAL	Palmoplantar hyperkeratosis with squamous cell carcinoma of skin and sex reversal, 610644 (3)	Palmoplantar hyperkeratosis with squamous cell carcinoma of skin and sex reversal	n	-	-	-	RSPO1	HGNC:21679	Palmoplantar hyperkeratosis with squamous cell carcinoma of skin and sex reversal, 610644 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
610651	XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP B	Xeroderma pigmentosum, group B, 610651 (3)	Xeroderma pigmentosum, group B	y	XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP B; XPB	Clinical Features	died	ERCC3	HGNC:3435	Xeroderma pigmentosum, group B, 610651 (3), Autosomal recessive	Autosomal recessive	n	y	[Oh et al. (2006) provided a follow-up of this patient, who was the first identified with XP complementation group B. She had severe features of XP, including extreme sensitivity to sunlight, pigmentation abnormalities, and multiple skin cancers. She also had severe features of Cockayne syndrome, including wizened facial appearance, dwarfism, sensorineural deafness, microcephaly, severe mental retardation, microphthalmia, cataracts, optic atrophy, pigmentary retinal degeneration, hyperreflexia, ataxia, decreased nerve conduction velocities, enlarged cerebral ventricles, basal ganglia calcifications, and immature sexual development. She died at age 33 years of cardiovascular disease	L6	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L6	L6	post-infant-lethal
610678	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 4	Combined oxidative phosphorylation deficiency 4, 610678 (3)	Combined oxidative phosphorylation deficiency 4	y	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 4; COXPD4	Clinical Features|Clinical Synopsis	died|fatal|death|deaths	TUFM	HGNC:12420	Combined oxidative phosphorylation deficiency 4, 610678 (3), Autosomal recessive	Autosomal recessive	n	y	[Death in infancy may occur]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
610682	OSTEOGENESIS IMPERFECTA, TYPE VII	Osteogenesis imperfecta, type VII, 610682 (3)	Osteogenesis imperfecta, type VII	y	OSTEOGENESIS IMPERFECTA, TYPE VII; OI7	Description|Clinical Features|Clinical Synopsis|Phenotype	lethal|death|deaths|died	CRTAP	HGNC:2379	Osteogenesis imperfecta, type VII, 610682 (3), Autosomal recessive	Autosomal recessive	n	y	[Death in infancy secondary to respiratory insufficiency/pneumonia]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
610687	NEMALINE MYOPATHY 7	Nemaline myopathy 7, autosomal recessive, 610687 (3)	Nemaline myopathy 7, autosomal recessive	n	-	-	-	CFL2	HGNC:1875	Nemaline myopathy 7, autosomal recessive, 610687 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
610688	JOUBERT SYNDROME 6	Joubert syndrome 6, 610688 (3)	Joubert syndrome 6	n	-	-	-	TMEM67	HGNC:28396	Joubert syndrome 6, 610688 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	ambiguous|lethal|nonlethal	lethal|nonlethal	L1|L4	L1	pre-infant-lethal
610706	DEAFNESS, CONGENITAL, WITH INNER EAR AGENESIS, MICROTIA, AND MICRODONTIA	Deafness, congenital with inner ear agenesis, microtia, and microdontia, 610706 (3)	Deafness, congenital with inner ear agenesis, microtia, and microdontia	n	-	-	-	FGF3	HGNC:3681	Deafness, congenital with inner ear agenesis, microtia, and microdontia, 610706 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
610708	OPTIC ATROPHY 5	Optic atrophy 5, 610708 (3)	Optic atrophy 5	n	-	-	-	DNM1L	HGNC:2973	Optic atrophy 5, 610708 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L2	L2	pre-infant-lethal
610717	NEUTRAL LIPID STORAGE DISEASE WITH MYOPATHY	Neutral lipid storage disease with myopathy, 610717 (3)	Neutral lipid storage disease with myopathy	y	NEUTRAL LIPID STORAGE DISEASE WITH MYOPATHY; NLSDM	Clinical Features	died	PNPLA2	HGNC:30802	Neutral lipid storage disease with myopathy, 610717 (3), Autosomal recessive	Autosomal recessive	n	y	[Fischer et al. (2007) described 3 affected females from 3 families from the Netherlands, France, and Algeria who showed multisystem triglyceride storage and myopathy, inconstantly associated with delays in walking, variable cardiac abnormalities, and hepatomegaly. One suffered from diabetes with onset at age 12 and died from cardiovascular complications at age 34]	L6	y	-	lethal	lethal	lethal	L6	L6	post-infant-lethal
610725	NEPHROTIC SYNDROME, TYPE 3	Nephrotic syndrome, type 3, 610725 (3)	Nephrotic syndrome, type 3	n	-	-	-	PLCE1	HGNC:17175	Nephrotic syndrome, type 3, 610725 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
610733	NOONAN SYNDROME 4	Noonan syndrome 4, 610733 (3)	Noonan syndrome 4	n	-	-	-	SOS1	HGNC:11187	Noonan syndrome 4, 610733 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
610738	NEUTROPENIA, SEVERE CONGENITAL, 3, AUTOSOMAL RECESSIVE	Neutropenia, severe congenital 3, autosomal recessive, 610738 (3)	Neutropenia, severe congenital 3, autosomal recessive	y	NEUTROPENIA, SEVERE CONGENITAL, 3, AUTOSOMAL RECESSIVE; SCN3	Clinical Features	died	HAX1	HGNC:16915	Neutropenia, severe congenital 3, autosomal recessive, 610738 (3), Autosomal recessive	Autosomal recessive	y	y	[Koren et al. (1989) reported a family in which a male and female sib with first-cousin parents had what was called congenital dysgranulopoietic neutropenia. The female suffered from omphalitis due to enterobacter at age 2 weeks and subsequently died from sepsis at age 1 month]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
610743	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 8	Spinocerebellar ataxia, autosomal recessive 8, 610743 (3)	Spinocerebellar ataxia, autosomal recessive 8	y	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 8; SCAR8	Clinical Features	death|deaths|died	SYNE1	HGNC:17089	Spinocerebellar ataxia, autosomal recessive 8, 610743 (3), Autosomal recessive	Autosomal recessive	n	y	[Synofzik et al. (2016) reported 23 probands of European descent, none of whom were French Canadian, with SCAR8... Three patients, including 2 sibs, had a multisystem disorder with impaired intellectual development (IQ of 49 in 1 patient) and respiratory dysfunction, which resulted in death at age 36 years in 1]	L6	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L3|L6	L3	pre-infant-lethal
610755	MULTIPLE ENDOCRINE NEOPLASIA, TYPE IV	Multiple endocrine neoplasia, type IV, 610755 (3)	Multiple endocrine neoplasia, type IV	y	MULTIPLE ENDOCRINE NEOPLASIA, TYPE IV; MEN4	Clinical Features	died	CDKN1B	HGNC:1785	Multiple endocrine neoplasia, type IV, 610755 (3), Autosomal dominant	Autosomal dominant	n	n	-	-	-	-	ambiguous	ambiguous	ambiguous	-	-	-
610758	CEREBROOCULOFACIOSKELETAL SYNDROME 4	Cerebrooculofacioskeletal syndrome 4, 610758 (3)	Cerebrooculofacioskeletal syndrome 4	y	CEREBROOCULOFACIOSKELETAL SYNDROME 4; COFS4	Clinical Features|Clinical Synopsis|Phenotype	death|deaths|died	ERCC1	HGNC:3433	Cerebrooculofacioskeletal syndrome 4, 610758 (3), Autosomal recessive	Autosomal recessive	n	y	[Jaspers et al. (2007) described a patient with COFS who was the child of nonconsanguineous white Italian parents. The patient was born after a 37-week pregnancy complicated by intrauterine growth retardation... Respiratory failure due to bilateral pneumonia was the cause of death at age 14 months]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
610759	CORNELIA DE LANGE SYNDROME 3 WITH OR WITHOUT MIDLINE BRAIN DEFECTS	Cornelia de Lange syndrome 3, 610759 (3)	Cornelia de Lange syndrome 3	n	-	-	-	SMC3	HGNC:2468	Cornelia de Lange syndrome 3, 610759 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
610768	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Im	Congenital disorder of glycosylation, type Im, 610768 (3)	Congenital disorder of glycosylation, type Im	y	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Im; CDG1M	Clinical Features|Clinical Synopsis|Phenotype	death|deaths|died	DOLK	HGNC:23406	Congenital disorder of glycosylation, type Im, 610768 (3), Autosomal recessive	Autosomal recessive	n	y	[Death in early infancy (in some patients)]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
610773	MITOCHONDRIAL PHOSPHATE CARRIER DEFICIENCY	Mitochondrial phosphate carrier deficiency, 610773 (3)	Mitochondrial phosphate carrier deficiency	y	MITOCHONDRIAL PHOSPHATE CARRIER DEFICIENCY; MPCD	Description|Clinical Features|Clinical Synopsis	death|deaths	SLC25A3	HGNC:10989	Mitochondrial phosphate carrier deficiency, 610773 (3), Autosomal recessive	Autosomal recessive	y	y	[Mayr et al. (2007) described 2 sisters, offspring of nonconsanguineous Turkish parents, with hypertrophic cardiomyopathy apparent soon after birth. Both presented in the first day of life with hypotonia, cyanosis, and respiratory insufficiency requiring intervention. Echocardiography revealed hypertrophic cardiomyopathy with low cardiac output. Metabolic workup revealed elevated plasma lactate and an increased lactate:pyruvate ratio of 62. Both had severe hypotonia with failure to thrive, resulting in death at 4 and 9 months of age]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
610798	IMMUNODEFICIENCY DUE TO DEFECT IN MAPBP-INTERACTING PROTEIN	Immunodeficiency due to defect in MAPBP-interacting protein, 610798 (3)	Immunodeficiency due to defect in MAPBP-interacting protein	n	-	-	-	LAMTOR2	HGNC:29796	Immunodeficiency due to defect in MAPBP-interacting protein, 610798 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
610805	CONGENITAL ANOMALIES OF KIDNEY AND URINARY TRACT 1	Congenital anomalies of kidney and urinary tract 1, 610805 (3)	Congenital anomalies of kidney and urinary tract 1	y	CONGENITAL ANOMALIES OF KIDNEY AND URINARY TRACT 1; CAKUT1	Description	death|deaths	DSTYK	HGNC:29043	Congenital anomalies of kidney and urinary tract 1, 610805 (3), Autosomal dominant	Autosomal dominant	y	y	[CAKUT occurs in about 1 in 500 live births, but are severe enough to cause neonatal death in about 1 in 2,000 births]	L2	y	-	lethal	lethal	lethal	L2|L3	L2	pre-infant-lethal
610828	HOLOPROSENCEPHALY 7	Holoprosencephaly 7, 610828 (3)	Holoprosencephaly 7	y	HOLOPROSENCEPHALY 7; HPE7	Clinical Features	miscarriage|miscarriages	PTCH1	HGNC:9585	Holoprosencephaly 7, 610828 (3), Autosomal dominant	Autosomal dominant	y	n	-	-	-	-	ambiguous	ambiguous|nonlethal	ambiguous	-	-	-
610829	HOLOPROSENCEPHALY 9	Holoprosencephaly 9, 610829 (3)	Holoprosencephaly 9	y	HOLOPROSENCEPHALY 9; HPE9	Clinical Features	died	GLI2	HGNC:4318	Holoprosencephaly 9, 610829 (3), Autosomal dominant	Autosomal dominant	n	y	[Ribeiro et al. (2005) stated that this patient had the same syndrome as that previously reported by Guion-Almeida et al. (1999), who described a Brazilian female infant with holoprosencephaly, bilateral clinical anophthalmia, and agenesis of the eye globes and optic nerves. She presented with severe respiratory distress at birth, required resuscitation, and subsequently died at 9 days of age]	L2	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L2	L2	pre-infant-lethal
610832	FANCONI ANEMIA, COMPLEMENTATION GROUP N	Fanconi anemia, complementation group N, 610832 (3)	Fanconi anemia, complementation group N	y	FANCONI ANEMIA, COMPLEMENTATION GROUP N; FANCN	Clinical Features	died	PALB2	HGNC:26144	Fanconi anemia, complementation group N, 610832 (3)	-	n	y	[Xia et al. (2007) described a female patient with a severe and unclassified form of Fanconi anemia. She was born after an uneventful pregnancy of 40 weeks, with low birth weight. Congenital abnormalities included microcephaly, hypertelorism, short neck, heart defect, long boneless thumb on the right hand, hypoplastic thumb on the left hand, imperforate anus, ectopic right kidney, cafe-au-lait spots, and epicanthus. The patient developed aplastic anemia at age 2 and died at 2 years and 4 months of age from a kaposiform hemangioendothelioma of the left retroocular cavity that had invaded the brain]	L4	y	-	lethal	lethal	lethal	L4	L4	post-infant-lethal
610842	PSEUDOXANTHOMA ELASTICUM-LIKE DISORDER WITH MULTIPLE COAGULATION FACTOR DEFICIENCY	Pseudoxanthoma elasticum-like disorder with multiple coagulation factor deficiency, 610842 (3)	Pseudoxanthoma elasticum-like disorder with multiple coagulation factor deficiency	n	-	-	-	GGCX	HGNC:4247	Pseudoxanthoma elasticum-like disorder with multiple coagulation factor deficiency, 610842 (3)	-	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L2	L2	pre-infant-lethal
610878	VESICOURETERAL REFLUX 2	Vesicoureteral reflux 2, 610878 (3)	Vesicoureteral reflux 2	n	-	-	-	ROBO2	HGNC:10250	Vesicoureteral reflux 2, 610878 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
610896	BRANCHIOOTORENAL SYNDROME 2	Branchiootorenal syndrome 2, 610896 (3)	Branchiootorenal syndrome 2	n	-	-	-	SIX5	HGNC:10891	Branchiootorenal syndrome 2, 610896 (3)	-	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
610913	SURFACTANT METABOLISM DYSFUNCTION, PULMONARY, 2	Surfactant metabolism dysfunction, pulmonary, 2, 610913 (3)	Surfactant metabolism dysfunction, pulmonary, 2	y	SURFACTANT METABOLISM DYSFUNCTION, PULMONARY, 2; SMDP2	Clinical Features	died	SFTPC	HGNC:10802	Surfactant metabolism dysfunction, pulmonary, 2, 610913 (3), Autosomal dominant	Autosomal dominant	y	y	[Nogee et al. (2001) reported a female infant who developed severe respiratory insufficiency at 6 weeks of age. She had cyanosis and tachypnea while breathing room air. Chest radiography showed hyperinflation with increased interstitial markings. Open-lung biopsy showed changes most consistent with cellular or nonspecific interstitial pneumonitis with hyperplasia of type II alveolar cells and interstitial infiltrate of mature lymphocytes and scattered myofibroblasts. Some non-inflated alveoli were filled with macrophages. Treatment with supplemental oxygen and corticosteroids resulted in some clinical improvement. The child's mother had infantile respiratory disease and received a pathologic diagnosis of desquamative interstitial pneumonitis (see DIP, 263000) at age 1 year. She was treated with glucocorticoids until age 15 years. She died after childbirth from respiratory failure]	LU	n	y	lethal	lethal	lethal	LU	LU	post-infant-lethal
610915	OSTEOGENESIS IMPERFECTA, TYPE VIII	Osteogenesis imperfecta, type VIII, 610915 (3)	Osteogenesis imperfecta, type VIII	y	OSTEOGENESIS IMPERFECTA, TYPE VIII; OI8	Description|Clinical Features|Phenotype	lethal|died	P3H1	HGNC:19316	Osteogenesis imperfecta, type VIII, 610915 (3), Autosomal recessive	Autosomal recessive	n	y	[Cabral et al. (2007) described 5 patients with a lethal/severe osteogenesis imperfecta-like bone dysplasia caused by mutation in the LEPRE1 gene]	LU	y	-	lethal	lethal	lethal	LU	LU	post-infant-lethal
610921	SURFACTANT METABOLISM DYSFUNCTION, PULMONARY, 3	Surfactant metabolism dysfunction, pulmonary, 3, 610921 (3)	Surfactant metabolism dysfunction, pulmonary, 3	y	SURFACTANT METABOLISM DYSFUNCTION, PULMONARY, 3; SMDP3	Clinical Features|Clinical Synopsis|Phenotype	died|die	ABCA3	HGNC:33	Surfactant metabolism dysfunction, pulmonary, 3, 610921 (3), Autosomal recessive	Autosomal recessive	y	y	[Most affected infants die in the first month of life / Shulenin et al. (2004) evaluated a total of 337 full-term infants with severe neonatal respiratory distress. Most patients were found to have identifiable causes, including malformation, infection, SMDP1 (47 infants, 14%), or SMDP2 (610913) (6 infants). Of 16 patients found to have pathogenic mutations in the ABCA3 gene, 11 died within the neonatal period, 2 died within 3 months of age, 1 died after lung transplantation, and 1 was lost to follow-up]	L2	y	-	lethal	lethal	lethal	L2	L2	pre-infant-lethal
610951	CEROID LIPOFUSCINOSIS, NEURONAL, 7	Ceroid lipofuscinosis, neuronal, 7, 610951 (3)	Ceroid lipofuscinosis, neuronal, 7	y	CEROID LIPOFUSCINOSIS, NEURONAL, 7; CLN7	Clinical Features	died	MFSD8	HGNC:28486	Ceroid lipofuscinosis, neuronal, 7, 610951 (3), Autosomal recessive	Autosomal recessive	y	y	[Stogmann et al. (2009) reported a consanguineous Egyptian family in which 5 members had late-infantile CLN. The average age at onset was 5 years, and all patients presented with seizures, including complex partial, secondary generalized tonic-clonic, and myoclonic jerks... Two patients died at age 13 years]	L5	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L5	L5	post-infant-lethal
610954	PITT-HOPKINS SYNDROME	Pitt-Hopkins syndrome, 610954 (3)	Pitt-Hopkins syndrome	y	PITT-HOPKINS SYNDROME; PTHS	Clinical Features	died	TCF4	HGNC:11634	Pitt-Hopkins syndrome, 610954 (3), Autosomal dominant	Autosomal dominant	y	y	Pitt and Hopkins (1978) described 2 unrelated patients with a sporadic disorder comprising mental retardation, wide mouth, and intermittent overbreathing... He died of pneumonia at the age of 20 years]	L6	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L6	L6	post-infant-lethal
610965	XFE PROGEROID SYNDROME	XFE progeroid syndrome, 610965 (3)	XFE progeroid syndrome	y	XFE PROGEROID SYNDROME; XFEPS	Clinical Features|Clinical Synopsis|Phenotype	died|death|deaths	ERCC4	HGNC:3436	XFE progeroid syndrome, 610965 (3), Autosomal recessive	Autosomal recessive	n	y	[Death at age 16]	L5	y	-	lethal	lethal	lethal	L4|L5	L4	post-infant-lethal
610967	OSTEOGENESIS IMPERFECTA, TYPE V	Osteogenesis imperfecta, type V, 610967 (3)	Osteogenesis imperfecta, type V	y	OSTEOGENESIS IMPERFECTA, TYPE V; OI5	Description	lethal	IFITM5	HGNC:16644	Osteogenesis imperfecta, type V, 610967 (3), Autosomal dominant	Autosomal dominant	y	n	-	-	-	-	ambiguous	ambiguous	ambiguous	-	-	-
610968	OSTEOGENESIS IMPERFECTA, TYPE XI	Osteogenesis imperfecta, type XI, 610968 (3)	Osteogenesis imperfecta, type XI	y	OSTEOGENESIS IMPERFECTA, TYPE XI; OI11	Phenotype	lethal	FKBP10	HGNC:18169	Osteogenesis imperfecta, type XI, 610968 (3), Autosomal recessive	Autosomal recessive	n	n	-	-	-	-	ambiguous	ambiguous|lethal	lethal	L6	L6	post-infant-lethal
610978	CHOREOATHETOSIS AND CONGENITAL HYPOTHYROIDISM WITH OR WITHOUT PULMONARY DYSFUNCTION	Choreoathetosis, hypothyroidism, and neonatal respiratory distress, 610978 (3)	Choreoathetosis, hypothyroidism, and neonatal respiratory distress	y	CHOREOATHETOSIS AND CONGENITAL HYPOTHYROIDISM WITH OR WITHOUT PULMONARY DYSFUNCTION; CAHTP	Clinical Features	died	NKX2-1	HGNC:11825	Choreoathetosis, hypothyroidism, and neonatal respiratory distress, 610978 (3), Autosomal dominant	Autosomal dominant	y	y	[Doyle et al. (2004) reported a 3-generation family in which 4 members had congenital hypothyroidism, neonatal respiratory distress, and ataxia... The maternal grandmother had a twin who died at birth of respiratory distress / Carre et al. (2009) reported the clinical spectrum of 46 patients from 28 families with NKX2-1 mutations... On follow-up, 5 (20%) of 25 developed severe chronic interstitial lung disease, and 4 (16%) of 25 died from respiratory failure or infant respiratory distress syndrome]	L2	y	y	lethal	lethal|nonlethal	lethal|nonlethal	L2	L2	pre-infant-lethal
610984	COMPLEMENT FACTOR I DEFICIENCY	Complement factor I deficiency, 610984 (3)	Complement factor I deficiency	y	COMPLEMENT FACTOR I DEFICIENCY; CFID	Clinical Features	died|fatal	CFI	HGNC:5394	Complement factor I deficiency, 610984 (3), Autosomal recessive	Autosomal recessive	y	y	[Baracho et al. (2003) reported 2 Brazilian sisters, born of consanguineous parents, with complement factor I deficiency. Both had complete absence of serum factor I and decreased levels of factor H (CFH; 134370), C3, and factor B. The older patient, who was 20 years of age, developed systemic lupus erythematosus (SLE; 152700) and glomerulonephritis, and had several infectious episodes during her childhood. The younger sister developed a severe intestinal infection that evolved to fatal sepsis at age 3 years]	L4	y	-	lethal	lethal	lethal	L4	L4	post-infant-lethal
611022	DEAFNESS, AUTOSOMAL RECESSIVE 24	Deafness, autosomal recessive 24, 611022 (3)	Deafness, autosomal recessive 24	n	-	-	-	RDX	HGNC:9944	Deafness, autosomal recessive 24, 611022 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
611038	MICROPHTHALMIA, SYNDROMIC 16	Microphthalmia, syndromic 16, 611038 (3)	Microphthalmia, syndromic 16	y	MICROPHTHALMIA, SYNDROMIC 16; MCOPS16	Clinical Features	died	RAX	HGNC:18662	Microphthalmia, syndromic 16, 611038 (3), Autosomal recessive	Autosomal recessive	y	y	[who had died in infancy]	L3	n	y	lethal	lethal	lethal	L3	L3	pre-infant-lethal
611040	MICROPHTHALMIA, ISOLATED 5	Microphthalmia, isolated 5, 611040 (3)	Microphthalmia, isolated 5	n	-	-	-	MFRP	HGNC:18121	Microphthalmia, isolated 5, 611040 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
611067	NEURONOPATHY, DISTAL HEREDITARY MOTOR, AUTOSOMAL RECESSIVE 4	Neuronopathy, distal hereditary motor, autosomal recessive 4, 611067 (3)	Neuronopathy, distal hereditary motor, autosomal recessive 4	n	-	-	-	PLEKHG5	HGNC:29105	Neuronopathy, distal hereditary motor, autosomal recessive 4, 611067 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
611087	POLYHYDRAMNIOS, MEGALENCEPHALY, AND SYMPTOMATIC EPILEPSY	Polyhydramnios, megalencephaly, and symptomatic epilepsy, 611087 (3)	Polyhydramnios, megalencephaly, and symptomatic epilepsy	y	POLYHYDRAMNIOS, MEGALENCEPHALY, AND SYMPTOMATIC EPILEPSY; PMSE	Clinical Features|Clinical Synopsis	death|deaths|died	STRADA	HGNC:30172	Polyhydramnios, megalencephaly, and symptomatic epilepsy, 611087 (3), Autosomal recessive	Autosomal recessive	y	y	[Puffenberger et al. (2007) studied 16 distantly related Old Order Mennonite children with a syndrome they designated PMSE for 'polyhydramnios, megalencephaly, and symptomatic epilepsy.'.. Six of the 16 children with PMSE syndrome died between ages 7 months and 6 years]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
611090	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 12	Intellectual developmental disorder, autosomal recessive 12, 611090 (3)	Intellectual developmental disorder, autosomal recessive 12	n	-	-	-	ST3GAL3	HGNC:10866	Intellectual developmental disorder, autosomal recessive 12, 611090 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
611091	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 5	Intellectual developmental disorder, autosomal recessive 5, 611091 (3)	Intellectual developmental disorder, autosomal recessive 5	n	-	-	-	NSUN2	HGNC:25994	Intellectual developmental disorder, autosomal recessive 5, 611091 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
611092	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 6	Intellectual developmental disorder, autosomal recessive 6, 611092 (3)	Intellectual developmental disorder, autosomal recessive 6	n	-	-	-	GRIK2	HGNC:4580	Intellectual developmental disorder, autosomal recessive 6, 611092 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
611093	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 7	Intellectual developmental disorder, autosomal recessive 7, 611093 (3)	Intellectual developmental disorder, autosomal recessive 7	n	-	-	-	TUSC3	HGNC:30242	Intellectual developmental disorder, autosomal recessive 7, 611093 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
611105	LEUKOENCEPHALOPATHY WITH BRAINSTEM AND SPINAL CORD INVOLVEMENT AND LACTATE ELEVATION	Leukoencephalopathy with brain stem and spinal cord involvement and lactate elevation, 611105 (3)	Leukoencephalopathy with brain stem and spinal cord involvement and lactate elevation	y	LEUKOENCEPHALOPATHY WITH BRAINSTEM AND SPINAL CORD INVOLVEMENT AND LACTATE ELEVATION; LBSL	Clinical Features	died|lethal	DARS2	HGNC:25538	Leukoencephalopathy with brain stem and spinal cord involvement and lactate elevation, 611105 (3), Autosomal recessive	Autosomal recessive	y	y	[Miyake et al. (2011) reported 3 Japanese sibs, born of consanguineous parents, with a severe form of LBSL due to a homozygous mutation in the DARS2 gene (610956.0012). The 21-year-old proband developed truncal ataxia at age 3 years, followed by nystagmus, slurred speech, tremor, muscle tonus abnormality, and mental retardation; he could speak only 1 or 2 words. Other features in the proband included peripheral muscle atrophy and weakness, joint contractures, hyporeflexia, and disrupted deep sensation. His 2 sibs, who showed onset before age 12 months, died in childhood of respiratory disease]	L4	y	-	lethal	lethal	lethal	L4	L4	post-infant-lethal
611126	MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 20	Mitochondrial complex I deficiency, nuclear type 20, 611126 (3)	Mitochondrial complex I deficiency, nuclear type 20	y	MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 20; MC1DN20	Clinical Features	died	ACAD9	HGNC:21497	Mitochondrial complex I deficiency, nuclear type 20, 611126 (3), Autosomal recessive	Autosomal recessive	y	y	[Haack et al. (2010) reported 4 patients, including 2 sibs, with mitochondrial complex I deficiency. In the 2 sibs, the sister presented soon after birth with cardiorespiratory depression, hypertrophic cardiomyopathy, encephalopathy, and severe lactic acidosis, and died at 46 days of age]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
611131	RETINITIS PIGMENTOSA 37	Retinitis pigmentosa 37, 611131 (3)	Retinitis pigmentosa 37	n	-	-	-	NR2E3	HGNC:7974	Retinitis pigmentosa 37, 611131 (3), Autosomal dominant, Autosomal recessive	Autosomal dominant, Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
611134	MECKEL SYNDROME, TYPE 4	Meckel syndrome 4, 611134 (3)	Meckel syndrome 4	y	MECKEL SYNDROME, TYPE 4; MKS4	Description|Clinical Synopsis	lethal	CEP290	HGNC:29021	Meckel syndrome 4, 611134 (3), Autosomal recessive	Autosomal recessive	n	y	[Lethal in utero or perinatal lethal]	L1	y	-	lethal	ambiguous|lethal|nonlethal	lethal|nonlethal	L1	L1	pre-infant-lethal
611174	HAMAMY SYNDROME	Hamamy syndrome, 611174 (3)	Hamamy syndrome	n	-	-	-	IRX5	HGNC:14361	Hamamy syndrome, 611174 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
611182	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIh	Congenital disorder of glycosylation, type IIh, 611182 (3)	Congenital disorder of glycosylation, type IIh	y	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIh; CDG2H	Clinical Features	died	COG8	HGNC:18623	Congenital disorder of glycosylation, type IIh, 611182 (3)	-	y	y	[Arora et al. (2019) reported a patient with CDG2H who showed antenatal findings: an increased nuchal translucency on a 12-week prenatal ultrasound; moderate unilateral ventriculomegaly, Dandy-Walker malformation, and bilateral joint contractures on a 28-week ultrasound; and fetal growth restriction, bilaterally dilated ventricles with dangling choroid plexuses, and Dandy-Walker malformation at 37 weeks' gestation. ... He died at day 2 of life. Autopsy revealed brain abnormalities, including absent corpus callosum, dilated ventricles, vermian agenesis, and enlarged cisternal magna. A similarly affected older sib died at 1 day of life]	L2	y	y	lethal	lethal	lethal	L2	L2	pre-infant-lethal
611209	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIg	Congenital disorder of glycosylation, type IIg, 611209 (3)	Congenital disorder of glycosylation, type IIg	n	-	-	-	COG1	HGNC:6545	Congenital disorder of glycosylation, type IIg, 611209 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
611225	SPASTIC PARAPLEGIA 18B, AUTOSOMAL RECESSIVE	Spastic paraplegia 18B, autosomal recessive, 611225 (3)	Spastic paraplegia 18B, autosomal recessive	n	-	-	-	ERLIN2	HGNC:1356	Spastic paraplegia 18B, autosomal recessive, 611225 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
611228	CHARCOT-MARIE-TOOTH DISEASE, TYPE 4J	Charcot-Marie-Tooth disease, type 4J, 611228 (3)	Charcot-Marie-Tooth disease, type 4J	n	-	-	-	FIG4	HGNC:16873	Charcot-Marie-Tooth disease, type 4J, 611228 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L3	L3	pre-infant-lethal
611263	SHORT-RIB THORACIC DYSPLASIA 2 WITH OR WITHOUT POLYDACTYLY	Short-rib thoracic dysplasia 2 with or without polydactyly, 611263 (3)	Short-rib thoracic dysplasia 2 with or without polydactyly	y	SHORT-RIB THORACIC DYSPLASIA 2 WITH OR WITHOUT POLYDACTYLY; SRTD2	Description|Clinical Features|Phenotype	lethal|miscarriage|miscarriages|stillborn	IFT80	HGNC:29262	Short-rib thoracic dysplasia 2 with or without polydactyly, 611263 (3), Autosomal recessive	Autosomal recessive	y	y	[Some forms of SRTD are lethal in the neonatal period due to respiratory insufficiency secondary to a severely restricted thoracic cage, whereas others are compatible with life (summary by Huber and Cormier-Daire, 2012 and Schmidts et al., 2013) / Bizaoui et al. (2019) reported 4 fetuses from 2 unrelated families with a clinical diagnosis of Beemer-Langer syndrome (see SRTD12, 269860) and mutations in the IFT80 gene. Family 1 was a consanguineous Pakistani family in which the first pregnancy ended in early miscarriage]	L1	y	-	lethal	lethal	lethal	L1	L1	pre-infant-lethal
611283	ISOBUTYRYL-CoA DEHYDROGENASE DEFICIENCY	Isobutyryl-CoA dehydrogenase deficiency, 611283 (3)	Isobutyryl-CoA dehydrogenase deficiency	n	-	-	-	ACAD8	HGNC:87	Isobutyryl-CoA dehydrogenase deficiency, 611283 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
611291	SEVERE COMBINED IMMUNODEFICIENCY WITH MICROCEPHALY, GROWTH RETARDATION, AND SENSITIVITY TO IONIZING RADIATION	Severe combined immunodeficiency with microcephaly, growth retardation, and sensitivity to ionizing radiation, 611291 (3)	Severe combined immunodeficiency with microcephaly, growth retardation, and sensitivity to ionizing radiation	y	SEVERE COMBINED IMMUNODEFICIENCY WITH MICROCEPHALY, GROWTH RETARDATION, AND SENSITIVITY TO IONIZING RADIATION	Clinical Features	lethal	NHEJ1	HGNC:25737	Severe combined immunodeficiency with microcephaly, growth retardation, and sensitivity to ionizing radiation, 611291 (3)	-	n	y	Buck et al. (2006) reported 5 patients in which SCID was associated with microcephaly and growth retardation. Severe growth retardation and dystrophy were observed in 4 of the 5 patients, and microcephaly was present in all 5 patients at birth. Dysmorphic features and various malformations were observed in 4 of the 5 patients. Recurrent infections occurred in all 5 patients and were lethal in 2. All 5 patients had hypogammaglobulinemia with severe B and T lymphocytopenia, but normal NK cell levels]	LU	y	-	lethal	lethal	lethal	LU	LU	post-infant-lethal
611302	SPASTIC ATAXIA 2, AUTOSOMAL RECESSIVE	Spastic ataxia 2, autosomal recessive, 611302 (3)	Spastic ataxia 2, autosomal recessive	n	-	-	-	KIF1C	HGNC:6317	Spastic ataxia 2, autosomal recessive, 611302 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
611307	MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 12	Muscular dystrophy, limb-girdle, autosomal recessive 12, 611307 (3)	Muscular dystrophy, limb-girdle, autosomal recessive 12	n	-	-	-	ANO5	HGNC:27337	Muscular dystrophy, limb-girdle, autosomal recessive 12, 611307 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
611363	ATRIAL SEPTAL DEFECT 4	Atrial septal defect 4, 611363 (3)	Atrial septal defect 4	y	ATRIAL SEPTAL DEFECT 4; ASD4	Clinical Features|Phenotype	died	TBX20	HGNC:11598	Atrial septal defect 4, 611363 (3)	-	n	y	[Kirk et al. (2007) identified 2 families with congenital heart defects, in which affected individuals displayed a complex spectrum of cardiac developmental abnormalities, including defects in septation, chamber growth, and valvulogenesis, and heterozygous mutation in the TBX20 gene. ... An older sister of the proband died at age 11 months because of congenital mitral valve stenosis associated with a small left ventricle and endocardial fibroelastosis. Another sister died at age 7 years of right heart failure due to severe primary pulmonary hypertension. A man from the earliest of 3 generations in this family, deceased at the time of report, had mitral valve disease]	L3	n	y	lethal	lethal	lethal	L3	L3	pre-infant-lethal
611369	LETHAL CONGENITAL CONTRACTURE SYNDROME 3	Lethal congenital contractural syndrome 3, 611369 (3)	Lethal congenital contractural syndrome 3	y	LETHAL CONGENITAL CONTRACTURE SYNDROME 3; LCCS3	Clinical Features|Clinical Synopsis	death|deaths|lethal	PIP5K1C	HGNC:8996	Lethal congenital contractural syndrome 3, 611369 (3), Autosomal recessive	Autosomal recessive	n	y	[Death due to respiratory insufficiency within minutes to hours after birth]	L2	y	-	lethal	lethal	lethal	L2	L2	pre-infant-lethal
611377	BRACHYDACTYLY, TYPE B2	Brachydactyly, type B2, 611377 (3)	Brachydactyly, type B2	n	-	-	-	NOG	HGNC:7866	Brachydactyly, type B2, 611377 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
611383	USHER SYNDROME, TYPE IID	Usher syndrome, type 2D, 611383 (3)	Usher syndrome, type 2D	n	-	-	-	WHRN	HGNC:16361	Usher syndrome, type 2D, 611383 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
611390	SPASTIC ATAXIA 3, AUTOSOMAL RECESSIVE	Spastic ataxia 3, autosomal recessive, 611390 (3)	Spastic ataxia 3, autosomal recessive	n	-	-	-	MARS2	HGNC:25133	Spastic ataxia 3, autosomal recessive, 611390 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
611391	CATARACT 33, MULTIPLE TYPES	Cataract 33, multiple types, 611391 (3)	Cataract 33, multiple types	n	-	-	-	BFSP1	HGNC:1040	Cataract 33, multiple types, 611391 (3), Autosomal dominant, Autosomal recessive	Autosomal dominant, Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
611407	CARDIOMYOPATHY, DILATED, 1W	Cardiomyopathy, dilated, 1W, 611407 (3)	Cardiomyopathy, dilated, 1W	y	CARDIOMYOPATHY, DILATED, 1W; CMD1W	Phenotype	died	VCL	HGNC:12665	Cardiomyopathy, dilated, 1W, 611407 (3)	-	n	n	-	-	-	-	ambiguous	ambiguous|lethal	lethal	LU	LU	post-infant-lethal
611431	LEGIUS SYNDROME	Legius syndrome, 611431 (3)	Legius syndrome	n	-	-	-	SPRED1	HGNC:20249	Legius syndrome, 611431 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
611489	CORTICOSTEROID-BINDING GLOBULIN DEFICIENCY	Corticosteroid-binding globulin deficiency, 611489 (3)	Corticosteroid-binding globulin deficiency	n	-	-	-	SERPINA6	HGNC:1540	Corticosteroid-binding globulin deficiency, 611489 (3), Autosomal dominant, Autosomal recessive	Autosomal dominant, Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
611490	OSTEOPETROSIS, AUTOSOMAL RECESSIVE 4	Osteopetrosis, autosomal recessive 4, 611490 (3)	Osteopetrosis, autosomal recessive 4	y	OSTEOPETROSIS, AUTOSOMAL RECESSIVE 4; OPTB4	Clinical Features	died	CLCN7	HGNC:2025	Osteopetrosis, autosomal recessive 4, 611490 (3), Autosomal recessive	Autosomal recessive	n	y	[Cleiren et al. (2001) reported a girl, born to second-cousin parents of Chinese ancestry, who presented at 3 months of age with Bell palsy. Radiographic skeletal survey revealed severe osteopetrosis and several nondisplaced oblique fractures. She had anemia, reticulocytosis, hepatosplenomegaly, and mild optic nerve atrophy. The child underwent a mismatched allogeneic marrow transplant but died at age 18 months from sepsis and respiratory failure]	L3	y	-	lethal	ambiguous|lethal|nonlethal	lethal|nonlethal	L3	L3	pre-infant-lethal
611493	ATRIAL FIBRILLATION, FAMILIAL, 4	Atrial fibrillation, familial, 4, 611493 (3)	Atrial fibrillation, familial, 4	n	-	-	-	KCNE2	HGNC:6242	Atrial fibrillation, familial, 4, 611493 (3)	-	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	LU	LU	post-infant-lethal
611498	NEPHRONOPHTHISIS 7	Nephronophthisis 7, 611498 (3)	Nephronophthisis 7	n	-	-	-	GLIS2	HGNC:29450	Nephronophthisis 7, 611498 (3)	-	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
611521	IMMUNODEFICIENCY 35	Immunodeficiency 35, 611521 (3)	Immunodeficiency 35	n	-	-	-	TYK2	HGNC:12440	Immunodeficiency 35, 611521 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
611523	PONTOCEREBELLAR HYPOPLASIA, TYPE 6	Pontocerebellar hypoplasia, type 6, 611523 (3)	Pontocerebellar hypoplasia, type 6	y	PONTOCEREBELLAR HYPOPLASIA, TYPE 6; PCH6	Clinical Features|Clinical Synopsis	died|death|deaths	RARS2	HGNC:21406	Pontocerebellar hypoplasia, type 6, 611523 (3), Autosomal recessive	Autosomal recessive	n	y	[Edvardson et al. (2007) investigated 3 patients, the products of a consanguineous Sephardic Jewish marriage, who had infantile encephalopathy and a putative defect in mitochondrial translation. The eldest of the 3 affected children showed generalized hypotonia and poor sucking at several hours of age, and brain magnetic imaging (MRI) at age 3 days showed cerebellar and vermian hypoplasia but normal brain volume. Recurrent apnea from age 1 week was controlled by phenobarbital, but intractable seizures starting at age 2 months were resistant to multidrug therapy. Microcephaly became evident at age 1 year. No developmental milestones were attained, and muscle tone became spastic. The results of funduscopic observations were normal. Serial brain MRI revealed progressive atrophy of the cerebellum, pons, cerebral cortex, and white matter. The patient died at age 16 months]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
611543	CAVITARY OPTIC DISC ANOMALIES	Cavitary optic disc anomalies, 611543 (3)	Cavitary optic disc anomalies	n	-	-	-	MMP19	HGNC:7165	Cavitary optic disc anomalies, 611543 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
611544	CATARACT 17, MULTIPLE TYPES	Cataract 17, multiple types, 611544 (3)	Cataract 17, multiple types	n	-	-	-	CRYBB1	HGNC:2397	Cataract 17, multiple types, 611544 (3), Autosomal dominant, Autosomal recessive	Autosomal dominant, Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
611548	PREMATURE OVARIAN FAILURE 5	Premature ovarian failure 5, 611548 (3)	Premature ovarian failure 5	n	-	-	-	NOBOX	HGNC:22448	Premature ovarian failure 5, 611548 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
611553	NOONAN SYNDROME 5	Noonan syndrome 5, 611553 (3)	Noonan syndrome 5	n	-	-	-	RAF1	HGNC:9829	Noonan syndrome 5, 611553 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
611554	LEOPARD SYNDROME 2	LEOPARD syndrome 2, 611554 (3)	LEOPARD syndrome 2	n	-	-	-	RAF1	HGNC:9829	LEOPARD syndrome 2, 611554 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
611556	GLYCOGEN STORAGE DISEASE 0, MUSCLE	Glycogen storage disease 0, muscle, 611556 (3)	Glycogen storage disease 0, muscle	y	GLYCOGEN STORAGE DISEASE 0, MUSCLE; GSD0B	Clinical Features|Clinical Synopsis|Phenotype	death|deaths|died	GYS1	HGNC:4706	Glycogen storage disease 0, muscle, 611556 (3), Autosomal recessive	Autosomal recessive	y	y	[Cameron et al. (2009) reported an 8-year-old boy, born to consanguineous parents of South Indian ancestry, who died suddenly while exercising with classmates at school. He had been healthy and had no history of exercise intolerance. At autopsy, the heart appeared structurally normal, with appropriate size, weight, and ventricular wall thickness; however, skeletal muscle showed evidence suggestive of an underlying mitochondrial abnormality, with proliferation of mitochondria, pre-ragged-red fibers, and type 1 fiber predominance. Cytochrome oxidase activity was preserved, but mitochondrial ultrastructure appeared to be abnormal, and glycogen stores were depleted. Some cardiac mitochondria appeared to have an abnormal ultrastructure similar to that seen in skeletal muscle. Family history revealed a sister who had died at 6 days of life of undetermined cause]	L2	y	y	lethal	lethal	lethal	L2	L2	pre-infant-lethal
611560	JOUBERT SYNDROME 7	Joubert syndrome 7, 611560 (3)	Joubert syndrome 7	y	JOUBERT SYNDROME 7; JBTS7	Clinical Features	died	RPGRIP1L	HGNC:29168	Joubert syndrome 7, 611560 (3), Autosomal recessive	Autosomal recessive	n	y	[Brancati et al. (2008) identified homozygous mutations in the RPGRIP1L gene in 2 (12%) of 16 families with the cerebello-renal type of Joubert syndrome... She died at age 17.5 years from renal failure, while he was still alive at age 22 years after kidney transplant. Both had the molar tooth sign on MRI]	L5	y	-	lethal	lethal	lethal	L1|L5	L1	pre-infant-lethal
611561	MECKEL SYNDROME, TYPE 5	Meckel syndrome 5, 611561 (3)	Meckel syndrome 5	y	MECKEL SYNDROME, TYPE 5; MKS5	Clinical Synopsis	death|deaths	RPGRIP1L	HGNC:29168	Meckel syndrome 5, 611561 (3), Autosomal recessive	Autosomal recessive	n	y	[Prenatal or perinatal death]	L1	y	-	lethal	lethal	lethal	L1|L5	L1	pre-infant-lethal
611584	WAARDENBURG SYNDROME, TYPE 2E	Waardenburg syndrome, type 2E, with or without neurologic involvement, 611584 (3)	Waardenburg syndrome, type 2E, with or without neurologic involvement	n	-	-	-	SOX10	HGNC:11190	Waardenburg syndrome, type 2E, with or without neurologic involvement, 611584 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L2	L2	pre-infant-lethal
611588	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 4	Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 4, 611588 (3)	Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 4	n	-	-	-	FKTN	HGNC:3622	Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 4, 611588 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L2|L5	L2	pre-infant-lethal
611590	RENAL TUBULAR ACIDOSIS, DISTAL, 4, WITH HEMOLYTIC ANEMIA	Distal renal tubular acidosis 4 with hemolytic anemia, 611590 (3)	Distal renal tubular acidosis 4 with hemolytic anemia	n	-	-	-	SLC4A1	HGNC:11027	Distal renal tubular acidosis 4 with hemolytic anemia, 611590 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	ambiguous|lethal|nonlethal	lethal|nonlethal	L6	L6	post-infant-lethal
611597	CATARACT 12, MULTIPLE TYPES	Cataract 12, multiple types, 611597 (3)	Cataract 12, multiple types	n	-	-	-	BFSP2	HGNC:1041	Cataract 12, multiple types, 611597 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
611603	LISSENCEPHALY 3	Lissencephaly 3, 611603 (3)	Lissencephaly 3	n	-	-	-	TUBA1A	HGNC:20766	Lissencephaly 3, 611603 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
611615	CARDIOMYOPATHY, DILATED, 1X	Cardiomyopathy, dilated, 1X, 611615 (3)	Cardiomyopathy, dilated, 1X	y	CARDIOMYOPATHY, DILATED, 1X; CMD1X	Clinical Features	died	FKTN	HGNC:3622	Cardiomyopathy, dilated, 1X, 611615 (3), Autosomal recessive	Autosomal recessive	n	y	[Murakami et al. (2006) described 6 Japanese patients from 4 families with dilated cardiomyopathy and mild or no limb-girdle muscle involvement, normal intelligence, and no history of seizures. One patient died at age 12 years from rapidly progressive CMD, and another underwent cardiac transplantation at age 18 years]	L5	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L2|L5	L2	pre-infant-lethal
611638	MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 5	Microphthalmia with coloboma 5, 611638 (3)	Microphthalmia with coloboma 5	n	-	-	-	SHH	HGNC:10848	Microphthalmia with coloboma 5, 611638 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L3	L3	pre-infant-lethal
611705	CONGENITAL MYOPATHY 5 WITH CARDIOMYOPATHY	Congenital myopathy 5 with cardiomyopathy, 611705 (3)	Congenital myopathy 5 with cardiomyopathy	y	CONGENITAL MYOPATHY 5 WITH CARDIOMYOPATHY; CMYP5	Description|Clinical Features|Clinical Synopsis|Phenotype	death|deaths|fatal|lethal	TTN	HGNC:12403	Congenital myopathy 5 with cardiomyopathy, 611705 (3), Autosomal recessive	Autosomal recessive	y	y	[Sudden death due to cardiomyopathy may occur]	LU	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L6|LU	L6	post-infant-lethal
611719	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 5	Combined oxidative phosphorylation deficiency 5, 611719 (3)	Combined oxidative phosphorylation deficiency 5	y	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 5; COXPD5	Clinical Features|Clinical Synopsis	died|death|deaths	MRPS22	HGNC:14508	Combined oxidative phosphorylation deficiency 5, 611719 (3), Autosomal recessive	Autosomal recessive	n	y	[Death often in first months of life / Saada et al. (2007) reported 3 sibs, born of consanguineous parents, with antenatal onset of a severe mitochondrial disorder. Late in gestation, ultrasound showed generalized edema, especially of the neck, labia, and palms, with prominent subcutaneous edema and ascites at birth. Laboratory investigations showed severe lactic acidemia and increased serum ammonia. Hypertrophic cardiomyopathy and tubulopathy developed within the first week, and the infants died within the first month of life]	L2	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L2	L2	pre-infant-lethal
611721	COMBINED SAPOSIN DEFICIENCY	Combined SAP deficiency, 611721 (3)	Combined SAP deficiency	y	COMBINED SAPOSIN DEFICIENCY; PSAPD	Description|Clinical Features|Clinical Synopsis|Phenotype	fatal|death|deaths|died	PSAP	HGNC:9498	Combined SAP deficiency, 611721 (3), Autosomal recessive	Autosomal recessive	y	y	[Kuchar et al. (2009) reported a male infant with combined saposin deficiency. Directly after birth, the child had treatment-resistant clonic movements and poor feeding. By 4 weeks, he developed hypotonia, myoclonus, and hepatosplenomegaly. He also had atrophic optic discs, and brain imaging showed a thin corpus callosum, bilateral absence of the gyrus cinguli, and periventricular white matter abnormalities. Various tissue samples showed generalized lysosomal storage accumulation, and enzymatic studies showed reduced activity of glucosylceramidase and more markedly reduced activity of galactosylceramidase. Urinary analysis revealed an elevation of a number of glycosphingolipids, with globotriaosylceramide showing the greatest increase. Persistent seizures and respiratory infections led to death at age 55 days]	L3	y	-	lethal	lethal	lethal	L3|L4|L5	L3	pre-infant-lethal
611722	KRABBE DISEASE, ATYPICAL, DUE TO SAPOSIN A DEFICIENCY	Krabbe disease, atypical, 611722 (3)	Krabbe disease, atypical	y	KRABBE DISEASE, ATYPICAL, DUE TO SAPOSIN A DEFICIENCY; KRBSAPA	Clinical Features|Clinical Synopsis	died|death|deaths	PSAP	HGNC:9498	Krabbe disease, atypical, 611722 (3), Autosomal recessive	Autosomal recessive	y	y	[Spiegel et al. (2005) reported a child, born of consanguineous Arab parents, with saposin A deficiency. She developed normally until age 3.5 months, at which time she showed rapid neurologic deterioration and loss of acquired milestones. At age 6 months, she was almost in a vegetative state without eye contact and with little spontaneous movement. Muscle tone was increased, but reflexes were depressed. Brain imaging showed generalized brain atrophy and diffuse white matter dysmyelination. CSF protein was increased. She died 2 months later of central apnea and respiratory failure]	L3	y	-	lethal	lethal	lethal	L3|L4|L5	L3	pre-infant-lethal
611726	EPILEPSY, PROGRESSIVE MYOCLONIC, 3, WITH OR WITHOUT INTRACELLULAR INCLUSIONS	Epilepsy, progressive myoclonic 3, with or without intracellular inclusions, 611726 (3)	Epilepsy, progressive myoclonic 3, with or without intracellular inclusions	y	EPILEPSY, PROGRESSIVE MYOCLONIC, 3, WITH OR WITHOUT INTRACELLULAR INCLUSIONS; EPM3	Clinical Features	died	KCTD7	HGNC:21957	Epilepsy, progressive myoclonic 3, with or without intracellular inclusions, 611726 (3), Autosomal recessive	Autosomal recessive	n	y	[Staropoli et al. (2012) reported 2 Mexican sibs with onset of severe intractable myoclonic seizures at ages 9 and 8 months, respectively, after normal development... Both sibs died from complications of progressive disease in their mid-teen]	L5	y	-	lethal	lethal	lethal	L5	L5	post-infant-lethal
611755	LEBER CONGENITAL AMAUROSIS 10	Leber congenital amaurosis 10, 611755 (3)	Leber congenital amaurosis 10	y	LEBER CONGENITAL AMAUROSIS 10; LCA10	Clinical Features	death|deaths	CEP290	HGNC:29021	Leber congenital amaurosis 10, 611755 (3)	-	n	n	-	-	-	-	ambiguous	ambiguous|lethal|nonlethal	lethal|nonlethal	L1	L1	pre-infant-lethal
611762	FAMILIAL COLD AUTOINFLAMMATORY SYNDROME 2	Familial cold autoinflammatory syndrome 2, 611762 (3)	Familial cold autoinflammatory syndrome 2	n	-	-	-	NLRP12	HGNC:22938	Familial cold autoinflammatory syndrome 2, 611762 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
611771	LIPOPROTEIN GLOMERULOPATHY	Lipoprotein glomerulopathy, 611771 (3)	Lipoprotein glomerulopathy	n	-	-	-	APOE	HGNC:613	Lipoprotein glomerulopathy, 611771 (3)	-	-	-	-	-	-	-	nonlethal	ambiguous|nonlethal	ambiguous	-	-	-
611773	ANGIOPATHY, HEREDITARY, WITH NEPHROPATHY, ANEURYSMS, AND MUSCLE CRAMPS	Angiopathy, hereditary, with nephropathy, aneurysms, and muscle cramps, 611773 (3)	Angiopathy, hereditary, with nephropathy, aneurysms, and muscle cramps	n	-	-	-	COL4A1	HGNC:2202	Angiopathy, hereditary, with nephropathy, aneurysms, and muscle cramps, 611773 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L1|L6	L1	pre-infant-lethal
611777	BRUGADA SYNDROME 2	Brugada syndrome 2, 611777 (3)	Brugada syndrome 2	y	BRUGADA SYNDROME 2; BRGDA2	Description|Clinical Features|Clinical Synopsis|Phenotype	death|deaths|died	GPD1L	HGNC:28956	Brugada syndrome 2, 611777 (3), Autosomal dominant	Autosomal dominant	n	y	[Brugada syndrome is characterized by an ST segment elevation in the right precordial electrocardiogram leads (so-called type 1 ECG) and a high incidence of sudden death in patients with structurally normal hearts. The syndrome typically manifests during adulthood, with a mean age of sudden death of 41 +/- 15 years, but also occurs in infants and children / Van Norstrand et al. (2007) analyzed the GPD1L gene in necropsy tissue from 83 unrelated cases of sudden unexplained death and identified a mutation (E83K; 611778.0002) in a boy who died at 3 months of age. Mutation analysis was then performed on genomic DNA derived from 221 cases of sudden infant death syndrome (SIDS; 272120), revealing 2 additional mutations, in a girl who died at 5 weeks (I124K; 611778.0003) and a boy who died at 1 month of age (R273C; 611778.0004), respectively / *** In Molecular genetics]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
611783	ERYTHROCYTOSIS, FAMILIAL, 4	Erythrocytosis, familial, 4, 611783 (3)	Erythrocytosis, familial, 4	n	-	-	-	EPAS1	HGNC:3374	Erythrocytosis, familial, 4, 611783 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
611788	AORTIC ANEURYSM, FAMILIAL THORACIC 6	Aortic aneurysm, familial thoracic 6, 611788 (3)	Aortic aneurysm, familial thoracic 6	y	AORTIC ANEURYSM, FAMILIAL THORACIC 6; AAT6	Clinical Features	death|deaths|died|fatal	ACTA2	HGNC:130	Aortic aneurysm, familial thoracic 6, 611788 (3), Autosomal dominant	Autosomal dominant	y	y	The majority of individuals with AAT6 studied by Guo et al. (2007) presented with acute ascending (type A) or descending (type B) aortic dissections, and 16 of the 24 deaths were due to type A dissections. Two individuals experienced type A dissections with documented ascending aortic diameters at 4.5 and 4.6 cm, whereas 11 individuals dissected at aortic diameters greater than 5.0 cm. Aortic dissections occurred in 3 individuals under 20 years of age, and 2 women died of dissections postpartum]	L5	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L3|L5	L3	pre-infant-lethal
611804	ELLIPTOCYTOSIS 1	Elliptocytosis-1, 611804 (3)	Elliptocytosis-1	y	ELLIPTOCYTOSIS 1; EL1	Clinical Features	died|stillborn	EPB41	HGNC:3377	Elliptocytosis-1, 611804 (3), Autosomal dominant, Autosomal recessive	Autosomal dominant, Autosomal recessive	n	y	[Nielsen and Strunk (1968) described a Dutch family in which, among the 7 offspring of related parents, both with elliptocytosis, 2 died in infancy of severe anemia; a third had erythrocytes that showed more marked morphologic changes than in heterozygotes and had severe anemia which was compensated by splenectomy. All 3 were presumably homozygotes. Three other sibs were heterozygotes and one was stillborn / Nielsen and Strunk (1968) described a Dutch family in which, among the 7 offspring of related parents, both with elliptocytosis, 2 died in infancy of severe anemia; a third had erythrocytes that showed more marked morphologic changes than in heterozygotes and had severe anemia which was compensated by splenectomy]	L1	y	y	lethal	lethal	lethal	L1	L1	pre-infant-lethal
611809	BESTROPHINOPATHY, AUTOSOMAL RECESSIVE	Bestrophinopathy, autosomal recessive, 611809 (3)	Bestrophinopathy, autosomal recessive	n	-	-	-	BEST1	HGNC:12703	Bestrophinopathy, autosomal recessive, 611809 (3)	-	-	-	-	-	-	-	nonlethal	ambiguous|nonlethal	ambiguous	-	-	-
611816	TEMPLE-BARAITSER SYNDROME	Temple-Baraitser syndrome, 611816 (3)	Temple-Baraitser syndrome	n	-	-	-	KCNH1	HGNC:6250	Temple-Baraitser syndrome, 611816 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
611818	LONG QT SYNDROME 9	Long QT syndrome 9, 611818 (3)	Long QT syndrome 9	y	LONG QT SYNDROME 9; LQT9	Description|Clinical Synopsis|Phenotype	death|deaths	CAV3	HGNC:1529	Long QT syndrome 9, 611818 (3), Autosomal dominant	Autosomal dominant	y	y	[Sudden unexplained infant death (SIDS) reported in some patients / Cronk et al. (2007) analyzed the CAV3 gene in necropsy tissue from 134 unrelated cases of sudden infant death syndrome (SIDS; 272120) and identified 3 missense mutations in 3 of 50 black infants (601253.0018; 601253.0020; 601253.0021)]	LU	y	-	lethal	lethal|nonlethal	lethal|nonlethal	LU	LU	post-infant-lethal
611819	LONG QT SYNDROME 10	Atrial fibrillation, familial, 17, 611819 (3)	Atrial fibrillation, familial, 17	y	LONG QT SYNDROME 10; LQT10	Clinical Features|Clinical Synopsis	death|deaths	SCN4B	HGNC:10592	Atrial fibrillation, familial, 17, 611819 (3), Autosomal dominant	Autosomal dominant	n	y	[Medeiros-Domingo et al. (2007) reported a 5-year-old Mexican mestizo girl who at 21 months of age was found to have asymptomatic bradycardia with rates less than 60 bpm. An ECG revealed profound QT prolongation with a QTc of 712 ms and intermittent 2:1 AV block; during 1:1 conduction, macroscopic T-wave alternans was observed. The patient's medical history included fetal bradycardia noted at 24 weeks of gestation and a small ventricular septal defect that spontaneously closed by 6 months of age. She remained asymptomatic after placement of an epicardial pacemaker. She had 2 paternal great aunts who had sudden cardiac death, 1 at age 35 years after delivery of twins and 1 at age 8 years during exercise]	L4	n	y	lethal	lethal	lethal	L4	L4	post-infant-lethal
611819	LONG QT SYNDROME 10	Long QT syndrome 10, 611819 (3)	Long QT syndrome 10	y	LONG QT SYNDROME 10; LQT10	Clinical Features|Clinical Synopsis	death|deaths	SCN4B	HGNC:10592	Long QT syndrome 10, 611819 (3), Autosomal dominant	Autosomal dominant	n	y	[Medeiros-Domingo et al. (2007) reported a 5-year-old Mexican mestizo girl who at 21 months of age was found to have asymptomatic bradycardia with rates less than 60 bpm. An ECG revealed profound QT prolongation with a QTc of 712 ms and intermittent 2:1 AV block; during 1:1 conduction, macroscopic T-wave alternans was observed. The patient's medical history included fetal bradycardia noted at 24 weeks of gestation and a small ventricular septal defect that spontaneously closed by 6 months of age. She remained asymptomatic after placement of an epicardial pacemaker. She had 2 paternal great aunts who had sudden cardiac death, 1 at age 35 years after delivery of twins and 1 at age 8 years during exercise]	L4	n	y	lethal	lethal	lethal	L4	L4	post-infant-lethal
611875	BRUGADA SYNDROME 3	Brugada syndrome 3, 611875 (3)	Brugada syndrome 3	y	BRUGADA SYNDROME 3; BRGDA3	Description|Clinical Features|Clinical Synopsis	death|deaths|died	CACNA1C	HGNC:1390	Brugada syndrome 3, 611875 (3), Autosomal dominant	Autosomal dominant	n	y	[Brugada syndrome is characterized by an ST segment elevation in the right precordial electrocardiogram leads (so-called type 1 ECG) and a high incidence of sudden death in patients with structurally normal hearts. The syndrome typically manifests during adulthood, with a mean age of sudden death of 41 +/- 15 years, but also occurs in infants and children /]	L5	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L4|L5	L4	post-infant-lethal
611876	BRUGADA SYNDROME 4	Brugada syndrome 4, 611876 (3)	Brugada syndrome 4	y	BRUGADA SYNDROME 4; BRGDA4	Description|Clinical Features|Clinical Synopsis	death|deaths|died	CACNB2	HGNC:1402	Brugada syndrome 4, 611876 (3), Autosomal dominant	Autosomal dominant	n	y	[Brugada syndrome is characterized by an ST segment elevation in the right precordial electrocardiogram leads (so-called type 1 ECG) and a high incidence of sudden death in patients with structurally normal hearts. The syndrome typically manifests during adulthood, with a mean age of sudden death of 41 +/- 15 years, but also occurs in infants and children]	L5	y	-	lethal	lethal	lethal	L5	L5	post-infant-lethal
611878	CARDIOMYOPATHY, DILATED, 1Y	Cardiomyopathy, dilated, 1Y, 611878 (3)	Cardiomyopathy, dilated, 1Y	y	CARDIOMYOPATHY, DILATED, 1Y; CMD1Y	Description|Clinical Features|Clinical Synopsis	death|deaths|died|fatal	TPM1	HGNC:12010	Cardiomyopathy, dilated, 1Y, 611878 (3), Autosomal dominant	Autosomal dominant	n	y	[Nijak et al. (2018) studied a family in which 2 sisters had LVNC and EA. The more severely affected sister developed progressive heart failure and died at age 3.5 years, while awaiting transplantation]	L4	y	-	lethal	lethal	lethal	L4|LU	L4	post-infant-lethal
611878	CARDIOMYOPATHY, DILATED, 1Y	Left ventricular noncompaction 9, 611878 (3)	Left ventricular noncompaction 9	y	CARDIOMYOPATHY, DILATED, 1Y; CMD1Y	Description|Clinical Features|Clinical Synopsis	death|deaths|died|fatal	TPM1	HGNC:12010	Left ventricular noncompaction 9, 611878 (3), Autosomal dominant	Autosomal dominant	n	y	[Nijak et al. (2018) studied a family in which 2 sisters had LVNC and EA. The more severely affected sister developed progressive heart failure and died at age 3.5 years, while awaiting transplantation]	L4	y	-	lethal	lethal	lethal	L4|LU	L4	post-infant-lethal
611879	CARDIOMYOPATHY, DILATED, 1Z	Cardiomyopathy, dilated, 1Z, 611879 (3)	Cardiomyopathy, dilated, 1Z	y	CARDIOMYOPATHY, DILATED, 1Z; CMD1Z	Clinical Features|Clinical Synopsis|Phenotype	death|deaths|demise|died|miscarriage|miscarriages|stillbirth|stillbirths|stillborn	TNNC1	HGNC:11943	Cardiomyopathy, dilated, 1Z, 611879 (3), Autosomal dominant	Autosomal dominant	y	y	[Mogensen et al. (2004) studied a 3-generation family with severe dilated cardiomyopathy in which the proband had sudden onset of heart failure at 21 years of age and underwent cardiac transplantation 2 months later. His mother died at 45 years of age awaiting cardiac transplantation, his maternal grandfather died of heart failure at 62 years of age after 8 months of medical treatment, and a maternal aunt had unexplained sudden death at 21 years of age]	L6	y	y	lethal	ambiguous|lethal	lethal	L6	L6	post-infant-lethal
611881	GLYCOGEN STORAGE DISEASE XII	Glycogen storage disease XII, 611881 (3)	Glycogen storage disease XII	n	-	-	-	ALDOA	HGNC:414	Glycogen storage disease XII, 611881 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
611884	CILIARY DYSKINESIA, PRIMARY, 7	Ciliary dyskinesia, primary, 7, with or without situs inversus, 611884 (3)	Ciliary dyskinesia, primary, 7, with or without situs inversus	n	-	-	-	DNAH11	HGNC:2942	Ciliary dyskinesia, primary, 7, with or without situs inversus, 611884 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
611890	CONGENITAL ARTHROGRYPOSIS WITH ANTERIOR HORN CELL DISEASE	Congenital arthrogryposis with anterior horn cell disease, 611890 (3)	Congenital arthrogryposis with anterior horn cell disease	y	CONGENITAL ARTHROGRYPOSIS WITH ANTERIOR HORN CELL DISEASE; CAAHD	Description|Clinical Features|Clinical Synopsis|Phenotype	death|deaths|die|fatal|lethal|died|stillborn	GLE1	HGNC:4315	Congenital arthrogryposis with anterior horn cell disease, 611890 (3), Autosomal recessive	Autosomal recessive	n	y	[Vuopala et al. (1995) described 15 infants from 11 Finnish families with a phenotype of lethal arthrogryposis and anterior horn motor neuron loss. The clinical presentation was the fetal akinesia deformation sequence (FADS) with multiple contractures and facial anomalies. The phenotype was uniform with low-set ears, hypoplastic jaw, short neck, and contractures. Malpositions in the extremities were moderate, distal, and inwardly spiral. The mean gestational age was 34 weeks, with 8 infants being born at term. Most of the cases were perinatal lethal; 3 infants were stillborn, 5 died within 1 hour, 6 died within a few days, and 1 survived for 20 days]	L1	y	-	lethal	lethal	lethal	L1	L1	pre-infant-lethal
611895	AMYOTROPHIC LATERAL SCLEROSIS 9	Amyotrophic lateral sclerosis 9, 611895 (3)	Amyotrophic lateral sclerosis 9	n	-	-	-	ANG	HGNC:483	Amyotrophic lateral sclerosis 9, 611895 (3)	-	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
611938	VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 2	Ventricular tachycardia, catecholaminergic polymorphic, 2, 611938 (3)	Ventricular tachycardia, catecholaminergic polymorphic, 2	y	VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 2; CPVT2	Clinical Features|Clinical Synopsis	death|deaths	CASQ2	HGNC:1513	Ventricular tachycardia, catecholaminergic polymorphic, 2, 611938 (3), Autosomal recessive	Autosomal recessive	y	y	[Lahat et al. (2001) studied 41 members of 7 families from a highly inbred Bedouin tribe in northern Israel in which 9 children had unexplained sudden death]	L4	y	-	lethal	lethal	lethal	L4	L4	post-infant-lethal
611943	RIDDLE SYNDROME	RIDDLE syndrome, 611943 (3)	RIDDLE syndrome	y	RIDDLE SYNDROME; RIDL	Clinical Features	death|deaths	RNF168	HGNC:26661	RIDDLE syndrome, 611943 (3), Autosomal recessive	Autosomal recessive	y	y	[Devgan et al. (2011) reported a Turkish man, born of unrelated parents, who presented with short stature and mild ataxia at age 16 years. He had microcephaly but displayed displayed normal intelligence. Other features included conjunctival telangiectasia, recurrent sinus infections, decreased serum IgA, and increased alpha-fetoprotein. At age 29 years, the patient presented with progressive pulmonary failure that resulted in death at age 30]	L6	y	-	lethal	lethal	lethal	L6	L6	post-infant-lethal
612004	THROMBOCYTOPENIA 4	Thrombocytopenia 4, 612004 (3)	Thrombocytopenia 4	n	-	-	-	CYCS	HGNC:19986	Thrombocytopenia 4, 612004 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
612015	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE In	Congenital disorder of glycosylation, type In, 612015 (3)	Congenital disorder of glycosylation, type In	y	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE In; CDG1N	Clinical Features	died	RFT1	HGNC:30220	Congenital disorder of glycosylation, type In, 612015 (3), Autosomal recessive	Autosomal recessive	n	y	[Vleugels et al. (2009) reported 3 unrelated children with CDG1N. One was of Scottish descent, the second was born of consanguineous Italian parents, and the third was born of consanguineous Algerian parents. All were severely affected and presented in infancy with feeding difficulties and failure to thrive. Dysmorphic features were somewhat variable, but included microcephaly, micrognathia, short neck, adducted thumbs, valgus foot deformities, and inverted nipples. All had severe mental retardation with limited development, hypotonia, seizures, myoclonic jerks, decreased visual acuity, and sensorineural deafness. One patient died at age 8 months]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
612016	COENZYME Q10 DEFICIENCY, PRIMARY, 4	Coenzyme Q10 deficiency, primary, 4, 612016 (3)	Coenzyme Q10 deficiency, primary, 4	y	COENZYME Q10 DEFICIENCY, PRIMARY, 4; COQ10D4	Clinical Features	died	COQ8A	HGNC:16812	Coenzyme Q10 deficiency, primary, 4, 612016 (3), Autosomal recessive	Autosomal recessive	y	y	[Traschutz et al. (2020) reported the clinical features in 59 patients with COQ10D4... A few patients had a comparatively severe disease trajectory, including one patient (P31) who never learned to walk due to severe motor and cognitive impairment and eventually developed drug-resistant epilepsy and tetraparesis, and another patient (P24) who had intractable seizures and died at age 17 years of dilated cardiomyopathy]	L5	y	-	lethal	lethal	lethal	L5	L5	post-infant-lethal
612018	CATARACT 47	Cataract 47, juvenile, with microcornea, 612018 (3)	Cataract 47, juvenile, with microcornea	n	-	-	-	SLC16A12	HGNC:23094	Cataract 47, juvenile, with microcornea, 612018 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
612020	SPASTIC PARAPLEGIA 39, AUTOSOMAL RECESSIVE	Spastic paraplegia 39, autosomal recessive, 612020 (3)	Spastic paraplegia 39, autosomal recessive	n	-	-	-	PNPLA6	HGNC:16268	Spastic paraplegia 39, autosomal recessive, 612020 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
612042	RECOMBINATION RATE QUANTITATIVE TRAIT LOCUS 1	Recombination rate QTL 1, 612042 (3)	Recombination rate QTL 1	n	-	-	-	RNF212	HGNC:27729	Recombination rate QTL 1, 612042 (3)	-	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
612067	DYSTONIA 16	Dystonia 16, 612067 (3)	Dystonia 16	n	-	-	-	PRKRA	HGNC:9438	Dystonia 16, 612067 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
612069	AMYOTROPHIC LATERAL SCLEROSIS 10 WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA	Amyotrophic lateral sclerosis 10, with or without FTD, 612069 (3)	Amyotrophic lateral sclerosis 10, with or without FTD	y	AMYOTROPHIC LATERAL SCLEROSIS 10 WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA; ALS10	Clinical Features	death|deaths|died	TARDBP	HGNC:11571	Amyotrophic lateral sclerosis 10, with or without FTD, 612069 (3), Autosomal dominant	Autosomal dominant	n	y	[The mean age of symptoms onset was 47 years (range 44 to 52). Mean disease duration was 5.5 years (range 4 to 7) from symptom onset to death]	L6	y	-	lethal	lethal	lethal	L6	L6	post-infant-lethal
612069	AMYOTROPHIC LATERAL SCLEROSIS 10 WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA	Frontotemporal lobar degeneration, TARDBP-related, 612069 (3)	Frontotemporal lobar degeneration, TARDBP-related	y	AMYOTROPHIC LATERAL SCLEROSIS 10 WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA; ALS10	Clinical Features	death|deaths|died	TARDBP	HGNC:11571	Frontotemporal lobar degeneration, TARDBP-related, 612069 (3), Autosomal dominant	Autosomal dominant	n	y	[The mean age of symptoms onset was 47 years (range 44 to 52). Mean disease duration was 5.5 years (range 4 to 7) from symptom onset to death]	L6	y	-	lethal	lethal	lethal	L6	L6	post-infant-lethal
612073	MITOCHONDRIAL DNA DEPLETION SYNDROME 5 (ENCEPHALOMYOPATHIC WITH OR WITHOUT METHYLMALONIC ACIDURIA)	Mitochondrial DNA depletion syndrome 5 (encephalomyopathic with or without methylmalonic aciduria), 612073 (3)	Mitochondrial DNA depletion syndrome 5 (encephalomyopathic with or without methylmalonic aciduria)	y	MITOCHONDRIAL DNA DEPLETION SYNDROME 5 (ENCEPHALOMYOPATHIC WITH OR WITHOUT METHYLMALONIC ACIDURIA); MTDPS5	Clinical Features	died	SUCLA2	HGNC:11448	Mitochondrial DNA depletion syndrome 5 (encephalomyopathic with or without methylmalonic aciduria), 612073 (3), Autosomal recessive	Autosomal recessive	n	y	[Carrozzo et al. (2007) also reported 11 patients from 8 related families in the Faroe Islands with neonatal onset of encephalomyopathy. Ten of the patients were in the report of Ostergaard et al. (2007) (Chinnery, 2007). Affected patients had feeding problems since birth and showed failure to thrive. Other features included severe muscle hypotonia with progressive areflexia, profound motor developmental delay, and none learned to sit or stand without support. They had progressive neurologic deterioration from the age of 12 to 14 months, and developed a hyperkinetic-dystonic movement disorder with external ophthalmoplegia. All developed profound sensorineural deafness. One had seizures, 2 had polyneuropathy, 1 had mild cardiomyopathy, and 1 had renal tubular dysfunction. Six patients died as children due to infection]	L4	y	-	lethal	lethal	lethal	L4	L4	post-infant-lethal
612075	MITOCHONDRIAL DNA DEPLETION SYNDROME 8A (ENCEPHALOMYOPATHIC TYPE WITH RENAL TUBULOPATHY)	Mitochondrial DNA depletion syndrome 8A (encephalomyopathic type with renal tubulopathy), 612075 (3)	Mitochondrial DNA depletion syndrome 8A (encephalomyopathic type with renal tubulopathy)	y	MITOCHONDRIAL DNA DEPLETION SYNDROME 8A (ENCEPHALOMYOPATHIC TYPE WITH RENAL TUBULOPATHY); MTDPS8A	Clinical Features|Clinical Synopsis|Phenotype	death|deaths|died|fatal	RRM2B	HGNC:17296	Mitochondrial DNA depletion syndrome 8A (encephalomyopathic type with renal tubulopathy), 612075 (3), Autosomal recessive	Autosomal recessive	y	y	[Kollberg et al. (2009) reported 2 Sudanese brothers, born of consanguineous parents, with a severe form of fatal autosomal recessive encephalomyopathic mtDNA depletion syndrome. The older brother presented at age 2 months with feeding difficulties, failure to thrive, hypotonia, lactic acidosis, and massive aminoaciduria consistent with a renal proximal tubulopathy. He also had poor visual contact and developed seizures. The disorder progressed rapidly, and he died of respiratory insufficiency at the age of 3 months]	L3	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L3|L4	L3	pre-infant-lethal
612075	MITOCHONDRIAL DNA DEPLETION SYNDROME 8A (ENCEPHALOMYOPATHIC TYPE WITH RENAL TUBULOPATHY)	Mitochondrial DNA depletion syndrome 8B (MNGIE type), 612075 (3)	Mitochondrial DNA depletion syndrome 8B (MNGIE type)	y	MITOCHONDRIAL DNA DEPLETION SYNDROME 8A (ENCEPHALOMYOPATHIC TYPE WITH RENAL TUBULOPATHY); MTDPS8A	Clinical Features|Clinical Synopsis|Phenotype	death|deaths|died|fatal	RRM2B	HGNC:17296	Mitochondrial DNA depletion syndrome 8B (MNGIE type), 612075 (3), Autosomal recessive	Autosomal recessive	y	y	[Kollberg et al. (2009) reported 2 Sudanese brothers, born of consanguineous parents, with a severe form of fatal autosomal recessive encephalomyopathic mtDNA depletion syndrome. The older brother presented at age 2 months with feeding difficulties, failure to thrive, hypotonia, lactic acidosis, and massive aminoaciduria consistent with a renal proximal tubulopathy. He also had poor visual contact and developed seizures. The disorder progressed rapidly, and he died of respiratory insufficiency at the age of 3 months]	L3	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L3|L4	L3	pre-infant-lethal
612076	HYPOURICEMIA, RENAL, 2	Hypouricemia, renal, 2, 612076 (3)	Hypouricemia, renal, 2	n	-	-	-	SLC2A9	HGNC:13446	Hypouricemia, renal, 2, 612076 (3), Autosomal dominant, Autosomal recessive	Autosomal dominant, Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
612095	RETINITIS PIGMENTOSA 41	Retinitis pigmentosa 41, 612095 (3)	Retinitis pigmentosa 41	n	-	-	-	PROM1	HGNC:9454	Retinitis pigmentosa 41, 612095 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	ambiguous|nonlethal	ambiguous	-	-	-
612098	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 11	Cardiomyopathy, hypertrophic, 11, 612098 (3)	Cardiomyopathy, hypertrophic, 11	y	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 11; CMH11	Clinical Features	death|deaths	ACTC1	HGNC:143	Cardiomyopathy, hypertrophic, 11, 612098 (3), Autosomal dominant	Autosomal dominant	y	n	-	-	-	-	ambiguous	ambiguous|nonlethal	ambiguous	-	-	-
612109	OCULOAURICULAR SYNDROME	Oculoauricular syndrome, 612109 (3)	Oculoauricular syndrome	n	-	-	-	HMX1	HGNC:5017	Oculoauricular syndrome, 612109 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
612119	TREHALASE DEFICIENCY	Trehalase deficiency, 612119 (3)	Trehalase deficiency	n	-	-	-	TREH	HGNC:12266	Trehalase deficiency, 612119 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
612124	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 12	Cardiomyopathy, hypertrophic, 12, 612124 (3)	Cardiomyopathy, hypertrophic, 12	y	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 12; CMH12	Clinical Features|Clinical Synopsis|Phenotype	death|deaths	CSRP3	HGNC:2472	Cardiomyopathy, hypertrophic, 12, 612124 (3), Autosomal dominant	Autosomal dominant	n	y	[Geier et al. (2008) reported the clinical characteristics of affected individuals from 5 CMH families with mutations in the CSRP3 gene, 3 of which had been previously studied by Geier et al. (2003). Most affected persons had pronounced hypertrophy and reported onset of symptoms in young adulthood. A history of sudden death was present in 2 families]	LU	y	-	lethal	lethal	lethal	LU	LU	post-infant-lethal
612126	GLUT1 DEFICIENCY SYNDROME 2	GLUT1 deficiency syndrome 2, childhood onset, 612126 (3)	GLUT1 deficiency syndrome 2, childhood onset	n	-	-	-	SLC2A1	HGNC:11005	GLUT1 deficiency syndrome 2, childhood onset, 612126 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
612132	ECTODERMAL DYSPLASIA AND IMMUNODEFICIENCY 2	Ectodermal dysplasia and immunodeficiency 2, 612132 (3)	Ectodermal dysplasia and immunodeficiency 2	y	ECTODERMAL DYSPLASIA AND IMMUNODEFICIENCY 2; EDAID2	Clinical Features	death|deaths|died	NFKBIA	HGNC:7797	Ectodermal dysplasia and immunodeficiency 2, 612132 (3), Autosomal dominant	Autosomal dominant	y	y	[Lopez-Granados et al. (2008) reported a male infant with anhidrotic ectodermal dysplasia and T-cell immunodeficiency. He had failure to thrive, developed multiple infections including gastrointestinal and respiratory infections, and died at age 9 months from complications of a cord blood transplant]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
612138	EPIDERMOLYSIS BULLOSA SIMPLEX 5C, WITH PYLORIC ATRESIA	Epidermolysis bullosa simplex 5C, with pyloric atresia, 612138 (3)	Epidermolysis bullosa simplex 5C, with pyloric atresia	y	EPIDERMOLYSIS BULLOSA SIMPLEX 5C, WITH PYLORIC ATRESIA; EBS5C	Description|Clinical Features|Clinical Synopsis|Phenotype	death|deaths|died|lethal	PLEC	HGNC:9069	Epidermolysis bullosa simplex 5C, with pyloric atresia, 612138 (3), Autosomal recessive	Autosomal recessive	y	y	[Nakamura et al. (2005) reported 3 patients from 2 unrelated families with EBSPA. In the first family, 2 brothers were born with multiple blisters and ulcers on all areas of the body. Pyloric atresia was apparent by ultrasound during the pregnancies. Both died at ages 16 and 4 months, respectively]	L3	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L2|L3|L6	L2	pre-infant-lethal
612158	CARDIOMYOPATHY, DILATED, 1AA, WITH OR WITHOUT LEFT VENTRICULAR NONCOMPACTION	Cardiomyopathy, dilated, 1AA, with or without LVNC, 612158 (3)	Cardiomyopathy, dilated, 1AA, with or without LVNC	y	CARDIOMYOPATHY, DILATED, 1AA, WITH OR WITHOUT LEFT VENTRICULAR NONCOMPACTION; CMD1AA	Clinical Features|Clinical Synopsis|Phenotype	death|deaths|died	ACTN2	HGNC:164	Cardiomyopathy, dilated, 1AA, with or without LVNC, 612158 (3), Autosomal dominant	Autosomal dominant	n	y	[Mohapatra et al. (2003) reported a 7-year-old girl who died of dilated cardiomyopathy only a few weeks after the onset of symptoms]	L4	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L4	L4	post-infant-lethal
612158	CARDIOMYOPATHY, DILATED, 1AA, WITH OR WITHOUT LEFT VENTRICULAR NONCOMPACTION	Cardiomyopathy, hypertrophic, 23, with or without LVNC, 612158 (3)	Cardiomyopathy, hypertrophic, 23, with or without LVNC	y	CARDIOMYOPATHY, DILATED, 1AA, WITH OR WITHOUT LEFT VENTRICULAR NONCOMPACTION; CMD1AA	Clinical Features|Clinical Synopsis|Phenotype	death|deaths|died	ACTN2	HGNC:164	Cardiomyopathy, hypertrophic, 23, with or without LVNC, 612158 (3), Autosomal dominant	Autosomal dominant	n	y	[Mohapatra et al. (2003) reported a 7-year-old girl who died of dilated cardiomyopathy only a few weeks after the onset of symptoms]	L4	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L4	L4	post-infant-lethal
612164	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 4	Developmental and epileptic encephalopathy 4, 612164 (3)	Developmental and epileptic encephalopathy 4	y	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 4; DEE4	Clinical Features	died	STXBP1	HGNC:11444	Developmental and epileptic encephalopathy 4, 612164 (3), Autosomal dominant, Autosomal recessive	Autosomal dominant, Autosomal recessive	y	y	[Carvill et al. (2014) reported 3 unrelated patients with DEE4, who were clinically diagnosed with Dravet syndrome. T... One severely affected patient showed cerebral atrophy on brain MRI, and the other severely affected patient died at age 11 years]	L5	y	-	lethal	lethal	lethal	L5	L5	post-infant-lethal
612199	CEREBRORETINAL MICROANGIOPATHY WITH CALCIFICATIONS AND CYSTS 1	Cerebroretinal microangiopathy with calcifications and cysts, 612199 (3)	Cerebroretinal microangiopathy with calcifications and cysts	y	CEREBRORETINAL MICROANGIOPATHY WITH CALCIFICATIONS AND CYSTS 1; CRMCC1	Clinical Features|Phenotype	died|lethal	CTC1	HGNC:26169	Cerebroretinal microangiopathy with calcifications and cysts, 612199 (3), Autosomal recessive	Autosomal recessive	y	y	[Toiviainen-Salo et al. (2011) specifically addressed the skeletal phenotype of 9 unrelated Finnish patients with CRMCC, including 8 who had been reported by Linnankivi et al. (2006) and 1 novel patient. The patients ranged in age from 4 to 31 years, and 6 had died between ages 6 and 31]	L4	y	-	lethal	lethal	lethal	L4	L4	post-infant-lethal
612201	ATRIAL FIBRILLATION, FAMILIAL, 6	Atrial fibrillation, familial, 6, 612201 (3)	Atrial fibrillation, familial, 6	n	-	-	-	NPPA	HGNC:7939	Atrial fibrillation, familial, 6, 612201 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	LU	LU	post-infant-lethal
612219	EWING SARCOMA	Ewing sarcoma, 612219 (3)	Ewing sarcoma	n	-	-	-	EWSR1	HGNC:3508	Ewing sarcoma, 612219 (3)	-	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
612219	EWING SARCOMA	Neuroepithelioma, 612219 (3)	Neuroepithelioma	n	-	-	-	EWSR1	HGNC:3508	Neuroepithelioma, 612219 (3)	-	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
612225	MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 9	Maturity-onset diabetes of the young, type IX, 612225 (3)	Maturity-onset diabetes of the young, type IX	n	-	-	-	PAX4	HGNC:8618	Maturity-onset diabetes of the young, type IX, 612225 (3)	-	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
612233	LEUKODYSTROPHY, HYPOMYELINATING, 4	Leukodystrophy, hypomyelinating, 4, 612233 (3)	Leukodystrophy, hypomyelinating, 4	y	LEUKODYSTROPHY, HYPOMYELINATING, 4; HLD4	Clinical Features|Clinical Synopsis	death|deaths|died|lethal|fatal	HSPD1	HGNC:5261	Leukodystrophy, hypomyelinating, 4, 612233 (3), Autosomal recessive	Autosomal recessive	n	y	[Magen et al. (2008) reported a large consanguineous Israeli Bedouin family with an autosomal recessive form of severe hypomyelinating leukoencephalopathy. Ten patients were examined in detail. All had onset between birth and age 3 months of hypotonia, nystagmus, and psychomotor developmental delay, followed by appearance of prominent spasticity, developmental arrest, and regression. Head circumference, which was normal at birth, showed decreased growth rate. Seizures were reported in 6 patients. Feeding problems commonly led to malnutrition and growth failure. Death usually occurred within the first 2 decades of life from aspiration pneumonia or sudden death of unknown cause. One patient presented with hydrops fetalis and died at age 2 years. Patients with the more severe course died before the age of 2 years, with some patients never gaining social eye contact or any other developmental milestone]	L3	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L3	L3	pre-infant-lethal
612237	CHONDROSARCOMA, EXTRASKELETAL MYXOID	Chondrosarcoma, extraskeletal myxoid, 612237 (3)	Chondrosarcoma, extraskeletal myxoid	y	CHONDROSARCOMA, EXTRASKELETAL MYXOID	Clinical Features	died	NR4A3	HGNC:7982	Chondrosarcoma, extraskeletal myxoid, 612237 (3)	-	n	y	[Hisaoka et al. (2004) reported a 41-year-old Japanese man who had a local excision for EMC in his right sole at age 36 years, and amputation of the right foot because of local recurrence 2 years later. He developed metastases in the lung and popliteal fossa and died 6 years after surgery for the metastases]	L6	y	-	lethal	lethal	lethal	L6	L6	post-infant-lethal
612240	ATRIAL FIBRILLATION, FAMILIAL, 7	Atrial fibrillation, familial, 7, 612240 (3)	Atrial fibrillation, familial, 7	n	-	-	-	KCNA5	HGNC:6224	Atrial fibrillation, familial, 7, 612240 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
612247	CROUZON SYNDROME WITH ACANTHOSIS NIGRICANS	Crouzon syndrome with acanthosis nigricans, 612247 (3)	Crouzon syndrome with acanthosis nigricans	n	-	-	-	FGFR3	HGNC:3690	Crouzon syndrome with acanthosis nigricans, 612247 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L2|L3	L2	pre-infant-lethal
612260	IMMUNODEFICIENCY 68	Immunodeficiency 68, 612260 (3)	Immunodeficiency 68	y	IMMUNODEFICIENCY 68; IMD68	Description|Clinical Features|Clinical Synopsis|Phenotype	death|deaths|died	MYD88	HGNC:7562	Immunodeficiency 68, 612260 (3), Autosomal recessive	Autosomal recessive	y	y	[Von Bernuth et al. (2008) reported 9 children from 2 consanguineous and 3 nonconsanguineous kindreds with IMD68. The families originated from France, Turkey, Portugal, and Spain. In infancy, the children developed life-threatening, often recurrent, pyogenic bacterial infections, including invasive pneumococcal meningitis. Other organisms included Pseudomonas and Staphylococcus aureus. Many patients had upper respiratory infections, such as pharyngitis, adenitis, and deep tissue abscesses. The patients had a poor inflammatory response to the infections, with no fever and low white blood cell counts. C-reactive protein levels were variable. Three children died between 1 and 11 months of age, and the 6 surviving children were between 3 and 16 years of age]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
612281	ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 6	Ichthyosis, congenital, autosomal recessive 6, 612281 (3)	Ichthyosis, congenital, autosomal recessive 6	n	-	-	-	NIPAL4	HGNC:28018	Ichthyosis, congenital, autosomal recessive 6, 612281 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
612284	MECKEL SYNDROME, TYPE 6	Meckel syndrome 6, 612284 (3)	Meckel syndrome 6	y	MECKEL SYNDROME, TYPE 6; MKS6	Clinical Synopsis	lethal	CC2D2A	HGNC:29253	Meckel syndrome 6, 612284 (3), Autosomal recessive	Autosomal recessive	y	y	[Lethal in utero or perinatal lethal]	L1	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L1	L1	pre-infant-lethal
612285	JOUBERT SYNDROME 9	Joubert syndrome 9, 612285 (3)	Joubert syndrome 9	n	-	-	-	CC2D2A	HGNC:29253	Joubert syndrome 9, 612285 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L1	L1	pre-infant-lethal
612286	NEPHROLITHIASIS/OSTEOPOROSIS, HYPOPHOSPHATEMIC, 1	Nephrolithiasis/osteoporosis, hypophosphatemic, 1, 612286 (3)	Nephrolithiasis/osteoporosis, hypophosphatemic, 1	n	-	-	-	SLC34A1	HGNC:11019	Nephrolithiasis/osteoporosis, hypophosphatemic, 1, 612286 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
612287	NEPHROLITHIASIS/OSTEOPOROSIS, HYPOPHOSPHATEMIC, 2	Nephrolithiasis/osteoporosis, hypophosphatemic, 2, 612287 (3)	Nephrolithiasis/osteoporosis, hypophosphatemic, 2	n	-	-	-	NHERF1	HGNC:11075	Nephrolithiasis/osteoporosis, hypophosphatemic, 2, 612287 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
612289	FONTAINE PROGEROID SYNDROME	Fontaine progeroid syndrome, 612289 (3)	Fontaine progeroid syndrome	y	FONTAINE PROGEROID SYNDROME; FPS	Description|Clinical Features|Clinical Synopsis|Phenotype	death|deaths|died|lethality|demise	SLC25A24	HGNC:20662	Fontaine progeroid syndrome, 612289 (3), Autosomal dominant	Autosomal dominant	y	y	[Castori et al. (2009) described a male infant born with marked IUGR and oligohydramnios, for which he was delivered by cesarean section at 32 weeks' gestation. At birth he was cyanotic and hypotonic, with severe respiratory distress, and he died at 20 hours after birth from cardiopulmonary failure / Writzl et al. (2017) studied 2 boys and 2 girls with a progeroid appearance... All 4 patients died within the first year of life: patients 3 and 4 from respiratory distress, at 7 hours and 20 hours after birth, respectively; patient 1 from pulmonary hypertension at age 6 months; and patient 2 from sepsis at age 7 months]	L2	y	-	lethal	lethal	lethal	L2	L2	pre-infant-lethal
612290	MICROTIA, HEARING IMPAIRMENT, AND CLEFT PALATE	Microtia with or without hearing impairment (AD), 612290 (3)	Microtia with or without hearing impairment (AD)	n	-	-	-	HOXA2	HGNC:5103	Microtia with or without hearing impairment (AD), 612290 (3), Autosomal dominant, Autosomal recessive	Autosomal dominant, Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
612291	JOUBERT SYNDROME 8	Joubert syndrome 8, 612291 (3)	Joubert syndrome 8	n	-	-	-	ARL13B	HGNC:25419	Joubert syndrome 8, 612291 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
612292	BIRK-BAREL SYNDROME	Birk-Barel syndrome, 612292 (3)	Birk-Barel syndrome	n	-	-	-	KCNK9	HGNC:6283	Birk-Barel syndrome, 612292 (3)	-	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
612300	HEMOLYTIC ANEMIA, CD59-MEDIATED, WITH OR WITHOUT IMMUNE-MEDIATED POLYNEUROPATHY	Hemolytic anemia, CD59-mediated, with or without immune-mediated polyneuropathy, 612300 (3)	Hemolytic anemia, CD59-mediated, with or without immune-mediated polyneuropathy	y	HEMOLYTIC ANEMIA, CD59-MEDIATED, WITH OR WITHOUT IMMUNE-MEDIATED POLYNEUROPATHY; HACD59	Clinical Features	died	CD59	HGNC:1689	Hemolytic anemia, CD59-mediated, with or without immune-mediated polyneuropathy, 612300 (3), Autosomal recessive	Autosomal recessive	n	y	[Nevo et al. (2013) reported 5 children from 4 unrelated families of North African Jewish descent who presented with infantile onset of relapsing immune-mediated polyneuropathy and chronic hemolysis. One of the families was consanguineous... One patient died of acute respiratory failure at age 3.5 years]	L4	y	-	lethal	lethal	lethal	L4	L4	post-infant-lethal
612301	OSTEOPETROSIS, AUTOSOMAL RECESSIVE 7	Osteopetrosis, autosomal recessive 7, 612301 (3)	Osteopetrosis, autosomal recessive 7	y	OSTEOPETROSIS, AUTOSOMAL RECESSIVE 7; OPTB7	Clinical Synopsis	death|deaths	TNFRSF11A	HGNC:11908	Osteopetrosis, autosomal recessive 7, 612301 (3), Autosomal recessive	Autosomal recessive	n	y	[Death in first years of life (in some patients)]	L4	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L4	L4	post-infant-lethal
612304	THROMBOPHILIA DUE TO PROTEIN C DEFICIENCY, AUTOSOMAL RECESSIVE	Thrombophilia 3 due to protein C deficiency, autosomal recessive, 612304 (3)	Thrombophilia 3 due to protein C deficiency, autosomal recessive	y	THROMBOPHILIA DUE TO PROTEIN C DEFICIENCY, AUTOSOMAL RECESSIVE; THPH4	Clinical Features|Clinical Synopsis|Phenotype	death|deaths|died|lethal|fatal	PROC	HGNC:9451	Thrombophilia 3 due to protein C deficiency, autosomal recessive, 612304 (3), Autosomal recessive	Autosomal recessive	n	y	[Newborn deaths]	L2	y	-	lethal	ambiguous|lethal	lethal	L2	L2	pre-infant-lethal
612310	PREMATURE OVARIAN FAILURE 6	Premature ovarian failure 6, 612310 (3)	Premature ovarian failure 6	n	-	-	-	FIGLA	HGNC:24669	Premature ovarian failure 6, 612310 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
612313	GLASS SYNDROME	Glass syndrome, 612313 (3)	Glass syndrome	n	-	-	-	SATB2	HGNC:21637	Glass syndrome, 612313 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
612319	SPASTIC PARAPLEGIA 35, AUTOSOMAL RECESSIVE, WITH OR WITHOUT NEURODEGENERATION	Spastic paraplegia 35, autosomal recessive, 612319 (3)	Spastic paraplegia 35, autosomal recessive	y	SPASTIC PARAPLEGIA 35, AUTOSOMAL RECESSIVE, WITH OR WITHOUT NEURODEGENERATION; SPG35	Clinical Features	died	FA2H	HGNC:21197	Spastic paraplegia 35, autosomal recessive, 612319 (3), Autosomal recessive	Autosomal recessive	y	y	[Kruer et al. (2010) reported 3 Italian brothers from a consanguineous family who presented with gait impairment and frequent falls due to spastic paraplegia between ages 4 and 5 years. The disorder was progressive, with later development of ataxia, dysmetria, spastic quadriparesis, optic atrophy, ocular apraxia, dysarthria, and scoliosis. Two died from respiratory complications in their late twenties, and 1 developed seizures]	L6	y	y	lethal	lethal	lethal	L6	L6	post-infant-lethal
612336	THROMBOPHILIA DUE TO PROTEIN S DEFICIENCY, AUTOSOMAL DOMINANT	Thrombophilia 5 due to protein S deficiency, autosomal dominant, 612336 (3)	Thrombophilia 5 due to protein S deficiency, autosomal dominant	n	-	-	-	PROS1	HGNC:9456	Thrombophilia 5 due to protein S deficiency, autosomal dominant, 612336 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L2	L2	pre-infant-lethal
612337	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 22	Intellectual developmental disorder, autosomal dominant 22, 612337 (3)	Intellectual developmental disorder, autosomal dominant 22	n	-	-	-	ZBTB18	HGNC:13030	Intellectual developmental disorder, autosomal dominant 22, 612337 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
612347	JERVELL AND LANGE-NIELSEN SYNDROME 2	Jervell and Lange-Nielsen syndrome 2, 612347 (3)	Jervell and Lange-Nielsen syndrome 2	y	JERVELL AND LANGE-NIELSEN SYNDROME 2; JLNS2	Clinical Synopsis	death|deaths	KCNE1	HGNC:6240	Jervell and Lange-Nielsen syndrome 2, 612347 (3), Autosomal recessive	Autosomal recessive	n	y	[Sudden cardiac death]	LU	y	-	lethal	lethal	lethal	LU	LU	post-infant-lethal
612350	EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 3	Ehlers-Danlos syndrome, spondylodysplastic type, 3, 612350 (3)	Ehlers-Danlos syndrome, spondylodysplastic type, 3	n	-	-	-	SLC39A13	HGNC:20859	Ehlers-Danlos syndrome, spondylodysplastic type, 3, 612350 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
612356	HEPARIN COFACTOR II DEFICIENCY	Thrombophilia 10 due to heparin cofactor II deficiency, 612356 (3)	Thrombophilia 10 due to heparin cofactor II deficiency	n	-	-	-	SERPIND1	HGNC:4838	Thrombophilia 10 due to heparin cofactor II deficiency, 612356 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
612370	HYPOGONADOTROPIC HYPOGONADISM 5 WITH OR WITHOUT ANOSMIA	Hypogonadotropic hypogonadism 5 with or without anosmia, 612370 (3)	Hypogonadotropic hypogonadism 5 with or without anosmia	n	-	-	-	CHD7	HGNC:20626	Hypogonadotropic hypogonadism 5 with or without anosmia, 612370 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L2	L2	pre-infant-lethal
612379	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Iq	Congenital disorder of glycosylation, type Iq, 612379 (3)	Congenital disorder of glycosylation, type Iq	n	-	-	-	SRD5A3	HGNC:25812	Congenital disorder of glycosylation, type Iq, 612379 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
612389	PONTOCEREBELLAR HYPOPLASIA, TYPE 2B	Pontocerebellar hypoplasia type 2B, 612389 (3)	Pontocerebellar hypoplasia type 2B	y	PONTOCEREBELLAR HYPOPLASIA, TYPE 2B; PCH2B	Clinical Features|Clinical Synopsis	died|die	TSEN2	HGNC:28422	Pontocerebellar hypoplasia type 2B, 612389 (3), Autosomal recessive	Autosomal recessive	n	y	[Bierhals et al. (2013) reported a 4-year-old German boy with PCH2B. At birth, he showed microcephaly (-3.54 SD) and a receding forehead with overlapping cranial sutures. He had poor sucking and intermittent opisthotonus. At age 3.5 months, his microcephaly had progressed (-6.8 SD), and brain imaging showed simplified gyration with a thin corpus callosum, cerebral atrophy, enlarged ventricles, and hypoplasia of the brainstem, cerebellum, and cerebellar vermis, creating a 'dragonfly-like' pattern. At age 8 months, he developed an epileptic encephalopathy with refractory myoclonic and tonic seizures. He was unable to fix or follow visually and had axial hypotonia, limb hypertonia, and extensor plantar responses. At age 3 years, his head circumference was -11.4 SD and he showed severe spasticity with hyperkinetic involuntary movements. He died at age 4 years, 6 months]	L4	y	-	lethal	lethal	lethal	L4	L4	post-infant-lethal
612394	BONE FRAGILITY WITH CONTRACTURES, ARTERIAL RUPTURE, AND DEAFNESS	Lysyl hydroxylase 3 deficiency, 612394 (3)	Lysyl hydroxylase 3 deficiency	y	BONE FRAGILITY WITH CONTRACTURES, ARTERIAL RUPTURE, AND DEAFNESS; BCARD	Clinical Features	stillborn	PLOD3	HGNC:9083	Lysyl hydroxylase 3 deficiency, 612394 (3), Autosomal recessive	Autosomal recessive	y	y	[Salo et al. (2008) described a female proband with a novel connective tissue disorder secondary to lysyl hydroxylase-3 (LH3) deficiency ... A male sib was stillborn at 28 weeks' gestation. Intrauterine growth retardation complicated the pregnancy. Autopsy revealed a porencephalic cyst with dilation of the cerebral ventricles]	L1	n	y	lethal	lethal	lethal	L1	L1	pre-infant-lethal
612416	FACTOR XI DEFICIENCY	Factor XI deficiency, autosomal dominant, 612416 (3)	Factor XI deficiency, autosomal dominant	y	FACTOR XI DEFICIENCY	Clinical Features	death|deaths	F11	HGNC:3529	Factor XI deficiency, autosomal dominant, 612416 (3)	-	n	y	[Clarkson et al. (1991) described a 54-year-old white man who acquired factor XI deficiency from a liver transplant performed for chronic active hepatitis secondary to hepatitis B infection. The donor of the liver was of Ashkenazi Jewish descent and had a history of bleeding after dental procedures. Before his death from intracerebral bleeding, he had been shown to have an isolated prolonged PTT value]	L6	y	-	lethal	lethal	lethal	L6	L6	post-infant-lethal
612416	FACTOR XI DEFICIENCY	Factor XI deficiency, autosomal recessive, 612416 (3)	Factor XI deficiency, autosomal recessive	y	FACTOR XI DEFICIENCY	Clinical Features	death|deaths	F11	HGNC:3529	Factor XI deficiency, autosomal recessive, 612416 (3)	-	n	y	[Clarkson et al. (1991) described a 54-year-old white man who acquired factor XI deficiency from a liver transplant performed for chronic active hepatitis secondary to hepatitis B infection. The donor of the liver was of Ashkenazi Jewish descent and had a history of bleeding after dental procedures. Before his death from intracerebral bleeding, he had been shown to have an isolated prolonged PTT value]	L6	y	-	lethal	lethal	lethal	L6	L6	post-infant-lethal
612422	CARDIOMYOPATHY, FAMILIAL RESTRICTIVE, 3	Cardiomyopathy, familial restrictive, 3, 612422 (3)	Cardiomyopathy, familial restrictive, 3	y	CARDIOMYOPATHY, FAMILIAL RESTRICTIVE, 3; RCM3	Phenotype	death|deaths	TNNT2	HGNC:11949	Cardiomyopathy, familial restrictive, 3, 612422 (3), Autosomal dominant	Autosomal dominant	n	n	-	-	-	-	ambiguous	ambiguous|lethal	lethal	L3|L5	L3	pre-infant-lethal
612423	PREKALLIKREIN DEFICIENCY	Fletcher factor (prekallikrein) deficiency, 612423 (3)	Fletcher factor (prekallikrein) deficiency	n	-	-	-	KLKB1	HGNC:6371	Fletcher factor (prekallikrein) deficiency, 612423 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
612431	DEAFNESS, AUTOSOMAL DOMINANT 27	Deafness, autosomal dominant 27, 612431 (3)	Deafness, autosomal dominant 27	n	-	-	-	REST	HGNC:9966	Deafness, autosomal dominant 27, 612431 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
612437	EPILEPSY, PROGRESSIVE MYOCLONIC, 1B	Epilepsy, progressive myoclonic 1B, 612437 (3)	Epilepsy, progressive myoclonic 1B	n	-	-	-	PRICKLE1	HGNC:17019	Epilepsy, progressive myoclonic 1B, 612437 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
612438	LEUKODYSTROPHY, HYPOMYELINATING, 6	Leukodystrophy, hypomyelinating, 6, 612438 (3)	Leukodystrophy, hypomyelinating, 6	n	-	-	-	TUBB4A	HGNC:20774	Leukodystrophy, hypomyelinating, 6, 612438 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	ambiguous|nonlethal	ambiguous	-	-	-
612444	CILIARY DYSKINESIA, PRIMARY, 9	Ciliary dyskinesia, primary, 9, with or without situs inversus, 612444 (3)	Ciliary dyskinesia, primary, 9, with or without situs inversus	n	-	-	-	DNAI2	HGNC:18744	Ciliary dyskinesia, primary, 9, with or without situs inversus, 612444 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
612446	COMPLEMENT COMPONENT 6 DEFICIENCY	C6 deficiency, 612446 (3)	C6 deficiency	n	-	-	-	C6	HGNC:1339	C6 deficiency, 612446 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
612462	PSEUDOHYPOPARATHYROIDISM, TYPE IC	Pseudohypoparathyroidism Ic, 612462 (3)	Pseudohypoparathyroidism Ic	n	-	-	-	GNAS	HGNC:4392	Pseudohypoparathyroidism Ic, 612462 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L3	L3	pre-infant-lethal
612463	PSEUDOPSEUDOHYPOPARATHYROIDISM	Pseudopseudohypoparathyroidism, 612463 (3)	Pseudopseudohypoparathyroidism	n	-	-	-	GNAS	HGNC:4392	Pseudopseudohypoparathyroidism, 612463 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L3	L3	pre-infant-lethal
612518	CILIARY DYSKINESIA, PRIMARY, 10	Ciliary dyskinesia, primary, 10, 612518 (3)	Ciliary dyskinesia, primary, 10	n	-	-	-	DNAAF2	HGNC:20188	Ciliary dyskinesia, primary, 10, 612518 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
612520	TYPE 1 DIABETES MELLITUS 20	Diabetes mellitus, insulin-dependent, 20, 612520 (3)	Diabetes mellitus, insulin-dependent, 20	n	-	-	-	HNF1A	HGNC:11621	Diabetes mellitus, insulin-dependent, 20, 612520 (3)	-	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	LU	LU	post-infant-lethal
612526	LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 3	Lipodystrophy, congenital generalized, type 3, 612526 (3)	Lipodystrophy, congenital generalized, type 3	y	LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 3; CGL3	Phenotype	death|deaths	CAV1	HGNC:1527	Lipodystrophy, congenital generalized, type 3, 612526 (3), Autosomal recessive	Autosomal recessive	y	n	-	-	-	-	ambiguous	ambiguous|lethal	lethal	L4|L6	L4	post-infant-lethal
612527	DIAMOND-BLACKFAN ANEMIA 4	Diamond-Blackfan anemia 4, 612527 (3)	Diamond-Blackfan anemia 4	n	-	-	-	RPS17	HGNC:10397	Diamond-Blackfan anemia 4, 612527 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
612528	DIAMOND-BLACKFAN ANEMIA 5	Diamond-Blackfan anemia 5, 612528 (3)	Diamond-Blackfan anemia 5	n	-	-	-	RPL35A	HGNC:10345	Diamond-Blackfan anemia 5, 612528 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
612529	AMELOGENESIS IMPERFECTA, HYPOMATURATION TYPE, IIA2	Amelogenesis imperfecta, type IIA2, 612529 (3)	Amelogenesis imperfecta, type IIA2	n	-	-	-	MMP20	HGNC:7167	Amelogenesis imperfecta, type IIA2, 612529 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
612539	SPASTIC PARAPLEGIA 42, AUTOSOMAL DOMINANT	Spastic paraplegia 42, autosomal dominant, 612539 (3)	Spastic paraplegia 42, autosomal dominant	n	-	-	-	SLC33A1	HGNC:95	Spastic paraplegia 42, autosomal dominant, 612539 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L3	L3	pre-infant-lethal
612541	NEUTROPENIA, SEVERE CONGENITAL, 4, AUTOSOMAL RECESSIVE	Dursun syndrome, 612541 (3)	Dursun syndrome	y	NEUTROPENIA, SEVERE CONGENITAL, 4, AUTOSOMAL RECESSIVE; SCN4	Clinical Features	died	G6PC3	HGNC:24861	Dursun syndrome, 612541 (3), Autosomal recessive	Autosomal recessive	y	y	[Dursun et al. (2009) described a Turkish brother and sister, born of nonconsanguineous parents, with pulmonary arterial hypertension, cardiac abnormalities including secundum-type atrial septal defect, hematologic abnormalities including intermittent neutropenia, lymphopenia, monocytosis, and anemia, and marked thymic involution. Both sibs also had pectus carinatum, long fingers, proximally placed thumb, broad nasal bridge, and high-arched palate. The male proband had bilateral inguinal hernias and undescended testes. In a follow-up of the patients reported by Dursun et al. (2009), Banka et al. (2010) noted that both children died of severe respiratory distress due to primary pulmonary hypertension at age 18 months]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
612541	NEUTROPENIA, SEVERE CONGENITAL, 4, AUTOSOMAL RECESSIVE	Neutropenia, severe congenital 4, autosomal recessive, 612541 (3)	Neutropenia, severe congenital 4, autosomal recessive	y	NEUTROPENIA, SEVERE CONGENITAL, 4, AUTOSOMAL RECESSIVE; SCN4	Clinical Features	died	G6PC3	HGNC:24861	Neutropenia, severe congenital 4, autosomal recessive, 612541 (3), Autosomal recessive	Autosomal recessive	y	y	[Dursun et al. (2009) described a Turkish brother and sister, born of nonconsanguineous parents, with pulmonary arterial hypertension, cardiac abnormalities including secundum-type atrial septal defect, hematologic abnormalities including intermittent neutropenia, lymphopenia, monocytosis, and anemia, and marked thymic involution. Both sibs also had pectus carinatum, long fingers, proximally placed thumb, broad nasal bridge, and high-arched palate. The male proband had bilateral inguinal hernias and undescended testes. In a follow-up of the patients reported by Dursun et al. (2009), Banka et al. (2010) noted that both children died of severe respiratory distress due to primary pulmonary hypertension at age 18 months]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
612556	ADIPONECTIN DEFICIENCY	Adiponectin deficiency, 612556 (3)	Adiponectin deficiency	y	ADIPONECTIN DEFICIENCY; ADPOD	Description	death|deaths	ADIPOQ	HGNC:13633	Adiponectin deficiency, 612556 (3), Autosomal dominant	Autosomal dominant	y	n	-	-	-	-	ambiguous	ambiguous	ambiguous	-	-	-
612561	DIAMOND-BLACKFAN ANEMIA 6	Diamond-Blackfan anemia 6, 612561 (3)	Diamond-Blackfan anemia 6	n	-	-	-	RPL5	HGNC:10360	Diamond-Blackfan anemia 6, 612561 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
612562	DIAMOND-BLACKFAN ANEMIA 7	Diamond-Blackfan anemia 7, 612562 (3)	Diamond-Blackfan anemia 7	n	-	-	-	RPL11	HGNC:10301	Diamond-Blackfan anemia 7, 612562 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
612563	DIAMOND-BLACKFAN ANEMIA 8	Diamond-Blackfan anemia 8, 612563 (3)	Diamond-Blackfan anemia 8	n	-	-	-	RPS7	HGNC:10440	Diamond-Blackfan anemia 8, 612563 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
612567	INFLAMMATORY BOWEL DISEASE 25, AUTOSOMAL RECESSIVE	Inflammatory bowel disease 25, early onset, autosomal recessive, 612567 (3)	Inflammatory bowel disease 25, early onset, autosomal recessive	n	-	-	-	IL10RB	HGNC:5965	Inflammatory bowel disease 25, early onset, autosomal recessive, 612567 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
612572	RETINITIS PIGMENTOSA 46	Retinitis pigmentosa 46, 612572 (3)	Retinitis pigmentosa 46	n	-	-	-	IDH3B	HGNC:5385	Retinitis pigmentosa 46, 612572 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
612577	AMYOTROPHIC LATERAL SCLEROSIS 11	Amyotrophic lateral sclerosis 11, 612577 (3)	Amyotrophic lateral sclerosis 11	n	-	-	-	FIG4	HGNC:16873	Amyotrophic lateral sclerosis 11, 612577 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L3	L3	pre-infant-lethal
612580	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 3	Intellectual developmental disorder, autosomal dominant 3, 612580 (3)	Intellectual developmental disorder, autosomal dominant 3	n	-	-	-	CDH15	HGNC:1754	Intellectual developmental disorder, autosomal dominant 3, 612580 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
612621	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 5	Intellectual developmental disorder, autosomal dominant 5, 612621 (3)	Intellectual developmental disorder, autosomal dominant 5	n	-	-	-	SYNGAP1	HGNC:11497	Intellectual developmental disorder, autosomal dominant 5, 612621 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
612631	ADENYLATE KINASE DEFICIENCY, HEMOLYTIC ANEMIA DUE TO	Hemolytic anemia due to adenylate kinase deficiency, 612631 (3)	Hemolytic anemia due to adenylate kinase deficiency	n	-	-	-	AK1	HGNC:361	Hemolytic anemia due to adenylate kinase deficiency, 612631 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
612643	DEAFNESS, AUTOSOMAL DOMINANT 3B	Deafness, autosomal dominant 3B, 612643 (3)	Deafness, autosomal dominant 3B	n	-	-	-	GJB6	HGNC:4288	Deafness, autosomal dominant 3B, 612643 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
612644	DEAFNESS, AUTOSOMAL DOMINANT 2B	Deafness, autosomal dominant 2B, 612644 (3)	Deafness, autosomal dominant 2B	n	-	-	-	GJB3	HGNC:4285	Deafness, autosomal dominant 2B, 612644 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
612645	DEAFNESS, AUTOSOMAL RECESSIVE 1B	Deafness, autosomal recessive 1B, 612645 (3)	Deafness, autosomal recessive 1B	n	-	-	-	GJB6	HGNC:4288	Deafness, autosomal recessive 1B, 612645 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
612649	CILIARY DYSKINESIA, PRIMARY, 11	Ciliary dyskinesia, primary, 11, 612649 (3)	Ciliary dyskinesia, primary, 11	n	-	-	-	RSPH4A	HGNC:21558	Ciliary dyskinesia, primary, 11, 612649 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
612650	CILIARY DYSKINESIA, PRIMARY, 12	Ciliary dyskinesia, primary, 12, 612650 (3)	Ciliary dyskinesia, primary, 12	n	-	-	-	RSPH9	HGNC:21057	Ciliary dyskinesia, primary, 12, 612650 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
612651	ENDOCRINE-CEREBROOSTEODYSPLASIA	Endocrine-cerebroosteodysplasia, 612651 (3)	Endocrine-cerebroosteodysplasia	y	ENDOCRINE-CEREBROOSTEODYSPLASIA; ECO	Clinical Features|Clinical Synopsis	died|death|deaths	CILK1	HGNC:21219	Endocrine-cerebroosteodysplasia, 612651 (3), Autosomal recessive	Autosomal recessive	y	y	[Death in utero or as neonate]	L1	y	-	lethal	lethal	lethal	L1	L1	pre-infant-lethal
612653	SPHEROCYTOSIS, TYPE 4	Spherocytosis, type 4, 612653 (3)	Spherocytosis, type 4	n	-	-	-	SLC4A1	HGNC:11027	Spherocytosis, type 4, 612653 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	ambiguous|lethal|nonlethal	lethal|nonlethal	L6	L6	post-infant-lethal
612656	EPISODIC ATAXIA, TYPE 6	Episodic ataxia, type 6, 612656 (3)	Episodic ataxia, type 6	n	-	-	-	SLC1A3	HGNC:10941	Episodic ataxia, type 6, 612656 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
612657	CONE-ROD DYSTROPHY 12	Cone-rod dystrophy 12, 612657 (3)	Cone-rod dystrophy 12	n	-	-	-	PROM1	HGNC:9454	Cone-rod dystrophy 12, 612657 (3), Autosomal dominant, Autosomal recessive	Autosomal dominant, Autosomal recessive	-	-	-	-	-	-	nonlethal	ambiguous|nonlethal	ambiguous	-	-	-
612674	POLYNEUROPATHY, HEARING LOSS, ATAXIA, RETINITIS PIGMENTOSA, AND CATARACT	Polyneuropathy, hearing loss, ataxia, retinitis pigmentosa, and cataract, 612674 (3)	Polyneuropathy, hearing loss, ataxia, retinitis pigmentosa, and cataract	n	-	-	-	ABHD12	HGNC:15868	Polyneuropathy, hearing loss, ataxia, retinitis pigmentosa, and cataract, 612674 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
612690	SPHEROCYTOSIS, TYPE 5	Spherocytosis, type 5, 612690 (3)	Spherocytosis, type 5	n	-	-	-	EPB42	HGNC:3381	Spherocytosis, type 5, 612690 (3)	-	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
612692	AGAMMAGLOBULINEMIA 6, AUTOSOMAL RECESSIVE	Agammaglobulinemia 6, 612692 (3)	Agammaglobulinemia 6	n	-	-	-	CD79B	HGNC:1699	Agammaglobulinemia 6, 612692 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
612702	HYPOGONADOTROPIC HYPOGONADISM 6 WITH OR WITHOUT ANOSMIA	Hypogonadotropic hypogonadism 6 with or without anosmia, 612702 (3)	Hypogonadotropic hypogonadism 6 with or without anosmia	n	-	-	-	FGF8	HGNC:3686	Hypogonadotropic hypogonadism 6 with or without anosmia, 612702 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
612703	MICROCEPHALY 7, PRIMARY, AUTOSOMAL RECESSIVE	Microcephaly 7, primary, autosomal recessive, 612703 (3)	Microcephaly 7, primary, autosomal recessive	n	-	-	-	STIL	HGNC:10879	Microcephaly 7, primary, autosomal recessive, 612703 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
612712	LEBER CONGENITAL AMAUROSIS 13	Leber congenital amaurosis 13, 612712 (3)	Leber congenital amaurosis 13	n	-	-	-	RDH12	HGNC:19977	Leber congenital amaurosis 13, 612712 (3), Autosomal dominant, Autosomal recessive	Autosomal dominant, Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
612713	KAHRIZI SYNDROME	Kahrizi syndrome, 612713 (3)	Kahrizi syndrome	n	-	-	-	SRD5A3	HGNC:25812	Kahrizi syndrome, 612713 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
612714	EXOCRINE PANCREATIC INSUFFICIENCY, DYSERYTHROPOIETIC ANEMIA, AND CALVARIAL HYPEROSTOSIS	Exocrine pancreatic insufficiency, dyserythropoietic anemia, and calvarial hyperostosis, 612714 (3)	Exocrine pancreatic insufficiency, dyserythropoietic anemia, and calvarial hyperostosis	y	EXOCRINE PANCREATIC INSUFFICIENCY, DYSERYTHROPOIETIC ANEMIA, AND CALVARIAL HYPEROSTOSIS	Clinical Features	died	COX4I2	HGNC:16232	Exocrine pancreatic insufficiency, dyserythropoietic anemia, and calvarial hyperostosis, 612714 (3), Autosomal recessive	Autosomal recessive	n	y	[Shteyer et al. (2009) reported 3 brothers from a consanguineous Arab Muslim family with exocrine pancreatic insufficiency, dyserythropoietic anemia, and calvarial hyperostosis... She also had allergic rhinitis and severe asthma and was easily fatigued. Speech and comprehension were age appropriate, but she was doing poorly at school. Two additional infants from this family had died with severe jaundice, anemia, and hepatosplenomegaly]	L3	n	y	lethal	lethal	lethal	L3	L3	pre-infant-lethal
612716	DYSTONIA, DOPA-RESPONSIVE, DUE TO SEPIAPTERIN REDUCTASE DEFICIENCY	Dystonia, dopa-responsive, due to sepiapterin reductase deficiency, 612716 (3)	Dystonia, dopa-responsive, due to sepiapterin reductase deficiency	n	-	-	-	SPR	HGNC:11257	Dystonia, dopa-responsive, due to sepiapterin reductase deficiency, 612716 (3), ?Autosomal dominant, Autosomal recessive	Autosomal dominant, Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
612718	CEREBRAL CREATINE DEFICIENCY SYNDROME 3	Cerebral creatine deficiency syndrome 3, 612718 (3)	Cerebral creatine deficiency syndrome 3	n	-	-	-	GATM	HGNC:4175	Cerebral creatine deficiency syndrome 3, 612718 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	ambiguous|nonlethal	ambiguous	-	-	-
612736	CEREBRAL CREATINE DEFICIENCY SYNDROME 2	Cerebral creatine deficiency syndrome 2, 612736 (3)	Cerebral creatine deficiency syndrome 2	y	CEREBRAL CREATINE DEFICIENCY SYNDROME 2; CCDS2	Clinical Features	died	GAMT	HGNC:4136	Cerebral creatine deficiency syndrome 2, 612736 (3), Autosomal recessive	Autosomal recessive	y	n	-	-	-	-	ambiguous	ambiguous	ambiguous	-	-	-
612740	PORPHYRIA, ACUTE HEPATIC	Porphyria, acute hepatic, 612740 (3)	Porphyria, acute hepatic	y	PORPHYRIA, ACUTE HEPATIC	Clinical Features	died	ALAD	HGNC:395	Porphyria, acute hepatic, 612740 (3), Autosomal recessive	Autosomal recessive	n	y	[Thunell et al. (1987) reported ALAD-deficient porphyria in a 3-year-old boy. He presented in the neonatal period and infancy with recurrent attacks of pain, vomiting, hyponatremia, and symptoms of polyneuropathy that compromised motor functions, including respiration. He excreted large amounts of 5-aminolevulinic acid and coproporphyrin and minor amounts of porphobilinogen in the urine... Doss et al. (2004) reported that the patient reported by Thunell et al. (1987, 1992) died at age 9 years]	L4	y	-	lethal	lethal	lethal	L4	L4	post-infant-lethal
612775	CONE-ROD DYSTROPHY 9	Cone-rod dystrophy 9, 612775 (3)	Cone-rod dystrophy 9	n	-	-	-	ADAM9	HGNC:216	Cone-rod dystrophy 9, 612775 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
612780	SEIZURES, SENSORINEURAL DEAFNESS, ATAXIA, IMPAIRED INTELLECTUAL DEVELOPMENT, AND ELECTROLYTE IMBALANCE	SESAME syndrome, 612780 (3)	SESAME syndrome	y	SEIZURES, SENSORINEURAL DEAFNESS, ATAXIA, IMPAIRED INTELLECTUAL DEVELOPMENT, AND ELECTROLYTE IMBALANCE; SESAMES	Clinical Features	died	KCNJ10	HGNC:6256	SESAME syndrome, 612780 (3), Autosomal recessive	Autosomal recessive	y	y	[Scholl et al. (2009) reported 5 patients from 4 families with a complex disorder characterized by onset of generalized seizures in infancy, delayed psychomotor development, ataxia, and sensorineural hearing loss. One patient was reported in detail.. She had 2 presumably affected sibs: 1 had seizures, was never able to walk, and died at age from a diarrheal illness, and the other presented with seizures and vomiting at age 5 months, was unable to walk until 16 months, and died at 18 months from an infection]	L3	n	y	lethal	lethal|nonlethal	lethal|nonlethal	L3	L3	pre-infant-lethal
612781	ISOLATED GROWTH HORMONE DEFICIENCY, TYPE IB	Growth hormone deficiency, isolated, type IB, 612781 (3)	Growth hormone deficiency, isolated, type IB	n	-	-	-	GH1	HGNC:4261	Growth hormone deficiency, isolated, type IB, 612781 (3)	-	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
612782	IMMUNODEFICIENCY 9	Immunodeficiency 9, 612782 (3)	Immunodeficiency 9	y	IMMUNODEFICIENCY 9; IMD9	Clinical Features|Clinical Synopsis	died|death|deaths	ORAI1	HGNC:25896	Immunodeficiency 9, 612782 (3), Autosomal recessive	Autosomal recessive	y	y	[Partiseti et al. (1994) reported a patient with primary immunodeficiency characterized by lack of T-cell proliferation. Detailed studies of patient lymphocytes showed absence of calcium influx in response to activation of the T-cell receptor (TCR) compared to control lymphocytes. Intracellular calcium release in patient cells was similar to controls. McCarl et al. (2009) reported detailed clinical features of the patient (P4) reported by Partiseti et al. (1994) and his similarly affected brother (P3). The proband presented at birth with facial dysmorphism, clubfoot, and hypocalcemia. During the first year of life, he had failure to thrive and recurrent infections, including chronic diarrhea, chronic candidiasis, pneumonia, and pyelonephritis. He had a small thymus with normal numbers of lymphocytes, but T-cell proliferation was severely impaired in response to stimuli. At age 7 months, he developed neutropenia and thrombocytopenia. Additional features included developmental delay, congenital muscular hypotonia, spasticity, and encephalopathy. The child died at age 11 months from progressive encephalopathy and seizures. His older, similarly affected brother died of pneumonia at age 5 month]	L3	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L3	L3	pre-infant-lethal
612783	IMMUNODEFICIENCY 10	Immunodeficiency 10, 612783 (3)	Immunodeficiency 10	y	IMMUNODEFICIENCY 10; IMD10	Clinical Features|Phenotype	died|fatal|lethal	STIM1	HGNC:11386	Immunodeficiency 10, 612783 (3), Autosomal recessive	Autosomal recessive	y	y	[Picard et al. (2009) reported 3 sibs, born of a consanguineous family from central Europe, who had recurrent infections due to defective T-cell function. Muscle hypotonia and partial iris hypoplasia were noted in the neonatal period. Within a few months, patients developed lymphadenopathy and hepatosplenomegaly associated with autoimmune hemolytic anemia and thrombocytopenia. During the first year of life, all children developed recurrent infections. Defects in enamel dentition were also noted. One died at age 9 years from complications of a bone marrow transplant, whereas another died from the nephrotic syndrome and recurrent infections at age 18 months]	L3	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L3	L3	pre-infant-lethal
612794	ATRIAL SEPTAL DEFECT 5	Atrial septal defect 5, 612794 (3)	Atrial septal defect 5	n	-	-	-	ACTC1	HGNC:143	Atrial septal defect 5, 612794 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	ambiguous|nonlethal	ambiguous	-	-	-
612798	QUESTION MARK EARS, ISOLATED	Question mark ears, isolated, 612798 (3)	Question mark ears, isolated	n	-	-	-	EDN1	HGNC:3176	Question mark ears, isolated, 612798 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
612813	SPONDYLOEPIMETAPHYSEAL DYSPLASIA, AGGRECAN TYPE	Spondyloepimetaphyseal dysplasia, aggrecan type, 612813 (3)	Spondyloepimetaphyseal dysplasia, aggrecan type	n	-	-	-	ACAN	HGNC:319	Spondyloepimetaphyseal dysplasia, aggrecan type, 612813 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
612838	BRUGADA SYNDROME 5	Brugada syndrome 5, 612838 (3)	Brugada syndrome 5	y	BRUGADA SYNDROME 5; BRGDA5	Description|Clinical Features	death|deaths	SCN1B	HGNC:10586	Brugada syndrome 5, 612838 (3)	-	n	y	[Brugada syndrome is characterized by an ST segment elevation in the right precordial electrocardiogram leads (so-called type 1 ECG) and a high incidence of sudden death in patients with structurally normal hearts. The syndrome typically manifests during adulthood, with a mean age of sudden death of 41 +/- 15 years, but also occurs in infants and children (summary by Antzelevitch et al., 2005)]	L6	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L3|L6	L3	pre-infant-lethal
612838	BRUGADA SYNDROME 5	Cardiac conduction defect, nonspecific, 612838 (3)	Cardiac conduction defect, nonspecific	y	BRUGADA SYNDROME 5; BRGDA5	Description|Clinical Features	death|deaths	SCN1B	HGNC:10586	Cardiac conduction defect, nonspecific, 612838 (3)	-	n	y	[Brugada syndrome is characterized by an ST segment elevation in the right precordial electrocardiogram leads (so-called type 1 ECG) and a high incidence of sudden death in patients with structurally normal hearts. The syndrome typically manifests during adulthood, with a mean age of sudden death of 41 +/- 15 years, but also occurs in infants and children (summary by Antzelevitch et al., 2005)]	L6	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L3|L6	L3	pre-infant-lethal
612840	LEUKOCYTE ADHESION DEFICIENCY, TYPE III	Leukocyte adhesion deficiency, type III, 612840 (3)	Leukocyte adhesion deficiency, type III	y	LEUKOCYTE ADHESION DEFICIENCY, TYPE III; LAD3	Clinical Features	died	FERMT3	HGNC:23151	Leukocyte adhesion deficiency, type III, 612840 (3), Autosomal recessive	Autosomal recessive	y	y	[Alon et al. (2003) reported an Arab child, born of consanguineous parents, who developed periumbilical cellulitis and Staphylococcal septicemia at age 5 days... He died at age 6 years from a disseminated fungal infection after a mismatched bone marrow transplantation. A younger brother who presented with the same clinical and hematologic phenotypes at birth died at 1 week of age from sepsis]	L2	y	y	lethal	lethal	lethal	L2	L2	pre-infant-lethal
612847	BRACHYOLMIA TYPE 4 WITH MILD EPIPHYSEAL AND METAPHYSEAL CHANGES	Brachyolmia 4 with mild epiphyseal and metaphyseal changes, 612847 (3)	Brachyolmia 4 with mild epiphyseal and metaphyseal changes	n	-	-	-	PAPSS2	HGNC:8604	Brachyolmia 4 with mild epiphyseal and metaphyseal changes, 612847 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
612852	CHRONIC RECURRENT MULTIFOCAL OSTEOMYELITIS 2, WITH PERIOSTITIS AND PUSTULOSIS	Interleukin 1 receptor antagonist deficiency, 612852 (3)	Interleukin 1 receptor antagonist deficiency	y	CHRONIC RECURRENT MULTIFOCAL OSTEOMYELITIS 2, WITH PERIOSTITIS AND PUSTULOSIS; CRMO2	Clinical Features|Clinical Synopsis	died|fatal	IL1RN	HGNC:6000	Interleukin 1 receptor antagonist deficiency, 612852 (3), Autosomal recessive	Autosomal recessive	y	y	[Aksentijevich et al. (2009) described 9 children from 6 unrelated families who had neonatal onset of sterile multifocal osteomyelitis, periostitis, and pustulosis. All patients presented by 2.5 weeks of age; the common manifesting features included fetal distress, pustular rash, joint swelling, oral mucosal lesions, and pain with movement. Over time, cutaneous pustulosis developed, ranging from discrete crops of pustules to generalized severe pustulosis or ichthyosiform lesions. Biopsies of skin lesions from 2 patients showed extensive infiltration of epidermis and dermis by neutrophils, pustule formation along hair follicles, acanthosis, and hyperkeratosis. Histopathologic evidence of vasculitis was observed in the connective and fat tissue adjacent to bone in 1 patient. Nail changes were seen in 4 children, 2 of whom had separation of the nail and nail bed similar to the onychomadesis seen in psoriasis. Three patients underwent cervical vertebral fusion secondary to collapsing vertebral osteolytic lesions. Cerebral vasculitis or vasculopathy was seen on MRI in 1 patient. Two of the children died of multiorgan failure secondary to the inflammatory response syndrome, at 2 months and 21 months of age, respectively]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
612852	CHRONIC RECURRENT MULTIFOCAL OSTEOMYELITIS 2, WITH PERIOSTITIS AND PUSTULOSIS	Chronic recurrent multifocal osteomyelitis 2, with periostitis and pustulosis, 612852 (3)	Chronic recurrent multifocal osteomyelitis 2, with periostitis and pustulosis	y	CHRONIC RECURRENT MULTIFOCAL OSTEOMYELITIS 2, WITH PERIOSTITIS AND PUSTULOSIS; CRMO2	Clinical Features|Clinical Synopsis	died|fatal	IL1RN	HGNC:6000	Chronic recurrent multifocal osteomyelitis 2, with periostitis and pustulosis, 612852 (3), Autosomal recessive	Autosomal recessive	y	y	[Two of the children died of multiorgan failure secondary to the inflammatory response syndrome, at 2 months and 21 months of age, respectively;]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
612877	CARDIOMYOPATHY, DILATED, 1BB	Cardiomyopathy, dilated, 1BB, 612877 (3)	Cardiomyopathy, dilated, 1BB	y	CARDIOMYOPATHY, DILATED, 1BB; CMD1BB	Phenotype	died	DSG2	HGNC:3049	Cardiomyopathy, dilated, 1BB, 612877 (3), Autosomal recessive	Autosomal recessive	y	n	-	-	-	-	ambiguous	ambiguous|lethal	lethal	LU	LU	post-infant-lethal
612900	CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 2	Cerebral palsy, spastic quadriplegic, 2, 612900 (3)	Cerebral palsy, spastic quadriplegic, 2	n	-	-	-	KANK1	HGNC:19309	Cerebral palsy, spastic quadriplegic, 2, 612900 (3)	-	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
612908	KERATOSIS PALMOPLANTARIS STRIATA II	Keratosis palmoplantaris striata II, 612908 (3)	Keratosis palmoplantaris striata II	n	-	-	-	DSP	HGNC:3052	Keratosis palmoplantaris striata II, 612908 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L2|L4|L5|LU	L2	pre-infant-lethal
612921	THREE M SYNDROME 2	3-M syndrome 2, 612921 (3)	3-M syndrome 2	n	-	-	-	OBSL1	HGNC:29092	3-M syndrome 2, 612921 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
612932	GLYCOGEN STORAGE DISEASE XIII	Glycogen storage disease XIII, 612932 (3)	Glycogen storage disease XIII	n	-	-	-	ENO3	HGNC:3354	Glycogen storage disease XIII, 612932 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
612933	GLYCOGEN STORAGE DISEASE XI	Glycogen storage disease XI, 612933 (3)	Glycogen storage disease XI	n	-	-	-	LDHA	HGNC:6535	Glycogen storage disease XI, 612933 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
612936	SPASTIC PARAPLEGIA 50, AUTOSOMAL RECESSIVE	Spastic paraplegia 50, autosomal recessive, 612936 (3)	Spastic paraplegia 50, autosomal recessive	y	SPASTIC PARAPLEGIA 50, AUTOSOMAL RECESSIVE; SPG50	Clinical Features	died	AP4M1	HGNC:574	Spastic paraplegia 50, autosomal recessive, 612936 (3), Autosomal recessive	Autosomal recessive	y	y	[Verkerk et al. (2009) reported a consanguineous Moroccan family in which 5 sibs had spastic quadriplegic cerebral palsy and severe mental retardation...There was minimal progression during 20-year follow-up. One patient died at 17 months of aspiration pneumonia]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
612937	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 15	Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 15, 612937 (3)	Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 15	y	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 15; MDDGC15	Clinical Features	died	DPM3	HGNC:3007	Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 15, 612937 (3), Autosomal recessive	Autosomal recessive	y	y	[Svahn et al. (2019) reported 2 unrelated men with limb-girdle muscular dystrophy and dilated cardiomyopathy. Patient 1 was a 26-year-old man who had onset of muscle weakness in childhood and developed dilated cardiomyopathy in early adulthood. History revealed mildly delayed motor development and difficulty playing sports. Examination as an adult showed Gowers sign, calf hypertrophy, mild scapular winging, and progressive proximal and distal lower limb weakness. EMG showed myopathic changes. Patient 2 was a 48-year-old man diagnosed with dilated cardiomyopathy at 18 years of age. He also had increased serum creatine kinase and moderate limb-girdle muscle weakness with calf hypertrophy. He underwent successful heart transplantation, but later developed neurologic deficits associated with ischemic and hemorrhagic stroke. The muscle weakness was progressive with proximal and distal involvement, resulting in inability to walk without assistance or to climb stairs. He had no facial or oculomotor weakness. A similarly affected sister died at age 7 year]	L4	n	y	lethal	lethal	lethal	L4	L4	post-infant-lethal
612938	GROWTH RETARDATION, DEVELOPMENTAL DELAY, AND FACIAL DYSMORPHISM	Growth retardation, developmental delay, facial dysmorphism, 612938 (3)	Growth retardation, developmental delay, facial dysmorphism	y	GROWTH RETARDATION, DEVELOPMENTAL DELAY, AND FACIAL DYSMORPHISM; GDFD	Clinical Features|Clinical Synopsis	death|deaths	FTO	HGNC:24678	Growth retardation, developmental delay, facial dysmorphism, 612938 (3), Autosomal recessive	Autosomal recessive	n	y	[Boissel et al. (2009) reported a consanguineous Palestinian Arab family in which 9 individuals had a severe multiple congenital anomaly syndrome with death by age 3 years]	L4	y	-	lethal	lethal	lethal	L4	L4	post-infant-lethal
612940	CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIB	Cutis laxa, autosomal recessive, type IIB, 612940 (3)	Cutis laxa, autosomal recessive, type IIB	n	-	-	-	PYCR1	HGNC:9721	Cutis laxa, autosomal recessive, type IIB, 612940 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
612943	RETINITIS PIGMENTOSA 42	Retinitis pigmentosa 42, 612943 (3)	Retinitis pigmentosa 42	n	-	-	-	KLHL7	HGNC:15646	Retinitis pigmentosa 42, 612943 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L3	L3	pre-infant-lethal
612949	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 39 WITH LEUKODYSTROPHY	Developmental and epileptic encephalopathy 39, 612949 (3)	Developmental and epileptic encephalopathy 39	n	-	-	-	SLC25A12	HGNC:10982	Developmental and epileptic encephalopathy 39, 612949 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
612951	LEUKOENCEPHALOPATHY, CYSTIC, WITHOUT MEGALENCEPHALY	Leukoencephalopathy, cystic, without megalencephaly, 612951 (3)	Leukoencephalopathy, cystic, without megalencephaly	n	-	-	-	RNASET2	HGNC:21686	Leukoencephalopathy, cystic, without megalencephaly, 612951 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
612952	AICARDI-GOUTIERES SYNDROME 5	Aicardi-Goutieres syndrome 5, 612952 (3)	Aicardi-Goutieres syndrome 5	y	AICARDI-GOUTIERES SYNDROME 5; AGS5	Clinical Features	died	SAMHD1	HGNC:15925	Aicardi-Goutieres syndrome 5, 612952 (3), Autosomal recessive	Autosomal recessive	n	y	[Leshinsky-Silver et al. (2011) reported a boy, born of unrelated Ashkenazi Jewish parents, who presented at age 3 weeks with failure to thrive, poor growth, and lack of development. He had central hypotonia with brisk tendon reflexes and choreoathetoid movements. Brain MRI showed extensive white matter destruction, delayed myelination, hypoplasia of the corpus callosum, severe cortical atrophy, destructive lesions of the aqueductal body and pons, and pathologic lesions in the frontal lobe and basal ganglia. Blood samples showed increased serum lactate, anemia, and thrombocytosis. He had profound mental retardation, poor growth, and severe irritability, and died at age 15 months]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
612953	PARKINSON DISEASE 14, AUTOSOMAL RECESSIVE	Parkinson disease 14, autosomal recessive, 612953 (3)	Parkinson disease 14, autosomal recessive	n	-	-	-	PLA2G6	HGNC:9039	Parkinson disease 14, autosomal recessive, 612953 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L3|L6	L3	pre-infant-lethal
612954	MYOPATHY, MYOFIBRILLAR, 6	Myopathy, myofibrillar, 6, 612954 (3)	Myopathy, myofibrillar, 6	y	MYOPATHY, MYOFIBRILLAR, 6; MFM6	Clinical Features|Clinical Synopsis|Phenotype	died|death|deaths	BAG3	HGNC:939	Myopathy, myofibrillar, 6, 612954 (3), Autosomal dominant	Autosomal dominant	n	y	[Odgerel et al. (2010) reported 4 patients from 3 unrelated families with MFM6. One of the patients was an Italian girl who had previously been reported by Sabatelli et al. (1992). Between ages 5 and 12 years, all developed a skeletal myopathy with severe generalized and proximal muscle weakness and atrophy and respiratory insufficiency, as well as cardiomyopathy. Muscle biopsy showed abnormal desmin (DES; 125660)-positive inclusions and myofibrillar breakdown with loss of Z-line streaming. All patients also had peripheral neuropathy with axonal loss, thin myelin sheaths, and giant axons on nerve biopsy. Two patients underwent cardiac transplant in their teens and were ventilator-dependent; the other 2 patients died at ages 9 and 20 years]	L4	y	-	lethal	lethal	lethal	L4|LU	L4	post-infant-lethal
612955	LONG QT SYNDROME 12	Long QT syndrome 12, 612955 (3)	Long QT syndrome 12	y	LONG QT SYNDROME 12; LQT12	Description|Clinical Synopsis|Phenotype	death|deaths|died	SNTA1	HGNC:11167	Long QT syndrome 12, 612955 (3), Autosomal dominant	Autosomal dominant	n	y	[Risk of sudden death due to cardiac arrhythmia / In 39 unrelated patients with LQTS who were negative for mutation in 9 known LQT-associated genes, Wu et al. (2008) analyzed the candidate gene SNTA1 and identified a novel missense mutation (A257G; 601017.0002) in 2 women and 1 boy. The mutation was not detected in 400 ethnically matched control alleles. One of the women was ascertained after the sudden death of her 11-year-old son due to ventricular fibrillation; however, neither woman's parents had abnormalities on ECG and all parents were negative for mutation, consistent with de novo genetic change in the 2 women]	L5	n	y	lethal	lethal	lethal	L5	L5	post-infant-lethal
612961	MULTIPLE SYNOSTOSES SYNDROME 3	Multiple synostoses syndrome 3, 612961 (3)	Multiple synostoses syndrome 3	n	-	-	-	FGF9	HGNC:3687	Multiple synostoses syndrome 3, 612961 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
612964	PREMATURE OVARIAN FAILURE 7	Adrenocortical insufficiency, 612964 (3)	Adrenocortical insufficiency	n	-	-	-	NR5A1	HGNC:7983	Adrenocortical insufficiency, 612964 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
612964	PREMATURE OVARIAN FAILURE 7	Premature ovarian failure 7, 612964 (3)	Premature ovarian failure 7	n	-	-	-	NR5A1	HGNC:7983	Premature ovarian failure 7, 612964 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
612965	46,XY SEX REVERSAL 3	46XY sex reversal 3, 612965 (3)	46XY sex reversal 3	n	-	-	-	NR5A1	HGNC:7983	46XY sex reversal 3, 612965 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
612968	CATARACT 34, MULTIPLE TYPES	Cataract 34, multiple types, 612968 (3)	Cataract 34, multiple types	n	-	-	-	FOXE3	HGNC:3808	Cataract 34, multiple types, 612968 (3)	-	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
612989	OPTIC ATROPHY 7 WITH OR WITHOUT AUDITORY NEUROPATHY	Optic atrophy 7, 612989 (3)	Optic atrophy 7	n	-	-	-	TMEM126A	HGNC:25382	Optic atrophy 7, 612989 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
612997	SPERMATOGENIC FAILURE 7	Spermatogenic failure 7, 612997 (3)	Spermatogenic failure 7	n	-	-	-	CATSPER1	HGNC:17116	Spermatogenic failure 7, 612997 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
612998	EMERY-DREIFUSS MUSCULAR DYSTROPHY 4, AUTOSOMAL DOMINANT	Emery-Dreifuss muscular dystrophy 4, autosomal dominant, 612998 (3)	Emery-Dreifuss muscular dystrophy 4, autosomal dominant	n	-	-	-	SYNE1	HGNC:17089	Emery-Dreifuss muscular dystrophy 4, autosomal dominant, 612998 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L3|L6	L3	pre-infant-lethal
612999	EMERY-DREIFUSS MUSCULAR DYSTROPHY 5, AUTOSOMAL DOMINANT	Emery-Dreifuss muscular dystrophy 5, autosomal dominant, 612999 (3)	Emery-Dreifuss muscular dystrophy 5, autosomal dominant	y	EMERY-DREIFUSS MUSCULAR DYSTROPHY 5, AUTOSOMAL DOMINANT; EDMD5	Clinical Features	died	SYNE2	HGNC:17084	Emery-Dreifuss muscular dystrophy 5, autosomal dominant, 612999 (3), Autosomal dominant	Autosomal dominant	y	y	[Zhang et al. (2007) reported a man who presented with proximal upper limb weakness and winged scapulae at age 8 years. Serum creatine kinase was increased and he later developed minor respiratory insufficiency. ...The authors reported a second family in which a woman with a history of muscular weakness died at age 30 years of cardiomyopathy]	L6	y	-	lethal	lethal	lethal	L6	L6	post-infant-lethal
613000	PALMOPLANTAR KERATODERMA, NONEPIDERMOLYTIC, FOCAL 1	Palmoplantar keratoderma, nonepidermolytic, focal, 613000 (3)	Palmoplantar keratoderma, nonepidermolytic, focal	n	-	-	-	KRT16	HGNC:6423	Palmoplantar keratoderma, nonepidermolytic, focal, 613000 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
613011	LYMPHOPROLIFERATIVE SYNDROME 1	Lymphoproliferative syndrome 1, 613011 (3)	Lymphoproliferative syndrome 1	y	LYMPHOPROLIFERATIVE SYNDROME 1; LPFS1	Clinical Features|Clinical Synopsis|Phenotype	died|fatal	ITK	HGNC:6171	Lymphoproliferative syndrome 1, 613011 (3), Autosomal recessive	Autosomal recessive	n	y	[Huck et al. (2009) reported 2 sisters, born of consanguineous Turkish parents, who died in childhood after developing severe immune dysregulation and therapy-resistant Epstein-Barr virus (EBV)-positive B-cell proliferation following EBV infection]	L4	y	-	lethal	lethal	lethal	L4	L4	post-infant-lethal
613013	NEUROBLASTOMA, SUSCEPTIBILITY TO, 2	Neuroblastoma with Hirschsprung disease, 613013 (3)	Neuroblastoma with Hirschsprung disease	y	NEUROBLASTOMA, SUSCEPTIBILITY TO, 2; NBLST2	Clinical Features	died	PHOX2B	HGNC:9143	Neuroblastoma with Hirschsprung disease, 613013 (3)	-	n	y	[McConville et al. (2006) reported a family with neuroblastoma. The index case, from whom no DNA was available, died at age 5 years with metastatic neuroblastoma and ganglioneuroblastoma]	L4	y	-	lethal	lethal	lethal	L3|L4	L3	pre-infant-lethal
613021	BRONCHIECTASIS WITH OR WITHOUT ELEVATED SWEAT CHLORIDE 2	Bronchiectasis with or without elevated sweat chloride 2, 613021 (3)	Bronchiectasis with or without elevated sweat chloride 2	n	-	-	-	SCNN1A	HGNC:10599	Bronchiectasis with or without elevated sweat chloride 2, 613021 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L2	L2	pre-infant-lethal
613027	GLYCOGEN STORAGE DISEASE IXc	Glycogen storage disease IXc, 613027 (3)	Glycogen storage disease IXc	n	-	-	-	PHKG2	HGNC:8931	Glycogen storage disease IXc, 613027 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
613038	PITUITARY HORMONE DEFICIENCY, COMBINED OR ISOLATED, 1	Pituitary hormone deficiency, combined or isolated, 1, 613038 (3)	Pituitary hormone deficiency, combined or isolated, 1	y	PITUITARY HORMONE DEFICIENCY, COMBINED OR ISOLATED, 1; CPHD1	Clinical Features|Phenotype	died	POU1F1	HGNC:9210	Pituitary hormone deficiency, combined or isolated, 1, 613038 (3), Autosomal dominant, Autosomal recessive	Autosomal dominant, Autosomal recessive	y	y	[In a Japanese girl with CPHD involving PRL, GH, and TSH, Okamoto et al. (1994) identified heterozygosity for the R271W mutation in the PIT1 gene. Her unaffected father and paternal grandmother and 2 aunts also carried the mutation, as did an older brother who had died at 10 days of age of hypoplastic left heart syndrome]	L2	y	-	lethal	lethal	lethal	L2	L2	pre-infant-lethal
613068	NEURODEGENERATION DUE TO CEREBRAL FOLATE TRANSPORT DEFICIENCY	Neurodegeneration due to cerebral folate transport deficiency, 613068 (3)	Neurodegeneration due to cerebral folate transport deficiency	n	-	-	-	FOLR1	HGNC:3791	Neurodegeneration due to cerebral folate transport deficiency, 613068 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
613070	LIVER FAILURE, INFANTILE, TRANSIENT	Liver failure, transient infantile, 613070 (3)	Liver failure, transient infantile	y	LIVER FAILURE, INFANTILE, TRANSIENT; LFIT	Clinical Features	died	TRMU	HGNC:25481	Liver failure, transient infantile, 613070 (3), Autosomal recessive	Autosomal recessive	y	y	[Zeharia et al. (2009) reported 7 unrelated families of Yemenite Jewish origin in which at least 1 family member had acute liver failure in early infancy... The presentation was the same, but 3 patients died at ages 2 to 4 months]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
613071	BRONCHIECTASIS WITH OR WITHOUT ELEVATED SWEAT CHLORIDE 3	Bronchiectasis with or without elevated sweat chloride 3, 613071 (3)	Bronchiectasis with or without elevated sweat chloride 3	n	-	-	-	SCNN1G	HGNC:10602	Bronchiectasis with or without elevated sweat chloride 3, 613071 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
613073	METAPHYSEAL ANADYSPLASIA 2	Metaphyseal anadysplasia 2, 613073 (3)	Metaphyseal anadysplasia 2	n	-	-	-	MMP9	HGNC:7176	Metaphyseal anadysplasia 2, 613073 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
613075	MACS SYNDROME	Macrocephaly, alopecia, cutis laxa, and scoliosis, 613075 (3)	Macrocephaly, alopecia, cutis laxa, and scoliosis	n	-	-	-	RIN2	HGNC:18750	Macrocephaly, alopecia, cutis laxa, and scoliosis, 613075 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
613076	MYOPATHY, MITOCHONDRIAL PROGRESSIVE, WITH CONGENITAL CATARACT AND DEVELOPMENTAL DELAY	Myopathy, mitochondrial progressive, with congenital cataract and developmental delay, 613076 (3)	Myopathy, mitochondrial progressive, with congenital cataract and developmental delay	n	-	-	-	GFER	HGNC:4236	Myopathy, mitochondrial progressive, with congenital cataract and developmental delay, 613076 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
613077	PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 5	Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 5, 613077 (3)	Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 5	n	-	-	-	RRM2B	HGNC:17296	Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 5, 613077 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L3|L4	L3	pre-infant-lethal
613078	NIJMEGEN BREAKAGE SYNDROME-LIKE DISORDER	Nijmegen breakage syndrome-like disorder, 613078 (3)	Nijmegen breakage syndrome-like disorder	n	-	-	-	RAD50	HGNC:9816	Nijmegen breakage syndrome-like disorder, 613078 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
613079	DEAFNESS, AUTOSOMAL RECESSIVE 77	Deafness, autosomal recessive 77, 613079 (3)	Deafness, autosomal recessive 77	n	-	-	-	LOXHD1	HGNC:26521	Deafness, autosomal recessive 77, 613079 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
613086	GLAUCOMA 3, PRIMARY CONGENITAL, D	Glaucoma 3, primary congenital, D, 613086 (3)	Glaucoma 3, primary congenital, D	n	-	-	-	LTBP2	HGNC:6715	Glaucoma 3, primary congenital, D, 613086 (3)	-	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
613087	ATRIAL SEPTAL DEFECT 6	Atrial septal defect 6, 613087 (3)	Atrial septal defect 6	n	-	-	-	TLL1	HGNC:11843	Atrial septal defect 6, 613087 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
613092	TUBULOINTERSTITIAL KIDNEY DISEASE, AUTOSOMAL DOMINANT, 4	Tubulointerstitial kidney disease, autosomal dominant, 4, 613092 (3)	Tubulointerstitial kidney disease, autosomal dominant, 4	n	-	-	-	REN	HGNC:9958	Tubulointerstitial kidney disease, autosomal dominant, 4, 613092 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L1	L1	pre-infant-lethal
613093	CONE DYSTROPHY 4	Cone dystrophy 4, 613093 (3)	Cone dystrophy 4	y	CONE DYSTROPHY 4; COD4	Description	death|deaths	PDE6C	HGNC:8787	Cone dystrophy 4, 613093 (3), Autosomal recessive	Autosomal recessive	n	n	-	-	-	-	ambiguous	ambiguous	ambiguous	-	-	-
613094	MICROPHTHALMIA, ISOLATED 4	Microphthalmia, isolated 4, 613094 (3)	Microphthalmia, isolated 4	n	-	-	-	GDF6	HGNC:4221	Microphthalmia, isolated 4, 613094 (3)	-	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
613095	POLYCYSTIC KIDNEY DISEASE 2 WITH OR WITHOUT POLYCYSTIC LIVER DISEASE	Polycystic kidney disease 2, 613095 (3)	Polycystic kidney disease 2	y	POLYCYSTIC KIDNEY DISEASE 2 WITH OR WITHOUT POLYCYSTIC LIVER DISEASE; PKD2	Clinical Features|Clinical Synopsis|Phenotype	death|deaths|died|lethal	PKD2	HGNC:9009	Polycystic kidney disease 2, 613095 (3), Autosomal dominant	Autosomal dominant	y	y	[One family with perinatal onset resulting in perinatal death has been reported]	L2	y	-	lethal	lethal	lethal	L2	L2	pre-infant-lethal
613100	GLAUCOMA 1, OPEN ANGLE, O	Glaucoma 1, open angle, 1O, 613100 (3)	Glaucoma 1, open angle, 1O	n	-	-	-	NTF4	HGNC:8024	Glaucoma 1, open angle, 1O, 613100 (3)	-	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
613101	HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 5, WITH OR WITHOUT MICROVILLUS INCLUSION DISEASE	Hemophagocytic lymphohistiocytosis, familial, 5, with or without microvillus inclusion disease, 613101 (3)	Hemophagocytic lymphohistiocytosis, familial, 5, with or without microvillus inclusion disease	y	HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 5, WITH OR WITHOUT MICROVILLUS INCLUSION DISEASE; FHL5	Clinical Features|Clinical Synopsis|Phenotype	died|death|deaths|fatal	STXBP2	HGNC:11445	Hemophagocytic lymphohistiocytosis, familial, 5, with or without microvillus inclusion disease, 613101 (3), Autosomal recessive	Autosomal recessive	y	y	[Stepensky et al. (2013) reported 6 children from 4 unrelated families who presented in the first weeks or months of life with intractable osmotic diarrhea and failure to thrive due to severe enteropathy, as well as classic hematologic and immunologic features of HLH. Three patients died in infancy or early childhood; the others were alive between ages 4 and 12 years of age]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
613102	HYPOTRICHOSIS AND RECURRENT SKIN VESICLES	Hypotrichosis and recurrent skin vesicles, 613102 (3)	Hypotrichosis and recurrent skin vesicles	n	-	-	-	DSC3	HGNC:3037	Hypotrichosis and recurrent skin vesicles, 613102 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
613105	CHOROIDAL DYSTROPHY, CENTRAL AREOLAR 2	Choroidal dystrophy, central areolar 2, 613105 (3)	Choroidal dystrophy, central areolar 2	n	-	-	-	PRPH2	HGNC:9942	Choroidal dystrophy, central areolar 2, 613105 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
613107	NEUTROPENIA, SEVERE CONGENITAL, 2, AUTOSOMAL DOMINANT	Neutropenia, severe congenital 2, autosomal dominant, 613107 (3)	Neutropenia, severe congenital 2, autosomal dominant	n	-	-	-	GFI1	HGNC:4237	Neutropenia, severe congenital 2, autosomal dominant, 613107 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
613108	CANDIDIASIS, FAMILIAL, 4	Candidiasis, familial, 4, autosomal recessive, 613108 (3)	Candidiasis, familial, 4, autosomal recessive	n	-	-	-	CLEC7A	HGNC:14558	Candidiasis, familial, 4, autosomal recessive, 613108 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
613112	MACROTHROMBOCYTOPENIA, ISOLATED, 1, AUTOSOMAL DOMINANT	Macrothrombocytopenia, isolated, 1, autosomal dominant, 613112 (3)	Macrothrombocytopenia, isolated, 1, autosomal dominant	n	-	-	-	TUBB1	HGNC:16257	Macrothrombocytopenia, isolated, 1, autosomal dominant, 613112 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
613115	NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE IIB	Neuropathy, hereditary sensory and autonomic, type IIB, 613115 (3)	Neuropathy, hereditary sensory and autonomic, type IIB	n	-	-	-	RETREG1	HGNC:25964	Neuropathy, hereditary sensory and autonomic, type IIB, 613115 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
613116	THROMBOPHILIA DUE TO HISTIDINE-RICH GLYCOPROTEIN DEFICIENCY	Thrombophilia 11 due to HRG deficiency, 613116 (3)	Thrombophilia 11 due to HRG deficiency	y	THROMBOPHILIA DUE TO HISTIDINE-RICH GLYCOPROTEIN DEFICIENCY; THPH11	Clinical Features	died	HRG	HGNC:5181	Thrombophilia 11 due to HRG deficiency, 613116 (3), Autosomal dominant	Autosomal dominant	n	y	[died of massive pulmonary embolism at age 34]	L6	y	-	lethal	lethal	lethal	L6	L6	post-infant-lethal
613118	ANTITHROMBIN III DEFICIENCY	Thrombophilia 7 due to antithrombin III deficiency, 613118 (3)	Thrombophilia 7 due to antithrombin III deficiency	n	-	-	-	SERPINC1	HGNC:775	Thrombophilia 7 due to antithrombin III deficiency, 613118 (3), Autosomal dominant, Autosomal recessive	Autosomal dominant, Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
613120	BRUGADA SYNDROME 7	Atrial fibrillation, familial, 16, 613120 (3)	Atrial fibrillation, familial, 16	y	BRUGADA SYNDROME 7; BRGDA7	Description|Clinical Features	death|deaths|died	SCN3B	HGNC:20665	Atrial fibrillation, familial, 16, 613120 (3), Autosomal dominant	Autosomal dominant	n	y	[Brugada syndrome is characterized by an ST segment elevation in the right precordial electrocardiogram leads (so-called type 1 ECG) and a high incidence of sudden death in patients with structurally normal hearts. The syndrome typically manifests during adulthood, with a mean age of sudden death of 41 +/- 15 years, but also occurs in infants and children (summary by Antzelevitch et al., 2005)]	L6	y	-	lethal	lethal	lethal	L6	L6	post-infant-lethal
613120	BRUGADA SYNDROME 7	Atrial fibrillation, familial, 16, 613120 (3)	Atrial fibrillation, familial, 16	y	BRUGADA SYNDROME 7; BRGDA7	Description|Clinical Features	death|deaths|died	SCN3B	HGNC:20665	Atrial fibrillation, familial, 16, 613120 (3), Autosomal dominant	Autosomal dominant	n	y	[Brugada syndrome is characterized by an ST segment elevation in the right precordial electrocardiogram leads (so-called type 1 ECG) and a high incidence of sudden death in patients with structurally normal hearts. The syndrome typically manifests during adulthood, with a mean age of sudden death of 41 +/- 15 years, but also occurs in infants and children (summary by Antzelevitch et al., 2005)	L6	y	-	lethal	lethal	lethal	L6	L6	post-infant-lethal
613120	BRUGADA SYNDROME 7	Brugada syndrome 7, 613120 (3)	Brugada syndrome 7	y	BRUGADA SYNDROME 7; BRGDA7	Description|Clinical Features	death|deaths|died	SCN3B	HGNC:20665	Brugada syndrome 7, 613120 (3), Autosomal dominant	Autosomal dominant	n	y	[Brugada syndrome is characterized by an ST segment elevation in the right precordial electrocardiogram leads (so-called type 1 ECG) and a high incidence of sudden death in patients with structurally normal hearts. The syndrome typically manifests during adulthood, with a mean age of sudden death of 41 +/- 15 years, but also occurs in infants and children (summary by Antzelevitch et al., 2005)]	L6	y	-	lethal	lethal	lethal	L6	L6	post-infant-lethal
613120	BRUGADA SYNDROME 7	Brugada syndrome 7, 613120 (3)	Brugada syndrome 7	y	BRUGADA SYNDROME 7; BRGDA7	Description|Clinical Features	death|deaths|died	SCN3B	HGNC:20665	Brugada syndrome 7, 613120 (3), Autosomal dominant	Autosomal dominant	n	y	[Brugada syndrome is characterized by an ST segment elevation in the right precordial electrocardiogram leads (so-called type 1 ECG) and a high incidence of sudden death in patients with structurally normal hearts. The syndrome typically manifests during adulthood, with a mean age of sudden death of 41 +/- 15 years, but also occurs in infants and children (summary by Antzelevitch et al., 2005)	L6	y	-	lethal	lethal	lethal	L6	L6	post-infant-lethal
613122	CARDIOMYOPATHY, DILATED, 1CC	Cardiomyopathy, dilated, 1CC, 613122 (3)	Cardiomyopathy, dilated, 1CC	y	CARDIOMYOPATHY, DILATED, 1CC; CMD1CC	Phenotype	died	NEXN	HGNC:29557	Cardiomyopathy, dilated, 1CC, 613122 (3), Autosomal dominant	Autosomal dominant	n	y	[had died from dilated cardiomyopathy]	LU	y	-	lethal	lethal	lethal	L6|LU	L6	post-infant-lethal
613123	BRUGADA SYNDROME 8	Brugada syndrome 8, 613123 (3)	Brugada syndrome 8	y	BRUGADA SYNDROME 8; BRGDA8	Description|Clinical Features	death|deaths	HCN4	HGNC:16882	Brugada syndrome 8, 613123 (3)	-	y	y	[Brugada syndrome is characterized by an ST segment elevation in the right precordial electrocardiogram leads (so-called type 1 ECG) and a high incidence of sudden death in patients with structurally normal hearts. The syndrome typically manifests during adulthood, with a mean age of sudden death of 41 +/- 15 years, but also occurs in infants and children (summary by Antzelevitch et al., 2005)]	L6	y	-	lethal	lethal	lethal	L6|LU	L6	post-infant-lethal
613135	PARKINSONISM-DYSTONIA 1, INFANTILE-ONSET	Parkinsonism-dystonia, infantile, 1, 613135 (3)	Parkinsonism-dystonia, infantile, 1	y	PARKINSONISM-DYSTONIA 1, INFANTILE-ONSET; PKDYS1	Description|Clinical Features|Clinical Synopsis	die|died|death|deaths	SLC6A3	HGNC:11049	Parkinsonism-dystonia, infantile, 1, 613135 (3), Autosomal recessive	Autosomal recessive	y	y	[Death often in the teenage years / Kurian et al. (2011) reported 11 children with dopamine transporter deficiency confirmed by genetic analysis, including the 3 patients reported by Kurian et al. (2009).. Four patients died between 9 and 16 years of age]	L4	y	-	lethal	lethal	lethal	L4	L4	post-infant-lethal
613148	INFLAMMATORY BOWEL DISEASE 28, AUTOSOMAL RECESSIVE	Inflammatory bowel disease 28, early onset, autosomal recessive, 613148 (3)	Inflammatory bowel disease 28, early onset, autosomal recessive	n	-	-	-	IL10RA	HGNC:5964	Inflammatory bowel disease 28, early onset, autosomal recessive, 613148 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
613150	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 2	Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 2, 613150 (3)	Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 2	y	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 2; MDDGA2	Description|Clinical Features|Clinical Synopsis	death|deaths|died|die	POMT2	HGNC:19743	Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 2, 613150 (3), Autosomal recessive	Autosomal recessive	y	y	[Majority of WWS patients die within the first year of life]	L3	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L3|L6	L3	pre-infant-lethal
613151	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH IMPAIRED INTELLECTUAL DEVELOPMENT), TYPE B, 3	Muscular dystrophy-dystroglycanopathy (congenital with impaired intellectual development), type B, 3, 613151 (3)	Muscular dystrophy-dystroglycanopathy (congenital with impaired intellectual development), type B, 3	n	-	-	-	POMGNT1	HGNC:19139	Muscular dystrophy-dystroglycanopathy (congenital with impaired intellectual development), type B, 3, 613151 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L3	L3	pre-infant-lethal
613152	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT), TYPE B, 4	Muscular dystrophy-dystroglycanopathy (congenital without impaired intellectual development), type B, 4, 613152 (3)	Muscular dystrophy-dystroglycanopathy (congenital without impaired intellectual development), type B, 4	n	-	-	-	FKTN	HGNC:3622	Muscular dystrophy-dystroglycanopathy (congenital without impaired intellectual development), type B, 4, 613152 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L2|L5	L2	pre-infant-lethal
613153	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 5	Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 5, 613153 (3)	Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 5	y	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 5; MDDGA5	Description|Clinical Features|Clinical Synopsis	death|deaths|died	FKRP	HGNC:17997	Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 5, 613153 (3), Autosomal recessive	Autosomal recessive	y	y	[Van Reeuwijk et al. (2010) reported a boy, born of consanguineous parents, with a clinical diagnosis of Walker-Warburg syndrome. He was born with severe hydrocephalus and showed limited spontaneous movements. He had microphthalmia, asymmetric pupils, absent pupillary light reflexes, and cataracts. Brain MRI showed aqueductal stenosis and small cerebellum and pons with kinking of the brainstem. Muscle biopsy showed muscular dystrophy. The infant died of respiratory distress at 6 days of age]	L2	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L2	L2	pre-infant-lethal
613154	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 6	Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 6, 613154 (3)	Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 6	y	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 6; MDDGA6	Description|Clinical Features	death|deaths|died	LARGE1	HGNC:6511	Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 6, 613154 (3), Autosomal recessive	Autosomal recessive	y	y	[Godfrey et al. (2007) identified 1 patient with LARGE-related WWS in a larger study of 92 patients with muscular dystrophy and evidence of a dystroglycanopathy. Although clinical details were limited, the patient had prenatal onset, feeding difficulties, increased serum creatine kinase, contractures, retinal dysplasia, low IQ, and death at age 8 weeks]	L3	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L3	L3	pre-infant-lethal
613155	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH IMPAIRED INTELLECTUAL DEVELOPMENT), TYPE B, 1	Muscular dystrophy-dystroglycanopathy (congenital with impaired intellectual development), type B, 1, 613155 (3)	Muscular dystrophy-dystroglycanopathy (congenital with impaired intellectual development), type B, 1	n	-	-	-	POMT1	HGNC:9202	Muscular dystrophy-dystroglycanopathy (congenital with impaired intellectual development), type B, 1, 613155 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L3	L3	pre-infant-lethal
613156	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH IMPAIRED INTELLECTUAL DEVELOPMENT), TYPE B, 2	Muscular dystrophy-dystroglycanopathy (congenital with impaired intellectual development), type B, 2, 613156 (3)	Muscular dystrophy-dystroglycanopathy (congenital with impaired intellectual development), type B, 2	y	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH IMPAIRED INTELLECTUAL DEVELOPMENT), TYPE B, 2; MDDGB2	Clinical Features	died	POMT2	HGNC:19743	Muscular dystrophy-dystroglycanopathy (congenital with impaired intellectual development), type B, 2, 613156 (3), Autosomal recessive	Autosomal recessive	y	y	[died of respiratory failure at age 24 years]	L6	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L3|L6	L3	pre-infant-lethal
613157	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 3	Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 3, 613157 (3)	Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 3	n	-	-	-	POMGNT1	HGNC:19139	Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 3, 613157 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L3	L3	pre-infant-lethal
613158	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 2	Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 2, 613158 (3)	Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 2	n	-	-	-	POMT2	HGNC:19743	Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 2, 613158 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L3|L6	L3	pre-infant-lethal
613159	NEPHRONOPHTHISIS-LIKE NEPHROPATHY 1	Nephronophthisis-like nephropathy 1, 613159 (3)	Nephronophthisis-like nephropathy 1	n	-	-	-	XPNPEP3	HGNC:28052	Nephronophthisis-like nephropathy 1, 613159 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
613161	BETA-UREIDOPROPIONASE DEFICIENCY	Beta-ureidopropionase deficiency, 613161 (3)	Beta-ureidopropionase deficiency	y	BETA-UREIDOPROPIONASE DEFICIENCY; UPB1D	Clinical Features	died	UPB1	HGNC:16297	Beta-ureidopropionase deficiency, 613161 (3), Autosomal recessive	Autosomal recessive	y	y	[Van Kuilenburg et al. (2004) reported 3 additional unrelated patients with genetically confirmed beta-ureidopropionase deficiency. ... Two brothers had died at birth and at age 9 months]	L2	n	y	lethal	lethal	lethal	L2	L2	pre-infant-lethal
613162	SPASTIC PARAPLEGIA 45, AUTOSOMAL RECESSIVE	Spastic paraplegia 45, autosomal recessive, 613162 (3)	Spastic paraplegia 45, autosomal recessive	n	-	-	-	NT5C2	HGNC:8022	Spastic paraplegia 45, autosomal recessive, 613162 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
613163	GABA-TRANSAMINASE DEFICIENCY	GABA-transaminase deficiency, 613163 (3)	GABA-transaminase deficiency	y	GABA-TRANSAMINASE DEFICIENCY	Description|Clinical Features|Clinical Synopsis	die|died|death|deaths	ABAT	HGNC:23	GABA-transaminase deficiency, 613163 (3), Autosomal recessive	Autosomal recessive	n	y	[Medina-Kauwe et al. (1999) described a second unrelated patient with GABA-aminotransferase deficiency and reviewed the patient reported by Jaeken et al. (1984). The phenotype in both included severe psychomotor retardation, hypotonia, hyperreflexia, lethargy, refractory seizures, high-pitched cry, and EEG abnormalities. The second patient did not have increased linear growth. Brain MRI of the second patient showed agenesis of the corpus callosum, cerebellar hypoplasia, a posterior fossa cyst, and abnormal gyration. GABA concentrations were significantly increased in all bodily fluids. He died at 5 months of age]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
613172	CARDIOMYOPATHY, DILATED, 1DD	Cardiomyopathy, dilated, 1DD, 613172 (3)	Cardiomyopathy, dilated, 1DD	y	CARDIOMYOPATHY, DILATED, 1DD; CMD1DD	Clinical Features|Clinical Synopsis|Phenotype	death|deaths|died	RBM20	HGNC:27424	Cardiomyopathy, dilated, 1DD, 613172 (3), Autosomal dominant	Autosomal dominant	n	y	[Sudden cardiac death / Li et al. (2010) described CMD patients with mutations in the RBM20 gene. One proband (Pedigree B) presented with a flu-like illness that prompted a chest x-ray examination, which revealed remarkable cardiomegaly. She was diagnosed with CMD at 46 years of age, and at age 53, she had decompensated heart failure; she died later that year. In another family (Pedigree D), the asymptomatic proband underwent clinical screening at age 43 years due to a strong family history of cardiovascular disease and was diagnosed with CMD, frequent ventricular premature beats, and ventricular tachycardia. Family history included early deaths in her sister (age 25) and 2 nieces (ages 14 and 16 years) from arrhythmias and/or complications after heart transplantation]	L5	y	y	lethal	lethal	lethal	L5	L5	post-infant-lethal
613177	CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IC	Cutis laxa, autosomal recessive, type IC, 613177 (3)	Cutis laxa, autosomal recessive, type IC	y	CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IC; ARCL1C	Clinical Features	death|deaths|died	LTBP4	HGNC:6717	Cutis laxa, autosomal recessive, type IC, 613177 (3), Autosomal recessive	Autosomal recessive	n	y	[Callewaert et al. (2013) studied affected individuals from 9 families with cutis laxa and mutations in the LTB4 gene (see MOLECULAR GENETICS)... . Overall the prognosis was poor, with a mortality rate over 80%; mean age at death was 4 years, and most succumbed to respiratory failure]	L4	y	-	lethal	lethal	lethal	L4	L4	post-infant-lethal
613179	PURINE NUCLEOSIDE PHOSPHORYLASE DEFICIENCY	Immunodeficiency due to purine nucleoside phosphorylase deficiency, 613179 (3)	Immunodeficiency due to purine nucleoside phosphorylase deficiency	y	PURINE NUCLEOSIDE PHOSPHORYLASE DEFICIENCY	Clinical Features	died	PNP	HGNC:7892	Immunodeficiency due to purine nucleoside phosphorylase deficiency, 613179 (3), Autosomal recessive	Autosomal recessive	y	y	[Hagberg et al. (1970) described brother and sister with ataxic diplegia and defective cellular immunity. At age 15 months, the sister had vaccinia gangrenosa, which was successfully drug-treated. She died of generalized varicella at age 4.5 years. The brother died at age 5 years of brain abscess]	L4	y	-	lethal	lethal	lethal	L4	L4	post-infant-lethal
613192	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 13	Intellectual developmental disorder, autosomal recessive 13, 613192 (3)	Intellectual developmental disorder, autosomal recessive 13	n	-	-	-	TRAPPC9	HGNC:30832	Intellectual developmental disorder, autosomal recessive 13, 613192 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
613193	CILIARY DYSKINESIA, PRIMARY, 13	Ciliary dyskinesia, primary, 13, 613193 (3)	Ciliary dyskinesia, primary, 13	n	-	-	-	DNAAF1	HGNC:30539	Ciliary dyskinesia, primary, 13, 613193 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
613194	RETINITIS PIGMENTOSA 50	Retinitis pigmentosa, concentric, 613194 (3)	Retinitis pigmentosa, concentric	n	-	-	-	BEST1	HGNC:12703	Retinitis pigmentosa, concentric, 613194 (3)	-	-	-	-	-	-	-	nonlethal	ambiguous|nonlethal	ambiguous	-	-	-
613194	RETINITIS PIGMENTOSA 50	Retinitis pigmentosa-50, 613194 (3)	Retinitis pigmentosa-50	n	-	-	-	BEST1	HGNC:12703	Retinitis pigmentosa-50, 613194 (3)	-	-	-	-	-	-	-	nonlethal	ambiguous|nonlethal	ambiguous	-	-	-
613195	WEILL-MARCHESANI SYNDROME 4	Weill-Marchesani 4 syndrome, recessive, 613195 (3)	Weill-Marchesani 4 syndrome, recessive	n	-	-	-	ADAMTS17	HGNC:17109	Weill-Marchesani 4 syndrome, recessive, 613195 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
613204	MUSCULAR DYSTROPHY, CONGENITAL, DUE TO INTEGRIN ALPHA-7 DEFICIENCY	Muscular dystrophy, congenital, due to ITGA7 deficiency, 613204 (3)	Muscular dystrophy, congenital, due to ITGA7 deficiency	n	-	-	-	ITGA7	HGNC:6143	Muscular dystrophy, congenital, due to ITGA7 deficiency, 613204 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
613205	MUSCULAR DYSTROPHY, CONGENITAL, LMNA-RELATED	Muscular dystrophy, congenital, 613205 (3)	Muscular dystrophy, congenital	n	-	-	-	LMNA	HGNC:6636	Muscular dystrophy, congenital, 613205 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	ambiguous|lethal|nonlethal	lethal|nonlethal	L1|L2|L6	L1	pre-infant-lethal
613211	AMELOGENESIS IMPERFECTA, HYPOMATURATION TYPE, IIA3	Amelogenesis imperfecta, type IIA3, 613211 (3)	Amelogenesis imperfecta, type IIA3	n	-	-	-	WDR72	HGNC:26790	Amelogenesis imperfecta, type IIA3, 613211 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
613216	NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1C	Night blindness, congenital stationary (complete), 1C, autosomal recessive, 613216 (3)	Night blindness, congenital stationary (complete), 1C, autosomal recessive	n	-	-	-	TRPM1	HGNC:7146	Night blindness, congenital stationary (complete), 1C, autosomal recessive, 613216 (3)	-	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
613217	DIARRHEA 5, WITH TUFTING ENTEROPATHY, CONGENITAL	Diarrhea 5, with tufting enteropathy, congenital, 613217 (3)	Diarrhea 5, with tufting enteropathy, congenital	y	DIARRHEA 5, WITH TUFTING ENTEROPATHY, CONGENITAL; DIAR5	Clinical Features	died	EPCAM	HGNC:11529	Diarrhea 5, with tufting enteropathy, congenital, 613217 (3), Autosomal recessive	Autosomal recessive	y	y	[Goulet et al. (1998) studied the clinical and histopathologic features of 47 infants with intractable diarrhea and villous atrophy of varying degrees, dividing them into 2 groups, with or without lamina propria mononuclear cell infiltration. Of the 18 patients in the latter group, 10 had mild to moderate villous atrophy and primarily epithelial abnormalities that appeared 'similar' to those described as 'tufting enteropathy' by Reifen et al. (1994), as well as pseudocystic and branching crypts. Three of the patients had affected sibs who died in the first few months of life with severe diarrhea of unknown origin, and 1 patient had consanguineous parents]	L3	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L3	L3	pre-infant-lethal
613224	NOONAN SYNDROME 6	Noonan syndrome 6, 613224 (3)	Noonan syndrome 6	n	-	-	-	NRAS	HGNC:7989	Noonan syndrome 6, 613224 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
613225	FACTOR XIII, A SUBUNIT, DEFICIENCY OF	Factor XIIIA deficiency, 613225 (3)	Factor XIIIA deficiency	y	FACTOR XIII, A SUBUNIT, DEFICIENCY OF	Clinical Features|Clinical Synopsis	died|spontaneous_abortion|spontaneous_abortions|miscarriage|miscarriages	F13A1	HGNC:3531	Factor XIIIA deficiency, 613225 (3), Autosomal recessive	Autosomal recessive	y	n	-	-	-	-	ambiguous	ambiguous	ambiguous	-	-	-
613227	CEREBELLAR ATAXIA, IMPAIRED INTELLECTUAL DEVELOPMENT, AND DYSEQUILIBRIUM SYNDROME 3	Cerebellar ataxia, impaired intellectual development and dysequilibrium syndrome 3, 613227 (3)	Cerebellar ataxia, impaired intellectual development and dysequilibrium syndrome 3	n	-	-	-	CA8	HGNC:1382	Cerebellar ataxia, impaired intellectual development and dysequilibrium syndrome 3, 613227 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
613235	FACTOR XIII, B SUBUNIT, DEFICIENCY OF	Factor XIIIB deficiency, 613235 (3)	Factor XIIIB deficiency	n	-	-	-	F13B	HGNC:3534	Factor XIIIB deficiency, 613235 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
613237	FOCAL SEGMENTAL GLOMERULOSCLEROSIS 5	Glomerulosclerosis, focal segmental, 5, 613237 (3)	Glomerulosclerosis, focal segmental, 5	n	-	-	-	INF2	HGNC:23791	Glomerulosclerosis, focal segmental, 5, 613237 (3)	-	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
613243	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 13	Cardiomyopathy, hypertrophic, 13, 613243 (3)	Cardiomyopathy, hypertrophic, 13	y	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 13; CMH13	Clinical Features	death|deaths	TNNC1	HGNC:11943	Cardiomyopathy, hypertrophic, 13, 613243 (3), Autosomal dominant	Autosomal dominant	n	n	-	-	-	-	ambiguous	ambiguous|lethal	lethal	L6	L6	post-infant-lethal
613244	LYNCH SYNDROME 8	Lynch syndrome 8, 613244 (3)	Lynch syndrome 8	n	-	-	-	EPCAM	HGNC:11529	Lynch syndrome 8, 613244 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L3	L3	pre-infant-lethal
613251	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 14	Cardiomyopathy, hypertrophic, 14, 613251 (3)	Cardiomyopathy, hypertrophic, 14	y	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 14; CMH14	Phenotype	death|deaths|died	MYH6	HGNC:7576	Cardiomyopathy, hypertrophic, 14, 613251 (3), Autosomal dominant	Autosomal dominant	y	y	[died of refractory congestive heart failure while awaiting heart transplantation at age 45 years]	L6	-	-	lethal	lethal|nonlethal	lethal|nonlethal	L6	L6	post-infant-lethal
613252	CARDIOMYOPATHY, DILATED, 1EE	Cardiomyopathy, dilated, 1EE, 613252 (3)	Cardiomyopathy, dilated, 1EE	n	-	-	-	MYH6	HGNC:7576	Cardiomyopathy, dilated, 1EE, 613252 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L6	L6	post-infant-lethal
613254	TUBEROUS SCLEROSIS 2	Tuberous sclerosis-2, 613254 (3)	Tuberous sclerosis-2	n	-	-	-	TSC2	HGNC:12363	Tuberous sclerosis-2, 613254 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
613255	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 15	Cardiomyopathy, hypertrophic, 15, 613255 (3)	Cardiomyopathy, hypertrophic, 15	y	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 15; CMH15	Clinical Features	death|deaths	VCL	HGNC:12665	Cardiomyopathy, hypertrophic, 15, 613255 (3), Autosomal dominant	Autosomal dominant	n	y	[Vasile et al. (2006) studied a 43-year-old woman with severe apical variant hypertrophic cardiomyopathy, who presented with congestive heart failure and moderate (New York Heart Association class III) symptoms of exertional dyspnea...Her family history was positive for sudden cardiac death involving an uncle]	LU	n	y	lethal	ambiguous|lethal	lethal	LU	LU	post-infant-lethal
613265	WAARDENBURG SYNDROME, TYPE 4B	Waardenburg syndrome, type 4B, 613265 (3)	Waardenburg syndrome, type 4B	y	WAARDENBURG SYNDROME, TYPE 4B; WS4B	Clinical Features	died	EDN3	HGNC:3178	Waardenburg syndrome, type 4B, 613265 (3), Autosomal dominant, Autosomal recessive	Autosomal dominant, Autosomal recessive	n	y	[Shamseldin et al. (2010) reported an 8-year-old Egyptian boy with WS4B confirmed by genetic analysis (R93G; 131242.0009). He was noted to have a white forelock, grayish blue eyes, hypoplastic ears, and intrauterine growth retardation at birth. Hirschsprung disease was diagnosed soon after. He also had mixed hearing loss with absence of brainstem auditory-evoked response. Family history revealed 2 sibs who died as neonates from complications related to Hirschsprung disease]	L2	n	y	lethal	lethal	lethal	L2	L2	pre-infant-lethal
613266	WAARDENBURG SYNDROME, TYPE 4C	Waardenburg syndrome, type 4C, 613266 (3)	Waardenburg syndrome, type 4C	n	-	-	-	SOX10	HGNC:11190	Waardenburg syndrome, type 4C, 613266 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L2	L2	pre-infant-lethal
613267	CORNEAL DYSTROPHY, FUCHS ENDOTHELIAL, 3	Corneal dystrophy, Fuchs endothelial, 3, 613267 (3)	Corneal dystrophy, Fuchs endothelial, 3	n	-	-	-	TCF4	HGNC:11634	Corneal dystrophy, Fuchs endothelial, 3, 613267 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L6	L6	post-infant-lethal
613268	CORNEAL DYSTROPHY, FUCHS ENDOTHELIAL, 4	Corneal dystrophy, Fuchs endothelial, 4, 613268 (3)	Corneal dystrophy, Fuchs endothelial, 4	n	-	-	-	SLC4A11	HGNC:16438	Corneal dystrophy, Fuchs endothelial, 4, 613268 (3)	-	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
613270	CORNEAL DYSTROPHY, FUCHS ENDOTHELIAL, 6	Corneal dystrophy, Fuchs endothelial, 6, 613270 (3)	Corneal dystrophy, Fuchs endothelial, 6	n	-	-	-	ZEB1	HGNC:11642	Corneal dystrophy, Fuchs endothelial, 6, 613270 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
613280	HYPERMANGANESEMIA WITH DYSTONIA 1	Hypermanganesemia with dystonia 1, 613280 (3)	Hypermanganesemia with dystonia 1	y	HYPERMANGANESEMIA WITH DYSTONIA 1; HMNDYT1	Clinical Features	died	SLC30A10	HGNC:25355	Hypermanganesemia with dystonia 1, 613280 (3), Autosomal recessive	Autosomal recessive	y	y	[Tuschl et al. (2012) reported 15 individuals from 8 families with HMNDTY1, including 4 patients from 3 families previously reported by Gospe et al. (2000), Tuschl et al. (2008), Sahni et al. (2007), and Brna et al. (2011). The patients presented between 2 and 15 years of age with gait disturbances and hypertonia, with some becoming wheelchair-bound. Most had a pure 4-limb dystonia, with a high stepping gait and fine motor impairment, sometimes with dysarthria, fine tremor, and bradykinesia; 1 had pure spastic paraparesis without extrapyramidal features. Intellectual development was normal. All had pathognomonic MRI brain scans with hyperintensities of the globus pallidus, putamen, caudate, subthalamic and dentate nucleus and sparing of the thalamus and ventral pons on T1-weighted images. Those with more extensive disease showed white matter and anterior pituitary involvement. Most patients had liver impairment with raised transaminases and unconjugated hyperbilirubinemia; 2 died of cirrhosis / Tuschl et al. (2008) reported an Arab girl with a constellation of clinical features consisting of hypermanganesemia, liver cirrhosis, an extrapyramidal motor disorder, and polycythemia... The patient had 4 healthy brothers and 3 healthy sisters; 1 older brother died at the age of 18 years from gastrointestinal hemorrhage secondary to cirrhosis]	L5	y	y	lethal	lethal	lethal	L5	L5	post-infant-lethal
613285	DEAFNESS, AUTOSOMAL RECESSIVE 25	Deafness, autosomal recessive 25, 613285 (3)	Deafness, autosomal recessive 25	n	-	-	-	GRXCR1	HGNC:31673	Deafness, autosomal recessive 25, 613285 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
613286	CARDIOMYOPATHY, DILATED, 1FF	Cardiomyopathy, dilated, 1FF, 613286 (3)	Cardiomyopathy, dilated, 1FF	n	-	-	-	TNNI3	HGNC:11947	Cardiomyopathy, dilated, 1FF, 613286 (3)	-	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L3|LU	L3	pre-infant-lethal
613287	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2N	Charcot-Marie-Tooth disease, axonal, type 2N, 613287 (3)	Charcot-Marie-Tooth disease, axonal, type 2N	n	-	-	-	AARS1	HGNC:20	Charcot-Marie-Tooth disease, axonal, type 2N, 613287 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	ambiguous|nonlethal	ambiguous	-	-	-
613307	DEAFNESS, AUTOSOMAL RECESSIVE 79	Deafness, autosomal recessive 79, 613307 (3)	Deafness, autosomal recessive 79	n	-	-	-	TPRN	HGNC:26894	Deafness, autosomal recessive 79, 613307 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
613308	DIAMOND-BLACKFAN ANEMIA 9	Diamond-Blackfan anemia 9, 613308 (3)	Diamond-Blackfan anemia 9	n	-	-	-	RPS10	HGNC:10383	Diamond-Blackfan anemia 9, 613308 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
613309	DIAMOND-BLACKFAN ANEMIA 10	Diamond-Blackfan anemia 10, 613309 (3)	Diamond-Blackfan anemia 10	n	-	-	-	RPS26	HGNC:10414	Diamond-Blackfan anemia 10, 613309 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
613310	EXUDATIVE VITREORETINOPATHY 5	Exudative vitreoretinopathy 5, 613310 (3)	Exudative vitreoretinopathy 5	n	-	-	-	TSPAN12	HGNC:21641	Exudative vitreoretinopathy 5, 613310 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
613312	HYPOPHOSPHATEMIC RICKETS, AUTOSOMAL RECESSIVE, 2	Hypophosphatemic rickets, autosomal recessive, 2, 613312 (3)	Hypophosphatemic rickets, autosomal recessive, 2	n	-	-	-	ENPP1	HGNC:3356	Hypophosphatemic rickets, autosomal recessive, 2, 613312 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L1	L1	pre-infant-lethal
613313	HEMOCHROMATOSIS, TYPE 2B	Hemochromatosis, type 2B, 613313 (3)	Hemochromatosis, type 2B	n	-	-	-	HAMP	HGNC:15598	Hemochromatosis, type 2B, 613313 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
613319	MIYOSHI MUSCULAR DYSTROPHY 3	Miyoshi muscular dystrophy 3, 613319 (3)	Miyoshi muscular dystrophy 3	n	-	-	-	ANO5	HGNC:27337	Miyoshi muscular dystrophy 3, 613319 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
613320	SPONDYLOMETAPHYSEAL DYSPLASIA, MEGARBANE-DAGHER-MELKI TYPE	Spondylometaphyseal dysplasia, Megarbane-Dagher-Melike type, 613320 (3)	Spondylometaphyseal dysplasia, Megarbane-Dagher-Melike type	y	SPONDYLOMETAPHYSEAL DYSPLASIA, MEGARBANE-DAGHER-MELKI TYPE; SMDMDM	Clinical Features|Phenotype	died|lethal	PAM16	HGNC:29679	Spondylometaphyseal dysplasia, Megarbane-Dagher-Melike type, 613320 (3), Autosomal recessive	Autosomal recessive	y	y	[Megarbane et al. (2008) described a consanguineous Lebanese family in which a sister and a brother had chondrodysplasia, developmental delay, severe pre- and postnatal short stature, dysmorphic facial appearance, narrow chest, prominent abdomen, and short limbs... The sister died at age 9 months as a result of respiratory insufficiency. A clinical and radiologic follow-up of the boy at age 18 months showed that the axial hypotonia, minor anomalies, and short stature were still present, whereas the bone abnormalities had improved]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
613327	LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 4	Lipodystrophy, congenital generalized, type 4, 613327 (3)	Lipodystrophy, congenital generalized, type 4	y	LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 4; CGL4	Clinical Features|Clinical Synopsis	death|deaths|died	CAVIN1	HGNC:9688	Lipodystrophy, congenital generalized, type 4, 613327 (3), Autosomal recessive	Autosomal recessive	y	y	[Sudden death due to cardiac arrhythmia may occur / Rajab et al. (2010) reported a 12-year-old girl from the U.K. who had a similar phenotype... She died at age 13 years from sudden cardiac death due to ventricular fibrillation]	L5	y	-	lethal	lethal	lethal	L5	L5	post-infant-lethal
613329	PLASMINOGEN ACTIVATOR INHIBITOR-1 DEFICIENCY	Plasminogen activator inhibitor-1 deficiency, 613329 (3)	Plasminogen activator inhibitor-1 deficiency	n	-	-	-	SERPINE1	HGNC:8583	Plasminogen activator inhibitor-1 deficiency, 613329 (3), Autosomal dominant, Autosomal recessive	Autosomal dominant, Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
613330	SPONDYLO-MEGAEPIPHYSEAL-METAPHYSEAL DYSPLASIA	Spondylo-megaepiphyseal-metaphyseal dysplasia, 613330 (3)	Spondylo-megaepiphyseal-metaphyseal dysplasia	y	SPONDYLO-MEGAEPIPHYSEAL-METAPHYSEAL DYSPLASIA; SMMD	Clinical Features	died	NKX3-2	HGNC:951	Spondylo-megaepiphyseal-metaphyseal dysplasia, 613330 (3), Autosomal recessive	Autosomal recessive	n	y	[Simsek-Kiper et al. (2019) reported a newborn boy, born to healthy Turkish parents who were not known to be related but came from the same Turkish village.. The boy also had duodenal atresia; following surgical repair, he developed sepsis and respiratory failure and died at 14 days of life]	L2	y	-	lethal	lethal	lethal	L2	L2	pre-infant-lethal
613341	LEBER CONGENITAL AMAUROSIS 14	Leber congenital amaurosis 14, 613341 (3)	Leber congenital amaurosis 14	n	-	-	-	LRAT	HGNC:6685	Leber congenital amaurosis 14, 613341 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
613341	LEBER CONGENITAL AMAUROSIS 14	Retinal dystrophy, early-onset severe, 613341 (3)	Retinal dystrophy, early-onset severe	n	-	-	-	LRAT	HGNC:6685	Retinal dystrophy, early-onset severe, 613341 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
613341	LEBER CONGENITAL AMAUROSIS 14	Retinitis pigmentosa, juvenile, 613341 (3)	Retinitis pigmentosa, juvenile	n	-	-	-	LRAT	HGNC:6685	Retinitis pigmentosa, juvenile, 613341 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
613345	HYPOKALEMIC PERIODIC PARALYSIS, TYPE 2	Hypokalemic periodic paralysis, type 2, 613345 (3)	Hypokalemic periodic paralysis, type 2	n	-	-	-	SCN4A	HGNC:10591	Hypokalemic periodic paralysis, type 2, 613345 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L1|L2|L3	L1	pre-infant-lethal
613353	MONONEUROPATHY OF THE MEDIAN NERVE, MILD	Mononeuropathy of the median nerve, mild, 613353 (3)	Mononeuropathy of the median nerve, mild	n	-	-	-	SH3TC2	HGNC:29427	Mononeuropathy of the median nerve, mild, 613353 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L6	L6	post-infant-lethal
613370	MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 10	Maturity-onset diabetes of the young, type 10, 613370 (3)	Maturity-onset diabetes of the young, type 10	n	-	-	-	INS	HGNC:6081	Maturity-onset diabetes of the young, type 10, 613370 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
613375	MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 11	Maturity-onset diabetes of the young, type 11, 613375 (3)	Maturity-onset diabetes of the young, type 11	n	-	-	-	BLK	HGNC:1057	Maturity-onset diabetes of the young, type 11, 613375 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
613382	BRACHYDACTYLY, TYPE E2	Brachydactyly, type E2, 613382 (3)	Brachydactyly, type E2	n	-	-	-	PTHLH	HGNC:9607	Brachydactyly, type E2, 613382 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
613385	AUTOIMMUNE DISEASE, MULTISYSTEM, WITH FACIAL DYSMORPHISM	Autoimmune disease, multisystem, with facial dysmorphism, 613385 (3)	Autoimmune disease, multisystem, with facial dysmorphism	y	AUTOIMMUNE DISEASE, MULTISYSTEM, WITH FACIAL DYSMORPHISM; ADMFD	Clinical Features|Clinical Synopsis	death|deaths|fatal	ITCH	HGNC:13890	Autoimmune disease, multisystem, with facial dysmorphism, 613385 (3), Autosomal recessive	Autosomal recessive	y	y	[Lohr et al. (2010) studied 10 Old Order Amish children from 8 related and consanguineous families with organomegaly, failure to thrive, developmental delay, dysmorphic features, and autoimmune inflammatory cell infiltration of the lungs, liver, and gut... Chronic lung disease was present in 9 of the 10 children, often clinically characterized as asthma and consisting of a cellular, nonspecific interstitial pneumonitis; respiratory failure was the cause of death in all 3 children who were deceased, at 6 months, 1.2 years, and 3 years of age, respectively]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
613390	FANCONI ANEMIA, COMPLEMENTATION GROUP O	Fanconi anemia, complementation group O, 613390 (3)	Fanconi anemia, complementation group O	y	FANCONI ANEMIA, COMPLEMENTATION GROUP O; FANCO	Clinical Features	died	RAD51C	HGNC:9820	Fanconi anemia, complementation group O, 613390 (3), Autosomal recessive	Autosomal recessive	n	y	[Vaz et al. (2010) reported a consanguineous Pakistani family in which 3 sibs had multiple severe congenital abnormalities characteristic of Fanconi anemia. One girl died at 2 months of age with 1 absent and 1 vestigial thumb, a congenital heart defect, imperforate anus, and hydronephrosis. Her lymphocytes showed elevated chromosome breakage after treatment with the DNA interstrand cross-linking agent mitomycin C, indicating a diagnosis of Fanconi anemia. A son died 2 days after birth with congenital abnormalities similar to those of his sister, and another pregnancy miscarried at 11 weeks]	L1	y	-	lethal	lethal	lethal	L1	L1	pre-infant-lethal
613391	DEAFNESS, AUTOSOMAL RECESSIVE 84A	Deafness, autosomal recessive 84A, 613391 (3)	Deafness, autosomal recessive 84A	n	-	-	-	PTPRQ	HGNC:9679	Deafness, autosomal recessive 84A, 613391 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
613398	WARSAW BREAKAGE SYNDROME	Warsaw breakage syndrome, 613398 (3)	Warsaw breakage syndrome	y	WARSAW BREAKAGE SYNDROME; WABS	Clinical Features	died	DDX11	HGNC:2736	Warsaw breakage syndrome, 613398 (3), Autosomal recessive	Autosomal recessive	n	y	[Capo-Chichi et al. (2013) reported 3 sibs from a consanguineous Lebanese family with Warsaw breakage syndrome. The female proband was examined at 20 months of age and was found to be hypotonic, with severe intellectual disability, small and receding forehead, short nose, small nares, short neck, clinodactyly of the fifth fingers, and a single palmar crease on both hands. She had no abnormalities on abdominal ultrasonography or echocardiography. CT of the brain showed small, rounded cochlea without visible cochlear turns or spirals, and bilateral sensorineural deafness was diagnosed by auditory evoked potential. Her brother also had severe intellectual disability, sensorineural deafness, and similar dysmorphic features, as well as prominent cheeks, flat philtrum, microretrognathism, and strabismus. Echocardiogram showed tetralogy of Fallot, and he died at age 4 years of heart failure]	L4	y	-	lethal	lethal	lethal	L4	L4	post-infant-lethal
613402	MICROCEPHALY, SEIZURES, AND DEVELOPMENTAL DELAY	Microcephaly, seizures, and developmental delay, 613402 (3)	Microcephaly, seizures, and developmental delay	n	-	-	-	PNKP	HGNC:9154	Microcephaly, seizures, and developmental delay, 613402 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
613404	ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 2	Arthrogryposis, renal dysfunction, and cholestasis 2, 613404 (3)	Arthrogryposis, renal dysfunction, and cholestasis 2	y	ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 2; ARCS2	Clinical Features|Clinical Synopsis|Phenotype	died|death|deaths	VIPAS39	HGNC:20347	Arthrogryposis, renal dysfunction, and cholestasis 2, 613404 (3), Autosomal recessive	Autosomal recessive	y	y	[Death in infancy, usually from sepsis, dehydration, or acidosis]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
613406	WITTEVEEN-KOLK SYNDROME	Witteveen-Kolk syndrome, 613406 (3)	Witteveen-Kolk syndrome	y	WITTEVEEN-KOLK SYNDROME; WITKOS	Clinical Features	died	SIN3A	HGNC:19353	Witteveen-Kolk syndrome, 613406 (3), Autosomal dominant	Autosomal dominant	y	y	[Bettelheim et al. (1998) reported 2 unrelated fetuses with significant left-sided congenital diaphragmatic hernia detected by ultrasound. One died in utero, and the other died 10 minutes after birth]	L1	y	-	lethal	lethal	lethal	L1	L1	pre-infant-lethal
613411	OGUCHI DISEASE 2	Oguchi disease-2, 613411 (3)	Oguchi disease-2	n	-	-	-	GRK1	HGNC:10013	Oguchi disease-2, 613411 (3)	-	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
613424	CARDIOMYOPATHY, DILATED, 1R	Cardiomyopathy, dilated, 1R, 613424 (3)	Cardiomyopathy, dilated, 1R	n	-	-	-	ACTC1	HGNC:143	Cardiomyopathy, dilated, 1R, 613424 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	ambiguous|nonlethal	ambiguous	-	-	-
613424	CARDIOMYOPATHY, DILATED, 1R	Left ventricular noncompaction 4, 613424 (3)	Left ventricular noncompaction 4	n	-	-	-	ACTC1	HGNC:143	Left ventricular noncompaction 4, 613424 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	ambiguous|nonlethal	ambiguous	-	-	-
613426	CARDIOMYOPATHY, DILATED, 1S	Cardiomyopathy, dilated, 1S, 613426 (3)	Cardiomyopathy, dilated, 1S	y	CARDIOMYOPATHY, DILATED, 1S; CMD1S	Clinical Features|Phenotype	death|deaths|demise|died	MYH7	HGNC:7577	Cardiomyopathy, dilated, 1S, 613426 (3), Autosomal dominant	Autosomal dominant	n	y	[Gifford et al. (2019) identified a 2-month-old infant with congestive heart failure requiring mechanical ventilation and inotropic support in whom echocardiography revealed severely depressed left ventricular function and deep left ventricular trabeculations, characteristic of left ventricular noncompaction (LVNC). The family history disclosed a sib who suffered fetal demise at 24 weeks' gestation]	L1	n	y	lethal	lethal|nonlethal	lethal|nonlethal	L1|L6	L1	pre-infant-lethal
613426	CARDIOMYOPATHY, DILATED, 1S	Left ventricular noncompaction 5, 613426 (3)	Left ventricular noncompaction 5	y	CARDIOMYOPATHY, DILATED, 1S; CMD1S	Clinical Features|Phenotype	death|deaths|demise|died	MYH7	HGNC:7577	Left ventricular noncompaction 5, 613426 (3), Autosomal dominant	Autosomal dominant	n	y	[Gifford et al. (2019) identified a 2-month-old infant with congestive heart failure requiring mechanical ventilation and inotropic support in whom echocardiography revealed severely depressed left ventricular function and deep left ventricular trabeculations, characteristic of left ventricular noncompaction (LVNC). The family history disclosed a sib who suffered fetal demise at 24 weeks' gestation]	L1	n	y	lethal	lethal|nonlethal	lethal|nonlethal	L1|L6	L1	pre-infant-lethal
613428	RETINITIS PIGMENTOSA 54	Retinitis pigmentosa 54, 613428 (3)	Retinitis pigmentosa 54	n	-	-	-	PCARE	HGNC:34383	Retinitis pigmentosa 54, 613428 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
613435	AMYOTROPHIC LATERAL SCLEROSIS 12 WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA	Amyotrophic lateral sclerosis 12 with or without frontotemporal dementia, 613435 (3)	Amyotrophic lateral sclerosis 12 with or without frontotemporal dementia	y	AMYOTROPHIC LATERAL SCLEROSIS 12 WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA; ALS12	Clinical Features|Clinical Synopsis|Phenotype	died|death|deaths	OPTN	HGNC:17142	Amyotrophic lateral sclerosis 12 with or without frontotemporal dementia, 613435 (3), Autosomal dominant, Autosomal recessive	Autosomal dominant, Autosomal recessive	y	y	[Feng et al. (2019) reported a Chinese woman who presented at 38 years of age with dysarthria, language difficulties, emotional lability, memory impairment, and executive dysfunction. PET scan imaging showed hypometabolic changes in several brain regions, including the frontotemporal lobes, consistent with FTD. Soon after, she developed features of ALS, including limb weakness and atrophy, tongue fasciculations, hyperactive reflexes with Babinski sign, and neurogenic changes on EMG. The disorder was rapidly progressive and she died of respiratory failure 18 months after disease onset]	L6	y	-	lethal	ambiguous|lethal	lethal	L6	L6	post-infant-lethal
613443	NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, STEREOTYPIC HAND MOVEMENTS, AND IMPAIRED LANGUAGE	Neurodevelopmental disorder with hypotonia, stereotypic hand movements, and impaired language, 613443 (3)	Neurodevelopmental disorder with hypotonia, stereotypic hand movements, and impaired language	n	-	-	-	MEF2C	HGNC:6996	Neurodevelopmental disorder with hypotonia, stereotypic hand movements, and impaired language, 613443 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
613451	FRONTONASAL DYSPLASIA 2	Frontonasal dysplasia 2, 613451 (3)	Frontonasal dysplasia 2	n	-	-	-	ALX4	HGNC:450	Frontonasal dysplasia 2, 613451 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
613454	RETT SYNDROME, CONGENITAL VARIANT	Rett syndrome, congenital variant, 613454 (3)	Rett syndrome, congenital variant	n	-	-	-	FOXG1	HGNC:3811	Rett syndrome, congenital variant, 613454 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
613456	FRONTONASAL DYSPLASIA 3	Frontonasal dysplasia 3, 613456 (3)	Frontonasal dysplasia 3	y	FRONTONASAL DYSPLASIA 3; FND3	Clinical Features	died	ALX1	HGNC:1494	Frontonasal dysplasia 3, 613456 (3), Autosomal recessive	Autosomal recessive	y	y	[Uz et al. (2010) also reported an unrelated Turkish girl with an almost identical phenotype, who had hypertelorism, extreme microphthalmia of the right eye and microphthalmia of the left eye, upper eyelid colobomata, lack of eyelashes and eyebrows, and palpable midline cranial cleft with a soft tissue mass in the left frontal area. She also had a broad nasal bridge with hypoplasia of the ala nasi, bilateral nonmidline cleft lip, very prominent glabella, complete cleft palate, and low-set posteriorly rotated ears. Brain MRI at 4 months of age showed severely delayed myelinization, thin corpus callosum, and asymmetric cerebellar vermis configuration on the left side. Motor development was delayed. She underwent reconstructive surgery but died in infancy from a pulmonary infection]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
613470	HEMOLYTIC ANEMIA, NONSPHEROCYTIC, DUE TO GLUCOSE PHOSPHATE ISOMERASE DEFICIENCY	Hemolytic anemia, nonspherocytic, due to glucose phosphate isomerase deficiency, 613470 (3)	Hemolytic anemia, nonspherocytic, due to glucose phosphate isomerase deficiency	y	HEMOLYTIC ANEMIA, NONSPHEROCYTIC, DUE TO GLUCOSE PHOSPHATE ISOMERASE DEFICIENCY	Clinical Features|Clinical Synopsis	death|deaths|stillbirth|stillbirths	GPI	HGNC:4458	Hemolytic anemia, nonspherocytic, due to glucose phosphate isomerase deficiency, 613470 (3), Autosomal recessive	Autosomal recessive	n	y	[Stillbirth or early neonatal death]	L1	y	-	lethal	lethal	lethal	L1	L1	pre-infant-lethal
613477	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 5	Developmental and epileptic encephalopathy 5, 613477 (3)	Developmental and epileptic encephalopathy 5	y	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 5; DEE5	Clinical Features	died	SPTAN1	HGNC:11273	Developmental and epileptic encephalopathy 5, 613477 (3), Autosomal dominant	Autosomal dominant	y	y	[Syrbe et al. (2017) reported 14 unrelated patients with DEE5. The patients, who ranged from 2 to 6 years of age, presented with various types of seizures between 2 and 9 months of age. Almost all were diagnosed with West syndrome, and EEG showed hypsarrhythmia in most. The seizures were refractory to medication in most. Three patients died.]	L4	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L4	L4	post-infant-lethal
613480	LYMPHATIC MALFORMATION 3	Lymphatic malformation 3, 613480 (3)	Lymphatic malformation 3	n	-	-	-	GJC2	HGNC:17494	Lymphatic malformation 3, 613480 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
613485	LONG QT SYNDROME 13	Long QT syndrome 13, 613485 (3)	Long QT syndrome 13	y	LONG QT SYNDROME 13; LQT13	Description|Clinical Features	death|deaths|died	KCNJ5	HGNC:6266	Long QT syndrome 13, 613485 (3), Autosomal dominant	Autosomal dominant	n	y	[Congenital long QT syndrome is electrocardiographically characterized by a prolonged QT interval and polymorphic ventricular arrhythmias (torsade de pointes). These cardiac arrhythmias may result in recurrent syncope, seizure, or sudden death (Jongbloed et al., 1999) / Yang et al. (2010) studied a large 4-generation Chinese family segregating autosomal dominant long QT syndrome (LQTS)...The proband had a younger brother who had a series of seizures and syncopal episodes after birth and died suddenly at 7 days of life]	L2	y	y	lethal	ambiguous|lethal	lethal	L2	L2	pre-infant-lethal
613489	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIj	Congenital disorder of glycosylation, type IIj, 613489 (3)	Congenital disorder of glycosylation, type IIj	y	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIj; CDG2J	Clinical Features|Clinical Synopsis	fatal|death|deaths	COG4	HGNC:18620	Congenital disorder of glycosylation, type IIj, 613489 (3), Autosomal recessive	Autosomal recessive	n	y	[Ng et al. (2011) reported an Indian child with a severe form of CDG2J, who had originally been reported by Miura et al. (2005). He had failure to thrive in infancy with recurrent diarrhea. He also had recurrent respiratory and gastrointestinal infections with sepsis and hypotensive shock at age 11 months. Other features included profound developmental delay, hypotonia, nystagmus, hepatosplenomegaly, and poor growth. Brain MRI showed diffuse cerebral atrophy and thinning of the corpus callosum. Seizures developed occurred at age 16 months. The course was progressive, and he developed liver cirrhosis, coagulopathy, and recurrent infections that were ultimately fatal around age 2 years]	L4	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L4	L4	post-infant-lethal
613490	ALPHA-1-ANTITRYPSIN DEFICIENCY	Emphysema due to AAT deficiency, 613490 (3)	Emphysema due to AAT deficiency	y	ALPHA-1-ANTITRYPSIN DEFICIENCY; A1ATD	Clinical Features|Phenotype	death|deaths|died	SERPINA1	HGNC:8941	Emphysema due to AAT deficiency, 613490 (3), Autosomal recessive	Autosomal recessive	y	y	[Laurell and Eriksson (1963) described absence of alpha-1-antitrypsin from the plasma in patients with degenerative lung disease leading to death in middle life]	L6	y	-	lethal	lethal	lethal	L6	L6	post-infant-lethal
613490	ALPHA-1-ANTITRYPSIN DEFICIENCY	Emphysema-cirrhosis, due to AAT deficiency, 613490 (3)	Emphysema-cirrhosis, due to AAT deficiency	y	ALPHA-1-ANTITRYPSIN DEFICIENCY; A1ATD	Clinical Features|Phenotype	death|deaths|died	SERPINA1	HGNC:8941	Emphysema-cirrhosis, due to AAT deficiency, 613490 (3), Autosomal recessive	Autosomal recessive	y	y	[Laurell and Eriksson (1963) described absence of alpha-1-antitrypsin from the plasma in patients with degenerative lung disease leading to death in middle life]	L6	y	-	lethal	lethal	lethal	L6	L6	post-infant-lethal
613490	ALPHA-1-ANTITRYPSIN DEFICIENCY	Hemorrhagic diathesis due to antithrombin Pittsburgh, 613490 (3)	Hemorrhagic diathesis due to antithrombin Pittsburgh	y	ALPHA-1-ANTITRYPSIN DEFICIENCY; A1ATD	Clinical Features|Phenotype	death|deaths|died	SERPINA1	HGNC:8941	Hemorrhagic diathesis due to antithrombin Pittsburgh, 613490 (3), Autosomal recessive	Autosomal recessive	y	y	[Laurell and Eriksson (1963) described absence of alpha-1-antitrypsin from the plasma in patients with degenerative lung disease leading to death in middle life]	L6	y	-	lethal	lethal	lethal	L6	L6	post-infant-lethal
613493	IMMUNODEFICIENCY, COMMON VARIABLE, 3	Immunodeficiency, common variable, 3, 613493 (3)	Immunodeficiency, common variable, 3	n	-	-	-	CD19	HGNC:1633	Immunodeficiency, common variable, 3, 613493 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
613494	IMMUNODEFICIENCY, COMMON VARIABLE, 4	Immunodeficiency, common variable, 4, 613494 (3)	Immunodeficiency, common variable, 4	n	-	-	-	TNFRSF13C	HGNC:17755	Immunodeficiency, common variable, 4, 613494 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
613496	IMMUNODEFICIENCY, COMMON VARIABLE, 6	Immunodeficiency, common variable, 6, 613496 (3)	Immunodeficiency, common variable, 6	n	-	-	-	CD81	HGNC:1701	Immunodeficiency, common variable, 6, 613496 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
613500	AGAMMAGLOBULINEMIA 2, AUTOSOMAL RECESSIVE	Agammaglobulinemia 2, 613500 (3)	Agammaglobulinemia 2	n	-	-	-	IGLL1	HGNC:5870	Agammaglobulinemia 2, 613500 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
613501	AGAMMAGLOBULINEMIA 3, AUTOSOMAL RECESSIVE	Agammaglobulinemia 3, 613501 (3)	Agammaglobulinemia 3	y	AGAMMAGLOBULINEMIA 3, AUTOSOMAL RECESSIVE; AGM3	Clinical Features	died	CD79A	HGNC:1698	Agammaglobulinemia 3, 613501 (3), Autosomal recessive	Autosomal recessive	y	y	[Wang et al. (2002) reported an 8-year-old Turkish boy with AGM3. He was noted to have recurrent lower respiratory infections and otitis media at about 8 months of age. He was found to have profound hypogammaglobulinemia and almost undetectable B cells, but normal T cells. He had muscle weakness and developed thickening of the skin consistent with dermatomyositis. Treatment with intravenous immunoglobulin (IV Ig) resulted in some clinical improvement, but he died of a pulmonary infection. Family history revealed that 2 older brothers had died of pulmonary infections at age 8 months]	L3	n	y	lethal	lethal	lethal	L3	L3	pre-infant-lethal
613517	MICROPHTHALMIA, ISOLATED 6	Microphthalmia, isolated 6, 613517 (3)	Microphthalmia, isolated 6	n	-	-	-	PRSS56	HGNC:39433	Microphthalmia, isolated 6, 613517 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
613546	AROMATASE DEFICIENCY	Aromatase deficiency, 613546 (3)	Aromatase deficiency	n	-	-	-	CYP19A1	HGNC:2594	Aromatase deficiency, 613546 (3)	-	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
613550	NEPHRONOPHTHISIS 11	Nephronophthisis 11, 613550 (3)	Nephronophthisis 11	y	NEPHRONOPHTHISIS 11; NPHP11	Clinical Features	died	TMEM67	HGNC:28396	Nephronophthisis 11, 613550 (3), Autosomal recessive	Autosomal recessive	y	y	[Boichis et al. (1973) described an association of nephronophthisis and congenital hepatic fibrosis in sibs. Five had demonstrated renal disease. Two died of renal failure at ages 7 and 15, and a third was maintained on hemodialysis]	L4	y	-	lethal	ambiguous|lethal|nonlethal	lethal|nonlethal	L1|L4	L1	pre-infant-lethal
613554	VON WILLEBRAND DISEASE, TYPE 2	von Willebrand disease, types 2A, 2B, 2M, and 2N, 613554 (3)	von Willebrand disease, types 2A, 2B, 2M, and 2N	n	-	-	-	VWF	HGNC:12726	von Willebrand disease, types 2A, 2B, 2M, and 2N, 613554 (3), Autosomal dominant, Autosomal recessive	Autosomal dominant, Autosomal recessive	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L4	L4	post-infant-lethal
613559	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 7	Combined oxidative phosphorylation deficiency 7, 613559 (3)	Combined oxidative phosphorylation deficiency 7	y	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 7; COXPD7	Clinical Features	death|deaths|died	MTRFR	HGNC:26784	Combined oxidative phosphorylation deficiency 7, 613559 (3), Autosomal recessive	Autosomal recessive	y	y	[Antonicka et al. (2010) reported 3 patients, including 2 sibs, with a complex phenotype associated with a combined mitochondrial oxidative phosphorylation deficiency. The first child was a girl, born of consanguineous Turkish parents, who showed failure to thrive and psychomotor regression beginning at age 1 year. At 18 months, she had psychomotor retardation, ataxia, and ptosis. She later developed nystagmus, severe optic atrophy, decreased vision, and ophthalmoplegia. Brain MRI showed bilateral lesions in the thalami, brainstem, and medulla spinalis, consistent with a diagnosis of Leigh syndrome (256000). By the time of her death at age 8 years, she was hypermobile with ataxia and used a wheelchair]	L4	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L4	L4	post-infant-lethal
613561	MYOPATHY, LACTIC ACIDOSIS, AND SIDEROBLASTIC ANEMIA 2	Myopathy, lactic acidosis, and sideroblastic anemia 2, 613561 (3)	Myopathy, lactic acidosis, and sideroblastic anemia 2	y	MYOPATHY, LACTIC ACIDOSIS, AND SIDEROBLASTIC ANEMIA 2; MLASA2	Description|Clinical Features|Phenotype	death|deaths|died|fatal	YARS2	HGNC:24249	Myopathy, lactic acidosis, and sideroblastic anemia 2, 613561 (3), Autosomal recessive	Autosomal recessive	n	y	[In 2 sibs, born of consanguineous Turkish parents, with a severe from of MLASA2 resulting in death at ages 2 days and 3 months, Nakajima et al. (2014) identified a homozygous missense mutation (S435G; 610957.0005) in the highly conserved S4-like anticodon-binding domain of YARS2]	L2	y	-	lethal	lethal	lethal	L2	L2	pre-infant-lethal
613563	NOONAN SYNDROME-LIKE DISORDER WITH OR WITHOUT JUVENILE MYELOMONOCYTIC LEUKEMIA	Noonan syndrome-like disorder with or without juvenile myelomonocytic leukemia, 613563 (3)	Noonan syndrome-like disorder with or without juvenile myelomonocytic leukemia	n	-	-	-	CBL	HGNC:1541	Noonan syndrome-like disorder with or without juvenile myelomonocytic leukemia, 613563 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
613571	DISORDERED STEROIDOGENESIS DUE TO CYTOCHROME P450 OXIDOREDUCTASE DEFICIENCY	Disordered steroidogenesis due to cytochrome P450 oxidoreductase, 613571 (3)	Disordered steroidogenesis due to cytochrome P450 oxidoreductase	n	-	-	-	POR	HGNC:9208	Disordered steroidogenesis due to cytochrome P450 oxidoreductase, 613571 (3)	-	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L2	L2	pre-infant-lethal
613573	ECTODERMAL DYSPLASIA-SYNDACTYLY SYNDROME 1	Ectodermal dysplasia-syndactyly syndrome 1, 613573 (3)	Ectodermal dysplasia-syndactyly syndrome 1	n	-	-	-	NECTIN4	HGNC:19688	Ectodermal dysplasia-syndactyly syndrome 1, 613573 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
613575	RETINITIS PIGMENTOSA 55	Retinitis pigmentosa 55, 613575 (3)	Retinitis pigmentosa 55	n	-	-	-	ARL6	HGNC:13210	Retinitis pigmentosa 55, 613575 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
613581	RETINITIS PIGMENTOSA 56	Retinitis pigmentosa 56, 613581 (3)	Retinitis pigmentosa 56	n	-	-	-	IMPG2	HGNC:18362	Retinitis pigmentosa 56, 613581 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
613582	RETINITIS PIGMENTOSA 57	Retinitis pigmentosa 57, 613582 (3)	Retinitis pigmentosa 57	n	-	-	-	PDE6G	HGNC:8789	Retinitis pigmentosa 57, 613582 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
613587	OCCULT MACULAR DYSTROPHY	Occult macular dystrophy, 613587 (3)	Occult macular dystrophy	n	-	-	-	RP1L1	HGNC:15946	Occult macular dystrophy, 613587 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
613608	EPILEPSY, FAMILIAL ADULT MYOCLONIC, 3	Epilepsy, familial adult myoclonic, 3, 613608 (3)	Epilepsy, familial adult myoclonic, 3	n	-	-	-	MARCHF6	HGNC:30550	Epilepsy, familial adult myoclonic, 3, 613608 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
613610	CRANIOECTODERMAL DYSPLASIA 2	Cranioectodermal dysplasia 2, 613610 (3)	Cranioectodermal dysplasia 2	y	CRANIOECTODERMAL DYSPLASIA 2; CED2	Clinical Features|Phenotype	died	WDR35	HGNC:29250	Cranioectodermal dysplasia 2, 613610 (3), Autosomal recessive	Autosomal recessive	y	y	[Bacino et al. (2012) studied a Mexican family in which 4 sibs exhibited features that were characteristic of Sensenbrenner syndrome but also overlapped those of short-rib polydactyly syndromes (see SRTD7, 614091). Findings included cystic hygroma, dolichocephaly (associated with sagittal synostosis in 1 sib), prominent or tall forehead, low-set simple ears, high-arched or cleft palate, short stature, narrow thorax with short ribs, brachydactyly, polydactyly, hepatomegaly, renal and cardiac anomalies, and developmental delay. One sib was alive at 4 years of age, 2 of the sibs died at 9 months and 13 months of age, and an affected fetus was terminated at 21 weeks' gestation]	L3	y	-	lethal	lethal	lethal	L2|L3	L2	pre-infant-lethal
613611	CHOANAL ATRESIA AND LYMPHEDEMA	Choanal atresia and lymphedema, 613611 (3)	Choanal atresia and lymphedema	y	CHOANAL ATRESIA AND LYMPHEDEMA; CATLPH	Clinical Features	died	PTPN14	HGNC:9647	Choanal atresia and lymphedema, 613611 (3), Autosomal recessive	Autosomal recessive	n	y	[Har-El et al. (1991) provided follow-up of the family reported by Qazi et al. (1982). The boy and his paternal aunt from the original report both developed lymphedema of the lower extremities at age 5 years. The sister had died at age 5 months]	L3	n	y	lethal	lethal	lethal	L3	L3	pre-infant-lethal
613612	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIi	Congenital disorder of glycosylation, type IIi, 613612 (3)	Congenital disorder of glycosylation, type IIi	n	-	-	-	COG5	HGNC:14857	Congenital disorder of glycosylation, type IIi, 613612 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
613615	SENIOR-LOKEN SYNDROME 7	Senior-Loken syndrome 7, 613615 (3)	Senior-Loken syndrome 7	n	-	-	-	SDCCAG8	HGNC:10671	Senior-Loken syndrome 7, 613615 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
613616	HYPEROXALURIA, PRIMARY, TYPE III	Hyperoxaluria, primary, type III, 613616 (3)	Hyperoxaluria, primary, type III	n	-	-	-	HOGA1	HGNC:25155	Hyperoxaluria, primary, type III, 613616 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
613625	FACTOR V AND FACTOR VIII, COMBINED DEFICIENCY OF, 2	Factor V and factor VIII, combined deficiency of, 613625 (3)	Factor V and factor VIII, combined deficiency of	n	-	-	-	MCFD2	HGNC:18451	Factor V and factor VIII, combined deficiency of, 613625 (3)	-	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
613640	NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE IC	Neuropathy, hereditary sensory and autonomic, type IC, 613640 (3)	Neuropathy, hereditary sensory and autonomic, type IC	n	-	-	-	SPTLC2	HGNC:11278	Neuropathy, hereditary sensory and autonomic, type IC, 613640 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
613642	CARDIOMYOPATHY, DILATED, 1GG	Cardiomyopathy, dilated, 1GG, 613642 (3)	Cardiomyopathy, dilated, 1GG	n	-	-	-	SDHA	HGNC:10680	Cardiomyopathy, dilated, 1GG, 613642 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L3	L3	pre-infant-lethal
613646	METHYLMALONIC ACIDURIA, TRANSIENT, DUE TO TRANSCOBALAMIN RECEPTOR DEFECT	Methylmalonic aciduria, transient, due to transcobalamin receptor defect, 613646 (3)	Methylmalonic aciduria, transient, due to transcobalamin receptor defect	n	-	-	-	CD320	HGNC:16692	Methylmalonic aciduria, transient, due to transcobalamin receptor defect, 613646 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
613647	SPASTIC PARAPLEGIA 48, AUTOSOMAL RECESSIVE	Spastic paraplegia 48, autosomal recessive, 613647 (3)	Spastic paraplegia 48, autosomal recessive	n	-	-	-	AP5Z1	HGNC:22197	Spastic paraplegia 48, autosomal recessive, 613647 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
613652	C1q DEFICIENCY 1	C1q deficiency 1, 613652 (3)	C1q deficiency 1	y	C1q DEFICIENCY 1; C1QD1	Clinical Features	death|deaths	C1QA	HGNC:1241	C1q deficiency 1, 613652 (3), Autosomal recessive	Autosomal recessive	y	y	[resulting in death of 1 of them]	LU	y	-	lethal	lethal	lethal	LU	LU	post-infant-lethal
613657	D-2-HYDROXYGLUTARIC ACIDURIA 2	D-2-hydroxyglutaric aciduria 2, 613657 (3)	D-2-hydroxyglutaric aciduria 2	y	D-2-HYDROXYGLUTARIC ACIDURIA 2; D2HGA2	Clinical Features	died	IDH2	HGNC:5383	D-2-hydroxyglutaric aciduria 2, 613657 (3)	-	n	y	[Kranendijk et al. (2010) phenotypically characterized 17 unrelated patients with D-2-hydroxyglutaric aciduria who did not have a mutation in the D2HGDH gene (609186). These individuals had the same phenotypic spectrum associated with D2HGA (600721) caused by mutations in the D2HGDH gene (i.e., ranging from asymptomatic to developmental delay, epilepsy, hypotonia, cardiomyopathy, and dysmorphic features). Fifteen patients (9 females and 6 males) were found to have a mutation in the IDH gene (see MOLECULAR GENETICS). Nine patients had died between the ages of a few months to 14 years]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
613658	RAJAB INTERSTITIAL LUNG DISEASE WITH BRAIN CALCIFICATIONS 1	Rajab interstitial lung disease with brain calcifications 1, 613658 (3)	Rajab interstitial lung disease with brain calcifications 1	y	RAJAB INTERSTITIAL LUNG DISEASE WITH BRAIN CALCIFICATIONS 1; RILDBC1	Description|Clinical Features	death|deaths|died	FARSB	HGNC:17800	Rajab interstitial lung disease with brain calcifications 1, 613658 (3), Autosomal recessive	Autosomal recessive	y	y	[Antonellis et al. (2018) reported a boy, born of unrelated parents, with a complex multisystem neurodevelopmental disorder resulting in death at age 32 months]	L4	y	-	lethal	lethal	lethal	L4	L4	post-infant-lethal
613660	CONE-ROD DYSTROPHY 15	Cone-rod dystrophy 15, 613660 (3)	Cone-rod dystrophy 15	n	-	-	-	CDHR1	HGNC:14550	Cone-rod dystrophy 15, 613660 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
613660	CONE-ROD DYSTROPHY 15	Macular dystrophy, retinal, 613660 (3)	Macular dystrophy, retinal	n	-	-	-	CDHR1	HGNC:14550	Macular dystrophy, retinal, 613660 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
613660	CONE-ROD DYSTROPHY 15	Retinitis pigmentosa 65, 613660 (3)	Retinitis pigmentosa 65	n	-	-	-	CDHR1	HGNC:14550	Retinitis pigmentosa 65, 613660 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
613661	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ip	Congenital disorder of glycosylation, type Ip, 613661 (3)	Congenital disorder of glycosylation, type Ip	y	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ip; CDG1P	Clinical Features	death|deaths|died	ALG11	HGNC:32456	Congenital disorder of glycosylation, type Ip, 613661 (3), Autosomal recessive	Autosomal recessive	y	y	[Rind et al. (2010) reported 2 sibs, born of consanguineous Turkish parents, with a multisystem metabolic disorder characterized by hypotonia, seizures, developmental retardation, and death by age 2 years]	L4	y	-	lethal	lethal	lethal	L4	L4	post-infant-lethal
613662	MITOCHONDRIAL DNA DEPLETION SYNDROME 4B (MNGIE TYPE)	Mitochondrial DNA depletion syndrome 4B (MNGIE type), 613662 (3)	Mitochondrial DNA depletion syndrome 4B (MNGIE type)	y	MITOCHONDRIAL DNA DEPLETION SYNDROME 4B (MNGIE TYPE); MTDPS4B	Clinical Features	died	POLG	HGNC:9179	Mitochondrial DNA depletion syndrome 4B (MNGIE type), 613662 (3), Autosomal recessive	Autosomal recessive	y	y	[Giordano et al. (2009) reported a newborn boy with congenital myopathy and gastrointestinal pseudoobstruction due to compound heterozygous mutations in the POLG gene (174763.0006 and 174763.0021)... The patient died at age 20 days from respiratory failure]	L2	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L2|L3|L5|L6	L2	pre-infant-lethal
613668	MICROCEPHALY, POSTNATAL PROGRESSIVE, WITH SEIZURES AND BRAIN ATROPHY	Microcephaly, postnatal progressive, with seizures and brain atrophy, 613668 (3)	Microcephaly, postnatal progressive, with seizures and brain atrophy	n	-	-	-	MED17	HGNC:2375	Microcephaly, postnatal progressive, with seizures and brain atrophy, 613668 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
613670	INTELLECTUAL DEVELOPMENTAL DISORDER WITH LANGUAGE IMPAIRMENT AND WITH OR WITHOUT AUTISTIC FEATURES	Intellectual developmental disorder with language impairment with or without autistic features, 613670 (3)	Intellectual developmental disorder with language impairment with or without autistic features	n	-	-	-	FOXP1	HGNC:3823	Intellectual developmental disorder with language impairment with or without autistic features, 613670 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
613673	ANEMIA, CONGENITAL DYSERYTHROPOIETIC, TYPE IV	Dyserythropoietic anemia, congenital, type IV, 613673 (3)	Dyserythropoietic anemia, congenital, type IV	n	-	-	-	KLF1	HGNC:6345	Dyserythropoietic anemia, congenital, type IV, 613673 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
613674	VESICOURETERAL REFLUX 3	Vesicoureteral reflux 3, 613674 (3)	Vesicoureteral reflux 3	n	-	-	-	SOX17	HGNC:18122	Vesicoureteral reflux 3, 613674 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
613677	HYPERALDOSTERONISM, FAMILIAL, TYPE III	Hyperaldosteronism, familial, type III, 613677 (3)	Hyperaldosteronism, familial, type III	y	HYPERALDOSTERONISM, FAMILIAL, TYPE III; HALD3	Phenotype	lethality	KCNJ5	HGNC:6266	Hyperaldosteronism, familial, type III, 613677 (3), Autosomal dominant	Autosomal dominant	n	n	-	-	-	-	ambiguous	ambiguous|lethal	lethal	L2	L2	pre-infant-lethal
613679	PROTHROMBIN DEFICIENCY, CONGENITAL	Dysprothrombinemia, 613679 (3)	Dysprothrombinemia	n	-	-	-	F2	HGNC:3535	Dysprothrombinemia, 613679 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	ambiguous|nonlethal	ambiguous	-	-	-
613679	PROTHROMBIN DEFICIENCY, CONGENITAL	Hypoprothrombinemia, 613679 (3)	Hypoprothrombinemia	n	-	-	-	F2	HGNC:3535	Hypoprothrombinemia, 613679 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	ambiguous|nonlethal	ambiguous	-	-	-
613680	BEAULIEU-BOYCOTT-INNES SYNDROME	Beaulieu-Boycott-Innes syndrome, 613680 (3)	Beaulieu-Boycott-Innes syndrome	n	-	-	-	THOC6	HGNC:28369	Beaulieu-Boycott-Innes syndrome, 613680 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
613684	RUBINSTEIN-TAYBI SYNDROME 2	Rubinstein-Taybi syndrome 2, 613684 (3)	Rubinstein-Taybi syndrome 2	y	RUBINSTEIN-TAYBI SYNDROME 2; RSTS2	Clinical Features	death|deaths	EP300	HGNC:3373	Rubinstein-Taybi syndrome 2, 613684 (3), Autosomal dominant	Autosomal dominant	y	y	[Woods et al. (2014) reported a 5-year-old Caucasian male with a phenotype suggesting Cornelia de Lange syndrome (CDLS; 122470) in whom no mutations were found in CDLS-related genes. The boy presented with intrauterine growth restriction, failure to thrive, microcephaly, cryptorchidism, hirsutism, short stature, and intellectual disability. He also had severe progressive scoliosis and chest deformity. He did not have the cardinal features of RSTS such as the typical facial gestalt or broad thumbs or toes. Exome sequencing after the child's death from bronchopneumonia identified a novel mutation in the EP300 gene (602700.0009)]	L4	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L4	L4	post-infant-lethal
613686	SPONDYLOCOSTAL DYSOSTOSIS 4, AUTOSOMAL RECESSIVE	Spondylocostal dysostosis 4, autosomal recessive, 613686 (3)	Spondylocostal dysostosis 4, autosomal recessive	n	-	-	-	HES7	HGNC:15977	Spondylocostal dysostosis 4, autosomal recessive, 613686 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
613688	LONG QT SYNDROME 2	Long QT syndrome 2, 613688 (3)	Long QT syndrome 2	y	LONG QT SYNDROME 2; LQT2	Description|Clinical Synopsis|Phenotype	death|deaths	KCNH2	HGNC:6251	Long QT syndrome 2, 613688 (3), Autosomal dominant	Autosomal dominant	y	y	[Sudden cardiac death]	LU	y	-	lethal	lethal	lethal	LU	LU	post-infant-lethal
613690	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 7	Cardiomyopathy, hypertrophic, 7, 613690 (3)	Cardiomyopathy, hypertrophic, 7	y	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 7; CMH7	Clinical Features|Clinical Synopsis	death|deaths	TNNI3	HGNC:11947	Cardiomyopathy, hypertrophic, 7, 613690 (3), Autosomal dominant	Autosomal dominant	y	y	[Sudden cardiac death in some families / Arad et al. (2005) identified a proband with CMH7 with atrial fibrillation and apical cardiac hypertrophy. Five family members had undergone sudden cardiac death, and 3 additional mutation carriers in the family were found to have other CMH morphologies]	LU	y	y	lethal	lethal|nonlethal	lethal|nonlethal	L3|LU	L3	pre-infant-lethal
613693	LONG QT SYNDROME 6	Long QT syndrome 6, 613693 (3)	Long QT syndrome 6	y	LONG QT SYNDROME 6; LQT6	Description|Clinical Synopsis	death|deaths	KCNE2	HGNC:6242	Long QT syndrome 6, 613693 (3), Autosomal dominant	Autosomal dominant	n	y	[Sudden cardiac death]	LU	y	-	lethal	lethal|nonlethal	lethal|nonlethal	LU	LU	post-infant-lethal
613694	CARDIOMYOPATHY, DILATED, 1U	Cardiomyopathy, dilated, 1U, 613694 (3)	Cardiomyopathy, dilated, 1U	y	CARDIOMYOPATHY, DILATED, 1U; CMD1U	Clinical Features|Phenotype	death|deaths	PSEN1	HGNC:9508	Cardiomyopathy, dilated, 1U, 613694 (3), Autosomal dominant	Autosomal dominant	n	y	[Li et al. (2006) described an African American family with dilated cardiomyopathy segregating with mutation in the PSEN1 gene (CMD1U).... Both the cardiomyopathy and dementia progressed and resulted in repeated hospitalizations until the patient's death at age 78 years, in advanced heart failure]	L6	y	-	lethal	lethal	lethal	L6	L6	post-infant-lethal
613695	LONG QT SYNDROME 5	Long QT syndrome 5, 613695 (3)	Long QT syndrome 5	y	LONG QT SYNDROME 5; LQT5	Description|Clinical Synopsis	death|deaths	KCNE1	HGNC:6240	Long QT syndrome 5, 613695 (3), Autosomal dominant	Autosomal dominant	n	y	[Sudden cardiac death]	LU	y	-	lethal	lethal	lethal	LU	LU	post-infant-lethal
613697	CARDIOMYOPATHY, DILATED, 1V	Cardiomyopathy, dilated, 1V, 613697 (3)	Cardiomyopathy, dilated, 1V	y	CARDIOMYOPATHY, DILATED, 1V; CMD1V	Phenotype	death|deaths	PSEN2	HGNC:9509	Cardiomyopathy, dilated, 1V, 613697 (3), Autosomal dominant	Autosomal dominant	n	n	-	-	-	-	ambiguous	ambiguous|lethal	lethal	L6	L6	post-infant-lethal
613702	KLIPPEL-FEIL SYNDROME 3, AUTOSOMAL DOMINANT	Klippel-Feil syndrome 3, autosomal dominant, 613702 (3)	Klippel-Feil syndrome 3, autosomal dominant	n	-	-	-	GDF3	HGNC:4218	Klippel-Feil syndrome 3, autosomal dominant, 613702 (3)	-	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
613703	MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 6	Microphthalmia, isolated, with coloboma 6, 613703 (3)	Microphthalmia, isolated, with coloboma 6	n	-	-	-	GDF3	HGNC:4218	Microphthalmia, isolated, with coloboma 6, 613703 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
613703	MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 6	Microphthalmia with coloboma 6, digenic, 613703 (3)	Microphthalmia with coloboma 6, digenic	n	-	-	-	GDF6	HGNC:4221	Microphthalmia with coloboma 6, digenic, 613703 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
613704	MICROPHTHALMIA, ISOLATED 7	Microphthalmia, isolated 7, 613704 (3)	Microphthalmia, isolated 7	n	-	-	-	GDF3	HGNC:4218	Microphthalmia, isolated 7, 613704 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
613706	NOONAN SYNDROME 7	Noonan syndrome 7, 613706 (3)	Noonan syndrome 7	n	-	-	-	BRAF	HGNC:1097	Noonan syndrome 7, 613706 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L2	L2	pre-infant-lethal
613707	LEOPARD SYNDROME 3	LEOPARD syndrome 3, 613707 (3)	LEOPARD syndrome 3	n	-	-	-	BRAF	HGNC:1097	LEOPARD syndrome 3, 613707 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L2	L2	pre-infant-lethal
613708	NEUROPATHY, HEREDITARY SENSORY, TYPE ID	Neuropathy, hereditary sensory, type ID, 613708 (3)	Neuropathy, hereditary sensory, type ID	n	-	-	-	ATL1	HGNC:11231	Neuropathy, hereditary sensory, type ID, 613708 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	ambiguous|nonlethal	ambiguous	-	-	-
613710	THIAMINE METABOLISM DYSFUNCTION SYNDROME 4 (BILATERAL STRIATAL DEGENERATION AND PROGRESSIVE POLYNEUROPATHY TYPE)	Thiamine metabolism dysfunction syndrome 4 (progressive polyneuropathy type), 613710 (3)	Thiamine metabolism dysfunction syndrome 4 (progressive polyneuropathy type)	n	-	-	-	SLC25A19	HGNC:14409	Thiamine metabolism dysfunction syndrome 4 (progressive polyneuropathy type), 613710 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L3	L3	pre-infant-lethal
613717	TREACHER COLLINS SYNDROME 2	Treacher Collins syndrome 2, 613717 (3)	Treacher Collins syndrome 2	n	-	-	-	POLR1D	HGNC:20422	Treacher Collins syndrome 2, 613717 (3), Autosomal dominant, Autosomal recessive	Autosomal dominant, Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
613718	DEAFNESS, AUTOSOMAL RECESSIVE 74	Deafness, autosomal recessive 74, 613718 (3)	Deafness, autosomal recessive 74	n	-	-	-	MSRB3	HGNC:27375	Deafness, autosomal recessive 74, 613718 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
613720	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 7	Developmental and epileptic encephalopathy 7, 613720 (3)	Developmental and epileptic encephalopathy 7	n	-	-	-	KCNQ2	HGNC:6296	Developmental and epileptic encephalopathy 7, 613720 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	LU	LU	post-infant-lethal
613721	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 11	Developmental and epileptic encephalopathy 11, 613721 (3)	Developmental and epileptic encephalopathy 11	y	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 11; DEE11	Clinical Features	died	SCN2A	HGNC:10588	Developmental and epileptic encephalopathy 11, 613721 (3), Autosomal dominant	Autosomal dominant	y	y	[Touma et al. (2013) reported a pair of monozygotic twin boys with DEE11. Both developed refractory seizures (up to 60 per day) on the first day of life. One twin died on day 19 from iatrogenic cardiopulmonary arrest]	L2	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L2	L2	pre-infant-lethal
613722	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 12	Developmental and epileptic encephalopathy 12, 613722 (3)	Developmental and epileptic encephalopathy 12	y	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 12; DEE12	Clinical Features	died	PLCB1	HGNC:15917	Developmental and epileptic encephalopathy 12, 613722 (3), Autosomal recessive	Autosomal recessive	y	y	[Kurian et al. (2010) reported a boy, born of consanguineous parents from Bangladesh, who presented with seizures at age 10 weeks. Seizures were characterized by eye rolling, lip smacking, drooling and perioral cyanosis followed by tonic stiffening and flexion of arms and legs. At age 8 months, he developed refractory seizures and regression in all areas of development. By 13 months, EEG showed features of West syndrome, hypsarrhythmia, and generalized slowing, consistent with a diffuse encephalopathic process. He had no meaningful development, with poor visual fixation, severe head lag, axial hypotonia, and spastic quadriparesis. He died of infection at age 2.9 years]	L4	y	-	lethal	lethal	lethal	L4	L4	post-infant-lethal
613723	MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 17	Muscular dystrophy, limb-girdle, autosomal recessive 17, 613723 (3)	Muscular dystrophy, limb-girdle, autosomal recessive 17	y	MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 17; LGMDR17	Clinical Features	died	PLEC	HGNC:9069	Muscular dystrophy, limb-girdle, autosomal recessive 17, 613723 (3), Autosomal recessive	Autosomal recessive	y	y	[Gundesli et al. (2010) reported a consanguineous Turkish family in which 4 individuals had autosomal recessive limb-girdle muscular dystrophy with onset in childhood and progression during the teenage years... One had stopped walking at age 24, and died at age 36 after being bedridden with near total atrophy of the muscles and multiple contractures]	L6	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L2|L3|L6	L2	pre-infant-lethal
613728	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 10	Spinocerebellar ataxia, autosomal recessive 10, 613728 (3)	Spinocerebellar ataxia, autosomal recessive 10	n	-	-	-	ANO10	HGNC:25519	Spinocerebellar ataxia, autosomal recessive 10, 613728 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
613730	HEMORRHAGIC DESTRUCTION OF THE BRAIN, SUBEPENDYMAL CALCIFICATION, AND CATARACTS	Hemorrhagic destruction of the brain, subependymal calcification, and cataracts, 613730 (3)	Hemorrhagic destruction of the brain, subependymal calcification, and cataracts	y	HEMORRHAGIC DESTRUCTION OF THE BRAIN, SUBEPENDYMAL CALCIFICATION, AND CATARACTS; HDBSCC	Description|Clinical Features|Clinical Synopsis	death|deaths|died|stillbirth|stillbirths	JAM3	HGNC:15532	Hemorrhagic destruction of the brain, subependymal calcification, and cataracts, 613730 (3), Autosomal recessive	Autosomal recessive	n	y	[Akawi et al. (2013) reported 7 patients from 3 unrelated families with HDBSCC. Two of the families were consanguineous and of Turkish and Moroccan origin, respectively, and the third family was of Afghan origin. Affected individuals had a homogeneous phenotype, with neonatal onset of intracranial bleeding, intracranial calcification, and neurologic deterioration. All also had congenital cataracts. Some of the patients had seizures. Death occurred in infancy. Brain MRI, performed in some patients, showed edema, cystic changes of the brain parenchyma, white matter abnormalities, and necrotic hemorrhagic damage. Two sibs were found to have renal anomalies, including echogenic cortex, altered corticomedullary differentiation, and pelvicalyceal dilatation. Family histories revealed stillbirth or early neonatal death from unknown causes in 2 of the families]	L1	y	y	lethal	lethal	lethal	L1	L1	pre-infant-lethal
613731	RETINITIS PIGMENTOSA 4	Retinitis pigmentosa 4, autosomal dominant or recessive, 613731 (3)	Retinitis pigmentosa 4, autosomal dominant or recessive	n	-	-	-	RHO	HGNC:10012	Retinitis pigmentosa 4, autosomal dominant or recessive, 613731 (3), Autosomal dominant, Autosomal recessive	Autosomal dominant, Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
613735	BRAIN MALFORMATIONS WITH OR WITHOUT URINARY TRACT DEFECTS	Brain malformations with or without urinary tract defects, 613735 (3)	Brain malformations with or without urinary tract defects	n	-	-	-	NFIA	HGNC:7784	Brain malformations with or without urinary tract defects, 613735 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
613736	ACNE INVERSA, FAMILIAL, 2, WITH OR WITHOUT DOWLING-DEGOS DISEASE	Acne inversa, familial, 2, with or without Dowling-Degos disease, 613736 (3)	Acne inversa, familial, 2, with or without Dowling-Degos disease	n	-	-	-	PSENEN	HGNC:30100	Acne inversa, familial, 2, with or without Dowling-Degos disease, 613736 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
613743	ADRENAL INSUFFICIENCY, CONGENITAL, WITH 46,XY SEX REVERSAL, PARTIAL OR COMPLETE	Adrenal insufficiency, congenital, with 46XY sex reversal, partial or complete, 613743 (3)	Adrenal insufficiency, congenital, with 46XY sex reversal, partial or complete	y	ADRENAL INSUFFICIENCY, CONGENITAL, WITH 46,XY SEX REVERSAL, PARTIAL OR COMPLETE	Clinical Features	died	CYP11A1	HGNC:2590	Adrenal insufficiency, congenital, with 46XY sex reversal, partial or complete, 613743 (3)	-	n	y	[Rubtsov et al. (2009) described a patient with P450scc deficiency who showed no overt signs of adrenal insufficiency until the age of 9 years, when he began to experience episodes of weakness, dizziness, and vomiting. At birth he presented with bilateral cryptorchidism with inguinal testes, midshaft hypospadias, and bilateral talipes equinovarus. Karyotype was 46,XY. Ultrasound and magnetic resonance imaging showed normal-sized adrenals. The patient's twin, a phenotypic female, had died at age 2.5 years after an unknown illness presenting with weakness and cyanosis]	L4	n	y	lethal	lethal	lethal	L4	L4	post-infant-lethal
613744	SPASTIC PARAPLEGIA 51, AUTOSOMAL RECESSIVE	Spastic paraplegia 51, autosomal recessive, 613744 (3)	Spastic paraplegia 51, autosomal recessive	n	-	-	-	AP4E1	HGNC:573	Spastic paraplegia 51, autosomal recessive, 613744 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
613750	RETINITIS PIGMENTOSA 27	Retinitis pigmentosa 27, 613750 (3)	Retinitis pigmentosa 27	n	-	-	-	NRL	HGNC:8002	Retinitis pigmentosa 27, 613750 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
613751	HETEROTAXY, VISCERAL, 4, AUTOSOMAL	Heterotaxy, visceral, 4, autosomal, 613751 (3)	Heterotaxy, visceral, 4, autosomal	n	-	-	-	ACVR2B	HGNC:174	Heterotaxy, visceral, 4, autosomal, 613751 (3)	-	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
613752	HYPERMETHIONINEMIA WITH S-ADENOSYLHOMOCYSTEINE HYDROLASE DEFICIENCY	Hypermethioninemia with deficiency of S-adenosylhomocysteine hydrolase, 613752 (3)	Hypermethioninemia with deficiency of S-adenosylhomocysteine hydrolase	y	HYPERMETHIONINEMIA WITH S-ADENOSYLHOMOCYSTEINE HYDROLASE DEFICIENCY	Clinical Features	died	AHCY	HGNC:343	Hypermethioninemia with deficiency of S-adenosylhomocysteine hydrolase, 613752 (3), Autosomal recessive	Autosomal recessive	n	y	[In 3 daughters of Tunisian parents who were not known to be related but came from the same village in Tunisia, Labrune et al. (1990) described hypermethioninemia associated with failure to thrive, mental and motor retardation, facial dysmorphism with abnormal hair and teeth, and myocardiopathy. Hepatic S-adenosylhomocysteine hydrolase activity was decreased by 80% in the 3 children. Neonatal cholestasis was also a feature. A fourth daughter, who died of hepatic failure at the age of 9 months, was probably also affected]	L3	n	y	lethal	lethal	lethal	L3	L3	pre-infant-lethal
613756	RETINITIS PIGMENTOSA 49	Retinitis pigmentosa 49, 613756 (3)	Retinitis pigmentosa 49	n	-	-	-	CNGA1	HGNC:2148	Retinitis pigmentosa 49, 613756 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
613758	RETINITIS PIGMENTOSA 47	Retinitis pigmentosa 47, autosomal recessive, 613758 (3)	Retinitis pigmentosa 47, autosomal recessive	n	-	-	-	SAG	HGNC:10521	Retinitis pigmentosa 47, autosomal recessive, 613758 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	ambiguous|nonlethal	ambiguous	-	-	-
613759	IMMUNODEFICIENCY 90 WITH ENCEPHALOPATHY, FUNCTIONAL HYPOSPLENIA, AND HEPATIC DYSFUNCTION	Immunodeficiency 90 with encephalopathy, functional hyposplenia, and hepatic dysfunction, 613759 (3)	Immunodeficiency 90 with encephalopathy, functional hyposplenia, and hepatic dysfunction	y	IMMUNODEFICIENCY 90 WITH ENCEPHALOPATHY, FUNCTIONAL HYPOSPLENIA, AND HEPATIC DYSFUNCTION; IMD90	Description|Clinical Features|Clinical Synopsis	fatal|death|deaths|died	FADD	HGNC:3573	Immunodeficiency 90 with encephalopathy, functional hyposplenia, and hepatic dysfunction, 613759 (3), Autosomal recessive	Autosomal recessive	y	y	[Savic et al. (2015) reported a 3-year-old girl, born of consanguineous Pakistani parents, who presented with pneumococcal meningitis at 6 months of age. The family history was notable for the death of 2 male sibs from pneumococcal meningitis in infancy, and another female sib who died at 4 months of age from congenital cardiac abnormalities]	L3	n	y	lethal	lethal	lethal	L3	L3	pre-infant-lethal
613762	46,XY SEX REVERSAL 6	46XY sex reversal 6, 613762 (3)	46XY sex reversal 6	n	-	-	-	MAP3K1	HGNC:6848	46XY sex reversal 6, 613762 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
613763	CATARACT 16, MULTIPLE TYPES	Cataract 16, multiple types, 613763 (3)	Cataract 16, multiple types	n	-	-	-	CRYAB	HGNC:2389	Cataract 16, multiple types, 613763 (3), Autosomal dominant, Autosomal recessive	Autosomal dominant, Autosomal recessive	-	-	-	-	-	-	nonlethal	ambiguous|lethal|nonlethal	lethal|nonlethal	L3|L6	L3	pre-infant-lethal
613765	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 9	Cardiomyopathy, familial hypertrophic, 9, 613765 (3)	Cardiomyopathy, familial hypertrophic, 9	n	-	-	-	TTN	HGNC:12403	Cardiomyopathy, familial hypertrophic, 9, 613765 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L6|LU	L6	post-infant-lethal
613767	RETINITIS PIGMENTOSA 45	Retinitis pigmentosa 45, 613767 (3)	Retinitis pigmentosa 45	n	-	-	-	CNGB1	HGNC:2151	Retinitis pigmentosa 45, 613767 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
613769	RETINITIS PIGMENTOSA 44	Retinitis pigmentosa 44, 613769 (3)	Retinitis pigmentosa 44	n	-	-	-	RGR	HGNC:9990	Retinitis pigmentosa 44, 613769 (3)	-	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
613779	COMPLEMENT COMPONENT 3 DEFICIENCY, AUTOSOMAL RECESSIVE	C3 deficiency, 613779 (3)	C3 deficiency	n	-	-	-	C3	HGNC:1318	C3 deficiency, 613779 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
613780	AORTIC ANEURYSM, FAMILIAL THORACIC 7	Aortic aneurysm, familial thoracic 7, 613780 (3)	Aortic aneurysm, familial thoracic 7	y	AORTIC ANEURYSM, FAMILIAL THORACIC 7; AAT7	Clinical Features	death|deaths|died|fatal	MYLK	HGNC:7590	Aortic aneurysm, familial thoracic 7, 613780 (3), Autosomal dominant	Autosomal dominant	y	y	[Shalata et al. (2018) studied a large consanguineous Arab family in which 9 individuals had thoracic aortic aneurysm and dissection. The authors noted that the patients could be divided clinically into 2 groups: 6 of the patients presented at an earlier age, with average age at onset of 35 years, and had more severe disease with an almost uniformly fatal outcome (5 deaths)]	LU	y	-	lethal	lethal	lethal	L1|LU	L1	pre-infant-lethal
613783	COMPLEMENT COMPONENT C1s DEFICIENCY	C1s deficiency, 613783 (3)	C1s deficiency	n	-	-	-	C1S	HGNC:1247	C1s deficiency, 613783 (3)	-	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
613789	COMPLEMENT COMPONENT 8 DEFICIENCY, TYPE II	C8 deficiency, type II, 613789 (3)	C8 deficiency, type II	n	-	-	-	C8B	HGNC:1353	C8 deficiency, type II, 613789 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
613790	COMPLEMENT COMPONENT 8 DEFICIENCY, TYPE I	C8 deficiency, type I, 613790 (3)	C8 deficiency, type I	n	-	-	-	C8A	HGNC:1352	C8 deficiency, type I, 613790 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
613791	MASP2 DEFICIENCY	MASP2 deficiency, 613791 (3)	MASP2 deficiency	n	-	-	-	MASP2	HGNC:6902	MASP2 deficiency, 613791 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
613794	RETINITIS PIGMENTOSA 20	Retinitis pigmentosa 20, 613794 (3)	Retinitis pigmentosa 20	n	-	-	-	RPE65	HGNC:10294	Retinitis pigmentosa 20, 613794 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	ambiguous|nonlethal	ambiguous	-	-	-
613795	LOEYS-DIETZ SYNDROME 3	Loeys-Dietz syndrome 3, 613795 (3)	Loeys-Dietz syndrome 3	y	LOEYS-DIETZ SYNDROME 3; LDS3	Clinical Features	death|deaths	SMAD3	HGNC:6769	Loeys-Dietz syndrome 3, 613795 (3), Autosomal dominant	Autosomal dominant	y	y	[Van de Laar et al. (2011) studied 3 unrelated Dutch families with arterial aneurysms, dissections, and/or early-onset osteoarthritis. The largest family was a 4-generation pedigree in which 12 of 22 affected individuals presented with aneurysms of the aorta, primarily at the sinus of Valsalva, but also involving the abdominal aorta and/or other arteries such as the splenic, common iliac, mesenteric, renal, vertebral, or main pulmonary artery. There was a strong history of sudden death between 35 and 69 years of age, primarily due to dissection and/or rupture of the aorta, which sometimes occurred in mildly dilated aortas]	L6	y	-	lethal	lethal	lethal	L6	L6	post-infant-lethal
613796	IMMUNODEFICIENCY 31B	Immunodeficiency 31B, mycobacterial and viral infections, autosomal recessive, 613796 (3)	Immunodeficiency 31B, mycobacterial and viral infections, autosomal recessive	y	IMMUNODEFICIENCY 31B; IMD31B	Description|Clinical Features|Clinical Synopsis|Phenotype	fatal|died	STAT1	HGNC:11362	Immunodeficiency 31B, mycobacterial and viral infections, autosomal recessive, 613796 (3), Autosomal recessive	Autosomal recessive	n	y	[Chapgier et al. (2006) reported a 3-month-old infant of first-cousin Pakistani parents who presented with disseminated BCG infection following BCG vaccination. The patient had a diffuse maculopapular rash, massive hepatosplenomegaly, and respiratory distress. In spite of antimycobacterial and antiinflammatory treatment and eventual bone marrow transplantation, the patient died of multiorgan failure after numerous viral infections, including a fulminant Epstein-Barr virus infection, 3 months after transplantation]	L3	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L3|L4	L3	pre-infant-lethal
613800	MEIER-GORLIN SYNDROME 2	Meier-Gorlin syndrome 2, 613800 (3)	Meier-Gorlin syndrome 2	n	-	-	-	ORC4	HGNC:8490	Meier-Gorlin syndrome 2, 613800 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
613801	RETINITIS PIGMENTOSA 40	Retinitis pigmentosa-40, 613801 (3)	Retinitis pigmentosa-40	n	-	-	-	PDE6B	HGNC:8786	Retinitis pigmentosa-40, 613801 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	ambiguous|nonlethal	ambiguous	-	-	-
613803	MEIER-GORLIN SYNDROME 3	Meier-Gorlin syndrome 3, 613803 (3)	Meier-Gorlin syndrome 3	n	-	-	-	ORC6	HGNC:17151	Meier-Gorlin syndrome 3, 613803 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
613804	MEIER-GORLIN SYNDROME 4	Meier-Gorlin syndrome 4, 613804 (3)	Meier-Gorlin syndrome 4	n	-	-	-	CDT1	HGNC:24576	Meier-Gorlin syndrome 4, 613804 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
613807	CILIARY DYSKINESIA, PRIMARY, 14	Ciliary dyskinesia, primary, 14, 613807 (3)	Ciliary dyskinesia, primary, 14	n	-	-	-	CCDC39	HGNC:25244	Ciliary dyskinesia, primary, 14, 613807 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
613808	CILIARY DYSKINESIA, PRIMARY, 15	Ciliary dyskinesia, primary, 15, 613808 (3)	Ciliary dyskinesia, primary, 15	n	-	-	-	CCDC40	HGNC:26090	Ciliary dyskinesia, primary, 15, 613808 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
613809	RETINITIS PIGMENTOSA 39	Retinitis pigmentosa 39, 613809 (3)	Retinitis pigmentosa 39	n	-	-	-	USH2A	HGNC:12601	Retinitis pigmentosa 39, 613809 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
613810	RETINITIS PIGMENTOSA 43	Retinitis pigmentosa 43, 613810 (3)	Retinitis pigmentosa 43	n	-	-	-	PDE6A	HGNC:8785	Retinitis pigmentosa 43, 613810 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
613811	PONTOCEREBELLAR HYPOPLASIA, TYPE 2D	Pontocerebellar hypoplasia type 2D, 613811 (3)	Pontocerebellar hypoplasia type 2D	n	-	-	-	SEPSECS	HGNC:30605	Pontocerebellar hypoplasia type 2D, 613811 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
613812	BILE ACID SYNTHESIS DEFECT, CONGENITAL, 3	Bile acid synthesis defect, congenital, 3, 613812 (3)	Bile acid synthesis defect, congenital, 3	y	BILE ACID SYNTHESIS DEFECT, CONGENITAL, 3; CBAS3	Clinical Features	death|deaths|died|lethality	CYP7B1	HGNC:2652	Bile acid synthesis defect, congenital, 3, 613812 (3), Autosomal recessive	Autosomal recessive	y	y	[They speculated that the relatively early age of the patient and the severity of the liver disease may indicate that a mutation in the oxysterol 7-alpha-hydroxylase gene causes prenatal or early neonatal lethality, and that this case represents an exception to fetal death]	L1	n	-	lethal	lethal|nonlethal	lethal|nonlethal	L1	L1	pre-infant-lethal
613818	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 9	Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 9, 613818 (3)	Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 9	n	-	-	-	DAG1	HGNC:2666	Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 9, 613818 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L2	L2	pre-infant-lethal
613819	SHORT-RIB THORACIC DYSPLASIA 4 WITH OR WITHOUT POLYDACTYLY	Short-rib thoracic dysplasia 4 with or without polydactyly, 613819 (3)	Short-rib thoracic dysplasia 4 with or without polydactyly	y	SHORT-RIB THORACIC DYSPLASIA 4 WITH OR WITHOUT POLYDACTYLY; SRTD4	Description	lethal	TTC21B	HGNC:25660	Short-rib thoracic dysplasia 4 with or without polydactyly, 613819 (3), Autosomal recessive	Autosomal recessive	n	y	[Some forms of SRTD are lethal in the neonatal period due to respiratory insufficiency secondary to a severely restricted thoracic cage, whereas others are compatible with life (summary by Huber and Cormier-Daire, 2012 and Schmidts et al., 2013)]	L2	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L2	L2	pre-infant-lethal
613820	NEPHRONOPHTHISIS 12	Nephronophthisis 12, 613820 (3)	Nephronophthisis 12	n	-	-	-	TTC21B	HGNC:25660	Nephronophthisis 12, 613820 (3), Autosomal dominant, Autosomal recessive	Autosomal dominant, Autosomal recessive	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L2	L2	pre-infant-lethal
613823	SECKEL SYNDROME 5	Seckel syndrome 5, 613823 (3)	Seckel syndrome 5	n	-	-	-	CEP152	HGNC:29298	Seckel syndrome 5, 613823 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
613825	COMPLEMENT COMPONENT 9 DEFICIENCY	C9 deficiency, 613825 (3)	C9 deficiency	y	COMPLEMENT COMPONENT 9 DEFICIENCY; C9D	Phenotype	died	C9	HGNC:1358	C9 deficiency, 613825 (3)	-	n	n	-	-	-	-	ambiguous	ambiguous	ambiguous	-	-	-
613826	LEBER CONGENITAL AMAUROSIS 6	Leber congenital amaurosis 6, 613826 (3)	Leber congenital amaurosis 6	n	-	-	-	RPGRIP1	HGNC:13436	Leber congenital amaurosis 6, 613826 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
613827	RETINITIS PIGMENTOSA 48	Retinitis pigmentosa 48, 613827 (3)	Retinitis pigmentosa 48	n	-	-	-	GUCA1B	HGNC:4679	Retinitis pigmentosa 48, 613827 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
613829	LEBER CONGENITAL AMAUROSIS 7	Leber congenital amaurosis 7, 613829 (3)	Leber congenital amaurosis 7	n	-	-	-	CRX	HGNC:2383	Leber congenital amaurosis 7, 613829 (3)	-	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
613830	NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1D	Night blindness, congenital stationary (complete), 1D, autosomal recessive, 613830 (3)	Night blindness, congenital stationary (complete), 1D, autosomal recessive	n	-	-	-	SLC24A1	HGNC:10975	Night blindness, congenital stationary (complete), 1D, autosomal recessive, 613830 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
613834	MULTISYSTEMIC SMOOTH MUSCLE DYSFUNCTION SYNDROME	Multisystemic smooth muscle dysfunction syndrome, 613834 (3)	Multisystemic smooth muscle dysfunction syndrome	y	MULTISYSTEMIC SMOOTH MUSCLE DYSFUNCTION SYNDROME; MSMDS	Clinical Features	died	ACTA2	HGNC:130	Multisystemic smooth muscle dysfunction syndrome, 613834 (3), Autosomal dominant	Autosomal dominant	y	y	[Regalado et al. (2018) reviewed the medical records of 33 patients with MSMDS. Patients ranged in age from newborn to 37 years. Age of diagnosis ranged from newborn to 36 years. Most (21 of 33) patients were female. All patients had congenital mydriasis and related pupillary abnormalities at birth and presented in infancy with a patent ductus arteriosus or aortopulmonary window. Patients had cerebrovascular disease characterized by small vessel disease (hyperintense periventricular white matter lesions; 95%), intracranial artery stenosis (77%), ischemic strokes (27%), and seizures (18%). Twelve (36%) patients had thoracic aortic aneurysm repair or dissection at median age of 14 years, and aortic disease was fully penetrant by the age of 25 years. Three (9%) patients had axillary artery aneurysms complicated by thromboembolic episodes. Nine patients died between the ages of 0.5 and 32 years due to aortic, pulmonary, or stroke complications, or unknown causes]	L3	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L3|L5	L3	pre-infant-lethal
613835	LEBER CONGENITAL AMAUROSIS 8	Leber congenital amaurosis 8, 613835 (3)	Leber congenital amaurosis 8	n	-	-	-	CRB1	HGNC:2343	Leber congenital amaurosis 8, 613835 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
613837	LEBER CONGENITAL AMAUROSIS 11	Leber congenital amaurosis 11, 613837 (3)	Leber congenital amaurosis 11	n	-	-	-	IMPDH1	HGNC:6052	Leber congenital amaurosis 11, 613837 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
613838	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 16	Cardiomyopathy, hypertrophic, 16, 613838 (3)	Cardiomyopathy, hypertrophic, 16	n	-	-	-	MYOZ2	HGNC:1330	Cardiomyopathy, hypertrophic, 16, 613838 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
613839	MEGALOBLASTIC ANEMIA DUE TO DIHYDROFOLATE REDUCTASE DEFICIENCY	Megaloblastic anemia due to dihydrofolate reductase deficiency, 613839 (3)	Megaloblastic anemia due to dihydrofolate reductase deficiency	y	MEGALOBLASTIC ANEMIA DUE TO DIHYDROFOLATE REDUCTASE DEFICIENCY	Clinical Features	died	DHFR	HGNC:2861	Megaloblastic anemia due to dihydrofolate reductase deficiency, 613839 (3), Autosomal recessive	Autosomal recessive	n	y	[Banka et al. (2011) reported a boy, born of first-cousin British Pakistani parents, who presented at age 4 months with megaloblastic anemia and acquired microcephaly. He showed poor feeding, pallor, and soon developed pancytopenia and refractory seizures. Brain MRI showed severe cerebral and cerebellar atrophy. Laboratory studies showed normal serum folate, vitamin B12, and ferritin levels, but the CSF showed markedly decreased 5-methyltetrahydrofolate (5-MTHF) and low tetrahydrobiopterin (BH4). There was no methylmalonic aciduria, and plasma homocysteine was normal. Oral folinic acid improved the anemia and seizures, but the CSF BH4 levels continued to drop. At age 19 months, he was profoundly delayed with central hypotonia, poor head control, and inability to fix and follow. An older sib died at 28 weeks of age with a history of anemia and intractable seizures of undefined cause]	L3	n	y	lethal	lethal	lethal	L3	L3	pre-infant-lethal
613843	LEBER CONGENITAL AMAUROSIS 15	Leber congenital amaurosis 15, 613843 (3)	Leber congenital amaurosis 15	n	-	-	-	TULP1	HGNC:12423	Leber congenital amaurosis 15, 613843 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
613845	HYPERURICEMIA, PULMONARY HYPERTENSION, RENAL FAILURE, AND ALKALOSIS SYNDROME	Hyperuricemia, pulmonary hypertension, renal failure, and alkalosis, 613845 (3)	Hyperuricemia, pulmonary hypertension, renal failure, and alkalosis	y	HYPERURICEMIA, PULMONARY HYPERTENSION, RENAL FAILURE, AND ALKALOSIS SYNDROME; HUPRAS	Clinical Features|Clinical Synopsis	died|fatal	SARS2	HGNC:17697	Hyperuricemia, pulmonary hypertension, renal failure, and alkalosis, 613845 (3), Autosomal recessive	Autosomal recessive	y	y	[Belostotsky et al. (2011) reported in detail 3 patients from 2 unrelated Palestinian families from the same village. All were born premature (27-34 weeks' gestation) and presented in infancy with failure to thrive...The disorder was progressive, and all 3 patients died before age 14 months]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
613848	OSTEOGENESIS IMPERFECTA, TYPE X	Osteogenesis imperfecta, type X, 613848 (3)	Osteogenesis imperfecta, type X	y	OSTEOGENESIS IMPERFECTA, TYPE X; OI10	Clinical Features	died	SERPINH1	HGNC:1546	Osteogenesis imperfecta, type X, 613848 (3), Autosomal recessive	Autosomal recessive	n	y	[Christiansen et al. (2010) reported a child with a severe deforming form of OI who was born to a clinically normal consanguineous Saudi Arabian couple and was the only affected member in the extended family... . At age 3 years and 6 months he had sudden unexplained respiratory distress at home and died soon after arrival at the hospital]	L4	y	-	lethal	lethal	lethal	L4	L4	post-infant-lethal
613849	OSTEOGENESIS IMPERFECTA, TYPE XII	Osteogenesis imperfecta, type XII, 613849 (3)	Osteogenesis imperfecta, type XII	y	OSTEOGENESIS IMPERFECTA, TYPE XII; OI12	Clinical Features	died	SP7	HGNC:17321	Osteogenesis imperfecta, type XII, 613849 (3), Autosomal recessive	Autosomal recessive	n	y	[Lapunzina et al. (2010) reported an 8-year-old Egyptian boy with osteogenesis imperfecta and normal sclerae, who was born to consanguineous parents related as second cousins. Clinical features included recurrent fractures beginning at 3 months of age, mild bone deformities, delayed tooth eruption, and normal hearing. The family had a history of a similarly affected sib who, in addition to OI, was diagnosed with a congenital heart condition and died at the age of 4 years]	L4	n	y	lethal	lethal	lethal	L4	L4	post-infant-lethal
613854	CONGENITAL HEART DEFECTS, MULTIPLE TYPES, 6	Congenital heart defects, multiple types, 6, 613854 (3)	Congenital heart defects, multiple types, 6	n	-	-	-	GDF1	HGNC:4214	Congenital heart defects, multiple types, 6, 613854 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L2	L2	pre-infant-lethal
613855	EPISODIC ATAXIA, TYPE 5	Episodic ataxia, type 5, 613855 (3)	Episodic ataxia, type 5	n	-	-	-	CACNB4	HGNC:1404	Episodic ataxia, type 5, 613855 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
613856	ACHROMATOPSIA 4	Achromatopsia 4, 613856 (3)	Achromatopsia 4	n	-	-	-	GNAT2	HGNC:4394	Achromatopsia 4, 613856 (3)	-	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
613860	FICOLIN 3 DEFICIENCY	Immunodeficiency due to ficolin 3 deficiency, 613860 (3)	Immunodeficiency due to ficolin 3 deficiency	y	FICOLIN 3 DEFICIENCY	Clinical Features	died	FCN3	HGNC:3625	Immunodeficiency due to ficolin 3 deficiency, 613860 (3), Autosomal recessive	Autosomal recessive	y	y	[Schlapbach et al. (2011) reported 2 unrelated infants who were born prematurely and developed necrotizing enterocolitis associated with severe H-ficolin deficiency. One of the patients died at age 4 weeks; DNA was not available]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
613861	RETINITIS PIGMENTOSA 59	Retinitis pigmentosa 59, 613861 (3)	Retinitis pigmentosa 59	y	RETINITIS PIGMENTOSA 59; RP59	Clinical Features|Clinical Synopsis	died|fatal	DHDDS	HGNC:20603	Retinitis pigmentosa 59, 613861 (3), Autosomal recessive	Autosomal recessive	n	n	-	-	-	-	ambiguous	ambiguous|nonlethal	ambiguous	-	-	-
613862	RETINITIS PIGMENTOSA 38	Retinitis pigmentosa 38, 613862 (3)	Retinitis pigmentosa 38	n	-	-	-	MERTK	HGNC:7027	Retinitis pigmentosa 38, 613862 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
613869	MYOPATHY, MYOFIBRILLAR, FATAL INFANTILE HYPERTONIC, ALPHA-B CRYSTALLIN-RELATED	Myopathy, myofibrillar, fatal infantile hypertonic, alpha-B crystallin-related, 613869 (3)	Myopathy, myofibrillar, fatal infantile hypertonic, alpha-B crystallin-related	y	MYOPATHY, MYOFIBRILLAR, FATAL INFANTILE HYPERTONIC, ALPHA-B CRYSTALLIN-RELATED	Description|Clinical Features|Clinical Synopsis|Phenotype	death|deaths|fatal|died	CRYAB	HGNC:2389	Myopathy, myofibrillar, fatal infantile hypertonic, alpha-B crystallin-related, 613869 (3), Autosomal recessive	Autosomal recessive	n	y	[Lacson et al. (1994) reported 11 Canadian aboriginal infants of Cree ancestry with a similar form of fatal hypertonic muscular dystrophy. All presented in the first 8 weeks of life with respiratory insufficiency, except 1 who was hypertonic at age 3 weeks and died suddenly at age 6 weeks]	L3	y	-	lethal	ambiguous|lethal|nonlethal	lethal|nonlethal	L3|L6	L3	pre-infant-lethal
613873	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 17	Cardiomyopathy, hypertrophic, 17, 613873 (3)	Cardiomyopathy, hypertrophic, 17	y	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 17; CMH17	Clinical Features	died	JPH2	HGNC:14202	Cardiomyopathy, hypertrophic, 17, 613873 (3), Autosomal dominant	Autosomal dominant	n	y	[Matsushita et al. (2007) studied 4 Japanese probands with hypertrophic cardiomyopathy (CMH). The first proband was diagnosed at 14 years of age and had anterolateral hypertrophy of the free left ventricular wall. His mother, who was diagnosed at 40 years of age, had left ventricular hypertrophy (LVH) on electrocardiogram (ECG) and a sigmoid septum with hyperdynamic LV motion on echocardiography. A younger sister had died suddenly at 3 years of age]	L4	n	y	lethal	lethal	lethal	L1|L4	L1	pre-infant-lethal
613874	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 18	Cardiomyopathy, hypertrophic, 18, 613874 (3)	Cardiomyopathy, hypertrophic, 18	y	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 18; CMH18	Clinical Features	died	PLN	HGNC:9080	Cardiomyopathy, hypertrophic, 18, 613874 (3), Autosomal dominant	Autosomal dominant	y	y	[Medin et al. (2007) studied a family in which the 85-year-old female proband was diagnosed with apical CMH at 67 years of age, with a maximum wall thickness of 22 mm at the apex and normal thickness in basal segments. She originally presented with palpitations and chest pain at 59 years of age but had normal coronary angiography; she developed atrial fibrillation 2 years later, and continued to have occasional episodes of angina. Her brother was diagnosed with apical CMH at 72 years of age after presenting with palpitations, remained in atrial fibrillation after diagnosis, had atypical chest pain, and died suddenly at 81 years of age]	L6	n	y	lethal	lethal	lethal	L5|L6	L5	post-infant-lethal
613876	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 20	Cardiomyopathy, hypertrophic, 20, 613876 (3)	Cardiomyopathy, hypertrophic, 20	y	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 20; CMH20	Clinical Features	death|deaths|died	NEXN	HGNC:29557	Cardiomyopathy, hypertrophic, 20, 613876 (3), Autosomal dominant	Autosomal dominant	y	y	[Wang et al. (2010) studied 2 Han Chinese families with hypertrophic cardiomyopathy (CMH). In the first family, the 37-year-old female proband had nonobstructive cardiac hypertrophy with an interventricular septal thickness of 21 mm and normal left ventricular systolic function, with T-wave changes on electrocardiogram (ECG). The proband's mother had died a sudden cardiac death at 38 years of age; the proband also had an affected brother and daughter, both of whom had asymmetric septal hypertrophy on echocardiogram, and the brother also had voltage criteria for left ventricular hypertrophy (LVH) on ECG. In the second family, the 45-year-old male proband had a left ventricular anterior wall thickness of 17 mm. His grandmother had died suddenly with suspected heart disease at 40 years of age, and his father and brother were also affected]	L6	n	y	lethal	lethal	lethal	L6|LU	L6	post-infant-lethal
613877	LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 4	Lipodystrophy, familial partial, type 4, 613877 (3)	Lipodystrophy, familial partial, type 4	n	-	-	-	PLIN1	HGNC:9076	Lipodystrophy, familial partial, type 4, 613877 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
613881	CARDIOMYOPATHY, DILATED, 1HH	Cardiomyopathy, dilated, 1HH, 613881 (3)	Cardiomyopathy, dilated, 1HH	y	CARDIOMYOPATHY, DILATED, 1HH; CMD1HH	Clinical Features	died	BAG3	HGNC:939	Cardiomyopathy, dilated, 1HH, 613881 (3), Autosomal dominant	Autosomal dominant	n	y	[Norton et al. (2011) reported 17 individuals from 8 families with dilated cardiomyopathy who carried heterozygous mutations in the BAG3 gene. The age at onset or diagnosis of the CMD phenotype ranged from 21 years to 64 years (median, 44). Disease severity varied considerably: although 9 of the 17 mutation carriers with CMD underwent heart transplant or died with advanced heart failure, there were 4 mutation carriers who had no disease and 1 who was asymptomatic with only mild left ventricular dysfunction]	LU	y	-	lethal	lethal	lethal	L4|LU	L4	post-infant-lethal
613882	HYPOMAGNESEMIA 6, RENAL	Hypomagnesemia 6, renal, 613882 (3)	Hypomagnesemia 6, renal	n	-	-	-	CNNM2	HGNC:103	Hypomagnesemia 6, renal, 613882 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
613886	OBESITY, HYPERPHAGIA, AND DEVELOPMENTAL DELAY	Obesity, hyperphagia, and developmental delay, 613886 (3)	Obesity, hyperphagia, and developmental delay	n	-	-	-	NTRK2	HGNC:8032	Obesity, hyperphagia, and developmental delay, 613886 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
613887	CATARACT 36	Cataract 36, 613887 (3)	Cataract 36	n	-	-	-	TDRD7	HGNC:30831	Cataract 36, 613887 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
613908	SPINOCEREBELLAR ATAXIA 35	Spinocerebellar ataxia 35, 613908 (3)	Spinocerebellar ataxia 35	n	-	-	-	TGM6	HGNC:16255	Spinocerebellar ataxia 35, 613908 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
613912	COMPLEMENT FACTOR D DEFICIENCY	Complement factor D deficiency, 613912 (3)	Complement factor D deficiency	y	COMPLEMENT FACTOR D DEFICIENCY; CFDD	Clinical Features	died	CFD	HGNC:2771	Complement factor D deficiency, 613912 (3), Autosomal recessive	Autosomal recessive	n	y	[Sprong et al. (2006) reported a Turkish brother and sister with invasive meningococcal disease. The 19-month-old girl was admitted with purpura, high fever, coughing, diarrhea, and vomiting. Cerebrospinal fluid cultures grew N. meningitidis. She died in refractory shock about 47 hours after hospital admission]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
613916	DEAFNESS, AUTOSOMAL RECESSIVE 89	Deafness, autosomal recessive 89, 613916 (3)	Deafness, autosomal recessive 89	n	-	-	-	KARS1	HGNC:6215	Deafness, autosomal recessive 89, 613916 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L3|L6	L3	pre-infant-lethal
613925	MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 2A	Megalencephalic leukoencephalopathy with subcortical cysts 2A, 613925 (3)	Megalencephalic leukoencephalopathy with subcortical cysts 2A	n	-	-	-	HEPACAM	HGNC:26361	Megalencephalic leukoencephalopathy with subcortical cysts 2A, 613925 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
613926	MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 2B, REMITTING, WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT	Megalencephalic leukoencephalopathy with subcortical cysts 2B, remitting, with or without impaired intellectual development, 613926 (3)	Megalencephalic leukoencephalopathy with subcortical cysts 2B, remitting, with or without impaired intellectual development	n	-	-	-	HEPACAM	HGNC:26361	Megalencephalic leukoencephalopathy with subcortical cysts 2B, remitting, with or without impaired intellectual development, 613926 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
613943	ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 8	Ichthyosis, congenital, autosomal recessive 8, 613943 (3)	Ichthyosis, congenital, autosomal recessive 8	n	-	-	-	LIPN	HGNC:23452	Ichthyosis, congenital, autosomal recessive 8, 613943 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
613949	OKT4 EPITOPE DEFICIENCY	OKT4 epitope deficiency, 613949 (3)	OKT4 epitope deficiency	n	-	-	-	CD4	HGNC:1678	OKT4 epitope deficiency, 613949 (3)	-	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
613951	FANCONI ANEMIA, COMPLEMENTATION GROUP P	Fanconi anemia, complementation group P, 613951 (3)	Fanconi anemia, complementation group P	y	FANCONI ANEMIA, COMPLEMENTATION GROUP P; FANCP	Clinical Features	died	SLX4	HGNC:23845	Fanconi anemia, complementation group P, 613951 (3), Autosomal recessive	Autosomal recessive	y	y	[Kim et al. (2011) reported 2 unrelated patients with FANCP. One was a 15-year-old girl from south India who presented at age 9 years with isolated thrombocytopenia. She had short stature and vitiligo. The second was an American man of European descent with bilateral absent thumbs and right radial aplasia, pelvic kidney, undescended left testicle, malformed auricle, and short stature, as well as low platelets and anemia. He developed squamous cell carcinoma of the tongue at age 21 years and died at age 22]	L6	y	-	lethal	lethal	lethal	L6	L6	post-infant-lethal
613953	IMMUNODEFICIENCY 51	Immunodeficiency 51, 613953 (3)	Immunodeficiency 51	n	-	-	-	IL17RA	HGNC:5985	Immunodeficiency 51, 613953 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
613954	FRONTOTEMPORAL DEMENTIA AND/OR AMYOTROPHIC LATERAL SCLEROSIS 6	Frontotemporal dementia and/or amyotrophic lateral sclerosis 6, 613954 (3)	Frontotemporal dementia and/or amyotrophic lateral sclerosis 6	y	FRONTOTEMPORAL DEMENTIA AND/OR AMYOTROPHIC LATERAL SCLEROSIS 6; FTDALS6	Description|Clinical Features	death|deaths|fatal|died	VCP	HGNC:12666	Frontotemporal dementia and/or amyotrophic lateral sclerosis 6, 613954 (3), Autosomal dominant	Autosomal dominant	y	y	[Wong et al. (2018) reported 3 unrelated Dutch patients who presented with the behavioral variant of FTD between 41 and 60 years of age. Clinical features included reduced empathy, loss of interest in grooming, personality changes, aggressive and obsessive behavior, and word-finding and semantic difficulties. Brain imaging showed cortical atrophy. None had signs of a myopathy, motor neuron disease, or bone disease. The patients died between 46 and 67 years of age]	L6	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L6	L6	post-infant-lethal
613957	SPERMATOGENIC FAILURE 8	Spermatogenic failure 8, 613957 (3)	Spermatogenic failure 8	n	-	-	-	NR5A1	HGNC:7983	Spermatogenic failure 8, 613957 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
613958	SPERMATOGENIC FAILURE 9	Spermatogenic failure 9, 613958 (3)	Spermatogenic failure 9	y	SPERMATOGENIC FAILURE 9; SPGF9	Clinical Features	miscarriage|miscarriages	DPY19L2	HGNC:19414	Spermatogenic failure 9, 613958 (3), Autosomal recessive	Autosomal recessive	y	n	-	-	-	-	ambiguous	ambiguous	ambiguous	-	-	-
613960	GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, 3	Chronic granulomatous disease 3, autosomal recessive, 613960 (3)	Chronic granulomatous disease 3, autosomal recessive	y	GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, 3; CGD3	Clinical Features	died	NCF4	HGNC:7662	Chronic granulomatous disease 3, autosomal recessive, 613960 (3), Autosomal recessive	Autosomal recessive	y	n	-	-	-	-	ambiguous	ambiguous	ambiguous	-	-	-
613970	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 6, WITH OR WITHOUT SEIZURES	Intellectual developmental disorder, autosomal dominant 6, with or without seizures, 613970 (3)	Intellectual developmental disorder, autosomal dominant 6, with or without seizures	n	-	-	-	GRIN2B	HGNC:4586	Intellectual developmental disorder, autosomal dominant 6, with or without seizures, 613970 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
613977	CYANOSIS, TRANSIENT NEONATAL	Cyanosis, transient neonatal, 613977 (3)	Cyanosis, transient neonatal	n	-	-	-	HBG2	HGNC:4832	Cyanosis, transient neonatal, 613977 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
613978	HEMOGLOBIN H DISEASE	Hemoglobin H disease, nondeletional, 613978 (3)	Hemoglobin H disease, nondeletional	y	HEMOGLOBIN H DISEASE; HBH	Clinical Features	fatal	HBA1	HGNC:4823	Hemoglobin H disease, nondeletional, 613978 (3)	-	y	y	[Hb H disease is generally thought to be a mild disorder. However, there is marked phenotypic variability ranging from asymptomatic, to needing periodic transfusions, to severe anemia with hemolysis and hepatosplenomegaly, to fatal hydrops fetalis in utero]	L1	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L1	L1	pre-infant-lethal
613978	HEMOGLOBIN H DISEASE	Hemoglobin H disease, deletional and nondeletional, 613978 (3)	Hemoglobin H disease, deletional and nondeletional	y	HEMOGLOBIN H DISEASE; HBH	Clinical Features	fatal	HBA2	HGNC:4824	Hemoglobin H disease, deletional and nondeletional, 613978 (3)	-	y	y	[Hb H disease is generally thought to be a mild disorder. However, there is marked phenotypic variability ranging from asymptomatic, to needing periodic transfusions, to severe anemia with hemolysis and hepatosplenomegaly, to fatal hydrops fetalis in utero]	L1	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L1	L1	pre-infant-lethal
613980	ATRIAL FIBRILLATION, FAMILIAL, 9	Atrial fibrillation, familial, 9, 613980 (3)	Atrial fibrillation, familial, 9	y	ATRIAL FIBRILLATION, FAMILIAL, 9; ATFB9	Clinical Features	death|deaths	KCNJ2	HGNC:6263	Atrial fibrillation, familial, 9, 613980 (3), Autosomal dominant	Autosomal dominant	n	y	[Xia et al. (2005) studied a 4-generation Chinese family segregating autosomal dominant atrial fibrillation (AF). The proband was a 59-year-old man who had been diagnosed with AF at 54 years of age and had paroxysmal AF 2 to 3 times a month. His father and an older sister, who were diagnosed at age 58 years and 50 years, respectively, had persistent atrial fibrillation before their deaths]	L6	n	y	lethal	lethal	lethal	L5|L6|LU	L5	post-infant-lethal
613982	OSTEOGENESIS IMPERFECTA, TYPE VI	Osteogenesis imperfecta, type VI, 613982 (3)	Osteogenesis imperfecta, type VI	n	-	-	-	SERPINF1	HGNC:8824	Osteogenesis imperfecta, type VI, 613982 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
613983	RETINITIS PIGMENTOSA 60	Retinitis pigmentosa 60, 613983 (3)	Retinitis pigmentosa 60	n	-	-	-	PRPF6	HGNC:15860	Retinitis pigmentosa 60, 613983 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
613985	BETA-THALASSEMIA	Thalassemia, beta, 613985 (3)	Thalassemia, beta	y	BETA-THALASSEMIA	Clinical Features	die	HBB	HGNC:4827	Thalassemia, beta, 613985 (3)	-	y	y	[Modell et al. (2000) found that about 50% of UK patients with beta-thalassemia major die before the age of 35 years, mainly because conventional iron-chelation therapy is too burdensome for full adherence]	L6	y	-	lethal	ambiguous|lethal|nonlethal	lethal|nonlethal	L3|L6	L3	pre-infant-lethal
613986	PITUITARY HORMONE DEFICIENCY, COMBINED, 6	Pituitary hormone deficiency, combined, 6, 613986 (3)	Pituitary hormone deficiency, combined, 6	n	-	-	-	OTX2	HGNC:8522	Pituitary hormone deficiency, combined, 6, 613986 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L2	L2	pre-infant-lethal
613987	DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 2	Dyskeratosis congenita, autosomal recessive 2, 613987 (3)	Dyskeratosis congenita, autosomal recessive 2	n	-	-	-	NHP2	HGNC:14377	Dyskeratosis congenita, autosomal recessive 2, 613987 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
613988	DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 3	Dyskeratosis congenita, autosomal recessive 3, 613988 (3)	Dyskeratosis congenita, autosomal recessive 3	n	-	-	-	WRAP53	HGNC:25522	Dyskeratosis congenita, autosomal recessive 3, 613988 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
613989	DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 2	Dyskeratosis congenita, autosomal dominant 2, 613989 (3)	Dyskeratosis congenita, autosomal dominant 2	n	-	-	-	TERT	HGNC:11730	Dyskeratosis congenita, autosomal dominant 2, 613989 (3), Autosomal dominant, Autosomal recessive	Autosomal dominant, Autosomal recessive	-	-	-	-	-	-	nonlethal	ambiguous|nonlethal	ambiguous	-	-	-
613989	DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 2	Dyskeratosis congenita, autosomal recessive 4, 613989 (3)	Dyskeratosis congenita, autosomal recessive 4	n	-	-	-	TERT	HGNC:11730	Dyskeratosis congenita, autosomal recessive 4, 613989 (3), Autosomal dominant, Autosomal recessive	Autosomal dominant, Autosomal recessive	-	-	-	-	-	-	nonlethal	ambiguous|nonlethal	ambiguous	-	-	-
613990	DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 3	Dyskeratosis congenita, autosomal dominant 3, 613990 (3)	Dyskeratosis congenita, autosomal dominant 3	y	DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 3; DKCA3	Clinical Features	died	TINF2	HGNC:11824	Dyskeratosis congenita, autosomal dominant 3, 613990 (3), Autosomal dominant	Autosomal dominant	y	y	[Sasa et al. (2012) reported 2 unrelated patients with DKCA3 confirmed by genetic analysis (Q269X; 604319.0005 and Q271X; 604319.0007, respectively). .. She died at age 12 years from multiorgan failure]	L5	y	-	lethal	lethal	lethal	L3|L5	L3	pre-infant-lethal
614008	NESTOR-GUILLERMO PROGERIA SYNDROME	Nestor-Guillermo progeria syndrome, 614008 (3)	Nestor-Guillermo progeria syndrome	n	-	-	-	BANF1	HGNC:17397	Nestor-Guillermo progeria syndrome, 614008 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
614017	CILIARY DYSKINESIA, PRIMARY, 16	Ciliary dyskinesia, primary, 16, 614017 (3)	Ciliary dyskinesia, primary, 16	n	-	-	-	DNAL1	HGNC:23247	Ciliary dyskinesia, primary, 16, 614017 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
614018	EPILEPSY, PROGRESSIVE MYOCLONIC, 6	Epilepsy, progressive myoclonic 6, 614018 (3)	Epilepsy, progressive myoclonic 6	n	-	-	-	GOSR2	HGNC:4431	Epilepsy, progressive myoclonic 6, 614018 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L4	L4	post-infant-lethal
614019	LISSENCEPHALY 4	Lissencephaly 4 (with microcephaly), 614019 (3)	Lissencephaly 4 (with microcephaly)	y	LISSENCEPHALY 4; LIS4	Clinical Features|Phenotype	died	NDE1	HGNC:17619	Lissencephaly 4 (with microcephaly), 614019 (3), Autosomal recessive	Autosomal recessive	y	y	[Bakircioglu et al. (2011) reported 6 offspring from 3 consanguineous families with lissencephaly, extreme congenital microcephaly, and profound mental retardation. Two families were of Pakistani origin, and the third was of Turkish origin. The head circumferences of all patients were at least 10 SD below the mean, with onset at 18 weeks' gestation. Mental retardation was evident within the first few months of life; none of the children recognized their parents, and they showed little response to the outside world, even to painful stimuli. Seizures began by 3 months and evolved from occasional rhythmic jerks into complex partial and tonic-clonic seizures. The children gradually adopted a fetal position over the first 3 years of life, with a paucity of movements, but were not hypotonic or spastic. All but 1 died in the first 5 years of life of chest infections and aspiration]	L4	y	-	lethal	lethal	lethal	L4	L4	post-infant-lethal
614020	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 14	Intellectual developmental disorder, autosomal recessive 14, 614020 (3)	Intellectual developmental disorder, autosomal recessive 14	n	-	-	-	TECR	HGNC:4551	Intellectual developmental disorder, autosomal recessive 14, 614020 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
614021	VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 3	Ventricular tachycardia, catecholaminergic polymorphic, 3, 614021 (3)	Ventricular tachycardia, catecholaminergic polymorphic, 3	y	VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 3; CPVT3	Description|Clinical Features|Clinical Synopsis|Phenotype	death|deaths|died|fatal	TECRL	HGNC:27365	Ventricular tachycardia, catecholaminergic polymorphic, 3, 614021 (3), Autosomal recessive	Autosomal recessive	y	y	[Bhuiyan et al. (2007) studied a large consanguineous family of Sudanese origin in which 3 sibs died suddenly during physical activity. The first death occurred in a 10-year-old girl who died while playing in a fun park; no evaluation was performed. The second death involved her younger brother, who collapsed at 12 years of age while skating; during resuscitation he was noted to have several episodes of ventricular tachycardia. Electrocardiography (ECG) revealed a mildly prolonged QTc (450 to 490 ms) and premature ventricular contractions (PVCs) with a right bundle branch block (RBBB) morphology and superior axis, indicating a left ventricular origin. ECG showed no structural cardiac anomaly. He remained in a vegetative state until his death from pneumonia 2 years later. The third sib was a younger sister who underwent palliative surgery for tetralogy of Fallot in infancy, at which time ECG revealed a QTc of 440 ms; ECG at 14 months of age showed QTc of 480 to 490 ms. After corrective cardiac surgery at 3 years of age, ECG showed RBBB with QRS duration of 110 ms and QTc of 470 to 490 ms (uncorrected for widened QRS complex). She collapsed and died while playing sports at 8 years of age.]	L4	y	-	lethal	lethal	lethal	L4	L4	post-infant-lethal
614022	ATRIAL FIBRILLATION, FAMILIAL, 10	Atrial fibrillation, familial, 10, 614022 (3)	Atrial fibrillation, familial, 10	n	-	-	-	SCN5A	HGNC:10593	Atrial fibrillation, familial, 10, 614022 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L4|L5|L6|LU	L4	post-infant-lethal
614023	PHOSPHOSERINE PHOSPHATASE DEFICIENCY	Phosphoserine phosphatase deficiency, 614023 (3)	Phosphoserine phosphatase deficiency	n	-	-	-	PSPH	HGNC:9577	Phosphoserine phosphatase deficiency, 614023 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
614025	HEPATIC LIPASE DEFICIENCY	Hepatic lipase deficiency, 614025 (3)	Hepatic lipase deficiency	n	-	-	-	LIPC	HGNC:6619	Hepatic lipase deficiency, 614025 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
614028	APOLIPOPROTEIN C-III DEFICIENCY	Apolipoprotein C-III deficiency, 614028 (3)	Apolipoprotein C-III deficiency	n	-	-	-	APOC3	HGNC:610	Apolipoprotein C-III deficiency, 614028 (3)	-	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
614034	HEME OXYGENASE 1 DEFICIENCY	Heme oxygenase-1 deficiency, 614034 (3)	Heme oxygenase-1 deficiency	y	HEME OXYGENASE 1 DEFICIENCY; HMOX1D	Clinical Features	died	HMOX1	HGNC:5013	Heme oxygenase-1 deficiency, 614034 (3), Autosomal recessive	Autosomal recessive	y	n	-	-	-	-	ambiguous	ambiguous	ambiguous	-	-	-
614035	DEAFNESS, AUTOSOMAL RECESSIVE 29	Deafness, autosomal recessive 29, 614035 (3)	Deafness, autosomal recessive 29	n	-	-	-	CLDN14	HGNC:2035	Deafness, autosomal recessive 29, 614035 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
614038	LYMPHEDEMA, PRIMARY, WITH MYELODYSPLASIA	Emberger syndrome, 614038 (3)	Emberger syndrome	y	LYMPHEDEMA, PRIMARY, WITH MYELODYSPLASIA	Clinical Features	died	GATA2	HGNC:4171	Emberger syndrome, 614038 (3), Autosomal dominant	Autosomal dominant	y	y	[Emberger et al. (1979) reported a family in which 3 individuals over 2 generations, who had severe congenital deafness, also developed lower limb lymphedema in childhood and hematologic abnormalities, including pancytopenia in 2 of them and acute myeloblastic leukemia in 1 individual. The male proband was born deaf and developed bilateral lymphedema of the lower extremities at 4 years of age. At age 12 years, he was found to have acute myeloblastic leukemia, and died 1 year later]	L5	y	-	lethal	ambiguous|lethal	lethal	L5	L5	post-infant-lethal
614039	CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 1	Cortical dysplasia, complex, with other brain malformations 1, 614039 (3)	Cortical dysplasia, complex, with other brain malformations 1	n	-	-	-	TUBB3	HGNC:20772	Cortical dysplasia, complex, with other brain malformations 1, 614039 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
614042	MOYAMOYA DISEASE 5	Moyamoya disease 5, 614042 (3)	Moyamoya disease 5	n	-	-	-	ACTA2	HGNC:130	Moyamoya disease 5, 614042 (3)	-	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L3|L5	L3	pre-infant-lethal
614049	ATRIAL FIBRILLATION, FAMILIAL, 11	Atrial fibrillation, familial, 11, 614049 (3)	Atrial fibrillation, familial, 11	n	-	-	-	GJA5	HGNC:4279	Atrial fibrillation, familial, 11, 614049 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L4	L4	post-infant-lethal
614052	MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 2	Mitochondrial complex V (ATP synthase) deficiency, nuclear type 2, 614052 (3)	Mitochondrial complex V (ATP synthase) deficiency, nuclear type 2	y	MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 2; MC5DN2	Clinical Features|Clinical Synopsis	death|deaths|died	TMEM70	HGNC:26050	Mitochondrial complex V (ATP synthase) deficiency, nuclear type 2, 614052 (3), Autosomal recessive	Autosomal recessive	y	y	[Staretz-Chacham et al. (2019) reported 2 sibs, born to consanguineous Bedouin parents, with MC5DN. The older sib had mild cardiac hypertrophy on prenatal echocardiogram. He developed severe lactic acidosis on the first day of life, and he died after 3 days]	L2	y	-	lethal	lethal	lethal	L2	L2	pre-infant-lethal
614053	MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 3	Mitochondrial complex V (ATP synthase) deficiency, nuclear type 3, 614053 (3)	Mitochondrial complex V (ATP synthase) deficiency, nuclear type 3	n	-	-	-	ATP5F1E	HGNC:838	Mitochondrial complex V (ATP synthase) deficiency, nuclear type 3, 614053 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
614065	MYOPATHY, DISTAL, 4	Myopathy, distal, 4, 614065 (3)	Myopathy, distal, 4	n	-	-	-	FLNC	HGNC:3756	Myopathy, distal, 4, 614065 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L6	L6	post-infant-lethal
614066	SPASTIC PARAPLEGIA 47, AUTOSOMAL RECESSIVE	Spastic paraplegia 47, autosomal recessive, 614066 (3)	Spastic paraplegia 47, autosomal recessive	n	-	-	-	AP4B1	HGNC:572	Spastic paraplegia 47, autosomal recessive, 614066 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
614067	SPASTIC PARAPLEGIA 52, AUTOSOMAL RECESSIVE	Spastic paraplegia 52, autosomal recessive, 614067 (3)	Spastic paraplegia 52, autosomal recessive	n	-	-	-	AP4S1	HGNC:575	Spastic paraplegia 52, autosomal recessive, 614067 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
614069	IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 2	Immunodeficiency-centromeric instability-facial anomalies syndrome 2, 614069 (3)	Immunodeficiency-centromeric instability-facial anomalies syndrome 2	y	IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 2; ICF2	Clinical Features|Clinical Synopsis	death|deaths	ZBTB24	HGNC:21143	Immunodeficiency-centromeric instability-facial anomalies syndrome 2, 614069 (3), Autosomal recessive	Autosomal recessive	n	y	[Death in childhood may occur due to infection]	L4	y	-	lethal	lethal	lethal	L4	L4	post-infant-lethal
614072	HERMANSKY-PUDLAK SYNDROME 3	Hermansky-Pudlak syndrome 3, 614072 (3)	Hermansky-Pudlak syndrome 3	n	-	-	-	HPS3	HGNC:15597	Hermansky-Pudlak syndrome 3, 614072 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
614073	HERMANSKY-PUDLAK SYNDROME 4	Hermansky-Pudlak syndrome 4, 614073 (3)	Hermansky-Pudlak syndrome 4	n	-	-	-	HPS4	HGNC:15844	Hermansky-Pudlak syndrome 4, 614073 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
614074	HERMANSKY-PUDLAK SYNDROME 5	Hermansky-Pudlak syndrome 5, 614074 (3)	Hermansky-Pudlak syndrome 5	n	-	-	-	HPS5	HGNC:17022	Hermansky-Pudlak syndrome 5, 614074 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
614075	HERMANSKY-PUDLAK SYNDROME 6	Hermansky-Pudlak syndrome 6, 614075 (3)	Hermansky-Pudlak syndrome 6	y	HERMANSKY-PUDLAK SYNDROME 6; HPS6	Clinical Features	miscarriage|miscarriages	HPS6	HGNC:18817	Hermansky-Pudlak syndrome 6, 614075 (3), Autosomal recessive	Autosomal recessive	y	n	-	-	-	-	ambiguous	ambiguous	ambiguous	-	-	-
614076	HERMANSKY-PUDLAK SYNDROME 7	Hermansky-Pudlak syndrome 7, 614076 (3)	Hermansky-Pudlak syndrome 7	n	-	-	-	DTNBP1	HGNC:17328	Hermansky-Pudlak syndrome 7, 614076 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
614077	HERMANSKY-PUDLAK SYNDROME 8	Hermansky-Pudlak syndrome 8, 614077 (3)	Hermansky-Pudlak syndrome 8	n	-	-	-	BLOC1S3	HGNC:20914	Hermansky-Pudlak syndrome 8, 614077 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
614078	CHONDRODYSPLASIA WITH JOINT DISLOCATIONS, GPAPP TYPE	Chondrodysplasia with joint dislocations, GPAPP type, 614078 (3)	Chondrodysplasia with joint dislocations, GPAPP type	y	CHONDRODYSPLASIA WITH JOINT DISLOCATIONS, GPAPP TYPE	Phenotype	died	BPNT2	HGNC:26019	Chondrodysplasia with joint dislocations, GPAPP type, 614078 (3), Autosomal recessive	Autosomal recessive	n	n	-	-	-	-	ambiguous	ambiguous	ambiguous	-	-	-
614080	MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 1	Multiple congenital anomalies-hypotonia-seizures syndrome 1, 614080 (3)	Multiple congenital anomalies-hypotonia-seizures syndrome 1	y	MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 1; MCAHS1	Description|Clinical Features	die|death|deaths|died|miscarriage|miscarriages|spontaneous_abortion|spontaneous_abortions	PIGN	HGNC:8967	Multiple congenital anomalies-hypotonia-seizures syndrome 1, 614080 (3), Autosomal recessive	Autosomal recessive	y	y	[McInerney-Leo et al. (2016) reported a nonconsanguineous couple of northern European descent who had 2 pregnancies in which the fetus was affected with multiple congenital anomalies detected by prenatal ultrasound. Both affected fetuses had congenital diaphragmatic hernia, cleft lip, cystic and mildly echogenic kidneys, and pulmonary hypoplasia. Based on these findings, both fetuses were diagnosed clinically with Fryns syndrome (FRNS; 229850). The pregnancies were terminated and postmortem examination was not performed. An unrelated fetus with similar features of Fryns syndrome was born to an Iraqi couple with a history of 3 first-trimester miscarriages. Prenatal imaging and postmortem examination showed cystic hygroma, echogenic kidneys, multiple cardiac defects, congenital diaphragmatic hernia, exomphalos, short distal phalanges, distal and dysmorphic facial features, including hypertelorism, low-set ears, anteverted nares, flat nasal bridge, long philtrum, macrostomia, and cleft palate. Whole-exome sequencing identified biallelic truncating mutations in the PIGN gene (606097.0009-606097.0011) in all 3 fetuses that segregated with the disorder in the families]	L1	y	-	lethal	lethal	lethal	L1	L1	pre-infant-lethal
614082	FANCONI ANEMIA, COMPLEMENTATION GROUP G	Fanconi anemia, complementation group G, 614082 (3)	Fanconi anemia, complementation group G	n	-	-	-	FANCG	HGNC:3588	Fanconi anemia, complementation group G, 614082 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
614083	FANCONI ANEMIA, COMPLEMENTATION GROUP L	Fanconi anemia, complementation group L, 614083 (3)	Fanconi anemia, complementation group L	y	FANCONI ANEMIA, COMPLEMENTATION GROUP L; FANCL	Clinical Features|Clinical Synopsis|Phenotype	died|lethal	FANCL	HGNC:20748	Fanconi anemia, complementation group L, 614083 (3), Autosomal recessive	Autosomal recessive	n	y	[Vetro et al. (2015) reported 2 unrelated infants with a severe form of FANCL presenting as multiple congenital anomalies reminiscent of VACTERL (192350) or VACTERL-H (276950).... The infant died 2 months later and the abnormalities were confirmed by postmortem examination. Family history included 2 previous fetuses with congenital malformations; data available for 1 in which the pregnancy had been terminated revealed similar features. In the second family, a female Dutch infant (case 2) showed intrauterine growth retardation, hydrocephalus, facial dysmorphism with depressed nasal tip, microtia, microphthalmia, cleft palate, short neck, short forearms, radial club hands with absent thumbs, hypoplastic sacrum, and anal atresia with rectovaginal fistula. She also had cardiac defects and renal hypoplasia. She died at age 2 day]	L2	y	-	lethal	lethal	lethal	L2	L2	pre-infant-lethal
614089	ATRIAL SEPTAL DEFECT 3	Atrial septal defect 3, 614089 (3)	Atrial septal defect 3	n	-	-	-	MYH6	HGNC:7576	Atrial septal defect 3, 614089 (3)	-	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L6	L6	post-infant-lethal
614091	SHORT-RIB THORACIC DYSPLASIA 7 WITH OR WITHOUT POLYDACTYLY	Short-rib thoracic dysplasia 7 with or without polydactyly, 614091 (3)	Short-rib thoracic dysplasia 7 with or without polydactyly	y	SHORT-RIB THORACIC DYSPLASIA 7 WITH OR WITHOUT POLYDACTYLY; SRTD7	Description|Clinical Features|Phenotype	lethal|died	WDR35	HGNC:29250	Short-rib thoracic dysplasia 7 with or without polydactyly, 614091 (3), Autosomal recessive	Autosomal recessive	y	y	[Duran et al. (2017) reported 3 sibs and an unrelated female infant with an unusual form of SRPS that included bent ribs and long bones, and undermineralization of the calvarium. The sibs exhibited short ribs, short limbs, bilateral postaxial polydactyly of the hands and feet with aphalangia of the hands, and bending of humeri, radii, and ulnae. Other significant findings included echogenic kidneys and bowel, scalp edema,and cystic hygroma. The unrelated female infant was diagnosed with SRPS prenatally and died 1 week after birth]	L2	y	-	lethal	lethal	lethal	L2|L3	L2	pre-infant-lethal
614096	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 8	Combined oxidative phosphorylation deficiency 8, 614096 (3)	Combined oxidative phosphorylation deficiency 8	y	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 8; COXPD8	Description|Clinical Features|Clinical Synopsis|Phenotype	lethal|died|fatal|death|deaths	AARS2	HGNC:21022	Combined oxidative phosphorylation deficiency 8, 614096 (3), Autosomal recessive	Autosomal recessive	n	y	[Gotz et al. (2011) reported a Finnish girl who presented at age 3.5 months with failure to thrive, delayed motor development, and severe generalized muscle weakness. She was found to have severe hypertrophic cardiomyopathy with decreased contractility and an ejection fraction of 40%. There was no clear neurologic involvement, and brain imaging was normal, although EEG showed mild background abnormalities. Muscle biopsy showed scattered complex IV (COX)-deficient fibers, which suggested generalized muscle dysfunction and was considered a contraindication for heart transplant. There was no liver involvement. She died at age 10 months of cardiac insufficiency. Light microscopy showed histiocytoid cardiomyopathy. Postmortem, 80% of cardiomyocytes and 60% of skeletal muscle fibers were COX-deficient. There was a near-total deficiency of respiratory complex I and IV in the heart, severe complex I and IV deficiency in the brain, and partial complex III deficiency in both tissues; all complexes were unaffected in the liver. These findings indicated a tissue-specific defect in several components of the mitochondrial respiratory chain. Gotz et al. (2011) also reported a second unrelated Finnish female infant who was severely affected at birth. She had a large hypertrophic heart with poor myocardial contractility and severe metabolic acidosis. There was some neurologic involvement, with staring gaze, periodic stiffness, and abnormal EEG. She died at postnatal day 3, and autopsy showed an enlarged, hypertrophic heart and pulmonary hypoplasia, but no pathologic changes in the brain or liver. There was severe deficiency of complex I and complex IV in the heart, brain, and skeletal muscle, but not in the liver. Family history revealed an affected brother who had died in utero of hypertrophic cardiomyopathy]	L1	y	y	lethal	lethal	lethal	L1|LU	L1	pre-infant-lethal
614097	ACATALASEMIA	Acatalasemia, 614097 (3)	Acatalasemia	n	-	-	-	CAT	HGNC:1516	Acatalasemia, 614097 (3)	-	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
614098	KEPPEN-LUBINSKY SYNDROME	Keppen-Lubinsky syndrome, 614098 (3)	Keppen-Lubinsky syndrome	y	KEPPEN-LUBINSKY SYNDROME; KPLBS	Phenotype	death|deaths	KCNJ6	HGNC:6267	Keppen-Lubinsky syndrome, 614098 (3), Autosomal dominant	Autosomal dominant	n	n	-	-	-	-	ambiguous	ambiguous	ambiguous	-	-	-
614104	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 7	Intellectual developmental disorder, autosomal dominant 7, 614104 (3)	Intellectual developmental disorder, autosomal dominant 7	n	-	-	-	DYRK1A	HGNC:3091	Intellectual developmental disorder, autosomal dominant 7, 614104 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
614105	METHYLMALONATE SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	Methylmalonate semialdehyde dehydrogenase deficiency, 614105 (3)	Methylmalonate semialdehyde dehydrogenase deficiency	y	METHYLMALONATE SEMIALDEHYDE DEHYDROGENASE DEFICIENCY; MMSDHD	Clinical Features	death|deaths	ALDH6A1	HGNC:7179	Methylmalonate semialdehyde dehydrogenase deficiency, 614105 (3), Autosomal recessive	Autosomal recessive	y	y	[Sass et al. (2012) reported a boy, born of related parents of European origin, with MMSDHD. The child was first seen at age 12 months for mildly delayed development, microcephaly, and mild dysmorphic features, such as bulbous nose with hypoplastic nasal alae and long philtrum. Laboratory studies showed increased urinary 3-hydroxyisobutyric acid. He made significant progress on a low-protein, valine-restricted diet and showed normal age-appropriate development at age 25 months. He then developed a febrile illness and showed acute metabolic decompensation, resulting in death from hepatoencephalopathy secondary to liver failure]	L4	y	-	lethal	lethal	lethal	L4	L4	post-infant-lethal
614111	PYRUVATE DEHYDROGENASE E1-BETA DEFICIENCY	Pyruvate dehydrogenase E1-beta deficiency, 614111 (3)	Pyruvate dehydrogenase E1-beta deficiency	y	PYRUVATE DEHYDROGENASE E1-BETA DEFICIENCY; PDHBD	Description|Clinical Features	die|died	PDHB	HGNC:8808	Pyruvate dehydrogenase E1-beta deficiency, 614111 (3), Autosomal recessive	Autosomal recessive	y	y	[Okajima et al. (2008) reported 4 unrelated patients with PDHBD, all of whom were diagnosed by low PDC activity with normal E2 and E3 activities and biallelic mutations in the PDHB gene: a 6.5-year-old boy (patient A), a female infant who died at 1 month of age (patient B), a 26-year-old woman (patient C), and a girl who died at 13 months of age (patient D)]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
614114	MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 2	Mosaic variegated aneuploidy syndrome 2, 614114 (3)	Mosaic variegated aneuploidy syndrome 2	y	MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 2; MVA2	Clinical Features	died	CEP57	HGNC:30794	Mosaic variegated aneuploidy syndrome 2, 614114 (3), Autosomal recessive	Autosomal recessive	n	y	[Dysmorphic features became apparent at age 12 years and included a narrow head, frontal whorl hair pattern, bulbous nose, microretrognathia, a long face, epicanthal folds, and low-set ears. He died at age 15 years of sleep apnea (Snape et al., 2011)]	L5	y	-	lethal	lethal	lethal	L5	L5	post-infant-lethal
614115	CORTICAL MALFORMATIONS, OCCIPITAL	Cortical malformations, occipital, 614115 (3)	Cortical malformations, occipital	n	-	-	-	LAMC3	HGNC:6494	Cortical malformations, occipital, 614115 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
614116	NEUROPATHY, HEREDITARY SENSORY, TYPE IE	Neuropathy, hereditary sensory, type IE, 614116 (3)	Neuropathy, hereditary sensory, type IE	y	NEUROPATHY, HEREDITARY SENSORY, TYPE IE; HSN1E	Clinical Features|Clinical Synopsis	death|deaths|died	DNMT1	HGNC:2976	Neuropathy, hereditary sensory, type IE, 614116 (3), Autosomal dominant	Autosomal dominant	n	y	[Death in the fifth or sixth decade]	L6	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L6	L6	post-infant-lethal
614129	PERRAULT SYNDROME 3	Perrault syndrome 3, 614129 (3)	Perrault syndrome 3	n	-	-	-	CLPP	HGNC:2084	Perrault syndrome 3, 614129 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
614131	FOCAL SEGMENTAL GLOMERULOSCLEROSIS 6	Glomerulosclerosis, focal segmental, 6, 614131 (3)	Glomerulosclerosis, focal segmental, 6	y	FOCAL SEGMENTAL GLOMERULOSCLEROSIS 6; FSGS6	Clinical Features	died	MYO1E	HGNC:7599	Glomerulosclerosis, focal segmental, 6, 614131 (3), Autosomal recessive	Autosomal recessive	n	y	[Mele et al. (2011) reported an 18-year-old Italian girl, born of consanguineous parents, who presented at age 9 years with nephrotic-range proteinuria, microhematuria, hypoalbuminemia, and edema... An older sister had died at age 6 years of progressive renal failure]	L4	n	y	lethal	lethal	lethal	L4	L4	post-infant-lethal
614134	STICKLER SYNDROME, TYPE IV	Stickler syndrome, type IV, 614134 (3)	Stickler syndrome, type IV	n	-	-	-	COL9A1	HGNC:2217	Stickler syndrome, type IV, 614134 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
614152	DEAFNESS, AUTOSOMAL DOMINANT 64	Deafness, autosomal dominant 64, 614152 (3)	Deafness, autosomal dominant 64	n	-	-	-	DIABLO	HGNC:21528	Deafness, autosomal dominant 64, 614152 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
614153	SPINOCEREBELLAR ATAXIA 36	Spinocerebellar ataxia 36, 614153 (3)	Spinocerebellar ataxia 36	n	-	-	-	NOP56	HGNC:15911	Spinocerebellar ataxia 36, 614153 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
614156	HYPERBILIVERDINEMIA	Hyperbiliverdinemia, 614156 (3)	Hyperbiliverdinemia	y	HYPERBILIVERDINEMIA; HBLVD	Clinical Features	fatal	BLVRA	HGNC:1062	Hyperbiliverdinemia, 614156 (3), Autosomal dominant, Autosomal recessive	Autosomal dominant, Autosomal recessive	n	y	[Gafvels et al. (2009) reported a 63-year-old Swedish man with alcoholic liver failure and hyperbiliverdinemia manifested as green jaundice... He developed bleeding esophageal varices, ascites, cirrhotic liver failure, and fatal encephalopathy]	L6	y	-	lethal	lethal	lethal	L6	L6	post-infant-lethal
614162	IMMUNODEFICIENCY 31C	Immunodeficiency 31C, chronic mucocutaneous candidiasis, autosomal dominant, 614162 (3)	Immunodeficiency 31C, chronic mucocutaneous candidiasis, autosomal dominant	y	IMMUNODEFICIENCY 31C; IMD31C	Clinical Features	death|deaths|died	STAT1	HGNC:11362	Immunodeficiency 31C, chronic mucocutaneous candidiasis, autosomal dominant, 614162 (3), Autosomal dominant	Autosomal dominant	y	y	[Uzel et al. (2013) reported 5 unrelated children with IMD31C. Three patients presented with mucocutaneous candidiasis between 3 and 8 months of age... Two patients died in childhood]	L4	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L3|L4	L3	pre-infant-lethal
614165	PHEOCHROMOCYTOMA/PARAGANGLIOMA SYNDROME 5	Pheochromocytoma/paraganglioma syndrome 5, 614165 (3)	Pheochromocytoma/paraganglioma syndrome 5	n	-	-	-	SDHA	HGNC:10680	Pheochromocytoma/paraganglioma syndrome 5, 614165 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L3	L3	pre-infant-lethal
614167	MYOPIA 21, AUTOSOMAL DOMINANT	Myopia 21, autosomal dominant, 614167 (3)	Myopia 21, autosomal dominant	n	-	-	-	ZNF644	HGNC:29222	Myopia 21, autosomal dominant, 614167 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
614170	BRITTLE CORNEA SYNDROME 2	Brittle cornea syndrome 2, 614170 (3)	Brittle cornea syndrome 2	n	-	-	-	PRDM5	HGNC:9349	Brittle cornea syndrome 2, 614170 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
614172	IMMUNODEFICIENCY 21	Immunodeficiency 21, 614172 (3)	Immunodeficiency 21	y	IMMUNODEFICIENCY 21; IMD21	Description|Clinical Features|Clinical Synopsis	miscarriage|miscarriages|died	GATA2	HGNC:4171	Immunodeficiency 21, 614172 (3), Autosomal dominant	Autosomal dominant	n	n	-	-	-	-	ambiguous	ambiguous|lethal	lethal	L5	L5	post-infant-lethal
614173	JOUBERT SYNDROME 13	Joubert syndrome 13, 614173 (3)	Joubert syndrome 13	n	-	-	-	TCTN1	HGNC:26113	Joubert syndrome 13, 614173 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
614175	MECKEL SYNDROME, TYPE 10	Joubert syndrome 34, 614175 (3)	Joubert syndrome 34	n	-	-	-	B9D2	HGNC:28636	Joubert syndrome 34, 614175 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
614180	RETINITIS PIGMENTOSA 61	Retinitis pigmentosa 61, 614180 (3)	Retinitis pigmentosa 61	n	-	-	-	CLRN1	HGNC:12605	Retinitis pigmentosa 61, 614180 (3)	-	-	-	-	-	-	-	nonlethal	ambiguous|nonlethal	ambiguous	-	-	-
614181	RETINITIS PIGMENTOSA 62	Retinitis pigmentosa 62, 614181 (3)	Retinitis pigmentosa 62	n	-	-	-	MAK	HGNC:6816	Retinitis pigmentosa 62, 614181 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
614185	GELEOPHYSIC DYSPLASIA 2	Geleophysic dysplasia 2, 614185 (3)	Geleophysic dysplasia 2	y	GELEOPHYSIC DYSPLASIA 2; GPHYSD2	Clinical Synopsis|Phenotype	death|deaths	FBN1	HGNC:3603	Geleophysic dysplasia 2, 614185 (3), Autosomal dominant	Autosomal dominant	n	y	[Early death in some patients due to cardiorespiratory involvement]	LU	y	-	lethal	ambiguous|lethal|nonlethal	lethal|nonlethal	L2|LU	L2	pre-infant-lethal
614186	LEBER CONGENITAL AMAUROSIS 16	Leber congenital amaurosis 16, 614186 (3)	Leber congenital amaurosis 16	y	LEBER CONGENITAL AMAUROSIS 16; LCA16	Clinical Features	death|deaths	KCNJ13	HGNC:6259	Leber congenital amaurosis 16, 614186 (3), Autosomal recessive	Autosomal recessive	n	n	-	-	-	-	ambiguous	ambiguous|nonlethal	ambiguous	-	-	-
614188	CRANIOSYNOSTOSIS AND DENTAL ANOMALIES	Craniosynostosis and dental anomalies, 614188 (3)	Craniosynostosis and dental anomalies	n	-	-	-	IL11RA	HGNC:5967	Craniosynostosis and dental anomalies, 614188 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
614190	PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 3	Pigmented nodular adrenocortical disease, primary, 3, 614190 (3)	Pigmented nodular adrenocortical disease, primary, 3	n	-	-	-	PDE8B	HGNC:8794	Pigmented nodular adrenocortical disease, primary, 3, 614190 (3)	-	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
614196	NEPHROTIC SYNDROME, TYPE 6	Nephrotic syndrome, type 6, 614196 (3)	Nephrotic syndrome, type 6	n	-	-	-	PTPRO	HGNC:9678	Nephrotic syndrome, type 6, 614196 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
614198	MYASTHENIC SYNDROME, CONGENITAL, 16	Myasthenic syndrome, congenital, 16, 614198 (3)	Myasthenic syndrome, congenital, 16	n	-	-	-	SCN4A	HGNC:10591	Myasthenic syndrome, congenital, 16, 614198 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L1|L2|L3	L1	pre-infant-lethal
614199	NEPHROTIC SYNDROME, TYPE 5, WITH OR WITHOUT OCULAR ABNORMALITIES	Nephrotic syndrome, type 5, with or without ocular abnormalities, 614199 (3)	Nephrotic syndrome, type 5, with or without ocular abnormalities	n	-	-	-	LAMB2	HGNC:6487	Nephrotic syndrome, type 5, with or without ocular abnormalities, 614199 (3)	-	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L2	L2	pre-infant-lethal
614201	BLEEDING DISORDER, PLATELET-TYPE, 11	Bleeding disorder, platelet-type, 11, 614201 (3)	Bleeding disorder, platelet-type, 11	n	-	-	-	GP6	HGNC:14388	Bleeding disorder, platelet-type, 11, 614201 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
614202	RAFIQ SYNDROME	Rafiq syndrome, 614202 (3)	Rafiq syndrome	n	-	-	-	MAN1B1	HGNC:6823	Rafiq syndrome, 614202 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
614204	PSORIASIS 14, PUSTULAR	Psoriasis 14, pustular, 614204 (3)	Psoriasis 14, pustular	y	PSORIASIS 14, PUSTULAR; PSORS14	Clinical Features	died	IL36RN	HGNC:15561	Psoriasis 14, pustular, 614204 (3), Autosomal recessive	Autosomal recessive	y	y	[Marrakchi et al. (2011) studied 9 families from southern Tunisia segregating autosomal recessive generalized pustular psoriasis... Five family members had died after septicemia]	LU	y	-	lethal	lethal	lethal	LU	LU	post-infant-lethal
614205	THREE M SYNDROME 3	3-M syndrome 3, 614205 (3)	3-M syndrome 3	n	-	-	-	CCDC8	HGNC:25367	3-M syndrome 3, 614205 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
614207	HYPERPHOSPHATASIA WITH IMPAIRED INTELLECTUAL DEVELOPMENT SYNDROME 3	Hyperphosphatasia with impaired intellectual development syndrome 3, 614207 (3)	Hyperphosphatasia with impaired intellectual development syndrome 3	n	-	-	-	PGAP2	HGNC:17893	Hyperphosphatasia with impaired intellectual development syndrome 3, 614207 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
614213	NEUROPATHY, HEREDITARY SENSORY, TYPE IIC	Neuropathy, hereditary sensory, type IIC, 614213 (3)	Neuropathy, hereditary sensory, type IIC	n	-	-	-	KIF1A	HGNC:888	Neuropathy, hereditary sensory, type IIC, 614213 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L3	L3	pre-infant-lethal
614219	ADAMS-OLIVER SYNDROME 2	Adams-Oliver syndrome 2, 614219 (3)	Adams-Oliver syndrome 2	y	ADAMS-OLIVER SYNDROME 2; AOS2	Clinical Features	died	DOCK6	HGNC:19189	Adams-Oliver syndrome 2, 614219 (3), Autosomal recessive	Autosomal recessive	y	y	[Koiffmann et al. (1988) reported a Brazilian family with Adams-Oliver syndrome suggesting autosomal recessive inheritance. The proband, born of unaffected first cousins, had a congenital scalp defect with hypoplastic fingers and toes. Among 7 sibs, 3 sisters and 2 brothers were normal, whereas 2 brothers born with the same scalp defect died as a consequence of bleeding from this abnormal area]	LU	y	-	lethal	lethal	lethal	LU	LU	post-infant-lethal
614222	WARBURG MICRO SYNDROME 3	Warburg micro syndrome 3, 614222 (3)	Warburg micro syndrome 3	n	-	-	-	RAB18	HGNC:14244	Warburg micro syndrome 3, 614222 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
614224	RETINAL ARTERIAL MACROANEURYSM WITH SUPRAVALVULAR PULMONIC STENOSIS	Retinal arterial macroaneurysm with supravalvular pulmonic stenosis, 614224 (3)	Retinal arterial macroaneurysm with supravalvular pulmonic stenosis	n	-	-	-	IGFBP7	HGNC:5476	Retinal arterial macroaneurysm with supravalvular pulmonic stenosis, 614224 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
614225	WARBURG MICRO SYNDROME 2	Warburg micro syndrome 2, 614225 (3)	Warburg micro syndrome 2	n	-	-	-	RAB3GAP2	HGNC:17168	Warburg micro syndrome 2, 614225 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
614226	HOLOPROSENCEPHALY 11	Holoprosencephaly 11, 614226 (3)	Holoprosencephaly 11	n	-	-	-	CDON	HGNC:17104	Holoprosencephaly 11, 614226 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
614228	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2O	Charcot-Marie-Tooth disease, axonal, type 2O, 614228 (3)	Charcot-Marie-Tooth disease, axonal, type 2O	n	-	-	-	DYNC1H1	HGNC:2961	Charcot-Marie-Tooth disease, axonal, type 2O, 614228 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
614231	MICROCEPHALY, EPILEPSY, AND DIABETES SYNDROME 1	Microcephaly, epilepsy, and diabetes syndrome, 614231 (3)	Microcephaly, epilepsy, and diabetes syndrome	y	MICROCEPHALY, EPILEPSY, AND DIABETES SYNDROME 1; MEDS1	Clinical Features|Clinical Synopsis	died|death|deaths	IER3IP1	HGNC:18550	Microcephaly, epilepsy, and diabetes syndrome, 614231 (3), Autosomal recessive	Autosomal recessive	y	y	[De Wit et al. (2006) and Poulton et al. (2011) reported a male infant, born of consanguineous Moroccan parents, with a syndromic form of microcephaly. His head circumference was 2.5 SD below the mean at birth, and progressed to 3 SD below the mean at age 2 months. He had developmental delay, hypotonia, seizures, obesity, diabetes mellitus, and presumed hypogonadism. Brain MRI showed a simplified gyral pattern and EEG showed hypsarrhythmia. The diabetes and seizures were difficult to control and he died at age 18 months]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
614249	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 18, WITH OR WITHOUT EPILEPSY	Intellectual developmental disorder, autosomal recessive 18, with or without epilepsy, 614249 (3)	Intellectual developmental disorder, autosomal recessive 18, with or without epilepsy	n	-	-	-	MED23	HGNC:2372	Intellectual developmental disorder, autosomal recessive 18, with or without epilepsy, 614249 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
614254	NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL DOMINANT	Neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal dominant, 614254 (3)	Neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal dominant	n	-	-	-	GRIN1	HGNC:4584	Neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal dominant, 614254 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L2	L2	pre-infant-lethal
614255	NESCAV SYNDROME	NESCAV syndrome, 614255 (3)	NESCAV syndrome	y	NESCAV SYNDROME; NESCAVS	Clinical Features	death|deaths|died	KIF1A	HGNC:888	NESCAV syndrome, 614255 (3), Autosomal dominant	Autosomal dominant	y	y	[Nemani et al. (2020) identified 12 patients from 10 unrelated families with KIF1A-related disorders, confirmed by genetic testing, who were ascertained at a single tertiary center caring for patients with motor difficulties. The phenotype was highly variable. Two infants (patients 1 and 2) had a severe progressive encephalopathy with reduced fetal movements, arthrogryposis, spasticity, dystonia, axonal polyneuropathy, dysautonomia, seizures, optic atrophy, cerebellar atrophy, respiratory insufficiency, and almost no developmental progress. They died of respiratory insufficiency at 6 and 23 months of age]	L3	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L3	L3	pre-infant-lethal
614261	MICROCEPHALY-CAPILLARY MALFORMATION SYNDROME	Microcephaly-capillary malformation syndrome, 614261 (3)	Microcephaly-capillary malformation syndrome	y	MICROCEPHALY-CAPILLARY MALFORMATION SYNDROME; MICCAP	Clinical Features	died	STAMBP	HGNC:16950	Microcephaly-capillary malformation syndrome, 614261 (3), Autosomal recessive	Autosomal recessive	y	y	[Carter et al. (2011) reported 2 unrelated male infants with a similar congenital neurologic disorder...The second child, who died at age 17 months, had cerebral atrophy with white matter loss, thin corpus callosum, and hippocampal atrophy]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
614265	COMBINED MALONIC AND METHYLMALONIC ACIDURIA	Combined malonic and methylmalonic aciduria, 614265 (3)	Combined malonic and methylmalonic aciduria	n	-	-	-	ACSF3	HGNC:27288	Combined malonic and methylmalonic aciduria, 614265 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
614266	BARRETT ESOPHAGUS	Barrett esophagus/esophageal adenocarcinoma, 614266 (3)	Barrett esophagus/esophageal adenocarcinoma	y	BARRETT ESOPHAGUS	Phenotype	died	ASCC1	HGNC:24268	Barrett esophagus/esophageal adenocarcinoma, 614266 (3)	-	n	n	-	-	-	-	ambiguous	ambiguous|lethal	lethal	L2	L2	pre-infant-lethal
614266	BARRETT ESOPHAGUS	Barrett esophagus/esophageal adenocarcinoma, 614266 (3)	Barrett esophagus/esophageal adenocarcinoma	y	BARRETT ESOPHAGUS	Phenotype	died	CTHRC1	HGNC:18831	Barrett esophagus/esophageal adenocarcinoma, 614266 (3)	-	n	n	-	-	-	-	ambiguous	ambiguous	ambiguous	-	-	-
614266	BARRETT ESOPHAGUS	Barrett esophagus/esophageal adenocarcinoma, 614266 (3)	Barrett esophagus/esophageal adenocarcinoma	y	BARRETT ESOPHAGUS	Phenotype	died	MSR1	HGNC:7376	Barrett esophagus/esophageal adenocarcinoma, 614266 (3)	-	n	n	-	-	-	-	ambiguous	ambiguous	ambiguous	-	-	-
614278	PLATELET-ACTIVATING FACTOR ACETYLHYDROLASE DEFICIENCY	Platelet-activating factor acetylhydrolase deficiency, 614278 (3)	Platelet-activating factor acetylhydrolase deficiency	n	-	-	-	PLA2G7	HGNC:9040	Platelet-activating factor acetylhydrolase deficiency, 614278 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
614279	46,XY SEX REVERSAL 8	46XY sex reversal 8, 614279 (3)	46XY sex reversal 8	n	-	-	-	AKR1C2	HGNC:385	46XY sex reversal 8, 614279 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
614292	MYOPIA, HIGH, WITH CATARACT AND VITREORETINAL DEGENERATION	Myopia, high, with cataract and vitreoretinal degeneration, 614292 (3)	Myopia, high, with cataract and vitreoretinal degeneration	n	-	-	-	P3H2	HGNC:19317	Myopia, high, with cataract and vitreoretinal degeneration, 614292 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
614293	HYDATIDIFORM MOLE, RECURRENT, 2	Hydatidiform mole, recurrent, 2, 614293 (3)	Hydatidiform mole, recurrent, 2	y	HYDATIDIFORM MOLE, RECURRENT, 2; HYDM2	Description	death|deaths|miscarriage|miscarriages|pregnancy_loss|pregnancy_losses|stillbirth|stillbirths	KHDC3L	HGNC:33699	Hydatidiform mole, recurrent, 2, 614293 (3), Autosomal recessive	Autosomal recessive	y	y	[Other pregnancy losses in this condition include partial hydatidiform mole, stillbirths, ectopic pregnancies, early neonatal deaths, and miscarriages, some of which may be undiagnosed molar pregnancies. Normal pregnancies are extremely rare in families with this condition]	L1	y	-	lethal	lethal	lethal	L1	L1	pre-infant-lethal
614296	WOLFRAM-LIKE SYNDROME, AUTOSOMAL DOMINANT	Wolfram-like syndrome, autosomal dominant, 614296 (3)	Wolfram-like syndrome, autosomal dominant	n	-	-	-	WFS1	HGNC:12762	Wolfram-like syndrome, autosomal dominant, 614296 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L6	L6	post-infant-lethal
614298	NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 4	Neurodegeneration with brain iron accumulation 4, 614298 (3)	Neurodegeneration with brain iron accumulation 4	y	NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 4; NBIA4	Clinical Features	death|deaths|died	C19orf12	HGNC:25443	Neurodegeneration with brain iron accumulation 4, 614298 (3), Autosomal dominant, Autosomal recessive	Autosomal dominant, Autosomal recessive	y	y	[Dogu et al. (2013) reported 3 affected individuals from 2 unrelated consanguineous Turkish families with NBIA4. All patients had a relatively late onset of the disorder, between 25 and 29 years of age, and 2 showed very rapid progression leading to death 12 and 36 months after admission, respectively]	L6	y	-	lethal	lethal	lethal	L6	L6	post-infant-lethal
614299	MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 2 WITH HYPERGLYCINEMIA	Multiple mitochondrial dysfunctions syndrome 2 with hyperglycinemia, 614299 (3)	Multiple mitochondrial dysfunctions syndrome 2 with hyperglycinemia	y	MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 2 WITH HYPERGLYCINEMIA; MMDS2	Description|Clinical Features|Clinical Synopsis	die|died|death|deaths	BOLA3	HGNC:24415	Multiple mitochondrial dysfunctions syndrome 2 with hyperglycinemia, 614299 (3), Autosomal recessive	Autosomal recessive	y	y	[Baker et al. (2014) reported 3 unrelated children with a severe metabolic disorder resulting in neurologic dysfunction. The patients were of Caucasian, Indian, and African American descent, respectively. All had normal development in early infancy, but then showed regression in motor skills with loss of head control and severe hypotonia beginning between 6 and 8 months of age. Two had seizures, 2 had optic atrophy with poor vision, and 2 had spasticity with abnormal movements. All developed hypertrophic cardiomyopathy. The patients died at ages 7 months, 22 months, and 11 years]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
614300	HYPERMETHIONINEMIA DUE TO ADENOSINE KINASE DEFICIENCY	Hypermethioninemia due to adenosine kinase deficiency, 614300 (3)	Hypermethioninemia due to adenosine kinase deficiency	y	HYPERMETHIONINEMIA DUE TO ADENOSINE KINASE DEFICIENCY	Clinical Features	died	ADK	HGNC:257	Hypermethioninemia due to adenosine kinase deficiency, 614300 (3), Autosomal recessive	Autosomal recessive	n	y	[Bjursell et al. (2011) reported 2 Swedish sibs with severe developmental delay, mild liver dysfunction, and hypermethioninemia. Both had failure to thrive in the neonatal period and later showed hypotonia, profound psychomotor delay, and liver dysfunction. Both developed seizures before age 3 years. Dysmorphic features included macrocephaly, frontal bossing, hypertelorism, and slender hands and feet. During childhood, both had sparse or absent language and slowly progressive muscular weakness and wasting. EEG showed slow background activity with diffuse multifocal discharges in some instances and abundant spike slow-wave complexes of high amplitude at other times. The girl died during sleep at 10 years of age]	L5	y	-	lethal	lethal	lethal	L5	L5	post-infant-lethal
614302	EMERY-DREIFUSS MUSCULAR DYSTROPHY 7, AUTOSOMAL DOMINANT	Emery-Dreifuss muscular dystrophy 7, AD, 614302 (3)	Emery-Dreifuss muscular dystrophy 7, AD	y	EMERY-DREIFUSS MUSCULAR DYSTROPHY 7, AUTOSOMAL DOMINANT; EDMD7	Clinical Features	died	TMEM43	HGNC:28472	Emery-Dreifuss muscular dystrophy 7, AD, 614302 (3), Autosomal dominant	Autosomal dominant	n	y	[Liang et al. (2011) reported 2 unrelated Japanese patients with adult-onset Emery-Dreifuss muscular dystrophy. The first patient was a 40-year-old man who was diagnosed with typical clinical EDMD with limb-girdle type muscular dystrophy with cardiac conduction defects and muscle biopsy that showed marked fiber size variation with scattered internal nuclei. He died soon after, and no other medical records were available]	L6	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L6|LU	L6	post-infant-lethal
614305	SCLEROSTEOSIS 2	Sclerosteosis 2, 614305 (3)	Sclerosteosis 2	n	-	-	-	LRP4	HGNC:6696	Sclerosteosis 2, 614305 (3), Autosomal dominant, Autosomal recessive	Autosomal dominant, Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
614306	COGNITIVE IMPAIRMENT WITH OR WITHOUT CEREBELLAR ATAXIA	Cognitive impairment with or without cerebellar ataxia, 614306 (3)	Cognitive impairment with or without cerebellar ataxia	n	-	-	-	SCN8A	HGNC:10596	Cognitive impairment with or without cerebellar ataxia, 614306 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L5	L5	post-infant-lethal
614307	ALPHA-METHYLACYL-CoA RACEMASE DEFICIENCY	Alpha-methylacyl-CoA racemase deficiency, 614307 (3)	Alpha-methylacyl-CoA racemase deficiency	n	-	-	-	AMACR	HGNC:451	Alpha-methylacyl-CoA racemase deficiency, 614307 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L3	L3	pre-infant-lethal
614321	MYOPATHY, DISTAL, TATEYAMA TYPE	Myopathy, distal, Tateyama type, 614321 (3)	Myopathy, distal, Tateyama type	n	-	-	-	CAV3	HGNC:1529	Myopathy, distal, Tateyama type, 614321 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	LU	LU	post-infant-lethal
614322	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 12	Spinocerebellar ataxia, autosomal recessive 12, 614322 (3)	Spinocerebellar ataxia, autosomal recessive 12	n	-	-	-	WWOX	HGNC:12799	Spinocerebellar ataxia, autosomal recessive 12, 614322 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L3	L3	pre-infant-lethal
614324	OVARIAN DYSGENESIS 3	Ovarian dysgenesis 3, 614324 (3)	Ovarian dysgenesis 3	n	-	-	-	PSMC3IP	HGNC:17928	Ovarian dysgenesis 3, 614324 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
614325	PITT-HOPKINS-LIKE SYNDROME 2	Pitt-Hopkins-like syndrome 2, 614325 (3)	Pitt-Hopkins-like syndrome 2	n	-	-	-	NRXN1	HGNC:8008	Pitt-Hopkins-like syndrome 2, 614325 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
614327	TUMOR PREDISPOSITION SYNDROME 1	Tumor predisposition syndrome 1, 614327 (3)	Tumor predisposition syndrome 1	n	-	-	-	BAP1	HGNC:950	Tumor predisposition syndrome 1, 614327 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
614331	COLORECTAL CANCER, HEREDITARY NONPOLYPOSIS, TYPE 6	Colorectal cancer, hereditary nonpolyposis, type 6, 614331 (3)	Colorectal cancer, hereditary nonpolyposis, type 6	n	-	-	-	TGFBR2	HGNC:11773	Colorectal cancer, hereditary nonpolyposis, type 6, 614331 (3)	-	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L4	L4	post-infant-lethal
614335	ARTHROGRYPOSIS, DISTAL, TYPE 1B	Arthrogryposis, distal, type 1B, 614335 (3)	Arthrogryposis, distal, type 1B	n	-	-	-	MYBPC1	HGNC:7549	Arthrogryposis, distal, type 1B, 614335 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L2	L2	pre-infant-lethal
614337	LYNCH SYNDROME 4	Lynch syndrome 4, 614337 (3)	Lynch syndrome 4	y	LYNCH SYNDROME 4; LYNCH4	Clinical Features	died	PMS2	HGNC:9122	Lynch syndrome 4, 614337 (3)	-	y	y	[died of metastatic esophageal adenocarcinoma]	L6	y	-	lethal	lethal	lethal	L4|L6	L4	post-infant-lethal
614340	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 27	Intellectual developmental disorder, autosomal recessive 27, 614340 (3)	Intellectual developmental disorder, autosomal recessive 27	n	-	-	-	LINS1	HGNC:30922	Intellectual developmental disorder, autosomal recessive 27, 614340 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
614350	LYNCH SYNDROME 5	Lynch syndrome 5, 614350 (3)	Lynch syndrome 5	y	LYNCH SYNDROME 5; LYNCH5	Clinical Features	died	MSH6	HGNC:7329	Lynch syndrome 5, 614350 (3), Autosomal dominant	Autosomal dominant	y	y	[The father died of colon cancer at the age of 83 years and her paternal grandmother died of endometrial cancer at the age of 69 years]	L6	n	y	lethal	lethal	lethal	L4|L6	L4	post-infant-lethal
614370	SURFACTANT METABOLISM DYSFUNCTION, PULMONARY, 5	Surfactant metabolism dysfunction, pulmonary, 5, 614370 (3)	Surfactant metabolism dysfunction, pulmonary, 5	n	-	-	-	CSF2RB	HGNC:2436	Surfactant metabolism dysfunction, pulmonary, 5, 614370 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
614376	SHORT-RIB THORACIC DYSPLASIA 5 WITH OR WITHOUT POLYDACTYLY	Short-rib thoracic dysplasia 5 with or without polydactyly, 614376 (3)	Short-rib thoracic dysplasia 5 with or without polydactyly	y	SHORT-RIB THORACIC DYSPLASIA 5 WITH OR WITHOUT POLYDACTYLY; SRTD5	Description	lethal	WDR19	HGNC:18340	Short-rib thoracic dysplasia 5 with or without polydactyly, 614376 (3), Autosomal recessive	Autosomal recessive	y	y	[Some forms of SRTD are lethal in the neonatal period]	L2	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L2	L2	pre-infant-lethal
614377	NEPHRONOPHTHISIS 13	Nephronophthisis 13, 614377 (3)	Nephronophthisis 13	n	-	-	-	WDR19	HGNC:18340	Nephronophthisis 13, 614377 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L2	L2	pre-infant-lethal
614378	CRANIOECTODERMAL DYSPLASIA 4	Cranioectodermal dysplasia 4, 614378 (3)	Cranioectodermal dysplasia 4	n	-	-	-	WDR19	HGNC:18340	Cranioectodermal dysplasia 4, 614378 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L2	L2	pre-infant-lethal
614379	COMPLEMENT COMPONENT 4B DEFICIENCY	C4B deficiency, 614379 (3)	C4B deficiency	n	-	-	-	C4B	HGNC:1324	C4B deficiency, 614379 (3)	-	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
614380	COMPLEMENT COMPONENT 4A DEFICIENCY	C4a deficiency, 614380 (3)	C4a deficiency	n	-	-	-	C4A	HGNC:1323	C4a deficiency, 614380 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
614381	LEUKODYSTROPHY, HYPOMYELINATING, 8, WITH OR WITHOUT OLIGODONTIA AND/OR HYPOGONADOTROPIC HYPOGONADISM	Leukodystrophy, hypomyelinating, 8, with or without oligodontia and/or hypogonadotropic hypogonadism, 614381 (3)	Leukodystrophy, hypomyelinating, 8, with or without oligodontia and/or hypogonadotropic hypogonadism	n	-	-	-	POLR3B	HGNC:30348	Leukodystrophy, hypomyelinating, 8, with or without oligodontia and/or hypogonadotropic hypogonadism, 614381 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
614385	COLORECTAL CANCER, HEREDITARY NONPOLYPOSIS, TYPE 7	Colorectal cancer, hereditary nonpolyposis, type 7, 614385 (3)	Colorectal cancer, hereditary nonpolyposis, type 7	n	-	-	-	MLH3	HGNC:7128	Colorectal cancer, hereditary nonpolyposis, type 7, 614385 (3)	-	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
614388	ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 1	Encephalopathy, lethal, due to defective mitochondrial peroxisomal fission 1, 614388 (3)	Encephalopathy, lethal, due to defective mitochondrial peroxisomal fission 1	y	ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 1; EMPF1	Description|Clinical Features|Phenotype	death|deaths|died|lethal	DNM1L	HGNC:2973	Encephalopathy, lethal, due to defective mitochondrial peroxisomal fission 1, 614388 (3), Autosomal dominant, Autosomal recessive	Autosomal dominant, Autosomal recessive	y	y	[Yoon et al. (2016) reported 2 infant sibs, born of unrelated Filipino parents with EMPF resulting in death in infancy. Both presented at birth with profound hypotonia, absent respiratory effort, no spontaneous movements, and absent deep tendon reflexes. Brain imaging was normal in 1 infant, whereas it showed a profound hypoxic-ischemic insult in the other. Laboratory studies did not show increased serum lactate or biochemical evidence of a peroxisomal disorder. The patients died at ages 8 days and 3 weeks]	L2	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L2	L2	pre-infant-lethal
614399	CONGENITAL MYOPATHY 10A, SEVERE VARIANT	Congenital myopathy 10A, severe variant, 614399 (3)	Congenital myopathy 10A, severe variant	y	CONGENITAL MYOPATHY 10A, SEVERE VARIANT; CMYP10A	Description|Clinical Features|Clinical Synopsis	die|died|death|deaths	MEGF10	HGNC:29634	Congenital myopathy 10A, severe variant, 614399 (3), Autosomal recessive	Autosomal recessive	y	y	[Death may occur in childhood due to respiratory failure]	L4	y	-	lethal	lethal	lethal	L4|L5	L4	post-infant-lethal
614409	SPASTIC PARAPLEGIA 46, AUTOSOMAL RECESSIVE	Spastic paraplegia 46, autosomal recessive, 614409 (3)	Spastic paraplegia 46, autosomal recessive	n	-	-	-	GBA2	HGNC:18986	Spastic paraplegia 46, autosomal recessive, 614409 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
614416	RADIOHUMERAL FUSIONS WITH OTHER SKELETAL AND CRANIOFACIAL ANOMALIES	Craniosynostosis with radiohumeral fusions and other skeletal and craniofacial anomalies, 614416 (3)	Craniosynostosis with radiohumeral fusions and other skeletal and craniofacial anomalies	y	RADIOHUMERAL FUSIONS WITH OTHER SKELETAL AND CRANIOFACIAL ANOMALIES; RHFCA	Clinical Features	death|deaths|died	CYP26B1	HGNC:20581	Craniosynostosis with radiohumeral fusions and other skeletal and craniofacial anomalies, 614416 (3)	-	n	y	[Laue et al. (2011) reported 3 sibs and an unrelated Turkish patient with craniosynostosis and multiple skeletal anomalies. The 3 sibs, born to first-cousin parents, exhibited occipital encephalocele, radiohumeral fusions, oligodactyly, advanced osseous maturation, and calvarial mineralization defects. The proband presented as a fetal death in utero at 35 weeks' gestation; the pregnancies of his sibs were terminated at 15 and 12 weeks' gestation after ultrasonography showed them to be affected]	L1	y	-	lethal	lethal	lethal	L1	L1	pre-infant-lethal
614417	EPILEPSY, FAMILIAL TEMPORAL LOBE, 5	Epilepsy, familial temporal lobe, 5, 614417 (3)	Epilepsy, familial temporal lobe, 5	n	-	-	-	CPA6	HGNC:17245	Epilepsy, familial temporal lobe, 5, 614417 (3), Autosomal dominant, Autosomal recessive	Autosomal dominant, Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
614418	FEBRILE SEIZURES, FAMILIAL, 11	Febrile seizures, familial, 11, 614418 (3)	Febrile seizures, familial, 11	n	-	-	-	CPA6	HGNC:17245	Febrile seizures, familial, 11, 614418 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
614419	ASPARTATE AMINOTRANSFERASE, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 1	Aspartate aminotransferase, serum level of, QTL1, 614419 (3)	Aspartate aminotransferase, serum level of, QTL1	n	-	-	-	GOT1	HGNC:4432	Aspartate aminotransferase, serum level of, QTL1, 614419 (3)	-	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
614420	SYSTEMIC LUPUS ERYTHEMATOSUS 16	Systemic lupus erythematosus 16, 614420 (3)	Systemic lupus erythematosus 16	n	-	-	-	DNASE1L3	HGNC:2959	Systemic lupus erythematosus 16, 614420 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
614424	JOUBERT SYNDROME 14	Joubert syndrome 14, 614424 (3)	Joubert syndrome 14	y	JOUBERT SYNDROME 14; JBTS14	Clinical Features|Clinical Synopsis	died|death|deaths	TMEM237	HGNC:14432	Joubert syndrome 14, 614424 (3), Autosomal recessive	Autosomal recessive	y	y	[Death often occurs in the first decade]	L4	y	-	lethal	lethal	lethal	L4	L4	post-infant-lethal
614429	VENTRICULAR SEPTAL DEFECT 1	Ventricular septal defect 1, 614429 (3)	Ventricular septal defect 1	y	VENTRICULAR SEPTAL DEFECT 1; VSD1	Description	death|deaths	GATA4	HGNC:4173	Ventricular septal defect 1, 614429 (3), Autosomal dominant	Autosomal dominant	n	y	[Large VSDs that go unrepaired may give rise to cardiac enlargement, congestive heart failure, pulmonary hypertension, Eisenmenger's syndrome, delayed fetal brain development, arrhythmias, and even sudden cardiac death (summary by Wang et al. (2011, 2011))]	LU	y	-	lethal	lethal|nonlethal	lethal|nonlethal	LU	LU	post-infant-lethal
614430	ATRIOVENTRICULAR SEPTAL DEFECT 4	Atrioventricular septal defect 4, 614430 (3)	Atrioventricular septal defect 4	n	-	-	-	GATA4	HGNC:4173	Atrioventricular septal defect 4, 614430 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	LU	LU	post-infant-lethal
614431	VENTRICULAR SEPTAL DEFECT 2	Ventricular septal defect 2, 614431 (3)	Ventricular septal defect 2	y	VENTRICULAR SEPTAL DEFECT 2; VSD2	Description	death|deaths	CITED2	HGNC:1987	Ventricular septal defect 2, 614431 (3), Autosomal dominant	Autosomal dominant	n	y	[Large VSDs that go unrepaired may give rise to cardiac enlargement, congestive heart failure, pulmonary hypertension, Eisenmenger's syndrome, delayed fetal brain development, arrhythmias, and even sudden cardiac death (summary by Wang et al. (2011, 2011))]	LU	y	-	lethal	lethal|nonlethal	lethal|nonlethal	LU	LU	post-infant-lethal
614432	VENTRICULAR SEPTAL DEFECT 3	Ventricular septal defect 3, 614432 (3)	Ventricular septal defect 3	y	VENTRICULAR SEPTAL DEFECT 3; VSD3	Description	death|deaths	NKX2-5	HGNC:2488	Ventricular septal defect 3, 614432 (3), Autosomal dominant	Autosomal dominant	n	y	[Large VSDs that go unrepaired may give rise to cardiac enlargement, congestive heart failure, pulmonary hypertension, Eisenmenger's syndrome, delayed fetal brain development, arrhythmias, and even sudden cardiac death (summary by Wang et al. (2011, 2011))]	LU	y	-	lethal	ambiguous|lethal|nonlethal	lethal|nonlethal	LU	LU	post-infant-lethal
614433	ATRIAL SEPTAL DEFECT 8	Atrial septal defect 8, 614433 (3)	Atrial septal defect 8	n	-	-	-	CITED2	HGNC:1987	Atrial septal defect 8, 614433 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	LU	LU	post-infant-lethal
614435	HYPOPLASTIC LEFT HEART SYNDROME 2	Hypoplastic left heart syndrome 2, 614435 (3)	Hypoplastic left heart syndrome 2	n	-	-	-	NKX2-5	HGNC:2488	Hypoplastic left heart syndrome 2, 614435 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	ambiguous|lethal|nonlethal	lethal|nonlethal	LU	LU	post-infant-lethal
614436	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2P	Charcot-Marie-Tooth disease, axonal, type 2P, 614436 (3)	Charcot-Marie-Tooth disease, axonal, type 2P	n	-	-	-	LRSAM1	HGNC:25135	Charcot-Marie-Tooth disease, axonal, type 2P, 614436 (3), Autosomal dominant, Autosomal recessive	Autosomal dominant, Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
614437	CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IB	Cutis laxa, autosomal recessive, type IB, 614437 (3)	Cutis laxa, autosomal recessive, type IB	y	CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IB; ARCL1B	Clinical Features|Phenotype	death|deaths|died|lethal	EFEMP2	HGNC:3219	Cutis laxa, autosomal recessive, type IB, 614437 (3), Autosomal recessive	Autosomal recessive	n	y	[Hoyer et al. (2009) reported the third case of cutis laxa due to FBLN4 mutation (604633.0004). The patient was an infant girl who was born of consanguineous Iraqi parents, from a pregnancy remarkable for fetal overgrowth and oligohydramnios, and who died immediately after birth with extreme bradycardia]	L2	y	-	lethal	lethal	lethal	L2	L2	pre-infant-lethal
614438	CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIIB	Cutis laxa, autosomal recessive, type IIIB, 614438 (3)	Cutis laxa, autosomal recessive, type IIIB	n	-	-	-	PYCR1	HGNC:9721	Cutis laxa, autosomal recessive, type IIIB, 614438 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
614441	HYPERTROPHIC OSTEOARTHROPATHY, PRIMARY, AUTOSOMAL RECESSIVE, 2	Hypertrophic osteoarthropathy, primary, autosomal recessive 2, 614441 (3)	Hypertrophic osteoarthropathy, primary, autosomal recessive 2	n	-	-	-	SLCO2A1	HGNC:10955	Hypertrophic osteoarthropathy, primary, autosomal recessive 2, 614441 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
614450	HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 6	Hypothyroidism, congenital, nongoitrous, 6, 614450 (3)	Hypothyroidism, congenital, nongoitrous, 6	n	-	-	-	THRA	HGNC:11796	Hypothyroidism, congenital, nongoitrous, 6, 614450 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
614455	CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE E	Charcot-Marie-Tooth disease, dominant intermediate E, 614455 (3)	Charcot-Marie-Tooth disease, dominant intermediate E	n	-	-	-	INF2	HGNC:23791	Charcot-Marie-Tooth disease, dominant intermediate E, 614455 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
614457	ICHTHYOSIS, SPASTIC QUADRIPLEGIA, AND IMPAIRED INTELLECTUAL DEVELOPMENT	Ichthyosis, spastic quadriplegia, and impaired intellectual development, 614457 (3)	Ichthyosis, spastic quadriplegia, and impaired intellectual development	y	ICHTHYOSIS, SPASTIC QUADRIPLEGIA, AND IMPAIRED INTELLECTUAL DEVELOPMENT; ISQMR	Clinical Features	died	ELOVL4	HGNC:14415	Ichthyosis, spastic quadriplegia, and impaired intellectual development, 614457 (3), Autosomal recessive	Autosomal recessive	y	y	[similarly affected sib died at 6 months of age.]	L3	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L3	L3	pre-infant-lethal
614458	THIAMINE METABOLISM DYSFUNCTION SYNDROME 5 (EPISODIC ENCEPHALOPATHY TYPE)	Thiamine metabolism dysfunction syndrome 5 (episodic encephalopathy type), 614458 (3)	Thiamine metabolism dysfunction syndrome 5 (episodic encephalopathy type)	y	THIAMINE METABOLISM DYSFUNCTION SYNDROME 5 (EPISODIC ENCEPHALOPATHY TYPE); THMD5	Clinical Features	died	TPK1	HGNC:17358	Thiamine metabolism dysfunction syndrome 5 (episodic encephalopathy type), 614458 (3), Autosomal recessive	Autosomal recessive	y	y	[Mayr et al. (2011) reported 5 individuals from 3 unrelated families with variable manifestations of thiamine pyrophosphokinase deficiency. Two sisters had the most severe phenotype compared to the other patients. The older sister showed developmental delay from the first year of life, and lost the ability to walk after an infection-induced encephalopathic episode at age 15 months. During this episode, she had increased serum and CSF lactate. She started to walk again at 3 years of age, but continued to show muscular hypotonia and delayed psychomotor development. She had 2 further crises with encephalopathy and lactic acidosis triggered by viral infections, and died during the last crisis at the age of 8.5 years. Her sister had normal development until 18 months when she developed recurrent encephalopathic episodes associated with mildly increased CSF lactate and resulting in gait and truncal ataxia, dystonia, and eventual loss of ability to walk. She died at the age of 3.5 years during a viral infection. Both girls showed episodic increased urinary alpha-ketoglutaric acid]	L4	y	-	lethal	lethal	lethal	L4	L4	post-infant-lethal
614462	HYPERGLYCINEMIA, LACTIC ACIDOSIS, AND SEIZURES	Hyperglycinemia, lactic acidosis, and seizures, 614462 (3)	Hyperglycinemia, lactic acidosis, and seizures	y	HYPERGLYCINEMIA, LACTIC ACIDOSIS, AND SEIZURES; HGCLAS	Description|Clinical Features	death|deaths|died	LIAS	HGNC:16429	Hyperglycinemia, lactic acidosis, and seizures, 614462 (3), Autosomal recessive	Autosomal recessive	y	y	[Baker et al. (2014) reported 2 unrelated children who presented in the first days of life with hypotonia and seizures. A Somalian girl, born of consanguineous parents, had a severe disease course with failure to thrive, microcephaly, severe psychomotor retardation, myoclonus, and spasticity resulting in death at 2 years 8 months of age. Brain imaging showed cerebral atrophy of the cortex and white matter, as well as multiple signal abnormalities in the subcortical and cerebellar regions. The other child, a boy born of unrelated Turkish parents, responded to antiseizure medication and had his last seizure at age 12 years, but had delayed psychomotor development. His sister presented at birth with hypotonia and seizures, and died at age 7 months / Baker et al. (2014) reported 2 unrelated children who presented in the first days of life with hypotonia and seizures. A Somalian girl, born of consanguineous parents, had a severe disease course with failure to thrive, microcephaly, severe psychomotor retardation, myoclonus, and spasticity resulting in death at 2 years 8 months of age]	L3	y	y	lethal	lethal	lethal	L3	L3	pre-infant-lethal
614464	JOUBERT SYNDROME 15	Joubert syndrome 15, 614464 (3)	Joubert syndrome 15	n	-	-	-	CEP41	HGNC:12370	Joubert syndrome 15, 614464 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
614465	JOUBERT SYNDROME 16	Joubert syndrome 16, 614465 (3)	Joubert syndrome 16	n	-	-	-	TMEM138	HGNC:26944	Joubert syndrome 16, 614465 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
614468	FAMILIAL COLD AUTOINFLAMMATORY SYNDROME 3	Familial cold autoinflammatory syndrome 3, 614468 (3)	Familial cold autoinflammatory syndrome 3	n	-	-	-	PLCG2	HGNC:9066	Familial cold autoinflammatory syndrome 3, 614468 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
614470	RAS-ASSOCIATED AUTOIMMUNE LEUKOPROLIFERATIVE DISORDER	RAS-associated autoimmune leukoproliferative disorder, 614470 (3)	RAS-associated autoimmune leukoproliferative disorder	y	RAS-ASSOCIATED AUTOIMMUNE LEUKOPROLIFERATIVE DISORDER; RALD	Clinical Features	death|deaths|died	KRAS	HGNC:6407	RAS-associated autoimmune leukoproliferative disorder, 614470 (3), Autosomal dominant	Autosomal dominant	n	y	[Niemela et al. (2010) reported 2 unrelated Caucasian girls with RALD presenting in childhood. One had lymphadenopathy, splenomegaly, and recurrent upper respiratory infections. She developed several autoimmune conditions, including hemolytic anemia and thrombocytopenia. Laboratory studies showed hypergammaglobulinemia, B-cell lymphocytosis, monocytosis, and autoantibodies. Alpha/beta CD4-/CD8- T cells were not increased. She continued to have recurrent inflammatory episodes affecting the respiratory tract, but without documentation of an infectious agent. She died at age 13 years after a fever and cardiac arrest]	L5	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L5	L5	post-infant-lethal
614473	ARTERIAL CALCIFICATION, GENERALIZED, OF INFANCY, 2	Arterial calcification, generalized, of infancy, 2, 614473 (3)	Arterial calcification, generalized, of infancy, 2	y	ARTERIAL CALCIFICATION, GENERALIZED, OF INFANCY, 2; GACI2	Description|Clinical Features|Clinical Synopsis|Phenotype	fatal|died|die	ABCC6	HGNC:57	Arterial calcification, generalized, of infancy, 2, 614473 (3), Autosomal recessive	Autosomal recessive	y	y	[Glatz et al. (2006) described 2 patients with idiopathic infantile arterial calcification (IIAC). The first was an infant girl who presented at 33 days of life with tachypnea, tachycardia, cool extremities, and poor peripheral pulses. Echocardiography demonstrated cardiac dysfunction and an electrocardiogram and cardiac enzyme levels were suggestive of myocardial infarction (MI). Despite intensive care, her condition deteriorated over the next 2 weeks and the patient died after withdrawal of support at 6.5 weeks of age]	L3	y	-	lethal	lethal	lethal	L3|LU	L3	pre-infant-lethal
614474	ATRIOVENTRICULAR SEPTAL DEFECT 5	Atrioventricular septal defect 5, 614474 (3)	Atrioventricular septal defect 5	n	-	-	-	GATA6	HGNC:4174	Atrioventricular septal defect 5, 614474 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L2	L2	pre-infant-lethal
614475	ATRIAL SEPTAL DEFECT 9	Atrial septal defect 9, 614475 (3)	Atrial septal defect 9	n	-	-	-	GATA6	HGNC:4174	Atrial septal defect 9, 614475 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L2	L2	pre-infant-lethal
614480	HYPERTRIGLYCERIDEMIA, TRANSIENT INFANTILE	Hypertriglyceridemia, transient infantile, 614480 (3)	Hypertriglyceridemia, transient infantile	n	-	-	-	GPD1	HGNC:4455	Hypertriglyceridemia, transient infantile, 614480 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
614482	HUPPKE-BRENDEL SYNDROME	Huppke-Brendel syndrome, 614482 (3)	Huppke-Brendel syndrome	y	HUPPKE-BRENDEL SYNDROME; HPBDS	Clinical Features|Clinical Synopsis	died|death|deaths	SLC33A1	HGNC:95	Huppke-Brendel syndrome, 614482 (3), Autosomal recessive	Autosomal recessive	y	y	[All patients died between ages 22 months and 6 years, from various causes.]	L3	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L3	L3	pre-infant-lethal
614483	BRAIN SMALL VESSEL DISEASE 2	Brain small vessel disease 2, 614483 (3)	Brain small vessel disease 2	y	BRAIN SMALL VESSEL DISEASE 2; BSVD2	Clinical Features|Phenotype	died	COL4A2	HGNC:2203	Brain small vessel disease 2, 614483 (3), Autosomal dominant	Autosomal dominant	y	n	-	-	-	-	ambiguous	ambiguous	ambiguous	-	-	-
614485	TRIGONOCEPHALY 2	Trigonocephaly 2, 614485 (3)	Trigonocephaly 2	n	-	-	-	FREM1	HGNC:23399	Trigonocephaly 2, 614485 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L2	L2	pre-infant-lethal
614486	THROMBOPHILIA DUE TO THROMBOMODULIN DEFECT	Thrombophilia 12 due to thrombomodulin defect, 614486 (3)	Thrombophilia 12 due to thrombomodulin defect	y	THROMBOPHILIA DUE TO THROMBOMODULIN DEFECT; THPH12	Clinical Features|Phenotype	died|fatal|fetal_loss|fetal_losses	THBD	HGNC:11784	Thrombophilia 12 due to thrombomodulin defect, 614486 (3), Autosomal dominant	Autosomal dominant	n	n	-	-	-	-	ambiguous	ambiguous	ambiguous	-	-	-
614487	SPASTIC ATAXIA 5, AUTOSOMAL RECESSIVE	Spastic ataxia 5, autosomal recessive, 614487 (3)	Spastic ataxia 5, autosomal recessive	y	SPASTIC ATAXIA 5, AUTOSOMAL RECESSIVE; SPAX5	Clinical Features	died	AFG3L2	HGNC:315	Spastic ataxia 5, autosomal recessive, 614487 (3), Autosomal recessive	Autosomal recessive	y	y	[Pierson et al. (2011) reported 2 brothers, born of consanguineous Hispanic parents from Colombia, with early-onset spinocerebellar ataxia with spasticity and myoclonic epilepsy. Their disease courses were similar, although the younger sib had a more severe phenotype and died of pneumonia at age 13 years]	L5	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L5	L5	post-infant-lethal
614491	PSEUDOHYPOALDOSTERONISM, TYPE IIB	Pseudohypoaldosteronism, type IIB, 614491 (3)	Pseudohypoaldosteronism, type IIB	n	-	-	-	WNK4	HGNC:14544	Pseudohypoaldosteronism, type IIB, 614491 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
614492	PSEUDOHYPOALDOSTERONISM, TYPE IIC	Pseudohypoaldosteronism, type IIC, 614492 (3)	Pseudohypoaldosteronism, type IIC	n	-	-	-	WNK1	HGNC:14540	Pseudohypoaldosteronism, type IIC, 614492 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	LU	LU	post-infant-lethal
614493	WISKOTT-ALDRICH SYNDROME 2	Wiskott-Aldrich syndrome 2, 614493 (3)	Wiskott-Aldrich syndrome 2	y	WISKOTT-ALDRICH SYNDROME 2; WAS2	Description|Clinical Features|Clinical Synopsis	death|deaths|died	WIPF1	HGNC:12736	Wiskott-Aldrich syndrome 2, 614493 (3), Autosomal recessive	Autosomal recessive	y	y	[Wiskott-Aldrich syndrome-2 (WAS2) is an autosomal recessive immunologic disorder characterized by onset of recurrent infections in infancy. Other features include thrombocytopenia with normal platelet volume and eczema. Laboratory studies show decreased CD8+ T cells, variably increased Ig, particularly IgE, low B cells, aberrant function of T and NK cells, and impaired T-cell migration. The cellular abnormalities are thought to result from defective F-actin polymerization. Death in early childhood may occur; hematopoietic stem cell transplantation is curative (summary by Lanzi et al., 2012)]	L4	y	-	lethal	lethal	lethal	L4	L4	post-infant-lethal
614495	PSEUDOHYPOALDOSTERONISM, TYPE IID	Pseudohypoaldosteronism, type IID, 614495 (3)	Pseudohypoaldosteronism, type IID	n	-	-	-	KLHL3	HGNC:6354	Pseudohypoaldosteronism, type IID, 614495 (3), Autosomal dominant, Autosomal recessive	Autosomal dominant, Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
614496	PSEUDOHYPOALDOSTERONISM, TYPE IIE	Pseudohypoaldosteronism, type IIE, 614496 (3)	Pseudohypoaldosteronism, type IIE	n	-	-	-	CUL3	HGNC:2553	Pseudohypoaldosteronism, type IIE, 614496 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
614497	MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 7	Microphthalmia, isolated, with coloboma 7, 614497 (3)	Microphthalmia, isolated, with coloboma 7	n	-	-	-	ABCB6	HGNC:47	Microphthalmia, isolated, with coloboma 7, 614497 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
614498	RIGIDITY AND MULTIFOCAL SEIZURE SYNDROME, LETHAL NEONATAL	Rigidity and multifocal seizure syndrome, lethal neonatal, 614498 (3)	Rigidity and multifocal seizure syndrome, lethal neonatal	y	RIGIDITY AND MULTIFOCAL SEIZURE SYNDROME, LETHAL NEONATAL; RMFSL	Description|Clinical Features|Clinical Synopsis|Phenotype	die|lethal|death|deaths|died	BRAT1	HGNC:21701	Rigidity and multifocal seizure syndrome, lethal neonatal, 614498 (3), Autosomal recessive	Autosomal recessive	y	y	[Van de Pol et al. (2015) reported 3 sibs, born of consanguineous Moroccan parents, with infantile onset of epileptic encephalopathy resulting in death between 2 and 17 months of age]	L3	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L3	L3	pre-infant-lethal
614499	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 34, WITH VARIANT LISSENCEPHALY	Intellectual developmental disorder, autosomal recessive 34, with variant lissencephaly, 614499 (3)	Intellectual developmental disorder, autosomal recessive 34, with variant lissencephaly	y	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 34, WITH VARIANT LISSENCEPHALY; MRT34	Clinical Synopsis|Phenotype	death|deaths	CRADD	HGNC:2340	Intellectual developmental disorder, autosomal recessive 34, with variant lissencephaly, 614499 (3), Autosomal recessive	Autosomal recessive	y	n	-	-	-	-	ambiguous	ambiguous	ambiguous	-	-	-
614500	CONE-ROD DYSTROPHY 16	Cone-rod dystrophy 16, 614500 (3)	Cone-rod dystrophy 16	n	-	-	-	CFAP418	HGNC:27232	Cone-rod dystrophy 16, 614500 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
614500	CONE-ROD DYSTROPHY 16	Retinitis pigmentosa 64, 614500 (3)	Retinitis pigmentosa 64	n	-	-	-	CFAP418	HGNC:27232	Retinitis pigmentosa 64, 614500 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
614501	NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, CRANIOFACIAL ABNORMALITIES, AND SEIZURES	Neurodevelopmental disorder with hypotonia, craniofacial abnormalities, and seizures, 614501 (3)	Neurodevelopmental disorder with hypotonia, craniofacial abnormalities, and seizures	n	-	-	-	SNIP1	HGNC:30587	Neurodevelopmental disorder with hypotonia, craniofacial abnormalities, and seizures, 614501 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
614504	USHER SYNDROME, TYPE IIIB	Usher syndrome type 3B, 614504 (3)	Usher syndrome type 3B	y	USHER SYNDROME, TYPE IIIB; USH3B	Clinical Features	died	HARS1	HGNC:4816	Usher syndrome type 3B, 614504 (3), Autosomal recessive	Autosomal recessive	y	n	-	-	-	-	ambiguous	ambiguous|nonlethal	ambiguous	-	-	-
614507	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ir	Congenital disorder of glycosylation, type Ir, 614507 (3)	Congenital disorder of glycosylation, type Ir	n	-	-	-	DDOST	HGNC:2728	Congenital disorder of glycosylation, type Ir, 614507 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
614508	MIRROR MOVEMENTS 2	Mirror movements 2, 614508 (3)	Mirror movements 2	n	-	-	-	RAD51	HGNC:9817	Mirror movements 2, 614508 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
614514	THROMBOPHILIA DUE TO PROTEIN S DEFICIENCY, AUTOSOMAL RECESSIVE	Thrombophilia 5 due to protein S deficiency, autosomal recessive, 614514 (3)	Thrombophilia 5 due to protein S deficiency, autosomal recessive	y	THROMBOPHILIA DUE TO PROTEIN S DEFICIENCY, AUTOSOMAL RECESSIVE; THPH6	Clinical Features	died	PROS1	HGNC:9456	Thrombophilia 5 due to protein S deficiency, autosomal recessive, 614514 (3), Autosomal recessive	Autosomal recessive	n	y	[died on the eighth day of life]	L2	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L2	L2	pre-infant-lethal
614524	FIBROCHONDROGENESIS 2	Fibrochondrogenesis 2, 614524 (3)	Fibrochondrogenesis 2	y	FIBROCHONDROGENESIS 2; FBCG2	Description|Clinical Features	lethality|died	COL11A2	HGNC:2187	Fibrochondrogenesis 2, 614524 (3), Autosomal dominant, Autosomal recessive	Autosomal dominant, Autosomal recessive	y	y	[Tompson et al. (2012) reported 2 unrelated probands with fibrochondrogenesis who died at birth / The chest is small, causing perinatal respiratory problems which usually, but not always, result in lethality]	L2	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L2	L2	pre-infant-lethal
614546	EFAVIRENZ, POOR METABOLISM OF	Efavirenz, poor metabolism of, 614546 (3)	Efavirenz, poor metabolism of	n	-	-	-	CYP2B6	HGNC:2615	Efavirenz, poor metabolism of, 614546 (3)	-	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
614557	EHLERS-DANLOS SYNDROME, KYPHOSCOLIOTIC TYPE, 2	Ehlers-Danlos syndrome, kyphoscoliotic type, 2, 614557 (3)	Ehlers-Danlos syndrome, kyphoscoliotic type, 2	y	EHLERS-DANLOS SYNDROME, KYPHOSCOLIOTIC TYPE, 2; EDSKSCL2	Clinical Features	died	FKBP14	HGNC:18625	Ehlers-Danlos syndrome, kyphoscoliotic type, 2, 614557 (3), Autosomal recessive	Autosomal recessive	y	y	[Baumann et al. (2012) reported a 16-year-old Austrian boy who was born with severe muscle hypotonia, paucity of antigravity movements, poor sucking, hypermobile joints, and slightly bluish sclerae... She had an older sister who was born with hypotonia, developed mild but progressive kyphoscoliosis and follicular hyperkeratosis, and died unexpectedly at 12 years of age from aortic rupture]	L5	n	y	lethal	lethal	lethal	L5	L5	post-infant-lethal
614558	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 13	Developmental and epileptic encephalopathy 13, 614558 (3)	Developmental and epileptic encephalopathy 13	y	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 13; DEE13	Clinical Features	died	SCN8A	HGNC:10596	Developmental and epileptic encephalopathy 13, 614558 (3), Autosomal dominant	Autosomal dominant	y	y	[Veeramah et al. (2012) reported a 15-year-old girl with onset of refractory generalized seizures at age 6 months. At age 4 years, the seizure phenotype changed to epileptic spasms, followed by regression of speech and language skills... The patient died suddenly at age 15 years]	L5	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L5	L5	post-infant-lethal
614559	INFANTILE CEREBELLAR-RETINAL DEGENERATION	Infantile cerebellar-retinal degeneration, 614559 (3)	Infantile cerebellar-retinal degeneration	y	INFANTILE CEREBELLAR-RETINAL DEGENERATION; ICRD	Clinical Features	died	ACO2	HGNC:118	Infantile cerebellar-retinal degeneration, 614559 (3), Autosomal recessive	Autosomal recessive	y	y	[Blackburn et al. (2020) described the clinical characteristics of 5 patients with biallelic mutations in ACO2. Patients 1 and 2 were brothers, aged 12 and 15 years, who had relatively mild symptoms, including episodic ataxia, mild developmental delays, dysarthria, and behavioral problems. Brain MRI in patient 2 at age 6 years showed small midbrain, pons, and middle cerebellar peduncles. Patient 3 had cerebellar hypoplasia, ataxia, seizures, optic atrophy, and retinitis pigmentosa. At age 26 years, she had moderately to severely impaired ID, a vocabulary of 4 to 5 words, and was nonambulatory. Patient 4 had severe neonatal hypotonia, diminished reflexes, and central apnea resulting in ventilator dependence. Ophthalmologic examination showed bilateral retinal degeneration and optic atrophy. Brain MRI at age 5 months showed dilatation of the ventricles, prominent subarachnoid spaces, thinning of the corpus callosum, hypoplastic cerebellar vermis, and a hypoplastic pons. He developed multifocal epilepsy and died at 9 months of age]	L3	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L3	L3	pre-infant-lethal
614563	CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 13	Cortical dysplasia, complex, with other brain malformations 13, 614563 (3)	Cortical dysplasia, complex, with other brain malformations 13	n	-	-	-	DYNC1H1	HGNC:2961	Cortical dysplasia, complex, with other brain malformations 13, 614563 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
614565	NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1E	Night blindness, congenital stationary (complete), 1E, autosomal recessive, 614565 (3)	Night blindness, congenital stationary (complete), 1E, autosomal recessive	n	-	-	-	GPR179	HGNC:31371	Night blindness, congenital stationary (complete), 1E, autosomal recessive, 614565 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
614575	CEREBELLAR ATAXIA, NEUROPATHY, AND VESTIBULAR AREFLEXIA SYNDROME	Cerebellar ataxia, neuropathy, and vestibular areflexia syndrome, 614575 (3)	Cerebellar ataxia, neuropathy, and vestibular areflexia syndrome	n	-	-	-	RFC1	HGNC:9969	Cerebellar ataxia, neuropathy, and vestibular areflexia syndrome, 614575 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
614576	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIl	Congenital disorder of glycosylation, type IIl, 614576 (3)	Congenital disorder of glycosylation, type IIl	y	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIl; CDG2L	Description|Clinical Features|Clinical Synopsis|Phenotype	death|deaths|died|fatal	COG6	HGNC:18621	Congenital disorder of glycosylation, type IIl, 614576 (3), Autosomal recessive	Autosomal recessive	n	y	[Rymen et al. (2015) reported 7 additional patients with CDG2L, including the sister and 2 sib cousins of the patient reported by Lubbehusen et al. (2010).... Five of the 7 patients died in the first days or weeks of life]	L2	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L2	L2	pre-infant-lethal
614582	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 9	Combined oxidative phosphorylation deficiency 9, 614582 (3)	Combined oxidative phosphorylation deficiency 9	y	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 9; COXPD9	Clinical Features|Clinical Synopsis	death|deaths|died	MRPL3	HGNC:10379	Combined oxidative phosphorylation deficiency 9, 614582 (3), Autosomal recessive	Autosomal recessive	n	y	[Bursle et al. (2017) reported a male infant, born of unrelated parents, with a severe mitochondrial disorder resulting in death at 11 months of age]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
614583	BARAITSER-WINTER SYNDROME 2	Baraitser-Winter syndrome 2, 614583 (3)	Baraitser-Winter syndrome 2	n	-	-	-	ACTG1	HGNC:144	Baraitser-Winter syndrome 2, 614583 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
614592	BENT BONE DYSPLASIA SYNDROME 1	Bent bone dysplasia syndrome, 614592 (3)	Bent bone dysplasia syndrome	y	BENT BONE DYSPLASIA SYNDROME 1; BBDS1	Description|Phenotype	lethal	FGFR2	HGNC:3689	Bent bone dysplasia syndrome, 614592 (3), Autosomal dominant	Autosomal dominant	y	y	[Merrill et al. (2012) studied 4 fetuses, 3 female and 1 male, with a perinatal lethal skeletal dysplasia characterized by poor mineralization of the calvarium, craniosynostosis, dysmorphic facial features, prenatal teeth, hypoplastic pubis and clavicles, osteopenia, and bent long bones]	L2	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L1|L2|L3	L1	pre-infant-lethal
614594	OLMSTED SYNDROME 1	Olmsted syndrome 1, 614594 (3)	Olmsted syndrome 1	y	OLMSTED SYNDROME 1; OLMS1	Clinical Features	died	TRPV3	HGNC:18084	Olmsted syndrome 1, 614594 (3), Autosomal dominant	Autosomal dominant	y	y	[Lin et al. (2012) studied 5 sporadic Chinese patients with Olmsted syndrome, and 1 patient whose affected daughter died at 2 years of age]	L4	y	-	lethal	lethal	lethal	L4	L4	post-infant-lethal
614595	PREECLAMPSIA/ECLAMPSIA 5	Preeclampsia/eclampsia 5, 614595 (3)	Preeclampsia/eclampsia 5	n	-	-	-	CORIN	HGNC:19012	Preeclampsia/eclampsia 5, 614595 (3)	-	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
614602	TRICHOHEPATOENTERIC SYNDROME 2	Trichohepatoenteric syndrome 2, 614602 (3)	Trichohepatoenteric syndrome 2	n	-	-	-	SKIC2	HGNC:10898	Trichohepatoenteric syndrome 2, 614602 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
614607	COFFIN-SIRIS SYNDROME 2	Coffin-Siris syndrome 2, 614607 (3)	Coffin-Siris syndrome 2	y	COFFIN-SIRIS SYNDROME 2; CSS2	Description|Phenotype	death|deaths|lethal	ARID1A	HGNC:11110	Coffin-Siris syndrome 2, 614607 (3), Autosomal dominant	Autosomal dominant	n	y	[Coffin-Siris syndrome is a congenital malformation syndrome characterized by developmental delay, intellectual disability, coarse facial features, feeding difficulties, and hypoplastic or absent fifth fingernails and fifth distal phalanges. Other more variable features may also occur. Patients with ARID1A mutations have a wide spectrum of manifestations, from severe intellectual disability and serious internal complications that could result in early death to mild intellectual disability (summary by Kosho et al., 2014)]	LU	y	-	lethal	lethal	lethal	LU	LU	post-infant-lethal
614608	COFFIN-SIRIS SYNDROME 3	Coffin-Siris syndrome 3, 614608 (3)	Coffin-Siris syndrome 3	n	-	-	-	SMARCB1	HGNC:11103	Coffin-Siris syndrome 3, 614608 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
614609	COFFIN-SIRIS SYNDROME 4	Coffin-Siris syndrome 4, 614609 (3)	Coffin-Siris syndrome 4	n	-	-	-	SMARCA4	HGNC:11100	Coffin-Siris syndrome 4, 614609 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
614613	ACRODYSOSTOSIS 2 WITH OR WITHOUT HORMONE RESISTANCE	Acrodysostosis 2, with or without hormone resistance, 614613 (3)	Acrodysostosis 2, with or without hormone resistance	n	-	-	-	PDE4D	HGNC:8783	Acrodysostosis 2, with or without hormone resistance, 614613 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
614614	DEAFNESS, AUTOSOMAL DOMINANT 4B	Deafness, autosomal dominant 4B, 614614 (3)	Deafness, autosomal dominant 4B	n	-	-	-	CEACAM16	HGNC:31948	Deafness, autosomal dominant 4B, 614614 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
614615	JOUBERT SYNDROME 17	Joubert syndrome 17, 614615 (3)	Joubert syndrome 17	n	-	-	-	CPLANE1	HGNC:25801	Joubert syndrome 17, 614615 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L1	L1	pre-infant-lethal
614616	DIARRHEA 6	Diarrhea 6, 614616 (3)	Diarrhea 6	n	-	-	-	GUCY2C	HGNC:4688	Diarrhea 6, 614616 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L3	L3	pre-infant-lethal
614617	DEAFNESS, AUTOSOMAL RECESSIVE 86	Deafness, autosomal recessive 86, 614617 (3)	Deafness, autosomal recessive 86	n	-	-	-	TBC1D24	HGNC:29203	Deafness, autosomal recessive 86, 614617 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L2|L3	L2	pre-infant-lethal
614618	HYPEREKPLEXIA 3	Hyperekplexia 3, 614618 (3)	Hyperekplexia 3	n	-	-	-	SLC6A5	HGNC:11051	Hyperekplexia 3, 614618 (3), Autosomal dominant, Autosomal recessive	Autosomal dominant, Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
614619	HYPEREKPLEXIA 2	Hyperekplexia 2, 614619 (3)	Hyperekplexia 2	n	-	-	-	GLRB	HGNC:4329	Hyperekplexia 2, 614619 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
614621	UV-SENSITIVE SYNDROME 2	UV-sensitive syndrome 2, 614621 (3)	UV-sensitive syndrome 2	n	-	-	-	ERCC8	HGNC:3439	UV-sensitive syndrome 2, 614621 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L3	L3	pre-infant-lethal
614640	UV-SENSITIVE SYNDROME 3	UV-sensitive syndrome 3, 614640 (3)	UV-sensitive syndrome 3	n	-	-	-	UVSSA	HGNC:29304	UV-sensitive syndrome 3, 614640 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
614643	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 7	Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 7, 614643 (3)	Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 7	y	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 7; MDDGA7	Description|Clinical Features|Clinical Synopsis	death|deaths|died|die	CRPPA	HGNC:37276	Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 7, 614643 (3), Autosomal recessive	Autosomal recessive	y	y	[Chitayat et al. (1995) reported a 37-week-old fetus who was found to have hydrocephalus and retinal detachment on prenatal ultrasound, leading to a diagnosis of WWS. Fetal movements were weak. After delivery, the baby was hypotonic, in a 'frog leg' position, and did not move or cry. He had large fontanels, frontal bossing, deep-set eyes, retrognathia, and small, simple, low-set ears. The eyes had central circular defects in the posterior cornea with abnormal adhesions and anterior segment anomalies consistent with a variant of Peters anomaly. Brain MRI showed hydrocephalus, type II lissencephaly, and cerebellar hypoplasia. He died at age 3 months]	L3	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L3	L3	pre-infant-lethal
614650	COENZYME Q10 DEFICIENCY, PRIMARY, 6	Coenzyme Q10 deficiency, primary, 6, 614650 (3)	Coenzyme Q10 deficiency, primary, 6	y	COENZYME Q10 DEFICIENCY, PRIMARY, 6; COQ10D6	Clinical Features|Clinical Synopsis	died|death|deaths	COQ6	HGNC:20233	Coenzyme Q10 deficiency, primary, 6, 614650 (3), Autosomal recessive	Autosomal recessive	y	y	[Death in childhood may occur due to end-stage renal disease / Heeringa et al. (2011) reported 11 children from 5 families with autosomal recessive coenzyme Q10 deficiency manifest as nephrotic syndrome. Nine of the 11 patients had sensorineural deafness. The patients presented with proteinuria at a median age of 1.2 years (range, 0.2-6.4 years) and progressed to end-stage renal failure at a median age of 1.7 years (range, 0.4-9.3 years). Five children died in early childhood (median age of 5.0 years)]	L4	y	-	lethal	lethal	lethal	L4	L4	post-infant-lethal
614651	COENZYME Q10 DEFICIENCY, PRIMARY, 2	Coenzyme Q10 deficiency, primary, 2, 614651 (3)	Coenzyme Q10 deficiency, primary, 2	y	COENZYME Q10 DEFICIENCY, PRIMARY, 2; COQ10D2	Clinical Features|Clinical Synopsis	died|death|deaths	PDSS1	HGNC:17759	Coenzyme Q10 deficiency, primary, 2, 614651 (3), Autosomal recessive	Autosomal recessive	y	y	[died at 16 months of age]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
614652	COENZYME Q10 DEFICIENCY, PRIMARY, 3	Coenzyme Q10 deficiency, primary, 3, 614652 (3)	Coenzyme Q10 deficiency, primary, 3	y	COENZYME Q10 DEFICIENCY, PRIMARY, 3; COQ10D3	Clinical Features|Clinical Synopsis|Phenotype	died|fatal	PDSS2	HGNC:23041	Coenzyme Q10 deficiency, primary, 3, 614652 (3), Autosomal recessive	Autosomal recessive	n	y	[This patient died at age 8 months]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
614653	NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE VI	Neuropathy, hereditary sensory and autonomic, type VI, 614653 (3)	Neuropathy, hereditary sensory and autonomic, type VI	y	NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE VI; HSAN6	Clinical Features|Clinical Synopsis|Phenotype	died|death|deaths|lethality	DST	HGNC:1090	Neuropathy, hereditary sensory and autonomic, type VI, 614653 (3), Autosomal recessive	Autosomal recessive	y	y	[all died by age 2 years]	L3	y	y	lethal	lethal|nonlethal	lethal|nonlethal	L3	L3	pre-infant-lethal
614654	COENZYME Q10 DEFICIENCY, PRIMARY, 5	Coenzyme Q10 deficiency, primary, 5, 614654 (3)	Coenzyme Q10 deficiency, primary, 5	y	COENZYME Q10 DEFICIENCY, PRIMARY, 5; COQ10D5	Clinical Features|Clinical Synopsis	died|miscarriage|miscarriages	COQ9	HGNC:25302	Coenzyme Q10 deficiency, primary, 5, 614654 (3), Autosomal recessive	Autosomal recessive	n	y	[Rahman et al. (2001) reported a boy, the seventh child of healthy unrelated Pakistani parents, who presented in the first day of life with poor feeding, hypothermia, and seizures... Family history revealed that 5 older sibs were healthy, but another sib had died on day 1 of life with seizures, aminoaciduria, and acidosis. The mother had previously had 5 first-trimester miscarriages / The patients died in infancy or early childhood]	L1	y	y	lethal	lethal	lethal	L1	L1	pre-infant-lethal
614662	CORTISONE REDUCTASE DEFICIENCY 2	Cortisone reductase deficiency 2, 614662 (3)	Cortisone reductase deficiency 2	n	-	-	-	HSD11B1	HGNC:5208	Cortisone reductase deficiency 2, 614662 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
614665	MECONIUM ILEUS	Meconium ileus, 614665 (3)	Meconium ileus	y	MECONIUM ILEUS	Clinical Features	died	GUCY2C	HGNC:4688	Meconium ileus, 614665 (3), Autosomal recessive	Autosomal recessive	n	y	[Tal et al. (1985) reported a consanguineous Bedouin family in which 4 of 12 sibs had meconium ileus with normal sweat electrolytes. Two of the affected sibs also developed chronic diarrhea in infancy, 1 of whom died at 4 months of age from sepsis and severe malnutrition; postmortem examination revealed no pathologic findings consistent with cystic fibrosis]	L3	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L3	L3	pre-infant-lethal
614669	AURICULOCONDYLAR SYNDROME 2A	Auriculocondylar syndrome 2A, 614669 (3)	Auriculocondylar syndrome 2A	n	-	-	-	PLCB4	HGNC:9059	Auriculocondylar syndrome 2A, 614669 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
614673	MICROCEPHALY 8, PRIMARY, AUTOSOMAL RECESSIVE	Microcephaly 8, primary, autosomal recessive, 614673 (3)	Microcephaly 8, primary, autosomal recessive	y	MICROCEPHALY 8, PRIMARY, AUTOSOMAL RECESSIVE; MCPH8	Clinical Features	died	CEP135	HGNC:29086	Microcephaly 8, primary, autosomal recessive, 614673 (3), Autosomal recessive	Autosomal recessive	n	y	[Hussain et al. (2012) reported 2 sibs, born of consanguineous Pakistani parents, with primary microcephaly apparent at birth. Each had a sloping forehead, retrognathia, severe cognitive deficits, and unintelligible speech at age 5 years. One died at age 11 years]	L5	y	-	lethal	lethal	lethal	L5	L5	post-infant-lethal
614674	PERIODIC FEVER, MENSTRUAL CYCLE-DEPENDENT	Periodic fever, menstrual cycle dependent, 614674 (3)	Periodic fever, menstrual cycle dependent	y	PERIODIC FEVER, MENSTRUAL CYCLE-DEPENDENT	Clinical Features|Clinical Synopsis	spontaneous_abortion|spontaneous_abortions|fetal_loss|fetal_losses	HTR1A	HGNC:5286	Periodic fever, menstrual cycle dependent, 614674 (3), Autosomal dominant	Autosomal dominant	n	n	-	-	-	-	ambiguous	ambiguous	ambiguous	-	-	-
614675	BONE MARROW FAILURE SYNDROME 1	Bone marrow failure syndrome 1, 614675 (3)	Bone marrow failure syndrome 1	n	-	-	-	SRP72	HGNC:11303	Bone marrow failure syndrome 1, 614675 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
614678	PONTOCEREBELLAR HYPOPLASIA, TYPE 1B	Pontocerebellar hypoplasia, type 1B, 614678 (3)	Pontocerebellar hypoplasia, type 1B	y	PONTOCEREBELLAR HYPOPLASIA, TYPE 1B; PCH1B	Clinical Features|Clinical Synopsis|Phenotype	died|fatal|death|deaths	EXOSC3	HGNC:17944	Pontocerebellar hypoplasia, type 1B, 614678 (3), Autosomal recessive	Autosomal recessive	n	y	[Ryan et al. (2000) reported 5 patients, including 2 sibs, with pontocerebellar hypoplasia associated with anterior horn cell disease of the spinal cord. The 2 sibs died at ages 6 days and 5 months, respectively]	L2	y	-	lethal	lethal	lethal	L2	L2	pre-infant-lethal
614679	CILIARY DYSKINESIA, PRIMARY, 17	Ciliary dyskinesia, primary, 17, 614679 (3)	Ciliary dyskinesia, primary, 17	n	-	-	-	CCDC103	HGNC:32700	Ciliary dyskinesia, primary, 17, 614679 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
614691	CATARACT 38	Cataract 38, autosomal recessive, 614691 (3)	Cataract 38, autosomal recessive	n	-	-	-	AGK	HGNC:21869	Cataract 38, autosomal recessive, 614691 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L2	L2	pre-infant-lethal
614700	IMMUNODEFICIENCY, COMMON VARIABLE, 8, WITH AUTOIMMUNITY	Immunodeficiency, common variable, 8, with autoimmunity, 614700 (3)	Immunodeficiency, common variable, 8, with autoimmunity	y	IMMUNODEFICIENCY, COMMON VARIABLE, 8, WITH AUTOIMMUNITY; CVID8	Clinical Features	died	LRBA	HGNC:1742	Immunodeficiency, common variable, 8, with autoimmunity, 614700 (3), Autosomal recessive	Autosomal recessive	n	y	[Lopez-Herrera et al. (2012) reported 5 patients from 4 unrelated consanguineous families with early-childhood onset of humoral immune deficiency and autoimmunity. In an Arabian family, 2 sibs presented in infancy with idiopathic thrombocytopenic purpura (ITP) followed by recurrent respiratory infections or otitis media.... The fifth patient was an Iranian women who died at age 19 years after respiratory failure]	L6	y	-	lethal	lethal	lethal	L6	L6	post-infant-lethal
614701	CORNELIA DE LANGE SYNDROME 4 WITH OR WITHOUT MIDLINE BRAIN DEFECTS	Cornelia de Lange syndrome 4, 614701 (3)	Cornelia de Lange syndrome 4	n	-	-	-	RAD21	HGNC:9811	Cornelia de Lange syndrome 4, 614701 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
614702	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 10	Combined oxidative phosphorylation deficiency 10, 614702 (3)	Combined oxidative phosphorylation deficiency 10	y	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 10; COXPD10	Description|Clinical Features|Clinical Synopsis|Phenotype	fatal|died|death|deaths	MTO1	HGNC:19261	Combined oxidative phosphorylation deficiency 10, 614702 (3), Autosomal recessive	Autosomal recessive	n	y	[Ghezzi et al. (2012) reported 2 Italian sibs, born of unrelated parents, with fatal infantile hypertrophic cardiomyopathy. Both patients showed reduced fetal growth. The first presented soon after birth with lactic acidosis and severe hypoglycemia. Electroencephalogram (EEG) and cerebral, hepatic, and splenic echography were normal. Interventricular septum hypertrophy of the heart was detected on the fifteenth day of life, and he died of sudden bradycardia on day 19]	L2	y	-	lethal	lethal	lethal	L2	L2	pre-infant-lethal
614706	CEROID LIPOFUSCINOSIS, NEURONAL, 11	Ceroid lipofuscinosis, neuronal, 11, 614706 (3)	Ceroid lipofuscinosis, neuronal, 11	n	-	-	-	GRN	HGNC:4601	Ceroid lipofuscinosis, neuronal, 11, 614706 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L6	L6	post-infant-lethal
614707	BROWN-VIALETTO-VAN LAERE SYNDROME 2	Brown-Vialetto-Van Laere syndrome 2, 614707 (3)	Brown-Vialetto-Van Laere syndrome 2	y	BROWN-VIALETTO-VAN LAERE SYNDROME 2; BVVLS2	Clinical Features|Clinical Synopsis|Phenotype	died|death|deaths	SLC52A2	HGNC:30224	Brown-Vialetto-Van Laere syndrome 2, 614707 (3), Autosomal recessive	Autosomal recessive	y	y	[Ciccolella et al. (2013) reported a boy with severe, early-onset BVVLS2. He had normal early psychomotor development and began to walk at age 12 months. At age 2 years, he presented with progressive dysphonia and exercise intolerance with dyspnea and cyanosis. He later developed sensorineural hearing loss, decreased visual acuity, shoulder and axial muscle weakness, kyphosis, wasting and weakness of the hand muscles, and walking difficulties with foot drop. The disorder was rapidly progressive; at age 3 years, he was hospitalized for acute respiratory failure and died]	L4	y	-	lethal	lethal	lethal	L4	L4	post-infant-lethal
614714	POROKERATOSIS 7, MULTIPLE TYPES	Porokeratosis 7, multiple types, 614714 (3)	Porokeratosis 7, multiple types	n	-	-	-	MVD	HGNC:7529	Porokeratosis 7, multiple types, 614714 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
614723	ADENINE PHOSPHORIBOSYLTRANSFERASE DEFICIENCY	Adenine phosphoribosyltransferase deficiency, 614723 (3)	Adenine phosphoribosyltransferase deficiency	n	-	-	-	APRT	HGNC:626	Adenine phosphoribosyltransferase deficiency, 614723 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
614727	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIk	Congenital disorder of glycosylation, type IIk, 614727 (3)	Congenital disorder of glycosylation, type IIk	y	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIk; CDG2K	Clinical Features	died	TMEM165	HGNC:30760	Congenital disorder of glycosylation, type IIk, 614727 (3), Autosomal recessive	Autosomal recessive	n	y	[Foulquier et al. (2012) reported 5 patients from 4 families with CDG2K. The first family contained 2 affected sibs, born of Georgian Jewish parents. The 19-year-old boy had psychomotor retardation and severe growth retardation. He also had midface hypoplasia, muscle weakness, fat excess, joint laxity, and hepatosplenomegaly with increased serum transaminases. Laboratory studies showed increased creatine kinase and partial growth hormone deficiency. Skeletal anomalies included osteoporosis and epiphyseal, metaphyseal, and diaphyseal dysplasia. Brain MRI showed white matter abnormalities and hypoplasia of the pituitary gland. His sister, who had similar clinical features, also had recurrent, unexplained fever episodes; she died at 14 months of age from an acute infectious shock]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
614732	INTRAUTERINE GROWTH RETARDATION, METAPHYSEAL DYSPLASIA, ADRENAL HYPOPLASIA CONGENITA, AND GENITAL ANOMALIES	IMAGE syndrome, 614732 (3)	IMAGE syndrome	y	INTRAUTERINE GROWTH RETARDATION, METAPHYSEAL DYSPLASIA, ADRENAL HYPOPLASIA CONGENITA, AND GENITAL ANOMALIES; IMAGE	Clinical Features	died	CDKN1C	HGNC:1786	IMAGE syndrome, 614732 (3), Autosomal dominant	Autosomal dominant	y	y	[Bergada et al. (2005) studied 4 children with IMAGE association (3 males, 1 female) from a large 5-generation pedigree. Ten additional members who died during the neonatal period who were born with intrauterine growth retardation (IUGR) and/or hyperpigmentation were presumed to have been affected as well]	L2	y	y	lethal	lethal	lethal	L2	L2	pre-infant-lethal
614736	GLUCOCORTICOID DEFICIENCY 4 WITH OR WITHOUT MINERALOCORTICOID DEFICIENCY	Glucocorticoid deficiency 4, with or without mineralocorticoid deficiency, 614736 (3)	Glucocorticoid deficiency 4, with or without mineralocorticoid deficiency	y	GLUCOCORTICOID DEFICIENCY 4 WITH OR WITHOUT MINERALOCORTICOID DEFICIENCY; GCCD4	Clinical Features	death|deaths|died	NNT	HGNC:7863	Glucocorticoid deficiency 4, with or without mineralocorticoid deficiency, 614736 (3), Autosomal recessive	Autosomal recessive	n	y	[Hershkovitz et al. (2015) reported a 20-year-old Israeli Jewish man who presented at age 10 months with apathy, vomiting, and dehydration, and was found to be severely hyponatremic, with hyperkalemia and significant urinary sodium excretion.. His consanguineous parents had 2 earlier-born children who died at 3 and 4 months of age due to a short illness defined as 'gastroenteritis]	L3	n	y	lethal	lethal	lethal	L3	L3	pre-infant-lethal
614739	3-METHYLGLUTACONIC ACIDURIA WITH DEAFNESS, ENCEPHALOPATHY, AND LEIGH-LIKE SYNDROME	3-methylglutaconic aciduria with deafness, encephalopathy, and Leigh-like syndrome, 614739 (3)	3-methylglutaconic aciduria with deafness, encephalopathy, and Leigh-like syndrome	y	3-METHYLGLUTACONIC ACIDURIA WITH DEAFNESS, ENCEPHALOPATHY, AND LEIGH-LIKE SYNDROME; MEGDEL	Clinical Features	died	SERAC1	HGNC:21061	3-methylglutaconic aciduria with deafness, encephalopathy, and Leigh-like syndrome, 614739 (3), Autosomal recessive	Autosomal recessive	n	y	[Maas et al. (2017) reviewed the clinical features of 67 patients with MEGDHEL, including 39 previously unreported individuals. Most (64%) of the families were consanguineous. Most of the individuals were of European ancestry, although several dozen patients were from Africa, Asia, the Middle East, or Australia, indicating that MEGDHEL is a panethnic disorder. With the exception of 2 families with a milder phenotype and onset later in childhood, all affected individuals showed a strikingly homogeneous phenotype and time course. Sixteen patients died at a median age of 9 years, mostly due to respiratory infections]	L4	y	-	lethal	lethal	lethal	L4	L4	post-infant-lethal
614741	MITOCHONDRIAL PYRUVATE CARRIER DEFICIENCY	Mitochondrial pyruvate carrier deficiency, 614741 (3)	Mitochondrial pyruvate carrier deficiency	y	MITOCHONDRIAL PYRUVATE CARRIER DEFICIENCY; MPYCD	Clinical Features	death|deaths	MPC1	HGNC:21606	Mitochondrial pyruvate carrier deficiency, 614741 (3), Autosomal recessive	Autosomal recessive	n	y	[Brivet et al. (2003) reported a girl, born of related Algerian parents, with a severe metabolic disorder resulting in death at age 19 months]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
614742	PULMONARY FIBROSIS AND/OR BONE MARROW FAILURE SYNDROME, TELOMERE-RELATED, 1	Pulmonary fibrosis and/or bone marrow failure syndrome, telomere-related, 1, 614742 (3)	Pulmonary fibrosis and/or bone marrow failure syndrome, telomere-related, 1	y	PULMONARY FIBROSIS AND/OR BONE MARROW FAILURE SYNDROME, TELOMERE-RELATED, 1; PFBMFT1	Description|Clinical Features|Phenotype	fatal|death|deaths	TERT	HGNC:11730	Pulmonary fibrosis and/or bone marrow failure syndrome, telomere-related, 1, 614742 (3), Autosomal dominant	Autosomal dominant	y	n	-	-	-	-	ambiguous	ambiguous|nonlethal	ambiguous	-	-	-
614744	FACIAL PARESIS, HEREDITARY CONGENITAL, 3	Facial paresis, hereditary congenital, 3, 614744 (3)	Facial paresis, hereditary congenital, 3	n	-	-	-	HOXB1	HGNC:5111	Facial paresis, hereditary congenital, 3, 614744 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
614748	EPIDERMOLYSIS BULLOSA, JUNCTIONAL 7, WITH INTERSTITIAL LUNG DISEASE AND NEPHROTIC SYNDROME	Epidermolysis bullosa, junctional 7, with interstitial lung disease and nephrotic syndrome, 614748 (3)	Epidermolysis bullosa, junctional 7, with interstitial lung disease and nephrotic syndrome	y	EPIDERMOLYSIS BULLOSA, JUNCTIONAL 7, WITH INTERSTITIAL LUNG DISEASE AND NEPHROTIC SYNDROME; JEB7	Description|Clinical Features|Clinical Synopsis|Phenotype	lethal|died|death|deaths	ITGA3	HGNC:6139	Epidermolysis bullosa, junctional 7, with interstitial lung disease and nephrotic syndrome, 614748 (3), Autosomal recessive	Autosomal recessive	y	y	[died of multiorgan failure at 2 months of age]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
614749	HYPERPHOSPHATASIA WITH IMPAIRED INTELLECTUAL DEVELOPMENT SYNDROME 2	Hyperphosphatasia with impaired intellectual development syndrome 2, 614749 (3)	Hyperphosphatasia with impaired intellectual development syndrome 2	y	HYPERPHOSPHATASIA WITH IMPAIRED INTELLECTUAL DEVELOPMENT SYNDROME 2; HPMRS2	Clinical Features	died	PIGO	HGNC:23215	Hyperphosphatasia with impaired intellectual development syndrome 2, 614749 (3), Autosomal recessive	Autosomal recessive	y	y	[died at age 22 months of severe generalized seizure]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
614750	MYASTHENIC SYNDROME, CONGENITAL, 13	Myasthenic syndrome, congenital, 13, with tubular aggregates, 614750 (3)	Myasthenic syndrome, congenital, 13, with tubular aggregates	n	-	-	-	DPAGT1	HGNC:2995	Myasthenic syndrome, congenital, 13, with tubular aggregates, 614750 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L3	L3	pre-infant-lethal
614753	MALAN SYNDROME	Malan syndrome, 614753 (3)	Malan syndrome	n	-	-	-	NFIX	HGNC:7788	Malan syndrome, 614753 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L2	L2	pre-infant-lethal
614756	CEREBELLAR DYSFUNCTION WITH VARIABLE COGNITIVE AND BEHAVIORAL ABNORMALITIES	Cerebellar dysfunction with variable cognitive and behavioral abnormalities, 614756 (3)	Cerebellar dysfunction with variable cognitive and behavioral abnormalities	n	-	-	-	CAMTA1	HGNC:18806	Cerebellar dysfunction with variable cognitive and behavioral abnormalities, 614756 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
614779	HETEROTAXY, VISCERAL, 6, AUTOSOMAL	Heterotaxy, visceral, 6, autosomal recessive, 614779 (3)	Heterotaxy, visceral, 6, autosomal recessive	y	HETEROTAXY, VISCERAL, 6, AUTOSOMAL; HTX6	Clinical Features	died	CFAP53	HGNC:26530	Heterotaxy, visceral, 6, autosomal recessive, 614779 (3), Autosomal recessive	Autosomal recessive	y	n	-	-	-	-	ambiguous	ambiguous	ambiguous	-	-	-
614782	TREMOR, HEREDITARY ESSENTIAL, 4	Essential tremor, hereditary, 4, 614782 (3)	Essential tremor, hereditary, 4	n	-	-	-	FUS	HGNC:4010	Essential tremor, hereditary, 4, 614782 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L6	L6	post-infant-lethal
614800	SHORT STATURE, OPTIC NERVE ATROPHY, AND PELGER-HUET ANOMALY	Short stature, optic nerve atrophy, and Pelger-Huet anomaly, 614800 (3)	Short stature, optic nerve atrophy, and Pelger-Huet anomaly	n	-	-	-	NBAS	HGNC:15625	Short stature, optic nerve atrophy, and Pelger-Huet anomaly, 614800 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L3	L3	pre-infant-lethal
614808	AMYOTROPHIC LATERAL SCLEROSIS 18	Amyotrophic lateral sclerosis 18, 614808 (3)	Amyotrophic lateral sclerosis 18	n	-	-	-	PFN1	HGNC:8881	Amyotrophic lateral sclerosis 18, 614808 (3)	-	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
614809	C3 GLOMERULOPATHY 3	Nephropathy due to CFHR5 deficiency, 614809 (3)	Nephropathy due to CFHR5 deficiency	n	-	-	-	CFHR5	HGNC:24668	Nephropathy due to CFHR5 deficiency, 614809 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
614813	SHORT STATURE, ONYCHODYSPLASIA, FACIAL DYSMORPHISM, AND HYPOTRICHOSIS	Short stature, onychodysplasia, facial dysmorphism, and hypotrichosis, 614813 (3)	Short stature, onychodysplasia, facial dysmorphism, and hypotrichosis	n	-	-	-	POC1A	HGNC:24488	Short stature, onychodysplasia, facial dysmorphism, and hypotrichosis, 614813 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
614814	ADAMS-OLIVER SYNDROME 3	Adams-Oliver syndrome 3, 614814 (3)	Adams-Oliver syndrome 3	n	-	-	-	RBPJ	HGNC:5724	Adams-Oliver syndrome 3, 614814 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
614815	JOUBERT SYNDROME 18	Joubert syndrome 18, 614815 (3)	Joubert syndrome 18	n	-	-	-	TCTN3	HGNC:24519	Joubert syndrome 18, 614815 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L1	L1	pre-infant-lethal
614816	LOEYS-DIETZ SYNDROME 4	Loeys-Dietz syndrome 4, 614816 (3)	Loeys-Dietz syndrome 4	n	-	-	-	TGFB2	HGNC:11768	Loeys-Dietz syndrome 4, 614816 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
614817	INTERSTITIAL NEPHRITIS, KARYOMEGALIC	Interstitial nephritis, karyomegalic, 614817 (3)	Interstitial nephritis, karyomegalic	y	INTERSTITIAL NEPHRITIS, KARYOMEGALIC; KMIN	Clinical Features	died	FAN1	HGNC:29170	Interstitial nephritis, karyomegalic, 614817 (3), Autosomal recessive	Autosomal recessive	y	y	[Verine et al. (2010) reported a 50-year-old French woman who presented with asymptomatic renal failure and mild proteinuria without hematuria. Renal biopsy showed large tubulointerstitial fibrosis and massively enlarged tubular epithelial cell nuclei, consistent with karyomegalic interstitial nephritis. Family history revealed a brother who died of renal insufficiency at 35 years of age]	L6	y	-	lethal	lethal	lethal	L6	L6	post-infant-lethal
614820	ALTERNATING HEMIPLEGIA OF CHILDHOOD 2	Alternating hemiplegia of childhood 2, 614820 (3)	Alternating hemiplegia of childhood 2	n	-	-	-	ATP1A3	HGNC:801	Alternating hemiplegia of childhood 2, 614820 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	ambiguous|nonlethal	ambiguous	-	-	-
614822	SPERMATOGENIC FAILURE 10	Spermatogenic failure 10, 614822 (3)	Spermatogenic failure 10	n	-	-	-	SEPTIN12	HGNC:26348	Spermatogenic failure 10, 614822 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
614823	AORTIC VALVE DISEASE 2	Aortic valve disease 2, 614823 (3)	Aortic valve disease 2	y	AORTIC VALVE DISEASE 2; AOVD2	Phenotype	died	SMAD6	HGNC:6772	Aortic valve disease 2, 614823 (3), Autosomal dominant	Autosomal dominant	n	n	-	-	-	-	ambiguous	ambiguous	ambiguous	-	-	-
614830	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 8	Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 8, 614830 (3)	Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 8	y	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 8; MDDGA8	Description|Clinical Features|Clinical Synopsis	death|deaths|died|die	POMGNT2	HGNC:25902	Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 8, 614830 (3), Autosomal recessive	Autosomal recessive	n	y	[died within the first months of life]	L3	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L3	L3	pre-infant-lethal
614831	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 13	Spinocerebellar ataxia, autosomal recessive 13, 614831 (3)	Spinocerebellar ataxia, autosomal recessive 13	n	-	-	-	GRM1	HGNC:4593	Spinocerebellar ataxia, autosomal recessive 13, 614831 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
614832	AMELOGENESIS IMPERFECTA, HYPOMATURATION TYPE, IIA4	Amelogenesis imperfecta, type IIA4, 614832 (3)	Amelogenesis imperfecta, type IIA4	n	-	-	-	ODAPH	HGNC:26300	Amelogenesis imperfecta, type IIA4, 614832 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
614833	MICROCEPHALY, SHORT STATURE, AND POLYMICROGYRIA WITH OR WITHOUT SEIZURES	Microcephaly, short stature, and polymicrogyria with seizures, 614833 (3)	Microcephaly, short stature, and polymicrogyria with seizures	y	MICROCEPHALY, SHORT STATURE, AND POLYMICROGYRIA WITH OR WITHOUT SEIZURES; MSSP	Clinical Features	died	RTTN	HGNC:18654	Microcephaly, short stature, and polymicrogyria with seizures, 614833 (3), Autosomal recessive	Autosomal recessive	n	y	[Shamseldin et al. (2015) described 3 unrelated families segregating microcephaly, short stature, and polymicrogyria without seizures.... In the third family, 2 Canadian brothers were affected... He died at 19 days of age]	L2	y	-	lethal	lethal	lethal	L2	L2	pre-infant-lethal
614837	HYPOGONADOTROPIC HYPOGONADISM 8 WITH OR WITHOUT ANOSMIA	Hypogonadotropic hypogonadism 8 with or without anosmia, 614837 (3)	Hypogonadotropic hypogonadism 8 with or without anosmia	y	HYPOGONADOTROPIC HYPOGONADISM 8 WITH OR WITHOUT ANOSMIA; HH8	Clinical Features	miscarriage|miscarriages	KISS1R	HGNC:4510	Hypogonadotropic hypogonadism 8 with or without anosmia, 614837 (3), Autosomal recessive	Autosomal recessive	n	n	-	-	-	-	ambiguous	ambiguous	ambiguous	-	-	-
614838	HYPOGONADOTROPIC HYPOGONADISM 9 WITH OR WITHOUT ANOSMIA	Hypogonadotropic hypogonadism 9 with or without anosmia, 614838 (3)	Hypogonadotropic hypogonadism 9 with or without anosmia	n	-	-	-	NSMF	HGNC:29843	Hypogonadotropic hypogonadism 9 with or without anosmia, 614838 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
614839	HYPOGONADOTROPIC HYPOGONADISM 10 WITH OR WITHOUT ANOSMIA	Hypogonadotropic hypogonadism 10 with or without anosmia, 614839 (3)	Hypogonadotropic hypogonadism 10 with or without anosmia	y	HYPOGONADOTROPIC HYPOGONADISM 10 WITH OR WITHOUT ANOSMIA; HH10	Clinical Features	pregnancy_loss|pregnancy_losses	TAC3	HGNC:11521	Hypogonadotropic hypogonadism 10 with or without anosmia, 614839 (3), Autosomal recessive	Autosomal recessive	n	n	-	-	-	-	ambiguous	ambiguous	ambiguous	-	-	-
614840	HYPOGONADOTROPIC HYPOGONADISM 11 WITH OR WITHOUT ANOSMIA	Hypogonadotropic hypogonadism 11 with or without anosmia, 614840 (3)	Hypogonadotropic hypogonadism 11 with or without anosmia	n	-	-	-	TACR3	HGNC:11528	Hypogonadotropic hypogonadism 11 with or without anosmia, 614840 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
614844	NEPHRONOPHTHISIS 14	Joubert syndrome 19, 614844 (3)	Joubert syndrome 19	n	-	-	-	ZNF423	HGNC:16762	Joubert syndrome 19, 614844 (3), Autosomal dominant, Autosomal recessive	Autosomal dominant, Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
614844	NEPHRONOPHTHISIS 14	Nephronophthisis 14, 614844 (3)	Nephronophthisis 14	n	-	-	-	ZNF423	HGNC:16762	Nephronophthisis 14, 614844 (3), Autosomal dominant, Autosomal recessive	Autosomal dominant, Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
614845	NEPHRONOPHTHISIS 15	Nephronophthisis 15, 614845 (3)	Nephronophthisis 15	n	-	-	-	CEP164	HGNC:29182	Nephronophthisis 15, 614845 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
614852	MICROCEPHALY 9, PRIMARY, AUTOSOMAL RECESSIVE	Microcephaly 9, primary, autosomal recessive, 614852 (3)	Microcephaly 9, primary, autosomal recessive	n	-	-	-	CEP152	HGNC:29298	Microcephaly 9, primary, autosomal recessive, 614852 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
614856	OSTEOGENESIS IMPERFECTA, TYPE XIII	Osteogenesis imperfecta, type XIII, 614856 (3)	Osteogenesis imperfecta, type XIII	y	OSTEOGENESIS IMPERFECTA, TYPE XIII; OI13	Description	lethal	BMP1	HGNC:1067	Osteogenesis imperfecta, type XIII, 614856 (3), Autosomal recessive	Autosomal recessive	n	n	-	-	-	-	ambiguous	ambiguous	ambiguous	-	-	-
614857	METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, cblJ TYPE	Methylmalonic aciduria and homocystinuria, cblJ type, 614857 (3)	Methylmalonic aciduria and homocystinuria, cblJ type	n	-	-	-	ABCD4	HGNC:68	Methylmalonic aciduria and homocystinuria, cblJ type, 614857 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
614858	HYPOGONADOTROPIC HYPOGONADISM 14 WITH OR WITHOUT ANOSMIA	Hypogonadotropic hypogonadism 14 with or without anosmia, 614858 (3)	Hypogonadotropic hypogonadism 14 with or without anosmia	n	-	-	-	WDR11	HGNC:13831	Hypogonadotropic hypogonadism 14 with or without anosmia, 614858 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
614859	PEROXISOME BIOGENESIS DISORDER 3A (ZELLWEGER)	Peroxisome biogenesis disorder 3A (Zellweger), 614859 (3)	Peroxisome biogenesis disorder 3A (Zellweger)	y	PEROXISOME BIOGENESIS DISORDER 3A (ZELLWEGER); PBD3A	Description|Clinical Features|Phenotype	die|died	PEX12	HGNC:8854	Peroxisome biogenesis disorder 3A (Zellweger), 614859 (3), Autosomal recessive	Autosomal recessive	n	y	[Konkol'ova et al. (2015) described a patient with Zellweger syndrome, the son of healthy, nonconsanguineous Caucasian parents... The patient died at age 23 days of cardiorespiratory failure]	L2	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L2	L2	pre-infant-lethal
614862	PEROXISOME BIOGENESIS DISORDER 4A (ZELLWEGER)	Peroxisome biogenesis disorder 4A (Zellweger), 614862 (3)	Peroxisome biogenesis disorder 4A (Zellweger)	y	PEROXISOME BIOGENESIS DISORDER 4A (ZELLWEGER); PBD4A	Description|Clinical Features|Clinical Synopsis	die|died|death|deaths	PEX6	HGNC:8859	Peroxisome biogenesis disorder 4A (Zellweger), 614862 (3), Autosomal recessive	Autosomal recessive	n	y	[Respiratory failure (leading to death at 7 months)]	L3	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L3|L4	L3	pre-infant-lethal
614863	PEROXISOME BIOGENESIS DISORDER 4B	Peroxisome biogenesis disorder 4B, 614863 (3)	Peroxisome biogenesis disorder 4B	y	PEROXISOME BIOGENESIS DISORDER 4B; PBD4B	Clinical Features|Clinical Synopsis	died|death|deaths	PEX6	HGNC:8859	Peroxisome biogenesis disorder 4B, 614863 (3), Autosomal dominant, Autosomal recessive	Autosomal dominant, Autosomal recessive	y	y	[Progressive disease leading to death at age 4]	L4	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L3|L4	L3	pre-infant-lethal
614866	PEROXISOME BIOGENESIS DISORDER 5A (ZELLWEGER)	Peroxisome biogenesis disorder 5A (Zellweger), 614866 (3)	Peroxisome biogenesis disorder 5A (Zellweger)	y	PEROXISOME BIOGENESIS DISORDER 5A (ZELLWEGER); PBD5A	Description|Clinical Synopsis	die|death|deaths	PEX2	HGNC:9717	Peroxisome biogenesis disorder 5A (Zellweger), 614866 (3), Autosomal recessive	Autosomal recessive	n	y	[The peroxisomal biogenesis disorder (PBD) Zellweger syndrome (ZS) is an autosomal recessive multiple congenital anomaly syndrome. Affected children present in the newborn period with profound hypotonia, seizures, and inability to feed. Characteristic craniofacial anomalies, eye abnormalities, neuronal migration defects, hepatomegaly, and chondrodysplasia punctata are present. Children with this condition do not show any significant development and usually die in the first year of life (summary by Steinberg et al., 2006)]	L3	y	-	lethal	lethal	lethal	L3|L4	L3	pre-infant-lethal
614867	PEROXISOME BIOGENESIS DISORDER 5B	Peroxisome biogenesis disorder 5B, 614867 (3)	Peroxisome biogenesis disorder 5B	y	PEROXISOME BIOGENESIS DISORDER 5B; PBD5B	Clinical Features	died	PEX2	HGNC:9717	Peroxisome biogenesis disorder 5B, 614867 (3), Autosomal recessive	Autosomal recessive	n	y	[Shimozawa et al. (1999) studied a Welsh female with IRD who presented at the age of 1 year with delayed milestones and joint laxity. Later, retinitis pigmentosa manifested and biochemical investigation showed accumulation of very long chain fatty acids (VLCFAs) and phytanic acid and an abnormal bile acid profile. The activities of dihydroxyacetone phosphate acyltransferase (DHAP-AT) were reduced in platelets and fibroblasts. The patient died at 3 years of age following an episode of bronchiolitis]	L4	y	-	lethal	lethal	lethal	L3|L4	L3	pre-infant-lethal
614868	IMMUNODEFICIENCY 110 WITH LYMPHOPROLIFERATION	T-cell immunodeficiency, recurrent infections, autoimmunity, and cardiac malformations, 614868 (3)	T-cell immunodeficiency, recurrent infections, autoimmunity, and cardiac malformations	y	IMMUNODEFICIENCY 110 WITH LYMPHOPROLIFERATION; IMD110	Clinical Features	died	STK4	HGNC:11408	T-cell immunodeficiency, recurrent infections, autoimmunity, and cardiac malformations, 614868 (3), Autosomal recessive	Autosomal recessive	y	y	[Abdollahpour et al. (2012) reported 3 patients, a brother and sister and their niece, from a consanguineous Iranian family who presented with a primary immunodeficiency resulting in bacterial and viral infections, mucocutaneous candidiasis, cutaneous warts, and recurrent skin abscesses. Two sibs of the brother and sister died in their first year of life due to septicemia]	L3	n	y	lethal	lethal	lethal	L3	L3	pre-infant-lethal
614869	USHER SYNDROME, TYPE IJ	Usher syndrome, type IJ, 614869 (3)	Usher syndrome, type IJ	n	-	-	-	CIB2	HGNC:24579	Usher syndrome, type IJ, 614869 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
614870	PEROXISOME BIOGENESIS DISORDER 6A (ZELLWEGER)	Peroxisome biogenesis disorder 6A (Zellweger), 614870 (3)	Peroxisome biogenesis disorder 6A (Zellweger)	y	PEROXISOME BIOGENESIS DISORDER 6A (ZELLWEGER); PBD6A	Description|Clinical Features|Clinical Synopsis	die|died|death|deaths	PEX10	HGNC:8851	Peroxisome biogenesis disorder 6A (Zellweger), 614870 (3), Autosomal recessive	Autosomal recessive	n	y	[Death in neonatal period or early infancy / Krause et al. (2006) described a Turkish male infant (PBD-HR7) with rapidly progressive Zellweger syndrome. The infant had hypotonia, seizures, renal cysts, and dysmorphic features, including a broad nasal bridge, external ear deformity, and 'sickle foot.' He died at 4 days of age]	L2	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L2	L2	pre-infant-lethal
614871	PEROXISOME BIOGENESIS DISORDER 6B	Peroxisome biogenesis disorder 6B, 614871 (3)	Peroxisome biogenesis disorder 6B	n	-	-	-	PEX10	HGNC:8851	Peroxisome biogenesis disorder 6B, 614871 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L2	L2	pre-infant-lethal
614872	PEROXISOME BIOGENESIS DISORDER 7A (ZELLWEGER)	Peroxisome biogenesis disorder 7A (Zellweger), 614872 (3)	Peroxisome biogenesis disorder 7A (Zellweger)	y	PEROXISOME BIOGENESIS DISORDER 7A (ZELLWEGER); PBD7A	Description|Clinical Features	die|died	PEX26	HGNC:22965	Peroxisome biogenesis disorder 7A (Zellweger), 614872 (3), Autosomal recessive	Autosomal recessive	y	y	[Children with this condition do not show any significant development and usually die in the first year of life (summary by Steinberg et al., 2006)]	L3	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L3	L3	pre-infant-lethal
614873	PEROXISOME BIOGENESIS DISORDER 7B	Peroxisome biogenesis disorder 7B, 614873 (3)	Peroxisome biogenesis disorder 7B	n	-	-	-	PEX26	HGNC:22965	Peroxisome biogenesis disorder 7B, 614873 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L3	L3	pre-infant-lethal
614874	CILIARY DYSKINESIA, PRIMARY, 18	Ciliary dyskinesia, primary, 18, 614874 (3)	Ciliary dyskinesia, primary, 18	n	-	-	-	DNAAF5	HGNC:26013	Ciliary dyskinesia, primary, 18, 614874 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
614876	PEROXISOME BIOGENESIS DISORDER 8A (ZELLWEGER)	Peroxisome biogenesis disorder 8A (Zellweger), 614876 (3)	Peroxisome biogenesis disorder 8A (Zellweger)	y	PEROXISOME BIOGENESIS DISORDER 8A (ZELLWEGER); PBD8A	Description	die	PEX16	HGNC:8857	Peroxisome biogenesis disorder 8A (Zellweger), 614876 (3), Autosomal recessive	Autosomal recessive	n	y	[Zellweger syndrome (ZS) is an autosomal recessive multiple congenital anomaly syndrome resulting from disordered peroxisome biogenesis. Affected children present in the newborn period with profound hypotonia, seizures, and inability to feed. Characteristic craniofacial anomalies, eye abnormalities, neuronal migration defects, hepatomegaly, and chondrodysplasia punctata are present. Children with this condition do not show any significant development and usually die in the first year of life (summary by Steinberg et al., 2006)]	L3	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L3	L3	pre-infant-lethal
614877	PEROXISOME BIOGENESIS DISORDER 8B	Peroxisome biogenesis disorder 8B, 614877 (3)	Peroxisome biogenesis disorder 8B	n	-	-	-	PEX16	HGNC:8857	Peroxisome biogenesis disorder 8B, 614877 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L3	L3	pre-infant-lethal
614878	AUTOINFLAMMATION, ANTIBODY DEFICIENCY, AND IMMUNE DYSREGULATION	Autoinflammation, antibody deficiency, and immune dysregulation syndrome, 614878 (3)	Autoinflammation, antibody deficiency, and immune dysregulation syndrome	n	-	-	-	PLCG2	HGNC:9066	Autoinflammation, antibody deficiency, and immune dysregulation syndrome, 614878 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
614879	PEROXISOME BIOGENESIS DISORDER 9B	Peroxisome biogenesis disorder 9B, 614879 (3)	Peroxisome biogenesis disorder 9B	y	PEROXISOME BIOGENESIS DISORDER 9B; PBD9B	Clinical Features	died	PEX7	HGNC:8860	Peroxisome biogenesis disorder 9B, 614879 (3), Autosomal recessive	Autosomal recessive	n	y	[Van den Brink et al. (2003) reported 2 probands with Refsum disease. The first proband originated from a family comprising 8 sibs and was 1 of 3 affected...One other male sib died of supposed poliomyelitis with symptoms of weakness and ataxia at age 12 years]	L5	n	y	lethal	lethal	lethal	L2|L5	L2	pre-infant-lethal
614881	NEURONOPATHY, DISTAL HEREDITARY MOTOR, AUTOSOMAL RECESSIVE 5	Neuronopathy, distal hereditary motor, autosomal recessive 5, 614881 (3)	Neuronopathy, distal hereditary motor, autosomal recessive 5	n	-	-	-	DNAJB2	HGNC:5228	Neuronopathy, distal hereditary motor, autosomal recessive 5, 614881 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
614882	PEROXISOME BIOGENESIS DISORDER 10A (ZELLWEGER)	Peroxisome biogenesis disorder 10A (Zellweger), 614882 (3)	Peroxisome biogenesis disorder 10A (Zellweger)	y	PEROXISOME BIOGENESIS DISORDER 10A (ZELLWEGER); PBD10A	Description|Clinical Features	die|death|deaths|died	PEX3	HGNC:8858	Peroxisome biogenesis disorder 10A (Zellweger), 614882 (3), Autosomal recessive	Autosomal recessive	n	y	[Muntau et al. (2000) reported 2 unrelated patients with Zellweger syndrome of complementation group G. The patients were male infants from unrelated consanguineous Dutch and Italian families. One showed marked muscular hypotonia at birth. Dysmorphic features included hypertelorism, prominent epicanthic folds, and a high, broad forehead with round face. Seizures developed on day 1 but were controlled with treatment. His condition deteriorated rapidly, with death at age 4 months. The other patient was cyanotic and markedly hypotonic at birth with absent deep tendon reflexes. He had a prominent midface and an antimongoloid slant of the palpebral fissures, ocular hypertelorism, small low-set ears, a prominent nose, and a high-arched palate. The patient died at age 19 days. A brother had been similarly affected and died at age 15 days]	L2	y	y	lethal	lethal	lethal	L2	L2	pre-infant-lethal
614883	PEROXISOME BIOGENESIS DISORDER 11A (ZELLWEGER)	Peroxisome biogenesis disorder 11A (Zellweger), 614883 (3)	Peroxisome biogenesis disorder 11A (Zellweger)	y	PEROXISOME BIOGENESIS DISORDER 11A (ZELLWEGER); PBD11A	Description|Clinical Features	die|died	PEX13	HGNC:8855	Peroxisome biogenesis disorder 11A (Zellweger), 614883 (3), Autosomal recessive	Autosomal recessive	n	y	[Al-Dirbashi et al. (2009) studied 2 Saudi patients, children of consanguineous parents, with Zellweger syndrome who were identified in the neonatal intensive care unit (NICU). The first patient was admitted immediately after birth with severe hypotonia. He had large anterior fontanel and high forehead. Magnetic resonance imaging (MRI) of the brain showed polymicrogyria, lissencephaly, and poor myelination. Consistent with the MRI findings, his electroencephalogram (EEG) revealed cortical dysfunction and seizure activity. He died at 6 weeks of age with cardiopulmonary arrest]	L3	y	-	lethal	lethal	lethal	L3|L4	L3	pre-infant-lethal
614885	PEROXISOME BIOGENESIS DISORDER 11B	Peroxisome biogenesis disorder 11B, 614885 (3)	Peroxisome biogenesis disorder 11B	y	PEROXISOME BIOGENESIS DISORDER 11B; PBD11B	Clinical Features	died	PEX13	HGNC:8855	Peroxisome biogenesis disorder 11B, 614885 (3), Autosomal recessive	Autosomal recessive	n	y	[Krause et al. (2006) reported a Turkish girl with a progressive clinical course characterized by hypotonia and cataracts. She had caudal neuropore and inverted nipples, but none of the dysmorphic features seen in classic Zellweger syndrome. She died at 31 months of age]	L4	y	-	lethal	lethal	lethal	L3|L4	L3	pre-infant-lethal
614886	PEROXISOME BIOGENESIS DISORDER 12A (ZELLWEGER)	Peroxisome biogenesis disorder 12A (Zellweger), 614886 (3)	Peroxisome biogenesis disorder 12A (Zellweger)	y	PEROXISOME BIOGENESIS DISORDER 12A (ZELLWEGER); PBD12A	Description|Clinical Features|Clinical Synopsis	die|died|death|deaths	PEX19	HGNC:9713	Peroxisome biogenesis disorder 12A (Zellweger), 614886 (3), Autosomal recessive	Autosomal recessive	n	y	[Zellweger syndrome (ZS) is an autosomal recessive multiple congenital anomaly syndrome resulting from disordered peroxisome biogenesis. Affected children present in the newborn period with profound hypotonia, seizures, and inability to feed. Characteristic craniofacial anomalies, eye abnormalities, neuronal migration defects, hepatomegaly, and chondrodysplasia punctata are present. Children with this condition do not show any significant development and usually die in the first year of life (summary by Steinberg et al., 2006)]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
614887	PEROXISOME BIOGENESIS DISORDER 13A (ZELLWEGER)	Peroxisome biogenesis disorder 13A (Zellweger), 614887 (3)	Peroxisome biogenesis disorder 13A (Zellweger)	y	PEROXISOME BIOGENESIS DISORDER 13A (ZELLWEGER); PBD13A	Description|Clinical Features	die|died	PEX14	HGNC:8856	Peroxisome biogenesis disorder 13A (Zellweger), 614887 (3), Autosomal recessive	Autosomal recessive	n	y	[Shimozawa et al. (2004) studied a patient with Zellweger syndrome. At birth the patient showed typical craniofacial dysmorphia of Zellweger syndrome, including large open fontanels, high forehead, flat occiput, low/broad nasal bridge, and micrognathia, as well as neurologic abnormalities including hypotonia. Plasma analysis showed elevated very long chain fatty acids (VLCFA) and di- and trihydroxycholestanoic acid, and a normal phytanic acid level. Erythrocyte plasmalogens were undetectable. The patient died at 10 days of age]	L2	y	-	lethal	lethal	lethal	L2	L2	pre-infant-lethal
614889	IMMUNODEFICIENCY 28	Immunodeficiency 28, mycobacteriosis, 614889 (3)	Immunodeficiency 28, mycobacteriosis	y	IMMUNODEFICIENCY 28; IMD28	Description|Clinical Features|Phenotype	fatal|died	IFNGR2	HGNC:5440	Immunodeficiency 28, mycobacteriosis, 614889 (3), Autosomal recessive	Autosomal recessive	y	y	[Oleaga-Quintas et al. (2018) reported 3 patients with mycobacterial disease, including 2 sibs from a consanguineous Turkish family and a patient from a consanguineous Indian family... At age 11 months, he developed inguinal and axillary lymphadenitis and hepatosplenomegaly. M. chelonei was cultured from a lymph node. He died at the age of 5 years from persistent disseminated disease]	L4	y	-	lethal	lethal	lethal	L4	L4	post-infant-lethal
614890	IMMUNODEFICIENCY 29	Immunodeficiency 29, mycobacteriosis, 614890 (3)	Immunodeficiency 29, mycobacteriosis	y	IMMUNODEFICIENCY 29; IMD29	Clinical Features	died	IL12B	HGNC:5970	Immunodeficiency 29, mycobacteriosis, 614890 (3), Autosomal recessive	Autosomal recessive	n	y	[Picard et al. (2002) reported 12 additional patients with IL12B deficiency from 5 additional kindreds and reviewed the phenotype of all patients. Among 13 patients with IL12 deficiency, including the patient originally reported by Altare et al. (1998), 1 child had salmonellosis only and 12 suffered from clinical disease due to BCG or environmental nontuberculous mycobacteria. One patient also had clinical disease caused by virulent Mycobacterium tuberculosis, 5 patients had clinical disease caused by Salmonella serotypes, and 1 patient had clinical disease caused by Nocardia asteroides. The clinical outcome varied from case to case. Five patients, aged 2 to 11 years, died of overwhelming infection, whereas 8 patients, aged 3 to 12 years, were still in good health and not taking antibiotics at the time of report]	L4	y	-	lethal	lethal	lethal	L4	L4	post-infant-lethal
614891	IMMUNODEFICIENCY 30	Immunodeficiency 30, 614891 (3)	Immunodeficiency 30	y	IMMUNODEFICIENCY 30; IMD30	Clinical Features|Phenotype	fatal|lethal	IL12RB1	HGNC:5971	Immunodeficiency 30, 614891 (3), Autosomal recessive	Autosomal recessive	n	y	[Fieschi et al. (2003) identified 41 patients in 29 kindreds from 17 countries in Africa, America, Europe, and Asia with complete IL12RB1 surface expression deficiency. Opportunistic childhood infections with weakly virulent Salmonella and Mycobacteria were observed in 34 patients, but 3 patients had clinical tuberculosis, including 1 with salmonellosis. Salmonellosis, but not the mycobacterial infections, was recurrent. BCG vaccination and disease protected against environmental mycobacteriosis, but not against salmonellosis. BCG disease occurred in only 9 of 27 inoculated children. Fatality before age 8 occurred in 5 patients, 3 due to M. avium in non-BCG-vaccinated children and 2 due to disseminated BCG; the remaining patients were alive and well]	L4	y	-	lethal	lethal	lethal	L4	L4	post-infant-lethal
614892	IMMUNODEFICIENCY 31A	Immunodeficiency 31A, mycobacteriosis, autosomal dominant, 614892 (3)	Immunodeficiency 31A, mycobacteriosis, autosomal dominant	n	-	-	-	STAT1	HGNC:11362	Immunodeficiency 31A, mycobacteriosis, autosomal dominant, 614892 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L3|L4	L3	pre-infant-lethal
614893	IMMUNODEFICIENCY 32A	Immunodeficiency 32A, mycobacteriosis, autosomal dominant, 614893 (3)	Immunodeficiency 32A, mycobacteriosis, autosomal dominant	n	-	-	-	IRF8	HGNC:5358	Immunodeficiency 32A, mycobacteriosis, autosomal dominant, 614893 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L5	L5	post-infant-lethal
614895	CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 4F	Charcot-Marie-Tooth disease, type 4F, 614895 (3)	Charcot-Marie-Tooth disease, type 4F	n	-	-	-	PRX	HGNC:13797	Charcot-Marie-Tooth disease, type 4F, 614895 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	ambiguous|nonlethal	ambiguous	-	-	-
614896	SINOATRIAL NODE DYSFUNCTION AND DEAFNESS	Sinoatrial node dysfunction and deafness, 614896 (3)	Sinoatrial node dysfunction and deafness	n	-	-	-	CACNA1D	HGNC:1391	Sinoatrial node dysfunction and deafness, 614896 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
614898	SPASTIC PARAPLEGIA 53, AUTOSOMAL RECESSIVE	Spastic paraplegia 53, autosomal recessive, 614898 (3)	Spastic paraplegia 53, autosomal recessive	n	-	-	-	VPS37A	HGNC:24928	Spastic paraplegia 53, autosomal recessive, 614898 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
614899	DEAFNESS, AUTOSOMAL RECESSIVE 93	Deafness, autosomal recessive 93, 614899 (3)	Deafness, autosomal recessive 93	n	-	-	-	CABP2	HGNC:1385	Deafness, autosomal recessive 93, 614899 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
614915	LETHAL CONGENITAL CONTRACTURE SYNDROME 4	Lethal congenital contracture syndrome 4, 614915 (3)	Lethal congenital contracture syndrome 4	y	LETHAL CONGENITAL CONTRACTURE SYNDROME 4; LCCS4	Clinical Synopsis	death|deaths|lethal	MYBPC1	HGNC:7549	Lethal congenital contracture syndrome 4, 614915 (3), Autosomal recessive	Autosomal recessive	n	y	[Death due to respiratory insufficiency within minutes to hours after birth]	L2	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L2	L2	pre-infant-lethal
614916	VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 4	Ventricular tachycardia, catecholaminergic polymorphic, 4, 614916 (3)	Ventricular tachycardia, catecholaminergic polymorphic, 4	y	VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 4; CPVT4	Clinical Features|Clinical Synopsis	death|deaths|died	CALM1	HGNC:1442	Ventricular tachycardia, catecholaminergic polymorphic, 4, 614916 (3), Autosomal dominant	Autosomal dominant	n	y	[Sudden death / Nyegaard et al. (2012) studied a large 4-generation Swedish family with a history of ventricular arrhythmias, syncope, and sudden death, predominantly in association with physical exercise or stress... The proband's older sister had 6 children, 4 of whom were affected, including a son who died suddenly at 13 years of age while on a beta-1 adrenergic receptor blocker for syncopal episodes that had started at 2.5 years of age]	L5	y	-	lethal	lethal	lethal	L3|L5	L3	pre-infant-lethal
614920	PEROXISOME BIOGENESIS DISORDER 14B	Peroxisome biogenesis disorder 14B, 614920 (3)	Peroxisome biogenesis disorder 14B	y	PEROXISOME BIOGENESIS DISORDER 14B; PEX14B	Clinical Features	miscarriage|miscarriages	PEX11B	HGNC:8853	Peroxisome biogenesis disorder 14B, 614920 (3), Autosomal recessive	Autosomal recessive	y	y	[Ebberink et al. (2012) described a 26-year-old Dutch man with mild intellectual disability and a normal karyotype who was the fourth child of nonconsanguineous parents and had 2 healthy brothers and 1 healthy sister. The mother had had 3 miscarriages]	L1	n	y	lethal	lethal	lethal	L1	L1	pre-infant-lethal
614921	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE It	Congenital disorder of glycosylation, type It, 614921 (3)	Congenital disorder of glycosylation, type It	y	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE It; CDG1T	Clinical Features	died	PGM1	HGNC:8905	Congenital disorder of glycosylation, type It, 614921 (3), Autosomal recessive	Autosomal recessive	y	y	[Timal et al. (2012) reported 2 unrelated children with congenital disorder of glycosylation type It. One boy was adopted and of Colombian origin. He had cerebral thrombosis and dilated cardiomyopathy, and died at age 8 years]	L4	y	-	lethal	lethal	lethal	L4	L4	post-infant-lethal
614922	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 11	Combined oxidative phosphorylation deficiency 11, 614922 (3)	Combined oxidative phosphorylation deficiency 11	y	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 11; COXPD11	Description|Clinical Features|Clinical Synopsis	died|death|deaths|stillborn	RMND1	HGNC:21176	Combined oxidative phosphorylation deficiency 11, 614922 (3), Autosomal recessive	Autosomal recessive	n	y	[Garcia-Diaz et al. (2012) provided follow-up of the family reported by Ferreiro-Barros et al. (2008) and reported 4 additional affected family members. Three infants presented with severe neonatal encephaloneuromyopathy at birth and showed lethargy, respiratory failure, profound floppiness, hyporeflexia or areflexia, equinus deformities, lactic acidosis, and death in the first year of life, whereas the fifth affected individual was stillborn and did not have skeletal deformities]	L1	y	-	lethal	lethal	lethal	L1	L1	pre-infant-lethal
614923	BRANCHED-CHAIN KETO ACID DEHYDROGENASE KINASE DEFICIENCY	Branched-chain keto acid dehydrogenase kinase deficiency, 614923 (3)	Branched-chain keto acid dehydrogenase kinase deficiency	n	-	-	-	BCKDK	HGNC:16902	Branched-chain keto acid dehydrogenase kinase deficiency, 614923 (3)	-	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
614924	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 12	Combined oxidative phosphorylation deficiency 12, 614924 (3)	Combined oxidative phosphorylation deficiency 12	y	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 12; COXPD12	Clinical Features	death|deaths	EARS2	HGNC:29419	Combined oxidative phosphorylation deficiency 12, 614924 (3), Autosomal recessive	Autosomal recessive	n	y	[Talim et al. (2013) reported a male infant, born of consanguineous parents, with multiple congenital anomalies and multisystem dysfunction resulting in death at age 3 months from bronchopneumonia]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
614926	PERRAULT SYNDROME 2	Perrault syndrome 2, 614926 (3)	Perrault syndrome 2	n	-	-	-	HARS2	HGNC:4817	Perrault syndrome 2, 614926 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
614931	ECTODERMAL DYSPLASIA 9, HAIR/NAIL TYPE	Ectodermal dysplasia 9, hair/nail type, 614931 (3)	Ectodermal dysplasia 9, hair/nail type	n	-	-	-	HOXC13	HGNC:5125	Ectodermal dysplasia 9, hair/nail type, 614931 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
614932	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 13	Combined oxidative phosphorylation deficiency 13, 614932 (3)	Combined oxidative phosphorylation deficiency 13	y	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 13; COXPD13	Clinical Features	died	PNPT1	HGNC:23166	Combined oxidative phosphorylation deficiency 13, 614932 (3), Autosomal recessive	Autosomal recessive	y	y	[Bamborschke et al. (2021) reported a patient who presented at 3 months of age with feeding difficulties, hyperexcitability, and a sterile febrile episode. Brain MRI showed enlarged cerebrospinal fluid spaces, a thin corpus callosum, and abnormal signal in the frontal temporal region that was suspicious for necrosis. She had severe neurodevelopmental regression and secondary microcephaly. At 6 months of age, she developed seizures and had dystonic crises with dyskinesia and opisthotonic posturing. Laboratory testing revealed an increased interferon score, which was consistent with constitutive type I interferon activation. She died at 20 months of age due to cardiorespiratory arrest]	L3	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L3	L3	pre-infant-lethal
614934	DEAFNESS, AUTOSOMAL RECESSIVE 70, WITH OR WITHOUT ADULT-ONSET NEURODEGENERATION	Deafness, autosomal recessive 70, with or without adult-onset neurodegeneration, 614934 (3)	Deafness, autosomal recessive 70, with or without adult-onset neurodegeneration	n	-	-	-	PNPT1	HGNC:23166	Deafness, autosomal recessive 70, with or without adult-onset neurodegeneration, 614934 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L3	L3	pre-infant-lethal
614935	CILIARY DYSKINESIA, PRIMARY, 19	Ciliary dyskinesia, primary, 19, 614935 (3)	Ciliary dyskinesia, primary, 19	n	-	-	-	DNAAF11	HGNC:16725	Ciliary dyskinesia, primary, 19, 614935 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
614940	ECTODERMAL DYSPLASIA 11A, HYPOHIDROTIC/HAIR/TOOTH TYPE, AUTOSOMAL DOMINANT	Ectodermal dysplasia 11A, hypohidrotic/hair/tooth type, autosomal dominant, 614940 (3)	Ectodermal dysplasia 11A, hypohidrotic/hair/tooth type, autosomal dominant	y	ECTODERMAL DYSPLASIA 11A, HYPOHIDROTIC/HAIR/TOOTH TYPE, AUTOSOMAL DOMINANT; ECTD11A	Clinical Synopsis	death|deaths	EDARADD	HGNC:14341	Ectodermal dysplasia 11A, hypohidrotic/hair/tooth type, autosomal dominant, 614940 (3), Autosomal dominant	Autosomal dominant	n	n	-	-	-	-	ambiguous	ambiguous	ambiguous	-	-	-
614941	ECTODERMAL DYSPLASIA 11B, HYPOHIDROTIC/HAIR/TOOTH TYPE, AUTOSOMAL RECESSIVE	Ectodermal dysplasia 11B, hypohidrotic/hair/tooth type, autosomal recessive, 614941 (3)	Ectodermal dysplasia 11B, hypohidrotic/hair/tooth type, autosomal recessive	y	ECTODERMAL DYSPLASIA 11B, HYPOHIDROTIC/HAIR/TOOTH TYPE, AUTOSOMAL RECESSIVE; ECTD11B	Clinical Synopsis	death|deaths	EDARADD	HGNC:14341	Ectodermal dysplasia 11B, hypohidrotic/hair/tooth type, autosomal recessive, 614941 (3), Autosomal recessive	Autosomal recessive	n	n	-	-	-	-	ambiguous	ambiguous	ambiguous	-	-	-
614944	DEAFNESS, AUTOSOMAL RECESSIVE 84B	Deafness, autosomal recessive 84B, 614944 (3)	Deafness, autosomal recessive 84B	n	-	-	-	OTOGL	HGNC:26901	Deafness, autosomal recessive 84B, 614944 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
614945	DEAFNESS, AUTOSOMAL RECESSIVE 18B	Deafness, autosomal recessive 18B, 614945 (3)	Deafness, autosomal recessive 18B	n	-	-	-	OTOG	HGNC:8516	Deafness, autosomal recessive 18B, 614945 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
614946	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 14	Combined oxidative phosphorylation deficiency 14, 614946 (3)	Combined oxidative phosphorylation deficiency 14	y	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 14; COXPD14	Clinical Features|Clinical Synopsis|Phenotype	died|fatal|death|deaths	FARS2	HGNC:21062	Combined oxidative phosphorylation deficiency 14, 614946 (3), Autosomal recessive	Autosomal recessive	n	y	[Elo et al. (2012) reported a Finnish family in which 2 sisters had a fatal infantile mitochondrial encephalopathy. The proband developed treatment-resistant myoclonic seizures on the second day of life. Laboratory studies showed generalized aminoaciduria and increased lactate in the blood and cerebrospinal fluid. Initial brain MRI and EEG were normal, but EEG at 6 weeks showed multifocal spikes and brain MRI at 3 months showed severe central and cortical atrophy with signal increases in the putamina. Liver biopsy showed enlarged hepatocytes, increased glycogen, and iron and copper accumulation, but transaminases were normal. Muscle biopsy showed decreased COX immunostaining and subsarcolemmal glycogen, but no ragged-red fibers. Complex I activity in muscle was increased compared to control values, but succinate dehydrogenase was 50% and COX was 16% of control. She had microcephaly and slightly coarse retinal pigmentation, but normal optic nerve. She had no psychomotor development, and died at age 8 months]	L3	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L3	L3	pre-infant-lethal
614947	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 15	Combined oxidative phosphorylation deficiency 15, 614947 (3)	Combined oxidative phosphorylation deficiency 15	y	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 15; COXPD15	Clinical Features	died	MTFMT	HGNC:29666	Combined oxidative phosphorylation deficiency 15, 614947 (3), Autosomal recessive	Autosomal recessive	n	y	[Haack et al. (2014) reported 9 patients from 8 unrelated families with COXPD15. The phenotype was variable in severity, but all had an encephalomyopathic phenotype with onset in infancy or early childhood of delayed psychomotor development and subsequent retardation, gait ataxia, and hypotonia... Two patients died in early childhood, some showed episodic decompensation, and others were able to attend special school or do supervised shelter work]	L4	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L4	L4	post-infant-lethal
614959	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 14	Developmental and epileptic encephalopathy 14, 614959 (3)	Developmental and epileptic encephalopathy 14	y	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 14; DEE14	Clinical Features	died	KCNT1	HGNC:18865	Developmental and epileptic encephalopathy 14, 614959 (3), Autosomal dominant	Autosomal dominant	y	y	[Coppola et al. (1995) first delineated MMPSI as a clinical entity. Fourteen infants presented at a mean age of 3 months with nearly continuous multifocal seizures involving both cerebral hemispheres... The patients showed developmental regression and became quadriplegic with severe axial hypotonia. Three patients died at ages 7 months, 7 years, and 8 years]	L3	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L3	L3	pre-infant-lethal
614961	PONTOCEREBELLAR HYPOPLASIA, TYPE 8	Pontocerebellar hypoplasia, type 8, 614961 (3)	Pontocerebellar hypoplasia, type 8	n	-	-	-	CHMP1A	HGNC:8740	Pontocerebellar hypoplasia, type 8, 614961 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
614962	LEPTIN DEFICIENCY OR DYSFUNCTION	Obesity, morbid, due to leptin deficiency, 614962 (3)	Obesity, morbid, due to leptin deficiency	y	LEPTIN DEFICIENCY OR DYSFUNCTION; LEPD	Clinical Features	died	LEP	HGNC:6553	Obesity, morbid, due to leptin deficiency, 614962 (3), Autosomal recessive	Autosomal recessive	y	y	[Ozata et al. (1999) noted that the 19 normal-weight individuals in this family were alive, whereas 7 of 11 obese individuals had died in childhood after infections, suggesting that the LEP mutation severely impairs key biologic functions during childhood with negative impact on survival]	L4	y	-	lethal	lethal	lethal	L4	L4	post-infant-lethal
614963	LEPTIN RECEPTOR DEFICIENCY	Obesity, morbid, due to leptin receptor deficiency, 614963 (3)	Obesity, morbid, due to leptin receptor deficiency	n	-	-	-	LEPR	HGNC:6554	Obesity, morbid, due to leptin receptor deficiency, 614963 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
614969	PONTOCEREBELLAR HYPOPLASIA, TYPE 7	Pontocerebellar hypoplasia, type 7, 614969 (3)	Pontocerebellar hypoplasia, type 7	y	PONTOCEREBELLAR HYPOPLASIA, TYPE 7; PCH7	Clinical Features|Clinical Synopsis	died|death|deaths	TOE1	HGNC:15954	Pontocerebellar hypoplasia, type 7, 614969 (3), Autosomal recessive	Autosomal recessive	n	y	[Anderson et al. (2011) reported a male infant, born of unrelated Caucasian parents, with primary hypogonadism and pontocerebellar hypoplasia... He showed progressive deterioration in respiratory drive and died at age 5.5 months]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
614970	JOUBERT SYNDROME 20	Joubert syndrome 20, 614970 (3)	Joubert syndrome 20	n	-	-	-	TMEM231	HGNC:37234	Joubert syndrome 20, 614970 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L1	L1	pre-infant-lethal
614972	CHOLESTASIS, INTRAHEPATIC, OF PREGNANCY 3	Cholestasis, intrahepatic, of pregnancy, 3, 614972 (3)	Cholestasis, intrahepatic, of pregnancy, 3	y	CHOLESTASIS, INTRAHEPATIC, OF PREGNANCY 3; ICP3	Description|Clinical Features|Clinical Synopsis	death|deaths	ABCB4	HGNC:45	Cholestasis, intrahepatic, of pregnancy, 3, 614972 (3), Autosomal dominant, Autosomal recessive	Autosomal dominant, Autosomal recessive	n	n	-	-	-	-	ambiguous	ambiguous|nonlethal	ambiguous	-	-	-
614974	FOCAL FACIAL DERMAL DYSPLASIA 4	Focal facial dermal dysplasia 4, 614974 (3)	Focal facial dermal dysplasia 4	n	-	-	-	CYP26C1	HGNC:20577	Focal facial dermal dysplasia 4, 614974 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
614976	CARPENTER SYNDROME 2	Carpenter syndrome 2, 614976 (3)	Carpenter syndrome 2	n	-	-	-	MEGF8	HGNC:3233	Carpenter syndrome 2, 614976 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
614979	RETINAL DYSTROPHY, OPTIC NERVE EDEMA, SPLENOMEGALY, ANHIDROSIS, AND MIGRAINE HEADACHE SYNDROME	ROSAH syndrome, 614979 (3)	ROSAH syndrome	n	-	-	-	ALPK1	HGNC:20917	ROSAH syndrome, 614979 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
614980	CONGENITAL HEART DEFECTS, MULTIPLE TYPES, 2	Congenital heart defects, nonsyndromic, 2, 614980 (3)	Congenital heart defects, nonsyndromic, 2	y	CONGENITAL HEART DEFECTS, MULTIPLE TYPES, 2; CHTD2	Clinical Features	death|deaths|died|stillbirth|stillbirths	TAB2	HGNC:17075	Congenital heart defects, nonsyndromic, 2, 614980 (3), Autosomal dominant	Autosomal dominant	y	y	[Chen et al. (2020) described a large Chinese family in which 8 members over 3 generations had congenital heart disease, primarily valvular defects. Affected individuals reported tachypnea, shortness of breath, and fatigue. The proband (II:5) had mild aortic stenosis as well as mild mitral, tricuspid, and aortic valve regurgitation. Atrial septal aneurysms were detected in her 3 affected sisters (II:1, II:7, and II:9); other abnormalities included mild mitral valve prolapse with mitral and pulmonic regurgitation in 1 sister (II:7), and left atrial and ventricular dilatation in another (II:9). One sister (II:7) also had a 3-year-old son (III:11) who was diagnosed with mild left ventricular and right atrial dilatation as well as mild mitral valve prolapse with regurgitation. The 4 sisters' mother had died in her late 50s due to sudden cardiac arrhythmia. The proband had a daughter with biventricular dilatation who experienced sudden cardiac death at age 2 years / Weiss et al. (2015) reported a 3-generation family in which 4 individuals had congenital heart defects. The proband was a female infant who was noted at birth to have tetralogy of Fallot, short-segment pulmonary atresia, large malalignment ventricular septal defect, and small atrial septal defect. The mitral and tricuspid valves were both prolapsed, with thickened and myxomatous leaflets. The proband's 32-year-old mother was diagnosed at age 2 years with bicuspid aortic valve and ventricular septal defect. Echocardiogram in adulthood also showed mild aortic valve stenosis and mildly prolapsing myxomatous mitral and tricuspid valves. The 66-year-old maternal grandmother was diagnosed at age 13 years with mitral regurgitation due to a myxomatous and prolapsed valve, for which she underwent valve replacement at age 22. Echocardiography later showed a myxomatous and prolapsed tricuspid valve, and she also had atrial fibrillation. Family history revealed that the grandmother's first pregnancy resulted in a male stillbirth; autopsy showed bicuspid aortic valve and aortic stenosis, as well as hydrops fetalis / Thienpont et al. (2010) described 2 patients with multiple types of congenital heart defects who were found to have a mutation in the TAB2 gene. One patient was a woman with left ventricular outflow tract obstruction, subaortic stenosis due to a fibromuscular shelf, residual aortic regurgitation, and atrial fibrillation; she died from heart failure at 61 years of age]	L1	y	y	lethal	lethal	lethal	L1	L1	pre-infant-lethal
615005	EPILEPSY, NOCTURNAL FRONTAL LOBE, 5	Epilepsy nocturnal frontal lobe, 5, 615005 (3)	Epilepsy nocturnal frontal lobe, 5	n	-	-	-	KCNT1	HGNC:18865	Epilepsy nocturnal frontal lobe, 5, 615005 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L3	L3	pre-infant-lethal
615006	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 15	Developmental and epileptic encephalopathy 15, 615006 (3)	Developmental and epileptic encephalopathy 15	n	-	-	-	ST3GAL3	HGNC:10866	Developmental and epileptic encephalopathy 15, 615006 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
615007	BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 4	Basal ganglia calcification, idiopathic, 4, 615007 (3)	Basal ganglia calcification, idiopathic, 4	y	BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 4; IBGC4	Clinical Features	died	PDGFRB	HGNC:8804	Basal ganglia calcification, idiopathic, 4, 615007 (3), Autosomal dominant	Autosomal dominant	n	y	Nicolas et al. (2013) reported a large 3-generation French family in which multiple members had basal ganglia calcifications apparent on brain imaging. ...One patient had severe personality disorder, nystagmus, and suicide attempts, and died at age 34 years]	L6	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L3|L6	L3	pre-infant-lethal
615008	NEPHROTIC SYNDROME, TYPE 7	Nephrotic syndrome, type 7, 615008 (3)	Nephrotic syndrome, type 7	y	NEPHROTIC SYNDROME, TYPE 7; NPHS7	Clinical Features	died	DGKE	HGNC:2852	Nephrotic syndrome, type 7, 615008 (3), Autosomal recessive	Autosomal recessive	n	n	-	-	-	-	ambiguous	ambiguous	ambiguous	-	-	-
615009	SCHUURS-HOEIJMAKERS SYNDROME	Schuurs-Hoeijmakers syndrome, 615009 (3)	Schuurs-Hoeijmakers syndrome	n	-	-	-	PACS1	HGNC:30032	Schuurs-Hoeijmakers syndrome, 615009 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
615010	AICARDI-GOUTIERES SYNDROME 6	Aicardi-Goutieres syndrome 6, 615010 (3)	Aicardi-Goutieres syndrome 6	n	-	-	-	ADAR	HGNC:225	Aicardi-Goutieres syndrome 6, 615010 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
615018	BLOOD GROUP, SID SYSTEM	Sd(a) polyagglutination syndrome, 615018 (3)	Sd(a) polyagglutination syndrome	n	-	-	-	B4GALNT2	HGNC:24136	Sd(a) polyagglutination syndrome, 615018 (3)	-	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
615023	ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 9	Ichthyosis, congenital, autosomal recessive 9, 615023 (3)	Ichthyosis, congenital, autosomal recessive 9	n	-	-	-	CERS3	HGNC:23752	Ichthyosis, congenital, autosomal recessive 9, 615023 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
615024	ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 10	Ichthyosis, congenital, autosomal recessive 10, 615024 (3)	Ichthyosis, congenital, autosomal recessive 10	n	-	-	-	PNPLA1	HGNC:21246	Ichthyosis, congenital, autosomal recessive 10, 615024 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
615026	RIBOFLAVIN DEFICIENCY	Riboflavin deficiency, 615026 (3)	Riboflavin deficiency	n	-	-	-	SLC52A1	HGNC:30225	Riboflavin deficiency, 615026 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
615028	EPIDERMOLYSIS BULLOSA SIMPLEX 4, LOCALIZED OR GENERALIZED INTERMEDIATE, AUTOSOMAL RECESSIVE	Epidermolysis bullosa simplex 4, localized or generalized intermediate, autosomal recessive, 615028 (3)	Epidermolysis bullosa simplex 4, localized or generalized intermediate, autosomal recessive	n	-	-	-	EXPH5	HGNC:30578	Epidermolysis bullosa simplex 4, localized or generalized intermediate, autosomal recessive, 615028 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
615030	SPASTIC PARAPLEGIA 56, AUTOSOMAL RECESSIVE, WITH OR WITHOUT PSEUDOXANTHOMA ELASTICUM	Spastic paraplegia 56, autosomal recessive, 615030 (3)	Spastic paraplegia 56, autosomal recessive	n	-	-	-	CYP2U1	HGNC:20582	Spastic paraplegia 56, autosomal recessive, 615030 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
615031	NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE IX, WITH DEVELOPMENTAL DELAY	Neuropathy, hereditary sensory and autonomic, type IX, with developmental delay, 615031 (3)	Neuropathy, hereditary sensory and autonomic, type IX, with developmental delay	y	NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE IX, WITH DEVELOPMENTAL DELAY; HSAN9	Clinical Features|Clinical Synopsis	died|fatal	TECPR2	HGNC:19957	Neuropathy, hereditary sensory and autonomic, type IX, with developmental delay, 615031 (3), Autosomal recessive	Autosomal recessive	y	y	[Oz-Levi et al. (2012) reported 5 individuals from 3 apparently unrelated Jewish Bukharian families with a disorder that the authors designated spastic paraplegia-49 (SPG49)... Four patients had episodes of decreased alertness, aggravation of hypotonia, and inefficient respiration requiring mechanical ventilation. One patient died at age 5.5 years from aspiration.]	L4	y	-	lethal	lethal	lethal	L4	L4	post-infant-lethal
615032	INTELLECTUAL DEVELOPMENTAL DISORDER WITH AUTISM AND MACROCEPHALY	Intellectual developmental disorder with autism and macrocephaly, 615032 (3)	Intellectual developmental disorder with autism and macrocephaly	n	-	-	-	CHD8	HGNC:20153	Intellectual developmental disorder with autism and macrocephaly, 615032 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
615033	SPASTIC PARAPLEGIA 54, AUTOSOMAL RECESSIVE	Spastic paraplegia 54, autosomal recessive, 615033 (3)	Spastic paraplegia 54, autosomal recessive	n	-	-	-	DDHD2	HGNC:29106	Spastic paraplegia 54, autosomal recessive, 615033 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
615034	DYSTONIA 24	Dystonia 24, 615034 (3)	Dystonia 24	n	-	-	-	ANO3	HGNC:14004	Dystonia 24, 615034 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
615035	SPASTIC PARAPLEGIA 55, AUTOSOMAL RECESSIVE	Spastic paraplegia 55, autosomal recessive, 615035 (3)	Spastic paraplegia 55, autosomal recessive	n	-	-	-	MTRFR	HGNC:26784	Spastic paraplegia 55, autosomal recessive, 615035 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L4	L4	post-infant-lethal
615041	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 10	Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 10, 615041 (3)	Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 10	y	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 10; MDDGA10	Description|Clinical Features|Clinical Synopsis|Phenotype	death|deaths|died	RXYLT1	HGNC:13530	Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 10, 615041 (3), Autosomal recessive	Autosomal recessive	n	y	[Death in utero]	L1	y	-	lethal	lethal	lethal	L1	L1	pre-infant-lethal
615042	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Iu	Congenital disorder of glycosylation, type Iu, 615042 (3)	Congenital disorder of glycosylation, type Iu	y	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Iu; CDG1U	Clinical Features|Clinical Synopsis	death|deaths|died	DPM2	HGNC:3006	Congenital disorder of glycosylation, type Iu, 615042 (3), Autosomal recessive	Autosomal recessive	y	y	[Barone et al. (2012) reported 3 patients from 2 unrelated families with a severe multisystem and neurologic phenotype resulting in early death. Two brothers, born of consanguineous Sicilian parents, had originally been reported by Messina et al. (2009). At birth, both boys showed severe hypotonia, myopathic facies, and dysmorphic features. One had micrognathia, malocclusion, and strabismus. Both had severe congenital contractures of the joints and scoliosis. Onset of severe focal, generalized, or myoclonic seizures began between 3 and 5 months of age. Both had profoundly delayed psychomotor development without visual tracking, head control, or speech. Microcephaly was also present, and brain MRI of 1 showed cerebellar hypoplasia. The boys died of respiratory infections at ages 16 and 7 months, respectively]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
615048	SPINAL MUSCULAR ATROPHY, JOKELA TYPE	Spinal muscular atrophy, Jokela type, 615048 (3)	Spinal muscular atrophy, Jokela type	n	-	-	-	CHCHD10	HGNC:15559	Spinal muscular atrophy, Jokela type, 615048 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L6	L6	post-infant-lethal
615058	NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1F	Night blindness, congenital stationary (complete), 1F, autosomal recessive, 615058 (3)	Night blindness, congenital stationary (complete), 1F, autosomal recessive	n	-	-	-	LRIT3	HGNC:24783	Night blindness, congenital stationary (complete), 1F, autosomal recessive, 615058 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
615059	HYPOTRICHOSIS 11	Hypotrichosis 11, 615059 (3)	Hypotrichosis 11	n	-	-	-	SNRPE	HGNC:11161	Hypotrichosis 11, 615059 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
615065	ARTHROGRYPOSIS, DISTAL, TYPE 5D	Arthrogryposis, distal, type 5D, 615065 (3)	Arthrogryposis, distal, type 5D	y	ARTHROGRYPOSIS, DISTAL, TYPE 5D; DA5D	Clinical Features	died	ECEL1	HGNC:3147	Arthrogryposis, distal, type 5D, 615065 (3), Autosomal recessive	Autosomal recessive	n	y	[Patil et al. (2014) reported a 5-year-old female, born to consanguineous parents, with features of autosomal recessive distal arthrogryposis type 5D. The patient had congenital joint contractures involving upper and lower limbs with restricted movement of elbow and knee joints, bilateral pes planus, rocker-bottom feet, mild scoliosis, lumbar lordosis, andhip dislocation. In addition, she had a submucosal cleft palate, frontal upsweep of hairs, downslanting palpebral fissures, and furrowing of the tongue. Hands showed ulnar deviation of fingers, webbing, camptodactyly, and adducted thumbs. Ophthalmologic examination revealed ptosis, hyperopic astigmatic refractive error, and exotropia with a lightly pigmented fundus. Cognitive function was normal. The patient had short stature (height -3SD), pterygia, and hypoplastic labia majora. A younger brother, who died at 5 days of age of unknown cause, reportedly had joint contractures]	L2	n	y	lethal	lethal	lethal	L2	L2	pre-infant-lethal
615066	OSTEOGENESIS IMPERFECTA, TYPE XIV	Osteogenesis imperfecta, type XIV, 615066 (3)	Osteogenesis imperfecta, type XIV	y	OSTEOGENESIS IMPERFECTA, TYPE XIV; OI14	Description	lethal	TMEM38B	HGNC:25535	Osteogenesis imperfecta, type XIV, 615066 (3), Autosomal recessive	Autosomal recessive	n	n	-	-	-	-	ambiguous	ambiguous	ambiguous	-	-	-
615067	CILIARY DYSKINESIA, PRIMARY, 20	Ciliary dyskinesia, primary, 20, 615067 (3)	Ciliary dyskinesia, primary, 20	n	-	-	-	ODAD1	HGNC:26560	Ciliary dyskinesia, primary, 20, 615067 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
615071	ALAZAMI SYNDROME	Alazami syndrome, 615071 (3)	Alazami syndrome	n	-	-	-	LARP7	HGNC:24912	Alazami syndrome, 615071 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
615072	BRACHYDACTYLY, TYPE A1, C	Brachydactyly, type A1, C, 615072 (3)	Brachydactyly, type A1, C	n	-	-	-	GDF5	HGNC:4220	Brachydactyly, type A1, C, 615072 (3), Autosomal dominant, Autosomal recessive	Autosomal dominant, Autosomal recessive	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L1	L1	pre-infant-lethal
615073	DYSTONIA 25	Dystonia 25, 615073 (3)	Dystonia 25	n	-	-	-	GNAL	HGNC:4388	Dystonia 25, 615073 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
615074	GAND SYNDROME	GAND syndrome, 615074 (3)	GAND syndrome	n	-	-	-	GATAD2B	HGNC:30778	GAND syndrome, 615074 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
615075	NEURODEVELOPMENTAL DISORDER WITH SPASTIC DIPLEGIA AND VISUAL DEFECTS	Neurodevelopmental disorder with spastic diplegia and visual defects, 615075 (3)	Neurodevelopmental disorder with spastic diplegia and visual defects	n	-	-	-	CTNNB1	HGNC:2514	Neurodevelopmental disorder with spastic diplegia and visual defects, 615075 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
615081	SPERMATOGENIC FAILURE 11	Spermatogenic failure 11, 615081 (3)	Spermatogenic failure 11	n	-	-	-	KLHL10	HGNC:18829	Spermatogenic failure 11, 615081 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
615084	MITOCHONDRIAL DNA DEPLETION SYNDROME 11	Mitochondrial DNA depletion syndrome 11, 615084 (3)	Mitochondrial DNA depletion syndrome 11	y	MITOCHONDRIAL DNA DEPLETION SYNDROME 11; MTDPS11	Clinical Features	death|deaths|died	MGME1	HGNC:16205	Mitochondrial DNA depletion syndrome 11, 615084 (3), Autosomal recessive	Autosomal recessive	n	y	[Kornblum et al. (2013) reported a Lebanese family in which 3 sibs had a severe multisystem mitochondrial disorder starting in the first decade ...The youngest had similar features, but also had dilated cardiomyopathy that resulted in cardiac failure and death at age 25 years]	L6	y	-	lethal	lethal	lethal	L6	L6	post-infant-lethal
615085	OSTEOPETROSIS, AUTOSOMAL RECESSIVE 8	Osteopetrosis, autosomal recessive 8, 615085 (3)	Osteopetrosis, autosomal recessive 8	y	OSTEOPETROSIS, AUTOSOMAL RECESSIVE 8; OPTB8	Clinical Features	died	SNX10	HGNC:14974	Osteopetrosis, autosomal recessive 8, 615085 (3), Autosomal recessive	Autosomal recessive	n	y	[Aker et al. (2012) studied 4 affected children from 2 consanguineous Palestinian families with osteopetrosis (OPT)... Two of the patients underwent bone marrow transplantation at ages 10 months and 19 months, respectively, and at follow-up had normal growth and development. One patient died at 32 months of age]	L4	y	-	lethal	lethal	lethal	L4	L4	post-infant-lethal
615092	LEFT VENTRICULAR NONCOMPACTION 7	Left ventricular noncompaction 7, 615092 (3)	Left ventricular noncompaction 7	n	-	-	-	MIB1	HGNC:21086	Left ventricular noncompaction 7, 615092 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
615095	MICROCEPHALY 10, PRIMARY, AUTOSOMAL RECESSIVE	Microcephaly 10, primary, autosomal recessive, 615095 (3)	Microcephaly 10, primary, autosomal recessive	y	MICROCEPHALY 10, PRIMARY, AUTOSOMAL RECESSIVE; MCPH10	Description|Clinical Features	death|deaths	ZNF335	HGNC:15807	Microcephaly 10, primary, autosomal recessive, 615095 (3), Autosomal recessive	Autosomal recessive	n	y	[Primary microcephaly-10 (MCPH10) is an autosomal recessive disorder characterized by extremely small head size (-9 SD) at birth and death usually by 1 year of age / Stouffs et al. (2018) reported 2 boys with MCPH10. At birth, one boy, of North African descent, had severe microcephaly (head circumference -3.24 SD), low sloping forehead, flat occiput, and generalized hypotonia. He developed seizures with bradycardia and apnea in the first hours of life that were refractory to therapy and led to death at 5 days of age]	L2	y	-	lethal	lethal	lethal	L2	L2	pre-infant-lethal
615107	COWDEN SYNDROME 4	Cowden syndrome 4, 615107 (3)	Cowden syndrome 4	n	-	-	-	KLLN	HGNC:37212	Cowden syndrome 4, 615107 (3)	-	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
615108	COWDEN SYNDROME 5	Cowden syndrome 5, 615108 (3)	Cowden syndrome 5	n	-	-	-	PIK3CA	HGNC:8975	Cowden syndrome 5, 615108 (3)	-	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
615109	COWDEN SYNDROME 6	Cowden syndrome 6, 615109 (3)	Cowden syndrome 6	n	-	-	-	AKT1	HGNC:391	Cowden syndrome 6, 615109 (3)	-	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
615112	UROFACIAL SYNDROME 2	Urofacial syndrome 2, 615112 (3)	Urofacial syndrome 2	n	-	-	-	LRIG2	HGNC:20889	Urofacial syndrome 2, 615112 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
615113	MICROPHTHALMIA, ISOLATED 8	Microphthalmia, isolated 8, 615113 (3)	Microphthalmia, isolated 8	y	MICROPHTHALMIA, ISOLATED 8; MCOP8	Clinical Features	died	ALDH1A3	HGNC:409	Microphthalmia, isolated 8, 615113 (3), Autosomal recessive	Autosomal recessive	y	y	[Fares-Taie et al. (2013) also studied a consanguineous Turkish family in which the proband was a girl with bilateral microphthalmia, more severe on the right. She had no other health problems and displayed normal intelligence. A maternal uncle had died at age 1 month with bilateral clinical anophthalmia]	L2	n	y	lethal	lethal	lethal	L2	L2	pre-infant-lethal
615119	MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 6	Mitochondrial complex IV deficiency, nuclear type 6, 615119 (3)	Mitochondrial complex IV deficiency, nuclear type 6	y	MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 6; MC4DN6	Description|Clinical Features|Phenotype	death|deaths|died	COX15	HGNC:2263	Mitochondrial complex IV deficiency, nuclear type 6, 615119 (3), Autosomal recessive	Autosomal recessive	y	n	-	-	-	-	ambiguous	ambiguous	ambiguous	-	-	-
615120	MYASTHENIC SYNDROME, CONGENITAL, 8	Myasthenic syndrome, congenital, 8, with pre- and postsynaptic defects, 615120 (3)	Myasthenic syndrome, congenital, 8, with pre- and postsynaptic defects	y	MYASTHENIC SYNDROME, CONGENITAL, 8; CMS8	Clinical Features	died	AGRN	HGNC:329	Myasthenic syndrome, congenital, 8, with pre- and postsynaptic defects, 615120 (3), Autosomal recessive	Autosomal recessive	n	y	[Maselli et al. (2012) reported a 39-year-old man with a relatively severe form of congenital myasthenic syndrome. In childhood, he had ptosis, was easily fatigued, and had numerous episodes of respiratory insufficiency requiring tracheotomy. An older brother with similar symptoms died in childhood]	L4	n	y	lethal	lethal	lethal	L4	L4	post-infant-lethal
615122	LYMPHOPROLIFERATIVE SYNDROME 2	Lymphoproliferative syndrome 2, 615122 (3)	Lymphoproliferative syndrome 2	y	LYMPHOPROLIFERATIVE SYNDROME 2; LPFS2	Clinical Features	died	CD27	HGNC:11922	Lymphoproliferative syndrome 2, 615122 (3), Autosomal recessive	Autosomal recessive	n	y	[Van Montfrans et al. (2012) reported a 21-year-old man of Moroccan descent, born of consanguineous parents, with combined immunodeficiency and persistent symptomatic EBV viremia since early childhood... Family history revealed an older brother who presented with EBV-induced lymphadenopathy, fever, hepatosplenomegaly, and uveitis. In this patient, T-cell responses to mitogens and antigens were absent. He eventually developed aplastic anemia and died in childhood]	L4	n	y	lethal	lethal	lethal	L4	L4	post-infant-lethal
615139	FACIAL DYSMORPHISM, IMMUNODEFICIENCY, LIVEDO, AND SHORT STATURE	FILS syndrome, 615139 (3)	FILS syndrome	n	-	-	-	POLE	HGNC:9177	FILS syndrome, 615139 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L3	L3	pre-infant-lethal
615145	MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 9	Microphthalmia, syndromic 15, 615145 (3)	Microphthalmia, syndromic 15	n	-	-	-	TENM3	HGNC:29944	Microphthalmia, syndromic 15, 615145 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
615147	RETINAL DYSTROPHY, IRIS COLOBOMA, AND COMEDOGENIC ACNE SYNDROME	Retinal dystrophy, iris coloboma, and comedogenic acne syndrome, 615147 (3)	Retinal dystrophy, iris coloboma, and comedogenic acne syndrome	n	-	-	-	RBP4	HGNC:9922	Retinal dystrophy, iris coloboma, and comedogenic acne syndrome, 615147 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
615155	STEEL SYNDROME	Steel syndrome, 615155 (3)	Steel syndrome	n	-	-	-	COL27A1	HGNC:22986	Steel syndrome, 615155 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
615156	PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 6	Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 6, 615156 (3)	Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 6	n	-	-	-	DNA2	HGNC:2939	Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 6, 615156 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
615157	MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 2	Mitochondrial complex III deficiency, nuclear type 2, 615157 (3)	Mitochondrial complex III deficiency, nuclear type 2	y	MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 2; MC3DN2	Clinical Features|Clinical Synopsis	death|deaths	TTC19	HGNC:26006	Mitochondrial complex III deficiency, nuclear type 2, 615157 (3), Autosomal recessive	Autosomal recessive	n	y	[Nogueira et al. (2013) reported 4 Portuguese sibs, born of parents who were likely related, with a complex neurodegenerative disease associated with significant psychiatric features. The age at onset varied between 12 and 34 years, but followed a relentlessly progressive course in each patient, resulting in death in 2 patients between ages 30 and 49 years]	L6	y	-	lethal	lethal	lethal	L6	L6	post-infant-lethal
615158	MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 3	Mitochondrial complex III deficiency, nuclear type 3, 615158 (3)	Mitochondrial complex III deficiency, nuclear type 3	n	-	-	-	UQCRB	HGNC:12582	Mitochondrial complex III deficiency, nuclear type 3, 615158 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
615159	MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 4	Mitochondrial complex III deficiency, nuclear type 4, 615159 (3)	Mitochondrial complex III deficiency, nuclear type 4	y	MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 4; MC3DN4	Clinical Features	lethal	UQCRQ	HGNC:29594	Mitochondrial complex III deficiency, nuclear type 4, 615159 (3), Autosomal recessive	Autosomal recessive	n	n	-	-	-	-	ambiguous	ambiguous	ambiguous	-	-	-
615160	MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 5	Mitochondrial complex III deficiency, nuclear type 5, 615160 (3)	Mitochondrial complex III deficiency, nuclear type 5	n	-	-	-	UQCRC2	HGNC:12586	Mitochondrial complex III deficiency, nuclear type 5, 615160 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
615179	ALBINISM, OCULOCUTANEOUS, TYPE VII	Albinism, oculocutaneous, type VII, 615179 (3)	Albinism, oculocutaneous, type VII	n	-	-	-	LRMDA	HGNC:23405	Albinism, oculocutaneous, type VII, 615179 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
615181	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 11	Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 11, 615181 (3)	Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 11	n	-	-	-	B3GALNT2	HGNC:28596	Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 11, 615181 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
615182	COMBINED D-2- AND L-2-HYDROXYGLUTARIC ACIDURIA	Combined D-2- and L-2-hydroxyglutaric aciduria, 615182 (3)	Combined D-2- and L-2-hydroxyglutaric aciduria	y	COMBINED D-2- AND L-2-HYDROXYGLUTARIC ACIDURIA; D2L2AD	Description|Clinical Features|Clinical Synopsis	death|deaths|died	SLC25A1	HGNC:10979	Combined D-2- and L-2-hydroxyglutaric aciduria, 615182 (3), Autosomal recessive	Autosomal recessive	y	y	[Muntau et al. (2000) reported 3 patients, including 2 sibs, with severe neonatal encephalopathy associated with combined D-2- and L-2-hydroxyglutaric aciduria... After birth, the girl showed a severe, rapidly deteriorating neonatal onset encephalopathy with intractable seizures, hypotonia, recurrent inspiratory stridor, and dyspnea, resulting in death at age 2.5 months. Extensive laboratory studies in this patient also showed increased 2-oxoglutaric acid and variably increased D-2-HG and L-2-HG in urine, plasma, and cerebrospinal fluid. Muntau et al. (2000) hypothesized that the variable levels of these organic acids in this patient reflected repeated testing at different ages. The third child showed a similar course, with neonatal encephalopathy, respiratory insufficiency, seizures, hypotonia, choreoathetotic and dystonic movements, microcephaly, cortical visual failure, and severe developmental delay. Brain MRI showed enlargement of lateral ventricles, delayed gyration, opercularization, and myelination, cysts over the caudate nucleus, and cerebellar hypoplasia. This patient died at the age of 8 months. Organic acid studies showed combined elevation of D-2-HG, L-2-HG, and 2-oxoglutaric acid. An older brother had died of unknown causes on the first day of life]	L2	y	y	lethal	ambiguous|lethal	lethal	L2	L2	pre-infant-lethal
615184	CARDIOMYOPATHY, DILATED, 1II	Cardiomyopathy, dilated, 1II, 615184 (3)	Cardiomyopathy, dilated, 1II	y	CARDIOMYOPATHY, DILATED, 1II; CMD1II	Clinical Features|Phenotype	death|deaths|died	CRYAB	HGNC:2389	Cardiomyopathy, dilated, 1II, 615184 (3), Autosomal dominant	Autosomal dominant	n	y	[Inagaki et al. (2006) studied a 71-year-old Japanese woman with mild, late-onset dilated cardiomyopathy (CMD) who developed cardiac symptoms only after the fourth decade of life. Her electrocardiogram (ECG) showed ventricular tachycardia, with apparent inverted T waves in leads V4 to V6. She had 6 sibs, 2 of whom had CMD at ages 56 and 66 years; 2 other sibs had sudden cardiac death at ages 60 and 72 years]	L6	n	y	lethal	ambiguous|lethal|nonlethal	lethal|nonlethal	L3|L6	L3	pre-infant-lethal
615185	CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE F	Charcot-Marie-Tooth disease, dominant intermediate F, 615185 (3)	Charcot-Marie-Tooth disease, dominant intermediate F	n	-	-	-	GNB4	HGNC:20731	Charcot-Marie-Tooth disease, dominant intermediate F, 615185 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
615188	CATARACT 39, MULTIPLE TYPES	Cataract 39, multiple types, autosomal dominant, 615188 (3)	Cataract 39, multiple types, autosomal dominant	n	-	-	-	CRYGB	HGNC:2409	Cataract 39, multiple types, autosomal dominant, 615188 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
615190	DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 5	Dyskeratosis congenita, autosomal dominant 4, 615190 (3)	Dyskeratosis congenita, autosomal dominant 4	y	DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 5; DKCB5	Clinical Features	died	RTEL1	HGNC:15888	Dyskeratosis congenita, autosomal dominant 4, 615190 (3), Autosomal dominant, Autosomal recessive	Autosomal dominant, Autosomal recessive	y	y	[Lamm et al. (2009) reported a family in which 4 sibs, born of unrelated European parents, presented with Hoyeraal-Hreidarsson syndrome. The patients had nail dystrophy, leukoplakia, bone marrow failure, severe B-cell immunodeficiency, intrauterine growth retardation, growth retardation, microcephaly, cerebellar hypoplasia, and esophageal dysfunction. Three of the sibs died between ages 3 and 7 years, whereas the fourth was alive at age 22 years following bone marrow transplantation]	L4	y	-	lethal	lethal	lethal	L4|L6	L4	post-infant-lethal
615190	DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 5	Dyskeratosis congenita, autosomal recessive 5, 615190 (3)	Dyskeratosis congenita, autosomal recessive 5	y	DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 5; DKCB5	Clinical Features	died	RTEL1	HGNC:15888	Dyskeratosis congenita, autosomal recessive 5, 615190 (3), Autosomal dominant, Autosomal recessive	Autosomal dominant, Autosomal recessive	y	y	[Lamm et al. (2009) reported a family in which 4 sibs, born of unrelated European parents, presented with Hoyeraal-Hreidarsson syndrome. The patients had nail dystrophy, leukoplakia, bone marrow failure, severe B-cell immunodeficiency, intrauterine growth retardation, growth retardation, microcephaly, cerebellar hypoplasia, and esophageal dysfunction. Three of the sibs died between ages 3 and 7 years, whereas the fourth was alive at age 22 years following bone marrow transplantation]	L4	y	-	lethal	lethal	lethal	L4|L6	L4	post-infant-lethal
615191	LISSENCEPHALY 5	Lissencephaly 5, 615191 (3)	Lissencephaly 5	n	-	-	-	LAMB1	HGNC:6486	Lissencephaly 5, 615191 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
615193	BLEEDING DISORDER, PLATELET-TYPE, 15	Bleeding disorder, platelet-type, 15, 615193 (3)	Bleeding disorder, platelet-type, 15	n	-	-	-	ACTN1	HGNC:163	Bleeding disorder, platelet-type, 15, 615193 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
615198	OSTEOSCLEROTIC METAPHYSEAL DYSPLASIA	Osteosclerotic metaphyseal dysplasia, 615198 (3)	Osteosclerotic metaphyseal dysplasia	n	-	-	-	LRRK1	HGNC:18608	Osteosclerotic metaphyseal dysplasia, 615198 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
615206	IMMUNODEFICIENCY 11A	Immunodeficiency 11A, 615206 (3)	Immunodeficiency 11A	y	IMMUNODEFICIENCY 11A; IMD11A	Clinical Features	died	CARD11	HGNC:16393	Immunodeficiency 11A, 615206 (3), Autosomal recessive	Autosomal recessive	y	y	[Stepensky et al. (2013) reported a girl, born of consanguineous parents of Palestinian descent, with CARD11 immunodeficiency. The patient presented in infancy with recurrent respiratory infections and later developed P. jirovecii pneumonia. Two sibs had died in infancy with recurrent infections]	L3	n	y	lethal	ambiguous|lethal|nonlethal	lethal|nonlethal	L3	L3	pre-infant-lethal
615207	IMMUNODEFICIENCY 56	Immunodeficiency 56, 615207 (3)	Immunodeficiency 56	y	IMMUNODEFICIENCY 56; IMD56	Clinical Features	died	IL21R	HGNC:6006	Immunodeficiency 56, 615207 (3), Autosomal recessive	Autosomal recessive	n	y	[Kotlarz et al. (2013) reported 2 sibs, born of consanguineous Lebanese parents, with immunodeficiency. The patients had early onset of recurrent infections, as well as chronic cholangitis and biliary and hepatic cirrhosis associated with Cryptosporidium infection. One patient died after complications of liver transplantation and the other patient died after complications from hematopoietic stem cell transplantation]	LU	y	y	lethal	lethal	lethal	LU	LU	post-infant-lethal
615217	ATAXIA-OCULOMOTOR APRAXIA 3	Ataxia-oculomotor apraxia 3, 615217 (3)	Ataxia-oculomotor apraxia 3	n	-	-	-	PIK3R5	HGNC:30035	Ataxia-oculomotor apraxia 3, 615217 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
615219	HYDROCEPHALUS, CONGENITAL, 2, WITH OR WITHOUT BRAIN OR EYE ANOMALIES	Hydrocephalus, congenital, 2, with or without brain or eye anomalies, 615219 (3)	Hydrocephalus, congenital, 2, with or without brain or eye anomalies	y	HYDROCEPHALUS, CONGENITAL, 2, WITH OR WITHOUT BRAIN OR EYE ANOMALIES; HYC2	Description|Clinical Features|Clinical Synopsis|Phenotype	die|died|stillbirth|stillbirths|stillborn	MPDZ	HGNC:7208	Hydrocephalus, congenital, 2, with or without brain or eye anomalies, 615219 (3), Autosomal recessive	Autosomal recessive	y	y	[Al-Dosari et al. (2013) reported a consanguineous Saudi Arabian family in which several individuals had congenital communicating hydrocephalus. A 27-year-old unaffected pregnant woman presented at 30 weeks' gestation when ultrasound of the fetus showed extreme hydrocephalus with callosal dysgenesis or agenesis and thinning of the cerebral cortex. The findings were confirmed after birth. The cerebral aqueduct was not dilated. The infant soon developed seizures. Ventriculoperitoneal shunt was placed at 25 days, and follow-up at age 10 months showed that she had started to roll over and babble. Family history of the mother was significant for 2 affected sibs who had mildly decreased IQ, 2 brothers who died as young children due to complications of hydrocephalus, 2 affected stillbirths in her mother, and 1 abortion in her mother possibly affected by history]	L1	y	-	lethal	lethal	lethal	L1	L1	pre-infant-lethal
615220	OSTEOGENESIS IMPERFECTA, TYPE XV	Osteogenesis imperfecta, type XV, 615220 (3)	Osteogenesis imperfecta, type XV	y	OSTEOGENESIS IMPERFECTA, TYPE XV; OI15	Description	lethal	WNT1	HGNC:12774	Osteogenesis imperfecta, type XV, 615220 (3), Autosomal recessive	Autosomal recessive	n	n	-	-	-	-	ambiguous	ambiguous	ambiguous	-	-	-
615222	SMITH-MCCORT DYSPLASIA 2	Smith-McCort dysplasia 2, 615222 (3)	Smith-McCort dysplasia 2	n	-	-	-	RAB33B	HGNC:16075	Smith-McCort dysplasia 2, 615222 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
615224	ADVANCED SLEEP PHASE SYNDROME, FAMILIAL, 2	Advanced sleep-phase syndrome, familial, 2, 615224 (3)	Advanced sleep-phase syndrome, familial, 2	n	-	-	-	CSNK1D	HGNC:2452	Advanced sleep-phase syndrome, familial, 2, 615224 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
615225	PALMOPLANTAR CARCINOMA, MULTIPLE SELF-HEALING	Palmoplantar carcinoma, multiple self-healing, 615225 (3)	Palmoplantar carcinoma, multiple self-healing	n	-	-	-	NLRP1	HGNC:14374	Palmoplantar carcinoma, multiple self-healing, 615225 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
615235	CARDIOMYOPATHY, DILATED, 1JJ	Cardiomyopathy, dilated, 1JJ, 615235 (3)	Cardiomyopathy, dilated, 1JJ	n	-	-	-	LAMA4	HGNC:6484	Cardiomyopathy, dilated, 1JJ, 615235 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
615237	CONGENITAL SHORT BOWEL SYNDROME	Congenital short bowel syndrome, 615237 (3)	Congenital short bowel syndrome	y	CONGENITAL SHORT BOWEL SYNDROME; CSBS	Clinical Features	death|deaths|died	CLMP	HGNC:24039	Congenital short bowel syndrome, 615237 (3), Autosomal recessive	Autosomal recessive	y	y	[Hamilton et al. (1969) described a 7-year-old girl, born to nonconsanguineous French Canadian parents, who presented at 4 months of age with chronic diarrhea and failure to thrive... he proband had 3 healthy sisters and 1 sister who had died at 1 month of age]	L3	n	y	lethal	lethal	lethal	L3	L3	pre-infant-lethal
615244	NEPHROTIC SYNDROME, TYPE 8	Nephrotic syndrome, type 8, 615244 (3)	Nephrotic syndrome, type 8	y	NEPHROTIC SYNDROME, TYPE 8; NPHS8	Clinical Features|Clinical Synopsis	died|fatal	ARHGDIA	HGNC:678	Nephrotic syndrome, type 8, 615244 (3), Autosomal recessive	Autosomal recessive	n	y	[Gupta et al. (2013) reported 2 sisters, born of consanguineous Pakistani parents, with congenital nephrotic syndrome. Both girls presented in the first weeks of life with severe proteinuria, hypoalbuminemia, and generalized edema. Renal biopsy of 1 patient showed diffuse mesangial sclerosis, with small glomeruli, hypercellularity, increased extracellular matrix, and contracted/collapsed glomerular tufts surrounded by immature or abnormal podocytes. Electron microscopy showed diffuse effacement of foot processes, thinning of the glomerular basement membrane, and swollen endothelial cells. One patient underwent renal transplant at age 2 years, but the graft never functioned due to venous thrombosis, and she remained on dialysis. The second child died at age 2 months without treatment]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
615248	CARDIOMYOPATHY, DILATED, 1KK	Cardiomyopathy, dilated, 1KK, 615248 (3)	Cardiomyopathy, dilated, 1KK	y	CARDIOMYOPATHY, DILATED, 1KK; CMD1KK	Clinical Features	death|deaths	MYPN	HGNC:23246	Cardiomyopathy, dilated, 1KK, 615248 (3), Autosomal dominant	Autosomal dominant	y	y	[Duboscq-Bidot et al. (2008) studied 6 patients from 2 families, as well as 2 sporadic patients, with isolated dilated cardiomyopathy due to mutations in the myopalladin gene (see MOLECULAR GENETICS). Mean age at diagnosis was 40 years. Of the 8 patients, 4 had incomplete left bundle branch block (BBB) on electrocardiogram, 1 had complete left BBB, and 1 had right BBB; 3 patients had left ventricular hypertrophy. There were 3 cardiac deaths due to refractory congestive heart failure, at 20, 29, and 55 years of age]	L6	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L6	L6	post-infant-lethal
615248	CARDIOMYOPATHY, DILATED, 1KK	Cardiomyopathy, familial restrictive, 4, 615248 (3)	Cardiomyopathy, familial restrictive, 4	y	CARDIOMYOPATHY, DILATED, 1KK; CMD1KK	Clinical Features	death|deaths	MYPN	HGNC:23246	Cardiomyopathy, familial restrictive, 4, 615248 (3), Autosomal dominant	Autosomal dominant	y	y	[Duboscq-Bidot et al. (2008) studied 6 patients from 2 families, as well as 2 sporadic patients, with isolated dilated cardiomyopathy due to mutations in the myopalladin gene (see MOLECULAR GENETICS). Mean age at diagnosis was 40 years. Of the 8 patients, 4 had incomplete left bundle branch block (BBB) on electrocardiogram, 1 had complete left BBB, and 1 had right BBB; 3 patients had left ventricular hypertrophy. There were 3 cardiac deaths due to refractory congestive heart failure, at 20, 29, and 55 years of age]	L6	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L6	L6	post-infant-lethal
615248	CARDIOMYOPATHY, DILATED, 1KK	Cardiomyopathy, hypertrophic, 22, 615248 (3)	Cardiomyopathy, hypertrophic, 22	y	CARDIOMYOPATHY, DILATED, 1KK; CMD1KK	Clinical Features	death|deaths	MYPN	HGNC:23246	Cardiomyopathy, hypertrophic, 22, 615248 (3), Autosomal dominant	Autosomal dominant	y	y	[Duboscq-Bidot et al. (2008) studied 6 patients from 2 families, as well as 2 sporadic patients, with isolated dilated cardiomyopathy due to mutations in the myopalladin gene (see MOLECULAR GENETICS). Mean age at diagnosis was 40 years. Of the 8 patients, 4 had incomplete left bundle branch block (BBB) on electrocardiogram, 1 had complete left BBB, and 1 had right BBB; 3 patients had left ventricular hypertrophy. There were 3 cardiac deaths due to refractory congestive heart failure, at 20, 29, and 55 years of age]	L6	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L6	L6	post-infant-lethal
615249	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 12	Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 12, 615249 (3)	Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 12	y	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 12; MDDGA12	Clinical Features	died	POMK	HGNC:26267	Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 12, 615249 (3), Autosomal recessive	Autosomal recessive	n	y	[Jae et al. (2013) identified a girl, born to nonconsanguineous parents (Family 40), who was delivered after a pregnancy complicated by polyhydramnios. Her birth weight was 3,820 grams and her head circumference was 48 cm. Brain MRI showed triventricular hydrocephalus with a very thin cortex, compression of the cerebellar hemispheres and brainstem, and an Arnold-Chiari malformation. She received a ventriculoperitoneal shunt. Ophthalmologic evaluation showed persistent hypoplastic primary vitreous in both eyes, high myopia of the right eye, and microphthalmia of the left eye. The child had severe hypotonia and muscle weakness with a creatine kinase level of 7,000 U/L. A CT scan at 17 months showed dilated cerebral ventricles with agyria, and hypoplasia of the cerebellum and brainstem. The right eye lens showed cataract. Muscle biopsy at 18 months revealed muscular dystrophy, and immunohistochemistry demonstrated the presence of merosin, dystrophin, and alpha-, beta- and gamma-sarcoglycans. The girl died at the age of almost 3 years]	L4	y	-	lethal	lethal	lethal	L4	L4	post-infant-lethal
615266	HYPOGONADOTROPIC HYPOGONADISM 17 WITH OR WITHOUT ANOSMIA	Hypogonadotropic hypogonadism 17 with or without anosmia, 615266 (3)	Hypogonadotropic hypogonadism 17 with or without anosmia	n	-	-	-	SPRY4	HGNC:15533	Hypogonadotropic hypogonadism 17 with or without anosmia, 615266 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
615268	CEREBELLAR ATAXIA, IMPAIRED INTELLECTUAL DEVELOPMENT, AND DYSEQUILIBRIUM SYNDROME 4	Cerebellar ataxia, impaired intellectual development, and dysequilibrium syndrome 4, 615268 (3)	Cerebellar ataxia, impaired intellectual development, and dysequilibrium syndrome 4	n	-	-	-	ATP8A2	HGNC:13533	Cerebellar ataxia, impaired intellectual development, and dysequilibrium syndrome 4, 615268 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
615269	HYPOGONADOTROPIC HYPOGONADISM 19 WITH OR WITHOUT ANOSMIA	Hypogonadotropic hypogonadism 19 with or without anosmia, 615269 (3)	Hypogonadotropic hypogonadism 19 with or without anosmia	n	-	-	-	DUSP6	HGNC:3072	Hypogonadotropic hypogonadism 19 with or without anosmia, 615269 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
615270	HYPOGONADOTROPIC HYPOGONADISM 20 WITH OR WITHOUT ANOSMIA	Hypogonadotropic hypogonadism 20 with or without anosmia, 615270 (3)	Hypogonadotropic hypogonadism 20 with or without anosmia	n	-	-	-	FGF17	HGNC:3673	Hypogonadotropic hypogonadism 20 with or without anosmia, 615270 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
615271	HYPOGONADOTROPIC HYPOGONADISM 21 WITH OR WITHOUT ANOSMIA	Hypogonadotropic hypogonadism 21 with anosmia, 615271 (3)	Hypogonadotropic hypogonadism 21 with anosmia	n	-	-	-	FLRT3	HGNC:3762	Hypogonadotropic hypogonadism 21 with anosmia, 615271 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
615272	FANCONI ANEMIA, COMPLEMENTATION GROUP Q	Fanconi anemia, complementation group Q, 615272 (3)	Fanconi anemia, complementation group Q	y	FANCONI ANEMIA, COMPLEMENTATION GROUP Q; FANCQ	Clinical Features	died	ERCC4	HGNC:3436	Fanconi anemia, complementation group Q, 615272 (3), Autosomal recessive	Autosomal recessive	n	y	[Bogliolo et al. (2013) reported 2 unrelated patients, of Spanish and German origin, respectively, with an unclassified form of Fanconi anemia. The first patient presented in the neonatal period with bilateral absent thumbs, microsomy, esophageal atresia, a ventrally translocated anus, and dysplastic, low-set ears. She did not have skin hyperpigmentation, photosensitivity, sunlight-induced scarring, or atrophy. She developed bone marrow failure at age 2 years and died from complications of a bone marrow transplant at age 4 years]	L4	y	-	lethal	lethal	lethal	L4|L5	L4	post-infant-lethal
615273	CONGENITAL DISORDER OF DEGLYCOSYLATION 1	Congenital disorder of deglycosylation 1, 615273 (3)	Congenital disorder of deglycosylation 1	n	-	-	-	NGLY1	HGNC:17646	Congenital disorder of deglycosylation 1, 615273 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
615274	CATARACT 15, MULTIPLE TYPES	Cataract 15, multiple types, 615274 (3)	Cataract 15, multiple types	n	-	-	-	MIP	HGNC:7103	Cataract 15, multiple types, 615274 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
615277	CATARACT 19, MULTIPLE TYPES	Cataract 19, multiple types, 615277 (3)	Cataract 19, multiple types	n	-	-	-	LIM2	HGNC:6610	Cataract 19, multiple types, 615277 (3), Autosomal dominant, Autosomal recessive	Autosomal dominant, Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
615278	CARDIOFACIOCUTANEOUS SYNDROME 2	Cardiofaciocutaneous syndrome 2, 615278 (3)	Cardiofaciocutaneous syndrome 2	n	-	-	-	KRAS	HGNC:6407	Cardiofaciocutaneous syndrome 2, 615278 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L5	L5	post-infant-lethal
615279	CARDIOFACIOCUTANEOUS SYNDROME 3	Cardiofaciocutaneous syndrome 3, 615279 (3)	Cardiofaciocutaneous syndrome 3	n	-	-	-	MAP2K1	HGNC:6840	Cardiofaciocutaneous syndrome 3, 615279 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
615280	CARDIOFACIOCUTANEOUS SYNDROME 4	Cardiofaciocutaneous syndrome 4, 615280 (3)	Cardiofaciocutaneous syndrome 4	y	CARDIOFACIOCUTANEOUS SYNDROME 4; CFC4	Clinical Features|Phenotype	died	MAP2K2	HGNC:6842	Cardiofaciocutaneous syndrome 4, 615280 (3), Autosomal dominant	Autosomal dominant	y	n	-	-	-	-	ambiguous	ambiguous	ambiguous	-	-	-
615281	HYPOMYELINATION WITH BRAINSTEM AND SPINAL CORD INVOLVEMENT AND LEG SPASTICITY	Hypomyelination with brainstem and spinal cord involvement and leg spasticity, 615281 (3)	Hypomyelination with brainstem and spinal cord involvement and leg spasticity	n	-	-	-	DARS1	HGNC:2678	Hypomyelination with brainstem and spinal cord involvement and leg spasticity, 615281 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
615282	CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 2	Cortical dysplasia, complex, with other brain malformations 2, 615282 (3)	Cortical dysplasia, complex, with other brain malformations 2	n	-	-	-	KIF5C	HGNC:6325	Cortical dysplasia, complex, with other brain malformations 2, 615282 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
615284	CHARCOT-MARIE-TOOTH DISEASE, TYPE 4B3	Charcot-Marie-Tooth disease, type 4B3, 615284 (3)	Charcot-Marie-Tooth disease, type 4B3	n	-	-	-	SBF1	HGNC:10542	Charcot-Marie-Tooth disease, type 4B3, 615284 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
615285	NEUTROPENIA, SEVERE CONGENITAL, 5, AUTOSOMAL RECESSIVE	Neutropenia, severe congenital, 5, autosomal recessive, 615285 (3)	Neutropenia, severe congenital, 5, autosomal recessive	y	NEUTROPENIA, SEVERE CONGENITAL, 5, AUTOSOMAL RECESSIVE; SCN5	Clinical Features|Clinical Synopsis	died|death|deaths	VPS45	HGNC:14579	Neutropenia, severe congenital, 5, autosomal recessive, 615285 (3), Autosomal recessive	Autosomal recessive	n	y	[Stepensky et al. (2013) reported 3 patients from 2 unrelated consanguineous Palestinian families with severe congenital neutropenia and myelofibrosis. Two deceased sibs with a similar disorder were also described. The patients presented between 1 and 7 months of age with recurrent bacterial infections, predominantly pneumonia and soft tissue infections. Laboratory studies showed profound neutropenia, progressive anemia, and later development of thrombocytopenia. Peripheral blood smear showed anisocytosis and poikilocytosis, neutropenia, and thrombocytopenia with few giant platelets. Bone marrow biopsy showed myeloid hyperplasia and fibrosis. Other features included nephromegaly, splenomegaly, and osteosclerosis. Two patients died at age 3 months and 3 years, respectively]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
615286	NEURODEVELOPMENTAL DISORDER WITH BRAIN ABNORMALITIES, POOR GROWTH, AND DYSMORPHIC FACIES	Neurodevelopmental disorder with brain abnormalities, poor growth, and dysmorphic facies, 615286 (3)	Neurodevelopmental disorder with brain abnormalities, poor growth, and dysmorphic facies	n	-	-	-	ADAT3	HGNC:25151	Neurodevelopmental disorder with brain abnormalities, poor growth, and dysmorphic facies, 615286 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
615287	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 13	Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 13, 615287 (3)	Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 13	y	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 13; MDDGA13	Description|Clinical Features|Clinical Synopsis	death|deaths|died	B4GAT1	HGNC:15685	Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 13, 615287 (3), Autosomal recessive	Autosomal recessive	n	y	[Shaheen et al. (2013) reported 7 children from a highly consanguineous Saudi Arabian family with MDDGA13. The proband was born with occipital encephalocele, anencephaly, cloudy cornea, proptotic eyes, spasticity, micropenis, and multicystic dysplastic kidneys. Serum creatine kinase was highly elevated; he died on the sixth day of life. The other affected individuals had similar features and died either in utero or shortly after birth, although 1 patient survived to 8 months of age]	L1	y	-	lethal	lethal	lethal	L1	L1	pre-infant-lethal
615290	SPINAL MUSCULAR ATROPHY, LOWER EXTREMITY-PREDOMINANT, 2A, CHILDHOOD ONSET, AUTOSOMAL DOMINANT	Spinal muscular atrophy, lower extremity-predominant, 2A, autosomal dominant, 615290 (3)	Spinal muscular atrophy, lower extremity-predominant, 2A, autosomal dominant	y	SPINAL MUSCULAR ATROPHY, LOWER EXTREMITY-PREDOMINANT, 2A, CHILDHOOD ONSET, AUTOSOMAL DOMINANT; SMALED2A	Clinical Features	died	BICD2	HGNC:17208	Spinal muscular atrophy, lower extremity-predominant, 2A, autosomal dominant, 615290 (3), Autosomal dominant	Autosomal dominant	n	n	-	-	-	-	ambiguous	ambiguous|lethal	lethal	L3	L3	pre-infant-lethal
615294	CILIARY DYSKINESIA, PRIMARY, 21	Ciliary dyskinesia, primary, 21, 615294 (3)	Ciliary dyskinesia, primary, 21	n	-	-	-	DRC1	HGNC:24245	Ciliary dyskinesia, primary, 21, 615294 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
615297	ADAMS-OLIVER SYNDROME 4	Adams-Oliver syndrome 4, 615297 (3)	Adams-Oliver syndrome 4	n	-	-	-	EOGT	HGNC:28526	Adams-Oliver syndrome 4, 615297 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
615298	SYMPHALANGISM, PROXIMAL, 1B	Symphalangism, proximal, 1B, 615298 (3)	Symphalangism, proximal, 1B	n	-	-	-	GDF5	HGNC:4220	Symphalangism, proximal, 1B, 615298 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L1	L1	pre-infant-lethal
615300	PERRAULT SYNDROME 4	Perrault syndrome 4, 615300 (3)	Perrault syndrome 4	y	PERRAULT SYNDROME 4; PRLTS4	Clinical Features	death|deaths|died	LARS2	HGNC:17095	Perrault syndrome 4, 615300 (3), Autosomal recessive	Autosomal recessive	y	y	[Van der Knaap et al. (2019) reported 4 unrelated patients, 2 females and 2 males, with PRLTS4. The females presented with congenital sensorineural deafness and were later diagnosed with ovarian failure. Patient 1, a female, had mildly delayed early development, but was able to work as an adult. Following a fall at age 33 years, she showed progressive neurologic decline, with cerebellar ataxia, spasticity, supranuclear gaze palsy, and dysphagia. She died at age 35.5 years]	L6	y	-	lethal	lethal	lethal	L3|L6	L3	pre-infant-lethal
615314	CRANIOSYNOSTOSIS 3	Craniosynostosis 3, 615314 (3)	Craniosynostosis 3	n	-	-	-	TCF12	HGNC:11623	Craniosynostosis 3, 615314 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
615327	DOWLING-DEGOS DISEASE 2	Dowling-Degos disease 2, 615327 (3)	Dowling-Degos disease 2	n	-	-	-	POFUT1	HGNC:14988	Dowling-Degos disease 2, 615327 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
615328	SHAHEEN SYNDROME	Shaheen syndrome, 615328 (3)	Shaheen syndrome	n	-	-	-	COG6	HGNC:18621	Shaheen syndrome, 615328 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L2	L2	pre-infant-lethal
615330	MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 3	Multiple mitochondrial dysfunctions syndrome 3, 615330 (3)	Multiple mitochondrial dysfunctions syndrome 3	y	MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 3; MMDS3	Description|Clinical Features|Clinical Synopsis	die|death|deaths|died|lethal	IBA57	HGNC:27302	Multiple mitochondrial dysfunctions syndrome 3, 615330 (3), Autosomal recessive	Autosomal recessive	y	y	[Ajit Bolar et al. (2013) reported 2 sibs, born of consanguineous Moroccan parents, with a lethal encephalomyopathy and myopathy resulting from mitochondrial dysfunction.... The second infant showed similar features and died 15 minutes after birth]	L2	y	-	lethal	lethal	lethal	L2	L2	pre-infant-lethal
615338	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 16	Developmental and epileptic encephalopathy 16, 615338 (3)	Developmental and epileptic encephalopathy 16	y	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 16; DEE16	Description|Clinical Features|Clinical Synopsis	die|died	TBC1D24	HGNC:29203	Developmental and epileptic encephalopathy 16, 615338 (3), Autosomal recessive	Autosomal recessive	y	y	[Milh et al. (2013) reported 2 sisters, born of unrelated parents, with DEE16 manifest clinically as malignant migrating partial seizures of infancy (MMPSI). Both had onset of clonic seizures early in the second month of life that progressed to a 'stormy' phase, with almost continuous clonic migrating seizures and psychomotor regression. Both patients had severe neurologic impairment with axial hypotonia, no voluntary movement, no eye contact, and acquired microcephaly. Brain MRI at birth was normal in both patients, but later showed brain atrophy. One sib died of seizures at age 18 months]	L3	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L2|L3	L2	pre-infant-lethal
615342	PULMONARY HYPERTENSION, PRIMARY, 2	Pulmonary hypertension, primary, 2, 615342 (3)	Pulmonary hypertension, primary, 2	y	PULMONARY HYPERTENSION, PRIMARY, 2; PPH2	Clinical Features	died	SMAD9	HGNC:6774	Pulmonary hypertension, primary, 2, 615342 (3), Autosomal dominant	Autosomal dominant	n	y	[Shintani et al. (2009) reported a boy who was diagnosed with pulmonary hypertension at age 8 years. Two sibs of the proband had died of pulmonary disease at ages 13 years and less than 2 years]	L3	n	y	lethal	lethal	lethal	L3	L3	pre-infant-lethal
615343	PULMONARY HYPERTENSION, PRIMARY, 3	Pulmonary hypertension, primary, 3, 615343 (3)	Pulmonary hypertension, primary, 3	y	PULMONARY HYPERTENSION, PRIMARY, 3; PPH3	Clinical Features	died	CAV1	HGNC:1527	Pulmonary hypertension, primary, 3, 615343 (3), Autosomal dominant	Autosomal dominant	y	y	[Austin et al. (2012) reported a 3-generation family in which 6 individuals were diagnosed with primary pulmonary hypertension between ages 4 and 67 years. One patient died at age 4 years]	L4	y	-	lethal	ambiguous|lethal	lethal	L4|L6	L4	post-infant-lethal
615344	PULMONARY HYPERTENSION, PRIMARY, 4	Pulmonary hypertension, primary, 4, 615344 (3)	Pulmonary hypertension, primary, 4	y	PULMONARY HYPERTENSION, PRIMARY, 4; PPH4	Clinical Features	died	KCNK3	HGNC:6278	Pulmonary hypertension, primary, 4, 615344 (3), Autosomal dominant	Autosomal dominant	n	y	[Ma et al. (2013) reported 3 unrelated families with primary pulmonary hypertension. Subsequently, 3 patients with sporadic disease were identified. The age at diagnosis ranged from 8 to 44 years, and both males and females were affected. Some patients developed cardiac arrhythmias. No patients responded to acute vasodilator challenge. Three patients eventually required lung transplantation and 3 patients died in their forties]	L6	y	-	lethal	lethal	lethal	L6	L6	post-infant-lethal
615346	PRECOCIOUS PUBERTY, CENTRAL, 2	Precocious puberty, central, 2, 615346 (3)	Precocious puberty, central, 2	n	-	-	-	MKRN3	HGNC:7114	Precocious puberty, central, 2, 615346 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
615348	NEMALINE MYOPATHY 8	Nemaline myopathy 8, autosomal recessive, 615348 (3)	Nemaline myopathy 8, autosomal recessive	y	NEMALINE MYOPATHY 8; NEM8	Description|Clinical Features|Clinical Synopsis	die|death|deaths	KLHL40	HGNC:30372	Nemaline myopathy 8, autosomal recessive, 615348 (3), Autosomal recessive	Autosomal recessive	y	y	[Ravenscroft et al. (2013) reported a large cohort of patients with severe nemaline myopathy. Many were of Japanese descent, although patients were ascertained from other areas as well. The phenotype was severe, and included fetal akinesia or hypokinesia, contractures, fractures, respiratory failure, and swallowing difficulties apparent at birth. Other features included facial weakness and chest deformity. The average age at death was 5 months]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
615349	EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 2	Ehlers-Danlos syndrome, spondylodysplastic type, 2, 615349 (3)	Ehlers-Danlos syndrome, spondylodysplastic type, 2	n	-	-	-	B3GALT6	HGNC:17978	Ehlers-Danlos syndrome, spondylodysplastic type, 2, 615349 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L1|L4	L1	pre-infant-lethal
615350	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 14	Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 14, 615350 (3)	Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 14	n	-	-	-	GMPPB	HGNC:22932	Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 14, 615350 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L5	L5	post-infant-lethal
615351	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH IMPAIRED INTELLECTUAL DEVELOPMENT), TYPE B, 14	Muscular dystrophy-dystroglycanopathy (congenital with impaired intellectual development), type B, 14, 615351 (3)	Muscular dystrophy-dystroglycanopathy (congenital with impaired intellectual development), type B, 14	y	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH IMPAIRED INTELLECTUAL DEVELOPMENT), TYPE B, 14; MDDGB14	Clinical Features	died	GMPPB	HGNC:22932	Muscular dystrophy-dystroglycanopathy (congenital with impaired intellectual development), type B, 14, 615351 (3), Autosomal recessive	Autosomal recessive	y	y	[died at age 14 years]	L5	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L5	L5	post-infant-lethal
615352	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 14	Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 14, 615352 (3)	Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 14	n	-	-	-	GMPPB	HGNC:22932	Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 14, 615352 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L5	L5	post-infant-lethal
615355	NOONAN SYNDROME 8	Noonan syndrome 8, 615355 (3)	Noonan syndrome 8	y	NOONAN SYNDROME 8; NS8	Clinical Features	died	RIT1	HGNC:10023	Noonan syndrome 8, 615355 (3), Autosomal dominant	Autosomal dominant	y	y	[Aoki et al. (2013) reported 17 unrelated individuals with Noonan syndrome-8 who ranged in age from a few months to 15 years... One infant with cardiomyopathy and pleural effusion died at age 53 days, and 1 child developed acute lymphoblastic leukemia at age 5 years]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
615356	MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 18	Muscular dystrophy, limb-girdle, autosomal recessive 18, 615356 (3)	Muscular dystrophy, limb-girdle, autosomal recessive 18	n	-	-	-	TRAPPC11	HGNC:25751	Muscular dystrophy, limb-girdle, autosomal recessive 18, 615356 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
615360	LEBER CONGENITAL AMAUROSIS 17	Leber congenital amaurosis 17, 615360 (3)	Leber congenital amaurosis 17	n	-	-	-	GDF6	HGNC:4221	Leber congenital amaurosis 17, 615360 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
615361	HYPOCALCEMIA, AUTOSOMAL DOMINANT 2	Hypocalcemia, autosomal dominant 2, 615361 (3)	Hypocalcemia, autosomal dominant 2	n	-	-	-	GNA11	HGNC:4379	Hypocalcemia, autosomal dominant 2, 615361 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
615362	CEROID LIPOFUSCINOSIS, NEURONAL, 13 (KUFS TYPE)	Ceroid lipofuscinosis, neuronal, 13 (Kufs type), 615362 (3)	Ceroid lipofuscinosis, neuronal, 13 (Kufs type)	y	CEROID LIPOFUSCINOSIS, NEURONAL, 13 (KUFS TYPE); CLN13	Description|Clinical Features	death|deaths|died	CTSF	HGNC:2531	Ceroid lipofuscinosis, neuronal, 13 (Kufs type), 615362 (3), Autosomal recessive	Autosomal recessive	y	y	[died at age 42]	L6	y	-	lethal	lethal	lethal	L6	L6	post-infant-lethal
615363	ESTROGEN RESISTANCE	Estrogen resistance, 615363 (3)	Estrogen resistance	n	-	-	-	ESR1	HGNC:3467	Estrogen resistance, 615363 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
615368	LETHAL CONGENITAL CONTRACTURE SYNDROME 5	Lethal congenital contracture syndrome 5, 615368 (3)	Lethal congenital contracture syndrome 5	y	LETHAL CONGENITAL CONTRACTURE SYNDROME 5; LCCS5	Clinical Features|Clinical Synopsis|Phenotype	death|deaths|lethal	DNM2	HGNC:2974	Lethal congenital contracture syndrome 5, 615368 (3), Autosomal recessive	Autosomal recessive	y	y	[Koutsopoulos et al. (2013) reported 3 sibs, born of consanguineous Pakistani parents, with a lethal congenital neuromuscular syndrome... Death occurred at ages 5 days, 19 days, and 4 months]	L2	y	-	lethal	ambiguous|lethal|nonlethal	lethal|nonlethal	L2	L2	pre-infant-lethal
615369	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 94	Developmental and epileptic encephalopathy 94, 615369 (3)	Developmental and epileptic encephalopathy 94	n	-	-	-	CHD2	HGNC:1917	Developmental and epileptic encephalopathy 94, 615369 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
615373	LEFT VENTRICULAR NONCOMPACTION 8	Cardiomyopathy, dilated, 1LL, 615373 (3)	Cardiomyopathy, dilated, 1LL	n	-	-	-	PRDM16	HGNC:14000	Cardiomyopathy, dilated, 1LL, 615373 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
615373	LEFT VENTRICULAR NONCOMPACTION 8	Left ventricular noncompaction 8, 615373 (3)	Left ventricular noncompaction 8	n	-	-	-	PRDM16	HGNC:14000	Left ventricular noncompaction 8, 615373 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
615374	CONE-ROD DYSTROPHY 18	Cone-rod dystrophy 18, 615374 (3)	Cone-rod dystrophy 18	n	-	-	-	RAB28	HGNC:9768	Cone-rod dystrophy 18, 615374 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
615376	CHARCOT-MARIE-TOOTH DISEASE, RECESSIVE INTERMEDIATE C	Charcot-Marie-Tooth disease, recessive intermediate C, 615376 (3)	Charcot-Marie-Tooth disease, recessive intermediate C	n	-	-	-	PLEKHG5	HGNC:29105	Charcot-Marie-Tooth disease, recessive intermediate C, 615376 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
615377	ATRIAL FIBRILLATION, FAMILIAL, 13	Atrial fibrillation, familial, 13, 615377 (3)	Atrial fibrillation, familial, 13	n	-	-	-	SCN1B	HGNC:10586	Atrial fibrillation, familial, 13, 615377 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L3|L6	L3	pre-infant-lethal
615378	ATRIAL FIBRILLATION, FAMILIAL, 14	Atrial fibrillation, familial, 14, 615378 (3)	Atrial fibrillation, familial, 14	n	-	-	-	SCN2B	HGNC:10589	Atrial fibrillation, familial, 14, 615378 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
615381	MANDIBULAR HYPOPLASIA, DEAFNESS, PROGEROID FEATURES, AND LIPODYSTROPHY SYNDROME	Mandibular hypoplasia, deafness, progeroid features, and lipodystrophy syndrome, 615381 (3)	Mandibular hypoplasia, deafness, progeroid features, and lipodystrophy syndrome	y	MANDIBULAR HYPOPLASIA, DEAFNESS, PROGEROID FEATURES, AND LIPODYSTROPHY SYNDROME; MDPL	Phenotype	death|deaths	POLD1	HGNC:9175	Mandibular hypoplasia, deafness, progeroid features, and lipodystrophy syndrome, 615381 (3), Autosomal dominant	Autosomal dominant	n	n	-	-	-	-	ambiguous	ambiguous	ambiguous	-	-	-
615382	NEPHRONOPHTHISIS 16	Nephronophthisis 16, 615382 (3)	Nephronophthisis 16	n	-	-	-	ANKS6	HGNC:26724	Nephronophthisis 16, 615382 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
615386	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 14	Spinocerebellar ataxia, autosomal recessive 14, 615386 (3)	Spinocerebellar ataxia, autosomal recessive 14	n	-	-	-	SPTBN2	HGNC:11276	Spinocerebellar ataxia, autosomal recessive 14, 615386 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
615395	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 16	Combined oxidative phosphorylation deficiency 16, 615395 (3)	Combined oxidative phosphorylation deficiency 16	y	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 16; COXPD16	Clinical Features|Clinical Synopsis	died|fatal	MRPL44	HGNC:16650	Combined oxidative phosphorylation deficiency 16, 615395 (3), Autosomal recessive	Autosomal recessive	y	y	[Carroll et al. (2013) reported 2 Finnish sisters with hypertrophic cardiomyopathy and liver steatosis. One sister died of cardiac failure after a respiratory infection at age 6 months]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
615396	LEFT VENTRICULAR NONCOMPACTION 10	Cardiomyopathy, dilated, 1MM, 615396 (3)	Cardiomyopathy, dilated, 1MM	y	LEFT VENTRICULAR NONCOMPACTION 10; LVNC10	Clinical Synopsis	fatal	MYBPC3	HGNC:7551	Cardiomyopathy, dilated, 1MM, 615396 (3), Autosomal dominant	Autosomal dominant	n	y	Heart failure, progressive and sometimes fatal]	LU	y	-	lethal	lethal	lethal	L2|LU	L2	pre-infant-lethal
615396	LEFT VENTRICULAR NONCOMPACTION 10	Left ventricular noncompaction 10, 615396 (3)	Left ventricular noncompaction 10	y	LEFT VENTRICULAR NONCOMPACTION 10; LVNC10	Clinical Synopsis	fatal	MYBPC3	HGNC:7551	Left ventricular noncompaction 10, 615396 (3), Autosomal dominant	Autosomal dominant	n	y	Heart failure, progressive and sometimes fatal]	LU	y	-	lethal	lethal	lethal	L2|LU	L2	pre-infant-lethal
615397	MECKEL SYNDROME, TYPE 11	Meckel syndrome 11, 615397 (3)	Meckel syndrome 11	y	MECKEL SYNDROME, TYPE 11; MKS11	Clinical Synopsis	death|deaths	TMEM231	HGNC:37234	Meckel syndrome 11, 615397 (3), Autosomal recessive	Autosomal recessive	n	y	[Death in utero or early infancy]	L1	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L1	L1	pre-infant-lethal
615398	MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 3	Multiple congenital anomalies-hypotonia-seizures syndrome 3, 615398 (3)	Multiple congenital anomalies-hypotonia-seizures syndrome 3	y	MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 3; MCAHS3	Description|Clinical Features	die|died	PIGT	HGNC:14938	Multiple congenital anomalies-hypotonia-seizures syndrome 3, 615398 (3), Autosomal recessive	Autosomal recessive	y	y	[Multiple congenital anomalies-hypotonia-seizures syndrome is an autosomal recessive disorder characterized by neonatal hypotonia, lack of psychomotor development, seizures, dysmorphic features, and variable congenital anomalies involving the cardiac, urinary, and gastrointestinal systems. Most affected individuals die before 3 years of age (summary by Maydan et al., 2011). The disorder is caused by a defect in glycosylphosphatidylinositol (GPI) biosynthesis]	L4	y	-	lethal	lethal	lethal	L4	L4	post-infant-lethal
615401	IMMUNODEFICIENCY 8 WITH LYMPHOPROLIFERATION	Immunodeficiency 8, 615401 (3)	Immunodeficiency 8	y	IMMUNODEFICIENCY 8 WITH LYMPHOPROLIFERATION; IMD8	Clinical Features	death|deaths|died	CORO1A	HGNC:2252	Immunodeficiency 8, 615401 (3), Autosomal recessive	Autosomal recessive	y	y	[Moshous et al. (2013) reported 3 sibs, born of consanguineous parents of Moroccan ancestry, who developed an aggressive Epstein-Barr virus (EBV)-associated B-cell lymphoproliferative disorder at ages 12, 7.5, and 14 months, respectively. The proband was the third-born child, a 14-month-old girl who had recurrent upper and lower respiratory infections during the first year of life and was found to have diffuse lymphadenopathy associated with significant CD4+ lymphopenia. Lymph node biopsy was positive for EBV, consistent with a diagnosis of EBV-induced B-cell lymphoproliferative syndrome. She was treated with chemotherapy, but died of complications 4 months after bone marrow transplantation. Family history revealed 2 affected older sibs who presented with B-cell lymphoma, which was retrospectively diagnosed as EBV-induced B-cell lymphoproliferation. One child died in infancy during induction chemotherapy, and the other underwent successful chemotherapy]	L3	y	y	lethal	lethal	lethal	L3	L3	pre-infant-lethal
615402	DYSCHROMATOSIS UNIVERSALIS HEREDITARIA 3	Dyschromatosis universalis hereditaria 3, 615402 (3)	Dyschromatosis universalis hereditaria 3	n	-	-	-	ABCB6	HGNC:47	Dyschromatosis universalis hereditaria 3, 615402 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
615411	CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 3	Cortical dysplasia, complex, with other brain malformations 3, 615411 (3)	Cortical dysplasia, complex, with other brain malformations 3	n	-	-	-	KIF2A	HGNC:6318	Cortical dysplasia, complex, with other brain malformations 3, 615411 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
615412	CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 4	Cortical dysplasia, complex, with other brain malformations 4, 615412 (3)	Cortical dysplasia, complex, with other brain malformations 4	n	-	-	-	TUBG1	HGNC:12417	Cortical dysplasia, complex, with other brain malformations 4, 615412 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
615413	SPERMATOGENIC FAILURE 12	Spermatogenic failure 12, 615413 (3)	Spermatogenic failure 12	n	-	-	-	NANOS1	HGNC:23044	Spermatogenic failure 12, 615413 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
615415	RENAL-HEPATIC-PANCREATIC DYSPLASIA 2	Renal-hepatic-pancreatic dysplasia 2, 615415 (3)	Renal-hepatic-pancreatic dysplasia 2	y	RENAL-HEPATIC-PANCREATIC DYSPLASIA 2; RHPD2	Description|Clinical Features|Clinical Synopsis|Phenotype	death|deaths|demise|died|stillborn	NEK8	HGNC:13387	Renal-hepatic-pancreatic dysplasia 2, 615415 (3), Autosomal recessive	Autosomal recessive	n	y	[Death in utero or early childhood]	L1	y	-	lethal	lethal	lethal	L1	L1	pre-infant-lethal
615418	MITOCHONDRIAL DNA DEPLETION SYNDROME 12B (CARDIOMYOPATHIC TYPE), AUTOSOMAL RECESSIVE	Mitochondrial DNA depletion syndrome 12B (cardiomyopathic type) AR, 615418 (3)	Mitochondrial DNA depletion syndrome 12B (cardiomyopathic type) AR	n	-	-	-	SLC25A4	HGNC:10990	Mitochondrial DNA depletion syndrome 12B (cardiomyopathic type) AR, 615418 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L2	L2	pre-infant-lethal
615419	HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 1	Hypotonia, infantile, with psychomotor retardation and characteristic facies 1, 615419 (3)	Hypotonia, infantile, with psychomotor retardation and characteristic facies 1	n	-	-	-	NALCN	HGNC:19082	Hypotonia, infantile, with psychomotor retardation and characteristic facies 1, 615419 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L3	L3	pre-infant-lethal
615420	MYOPIA 22, AUTOSOMAL DOMINANT	Myopia 22, autosomal dominant, 615420 (3)	Myopia 22, autosomal dominant	n	-	-	-	PRIMPOL	HGNC:26575	Myopia 22, autosomal dominant, 615420 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
615425	EPIDERMOLYSIS BULLOSA SIMPLEX 3, LOCALIZED OR GENERALIZED INTERMEDIATE, WITH BP230 DEFICIENCY	Epidermolysis bullosa simplex 3, localized or generalized intermediate, with bp230 deficiency, 615425 (3)	Epidermolysis bullosa simplex 3, localized or generalized intermediate, with bp230 deficiency	n	-	-	-	DST	HGNC:1090	Epidermolysis bullosa simplex 3, localized or generalized intermediate, with bp230 deficiency, 615425 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L3	L3	pre-infant-lethal
615426	AMYOTROPHIC LATERAL SCLEROSIS 20	Amyotrophic lateral sclerosis 20, 615426 (3)	Amyotrophic lateral sclerosis 20	n	-	-	-	HNRNPA1	HGNC:5031	Amyotrophic lateral sclerosis 20, 615426 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
615431	MYOPIA 23, AUTOSOMAL RECESSIVE	Myopia 23, autosomal recessive, 615431 (3)	Myopia 23, autosomal recessive	n	-	-	-	LRPAP1	HGNC:6701	Myopia 23, autosomal recessive, 615431 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
615434	RETINITIS PIGMENTOSA 82 WITH OR WITHOUT SITUS INVERSUS	Retinitis pigmentosa with or without situs inversus, 615434 (3)	Retinitis pigmentosa with or without situs inversus	y	RETINITIS PIGMENTOSA 82 WITH OR WITHOUT SITUS INVERSUS; RP82	Description	die	ARL2BP	HGNC:17146	Retinitis pigmentosa with or without situs inversus, 615434 (3), Autosomal recessive	Autosomal recessive	y	n	-	-	-	-	ambiguous	ambiguous	ambiguous	-	-	-
615436	AORTIC ANEURYSM, FAMILIAL THORACIC 8	Aortic aneurysm, familial thoracic 8, 615436 (3)	Aortic aneurysm, familial thoracic 8	y	AORTIC ANEURYSM, FAMILIAL THORACIC 8; AAT8	Clinical Features	died	PRKG1	HGNC:9414	Aortic aneurysm, familial thoracic 8, 615436 (3), Autosomal dominant	Autosomal dominant	n	y	[Tran-Fadulu et al. (2006) described 3 families with autosomal dominant inheritance of thoracic aortic aneurysms leading to either type A or type B dissections and a young age of onset of aortic dissections in both men and women. One family (TAA216) was a large 6-generation pedigree in which the second-generation matriach died suddenly at 35 years of age from rupture of the ascending aorta, with cystic medial necrosis noted on pathology. One of her daughters died suddenly at 18 years of age due to type A aortic dissection with rupture; a second daughter died of type A dissection at 45 years of age, with medial degeneration noted on pathology]	L5	y	y	lethal	lethal	lethal	L5	L5	post-infant-lethal
615440	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 17	Combined oxidative phosphorylation deficiency 17, 615440 (3)	Combined oxidative phosphorylation deficiency 17	y	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 17; COXPD17	Description|Clinical Features|Clinical Synopsis|Phenotype	fatal|died|death|deaths	ELAC2	HGNC:14198	Combined oxidative phosphorylation deficiency 17, 615440 (3), Autosomal recessive	Autosomal recessive	n	y	[Haack et al. (2013) reported 5 patients from 3 unrelated families with onset of severe hypertrophic cardiomyopathy between 2 and 5 months of age. Two of the families were consanguineous. The infants usually presented with poor growth, hypotonia, and lactic acidosis; most showed delayed psychomotor development after normal early development in the first few months of life. Two patients died before 12 months of age, and a third died at age 4 years, 9 months]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
615441	CARDIAC ARRHYTHMIA SYNDROME, WITH OR WITHOUT SKELETAL MUSCLE WEAKNESS	Cardiac arrhythmia syndrome, with or without skeletal muscle weakness, 615441 (3)	Cardiac arrhythmia syndrome, with or without skeletal muscle weakness	y	CARDIAC ARRHYTHMIA SYNDROME, WITH OR WITHOUT SKELETAL MUSCLE WEAKNESS; CARDAR	Description|Clinical Features|Clinical Synopsis|Phenotype	died|death|deaths	TRDN	HGNC:12261	Cardiac arrhythmia syndrome, with or without skeletal muscle weakness, 615441 (3), Autosomal recessive	Autosomal recessive	y	y	[Rossi et al. (2020) studied an Afghan family in which a brother and sister had died suddenly at 2 years and 3 years of age, respectively, while playing at home]	L4	y	-	lethal	lethal	lethal	L4	L4	post-infant-lethal
615444	CILIARY DYSKINESIA, PRIMARY, 22	Ciliary dyskinesia, primary, 22, 615444 (3)	Ciliary dyskinesia, primary, 22	n	-	-	-	ZMYND10	HGNC:19412	Ciliary dyskinesia, primary, 22, 615444 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
615451	CILIARY DYSKINESIA, PRIMARY, 23	Ciliary dyskinesia, primary, 23, 615451 (3)	Ciliary dyskinesia, primary, 23	n	-	-	-	ODAD2	HGNC:25583	Ciliary dyskinesia, primary, 23, 615451 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
615453	MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 6	Mitochondrial complex III deficiency, nuclear type 6, 615453 (3)	Mitochondrial complex III deficiency, nuclear type 6	n	-	-	-	CYC1	HGNC:2579	Mitochondrial complex III deficiency, nuclear type 6, 615453 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
615458	MICROCORNEA, MYOPIC CHORIORETINAL ATROPHY, AND TELECANTHUS	Microcornea, myopic chorioretinal atrophy, and telecanthus, 615458 (3)	Microcornea, myopic chorioretinal atrophy, and telecanthus	n	-	-	-	ADAMTS18	HGNC:17110	Microcornea, myopic chorioretinal atrophy, and telecanthus, 615458 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
615465	HARTSFIELD SYNDROME	Hartsfield syndrome, 615465 (3)	Hartsfield syndrome	y	HARTSFIELD SYNDROME; HRTFDS	Clinical Features	died	FGFR1	HGNC:3688	Hartsfield syndrome, 615465 (3), Autosomal dominant	Autosomal dominant	y	y	[Hartsfield et al. (1984) reported a male infant born with multiple congenital anomalies, including lobar holoprosencephaly, ectrodactyly, and cleft lip/palate, who died at age 7 days]	L2	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L2|L3	L2	pre-infant-lethal
615468	IMMUNODEFICIENCY 12	Immunodeficiency 12, 615468 (3)	Immunodeficiency 12	y	IMMUNODEFICIENCY 12; IMD12	Clinical Features|Clinical Synopsis	died|death|deaths	MALT1	HGNC:6819	Immunodeficiency 12, 615468 (3), Autosomal recessive	Autosomal recessive	y	y	[Jabara et al. (2013) reported 2 sibs, born of consanguineous Lebanese parents, with a primary immunodeficiency characterized by onset in infancy of recurrent bacterial and candidal infections resulting in bronchiectasis and growth delay. Manifestations included mastoiditis, aphthous ulcers, cheilitis, gingivitis, esophagitis, gastritis, duodenitis, and meningitis. Organisms included Pseudomonas, Streptococcus, Haemophilus influenza, Klebsiella, and cytomegalovirus (CMV), among others. The patients died at ages 7 and 13.5 years]	L4	y	-	lethal	lethal	lethal	L4	L4	post-infant-lethal
615471	MITOCHONDRIAL DNA DEPLETION SYNDROME 13 (ENCEPHALOMYOPATHIC TYPE)	Mitochondrial DNA depletion syndrome 13 (encephalomyopathic type), 615471 (3)	Mitochondrial DNA depletion syndrome 13 (encephalomyopathic type)	y	MITOCHONDRIAL DNA DEPLETION SYNDROME 13 (ENCEPHALOMYOPATHIC TYPE); MTDPS13	Clinical Features|Clinical Synopsis	death|deaths|died|miscarriage|miscarriages	FBXL4	HGNC:13601	Mitochondrial DNA depletion syndrome 13 (encephalomyopathic type), 615471 (3), Autosomal recessive	Autosomal recessive	n	y	[Bonnen et al. (2013) reported 3 unrelated consanguineous Arabian families segregating a severe mitochondrial encephalomyopathy. In the first family, 5 infants presented at birth or in the first months of life with global developmental delay, hypotonia, and persistent lactic acidosis resulting in early death by age 4 years. One infant died at age 3 days / The proband's unaffected mother had a history of 3 miscarriages]	L1	y	y	lethal	lethal	lethal	L1	L1	pre-infant-lethal
615473	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 17	Developmental and epileptic encephalopathy 17, 615473 (3)	Developmental and epileptic encephalopathy 17	y	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 17; DEE17	Clinical Features	died	GNAO1	HGNC:4389	Developmental and epileptic encephalopathy 17, 615473 (3), Autosomal dominant	Autosomal dominant	y	y	[Nakamura et al. (2013) reported 4 unrelated girls with early-onset epileptic encephalopathy. Three patients had onset of intractable tonic seizures in the first weeks of life associated with suppression-burst pattern on EEG, consistent with a clinical diagnosis of Ohtahara syndrome. The fourth patient presented with opisthotonic posturing and developmental delay at age 7 months. All had severely delayed psychomotor development, with lack of sitting and no speech; only 1 patient had head control. One child died at age 11 months]	L3	y	-	lethal	lethal	lethal	L3|L4	L3	pre-infant-lethal
615474	PRIMARY ALDOSTERONISM, SEIZURES, AND NEUROLOGIC ABNORMALITIES	Primary aldosteronism, seizures, and neurologic abnormalities, 615474 (3)	Primary aldosteronism, seizures, and neurologic abnormalities	n	-	-	-	CACNA1D	HGNC:1391	Primary aldosteronism, seizures, and neurologic abnormalities, 615474 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
615476	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 18	Developmental and epileptic encephalopathy 18, 615476 (3)	Developmental and epileptic encephalopathy 18	y	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 18; DEE18	Clinical Features	died	SZT2	HGNC:29040	Developmental and epileptic encephalopathy 18, 615476 (3), Autosomal recessive	Autosomal recessive	y	y	[Basel-Vanagaite et al. (2013) reported 2 unrelated children with early-onset epileptic encephalopathy... One of her brothers likely had the same condition; he had profound developmental delay and intractable seizures, and died at age 3 years from respiratory infection.]	L4	n	y	lethal	lethal	lethal	L4	L4	post-infant-lethal
615481	CILIARY DYSKINESIA, PRIMARY, 24	Ciliary dyskinesia, primary, 24, 615481 (3)	Ciliary dyskinesia, primary, 24	n	-	-	-	RSPH1	HGNC:12371	Ciliary dyskinesia, primary, 24, 615481 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
615482	CILIARY DYSKINESIA, PRIMARY, 25	Ciliary dyskinesia, primary, 25, 615482 (3)	Ciliary dyskinesia, primary, 25	n	-	-	-	DNAAF4	HGNC:21493	Ciliary dyskinesia, primary, 25, 615482 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
615483	BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 5	Basal ganglia calcification, idiopathic, 5, 615483 (3)	Basal ganglia calcification, idiopathic, 5	n	-	-	-	PDGFB	HGNC:8800	Basal ganglia calcification, idiopathic, 5, 615483 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	ambiguous|nonlethal	ambiguous	-	-	-
615485	BAINBRIDGE-ROPERS SYNDROME	Bainbridge-Ropers syndrome, 615485 (3)	Bainbridge-Ropers syndrome	n	-	-	-	ASXL3	HGNC:29357	Bainbridge-Ropers syndrome, 615485 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
615486	INTERSTITIAL LUNG AND LIVER DISEASE	Interstitial lung and liver disease, 615486 (3)	Interstitial lung and liver disease	y	INTERSTITIAL LUNG AND LIVER DISEASE; ILLD	Clinical Features|Clinical Synopsis	death|deaths	MARS1	HGNC:6898	Interstitial lung and liver disease, 615486 (3), Autosomal recessive	Autosomal recessive	n	y	[Hadchouel et al. (2015) reported 26 patients from Reunion Island or the nearby islands of Comoros and Madagascar who had onset of severe respiratory distress in early childhood. Features included dyspnea, cough, digital clubbing, and failure to thrive. Respiratory insufficiency often resulted in death in childhood due to lung fibrosis]	L4	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L4	L4	post-infant-lethal
615490	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2R	Charcot-Marie-Tooth disease, type 2R, 615490 (3)	Charcot-Marie-Tooth disease, type 2R	y	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2R; CMT2R	Clinical Features	died	TRIM2	HGNC:15974	Charcot-Marie-Tooth disease, type 2R, 615490 (3), Autosomal recessive	Autosomal recessive	n	y	[Pehlivan et al. (2015) reported a Turkish boy, born of consanguineous parents, with onset of CMT2R in early infancy. He was noted to have tracheomalacia at age 15 days. At age 6 months, he developed respiratory insufficiency associated with vocal cord paralysis necessitating tracheostomy. At age 16 months, he had axial hypotonia, muscle weakness, increased tone in the lower limbs, knee contracture, hammertoes, pes equinus and pes cavus, and absent deep tendon reflexes. EMG showed markedly reduced amplitudes with decreased motor nerve conductive velocities consistent with severe axonal polyneuropathy. He died of respiratory distress at age 2 years, 9 months]	L4	y	-	lethal	lethal	lethal	L4	L4	post-infant-lethal
615491	SPASTIC PARAPLEGIA 79B, AUTOSOMAL RECESSIVE	Spastic paraplegia 79B, autosomal recessive, 615491 (3)	Spastic paraplegia 79B, autosomal recessive	n	-	-	-	UCHL1	HGNC:12513	Spastic paraplegia 79B, autosomal recessive, 615491 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
615493	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 37	Intellectual developmental disorder, autosomal recessive 37, 615493 (3)	Intellectual developmental disorder, autosomal recessive 37	n	-	-	-	ANK3	HGNC:494	Intellectual developmental disorder, autosomal recessive 37, 615493 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
615500	CILIARY DYSKINESIA, PRIMARY, 26	Ciliary dyskinesia, primary, 26, 615500 (3)	Ciliary dyskinesia, primary, 26	n	-	-	-	CFAP298	HGNC:1301	Ciliary dyskinesia, primary, 26, 615500 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
615501	MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP C	Molybdenum cofactor deficiency C, 615501 (3)	Molybdenum cofactor deficiency C	y	MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP C; MOCODC	Clinical Features|Clinical Synopsis	died|spontaneous_abortion|spontaneous_abortions|death|deaths	GPHN	HGNC:15465	Molybdenum cofactor deficiency C, 615501 (3), Autosomal recessive	Autosomal recessive	n	y	[Reiss et al. (2001) studied the last of 3 affected infants born to a Danish mother and father who were cousins. All 3 died in the neonatal period (at day 12, 29, and 3, respectively) with symptoms identical to those of molybdenum cofactor (MoCo) deficiency. Three other pregnancies of the mother resulted in 2 healthy sibs and 1 spontaneous abortion]	L1	y	y	lethal	lethal	lethal	L1	L1	pre-infant-lethal
615502	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 21	Intellectual developmental disorder, autosomal dominant 21, 615502 (3)	Intellectual developmental disorder, autosomal dominant 21	n	-	-	-	CTCF	HGNC:13723	Intellectual developmental disorder, autosomal dominant 21, 615502 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
615503	SHORT-RIB THORACIC DYSPLASIA 8 WITH OR WITHOUT POLYDACTYLY	Short-rib thoracic dysplasia 8 with or without polydactyly, 615503 (3)	Short-rib thoracic dysplasia 8 with or without polydactyly	y	SHORT-RIB THORACIC DYSPLASIA 8 WITH OR WITHOUT POLYDACTYLY; SRTD8	Description|Clinical Features	lethal|died	DYNC2I1	HGNC:21862	Short-rib thoracic dysplasia 8 with or without polydactyly, 615503 (3), Autosomal recessive	Autosomal recessive	y	y	[Some forms of SRTD are lethal in the neonatal period due to respiratory insufficiency secondary to a severely restricted thoracic cage, whereas others are compatible with life (summary by Huber and Cormier-Daire, 2012 and Schmidts et al., 2013) / McInerney-Leo et al. (2013) studied a nonconsanguineous Australian family of British and Maori descent in which the healthy parents had 2 offspring with short-rib polydactyly syndrome, clinically classified as SRPS type III (SRTD3; 613091). The first child presented with short long bones on ultrasound at 6 weeks' gestation. Follow-up ultrasound at 31 weeks' showed polyhydramnios, severe shortening of long bones with bowed femurs, macrocephaly, short ribs, and ambiguous genitalia. Born at 32 weeks' gestation, the baby died at 2 hours of life]	L2	y	-	lethal	lethal	lethal	L2	L2	pre-infant-lethal
615504	CILIARY DYSKINESIA, PRIMARY, 27	Ciliary dyskinesia, primary, 27, 615504 (3)	Ciliary dyskinesia, primary, 27	n	-	-	-	CCDC65	HGNC:29937	Ciliary dyskinesia, primary, 27, 615504 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
615505	CILIARY DYSKINESIA, PRIMARY, 28	Ciliary dyskinesia, primary, 28, 615505 (3)	Ciliary dyskinesia, primary, 28	n	-	-	-	SPAG1	HGNC:11212	Ciliary dyskinesia, primary, 28, 615505 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
615506	TELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 5	Telangiectasia, hereditary hemorrhagic, type 5, 615506 (3)	Telangiectasia, hereditary hemorrhagic, type 5	y	TELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 5; HHT5	Clinical Features	died	GDF2	HGNC:4217	Telangiectasia, hereditary hemorrhagic, type 5, 615506 (3), Autosomal dominant	Autosomal dominant	n	n	-	-	-	-	ambiguous	ambiguous	ambiguous	-	-	-
615508	ERYTHRODERMA, CONGENITAL, WITH PALMOPLANTAR KERATODERMA, HYPOTRICHOSIS, AND HYPER-IgE	Erythroderma, congenital, with palmoplantar keratoderma, hypotrichosis, and hyper IgE, 615508 (3)	Erythroderma, congenital, with palmoplantar keratoderma, hypotrichosis, and hyper IgE	y	ERYTHRODERMA, CONGENITAL, WITH PALMOPLANTAR KERATODERMA, HYPOTRICHOSIS, AND HYPER-IgE; EPKHE	Clinical Features|Clinical Synopsis	died|death|deaths	DSG1	HGNC:3048	Erythroderma, congenital, with palmoplantar keratoderma, hypotrichosis, and hyper IgE, 615508 (3), Autosomal recessive	Autosomal recessive	n	y	[Samuelov et al. (2013) studied 2 sisters, born of first-cousin Arab Muslim parents, who exhibited hypotrichosis and congenital erythroderma reminiscent of congenital ichthyosiform erythroderma (see 242100), with skin erosions and scaling as well as yellowish papules and plaques at the periphery of the palms, along the volar surfaces of the fingers, and over the weight-bearing areas of the soles of the feet. In addition, both sisters had severe food allergies, markedly elevated IgE levels, and recurrent infections with malabsorption and wasting. One sister had eosinophilic esophagitis, whereas the other had severe esophageal reflux and a ventricular septal defect. Samuelov et al. (2013) also studied a 9-month-old girl, born of first-cousin parents of Druze descent, who had congenital erythroderma and severe dermatitis, hypotrichosis, recurrent skin and respiratory infections, multiple food allergies, and growth retardation. A similarly affected sister, who also had microcephaly and mild pulmonic stenosis, had died at 2 years of age from sepsis. Two additional family members were reported to have died at 2.5 years of age due to a similar disorder]	L4	y	-	lethal	ambiguous|lethal	lethal	L4	L4	post-infant-lethal
615510	ALACRIMA, ACHALASIA, AND IMPAIRED INTELLECTUAL DEVELOPMENT SYNDROME	Alacrima, achalasia, and impaired intellectual development syndrome, 615510 (3)	Alacrima, achalasia, and impaired intellectual development syndrome	n	-	-	-	GMPPA	HGNC:22923	Alacrima, achalasia, and impaired intellectual development syndrome, 615510 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
615511	MYOPATHY DUE TO MYOADENYLATE DEAMINASE DEFICIENCY	Myopathy due to myoadenylate deaminase deficiency, 615511 (3)	Myopathy due to myoadenylate deaminase deficiency	n	-	-	-	AMPD1	HGNC:468	Myopathy due to myoadenylate deaminase deficiency, 615511 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
615512	TRIOSEPHOSPHATE ISOMERASE DEFICIENCY	Hemolytic anemia due to triosephosphate isomerase deficiency, 615512 (3)	Hemolytic anemia due to triosephosphate isomerase deficiency	y	TRIOSEPHOSPHATE ISOMERASE DEFICIENCY; TPID	Description|Clinical Features|Clinical Synopsis	die|death|deaths|died	TPI1	HGNC:12009	Hemolytic anemia due to triosephosphate isomerase deficiency, 615512 (3), Autosomal recessive	Autosomal recessive	y	y	[Fermo et al. (2010) reported 2 unrelated children with TPI deficiency. The first was an Italian girl born of nonconsanguineous parents... He later developed recurrent infections and showed decreased muscle tone with abnormal posturing; he died from respiratory failure at age 10 weeks]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
615513	IMMUNODEFICIENCY 14A WITH LYMPHOPROLIFERATION, AUTOSOMAL DOMINANT	Immunodeficiency 14A, autosomal dominant, 615513 (3)	Immunodeficiency 14A, autosomal dominant	n	-	-	-	PIK3CD	HGNC:8977	Immunodeficiency 14A, autosomal dominant, 615513 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L3	L3	pre-infant-lethal
615515	AMYOTROPHIC LATERAL SCLEROSIS 19	Amyotrophic lateral sclerosis 19, 615515 (3)	Amyotrophic lateral sclerosis 19	n	-	-	-	ERBB4	HGNC:3432	Amyotrophic lateral sclerosis 19, 615515 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
615516	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 38	Intellectual developmental disorder, autosomal recessive 38, 615516 (3)	Intellectual developmental disorder, autosomal recessive 38	n	-	-	-	HERC2	HGNC:4868	Intellectual developmental disorder, autosomal recessive 38, 615516 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
615522	COLE DISEASE	Cole disease, 615522 (3)	Cole disease	n	-	-	-	ENPP1	HGNC:3356	Cole disease, 615522 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L1	L1	pre-infant-lethal
615523	CORNEAL DYSTROPHY, FUCHS ENDOTHELIAL, 8	Corneal dystrophy, Fuchs endothelial, 8, 615523 (3)	Corneal dystrophy, Fuchs endothelial, 8	n	-	-	-	AGBL1	HGNC:26504	Corneal dystrophy, Fuchs endothelial, 8, 615523 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
615524	MICROPHTHALMIA, SYNDROMIC 12	Microphthalmia, syndromic 12, 615524 (3)	Microphthalmia, syndromic 12	y	MICROPHTHALMIA, SYNDROMIC 12; MCOPS12	Clinical Features|Clinical Synopsis	death|deaths|lethality	RARB	HGNC:9865	Microphthalmia, syndromic 12, 615524 (3), Autosomal dominant, Autosomal recessive	Autosomal dominant, Autosomal recessive	n	y	[Early lethality in most cases]	LU	y	-	lethal	lethal	lethal	LU	LU	post-infant-lethal
615528	PARKINSON DISEASE 19A, JUVENILE-ONSET	Parkinson disease 19a, juvenile-onset, 615528 (3)	Parkinson disease 19a, juvenile-onset	n	-	-	-	DNAJC6	HGNC:15469	Parkinson disease 19a, juvenile-onset, 615528 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
615528	PARKINSON DISEASE 19A, JUVENILE-ONSET	Parkinson disease 19b, early-onset, 615528 (3)	Parkinson disease 19b, early-onset	n	-	-	-	DNAJC6	HGNC:15469	Parkinson disease 19b, early-onset, 615528 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
615530	PARKINSON DISEASE 20, EARLY-ONSET	Parkinson disease 20, early-onset, 615530 (3)	Parkinson disease 20, early-onset	n	-	-	-	SYNJ1	HGNC:11503	Parkinson disease 20, early-onset, 615530 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L4	L4	post-infant-lethal
615537	RETICULATE ACROPIGMENTATION OF KITAMURA	Reticulate acropigmentation of Kitamura, 615537 (3)	Reticulate acropigmentation of Kitamura	n	-	-	-	ADAM10	HGNC:188	Reticulate acropigmentation of Kitamura, 615537 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
615539	EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE, 2	Ehlers-Danlos syndrome, musculocontractural type 2, 615539 (3)	Ehlers-Danlos syndrome, musculocontractural type 2	n	-	-	-	DSE	HGNC:21144	Ehlers-Danlos syndrome, musculocontractural type 2, 615539 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
615540	DEAFNESS, AUTOSOMAL RECESSIVE 76	Deafness, autosomal recessive 76, 615540 (3)	Deafness, autosomal recessive 76	n	-	-	-	SYNE4	HGNC:26703	Deafness, autosomal recessive 76, 615540 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
615541	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 39	Intellectual developmental disorder, autosomal recessive 39, 615541 (3)	Intellectual developmental disorder, autosomal recessive 39	n	-	-	-	TTI2	HGNC:26262	Intellectual developmental disorder, autosomal recessive 39, 615541 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
615546	VAN MALDERGEM SYNDROME 2	Van Maldergem syndrome 2, 615546 (3)	Van Maldergem syndrome 2	n	-	-	-	FAT4	HGNC:23109	Van Maldergem syndrome 2, 615546 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
615547	SCHAAF-YANG SYNDROME	Schaaf-Yang syndrome, 615547 (3)	Schaaf-Yang syndrome	y	SCHAAF-YANG SYNDROME; SHFYNG	Description|Clinical Features|Clinical Synopsis|Phenotype	die|death|deaths|died|lethal|miscarriage|miscarriages	MAGEL2	HGNC:6814	Schaaf-Yang syndrome, 615547 (3), Autosomal dominant	Autosomal dominant	y	y	[Some patients die in utero with fetal akinesia whereas others can live with disability]	L1	y	-	lethal	lethal	lethal	L1	L1	pre-infant-lethal
615548	NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE VII	Neuropathy, hereditary sensory and autonomic, type VII, 615548 (3)	Neuropathy, hereditary sensory and autonomic, type VII	n	-	-	-	SCN11A	HGNC:10583	Neuropathy, hereditary sensory and autonomic, type VII, 615548 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
615550	DIAMOND-BLACKFAN ANEMIA 12	Diamond-Blackfan anemia 12, 615550 (3)	Diamond-Blackfan anemia 12	n	-	-	-	RPL15	HGNC:10306	Diamond-Blackfan anemia 12, 615550 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
615551	EPISODIC PAIN SYNDROME, FAMILIAL, 2	Episodic pain syndrome, familial, 2, 615551 (3)	Episodic pain syndrome, familial, 2	n	-	-	-	SCN10A	HGNC:10582	Episodic pain syndrome, familial, 2, 615551 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
615552	EPISODIC PAIN SYNDROME, FAMILIAL, 3	Episodic pain syndrome, familial, 3, 615552 (3)	Episodic pain syndrome, familial, 3	n	-	-	-	SCN11A	HGNC:10583	Episodic pain syndrome, familial, 3, 615552 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
615553	ARTHROGRYPOSIS, IMPAIRED INTELLECTUAL DEVELOPMENT, AND SEIZURES	Arthrogryposis, impaired intellectual development, and seizures, 615553 (3)	Arthrogryposis, impaired intellectual development, and seizures	n	-	-	-	SLC35A3	HGNC:11023	Arthrogryposis, impaired intellectual development, and seizures, 615553 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
615554	MULTIPLE FIBROADENOMAS OF THE BREAST	Multiple fibroadenomas of the breast, 615554 (3)	Multiple fibroadenomas of the breast	n	-	-	-	PRLR	HGNC:9446	Multiple fibroadenomas of the breast, 615554 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
615555	HYPERPROLACTINEMIA	Hyperprolactinemia, 615555 (3)	Hyperprolactinemia	n	-	-	-	PRLR	HGNC:9446	Hyperprolactinemia, 615555 (3), Autosomal dominant, Autosomal recessive	Autosomal dominant, Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
615558	HYPOBETALIPOPROTEINEMIA, FAMILIAL, 1	Hypobetalipoproteinemia, 615558 (3)	Hypobetalipoproteinemia	y	HYPOBETALIPOPROTEINEMIA, FAMILIAL, 1; FHBL1	Clinical Features	died	APOB	HGNC:603	Hypobetalipoproteinemia, 615558 (3), Autosomal recessive	Autosomal recessive	y	y	[Harano et al. (1989) identified homozygous hypobetalipoproteinemia in 3 sibs. Both parents and 2 children of 1 of the sibs were heterozygous. The 75-year-old proband, the father of the 3 sibs, died of fever of unknown cause, thrombocytopenia, and anemia]	L6	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L6	L6	post-infant-lethal
615559	AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME, TYPE III	Autoimmune lymphoproliferative syndrome, type III, 615559 (3)	Autoimmune lymphoproliferative syndrome, type III	y	AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME, TYPE III; ALPS3	Clinical Features	died	PRKCD	HGNC:9399	Autoimmune lymphoproliferative syndrome, type III, 615559 (3), Autosomal recessive	Autosomal recessive	y	y	[In a follow-up of the patients reported by Andre et al. (2007), Belot et al. (2013) noted that none of them presented with features of early-onset immunodeficiency, although 1 died at age 13 years of septic shock]	L5	y	-	lethal	lethal	lethal	L5	L5	post-infant-lethal
615560	OTOFACIOCERVICAL SYNDROME 2, WITH T-CELL DEFICIENCY	Otofaciocervical syndrome 2, 615560 (3)	Otofaciocervical syndrome 2	y	OTOFACIOCERVICAL SYNDROME 2, WITH T-CELL DEFICIENCY; OTFCS2	Description|Clinical Features|Phenotype	fatal|died	PAX1	HGNC:8615	Otofaciocervical syndrome 2, 615560 (3), Autosomal recessive	Autosomal recessive	y	y	[Patients have been reported who also exhibit altered thymus development with T-cell immunodeficiency and recurrent, sometimes fatal, infections (Paganini et al., 2017; Yamazaki et al., 2020) / Paganini et al. (2017) reported 2 distantly related newborns (V:1 and V:18)... Another infant in the family, born to first cousins, also had bilateral ear malformations and died at age 32 days of sepsis]	L3	y	y	lethal	lethal	lethal	L3	L3	pre-infant-lethal
615573	NEPHROTIC SYNDROME, TYPE 9	Nephrotic syndrome, type 9, 615573 (3)	Nephrotic syndrome, type 9	n	-	-	-	COQ8B	HGNC:19041	Nephrotic syndrome, type 9, 615573 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
615574	ASPARAGINE SYNTHETASE DEFICIENCY	Asparagine synthetase deficiency, 615574 (3)	Asparagine synthetase deficiency	y	ASPARAGINE SYNTHETASE DEFICIENCY; ASNSD	Description|Clinical Features|Clinical Synopsis|Phenotype	death|deaths|died	ASNS	HGNC:753	Asparagine synthetase deficiency, 615574 (3), Autosomal recessive	Autosomal recessive	y	y	[Sun et al. (2017) reported 2 sisters from a consanguineous Indian family with ASNSD. In addition to typical features of the disorder, including congenital microcephaly with a progressive course, severe psychomotor delay, appendicular hypertonia, hyperreflexia, and progressive brain atrophy, both girls had diaphragmatic eventration. Neither patient had epilepsy, but one had hyperekplexia and the other had an abnormal EEG. One of the sisters was described as having unusual jittery movements. One girl died at 6 months of age and the other at 11 days]	L2	y	-	lethal	lethal	lethal	L2	L2	pre-infant-lethal
615575	NEURONOPATHY, DISTAL HEREDITARY MOTOR, AUTOSOMAL DOMINANT 6	Neuronopathy, distal hereditary motor, autosomal dominant 6, 615575 (3)	Neuronopathy, distal hereditary motor, autosomal dominant 6	n	-	-	-	FBXO38	HGNC:28844	Neuronopathy, distal hereditary motor, autosomal dominant 6, 615575 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
615577	IMMUNODEFICIENCY, COMMON VARIABLE, 10	Immunodeficiency, common variable, 10, 615577 (3)	Immunodeficiency, common variable, 10	y	IMMUNODEFICIENCY, COMMON VARIABLE, 10; CVID10	Clinical Features	died	NFKB2	HGNC:7795	Immunodeficiency, common variable, 10, 615577 (3), Autosomal dominant	Autosomal dominant	y	y	Aird et al. (2019) reported a 13-year-old girl who developed progressive hair loss, trachyonychia, psoriatic-like dermatitis, and atopic dermatitis at 2 years of age. She had recurrent sinopulmonary infections and was found to have hypogammaglobulinemia at age 6. At age 9, she had cytomegalovirus (CMV) pneumonia that was treated with ganciclovir. She had reduced serum cortisol and ACTH, and was treated with glucocorticoid replacement. At age 12, she had reactivation of the CMV infection that was associated with progressive nephrotic syndrome, and proteinuria fluctuated in concert with CMV titers. Renal histology showed focal segmental glomerulosclerosis. She developed Pneumocystis jiroveci pneumonia and a fungal lung infection, and died at age 13 of multiorgan failure]	L5	y	-	lethal	lethal	lethal	L5	L5	post-infant-lethal
615578	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 18	Combined oxidative phosphorylation deficiency 18, 615578 (3)	Combined oxidative phosphorylation deficiency 18	n	-	-	-	SFXN4	HGNC:16088	Combined oxidative phosphorylation deficiency 18, 615578 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
615582	LOEYS-DIETZ SYNDROME 5	Loeys-Dietz syndrome 5, 615582 (3)	Loeys-Dietz syndrome 5	y	LOEYS-DIETZ SYNDROME 5; LDS5	Clinical Features	died	TGFB3	HGNC:11769	Loeys-Dietz syndrome 5, 615582 (3), Autosomal dominant	Autosomal dominant	y	y	[Bertoli-Avella et al. (2015) studied a large, 3-generation Dutch pedigree with 12 affected individuals, including 7 patients between 40 years and 68 years of age who presented with aneurysms and dissections that mainly involved the descending thoracic and abdominal aorta; 3 of those patients died from aortic dissection and rupture]	L6	y	-	lethal	lethal	lethal	L5|L6	L5	post-infant-lethal
615583	VERHEIJ SYNDROME	Verheij syndrome, 615583 (3)	Verheij syndrome	y	VERHEIJ SYNDROME; VRJS	Clinical Features	died	PUF60	HGNC:17042	Verheij syndrome, 615583 (3), Autosomal dominant	Autosomal dominant	n	y	[Verheij et al. (2009) reported 2 unrelated Dutch children born with multiple and somewhat overlapping congenital anomalies associated with large heterozygous de novo deletions of chromosome 8q24... Dysmorphic features included triangular ears with flattened helices, prominent nasal tip, and hypoplastic nasal alae. Some features were reminiscent of Langer-Giedion syndrome (150230), but she died at age 11 months from a subdural hematoma before classic features of that syndrome could develop]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
615592	IMMUNODEFICIENCY 15B	Immunodeficiency 15B, 615592 (3)	Immunodeficiency 15B	y	IMMUNODEFICIENCY 15B; IMD15B	Clinical Features|Clinical Synopsis|Phenotype	death|deaths|died|fatal|lethal	IKBKB	HGNC:5960	Immunodeficiency 15B, 615592 (3), Autosomal recessive	Autosomal recessive	n	y	[Nielsen et al. (2014) reported a female infant, born of consanguineous Turkish parents, with severe immunodeficiency resulting in death at age 14 months. After uneventful vaccination with BCG, she presented at age 5 months with fungal pneumonia (Pneumocystis jirovecii). Immunologic workup showed increased serum IgM, absence of isotype-switched memory B cells, and low numbers of CD45R0+ memory T cells. At age 9 months, she presented with systemic infection by Mycobacterium bovis. Despite intense treatment, she died of cardiac arrest]	L3	y	-	lethal	ambiguous|lethal	lethal	L3	L3	pre-infant-lethal
615596	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Iw, AUTOSOMAL RECESSIVE	Congenital disorder of glycosylation, type Iw, autosomal recessive, 615596 (3)	Congenital disorder of glycosylation, type Iw, autosomal recessive	n	-	-	-	STT3A	HGNC:6172	Congenital disorder of glycosylation, type Iw, autosomal recessive, 615596 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
615597	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ix	Congenital disorder of glycosylation, type Ix, 615597 (3)	Congenital disorder of glycosylation, type Ix	y	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ix; CDG1X	Clinical Features|Clinical Synopsis	died|death|deaths	STT3B	HGNC:30611	Congenital disorder of glycosylation, type Ix, 615597 (3), Autosomal recessive	Autosomal recessive	y	y	[died at age 4 years]	L4	y	-	lethal	lethal	lethal	L4	L4	post-infant-lethal
615598	PALMOPLANTAR KERATODERMA, NAGASHIMA TYPE	Palmoplantar keratoderma, Nagashima type, 615598 (3)	Palmoplantar keratoderma, Nagashima type	n	-	-	-	SERPINB7	HGNC:13902	Palmoplantar keratoderma, Nagashima type, 615598 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
615599	NEURODEVELOPMENTAL DISORDER WITH FEEDING DIFFICULTIES, THIN CORPUS CALLOSUM, AND FOOT DEFORMITY	Intellectual developmental disorder, autosomal recessive 40, 615599 (3)	Intellectual developmental disorder, autosomal recessive 40	n	-	-	-	TAF2	HGNC:11536	Intellectual developmental disorder, autosomal recessive 40, 615599 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
615604	L-FERRITIN DEFICIENCY	L-ferritin deficiency, dominant and recessive, 615604 (3)	L-ferritin deficiency, dominant and recessive	n	-	-	-	FTL	HGNC:3999	L-ferritin deficiency, dominant and recessive, 615604 (3), Autosomal dominant, Autosomal recessive	Autosomal dominant, Autosomal recessive	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L6	L6	post-infant-lethal
615607	IMMUNODEFICIENCY 17	Immunodeficiency 17, CD3 gamma deficient, 615607 (3)	Immunodeficiency 17, CD3 gamma deficient	y	IMMUNODEFICIENCY 17; IMD17	Description|Clinical Features|Clinical Synopsis	lethal|died|die	CD3G	HGNC:1675	Immunodeficiency 17, CD3 gamma deficient, 615607 (3), Autosomal recessive	Autosomal recessive	y	y	[Recio et al. (2007) reported 2 brothers, born of consanguineous parents, with IMD17. The patients presented in infancy with recurrent infections, and immune work-up showed partial T lymphocytopenia and low CD3, but normal B cells, NK cells, and immunoglobulins. Proliferative responses were low compared with controls. Both patients also had inflammatory bowel disease without evidence of autoimmunity. One boy underwent bone marrow transplantation, but died at age 20 months, whereas the other boy died at age 9 months before transplantation]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
615615	IMMUNODEFICIENCY 18	Immunodeficiency 18, 615615 (3)	Immunodeficiency 18	y	IMMUNODEFICIENCY 18; IMD18	Description|Clinical Features|Phenotype	death|deaths|died	CD3E	HGNC:1674	Immunodeficiency 18, 615615 (3), Autosomal recessive	Autosomal recessive	n	y	[De Saint Basile et al. (2004) reported 3 sibs, born of consanguineous parents, with recurrent multisystem infections due to SCID apparent in the first months of life. One child died of pneumonitis at age 5 months, and a second died at age 3 months. The third infant received a bone marrow transplant soon after birth, but died 25 days later]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
615615	IMMUNODEFICIENCY 18	Immunodeficiency 18, SCID variant, 615615 (3)	Immunodeficiency 18, SCID variant	y	IMMUNODEFICIENCY 18; IMD18	Description|Clinical Features|Phenotype	death|deaths|died	CD3E	HGNC:1674	Immunodeficiency 18, SCID variant, 615615 (3), Autosomal recessive	Autosomal recessive	n	y	[De Saint Basile et al. (2004) reported 3 sibs, born of consanguineous parents, with recurrent multisystem infections due to SCID apparent in the first months of life. One child died of pneumonitis at age 5 months, and a second died at age 3 months. The third infant received a bone marrow transplant soon after birth, but died 25 days later]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
615616	ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 13	Arrhythmogenic right ventricular dysplasia 13, 615616 (3)	Arrhythmogenic right ventricular dysplasia 13	y	ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 13; ARVD13	Description|Clinical Features	death|deaths|died	CTNNA3	HGNC:2511	Arrhythmogenic right ventricular dysplasia 13, 615616 (3), Autosomal dominant	Autosomal dominant	y	n	-	-	-	-	ambiguous	ambiguous	ambiguous	-	-	-
615617	IMMUNODEFICIENCY 19	Immunodeficiency 19, severe combined, 615617 (3)	Immunodeficiency 19, severe combined	y	IMMUNODEFICIENCY 19; IMD19	Description|Clinical Features|Clinical Synopsis	lethal|died|death|deaths	CD3D	HGNC:1673	Immunodeficiency 19, severe combined, 615617 (3), Autosomal recessive	Autosomal recessive	n	y	[age of 2 months with fever, tachypnea, and tachycardia and died of multiorgan failure]	L3	y	y	lethal	lethal	lethal	L3	L3	pre-infant-lethal
615629	DEAFNESS, AUTOSOMAL DOMINANT 56	Deafness, autosomal dominant 56, 615629 (3)	Deafness, autosomal dominant 56	n	-	-	-	TNC	HGNC:5318	Deafness, autosomal dominant 56, 615629 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
615630	SHORT-RIB THORACIC DYSPLASIA 10 WITH OR WITHOUT POLYDACTYLY	Short-rib thoracic dysplasia 10 with or without polydactyly, 615630 (3)	Short-rib thoracic dysplasia 10 with or without polydactyly	y	SHORT-RIB THORACIC DYSPLASIA 10 WITH OR WITHOUT POLYDACTYLY; SRTD10	Description	lethal	IFT172	HGNC:30391	Short-rib thoracic dysplasia 10 with or without polydactyly, 615630 (3), Autosomal recessive	Autosomal recessive	n	y	[Some forms of SRTD are lethal in the neonatal period due to respiratory insufficiency secondary to a severely restricted thoracic cage, whereas others are compatible with life (summary by Huber and Cormier-Daire, 2012 and Schmidts et al., 2013]	L2	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L2	L2	pre-infant-lethal
615631	ANEMIA, CONGENITAL DYSERYTHROPOIETIC, TYPE Ib	Dyserythropoietic anemia, congenital, type Ib, 615631 (3)	Dyserythropoietic anemia, congenital, type Ib	n	-	-	-	CDIN1	HGNC:26929	Dyserythropoietic anemia, congenital, type Ib, 615631 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
615632	NEUROPATHY, HEREDITARY SENSORY, TYPE IF	Neuropathy, hereditary sensory, type IF, 615632 (3)	Neuropathy, hereditary sensory, type IF	n	-	-	-	ATL3	HGNC:24526	Neuropathy, hereditary sensory, type IF, 615632 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
615633	SHORT-RIB THORACIC DYSPLASIA 11 WITH OR WITHOUT POLYDACTYLY	Short-rib thoracic dysplasia 11 with or without polydactyly, 615633 (3)	Short-rib thoracic dysplasia 11 with or without polydactyly	y	SHORT-RIB THORACIC DYSPLASIA 11 WITH OR WITHOUT POLYDACTYLY; SRTD11	Description|Clinical Features|Clinical Synopsis	lethal|died|fatal|stillborn|die	DYNC2I2	HGNC:28296	Short-rib thoracic dysplasia 11 with or without polydactyly, 615633 (3), Autosomal recessive	Autosomal recessive	n	y	[Some forms of SRTD are lethal in the neonatal period due to respiratory insufficiency secondary to a severely restricted thoracic cage, whereas others are compatible with life (summary by Huber and Cormier-Daire, 2012 and Schmidts et al., 2013) / Huber et al. (2013) studied a consanguineous Algerian family in which 3 sibs had short-rib thoracic dysplasia....The third case was diagnosed at 20 weeks of gestation and was stillborn at 42 weeks of gestation]	L1	y	-	lethal	lethal	lethal	L1	L1	pre-infant-lethal
615636	JOUBERT SYNDROME 21	Joubert syndrome 21, 615636 (3)	Joubert syndrome 21	y	JOUBERT SYNDROME 21; JBTS21	Clinical Features|Clinical Synopsis	death|deaths|stillborn	CSPP1	HGNC:26193	Joubert syndrome 21, 615636 (3), Autosomal recessive	Autosomal recessive	n	y	[Shaheen et al. (2014) also reported 2 fetuses in a consanguineous family of Saudi Arabian origin who were stillborn with severe brain malformations reminiscent of Meckel syndrome (249000). Features included hydranencephaly, large fontanels and wide cranial sutures, occipital encephalocele, anophthalmia/partially fused eyes, single nostril, and hyperechogenic kidneys. Another pregnancy in this family ended in a spontaneous first-trimester abortion]	L1	y	-	lethal	lethal	lethal	L1	L1	pre-infant-lethal
615637	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 41	Intellectual developmental disorder, autosomal recessive 41, 615637 (3)	Intellectual developmental disorder, autosomal recessive 41	n	-	-	-	KPTN	HGNC:6404	Intellectual developmental disorder, autosomal recessive 41, 615637 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
615643	NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 6	Neurodegeneration with brain iron accumulation 6, 615643 (3)	Neurodegeneration with brain iron accumulation 6	n	-	-	-	COASY	HGNC:29932	Neurodegeneration with brain iron accumulation 6, 615643 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L3	L3	pre-infant-lethal
615651	LEUKOENCEPHALOPATHY WITH ATAXIA	Leukoencephalopathy with ataxia, 615651 (3)	Leukoencephalopathy with ataxia	n	-	-	-	CLCN2	HGNC:2020	Leukoencephalopathy with ataxia, 615651 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
615663	WARBURG MICRO SYNDROME 4	Warburg micro syndrome 4, 615663 (3)	Warburg micro syndrome 4	n	-	-	-	TBC1D20	HGNC:16133	Warburg micro syndrome 4, 615663 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
615665	JOUBERT SYNDROME 22	Joubert syndrome 22, 615665 (3)	Joubert syndrome 22	n	-	-	-	PDE6D	HGNC:8788	Joubert syndrome 22, 615665 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
615673	MYOPATHY WITH EXTRAPYRAMIDAL SIGNS	Myopathy with extrapyramidal signs, 615673 (3)	Myopathy with extrapyramidal signs	n	-	-	-	MICU1	HGNC:1530	Myopathy with extrapyramidal signs, 615673 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
615681	SPASTIC PARAPLEGIA 62, AUTOSOMAL RECESSIVE	Spastic paraplegia 62, autosomal recessive, 615681 (3)	Spastic paraplegia 62, autosomal recessive	n	-	-	-	ERLIN1	HGNC:16947	Spastic paraplegia 62, autosomal recessive, 615681 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
615683	SPASTIC PARAPLEGIA 64, AUTOSOMAL RECESSIVE	Spastic paraplegia 64, autosomal recessive, 615683 (3)	Spastic paraplegia 64, autosomal recessive	n	-	-	-	ENTPD1	HGNC:3363	Spastic paraplegia 64, autosomal recessive, 615683 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
615688	VASCULITIS, AUTOINFLAMMATION, IMMUNODEFICIENCY, AND HEMATOLOGIC DEFECTS SYNDROME	Vasculitis, autoinflammation, immunodeficiency, and hematologic defects syndrome, 615688 (3)	Vasculitis, autoinflammation, immunodeficiency, and hematologic defects syndrome	y	VASCULITIS, AUTOINFLAMMATION, IMMUNODEFICIENCY, AND HEMATOLOGIC DEFECTS SYNDROME; VAIHS	Phenotype	death|deaths	ADA2	HGNC:1839	Vasculitis, autoinflammation, immunodeficiency, and hematologic defects syndrome, 615688 (3), Autosomal recessive	Autosomal recessive	n	n	-	-	-	-	ambiguous	ambiguous|lethal	lethal	L6	L6	post-infant-lethal
615696	DOWLING-DEGOS DISEASE 4	Dowling-Degos disease 4, 615696 (3)	Dowling-Degos disease 4	n	-	-	-	POGLUT1	HGNC:22954	Dowling-Degos disease 4, 615696 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
615703	MORBID OBESITY AND SPERMATOGENIC FAILURE	Morbid obesity and spermatogenic failure, 615703 (3)	Morbid obesity and spermatogenic failure	n	-	-	-	CEP19	HGNC:28209	Morbid obesity and spermatogenic failure, 615703 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
615704	POIKILODERMA, HEREDITARY FIBROSING, WITH TENDON CONTRACTURES, MYOPATHY, AND PULMONARY FIBROSIS	Poikiloderma, hereditary fibrosing, with tendon contractures, myopathy, and pulmonary fibrosis, 615704 (3)	Poikiloderma, hereditary fibrosing, with tendon contractures, myopathy, and pulmonary fibrosis	y	POIKILODERMA, HEREDITARY FIBROSING, WITH TENDON CONTRACTURES, MYOPATHY, AND PULMONARY FIBROSIS; POIKTMP	Clinical Features	died	FAM111B	HGNC:24200	Poikiloderma, hereditary fibrosing, with tendon contractures, myopathy, and pulmonary fibrosis, 615704 (3), Autosomal dominant	Autosomal dominant	y	y	[Khumalo et al. (2006) described a 2-generation South African family of European descent in which the proband was a 26-year-old woman with a history of heat intolerance and facial skin lesions from early childhood. At 9 years of age she developed Achilles tendon contractures, requiring surgery at 14 years of age. Examination showed telangiectasia, mottled hyper- and hypopigmentation, papules, and epidermal atrophy of the cheeks and face. She had fine scalp hair, thin eyebrows, and virtually no hair on her arms or legs, which also showed variable pigmentation. There was bilateral atrophy of thenar and hypothenar eminences, and limited extension of fingers due to sclerosis, but no Raynaud phenomenon. She exhibited hypohidrosis, but teeth and nails were normal. Pulmonary evaluation showed restrictive impairment of lung function but normal chest x-ray. Her father and older brother had similar skin and tendon abnormalities and had died of diffuse interstitial pulmonary fibrosis at the age of 56 and 30 years, respectively]	L6	n	y	lethal	lethal	lethal	L6	L6	post-infant-lethal
615705	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 15	Spinocerebellar ataxia, autosomal recessive 15, 615705 (3)	Spinocerebellar ataxia, autosomal recessive 15	n	-	-	-	RUBCN	HGNC:28991	Spinocerebellar ataxia, autosomal recessive 15, 615705 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
615706	AURICULOCONDYLAR SYNDROME 3	Auriculocondylar syndrome 3, 615706 (3)	Auriculocondylar syndrome 3	n	-	-	-	EDN1	HGNC:3176	Auriculocondylar syndrome 3, 615706 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
615707	IMMUNODEFICIENCY 20	Immunodeficiency 20, 615707 (3)	Immunodeficiency 20	n	-	-	-	FCGR3A	HGNC:3619	Immunodeficiency 20, 615707 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
615709	SACRAL AGENESIS WITH VERTEBRAL ANOMALIES	Sacral agenesis with vertebral anomalies, 615709 (3)	Sacral agenesis with vertebral anomalies	y	SACRAL AGENESIS WITH VERTEBRAL ANOMALIES; SAVA	Clinical Features|Clinical Synopsis	died|death|deaths	TBXT	HGNC:11515	Sacral agenesis with vertebral anomalies, 615709 (3), Autosomal recessive	Autosomal recessive	n	y	[Early death may occur / Postma et al. (2014) reported 4 children from 3 consanguineous families with abnormalities of the spine, including sacral agenesis, abnormal ossification of all vertebral bodies, and a persistent notochordal canal during development. Sacral agenesis and a persistent notochord were detected prenatally in 3 of the patients. During ultrasound follow-up, the tubular notochord structure became progressively less visible and was gradually replaced by vertebral bodies. Two sibs died in the neonatal period]	L2	y	y	lethal	lethal	lethal	L2	L2	pre-infant-lethal
615710	MITCHELL-RILEY SYNDROME	Mitchell-Riley syndrome, 615710 (3)	Mitchell-Riley syndrome	y	MITCHELL-RILEY SYNDROME; MTCHRS	Clinical Features|Clinical Synopsis	died|fatal	RFX6	HGNC:21478	Mitchell-Riley syndrome, 615710 (3), Autosomal recessive	Autosomal recessive	y	y	[Smith et al. (2010) reported 2 unrelated patients with IUGR and duodenal atresia: one was a male infant, born to nonconsanguineous French parents, in whom neonatal diabetes was diagnosed at day 2. His course was complicated by refractory ascites, sepsis, and gastrointestinal hemorrhage, from which he died at 2.5 months of age]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
615715	BONE MARROW FAILURE SYNDROME 2	Bone marrow failure syndrome 2, 615715 (3)	Bone marrow failure syndrome 2	n	-	-	-	ERCC6L2	HGNC:26922	Bone marrow failure syndrome 2, 615715 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
615716	HYPERPHOSPHATASIA WITH IMPAIRED INTELLECTUAL DEVELOPMENT SYNDROME 4	Hyperphosphatasia with impaired intellectual development syndrome 4, 615716 (3)	Hyperphosphatasia with impaired intellectual development syndrome 4	y	HYPERPHOSPHATASIA WITH IMPAIRED INTELLECTUAL DEVELOPMENT SYNDROME 4; HPMRS4	Clinical Features	died	PGAP3	HGNC:23719	Hyperphosphatasia with impaired intellectual development syndrome 4, 615716 (3), Autosomal recessive	Autosomal recessive	y	y	[died at the age of 18 months due to aspiration pneumonia]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
615722	BOSCH-BOONSTRA-SCHAAF OPTIC ATROPHY SYNDROME	Bosch-Boonstra-Schaaf optic atrophy syndrome, 615722 (3)	Bosch-Boonstra-Schaaf optic atrophy syndrome	n	-	-	-	NR2F1	HGNC:7975	Bosch-Boonstra-Schaaf optic atrophy syndrome, 615722 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
615723	PREMATURE OVARIAN FAILURE 8	Premature ovarian failure 8, 615723 (3)	Premature ovarian failure 8	n	-	-	-	STAG3	HGNC:11356	Premature ovarian failure 8, 615723 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
615724	PREMATURE OVARIAN FAILURE 9	Premature ovarian failure 9, 615724 (3)	Premature ovarian failure 9	n	-	-	-	HFM1	HGNC:20193	Premature ovarian failure 9, 615724 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
615725	RETINITIS PIGMENTOSA 68	Retinitis pigmentosa 68, 615725 (3)	Retinitis pigmentosa 68	n	-	-	-	SLC7A14	HGNC:29326	Retinitis pigmentosa 68, 615725 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
615726	PACHYONYCHIA CONGENITA 3	Pachyonychia congenita 3, 615726 (3)	Pachyonychia congenita 3	y	PACHYONYCHIA CONGENITA 3; PC3	Clinical Features	died	KRT6A	HGNC:6443	Pachyonychia congenita 3, 615726 (3), Autosomal dominant	Autosomal dominant	y	y	[Goldberg et al. (2020) presented a case series of 9 children with PC3 and symptomatic mucosal involvement. Oral leukokeratosis presented early in the neonatal period. Seven patients had painful feeding as infants; 4 were diagnosed with failure to thrive, 3 of whom required a feeding tube. One patient (case 8) was diagnosed with oral and airway leukokeratosis with severe vocal cord involvement. He died at age 4 as a result of acute laryngitis that led to cardiorespiratory arrest]	L4	y	-	lethal	lethal	lethal	L4	L4	post-infant-lethal
615728	PACHYONYCHIA CONGENITA 4	Pachyonychia congenita 4, 615728 (3)	Pachyonychia congenita 4	n	-	-	-	KRT6B	HGNC:6444	Pachyonychia congenita 4, 615728 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
615731	NEMALINE MYOPATHY 9	Nemaline myopathy 9, 615731 (3)	Nemaline myopathy 9	y	NEMALINE MYOPATHY 9; NEM9	Description|Clinical Features|Clinical Synopsis|Phenotype	death|deaths|died|die	KLHL41	HGNC:16905	Nemaline myopathy 9, 615731 (3), Autosomal recessive	Autosomal recessive	n	y	[Gupta et al. (2013) reported 5 unrelated children with nemaline myopathy and variable severity. Two infants presented at birth in breech presentation and with severe fetal akinesia, consistent with onset of muscle weakness in utero; they showed poor or no antigravity movements and died at ages 1 day and 3 months]	L2	y	-	lethal	lethal	lethal	L2	L2	pre-infant-lethal
615735	PALMOPLANTAR KERATODERMA, NONEPIDERMOLYTIC, FOCAL OR DIFFUSE	Palmoplantar keratoderma, nonepidermolytic, focal or diffuse, 615735 (3)	Palmoplantar keratoderma, nonepidermolytic, focal or diffuse	n	-	-	-	KRT6C	HGNC:20406	Palmoplantar keratoderma, nonepidermolytic, focal or diffuse, 615735 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
615744	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 19	Developmental and epileptic encephalopathy 19, 615744 (3)	Developmental and epileptic encephalopathy 19	n	-	-	-	GABRA1	HGNC:4075	Developmental and epileptic encephalopathy 19, 615744 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
615745	ATRIAL STANDSTILL 2	Atrial standstill 2, 615745 (3)	Atrial standstill 2	y	ATRIAL STANDSTILL 2; ATRST2	Clinical Features	death|deaths|died	NPPA	HGNC:7939	Atrial standstill 2, 615745 (3), Autosomal recessive	Autosomal recessive	n	y	[Disertori et al. (2013) provided follow-up on the 8 patients originally studied by Disertori et al. (1983) and described 5 more patients from the same community in northeastern Italy with atrial dilation and standstill, 1 from 1 of the original families and 4 from 3 new families. The 13 patients were 31 to 58 years of age at the time of diagnosis. Diagnosis at onset was idiopathic atrial dilation, associated with AS in 7 and bradycardia-tachycardia syndrome in 6; the latter group developed AS during follow-up. Cerebral embolism occurred in 7 of 13 patients, with peripheral embolism in 1. Of the original 8 patients, 5 died 8 to 25 years after diagnosis, 4 with out-of-hospital sudden death]	LU	y	-	lethal	lethal|nonlethal	lethal|nonlethal	LU	LU	post-infant-lethal
615750	MOYAMOYA DISEASE 6 WITH OR WITHOUT ACHALASIA	Moyamoya 6 with achalasia, 615750 (3)	Moyamoya 6 with achalasia	n	-	-	-	GUCY1A1	HGNC:4685	Moyamoya 6 with achalasia, 615750 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
615751	CARBONIC ANHYDRASE VA DEFICIENCY, HYPERAMMONEMIA DUE TO	Hyperammonemia due to carbonic anhydrase VA deficiency, 615751 (3)	Hyperammonemia due to carbonic anhydrase VA deficiency	n	-	-	-	CA5A	HGNC:1377	Hyperammonemia due to carbonic anhydrase VA deficiency, 615751 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
615752	CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 14B (BILATERAL PERISYLVIAN)	Cortical dysplasia, complex, with other brain malformations 14B, (bilateral perisylvian), 615752 (3)	Cortical dysplasia, complex, with other brain malformations 14B, (bilateral perisylvian)	n	-	-	-	ADGRG1	HGNC:4512	Cortical dysplasia, complex, with other brain malformations 14B, (bilateral perisylvian), 615752 (3)	-	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
615760	MICROCEPHALY, PROGRESSIVE, WITH SEIZURES AND CEREBRAL AND CEREBELLAR ATROPHY	Microcephaly, progressive, seizures, and cerebral and cerebellar atrophy, 615760 (3)	Microcephaly, progressive, seizures, and cerebral and cerebellar atrophy	y	MICROCEPHALY, PROGRESSIVE, WITH SEIZURES AND CEREBRAL AND CEREBELLAR ATROPHY; MSCCA	Phenotype	death|deaths	QARS1	HGNC:9751	Microcephaly, progressive, seizures, and cerebral and cerebellar atrophy, 615760 (3), Autosomal recessive	Autosomal recessive	n	n	-	-	-	-	ambiguous	ambiguous	ambiguous	-	-	-
615761	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 23	Intellectual developmental disorder, autosomal dominant 23, 615761 (3)	Intellectual developmental disorder, autosomal dominant 23	n	-	-	-	SETD5	HGNC:25566	Intellectual developmental disorder, autosomal dominant 23, 615761 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
615763	CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 5	Cortical dysplasia, complex, with other brain malformations 5, 615763 (3)	Cortical dysplasia, complex, with other brain malformations 5	n	-	-	-	TUBB2A	HGNC:12412	Cortical dysplasia, complex, with other brain malformations 5, 615763 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
615768	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 16	Spinocerebellar ataxia, autosomal recessive 16, 615768 (3)	Spinocerebellar ataxia, autosomal recessive 16	n	-	-	-	STUB1	HGNC:11427	Spinocerebellar ataxia, autosomal recessive 16, 615768 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L6	L6	post-infant-lethal
615771	CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 6	Cortical dysplasia, complex, with other brain malformations 6, 615771 (3)	Cortical dysplasia, complex, with other brain malformations 6	n	-	-	-	TUBB	HGNC:20778	Cortical dysplasia, complex, with other brain malformations 6, 615771 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
615774	OOCYTE/ZYGOTE/EMBRYO MATURATION ARREST 1	Oocyte/zygote/embryo maturation arrest 1, 615774 (3)	Oocyte/zygote/embryo maturation arrest 1	n	-	-	-	ZP1	HGNC:13187	Oocyte/zygote/embryo maturation arrest 1, 615774 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
615777	DESBUQUOIS DYSPLASIA 2	Desbuquois dysplasia 2, 615777 (3)	Desbuquois dysplasia 2	n	-	-	-	XYLT1	HGNC:15516	Desbuquois dysplasia 2, 615777 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
615779	CONGENITAL HEART DEFECTS, MULTIPLE TYPES, 4	Congenital heart defects, multiple types, 4, 615779 (3)	Congenital heart defects, multiple types, 4	y	CONGENITAL HEART DEFECTS, MULTIPLE TYPES, 4; CHTD4	Clinical Features|Phenotype	died	NR2F2	HGNC:7976	Congenital heart defects, multiple types, 4, 615779 (3), Autosomal dominant	Autosomal dominant	y	y	[Qiao et al. (2018) studied a Han Chinese family (family 1) in which 5 affected individuals over 3 generations had double-outlet right ventricle (DORV) and VSD. The proband was a 1-year old boy whose 26-year-old father was also affected, as well as a paternal uncle and that uncle's 6-year-old daughter. The paternal grandfather, who died at age 50, was also reported to have been affected]	L6	n	y	lethal	lethal	lethal	L2|L6	L2	pre-infant-lethal
615780	RETINITIS PIGMENTOSA 69	Retinitis pigmentosa 69, 615780 (3)	Retinitis pigmentosa 69	n	-	-	-	KIZ	HGNC:15865	Retinitis pigmentosa 69, 615780 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
615785	WHITE SPONGE NEVUS 2	White sponge nevus 2, 615785 (3)	White sponge nevus 2	n	-	-	-	KRT13	HGNC:6415	White sponge nevus 2, 615785 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
615789	SHORT STATURE WITH MICROCEPHALY AND DISTINCTIVE FACIES	Short stature with microcephaly and distinctive facies, 615789 (3)	Short stature with microcephaly and distinctive facies	y	SHORT STATURE WITH MICROCEPHALY AND DISTINCTIVE FACIES; SSMCF	Clinical Features|Clinical Synopsis	died	CRIPT	HGNC:14312	Short stature with microcephaly and distinctive facies, 615789 (3), Autosomal recessive	Autosomal recessive	n	y	[Shaheen et al. (2014) studied 2 unrelated Saudi Arabian boys with height and weight more than 3 SD below the mean at birth and persistent growth deficiency postnatally, which the authors designated 'primordial dwarfism.' ... Brain MRI showed bifrontal subdural hygroma in 1 patient who had profound global developmental delay at age 3 years; in the other, who died at 2 months of age, there was increased white matter signal and hypogenesis of corpus callosum. The patient who died had recurrent infections and persistent anemia with anisopoikilocytosis]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
615802	NEURODEVELOPMENTAL DISORDER WITH DYSMORPHIC FEATURES, SPASTICITY, AND BRAIN ABNORMALITIES	Neurodevelopmental disorder with dysmorphic features, spasticity, and brain abnormalities, 615802 (3)	Neurodevelopmental disorder with dysmorphic features, spasticity, and brain abnormalities	n	-	-	-	PGAP1	HGNC:25712	Neurodevelopmental disorder with dysmorphic features, spasticity, and brain abnormalities, 615802 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
615803	PONTOCEREBELLAR HYPOPLASIA, TYPE 10	Pontocerebellar hypoplasia, type 10, 615803 (3)	Pontocerebellar hypoplasia, type 10	y	PONTOCEREBELLAR HYPOPLASIA, TYPE 10; PCH10	Phenotype	death|deaths	CLP1	HGNC:16999	Pontocerebellar hypoplasia, type 10, 615803 (3), Autosomal recessive	Autosomal recessive	n	n	-	-	-	-	ambiguous	ambiguous	ambiguous	-	-	-
615809	PONTOCEREBELLAR HYPOPLASIA, TYPE 9	Pontocerebellar hypoplasia, type 9, 615809 (3)	Pontocerebellar hypoplasia, type 9	y	PONTOCEREBELLAR HYPOPLASIA, TYPE 9; PCH9	Clinical Features	died	AMPD2	HGNC:469	Pontocerebellar hypoplasia, type 9, 615809 (3), Autosomal recessive	Autosomal recessive	n	y	[Marsh et al. (2015) reported 5 sibs, born of consanguineous parents of Middle Eastern descent, with severe PCH9 associated with axonal peripheral neuropathy in 2 of the patients who survived infancy. All patients had profound global developmental delay, postnatal microcephaly, and pontocerebellar hypoplasia with absence of the corpus callosum on brain imaging. Additional features included axial hypotonia with spasticity, hyperreflexia, extensor plantar responses, cortical visual impairment, impaired swallowing, and early-onset seizures. The patients also had dysmorphic features, including bitemporal narrowing, midface hypoplasia, hypotonic facies, downslanting palpebral fissures, broad nasal bridge, short upper lip, macroglossia, and abnormally shaped ears. Three patients died of infection during the first 2 years of life]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
615812	ABDOMINAL OBESITY-METABOLIC SYNDROME 3	Abdominal obesity-metabolic syndrome 3, 615812 (3)	Abdominal obesity-metabolic syndrome 3	y	ABDOMINAL OBESITY-METABOLIC SYNDROME 3; AOMS3	Clinical Features|Clinical Synopsis|Phenotype	death|deaths|died	DYRK1B	HGNC:3092	Abdominal obesity-metabolic syndrome 3, 615812 (3), Autosomal dominant	Autosomal dominant	n	y	[Risk of sudden death / Keramati et al. (2014) studied 3 large multigenerational families from a community in southwest Iran in which 25 affected members had early-onset myocardial infarction or coronary artery disease as well as central obesity, type 2 diabetes, and hypertension, a constellation of features that met the standard definition of metabolic syndrome. Central obesity was of juvenile onset, and all 25 affected family members had early-onset myocardial infarction or coronary artery disease at a mean age of 44 years. The presence of central obesity, type 2 diabetes, and hypertension was not explained by neurohormonal activation. Among the affected individuals, 3 had stroke and there were 3 sudden deaths]	LU	y	-	lethal	lethal	lethal	LU	LU	post-infant-lethal
615816	IMMUNODEFICIENCY 23	Immunodeficiency 23, 615816 (3)	Immunodeficiency 23	y	IMMUNODEFICIENCY 23; IMD23	Clinical Features	died	PGM3	HGNC:8907	Immunodeficiency 23, 615816 (3), Autosomal recessive	Autosomal recessive	y	y	[Lundin et al. (2015) provided follow-up of this family and noted that the report of Bjorksten and Lundmark (1976) may be the first description of this disorder. Three of the 4 sibs died between 10 and 16 years of age. Infections included pneumonia, otitis media, upper respiratory infections, and skin abscesses]	L5	y	y	lethal	lethal	lethal	L5	L5	post-infant-lethal
615817	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 43	Intellectual developmental disorder, autosomal recessive 43, 615817 (3)	Intellectual developmental disorder, autosomal recessive 43	n	-	-	-	WASHC4	HGNC:29174	Intellectual developmental disorder, autosomal recessive 43, 615817 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
615821	CARDIOMYOPATHY, DILATED, WITH WOOLLY HAIR, KERATODERMA, AND TOOTH AGENESIS	Dilated cardiomyopathy with woolly hair, keratoderma, and tooth agenesis, 615821 (3)	Dilated cardiomyopathy with woolly hair, keratoderma, and tooth agenesis	y	CARDIOMYOPATHY, DILATED, WITH WOOLLY HAIR, KERATODERMA, AND TOOTH AGENESIS; DCWHKTA	Clinical Features|Clinical Synopsis|Phenotype	death|deaths|died	DSP	HGNC:3052	Dilated cardiomyopathy with woolly hair, keratoderma, and tooth agenesis, 615821 (3), Autosomal dominant	Autosomal dominant	n	y	[Boyden et al. (2016) described 3 unrelated children, 1 girl and 2 boys, who had erythrokeratodermia at birth or shortly thereafter and also exhibited scant woolly hair, sparse or absent eyebrows and eyelashes, enamel defects with multiple caries of primary teeth and variable tooth agenesis of secondary dentition, palmoplantar keratoderma, onychodystrophy of all nails, and moderate to severe dilated cardiomyopathy. One of the boys died at age 3 years from heart failure, whereas the remaining 2 children had relatively preserved ventricular function]	L4	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L2|L4|L5|LU	L2	pre-infant-lethal
615824	MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 7	Mitochondrial complex III deficiency, nuclear type 7, 615824 (3)	Mitochondrial complex III deficiency, nuclear type 7	y	MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 7; MC3DN7	Clinical Features	died	UQCC2	HGNC:21237	Mitochondrial complex III deficiency, nuclear type 7, 615824 (3), Autosomal recessive	Autosomal recessive	n	y	[Feichtinger et al. (2017) reported a female infant, born of consanguineous Turkish parents, with MC3DN7. She was born prematurely at 32 weeks' gestation due to a pregnancy complicated by intrauterine growth retardation and oligohydramnios. She presented with respiratory distress syndrome and developed seizures in the first weeks of life that progressed to status epilepticus. Laboratory findings included profound lactic acidosis and increased urinary pyruvate. She died at age 33 days]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
615828	VULTO-VAN SILFHOUT-DE VRIES SYNDROME	Vulto-van Silfout-de Vries syndrome, 615828 (3)	Vulto-van Silfout-de Vries syndrome	n	-	-	-	DEAF1	HGNC:14677	Vulto-van Silfout-de Vries syndrome, 615828 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L4	L4	post-infant-lethal
615829	XIA-GIBBS SYNDROME	Xia-Gibbs syndrome, 615829 (3)	Xia-Gibbs syndrome	n	-	-	-	AHDC1	HGNC:25230	Xia-Gibbs syndrome, 615829 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
615833	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 21	Developmental and epileptic encephalopathy 21, 615833 (3)	Developmental and epileptic encephalopathy 21	n	-	-	-	NECAP1	HGNC:24539	Developmental and epileptic encephalopathy 21, 615833 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
615834	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 26	Intellectual developmental disorder, autosomal dominant 26, 615834 (3)	Intellectual developmental disorder, autosomal dominant 26	n	-	-	-	AUTS2	HGNC:14262	Intellectual developmental disorder, autosomal dominant 26, 615834 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
615838	MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 8	Mitochondrial complex III deficiency, nuclear type 8, 615838 (3)	Mitochondrial complex III deficiency, nuclear type 8	y	MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 8; MC3DN8	Clinical Features|Clinical Synopsis	death|deaths	LYRM7	HGNC:28072	Mitochondrial complex III deficiency, nuclear type 8, 615838 (3), Autosomal recessive	Autosomal recessive	n	y	[Invernizzi et al. (2013) reported a girl, born of consanguineous Moroccan parents, with a severe neuromuscular disorder resulting in death from respiratory failure at age 28 months]	L4	y	-	lethal	lethal	lethal	L4	L4	post-infant-lethal
615846	AICARDI-GOUTIERES SYNDROME 7	Aicardi-Goutieres syndrome 7, 615846 (3)	Aicardi-Goutieres syndrome 7	y	AICARDI-GOUTIERES SYNDROME 7; AGS7	Clinical Features	died	IFIH1	HGNC:18873	Aicardi-Goutieres syndrome 7, 615846 (3), Autosomal dominant	Autosomal dominant	y	y	[Amari et al. (2020) reported a female infant who was found on prenatal ultrasound at 16 weeks' gestation to have a single umbilical artery, intestinal hyperechogenicity, and mitral valve regurgitation... She developed pulmonary hypertension, respiratory distress, right-sided heart failure, and ascites. She died at 3 months of age from respiratory failure and pulmonary hypertension]	L3	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L3|L4	L3	pre-infant-lethal
615848	TUMOR PREDISPOSITION SYNDROME 3	Tumor predisposition syndrome 3, 615848 (3)	Tumor predisposition syndrome 3	n	-	-	-	POT1	HGNC:17284	Tumor predisposition syndrome 3, 615848 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
615849	CULLER-JONES SYNDROME	Culler-Jones syndrome, 615849 (3)	Culler-Jones syndrome	n	-	-	-	GLI2	HGNC:4318	Culler-Jones syndrome, 615849 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L2	L2	pre-infant-lethal
615851	PONTOCEREBELLAR HYPOPLASIA, TYPE 2E	Pontocerebellar hypoplasia, type 2E, 615851 (3)	Pontocerebellar hypoplasia, type 2E	n	-	-	-	VPS53	HGNC:25608	Pontocerebellar hypoplasia, type 2E, 615851 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
615859	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 23	Developmental and epileptic encephalopathy 23, 615859 (3)	Developmental and epileptic encephalopathy 23	n	-	-	-	DOCK7	HGNC:19190	Developmental and epileptic encephalopathy 23, 615859 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
615860	CONE-ROD DYSTROPHY 19	Cone-rod dystrophy 19, 615860 (3)	Cone-rod dystrophy 19	n	-	-	-	TTLL5	HGNC:19963	Cone-rod dystrophy 19, 615860 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
615861	NEPHROTIC SYNDROME, TYPE 10	Nephrotic syndrome, type 10, 615861 (3)	Nephrotic syndrome, type 10	n	-	-	-	EMP2	HGNC:3334	Nephrotic syndrome, type 10, 615861 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
615862	NEPHRONOPHTHISIS 18	Nephronophthisis 18, 615862 (3)	Nephronophthisis 18	n	-	-	-	CEP83	HGNC:17966	Nephronophthisis 18, 615862 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
615863	DIARRHEA 7, PROTEIN-LOSING ENTEROPATHY TYPE	Diarrhea 7, protein-losing enteropathy type, 615863 (3)	Diarrhea 7, protein-losing enteropathy type	y	DIARRHEA 7, PROTEIN-LOSING ENTEROPATHY TYPE; DIAR7	Clinical Features|Clinical Synopsis	died|die	DGAT1	HGNC:2843	Diarrhea 7, protein-losing enteropathy type, 615863 (3), Autosomal recessive	Autosomal recessive	y	y	[died from complications at age 17 months]	L3	y	y	lethal	lethal	lethal	L3	L3	pre-infant-lethal
615866	INTELLECTUAL DEVELOPMENTAL DISORDER WITH MICROCEPHALY AND WITH OR WITHOUT OCULAR MALFORMATIONS OR HYPOGONADOTROPIC HYPOGONADISM	Intellectual developmental disorder with microcephaly and with or without ocular malformations or hypogonadotropic hypogonadism, 615866 (3)	Intellectual developmental disorder with microcephaly and with or without ocular malformations or hypogonadotropic hypogonadism	n	-	-	-	SOX11	HGNC:11191	Intellectual developmental disorder with microcephaly and with or without ocular malformations or hypogonadotropic hypogonadism, 615866 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
615871	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 24	Developmental and epileptic encephalopathy 24, 615871 (3)	Developmental and epileptic encephalopathy 24	y	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 24; DEE24	Clinical Features	died	HCN1	HGNC:4845	Developmental and epileptic encephalopathy 24, 615871 (3), Autosomal dominant	Autosomal dominant	y	y	[Marini et al. (2018) reported 8 unrelated patients with DEE24. The patients had onset of various types of refractory seizures in infancy. Seizure types included severe febrile seizures, focal, tonic, atonic, myoclonic-atonic, and tonic-clonic. Two patients died at 14 and 15 months of age, and the remaining patients had variably impaired intellectual development sometimes with language delay or autistic features]	L3	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L3	L3	pre-infant-lethal
615872	CILIARY DYSKINESIA, PRIMARY, 29	Ciliary dyskinesia, primary, 29, 615872 (3)	Ciliary dyskinesia, primary, 29	n	-	-	-	CCNO	HGNC:18576	Ciliary dyskinesia, primary, 29, 615872 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
615873	HELSMOORTEL-VAN DER AA SYNDROME	Helsmoortel-van der Aa syndrome, 615873 (3)	Helsmoortel-van der Aa syndrome	n	-	-	-	ADNP	HGNC:15766	Helsmoortel-van der Aa syndrome, 615873 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
615877	MICROPHTHALMIA/COLOBOMA AND SKELETAL DYSPLASIA SYNDROME	Microphthalmia/coloboma and skeletal dysplasia syndrome, 615877 (3)	Microphthalmia/coloboma and skeletal dysplasia syndrome	n	-	-	-	MAB21L2	HGNC:6758	Microphthalmia/coloboma and skeletal dysplasia syndrome, 615877 (3), Autosomal dominant, Autosomal recessive	Autosomal dominant, Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
615878	CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC, 4	Cholestasis, progressive familial intrahepatic 4, 615878 (3)	Cholestasis, progressive familial intrahepatic 4	y	CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC, 4; PFIC4	Clinical Features|Phenotype	died|lethal	TJP2	HGNC:11828	Cholestasis, progressive familial intrahepatic 4, 615878 (3), Autosomal recessive	Autosomal recessive	n	y	[Sambrotta et al. (2014) reported 12 patients from 8 families with early childhood onset of severe progressive liver disease. One child died at age 13 months, 9 patients required a liver transplant, and 2 had stable liver disease with mild portal hypertension at ages 4 and 7 years, respectively. Laboratory studies showed normal or mildly increased GGT levels]	L3	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L3	L3	pre-infant-lethal
615879	TATTON-BROWN-RAHMAN SYNDROME	Tatton-Brown-Rahman syndrome, 615879 (3)	Tatton-Brown-Rahman syndrome	n	-	-	-	DNMT3A	HGNC:2978	Tatton-Brown-Rahman syndrome, 615879 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
615881	PLASMA TRIGLYCERIDE LEVEL QUANTITATIVE TRAIT LOCUS	Plasma triglyceride level QTL, low, 615881 (3)	Plasma triglyceride level QTL, low	n	-	-	-	ANGPTL4	HGNC:16039	Plasma triglyceride level QTL, low, 615881 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
615883	MYOPATHY, TUBULAR AGGREGATE, 2	Myopathy, tubular aggregate, 2, 615883 (3)	Myopathy, tubular aggregate, 2	n	-	-	-	ORAI1	HGNC:25896	Myopathy, tubular aggregate, 2, 615883 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L3	L3	pre-infant-lethal
615885	HYPOTRICHOSIS 12	Hypotrichosis 12, 615885 (3)	Hypotrichosis 12	n	-	-	-	RPL21	HGNC:10313	Hypotrichosis 12, 615885 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
615887	AMELOGENESIS IMPERFECTA, HYPOMATURATION TYPE, IIA5	Amelogenesis imperfecta, type IIA5, 615887 (3)	Amelogenesis imperfecta, type IIA5	n	-	-	-	SLC24A4	HGNC:10978	Amelogenesis imperfecta, type IIA5, 615887 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
615889	LEUKOENCEPHALOPATHY, PROGRESSIVE, WITH OVARIAN FAILURE	Leukoencephalopathy, progressive, with ovarian failure, 615889 (3)	Leukoencephalopathy, progressive, with ovarian failure	y	LEUKOENCEPHALOPATHY, PROGRESSIVE, WITH OVARIAN FAILURE; LKENP	Clinical Features	died	AARS2	HGNC:21022	Leukoencephalopathy, progressive, with ovarian failure, 615889 (3), Autosomal recessive	Autosomal recessive	n	y	[Dallabona et al. (2014) reported 5 unrelated women and 1 man with a progressive leukoencephalopathic neurodegenerative disorder... Most of the 6 patients either became wheelchair-bound or bedridden, and 2 died]	LU	y	-	lethal	lethal	lethal	L1|LU	L1	pre-infant-lethal
615895	POLYGLUCOSAN BODY MYOPATHY 1 WITH OR WITHOUT IMMUNODEFICIENCY	Polyglucosan body myopathy 1 with or without immunodeficiency, 615895 (3)	Polyglucosan body myopathy 1 with or without immunodeficiency	y	POLYGLUCOSAN BODY MYOPATHY 1 WITH OR WITHOUT IMMUNODEFICIENCY; PGBM1	Clinical Features|Phenotype	death|deaths|died	RBCK1	HGNC:15864	Polyglucosan body myopathy 1 with or without immunodeficiency, 615895 (3), Autosomal recessive	Autosomal recessive	y	y	[Boisson et al. (2012) reported 2 sisters and an unrelated boy with a complex phenotype characterized by primary immunodeficiency, a hyperinflammatory state, and cardiac and skeletal muscle amylopectinosis... The patients all died between ages 3.5 and 8 years]	L4	y	-	lethal	lethal	lethal	L4	L4	post-infant-lethal
615897	IMMUNODEFICIENCY 24	Immunodeficiency 24, 615897 (3)	Immunodeficiency 24	y	IMMUNODEFICIENCY 24; IMD24	Clinical Features|Clinical Synopsis	died|death|deaths	CTPS1	HGNC:2519	Immunodeficiency 24, 615897 (3), Autosomal recessive	Autosomal recessive	n	y	[May result in early death]	LU	y	-	lethal	lethal	lethal	LU	LU	post-infant-lethal
615905	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 25 WITH AMELOGENESIS IMPERFECTA	Developmental and epileptic encephalopathy 25, with amelogenesis imperfecta, 615905 (3)	Developmental and epileptic encephalopathy 25, with amelogenesis imperfecta	y	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 25 WITH AMELOGENESIS IMPERFECTA; DEE25	Clinical Features	died	SLC13A5	HGNC:23089	Developmental and epileptic encephalopathy 25, with amelogenesis imperfecta, 615905 (3), Autosomal recessive	Autosomal recessive	y	y	[Hardies et al. (2015) reported 8 patients from 4 unrelated families of European descent with DEE25. All patients developed focal clonic seizures on the first day of life, followed by ongoing multiple seizure types, including hemiconvulsions and generalized tonic-clonic seizures. Seven patients had status epilepticus, including 1 who died from it, and 6 showed fever sensitivity]	LU	y	-	lethal	lethal	lethal	LU	LU	post-infant-lethal
615907	LYMPHATIC MALFORMATION 4	Lymphatic malformation 4, 615907 (3)	Lymphatic malformation 4	n	-	-	-	VEGFC	HGNC:12682	Lymphatic malformation 4, 615907 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
615909	DIAMOND-BLACKFAN ANEMIA 13	Diamond-Blackfan anemia 13, 615909 (3)	Diamond-Blackfan anemia 13	n	-	-	-	RPS29	HGNC:10419	Diamond-Blackfan anemia 13, 615909 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
615911	FRONTOTEMPORAL DEMENTIA AND/OR AMYOTROPHIC LATERAL SCLEROSIS 2	Frontotemporal dementia and/or amyotrophic lateral sclerosis 2, 615911 (3)	Frontotemporal dementia and/or amyotrophic lateral sclerosis 2	y	FRONTOTEMPORAL DEMENTIA AND/OR AMYOTROPHIC LATERAL SCLEROSIS 2; FTDALS2	Clinical Features	died	CHCHD10	HGNC:15559	Frontotemporal dementia and/or amyotrophic lateral sclerosis 2, 615911 (3), Autosomal dominant	Autosomal dominant	y	y	[Bannwarth et al. (2014) reported a large 5-generation French family in which multiple individuals had a late-onset neurodegenerative disorder comprising frontotemporal dementia, cerebellar ataxia, myopathy, and motor neuron disease consistent with amyotrophic lateral sclerosis. Clinical information, muscle biopsies, and DNA were available from 8 affected individuals, including 6 who were deceased. The proband presented at age 50 years with cerebellar ataxia associated with progressive bulbar dysfunction, dementia, and sensorineural deafness. She had extensor plantar responses, dysphagia, dysarthria, and a frontal lobe syndrome. She died at age 67. Seven other family members had variable manifestations of a similar disorder: some presented with ataxia, some with motor neuron disease, and some with both. All developed frontotemporal dementia, except 1 patient who died at age 51]	L6	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L6	L6	post-infant-lethal
615916	CARDIOMYOPATHY, DILATED, 1NN	Cardiomyopathy, dilated, 1NN, 615916 (3)	Cardiomyopathy, dilated, 1NN	n	-	-	-	RAF1	HGNC:9829	Cardiomyopathy, dilated, 1NN, 615916 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
615917	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 20	Combined oxidative phosphorylation deficiency 20, 615917 (3)	Combined oxidative phosphorylation deficiency 20	y	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 20; COXPD20	Clinical Features	death|deaths|died	VARS2	HGNC:21642	Combined oxidative phosphorylation deficiency 20, 615917 (3), Autosomal recessive	Autosomal recessive	y	y	[Bruni et al. (2018) reported 13 patients with COXPD20 from 6 unrelated families of European, Hispanic, and Middle Eastern descent. All except 3 patients presented at birth. Twelve of the 13 patients had hypotonia, 9 of 11 tested had hypertrophic cardiomyopathy, 6 had epilepsy, and 11 had lactic acidosis. MRI, performed in 8 patients, showed cerebellar atrophy in 6, thalamic abnormalities in 4, white matter changes in 3, cerebral atrophy in 3, and basal ganglia calcifications in 1. Most of the patients had died, with age of death ranging from 9 days to 9 years]	L2	y	-	lethal	lethal	lethal	L2	L2	pre-infant-lethal
615918	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 21	Combined oxidative phosphorylation deficiency 21, 615918 (3)	Combined oxidative phosphorylation deficiency 21	y	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 21; COXPD21	Description|Clinical Features|Clinical Synopsis	death|deaths|died	TARS2	HGNC:30740	Combined oxidative phosphorylation deficiency 21, 615918 (3), Autosomal recessive	Autosomal recessive	y	y	[died a few months after birth]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
615922	RETINITIS PIGMENTOSA 70	Retinitis pigmentosa 70, 615922 (3)	Retinitis pigmentosa 70	n	-	-	-	PRPF4	HGNC:17349	Retinitis pigmentosa 70, 615922 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
615923	EPIPHYSEAL CHONDRODYSPLASIA, MIURA TYPE	Epiphyseal chondrodysplasia, Miura type, 615923 (3)	Epiphyseal chondrodysplasia, Miura type	n	-	-	-	NPR2	HGNC:7944	Epiphyseal chondrodysplasia, Miura type, 615923 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
615924	ENCEPHALOPATHY, PROGRESSIVE, WITH OR WITHOUT LIPODYSTROPHY	Encephalopathy, progressive, with or without lipodystrophy, 615924 (3)	Encephalopathy, progressive, with or without lipodystrophy	y	ENCEPHALOPATHY, PROGRESSIVE, WITH OR WITHOUT LIPODYSTROPHY; PELD	Description|Clinical Features|Clinical Synopsis	death|deaths|died	BSCL2	HGNC:15832	Encephalopathy, progressive, with or without lipodystrophy, 615924 (3), Autosomal recessive	Autosomal recessive	n	y	[Guillen-Navarro et al. (2013) reported 6 children from 4 families from Murcia in southeastern Spain with a severe progressive encephalopathy. The patients developed symptoms between ages 2 and 3 years, and 5 of them died between ages 6 and 8 years]	L4	y	-	lethal	ambiguous|lethal|nonlethal	lethal|nonlethal	L3|L4	L3	pre-infant-lethal
615925	GROWTH HORMONE DEFICIENCY, ISOLATED PARTIAL	Growth hormone deficiency, isolated partial, 615925 (3)	Growth hormone deficiency, isolated partial	n	-	-	-	GHSR	HGNC:4267	Growth hormone deficiency, isolated partial, 615925 (3), Autosomal dominant, Autosomal recessive	Autosomal dominant, Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
615934	STING-ASSOCIATED VASCULOPATHY, INFANTILE-ONSET	STING-associated vasculopathy, infantile-onset, 615934 (3)	STING-associated vasculopathy, infantile-onset	y	STING-ASSOCIATED VASCULOPATHY, INFANTILE-ONSET; SAVI	Clinical Features	died	STING1	HGNC:27962	STING-associated vasculopathy, infantile-onset, 615934 (3), Autosomal dominant	Autosomal dominant	y	y	[Liu et al. (2014) reported 6 unrelated children with an inflammatory vasculopathy... All patients had failure to thrive, and 2 died in their teenage years of pulmonary complications]	L5	y	-	lethal	lethal	lethal	L5	L5	post-infant-lethal
615935	PANCREATIC AGENESIS 2	Pancreatic agenesis 2, 615935 (3)	Pancreatic agenesis 2	y	PANCREATIC AGENESIS 2; PAGEN2	Clinical Features|Phenotype	fatal	PTF1A	HGNC:23734	Pancreatic agenesis 2, 615935 (3), Autosomal recessive	Autosomal recessive	n	y	[Weedon et al. (2014) reported 14 affected individuals from 10 families with isolated pancreatic hypoplasia or agenesis.. No neurologic features were reported, except for 1 patient who exhibited mild developmental delay, and no other abnormalities were reported, except for 1 patient who had fatal cholestatic liver failure]	LU	y	-	lethal	lethal	lethal	L3|LU	L3	pre-infant-lethal
615937	MEGALENCEPHALY-POLYMICROGYRIA-POLYDACTYLY-HYDROCEPHALUS SYNDROME 2	Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 2, 615937 (3)	Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 2	n	-	-	-	AKT3	HGNC:393	Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 2, 615937 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
615938	MEGALENCEPHALY-POLYMICROGYRIA-POLYDACTYLY-HYDROCEPHALUS SYNDROME 3	Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 3, 615938 (3)	Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 3	n	-	-	-	CCND2	HGNC:1583	Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 3, 615938 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
615942	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 44	Intellectual developmental disorder, autosomal recessive 44, 615942 (3)	Intellectual developmental disorder, autosomal recessive 44	n	-	-	-	METTL23	HGNC:26988	Intellectual developmental disorder, autosomal recessive 44, 615942 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
615945	SPINOCEREBELLAR ATAXIA 37	Spinocerebellar ataxia 37, 615945 (3)	Spinocerebellar ataxia 37	y	SPINOCEREBELLAR ATAXIA 37; SCA37	Phenotype	lethality	DAB1	HGNC:2661	Spinocerebellar ataxia 37, 615945 (3), Autosomal dominant	Autosomal dominant	y	n	-	-	-	-	ambiguous	ambiguous	ambiguous	-	-	-
615946	MYOPIA 24, AUTOSOMAL DOMINANT	Myopia 24, autosomal dominant, 615946 (3)	Myopia 24, autosomal dominant	n	-	-	-	SLC39A5	HGNC:20502	Myopia 24, autosomal dominant, 615946 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
615947	HYPERLIPOPROTEINEMIA, TYPE ID	Hyperlipoproteinemia, type 1D, 615947 (3)	Hyperlipoproteinemia, type 1D	n	-	-	-	GPIHBP1	HGNC:24945	Hyperlipoproteinemia, type 1D, 615947 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
615948	OROFACIODIGITAL SYNDROME XIV	Orofaciodigital syndrome XIV, 615948 (3)	Orofaciodigital syndrome XIV	y	OROFACIODIGITAL SYNDROME XIV; OFD14	Clinical Features	died	C2CD3	HGNC:24564	Orofaciodigital syndrome XIV, 615948 (3), Autosomal recessive	Autosomal recessive	n	y	[Thauvin-Robinet et al. (2014) reported a 4-year-old boy, born of consanguineous parents, with a severe form of orofaciodigital syndrome.. A similarly affected sib, who also had cardiac manifestations, died in the neonatal period]	L2	n	y	lethal	lethal	lethal	L2	L2	pre-infant-lethal
615952	AUTOIMMUNE DISEASE, MULTISYSTEM, INFANTILE-ONSET, 1	Autoimmune disease, multisystem, infantile-onset, 1, 615952 (3)	Autoimmune disease, multisystem, infantile-onset, 1	n	-	-	-	STAT3	HGNC:11364	Autoimmune disease, multisystem, infantile-onset, 1, 615952 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
615957	SPINOCEREBELLAR ATAXIA 38	Spinocerebellar ataxia 38, 615957 (3)	Spinocerebellar ataxia 38	n	-	-	-	ELOVL5	HGNC:21308	Spinocerebellar ataxia 38, 615957 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
615959	MYOPATHY, CENTRONUCLEAR, 5	Centronuclear myopathy 5, 615959 (3)	Centronuclear myopathy 5	y	MYOPATHY, CENTRONUCLEAR, 5; CNM5	Description|Clinical Features|Clinical Synopsis	die|died|death|deaths	SPEG	HGNC:16901	Centronuclear myopathy 5, 615959 (3), Autosomal recessive	Autosomal recessive	y	y	[Agrawal et al. (2014) reported 3 unrelated children with severe hypotonia since birth. The first child, born of consanguineous Turkish parents, died at age 3 weeks. She had respiratory insufficiency and required tube feeding. Other features included bilateral hip contractures, narrow and high-arched palate, microstomia, and retrognathia. Two older sibs had each died at 2 days of age]	L2	y	y	lethal	lethal	lethal	L2	L2	pre-infant-lethal
615960	PORETTI-BOLTSHAUSER SYNDROME	Poretti-Boltshauser syndrome, 615960 (3)	Poretti-Boltshauser syndrome	n	-	-	-	LAMA1	HGNC:6481	Poretti-Boltshauser syndrome, 615960 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
615961	ACID-LABILE SUBUNIT DEFICIENCY	Acid-labile subunit, deficiency of, 615961 (3)	Acid-labile subunit, deficiency of	n	-	-	-	IGFALS	HGNC:5468	Acid-labile subunit, deficiency of, 615961 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
615962	GLUCOCORTICOID RESISTANCE, GENERALIZED	Glucocorticoid resistance, 615962 (3)	Glucocorticoid resistance	y	GLUCOCORTICOID RESISTANCE, GENERALIZED; GCCR	Clinical Features	died	NR3C1	HGNC:7978	Glucocorticoid resistance, 615962 (3), Autosomal dominant	Autosomal dominant	n	n	-	-	-	-	ambiguous	ambiguous	ambiguous	-	-	-
615963	VESICOURETERAL REFLUX 8	Vesicoureteral reflux 8, 615963 (3)	Vesicoureteral reflux 8	n	-	-	-	TNXB	HGNC:11976	Vesicoureteral reflux 8, 615963 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
615966	IMMUNODEFICIENCY 26 WITH OR WITHOUT NEUROLOGIC ABNORMALITIES	Immunodeficiency 26, with or without neurologic abnormalities, 615966 (3)	Immunodeficiency 26, with or without neurologic abnormalities	y	IMMUNODEFICIENCY 26 WITH OR WITHOUT NEUROLOGIC ABNORMALITIES; IMD26	Clinical Features	died	PRKDC	HGNC:9413	Immunodeficiency 26, with or without neurologic abnormalities, 615966 (3), Autosomal recessive	Autosomal recessive	y	y	[Woodbine et al. (2013) reported a boy, born of unrelated parents, with SCID characterized by absent circulating B and T cells and normal NK cells. The patient had intrauterine growth retardation and presented with suspected sepsis and persistent oral and perineal candidiasis at age 3 weeks. He was microcephalic and had dysmorphic features, including prominent forehead, broad nasal bridge, deep-set eyes, long philtrum with thin upper lip, small chin, low-set ears, overlapping fingers, and postaxial polysyndactyly of the right foot. He showed little developmental progress, and he was found to have profound hearing loss and severe visual impairment. Brain imaging showed simplified gyral pattern, mild frontal pachygyria, small hippocampi, hypomyelinated white matter, thin corpus callosum, and cerebellar vermis hypoplasia. He died at age 31 months with intractable seizures]	L4	y	-	lethal	lethal	lethal	L4	L4	post-infant-lethal
615969	ALPHA-FETOPROTEIN DEFICIENCY	Alpha-fetoprotein deficiency, 615969 (3)	Alpha-fetoprotein deficiency	n	-	-	-	AFP	HGNC:317	Alpha-fetoprotein deficiency, 615969 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
615972	NANOPHTHALMOS 4	Nanophthalmos 4, 615972 (3)	Nanophthalmos 4	n	-	-	-	TMEM98	HGNC:24529	Nanophthalmos 4, 615972 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
615973	CONE-ROD DYSTROPHY 20	Cone-rod dystrophy 20, 615973 (3)	Cone-rod dystrophy 20	n	-	-	-	POC1B	HGNC:30836	Cone-rod dystrophy 20, 615973 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
615978	IMMUNODEFICIENCY 27B	Immunodeficiency 27B, mycobacteriosis, AD, 615978 (3)	Immunodeficiency 27B, mycobacteriosis, AD	n	-	-	-	IFNGR1	HGNC:5439	Immunodeficiency 27B, mycobacteriosis, AD, 615978 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L4	L4	post-infant-lethal
615980	LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 6	Lipodystrophy, familial partial, type 6, 615980 (3)	Lipodystrophy, familial partial, type 6	n	-	-	-	LIPE	HGNC:6621	Lipodystrophy, familial partial, type 6, 615980 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
615981	BARDET-BIEDL SYNDROME 2	Bardet-Biedl syndrome 2, 615981 (3)	Bardet-Biedl syndrome 2	n	-	-	-	BBS2	HGNC:967	Bardet-Biedl syndrome 2, 615981 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
615982	BARDET-BIEDL SYNDROME 4	Bardet-Biedl syndrome 4, 615982 (3)	Bardet-Biedl syndrome 4	n	-	-	-	BBS4	HGNC:969	Bardet-Biedl syndrome 4, 615982 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
615983	BARDET-BIEDL SYNDROME 5	Bardet-Biedl syndrome 5, 615983 (3)	Bardet-Biedl syndrome 5	n	-	-	-	BBS5	HGNC:970	Bardet-Biedl syndrome 5, 615983 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
615984	BARDET-BIEDL SYNDROME 7	Bardet-Biedl syndrome 7, 615984 (3)	Bardet-Biedl syndrome 7	n	-	-	-	BBS7	HGNC:18758	Bardet-Biedl syndrome 7, 615984 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
615985	BARDET-BIEDL SYNDROME 8	Bardet-Biedl syndrome 8, 615985 (3)	Bardet-Biedl syndrome 8	n	-	-	-	TTC8	HGNC:20087	Bardet-Biedl syndrome 8, 615985 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
615986	BARDET-BIEDL SYNDROME 9	Bardet-Biedl syndrome 9, 615986 (3)	Bardet-Biedl syndrome 9	n	-	-	-	BBS9	HGNC:30000	Bardet-Biedl syndrome 9, 615986 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
615987	BARDET-BIEDL SYNDROME 10	Bardet-Biedl syndrome 10, 615987 (3)	Bardet-Biedl syndrome 10	y	BARDET-BIEDL SYNDROME 10; BBS10	Phenotype	lethal	BBS10	HGNC:26291	Bardet-Biedl syndrome 10, 615987 (3), Autosomal recessive	Autosomal recessive	n	n	-	-	-	-	ambiguous	ambiguous	ambiguous	-	-	-
615989	BARDET-BIEDL SYNDROME 12	Bardet-Biedl syndrome 12, 615989 (3)	Bardet-Biedl syndrome 12	y	BARDET-BIEDL SYNDROME 12; BBS12	Clinical Features	death|deaths	BBS12	HGNC:26648	Bardet-Biedl syndrome 12, 615989 (3), Autosomal recessive	Autosomal recessive	n	y	[Dulfer et al. (2010) reported 2 female sibs with BBS resulting from compound heterozygous truncating mutations in the BBS12 gene. Each also carried a third heterozygous mutation in the BBS10 gene (610148). The first patient had postaxial polydactyly type A and severe hydrometrocolpos, resulting in prolonged delivery with hypoxia and death at delivery]	L2	y	-	lethal	lethal	lethal	L2	L2	pre-infant-lethal
615990	BARDET-BIEDL SYNDROME 13	Bardet-Biedl syndrome 13, 615990 (3)	Bardet-Biedl syndrome 13	n	-	-	-	MKS1	HGNC:7121	Bardet-Biedl syndrome 13, 615990 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L1	L1	pre-infant-lethal
615993	BARDET-BIEDL SYNDROME 16	Bardet-Biedl syndrome 16, 615993 (3)	Bardet-Biedl syndrome 16	n	-	-	-	SDCCAG8	HGNC:10671	Bardet-Biedl syndrome 16, 615993 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
615994	BARDET-BIEDL SYNDROME 17	Bardet-Biedl syndrome 17, 615994 (3)	Bardet-Biedl syndrome 17	y	BARDET-BIEDL SYNDROME 17; BBS17	Clinical Features	died	LZTFL1	HGNC:6741	Bardet-Biedl syndrome 17, 615994 (3), Autosomal recessive	Autosomal recessive	y	y	Deffert et al. (2007) studied 2 sibs with Bardet-Biedl syndrome from a consanguineous Algerian family. Both sibs presented with developmental delay, obesity, unilateral central polydactyly, bilateral postaxial polydactyly of feet, situs inversus, and hypogenitalism with micropenis and atrophic testes. The younger sib was 9 years old at the time of the report; the older sib had died at the age of 22 of renal failure, with which he had been diagnosed at age 17 years]	L6	y	-	lethal	lethal	lethal	L6	L6	post-infant-lethal
615996	BARDET-BIEDL SYNDROME 19	Bardet-Biedl syndrome 19, 615996 (3)	Bardet-Biedl syndrome 19	n	-	-	-	IFT27	HGNC:18626	Bardet-Biedl syndrome 19, 615996 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
616000	ANALBUMINEMIA	Analbuminemia, 616000 (3)	Analbuminemia	y	ANALBUMINEMIA; ANALBA	Description|Clinical Features|Clinical Synopsis	death|deaths|died|miscarriage|miscarriages	ALB	HGNC:399	Analbuminemia, 616000 (3), Autosomal recessive	Autosomal recessive	y	y	[Analbuminemia often leads to fetal or neonatal death in sibs in families of analbuminemic individuals, which may explain the rarity of the trait (summary by Caridi et al., 2014)]	L1	y	-	lethal	lethal	lethal	L1	L1	pre-infant-lethal
616002	FOCAL SEGMENTAL GLOMERULOSCLEROSIS 7	Glomerulosclerosis, focal segmental, 7, 616002 (3)	Glomerulosclerosis, focal segmental, 7	n	-	-	-	PAX2	HGNC:8616	Glomerulosclerosis, focal segmental, 7, 616002 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	LU	LU	post-infant-lethal
616004	DYSFIBRINOGENEMIA, CONGENITAL	Dysfibrinogenemia, congenital, 616004 (3)	Dysfibrinogenemia, congenital	y	DYSFIBRINOGENEMIA, CONGENITAL	Phenotype	miscarriage|miscarriages	FGA	HGNC:3661	Dysfibrinogenemia, congenital, 616004 (3)	-	n	n	-	-	-	-	ambiguous	ambiguous|lethal	lethal	L2|LU	L2	pre-infant-lethal
616004	DYSFIBRINOGENEMIA, CONGENITAL	Hypodysfibrinogenemia, congenital, 616004 (3)	Hypodysfibrinogenemia, congenital	y	DYSFIBRINOGENEMIA, CONGENITAL	Phenotype	miscarriage|miscarriages	FGA	HGNC:3661	Hypodysfibrinogenemia, congenital, 616004 (3)	-	n	n	-	-	-	-	ambiguous	ambiguous|lethal	lethal	L2|LU	L2	pre-infant-lethal
616004	DYSFIBRINOGENEMIA, CONGENITAL	Dysfibrinogenemia, congenital, 616004 (3)	Dysfibrinogenemia, congenital	y	DYSFIBRINOGENEMIA, CONGENITAL	Phenotype	miscarriage|miscarriages	FGB	HGNC:3662	Dysfibrinogenemia, congenital, 616004 (3)	-	n	n	-	-	-	-	ambiguous	ambiguous|lethal	lethal	L2	L2	pre-infant-lethal
616004	DYSFIBRINOGENEMIA, CONGENITAL	Dysfibrinogenemia, congenital, 616004 (3)	Dysfibrinogenemia, congenital	y	DYSFIBRINOGENEMIA, CONGENITAL	Phenotype	miscarriage|miscarriages	FGG	HGNC:3694	Dysfibrinogenemia, congenital, 616004 (3)	-	n	n	-	-	-	-	ambiguous	ambiguous|lethal	lethal	L2	L2	pre-infant-lethal
616004	DYSFIBRINOGENEMIA, CONGENITAL	Hypodysfibrinogenemia, 616004 (3)	Hypodysfibrinogenemia	y	DYSFIBRINOGENEMIA, CONGENITAL	Phenotype	miscarriage|miscarriages	FGG	HGNC:3694	Hypodysfibrinogenemia, 616004 (3)	-	n	n	-	-	-	-	ambiguous	ambiguous|lethal	lethal	L2	L2	pre-infant-lethal
616005	IMMUNODEFICIENCY 36 WITH LYMPHOPROLIFERATION	Immunodeficiency 36, 616005 (3)	Immunodeficiency 36	y	IMMUNODEFICIENCY 36 WITH LYMPHOPROLIFERATION; IMD36	Clinical Features	death|deaths|died	PIK3R1	HGNC:8979	Immunodeficiency 36, 616005 (3), Autosomal dominant	Autosomal dominant	y	y	[lkaim et al. (2016) retrospectively analyzed 36 patients with PIK3R1-associated immunodeficiency, including the 8 patients previously reported by Deau et al. (2014) and Lucas et al. (2014).... Five patients died, including 4 from lymphoma]	LU	y	-	lethal	lethal|nonlethal	lethal|nonlethal	LU	LU	post-infant-lethal
616006	HENNEKAM LYMPHANGIECTASIA-LYMPHEDEMA SYNDROME 2	Hennekam lymphangiectasia-lymphedema syndrome 2, 616006 (3)	Hennekam lymphangiectasia-lymphedema syndrome 2	n	-	-	-	FAT4	HGNC:23109	Hennekam lymphangiectasia-lymphedema syndrome 2, 616006 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
616007	CATARACTS, GROWTH HORMONE DEFICIENCY, SENSORY NEUROPATHY, SENSORINEURAL HEARING LOSS, AND SKELETAL DYSPLASIA	Cataracts, growth hormone deficiency, sensory neuropathy, sensorineural hearing loss, and skeletal dysplasia, 616007 (3)	Cataracts, growth hormone deficiency, sensory neuropathy, sensorineural hearing loss, and skeletal dysplasia	y	CATARACTS, GROWTH HORMONE DEFICIENCY, SENSORY NEUROPATHY, SENSORINEURAL HEARING LOSS, AND SKELETAL DYSPLASIA; CAGSSS	Clinical Features	pregnancy_loss|pregnancy_losses	IARS2	HGNC:29685	Cataracts, growth hormone deficiency, sensory neuropathy, sensorineural hearing loss, and skeletal dysplasia, 616007 (3), Autosomal recessive	Autosomal recessive	y	n	-	-	-	-	ambiguous	ambiguous	ambiguous	-	-	-
616022	NEUTROPENIA, SEVERE CONGENITAL, 6, AUTOSOMAL RECESSIVE	Neutropenia, severe congenital, 6, autosomal recessive, 616022 (3)	Neutropenia, severe congenital, 6, autosomal recessive	y	NEUTROPENIA, SEVERE CONGENITAL, 6, AUTOSOMAL RECESSIVE; SCN6	Clinical Features	died	JAGN1	HGNC:26926	Neutropenia, severe congenital, 6, autosomal recessive, 616022 (3), Autosomal recessive	Autosomal recessive	y	y	[Boztug et al. (2014) reported 14 patients from 9 families with severe congenital neutropenia. Patients presented in early childhood with recurrent bacterial infections of the upper and lower respiratory tract and skin. Laboratory studies showed neutropenia. Bone marrow biopsy showed maturational arrest of granulocytes at the promyelocyte/myelocyte stage. Electron microscopy of patient neutrophils showed an abnormal and enlarged endoplasmic reticulum (ER) with almost complete absence of granules, as well as evidence of increased ER stress. Patient cells showed increased apoptosis compared to control cells. One patient died at age 5 years; the others, aged 5 to 28 years, were alive and well. Two patients underwent hematopoietic bone marrow transplantation]	L4	y	-	lethal	lethal	lethal	L4	L4	post-infant-lethal
616025	GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 11	Glycosylphosphatidylinositol biosynthesis defect 11, 616025 (3)	Glycosylphosphatidylinositol biosynthesis defect 11	y	GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 11; GPIBD11	Clinical Features	died	PIGW	HGNC:23213	Glycosylphosphatidylinositol biosynthesis defect 11, 616025 (3), Autosomal recessive	Autosomal recessive	y	y	[A similarly affected sib had died at 7 months of age]	L3	n	y	lethal	lethal	lethal	L3	L3	pre-infant-lethal
616026	FANCONI RENOTUBULAR SYNDROME 4 WITH MATURITY-ONSET DIABETES OF THE YOUNG	Fanconi renotubular syndrome 4, with maturity-onset diabetes of the young, 616026 (3)	Fanconi renotubular syndrome 4, with maturity-onset diabetes of the young	n	-	-	-	HNF4A	HGNC:5024	Fanconi renotubular syndrome 4, with maturity-onset diabetes of the young, 616026 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
616028	ADAMS-OLIVER SYNDROME 5	Adams-Oliver syndrome 5, 616028 (3)	Adams-Oliver syndrome 5	y	ADAMS-OLIVER SYNDROME 5; AOS5	Clinical Features	died	NOTCH1	HGNC:7881	Adams-Oliver syndrome 5, 616028 (3), Autosomal dominant	Autosomal dominant	y	y	[Vandersteen and Dixon (2011) described a father and 2 daughters from New Zealand with Adams-Oliver syndrome. The proband was a 24-year-old woman with congenital prominent scalp veins, cutis marmorata telangiectatica congenita (CMTC; 219250), and brachydactyly. She had mild motor delay with an in-toeing gait, and radiographs showed bilateral hip dysplasia. Brain MRI at age 7 years showed white matter abnormalities, with multiple high-signal intensities in the periventricular white matter and larger lesions at the gray/white matter junction. At age 24 years, she had short stature, no visible cutaneous vascular malformation of the scalp, and normal hair growth. Her more severely affected sister had cutis aplasia and prominent veins on the scalp, brachydactyly of all digits, and nail aplasia of all toes except the left hallux. She also exhibited extensive generalized CMTC and was diagnosed with pulmonary hypertension; she died of complications of right-sided heart failure at 3.5 years of age]	L4	y	-	lethal	lethal	lethal	L4|L5	L4	post-infant-lethal
616029	ECTODERMAL DYSPLASIA/SHORT STATURE SYNDROME	Ectodermal dysplasia/short stature syndrome, 616029 (3)	Ectodermal dysplasia/short stature syndrome	n	-	-	-	GRHL2	HGNC:2799	Ectodermal dysplasia/short stature syndrome, 616029 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
616030	HYPOGONADOTROPIC HYPOGONADISM 22 WITH OR WITHOUT ANOSMIA	Hypogonadotropic hypogonadism 22, with or without anosmia, 616030 (3)	Hypogonadotropic hypogonadism 22, with or without anosmia	n	-	-	-	FEZF1	HGNC:22788	Hypogonadotropic hypogonadism 22, with or without anosmia, 616030 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
616032	FOCAL SEGMENTAL GLOMERULOSCLEROSIS 8	Focal segmental glomerulosclerosis 8, 616032 (3)	Focal segmental glomerulosclerosis 8	n	-	-	-	ANLN	HGNC:14082	Focal segmental glomerulosclerosis 8, 616032 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
616033	MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 1	Microcephaly, short stature, and impaired glucose metabolism 1, 616033 (3)	Microcephaly, short stature, and impaired glucose metabolism 1	n	-	-	-	TRMT10A	HGNC:28403	Microcephaly, short stature, and impaired glucose metabolism 1, 616033 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
616034	2,4-DIENOYL-CoA REDUCTASE DEFICIENCY	2,4-dienoyl-CoA reductase deficiency, 616034 (3)	2,4-dienoyl-CoA reductase deficiency	y	2,4-DIENOYL-CoA REDUCTASE DEFICIENCY; DECRD	Clinical Features|Clinical Synopsis	died|death|deaths	NADK2	HGNC:26404	2,4-dienoyl-CoA reductase deficiency, 616034 (3), Autosomal recessive	Autosomal recessive	y	y	[In a black female infant presenting in the neonatal period with persistent hypotonia, Roe et al. (1990) found deficiency of 2,4-dienoyl-coenzyme A reductase. Biochemical studies had shown hyperlysinemia, hypocarnitinemia, a normal organic acid profile, and an unusual acylcarnitine species in both urine and blood. The latter metabolite was identified by mass spectrometry as 2-trans,4-cis-decadienoylcarnitine, derived from incomplete oxidation of linoleic acid. In spite of dietary therapy, the patient died of respiratory acidosis at 4 months of age]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
616037	CILIARY DYSKINESIA, PRIMARY, 30	Ciliary dyskinesia, primary, 30, 616037 (3)	Ciliary dyskinesia, primary, 30	n	-	-	-	ODAD3	HGNC:28303	Ciliary dyskinesia, primary, 30, 616037 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
616038	NEU-LAXOVA SYNDROME 2	Neu-Laxova syndrome 2, 616038 (3)	Neu-Laxova syndrome 2	y	NEU-LAXOVA SYNDROME 2; NLS2	Description|Clinical Features|Clinical Synopsis|Phenotype	lethality|died|stillborn|death|deaths	PSAT1	HGNC:19129	Neu-Laxova syndrome 2, 616038 (3), Autosomal recessive	Autosomal recessive	n	y	[Usually death in utero or rarely in neonatal period]	L1	y	-	lethal	lethal	lethal	L1	L1	pre-infant-lethal
616039	CHARCOT-MARIE-TOOTH DISEASE, RECESSIVE INTERMEDIATE D	Charcot-Marie-Tooth disease, recessive intermediate D, 616039 (3)	Charcot-Marie-Tooth disease, recessive intermediate D	n	-	-	-	COX6A1	HGNC:2277	Charcot-Marie-Tooth disease, recessive intermediate D, 616039 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
616040	MYASTHENIC SYNDROME, CONGENITAL, 7A, PRESYNAPTIC, AND DISTAL MOTOR NEUROPATHY, AUTOSOMAL DOMINANT	Myasthenic syndrome, congenital, 7A, presynaptic, and distal motor neuropathy, autosomal dominant, 616040 (3)	Myasthenic syndrome, congenital, 7A, presynaptic, and distal motor neuropathy, autosomal dominant	n	-	-	-	SYT2	HGNC:11510	Myasthenic syndrome, congenital, 7A, presynaptic, and distal motor neuropathy, autosomal dominant, 616040 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
616044	DEAFNESS, AUTOSOMAL DOMINANT 65	Deafness, autosomal dominant 65, 616044 (3)	Deafness, autosomal dominant 65	n	-	-	-	TBC1D24	HGNC:29203	Deafness, autosomal dominant 65, 616044 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L2|L3	L2	pre-infant-lethal
616050	AUTOINFLAMMATION WITH INFANTILE ENTEROCOLITIS	Autoinflammation with infantile enterocolitis, 616050 (3)	Autoinflammation with infantile enterocolitis	y	AUTOINFLAMMATION WITH INFANTILE ENTEROCOLITIS; AIFEC	Clinical Features|Phenotype	died|fatal|death|deaths	NLRC4	HGNC:16412	Autoinflammation with infantile enterocolitis, 616050 (3), Autosomal dominant	Autosomal dominant	n	y	[Romberg et al. (2014) reported a father and his 2 sons with an autoinflammatory syndrome characterized by neonatal-onset enterocolitis, periodic fever, and fatal or near-fatal episodes of autoinflammation... He developed a coagulopathy with pancytopenia and died at age 23 days from diffuse alveolar hemorrhage]	L2	y	-	lethal	lethal	lethal	L2	L2	pre-infant-lethal
616052	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 7	Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 7, 616052 (3)	Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 7	n	-	-	-	CRPPA	HGNC:37276	Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 7, 616052 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L3	L3	pre-infant-lethal
616056	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 26	Developmental and epileptic encephalopathy 26, 616056 (3)	Developmental and epileptic encephalopathy 26	n	-	-	-	KCNB1	HGNC:6231	Developmental and epileptic encephalopathy 26, 616056 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
616063	POROKERATOSIS 8, DISSEMINATED SUPERFICIAL ACTINIC TYPE	Porokeratosis 8, disseminated superficial actinic type, 616063 (3)	Porokeratosis 8, disseminated superficial actinic type	n	-	-	-	SLC17A9	HGNC:16192	Porokeratosis 8, disseminated superficial actinic type, 616063 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
616067	46,XY SEX REVERSAL 9	46XY sex reversal 9, 616067 (3)	46XY sex reversal 9	n	-	-	-	ZFPM2	HGNC:16700	46XY sex reversal 9, 616067 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
616078	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 29	Intellectual developmental disorder, autosomal dominant 29, 616078 (3)	Intellectual developmental disorder, autosomal dominant 29	n	-	-	-	SETBP1	HGNC:15573	Intellectual developmental disorder, autosomal dominant 29, 616078 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L2	L2	pre-infant-lethal
616081	PONTOCEREBELLAR HYPOPLASIA, TYPE 1C	Pontocerebellar hypoplasia, type 1C, 616081 (3)	Pontocerebellar hypoplasia, type 1C	y	PONTOCEREBELLAR HYPOPLASIA, TYPE 1C; PCH1C	Description|Clinical Features|Clinical Synopsis	die|died|fatal	EXOSC8	HGNC:17035	Pontocerebellar hypoplasia, type 1C, 616081 (3), Autosomal recessive	Autosomal recessive	n	y	[Boczonadi et al. (2014) reported a large consanguineous Hungarian Roma family in which 18 children presented between 2 and 4 months of age with failure to thrive, severe muscle weakness, spastic tetraparesis, and psychomotor retardation. Vision and hearing were impaired in all patients, and deterioration of their condition was usually triggered by intercurrent infection. All affected children died of respiratory failure before 20 months of age. Two sibs from another Hungarian Roma family were similarly affected: 1 died at age 13 months, whereas the other was alive but severely disabled at age 9 months]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
616083	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 30, WITH SPEECH DELAY AND BEHAVIORAL ABNORMALITIES	Intellectual developmental disorder, autosomal dominant 30, 616083 (3)	Intellectual developmental disorder, autosomal dominant 30	n	-	-	-	ZMYND11	HGNC:16966	Intellectual developmental disorder, autosomal dominant 30, 616083 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
616084	SIDEROBLASTIC ANEMIA WITH B-CELL IMMUNODEFICIENCY, PERIODIC FEVERS, AND DEVELOPMENTAL DELAY	Sideroblastic anemia with B-cell immunodeficiency, periodic fevers, and developmental delay, 616084 (3)	Sideroblastic anemia with B-cell immunodeficiency, periodic fevers, and developmental delay	y	SIDEROBLASTIC ANEMIA WITH B-CELL IMMUNODEFICIENCY, PERIODIC FEVERS, AND DEVELOPMENTAL DELAY; SIFD	Description|Clinical Features|Clinical Synopsis|Phenotype	death|deaths|died|lethal	TRNT1	HGNC:17341	Sideroblastic anemia with B-cell immunodeficiency, periodic fevers, and developmental delay, 616084 (3), Autosomal recessive	Autosomal recessive	n	y	[Death may occur in the first decade]	L4	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L4	L4	post-infant-lethal
616095	MONOCARBOXYLATE TRANSPORTER 1 DEFICIENCY	Monocarboxylate transporter 1 deficiency, 616095 (3)	Monocarboxylate transporter 1 deficiency	n	-	-	-	SLC16A1	HGNC:10922	Monocarboxylate transporter 1 deficiency, 616095 (3), Autosomal dominant, Autosomal recessive	Autosomal dominant, Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
616099	PALMOPLANTAR KERATODERMA AND WOOLLY HAIR	Palmoplantar keratoderma and woolly hair, 616099 (3)	Palmoplantar keratoderma and woolly hair	y	PALMOPLANTAR KERATODERMA AND WOOLLY HAIR; PPKWH	Clinical Features	death|deaths	KANK2	HGNC:29300	Palmoplantar keratoderma and woolly hair, 616099 (3), Autosomal recessive	Autosomal recessive	y	n	-	-	-	-	ambiguous	ambiguous|nonlethal	ambiguous	-	-	-
616100	IMMUNE DYSREGULATION WITH AUTOIMMUNITY, IMMUNODEFICIENCY, AND LYMPHOPROLIFERATION	Immune dysregulation with autoimmunity, immunodeficiency, and lymphoproliferation, 616100 (3)	Immune dysregulation with autoimmunity, immunodeficiency, and lymphoproliferation	y	IMMUNE DYSREGULATION WITH AUTOIMMUNITY, IMMUNODEFICIENCY, AND LYMPHOPROLIFERATION; IDAIL	Clinical Features	died	CTLA4	HGNC:2505	Immune dysregulation with autoimmunity, immunodeficiency, and lymphoproliferation, 616100 (3), Autosomal dominant	Autosomal dominant	y	y	[Kuehn et al. (2014) reported 6 patients from 4 families with a complex immune disorder they referred to as 'CTLA4 haploinsufficiency with autoimmune infiltration (CHAI).' In 1 family, a 22-year-old woman developed autoimmune thrombocytopenia as well as brain, gastrointestinal, and lung lymphocytic infiltrates in early childhood. She had chronic lymphocytic enteropathy and diarrhea. Peripheral blood studies showed hypogammaglobulinemia and lymphopenia mostly affecting T cells. Immunosuppressive treatment resulted in some clinical improvement. Her father presented at age 40 with inflammatory lung lesions and lymphocytic enteropathy. He also had hypogammaglobulinemia and clonally expanded gamma/delta-CD8+ T cells (large granular lymphocytes) that suppressed the bone marrow. He eventually died of central line infection]	L6	y	-	lethal	lethal	lethal	L6	L6	post-infant-lethal
616116	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 46	Intellectual developmental disorder, autosomal recessive 46, 616116 (3)	Intellectual developmental disorder, autosomal recessive 46	n	-	-	-	NDST1	HGNC:7680	Intellectual developmental disorder, autosomal recessive 46, 616116 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
616117	CARDIAC CONDUCTION DISEASE WITH OR WITHOUT DILATED CARDIOMYOPATHY	Cardiac conduction disease with or without dilated cardiomyopathy, 616117 (3)	Cardiac conduction disease with or without dilated cardiomyopathy	y	CARDIAC CONDUCTION DISEASE WITH OR WITHOUT DILATED CARDIOMYOPATHY; CCDD	Clinical Features|Clinical Synopsis	death|deaths|died	TNNI3K	HGNC:19661	Cardiac conduction disease with or without dilated cardiomyopathy, 616117 (3), Autosomal dominant	Autosomal dominant	y	y	[Early sudden death may occur (1.5 years, 16 years, and 13 years reported in some patients)]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
616118	MACULAR DEGENERATION, EARLY-ONSET	Macular degeneration, early-onset, 616118 (3)	Macular degeneration, early-onset	n	-	-	-	FBN2	HGNC:3604	Macular degeneration, early-onset, 616118 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L3	L3	pre-infant-lethal
616126	IMMUNODEFICIENCY 38 WITH BASAL GANGLIA CALCIFICATION	Immunodeficiency 38, 616126 (3)	Immunodeficiency 38	y	IMMUNODEFICIENCY 38 WITH BASAL GANGLIA CALCIFICATION; IMD38	Clinical Features	died	ISG15	HGNC:4053	Immunodeficiency 38, 616126 (3), Autosomal recessive	Autosomal recessive	n	y	[Zhang et al. (2015) investigated 3 sibs from China with idiopathic basal ganglia calcification (IBGC). The oldest child (P4) died during an episode of epileptic seizures at the age of 13 years; the other 2 sibs, aged 11 and 13 years at the time of study, suffered only occasional seizures]	L5	y	-	lethal	lethal	lethal	L5	L5	post-infant-lethal
616127	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 17	Spinocerebellar ataxia, autosomal recessive 17, 616127 (3)	Spinocerebellar ataxia, autosomal recessive 17	n	-	-	-	CWF19L1	HGNC:25613	Spinocerebellar ataxia, autosomal recessive 17, 616127 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
616138	PERRAULT SYNDROME 5	Perrault syndrome 5, 616138 (3)	Perrault syndrome 5	n	-	-	-	TWNK	HGNC:1160	Perrault syndrome 5, 616138 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L4|L6	L4	post-infant-lethal
616139	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 27	Developmental and epileptic encephalopathy 27, 616139 (3)	Developmental and epileptic encephalopathy 27	n	-	-	-	GRIN2B	HGNC:4586	Developmental and epileptic encephalopathy 27, 616139 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
616140	LEUKODYSTROPHY, HYPOMYELINATING, 9	Leukodystrophy, hypomyelinating, 9, 616140 (3)	Leukodystrophy, hypomyelinating, 9	y	LEUKODYSTROPHY, HYPOMYELINATING, 9; HLD9	Clinical Features	died	RARS1	HGNC:9870	Leukodystrophy, hypomyelinating, 9, 616140 (3), Autosomal recessive	Autosomal recessive	n	y	[Nafisinia et al. (2017) described a sister and brother, born to unrelated Maltese parents, and a male patient, born to first-cousin Turkish parents, with a hypomyelinating disorder similar to Pelizaeus-Merzbacher disease (312080)... The Turkish patient had 2 aunts and an uncle in the paternal line who had severe, incompletely characterized neurologic disorders and died between 2 months and 12 years without having learned to walk or speak]	L3	n	y	lethal	lethal	lethal	L3	L3	pre-infant-lethal
616145	CATEL-MANZKE SYNDROME	Catel-Manzke syndrome, 616145 (3)	Catel-Manzke syndrome	y	CATEL-MANZKE SYNDROME; CATMANS	Clinical Features	died|stillborn	TGDS	HGNC:20324	Catel-Manzke syndrome, 616145 (3), Autosomal recessive	Autosomal recessive	n	y	[A subsequent pregnancy resulted in delivery at 26 weeks of a stillborn female fetus with cleft palate, index finger anomalies, and congenital heart malformation]	L1	y	-	lethal	lethal	lethal	L1	L1	pre-infant-lethal
616151	MACULAR DYSTROPHY, VITELLIFORM, 4	Macular dystrophy, vitelliform, 4, 616151 (3)	Macular dystrophy, vitelliform, 4	y	MACULAR DYSTROPHY, VITELLIFORM, 4; VMD4	Phenotype	died	IMPG1	HGNC:6055	Macular dystrophy, vitelliform, 4, 616151 (3), Autosomal dominant, Autosomal recessive	Autosomal dominant, Autosomal recessive	y	n	-	-	-	-	ambiguous	ambiguous|nonlethal	ambiguous	-	-	-
616152	MACULAR DYSTROPHY, VITELLIFORM, 5	Macular dystrophy, vitelliform, 5, 616152 (3)	Macular dystrophy, vitelliform, 5	n	-	-	-	IMPG2	HGNC:18362	Macular dystrophy, vitelliform, 5, 616152 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
616154	PEROXISOMAL FATTY ACYL-CoA REDUCTASE 1 DISORDER	Peroxisomal fatty acyl-CoA reductase 1 disorder, 616154 (3)	Peroxisomal fatty acyl-CoA reductase 1 disorder	n	-	-	-	FAR1	HGNC:26222	Peroxisomal fatty acyl-CoA reductase 1 disorder, 616154 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
616155	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2S	Charcot-Marie-Tooth disease, axonal, type 2S, 616155 (3)	Charcot-Marie-Tooth disease, axonal, type 2S	n	-	-	-	IGHMBP2	HGNC:5542	Charcot-Marie-Tooth disease, axonal, type 2S, 616155 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L3	L3	pre-infant-lethal
616158	NEURODEVELOPMENTAL DISORDER WITH NEONATAL RESPIRATORY INSUFFICIENCY, HYPOTONIA, AND FEEDING DIFFICULTIES	Neurodevelopmental disorder with neonatal respiratory insufficiency, hypotonia, and feeding difficulties, 616158 (3)	Neurodevelopmental disorder with neonatal respiratory insufficiency, hypotonia, and feeding difficulties	n	-	-	-	PURA	HGNC:9701	Neurodevelopmental disorder with neonatal respiratory insufficiency, hypotonia, and feeding difficulties, 616158 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
616165	NEMALINE MYOPATHY 10	Nemaline myopathy 10, 616165 (3)	Nemaline myopathy 10	y	NEMALINE MYOPATHY 10; NEM10	Description|Clinical Features|Clinical Synopsis	die|died|lethal|death|deaths	LMOD3	HGNC:6649	Nemaline myopathy 10, 616165 (3), Autosomal recessive	Autosomal recessive	y	y	[Yuen et al. (2014) reported 21 patients from 14 families with a severe form of congenital nemaline myopathy. Most patients had antenatal features of the disorder, including polyhydramnios (62%), decreased or absent fetal movements (48%), and joint contractures (48%). Premature birth occurred in 35%. All patients had severe generalized hypotonia and weakness at birth, respiratory insufficiency, feeding difficulties, and bulbar weakness. Ophthalmoplegia was observed in 29%. Most patients died of respiratory failure in the neonatal period]	L2	y	-	lethal	lethal	lethal	L2	L2	pre-infant-lethal
616166	AORTIC ANEURYSM, FAMILIAL THORACIC 9	Aortic aneurysm, familial thoracic 9, 616166 (3)	Aortic aneurysm, familial thoracic 9	y	AORTIC ANEURYSM, FAMILIAL THORACIC 9; AAT9	Clinical Features	death|deaths|died	MFAP5	HGNC:29673	Aortic aneurysm, familial thoracic 9, 616166 (3), Autosomal dominant	Autosomal dominant	n	y	[Barbier et al. (2014) studied a large 3-generation family in which the female proband was discovered to have aortic root dilation during investigation of lone paroxysmal atrial fibrillation (AF) at age 50 years... Family history also included coronary artery bypass surgery in a maternal uncle at age 60 years, and stroke at age 55 years, sudden death before age 50 years, and heart disease at age 55 years in 3 brothers of the maternal grandmother, respectively]	L6	n	y	lethal	lethal	lethal	L6	L6	post-infant-lethal
616170	MACULAR DYSTROPHY WITH CENTRAL CONE INVOLVEMENT	Macular dystrophy with central cone involvement, 616170 (3)	Macular dystrophy with central cone involvement	n	-	-	-	MFSD8	HGNC:28486	Macular dystrophy with central cone involvement, 616170 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L5	L5	post-infant-lethal
616171	MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 2	Microcephaly and chorioretinopathy, autosomal recessive, 2, 616171 (3)	Microcephaly and chorioretinopathy, autosomal recessive, 2	n	-	-	-	PLK4	HGNC:11397	Microcephaly and chorioretinopathy, autosomal recessive, 2, 616171 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
616172	GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 9	Generalized epilepsy with febrile seizures plus, type 9, 616172 (3)	Generalized epilepsy with febrile seizures plus, type 9	n	-	-	-	STX1B	HGNC:18539	Generalized epilepsy with febrile seizures plus, type 9, 616172 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
616185	OVARIAN DYSGENESIS 4	Ovarian dysgenesis 4, 616185 (3)	Ovarian dysgenesis 4	n	-	-	-	MCM9	HGNC:21484	Ovarian dysgenesis 4, 616185 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
616187	EPILEPSY, PROGRESSIVE MYOCLONIC 7	Epilepsy, progressive myoclonic 7, 616187 (3)	Epilepsy, progressive myoclonic 7	n	-	-	-	KCNC1	HGNC:6233	Epilepsy, progressive myoclonic 7, 616187 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
616192	ATAXIA, COMBINED CEREBELLAR AND PERIPHERAL, WITH HEARING LOSS AND DIABETES MELLITUS	Ataxia, combined cerebellar and peripheral, with hearing loss and diabetes mellitus, 616192 (3)	Ataxia, combined cerebellar and peripheral, with hearing loss and diabetes mellitus	n	-	-	-	DNAJC3	HGNC:9439	Ataxia, combined cerebellar and peripheral, with hearing loss and diabetes mellitus, 616192 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
616193	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 47	Intellectual developmental disorder, autosomal recessive 47, 616193 (3)	Intellectual developmental disorder, autosomal recessive 47	n	-	-	-	FMN2	HGNC:14074	Intellectual developmental disorder, autosomal recessive 47, 616193 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
616198	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 23	Combined oxidative phosphorylation deficiency 23, 616198 (3)	Combined oxidative phosphorylation deficiency 23	y	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 23; COXPD23	Description|Clinical Features	death|deaths	GTPBP3	HGNC:14880	Combined oxidative phosphorylation deficiency 23, 616198 (3), Autosomal recessive	Autosomal recessive	n	y	[Combined oxidative phosphorylation deficiency-23 is an autosomal recessive disorder characterized by early childhood onset of hypertrophic cardiomyopathy and/or neurologic symptoms, including hypotonia and delayed psychomotor development. Laboratory investigations are consistent with a defect in mitochondrial function resulting in lactic acidosis, impaired activities of respiratory complexes I and IV, and defective translation of mitochondrial proteins. Brain imaging shows abnormal lesions in the basal ganglia, thalamus, and brainstem. The severity of the disorder is variable, ranging from death in early infancy to survival into the second decade (summary by Kopajtich et al., 2014)]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
616199	POLYGLUCOSAN BODY MYOPATHY 2	Polyglucosan body myopathy 2, 616199 (3)	Polyglucosan body myopathy 2	n	-	-	-	GYG1	HGNC:4699	Polyglucosan body myopathy 2, 616199 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
616200	RUIJS-AALFS SYNDROME	Ruijs-Aalfs syndrome, 616200 (3)	Ruijs-Aalfs syndrome	y	RUIJS-AALFS SYNDROME; RJALS	Description|Phenotype	died	SPRTN	HGNC:25356	Ruijs-Aalfs syndrome, 616200 (3), Autosomal recessive	Autosomal recessive	n	y	[Lessel et al. (2014) studied 2 brothers from a nonconsanguineous Australian family of European ancestry who exhibited low body weight, micrognathia, triangular face, muscular atrophy, lipodystrophy, bilateral simian creases, delayed bone age, and mild joint restrictions in the fingers and elbows. In addition, both brothers developed early-onset hepatocellular carcinoma, at ages 16 and 14 years, respectively. The older brother died at age 18 from complications of acute fulminant hepatic failure]	L5	y	-	lethal	lethal	lethal	L5	L5	post-infant-lethal
616201	CHRONIC ATRIAL AND INTESTINAL DYSRHYTHMIA	Chronic atrial and intestinal dysrhythmia, 616201 (3)	Chronic atrial and intestinal dysrhythmia	n	-	-	-	SGO1	HGNC:25088	Chronic atrial and intestinal dysrhythmia, 616201 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
616202	CEREBELLOFACIODENTAL SYNDROME	Cerebellofaciodental syndrome, 616202 (3)	Cerebellofaciodental syndrome	n	-	-	-	BRF1	HGNC:11551	Cerebellofaciodental syndrome, 616202 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
616204	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 18	Spinocerebellar ataxia, autosomal recessive 18, 616204 (3)	Spinocerebellar ataxia, autosomal recessive 18	n	-	-	-	GRID2	HGNC:4576	Spinocerebellar ataxia, autosomal recessive 18, 616204 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
616208	AMYOTROPHIC LATERAL SCLEROSIS 22 WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA	Amyotrophic lateral sclerosis 22 with or without frontotemporal dementia, 616208 (3)	Amyotrophic lateral sclerosis 22 with or without frontotemporal dementia	n	-	-	-	TUBA4A	HGNC:12407	Amyotrophic lateral sclerosis 22 with or without frontotemporal dementia, 616208 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
616211	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 28	Developmental and epileptic encephalopathy 28, 616211 (3)	Developmental and epileptic encephalopathy 28	y	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 28; DEE28	Description|Clinical Features|Clinical Synopsis|Phenotype	death|deaths|died|lethal	WWOX	HGNC:12799	Developmental and epileptic encephalopathy 28, 616211 (3), Autosomal recessive	Autosomal recessive	y	y	[Abdel-Salam et al. (2014) reported an Egyptian girl, born of consanguineous parents, with a severe lethal neurologic phenotype resulting in death at age 16 months. At age 12 months, the patient had microcephaly (-4.6 SD), poor growth, and lack of psychomotor development. She developed intractable seizures at age 2 months. She had myoclonic movements and hyperreflexia as well as optic atrophy with retinal dysfunction. Brain MRI showed supratentorial atrophy with simplified gyral pattern, hypoplasia of the hippocampus and the temporal lobe, and thin corpus callosum. She was 1 of twins; the other twin was unaffected and heterozygous for the mutation. An older sib had died at age 3 months of a similar disorder / Premature death may occur]	L3	y	y	lethal	lethal|nonlethal	lethal|nonlethal	L3	L3	pre-infant-lethal
616212	LISSENCEPHALY 6 WITH MICROCEPHALY	Lissencephaly 6, with microcephaly, 616212 (3)	Lissencephaly 6, with microcephaly	n	-	-	-	KATNB1	HGNC:6217	Lissencephaly 6, with microcephaly, 616212 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
616214	HYPERPROINSULINEMIA	Hyperproinsulinemia, 616214 (3)	Hyperproinsulinemia	n	-	-	-	INS	HGNC:6081	Hyperproinsulinemia, 616214 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
616216	THROMBOCYTOPENIA 5	Thrombocytopenia 5, 616216 (3)	Thrombocytopenia 5	y	THROMBOCYTOPENIA 5; THC5	Clinical Features	miscarriage|miscarriages	ETV6	HGNC:3495	Thrombocytopenia 5, 616216 (3), Autosomal dominant	Autosomal dominant	n	n	-	-	-	-	ambiguous	ambiguous	ambiguous	-	-	-
616217	NEPHRONOPHTHISIS 19	Nephronophthisis 19, 616217 (3)	Nephronophthisis 19	y	NEPHRONOPHTHISIS 19; NPHP19	Clinical Features	died	DCDC2	HGNC:18141	Nephronophthisis 19, 616217 (3), Autosomal recessive	Autosomal recessive	y	y	[Schueler et al. (2015) reported a boy, born of consanguineous parents, who developed hepatic fibrosis at age 11 months and end-stage renal disease due to nephronophthisis at age 14 years. Renal evaluation showed increased echogenicity, severe interstitial fibrosis, and tubular dilation with prominent epithelial luminal budding. The patient had hepatosplenomegaly with extensive fibrosis, destruction of the bile ducts, focal bile ductal proliferation, and cholestasis. He died at 16 years of age from esophageal bleeding]	L5	y	-	lethal	lethal	lethal	L5	L5	post-infant-lethal
616219	FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, 5	Fibrosis of extraocular muscles, congenital, 5, 616219 (3)	Fibrosis of extraocular muscles, congenital, 5	n	-	-	-	COL25A1	HGNC:18603	Fibrosis of extraocular muscles, congenital, 5, 616219 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
616220	FOCAL SEGMENTAL GLOMERULOSCLEROSIS 9	Focal segmental glomerulosclerosis 9, 616220 (3)	Focal segmental glomerulosclerosis 9	n	-	-	-	CRB2	HGNC:18688	Focal segmental glomerulosclerosis 9, 616220 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L1	L1	pre-infant-lethal
616221	AMELOGENESIS IMPERFECTA, TYPE IH	Amelogenesis imperfecta, type IH, 616221 (3)	Amelogenesis imperfecta, type IH	n	-	-	-	ITGB6	HGNC:6161	Amelogenesis imperfecta, type IH, 616221 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
616224	MYASTHENIC SYNDROME, CONGENITAL, 22	Myasthenic syndrome, congenital, 22, 616224 (3)	Myasthenic syndrome, congenital, 22	n	-	-	-	PREPL	HGNC:30228	Myasthenic syndrome, congenital, 22, 616224 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
616228	MYASTHENIC SYNDROME, CONGENITAL, 14	Myasthenic syndrome, congenital, 14, with tubular aggregates, 616228 (3)	Myasthenic syndrome, congenital, 14, with tubular aggregates	n	-	-	-	ALG2	HGNC:23159	Myasthenic syndrome, congenital, 14, with tubular aggregates, 616228 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
616229	OSTEOGENESIS IMPERFECTA, TYPE XVI	Osteogenesis imperfecta, type XVI, 616229 (3)	Osteogenesis imperfecta, type XVI	y	OSTEOGENESIS IMPERFECTA, TYPE XVI; OI16	Clinical Features	died|miscarriage|miscarriages	CREB3L1	HGNC:18856	Osteogenesis imperfecta, type XVI, 616229 (3), Autosomal recessive	Autosomal recessive	y	y	[Symoens et al. (2013) reported a Turkish family in which 2 sibs had osteogenesis imperfecta. The first affected child had fractures in utero and was small for gestational age. He continued to have fractures after birth, and x-rays showed beaded ribs, callus formation, and multiple fractured tubular bones with an accordion-like broadened appearance. He was hospitalized several times due to recurrent constipation and bronchopneumonia, and developed cardiac insufficiency and hepatomegaly. He died at 9 months of age... There was a healthy daughter with blue sclerae who had not experienced any fractures, and the mother also had had 1 miscarriage of unknown cause]	L1	y	y	lethal	lethal	lethal	L1	L1	pre-infant-lethal
616230	EPILEPSY, PROGRESSIVE MYOCLONIC, 8	Epilepsy, progressive myoclonic, 8, 616230 (3)	Epilepsy, progressive myoclonic, 8	n	-	-	-	CERS1	HGNC:14253	Epilepsy, progressive myoclonic, 8, 616230 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
616231	MYOPATHY, VACUOLAR, WITH CASQ1 AGGREGATES	Myopathy, vacuolar, with CASQ1 aggregates, 616231 (3)	Myopathy, vacuolar, with CASQ1 aggregates	n	-	-	-	CASQ1	HGNC:1512	Myopathy, vacuolar, with CASQ1 aggregates, 616231 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
616239	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 24	Combined oxidative phosphorylation deficiency 24, 616239 (3)	Combined oxidative phosphorylation deficiency 24	y	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 24; COXPD24	Description|Clinical Features|Clinical Synopsis|Phenotype	die|death|deaths|died|fatal	NARS2	HGNC:26274	Combined oxidative phosphorylation deficiency 24, 616239 (3), Autosomal recessive	Autosomal recessive	n	y	[Simon et al. (2015) reported 2 brothers, born of unrelated Caucasian parents (family LS06), with a severe neurodegenerative disorder resulting in death at 15 and 6 months of age]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
616247	LONG QT SYNDROME 14	Long QT syndrome 14, 616247 (3)	Long QT syndrome 14	y	LONG QT SYNDROME 14; LQT14	Description|Clinical Features|Clinical Synopsis	death|deaths|died	CALM1	HGNC:1442	Long QT syndrome 14, 616247 (3), Autosomal dominant	Autosomal dominant	y	y	[Boczek et al. (2016) reported 2 unrelated infants with LQTS and the F142L mutation in the CALM1 gene (114180.0004). The first patient was a girl whose ECG shortly after birth showed a prolonged QTc of 612 ms and 2:1 AV block. She was treated with beta blockers, and a dual chamber pacemaker was placed at 19 months of age. Shortly thereafter she experienced cardiac arrest, which resulted in anoxic brain injury and seizure-like syncopal episodes. At age 2 years, she developed altered mental status and was found to have severely diminished left ventricular systolic function, which deteriorated to VF from which she could not be resuscitated. Autopsy showed cardiomegaly with dilation and hypertrophy. The second patient was a boy who was bradycardic at birth, prompting an ECG which showed a QTc interval of 620 ms. He was treated with beta blockers and a pacemaker, which attenuated his QTc to 540 ms. At 1.25 years of age, he died suddenly; pacemaker interrogation showed sinus rhythm with 1:1 conduction before a period of fast VF]	L3	y	-	lethal	lethal	lethal	L3|L5	L3	pre-infant-lethal
616249	LONG QT SYNDROME 15	Long QT syndrome 15, 616249 (3)	Long QT syndrome 15	y	LONG QT SYNDROME 15; LQT15	Description|Clinical Features|Clinical Synopsis|Phenotype	death|deaths|died|miscarriage|miscarriages	CALM2	HGNC:1445	Long QT syndrome 15, 616249 (3), Autosomal dominant	Autosomal dominant	y	y	[Sudden death (in some patients) / Makita et al. (2014) studied 5 unrelated patients of varying ancestry who had prolonged QTc intervals and demonstrated congenital arrhythmia susceptibility... She died at age 11 while dancing at a wedding. ]	L5	y	-	lethal	lethal	lethal	L5	L5	post-infant-lethal
616255	SHORT STATURE WITH NONSPECIFIC SKELETAL ABNORMALITIES	Short stature with nonspecific skeletal abnormalities, 616255 (3)	Short stature with nonspecific skeletal abnormalities	n	-	-	-	NPR2	HGNC:7944	Short stature with nonspecific skeletal abnormalities, 616255 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
616260	TENORIO SYNDROME	Tenorio syndrome, 616260 (3)	Tenorio syndrome	n	-	-	-	RNF125	HGNC:21150	Tenorio syndrome, 616260 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
616263	NEUROLOGIC, ENDOCRINE, AND PANCREATIC DISEASE, MULTISYSTEM, INFANTILE-ONSET 1	Infantile-onset multisystem neurologic, endocrine, and pancreatic disease, 616263 (3)	Infantile-onset multisystem neurologic, endocrine, and pancreatic disease	n	-	-	-	PTRH2	HGNC:24265	Infantile-onset multisystem neurologic, endocrine, and pancreatic disease, 616263 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
616266	CONGENITAL CONTRACTURES OF THE LIMBS AND FACE, HYPOTONIA, AND DEVELOPMENTAL DELAY	Congenital contractures of the limbs and face, hypotonia, and developmental delay, 616266 (3)	Congenital contractures of the limbs and face, hypotonia, and developmental delay	y	CONGENITAL CONTRACTURES OF THE LIMBS AND FACE, HYPOTONIA, AND DEVELOPMENTAL DELAY; CLIFAHDD	Clinical Features|Phenotype	died|lethal	NALCN	HGNC:19082	Congenital contractures of the limbs and face, hypotonia, and developmental delay, 616266 (3), Autosomal dominant	Autosomal dominant	y	y	[The patients died at age 3 months and 9 months due to severe pneumonia]	L3	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L3	L3	pre-infant-lethal
616267	ATAXIA-OCULOMOTOR APRAXIA 4	Ataxia-oculomotor apraxia 4, 616267 (3)	Ataxia-oculomotor apraxia 4	n	-	-	-	PNKP	HGNC:9154	Ataxia-oculomotor apraxia 4, 616267 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
616268	ARBOLEDA-THAM SYNDROME	Arboleda-Tham syndrome, 616268 (3)	Arboleda-Tham syndrome	n	-	-	-	KAT6A	HGNC:13013	Arboleda-Tham syndrome, 616268 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
616269	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 48	Intellectual developmental disorder, autosomal recessive 48, 616269 (3)	Intellectual developmental disorder, autosomal recessive 48	n	-	-	-	SLC6A17	HGNC:31399	Intellectual developmental disorder, autosomal recessive 48, 616269 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
616270	AMELOGENESIS IMPERFECTA, TYPE IF	Amelogenesis imperfecta, type IF, 616270 (3)	Amelogenesis imperfecta, type IF	n	-	-	-	AMBN	HGNC:452	Amelogenesis imperfecta, type IF, 616270 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
616271	3-METHYLGLUTACONIC ACIDURIA, TYPE VIIB	3-methylglutaconic aciduria, type VIIB, autosomal recessive, 616271 (3)	3-methylglutaconic aciduria, type VIIB, autosomal recessive	y	3-METHYLGLUTACONIC ACIDURIA, TYPE VIIB; MGCA7B	Clinical Features|Clinical Synopsis	death|deaths|died	CLPB	HGNC:30664	3-methylglutaconic aciduria, type VIIB, autosomal recessive, 616271 (3), Autosomal recessive	Autosomal recessive	y	y	[ died from respiratory failure on day 8 of life]	L2	y	-	lethal	ambiguous|lethal	lethal	L2|L3	L2	pre-infant-lethal
616276	COENZYME Q10 DEFICIENCY, PRIMARY, 7	Coenzyme Q10 deficiency, primary, 7, 616276 (3)	Coenzyme Q10 deficiency, primary, 7	y	COENZYME Q10 DEFICIENCY, PRIMARY, 7; COQ10D7	Description|Clinical Features|Clinical Synopsis	death|deaths|died|fatal|die	COQ4	HGNC:19693	Coenzyme Q10 deficiency, primary, 7, 616276 (3), Autosomal recessive	Autosomal recessive	y	y	[Most patients die in the first days of life / Chung et al. (2015) reported 6 girls from 4 unrelated families with severe COQ10D7 resulting in death in the first days or weeks of life or in infancy (range, 36 hours to 19 months of age)]	L2	y	-	lethal	lethal	lethal	L2	L2	pre-infant-lethal
616277	MITOCHONDRIAL SHORT-CHAIN ENOYL-CoA HYDRATASE 1 DEFICIENCY	Mitochondrial short-chain enoyl-CoA hydratase 1 deficiency, 616277 (3)	Mitochondrial short-chain enoyl-CoA hydratase 1 deficiency	y	MITOCHONDRIAL SHORT-CHAIN ENOYL-CoA HYDRATASE 1 DEFICIENCY; ECHS1D	Clinical Features	death|deaths|died	ECHS1	HGNC:3151	Mitochondrial short-chain enoyl-CoA hydratase 1 deficiency, 616277 (3), Autosomal recessive	Autosomal recessive	y	y	[Peters et al. (2014) reported 2 sibs, born of unrelated parents of Greek ancestry, with a severe neurologic disorder resulting in death from cardiorespiratory failure at ages 4 and 8 months]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
616280	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2U	Charcot-Marie-Tooth disease, axonal, type 2U, 616280 (3)	Charcot-Marie-Tooth disease, axonal, type 2U	n	-	-	-	MARS1	HGNC:6898	Charcot-Marie-Tooth disease, axonal, type 2U, 616280 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L4	L4	post-infant-lethal
616281	NEURODEVELOPMENTAL DISORDER WITH SPASTIC PARAPLEGIA AND MICROCEPHALY	Neurodevelopmental disorder with microcephaly and spastic paraplegia, 616281 (3)	Neurodevelopmental disorder with microcephaly and spastic paraplegia	n	-	-	-	GPT2	HGNC:18062	Neurodevelopmental disorder with microcephaly and spastic paraplegia, 616281 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
616286	LETHAL CONGENITAL CONTRACTURE SYNDROME 7	Lethal congenital contracture syndrome 7, 616286 (3)	Lethal congenital contracture syndrome 7	y	LETHAL CONGENITAL CONTRACTURE SYNDROME 7; LCCS7	Description|Clinical Features|Clinical Synopsis|Phenotype	death|deaths|lethal|died	CNTNAP1	HGNC:8011	Lethal congenital contracture syndrome 7, 616286 (3), Autosomal recessive	Autosomal recessive	n	y	[Lakhani et al. (2017) reported a large consanguineous Arab family from Qatar in which 3 sisters had LCCS7. The pregnancies were complicated by polyhydramnios, and prenatal ultrasound showed mild contractures or abnormal positioning of the limbs. Two of the patients lacked spontaneous movements and had poor breathing leading to death in the minutes after birth, whereas the third was immediately intubated and survived]	L2	y	-	lethal	lethal	lethal	L2	L2	pre-infant-lethal
616287	LETHAL CONGENITAL CONTRACTURE SYNDROME 8	Lethal congenital contracture syndrome 8, 616287 (3)	Lethal congenital contracture syndrome 8	y	LETHAL CONGENITAL CONTRACTURE SYNDROME 8; LCCS8	Description|Clinical Features|Clinical Synopsis|Phenotype	death|deaths|lethal|died	ADCY6	HGNC:237	Lethal congenital contracture syndrome 8, 616287 (3), Autosomal recessive	Autosomal recessive	y	y	[Death within 3 months of life / Lethal congenital contracture syndrome-8 (LCCS8), an axoglial form of arthrogryposis multiplex congenita, is characterized by congenital distal joint contractures, reduced fetal movements, and severe motor paralysis leading to death early in the neonatal period (Laquerriere et al., 2014)]	L2	y	-	lethal	lethal	lethal	L2	L2	pre-infant-lethal
616289	OPTIC ATROPHY 9	Optic atrophy 9, 616289 (3)	Optic atrophy 9	n	-	-	-	ACO2	HGNC:118	Optic atrophy 9, 616289 (3), Autosomal dominant, Autosomal recessive	Autosomal dominant, Autosomal recessive	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L3	L3	pre-infant-lethal
616291	LICHTENSTEIN-KNORR SYNDROME	Lichtenstein-Knorr syndrome, 616291 (3)	Lichtenstein-Knorr syndrome	n	-	-	-	SLC9A1	HGNC:11071	Lichtenstein-Knorr syndrome, 616291 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
616294	COLE-CARPENTER SYNDROME 2	Cole-Carpenter syndrome 2, 616294 (3)	Cole-Carpenter syndrome 2	n	-	-	-	SEC24D	HGNC:10706	Cole-Carpenter syndrome 2, 616294 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
616295	PEELING SKIN WITH LEUKONYCHIA, ACRAL PUNCTATE KERATOSES, CHEILITIS, AND KNUCKLE PADS	Peeling skin with leukonychia, acral punctate keratoses, cheilitis, and knuckle pads, 616295 (3)	Peeling skin with leukonychia, acral punctate keratoses, cheilitis, and knuckle pads	n	-	-	-	CAST	HGNC:1515	Peeling skin with leukonychia, acral punctate keratoses, cheilitis, and knuckle pads, 616295 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
616298	SINGLETON-MERTEN SYNDROME 2	Singleton-Merten syndrome 2, 616298 (3)	Singleton-Merten syndrome 2	n	-	-	-	RIGI	HGNC:19102	Singleton-Merten syndrome 2, 616298 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
616299	LIPOYLTRANSFERASE 1 DEFICIENCY	Lipoyltransferase 1 deficiency, 616299 (3)	Lipoyltransferase 1 deficiency	y	LIPOYLTRANSFERASE 1 DEFICIENCY; LIPT1D	Clinical Features|Clinical Synopsis|Phenotype	death|deaths|fatal	LIPT1	HGNC:29569	Lipoyltransferase 1 deficiency, 616299 (3), Autosomal recessive	Autosomal recessive	n	y	[Tort et al. (2014) reported a female infant, born of unrelated parents, who presented with sudden clinical deterioration and bradycardia on the second day of life. She had moderate jaundice, hypoactivity, and weak cry, and a perinatal infection was suspected. Physical examination showed generalized hypertonia and dystonic movements of the hands and feet. She developed pulmonary hypertension and further clinical deterioration, resulting in cardiorespiratory arrest and death at age 9 days]	L2	y	-	lethal	lethal	lethal	L2	L2	pre-infant-lethal
616300	SHORT-RIB THORACIC DYSPLASIA 13 WITH OR WITHOUT POLYDACTYLY	Short-rib thoracic dysplasia 13 with or without polydactyly, 616300 (3)	Short-rib thoracic dysplasia 13 with or without polydactyly	y	SHORT-RIB THORACIC DYSPLASIA 13 WITH OR WITHOUT POLYDACTYLY; SRTD13	Clinical Features|Clinical Synopsis	death|deaths|died|miscarriage|miscarriages|stillbirth|stillbirths	CEP120	HGNC:26690	Short-rib thoracic dysplasia 13 with or without polydactyly, 616300 (3), Autosomal recessive	Autosomal recessive	n	y	[Death occurs early in neonatal period due to respiratory failure / Fetal death may occur]	L1	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L1	L1	pre-infant-lethal
616307	SENIOR-LOKEN SYNDROME 8	Senior-Loken syndrome 8, 616307 (3)	Senior-Loken syndrome 8	n	-	-	-	WDR19	HGNC:18340	Senior-Loken syndrome 8, 616307 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L2	L2	pre-infant-lethal
616311	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 33	Intellectual developmental disorder, autosomal dominant 33, 616311 (3)	Intellectual developmental disorder, autosomal dominant 33	n	-	-	-	DPP6	HGNC:3010	Intellectual developmental disorder, autosomal dominant 33, 616311 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
616313	MYASTHENIC SYNDROME, CONGENITAL, 2A, SLOW-CHANNEL	Myasthenic syndrome, congenital, 2A, slow-channel, 616313 (3)	Myasthenic syndrome, congenital, 2A, slow-channel	n	-	-	-	CHRNB1	HGNC:1961	Myasthenic syndrome, congenital, 2A, slow-channel, 616313 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
616322	MYASTHENIC SYNDROME, CONGENITAL, 3B, FAST-CHANNEL	Myasthenic syndrome, congenital, 3B, fast-channel, 616322 (3)	Myasthenic syndrome, congenital, 3B, fast-channel	y	MYASTHENIC SYNDROME, CONGENITAL, 3B, FAST-CHANNEL; CMS3B	Clinical Features	died	CHRND	HGNC:1965	Myasthenic syndrome, congenital, 3B, fast-channel, 616322 (3), Autosomal recessive	Autosomal recessive	y	y	[Brownlow et al. (2001) reported a 6-year-old girl who showed decreased fetal movements and was born with CMS and congenital contractures of both hands. She showed breathing and eating difficulties soon after birth and had mildly delayed walking. At age 6, while on pyridostigmine, she had ptosis, limitation of eye movements, intermittent swallowing difficulty, and fatigable muscle weakness of the upper and lower limbs. Single-fiber EMG showed increased jitter with blocking. A brother had reduced fetal movements and hand contractures, and died at age 5 months]	L3	n	y	lethal	lethal	lethal	L1|L3	L1	pre-infant-lethal
616324	MYASTHENIC SYNDROME, CONGENITAL, 4B, FAST-CHANNEL	Myasthenic syndrome, congenital, 4B, fast-channel, 616324 (3)	Myasthenic syndrome, congenital, 4B, fast-channel	y	MYASTHENIC SYNDROME, CONGENITAL, 4B, FAST-CHANNEL; CMS4B	Clinical Features|Clinical Synopsis	died|death|deaths	CHRNE	HGNC:1966	Myasthenic syndrome, congenital, 4B, fast-channel, 616324 (3), Autosomal recessive	Autosomal recessive	y	y	[Shen et al. (2012) reported an 8-year-old boy, born of consanguineous parents, with fast-channel congenital myasthenic syndrome. The patient, who had severe myasthenic symptoms since birth, was wheelchair-bound. Three similarly affected sibs died in infancy, and he had 1 similarly affected brother]	L3	n	y	lethal	lethal|nonlethal	lethal|nonlethal	L3	L3	pre-infant-lethal
616325	MYASTHENIC SYNDROME, CONGENITAL, 9, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY	Myasthenic syndrome, congenital, 9, associated with acetylcholine receptor deficiency, 616325 (3)	Myasthenic syndrome, congenital, 9, associated with acetylcholine receptor deficiency	y	MYASTHENIC SYNDROME, CONGENITAL, 9, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY; CMS9	Clinical Features	died	MUSK	HGNC:7525	Myasthenic syndrome, congenital, 9, associated with acetylcholine receptor deficiency, 616325 (3), Autosomal recessive	Autosomal recessive	n	y	[Chevessier et al. (2004) reported a 27-year-old French woman with congenital myasthenic syndrome. Her similarly affected brother died at 1.5 years of age]	L3	n	y	lethal	lethal	lethal	L1|L3	L1	pre-infant-lethal
616326	MYASTHENIC SYNDROME, CONGENITAL, 11, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY	Myasthenic syndrome, congenital, 11, associated with acetylcholine receptor deficiency, 616326 (3)	Myasthenic syndrome, congenital, 11, associated with acetylcholine receptor deficiency	n	-	-	-	RAPSN	HGNC:9863	Myasthenic syndrome, congenital, 11, associated with acetylcholine receptor deficiency, 616326 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L3	L3	pre-infant-lethal
616329	MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 13	Maturity-onset diabetes of the young, type 13, 616329 (3)	Maturity-onset diabetes of the young, type 13	n	-	-	-	KCNJ11	HGNC:6257	Maturity-onset diabetes of the young, type 13, 616329 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L3	L3	pre-infant-lethal
616331	ROBINOW SYNDROME, AUTOSOMAL DOMINANT 2	Robinow syndrome, autosomal dominant 2, 616331 (3)	Robinow syndrome, autosomal dominant 2	n	-	-	-	DVL1	HGNC:3084	Robinow syndrome, autosomal dominant 2, 616331 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
616335	MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 3	Microcephaly and chorioretinopathy, autosomal recessive, 3, 616335 (3)	Microcephaly and chorioretinopathy, autosomal recessive, 3	n	-	-	-	TUBGCP4	HGNC:16691	Microcephaly and chorioretinopathy, autosomal recessive, 3, 616335 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
616339	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 29	Developmental and epileptic encephalopathy 29, 616339 (3)	Developmental and epileptic encephalopathy 29	n	-	-	-	AARS1	HGNC:20	Developmental and epileptic encephalopathy 29, 616339 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	ambiguous|nonlethal	ambiguous	-	-	-
616340	DEAFNESS, AUTOSOMAL DOMINANT 67	Deafness, autosomal dominant 67, 616340 (3)	Deafness, autosomal dominant 67	n	-	-	-	OSBPL2	HGNC:15761	Deafness, autosomal dominant 67, 616340 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
616341	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 30	Developmental and epileptic encephalopathy 30, 616341 (3)	Developmental and epileptic encephalopathy 30	y	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 30; DEE30	Description|Clinical Features|Clinical Synopsis	die|died|death|deaths	SIK1	HGNC:11142	Developmental and epileptic encephalopathy 30, 616341 (3), Autosomal dominant	Autosomal dominant	y	y	[Early death may occur / Hansen et al. (2015) reported 6 unrelated children with a severe neurodevelopmental disorder associated with early-onset refractory epilepsy... Two patients died in infancy, and the 4 who survived showed severe cognitive impairment with poor or absent speech and autistic features]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
616346	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 31A	Developmental and epileptic encephalopathy 31A, autosomal dominant, 616346 (3)	Developmental and epileptic encephalopathy 31A, autosomal dominant	n	-	-	-	DNM1	HGNC:2972	Developmental and epileptic encephalopathy 31A, autosomal dominant, 616346 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
616351	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 34	Intellectual developmental disorder, autosomal dominant 34, 616351 (3)	Intellectual developmental disorder, autosomal dominant 34	n	-	-	-	CERT1	HGNC:2205	Intellectual developmental disorder, autosomal dominant 34, 616351 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
616353	DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 6	Dyskeratosis congenita, autosomal recessive 6, 616353 (3)	Dyskeratosis congenita, autosomal recessive 6	n	-	-	-	PARN	HGNC:8609	Dyskeratosis congenita, autosomal recessive 6, 616353 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
616354	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 20	Spinocerebellar ataxia, autosomal recessive 20, 616354 (3)	Spinocerebellar ataxia, autosomal recessive 20	n	-	-	-	SNX14	HGNC:14977	Spinocerebellar ataxia, autosomal recessive 20, 616354 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
616355	HOUGE-JANSSENS SYNDROME 1	Houge-Janssens syndrome 1, 616355 (3)	Houge-Janssens syndrome 1	n	-	-	-	PPP2R5D	HGNC:9312	Houge-Janssens syndrome 1, 616355 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
616357	DEAFNESS, AUTOSOMAL DOMINANT 40	Deafness, autosomal dominant 40, 616357 (3)	Deafness, autosomal dominant 40	n	-	-	-	CRYM	HGNC:2418	Deafness, autosomal dominant 40, 616357 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
616362	HOUGE-JANSSENS SYNDROME 2	Houge-Janssens syndrome 2, 616362 (3)	Houge-Janssens syndrome 2	n	-	-	-	PPP2R1A	HGNC:9302	Houge-Janssens syndrome 2, 616362 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
616364	WHITE-SUTTON SYNDROME	White-Sutton syndrome, 616364 (3)	White-Sutton syndrome	n	-	-	-	POGZ	HGNC:18801	White-Sutton syndrome, 616364 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
616366	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 32	Developmental and epileptic encephalopathy 32, 616366 (3)	Developmental and epileptic encephalopathy 32	n	-	-	-	KCNA2	HGNC:6220	Developmental and epileptic encephalopathy 32, 616366 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
616367	MANDIBULOFACIAL DYSOSTOSIS WITH ALOPECIA	Mandibulofacial dysostosis with alopecia, 616367 (3)	Mandibulofacial dysostosis with alopecia	n	-	-	-	EDNRA	HGNC:3179	Mandibulofacial dysostosis with alopecia, 616367 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
616368	CHOPS SYNDROME	CHOPS syndrome, 616368 (3)	CHOPS syndrome	n	-	-	-	AFF4	HGNC:17869	CHOPS syndrome, 616368 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
616370	MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 4	Multiple mitochondrial dysfunctions syndrome 4, 616370 (3)	Multiple mitochondrial dysfunctions syndrome 4	y	MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 4; MMDS4	Description|Clinical Features|Clinical Synopsis	death|deaths|died|fatal|miscarriage|miscarriages	ISCA2	HGNC:19857	Multiple mitochondrial dysfunctions syndrome 4, 616370 (3), Autosomal recessive	Autosomal recessive	n	y	[Alfadhel et al. (2018) reported 10 children from 9 unrelated consanguineous Saudi families with MMDS4. Many of the families had a history of death of other sibs affected with a similar disorder or of recurrent miscarriages... Five patients died between 11 and 28 months of age, usually due to recurrent chest infections / Toldo et al. (2018) reported a female infant of Italian descent with MMDS4... The patient developed rapidly progressive respiratory failure resulting in death at age 3 months]	L1	y	y	lethal	lethal	lethal	L1	L1	pre-infant-lethal
616371	PULMONARY FIBROSIS AND/OR BONE MARROW FAILURE SYNDROME, TELOMERE-RELATED, 4	Pulmonary fibrosis and/or bone marrow failure syndrome, telomere-related, 4, 616371 (3)	Pulmonary fibrosis and/or bone marrow failure syndrome, telomere-related, 4	n	-	-	-	PARN	HGNC:8609	Pulmonary fibrosis and/or bone marrow failure syndrome, telomere-related, 4, 616371 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
616373	PULMONARY FIBROSIS AND/OR BONE MARROW FAILURE SYNDROME, TELOMERE-RELATED, 3	Pulmonary fibrosis and/or bone marrow failure syndrome, telomere-related, 3, 616373 (3)	Pulmonary fibrosis and/or bone marrow failure syndrome, telomere-related, 3	y	PULMONARY FIBROSIS AND/OR BONE MARROW FAILURE SYNDROME, TELOMERE-RELATED, 3; PFBMFT3	Phenotype	died	RTEL1	HGNC:15888	Pulmonary fibrosis and/or bone marrow failure syndrome, telomere-related, 3, 616373 (3), Autosomal dominant	Autosomal dominant	y	y	[died of pulmonary fibrosis at age 58 years]	L6	n	y	lethal	lethal	lethal	L4|L6	L4	post-infant-lethal
616389	NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1G	Night blindness, congenital stationary, type 1G, 616389 (3)	Night blindness, congenital stationary, type 1G	n	-	-	-	GNAT1	HGNC:4393	Night blindness, congenital stationary, type 1G, 616389 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
616390	TRICHOTHIODYSTROPHY 2, PHOTOSENSITIVE	Trichothiodystrophy 2, photosensitive, 616390 (3)	Trichothiodystrophy 2, photosensitive	n	-	-	-	ERCC3	HGNC:3435	Trichothiodystrophy 2, photosensitive, 616390 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L6	L6	post-infant-lethal
616393	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 38	Intellectual developmental disorder, autosomal dominant 38, 616393 (3)	Intellectual developmental disorder, autosomal dominant 38	n	-	-	-	EEF1A2	HGNC:3192	Intellectual developmental disorder, autosomal dominant 38, 616393 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
616394	RETINITIS PIGMENTOSA 71	Retinitis pigmentosa 71, 616394 (3)	Retinitis pigmentosa 71	n	-	-	-	IFT172	HGNC:30391	Retinitis pigmentosa 71, 616394 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L2	L2	pre-infant-lethal
616395	TRICHOTHIODYSTROPHY 3, PHOTOSENSITIVE	Trichothiodystrophy 3, photosensitive, 616395 (3)	Trichothiodystrophy 3, photosensitive	y	TRICHOTHIODYSTROPHY 3, PHOTOSENSITIVE; TTD3	Clinical Features	died	GTF2H5	HGNC:21157	Trichothiodystrophy 3, photosensitive, 616395 (3), Autosomal recessive	Autosomal recessive	y	y	[Michalska et al. (2019) reported a male infant with TTD3 who was born prematurely at 33 weeks' gestation from a pregnancy complicated by intrauterine growth retardation... He also had hypertonia, and an MRI showed delayed myelination, dilated ventricles, and structural alterations of the frontal lobe. He died at 6 months of age]	L3	n	y	lethal	lethal	lethal	L3	L3	pre-infant-lethal
616398	DYSTONIA 26, MYOCLONIC	Dystonia 26, myoclonic, 616398 (3)	Dystonia 26, myoclonic	n	-	-	-	KCTD17	HGNC:25705	Dystonia 26, myoclonic, 616398 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
616399	BRUGADA SYNDROME 9	Brugada syndrome 9, 616399 (3)	Brugada syndrome 9	y	BRUGADA SYNDROME 9; BRGDA9	Description|Clinical Features|Clinical Synopsis|Phenotype	death|deaths|died	KCND3	HGNC:6239	Brugada syndrome 9, 616399 (3), Autosomal dominant	Autosomal dominant	n	y	[Brugada syndrome is characterized by ST segment elevation in the right precordial electrocardiogram leads (so-called type 1 ECG) and a high incidence of sudden death in patients with structurally normal hearts. The syndrome typically manifests during adulthood, with a mean age of sudden death of 41 +/- 15 years, but also occurs in infants and children (summary by Antzelevitch et al., 2005)]	L6	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L6	L6	post-infant-lethal
616402	MICROCEPHALY 14, PRIMARY, AUTOSOMAL RECESSIVE	Microcephaly 14, primary, autosomal recessive, 616402 (3)	Microcephaly 14, primary, autosomal recessive	n	-	-	-	SASS6	HGNC:25403	Microcephaly 14, primary, autosomal recessive, 616402 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
616409	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 33	Developmental and epileptic encephalopathy 33, 616409 (3)	Developmental and epileptic encephalopathy 33	n	-	-	-	EEF1A2	HGNC:3192	Developmental and epileptic encephalopathy 33, 616409 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
616411	DYSTONIA 27	Dystonia 27, 616411 (3)	Dystonia 27	n	-	-	-	COL6A3	HGNC:2213	Dystonia 27, 616411 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L5|L6	L5	post-infant-lethal
616413	BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 6	Basal ganglia calcification, idiopathic, 6, 616413 (3)	Basal ganglia calcification, idiopathic, 6	n	-	-	-	XPR1	HGNC:12827	Basal ganglia calcification, idiopathic, 6, 616413 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
616415	FAMILIAL ADENOMATOUS POLYPOSIS 3	Familial adenomatous polyposis 3, 616415 (3)	Familial adenomatous polyposis 3	y	FAMILIAL ADENOMATOUS POLYPOSIS 3; FAP3	Clinical Features	died	NTHL1	HGNC:8028	Familial adenomatous polyposis 3, 616415 (3), Autosomal recessive	Autosomal recessive	n	n	-	-	-	-	ambiguous	ambiguous	ambiguous	-	-	-
616418	HYPOMAGNESEMIA, SEIZURES, AND IMPAIRED INTELLECTUAL DEVELOPMENT 1	Hypomagnesemia, seizures, and impaired intellectual development 1, 616418 (3)	Hypomagnesemia, seizures, and impaired intellectual development 1	n	-	-	-	CNNM2	HGNC:103	Hypomagnesemia, seizures, and impaired intellectual development 1, 616418 (3), Autosomal dominant, Autosomal recessive	Autosomal dominant, Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
616420	LEUKODYSTROPHY, HYPOMYELINATING, 10	Leukodystrophy, hypomyelinating, 10, 616420 (3)	Leukodystrophy, hypomyelinating, 10	y	LEUKODYSTROPHY, HYPOMYELINATING, 10; HLD10	Clinical Synopsis	death|deaths	PYCR2	HGNC:30262	Leukodystrophy, hypomyelinating, 10, 616420 (3), Autosomal recessive	Autosomal recessive	n	y	[Death often occurs in first decade]	L4	y	-	lethal	lethal	lethal	L4	L4	post-infant-lethal
616421	MYOCLONIC-ATONIC EPILEPSY	Myoclonic-atonic epilepsy, 616421 (3)	Myoclonic-atonic epilepsy	n	-	-	-	SLC6A1	HGNC:11042	Myoclonic-atonic epilepsy, 616421 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
616428	MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 10	Microphthalmia, isolated, with coloboma 10, 616428 (3)	Microphthalmia, isolated, with coloboma 10	n	-	-	-	RBP4	HGNC:9922	Microphthalmia, isolated, with coloboma 10, 616428 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
616433	IMMUNODEFICIENCY 40	Immunodeficiency 40, 616433 (3)	Immunodeficiency 40	y	IMMUNODEFICIENCY 40; IMD40	Description|Clinical Features|Clinical Synopsis	die|died|death|deaths	DOCK2	HGNC:2988	Immunodeficiency 40, 616433 (3), Autosomal recessive	Autosomal recessive	n	y	[Death in childhood occurs without bone marrow transplantation]	L4	y	-	lethal	lethal	lethal	L4	L4	post-infant-lethal
616435	FANCONI ANEMIA, COMPLEMENTATION GROUP T	Fanconi anemia, complementation group T, 616435 (3)	Fanconi anemia, complementation group T	y	FANCONI ANEMIA, COMPLEMENTATION GROUP T; FANCT	Clinical Features	died	UBE2T	HGNC:25009	Fanconi anemia, complementation group T, 616435 (3), Autosomal recessive	Autosomal recessive	n	y	[Hira et al. (2015) reported 2 unrelated Japanese patients, a girl (PNGS-252) and a boy (PNGS-255), with Fanconi anemia. Both patients presented at birth with thumb abnormalities: the girl had a hypoplastic thumb and the boy had bilateral thumb polydactyly. The girl also had short stature and abnormalities of external genitalia, whereas the boy had facial palsy and dysplasia of the middle ear bone. Both were found to have thrombocytopenia and anemia as well as increased rate of chromosomal breakage. The girl developed pancytopenia, and the boy was diagnosed with refractory anemia evolving to acute myeloid leukemia associated with a somatic 3q abnormality. Both received bone marrow transplantation, which was successful in the girl; however, the boy died at age 8 years]	L4	y	-	lethal	lethal	lethal	L4	L4	post-infant-lethal
616437	FRONTOTEMPORAL DEMENTIA AND/OR AMYOTROPHIC LATERAL SCLEROSIS 3	Frontotemporal dementia and/or amyotrophic lateral sclerosis 3, 616437 (3)	Frontotemporal dementia and/or amyotrophic lateral sclerosis 3	n	-	-	-	SQSTM1	HGNC:11280	Frontotemporal dementia and/or amyotrophic lateral sclerosis 3, 616437 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	LU	LU	post-infant-lethal
616439	FRONTOTEMPORAL DEMENTIA AND/OR AMYOTROPHIC LATERAL SCLEROSIS 4	Frontotemporal dementia and/or amyotrophic lateral sclerosis 4, 616439 (3)	Frontotemporal dementia and/or amyotrophic lateral sclerosis 4	y	FRONTOTEMPORAL DEMENTIA AND/OR AMYOTROPHIC LATERAL SCLEROSIS 4; FTDALS4	Clinical Features|Phenotype	death|deaths|died	TBK1	HGNC:11584	Frontotemporal dementia and/or amyotrophic lateral sclerosis 4, 616439 (3), Autosomal dominant	Autosomal dominant	n	y	[Pottier et al. (2015) reported 3 unrelated woman with FTDALS4 presenting as frontotemporal dementia or Alzheimer disease. The age at onset ranged from 70 to 80 years and death occurred between 72 and 90 years]	L6	y	-	lethal	lethal	lethal	L6	L6	post-infant-lethal
616445	CANDIDIASIS, FAMILIAL, 9	Candidiasis, familial, 9, 616445 (3)	Candidiasis, familial, 9	n	-	-	-	IL17RC	HGNC:18358	Candidiasis, familial, 9, 616445 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
616449	BASEL-VANAGAITE-SMIRIN-YOSEF SYNDROME	Basel-Vanagait-Smirin-Yosef syndrome, 616449 (3)	Basel-Vanagait-Smirin-Yosef syndrome	n	-	-	-	MED25	HGNC:28845	Basel-Vanagait-Smirin-Yosef syndrome, 616449 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
616452	B-CELL EXPANSION WITH NFKB AND T-CELL ANERGY	B-cell expansion with NFKB and T-cell anergy, 616452 (3)	B-cell expansion with NFKB and T-cell anergy	y	B-CELL EXPANSION WITH NFKB AND T-CELL ANERGY; BENTA	Phenotype	death|deaths	CARD11	HGNC:16393	B-cell expansion with NFKB and T-cell anergy, 616452 (3), Autosomal dominant	Autosomal dominant	n	n	-	-	-	-	ambiguous	ambiguous|lethal|nonlethal	lethal|nonlethal	L3	L3	pre-infant-lethal
616455	ZIMMERMANN-LABAND SYNDROME 2	Zimmermann-Laband syndrome 2, 616455 (3)	Zimmermann-Laband syndrome 2	n	-	-	-	ATP6V1B2	HGNC:854	Zimmermann-Laband syndrome 2, 616455 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	ambiguous|nonlethal	ambiguous	-	-	-
616457	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 50	Developmental and epileptic encephalopathy 50, 616457 (3)	Developmental and epileptic encephalopathy 50	y	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 50; DEE50	Clinical Features|Clinical Synopsis	died|death|deaths	CAD	HGNC:1424	Developmental and epileptic encephalopathy 50, 616457 (3), Autosomal recessive	Autosomal recessive	y	y	[Koch et al. (2017) reported 5 patients from 3 unrelated families with early-onset epileptic encephalopathy, 3 of whom died between 2.5 and 5 years of age]	L4	y	-	lethal	lethal	lethal	L4	L4	post-infant-lethal
616459	AL-RAQAD SYNDROME	Al-Raqad syndrome, 616459 (3)	Al-Raqad syndrome	n	-	-	-	DCPS	HGNC:29812	Al-Raqad syndrome, 616459 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
616462	ACROFACIAL DYSOSTOSIS, CINCINNATI TYPE	Acrofacial dysostosis, Cincinnati type, 616462 (3)	Acrofacial dysostosis, Cincinnati type	n	-	-	-	POLR1A	HGNC:17264	Acrofacial dysostosis, Cincinnati type, 616462 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
616469	RETINITIS PIGMENTOSA 72	Retinitis pigmentosa 72, 616469 (3)	Retinitis pigmentosa 72	n	-	-	-	ZNF408	HGNC:20041	Retinitis pigmentosa 72, 616469 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
616471	BETHLEM MYOPATHY 2	Bethlem myopathy 2, 616471 (3)	Bethlem myopathy 2	n	-	-	-	COL12A1	HGNC:2188	Bethlem myopathy 2, 616471 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
616479	PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 2	Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 2, 616479 (3)	Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 2	n	-	-	-	RNASEH1	HGNC:18466	Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 2, 616479 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
616481	CILIARY DYSKINESIA, PRIMARY, 32	Ciliary dyskinesia, primary, 32, 616481 (3)	Ciliary dyskinesia, primary, 32	n	-	-	-	RSPH3	HGNC:21054	Ciliary dyskinesia, primary, 32, 616481 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
616482	ACHONDROPLASIA, SEVERE, WITH DEVELOPMENTAL DELAY AND ACANTHOSIS NIGRICANS	SADDAN, 616482 (3)	SADDAN	y	ACHONDROPLASIA, SEVERE, WITH DEVELOPMENTAL DELAY AND ACANTHOSIS NIGRICANS; SADDAN	Description|Clinical Features	die|died	FGFR3	HGNC:3690	SADDAN, 616482 (3), Autosomal dominant	Autosomal dominant	y	y	[Zankl et al. (2008) reported a patient with the SADDAN phenotype. He had severe micromelia, frontal bossing, large anterior fontanel, depressed nasal bridge, reverse tibial bowing, small thorax, and hypotonia. Acanthosis nigricans was not present. He died at age 21 days due to respiratory failure. Zankl et al. (2008) noted that about half of patients reported with the K650M mutation died before 21 days of age, whereas others have shown longer survival]	L2	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L2|L3	L2	pre-infant-lethal
616483	INFANTILE LIVER FAILURE SYNDROME 2	Infantile liver failure syndrome 2, 616483 (3)	Infantile liver failure syndrome 2	y	INFANTILE LIVER FAILURE SYNDROME 2; ILFS2	Clinical Features	died	NBAS	HGNC:15625	Infantile liver failure syndrome 2, 616483 (3), Autosomal recessive	Autosomal recessive	y	y	[In 10 unrelated families, most apparently of European descent, Haack et al. (2015) identified 11 patients, aged 3 to 37 years, with onset of recurrent acute liver failure in infancy... None of the 11 patients died, but 2 had older sibs who died of acute liver failure in early infancy]	L3	n	y	lethal	lethal|nonlethal	lethal|nonlethal	L3	L3	pre-infant-lethal
616486	NEURODEVELOPMENTAL DISORDER WITH PROGRESSIVE MICROCEPHALY, SPASTICITY, AND BRAIN IMAGING ABNORMALITIES	Neurodevelopmental disorder with progressive microcephaly, spasticity, and brain abnormalities, 616486 (3)	Neurodevelopmental disorder with progressive microcephaly, spasticity, and brain abnormalities	y	NEURODEVELOPMENTAL DISORDER WITH PROGRESSIVE MICROCEPHALY, SPASTICITY, AND BRAIN IMAGING ABNORMALITIES; NEDMISBA	Description|Clinical Features	death|deaths|died|lethal	MFSD2A	HGNC:25897	Neurodevelopmental disorder with progressive microcephaly, spasticity, and brain abnormalities, 616486 (3), Autosomal recessive	Autosomal recessive	y	y	[Guemez-Gamboa et al. (2015) reported 4 children from 2 unrelated consanguineous families of Libyan and Egyptian origin, respectively, with a lethal microcephalic disorder. Head circumference was at the low-normal range at birth, but all developed progressive microcephaly (up to -6.2 SD). They had profoundly delayed psychomotor development with lack of head control, lack of ambulation, and lack of speech development. Additional neurologic features included spastic quadriparesis, hyperreflexia, hypotonia, and early-onset seizures. Brain imaging showed enlarged ventricles and hypoplasia of the corpus callosum, brainstem, and cerebellum. All the patients died before age 6 years]	L4	y	-	lethal	lethal	lethal	L4	L4	post-infant-lethal
616488	NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE VIII	Neuropathy, hereditary sensory and autonomic, type VIII, 616488 (3)	Neuropathy, hereditary sensory and autonomic, type VIII	n	-	-	-	PRDM12	HGNC:13997	Neuropathy, hereditary sensory and autonomic, type VIII, 616488 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
616489	SILVER-RUSSELL SYNDROME 3	Silver-Russell syndrome 3, 616489 (3)	Silver-Russell syndrome 3	n	-	-	-	IGF2	HGNC:5466	Silver-Russell syndrome 3, 616489 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
616490	JOUBERT SYNDROME 23	Joubert syndrome 23, 616490 (3)	Joubert syndrome 23	n	-	-	-	KIAA0586	HGNC:19960	Joubert syndrome 23, 616490 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L1	L1	pre-infant-lethal
616494	LEUKODYSTROPHY, HYPOMYELINATING, 11	Leukodystrophy, hypomyelinating, 11, 616494 (3)	Leukodystrophy, hypomyelinating, 11	n	-	-	-	POLR1C	HGNC:20194	Leukodystrophy, hypomyelinating, 11, 616494 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
616501	MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 13	Mitochondrial complex IV deficiency, nuclear type 13, 616501 (3)	Mitochondrial complex IV deficiency, nuclear type 13	y	MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 13; MC4DN13	Description|Clinical Features|Clinical Synopsis	death|deaths|died|fatal|lethal	COA6	HGNC:18025	Mitochondrial complex IV deficiency, nuclear type 13, 616501 (3), Autosomal recessive	Autosomal recessive	y	y	[Lethal in first weeks of life / Baertling et al. (2015) reported a female infant, born of consanguineous parents of Arab origin, with fatal cardioencephalomyopathy... She died at age 5 weeks. Patient fibroblasts showed isolated complex IV deficiency]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
616502	CONE-ROD DYSTROPHY 21	Cone-rod dystrophy 21, 616502 (3)	Cone-rod dystrophy 21	n	-	-	-	DRAM2	HGNC:28769	Cone-rod dystrophy 21, 616502 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
616503	LETHAL CONGENITAL CONTRACTURE SYNDROME 9	Lethal congenital contracture syndrome 9, 616503 (3)	Lethal congenital contracture syndrome 9	y	LETHAL CONGENITAL CONTRACTURE SYNDROME 9; LCCS9	Clinical Features|Clinical Synopsis|Phenotype	died|die|lethal	ADGRG6	HGNC:13841	Lethal congenital contracture syndrome 9, 616503 (3), Autosomal recessive	Autosomal recessive	n	y	[Affected individuals die soon after birth due to respiratory failure]	L2	y	-	lethal	lethal	lethal	L2	L2	pre-infant-lethal
616505	NEUROPATHY, HEREDITARY MOTOR AND SENSORY, TYPE VIB, WITH OPTIC ATROPHY	Neuropathy, hereditary motor and sensory, type VIB, 616505 (3)	Neuropathy, hereditary motor and sensory, type VIB	n	-	-	-	SLC25A46	HGNC:25198	Neuropathy, hereditary motor and sensory, type VIB, 616505 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L2	L2	pre-infant-lethal
616507	OSTEOGENESIS IMPERFECTA, TYPE XVII	Osteogenesis imperfecta, type XVII, 616507 (3)	Osteogenesis imperfecta, type XVII	n	-	-	-	SPARC	HGNC:11219	Osteogenesis imperfecta, type XVII, 616507 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
616509	CATARACT 44	Cataract 44, 616509 (3)	Cataract 44	n	-	-	-	LSS	HGNC:6708	Cataract 44, 616509 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
616516	EMERY-DREIFUSS MUSCULAR DYSTROPHY 3, AUTOSOMAL RECESSIVE	Emery-Dreifuss muscular dystrophy 3, autosomal recessive, 616516 (3)	Emery-Dreifuss muscular dystrophy 3, autosomal recessive	n	-	-	-	LMNA	HGNC:6636	Emery-Dreifuss muscular dystrophy 3, autosomal recessive, 616516 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	ambiguous|lethal|nonlethal	lethal|nonlethal	L1|L2|L6	L1	pre-infant-lethal
616517	ACHROMATOPSIA 7	Achromatopsia 7, 616517 (3)	Achromatopsia 7	n	-	-	-	ATF6	HGNC:791	Achromatopsia 7, 616517 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
616521	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 39	Intellectual developmental disorder, autosomal dominant 39, 616521 (3)	Intellectual developmental disorder, autosomal dominant 39	n	-	-	-	MYT1L	HGNC:7623	Intellectual developmental disorder, autosomal dominant 39, 616521 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
616531	NEURODEVELOPMENTAL DISORDER WITH SPASTICITY, HYPOMYELINATING LEUKODYSTROPHY, AND BRAIN ABNORMALITIES	Polymicrogyria, perisylvian, with cerebellar hypoplasia and arthrogryposis, 616531 (3)	Polymicrogyria, perisylvian, with cerebellar hypoplasia and arthrogryposis	y	NEURODEVELOPMENTAL DISORDER WITH SPASTICITY, HYPOMYELINATING LEUKODYSTROPHY, AND BRAIN ABNORMALITIES; NEDSPLB	Clinical Features	miscarriage|miscarriages	PI4KA	HGNC:8983	Polymicrogyria, perisylvian, with cerebellar hypoplasia and arthrogryposis, 616531 (3), Autosomal recessive	Autosomal recessive	y	y	[Pagnamenta et al. (2015) reported a family in which 3 fetuses were all diagnosed in utero with multiple congenital anomalies resulting in the termination of pregnancy between 16 and 34 weeks' gestation. All fetuses had bilateral perisylvian polymicrogyria and cerebellar hypoplasia or dysplasia. One had a small pons. Additional features included severe talipes equinovarus, externally rotated hips, and variable contractures of the limbs or fingers, consistent with arthrogryposis. Three had micrognathia and 2 had dolichocephaly. Muscle histology was reported to be within normal limits. The fetuses were conceived by nonconsanguineous parents of European ancestry; the parents had had 3 early miscarriages in addition to the affected fetuses]	L1	n	y	lethal	lethal|nonlethal	lethal|nonlethal	L1|L3	L1	pre-infant-lethal
616538	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 9	Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 9, 616538 (3)	Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 9	y	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 9; MDDGA9	Description|Clinical Features|Clinical Synopsis|Phenotype	death|deaths|died	DAG1	HGNC:2666	Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 9, 616538 (3), Autosomal recessive	Autosomal recessive	n	y	[Death in first days of life (family B) / Riemersma et al. (2015) reported a consanguineous Israeli-Arab family in which 5 female infants were born with multiple severe abnormalities consistent with WWS and died within a few hours to 3.5 months of life]	L2	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L2	L2	pre-infant-lethal
616539	PERIPHERAL NEUROPATHY WITH VARIABLE SPASTICITY, EXERCISE INTOLERANCE, AND DEVELOPMENTAL DELAY	Peripheral neuropathy with variable spasticity, exercise intolerance, and developmental delay, 616539 (3)	Peripheral neuropathy with variable spasticity, exercise intolerance, and developmental delay	y	PERIPHERAL NEUROPATHY WITH VARIABLE SPASTICITY, EXERCISE INTOLERANCE, AND DEVELOPMENTAL DELAY; PNSED	Clinical Features	died	TRMT5	HGNC:23141	Peripheral neuropathy with variable spasticity, exercise intolerance, and developmental delay, 616539 (3), Autosomal recessive	Autosomal recessive	y	y	[died in her sleep at age 55 years	L6	y	-	lethal	lethal	lethal	L6	L6	post-infant-lethal
616541	SHORT STATURE, MICROCEPHALY, AND ENDOCRINE DYSFUNCTION	Short stature, microcephaly, and endocrine dysfunction, 616541 (3)	Short stature, microcephaly, and endocrine dysfunction	y	SHORT STATURE, MICROCEPHALY, AND ENDOCRINE DYSFUNCTION; SSMED	Clinical Features	died	XRCC4	HGNC:12831	Short stature, microcephaly, and endocrine dysfunction, 616541 (3), Autosomal recessive	Autosomal recessive	n	y	De Bruin et al. (2015) studied a brother and sister from rural Chile who exhibited severe short stature, microcephaly, gonadal failure, and early-onset metabolic syndrome. Both sibs were small for gestational age and displayed progressive postnatal growth failure.... At 30 years of age, she underwent removal of a jejunal wall tumor which was determined to be a gastrointestinal stromal tumor; 1 year later, she was found to have diffuse intraabdominal metastases, which progressed despite treatment, and she died at 36 years of age	L6	y	-	lethal	lethal	lethal	L6	L6	post-infant-lethal
616544	RETINITIS PIGMENTOSA 73	Retinitis pigmentosa 73, 616544 (3)	Retinitis pigmentosa 73	n	-	-	-	HGSNAT	HGNC:26527	Retinitis pigmentosa 73, 616544 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L6	L6	post-infant-lethal
616546	SHORT-RIB THORACIC DYSPLASIA 14 WITH POLYDACTYLY	Short-rib thoracic dysplasia 14 with polydactyly, 616546 (3)	Short-rib thoracic dysplasia 14 with polydactyly	y	SHORT-RIB THORACIC DYSPLASIA 14 WITH POLYDACTYLY; SRTD14	Description|Clinical Features|Clinical Synopsis|Phenotype	lethal|died|spontaneous_abortion|spontaneous_abortions|die	KIAA0586	HGNC:19960	Short-rib thoracic dysplasia 14 with polydactyly, 616546 (3), Autosomal recessive	Autosomal recessive	n	y	[Affected fetuses frequently undergo spontaneous abortion]	L1	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L1	L1	pre-infant-lethal
616549	KLIPPEL-FEIL SYNDROME 4, AUTOSOMAL RECESSIVE, WITH NEMALINE MYOPATHY AND FACIAL DYSMORPHISM	Klippel-Feil syndrome 4, autosomal recessive, with myopathy and facial dysmorphism, 616549 (3)	Klippel-Feil syndrome 4, autosomal recessive, with myopathy and facial dysmorphism	y	KLIPPEL-FEIL SYNDROME 4, AUTOSOMAL RECESSIVE, WITH NEMALINE MYOPATHY AND FACIAL DYSMORPHISM; KFS4	Clinical Features|Phenotype	death|deaths|died|fatal	MYO18B	HGNC:18150	Klippel-Feil syndrome 4, autosomal recessive, with myopathy and facial dysmorphism, 616549 (3), Autosomal recessive	Autosomal recessive	y	y	[Malfatti et al. (2015) reported a female infant, born of consanguineous Portuguese parents, with severe nemaline myopathy and fatal cardiomyopathy. Prenatal ultrasound at 22 weeks' gestation showed reduced left ventricle and aortic valve growth. After birth, the infant showed hypotonia with reduced spontaneous movements, tendon contractures, and poor feeding. She also had dysmorphic features, including transversal enlargement of the skull, small and horizontal palpebral fissures, high-arched palate, low-set ears, pectus excavatum, large and low implanted thumbs, and clinodactyly. Cardiac abnormalities included hypertrophic left cavities, interatrial communication, and pulmonary hypertension. She had hemodynamic instability and poor respiratory status, resulting in death at age 4.5 months]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
616559	NOONAN SYNDROME 9	Noonan syndrome 9, 616559 (3)	Noonan syndrome 9	n	-	-	-	SOS2	HGNC:11188	Noonan syndrome 9, 616559 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
616562	RETINITIS PIGMENTOSA 74	Retinitis pigmentosa 74, 616562 (3)	Retinitis pigmentosa 74	n	-	-	-	BBS2	HGNC:967	Retinitis pigmentosa 74, 616562 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
616564	NOONAN SYNDROME 10	Noonan syndrome 10, 616564 (3)	Noonan syndrome 10	n	-	-	-	LZTR1	HGNC:6742	Noonan syndrome 10, 616564 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L2	L2	pre-infant-lethal
616570	CEREBROOCULOFACIOSKELETAL SYNDROME 3	Cerebrooculofacioskeletal syndrome 3, 616570 (3)	Cerebrooculofacioskeletal syndrome 3	y	CEREBROOCULOFACIOSKELETAL SYNDROME 3; COFS3	Clinical Features|Clinical Synopsis	death|deaths	ERCC5	HGNC:3437	Cerebrooculofacioskeletal syndrome 3, 616570 (3), Autosomal recessive	Autosomal recessive	n	y	[Hamel et al. (1996) and Nouspikel et al. (1997) studied a male who was born to healthy first-cousin Moroccan parents and had extremely severe early-onset Cockayne syndrome leading to death at 7 months of age]	L3	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L3	L3	pre-infant-lethal
616576	IMMUNODEFICIENCY, COMMON VARIABLE, 12, WITH AUTOIMMUNITY	Immunodeficiency, common variable, 12, 616576 (3)	Immunodeficiency, common variable, 12	y	IMMUNODEFICIENCY, COMMON VARIABLE, 12, WITH AUTOIMMUNITY; CVID12	Clinical Features	death|deaths|died	NFKB1	HGNC:7794	Immunodeficiency, common variable, 12, 616576 (3), Autosomal dominant	Autosomal dominant	y	y	[Lorenzini et al. (2020) identified 157 individuals from 68 unrelated families, mostly of European descent, with CVID12. Several families had previously been reported (see, e.g., Tuijnenburg et al., 2018).... At the time of the report, 17.1% of the cohort of patients had died at a median age of 52 years (range 35-78)]	L6	y	-	lethal	lethal	lethal	L6	L6	post-infant-lethal
616577	NEURODEVELOPMENTAL DISORDER WITH HEARING LOSS, SEIZURES, AND BRAIN ABNORMALITIES	Neurodevelopmental disorder with hearing loss, seizures, and brain abnormalities, 616577 (3)	Neurodevelopmental disorder with hearing loss, seizures, and brain abnormalities	n	-	-	-	AFG2A	HGNC:18119	Neurodevelopmental disorder with hearing loss, seizures, and brain abnormalities, 616577 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
616579	NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, IMPAIRED LANGUAGE, AND DYSMORPHIC FEATURES	Neurodevelopmental disorder with hypotonia, impaired language, and dysmorphic features, 616579 (3)	Neurodevelopmental disorder with hypotonia, impaired language, and dysmorphic features	n	-	-	-	CHAMP1	HGNC:20311	Neurodevelopmental disorder with hypotonia, impaired language, and dysmorphic features, 616579 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
616580	AU-KLINE SYNDROME	Au-Kline syndrome, 616580 (3)	Au-Kline syndrome	y	AU-KLINE SYNDROME; AUKS	Clinical Features	died	HNRNPK	HGNC:5044	Au-Kline syndrome, 616580 (3), Autosomal dominant	Autosomal dominant	y	y	[She died at age 12 days after the withdrawal of supportive medical care.]	L2	y	-	lethal	lethal	lethal	L2	L2	pre-infant-lethal
616583	SPONDYLOEPIPHYSEAL DYSPLASIA, STANESCU TYPE	Spondyloepiphyseal dysplasia, Stanescu type, 616583 (3)	Spondyloepiphyseal dysplasia, Stanescu type	n	-	-	-	COL2A1	HGNC:2200	Spondyloepiphyseal dysplasia, Stanescu type, 616583 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	ambiguous|lethal|nonlethal	lethal|nonlethal	L1|L2|L3	L1	pre-infant-lethal
616586	SPASTIC PARAPLEGIA 9B, AUTOSOMAL RECESSIVE	Spastic paraplegia 9B, autosomal recessive, 616586 (3)	Spastic paraplegia 9B, autosomal recessive	n	-	-	-	ALDH18A1	HGNC:9722	Spastic paraplegia 9B, autosomal recessive, 616586 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L3|L4	L3	pre-infant-lethal
616589	ADAMS-OLIVER SYNDROME 6	Adams-Oliver syndrome 6, 616589 (3)	Adams-Oliver syndrome 6	n	-	-	-	DLL4	HGNC:2910	Adams-Oliver syndrome 6, 616589 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
616592	KOSAKI OVERGROWTH SYNDROME	Kosaki overgrowth syndrome, 616592 (3)	Kosaki overgrowth syndrome	n	-	-	-	PDGFRB	HGNC:8804	Kosaki overgrowth syndrome, 616592 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L3|L6	L3	pre-infant-lethal
616603	CUTIS LAXA, AUTOSOMAL DOMINANT 3	Cutis laxa, autosomal dominant 3, 616603 (3)	Cutis laxa, autosomal dominant 3	y	CUTIS LAXA, AUTOSOMAL DOMINANT 3; ADCL3	Clinical Features	died|lethal|miscarriage|miscarriages	ALDH18A1	HGNC:9722	Cutis laxa, autosomal dominant 3, 616603 (3), Autosomal dominant	Autosomal dominant	n	y	[Jukkola et al. (1998) reported a Finnish boy with a lethal connective tissue disorder characterized by extreme hypermobility of the joints, lax skin, cataracts, severe growth retardation, and insufficient production of type I and type II procollagens... The patient died at age 3 years from progressive spinal stenosis due to failure of connective tissue structures joining the skull and spine]	L4	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L3|L4	L3	pre-infant-lethal
616617	HEIMLER SYNDROME 2	Heimler syndrome 2, 616617 (3)	Heimler syndrome 2	n	-	-	-	PEX6	HGNC:8859	Heimler syndrome 2, 616617 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L3|L4	L3	pre-infant-lethal
616622	IMMUNODEFICIENCY 42	Immunodeficiency 42, 616622 (3)	Immunodeficiency 42	n	-	-	-	RORC	HGNC:10260	Immunodeficiency 42, 616622 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
616625	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2W	Charcot-Marie-Tooth disease, axonal, type 2W, 616625 (3)	Charcot-Marie-Tooth disease, axonal, type 2W	n	-	-	-	HARS1	HGNC:4816	Charcot-Marie-Tooth disease, axonal, type 2W, 616625 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	ambiguous|nonlethal	ambiguous	-	-	-
616629	SENIOR-LOKEN SYNDROME 9	Senior-Loken syndrome 9, 616629 (3)	Senior-Loken syndrome 9	n	-	-	-	TRAF3IP1	HGNC:17861	Senior-Loken syndrome 9, 616629 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
616631	POROKERATOSIS 9, MULTIPLE TYPES	Porokeratosis 9, multiple types, 616631 (3)	Porokeratosis 9, multiple types	n	-	-	-	FDPS	HGNC:3631	Porokeratosis 9, multiple types, 616631 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
616632	SEIZURES, CORTICAL BLINDNESS, AND MICROCEPHALY SYNDROME	Seizures, cortical blindness, microcephaly syndrome, 616632 (3)	Seizures, cortical blindness, microcephaly syndrome	n	-	-	-	DIAPH1	HGNC:2876	Seizures, cortical blindness, microcephaly syndrome, 616632 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
616636	IMMUNODEFICIENCY 44	Immunodeficiency 44, 616636 (3)	Immunodeficiency 44	y	IMMUNODEFICIENCY 44; IMD44	Clinical Features	died	STAT2	HGNC:11363	Immunodeficiency 44, 616636 (3), Autosomal recessive	Autosomal recessive	y	y	[Hambleton et al. (2013) reported a 5-year-old boy, born of consanguineous parents, with a history of disseminated vaccine-strain measles that developed 6 days after routine measles/mumps/rubella (MMR) vaccination at age 18 months. An infant sib later died suddenly in the context of a 2-day febrile illness with features of overwhelming viral infection on postmortem examination]	L3	n	y	lethal	lethal	lethal	L3	L3	pre-infant-lethal
616638	SMITH-KINGSMORE SYNDROME	Smith-Kingsmore syndrome, 616638 (3)	Smith-Kingsmore syndrome	y	SMITH-KINGSMORE SYNDROME; SKS	Clinical Features	died	MTOR	HGNC:3942	Smith-Kingsmore syndrome, 616638 (3), Autosomal dominant	Autosomal dominant	y	y	[Smith et al. (2013) described a girl with megalencephaly and intractable seizures. The pregnancy was complicated by maternal hypothyroidism and preeclampsia, and the patient was born at 35 weeks' gestation by cesarian section for breech presentation. She had macrocephaly, poor feeding, hypoglycemia, thrombocytopenia, and hypotonia. Brain imaging showed callosal dysgenesis and mild dilatation of the posterior horns of the lateral ventricles. At age 2 months, she developed apneic seizures and EEG showed high voltage spike and slow wave activity. Treatment with antiepileptic medication was unsuccessful. The patient also had dysmorphic features including large anterior fontanel, frontal bossing, midface hypoplasia, small chin, hypertelorism with downslanting palpebral fissures, depressed nasal bridge, smooth philtrum, and thin upper lip. Other features included narrow thorax, umbilical hernia, rhizomelic limb shortening, and short proximal phalanges. She died of pneumonia at age 19 months]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
616645	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 34	Developmental and epileptic encephalopathy 34, 616645 (3)	Developmental and epileptic encephalopathy 34	n	-	-	-	SLC12A5	HGNC:13818	Developmental and epileptic encephalopathy 34, 616645 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
616647	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 35	Developmental and epileptic encephalopathy 35, 616647 (3)	Developmental and epileptic encephalopathy 35	y	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 35; DEE35	Description|Clinical Features|Clinical Synopsis	die|died|death|deaths	ITPA	HGNC:6176	Developmental and epileptic encephalopathy 35, 616647 (3), Autosomal recessive	Autosomal recessive	y	y	[Kevelam et al. (2015) reported 7 patients from 4 unrelated families with severe early-onset epileptic encephalopathy associated with a distinctive pattern of MRI abnormalities on brain imaging... Additional clinical features included cardiomyopathy (1 patient), electrocardiographic abnormalities (3 patients), and cataracts (3 sibs born of consanguineous parents). Six patients died between 10 months and 2.5 years]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
616649	SPHEROCYTOSIS, TYPE 2	Spherocytosis, type 2, 616649 (3)	Spherocytosis, type 2	n	-	-	-	SPTB	HGNC:11274	Spherocytosis, type 2, 616649 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L1	L1	pre-infant-lethal
616654	JOUBERT SYNDROME 24	Joubert syndrome 24, 616654 (3)	Joubert syndrome 24	n	-	-	-	TCTN2	HGNC:25774	Joubert syndrome 24, 616654 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
616657	SPASTIC TETRAPLEGIA, THIN CORPUS CALLOSUM, AND PROGRESSIVE MICROCEPHALY	Spastic tetraplegia, thin corpus callosum, and progressive microcephaly, 616657 (3)	Spastic tetraplegia, thin corpus callosum, and progressive microcephaly	n	-	-	-	SLC1A4	HGNC:10942	Spastic tetraplegia, thin corpus callosum, and progressive microcephaly, 616657 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
616668	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2X	Charcot-Marie-Tooth disease, axonal, type 2X, 616668 (3)	Charcot-Marie-Tooth disease, axonal, type 2X	n	-	-	-	SPG11	HGNC:11226	Charcot-Marie-Tooth disease, axonal, type 2X, 616668 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
616669	IMMUNODEFICIENCY 45	Immunodeficiency 45, 616669 (3)	Immunodeficiency 45	y	IMMUNODEFICIENCY 45; IMD45	Clinical Features|Phenotype	death|deaths|died|fatal	IFNAR2	HGNC:5433	Immunodeficiency 45, 616669 (3), Autosomal recessive	Autosomal recessive	y	y	[leading to the patient's death]	LU	y	-	lethal	lethal	lethal	LU	LU	post-infant-lethal
616672	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 27	Combined oxidative phosphorylation deficiency 27, 616672 (3)	Combined oxidative phosphorylation deficiency 27	y	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 27; COXPD27	Clinical Features|Clinical Synopsis	death|deaths|died	CARS2	HGNC:25695	Combined oxidative phosphorylation deficiency 27, 616672 (3), Autosomal recessive	Autosomal recessive	y	y	[Hallmann et al. (2014) reported 2 sibs, born of consanguineous Turkish parents, with a neurodegenerative disorder reminiscent of the mitochondrial disorder myoclonus epilepsy with ragged-red fibers (MERRF; 545000). The patients died at ages 28 and 18 years]	L5	y	-	lethal	lethal	lethal	L5	L5	post-infant-lethal
616680	SPASTIC PARAPLEGIA 75, AUTOSOMAL RECESSIVE	Spastic paraplegia 75, autosomal recessive, 616680 (3)	Spastic paraplegia 75, autosomal recessive	n	-	-	-	MAG	HGNC:6783	Spastic paraplegia 75, autosomal recessive, 616680 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
616681	MICROCEPHALY 16, PRIMARY, AUTOSOMAL RECESSIVE	Microcephaly 16, primary, autosomal recessive, 616681 (3)	Microcephaly 16, primary, autosomal recessive	y	MICROCEPHALY 16, PRIMARY, AUTOSOMAL RECESSIVE; MCPH16	Clinical Features	died	ANKLE2	HGNC:29101	Microcephaly 16, primary, autosomal recessive, 616681 (3), Autosomal recessive	Autosomal recessive	y	y	[Yamamoto et al. (2014) reported a boy, born of unrelated parents of Mexican descent, with severe primary microcephaly... A younger sister had severe microcephaly, spasticity, and abnormal skin pigmentation, but died in the first few weeks of life from cardiac failure]	L2	n	y	lethal	lethal	lethal	L2	L2	pre-infant-lethal
616682	SEIZURES, SCOLIOSIS, AND MACROCEPHALY/MICROCEPHALY SYNDROME	Seizures, scoliosis, and macrocephaly syndrome, 616682 (3)	Seizures, scoliosis, and macrocephaly syndrome	y	SEIZURES, SCOLIOSIS, AND MACROCEPHALY/MICROCEPHALY SYNDROME; SSMS	Clinical Features	died	EXT2	HGNC:3513	Seizures, scoliosis, and macrocephaly syndrome, 616682 (3), Autosomal recessive	Autosomal recessive	n	y	[El-Bazzal et al. (2019) reported 2 brothers, born of consanguineous Syrian parents, with severe global developmental delay, hypotonia, microcephaly, gastrointestinal abnormalities with poor feeding and constipation, osteopenia, and neurologic regression. Neither achieved walking or speech by 8 and 5 years of age; 1 was tube-fed. Both developed refractory seizures in the first years of life, and EEG showed abnormalities, including generalized and multifocal discharges and hypsarrhythmia in 1. Other features included flat forehead, large ears, decayed teeth, and gingival hypertrophy. Family history revealed a possibly affected sister who died at age 7 from respiratory distress]	L4	n	y	lethal	lethal|nonlethal	lethal|nonlethal	L4	L4	post-infant-lethal
616683	LEUKODYSTROPHY, HYPOMYELINATING, 12	Leukodystrophy, hypomyelinating, 12, 616683 (3)	Leukodystrophy, hypomyelinating, 12	y	LEUKODYSTROPHY, HYPOMYELINATING, 12; HLD12	Clinical Features	died	VPS11	HGNC:14583	Leukodystrophy, hypomyelinating, 12, 616683 (3), Autosomal recessive	Autosomal recessive	y	n	-	-	-	-	ambiguous	ambiguous	ambiguous	-	-	-
616684	CHARCOT-MARIE-TOOTH DISEASE, TYPE 4K	Charcot-Marie-Tooth disease, type 4K, 616684 (3)	Charcot-Marie-Tooth disease, type 4K	n	-	-	-	SURF1	HGNC:11474	Charcot-Marie-Tooth disease, type 4K, 616684 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L1|L3	L1	pre-infant-lethal
616687	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2Y	Charcot-Marie-Tooth disease, type 2Y, 616687 (3)	Charcot-Marie-Tooth disease, type 2Y	n	-	-	-	VCP	HGNC:12666	Charcot-Marie-Tooth disease, type 2Y, 616687 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L6	L6	post-infant-lethal
616688	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2Z	Charcot-Marie-Tooth disease, axonal, type 2Z, 616688 (3)	Charcot-Marie-Tooth disease, axonal, type 2Z	n	-	-	-	MORC2	HGNC:23573	Charcot-Marie-Tooth disease, axonal, type 2Z, 616688 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
616689	DEHYDRATED HEREDITARY STOMATOCYTOSIS 2	Dehydrated hereditary stomatocytosis 2, 616689 (3)	Dehydrated hereditary stomatocytosis 2	n	-	-	-	KCNN4	HGNC:6293	Dehydrated hereditary stomatocytosis 2, 616689 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
616697	DEAFNESS, AUTOSOMAL DOMINANT 69	Deafness, autosomal dominant 69, unilateral or asymmetric, 616697 (3)	Deafness, autosomal dominant 69, unilateral or asymmetric	n	-	-	-	KITLG	HGNC:6343	Deafness, autosomal dominant 69, unilateral or asymmetric, 616697 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	ambiguous|nonlethal	ambiguous	-	-	-
616708	DESANTO-SHINAWI SYNDROME	Desanto-Shinawi syndrome, 616708 (3)	Desanto-Shinawi syndrome	n	-	-	-	WAC	HGNC:17327	Desanto-Shinawi syndrome, 616708 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
616710	PARKINSON DISEASE 22, AUTOSOMAL DOMINANT	Parkinson disease 22, autosomal dominant, 616710 (3)	Parkinson disease 22, autosomal dominant	n	-	-	-	CHCHD2	HGNC:21645	Parkinson disease 22, autosomal dominant, 616710 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
616716	RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 5	Rhizomelic chondrodysplasia punctata, type 5, 616716 (3)	Rhizomelic chondrodysplasia punctata, type 5	y	RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 5; RCDP5	Description	die	PEX5	HGNC:9719	Rhizomelic chondrodysplasia punctata, type 5, 616716 (3), Autosomal recessive	Autosomal recessive	y	y	[Rhizomelic chondrodysplasia punctata (RCDP) is a peroxisomal disorder characterized by disproportionately short stature primarily affecting the proximal parts of the extremities, a typical facial appearance including a broad nasal bridge, epicanthus, high-arched palate, dysplastic external ears, and micrognathia, congenital contractures, characteristic ocular involvement, dwarfism, and severe mental retardation with spasticity. Biochemically, plasmalogen synthesis and phytanic acid alpha-oxidation are defective. Most patients die in the first decade of life (summary by Wanders and Waterham, 2005)]	L4	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L4	L4	post-infant-lethal
616719	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 21	Spinocerebellar ataxia, autosomal recessive 21, 616719 (3)	Spinocerebellar ataxia, autosomal recessive 21	n	-	-	-	SCYL1	HGNC:14372	Spinocerebellar ataxia, autosomal recessive 21, 616719 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
616720	MYASTHENIC SYNDROME, CONGENITAL, 19	Myasthenic syndrome, congenital, 19, 616720 (3)	Myasthenic syndrome, congenital, 19	y	MYASTHENIC SYNDROME, CONGENITAL, 19; CMS19	Clinical Features	death|deaths|died	COL13A1	HGNC:2190	Myasthenic syndrome, congenital, 19, 616720 (3), Autosomal recessive	Autosomal recessive	y	y	[Logan et al. (2015) reported 3 patients from 2 unrelated families with onset of congenital myasthenic syndrome soon after birth. Two unrelated patients were aged 2 years and 27 years at the time of the report; the younger sib of the older patient had died of respiratory insufficiency at age 8 years]	L4	y	-	lethal	lethal	lethal	L4	L4	post-infant-lethal
616721	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIn	Congenital disorder of glycosylation, type IIn, 616721 (3)	Congenital disorder of glycosylation, type IIn	n	-	-	-	SLC39A8	HGNC:20862	Congenital disorder of glycosylation, type IIn, 616721 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
616723	SPONDYLOEPIMETAPHYSEAL DYSPLASIA, FADEN-ALKURAYA TYPE	Spondyloepimetaphyseal dysplasia, Faden-Alkuraya type, 616723 (3)	Spondyloepimetaphyseal dysplasia, Faden-Alkuraya type	n	-	-	-	RSPRY1	HGNC:29420	Spondyloepimetaphyseal dysplasia, Faden-Alkuraya type, 616723 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
616724	TOOTH AGENESIS, SELECTIVE, 7	Tooth agenesis, selective, 7, 616724 (3)	Tooth agenesis, selective, 7	n	-	-	-	LRP6	HGNC:6698	Tooth agenesis, selective, 7, 616724 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
616726	CILIARY DYSKINESIA, PRIMARY, 33	Ciliary dyskinesia, primary, 33, 616726 (3)	Ciliary dyskinesia, primary, 33	n	-	-	-	GAS8	HGNC:4166	Ciliary dyskinesia, primary, 33, 616726 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
616728	CLEFT PALATE, PSYCHOMOTOR RETARDATION, AND DISTINCTIVE FACIAL FEATURES	Cleft palate, psychomotor retardation, and distinctive facial features, 616728 (3)	Cleft palate, psychomotor retardation, and distinctive facial features	n	-	-	-	KDM1A	HGNC:29079	Cleft palate, psychomotor retardation, and distinctive facial features, 616728 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
616730	NEPHROTIC SYNDROME, TYPE 11	Nephrotic syndrome, type 11, 616730 (3)	Nephrotic syndrome, type 11	n	-	-	-	NUP107	HGNC:29914	Nephrotic syndrome, type 11, 616730 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	ambiguous|nonlethal	ambiguous	-	-	-
616732	OPTIC ATROPHY 10 WITH OR WITHOUT ATAXIA, IMPAIRED INTELLECTUAL DEVELOPMENT, AND SEIZURES	Optic atrophy 10 with or without ataxia, impaired intellectual development and seizures, 616732 (3)	Optic atrophy 10 with or without ataxia, impaired intellectual development and seizures	y	OPTIC ATROPHY 10 WITH OR WITHOUT ATAXIA, IMPAIRED INTELLECTUAL DEVELOPMENT, AND SEIZURES; OPA10	Clinical Features	death|deaths	RTN4IP1	HGNC:18647	Optic atrophy 10 with or without ataxia, impaired intellectual development and seizures, 616732 (3), Autosomal recessive	Autosomal recessive	y	y	[death occurred before the age of 1 year and 5 year]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
616733	COENZYME Q10 DEFICIENCY, PRIMARY, 8	Coenzyme Q10 deficiency, primary, 8, 616733 (3)	Coenzyme Q10 deficiency, primary, 8	y	COENZYME Q10 DEFICIENCY, PRIMARY, 8; COQ10D8	Description|Clinical Features	fatal|died	COQ7	HGNC:2244	Coenzyme Q10 deficiency, primary, 8, 616733 (3), Autosomal recessive	Autosomal recessive	y	y	[He died at 12 months of age.]	L3	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L3	L3	pre-infant-lethal
616734	SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 2	Symmetric circumferential skin creases, congenital, 2, 616734 (3)	Symmetric circumferential skin creases, congenital, 2	y	SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 2; CSCSC2	Clinical Features	died	MAPRE2	HGNC:6891	Symmetric circumferential skin creases, congenital, 2, 616734 (3), Autosomal dominant	Autosomal dominant	n	y	[Tinsa et al. (2009) described a 9-year-old Tunisian boy, born of consanguineous parents, who had an increased number of deep skin creases of the limbs, mental retardation, seizures, and cleft palate..The proband had a healthy older sister, but another sister with circumferential ringed skin creases had died at 2 months of age]	L3	n	y	lethal	lethal	lethal	L3	L3	pre-infant-lethal
616736	TREMOR, HEREDITARY ESSENTIAL, 5	Essential tremor, hereditary, 5, 616736 (3)	Essential tremor, hereditary, 5	n	-	-	-	TENM4	HGNC:29945	Essential tremor, hereditary, 5, 616736 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
616737	TAKENOUCHI-KOSAKI SYNDROME	Takenouchi-Kosaki syndrome, 616737 (3)	Takenouchi-Kosaki syndrome	n	-	-	-	CDC42	HGNC:1736	Takenouchi-Kosaki syndrome, 616737 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
616738	RADIOULNAR SYNOSTOSIS WITH AMEGAKARYOCYTIC THROMBOCYTOPENIA 2	Radioulnar synostosis with amegakaryocytic thrombocytopenia 2, 616738 (3)	Radioulnar synostosis with amegakaryocytic thrombocytopenia 2	n	-	-	-	MECOM	HGNC:3498	Radioulnar synostosis with amegakaryocytic thrombocytopenia 2, 616738 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
616739	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 51	Intellectual developmental disorder, autosomal recessive 51, 616739 (3)	Intellectual developmental disorder, autosomal recessive 51	n	-	-	-	HNMT	HGNC:5028	Intellectual developmental disorder, autosomal recessive 51, 616739 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
616740	IMMUNODEFICIENCY 46	Immunodeficiency 46, 616740 (3)	Immunodeficiency 46	y	IMMUNODEFICIENCY 46; IMD46	Clinical Features|Clinical Synopsis	died|death|deaths	TFRC	HGNC:11763	Immunodeficiency 46, 616740 (3), Autosomal recessive	Autosomal recessive	n	y	[Early death may occur / Jabara et al. (2016) reported a large, highly consanguineous Kuwaiti kindred in which 14 children had a primary immunodeficiency resulting in severe childhood infections... Six patients died; 8 received hematopoietic stem cell transplantation with resolution of the phenotype	L4	y	-	lethal	lethal	lethal	L4	L4	post-infant-lethal
616744	AUTOINFLAMMATORY SYNDROME, FAMILIAL, BEHCET-LIKE 1	Autoinflammatory syndrome, familial, Behcet-like 1, 616744 (3)	Autoinflammatory syndrome, familial, Behcet-like 1	y	AUTOINFLAMMATORY SYNDROME, FAMILIAL, BEHCET-LIKE 1; AIFBL1	Clinical Features	died	TNFAIP3	HGNC:11896	Autoinflammatory syndrome, familial, Behcet-like 1, 616744 (3), Autosomal dominant	Autosomal dominant	y	y	[died at 8 years of age]	L4	y	-	lethal	lethal	lethal	L4	L4	post-infant-lethal
616749	HETEROTAXY, VISCERAL, 7, AUTOSOMAL	Heterotaxy, visceral, 7, autosomal, 616749 (3)	Heterotaxy, visceral, 7, autosomal	n	-	-	-	MMP21	HGNC:14357	Heterotaxy, visceral, 7, autosomal, 616749 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
616756	SPASTIC PARAPLEGIA AND PSYCHOMOTOR RETARDATION WITH OR WITHOUT SEIZURES	Spastic paraplegia and psychomotor retardation with or without seizures, 616756 (3)	Spastic paraplegia and psychomotor retardation with or without seizures	n	-	-	-	HACE1	HGNC:21033	Spastic paraplegia and psychomotor retardation with or without seizures, 616756 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
616760	WOOLLY HAIR, AUTOSOMAL RECESSIVE 3	Woolly hair, autosomal recessive 3, 616760 (3)	Woolly hair, autosomal recessive 3	n	-	-	-	KRT25	HGNC:30839	Woolly hair, autosomal recessive 3, 616760 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
616763	LEUKODYSTROPHY AND ACQUIRED MICROCEPHALY WITH OR WITHOUT DYSTONIA	Leukodystrophy and acquired microcephaly with or without dystonia, 616763 (3)	Leukodystrophy and acquired microcephaly with or without dystonia	n	-	-	-	PLEKHG2	HGNC:29515	Leukodystrophy and acquired microcephaly with or without dystonia, 616763 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
616777	SECKEL SYNDROME 9	Seckel syndrome 9, 616777 (3)	Seckel syndrome 9	y	SECKEL SYNDROME 9; SCKL9	Clinical Features|Clinical Synopsis	death|deaths|died|die	TRAIP	HGNC:30764	Seckel syndrome 9, 616777 (3), Autosomal recessive	Autosomal recessive	n	y	[Silengo et al. (2001) described 2 Italian sibs with a Seckel-like malformation syndrome characterized by intrauterine growth retardation (IUGR), microcephaly, beaked nose, failure to thrive, and early death. The first sib was a 46,XX girl who at birth underwent surgery for right diaphragmatic hernia. External genitalia appeared normal, with slight clitoral hypertrophy. Other features included micrognathia, low-set ears, hypertrichosis, and clubfeet. She died at age 40 days of respiratory distress]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
616779	CEREBRAL ARTERIOPATHY, AUTOSOMAL DOMINANT, WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY, TYPE 2	Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 2, 616779 (3)	Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 2	n	-	-	-	HTRA1	HGNC:9476	Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 2, 616779 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L6	L6	post-infant-lethal
616780	OOCYTE/ZYGOTE/EMBRYO MATURATION ARREST 2	Oocyte/zygote/embryo maturation arrest 2, 616780 (3)	Oocyte/zygote/embryo maturation arrest 2	n	-	-	-	TUBB8	HGNC:20773	Oocyte/zygote/embryo maturation arrest 2, 616780 (3), Autosomal dominant, Autosomal recessive	Autosomal dominant, Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
616781	JOUBERT SYNDROME 25	Joubert syndrome 25, 616781 (3)	Joubert syndrome 25	n	-	-	-	CEP104	HGNC:24866	Joubert syndrome 25, 616781 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
616784	JOUBERT SYNDROME 26	Joubert syndrome 26, 616784 (3)	Joubert syndrome 26	n	-	-	-	KATNIP	HGNC:29068	Joubert syndrome 26, 616784 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
616789	IMPAIRED INTELLECTUAL DEVELOPMENT AND DISTINCTIVE FACIAL FEATURES WITH OR WITHOUT CARDIAC DEFECTS	Impaired intellectual development and distinctive facial features with or without cardiac defects, 616789 (3)	Impaired intellectual development and distinctive facial features with or without cardiac defects	n	-	-	-	MED13L	HGNC:22962	Impaired intellectual development and distinctive facial features with or without cardiac defects, 616789 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
616794	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 28	Combined oxidative phosphorylation deficiency 28, 616794 (3)	Combined oxidative phosphorylation deficiency 28	y	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 28; COXPD28	Description|Clinical Features	death|deaths|died	SLC25A26	HGNC:20661	Combined oxidative phosphorylation deficiency 28, 616794 (3), Autosomal recessive	Autosomal recessive	n	y	[Kishita et al. (2015) reported 3 unrelated children with a severe multisystem disorder apparent since infancy, although the manifestations differed somewhat among the patients... The third patient, a girl born of consanguineous Moroccan parents, was the most severely affected. She was delivered by Caesarian section at 30 weeks' gestation due to reduced fetal movements, polyhydramnios, and fetal hydrops. She had hypotonia, bradycardia, increased lactate and pyruvate, and cystic necrosis of the brain; she died at 5 days of age from respiratory and multiple organ failure]	L2	y	-	lethal	lethal	lethal	L2	L2	pre-infant-lethal
616795	SPINOCEREBELLAR ATAXIA 42	Spinocerebellar ataxia 42, 616795 (3)	Spinocerebellar ataxia 42	n	-	-	-	CACNA1G	HGNC:1394	Spinocerebellar ataxia 42, 616795 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
616801	HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 2	Hypotonia, infantile, with psychomotor retardation and characteristic facies 2, 616801 (3)	Hypotonia, infantile, with psychomotor retardation and characteristic facies 2	n	-	-	-	UNC80	HGNC:26582	Hypotonia, infantile, with psychomotor retardation and characteristic facies 2, 616801 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
616803	LAMB-SHAFFER SYNDROME	Lamb-Shaffer syndrome, 616803 (3)	Lamb-Shaffer syndrome	n	-	-	-	SOX5	HGNC:11201	Lamb-Shaffer syndrome, 616803 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
616809	HYPERPHOSPHATASIA WITH IMPAIRED INTELLECTUAL DEVELOPMENT SYNDROME 6	Hyperphosphatasia with impaired intellectual development syndrome 6, 616809 (3)	Hyperphosphatasia with impaired intellectual development syndrome 6	y	HYPERPHOSPHATASIA WITH IMPAIRED INTELLECTUAL DEVELOPMENT SYNDROME 6; HPMRS6	Clinical Features|Clinical Synopsis	death|deaths	PIGY	HGNC:28213	Hyperphosphatasia with impaired intellectual development syndrome 6, 616809 (3), Autosomal recessive	Autosomal recessive	y	y	[death at age 7 months]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
616812	MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 25	Muscular dystrophy, limb-girdle, autosomal recessive 25, 616812 (3)	Muscular dystrophy, limb-girdle, autosomal recessive 25	n	-	-	-	BVES	HGNC:1152	Muscular dystrophy, limb-girdle, autosomal recessive 25, 616812 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
616814	OOCYTE/ZYGOTE/EMBRYO MATURATION ARREST 15	Oocyte/zygote/embryo maturation arrest 15, 616814 (3)	Oocyte/zygote/embryo maturation arrest 15	y	OOCYTE/ZYGOTE/EMBRYO MATURATION ARREST 15; OZEMA15	Description|Phenotype	lethality	TLE6	HGNC:30788	Oocyte/zygote/embryo maturation arrest 15, 616814 (3), Autosomal recessive	Autosomal recessive	y	n	-	-	-	-	ambiguous	ambiguous	ambiguous	-	-	-
616816	HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION	Hypotonia, infantile, with psychomotor retardation, 616816 (3)	Hypotonia, infantile, with psychomotor retardation	y	HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION; IHPMR	Clinical Features	died	CCDC174	HGNC:28033	Hypotonia, infantile, with psychomotor retardation, 616816 (3), Autosomal recessive	Autosomal recessive	n	y	[Volodarsky et al. (2015) reported 6 children from 2 unrelated families with a similar severe neurodevelopmental disorder. Two Egyptian sibs presented in the first month of life with severe generalized hypotonia requiring a feeding tube and artificial ventilation. The patients, aged 8 and 9 years at the time of the report, had mild psychomotor retardation with delayed speech acquisition. They still required continuous positive airway pressure (CPAP) and gastrostomy feeding. Brain imaging showed dilated lateral ventricles and thin corpus callosum. Four children from a consanguineous Israeli Arab Bedouin family had a similar, but more severe, disorder. Reduced fetal movements were apparent in some cases, and all had severe axial hypotonia and delayed psychomotor development. Brain imaging in 2 patients was normal. Three of the 4 died before 4 months of age, and 1 was alive at age 2 years]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
616817	MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 2	Microcephaly, short stature, and impaired glucose metabolism 2, 616817 (3)	Microcephaly, short stature, and impaired glucose metabolism 2	n	-	-	-	PPP1R15B	HGNC:14951	Microcephaly, short stature, and impaired glucose metabolism 2, 616817 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
616828	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIo	Congenital disorder of glycosylation, type IIo, 616828 (3)	Congenital disorder of glycosylation, type IIo	y	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIo; CDG2O	Clinical Features	died	CCDC115	HGNC:28178	Congenital disorder of glycosylation, type IIo, 616828 (3), Autosomal recessive	Autosomal recessive	n	y	[Jansen et al. (2016) reported 8 patients from 5 unrelated families with a severe metabolic disorder primarily affecting the liver. The patients presented with hypotonia, hepatosplenomegaly with elevated liver enzymes often associated with neonatal jaundice, and delayed psychomotor development. Laboratory abnormalities in most patients included low ceruloplasmin, hypercholesterolemia, decreased coagulation factors, and increased bone-derived alkaline phosphatase. Liver biopsies showed variable fibrosis, necrotic lesions, cirrhosis, and, in 1 patient, increased copper. Several patients had mild dysmorphic features, such as long face or ptosis. All patients had a type 2 pattern on serum transferrin isoelectric focusing (IEF), indicating abnormal N-glycosylation, as well as abnormal IEF of ApoC-III, indicating abnormal O-glycosylation. Two patients underwent liver transplant, one of whom died related to complications, and a third patient died at age 7 months]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
616829	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIp	Congenital disorder of glycosylation, type IIp, 616829 (3)	Congenital disorder of glycosylation, type IIp	n	-	-	-	TMEM199	HGNC:18085	Congenital disorder of glycosylation, type IIp, 616829 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
616831	LUSCAN-LUMISH SYNDROME	Luscan-Lumish syndrome, 616831 (3)	Luscan-Lumish syndrome	n	-	-	-	SETD2	HGNC:18420	Luscan-Lumish syndrome, 616831 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
616833	PAGET DISEASE OF BONE 6	Paget disease of bone 6, 616833 (3)	Paget disease of bone 6	n	-	-	-	ZNF687	HGNC:29277	Paget disease of bone 6, 616833 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
616834	MICROCEPHALY, CONGENITAL CATARACT, AND PSORIASIFORM DERMATITIS	Microcephaly, congenital cataract, and psoriasiform dermatitis, 616834 (3)	Microcephaly, congenital cataract, and psoriasiform dermatitis	n	-	-	-	MSMO1	HGNC:10545	Microcephaly, congenital cataract, and psoriasiform dermatitis, 616834 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
616835	MEIER-GORLIN SYNDROME 6	Meier-Gorlin syndrome 6, 616835 (3)	Meier-Gorlin syndrome 6	n	-	-	-	GMNN	HGNC:17493	Meier-Gorlin syndrome 6, 616835 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
616840	PARKINSON DISEASE 23, AUTOSOMAL RECESSIVE EARLY-ONSET	Parkinson disease 23, autosomal recessive, early onset, 616840 (3)	Parkinson disease 23, autosomal recessive, early onset	n	-	-	-	VPS13C	HGNC:23594	Parkinson disease 23, autosomal recessive, early onset, 616840 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
616843	LYMPHATIC MALFORMATION 6	Lymphatic malformation 6, 616843 (3)	Lymphatic malformation 6	y	LYMPHATIC MALFORMATION 6; LMPHM6	Description|Clinical Features	death|deaths|died	PIEZO1	HGNC:28993	Lymphatic malformation 6, 616843 (3), Autosomal recessive	Autosomal recessive	n	y	[Fotiou et al. (2015) identified 2 sib pairs and 1 sporadic case of GLD with mutations in the PIEZO1 gene. Nonimmune hydrops fetalis was documented in 2 of the families, with in utero death of 1 sib. Postnatally, the edema associated with the hydrops resolved completely in the other patients, but they re-presented with lymphedema of the peripheries in early childhood. Two of them suffered from intermittent, severe facial swelling due to recurrent cellulitis, which is rarely seen in other forms of primary lymphedema. There was no history of hemolytic anemia, and the immune profiles for both sibs were normal. None of the patients had dysmorphic features, learning disabilities, or seizures and the swelling was not severe. Fotiou et al. (2015) identified 5 additional patients from 3 similarly affected families with a PIEZO1 mutation. Of the 10 patients, 7 had NIHF and 2 died in utero]	L1	y	-	lethal	lethal	lethal	L1	L1	pre-infant-lethal
616849	BRACHYDACTYLY, TYPE A1, D	Brachydactyly, type A1, D, 616849 (3)	Brachydactyly, type A1, D	n	-	-	-	BMPR1B	HGNC:1077	Brachydactyly, type A1, D, 616849 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
616854	EVEN-PLUS SYNDROME	Even-plus syndrome, 616854 (3)	Even-plus syndrome	n	-	-	-	HSPA9	HGNC:5244	Even-plus syndrome, 616854 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
616859	SPASTICITY, CHILDHOOD-ONSET, WITH HYPERGLYCINEMIA	Spasticity, childhood-onset, with hyperglycinemia, 616859 (3)	Spasticity, childhood-onset, with hyperglycinemia	n	-	-	-	GLRX5	HGNC:20134	Spasticity, childhood-onset, with hyperglycinemia, 616859 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
616860	ANEMIA, SIDEROBLASTIC, 3, PYRIDOXINE-REFRACTORY	Anemia, sideroblastic, 3, pyridoxine-refractory, 616860 (3)	Anemia, sideroblastic, 3, pyridoxine-refractory	n	-	-	-	GLRX5	HGNC:20134	Anemia, sideroblastic, 3, pyridoxine-refractory, 616860 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
616863	HAO-FOUNTAIN SYNDROME	Hao-Fountain syndrome, 616863 (3)	Hao-Fountain syndrome	n	-	-	-	USP7	HGNC:12630	Hao-Fountain syndrome, 616863 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
616866	SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 1	Spinal muscular atrophy with congenital bone fractures 1, 616866 (3)	Spinal muscular atrophy with congenital bone fractures 1	y	SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 1; SMABF1	Description|Clinical Features|Clinical Synopsis	die|death|deaths|died	TRIP4	HGNC:12310	Spinal muscular atrophy with congenital bone fractures 1, 616866 (3), Autosomal recessive	Autosomal recessive	y	y	[Knierim et al. (2016) reported 5 patients from 3 unrelated families who were born with distal and proximal joint contractures and generalized severe muscle atrophy and were found to have mutations in the TRIP4 gene... Most children died from respiratory failure between 2 weeks and 16 months of age; 1 died of cardiac failure]	L2	y	-	lethal	lethal	lethal	L2	L2	pre-infant-lethal
616867	SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 2	Spinal muscular atrophy with congenital bone fractures 2, 616867 (3)	Spinal muscular atrophy with congenital bone fractures 2	y	SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 2; SMABF2	Description|Clinical Features|Clinical Synopsis|Phenotype	die|death|deaths|died|lethal|miscarriage|miscarriages|stillborn	ASCC1	HGNC:24268	Spinal muscular atrophy with congenital bone fractures 2, 616867 (3), Autosomal recessive	Autosomal recessive	y	y	[Death in the first days or months of life]	L2	y	-	lethal	ambiguous|lethal	lethal	L2	L2	pre-infant-lethal
616868	DIARRHEA 8, SECRETORY SODIUM, CONGENITAL	Diarrhea 8, secretory sodium, congenital, 616868 (3)	Diarrhea 8, secretory sodium, congenital	n	-	-	-	SLC9A3	HGNC:11073	Diarrhea 8, secretory sodium, congenital, 616868 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
616873	IMMUNODEFICIENCY, COMMON VARIABLE, 13	Immunodeficiency, common variable, 13, 616873 (3)	Immunodeficiency, common variable, 13	y	IMMUNODEFICIENCY, COMMON VARIABLE, 13; CVID13	Clinical Features	died	IKZF1	HGNC:13176	Immunodeficiency, common variable, 13, 616873 (3), Autosomal dominant	Autosomal dominant	y	n	-	-	-	-	ambiguous	ambiguous	ambiguous	-	-	-
616875	CEREBELLAR ATROPHY, VISUAL IMPAIRMENT, AND PSYCHOMOTOR RETARDATION	Cerebellar atrophy, visual impairment, and psychomotor retardation, 616875 (3)	Cerebellar atrophy, visual impairment, and psychomotor retardation	n	-	-	-	EMC1	HGNC:28957	Cerebellar atrophy, visual impairment, and psychomotor retardation, 616875 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
616878	METABOLIC CRISES, RECURRENT, WITH RHABDOMYOLYSIS, CARDIAC ARRHYTHMIAS, AND NEURODEGENERATION	Metabolic encephalomyopathic crises, recurrent, with rhabdomyolysis, cardiac arrhythmias, and neurodegeneration, 616878 (3)	Metabolic encephalomyopathic crises, recurrent, with rhabdomyolysis, cardiac arrhythmias, and neurodegeneration	y	METABOLIC CRISES, RECURRENT, WITH RHABDOMYOLYSIS, CARDIAC ARRHYTHMIAS, AND NEURODEGENERATION; MECRCN	Clinical Features	died	TANGO2	HGNC:25439	Metabolic encephalomyopathic crises, recurrent, with rhabdomyolysis, cardiac arrhythmias, and neurodegeneration, 616878 (3), Autosomal recessive	Autosomal recessive	y	y	[Lalani et al. (2016) studied 12 affected individuals from 9 families with episodic rhabdomyolysis, hypoglycemia, hyperammonemia, and susceptibility to cardiac tachyarrhythmias... In 1 family, affected twins from a dichorionic diamniotic pregnancy died at 2 years of age, the boy during an episode of hypoglycemia and lactic acidemia, and the girl due to worsening cardiomyopathy]	L4	y	-	lethal	lethal	lethal	L4	L4	post-infant-lethal
616881	LEUKODYSTROPHY, HYPOMYELINATING, 13	Leukodystrophy, hypomyelinating, 13, 616881 (3)	Leukodystrophy, hypomyelinating, 13	y	LEUKODYSTROPHY, HYPOMYELINATING, 13; HLD13	Clinical Features|Clinical Synopsis	died|death|deaths	HIKESHI	HGNC:26938	Leukodystrophy, hypomyelinating, 13, 616881 (3), Autosomal recessive	Autosomal recessive	n	y	[Sudden death may occur / Edvardson et al. (2016) reported 6 children from 3 unrelated families of Ashkenazi Jewish descent with a severe neurodevelopmental and neurodegenerative disorder apparent since infancy. The patients presented with feeding difficulties, axial hypotonia, and failure to thrive, followed by significantly delayed psychomotor development with poor or absent language, progressively decreasing head circumference percentile (up to -2 SD), spasticity, increased muscle tone, hyperreflexia, and clonus, more prominent in the lower limbs. Three sibs in 1 family had optic atrophy, visual impairment, and nystagmus; 1 also had central conduction delay on brainstem auditory evoked response. All 3 sibs died suddenly after short febrile illnesses before 15 years of age]	L5	y	y	lethal	lethal	lethal	L5	L5	post-infant-lethal
616890	SPLIT-FOOT MALFORMATION WITH MESOAXIAL POLYDACTYLY	Split-foot malformation with mesoaxial polydactyly, 616890 (3)	Split-foot malformation with mesoaxial polydactyly	n	-	-	-	MAP3K20	HGNC:17797	Split-foot malformation with mesoaxial polydactyly, 616890 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	ambiguous|nonlethal	ambiguous	-	-	-
616892	NEPHROTIC SYNDROME, TYPE 12	Nephrotic syndrome, type 12, 616892 (3)	Nephrotic syndrome, type 12	n	-	-	-	NUP93	HGNC:28958	Nephrotic syndrome, type 12, 616892 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
616894	ROBINOW SYNDROME, AUTOSOMAL DOMINANT 3	Robinow syndrome, autosomal dominant 3, 616894 (3)	Robinow syndrome, autosomal dominant 3	n	-	-	-	DVL3	HGNC:3087	Robinow syndrome, autosomal dominant 3, 616894 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
616897	OSTEOCHONDRODYSPLASIA, COMPLEX LETHAL, SYMOENS-BARNES-GISTELINCK TYPE	Osteochondrodysplasia, complex lethal, Symoens-Barnes-Gistelinck type, 616897 (3)	Osteochondrodysplasia, complex lethal, Symoens-Barnes-Gistelinck type	y	OSTEOCHONDRODYSPLASIA, COMPLEX LETHAL, SYMOENS-BARNES-GISTELINCK TYPE; OCLSBG	Description|Phenotype	lethal	TAPT1	HGNC:26887	Osteochondrodysplasia, complex lethal, Symoens-Barnes-Gistelinck type, 616897 (3), Autosomal recessive	Autosomal recessive	n	y	[A number sign is used with this entry because of evidence that the Symoens-Barnes-Gistelinck type of complex lethal osteochondrodysplasia (OCLSBG) is caused by homozygous mutation in the TAPT1 gene (612758) on chromosome 4p15]	LU	y	-	lethal	lethal	lethal	LU	LU	post-infant-lethal
616900	HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 3	Hypotonia, infantile, with psychomotor retardation and characteristic facies 3, 616900 (3)	Hypotonia, infantile, with psychomotor retardation and characteristic facies 3	n	-	-	-	TBCK	HGNC:28261	Hypotonia, infantile, with psychomotor retardation and characteristic facies 3, 616900 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
616901	DEVELOPMENTAL DELAY WITH SHORT STATURE, DYSMORPHIC FACIAL FEATURES, AND SPARSE HAIR 1	Developmental delay with short stature, dysmorphic facial features, and sparse hair, 616901 (3)	Developmental delay with short stature, dysmorphic facial features, and sparse hair	y	DEVELOPMENTAL DELAY WITH SHORT STATURE, DYSMORPHIC FACIAL FEATURES, AND SPARSE HAIR 1; DEDSSH1	Clinical Features|Clinical Synopsis	died|death|deaths	DPH1	HGNC:3003	Developmental delay with short stature, dysmorphic facial features, and sparse hair, 616901 (3), Autosomal recessive	Autosomal recessive	y	y	[Alazami et al. (2015) reported 4 patients from a consanguineous Saudi family (10DG0934) with syndromic intellectual disability. Loucks et al. (2015) provided more clinical details of these patients. The patients had delayed psychomotor development and an unusual skull shape, mainly scaphocephaly with or without craniosynostosis. Other features included short stature, hypertelorism, downslanting palpebral fissures, epicanthal folds, low-set ears, depressed nasal bridge, and micrognathia, as well as sparse hair of the scalp, eyelashes, and eyebrows. Brain imaging showed posterior malformations, including Dandy-Walker malformation, cerebellar vermis hypoplasia, and posterior fossa cyst. Three patients had a ventricular septal defect and 3 had a renal anomaly. Three patients died between 8 months and 4 years of age]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
616907	SPASTIC PARAPLEGIA 76, AUTOSOMAL RECESSIVE	Spastic paraplegia 76, autosomal recessive, 616907 (3)	Spastic paraplegia 76, autosomal recessive	n	-	-	-	CAPN1	HGNC:1476	Spastic paraplegia 76, autosomal recessive, 616907 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
616910	IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 3	Immunodeficiency-centromeric instability-facial anomalies syndrome 3, 616910 (3)	Immunodeficiency-centromeric instability-facial anomalies syndrome 3	y	IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 3; ICF3	Clinical Features	died	CDCA7	HGNC:14628	Immunodeficiency-centromeric instability-facial anomalies syndrome 3, 616910 (3), Autosomal recessive	Autosomal recessive	n	y	[Thijssen et al. (2015) reported 5 patients from 4 unrelated families with an immunodeficiency syndrome characterized by recurrent upper respiratory infections and associated with hypo- or agammaglobulinemia with normal B cells... Thijssen et al. (2015) noted that this patient died at 26 years of age]	L6	y	-	lethal	lethal	lethal	L6	L6	post-infant-lethal
616911	IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 4	Immunodeficiency-centromeric instability-facial anomalies syndrome 4, 616911 (3)	Immunodeficiency-centromeric instability-facial anomalies syndrome 4	y	IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 4; ICF4	Clinical Features	died	HELLS	HGNC:4861	Immunodeficiency-centromeric instability-facial anomalies syndrome 4, 616911 (3), Autosomal recessive	Autosomal recessive	n	y	[Thijssen et al. (2015) reported 5 patients from 4 unrelated families with an immunodeficiency syndrome characterized by recurrent respiratory infections and associated with hypo- or agammaglobulinemia with normal B cells. Cytogenetic studies showed abnormalities of chromosomes 1, 9, and 16, and hypomethylation of alpha-satellite DNA and pericentromeric satellite type II. All but 1 patient (a younger sib of another patient) had recurrent infections, all had facial anomalies, and 3 had delayed psychomotor development. The families were of various ethnic origins, including English, Japanese, French, and Italian; one family was confirmed to be consanguineous. One patient died at 1.2 years of age; 2 sibs underwent stem cell transplantation]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
616913	BLEEDING DISORDER, PLATELET-TYPE, 20	Bleeding disorder, platelet-type, 20, 616913 (3)	Bleeding disorder, platelet-type, 20	n	-	-	-	SLFN14	HGNC:32689	Bleeding disorder, platelet-type, 20, 616913 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
616914	MARFANOID-PROGEROID-LIPODYSTROPHY SYNDROME	Marfan lipodystrophy syndrome, 616914 (3)	Marfan lipodystrophy syndrome	n	-	-	-	FBN1	HGNC:3603	Marfan lipodystrophy syndrome, 616914 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	ambiguous|lethal|nonlethal	lethal|nonlethal	L2|LU	L2	pre-infant-lethal
616917	NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPOTONIA, SEIZURES, AND CEREBELLAR ATROPHY	Neurodevelopmental disorder with or without hypotonia, seizures, and cerebellar atrophy, 616917 (3)	Neurodevelopmental disorder with or without hypotonia, seizures, and cerebellar atrophy	y	NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPOTONIA, SEIZURES, AND CEREBELLAR ATROPHY; NEDHSCA	Clinical Features	died	PIGG	HGNC:25985	Neurodevelopmental disorder with or without hypotonia, seizures, and cerebellar atrophy, 616917 (3), Autosomal recessive	Autosomal recessive	y	n	-	-	-	-	ambiguous	ambiguous	ambiguous	-	-	-
616920	HEART AND BRAIN MALFORMATION SYNDROME	Heart and brain malformation syndrome, 616920 (3)	Heart and brain malformation syndrome	y	HEART AND BRAIN MALFORMATION SYNDROME; HBMS	Clinical Features|Clinical Synopsis	death|deaths|died	SMG9	HGNC:25763	Heart and brain malformation syndrome, 616920 (3), Autosomal recessive	Autosomal recessive	y	y	[Shaheen et al. (2016) reported 2 unrelated consanguineous families of Arab origin in which 5 patients had a severe multiple congenital anomaly syndrome. In the first family, the proband was a female infant who died at age 7 weeks. Antenatal ultrasound showed polyhydramnios, splaying of the cerebellum, and a ventricular septal defect. At birth, she showed craniofacial abnormalities, including prominent forehead and occiput, wide anterior fontanel, low-set malformed ears, depressed nasal bridge with anteverted nares, microphthalmia, and high-arched palate. She also had clenched hands with camptodactyly. Brain imaging showed Dandy-Walker malformation, cerebellar vermis hypoplasia, and hypoplastic corpus callosum. Cardiac abnormalities included interrupted aortic arch, hypoplastic valves, and ventricular septal defect. She developed seizures and sepsis, resulting in death. Family history revealed that the mother had a history of 3 abortions, and there were 2 older sibs with multiple congenital anomalies who died in utero or in the first year of life]	L1	y	y	lethal	lethal|nonlethal	lethal|nonlethal	L1	L1	pre-infant-lethal
616921	DYSKINESIA, LIMB AND OROFACIAL, INFANTILE-ONSET	Dyskinesia, limb and orofacial, infantile-onset, 616921 (3)	Dyskinesia, limb and orofacial, infantile-onset	n	-	-	-	PDE10A	HGNC:8772	Dyskinesia, limb and orofacial, infantile-onset, 616921 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
616922	STRIATAL DEGENERATION, AUTOSOMAL DOMINANT 2	Striatal degeneration, autosomal dominant, 616922 (3)	Striatal degeneration, autosomal dominant	n	-	-	-	PDE10A	HGNC:8772	Striatal degeneration, autosomal dominant, 616922 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
616924	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2CC	Charcot-Marie-Tooth disease, axonal, type 2CC, 616924 (3)	Charcot-Marie-Tooth disease, axonal, type 2CC	n	-	-	-	NEFH	HGNC:7737	Charcot-Marie-Tooth disease, axonal, type 2CC, 616924 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
616938	COFFIN-SIRIS SYNDROME 5	Coffin-Siris syndrome 5, 616938 (3)	Coffin-Siris syndrome 5	n	-	-	-	SMARCE1	HGNC:11109	Coffin-Siris syndrome 5, 616938 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
616941	AGAMMAGLOBULINEMIA 8A, AUTOSOMAL DOMINANT	Agammaglobulinemia 8A, autosomal dominant, 616941 (3)	Agammaglobulinemia 8A, autosomal dominant	n	-	-	-	TCF3	HGNC:11633	Agammaglobulinemia 8A, autosomal dominant, 616941 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L4	L4	post-infant-lethal
616943	TRICHOTHIODYSTROPHY 6, NONPHOTOSENSITIVE	Trichothiodystrophy 6, nonphotosensitive, 616943 (3)	Trichothiodystrophy 6, nonphotosensitive	n	-	-	-	GTF2E2	HGNC:4651	Trichothiodystrophy 6, nonphotosensitive, 616943 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
616944	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 41	Intellectual developmental disorder, autosomal dominant 41, 616944 (3)	Intellectual developmental disorder, autosomal dominant 41	n	-	-	-	TBL1XR1	HGNC:29529	Intellectual developmental disorder, autosomal dominant 41, 616944 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
616946	PREMATURE OVARIAN FAILURE 11	Premature ovarian failure 11, 616946 (3)	Premature ovarian failure 11	n	-	-	-	ERCC6	HGNC:3438	Premature ovarian failure 11, 616946 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L4	L4	post-infant-lethal
616949	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 23	Spinocerebellar ataxia, autosomal recessive 23, 616949 (3)	Spinocerebellar ataxia, autosomal recessive 23	n	-	-	-	TDP2	HGNC:17768	Spinocerebellar ataxia, autosomal recessive 23, 616949 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
616954	YOU-HOOVER-FONG SYNDROME	You-Hoover-Fong syndrome, 616954 (3)	You-Hoover-Fong syndrome	n	-	-	-	TELO2	HGNC:29099	You-Hoover-Fong syndrome, 616954 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
616959	RETINITIS PIGMENTOSA AND ERYTHROCYTIC MICROCYTOSIS	Retinitis pigmentosa and erythrocytic microcytosis, 616959 (3)	Retinitis pigmentosa and erythrocytic microcytosis	n	-	-	-	TRNT1	HGNC:17341	Retinitis pigmentosa and erythrocytic microcytosis, 616959 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L4	L4	post-infant-lethal
616963	HYPERCALCEMIA, INFANTILE, 2	Hypercalcemia, infantile, 2, 616963 (3)	Hypercalcemia, infantile, 2	n	-	-	-	SLC34A1	HGNC:11019	Hypercalcemia, infantile, 2, 616963 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
616973	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 42	Intellectual developmental disorder, autosomal dominant 42, 616973 (3)	Intellectual developmental disorder, autosomal dominant 42	n	-	-	-	GNB1	HGNC:4396	Intellectual developmental disorder, autosomal dominant 42, 616973 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
616974	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 30	Combined oxidative phosphorylation deficiency 30, 616974 (3)	Combined oxidative phosphorylation deficiency 30	y	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 30; COXPD30	Clinical Features|Clinical Synopsis|Phenotype	died|fatal|death|deaths	TRMT10C	HGNC:26022	Combined oxidative phosphorylation deficiency 30, 616974 (3), Autosomal recessive	Autosomal recessive	n	y	[Metodiev et al. (2016) reported 2 unrelated infants with a fatal systemic mitochondrial disease. One patient was of Caucasian descent and the other was of Kurdish descent. The patients presented at birth with hypotonia, feeding difficulties, and deafness. One also had cardiac left ventricular hypertrophy and brain imaging suggestive of frontal polymicrogyria. Laboratory studies in both patients showed lactic acidosis, increased cerebrospinal fluid lactate levels, increased serum alanine, and abnormal liver function tests. Both infants died of respiratory failure at age 5 months]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
616975	NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT ANOMALIES OF THE BRAIN, EYE, OR HEART	Neurodevelopmental disorder with or without anomalies of the brain, eye, or heart, 616975 (3)	Neurodevelopmental disorder with or without anomalies of the brain, eye, or heart	y	NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT ANOMALIES OF THE BRAIN, EYE, OR HEART; NEDBEH	Clinical Features	died	RERE	HGNC:9965	Neurodevelopmental disorder with or without anomalies of the brain, eye, or heart, 616975 (3), Autosomal dominant	Autosomal dominant	y	y	[male infant who died at 33 days of age]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
616977	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 43	Intellectual developmental disorder, autosomal dominant 43, 616977 (3)	Intellectual developmental disorder, autosomal dominant 43	n	-	-	-	HIVEP2	HGNC:4921	Intellectual developmental disorder, autosomal dominant 43, 616977 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
616981	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 37	Developmental and epileptic encephalopathy 37, 616981 (3)	Developmental and epileptic encephalopathy 37	n	-	-	-	FRRS1L	HGNC:1362	Developmental and epileptic encephalopathy 37, 616981 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
617004	POLYCYSTIC LIVER DISEASE 2 WITH OR WITHOUT KIDNEY CYSTS	Polycystic liver disease 2, 617004 (3)	Polycystic liver disease 2	y	POLYCYSTIC LIVER DISEASE 2 WITH OR WITHOUT KIDNEY CYSTS; PCLD2	Clinical Features	died	SEC63	HGNC:21082	Polycystic liver disease 2, 617004 (3), Autosomal dominant	Autosomal dominant	n	n	-	-	-	-	ambiguous	ambiguous	ambiguous	-	-	-
617006	AUTOIMMUNE DISEASE, MULTISYSTEM, INFANTILE-ONSET, 2	Autoimmune disease, multisystem, infantile-onset, 2, 617006 (3)	Autoimmune disease, multisystem, infantile-onset, 2	n	-	-	-	ZAP70	HGNC:12858	Autoimmune disease, multisystem, infantile-onset, 2, 617006 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
617008	CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 3	Cerebral palsy, spastic quadriplegic, 3, 617008 (3)	Cerebral palsy, spastic quadriplegic, 3	n	-	-	-	ADD3	HGNC:245	Cerebral palsy, spastic quadriplegic, 3, 617008 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
617011	MACROCEPHALY, DYSMORPHIC FACIES, AND PSYCHOMOTOR RETARDATION	Macrocephaly, dysmorphic facies, and psychomotor retardation, 617011 (3)	Macrocephaly, dysmorphic facies, and psychomotor retardation	n	-	-	-	HERC1	HGNC:4867	Macrocephaly, dysmorphic facies, and psychomotor retardation, 617011 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
617013	HYPERMANGANESEMIA WITH DYSTONIA 2	Hypermanganesemia with dystonia 2, 617013 (3)	Hypermanganesemia with dystonia 2	y	HYPERMANGANESEMIA WITH DYSTONIA 2; HMNDYT2	Clinical Features	died	SLC39A14	HGNC:20858	Hypermanganesemia with dystonia 2, 617013 (3), Autosomal recessive	Autosomal recessive	y	y	[Tuschl et al. (2016) reported 9 children from 5 unrelated consanguineous families with a severe neurodegenerative disorder with loss of developmental milestones and progressive dystonia appearing between 6 months and 3 years of age... Three patients died at ages 13 months, 4 years, and 8 years]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
617014	NEUTROPENIA, SEVERE CONGENITAL, 7, AUTOSOMAL RECESSIVE	Neutropenia, severe congenital, 7, autosomal recessive, 617014 (3)	Neutropenia, severe congenital, 7, autosomal recessive	y	NEUTROPENIA, SEVERE CONGENITAL, 7, AUTOSOMAL RECESSIVE; SCN7	Clinical Features	died	CSF3R	HGNC:2439	Neutropenia, severe congenital, 7, autosomal recessive, 617014 (3), Autosomal recessive	Autosomal recessive	n	y	[Triot et al. (2014) reported 3 sibs, born of consanguineous Turkish parents with onset of recurrent infections in infancy or early childhood. Laboratory studies showed peripheral neutropenia, but bone marrow biopsy of 2 patients showed full maturation of all 3 hematopoietic lineages without myelodysplasia. One patient died of pneumonia at age 3 months]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
617017	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2T	Charcot-Marie-Tooth disease, axonal, type 2T, 617017 (3)	Charcot-Marie-Tooth disease, axonal, type 2T	n	-	-	-	MME	HGNC:7154	Charcot-Marie-Tooth disease, axonal, type 2T, 617017 (3), Autosomal dominant, Autosomal recessive	Autosomal dominant, Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
617020	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 38	Developmental and epileptic encephalopathy 38, 617020 (3)	Developmental and epileptic encephalopathy 38	y	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 38; DEE38	Description|Clinical Features|Clinical Synopsis	death|deaths|died	ARV1	HGNC:29561	Developmental and epileptic encephalopathy 38, 617020 (3), Autosomal recessive	Autosomal recessive	y	y	[Palmer et al. (2016) reported a female infant, born of consanguineous Lebanese parents, with DEE38. By 6 weeks of life she had roving eye movements, visual inattention, hypermetropia, retinal dystrophy, central hypotonia, peripheral hypertonia, extensor posturing, and dystonia. She presented in status epilepticus at 4 months of age and subsequently had an intractable seizure disorder with hypsarrhythmia on EEG. She did not obtain developmental milestones and died at age 12 months]	L4	y	-	lethal	lethal	lethal	L4	L4	post-infant-lethal
617021	HYDROPS, LACTIC ACIDOSIS, AND SIDEROBLASTIC ANEMIA	Hydrops, lactic acidosis, and sideroblastic anemia, 617021 (3)	Hydrops, lactic acidosis, and sideroblastic anemia	y	HYDROPS, LACTIC ACIDOSIS, AND SIDEROBLASTIC ANEMIA; HLASA	Description|Clinical Features|Clinical Synopsis|Phenotype	death|deaths|died|lethal	LARS2	HGNC:17095	Hydrops, lactic acidosis, and sideroblastic anemia, 617021 (3), Autosomal recessive	Autosomal recessive	y	y	[Death in infancy may occur]	L3	y	-	lethal	lethal	lethal	L3|L6	L3	pre-infant-lethal
617022	LETHAL CONGENITAL CONTRACTURE SYNDROME 10	Lethal congenital contracture syndrome 10, 617022 (3)	Lethal congenital contracture syndrome 10	y	LETHAL CONGENITAL CONTRACTURE SYNDROME 10; LCCS10	Clinical Features|Phenotype	died|lethal	NEK9	HGNC:18591	Lethal congenital contracture syndrome 10, 617022 (3), Autosomal recessive	Autosomal recessive	n	y	[Casey et al. (2016) studied 2 Irish Traveller families with a recessive lethal skeletal dysplasia. In the first family, there were 2 offspring with fetal akinesia, multiple contractures, shortening of upper and lower limbs, short broad ribs, narrow chest and thorax, pulmonary hypoplasia, and protruding abdomen. In the second family, 3 offspring had the same features, and 2 of the 3 also exhibited bowed femurs. None of the affected infants survived past birth: 1 died 1 hour after birth, resuscitation failed in 2, 1 died in utero, and in 1 case the pregnancy was terminated]	L1	y	-	lethal	lethal	lethal	L1	L1	pre-infant-lethal
617023	RETINITIS PIGMENTOSA 75	Retinitis pigmentosa 75, 617023 (3)	Retinitis pigmentosa 75	n	-	-	-	AGBL5	HGNC:26147	Retinitis pigmentosa 75, 617023 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
617024	NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1H	Night blindness, congenital stationary, type 1H, 617024 (3)	Night blindness, congenital stationary, type 1H	n	-	-	-	GNB3	HGNC:4400	Night blindness, congenital stationary, type 1H, 617024 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
617026	PONTOCEREBELLAR HYPOPLASIA, TYPE 2F	Pontocerebellar hypoplasia, type 2F, 617026 (3)	Pontocerebellar hypoplasia, type 2F	y	PONTOCEREBELLAR HYPOPLASIA, TYPE 2F; PCH2F	Clinical Features	spontaneous_abortion|spontaneous_abortions	TSEN15	HGNC:16791	Pontocerebellar hypoplasia, type 2F, 617026 (3), Autosomal recessive	Autosomal recessive	n	y	[Alazami et al. (2015) reported a boy (13DG0167), born of consanguineous parents, with primary microcephaly and global developmental delay. Breuss et al. (2016) reported follow-up on this patient, who was born to Saudi parents. He showed progressive microcephaly (-9.7 SD), developed severe epilepsy at age 8 months, and was unable to sit, roll, speak, or follow visually at age 16 months. Other features included axial hypotonia, appendicular hypertonia with spasticity, and hyperreflexia with extensor plantar responses. Brain imaging showed hypoplasia of the cerebellum and pons. He had a similarly affected older sister, and the parents previously had 3 spontaneous abortions]	L1	n	y	lethal	lethal	lethal	L1	L1	pre-infant-lethal
617027	HYPERALDOSTERONISM, FAMILIAL, TYPE IV	Hyperaldosteronism, familial, type IV, 617027 (3)	Hyperaldosteronism, familial, type IV	n	-	-	-	CACNA1H	HGNC:1395	Hyperaldosteronism, familial, type IV, 617027 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
617028	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 54	Intellectual developmental disorder, autosomal recessive 54, 617028 (3)	Intellectual developmental disorder, autosomal recessive 54	n	-	-	-	TNIK	HGNC:30765	Intellectual developmental disorder, autosomal recessive 54, 617028 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
617030	MYOPATHY, DISTAL, 5	Myopathy, distal, 5, 617030 (3)	Myopathy, distal, 5	n	-	-	-	ADSS1	HGNC:20093	Myopathy, distal, 5, 617030 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
617035	PATENT DUCTUS ARTERIOSUS 2	Patent ductus arteriosus 2, 617035 (3)	Patent ductus arteriosus 2	n	-	-	-	TFAP2B	HGNC:11743	Patent ductus arteriosus 2, 617035 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L2	L2	pre-infant-lethal
617039	PATENT DUCTUS ARTERIOSUS 3	Patent ductus arteriosus 3, 617039 (3)	Patent ductus arteriosus 3	y	PATENT DUCTUS ARTERIOSUS 3; PDA3	Clinical Features	died	PRDM6	HGNC:9350	Patent ductus arteriosus 3, 617039 (3), Autosomal dominant	Autosomal dominant	n	y	[Li et al. (2016) restudied family A of Lynch et al. (1965) and noted that the proband also had a sib who died in the neonatal period of congestive heart failure; autopsy showed hypoplastic left heart, ventricular septal defect, mild pulmonary artery stenosis, and a large and severely dilated PDA]	L2	n	y	lethal	lethal	lethal	L2	L2	pre-infant-lethal
617041	DUANE RETRACTION SYNDROME 3 WITH OR WITHOUT DEAFNESS	Duane retraction syndrome 3, 617041 (3)	Duane retraction syndrome 3	n	-	-	-	MAFB	HGNC:6408	Duane retraction syndrome 3, 617041 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L6	L6	post-infant-lethal
617044	SHORT STATURE, DEVELOPMENTAL DELAY, AND CONGENITAL HEART DEFECTS	Short stature, developmental delay, and congenital heart defects, 617044 (3)	Short stature, developmental delay, and congenital heart defects	n	-	-	-	TKT	HGNC:11834	Short stature, developmental delay, and congenital heart defects, 617044 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
617046	SPASTIC PARAPLEGIA 77, AUTOSOMAL RECESSIVE	Spastic paraplegia 77, autosomal recessive, 617046 (3)	Spastic paraplegia 77, autosomal recessive	n	-	-	-	FARS2	HGNC:21062	Spastic paraplegia 77, autosomal recessive, 617046 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L3	L3	pre-infant-lethal
617047	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 26	Cardiomyopathy, familial hypertrophic, 26, 617047 (3)	Cardiomyopathy, familial hypertrophic, 26	y	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 26; CMH26	Description|Clinical Features|Clinical Synopsis|Phenotype	death|deaths|died	FLNC	HGNC:3756	Cardiomyopathy, familial hypertrophic, 26, 617047 (3), Autosomal dominant	Autosomal dominant	y	y	[Valdes-Mas et al. (2014) studied a 4-generation Spanish family segregating autosomal dominant hypertrophic cardiomyopathy, in which the proband was diagnosed at age 20 years, based on electrocardiography (ECG) showing left ventricular hypertrophy due to volume overload and echocardiography showing a 27-mm hypertrophic septum.... In addition, the proband's mother died suddenly at age 34, and her maternal grandmother and great-aunt died at ages 62 and 55, respectively, from cardiac causes]	L6	n	y	lethal	lethal|nonlethal	lethal|nonlethal	L6	L6	post-infant-lethal
617047	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 26	Cardiomyopathy, familial restrictive 5, 617047 (3)	Cardiomyopathy, familial restrictive 5	y	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 26; CMH26	Description|Clinical Features|Clinical Synopsis|Phenotype	death|deaths|died	FLNC	HGNC:3756	Cardiomyopathy, familial restrictive 5, 617047 (3), Autosomal dominant	Autosomal dominant	y	y	[Valdes-Mas et al. (2014) studied a 4-generation Spanish family segregating autosomal dominant hypertrophic cardiomyopathy, in which the proband was diagnosed at age 20 years, based on electrocardiography (ECG) showing left ventricular hypertrophy due to volume overload and echocardiography showing a 27-mm hypertrophic septum.... In addition, the proband's mother died suddenly at age 34, and her maternal grandmother and great-aunt died at ages 62 and 55, respectively, from cardiac causes]	L6	n	y	lethal	lethal|nonlethal	lethal|nonlethal	L6	L6	post-infant-lethal
617047	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 26	Arrhythmogenic right ventricular dysplasia, familial, 617047 (3)	Arrhythmogenic right ventricular dysplasia, familial	y	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 26; CMH26	Description|Clinical Features|Clinical Synopsis|Phenotype	death|deaths|died	FLNC	HGNC:3756	Arrhythmogenic right ventricular dysplasia, familial, 617047 (3), Autosomal dominant	Autosomal dominant	y	y	[sudden death had occurred before the age of 55 years in 3 (38%) of 8 known or suspected carriers.]	L6	y	y	lethal	lethal|nonlethal	lethal|nonlethal	L6	L6	post-infant-lethal
617049	CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC, 5	Cholestasis, progressive familial intrahepatic, 5, 617049 (3)	Cholestasis, progressive familial intrahepatic, 5	y	CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC, 5; PFIC5	Description|Clinical Features|Clinical Synopsis	death|deaths|died|fatal	NR1H4	HGNC:7967	Cholestasis, progressive familial intrahepatic, 5, 617049 (3), Autosomal recessive	Autosomal recessive	y	y	[Fatal unless liver transplant is performed / Gomez-Ospina et al. (2016) reported 4 children from 2 unrelated families with onset of severe cholestasis in early infancy. ...In the second family, 1 patient died awaiting transplantation and the other patient died at age 5 weeks from complications of an aortic thrombus]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
617051	NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY AND GRAY SCLERAE	Neurodevelopmental disorder with microcephaly and gray sclerae, 617051 (3)	Neurodevelopmental disorder with microcephaly and gray sclerae	n	-	-	-	PUS3	HGNC:25461	Neurodevelopmental disorder with microcephaly and gray sclerae, 617051 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
617052	BONE MARROW FAILURE SYNDROME 3	Bone marrow failure syndrome 3, 617052 (3)	Bone marrow failure syndrome 3	y	BONE MARROW FAILURE SYNDROME 3; BMFS3	Clinical Features	died	DNAJC21	HGNC:27030	Bone marrow failure syndrome 3, 617052 (3), Autosomal recessive	Autosomal recessive	n	y	[Dhanraj et al. (2017) reported 4 patients from 3 unrelated families with a bone marrow failure syndrome suggestive of Shwachman-Diamond syndrome. Two families were consanguineous of Afghan and First Nations Canadian descent, respectively, whereas the third family was of Indian descent. The patients presented in infancy or early childhood with pancytopenia and a hypocellular bone marrow. All had pancreatic exocrine dysfunction with decreased serum levels of pancreatic enzymes and abnormal echogenic findings on pancreatic ultrasound. Additional features included poor growth, short stature, evidence of metaphyseal dysplasia, and variably impaired cognitive and/or motor development. Two unrelated patients had retinal dystrophy, although 1 patient had another genetic defect (C2ORF71; 613425), which could have contributed to the eye phenotype. Two patients underwent bone marrow transplantation, but 1 died posttransplantation. Another patient died of infection at age 18 months]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
617053	MIRAGE SYNDROME	MIRAGE syndrome, 617053 (3)	MIRAGE syndrome	y	MIRAGE SYNDROME; MIRAGE	Description|Clinical Features|Clinical Synopsis	fatal|died	SAMD9	HGNC:1348	MIRAGE syndrome, 617053 (3), Autosomal dominant	Autosomal dominant	y	y	[Narumi et al. (2016) studied 11 patients who exhibited strikingly similar phenotypes, including moderate to severe growth restriction both prenatally and postnatally... Severe invasive infections, including sepsis, meningitis, and fungal infections, were invariably observed; 6 patients died before 2 years of age]	L3	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L3|L4	L3	pre-infant-lethal
617054	STRIATONIGRAL DEGENERATION, CHILDHOOD-ONSET	Striatonigral degeneration, childhood-onset, 617054 (3)	Striatonigral degeneration, childhood-onset	n	-	-	-	VAC14	HGNC:25507	Striatonigral degeneration, childhood-onset, 617054 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
617055	PERCHING SYNDROME	PERCHING syndrome, 617055 (3)	PERCHING syndrome	y	PERCHING SYNDROME; PERCHING	Description|Clinical Features|Clinical Synopsis	death|deaths|died	KLHL7	HGNC:15646	PERCHING syndrome, 617055 (3), Autosomal recessive	Autosomal recessive	y	y	[Angius et al. (2016) reported 5 patients from 4 unrelated consanguineous Turkish families with a phenotype reminiscent of Crisponi syndrome (see 272430). The patients presented in infancy with hyperthermia and abnormal paroxysmal contractions of the oropharyngeal muscles, resulting in feeding and swallowing difficulties. Additional features included camptodactyly, joint contractures, full cheeks, high-arched palate, and depressed nasal bridge. Three patients died between 7 and 24 months of age]	L3	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L3	L3	pre-infant-lethal
617056	TUBULOINTERSTITIAL KIDNEY DISEASE, AUTOSOMAL DOMINANT, 5	Tubulointerstitial kidney disease, autosomal dominant, 5, 617056 (3)	Tubulointerstitial kidney disease, autosomal dominant, 5	n	-	-	-	SEC61A1	HGNC:18276	Tubulointerstitial kidney disease, autosomal dominant, 5, 617056 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
617061	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 44, WITH MICROCEPHALY	Intellectual developmental disorder, autosomal dominant 44, with microcephaly, 617061 (3)	Intellectual developmental disorder, autosomal dominant 44, with microcephaly	n	-	-	-	TRIO	HGNC:12303	Intellectual developmental disorder, autosomal dominant 44, with microcephaly, 617061 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
617062	OKUR-CHUNG NEURODEVELOPMENTAL SYNDROME	Okur-Chung neurodevelopmental syndrome, 617062 (3)	Okur-Chung neurodevelopmental syndrome	n	-	-	-	CSNK2A1	HGNC:2457	Okur-Chung neurodevelopmental syndrome, 617062 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
617063	MEIER-GORLIN SYNDROME 7	Meier-Gorlin syndrome 7, 617063 (3)	Meier-Gorlin syndrome 7	n	-	-	-	CDC45	HGNC:1739	Meier-Gorlin syndrome 7, 617063 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
617070	PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 4	Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 4, 617070 (3)	Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 4	n	-	-	-	DGUOK	HGNC:2858	Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 4, 617070 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L3	L3	pre-infant-lethal
617073	TOOTH AGENESIS, SELECTIVE, 8	Tooth agenesis, selective, 8, 617073 (3)	Tooth agenesis, selective, 8	n	-	-	-	WNT10B	HGNC:12775	Tooth agenesis, selective, 8, 617073 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
617080	SEIZURES, BENIGN FAMILIAL INFANTILE, 5	Seizures, benign familial infantile, 5, 617080 (3)	Seizures, benign familial infantile, 5	n	-	-	-	SCN8A	HGNC:10596	Seizures, benign familial infantile, 5, 617080 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L5	L5	post-infant-lethal
617086	ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 2	Encephalopathy due to defective mitochondrial and peroxisomal fission 2, 617086 (3)	Encephalopathy due to defective mitochondrial and peroxisomal fission 2	y	ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 2; EMPF2	Clinical Features|Clinical Synopsis	died|death|deaths	MFF	HGNC:24858	Encephalopathy due to defective mitochondrial and peroxisomal fission 2, 617086 (3), Autosomal recessive	Autosomal recessive	y	y	[Koch et al. (2016) reported 3 patients, including an Austrian boy and 2 sibs born of consanguineous Turkish parents, with EMPF2... One patient died of respiratory failure at age 3 years; he had never acquired trunk control]	L4	y	-	lethal	lethal	lethal	L4	L4	post-infant-lethal
617087	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, AUTOSOMAL RECESSIVE, TYPE 2A2B	Charcot-Marie-Tooth disease, axonal, type 2A2B, 617087 (3)	Charcot-Marie-Tooth disease, axonal, type 2A2B	n	-	-	-	MFN2	HGNC:16877	Charcot-Marie-Tooth disease, axonal, type 2A2B, 617087 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L6	L6	post-infant-lethal
617088	SHORT-RIB THORACIC DYSPLASIA 15 WITH POLYDACTYLY	Short-rib thoracic dysplasia 15 with polydactyly, 617088 (3)	Short-rib thoracic dysplasia 15 with polydactyly	y	SHORT-RIB THORACIC DYSPLASIA 15 WITH POLYDACTYLY; SRTD15	Description|Clinical Features|Phenotype	lethal|died	DYNC2LI1	HGNC:24595	Short-rib thoracic dysplasia 15 with polydactyly, 617088 (3), Autosomal recessive	Autosomal recessive	y	y	[Some forms of SRTD are lethal in the neonatal period due to respiratory insufficiency secondary to a severely restricted thoracic cage, whereas others are compatible with life / Kessler et al. (2015) reported a family in which 3 sibs had polyhydramnios, narrow thorax, postaxial hexadactyly, and facial dysmorphism... After the next 3 pregnancies ended as missed abortions, a second affected girl was born]	L1	n	y	lethal	lethal	lethal	L1	L1	pre-infant-lethal
617090	MICROCEPHALY 17, PRIMARY, AUTOSOMAL RECESSIVE	Microcephaly 17, primary, autosomal recessive, 617090 (3)	Microcephaly 17, primary, autosomal recessive	y	MICROCEPHALY 17, PRIMARY, AUTOSOMAL RECESSIVE; MCPH17	Clinical Features|Clinical Synopsis	died|die	CIT	HGNC:1985	Microcephaly 17, primary, autosomal recessive, 617090 (3), Autosomal recessive	Autosomal recessive	y	y	[Harding et al. (2016) reported 6 patients from 3 unrelated families with severe MCPH17 associated with lissencephaly. Four of the patients died in the newborn period / Shaheen et al. (2016) reported 2 unrelated children, born of consanguineous Arab parents, with MCPH17. In the first family, ultrasound of the proband at 30 weeks' gestation showed polyhydramnios, intrauterine growth retardation, microcephaly, and absent left kidney. At age 4 months, she had severe microcephaly (-10 SD), short stature, and severe hypertonia with flexion contractures of upper and lower extremities. There was no history of seizures. She died at the age of 5 months; postmortem examination was not performed]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
617091	CILIARY DYSKINESIA, PRIMARY, 34	Ciliary dyskinesia, primary, 34, 617091 (3)	Ciliary dyskinesia, primary, 34	n	-	-	-	DNAJB13	HGNC:30718	Ciliary dyskinesia, primary, 34, 617091 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
617092	CILIARY DYSKINESIA, PRIMARY, 35	Ciliary dyskinesia, primary, 35, 617092 (3)	Ciliary dyskinesia, primary, 35	n	-	-	-	ODAD4	HGNC:25280	Ciliary dyskinesia, primary, 35, 617092 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
617093	GROWTH RETARDATION, IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND HEPATOPATHY	Growth retardation, impaired intellectual development, hypotonia, and hepatopathy, 617093 (3)	Growth retardation, impaired intellectual development, hypotonia, and hepatopathy	n	-	-	-	IARS1	HGNC:5330	Growth retardation, impaired intellectual development, hypotonia, and hepatopathy, 617093 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
617099	AUTOINFLAMMATION, PANNICULITIS, AND DERMATOSIS SYNDROME	Autoinflammation, panniculitis, and dermatosis syndrome, 617099 (3)	Autoinflammation, panniculitis, and dermatosis syndrome	y	AUTOINFLAMMATION, PANNICULITIS, AND DERMATOSIS SYNDROME; AIPDS	Clinical Features	died	OTULIN	HGNC:25118	Autoinflammation, panniculitis, and dermatosis syndrome, 617099 (3), Autosomal recessive	Autosomal recessive	y	y	[Damgaard et al. (2016) described 3 patients, 2 sisters and their male cousin, from a highly consanguineous family with a severe inflammatory syndrome evident soon after birth. The infants were born prematurely and exhibited repeated episodes of systemic inflammation with diarrhea, increased serum C-reactive protein, leukocytosis, and neutrophilia without evidence of infection. All 3 developed relapsing nodular neutrophil-rich panniculitis, recurrent fevers, failure to thrive, and painful swollen joints. Despite treatment with steroids and other immunosuppressive agents, the sisters died at ages 16 months and 5 years]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
617100	FAMILIAL ADENOMATOUS POLYPOSIS 4	Familial adenomatous polyposis 4, 617100 (3)	Familial adenomatous polyposis 4	n	-	-	-	MSH3	HGNC:7326	Familial adenomatous polyposis 4, 617100 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
617101	INTELLECTUAL DEVELOPMENTAL DISORDER WITH PERSISTENCE OF FETAL HEMOGLOBIN	Dias-Logan syndrome, 617101 (3)	Dias-Logan syndrome	n	-	-	-	BCL11A	HGNC:13221	Dias-Logan syndrome, 617101 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
617102	SHORT-RIB THORACIC DYSPLASIA 16 WITH OR WITHOUT POLYDACTYLY	Short-rib thoracic dysplasia 16 with or without polydactyly, 617102 (3)	Short-rib thoracic dysplasia 16 with or without polydactyly	y	SHORT-RIB THORACIC DYSPLASIA 16 WITH OR WITHOUT POLYDACTYLY; SRTD16	Description	lethal	IFT52	HGNC:15901	Short-rib thoracic dysplasia 16 with or without polydactyly, 617102 (3), Autosomal recessive	Autosomal recessive	y	y	[Some forms of SRTD are lethal in the neonatal period due to respiratory insufficiency secondary to a severely restricted thoracic cage, whereas others are compatible with life (summary by Huber and Cormier-Daire, 2012 and Schmidts et al., 2013)]	L2	y	-	lethal	lethal	lethal	L2	L2	pre-infant-lethal
617105	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 41	Developmental and epileptic encephalopathy 41, 617105 (3)	Developmental and epileptic encephalopathy 41	n	-	-	-	SLC1A2	HGNC:10940	Developmental and epileptic encephalopathy 41, 617105 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
617106	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 42	Developmental and epileptic encephalopathy 42, 617106 (3)	Developmental and epileptic encephalopathy 42	n	-	-	-	CACNA1A	HGNC:1388	Developmental and epileptic encephalopathy 42, 617106 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L4|L6	L4	post-infant-lethal
617107	THAUVIN-ROBINET-FAIVRE SYNDROME	Thauvin-Robinet-Faivre syndrome, 617107 (3)	Thauvin-Robinet-Faivre syndrome	y	THAUVIN-ROBINET-FAIVRE SYNDROME; TROFAS	Clinical Features	miscarriage|miscarriages|stillbirth|stillbirths	FIBP	HGNC:3705	Thauvin-Robinet-Faivre syndrome, 617107 (3), Autosomal recessive	Autosomal recessive	n	y	[Akawi et al. (2016) reported 3 sibs, born of consanguineous Arab parents, with an overgrowth syndrome associated with mildly delayed developmental milestones and intellectual disability... There was a family history of 3 miscarriages and 3 stillbirths]	L1	n	y	lethal	lethal	lethal	L1	L1	pre-infant-lethal
617108	SESSILE SERRATED POLYPOSIS CANCER SYNDROME	Sessile serrated polyposis cancer syndrome, 617108 (3)	Sessile serrated polyposis cancer syndrome	y	SESSILE SERRATED POLYPOSIS CANCER SYNDROME; SSPCS	Clinical Features|Phenotype	died	RNF43	HGNC:18505	Sessile serrated polyposis cancer syndrome, 617108 (3), Autosomal dominant	Autosomal dominant	y	n	-	-	-	-	ambiguous	ambiguous	ambiguous	-	-	-
617113	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 43	Developmental and epileptic encephalopathy 43, 617113 (3)	Developmental and epileptic encephalopathy 43	n	-	-	-	GABRB3	HGNC:4083	Developmental and epileptic encephalopathy 43, 617113 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
617114	MYOPATHY, MYOFIBRILLAR, 7	Myopathy, myofibrillar, 7, 617114 (3)	Myopathy, myofibrillar, 7	n	-	-	-	KY	HGNC:26576	Myopathy, myofibrillar, 7, 617114 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
617115	PEELING SKIN SYNDROME 5	Peeling skin syndrome 5, 617115 (3)	Peeling skin syndrome 5	n	-	-	-	SERPINB8	HGNC:8952	Peeling skin syndrome 5, 617115 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
617116	EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 2	Epilepsy, familial focal, with variable foci 2, 617116 (3)	Epilepsy, familial focal, with variable foci 2	y	EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 2; FFEVF2	Clinical Features	death|deaths|died	NPRL2	HGNC:24969	Epilepsy, familial focal, with variable foci 2, 617116 (3), Autosomal dominant	Autosomal dominant	n	y	[Weckhuysen et al. (2016) reported 2 sisters from a nonconsanguineous family (family E) of French descent with FFEVF2. The 27-year-old proband had onset of refractory NFLE at age 3 years... Family history was limited, but there were 3 additional family members on the paternal side of the family who had nonspecific seizures, including 1 individual who died suddenly of seizures at age 22 years, with a diagnosis of possible SUDEP (sudden death in epilepsy)]	L6	n	y	lethal	lethal	lethal	L6	L6	post-infant-lethal
617118	EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 3	Epilepsy, familial focal, with variable foci 3, 617118 (3)	Epilepsy, familial focal, with variable foci 3	y	EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 3; FFEVF3	Clinical Features	death|deaths	NPRL3	HGNC:14124	Epilepsy, familial focal, with variable foci 3, 617118 (3), Autosomal dominant	Autosomal dominant	y	y	[Weckhuysen et al. (2016) reported 2 sisters from a nonconsanguineous family (family E) of French descent with FFEVF2. The 27-year-old proband had onset of refractory NFLE at age 3 years... Family history was limited, but there were 3 additional family members on the paternal side of the family who had nonspecific seizures, including 1 individual who died suddenly of seizures at age 22 years, with a diagnosis of possible SUDEP (sudden death in epilepsy)]	L6	n	y	lethal	lethal	lethal	L6	L6	post-infant-lethal
617119	BARDET-BIEDL SYNDROME 22	Bardet-Biedl syndrome 22, 617119 (3)	Bardet-Biedl syndrome 22	n	-	-	-	IFT74	HGNC:21424	Bardet-Biedl syndrome 22, 617119 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
617120	JOUBERT SYNDROME 27	Joubert syndrome 27, 617120 (3)	Joubert syndrome 27	n	-	-	-	B9D1	HGNC:24123	Joubert syndrome 27, 617120 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
617121	JOUBERT SYNDROME 28	Joubert syndrome 28, 617121 (3)	Joubert syndrome 28	n	-	-	-	MKS1	HGNC:7121	Joubert syndrome 28, 617121 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L1	L1	pre-infant-lethal
617123	RETINITIS PIGMENTOSA 76	Retinitis pigmentosa 76, 617123 (3)	Retinitis pigmentosa 76	n	-	-	-	POMGNT1	HGNC:19139	Retinitis pigmentosa 76, 617123 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L3	L3	pre-infant-lethal
617125	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 56	Intellectual developmental disorder, autosomal recessive 56, 617125 (3)	Intellectual developmental disorder, autosomal recessive 56	n	-	-	-	ZC3H14	HGNC:20509	Intellectual developmental disorder, autosomal recessive 56, 617125 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
617126	ALAZAMI-YUAN SYNDROME	Alazami-Yuan syndrome, 617126 (3)	Alazami-Yuan syndrome	n	-	-	-	TAF6	HGNC:11540	Alazami-Yuan syndrome, 617126 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
617132	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 44	Developmental and epileptic encephalopathy 44, 617132 (3)	Developmental and epileptic encephalopathy 44	y	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 44; DEE44	Description|Clinical Features|Clinical Synopsis	die|died|death|deaths	UBA5	HGNC:23230	Developmental and epileptic encephalopathy 44, 617132 (3), Autosomal recessive	Autosomal recessive	y	y	[Colin et al. (2016) reported 5 children, ranging in age from 2.5 to 6 years, from 4 unrelated families with early-onset encephalopathy. The patients had failure to thrive, microcephaly, axial hypotonia often with peripheral hypertonia or spasticity, delayed psychomotor development with severe intellectual disability, poor visual pursuit, absent speech, and abnormal movements such as dystonia and opisthotonus. Several patients required tube feeding. Three children had onset of severe and intractable seizures in the first months of life; 2 had hypsarrhythmia on EEG, consistent with a clinical diagnosis of West syndrome. The 2 remaining patients did not have overt seizures, although 1 of these patients had abnormal EEG findings. Brain imaging showed variable abnormalities, including thin corpus callosum, cortical atrophy, cerebellar atrophy, and white matter changes. One child died at age 2.5 years]	L4	y	-	lethal	lethal	lethal	L4	L4	post-infant-lethal
617137	FRONTOMETAPHYSEAL DYSPLASIA 2	Frontometaphyseal dysplasia 2, 617137 (3)	Frontometaphyseal dysplasia 2	n	-	-	-	MAP3K7	HGNC:6859	Frontometaphyseal dysplasia 2, 617137 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
617140	ZTTK SYNDROME	ZTTK syndrome, 617140 (3)	ZTTK syndrome	n	-	-	-	SON	HGNC:11183	ZTTK syndrome, 617140 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
617143	MYASTHENIC SYNDROME, CONGENITAL, 20, PRESYNAPTIC	Myasthenic syndrome, congenital, 20, presynaptic, 617143 (3)	Myasthenic syndrome, congenital, 20, presynaptic	y	MYASTHENIC SYNDROME, CONGENITAL, 20, PRESYNAPTIC; CMS20	Clinical Features|Clinical Synopsis	died|death|deaths	SLC5A7	HGNC:14025	Myasthenic syndrome, congenital, 20, presynaptic, 617143 (3), Autosomal recessive	Autosomal recessive	n	y	[Bauche et al. (2016) reported 7 patients, including 2 brothers, with CMS20. The patients presented at birth with hypotonia and frequent episodic apneas often requiring ventilatory assistance. The 2 brothers had a more severe phenotype with antenatal hydramnios and arthrogryposis; these infants died at day 10 and day 15 of life]	L2	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L2	L2	pre-infant-lethal
617145	NEURODEGENERATION WITH ATAXIA, DYSTONIA, AND GAZE PALSY, CHILDHOOD-ONSET	Neurodegeneration with ataxia, dystonia, and gaze palsy, childhood-onset, 617145 (3)	Neurodegeneration with ataxia, dystonia, and gaze palsy, childhood-onset	n	-	-	-	SQSTM1	HGNC:11280	Neurodegeneration with ataxia, dystonia, and gaze palsy, childhood-onset, 617145 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	LU	LU	post-infant-lethal
617146	ARTHROGRYPOSIS, DISTAL, WITH IMPAIRED PROPRIOCEPTION AND TOUCH	Arthrogryposis, distal, with impaired proprioception and touch, 617146 (3)	Arthrogryposis, distal, with impaired proprioception and touch	n	-	-	-	PIEZO2	HGNC:26270	Arthrogryposis, distal, with impaired proprioception and touch, 617146 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	ambiguous|nonlethal	ambiguous	-	-	-
617153	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 45	Developmental and epileptic encephalopathy 45, 617153 (3)	Developmental and epileptic encephalopathy 45	n	-	-	-	GABRB1	HGNC:4081	Developmental and epileptic encephalopathy 45, 617153 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
617157	SHORT STATURE, BRACHYDACTYLY, IMPAIRED INTELLECTUAL DEVELOPMENT, AND SEIZURES	Short stature, brachydactyly, intellectual developmental disability, and seizures, 617157 (3)	Short stature, brachydactyly, intellectual developmental disability, and seizures	n	-	-	-	PRMT7	HGNC:25557	Short stature, brachydactyly, intellectual developmental disability, and seizures, 617157 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
617158	MYOPATHY, DISTAL, WITH RIMMED VACUOLES	Myopathy, distal, with rimmed vacuoles, 617158 (3)	Myopathy, distal, with rimmed vacuoles	n	-	-	-	SQSTM1	HGNC:11280	Myopathy, distal, with rimmed vacuoles, 617158 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	LU	LU	post-infant-lethal
617159	SIFRIM-HITZ-WEISS SYNDROME	Sifrim-Hitz-Weiss syndrome, 617159 (3)	Sifrim-Hitz-Weiss syndrome	n	-	-	-	CHD4	HGNC:1919	Sifrim-Hitz-Weiss syndrome, 617159 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
617162	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 46	Developmental and epileptic encephalopathy 46, 617162 (3)	Developmental and epileptic encephalopathy 46	n	-	-	-	GRIN2D	HGNC:4588	Developmental and epileptic encephalopathy 46, 617162 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
617164	SHORT STATURE-MICROGNATHIA SYNDROME	Short stature-micrognathia syndrome, 617164 (3)	Short stature-micrognathia syndrome	y	SHORT STATURE-MICROGNATHIA SYNDROME; SSMG	Description|Clinical Features|Clinical Synopsis	death|deaths|stillbirth|stillbirths|demise	ARCN1	HGNC:649	Short stature-micrognathia syndrome, 617164 (3), Autosomal dominant	Autosomal dominant	y	y	[Fetal demise may occur]	L1	y	-	lethal	lethal	lethal	L1	L1	pre-infant-lethal
617166	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 47	Developmental and epileptic encephalopathy 47, 617166 (3)	Developmental and epileptic encephalopathy 47	y	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 47; DEE47	Clinical Features	death|deaths	FGF12	HGNC:3668	Developmental and epileptic encephalopathy 47, 617166 (3), Autosomal dominant	Autosomal dominant	y	y	[Siekierska et al. (2016) reported 2 sibs, born of unrelated Caucasian parents, with early infantile epileptic encephalopathy resulting in death at ages 7 and 3.5 years]	L4	y	-	lethal	lethal	lethal	L4	L4	post-infant-lethal
617168	AORTIC ANEURYSM, FAMILIAL THORACIC 10	Aortic aneurysm, familial thoracic 10, 617168 (3)	Aortic aneurysm, familial thoracic 10	y	AORTIC ANEURYSM, FAMILIAL THORACIC 10; AAT10	Clinical Features	died	LOX	HGNC:6664	Aortic aneurysm, familial thoracic 10, 617168 (3), Autosomal dominant	Autosomal dominant	n	y	[Guo et al. (2016) studied 6 families segregating autosomal dominant thoracic aortic aneurysm with or without dissection. Thoracic aneurysms in affected individuals were either aortic root aneurysms or fusiform aneurysms that involved both the aortic root and ascending aorta. Some mutation carriers died of ascending aortic dissections, but there were no reports of aortic dissections with minimal enlargement of the ascending aorta, and none of the affected individuals presented with descending thoracic aortic aneurysms or dissections]	LU	y	-	lethal	lethal	lethal	LU	LU	post-infant-lethal
617169	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 74	Intellectual developmental disorder, autosomal recessive 74, 617169 (3)	Intellectual developmental disorder, autosomal recessive 74	n	-	-	-	APC2	HGNC:24036	Intellectual developmental disorder, autosomal recessive 74, 617169 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
617171	NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA AND IMPAIRED EXPRESSIVE LANGUAGE AND WITH OR WITHOUT SEIZURES	Neurodevelopmental disorder with hypotonia, impaired expressive language, and with or without seizures, 617171 (3)	Neurodevelopmental disorder with hypotonia, impaired expressive language, and with or without seizures	y	NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA AND IMPAIRED EXPRESSIVE LANGUAGE AND WITH OR WITHOUT SEIZURES; NEDHELS	Clinical Features	died	DEAF1	HGNC:14677	Neurodevelopmental disorder with hypotonia, impaired expressive language, and with or without seizures, 617171 (3), Autosomal recessive	Autosomal recessive	y	y	[Faqeih et al. (2014) reported 2 male first cousins, both about 2 years of age and born from a consanguineous Saudi family, with hypotonia, feeding difficulties, and poor growth apparent from infancy. They had global developmental delay, severely impaired intellectual development, speech delay, and microcephaly. One patient developed early-onset seizures. Brain imaging in both patients showed deep white matter abnormalities, delayed myelination, and a possibly abnormal gyral pattern. One of the cousins had a similarly affected sister who died at age 3]	L4	n	y	lethal	lethal|nonlethal	lethal|nonlethal	L4	L4	post-infant-lethal
617173	LODDER-MERLA SYNDROME, TYPE 1, WITH IMPAIRED INTELLECTUAL DEVELOPMENT AND CARDIAC ARRHYTHMIA	Lodder-Merla syndrome, type 1, with impaired intellectual development and cardiac arrhythmia, 617173 (3)	Lodder-Merla syndrome, type 1, with impaired intellectual development and cardiac arrhythmia	y	LODDER-MERLA SYNDROME, TYPE 1, WITH IMPAIRED INTELLECTUAL DEVELOPMENT AND CARDIAC ARRHYTHMIA; LDMLS1	Clinical Features	death|deaths|died	GNB5	HGNC:4401	Lodder-Merla syndrome, type 1, with impaired intellectual development and cardiac arrhythmia, 617173 (3), Autosomal recessive	Autosomal recessive	y	y	[The proband had 4 affected sibs who died in childhood, including her twin sister (IV.13) and an older brother (IV.11) who died suddenly at ages 8 months and 7 months, respectively, during periods when their seizures were well managed, suggesting that sinus node dysfunction was likely the cause of sudden death]	L3	-	y	lethal	lethal|nonlethal	lethal|nonlethal	L3	L3	pre-infant-lethal
617174	EHLERS-DANLOS SYNDROME, PERIODONTAL TYPE, 2	Ehlers-Danlos syndrome, periodontal type, 2, 617174 (3)	Ehlers-Danlos syndrome, periodontal type, 2	n	-	-	-	C1S	HGNC:1247	Ehlers-Danlos syndrome, periodontal type, 2, 617174 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
617175	RETINAL DYSTROPHY WITH OR WITHOUT EXTRAOCULAR ANOMALIES	Retinal dystrophy with or without extraocular anomalies, 617175 (3)	Retinal dystrophy with or without extraocular anomalies	n	-	-	-	RCBTB1	HGNC:18243	Retinal dystrophy with or without extraocular anomalies, 617175 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
617180	CHITAYAT SYNDROME	Chitayat syndrome, 617180 (3)	Chitayat syndrome	n	-	-	-	ERF	HGNC:3444	Chitayat syndrome, 617180 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
617182	LODDER-MERLA SYNDROME, TYPE 2, WITH DEVELOPMENTAL DELAY AND WITH OR WITHOUT CARDIAC ARRHYTHMIA	Lodder-Merla syndrome, type 2, with developmental delay and with or without cardiac arrhythmia, 617182 (3)	Lodder-Merla syndrome, type 2, with developmental delay and with or without cardiac arrhythmia	n	-	-	-	GNB5	HGNC:4401	Lodder-Merla syndrome, type 2, with developmental delay and with or without cardiac arrhythmia, 617182 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L3	L3	pre-infant-lethal
617183	HAREL-YOON SYNDROME	Harel-Yoon syndrome, 617183 (3)	Harel-Yoon syndrome	y	HAREL-YOON SYNDROME; HAYOS	Phenotype	lethality	ATAD3A	HGNC:25567	Harel-Yoon syndrome, 617183 (3), Autosomal dominant, Autosomal recessive	Autosomal dominant, Autosomal recessive	y	n	-	-	-	-	ambiguous	ambiguous|lethal	lethal	L2	L2	pre-infant-lethal
617184	MITOCHONDRIAL DNA DEPLETION SYNDROME 12A (CARDIOMYOPATHIC TYPE), AUTOSOMAL DOMINANT	Mitochondrial DNA depletion syndrome 12A (cardiomyopathic type) AD, 617184 (3)	Mitochondrial DNA depletion syndrome 12A (cardiomyopathic type) AD	y	MITOCHONDRIAL DNA DEPLETION SYNDROME 12A (CARDIOMYOPATHIC TYPE), AUTOSOMAL DOMINANT; MTDPS12A	Description|Clinical Features|Clinical Synopsis	die|died	SLC25A4	HGNC:10990	Mitochondrial DNA depletion syndrome 12A (cardiomyopathic type) AD, 617184 (3), Autosomal dominant	Autosomal dominant	n	y	[Thompson et al. (2016) reported 7 children from 6 unrelated families who presented at birth with profound hypotonia, little spontaneous movement, lactic acidosis, and respiratory insufficiency necessitating mechanical ventilation. Two infants were monozygotic twins. Four patients had hypertrophic cardiomyopathy. Five of the patients, including the twins, died in the first days or months of life]	L2	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L2	L2	pre-infant-lethal
617186	ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 1	Encephalopathy, progressive, early-onset, with brain edema and/or leukoencephalopathy, 617186 (3)	Encephalopathy, progressive, early-onset, with brain edema and/or leukoencephalopathy	y	ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 1; PEBEL1	Description|Clinical Features|Clinical Synopsis	death|deaths|died|lethal	NAXE	HGNC:18453	Encephalopathy, progressive, early-onset, with brain edema and/or leukoencephalopathy, 617186 (3), Autosomal recessive	Autosomal recessive	y	y	[Kremer et al. (2016) reported 6 patients from 4 unrelated families with lethal infantile encephalopathy... Several patients became comatose, and all 6 died between 16 and 28 months of age]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
617187	SPERMATOGENIC FAILURE 16	Spermatogenic failure 16, 617187 (3)	Spermatogenic failure 16	n	-	-	-	SUN5	HGNC:16252	Spermatogenic failure 16, 617187 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
617188	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 57	Intellectual developmental disorder, autosomal recessive 57, 617188 (3)	Intellectual developmental disorder, autosomal recessive 57	n	-	-	-	MBOAT7	HGNC:15505	Intellectual developmental disorder, autosomal recessive 57, 617188 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
617190	SHASHI-PENA SYNDROME	Shashi-Pena syndrome, 617190 (3)	Shashi-Pena syndrome	n	-	-	-	ASXL2	HGNC:23805	Shashi-Pena syndrome, 617190 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
617193	ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND THIN CORPUS CALLOSUM	Encephalopathy, progressive, early-onset, with brain atrophy and thin corpus callosum, 617193 (3)	Encephalopathy, progressive, early-onset, with brain atrophy and thin corpus callosum	y	ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND THIN CORPUS CALLOSUM; PEBAT	Clinical Features	died	TBCD	HGNC:11581	Encephalopathy, progressive, early-onset, with brain atrophy and thin corpus callosum, 617193 (3), Autosomal recessive	Autosomal recessive	n	y	[Miyake et al. (2016) reported 8 children from 4 unrelated families with a severe early-onset neurodegenerative encephalopathy... All 6 of these patients were immobile, and most were mechanically ventilated; 3 died]	LU	y	-	lethal	lethal	lethal	LU	LU	post-infant-lethal
617194	LETHAL CONGENITAL CONTRACTURE SYNDROME 11	Lethal congenital contracture syndrome 11, 617194 (3)	Lethal congenital contracture syndrome 11	y	LETHAL CONGENITAL CONTRACTURE SYNDROME 11; LCCS11	Clinical Features|Phenotype	died|lethal	GLDN	HGNC:29514	Lethal congenital contracture syndrome 11, 617194 (3), Autosomal recessive	Autosomal recessive	n	y	[Maluenda et al. (2016) studied 4 families with lethal congenital arthrogryposis in 6 affected individuals. The pregnancies were characterized by marked polyhydramnios and fetal akinesia on prenatal ultrasound at about 27 to 32 weeks' gestation (earlier ultrasounds appeared normal). Other features included flexion and extension contractures of the upper and lower limbs, respectively, as well as flexion of the wrists and fingers. Two of the affected individuals died at day 1 of life, 1 died in utero, and 3 pregnancies were terminated after diagnosis]	L1	y	-	lethal	lethal	lethal	L1	L1	pre-infant-lethal
617201	PERIVENTRICULAR NODULAR HETEROTOPIA 7	Periventricular nodular heterotopia 7, 617201 (3)	Periventricular nodular heterotopia 7	n	-	-	-	NEDD4L	HGNC:7728	Periventricular nodular heterotopia 7, 617201 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
617205	HETEROTAXY, VISCERAL, 8, AUTOSOMAL	Heterotaxy, visceral, 8, autosomal, 617205 (3)	Heterotaxy, visceral, 8, autosomal	y	HETEROTAXY, VISCERAL, 8, AUTOSOMAL; HTX8	Clinical Features|Clinical Synopsis|Phenotype	death|deaths|died	PKD1L1	HGNC:18053	Heterotaxy, visceral, 8, autosomal, 617205 (3), Autosomal recessive	Autosomal recessive	y	y	[Vetrini et al. (2016) reported 2 male infants, born of unrelated parents of northern European descent, with heterotaxy and complex congenital heart disease resulting in death shortly after birth and at age 3 weeks]	L2	y	-	lethal	lethal	lethal	L2	L2	pre-infant-lethal
617207	ENCEPHALOPATHY, PROGRESSIVE, WITH AMYOTROPHY AND OPTIC ATROPHY	Encephalopathy, progressive, with amyotrophy and optic atrophy, 617207 (3)	Encephalopathy, progressive, with amyotrophy and optic atrophy	n	-	-	-	TBCE	HGNC:11582	Encephalopathy, progressive, with amyotrophy and optic atrophy, 617207 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L2|L3	L2	pre-infant-lethal
617214	SPERMATOGENIC FAILURE 17	Spermatogenic failure 17, 617214 (3)	Spermatogenic failure 17	n	-	-	-	PLCZ1	HGNC:19218	Spermatogenic failure 17, 617214 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
617217	AMELOGENESIS IMPERFECTA, HYPOMATURATION TYPE, IIA6	Amelogenesis imperfecta, hypomaturation type, IIA6, 617217 (3)	Amelogenesis imperfecta, hypomaturation type, IIA6	n	-	-	-	GPR68	HGNC:4519	Amelogenesis imperfecta, hypomaturation type, IIA6, 617217 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
617222	SUDDEN CARDIAC FAILURE, INFANTILE	Sudden cardiac failure, infantile, 617222 (3)	Sudden cardiac failure, infantile	y	SUDDEN CARDIAC FAILURE, INFANTILE; SCFI	Clinical Features|Clinical Synopsis	death|deaths|died|fatal|die	PPA2	HGNC:28883	Sudden cardiac failure, infantile, 617222 (3), Autosomal recessive	Autosomal recessive	n	y	[Guimier et al. (2016) reported 7 children in 3 unrelated families who had sudden and unexpected fatal cardiac arrest between 4 and 20 months of age. In the first family, 4 of 5 children were affected, and in the second family, 2 of 2 children. Growth parameters and psychomotor milestones were normal, and no arrhythmias were ever recorded before death. A febrile illness or infection (e.g., gastroenteritis, otitis media) preceded the episode of acute and severe bradycardia/asystole by days or weeks. The mother and a maternal uncle in the first family had been diagnosed with Brugada syndrome (see 601144); however, flecainide testing was negative in the 2 children in whom it was performed. In the third family the proband presented with hypotonia, feeding difficulties, and failure to thrive at 3 months of age. Myopathy was suspected, and muscle biopsy showed variable-sized fibers, lipid accumulation, and nemaline rods. One month later, she was diagnosed with hypertrophic cardiomyopathy with heart failure, and died in the intensive care unit of cardiac arrest at age 4 months]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
617225	SPASTIC PARAPLEGIA 78, AUTOSOMAL RECESSIVE	Spastic paraplegia 78, autosomal recessive, 617225 (3)	Spastic paraplegia 78, autosomal recessive	n	-	-	-	ATP13A2	HGNC:30213	Spastic paraplegia 78, autosomal recessive, 617225 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L6	L6	post-infant-lethal
617228	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 31	Combined oxidative phosphorylation deficiency 31, 617228 (3)	Combined oxidative phosphorylation deficiency 31	y	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 31; COXPD31	Description|Clinical Features|Clinical Synopsis	die|died|death|deaths	MIPEP	HGNC:7104	Combined oxidative phosphorylation deficiency 31, 617228 (3), Autosomal recessive	Autosomal recessive	y	y	[Eldomery et al. (2016) reported 4 unrelated children with a severe multisystem disorder apparent from infancy. The patients had failure to thrive, hypotonia, LVNC, hypertrophic cardiomyopathy, and global developmental delay. Three patients died in the first weeks or years of life; the fourth was alive at age 4.5 years]	L2	y	-	lethal	lethal	lethal	L2	L2	pre-infant-lethal
617232	MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 21	Muscular dystrophy, limb-girdle, autosomal recessive 21, 617232 (3)	Muscular dystrophy, limb-girdle, autosomal recessive 21	n	-	-	-	POGLUT1	HGNC:22954	Muscular dystrophy, limb-girdle, autosomal recessive 21, 617232 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
617234	OOCYTE/ZYGOTE/EMBRYO MATURATION ARREST 16	Oocyte/zygote/embryo maturation arrest 16, 617234 (3)	Oocyte/zygote/embryo maturation arrest 16	n	-	-	-	PADI6	HGNC:20449	Oocyte/zygote/embryo maturation arrest 16, 617234 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
617235	MYOCLONUS, INTRACTABLE, NEONATAL	Myoclonus, intractable, neonatal, 617235 (3)	Myoclonus, intractable, neonatal	y	MYOCLONUS, INTRACTABLE, NEONATAL; NEIMY	Description|Clinical Features|Clinical Synopsis	die|died	KIF5A	HGNC:6323	Myoclonus, intractable, neonatal, 617235 (3), Autosomal dominant	Autosomal dominant	y	y	[Duis et al. (2016) reported 2 unrelated patients who presented shortly after birth with nearly continuous nonrhythmic large-amplitude myoclonic jerks associated with intermittent apnea. Neither patient had visual fixation, and both had hypotonia. Additional features included abnormal saccades, nystagmus, ptosis, and optic nerve pallor. Both had minimal developmental progress. One patient died at age 3 months, whereas the other was alive at age 5 years with microcephaly, poor feeding requiring gastrostomy tube, recurrent apnea, developmental arrest, myoclonus, and choreiform movements]	L3	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L3	L3	pre-infant-lethal
617236	CONE-ROD DYSTROPHY AND HEARING LOSS 1	Cone-rod dystrophy and hearing loss, 617236 (3)	Cone-rod dystrophy and hearing loss	n	-	-	-	CEP78	HGNC:25740	Cone-rod dystrophy and hearing loss, 617236 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
617237	IMMUNODEFICIENCY 49	Immunodeficiency 49, severe combined, 617237 (3)	Immunodeficiency 49, severe combined	n	-	-	-	BCL11B	HGNC:13222	Immunodeficiency 49, severe combined, 617237 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
617238	MYOPIA 25, AUTOSOMAL DOMINANT	Myopia 25, autosomal dominant, 617238 (3)	Myopia 25, autosomal dominant	n	-	-	-	P4HA2	HGNC:8547	Myopia 25, autosomal dominant, 617238 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
617239	MYASTHENIC SYNDROME, CONGENITAL, 21, PRESYNAPTIC	Myasthenic syndrome, congenital, 21, presynaptic, 617239 (3)	Myasthenic syndrome, congenital, 21, presynaptic	n	-	-	-	SLC18A3	HGNC:10936	Myasthenic syndrome, congenital, 21, presynaptic, 617239 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
617241	LUNG DISEASE, IMMUNODEFICIENCY, AND CHROMOSOME BREAKAGE SYNDROME	Lung disease, immunodeficiency, and chromosome breakage syndrome, 617241 (3)	Lung disease, immunodeficiency, and chromosome breakage syndrome	y	LUNG DISEASE, IMMUNODEFICIENCY, AND CHROMOSOME BREAKAGE SYNDROME; LICS	Description|Clinical Features|Clinical Synopsis	fatal|died|death|deaths	NSMCE3	HGNC:7677	Lung disease, immunodeficiency, and chromosome breakage syndrome, 617241 (3), Autosomal recessive	Autosomal recessive	y	n	-	-	-	-	ambiguous	ambiguous	ambiguous	-	-	-
617244	FANCONI ANEMIA, COMPLEMENTATION GROUP R	Fanconi anemia, complementation group R, 617244 (3)	Fanconi anemia, complementation group R	n	-	-	-	RAD51	HGNC:9817	Fanconi anemia, complementation group R, 617244 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
617248	3-METHYLGLUTACONIC ACIDURIA, TYPE VIII	3-methylglutaconic aciduria, type VIII, 617248 (3)	3-methylglutaconic aciduria, type VIII	y	3-METHYLGLUTACONIC ACIDURIA, TYPE VIII; MGCA8	Description|Clinical Features|Clinical Synopsis	death|deaths|died	HTRA2	HGNC:14348	3-methylglutaconic aciduria, type VIII, 617248 (3), Autosomal recessive	Autosomal recessive	n	y	[Olahova et al. (2017) reported 5 infants from 2 unrelated consanguineous families with MGCA8. One family was of Pakistani origin and the other was of Mexican origin. The patients had poor feeding, recurrent apneas with respiratory failure, and hypotonia. More variable features included neutropenia, bradycardia, seizures, and/or abnormal movements, such as dystonia, tremor, and clonus. Skeletal muscle biopsy of 1 patient showed denervation and atrophy. Laboratory studies showed increased lactate and urinary excretion of MGCA. All patients died within the first weeks or months of life]	L2	y	-	lethal	lethal	lethal	L2	L2	pre-infant-lethal
617253	SECKEL SYNDROME 10	Seckel syndrome 10, 617253 (3)	Seckel syndrome 10	y	SECKEL SYNDROME 10; SCKL10	Clinical Features	died	NSMCE2	HGNC:26513	Seckel syndrome 10, 617253 (3), Autosomal recessive	Autosomal recessive	n	y	[Payne et al. (2014) studied 2 unrelated 46,XX women with severe short stature and microcephaly; facial dysmorphism with small jaw and prominent midface; extremely insulin-resistant diabetes, fatty liver, and hypertriglyceridemia developing in childhood; and primary gonadal failure. One of the women was congenitally blind, reportedly due to retinal detachment, and died suddenly at age 33 years, presumably due to rupture of a previously documented abdominal aortic aneurysm]	L6	y	-	lethal	lethal	lethal	L6	L6	post-infant-lethal
617255	LISSENCEPHALY 8	Lissencephaly 8, 617255 (3)	Lissencephaly 8	n	-	-	-	TMTC3	HGNC:26899	Lissencephaly 8, 617255 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
617258	MYOPATHY, MYOFIBRILLAR, 8	Myopathy, myofibrillar, 8, 617258 (3)	Myopathy, myofibrillar, 8	y	MYOPATHY, MYOFIBRILLAR, 8; MFM8	Clinical Features	died	PYROXD1	HGNC:26162	Myopathy, myofibrillar, 8, 617258 (3), Autosomal recessive	Autosomal recessive	y	y	[died of pneumonia at age 43]	L6	n	y	lethal	lethal	lethal	L6	L6	post-infant-lethal
617260	GLOBAL DEVELOPMENTAL DELAY, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM, AND DYSMORPHIC FACIES	Global developmental delay, absent or hypoplastic corpus callosum, and dysmorphic facies, 617260 (3)	Global developmental delay, absent or hypoplastic corpus callosum, and dysmorphic facies	y	GLOBAL DEVELOPMENTAL DELAY, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM, AND DYSMORPHIC FACIES; GDACCF	Clinical Features	died	ZNF148	HGNC:12933	Global developmental delay, absent or hypoplastic corpus callosum, and dysmorphic facies, 617260 (3), Autosomal dominant	Autosomal dominant	n	y	[Stevens et al. (2016) reported 4 unrelated children with a similar intellectual disability syndrome. The patients presented at birth with respiratory insufficiency, hypotonia, and feeding problems. Three patients had abnormal prenatal imaging findings, including cystic kidneys in 2, one of whom also had a thin corpus callosum, and enlarged cerebral ventricles in the third. The most severely affected patient was a male who died at 6 days of age]	L2	y	-	lethal	lethal	lethal	L2	L2	pre-infant-lethal
617268	NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, SEIZURES, AND ABSENT LANGUAGE	Neurodevelopmental disorder with hypotonia, seizures, and absent language, 617268 (3)	Neurodevelopmental disorder with hypotonia, seizures, and absent language	n	-	-	-	HECW2	HGNC:29853	Neurodevelopmental disorder with hypotonia, seizures, and absent language, 617268 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
617270	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 58	Intellectual developmental disorder, autosomal recessive 58, 617270 (3)	Intellectual developmental disorder, autosomal recessive 58	y	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 58; MRT58	Clinical Features	died	ELP2	HGNC:18248	Intellectual developmental disorder, autosomal recessive 58, 617270 (3), Autosomal recessive	Autosomal recessive	y	y	[died at age 4.5 months]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
617271	NEPHRONOPHTHISIS 20	Nephronophthisis 20, 617271 (3)	Nephronophthisis 20	n	-	-	-	MAPKBP1	HGNC:29536	Nephronophthisis 20, 617271 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
617272	GLAUCOMA 3, PRIMARY CONGENITAL, E	Glaucoma 3, primary congenital, E, 617272 (3)	Glaucoma 3, primary congenital, E	n	-	-	-	TEK	HGNC:11724	Glaucoma 3, primary congenital, E, 617272 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	LU	LU	post-infant-lethal
617275	TOOTH AGENESIS, SELECTIVE, 9	Tooth agenesis, selective, 9, 617275 (3)	Tooth agenesis, selective, 9	n	-	-	-	GREM2	HGNC:17655	Tooth agenesis, selective, 9, 617275 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
617276	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 48	Developmental and epileptic encephalopathy 48, 617276 (3)	Developmental and epileptic encephalopathy 48	n	-	-	-	AP3B2	HGNC:567	Developmental and epileptic encephalopathy 48, 617276 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
617281	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 49	Developmental and epileptic encephalopathy 49, 617281 (3)	Developmental and epileptic encephalopathy 49	y	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 49; DEE49	Clinical Features|Phenotype	died|death|deaths	DENND5A	HGNC:19344	Developmental and epileptic encephalopathy 49, 617281 (3), Autosomal recessive	Autosomal recessive	y	y	[Han et al. (2016) reported 4 children from 2 unrelated consanguineous families of Saudi Arabian and Jordanian descent, respectively, with DEE49. The patients developed seizures in the neonatal period and thereafter showed severe global developmental delay with absent speech or only a few words. Two sisters in the first family had spastic tetraplegia and were dependent on support for all activities of daily living at 14 and 7 years of age. They had multiple daily seizures, tonic, myoclonic, and generalized tonic-clonic, and the younger sister also had exaggerated startle and startle-induced seizures. EEG in both patients showed slow background and frequent generalized spike-wave discharges interictally or in association with myoclonus. Brain imaging showed multiple small foci of calcification in the basal ganglia, as well as enlarged ventricles and dysgenesis of the corpus callosum. The older sister also had a Dandy-Walker malformation, hypoplastic vermis, and hydrocephalus. In the second family, the 7-year-old proband had a similar phenotype with anxiety and hyperactivity. Brain imaging showed multiple periventricular calcifications. Her younger sister, who was reportedly similarly affected, died at age 10 years]	L5	n	y	lethal	lethal	lethal	L5	L5	post-infant-lethal
617282	DYSTONIA, CHILDHOOD-ONSET, WITH OPTIC ATROPHY AND BASAL GANGLIA ABNORMALITIES	Dystonia, childhood-onset, with optic atrophy and basal ganglia abnormalities, 617282 (3)	Dystonia, childhood-onset, with optic atrophy and basal ganglia abnormalities	n	-	-	-	MECR	HGNC:19691	Dystonia, childhood-onset, with optic atrophy and basal ganglia abnormalities, 617282 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
617284	DYSTONIA 28, CHILDHOOD-ONSET	Dystonia 28, childhood-onset, 617284 (3)	Dystonia 28, childhood-onset	n	-	-	-	KMT2B	HGNC:15840	Dystonia 28, childhood-onset, 617284 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
617290	EPILEPSY, EARLY-ONSET, 1, VITAMIN B6-DEPENDENT	Epilepsy, early-onset, 1, vitamin B6-dependent, 617290 (3)	Epilepsy, early-onset, 1, vitamin B6-dependent	y	EPILEPSY, EARLY-ONSET, 1, VITAMIN B6-DEPENDENT; EPEO1	Clinical Features	died	PLPBP	HGNC:9457	Epilepsy, early-onset, 1, vitamin B6-dependent, 617290 (3), Autosomal recessive	Autosomal recessive	y	y	[One infant from the Syrian family died at 4.5 months of age,]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
617294	EPIDERMOLYSIS BULLOSA SIMPLEX 6, GENERALIZED INTERMEDIATE, WITH OR WITHOUT CARDIOMYOPATHY	Epidermolysis bullosa simplex 6, generalized intermediate, with or without cardiomyopathy, 617294 (3)	Epidermolysis bullosa simplex 6, generalized intermediate, with or without cardiomyopathy	y	EPIDERMOLYSIS BULLOSA SIMPLEX 6, GENERALIZED INTERMEDIATE, WITH OR WITHOUT CARDIOMYOPATHY; EBS6	Clinical Features|Clinical Synopsis|Phenotype	died|death|deaths	KLHL24	HGNC:25947	Epidermolysis bullosa simplex 6, generalized intermediate, with or without cardiomyopathy, 617294 (3), Autosomal dominant	Autosomal dominant	y	y	[Neonatal death can occur from extensive skin denudation and secondary infection]	L2	y	-	lethal	lethal	lethal	L2|L6	L2	pre-infant-lethal
617296	SPASTIC PARAPLEGIA, INTELLECTUAL DISABILITY, NYSTAGMUS, AND OBESITY	Spastic paraplegia, intellectual disability, nystagmus, and obesity, 617296 (3)	Spastic paraplegia, intellectual disability, nystagmus, and obesity	n	-	-	-	KIDINS220	HGNC:29508	Spastic paraplegia, intellectual disability, nystagmus, and obesity, 617296 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L1	L1	pre-infant-lethal
617297	AMELOGENESIS IMPERFECTA, TYPE IJ	Amelogenesis imperfecta, type IJ, 617297 (3)	Amelogenesis imperfecta, type IJ	n	-	-	-	ACP4	HGNC:14376	Amelogenesis imperfecta, type IJ, 617297 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
617300	LYMPHATIC MALFORMATION 7	Lymphatic malformation 7, 617300 (3)	Lymphatic malformation 7	y	LYMPHATIC MALFORMATION 7; LMPHM7	Description|Clinical Features	death|deaths|died|miscarriage|miscarriages|stillborn	EPHB4	HGNC:3395	Lymphatic malformation 7, 617300 (3), Autosomal dominant	Autosomal dominant	y	y	[Martin-Almedina et al. (2016) reported 2 unrelated families from the United Kingdom and Norway, respectively, with an inherited disorder characterized mainly by LRHF and/or ASD. The first family had 7 affected members spanning 3 generations. Four patients had LRHF of variable severity that improved spontaneously over time in those who survived the neonatal period, and 1 affected fetus died in utero]	L1	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L1	L1	pre-infant-lethal
617301	GLYCINE ENCEPHALOPATHY WITH NORMAL SERUM GLYCINE	Glycine encephalopathy with normal serum glycine, 617301 (3)	Glycine encephalopathy with normal serum glycine	y	GLYCINE ENCEPHALOPATHY WITH NORMAL SERUM GLYCINE	Description|Clinical Features|Clinical Synopsis	die|died|death|deaths	SLC6A9	HGNC:11056	Glycine encephalopathy with normal serum glycine, 617301 (3), Autosomal recessive	Autosomal recessive	n	y	[Kurolap et al. (2016) reported 4 children from 2 unrelated consanguineous Arab-Muslim families with glycine encephalopathy with normal serum glycine. One family contained an affected living 2-year-old girl and a subsequent affected fetus that was terminated; the other family contained 3 affected sibs who died at ages 2 days, 18 days, and 7 months]	L2	y	-	lethal	lethal	lethal	L2	L2	pre-infant-lethal
617303	MUCOPOLYSACCHARIDOSIS-PLUS SYNDROME	Mucopolysaccharidosis-plus syndrome, 617303 (3)	Mucopolysaccharidosis-plus syndrome	y	MUCOPOLYSACCHARIDOSIS-PLUS SYNDROME; MPSPS	Description|Clinical Features|Clinical Synopsis	die|death|deaths|died	VPS33A	HGNC:18179	Mucopolysaccharidosis-plus syndrome, 617303 (3), Autosomal recessive	Autosomal recessive	y	y	[Dursun et al. (2017) reported 2 sisters, born of consanguineous Turkish parents, with a multisystem disorder resulting in death at ages 6 years and 10 months]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
617304	RETINITIS PIGMENTOSA 77	Retinitis pigmentosa 77, 617304 (3)	Retinitis pigmentosa 77	n	-	-	-	REEP6	HGNC:30078	Retinitis pigmentosa 77, 617304 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
617306	COLOBOMA, OSTEOPETROSIS, MICROPHTHALMIA, MACROCEPHALY, ALBINISM, AND DEAFNESS	COMMAD syndrome, 617306 (3)	COMMAD syndrome	n	-	-	-	MITF	HGNC:7105	COMMAD syndrome, 617306 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
617308	BILE ACID SYNTHESIS DEFECT, CONGENITAL, 6	Bile acid synthesis defect, congenital, 6, 617308 (3)	Bile acid synthesis defect, congenital, 6	y	BILE ACID SYNTHESIS DEFECT, CONGENITAL, 6; CBAS6	Phenotype	death|deaths|died	ACOX2	HGNC:120	Bile acid synthesis defect, congenital, 6, 617308 (3), Autosomal recessive	Autosomal recessive	y	n	-	-	-	-	ambiguous	ambiguous	ambiguous	-	-	-
617315	ANTERIOR SEGMENT DYSGENESIS 6	Anterior segment dysgenesis 6, multiple subtypes, 617315 (3)	Anterior segment dysgenesis 6, multiple subtypes	n	-	-	-	CYP1B1	HGNC:2597	Anterior segment dysgenesis 6, multiple subtypes, 617315 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
617319	ANTERIOR SEGMENT DYSGENESIS 8	Anterior segment dysgenesis 8, 617319 (3)	Anterior segment dysgenesis 8	n	-	-	-	CPAMD8	HGNC:23228	Anterior segment dysgenesis 8, 617319 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
617320	ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 12	Ichthyosis, congenital, autosomal recessive 12, 617320 (3)	Ichthyosis, congenital, autosomal recessive 12	n	-	-	-	CASP14	HGNC:1502	Ichthyosis, congenital, autosomal recessive 12, 617320 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
617323	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 59	Intellectual developmental disorder, autosomal recessive 59, 617323 (3)	Intellectual developmental disorder, autosomal recessive 59	n	-	-	-	IMPA1	HGNC:6050	Intellectual developmental disorder, autosomal recessive 59, 617323 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
617330	HYPOTONIA, ATAXIA, AND DELAYED DEVELOPMENT SYNDROME	Hypotonia, ataxia, and delayed development syndrome, 617330 (3)	Hypotonia, ataxia, and delayed development syndrome	y	HYPOTONIA, ATAXIA, AND DELAYED DEVELOPMENT SYNDROME; HADDS	Phenotype	lethality	EBF3	HGNC:19087	Hypotonia, ataxia, and delayed development syndrome, 617330 (3), Autosomal dominant	Autosomal dominant	y	n	-	-	-	-	ambiguous	ambiguous	ambiguous	-	-	-
617333	INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND PTOSIS	Intellectual developmental disorder with dysmorphic facies and ptosis, 617333 (3)	Intellectual developmental disorder with dysmorphic facies and ptosis	n	-	-	-	BRPF1	HGNC:14255	Intellectual developmental disorder with dysmorphic facies and ptosis, 617333 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
617336	CONGENITAL MYOPATHY 24	Congenital myopathy 24, 617336 (3)	Congenital myopathy 24	n	-	-	-	MYPN	HGNC:23246	Congenital myopathy 24, 617336 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L6	L6	post-infant-lethal
617339	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 51	Developmental and epileptic encephalopathy 51, 617339 (3)	Developmental and epileptic encephalopathy 51	y	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 51; DEE51	Clinical Features|Clinical Synopsis	died	MDH2	HGNC:6971	Developmental and epileptic encephalopathy 51, 617339 (3), Autosomal recessive	Autosomal recessive	y	y	[Ait-El-Mkadem et al. (2017) reported 3 unrelated boys with DEE51. Two patients were 5 and 12 years of age, whereas the third died at age 1.5 years]	L4	y	-	lethal	lethal	lethal	L4	L4	post-infant-lethal
617341	CEREBRORETINAL MICROANGIOPATHY WITH CALCIFICATIONS AND CYSTS 2	Cerebroretinal microangiopathy with calcifications and cysts 2, 617341 (3)	Cerebroretinal microangiopathy with calcifications and cysts 2	y	CEREBRORETINAL MICROANGIOPATHY WITH CALCIFICATIONS AND CYSTS 2; CRMCC2	Clinical Features	died	STN1	HGNC:26200	Cerebroretinal microangiopathy with calcifications and cysts 2, 617341 (3), Autosomal recessive	Autosomal recessive	n	y	[Simon et al. (2016) reported 2 unrelated teenaged patients, both born of consanguineous Pakistani parents, with CRMCC2... The female patient also had neurologic symptoms, including spasticity, dystonia, and ataxia, and she died of gastrointestinal bleeding at age 16]	L5	y	-	lethal	lethal	lethal	L5	L5	post-infant-lethal
617343	HYPERPARATHYROIDISM 4	Hyperparathyroidism 4, 617343 (3)	Hyperparathyroidism 4	n	-	-	-	GCM2	HGNC:4198	Hyperparathyroidism 4, 617343 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
617347	HYPERLIPOPROTEINEMIA, TYPE III	Hyperlipoproteinemia, type III, 617347 (3)	Hyperlipoproteinemia, type III	y	HYPERLIPOPROTEINEMIA, TYPE III	Clinical Features|Phenotype	died|death|deaths	APOE	HGNC:613	Hyperlipoproteinemia, type III, 617347 (3)	-	n	n	-	-	-	-	ambiguous	ambiguous|nonlethal	ambiguous	-	-	-
617350	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 52	Developmental and epileptic encephalopathy 52, 617350 (3)	Developmental and epileptic encephalopathy 52	y	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 52; DEE52	Description|Clinical Features|Clinical Synopsis	death|deaths|died	SCN1B	HGNC:10586	Developmental and epileptic encephalopathy 52, 617350 (3), Autosomal recessive	Autosomal recessive	y	y	[Ramadan et al. (2017) described 5 children with DEE52 from 3 unrelated consanguineous Saudi families. The proband in family 1 presented at age 8 months with status epileptics and an EEG consistent with focal secondary generalized epilepsy with bursts of high voltage spikes lasting up to 5 minutes without clinical manifestation. Brain MRI showed nonspecific atrophy. Her epilepsy was resistant to treatment and she died at age 9 years. A brother presented at age 2 months with treatment-resistant tonic-clonic and absence seizures, episodic abnormal eye movements, and recurrent singultus; he died at age 9 months]	L3	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L3|L6	L3	pre-infant-lethal
617360	CONGENITAL HEART DEFECTS, DYSMORPHIC FACIAL FEATURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER	Congenital heart defects, dysmorphic facial features, and intellectual developmental disorder, 617360 (3)	Congenital heart defects, dysmorphic facial features, and intellectual developmental disorder	n	-	-	-	CDK13	HGNC:1733	Congenital heart defects, dysmorphic facial features, and intellectual developmental disorder, 617360 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
617364	CONGENITAL HEART DEFECTS AND ECTODERMAL DYSPLASIA	Congenital heart defects and ectodermal dysplasia, 617364 (3)	Congenital heart defects and ectodermal dysplasia	n	-	-	-	PRKD1	HGNC:9407	Congenital heart defects and ectodermal dysplasia, 617364 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
617384	HYPERPHENYLALANINEMIA, MILD, NON-BH4-DEFICIENT	Hyperphenylalaninemia, mild, non-BH4-deficient, 617384 (3)	Hyperphenylalaninemia, mild, non-BH4-deficient	y	HYPERPHENYLALANINEMIA, MILD, NON-BH4-DEFICIENT; HPANBH4	Clinical Features	died	DNAJC12	HGNC:28908	Hyperphenylalaninemia, mild, non-BH4-deficient, 617384 (3), Autosomal recessive	Autosomal recessive	n	n	-	-	-	-	ambiguous	ambiguous	ambiguous	-	-	-
617388	AUTOINFLAMMATION WITH ARTHRITIS AND DYSKERATOSIS	Autoinflammation with arthritis and dyskeratosis, 617388 (3)	Autoinflammation with arthritis and dyskeratosis	n	-	-	-	NLRP1	HGNC:14374	Autoinflammation with arthritis and dyskeratosis, 617388 (3), Autosomal dominant, Autosomal recessive	Autosomal dominant, Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
617389	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 53	Developmental and epileptic encephalopathy 53, 617389 (3)	Developmental and epileptic encephalopathy 53	y	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 53; DEE53	Description|Clinical Features|Clinical Synopsis	die|died|death|deaths	SYNJ1	HGNC:11503	Developmental and epileptic encephalopathy 53, 617389 (3), Autosomal recessive	Autosomal recessive	y	y	[Hardies et al. (2016) reported 3 unrelated families in which 2 sibs each had DEE53. Two of the families were consanguineous and of Moroccan origin, whereas the third family was Caucasian and nonconsanguineous... In 1 family, the 2 affected sibs died at 2.5 and 8 years of age]	L4	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L4	L4	post-infant-lethal
617391	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 54	Developmental and epileptic encephalopathy 54, 617391 (3)	Developmental and epileptic encephalopathy 54	n	-	-	-	HNRNPU	HGNC:5048	Developmental and epileptic encephalopathy 54, 617391 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
617392	ECTODERMAL DYSPLASIA 13, HAIR/TOOTH TYPE	Ectodermal dysplasia 13, hair/tooth type, 617392 (3)	Ectodermal dysplasia 13, hair/tooth type	n	-	-	-	KREMEN1	HGNC:17550	Ectodermal dysplasia 13, hair/tooth type, 617392 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
617393	NEURODEVELOPMENTAL DISORDER WITH EPILEPSY, CATARACTS, FEEDING DIFFICULTIES, AND DELAYED BRAIN MYELINATION	Neurodevelopmental disorder with epilepsy, cataracts, feeding difficulties, and delayed brain myelination, 617393 (3)	Neurodevelopmental disorder with epilepsy, cataracts, feeding difficulties, and delayed brain myelination	n	-	-	-	NACC1	HGNC:20967	Neurodevelopmental disorder with epilepsy, cataracts, feeding difficulties, and delayed brain myelination, 617393 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
617394	SCLEROSING CHOLANGITIS, NEONATAL	Sclerosing cholangitis, neonatal, 617394 (3)	Sclerosing cholangitis, neonatal	y	SCLEROSING CHOLANGITIS, NEONATAL; NSC	Clinical Features	died	DCDC2	HGNC:18141	Sclerosing cholangitis, neonatal, 617394 (3), Autosomal recessive	Autosomal recessive	y	y	[Grammatikopoulos et al. (2016) reported 7 patients from 6 unrelated families, 4 of whom were of Greek descent, with neonatal sclerosing cholangitis... Five patients underwent liver transplantation between 10 and 15 years of age, 1 patient was lost to follow-up at age 6 years, and another died at age 16 years without liver transplantation]	L5	y	-	lethal	lethal	lethal	L5	L5	post-infant-lethal
617396	ANAUXETIC DYSPLASIA 2	Anauxetic dysplasia 2, 617396 (3)	Anauxetic dysplasia 2	n	-	-	-	POP1	HGNC:30129	Anauxetic dysplasia 2, 617396 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
617397	PSEUDO-TORCH SYNDROME 2	Pseudo-TORCH syndrome 2, 617397 (3)	Pseudo-TORCH syndrome 2	y	PSEUDO-TORCH SYNDROME 2; PTORCH2	Description|Clinical Features|Clinical Synopsis	die|died|death|deaths	USP18	HGNC:12616	Pseudo-TORCH syndrome 2, 617397 (3), Autosomal recessive	Autosomal recessive	y	y	[Meuwissen et al. (2016) reported 3 sibs, born of consanguineous Turkish parents, with PTORCH2. One patient presented antenatally with microcephaly, cortical destruction, and calcifications in the subcortical regions, basal ganglia, and periventricular regions. This pregnancy was terminated at 23 weeks' gestation. The other 2 sibs were born alive, but died at ages 7 and 17 days]	L2	y	y	lethal	lethal	lethal	L2	L2	pre-infant-lethal
617402	CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIC	Cutis laxa, autosomal recessive, type IIC, 617402 (3)	Cutis laxa, autosomal recessive, type IIC	y	CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIC; ARCL2C	Clinical Features	died	ATP6V1E1	HGNC:857	Cutis laxa, autosomal recessive, type IIC, 617402 (3), Autosomal recessive	Autosomal recessive	y	y	[Van Damme et al. (2017) studied 2 Iranian sisters and a Kuwaiti sister and brother with autosomal recessive cutis laxa. All affected individuals exhibited generalized skin wrinkling with sparse subcutaneous fat and had dysmorphic progeroid facial features, including a 'mask-like' triangular face, short forehead, hypertelorism, entropion, low-set ears with misfolded helices, beaked nose with broad nasal base and narrow nostrils, and a short pointed chin. Additional features in the Iranian proband included hypotonia, clenched hands, ulnar deviation of the fingers, congenital hip dysplasia, flexion contractures of the knees, and club feet. Echocardiography revealed severe dilation of the ascending aortic root and moderate biventricular hypertrophy. She died at age 4 months]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
617403	CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IID	Cutis laxa, autosomal recessive, type IID, 617403 (3)	Cutis laxa, autosomal recessive, type IID	y	CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IID; ARCL2D	Clinical Features	died	ATP6V1A	HGNC:851	Cutis laxa, autosomal recessive, type IID, 617403 (3), Autosomal recessive	Autosomal recessive	y	y	[Van Damme et al. (2017) studied 3 unrelated patients with cutis laxa, including a German boy originally described by Van Asbeck et al. (2014)... Echocardiography revealed a small atrial septal defect with tortuous aortic arch, and his neonatal course was complicated by progressive cardiac failure, pneumonia, and sepsis. The patient died after a long period of intensive treatment]	LU	y	-	lethal	lethal|nonlethal	lethal|nonlethal	LU	LU	post-infant-lethal
617404	MUSCULAR DYSTROPHY, CONGENITAL, WITH CATARACTS AND INTELLECTUAL DISABILITY	Muscular dystrophy, congenital, with cataracts and intellectual disability, 617404 (3)	Muscular dystrophy, congenital, with cataracts and intellectual disability	n	-	-	-	INPP5K	HGNC:33882	Muscular dystrophy, congenital, with cataracts and intellectual disability, 617404 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
617405	SHORT-RIB THORACIC DYSPLASIA 17 WITH OR WITHOUT POLYDACTYLY	Short-rib thoracic dysplasia 17 with or without polydactyly, 617405 (3)	Short-rib thoracic dysplasia 17 with or without polydactyly	y	SHORT-RIB THORACIC DYSPLASIA 17 WITH OR WITHOUT POLYDACTYLY; SRTD17	Description|Phenotype	lethal|died	DYNLT2B	HGNC:28482	Short-rib thoracic dysplasia 17 with or without polydactyly, 617405 (3), Autosomal recessive	Autosomal recessive	n	y	[Some forms of SRTD are lethal in the neonatal period due to respiratory insufficiency secondary to a severely restricted thoracic cage, whereas others are compatible with life (summary by Huber and Cormier-Daire, 2012 and Schmidts et al., 2013)]	L2	y	-	lethal	lethal	lethal	L2	L2	pre-infant-lethal
617406	BARDET-BIEDL SYNDROME 21	Bardet-Biedl syndrome 21, 617406 (3)	Bardet-Biedl syndrome 21	n	-	-	-	CFAP418	HGNC:27232	Bardet-Biedl syndrome 21, 617406 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
617412	BRACHYCEPHALY, TRICHOMEGALY, AND DEVELOPMENTAL DELAY	Brachycephaly, trichomegaly, and developmental delay, 617412 (3)	Brachycephaly, trichomegaly, and developmental delay	n	-	-	-	RPS23	HGNC:10410	Brachycephaly, trichomegaly, and developmental delay, 617412 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
617425	IMMUNOSKELETAL DYSPLASIA WITH NEURODEVELOPMENTAL ABNORMALITIES	Immunoskeletal dysplasia with neurodevelopmental abnormalities, 617425 (3)	Immunoskeletal dysplasia with neurodevelopmental abnormalities	y	IMMUNOSKELETAL DYSPLASIA WITH NEURODEVELOPMENTAL ABNORMALITIES; ISDNA	Clinical Features|Clinical Synopsis	died|death|deaths	EXTL3	HGNC:3518	Immunoskeletal dysplasia with neurodevelopmental abnormalities, 617425 (3), Autosomal recessive	Autosomal recessive	n	y	[May result in death in neonatal period / Volpi et al. (2017) studied a Tunisian brother and sister and an unrelated Hispanic girl who all presented at birth with short-limb skeletal dysplasia and severe T-cell immunodeficiency... The sibs had hypogammaglobulinemia with increased IgE serum levels. They died at age 11 months and 7 months, after recurrent infections]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
617432	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 60	Intellectual developmental disorder, autosomal recessive 60, 617432 (3)	Intellectual developmental disorder, autosomal recessive 60	n	-	-	-	TAF13	HGNC:11546	Intellectual developmental disorder, autosomal recessive 60, 617432 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
617433	RETINITIS PIGMENTOSA 78	Retinitis pigmentosa 78, 617433 (3)	Retinitis pigmentosa 78	n	-	-	-	ARHGEF18	HGNC:17090	Retinitis pigmentosa 78, 617433 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
617435	LOPES-MACIEL-RODAN SYNDROME	Lopes-Maciel-Rodan syndrome, 617435 (3)	Lopes-Maciel-Rodan syndrome	y	LOPES-MACIEL-RODAN SYNDROME; LOMARS	Clinical Features	died	HTT	HGNC:4851	Lopes-Maciel-Rodan syndrome, 617435 (3), Autosomal recessive	Autosomal recessive	n	y	[Rodan et al. (2016) reported a consanguineous family from Ecuador in which 3 sibs had a neurodevelopmental disorder characterized by severe global developmental delay since birth, central hypotonia progressing to spastic quadriparesis, intellectual disability with poor or absent speech, and feeding difficulties. More variable features included dystonia, midline stereotypies, and high myopia. One patient had seizures and 1 patient had bruxism. One of the patients died unexpectedly at age 7 years]	L4	y	-	lethal	lethal	lethal	L4	L4	post-infant-lethal
617443	BLEEDING DISORDER, PLATELET-TYPE, 21	Bleeding disorder, platelet-type, 21, 617443 (3)	Bleeding disorder, platelet-type, 21	n	-	-	-	FLI1	HGNC:3749	Bleeding disorder, platelet-type, 21, 617443 (3), Autosomal dominant, Autosomal recessive	Autosomal dominant, Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
617450	JANSEN-DE VRIES SYNDROME	Jansen-de Vries syndrome, 617450 (3)	Jansen-de Vries syndrome	n	-	-	-	PPM1D	HGNC:9277	Jansen-de Vries syndrome, 617450 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
617452	INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES, SEIZURES, AND DISTAL LIMB ANOMALIES	Intellectual developmental disorder with dysmorphic facies, seizures, and distal limb anomalies, 617452 (3)	Intellectual developmental disorder with dysmorphic facies, seizures, and distal limb anomalies	n	-	-	-	OTUD6B	HGNC:24281	Intellectual developmental disorder with dysmorphic facies, seizures, and distal limb anomalies, 617452 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
617460	RETINITIS PIGMENTOSA 79	Retinitis pigmentosa 79, 617460 (3)	Retinitis pigmentosa 79	n	-	-	-	HK1	HGNC:4922	Retinitis pigmentosa 79, 617460 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L3	L3	pre-infant-lethal
617466	TOWNES-BROCKS SYNDROME 2	Townes-Brocks syndrome 2, 617466 (3)	Townes-Brocks syndrome 2	n	-	-	-	DACT1	HGNC:17748	Townes-Brocks syndrome 2, 617466 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
617468	ARTHROGRYPOSIS MULTIPLEX CONGENITA 1, NEUROGENIC, WITH MYELIN DEFECT	Arthrogryposis multiplex congenita 1, neurogenic, with myelin defect, 617468 (3)	Arthrogryposis multiplex congenita 1, neurogenic, with myelin defect	y	ARTHROGRYPOSIS MULTIPLEX CONGENITA 1, NEUROGENIC, WITH MYELIN DEFECT; AMC1	Description|Clinical Features|Clinical Synopsis	die|died	LGI4	HGNC:18712	Arthrogryposis multiplex congenita 1, neurogenic, with myelin defect, 617468 (3), Autosomal recessive	Autosomal recessive	y	y	[Most patients die in utero or in the neonatal period]	L1	y	-	lethal	lethal	lethal	L1	L1	pre-infant-lethal
617475	SPECIFIC GRANULE DEFICIENCY 2	Specific granule deficiency 2, 617475 (3)	Specific granule deficiency 2	y	SPECIFIC GRANULE DEFICIENCY 2; SGD2	Description|Clinical Features|Clinical Synopsis	die|died|death|deaths	SMARCD2	HGNC:11107	Specific granule deficiency 2, 617475 (3), Autosomal recessive	Autosomal recessive	y	y	[Witzel et al. (2017) reported 4 patients from 3 unrelated consanguineous families with SGD2... Two patients were alive after hematopoietic stem cell transplant, and 2 died at ages 1.5 months and 5.5 years, respectively]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
617478	STRUCTURAL HEART DEFECTS AND RENAL ANOMALIES SYNDROME	Structural heart defects and renal anomalies syndrome, 617478 (3)	Structural heart defects and renal anomalies syndrome	y	STRUCTURAL HEART DEFECTS AND RENAL ANOMALIES SYNDROME; SHDRA	Clinical Features|Clinical Synopsis	died|die	TMEM260	HGNC:20185	Structural heart defects and renal anomalies syndrome, 617478 (3), Autosomal recessive	Autosomal recessive	y	y	[Pagnamenta et al. (2021) reported 8 patients from 5 unrelated families with SHDRA and mutation in the TMEM260 gene... . Antenatal detection of severe congenital malformations led to termination of pregnancy in 3 cases; of 9 liveborn pregnancies, 6 patients died at 6 weeks to 5 years of age]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
617480	46,XX SEX REVERSAL 4	46XX sex reversal 4, 617480 (3)	46XX sex reversal 4	n	-	-	-	NR5A1	HGNC:7983	46XX sex reversal 4, 617480 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
617481	NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, HYPOTONIA, AND VARIABLE BRAIN ANOMALIES	Neurodevelopmental disorder with microcephaly, hypotonia, and variable brain anomalies, 617481 (3)	Neurodevelopmental disorder with microcephaly, hypotonia, and variable brain anomalies	n	-	-	-	PRUNE1	HGNC:13420	Neurodevelopmental disorder with microcephaly, hypotonia, and variable brain anomalies, 617481 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
617493	NEURODEVELOPMENTAL DISORDER WITH INVOLUNTARY MOVEMENTS	Neurodevelopmental disorder with involuntary movements, 617493 (3)	Neurodevelopmental disorder with involuntary movements	y	NEURODEVELOPMENTAL DISORDER WITH INVOLUNTARY MOVEMENTS; NEDIM	Clinical Features	death|deaths|died	GNAO1	HGNC:4389	Neurodevelopmental disorder with involuntary movements, 617493 (3), Autosomal dominant	Autosomal dominant	y	y	[Danti et al. (2017) reported 6 unrelated patients with NEDIM confirmed by genetic analysis...This patient had increased serum creatine kinase and renal failure, leading to multisystemic deterioration and death at age 4 years]	L4	y	-	lethal	lethal	lethal	L3|L4	L3	pre-infant-lethal
617506	NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 2	Noonan syndrome-like disorder with loose anagen hair 2, 617506 (3)	Noonan syndrome-like disorder with loose anagen hair 2	n	-	-	-	PPP1CB	HGNC:9282	Noonan syndrome-like disorder with loose anagen hair 2, 617506 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
617514	IMMUNODEFICIENCY 52	Immunodeficiency 52, 617514 (3)	Immunodeficiency 52	y	IMMUNODEFICIENCY 52; IMD52	Description|Clinical Features|Clinical Synopsis	die|died|death|deaths	LAT	HGNC:18874	Immunodeficiency 52, 617514 (3), Autosomal recessive	Autosomal recessive	n	y	[Keller et al. (2016) reported 3 infant sibs, born of consanguineous Arab parents, with IMD52 manifest as variable immunodysfunction with recurrent infections, lymphoproliferation, and autoimmune disease... She died at age 2 years from autoimmune hemolytic anemia and thrombocytopenia]	L4	y	-	lethal	lethal	lethal	L4	L4	post-infant-lethal
617516	STANKIEWICZ-ISIDOR SYNDROME	Stankiewicz-Isidor syndrome, 617516 (3)	Stankiewicz-Isidor syndrome	n	-	-	-	PSMD12	HGNC:9557	Stankiewicz-Isidor syndrome, 617516 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
617519	NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, NEUROPATHY, AND DEAFNESS	Neurodevelopmental disorder with hypotonia, neuropathy, and deafness, 617519 (3)	Neurodevelopmental disorder with hypotonia, neuropathy, and deafness	n	-	-	-	SPTBN4	HGNC:14896	Neurodevelopmental disorder with hypotonia, neuropathy, and deafness, 617519 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
617524	ERYTHROKERATODERMIA VARIABILIS ET PROGRESSIVA 2	Erythrokeratodermia variabilis et progressiva 2, 617524 (3)	Erythrokeratodermia variabilis et progressiva 2	n	-	-	-	GJB4	HGNC:4286	Erythrokeratodermia variabilis et progressiva 2, 617524 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
617525	ERYTHROKERATODERMIA VARIABILIS ET PROGRESSIVA 3	Erythrokeratodermia variabilis et progressiva 3, 617525 (3)	Erythrokeratodermia variabilis et progressiva 3	n	-	-	-	GJA1	HGNC:4274	Erythrokeratodermia variabilis et progressiva 3, 617525 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
617526	ERYTHROKERATODERMIA VARIABILIS ET PROGRESSIVA 4	Erythrokeratodermia variabilis et progressiva 4, 617526 (3)	Erythrokeratodermia variabilis et progressiva 4	y	ERYTHROKERATODERMIA VARIABILIS ET PROGRESSIVA 4; EKVP4	Clinical Features	died	KDSR	HGNC:4021	Erythrokeratodermia variabilis et progressiva 4, 617526 (3), Autosomal recessive	Autosomal recessive	y	n	-	-	-	-	ambiguous	ambiguous	ambiguous	-	-	-
617527	NEURODEVELOPMENTAL DISORDER WITH PROGRESSIVE MICROCEPHALY, SPASTICITY, AND BRAIN ANOMALIES	Neurodevelopmental disorder with progressive microcephaly, spasticity, and brain anomalies, 617527 (3)	Neurodevelopmental disorder with progressive microcephaly, spasticity, and brain anomalies	y	NEURODEVELOPMENTAL DISORDER WITH PROGRESSIVE MICROCEPHALY, SPASTICITY, AND BRAIN ANOMALIES; NDMSBA	Description|Clinical Features|Clinical Synopsis|Phenotype	die|death|deaths|died|lethal	PLAA	HGNC:9043	Neurodevelopmental disorder with progressive microcephaly, spasticity, and brain anomalies, 617527 (3), Autosomal recessive	Autosomal recessive	y	y	[Hall et al. (2017) reported 10 patients from 4 consanguineous families of Pakistani or Saudi Arabian origin with a severe neurodevelopmental disorder resulting in death from central apnea or pneumonia between 12 days and 6 years in all patients]	L2	y	-	lethal	lethal	lethal	L2	L2	pre-infant-lethal
617532	INTELLECTUAL DEVELOPMENTAL DISORDER WITH NEUROPSYCHIATRIC FEATURES	Intellectual developmental disorder with neuropsychiatric features, 617532 (3)	Intellectual developmental disorder with neuropsychiatric features	n	-	-	-	SLC45A1	HGNC:17939	Intellectual developmental disorder with neuropsychiatric features, 617532 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
617537	RAHMAN SYNDROME	Rahman syndrome, 617537 (3)	Rahman syndrome	n	-	-	-	H1-4	HGNC:4718	Rahman syndrome, 617537 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
617542	GAZE PALSY, FAMILIAL HORIZONTAL, WITH PROGRESSIVE SCOLIOSIS 2, WITH IMPAIRED INTELLECTUAL DEVELOPMENT	Gaze palsy, familial horizontal, with progressive scoliosis, 2, 617542 (3)	Gaze palsy, familial horizontal, with progressive scoliosis, 2	n	-	-	-	DCC	HGNC:2701	Gaze palsy, familial horizontal, with progressive scoliosis, 2, 617542 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
617547	RETINAL DYSTROPHY WITH OR WITHOUT MACULAR STAPHYLOMA	Retinal dystrophy with macular staphyloma, 617547 (3)	Retinal dystrophy with macular staphyloma	n	-	-	-	CFAP410	HGNC:1260	Retinal dystrophy with macular staphyloma, 617547 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
617557	GABRIELE-DE VRIES SYNDROME	Gabriele-de Vries syndrome, 617557 (3)	Gabriele-de Vries syndrome	n	-	-	-	YY1	HGNC:12856	Gabriele-de Vries syndrome, 617557 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
617560	SPASTIC ATAXIA 8, AUTOSOMAL RECESSIVE, WITH HYPOMYELINATING LEUKODYSTROPHY	Spastic ataxia 8, autosomal recessive, with hypomyelinating leukodystrophy, 617560 (3)	Spastic ataxia 8, autosomal recessive, with hypomyelinating leukodystrophy	n	-	-	-	NKX6-2	HGNC:19321	Spastic ataxia 8, autosomal recessive, with hypomyelinating leukodystrophy, 617560 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
617561	COHEN-GIBSON SYNDROME	Cohen-Gibson syndrome, 617561 (3)	Cohen-Gibson syndrome	n	-	-	-	EED	HGNC:3188	Cohen-Gibson syndrome, 617561 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
617562	MECKEL SYNDROME 13	Meckel syndrome 13, 617562 (3)	Meckel syndrome 13	y	MECKEL SYNDROME 13; MKS13	Clinical Features|Clinical Synopsis	lethality|death|deaths	TMEM107	HGNC:28128	Meckel syndrome 13, 617562 (3), Autosomal recessive	Autosomal recessive	n	y	[Perinatal death in patients with MKS13]	L2	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L2	L2	pre-infant-lethal
617563	OROFACIODIGITAL SYNDROME XVI	Orofaciodigital syndrome XVI, 617563 (3)	Orofaciodigital syndrome XVI	n	-	-	-	TMEM107	HGNC:28128	Orofaciodigital syndrome XVI, 617563 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L2	L2	pre-infant-lethal
617565	PERRAULT SYNDROME 6	Perrault syndrome 6, 617565 (3)	Perrault syndrome 6	n	-	-	-	ERAL1	HGNC:3424	Perrault syndrome 6, 617565 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
617571	ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 14	Ichthyosis, congenital, autosomal recessive 14, 617571 (3)	Ichthyosis, congenital, autosomal recessive 14	n	-	-	-	SULT2B1	HGNC:11459	Ichthyosis, congenital, autosomal recessive 14, 617571 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
617572	EXUDATIVE VITREORETINOPATHY 7	Exudative vitreoretinopathy 7, 617572 (3)	Exudative vitreoretinopathy 7	n	-	-	-	CTNNB1	HGNC:2514	Exudative vitreoretinopathy 7, 617572 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
617574	ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 13	Ichthyosis, congenital, autosomal recessive 13, 617574 (3)	Ichthyosis, congenital, autosomal recessive 13	n	-	-	-	SDR9C7	HGNC:29958	Ichthyosis, congenital, autosomal recessive 13, 617574 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
617575	RENI SYNDROME	RENI syndrome, 617575 (3)	RENI syndrome	y	RENI SYNDROME; RENI	Description|Clinical Features|Clinical Synopsis	demise|death|deaths|died	SGPL1	HGNC:10817	RENI syndrome, 617575 (3), Autosomal recessive	Autosomal recessive	y	y	[One child died suddenly at age 7 weeks,]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
617576	SPERMATOGENIC FAILURE 18	Spermatogenic failure 18, 617576 (3)	Spermatogenic failure 18	n	-	-	-	DNAH1	HGNC:2940	Spermatogenic failure 18, 617576 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
617577	CILIARY DYSKINESIA, PRIMARY, 37	Ciliary dyskinesia, primary, 37, 617577 (3)	Ciliary dyskinesia, primary, 37	n	-	-	-	DNAH1	HGNC:2940	Ciliary dyskinesia, primary, 37, 617577 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
617592	SPERMATOGENIC FAILURE 19	Spermatogenic failure 19, 617592 (3)	Spermatogenic failure 19	n	-	-	-	CFAP43	HGNC:26684	Spermatogenic failure 19, 617592 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
617593	SPERMATOGENIC FAILURE 20	Spermatogenic failure 20, 617593 (3)	Spermatogenic failure 20	n	-	-	-	CFAP44	HGNC:25631	Spermatogenic failure 20, 617593 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
617595	BIRK-LANDAU-PEREZ SYNDROME	Birk-Landau-Perez syndrome, 617595 (3)	Birk-Landau-Perez syndrome	n	-	-	-	SLC30A9	HGNC:1329	Birk-Landau-Perez syndrome, 617595 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
617598	MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 3	Mosaic variegated aneuploidy syndrome 3, 617598 (3)	Mosaic variegated aneuploidy syndrome 3	y	MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 3; MVA3	Clinical Features	died	TRIP13	HGNC:12307	Mosaic variegated aneuploidy syndrome 3, 617598 (3), Autosomal recessive	Autosomal recessive	n	y	[Yost et al. (2017) reported 6 probands with onset of Wilms tumor in early childhood. Five of the patients were of Asian or Pakistani origin, and 4 of these families were consanguineous. The sixth patient was of Norwegian descent. Four of the patients had evidence of aneuploidy and/or premature chromatid separation in lymphocytes. Most patients had additional, but highly variable, features. The most severely affected child had microcephaly, severe global developmental delay, arthrogryposis, cone-rod dystrophy, nystagmus, and dysmorphic features. Brain imaging showed cerebral cysts and neuronal migration defects. In contrast, the least severely affected individual had only Wilms tumor and short stature, and was alive at age 43 years with no reported neurologic abnormalities. Two of the other patients had microcephaly and seizures, one of whom had developmental delay. Rare findings in the patients included growth retardation and pigmentary abnormalities of the skin. One patient had a sister who died at age 4 years from a Sertoli-Leydig cell tumor of the ovary and acute myeloid leukemia, but samples from this patient were not available]	L4	n	y	lethal	lethal|nonlethal	lethal|nonlethal	L4	L4	post-infant-lethal
617599	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 55	Developmental and epileptic encephalopathy 55, 617599 (3)	Developmental and epileptic encephalopathy 55	y	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 55; DEE55	Description|Clinical Features|Clinical Synopsis	death|deaths|died	PIGP	HGNC:3046	Developmental and epileptic encephalopathy 55, 617599 (3), Autosomal recessive	Autosomal recessive	y	y	[Vetro et al. (2020) reported 4 patients from a large consanguineous kindred with DEE55. Two patients died at 12 years and 27 months of age]	L4	y	-	lethal	lethal	lethal	L4	L4	post-infant-lethal
617600	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 45	Intellectual developmental disorder, autosomal dominant 45, 617600 (3)	Intellectual developmental disorder, autosomal dominant 45	n	-	-	-	CIC	HGNC:14214	Intellectual developmental disorder, autosomal dominant 45, 617600 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
617601	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 46	Intellectual developmental disorder, autosomal dominant 46, 617601 (3)	Intellectual developmental disorder, autosomal dominant 46	n	-	-	-	KCNQ5	HGNC:6299	Intellectual developmental disorder, autosomal dominant 46, 617601 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
617602	CONGENITAL HEART DEFECTS AND SKELETAL MALFORMATIONS SYNDROME	Congenital heart defects and skeletal malformations syndrome, 617602 (3)	Congenital heart defects and skeletal malformations syndrome	n	-	-	-	ABL1	HGNC:76	Congenital heart defects and skeletal malformations syndrome, 617602 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
617604	MICROCEPHALY, SHORT STATURE, AND LIMB ABNORMALITIES	Microcephaly, short stature, and limb abnormalities, 617604 (3)	Microcephaly, short stature, and limb abnormalities	n	-	-	-	DONSON	HGNC:2993	Microcephaly, short stature, and limb abnormalities, 617604 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L1	L1	pre-infant-lethal
617609	NEPHROTIC SYNDROME, TYPE 15	Nephrotic syndrome, type 15, 617609 (3)	Nephrotic syndrome, type 15	n	-	-	-	MAGI2	HGNC:18957	Nephrotic syndrome, type 15, 617609 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
617610	POLYCYSTIC KIDNEY DISEASE 5	Polycystic kidney disease 5, 617610 (3)	Polycystic kidney disease 5	n	-	-	-	DZIP1L	HGNC:26551	Polycystic kidney disease 5, 617610 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
617613	MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 5	Multiple mitochondrial dysfunctions syndrome 5, 617613 (3)	Multiple mitochondrial dysfunctions syndrome 5	y	MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 5; MMDS5	Description|Clinical Features|Clinical Synopsis	death|deaths|died	ISCA1	HGNC:28660	Multiple mitochondrial dysfunctions syndrome 5, 617613 (3), Autosomal recessive	Autosomal recessive	y	y	[Death by 5 years of age]	L4	y	-	lethal	lethal	lethal	L4	L4	post-infant-lethal
617616	SKRABAN-DEARDORFF SYNDROME	Skraban-Deardorff syndrome, 617616 (3)	Skraban-Deardorff syndrome	n	-	-	-	WDR26	HGNC:21208	Skraban-Deardorff syndrome, 617616 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
617622	JOUBERT SYNDROME 30	Joubert syndrome 30, 617622 (3)	Joubert syndrome 30	n	-	-	-	ARMC9	HGNC:20730	Joubert syndrome 30, 617622 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
617626	FIBROMATOSIS, GINGIVAL, 5	Fibromatosis, gingival, 5, 617626 (3)	Fibromatosis, gingival, 5	n	-	-	-	REST	HGNC:9966	Fibromatosis, gingival, 5, 617626 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
617635	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 47	Intellectual developmental disorder, autosomal dominant 47, 617635 (3)	Intellectual developmental disorder, autosomal dominant 47	n	-	-	-	STAG1	HGNC:11354	Intellectual developmental disorder, autosomal dominant 47, 617635 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
617637	DEAFNESS, AUTOSOMAL RECESSIVE 106	Deafness autosomal recessive 106, 617637 (3)	Deafness autosomal recessive 106	n	-	-	-	EPS8L2	HGNC:21296	Deafness autosomal recessive 106, 617637 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
617638	IMMUNODEFICIENCY 11B WITH ATOPIC DERMATITIS	Immunodeficiency 11B with atopic dermatitis, 617638 (3)	Immunodeficiency 11B with atopic dermatitis	n	-	-	-	CARD11	HGNC:16393	Immunodeficiency 11B with atopic dermatitis, 617638 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	ambiguous|lethal|nonlethal	lethal|nonlethal	L3	L3	pre-infant-lethal
617639	DEAFNESS, AUTOSOMAL RECESSIVE 107	Deafness, autosomal recessive 107, 617639 (3)	Deafness, autosomal recessive 107	n	-	-	-	WBP2	HGNC:12738	Deafness, autosomal recessive 107, 617639 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
617641	CONGENITAL ANOMALIES OF KIDNEY AND URINARY TRACT SYNDROME WITH OR WITHOUT HEARING LOSS, ABNORMAL EARS, OR DEVELOPMENTAL DELAY	Congenital anomalies of kidney and urinary tract syndrome with or without hearing loss, abnormal ears, or developmental delay, 617641 (3)	Congenital anomalies of kidney and urinary tract syndrome with or without hearing loss, abnormal ears, or developmental delay	n	-	-	-	PBX1	HGNC:8632	Congenital anomalies of kidney and urinary tract syndrome with or without hearing loss, abnormal ears, or developmental delay, 617641 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
617642	POLYDACTYLY, POSTAXIAL, TYPE A7	Polydactyly, postaxial, type A7, 617642 (3)	Polydactyly, postaxial, type A7	n	-	-	-	IQCE	HGNC:29171	Polydactyly, postaxial, type A7, 617642 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
617643	CEREBELLAR ATROPHY, DEVELOPMENTAL DELAY, AND SEIZURES	Cerebellar atrophy, developmental delay, and seizures, 617643 (3)	Cerebellar atrophy, developmental delay, and seizures	n	-	-	-	KCNMA1	HGNC:6284	Cerebellar atrophy, developmental delay, and seizures, 617643 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
617660	VERTEBRAL, CARDIAC, RENAL, AND LIMB DEFECTS SYNDROME 1	Vertebral, cardiac, renal, and limb defects syndrome 1, 617660 (3)	Vertebral, cardiac, renal, and limb defects syndrome 1	y	VERTEBRAL, CARDIAC, RENAL, AND LIMB DEFECTS SYNDROME 1; VCRL1	Clinical Features|Clinical Synopsis	died	HAAO	HGNC:4796	Vertebral, cardiac, renal, and limb defects syndrome 1, 617660 (3), Autosomal recessive	Autosomal recessive	y	y	[Shi et al. (2017) reported 2 unrelated patients, each born of consanguineous parents of Iraqi (family A) and Lebanese (family B) descent, respectively, with VCRL1. Both patients had vertebral segmentation defects predominantly affecting the thoracolumbar spine and spinal lipoma; patient A had sacral agenesis and patient B had spinal dysraphism. Both had cardiac defects: atrial septal defect in patient A and hypoplastic left heart with mitral and aortic stenosis in patient B. Patient A had a cleft palate, bifid uvula, and laryngeal web with persistent tracheomalacia, and patient B had a left vocal cord palsy that was possibly iatrogenic with no other laryngeal defects. Additional features found in both patients included microcephaly, hypoplastic kidneys, and sensorineural hearing loss. Patient A had short stature, talipes, delayed development, moderate intellectual disability and behavioral issues at age 12 years, whereas patient B died at age 11 months from complications of hypoplastic left heart]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
617661	VERTEBRAL, CARDIAC, RENAL, AND LIMB DEFECTS SYNDROME 2	Vertebral, cardiac, renal, and limb defects syndrome 2, 617661 (3)	Vertebral, cardiac, renal, and limb defects syndrome 2	y	VERTEBRAL, CARDIAC, RENAL, AND LIMB DEFECTS SYNDROME 2; VCRL2	Clinical Features|Clinical Synopsis	died|stillborn	KYNU	HGNC:6469	Vertebral, cardiac, renal, and limb defects syndrome 2, 617661 (3), Autosomal recessive	Autosomal recessive	y	y	[Shi et al. (2017) reported 2 unrelated female patients, one born of consanguineous parents of Lebanese descent (family C) and the other born of unrelated parents from the United States (family D), with VCRL2. Both patients had segmentation defects predominantly affecting the thoracolumbar spine. Both had cardiac defects: patent ductus arteriosus in one patient and hypoplastic left heart in the other. Patient C had microcephaly, low-set ears, hypoplastic kidneys, rhizomelia, talipes, syndactyly, and anterior anus. She died at age 4 months of restrictive respiratory disease due to spondylocostal defects]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
617662	JOINT LAXITY, SHORT STATURE, AND MYOPIA	Joint laxity, short stature, and myopia, 617662 (3)	Joint laxity, short stature, and myopia	n	-	-	-	GZF1	HGNC:15808	Joint laxity, short stature, and myopia, 617662 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
617663	DEAFNESS, AUTOSOMAL DOMINANT 73	Deafness, autosomal dominant 73, 617663 (3)	Deafness, autosomal dominant 73	n	-	-	-	PTPRQ	HGNC:9679	Deafness, autosomal dominant 73, 617663 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
617664	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 32	Combined oxidative phosphorylation deficiency 32, 617664 (3)	Combined oxidative phosphorylation deficiency 32	y	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 32; COXPD32	Clinical Features|Clinical Synopsis	died|death|deaths	MRPS34	HGNC:16618	Combined oxidative phosphorylation deficiency 32, 617664 (3), Autosomal recessive	Autosomal recessive	n	y	[Lake et al. (2017) reported 6 patients from 4 unrelated families with COXPD. Two families were of Puerto Rican descent, 1 was Italian, and 1 French. Five patients presented in the first 4 to 6 months of life with developmental delay and neurodevelopmental regression. The sixth child (patient S4) presented at 10 days of age with poor feeding and neurologic symptoms, such as no eye contact, hypotonia, dystonia, and pyramidal syndrome of the lower limbs; he died at age 8.5 months. Another child (S1), born of consanguineous Italian parents, showed poor feeding, irritability, lethargy, and intermittent breathing abnormalities; he died at age 9 months]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
617665	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 56	Developmental and epileptic encephalopathy 56, 617665 (3)	Developmental and epileptic encephalopathy 56	n	-	-	-	YWHAG	HGNC:12852	Developmental and epileptic encephalopathy 56, 617665 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
617666	FRASER SYNDROME 2	Fraser syndrome 2, 617666 (3)	Fraser syndrome 2	y	FRASER SYNDROME 2; FRASRS2	Clinical Features	death|deaths|died	FREM2	HGNC:25396	Fraser syndrome 2, 617666 (3), Autosomal recessive	Autosomal recessive	n	y	[Shafeghati et al. (2008) reported a female fetus, the offspring of consanguineous Iranian parents, with a normal karyotype and cryptophthalmos, ambiguous external genitalia, syndactyly, bilobed lungs, bilateral renal agenesis, hypoplastic bladder, and agenesis of internal genitalia with streak ovaries. An earlier pregnancy in the family had resulted in the intrauterine death at 30 weeks of gestation of a male fetus with a normal karyotype in whom the diagnosis of Fraser syndrome was suggested by the presence of cryptophthalmos, syndactyly, ambiguous genitalia, imperforate anus, bilateral renal agenesis, pulmonary hypoplasia, and hydrocephalus. The authors noted that the findings in the sibs were consistent with classic Fraser syndrome / Jadeja et al. (2005) reported 2 unrelated consanguineous families segregating Fraser syndrome. The proband in the first family, who died 1 hour after birth, had cryptophthalmos, nasal dysplasia with hypoplastic alae nasi, multiple skin syndactyly in all extremities, and short thorax with abdominal distention]	L1	y	y	lethal	lethal|nonlethal	lethal|nonlethal	L1	L1	pre-infant-lethal
617667	FRASER SYNDROME 3	Fraser syndrome 3, 617667 (3)	Fraser syndrome 3	y	FRASER SYNDROME 3; FRASRS3	Clinical Features|Clinical Synopsis	stillborn	GRIP1	HGNC:18708	Fraser syndrome 3, 617667 (3), Autosomal recessive	Autosomal recessive	n	y	[Vogel et al. (2012) described 2 unrelated stillborn male fetuses, born to consanguineous parents, with Fraser syndrome]	L1	y	-	lethal	lethal	lethal	L1	L1	pre-infant-lethal
617668	ENCEPHALOPATHY, NEONATAL SEVERE, WITH LACTIC ACIDOSIS AND BRAIN ABNORMALITIES	Encephalopathy, neonatal severe, with lactic acidosis and brain abnormalities, 617668 (3)	Encephalopathy, neonatal severe, with lactic acidosis and brain abnormalities	y	ENCEPHALOPATHY, NEONATAL SEVERE, WITH LACTIC ACIDOSIS AND BRAIN ABNORMALITIES; NELABA	Description|Clinical Features|Clinical Synopsis	die|died|death|deaths	LIPT2	HGNC:37216	Encephalopathy, neonatal severe, with lactic acidosis and brain abnormalities, 617668 (3), Autosomal recessive	Autosomal recessive	n	y	[Habarou et al. (2017) reported 3 patients from 2 unrelated families with severe neonatal encephalopathy. Two sibs, born of unrelated German parents, died within the first 7 months of life without any psychomotor development]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
617669	ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND SPASTICITY	Encephalopathy, progressive, early-onset, with brain atrophy and spasticity, 617669 (3)	Encephalopathy, progressive, early-onset, with brain atrophy and spasticity	y	ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND SPASTICITY; PEBAS	Clinical Features	died|spontaneous_abortion|spontaneous_abortions	TRAPPC12	HGNC:24284	Encephalopathy, progressive, early-onset, with brain atrophy and spasticity, 617669 (3), Autosomal recessive	Autosomal recessive	n	y	[Milev et al. (2017) reported 3 children from 2 unrelated families with severe early-onset progressive encephalopathy characterized by microcephaly, global developmental delay, and hearing loss. One patient, born of consanguineous Palestinian parents, presented with brief flexion seizures at age 5 months and subsequently showed developmental regression and stagnation with loss of smiling, visual tracking, and social overtures. EEG showed hypsarrhythmia. Family history in this patient was notable for the mother having 5 previous pregnancies ending in spontaneous abortions, a sixth terminated for multiple anomalies, and another child born at 24 weeks' gestation who died soon after birth... One of the sisters died of respiratory insufficiency at age 4 years, 9 months]	L1	y	y	lethal	lethal	lethal	L1	L1	pre-infant-lethal
617671	HELIX SYNDROME	HELIX syndrome, 617671 (3)	HELIX syndrome	n	-	-	-	CLDN10	HGNC:2033	HELIX syndrome, 617671 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
617672	NEURODEGENERATION, CHILDHOOD-ONSET, WITH BRAIN ATROPHY	Neurodegeneration, childhood-onset, with brain atrophy, 617672 (3)	Neurodegeneration, childhood-onset, with brain atrophy	y	NEURODEGENERATION, CHILDHOOD-ONSET, WITH BRAIN ATROPHY; CONDBA	Phenotype	death|deaths	UBTF	HGNC:12511	Neurodegeneration, childhood-onset, with brain atrophy, 617672 (3), Autosomal dominant	Autosomal dominant	n	n	-	-	-	-	ambiguous	ambiguous	ambiguous	-	-	-
617675	MYOPATHY, MITOCHONDRIAL, AND ATAXIA	Myopathy, mitochondrial, and ataxia, 617675 (3)	Myopathy, mitochondrial, and ataxia	n	-	-	-	MSTO1	HGNC:29678	Myopathy, mitochondrial, and ataxia, 617675 (3), Autosomal dominant, Autosomal recessive	Autosomal dominant, Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
617681	BLEPHAROCHEILODONTIC SYNDROME 2	Blepharocheilodontic syndrome 2, 617681 (3)	Blepharocheilodontic syndrome 2	n	-	-	-	CTNND1	HGNC:2515	Blepharocheilodontic syndrome 2, 617681 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
617682	PILAROWSKI-BJORNSSON SYNDROME	Pilarowski-Bjornsson syndrome, 617682 (3)	Pilarowski-Bjornsson syndrome	n	-	-	-	CHD1	HGNC:1915	Pilarowski-Bjornsson syndrome, 617682 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
617690	OVARIAN DYSGENESIS 5	Ovarian dysgenesis 5, 617690 (3)	Ovarian dysgenesis 5	n	-	-	-	SOHLH1	HGNC:27845	Ovarian dysgenesis 5, 617690 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
617691	SPINOCEREBELLAR ATAXIA 44	Spinocerebellar ataxia 44, 617691 (3)	Spinocerebellar ataxia 44	n	-	-	-	GRM1	HGNC:4593	Spinocerebellar ataxia 44, 617691 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
617694	AL KAISSI SYNDROME	Al Kaissi syndrome, 617694 (3)	Al Kaissi syndrome	n	-	-	-	CDK10	HGNC:1770	Al Kaissi syndrome, 617694 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
617695	PONTOCEREBELLAR HYPOPLASIA, TYPE 11	Pontocerebellar hypoplasia, type 11, 617695 (3)	Pontocerebellar hypoplasia, type 11	n	-	-	-	TBC1D23	HGNC:25622	Pontocerebellar hypoplasia, type 11, 617695 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
617698	3-METHYLGLUTACONIC ACIDURIA, TYPE IX	3-methylglutaconic aciduria, type IX, 617698 (3)	3-methylglutaconic aciduria, type IX	y	3-METHYLGLUTACONIC ACIDURIA, TYPE IX; MGCA9	Clinical Features	died	TIMM50	HGNC:23656	3-methylglutaconic aciduria, type IX, 617698 (3), Autosomal recessive	Autosomal recessive	y	y	[Reyes et al. (2018) reported a child who had hypotonia, poor suck, and failure to thrive since birth. At age 2 months, he presented with infantile spasms, hypsarrhythmia, and psychomotor regression. At age 6 months, she was found to have elevated lactate in plasma and CSF, elevated plasma alanine, and elevated lactate and Krebs cycle intermediates in the urine. 3-methylglutaconic aciduria was absent. A muscle biopsy showed reduced respiratory chain complex II function. Electroretinogram and visual evoked potentials were abnormal. Brain MRI showed moderate brain atrophy and symmetric lesions of the thalami, cerebral peduncles, and pontomesencephalic tegmentum. MR spectroscopy showed a lactate peak in the brain cortex. She had respiratory arrest at age 17 months in the setting of pneumonia, and died at the age of 32 months from cardiorespiratory arrest]	L4	y	-	lethal	lethal	lethal	L4	L4	post-infant-lethal
617707	SPERMATOGENIC FAILURE 23	Spermatogenic failure 23, 617707 (3)	Spermatogenic failure 23	n	-	-	-	TEX14	HGNC:11737	Spermatogenic failure 23, 617707 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
617709	NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, ATAXIA, AND SEIZURES	Neurodevelopmental disorder with microcephaly, ataxia, and seizures, 617709 (3)	Neurodevelopmental disorder with microcephaly, ataxia, and seizures	y	NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, ATAXIA, AND SEIZURES; NEDMAS	Clinical Features|Clinical Synopsis	died|death|deaths	SARS1	HGNC:10537	Neurodevelopmental disorder with microcephaly, ataxia, and seizures, 617709 (3), Autosomal recessive	Autosomal recessive	y	y	[died at 30 months of age]	L4	y	-	lethal	lethal	lethal	L4	L4	post-infant-lethal
617710	NEURODEVELOPMENTAL DISORDER, MITOCHONDRIAL, WITH ABNORMAL MOVEMENTS AND LACTIC ACIDOSIS, WITH OR WITHOUT SEIZURES	Neurodevelopmental disorder, mitochondrial, with abnormal movements and lactic acidosis, with or without seizures, 617710 (3)	Neurodevelopmental disorder, mitochondrial, with abnormal movements and lactic acidosis, with or without seizures	y	NEURODEVELOPMENTAL DISORDER, MITOCHONDRIAL, WITH ABNORMAL MOVEMENTS AND LACTIC ACIDOSIS, WITH OR WITHOUT SEIZURES; NEMMLAS	Clinical Features	death|deaths|died	WARS2	HGNC:12730	Neurodevelopmental disorder, mitochondrial, with abnormal movements and lactic acidosis, with or without seizures, 617710 (3), Autosomal recessive	Autosomal recessive	y	y	[Wortmann et al. (2017) reported 6 patients from 5 unrelated families with a complex multisystemic neurodevelopmental disorder. The patients were of various ethnicities, including Serbian, Dutch, French, Iraqi, and Canadian. All had delayed development and intellectual disability with some highly variable features. Four of the children died; 1 died of multiorgan failure at age 23 days, 2 brothers from a second family who had severe epilepsy died at ages 3.5 years and 18 months, and a girl from another family died in an epileptic seizure at age 3 years]	L2	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L2	L2	pre-infant-lethal
617711	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 91	Developmental and epileptic encephalopathy 91, 617711 (3)	Developmental and epileptic encephalopathy 91	n	-	-	-	PPP3CA	HGNC:9314	Developmental and epileptic encephalopathy 91, 617711 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
617712	OOCYTE/ZYGOTE/EMBRYO MATURATION ARREST 3	Oocyte/zygote/embryo maturation arrest 3, 617712 (3)	Oocyte/zygote/embryo maturation arrest 3	n	-	-	-	ZP3	HGNC:13189	Oocyte/zygote/embryo maturation arrest 3, 617712 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
617713	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 33	Combined oxidative phosphorylation deficiency 33, 617713 (3)	Combined oxidative phosphorylation deficiency 33	y	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 33; COXPD33	Description|Clinical Features|Clinical Synopsis	death|deaths|died	C1QBP	HGNC:1243	Combined oxidative phosphorylation deficiency 33, 617713 (3), Autosomal recessive	Autosomal recessive	n	y	[Feichtinger et al. (2017) reported 2 unrelated infants who presented soon after birth with a severe multisystem disorder associated with increased serum lactate and metabolic acidosis. Both infants died of cardiorespiratory insufficiency in the first days or weeks of life]	L2	y	-	lethal	lethal	lethal	L2	L2	pre-infant-lethal
617717	AUDITORY NEUROPATHY AND OPTIC ATROPHY	Auditory neuropathy and optic atrophy, 617717 (3)	Auditory neuropathy and optic atrophy	n	-	-	-	FDXR	HGNC:3642	Auditory neuropathy and optic atrophy, 617717 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
617718	IMMUNODEFICIENCY 71 WITH INFLAMMATORY DISEASE AND CONGENITAL THROMBOCYTOPENIA	Immunodeficiency 71 with inflammatory disease and congenital thrombocytopenia, 617718 (3)	Immunodeficiency 71 with inflammatory disease and congenital thrombocytopenia	y	IMMUNODEFICIENCY 71 WITH INFLAMMATORY DISEASE AND CONGENITAL THROMBOCYTOPENIA; IMD71	Clinical Features|Clinical Synopsis|Phenotype	died|death|deaths	ARPC1B	HGNC:704	Immunodeficiency 71 with inflammatory disease and congenital thrombocytopenia, 617718 (3), Autosomal recessive	Autosomal recessive	y	y	[Death in childhood (in some patients)]	L4	y	-	lethal	lethal	lethal	L4	L4	post-infant-lethal
617719	EPIPHYSEAL DYSPLASIA, MULTIPLE, 7	Epiphyseal dysplasia, multiple, 7, 617719 (3)	Epiphyseal dysplasia, multiple, 7	n	-	-	-	CANT1	HGNC:19721	Epiphyseal dysplasia, multiple, 7, 617719 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L1	L1	pre-infant-lethal
617721	NEURONOPATHY, DISTAL HEREDITARY MOTOR, AUTOSOMAL DOMINANT 9	Neuronopathy, distal hereditary motor, autosomal dominant 9, 617721 (3)	Neuronopathy, distal hereditary motor, autosomal dominant 9	y	NEURONOPATHY, DISTAL HEREDITARY MOTOR, AUTOSOMAL DOMINANT 9; HMND9	Clinical Features	died	WARS1	HGNC:12729	Neuronopathy, distal hereditary motor, autosomal dominant 9, 617721 (3), Autosomal dominant	Autosomal dominant	y	n	-	-	-	-	ambiguous	ambiguous|lethal	lethal	L5	L5	post-infant-lethal
617729	GALLOWAY-MOWAT SYNDROME 3	Galloway-Mowat syndrome 3, 617729 (3)	Galloway-Mowat syndrome 3	y	GALLOWAY-MOWAT SYNDROME 3; GAMOS3	Description|Clinical Features|Clinical Synopsis	die|death|deaths|died	OSGEP	HGNC:18028	Galloway-Mowat syndrome 3, 617729 (3), Autosomal recessive	Autosomal recessive	n	y	[Chen et al. (2007) reported an infant with Galloway-Mowat syndrome. Prenatal ultrasound late in gestation revealed intrauterine growth retardation, microcephaly, and oligohydramnios. Postnatally, the infant had hypotonia, a sloping forehead, hypertelorism, epicanthal folds, microphthalmos, low-set floppy ears, small midface, high-arched palate, and micrognathia. At age 1 month, he showed developmental delay, proteinuria, and hypoalbuminemia. Brain MRI showed gyral abnormalities, frontal pachygyria, and deficient myelination. He died of multiple organ failure at age 2 months]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
617730	GALLOWAY-MOWAT SYNDROME 4	Galloway-Mowat syndrome 4, 617730 (3)	Galloway-Mowat syndrome 4	y	GALLOWAY-MOWAT SYNDROME 4; GAMOS4	Description|Clinical Features|Clinical Synopsis	die|death|deaths	TP53RK	HGNC:16197	Galloway-Mowat syndrome 4, 617730 (3), Autosomal recessive	Autosomal recessive	n	y	[Braun et al. (2017) reported 4 patients from 3 unrelated consanguineous families with GAMOS4. The families were of European/South African/Indian descent (family B77), Thai descent (patient N2984), and Moroccan descent (patient N2194). All patients presented with nephrotic syndrome with proteinuria in the first year of life followed shortly by end-stage renal disease resulting in death by age 3 years]	L4	y	-	lethal	lethal	lethal	L4	L4	post-infant-lethal
617731	GALLOWAY-MOWAT SYNDROME 5	Galloway-Mowat syndrome 5, 617731 (3)	Galloway-Mowat syndrome 5	y	GALLOWAY-MOWAT SYNDROME 5; GAMOS5	Description|Clinical Features|Clinical Synopsis	die|died|death|deaths	TPRKB	HGNC:24259	Galloway-Mowat syndrome 5, 617731 (3), Autosomal recessive	Autosomal recessive	n	y	[Braun et al. (2017) reported 2 unrelated patients born of consanguineous Egyptian (patient B123) and European (patient B1144) families with GAMOS5. The patients presented with nephrotic syndrome with proteinuria around 4 years of age. One developed end-stage renal disease and died at age 6.8 years, whereas the other did not develop end-stage renal disease and was still alive with normal renal function at age 6... One patient was noted to have deafness; this patient had an affected sib who presented with renal disease at 11 months of age and died at 13 months]	L3	y	y	lethal	lethal	lethal	L3	L3	pre-infant-lethal
617743	OOCYTE/ZYGOTE/EMBRYO MATURATION ARREST 4	Oocyte/zygote/embryo maturation arrest 4, 617743 (3)	Oocyte/zygote/embryo maturation arrest 4	n	-	-	-	PATL2	HGNC:33630	Oocyte/zygote/embryo maturation arrest 4, 617743 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
617744	IMMUNODEFICIENCY, DEVELOPMENTAL DELAY, AND HYPOHOMOCYSTEINEMIA	Immunodeficiency, developmental delay, and hypohomocysteinemia, 617744 (3)	Immunodeficiency, developmental delay, and hypohomocysteinemia	n	-	-	-	NFE2L2	HGNC:7782	Immunodeficiency, developmental delay, and hypohomocysteinemia, 617744 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
617746	SWEENEY-COX SYNDROME	Sweeney-Cox syndrome, 617746 (3)	Sweeney-Cox syndrome	n	-	-	-	TWIST1	HGNC:12428	Sweeney-Cox syndrome, 617746 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
617751	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 48	Intellectual developmental disorder, autosomal dominant 48, 617751 (3)	Intellectual developmental disorder, autosomal dominant 48	n	-	-	-	RAC1	HGNC:9801	Intellectual developmental disorder, autosomal dominant 48, 617751 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
617752	CLARK-BARAITSER SYNDROME	Intellectual developmental disorder, autosomal dominant 49, 617752 (3)	Intellectual developmental disorder, autosomal dominant 49	n	-	-	-	TRIP12	HGNC:12306	Intellectual developmental disorder, autosomal dominant 49, 617752 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
617755	NEURODEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND DISTAL LIMB ANOMALIES	Neurodevelopmental disorder with dysmorphic facies and distal limb anomalies, 617755 (3)	Neurodevelopmental disorder with dysmorphic facies and distal limb anomalies	n	-	-	-	BPTF	HGNC:3581	Neurodevelopmental disorder with dysmorphic facies and distal limb anomalies, 617755 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
617756	ERYTHROKERATODERMIA VARIABILIS ET PROGRESSIVA 5	Erythrokeratodermia variabilis et progressiva 5, 617756 (3)	Erythrokeratodermia variabilis et progressiva 5	n	-	-	-	KRT83	HGNC:6460	Erythrokeratodermia variabilis et progressiva 5, 617756 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
617757	JOUBERT SYNDROME 32	Joubert syndrome 32, 617757 (3)	Joubert syndrome 32	n	-	-	-	SUFU	HGNC:16466	Joubert syndrome 32, 617757 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
617760	MYOPATHY, CENTRONUCLEAR, 6, WITH FIBER-TYPE DISPROPORTION	Centronuclear myopathy 6 with fiber-type disproportion, 617760 (3)	Centronuclear myopathy 6 with fiber-type disproportion	y	MYOPATHY, CENTRONUCLEAR, 6, WITH FIBER-TYPE DISPROPORTION; CNM6	Clinical Features	died	MAP3K20	HGNC:17797	Centronuclear myopathy 6 with fiber-type disproportion, 617760 (3), Autosomal recessive	Autosomal recessive	y	n	-	-	-	-	ambiguous	ambiguous|nonlethal	ambiguous	-	-	-
617761	JOUBERT SYNDROME 31	Joubert syndrome 31, 617761 (3)	Joubert syndrome 31	n	-	-	-	CEP120	HGNC:26690	Joubert syndrome 31, 617761 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L1	L1	pre-infant-lethal
617763	SHORT STATURE, HEARING LOSS, RETINITIS PIGMENTOSA, AND DISTINCTIVE FACIES	Short stature, hearing loss, retinitis pigmentosa, and distinctive facies, 617763 (3)	Short stature, hearing loss, retinitis pigmentosa, and distinctive facies	n	-	-	-	EXOSC2	HGNC:17097	Short stature, hearing loss, retinitis pigmentosa, and distinctive facies, 617763 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
617767	JOUBERT SYNDROME 33	Joubert syndrome 33, 617767 (3)	Joubert syndrome 33	y	JOUBERT SYNDROME 33; JBTS33	Phenotype	died	PIBF1	HGNC:23352	Joubert syndrome 33, 617767 (3), Autosomal recessive	Autosomal recessive	y	y	[died at 15 days of life]	L2	y	-	lethal	lethal	lethal	L2	L2	pre-infant-lethal
617768	KLEEFSTRA SYNDROME 2	Kleefstra syndrome 2, 617768 (3)	Kleefstra syndrome 2	n	-	-	-	KMT2C	HGNC:13726	Kleefstra syndrome 2, 617768 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
617769	SPINOCEREBELLAR ATAXIA 45	Spinocerebellar ataxia 45, 617769 (3)	Spinocerebellar ataxia 45	n	-	-	-	FAT2	HGNC:3596	Spinocerebellar ataxia 45, 617769 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
617771	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 57	Developmental and epileptic encephalopathy 57, 617771 (3)	Developmental and epileptic encephalopathy 57	n	-	-	-	KCNT2	HGNC:18866	Developmental and epileptic encephalopathy 57, 617771 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
617772	DEAFNESS, AUTOSOMAL DOMINANT 34, WITH OR WITHOUT INFLAMMATION	Deafness, autosomal dominant 34, with or without inflammation, 617772 (3)	Deafness, autosomal dominant 34, with or without inflammation	n	-	-	-	NLRP3	HGNC:16400	Deafness, autosomal dominant 34, with or without inflammation, 617772 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L6	L6	post-infant-lethal
617773	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 61	Intellectual developmental disorder, autosomal recessive 61, 617773 (3)	Intellectual developmental disorder, autosomal recessive 61	n	-	-	-	RUSC2	HGNC:23625	Intellectual developmental disorder, autosomal recessive 61, 617773 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
617780	COMBINED IMMUNODEFICIENCY AND MEGALOBLASTIC ANEMIA WITH OR WITHOUT HYPERHOMOCYSTEINEMIA	Combined immunodeficiency and megaloblastic anemia with or without hyperhomocysteinemia, 617780 (3)	Combined immunodeficiency and megaloblastic anemia with or without hyperhomocysteinemia	y	COMBINED IMMUNODEFICIENCY AND MEGALOBLASTIC ANEMIA WITH OR WITHOUT HYPERHOMOCYSTEINEMIA; CIMAH	Clinical Features	died	MTHFD1	HGNC:7432	Combined immunodeficiency and megaloblastic anemia with or without hyperhomocysteinemia, 617780 (3), Autosomal recessive	Autosomal recessive	y	y	[Burda et al. (2015) reported 4 patients from 2 families with combined immunodeficiency and megaloblastic anemia...Her sibs remained well until age 6 weeks. Her sister (patient 4) developed moniliasis and presented at 9 weeks of age with anemia, vomiting, and labored breathing. Her brother (patient 5) presented with fever, lesions consistent with hand-foot-and-mouth disease, vomiting, and labored breathing. At age 9 weeks, he was found to have anemia, leukopenia, and thrombocytosis with extreme metabolic acidosis. Both died within hours]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
617781	RETINITIS PIGMENTOSA 80	Retinitis pigmentosa 80, 617781 (3)	Retinitis pigmentosa 80	n	-	-	-	IFT140	HGNC:29077	Retinitis pigmentosa 80, 617781 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L2	L2	pre-infant-lethal
617783	NEPHROTIC SYNDROME, TYPE 16	Nephrotic syndrome, type 16, 617783 (3)	Nephrotic syndrome, type 16	n	-	-	-	KANK2	HGNC:29300	Nephrotic syndrome, type 16, 617783 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	ambiguous|nonlethal	ambiguous	-	-	-
617787	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 50, WITH BEHAVIORAL ABNORMALITIES	Intellectual developmental disorder, autosomal dominant 50, with behavioral abnormalities, 617787 (3)	Intellectual developmental disorder, autosomal dominant 50, with behavioral abnormalities	n	-	-	-	NAA15	HGNC:30782	Intellectual developmental disorder, autosomal dominant 50, with behavioral abnormalities, 617787 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
617788	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 51	Intellectual developmental disorder, autosomal dominant 51, 617788 (3)	Intellectual developmental disorder, autosomal dominant 51	n	-	-	-	KMT5B	HGNC:24283	Intellectual developmental disorder, autosomal dominant 51, 617788 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
617796	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 52	Intellectual developmental disorder, autosomal dominant 52, 617796 (3)	Intellectual developmental disorder, autosomal dominant 52	n	-	-	-	ASH1L	HGNC:19088	Intellectual developmental disorder, autosomal dominant 52, 617796 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
617798	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 53	Intellectual developmental disorder, autosomal dominant 53, 617798 (3)	Intellectual developmental disorder, autosomal dominant 53	n	-	-	-	CAMK2A	HGNC:1460	Intellectual developmental disorder, autosomal dominant 53, 617798 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
617799	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 54	Intellectual developmental disorder, autosomal dominant 54, 617799 (3)	Intellectual developmental disorder, autosomal dominant 54	n	-	-	-	CAMK2B	HGNC:1461	Intellectual developmental disorder, autosomal dominant 54, 617799 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
617802	NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, SEIZURES, AND CORTICAL ATROPHY	Neurodevelopmental disorder with microcephaly, seizures, and cortical atrophy, 617802 (3)	Neurodevelopmental disorder with microcephaly, seizures, and cortical atrophy	y	NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, SEIZURES, AND CORTICAL ATROPHY; NDMSCA	Description|Clinical Features|Clinical Synopsis|Phenotype	death|deaths|died|pregnancy_loss|pregnancy_losses	VARS1	HGNC:12651	Neurodevelopmental disorder with microcephaly, seizures, and cortical atrophy, 617802 (3), Autosomal recessive	Autosomal recessive	y	y	[Friedman et al. (2019) reported 7 patients from 5 unrelated families with NDMSCA. Three of the families (2937, 3308, and 3439) were consanguineous and of Egyptian origin, another family (3007) was Syrian with remote consanguinity, and the fifth family (GB31) was Caucasian. Four patients died between 2.5 months and 10 years of age; the living patients ranged from 10 months to 5 years of age. All patients presented within the first days, weeks, or months with generalized or myoclonic seizures, often associated with hypsarrhythmia on EEG; seizures could be controlled in only some patients. All had severe to profound global developmental delay with axial hypotonia, peripheral spasticity, hyperreflexia, feeding difficulties, and absent language. Some patients had extrapyramidal signs. All but 1 had severe postnatal microcephaly (down to -8.2 SD). Two patients had transient elevation of liver enzymes and 1 had hepatomegaly. Brain imaging was normal in 1 patient, but showed progressive cortical atrophy and hypoplastic corpus callosum in the others; 1 patient had abnormal gyration and another had abnormal myelination. Neuropathologic examination of 1 child showed a reduction in cerebral white matter volume, gliosis, and decreased myelination, but preserved axonal density. In the Caucasian family (GB31), the mother had a history of recurrent pregnancy loss, often associated with neural tube defects]	L1	y	y	lethal	lethal	lethal	L1	L1	pre-infant-lethal
617804	NEURODEVELOPMENTAL DISORDER WITH VARIABLE MOTOR AND LANGUAGE IMPAIRMENT	Neurodevelopmental disorder with variable motor and speech impairment, 617804 (3)	Neurodevelopmental disorder with variable motor and speech impairment	y	NEURODEVELOPMENTAL DISORDER WITH VARIABLE MOTOR AND LANGUAGE IMPAIRMENT; NEDMIAL	Clinical Features|Phenotype	died|lethal	DHX30	HGNC:16716	Neurodevelopmental disorder with variable motor and speech impairment, 617804 (3), Autosomal dominant	Autosomal dominant	y	n	-	-	-	-	ambiguous	ambiguous	ambiguous	-	-	-
617805	RENAL HYPODYSPLASIA/APLASIA 3	Renal hypodysplasia/aplasia 3, 617805 (3)	Renal hypodysplasia/aplasia 3	y	RENAL HYPODYSPLASIA/APLASIA 3; RHDA3	Description|Clinical Features|Clinical Synopsis	fatal|died|death|deaths	GREB1L	HGNC:31042	Renal hypodysplasia/aplasia 3, 617805 (3), Autosomal dominant	Autosomal dominant	y	y	[Death in utero or in the perinatal period may occur]	L1	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L1	L1	pre-infant-lethal
617807	NEURODEVELOPMENTAL DISORDER WITH ATAXIC GAIT, ABSENT SPEECH, AND DECREASED CORTICAL WHITE MATTER	Neurodevelopmental disorder with ataxic gait, absent speech, and decreased cortical white matter, 617807 (3)	Neurodevelopmental disorder with ataxic gait, absent speech, and decreased cortical white matter	n	-	-	-	RAB11B	HGNC:9761	Neurodevelopmental disorder with ataxic gait, absent speech, and decreased cortical white matter, 617807 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
617808	COFFIN-SIRIS SYNDROME 6	Coffin-Siris syndrome 6, 617808 (3)	Coffin-Siris syndrome 6	n	-	-	-	ARID2	HGNC:18037	Coffin-Siris syndrome 6, 617808 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
617809	GELEOPHYSIC DYSPLASIA 3	Geleophysic dysplasia 3, 617809 (3)	Geleophysic dysplasia 3	y	GELEOPHYSIC DYSPLASIA 3; GPHYSD3	Clinical Features|Clinical Synopsis	died|death|deaths	LTBP3	HGNC:6716	Geleophysic dysplasia 3, 617809 (3), Autosomal dominant	Autosomal dominant	n	y	[cInerney-Leo et al. (2016) studied a mother (SKDP-4.2) and 2 sons (SKDP-4.4 and SKDP-4.3) who had short stature, brachydactyly, restricted movements in the elbow and wrist joints, and dysmorphic facial features including round face, full cheeks, well-defined eyebrows, bulbous nose, anteverted nares, and thick lips... Both boys developed alveolointerstitial pneumonia and died of respiratory failure, at age 4 years and age 18 months, respectively]	L4	y	-	lethal	ambiguous|lethal	lethal	L4	L4	post-infant-lethal
617810	GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 15	Glycosylphosphatidylinositol biosynthesis defect 15, 617810 (3)	Glycosylphosphatidylinositol biosynthesis defect 15	n	-	-	-	GPAA1	HGNC:4446	Glycosylphosphatidylinositol biosynthesis defect 15, 617810 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
617816	GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 16	Glycosylphosphatidylinositol biosynthesis defect 16, 617816 (3)	Glycosylphosphatidylinositol biosynthesis defect 16	n	-	-	-	PIGC	HGNC:8960	Glycosylphosphatidylinositol biosynthesis defect 16, 617816 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
617820	NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL RECESSIVE	Neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal recessive, 617820 (3)	Neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal recessive	n	-	-	-	GRIN1	HGNC:4584	Neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal recessive, 617820 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L2	L2	pre-infant-lethal
617821	EHLERS-DANLOS SYNDROME, ARTHROCHALASIA TYPE, 2	Ehlers-Danlos syndrome, arthrochalasia type, 2, 617821 (3)	Ehlers-Danlos syndrome, arthrochalasia type, 2	n	-	-	-	COL1A2	HGNC:2198	Ehlers-Danlos syndrome, arthrochalasia type, 2, 617821 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	ambiguous|lethal|nonlethal	lethal|nonlethal	L2|L4|L5	L2	pre-infant-lethal
617822	ALKURAYA-KUCINSKAS SYNDROME	Alkuraya-Kucinskas syndrome, 617822 (3)	Alkuraya-Kucinskas syndrome	y	ALKURAYA-KUCINSKAS SYNDROME; ALKKUCS	Description|Clinical Features|Clinical Synopsis	die|died|miscarriage|miscarriages	BLTP1	HGNC:26953	Alkuraya-Kucinskas syndrome, 617822 (3), Autosomal recessive	Autosomal recessive	y	y	[Most affected individuals die in utero or soon after birth]	L1	y	-	lethal	lethal	lethal	L1	L1	pre-infant-lethal
617827	IMMUNODEFICIENCY 55	Immunodeficiency 55, 617827 (3)	Immunodeficiency 55	y	IMMUNODEFICIENCY 55; IMD55	Clinical Features|Phenotype	died|lethal	GINS1	HGNC:28980	Immunodeficiency 55, 617827 (3), Autosomal recessive	Autosomal recessive	n	y	[Bernard et al. (2004) reported 2 French sisters, born of unrelated parents, with NK cell deficiency. The older child died from cytomegalovirus (CMV) infection at age 18 months, whereas the second child remained healthy at age 7 years and had a persistent lack of NK cells with no diagnosed viral infection]	L4	y	-	lethal	lethal	lethal	L4	L4	post-infant-lethal
617829	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 92	Developmental and epileptic encephalopathy 92, 617829 (3)	Developmental and epileptic encephalopathy 92	n	-	-	-	GABRB2	HGNC:4082	Developmental and epileptic encephalopathy 92, 617829 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
617830	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 58	Developmental and epileptic encephalopathy 58, 617830 (3)	Developmental and epileptic encephalopathy 58	n	-	-	-	NTRK2	HGNC:8032	Developmental and epileptic encephalopathy 58, 617830 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
617831	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 55, WITH SEIZURES	Intellectual developmental disorder, autosomal dominant 55, with seizures, 617831 (3)	Intellectual developmental disorder, autosomal dominant 55, with seizures	n	-	-	-	NUS1	HGNC:21042	Intellectual developmental disorder, autosomal dominant 55, with seizures, 617831 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
617836	DEVELOPMENTAL DELAY AND SEIZURES WITH OR WITHOUT MOVEMENT ABNORMALITIES	Developmental delay and seizures with or without movement abnormalities, 617836 (3)	Developmental delay and seizures with or without movement abnormalities	n	-	-	-	DHDDS	HGNC:20603	Developmental delay and seizures with or without movement abnormalities, 617836 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	ambiguous|nonlethal	ambiguous	-	-	-
617839	AMYOTROPHIC LATERAL SCLEROSIS 23	Amyotrophic lateral sclerosis 23, 617839 (3)	Amyotrophic lateral sclerosis 23	n	-	-	-	ANXA11	HGNC:535	Amyotrophic lateral sclerosis 23, 617839 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
617854	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 56	Intellectual developmental disorder, autosomal dominant 56, 617854 (3)	Intellectual developmental disorder, autosomal dominant 56	n	-	-	-	CLTC	HGNC:2092	Intellectual developmental disorder, autosomal dominant 56, 617854 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
617862	NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND BRAIN ATROPHY	Neurodevelopmental disorder with microcephaly, epilepsy, and brain atrophy, 617862 (3)	Neurodevelopmental disorder with microcephaly, epilepsy, and brain atrophy	n	-	-	-	TRAPPC6B	HGNC:23066	Neurodevelopmental disorder with microcephaly, epilepsy, and brain atrophy, 617862 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
617864	NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT SEIZURES AND GAIT ABNORMALITIES	Neurodevelopmental disorder with or without seizures and gait abnormalities, 617864 (3)	Neurodevelopmental disorder with or without seizures and gait abnormalities	n	-	-	-	GRIA4	HGNC:4574	Neurodevelopmental disorder with or without seizures and gait abnormalities, 617864 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
617865	NEURODEVELOPMENTAL DISORDER WITH MOVEMENT ABNORMALITIES, ABNORMAL GAIT, AND AUTISTIC FEATURES	Neurodevelopmental disorder with movement abnormalities, abnormal gait, and autistic features, 617865 (3)	Neurodevelopmental disorder with movement abnormalities, abnormal gait, and autistic features	n	-	-	-	ZSWIM6	HGNC:29316	Neurodevelopmental disorder with movement abnormalities, abnormal gait, and autistic features, 617865 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L2	L2	pre-infant-lethal
617866	SHORT-RIB THORACIC DYSPLASIA 18 WITH POLYDACTYLY	Short-rib thoracic dysplasia 18 with polydactyly, 617866 (3)	Short-rib thoracic dysplasia 18 with polydactyly	y	SHORT-RIB THORACIC DYSPLASIA 18 WITH POLYDACTYLY; SRTD18	Description|Clinical Features	lethal|died	IFT43	HGNC:29669	Short-rib thoracic dysplasia 18 with polydactyly, 617866 (3), Autosomal recessive	Autosomal recessive	y	y	[Some forms of SRTD are lethal in the neonatal period due to respiratory insufficiency secondary to a severely restricted thoracic cage, whereas others are compatible with life (summary by Huber and Cormier-Daire, 2012 and Schmidts et al., 2013) / Duran et al. (2017) reported a family (R06-303) in which a fetus from a dizygotic twin pregnancy showed features of short-rib polydactyly syndrome. Delivery occurred at 30 weeks' gestation and the affected newborn (R06-303A) died the following day]	L2	y	-	lethal	lethal	lethal	L2	L2	pre-infant-lethal
617873	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 35	Combined oxidative phosphorylation deficiency 35, 617873 (3)	Combined oxidative phosphorylation deficiency 35	n	-	-	-	TRIT1	HGNC:20286	Combined oxidative phosphorylation deficiency 35, 617873 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
617874	POLYCYSTIC LIVER DISEASE 3 WITH OR WITHOUT KIDNEY CYSTS	Polycystic liver disease 3 with or without kidney cysts, 617874 (3)	Polycystic liver disease 3 with or without kidney cysts	n	-	-	-	ALG8	HGNC:23161	Polycystic liver disease 3 with or without kidney cysts, 617874 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L3	L3	pre-infant-lethal
617875	POLYCYSTIC LIVER DISEASE 4 WITH OR WITHOUT KIDNEY CYSTS	Polycystic liver disease 4 with or without kidney cysts, 617875 (3)	Polycystic liver disease 4 with or without kidney cysts	n	-	-	-	LRP5	HGNC:6697	Polycystic liver disease 4 with or without kidney cysts, 617875 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
617877	SHORT STATURE, FACIAL DYSMORPHISM, AND SKELETAL ANOMALIES WITH OR WITHOUT CARDIAC ANOMALIES 1	Short stature, facial dysmorphism, and skeletal anomalies with or without cardiac anomalies 1, 617877 (3)	Short stature, facial dysmorphism, and skeletal anomalies with or without cardiac anomalies 1	n	-	-	-	BMP2	HGNC:1069	Short stature, facial dysmorphism, and skeletal anomalies with or without cardiac anomalies 1, 617877 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
617879	LEBER CONGENITAL AMAUROSIS WITH EARLY-ONSET DEAFNESS	Leber congenital amaurosis with early-onset deafness, 617879 (3)	Leber congenital amaurosis with early-onset deafness	n	-	-	-	TUBB4B	HGNC:20771	Leber congenital amaurosis with early-onset deafness, 617879 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
617882	CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE G	Charcot-Marie-Tooth disease, dominant intermediate G, 617882 (3)	Charcot-Marie-Tooth disease, dominant intermediate G	n	-	-	-	NEFL	HGNC:7739	Charcot-Marie-Tooth disease, dominant intermediate G, 617882 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
617883	FANCONI ANEMIA, COMPLEMENTATION GROUP S	Fanconi anemia, complementation group S, 617883 (3)	Fanconi anemia, complementation group S	y	FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS	Clinical Features|Phenotype	death|deaths|fatal|died|lethal	BRCA1	HGNC:1100	Fanconi anemia, complementation group S, 617883 (3), Autosomal recessive	Autosomal recessive	n	y	[Seo et al. (2018) reported 4 children from 2 unrelated consanguineous families (family A of Arab descent and family B of Turkish descent) who were born with multiple congenital anomalies and severe chromosomal fragility. All 4 children had failure to thrive, microcephaly, global developmental delay with impaired intellectual development, microphthalmia, and skin pigmentation lesions. Two sibs in family A had dysmorphic features, including triangular facies, upslanting palpebral fissures, and micrognathia. The 2 sibs in family B had brain gliosis. One child in family A developed fatal T-cell acute lymphoblastic leukemia at age 5, and 1 child in family B developed a neuroblastoma at age 2]	L4	y	-	lethal	lethal	lethal	L4	L4	post-infant-lethal
617895	SHORT-RIB THORACIC DYSPLASIA 19 WITH OR WITHOUT POLYDACTYLY	Short-rib thoracic dysplasia 19 with or without polydactyly, 617895 (3)	Short-rib thoracic dysplasia 19 with or without polydactyly	y	SHORT-RIB THORACIC DYSPLASIA 19 WITH OR WITHOUT POLYDACTYLY; SRTD19	Description|Clinical Features|Clinical Synopsis	lethal|died|death|deaths	IFT81	HGNC:14313	Short-rib thoracic dysplasia 19 with or without polydactyly, 617895 (3), Autosomal recessive	Autosomal recessive	y	y	[Some forms of SRTD are lethal in the neonatal period due to respiratory insufficiency secondary to a severely restricted thoracic cage, whereas others are compatible with life (summary by Huber and Cormier-Daire, 2012 and Schmidts et al., 2013) / Duran et al. (2016) studied 2 unrelated infants with short-rib thoracic dysplasia. The first patient (R98-443) was an African American boy who had dolichocephaly with prominent occiput, midface hypoplasia, handlebar clavicles, short ribs, and short curved appendicular bones, with the upper limbs particularly abnormally shaped. He developed respiratory distress soon after birth which worsened over time, and he died at 19 months of age. The second patient (R13-147A) was a male infant delivered at 35 weeks who died a few minutes after birth from respiratory failure due to severely hypoplastic lungs]	L2	y	-	lethal	lethal	lethal	L2	L2	pre-infant-lethal
617898	MULTIPLE SYNOSTOSES SYNDROME 4	Multiple synostoses syndrome 4, 617898 (3)	Multiple synostoses syndrome 4	n	-	-	-	GDF6	HGNC:4221	Multiple synostoses syndrome 4, 617898 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
617899	LEUKODYSTROPHY, HYPOMYELINATING, 14	Leukodystrophy, hypomyelinating, 14, 617899 (3)	Leukodystrophy, hypomyelinating, 14	y	LEUKODYSTROPHY, HYPOMYELINATING, 14; HLD14	Description|Clinical Features|Clinical Synopsis|Phenotype	die|died|lethal	UFM1	HGNC:20597	Leukodystrophy, hypomyelinating, 14, 617899 (3), Autosomal recessive	Autosomal recessive	n	y	[Hamilton et al. (2017) reported 16 children, aged 3 months to 7 years, with a severe neurodevelopmental disorder. Most of the patients were of Roma descent, suggesting a founder effect. The patients had profound developmental delay, usually without intentional movements or language development, although they were socially aware. Most had spasticity and extrapyramidal movements, mainly dystonia. All patients over 18 months of age developed severe intractable epilepsy. Additional features included microcephaly, poor growth, and respiratory insufficiency, often requiring tracheostomy. The median survival was 2 years: 9 patients died between 7 months and 7 years of age]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
617903	NEURODEVELOPMENTAL DISORDER WITH POOR LANGUAGE AND LOSS OF HAND SKILLS	Neurodevelopmental disorder with poor language and loss of hand skills, 617903 (3)	Neurodevelopmental disorder with poor language and loss of hand skills	n	-	-	-	GABBR2	HGNC:4507	Neurodevelopmental disorder with poor language and loss of hand skills, 617903 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
617904	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 59	Developmental and epileptic encephalopathy 59, 617904 (3)	Developmental and epileptic encephalopathy 59	n	-	-	-	GABBR2	HGNC:4507	Developmental and epileptic encephalopathy 59, 617904 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
617907	ERYTHROCYTOSIS, FAMILIAL, 5	Erythrocytosis, familial, 5, 617907 (3)	Erythrocytosis, familial, 5	n	-	-	-	EPO	HGNC:3415	Erythrocytosis, familial, 5, 617907 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
617912	CONGENITAL HEART DEFECTS, MULTIPLE TYPES, 5	Congenital heart defects, multiple types, 5, 617912 (3)	Congenital heart defects, multiple types, 5	n	-	-	-	GATA5	HGNC:15802	Congenital heart defects, multiple types, 5, 617912 (3), Autosomal dominant, Autosomal recessive	Autosomal dominant, Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
617913	NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, CATARACTS, AND RENAL ABNORMALITIES	Neurodevelopmental disorder with microcephaly, cataracts, and renal abnormalities, 617913 (3)	Neurodevelopmental disorder with microcephaly, cataracts, and renal abnormalities	y	NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, CATARACTS, AND RENAL ABNORMALITIES; NEDMCR	Clinical Features|Clinical Synopsis	died|death|deaths	GEMIN4	HGNC:15717	Neurodevelopmental disorder with microcephaly, cataracts, and renal abnormalities, 617913 (3), Autosomal recessive	Autosomal recessive	y	y	[Death in childhood may occur]	L4	y	-	lethal	lethal	lethal	L4	L4	post-infant-lethal
617914	MICROCEPHALY 20, PRIMARY, AUTOSOMAL RECESSIVE	Microcephaly 20, primary, autosomal recessive, 617914 (3)	Microcephaly 20, primary, autosomal recessive	n	-	-	-	KIF14	HGNC:19181	Microcephaly 20, primary, autosomal recessive, 617914 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
617915	HYPOTONIA, ATAXIA, DEVELOPMENTAL DELAY, AND TOOTH ENAMEL DEFECT SYNDROME	Hypotonia, ataxia, developmental delay, and tooth enamel defect syndrome, 617915 (3)	Hypotonia, ataxia, developmental delay, and tooth enamel defect syndrome	n	-	-	-	CTBP1	HGNC:2494	Hypotonia, ataxia, developmental delay, and tooth enamel defect syndrome, 617915 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
617920	AMYLOIDOSIS, PRIMARY LOCALIZED CUTANEOUS, 3	Amyloidosis, primary localized cutaneous, 3, 617920 (3)	Amyloidosis, primary localized cutaneous, 3	n	-	-	-	GPNMB	HGNC:4462	Amyloidosis, primary localized cutaneous, 3, 617920 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
617928	KERATOCONUS 9	Keratoconus 9, 617928 (3)	Keratoconus 9	n	-	-	-	TUBA3D	HGNC:24071	Keratoconus 9, 617928 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
617929	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 60	Developmental and epileptic encephalopathy 60, 617929 (3)	Developmental and epileptic encephalopathy 60	y	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 60; DEE60	Clinical Features	died	CNPY3	HGNC:11968	Developmental and epileptic encephalopathy 60, 617929 (3), Autosomal recessive	Autosomal recessive	y	y	[Mutoh et al. (2018) reported 3 patients from 2 unrelated Japanese families with developmental and epileptic encephalopathy, who were clinically diagnosed with West syndrome. The patients presented in the first months of life with myoclonic epilepsy, infantile spasms, and other seizure types associated with hypsarrhythmia on EEG. Two sibs later showed diffuse sharp- and slow-wave complexes on EEG, and the third patient had suppression-burst patterns. The seizures were initially partially controllable in the 2 sibs, but later became intractable. At ages 12 and 13 years, the sibs were bedridden with spastic quadriplegia and inability to roll over, and they had profound intellectual disability with absent speech and no communication. The third patient had refractory seizures and was severely disabled; he died at age 13 months]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
617931	SPINOCEREBELLAR ATAXIA 47	Spinocerebellar ataxia 47, 617931 (3)	Spinocerebellar ataxia 47	n	-	-	-	PUM1	HGNC:14957	Spinocerebellar ataxia 47, 617931 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
617933	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 61	Developmental and epileptic encephalopathy 61, 617933 (3)	Developmental and epileptic encephalopathy 61	n	-	-	-	ADAM22	HGNC:201	Developmental and epileptic encephalopathy 61, 617933 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
617935	EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 4	Epilepsy, familial focal, with variable foci 4, 617935 (3)	Epilepsy, familial focal, with variable foci 4	n	-	-	-	SCN3A	HGNC:10590	Epilepsy, familial focal, with variable foci 4, 617935 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
617936	BUTYRYLCHOLINESTERASE DEFICIENCY	Butyrylcholinesterase deficiency, 617936 (3)	Butyrylcholinesterase deficiency	n	-	-	-	BCHE	HGNC:983	Butyrylcholinesterase deficiency, 617936 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
617938	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 62	Developmental and epileptic encephalopathy 62, 617938 (3)	Developmental and epileptic encephalopathy 62	n	-	-	-	SCN3A	HGNC:10590	Developmental and epileptic encephalopathy 62, 617938 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
617941	SHWACHMAN-DIAMOND SYNDROME 2	Shwachman-Diamond syndrome 2, 617941 (3)	Shwachman-Diamond syndrome 2	y	SHWACHMAN-DIAMOND SYNDROME 2; SDS2	Clinical Features|Clinical Synopsis	died|die	EFL1	HGNC:25789	Shwachman-Diamond syndrome 2, 617941 (3), Autosomal recessive	Autosomal recessive	y	y	[Stepensky et al. (2017) reported a 6-year-old Mexican boy and his 4-year-old sister (family A) who had short stature, mild global developmental delay, severe myopia, exocrine pancreatic insufficiency, and bilateral genu varum... Two of the sibs and the unrelated girl died between 7 months and 15 months of age, whereas the remaining sib, who received pancreatic enzyme replacement from early infancy, was alive at age 15 months]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
617948	ELLIPTOCYTOSIS 3	Anemia, neonatal hemolytic, fatal or near-fatal, 617948 (3)	Anemia, neonatal hemolytic, fatal or near-fatal	y	ELLIPTOCYTOSIS 3; EL3	Clinical Features|Phenotype	died|fatal|fetal_loss|fetal_losses	SPTB	HGNC:11274	Anemia, neonatal hemolytic, fatal or near-fatal, 617948 (3)	-	y	y	[Gallagher et al. (1995) studied a Laotian kindred in which 4 third-trimester fetal losses occurred, associated with severe Coombs-negative hemolytic anemia and extensive extramedullary erythropoiesis]	L1	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L1	L1	pre-infant-lethal
617948	ELLIPTOCYTOSIS 3	Elliptocytosis-3, 617948 (3)	Elliptocytosis-3	y	ELLIPTOCYTOSIS 3; EL3	Clinical Features|Phenotype	died|fatal|fetal_loss|fetal_losses	SPTB	HGNC:11274	Elliptocytosis-3, 617948 (3)	-	y	y	[Gallagher et al. (1995) studied a Laotian kindred in which 4 third-trimester fetal losses occurred, associated with severe Coombs-negative hemolytic anemia and extensive extramedullary erythropoiesis]	L1	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L1	L1	pre-infant-lethal
617950	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 36	Combined oxidative phosphorylation deficiency 36, 617950 (3)	Combined oxidative phosphorylation deficiency 36	n	-	-	-	MRPS2	HGNC:14495	Combined oxidative phosphorylation deficiency 36, 617950 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
617951	LEUKODYSTROPHY, HYPOMYELINATING, 15	Leukodystrophy, hypomyelinating, 15, 617951 (3)	Leukodystrophy, hypomyelinating, 15	y	LEUKODYSTROPHY, HYPOMYELINATING, 15; HLD15	Clinical Features	died	EPRS1	HGNC:3418	Leukodystrophy, hypomyelinating, 15, 617951 (3), Autosomal recessive	Autosomal recessive	y	y	[Mendes et al. (2018) reported 4 unrelated patients with HLD15... She died at age 9 years due to pneumonia. The other patient showed motor regression with signs of upper motor neuron involvement, ataxia, dystonia, and athetoid movements around 2 years of age. She had episodic regression with febrile illnesses and later showed cognitive regression with sensorineural hearing loss, short stature, severe dysphagia necessitating a feeding tube, and optic atrophy. A similarly affected older sister had died at age 3 years]	L4	y	-	lethal	lethal	lethal	L4	L4	post-infant-lethal
617952	OSTEOGENESIS IMPERFECTA, TYPE XVIII	Osteogenesis imperfecta, type XVIII, 617952 (3)	Osteogenesis imperfecta, type XVIII	y	OSTEOGENESIS IMPERFECTA, TYPE XVIII; OI18	Clinical Features	died	TENT5A	HGNC:18345	Osteogenesis imperfecta, type XVIII, 617952 (3), Autosomal recessive	Autosomal recessive	y	y	[Doyard et al. (2018) reported 2 sibs and 2 unrelated patients with osteogenesis imperfecta and mutations in the FAM46A gene... He died suddenly and inexplicably at 4 years of age]	L4	y	-	lethal	lethal	lethal	L4	L4	post-infant-lethal
617954	MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 6	Multiple mitochondrial dysfunctions syndrome 6, 617954 (3)	Multiple mitochondrial dysfunctions syndrome 6	y	MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 6; MMDS6	Description|Clinical Features|Clinical Synopsis	die|died|death|deaths	PMPCB	HGNC:9119	Multiple mitochondrial dysfunctions syndrome 6, 617954 (3), Autosomal recessive	Autosomal recessive	n	y	[Vogtle et al. (2018) reported 5 children from 4 unrelated families with an early-onset neurodegenerative disorder. Two patients were alive at ages 5 and 6 years, and 3 died at ages 5 and 6 years]	L4	y	-	lethal	lethal	lethal	L4	L4	post-infant-lethal
617959	SPERMATOGENIC FAILURE 24	Spermatogenic failure 24, 617959 (3)	Spermatogenic failure 24	n	-	-	-	CFAP69	HGNC:26107	Spermatogenic failure 24, 617959 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
617960	SPERMATOGENIC FAILURE 25	Spermatogenic failure 25, 617960 (3)	Spermatogenic failure 25	n	-	-	-	TEX15	HGNC:11738	Spermatogenic failure 25, 617960 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
617964	LEUKODYSTROPHY, HYPOMYELINATING, 16	Leukodystrophy, hypomyelinating, 16, 617964 (3)	Leukodystrophy, hypomyelinating, 16	n	-	-	-	TMEM106B	HGNC:22407	Leukodystrophy, hypomyelinating, 16, 617964 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
617967	HYDROCEPHALUS, CONGENITAL, 3, WITH BRAIN ANOMALIES	Hydrocephalus, congenital, 3, with brain anomalies, 617967 (3)	Hydrocephalus, congenital, 3, with brain anomalies	y	HYDROCEPHALUS, CONGENITAL, 3, WITH BRAIN ANOMALIES; HYC3	Clinical Features|Clinical Synopsis	died|stillbirth|stillbirths|die	WDR81	HGNC:26600	Hydrocephalus, congenital, 3, with brain anomalies, 617967 (3), Autosomal recessive	Autosomal recessive	n	y	[Most patient die in utero or shortly after birth]	L1	y	-	lethal	lethal	lethal	L1|L2	L1	pre-infant-lethal
617970	RH-NULL, AMORPH TYPE	Rh-null disease, amorph type, 617970 (3)	Rh-null disease, amorph type	y	RH-NULL, AMORPH TYPE; RHNA	Clinical Features	died|stillbirth|stillbirths	RHCE	HGNC:10008	Rh-null disease, amorph type, 617970 (3), Autosomal recessive	Autosomal recessive	y	n	-	-	-	-	ambiguous	ambiguous	ambiguous	-	-	-
617971	METHEMOGLOBINEMIA, BETA TYPE	Methemoglobinemia, beta type, 617971 (3)	Methemoglobinemia, beta type	n	-	-	-	HBB	HGNC:4827	Methemoglobinemia, beta type, 617971 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	ambiguous|lethal|nonlethal	lethal|nonlethal	L3|L6	L3	pre-infant-lethal
617973	METHEMOGLOBINEMIA, ALPHA TYPE	Methemoglobinemia, alpha type, 617973 (3)	Methemoglobinemia, alpha type	n	-	-	-	HBA1	HGNC:4823	Methemoglobinemia, alpha type, 617973 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L1	L1	pre-infant-lethal
617974	SPONDYLOEPIMETAPHYSEAL DYSPLASIA, DI ROCCO TYPE	Spondyloepimetaphyseal dysplasia, Di Rocco type, 617974 (3)	Spondyloepimetaphyseal dysplasia, Di Rocco type	n	-	-	-	UFSP2	HGNC:25640	Spondyloepimetaphyseal dysplasia, Di Rocco type, 617974 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
617976	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 63	Developmental and epileptic encephalopathy 63, 617976 (3)	Developmental and epileptic encephalopathy 63	y	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 63; DEE63	Clinical Features	died	CPLX1	HGNC:2309	Developmental and epileptic encephalopathy 63, 617976 (3), Autosomal recessive	Autosomal recessive	y	y	[Redler et al. (2017) reported 3 patients from 2 unrelated consanguineous families with DEE63. The patients presented with seizures in the first weeks or months of life. The seizures, which manifested predominantly as migrating or progressive myoclonic epilepsy, but also included tonic and generalized seizures, were refractory to medication and occurred up to 100 times a day. EEG showed hyperexcitability with generalized spikes. Two Lebanese sisters had no meaningful development, were hypotonic, and were unable to sit, walk, crawl, or speak; 1 died at age 8 years]	L4	y	-	lethal	lethal	lethal	L4	L4	post-infant-lethal
617977	NEURODEVELOPMENTAL DISORDER WITH SPASTIC QUADRIPLEGIA AND BRAIN ABNORMALITIES WITH OR WITHOUT SEIZURES	Neurodevelopmental disorder with spastic quadriplegia and brain abnormalities with or without seizures, 617977 (3)	Neurodevelopmental disorder with spastic quadriplegia and brain abnormalities with or without seizures	n	-	-	-	WDR45B	HGNC:25072	Neurodevelopmental disorder with spastic quadriplegia and brain abnormalities with or without seizures, 617977 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
617980	ERYTHROCYTOSIS, FAMILIAL, 6	Erythrocytosis, familial, 6, 617980 (3)	Erythrocytosis, familial, 6	n	-	-	-	HBB	HGNC:4827	Erythrocytosis, familial, 6, 617980 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	ambiguous|lethal|nonlethal	lethal|nonlethal	L3|L6	L3	pre-infant-lethal
617981	ERYTHROCYTOSIS, FAMILIAL, 7	Erythrocytosis, familial, 7, 617981 (3)	Erythrocytosis, familial, 7	n	-	-	-	HBA1	HGNC:4823	Erythrocytosis, familial, 7, 617981 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L1	L1	pre-infant-lethal
617981	ERYTHROCYTOSIS, FAMILIAL, 7	Erythrocytosis, familial, 7, 617981 (3)	Erythrocytosis, familial, 7	n	-	-	-	HBA2	HGNC:4824	Erythrocytosis, familial, 7, 617981 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L1	L1	pre-infant-lethal
617982	VERVERI-BRADY SYNDROME	Ververi-Brady syndrome, 617982 (3)	Ververi-Brady syndrome	y	VERVERI-BRADY SYNDROME; VERBRAS	Clinical Features	died	QRICH1	HGNC:24713	Ververi-Brady syndrome, 617982 (3), Autosomal dominant	Autosomal dominant	y	n	-	-	-	-	ambiguous	ambiguous	ambiguous	-	-	-
617984	MICROCEPHALY 22, PRIMARY, AUTOSOMAL RECESSIVE	Microcephaly 22, primary, autosomal recessive, 617984 (3)	Microcephaly 22, primary, autosomal recessive	y	MICROCEPHALY 22, PRIMARY, AUTOSOMAL RECESSIVE; MCPH22	Clinical Features	death|deaths	NCAPD3	HGNC:28952	Microcephaly 22, primary, autosomal recessive, 617984 (3), Autosomal recessive	Autosomal recessive	n	y	Martin et al. (2016) reported 2 unrelated boys with primary microcephaly. One patient (P2) was a 6-year-old boy with short stature (-5.7 SD) and microcephaly (-5.4 SD). He had normal development, but later developed a malignant anaplastic medulloblastoma resulting in death at age 11 years]	L5	y	-	lethal	lethal	lethal	L5	L5	post-infant-lethal
617988	JABERI-ELAHI SYNDROME	Jaberi-Elahi syndrome, 617988 (3)	Jaberi-Elahi syndrome	y	JABERI-ELAHI SYNDROME; JABELS	Clinical Features	died	GTPBP2	HGNC:4670	Jaberi-Elahi syndrome, 617988 (3), Autosomal recessive	Autosomal recessive	y	y	[Jaberi et al. (2016) reported a consanguineous Iranian family (DS-100) in which 4 adult sibs had a neurodevelopmental disorder with onset in infancy. All had delayed psychomotor development with mildly delayed walking, delayed speech, intellectual disability (IQ of 40 to 50), and behavioral abnormalities. One of the patients died at age 21 years]	L6	y	-	lethal	lethal	lethal	L6	L6	post-infant-lethal
617991	CHUNG-JANSEN SYNDROME	Chung-Jansen syndrome, 617991 (3)	Chung-Jansen syndrome	n	-	-	-	PHIP	HGNC:15673	Chung-Jansen syndrome, 617991 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
617993	TUMORAL CALCINOSIS, HYPERPHOSPHATEMIC, FAMILIAL, 2	Tumoral calcinosis, hyperphosphatemic, familial, 2, 617993 (3)	Tumoral calcinosis, hyperphosphatemic, familial, 2	n	-	-	-	FGF23	HGNC:3680	Tumoral calcinosis, hyperphosphatemic, familial, 2, 617993 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
617996	OOCYTE/ZYGOTE/EMBRYO MATURATION ARREST 5	Oocyte/zygote/embryo maturation arrest 5, 617996 (3)	Oocyte/zygote/embryo maturation arrest 5	n	-	-	-	WEE2	HGNC:19684	Oocyte/zygote/embryo maturation arrest 5, 617996 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
618000	EHLERS-DANLOS SYNDROME, CLASSIC-LIKE, 2	Ehlers-Danlos syndrome, classic-like, 2, 618000 (3)	Ehlers-Danlos syndrome, classic-like, 2	n	-	-	-	AEBP1	HGNC:303	Ehlers-Danlos syndrome, classic-like, 2, 618000 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
618003	DEAFNESS, AUTOSOMAL RECESSIVE 57	Deafness, autosomal recessive 57, 618003 (3)	Deafness, autosomal recessive 57	n	-	-	-	PDZD7	HGNC:26257	Deafness, autosomal recessive 57, 618003 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
618004	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 64	Developmental and epileptic encephalopathy 64, 618004 (3)	Developmental and epileptic encephalopathy 64	n	-	-	-	RHOBTB2	HGNC:18756	Developmental and epileptic encephalopathy 64, 618004 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
618005	CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 1	Congenital disorder of glycosylation with defective fucosylation 1, 618005 (3)	Congenital disorder of glycosylation with defective fucosylation 1	y	CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 1; CDGF1	Clinical Features	died	FUT8	HGNC:4019	Congenital disorder of glycosylation with defective fucosylation 1, 618005 (3), Autosomal recessive	Autosomal recessive	y	y	[Ng et al. (2018) reported 3 unrelated children with a complex multisystem disorder apparent from birth. Two of the pregnancies were complicated by polyhydramnios, and all infants showed intrauterine growth retardation with microcephaly. The neonatal period was characterized by feeding difficulties, requiring G-tube placement in 2 patients, failure to thrive, hypotonia, and respiratory problems. All had short stature with short limbs, and 1 also had contractures, osteopenia, dislocated hips, and kyphoscoliosis. The patients had severe global developmental delay, intellectual disability, and seizures. All had variable dysmorphic features, such as broad forehead, bitemporal narrowing, buphthalmos, broad nasal bridge, high palate, short nose, retrognathia, and hirsutism, but there was no consistent appearance. Additional features were highly variable: 1 patient had a 2-vessel cord, hypothyroidism, an atrial septal defect, nephrocalcinosis, and congenital neutropenia, and another had hypoglycemia, congenital glaucoma, and onset of seizures in the neonatal period. One patient died at age 7 years; this patient had a similarly affected deceased older sib]	L4	y	-	lethal	lethal	lethal	L4	L4	post-infant-lethal
618006	LEUKODYSTROPHY, HYPOMYELINATING, 17	Leukodystrophy, hypomyelinating, 17, 618006 (3)	Leukodystrophy, hypomyelinating, 17	y	LEUKODYSTROPHY, HYPOMYELINATING, 17; HLD17	Description|Clinical Features|Clinical Synopsis	die|died|spontaneous_abortion|spontaneous_abortions|stillbirth|stillbirths|death|deaths	AIMP2	HGNC:20609	Leukodystrophy, hypomyelinating, 17, 618006 (3), Autosomal recessive	Autosomal recessive	n	y	[Shukla et al. (2018) reported 4 children from 2 unrelated consanguineous families of Indian descent with a profound neurodevelopmental disorder apparent from early infancy. The patients were unable to walk or speak, and achieved virtually no development milestones. They had microcephaly (-10 SD), spasticity with hyperreflexia, early-onset multifocal intractable seizures, and feeding difficulties with poor overall growth. Two older patients had kyphoscoliosis and contractures and variable dysmorphic features, including thick vermilion of lips, low hanging columella, gum hypertrophy, prognathism, widely spaced teeth, anteverted nostrils, and hirsutism. EEG showed major abnormalities, including multifocal spike wave discharges and hypsarrhythmia. Brain imaging showed cerebral and cerebellar atrophy, thin corpus callosum, spinal cord atrophy, T2-weighted hypointensities in the basal ganglia, and paucity of white matter, suggestive of demyelination. In the first family, 1 affected sib died at age 6 months due to intractable seizures, and the couple had an additional history of stillbirth, spontaneous abortion, and 3 medically-induced termination of pregnancies. In the second family, 1 of the affected sibs died at age 7 years]	L1	y	y	lethal	lethal	lethal	L1	L1	pre-infant-lethal
618008	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 65	Developmental and epileptic encephalopathy 65, 618008 (3)	Developmental and epileptic encephalopathy 65	n	-	-	-	CYFIP2	HGNC:13760	Developmental and epileptic encephalopathy 65, 618008 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
618009	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 61	Intellectual developmental disorder, autosomal dominant 61, 618009 (3)	Intellectual developmental disorder, autosomal dominant 61	n	-	-	-	MED13	HGNC:22474	Intellectual developmental disorder, autosomal dominant 61, 618009 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
618010	GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 17	Glycosylphosphatidylinositol biosynthesis defect 17, 618010 (3)	Glycosylphosphatidylinositol biosynthesis defect 17	n	-	-	-	PIGH	HGNC:8964	Glycosylphosphatidylinositol biosynthesis defect 17, 618010 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
618011	HYPEREKPLEXIA 4	Hyperekplexia 4, 618011 (3)	Hyperekplexia 4	y	HYPEREKPLEXIA 4; HKPX4	Description|Clinical Features|Clinical Synopsis	die|death|deaths|died	ATAD1	HGNC:25903	Hyperekplexia 4, 618011 (3), Autosomal recessive	Autosomal recessive	y	y	[Piard et al. (2018) reported 3 sibs, born of consanguineous Tunisian parents, with HKPX4. The patients presented at birth with respiratory distress necessitating assisted ventilation... The patients also had umbilical or inguinal hernias. All died between 3 and 6 months of age]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
618012	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 93	Developmental and epileptic encephalopathy 93, 618012 (3)	Developmental and epileptic encephalopathy 93	n	-	-	-	ATP6V1A	HGNC:851	Developmental and epileptic encephalopathy 93, 618012 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	LU	LU	post-infant-lethal
618019	RHIZOMELIC SKELETAL DYSPLASIA WITH OR WITHOUT PELGER-HUET ANOMALY	Rhizomelic skeletal dysplasia with or without Pelger-Huet anomaly, 618019 (3)	Rhizomelic skeletal dysplasia with or without Pelger-Huet anomaly	y	RHIZOMELIC SKELETAL DYSPLASIA WITH OR WITHOUT PELGER-HUET ANOMALY; SKPHA	Clinical Features|Phenotype	lethality|died|lethal	LBR	HGNC:6518	Rhizomelic skeletal dysplasia with or without Pelger-Huet anomaly, 618019 (3), Autosomal recessive	Autosomal recessive	y	n	-	-	-	-	ambiguous	ambiguous|lethal|nonlethal	lethal|nonlethal	L1	L1	pre-infant-lethal
618021	TETRAAMELIA SYNDROME 2	Tetraamelia syndrome 2, 618021 (3)	Tetraamelia syndrome 2	n	-	-	-	RSPO2	HGNC:28583	Tetraamelia syndrome 2, 618021 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
618027	COFFIN-SIRIS SYNDROME 7	Coffin-Siris syndrome 7, 618027 (3)	Coffin-Siris syndrome 7	n	-	-	-	DPF2	HGNC:9964	Coffin-Siris syndrome 7, 618027 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
618031	CORNEAL DYSTROPHY, POSTERIOR POLYMORPHOUS, 4	Corneal dystrophy, posterior polymorphous, 4, 618031 (3)	Corneal dystrophy, posterior polymorphous, 4	n	-	-	-	GRHL2	HGNC:2799	Corneal dystrophy, posterior polymorphous, 4, 618031 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
618036	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2DD	Charcot-Marie-Tooth disease, axonal, type 2DD, 618036 (3)	Charcot-Marie-Tooth disease, axonal, type 2DD	n	-	-	-	ATP1A1	HGNC:799	Charcot-Marie-Tooth disease, axonal, type 2DD, 618036 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
618042	IMMUNODEFICIENCY 100 WITH PULMONARY ALVEOLAR PROTEINOSIS AND HYPOGAMMAGLOBULINEMIA	Immunodeficiency 100 with pulmonary alveolar proteinosis and hypogammaglobulinemia, 618042 (3)	Immunodeficiency 100 with pulmonary alveolar proteinosis and hypogammaglobulinemia	y	IMMUNODEFICIENCY 100 WITH PULMONARY ALVEOLAR PROTEINOSIS AND HYPOGAMMAGLOBULINEMIA; IMD100	Description|Clinical Features|Clinical Synopsis	die|death|deaths|died	OAS1	HGNC:8086	Immunodeficiency 100 with pulmonary alveolar proteinosis and hypogammaglobulinemia, 618042 (3), Autosomal dominant	Autosomal dominant	y	y	[Many patients die of respiratory failure in infancy or early childhood]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
618048	PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 2	Proteasome-associated autoinflammatory syndrome 2, 618048 (3)	Proteasome-associated autoinflammatory syndrome 2	n	-	-	-	POMP	HGNC:20330	Proteasome-associated autoinflammatory syndrome 2, 618048 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
618050	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 57	Intellectual developmental disorder, autosomal dominant 57, 618050 (3)	Intellectual developmental disorder, autosomal dominant 57	n	-	-	-	TLK2	HGNC:11842	Intellectual developmental disorder, autosomal dominant 57, 618050 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
618052	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 27	Cardiomyopathy, familial hypertrophic 27, 618052 (3)	Cardiomyopathy, familial hypertrophic 27	y	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 27; CMH27	Clinical Features|Clinical Synopsis	died|death|deaths|fatal	ALPK3	HGNC:17574	Cardiomyopathy, familial hypertrophic 27, 618052 (3), Autosomal recessive	Autosomal recessive	y	y	[Death in utero or shortly after birth (in some patients)]	L1	y	-	lethal	lethal	lethal	L1	L1	pre-infant-lethal
618056	NEURODEVELOPMENTAL DISORDER WITH CEREBELLAR ATROPHY AND WITH OR WITHOUT SEIZURES	Neurodevelopmental disorder with cerebellar atrophy and with or without seizures, 618056 (3)	Neurodevelopmental disorder with cerebellar atrophy and with or without seizures	n	-	-	-	BRAT1	HGNC:21701	Neurodevelopmental disorder with cerebellar atrophy and with or without seizures, 618056 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L3	L3	pre-infant-lethal
618057	DRUG METABOLISM, ALTERED, CES1-RELATED	Drug metabolism, altered, CES1-related, 618057 (3)	Drug metabolism, altered, CES1-related	n	-	-	-	CES1	HGNC:1863	Drug metabolism, altered, CES1-related, 618057 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
618060	INTELLECTUAL DEVELOPMENTAL DISORDER WITH OR WITHOUT EPILEPSY OR CEREBELLAR ATAXIA	Intellectual developmental disorder with or without epilepsy or cerebellar ataxia, 618060 (3)	Intellectual developmental disorder with or without epilepsy or cerebellar ataxia	n	-	-	-	RORA	HGNC:10258	Intellectual developmental disorder with or without epilepsy or cerebellar ataxia, 618060 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
618061	POLYCYSTIC KIDNEY DISEASE 6 WITH OR WITHOUT POLYCYSTIC LIVER DISEASE	Polycystic kidney disease 6 with or without polycystic liver disease, 618061 (3)	Polycystic kidney disease 6 with or without polycystic liver disease	n	-	-	-	DNAJB11	HGNC:14889	Polycystic kidney disease 6 with or without polycystic liver disease, 618061 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
618063	CILIARY DYSKINESIA, PRIMARY, 38	Ciliary dyskinesia, primary, 38, 618063 (3)	Ciliary dyskinesia, primary, 38	n	-	-	-	CFAP300	HGNC:28188	Ciliary dyskinesia, primary, 38, 618063 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
618065	PONTOCEREBELLAR HYPOPLASIA, TYPE 1D	Pontocerebellar hypoplasia, type 1D, 618065 (3)	Pontocerebellar hypoplasia, type 1D	y	PONTOCEREBELLAR HYPOPLASIA, TYPE 1D; PCH1D	Clinical Features|Clinical Synopsis|Phenotype	died|death|deaths	EXOSC9	HGNC:9137	Pontocerebellar hypoplasia, type 1D, 618065 (3), Autosomal recessive	Autosomal recessive	y	y	[Burns et al. (2018) reported 4 unrelated children of various ethnicities under the age of 5 years with severe hypotonia apparent either at birth or in the first months of life... Another child (individual 2) had dysmorphic features, including low-set ears, short neck, hypertelorism, and epicanthal folds, arthrogryposis multiplex congenita, congenital fractures of the long bones, and cerebral atrophy; he died of respiratory failure at age 15 months]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
618067	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 66	Developmental and epileptic encephalopathy 66, 618067 (3)	Developmental and epileptic encephalopathy 66	n	-	-	-	PACS2	HGNC:23794	Developmental and epileptic encephalopathy 66, 618067 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
618076	NEURODEVELOPMENTAL DISORDER WITH SPASTICITY AND POOR GROWTH	Neurodevelopmental disorder with spasticity and poor growth, 618076 (3)	Neurodevelopmental disorder with spasticity and poor growth	y	NEURODEVELOPMENTAL DISORDER WITH SPASTICITY AND POOR GROWTH; NEDSG	Phenotype	lethal	UFC1	HGNC:26941	Neurodevelopmental disorder with spasticity and poor growth, 618076 (3), Autosomal recessive	Autosomal recessive	n	n	-	-	-	-	ambiguous	ambiguous	ambiguous	-	-	-
618084	PEELING SKIN SYNDROME 6	Peeling skin syndrome 6, 618084 (3)	Peeling skin syndrome 6	n	-	-	-	FLG2	HGNC:33276	Peeling skin syndrome 6, 618084 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
618086	SPERMATOGENIC FAILURE 28	Spermatogenic failure 28, 618086 (3)	Spermatogenic failure 28	n	-	-	-	FANCM	HGNC:23168	Spermatogenic failure 28, 618086 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
618087	SPINOCEREBELLAR ATAXIA 42, EARLY-ONSET, SEVERE, WITH NEURODEVELOPMENTAL DEFICITS	Spinocerebellar ataxia 42, early-onset, severe, with neurodevelopmental deficits, 618087 (3)	Spinocerebellar ataxia 42, early-onset, severe, with neurodevelopmental deficits	n	-	-	-	CACNA1G	HGNC:1394	Spinocerebellar ataxia 42, early-onset, severe, with neurodevelopmental deficits, 618087 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
618088	NEURODEVELOPMENTAL DISORDER WITH REGRESSION, ABNORMAL MOVEMENTS, LOSS OF SPEECH, AND SEIZURES	Neurodevelopmental disorder with regression, abnormal movements, loss of speech, and seizures, 618088 (3)	Neurodevelopmental disorder with regression, abnormal movements, loss of speech, and seizures	y	NEURODEVELOPMENTAL DISORDER WITH REGRESSION, ABNORMAL MOVEMENTS, LOSS OF SPEECH, AND SEIZURES; NEDAMSS	Clinical Features|Phenotype	died|lethality	IRF2BPL	HGNC:14282	Neurodevelopmental disorder with regression, abnormal movements, loss of speech, and seizures, 618088 (3), Autosomal dominant	Autosomal dominant	y	y	[Marcogliese et al. (2018) reported 7 unrelated patients, ranging in age from 2.5 to 43 years, with a neurodevelopmental disorder....One patient died at age 15 years due to feeding intolerance]	L5	y	-	lethal	lethal	lethal	L5	L5	post-infant-lethal
618089	INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND BEHAVIORAL ABNORMALITIES	Intellectual developmental disorder with dysmorphic facies and behavioral abnormalities, 618089 (3)	Intellectual developmental disorder with dysmorphic facies and behavioral abnormalities	n	-	-	-	FBXO11	HGNC:13590	Intellectual developmental disorder with dysmorphic facies and behavioral abnormalities, 618089 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
618090	NEURODEVELOPMENTAL DISORDER WITH EPILEPSY AND HYPOPLASIA OF THE CORPUS CALLOSUM	Neurodevelopmental disorder with epilepsy and hypoplasia of the corpus callosum, 618090 (3)	Neurodevelopmental disorder with epilepsy and hypoplasia of the corpus callosum	n	-	-	-	LNPK	HGNC:21610	Neurodevelopmental disorder with epilepsy and hypoplasia of the corpus callosum, 618090 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
618092	INTELLECTUAL DEVELOPMENTAL DISORDER WITH SPEECH DELAY, DYSMORPHIC FACIES, AND T-CELL ABNORMALITIES	Intellectual developmental disorder with dysmorphic facies, speech delay, and T-cell abnormalities, 618092 (3)	Intellectual developmental disorder with dysmorphic facies, speech delay, and T-cell abnormalities	n	-	-	-	BCL11B	HGNC:13222	Intellectual developmental disorder with dysmorphic facies, speech delay, and T-cell abnormalities, 618092 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
618093	SPINOCEREBELLAR ATAXIA 48	Spinocerebellar ataxia 48, 618093 (3)	Spinocerebellar ataxia 48	y	SPINOCEREBELLAR ATAXIA 48; SCA48	Clinical Features	died	STUB1	HGNC:11427	Spinocerebellar ataxia 48, 618093 (3), Autosomal dominant	Autosomal dominant	y	y	[Mol et al. (2020) reported a large Dutch kindred in which at least 9 individuals had SCA48. All patients were deceased at the time of the report. The mean age at disease onset was 65.3 years, and patients died after a mean disease duration of 13.2 years]	L6	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L6	L6	post-infant-lethal
618097	MICROCEPHALY, GROWTH RESTRICTION, AND INCREASED SISTER CHROMATID EXCHANGE 2	Microcephaly, growth restriction, and increased sister chromatid exchange 2, 618097 (3)	Microcephaly, growth restriction, and increased sister chromatid exchange 2	y	MICROCEPHALY, GROWTH RESTRICTION, AND INCREASED SISTER CHROMATID EXCHANGE 2; MGRISCE2	Clinical Features	died	TOP3A	HGNC:11992	Microcephaly, growth restriction, and increased sister chromatid exchange 2, 618097 (3), Autosomal recessive	Autosomal recessive	n	y	[Martin et al. (2018) reported 10 patients from 7 unrelated families with growth failure. The patients, who ranged in age from 5 months to 15 years, had intrauterine growth retardation, low birth growth parameters, and poor postnatal growth (weight between -2.7 and -7.5 SD, height between -2.7 to -5.8 SD), as well as microcephaly -2.3 to -5.7 SD. Multiple cafe-au-lait patches were observed in some patients, but none had a malar rash. Several patients had dilated cardiomyopathy, including 2 who died of the heart disease]	LU	y	-	lethal	lethal	lethal	LU	LU	post-infant-lethal
618103	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 64	Intellectual developmental disorder, autosomal recessive 64, 618103 (3)	Intellectual developmental disorder, autosomal recessive 64	n	-	-	-	LINGO1	HGNC:21205	Intellectual developmental disorder, autosomal recessive 64, 618103 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
618106	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 58	Intellectual developmental disorder, autosomal dominant 58, 618106 (3)	Intellectual developmental disorder, autosomal dominant 58	n	-	-	-	SET	HGNC:10760	Intellectual developmental disorder, autosomal dominant 58, 618106 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
618107	OSTEOPETROSIS, AUTOSOMAL DOMINANT 3	Osteopetrosis, autosomal dominant 3, 618107 (3)	Osteopetrosis, autosomal dominant 3	n	-	-	-	PLEKHM1	HGNC:29017	Osteopetrosis, autosomal dominant 3, 618107 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
618108	IMMUNODEFICIENCY 57 WITH AUTOINFLAMMATION	Immunodeficiency 57 with autoinflammation, 618108 (3)	Immunodeficiency 57 with autoinflammation	y	IMMUNODEFICIENCY 57 WITH AUTOINFLAMMATION; IMD57	Clinical Features|Phenotype	died|death|deaths	RIPK1	HGNC:10019	Immunodeficiency 57 with autoinflammation, 618108 (3), Autosomal recessive	Autosomal recessive	y	y	[Cuchet-Lourenco et al. (2018) reported 4 patients from 3 unrelated consanguineous families of Middle Eastern descent with a primary immunodeficiency... The fourth patient (P4), who did not undergo stem cell transplant, was alive and maintained on IVIG. In 1 family, 3 sibs had died of profuse bloody diarrhea between 6 and 12 months of age]	L3	y	-	lethal	ambiguous|lethal	lethal	L3	L3	pre-infant-lethal
618109	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 65	Intellectual developmental disorder, autosomal recessive 65, 618109 (3)	Intellectual developmental disorder, autosomal recessive 65	n	-	-	-	KDM5B	HGNC:18039	Intellectual developmental disorder, autosomal recessive 65, 618109 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
618112	SPERMATOGENIC FAILURE 31	Spermatogenic failure 31, 618112 (3)	Spermatogenic failure 31	n	-	-	-	PMFBP1	HGNC:17728	Spermatogenic failure 31, 618112 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
618113	ENCEPHALITIS/ENCEPHALOPATHY, MILD, WITH REVERSIBLE MYELIN VACUOLIZATION	Encephalitis/encephalopathy, mild, with reversible myelin vacuolization, 618113 (3)	Encephalitis/encephalopathy, mild, with reversible myelin vacuolization	n	-	-	-	MYRF	HGNC:1181	Encephalitis/encephalopathy, mild, with reversible myelin vacuolization, 618113 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L2	L2	pre-infant-lethal
618114	LIDDLE SYNDROME 2	Liddle syndrome 2, 618114 (3)	Liddle syndrome 2	n	-	-	-	SCNN1G	HGNC:10602	Liddle syndrome 2, 618114 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
618115	SPERMATOGENIC FAILURE 32	Spermatogenic failure 32, 618115 (3)	Spermatogenic failure 32	n	-	-	-	SOHLH1	HGNC:27845	Spermatogenic failure 32, 618115 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
618116	BONE MARROW FAILURE SYNDROME 4	Bone marrow failure syndrome 4, 618116 (3)	Bone marrow failure syndrome 4	n	-	-	-	MYSM1	HGNC:29401	Bone marrow failure syndrome 4, 618116 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
618117	OVARIAN DYSGENESIS 7	Ovarian dysgenesis 7, 618117 (3)	Ovarian dysgenesis 7	n	-	-	-	MRPS22	HGNC:14508	Ovarian dysgenesis 7, 618117 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L2	L2	pre-infant-lethal
618120	MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 5	Mitochondrial complex V (ATP synthase) deficiency, 618120 (3)	Mitochondrial complex V (ATP synthase) deficiency	n	-	-	-	ATP5F1D	HGNC:837	Mitochondrial complex V (ATP synthase) deficiency, 618120 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
618123	POLYDACTYLY, POSTAXIAL, TYPE A8	Polydactyly, postaxial, type A8, 618123 (3)	Polydactyly, postaxial, type A8	n	-	-	-	GLI1	HGNC:4317	Polydactyly, postaxial, type A8, 618123 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
618124	PERIPHERAL NEUROPATHY, AUTOSOMAL RECESSIVE, WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT	Peripheral neuropathy, autosomal recessive, with or without impaired intellectual development, 618124 (3)	Peripheral neuropathy, autosomal recessive, with or without impaired intellectual development	n	-	-	-	MCM3AP	HGNC:6946	Peripheral neuropathy, autosomal recessive, with or without impaired intellectual development, 618124 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
618129	MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL DOMINANT 4	Muscular dystrophy, limb-girdle, autosomal dominant 4, 618129 (3)	Muscular dystrophy, limb-girdle, autosomal dominant 4	n	-	-	-	CAPN3	HGNC:1480	Muscular dystrophy, limb-girdle, autosomal dominant 4, 618129 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	LU	LU	post-infant-lethal
618131	IMMUNODEFICIENCY 58	Immunodeficiency 58, 618131 (3)	Immunodeficiency 58	y	IMMUNODEFICIENCY 58; IMD58	Clinical Features	death|deaths|died	CARMIL2	HGNC:27089	Immunodeficiency 58, 618131 (3), Autosomal recessive	Autosomal recessive	n	y	[Wang et al. (2016) reported 6 patients from 3 unrelated families with a similar primary immunodeficiency disorder. ... He died of respiratory distress at age 17 years]	L5	y	-	lethal	lethal	lethal	L5	L5	post-infant-lethal
618135	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 8	Muscular dystrophy-dystroglycanopathy (limb-girdle) type C, 8, 618135 (3)	Muscular dystrophy-dystroglycanopathy (limb-girdle) type C, 8	n	-	-	-	POMGNT2	HGNC:25902	Muscular dystrophy-dystroglycanopathy (limb-girdle) type C, 8, 618135 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L3	L3	pre-infant-lethal
618138	MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 23	Muscular dystrophy, limb-girdle, autosomal recessive 23, 618138 (3)	Muscular dystrophy, limb-girdle, autosomal recessive 23	n	-	-	-	LAMA2	HGNC:6482	Muscular dystrophy, limb-girdle, autosomal recessive 23, 618138 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
618141	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 67	Developmental and epileptic encephalopathy 67, 618141 (3)	Developmental and epileptic encephalopathy 67	n	-	-	-	CUX2	HGNC:19347	Developmental and epileptic encephalopathy 67, 618141 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
618142	MICROCEPHALY, FACIAL DYSMORPHISM, RENAL AGENESIS, AND AMBIGUOUS GENITALIA SYNDROME	Microcephaly, facial dysmorphism, renal agenesis, and ambiguous genitalia syndrome, 618142 (3)	Microcephaly, facial dysmorphism, renal agenesis, and ambiguous genitalia syndrome	y	MICROCEPHALY, FACIAL DYSMORPHISM, RENAL AGENESIS, AND AMBIGUOUS GENITALIA SYNDROME; MFRG	Clinical Features|Clinical Synopsis	died|stillborn|death|deaths	CTU2	HGNC:28005	Microcephaly, facial dysmorphism, renal agenesis, and ambiguous genitalia syndrome, 618142 (3), Autosomal recessive	Autosomal recessive	y	y	[Death in utero or in neonatal period (in some patients)]	L1	y	-	lethal	lethal	lethal	L1	L1	pre-infant-lethal
618143	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 95	Developmental and epileptic encephalopathy 95, 618143 (3)	Developmental and epileptic encephalopathy 95	y	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 95; DEE95	Clinical Features	died	PIGS	HGNC:14937	Developmental and epileptic encephalopathy 95, 618143 (3), Autosomal recessive	Autosomal recessive	y	y	[Efthymiou et al. (2021) described 6 patients, including 1 sib pair, from 5 families with DEE95... Three patients died of complications associated with recurrent respiratory infections]	LU	y	-	lethal	lethal	lethal	LU	LU	post-infant-lethal
618144	USHER SYNDROME, TYPE IV	Usher syndrome, type IV, 618144 (3)	Usher syndrome, type IV	n	-	-	-	ARSG	HGNC:24102	Usher syndrome, type IV, 618144 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
618145	DEAFNESS, AUTOSOMAL RECESSIVE 111	Deafness, autosomal recessive 111, 618145 (3)	Deafness, autosomal recessive 111	n	-	-	-	MPZL2	HGNC:3496	Deafness, autosomal recessive 111, 618145 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
618148	EXTRAORAL HALITOSIS DUE TO METHANETHIOL OXIDASE DEFICIENCY	Extraoral halitosis due to MTO deficiency, 618148 (3)	Extraoral halitosis due to MTO deficiency	y	EXTRAORAL HALITOSIS DUE TO METHANETHIOL OXIDASE DEFICIENCY; EHMTO	Clinical Features	died	SELENBP1	HGNC:10719	Extraoral halitosis due to MTO deficiency, 618148 (3), Autosomal recessive	Autosomal recessive	y	n	-	-	-	-	ambiguous	ambiguous	ambiguous	-	-	-
618149	OROFACIAL CLEFT 8	Orofacial cleft 8, 618149 (3)	Orofacial cleft 8	n	-	-	-	TP63	HGNC:15979	Orofacial cleft 8, 618149 (3)	-	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L2	L2	pre-infant-lethal
618150	SAUL-WILSON SYNDROME	Saul-Wilson syndrome, 618150 (3)	Saul-Wilson syndrome	n	-	-	-	COG4	HGNC:18620	Saul-Wilson syndrome, 618150 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L4	L4	post-infant-lethal
618152	SPERMATOGENIC FAILURE 33	Spermatogenic failure 33, 618152 (3)	Spermatogenic failure 33	n	-	-	-	CFAP251	HGNC:28506	Spermatogenic failure 33, 618152 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
618153	SPERMATOGENIC FAILURE 34	Spermatogenic failure 34, 618153 (3)	Spermatogenic failure 34	n	-	-	-	FSIP2	HGNC:21675	Spermatogenic failure 34, 618153 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
618154	HENNEKAM LYMPHANGIECTASIA-LYMPHEDEMA SYNDROME 3	Hennekam lymphangiectasia-lymphedema syndrome 3, 618154 (3)	Hennekam lymphangiectasia-lymphedema syndrome 3	y	HENNEKAM LYMPHANGIECTASIA-LYMPHEDEMA SYNDROME 3; HKLLS3	Clinical Features	died|stillbirth|stillbirths	ADAMTS3	HGNC:219	Hennekam lymphangiectasia-lymphedema syndrome 3, 618154 (3), Autosomal recessive	Autosomal recessive	y	y	[Scheuerle et al. (2018) reported a male born at 32 weeks' gestation following prenatal identification of hydrops fetalis... A previous pregnancy had resulted in a stillbirth due to fetal hydrops... At age 17 weeks, the infant had respiratory decompensation and died after removal of support]	L3	y	y	lethal	lethal	lethal	L3	L3	pre-infant-lethal
618155	OPHTHALMOPLEGIA, EXTERNAL, WITH RIB AND VERTEBRAL ANOMALIES	Ophthalmoplegia, external, with rib and vertebral anomalies, 618155 (3)	Ophthalmoplegia, external, with rib and vertebral anomalies	n	-	-	-	MYF5	HGNC:7565	Ophthalmoplegia, external, with rib and vertebral anomalies, 618155 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
618156	SQUALENE SYNTHASE DEFICIENCY	Squalene synthase deficiency, 618156 (3)	Squalene synthase deficiency	n	-	-	-	FDFT1	HGNC:3629	Squalene synthase deficiency, 618156 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
618157	ISOLATED GROWTH HORMONE DEFICIENCY, TYPE IV	Growth hormone deficiency, isolated, type IV, 618157 (3)	Growth hormone deficiency, isolated, type IV	n	-	-	-	GHRHR	HGNC:4266	Growth hormone deficiency, isolated, type IV, 618157 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
618158	INTELLECTUAL DEVELOPMENTAL DISORDER WITH MACROCEPHALY, SEIZURES, AND SPEECH DELAY	Intellectual developmental disorder with macrocephaly, seizures, and speech delay, 618158 (3)	Intellectual developmental disorder with macrocephaly, seizures, and speech delay	n	-	-	-	PAK1	HGNC:8590	Intellectual developmental disorder with macrocephaly, seizures, and speech delay, 618158 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
618160	PITUITARY HORMONE DEFICIENCY, COMBINED OR ISOLATED, 7	Pituitary hormone deficiency, combined or isolated, 7, 618160 (3)	Pituitary hormone deficiency, combined or isolated, 7	y	PITUITARY HORMONE DEFICIENCY, COMBINED OR ISOLATED, 7; CPHD7	Clinical Features	died	RNPC3	HGNC:18666	Pituitary hormone deficiency, combined or isolated, 7, 618160 (3), Autosomal recessive	Autosomal recessive	y	y	[An older sib with congenital cataract, hypotonia, hyporeflexia, and absence of sucking reflex had died at the age of 3.5 months, presumably due to aspiration during feeding. Brain MRI scans were unavailable for these patients. The authors noted that the sibs' developmental and intellectual delay might be related to untreated congenital hypothyroidism during the first months of life, since there was no newborn screening for congenital hypothyroidism on the Caribbean island at the time of their birth]	L3	n	y	lethal	lethal	lethal	L3	L3	pre-infant-lethal
618161	JOUBERT SYNDROME 35	Joubert syndrome 35, 618161 (3)	Joubert syndrome 35	n	-	-	-	ARL3	HGNC:694	Joubert syndrome 35, 618161 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
618164	CARDIAC, FACIAL, AND DIGITAL ANOMALIES WITH DEVELOPMENTAL DELAY	Cardiac, facial, and digital anomalies with developmental delay, 618164 (3)	Cardiac, facial, and digital anomalies with developmental delay	n	-	-	-	TRAF7	HGNC:20456	Cardiac, facial, and digital anomalies with developmental delay, 618164 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
618165	BONE MARROW FAILURE SYNDROME 5	Bone marrow failure syndrome 5, 618165 (3)	Bone marrow failure syndrome 5	y	BONE MARROW FAILURE SYNDROME 5; BMFS5	Clinical Features	died	TP53	HGNC:11998	Bone marrow failure syndrome 5, 618165 (3), Autosomal dominant	Autosomal dominant	y	y	[Toki et al. (2018) reported 2 unrelated patients who presented in the first days or months of life with anemia and hypogammaglobulinemia... The second patient was a 5-year-old boy who had an afebrile seizure at age 9 months. He also had severe growth retardation, microcephaly (-4.9 SD), and overall developmental delay. He died at age 5 after a bone marrow transplant]	L4	y	-	lethal	lethal	lethal	L4|LU	L4	post-infant-lethal
618168	DIARRHEA 9	Diarrhea 9, 618168 (3)	Diarrhea 9	n	-	-	-	WNT2B	HGNC:12781	Diarrhea 9, 618168 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
618170	NEURODEGENERATION, CHILDHOOD-ONSET, STRESS-INDUCED, WITH VARIABLE ATAXIA AND SEIZURES	Neurodegeneration, childhood-onset, stress-induced, with variable ataxia and seizures, 618170 (3)	Neurodegeneration, childhood-onset, stress-induced, with variable ataxia and seizures	y	NEURODEGENERATION, CHILDHOOD-ONSET, STRESS-INDUCED, WITH VARIABLE ATAXIA AND SEIZURES; CONDSIAS	Description|Clinical Features|Clinical Synopsis|Phenotype	death|deaths|died	ADPRS	HGNC:21304	Neurodegeneration, childhood-onset, stress-induced, with variable ataxia and seizures, 618170 (3), Autosomal recessive	Autosomal recessive	y	y	[Ghosh et al. (2018) reported 6 unrelated families, 5 of which were determined to be consanguineous and 1 with parents who originated from the same small village in Sicily, with a neurodegenerative disorder apparent in childhood after normal early development with some speech and motor acquisition. In most cases, the neurodegeneration was associated with a physiologic stress, such as infection or seizures. The most severely affected family (family 1) included 9 children from the United Arab Emirates, 7 of whom died between 2 and 15 years of age]	L4	y	-	lethal	lethal	lethal	L4	L4	post-infant-lethal
618173	RETINITIS PIGMENTOSA 83	Retinitis pigmentosa 83, 618173 (3)	Retinitis pigmentosa 83	n	-	-	-	ARL3	HGNC:694	Retinitis pigmentosa 83, 618173 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
618174	CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 9	Cortical dysplasia, complex, with other brain malformations 9, 618174 (3)	Cortical dysplasia, complex, with other brain malformations 9	y	CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 9; CDCBM9	Clinical Features|Clinical Synopsis	died|death|deaths	CTNNA2	HGNC:2510	Cortical dysplasia, complex, with other brain malformations 9, 618174 (3), Autosomal recessive	Autosomal recessive	n	y	[Death in early childhood may occur]	L4	y	-	lethal	lethal	lethal	L4	L4	post-infant-lethal
618175	WARBURG-CINOTTI SYNDROME	Warburg-Cinotti syndrome, 618175 (3)	Warburg-Cinotti syndrome	n	-	-	-	DDR2	HGNC:2731	Warburg-Cinotti syndrome, 618175 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L3	L3	pre-infant-lethal
618176	NEPHROTIC SYNDROME, TYPE 17	Nephrotic syndrome, type 17, 618176 (3)	Nephrotic syndrome, type 17	y	NEPHROTIC SYNDROME, TYPE 17; NPHS17	Phenotype	lethality	NUP85	HGNC:8734	Nephrotic syndrome, type 17, 618176 (3), Autosomal recessive	Autosomal recessive	y	n	-	-	-	-	ambiguous	ambiguous	ambiguous	-	-	-
618177	NEPHROTIC SYNDROME, TYPE 18	Nephrotic syndrome, type 18, 618177 (3)	Nephrotic syndrome, type 18	n	-	-	-	NUP133	HGNC:18016	Nephrotic syndrome, type 18, 618177 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
618180	ECTODERMAL DYSPLASIA 14, HAIR/TOOTH TYPE, WITH OR WITHOUT HYPOHIDROSIS	Ectodermal dysplasia 14, hair/tooth type with or without hypohidrosis, 618180 (3)	Ectodermal dysplasia 14, hair/tooth type with or without hypohidrosis	n	-	-	-	TSPEAR	HGNC:1268	Ectodermal dysplasia 14, hair/tooth type with or without hypohidrosis, 618180 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
618182	ORTHOSTATIC HYPOTENSION 2	Orthostatic hypotension 2, 618182 (3)	Orthostatic hypotension 2	y	ORTHOSTATIC HYPOTENSION 2; ORTHYP2	Clinical Features|Clinical Synopsis	died|death|deaths	CYB561	HGNC:2571	Orthostatic hypotension 2, 618182 (3), Autosomal recessive	Autosomal recessive	n	y	[Early death may occur / Van den Berg et al. (2018) reported 2 pairs of adult sisters from 2 unrelated families of Dutch and American descent, with severe orthostatic hypotension apparent from infancy or early childhood... The American sisters had a brother with comparable complaints who died at age 16 years of unknown cause, and 3 of the 4 affected women died between 37 and 59 years of age]	L6	y	-	lethal	lethal	lethal	L6	L6	post-infant-lethal
618183	DIARRHEA 10, PROTEIN-LOSING ENTEROPATHY TYPE	Diarrhea 10, protein-losing enteropathy type, 618183 (3)	Diarrhea 10, protein-losing enteropathy type	y	DIARRHEA 10, PROTEIN-LOSING ENTEROPATHY TYPE; DIAR10	Description|Clinical Features|Clinical Synopsis|Phenotype	death|deaths|died	PLVAP	HGNC:13635	Diarrhea 10, protein-losing enteropathy type, 618183 (3), Autosomal recessive	Autosomal recessive	y	y	[Broekaert et al. (2018) reported a male infant, born to first-cousin parents of Turkish descent, who at the age of 9 days developed watery diarrhea and polyuria with hyponatremia, hypomagnesemia, hypocalcemia, and metabolic acidosis. His albumin level dropped from 28 to 4g/L by day 12 of life, and he also had markedly elevated gamma-GT (see 612346)...The patient developed portal vein thrombosis, and on day 15 he experienced hematochezia, likely due to disseminated intravascular coagulation, and died]	L2	y	-	lethal	lethal	lethal	L2	L2	pre-infant-lethal
618184	NEUROPATHY, CONGENITAL HYPOMYELINATING, 2	Hypomyelinating neuropathy, congenital, 2, 618184 (3)	Hypomyelinating neuropathy, congenital, 2	n	-	-	-	MPZ	HGNC:7225	Hypomyelinating neuropathy, congenital, 2, 618184 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	ambiguous|lethal|nonlethal	lethal|nonlethal	L6	L6	post-infant-lethal
618185	PERIVENTRICULAR NODULAR HETEROTOPIA 8	Periventricular nodular heterotopia 8, 618185 (3)	Periventricular nodular heterotopia 8	n	-	-	-	ARF1	HGNC:652	Periventricular nodular heterotopia 8, 618185 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
618186	NEUROPATHY, CONGENITAL HYPOMYELINATING, 3	Hypomyelinating neuropathy, congenital, 3, 618186 (3)	Hypomyelinating neuropathy, congenital, 3	y	NEUROPATHY, CONGENITAL HYPOMYELINATING, 3; CHN3	Description|Clinical Features|Clinical Synopsis|Phenotype	die|died|lethal|lethality	CNTNAP1	HGNC:8011	Hypomyelinating neuropathy, congenital, 3, 618186 (3), Autosomal recessive	Autosomal recessive	y	y	[Vallat et al. (2016) reported 2 sets of brothers from 2 unrelated nonconsanguineous families with CHN3. These families were subsequently reported as a French family by Nizon et al. (2017) (family 2 in Vallat et al., 2016), and a northern Irish family by Hengel et al. (2017) (family 2 in Hengel et al., 2017 and family 1 in Vallat et al., 2016). The patients presented at birth with severe hypotonia, poor or absent independent respiration and swallowing, absent or rare voluntary movements, and areflexia. All died within the first hours or months of life]	L2	y	-	lethal	lethal	lethal	L2	L2	pre-infant-lethal
618188	HYPERPARATHYROIDISM, TRANSIENT NEONATAL	Hyperparathyroidism, transient neonatal, 618188 (3)	Hyperparathyroidism, transient neonatal	n	-	-	-	TRPV6	HGNC:14006	Hyperparathyroidism, transient neonatal, 618188 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
618189	CARDIOMYOPATHY, DILATED, 2C	Cardiomyopathy, dilated, 2C, 618189 (3)	Cardiomyopathy, dilated, 2C	y	CARDIOMYOPATHY, DILATED, 2C; CMD2C	Description|Clinical Features|Clinical Synopsis|Phenotype	die|died|fatal	PPCS	HGNC:25686	Cardiomyopathy, dilated, 2C, 618189 (3), Autosomal recessive	Autosomal recessive	y	y	[Iuso et al. (2018) reported a German girl, born to healthy nonconsanguineous parents (family A), who presented in the first few hours after birth with oxygen desaturation and bradycardia and required ventilatory support. She had severe muscular hypotonia as well as minor dysmorphic features, including cutis laxa, abnormally placed thumbs, abnormal dermatoglyphics, hypoplastic labia minora, and hypoplastic toenails. Over the course of several hospitalizations, evaluation revealed severe dilated cardiomyopathy and pulmonary artery hypertension. She died of multiorgan failure at 3 months of age]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
618193	POLYCYSTIC LIPOMEMBRANOUS OSTEODYSPLASIA WITH SCLEROSING LEUKOENCEPHALOPATHY 2	Polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy 2, 618193 (3)	Polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy 2	y	POLYCYSTIC LIPOMEMBRANOUS OSTEODYSPLASIA WITH SCLEROSING LEUKOENCEPHALOPATHY 2; PLOSL2	Description|Clinical Synopsis	death|deaths	TREM2	HGNC:17761	Polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy 2, 618193 (3), Autosomal recessive	Autosomal recessive	y	y	[late neurologic stage with profound dementia and death by age 50]	L6	y	-	lethal	lethal	lethal	L6	L6	post-infant-lethal
618195	INTELLECTUAL DEVELOPMENTAL DISORDER AND RETINITIS PIGMENTOSA	Intellectual developmental disorder and retinitis pigmentosa, 618195 (3)	Intellectual developmental disorder and retinitis pigmentosa	n	-	-	-	SCAPER	HGNC:13081	Intellectual developmental disorder and retinitis pigmentosa, 618195 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
618196	CAPILLARY MALFORMATION-ARTERIOVENOUS MALFORMATION 2	Capillary malformation-arteriovenous malformation 2, 618196 (3)	Capillary malformation-arteriovenous malformation 2	n	-	-	-	EPHB4	HGNC:3395	Capillary malformation-arteriovenous malformation 2, 618196 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L1	L1	pre-infant-lethal
618197	MYASTHENIC SYNDROME, CONGENITAL, 23, PRESYNAPTIC	Myasthenic syndrome, congenital, 23, presynaptic, 618197 (3)	Myasthenic syndrome, congenital, 23, presynaptic	y	MYASTHENIC SYNDROME, CONGENITAL, 23, PRESYNAPTIC; CMS23	Clinical Features	fatal	SLC25A1	HGNC:10979	Myasthenic syndrome, congenital, 23, presynaptic, 618197 (3), Autosomal recessive	Autosomal recessive	y	n	-	-	-	-	ambiguous	ambiguous|lethal	lethal	L2	L2	pre-infant-lethal
618198	MYASTHENIC SYNDROME, CONGENITAL, 24, PRESYNAPTIC	Myasthenic syndrome, congenital, 24, presynaptic, 618198 (3)	Myasthenic syndrome, congenital, 24, presynaptic	y	MYASTHENIC SYNDROME, CONGENITAL, 24, PRESYNAPTIC; CMS24	Clinical Features	died	MYO9A	HGNC:7608	Myasthenic syndrome, congenital, 24, presynaptic, 618198 (3), Autosomal recessive	Autosomal recessive	n	y	[O'Connor et al. (2016) reported 3 patients from 2 unrelated families with CMS24. Patient 1 was a 4-year-old German girl, born of unrelated parents, who showed swallowing difficulties, proximal and distal muscle weakness, episodic apnea, respiratory failure, and ptosis in the neonatal period... he patients responded well to pyridostigmine treatment. Family history revealed that the patients had 4 sibs who died in the first year of life with respiratory failure and hypotonia]	L3	n	y	lethal	lethal	lethal	L3	L3	pre-infant-lethal
618201	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 68	Developmental and epileptic encephalopathy 68, 618201 (3)	Developmental and epileptic encephalopathy 68	y	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 68; DEE68	Description|Clinical Features|Clinical Synopsis	death|deaths|died|fatal	TRAK1	HGNC:29947	Developmental and epileptic encephalopathy 68, 618201 (3), Autosomal recessive	Autosomal recessive	y	y	[Anazi et al. (2017) reported 2 deceased infants from 2 unrelated consanguineous Arab families with DEE68. One patient (16DG0971) presented soon after birth with respiratory distress and developed intractable focal seizures at age 6 months necessitating intubation. He had global developmental delay, small head, axial hypotonia, and generalized spasticity. Brain imaging showed generalized brain atrophy and areas of diffusion restriction, and EEG showed a generalized encephalopathic state and evidence of partial seizures. He died at age 10 months and reportedly had a brother who was similarly affected. The second proband (17DG0780) presented soon after birth with refractory convulsions and jerky movements. Clinical details were limited, but he had dysmorphic features and sluggish pupils, and brain imaging showed diffuse brain atrophy and delayed myelination. He died at 9 months of age]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
618204	IMMUNODEFICIENCY 15A	Immunodeficiency 15A, 618204 (3)	Immunodeficiency 15A	y	IMMUNODEFICIENCY 15A; IMD15A	Clinical Synopsis	lethal	IKBKB	HGNC:5960	Immunodeficiency 15A, 618204 (3), Autosomal dominant	Autosomal dominant	y	n	-	-	-	-	ambiguous	ambiguous|lethal	lethal	L3	L3	pre-infant-lethal
618205	SNIJDERS BLOK-CAMPEAU SYNDROME	Snijders Blok-Campeau syndrome, 618205 (3)	Snijders Blok-Campeau syndrome	n	-	-	-	CHD3	HGNC:1918	Snijders Blok-Campeau syndrome, 618205 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
618213	INFLAMMATORY BOWEL DISEASE, IMMUNODEFICIENCY, AND ENCEPHALOPATHY	Inflammatory bowel disease, immunodeficiency, and encephalopathy, 618213 (3)	Inflammatory bowel disease, immunodeficiency, and encephalopathy	y	INFLAMMATORY BOWEL DISEASE, IMMUNODEFICIENCY, AND ENCEPHALOPATHY; IBDIMDE	Clinical Features|Clinical Synopsis	death|deaths	TGFB1	HGNC:11766	Inflammatory bowel disease, immunodeficiency, and encephalopathy, 618213 (3), Autosomal recessive	Autosomal recessive	n	y	[Kotlarz et al. (2018) reported 3 patients from 2 unrelated families who presented in infancy with severe inflammatory bowel disease manifest as bloody diarrhea and failure to thrive... Both sibs in family 2 showed severe neurologic deterioration with loss of communication and increased spasticity, resulting in death at ages 25 and 39 month]	L4	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L4	L4	post-infant-lethal
618218	BAKER-GORDON SYNDROME	Baker-Gordon syndrome, 618218 (3)	Baker-Gordon syndrome	n	-	-	-	SYT1	HGNC:11509	Baker-Gordon syndrome, 618218 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
618220	RETINITIS PIGMENTOSA 84	Retinitis pigmentosa 84, 618220 (3)	Retinitis pigmentosa 84	n	-	-	-	DHX38	HGNC:17211	Retinitis pigmentosa 84, 618220 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
618221	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 66	Intellectual developmental disorder, autosomal recessive 66, 618221 (3)	Intellectual developmental disorder, autosomal recessive 66	n	-	-	-	C12orf4	HGNC:1184	Intellectual developmental disorder, autosomal recessive 66, 618221 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
618222	MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 2	Mitochondrial complex I deficiency, nuclear type 2, 618222 (3)	Mitochondrial complex I deficiency, nuclear type 2	y	MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 2; MC1DN2	Clinical Features	death|deaths	NDUFS8	HGNC:7715	Mitochondrial complex I deficiency, nuclear type 2, 618222 (3), Autosomal recessive	Autosomal recessive	y	y	[Loeffen et al. (1998) reported a patient with mitochondrial complex I deficiency manifesting as Leigh syndrome (see 256000). The patient presented at age 5 weeks with poor feeding and episodes of apnea and cyanosis. The symptoms, which had existed since the first day of life, escalated in the course of an acute gastroenteritis. The parents were nonconsanguineous. Cardiac examination revealed a moderate hypertrophic obstructive cardiomyopathy. CT scan of the brain showed extensive white matter hypodensity, mild ventricular enlargement, and hypodense symmetric lesions in putamen and mesencephalon. The disorder progressed, leading to death at the age of 11 weeks from cardiorespiratory failure]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
618223	VERTEBRAL ANOMALIES AND VARIABLE ENDOCRINE AND T-CELL DYSFUNCTION	Vertebral anomalies and variable endocrine and T-cell dysfunction, 618223 (3)	Vertebral anomalies and variable endocrine and T-cell dysfunction	n	-	-	-	TBX2	HGNC:11597	Vertebral anomalies and variable endocrine and T-cell dysfunction, 618223 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
618224	MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 3	Mitochondrial complex I deficiency, nuclear type 3, 618224 (3)	Mitochondrial complex I deficiency, nuclear type 3	y	MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 3; MC1DN3	Clinical Features|Clinical Synopsis	death|deaths|died	NDUFS7	HGNC:7714	Mitochondrial complex I deficiency, nuclear type 3, 618224 (3), Autosomal recessive	Autosomal recessive	y	y	[Lebon et al. (2007) reported 2 brothers, born of consanguineous Turkish parents, with complex I deficiency and Leigh syndrome resulting in death in infancy... He became comatous and he died at 5 months of age. His brother had a similar clinical course and died at 6 months of age]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
618225	MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 4	Mitochondrial complex I deficiency, nuclear type 4, 618225 (3)	Mitochondrial complex I deficiency, nuclear type 4	y	MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 4; MC1DN4	Clinical Features|Clinical Synopsis	died|death|deaths	NDUFV1	HGNC:7716	Mitochondrial complex I deficiency, nuclear type 4, 618225 (3), Autosomal recessive	Autosomal recessive	y	y	[Schuelke et al. (1999) reported 2 brothers with complex I deficiency with mutations in the NDUFV1 gene. Pregnancy, delivery, and early infancy were normal in both children. At the age of 5 months, they presented with repeated vomiting and developed strabismus, progressive muscular hypotonia, myoclonic epilepsy, and psychomotor regression. Cranial CT scans showed brain atrophy, but cranial MRIs were not available to confirm Leigh syndrome. Lactate and pyruvate concentrations in blood and cerebrospinal fluid were elevated. Isolated complex I deficiency was demonstrated in muscle and cultured fibroblasts. The boys died at 14 and 17 months from aspiration pneumonia]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
618226	MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 5	Mitochondrial complex I deficiency, nuclear type 5, 618226 (3)	Mitochondrial complex I deficiency, nuclear type 5	y	MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 5; MC1DN5	Clinical Features|Clinical Synopsis	death|deaths|died	NDUFS1	HGNC:7707	Mitochondrial complex I deficiency, nuclear type 5, 618226 (3), Autosomal recessive	Autosomal recessive	n	y	[Benit et al. (2001) described patients with mitochondrial complex I deficiency and mutation in the NDUFS1 gene. One proband had unrelated healthy parents and was normal until age 4 months, when he developed psychomotor retardation with hypotonia. At age 7 months, he presented with nystagmus and bilateral optic atrophy. Leukodystrophy, lactic acidosis, and hyperlactatorachia were noted. He died at age 10 months. An older sister with similar findings died at age 7 months, and an older brother developed 2 episodes of ataxia and mild psychomotor retardation at age 2 years. In another family the proband, offspring of healthy unrelated parents, was normal until age 2 months, when he presented with growth retardation, axial hypotonia, hepatomegaly, and persistent hyperlactatemia. Magnetic resonance imaging showed hyperintensity of basal ganglia. The child later developed macrocytic anemia and dystonia. He died suddenly at age 5 months. His older sister presented with growth retardation, macrocytic anemia, and metabolic acidosis at age 3 months and died shortly thereafter in an acute episode of hyperlactatemia]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
618228	MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 6	Mitochondrial complex I deficiency, nuclear type 6, 618228 (3)	Mitochondrial complex I deficiency, nuclear type 6	y	MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 6; MC1DN6	Clinical Features|Clinical Synopsis	died|death|deaths	NDUFS2	HGNC:7708	Mitochondrial complex I deficiency, nuclear type 6, 618228 (3), Autosomal recessive	Autosomal recessive	y	y	[Loeffen et al. (2001) reported 3 unrelated families with isolated complex I deficiency. The first family, which was consanguineous, had 2 affected children. The first affected child, a male, was normal until 6 months of age when he manifested neurologic regression, with horizontal nystagmus and bilateral muscle atrophy with decreased axial muscle tone. Brain CT showed bilateral hypodensities of the basal ganglia, and echocardiogram showed left ventricular hypertrophy. He died of apnea at 24 months of age. The third-born child, a female, had similar symptoms except that they presented earlier and her deterioration was faster. In the second family, the affected child had neonatal onset of severe lactic acidosis and hypertrophic cardiomyopathy. She died at 4 days of age]	L2	y	-	lethal	lethal	lethal	L2	L2	pre-infant-lethal
618229	MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 7	Mitochondrial complex I deficiency, nuclear type 7, 618229 (3)	Mitochondrial complex I deficiency, nuclear type 7	y	MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 7; MC1DN7	Clinical Features|Clinical Synopsis|Phenotype	died|death|deaths|lethal	NDUFV2	HGNC:7717	Mitochondrial complex I deficiency, nuclear type 7, 618229 (3), Autosomal recessive	Autosomal recessive	y	y	[Cameron et al. (2015) reported 5 patients from 2 unrelated families with MC1DN7. Two infant sibs in 1 family presented with hypertrophic cardiomyopathy and lactic acidosis and died in the first days or months of life]	L2	y	-	lethal	lethal	lethal	L2	L2	pre-infant-lethal
618230	MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 8	Mitochondrial complex I deficiency, nuclear type 8, 618230 (3)	Mitochondrial complex I deficiency, nuclear type 8	y	MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 8; MC1DN8	Clinical Features|Clinical Synopsis	died|death|deaths	NDUFS3	HGNC:7710	Mitochondrial complex I deficiency, nuclear type 8, 618230 (3), Autosomal recessive	Autosomal recessive	y	y	[Death in the second decade (in Reunion Island patient)]	L5	y	-	lethal	lethal	lethal	L5	L5	post-infant-lethal
618231	EPIDERMODYSPLASIA VERRUCIFORMIS, SUSCEPTIBILITY TO, 2	Epidermodysplasia verruciformis 2, 618231 (3)	Epidermodysplasia verruciformis 2	n	-	-	-	TMC8	HGNC:20474	Epidermodysplasia verruciformis 2, 618231 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
618232	MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 9	Mitochondrial complex I deficiency, nuclear type 9, 618232 (3)	Mitochondrial complex I deficiency, nuclear type 9	y	MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 9; MC1DN9	Clinical Features|Clinical Synopsis|Phenotype	death|deaths|fatal|lethal	NDUFS6	HGNC:7713	Mitochondrial complex I deficiency, nuclear type 9, 618232 (3), Autosomal recessive	Autosomal recessive	n	y	[Kirby et al. (2004) reported 2 unrelated patients with complex I deficiency. Both patients had lethal infantile mitochondrial disease with death within the first 2 weeks of life]	L2	y	-	lethal	lethal	lethal	L2	L2	pre-infant-lethal
618233	MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 10	Mitochondrial complex I deficiency, nuclear type 10, 618233 (3)	Mitochondrial complex I deficiency, nuclear type 10	y	MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 10; MC1DN10	Clinical Features|Clinical Synopsis|Phenotype	death|deaths|died|fatal	NDUFAF2	HGNC:28086	Mitochondrial complex I deficiency, nuclear type 10, 618233 (3), Autosomal recessive	Autosomal recessive	n	y	[Hoefs et al. (2009) reported a girl, born of consanguineous parents, with fatal mitochondrial complex I deficiency. The patient presented at 3 months of age with nystagmus. At age 7 months, she had vomiting, renal tubular acidosis, poor feeding, and evidence of neurologic decline, including hypotonia and delayed motor development. Laboratory studies showed mildly increased blood lactate, and brain imaging showed signal abnormalities in the thalamus, cerebral peduncles, brainstem, and spinal cord. She developed dyskinetic movements and central hyperventilation, resulting in death at 1 year of age]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
618234	MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 11	Mitochondrial complex I deficiency, nuclear type 11, 618234 (3)	Mitochondrial complex I deficiency, nuclear type 11	y	MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 11; MC1DN11	Clinical Features|Clinical Synopsis|Phenotype	died|fatal	NDUFAF1	HGNC:18828	Mitochondrial complex I deficiency, nuclear type 11, 618234 (3), Autosomal recessive	Autosomal recessive	n	y	[Fassone et al. (2011) reported a French infant with fatal infantile hypertrophic cardiomyopathy and isolated complex I deficiency. The patient presented at age 6.5 months in cardiogenic shock with metabolic acidosis after a respiratory viral infection. Echocardiogram showed pericardial effusion, biventricular hypertrophy, and left ventricular dysfunction. Skeletal muscle biopsy showed increased lipid deposition and accumulation of enlarged and abnormal mitochondria and an isolated severe deficiency of complex I activity (25% of controls). She died soon after, despite aggressive treatment]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
618235	MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 13	Mitochondrial complex I deficiency, nuclear type 13, 618235 (3)	Mitochondrial complex I deficiency, nuclear type 13	y	MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 13; MC1DN13	Clinical Features|Clinical Synopsis	death|deaths|died	NDUFA2	HGNC:7685	Mitochondrial complex I deficiency, nuclear type 13, 618235 (3), Autosomal recessive	Autosomal recessive	y	y	[Hoefs et al. (2008) reported a boy, born to first-cousin Turkish parents, with mitochondrial complex I deficiency manifesting as Leigh syndrome (see 256000). The boy had hypertrophic cardiomyopathy and developmental delay from birth, and brain MRI showed cerebral atrophy and hypoplasia of the corpus callosum. After a varicella infection, he developed severe acidosis, seizures, and coma, and died of cardiovascular arrest at age 11 months]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
618236	MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 14	Mitochondrial complex I deficiency, nuclear type 14, 618236 (3)	Mitochondrial complex I deficiency, nuclear type 14	y	MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 14; MC1DN14	Clinical Features|Clinical Synopsis	death|deaths|fatal	NDUFA11	HGNC:20371	Mitochondrial complex I deficiency, nuclear type 14, 618236 (3), Autosomal recessive	Autosomal recessive	n	y	[Berger et al. (2008) reported 3 consanguineous families of Israeli Bedouin origin in which 6 offspring had severe mitochondrial complex I deficiency. Three of the affected children presented with a fatal infantile metabolic acidosis with death between ages 6 and 40 days]	L2	y	-	lethal	lethal	lethal	L2	L2	pre-infant-lethal
618237	MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 15	Mitochondrial complex I deficiency, nuclear type 15, 618237 (3)	Mitochondrial complex I deficiency, nuclear type 15	y	MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 15; MC1DN15	Clinical Features|Clinical Synopsis	died|death|deaths	NDUFAF4	HGNC:21034	Mitochondrial complex I deficiency, nuclear type 15, 618237 (3), Autosomal recessive	Autosomal recessive	y	y	[Saada et al. (2008) reported 6 patients, 5 of whom were from a consanguineous Arab Muslim family, with mitochondrial complex I deficiency who presented in infancy with devastating encephalomyopathy or antenatal cardiomyopathy. There were 9 affected members in the Arab Muslim family, but tissue was available for only 5 for enzymatic and molecular testing. All affected family presented soon after birth with severe metabolic acidosis and very high plasma-lactate levels. Three patients died at 2-5 days of age from intractable acidosis]	L2	y	-	lethal	lethal	lethal	L2	L2	pre-infant-lethal
618238	MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 16	Mitochondrial complex I deficiency, nuclear type 16, 618238 (3)	Mitochondrial complex I deficiency, nuclear type 16	y	MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 16; MC1DN16	Clinical Features|Clinical Synopsis|Phenotype	died|lethal|death|deaths	NDUFAF5	HGNC:15899	Mitochondrial complex I deficiency, nuclear type 16, 618238 (3), Autosomal recessive	Autosomal recessive	y	y	[Sugiana et al. (2008) reported a male infant, born of consanguineous Egyptian parents, with lethal neonatal complex I deficiency. The infant had intrauterine growth retardation, minor facial dysmorphism, unusual hair patterning, abnormal toes, and a small sacral pit. Cerebral ultrasound showed agenesis of the corpus callosum and ventricular septation. He also had a congenital left diaphragmatic hernia, adrenal insufficiency, and increased lactate in the blood and CSF. He died of cardiorespiratory arrest due to progressive lactic acidosis on day 7]	L2	y	-	lethal	lethal	lethal	L2	L2	pre-infant-lethal
618239	MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 17	Mitochondrial complex I deficiency, nuclear type 17, 618239 (3)	Mitochondrial complex I deficiency, nuclear type 17	n	-	-	-	NDUFAF6	HGNC:28625	Mitochondrial complex I deficiency, nuclear type 17, 618239 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	LU	LU	post-infant-lethal
618240	MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 18	Mitochondrial complex I deficiency, nuclear type 18, 618240 (3)	Mitochondrial complex I deficiency, nuclear type 18	y	MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 18; MC1DN18	Description|Clinical Features|Clinical Synopsis	death|deaths|died	NDUFAF3	HGNC:29918	Mitochondrial complex I deficiency, nuclear type 18, 618240 (3), Autosomal recessive	Autosomal recessive	y	y	[Saada et al. (2009) reported 5 patients from 3 families with severe complex I deficiency. All patients died by age 6 months]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
618241	MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 19	Mitochondrial complex I deficiency, nuclear type 19, 618241 (3)	Mitochondrial complex I deficiency, nuclear type 19	n	-	-	-	FOXRED1	HGNC:26927	Mitochondrial complex I deficiency, nuclear type 19, 618241 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
618242	MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 21	Mitochondrial complex I deficiency, nuclear type 21, 618242 (3)	Mitochondrial complex I deficiency, nuclear type 21	n	-	-	-	NUBPL	HGNC:20278	Mitochondrial complex I deficiency, nuclear type 21, 618242 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
618243	MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 22	Mitochondrial complex I deficiency, nuclear type 22, 618243 (3)	Mitochondrial complex I deficiency, nuclear type 22	y	MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 22; MC1DN22	Clinical Features|Clinical Synopsis	died|death|deaths	NDUFA10	HGNC:7684	Mitochondrial complex I deficiency, nuclear type 22, 618243 (3), Autosomal recessive	Autosomal recessive	n	y	[Hoefs et al. (2011) reported a boy with mitochondrial complex I deficiency nuclear type 22 manifesting as Leigh syndrome (see 256000). The patient showed delayed psychomotor development after a normal neonatal period, hypotonia, increased serum and CSF lactate, periods of abnormal breathing, and hypertrophic cardiomyopathy. Brain MRI showed symmetric lesions in the basal ganglia. He died at age 23 months from respiratory arrest and cardiac decompensation]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
618244	MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 23	Mitochondrial complex I deficiency, nuclear type 23, 618244 (3)	Mitochondrial complex I deficiency, nuclear type 23	n	-	-	-	NDUFA12	HGNC:23987	Mitochondrial complex I deficiency, nuclear type 23, 618244 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
618246	MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 25	Mitochondrial complex I deficiency, nuclear type 25, 618246 (3)	Mitochondrial complex I deficiency, nuclear type 25	y	MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 25; MC1DN25	Clinical Features|Clinical Synopsis|Phenotype	died|lethal|death|deaths	NDUFB3	HGNC:7698	Mitochondrial complex I deficiency, nuclear type 25, 618246 (3), Autosomal recessive	Autosomal recessive	n	y	[Calvo et al. (2012) reported a female infant, born of unrelated parents of British and Dutch descent, with severe lethal mitochondrial complex I deficiency. The pregnancy was complicated by intrauterine growth retardation and premature birth at 31 weeks' gestation; respiratory insufficiency required extensive artificial ventilation in the neonatal period. After discharge home, she showed hypotonia with poor feeding and significant lactic acidosis and died unexpectedly at age 4 months]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
618247	MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 26	Mitochondrial complex I deficiency, nuclear type 26, 618247 (3)	Mitochondrial complex I deficiency, nuclear type 26	y	MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 26; MC1DN26	Clinical Features|Clinical Synopsis	died|death|deaths	NDUFA9	HGNC:7693	Mitochondrial complex I deficiency, nuclear type 26, 618247 (3), Autosomal recessive	Autosomal recessive	n	y	[Patient A had a severe phenotype with onset soon after birth and death at 1 month of age]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
618248	MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 27	Mitochondrial complex I deficiency, nuclear type 27, 618248 (3)	Mitochondrial complex I deficiency, nuclear type 27	n	-	-	-	MTFMT	HGNC:29666	Mitochondrial complex I deficiency, nuclear type 27, 618248 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L4	L4	post-infant-lethal
618250	MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 29	Mitochondrial complex I deficiency, nuclear type 29, 618250 (3)	Mitochondrial complex I deficiency, nuclear type 29	n	-	-	-	TMEM126B	HGNC:30883	Mitochondrial complex I deficiency, nuclear type 29, 618250 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
618251	MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 31	Mitochondrial complex I deficiency, nuclear type 31, 618251 (3)	Mitochondrial complex I deficiency, nuclear type 31	y	MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 31; MC1DN31	Clinical Features|Clinical Synopsis	died|death|deaths	TIMMDC1	HGNC:1321	Mitochondrial complex I deficiency, nuclear type 31, 618251 (3), Autosomal recessive	Autosomal recessive	y	y	[Kremer et al. (2017) reported 3 unrelated patients (35791, 66744, and 96687) with mitochondrial complex I deficiency. All patients had severe neurologic dysfunction manifest as infantile-onset hypotonia, failure to thrive, and delayed or minimal psychomotor development. Additional more variable features included sensorineural deafness, dysmetria, dyskinetic movements, peripheral neuropathy, and nystagmus. One patient had brain imaging results consistent with Leigh syndrome, and another patient developed refractory seizures. Two patients died at ages 30 and 20 months]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
618252	MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 32	Mitochondrial complex I deficiency, nuclear type 32, 618252 (3)	Mitochondrial complex I deficiency, nuclear type 32	y	MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 32; MC1DN32	Clinical Features|Clinical Synopsis	died|death|deaths	NDUFB8	HGNC:7703	Mitochondrial complex I deficiency, nuclear type 32, 618252 (3), Autosomal recessive	Autosomal recessive	y	y	[Piekutowska-Abramczuk et al. (2018) reported 2 unrelated children with mitochondrial complex I deficiency. One child presented at 3 months of age with respiratory failure, seizures, and increased serum and CSF lactate.... Laboratory studies showed increased serum and CSF lactate and lesions in the basal ganglia and internal capsule, consistent with Leigh syndrome. He died at age 15 months]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
618253	MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 33	Mitochondrial complex I deficiency, nuclear type 33, 618253 (3)	Mitochondrial complex I deficiency, nuclear type 33	y	MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 33; MC1DN33	Clinical Features|Clinical Synopsis	died|death|deaths	NDUFA6	HGNC:7690	Mitochondrial complex I deficiency, nuclear type 33, 618253 (3), Autosomal recessive	Autosomal recessive	y	y	[Alston et al. (2018) reported 4 unrelated children with mitochondrial complex I deficiency. The patients had onset of delayed development and/or neurologic deterioration in the first weeks or years of life. Two patients died in infancy; the other 2 patients were unable to stand, walk, or speak, and had optic atrophy]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
618254	CILIARY DYSKINESIA, PRIMARY, 39	Ciliary dyskinesia, primary, 39, 618254 (3)	Ciliary dyskinesia, primary, 39	y	CILIARY DYSKINESIA, PRIMARY, 39; CILD39	Clinical Features|Clinical Synopsis	lethal	LRRC56	HGNC:25430	Ciliary dyskinesia, primary, 39, 618254 (3), Autosomal recessive	Autosomal recessive	n	y	[Bonnefoy et al. (2018) reported 4 patients from 3 unrelated families with a similar disorder suggestive of a ciliopathy... In the second family, 2 male fetuses born of consanguineous Kuwaiti parents were noted to have lethal congenital cardiac malformations on prenatal ultrasound]	LU	y	-	lethal	lethal	lethal	LU	LU	post-infant-lethal
618261	LYMPHOPROLIFERATIVE SYNDROME 3	Lymphoproliferative syndrome 3, 618261 (3)	Lymphoproliferative syndrome 3	n	-	-	-	CD70	HGNC:11937	Lymphoproliferative syndrome 3, 618261 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
618264	MIRROR MOVEMENTS 4	Mirror movements 4, 618264 (3)	Mirror movements 4	n	-	-	-	NTN1	HGNC:8029	Mirror movements 4, 618264 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
618265	ARTHROGRYPOSIS, CLEFT PALATE, CRANIOSYNOSTOSIS, AND IMPAIRED INTELLECTUAL DEVELOPMENT	Arthrogryposis, cleft palate, craniosynostosis, and impaired intellectual development, 618265 (3)	Arthrogryposis, cleft palate, craniosynostosis, and impaired intellectual development	n	-	-	-	PPP3CA	HGNC:9314	Arthrogryposis, cleft palate, craniosynostosis, and impaired intellectual development, 618265 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
618266	PONTOCEREBELLAR HYPOPLASIA, TYPE 12	Pontocerebellar hypoplasia, type 12, 618266 (3)	Pontocerebellar hypoplasia, type 12	y	PONTOCEREBELLAR HYPOPLASIA, TYPE 12; PCH12	Clinical Features|Clinical Synopsis|Phenotype	died|death|deaths|lethal	COASY	HGNC:29932	Pontocerebellar hypoplasia, type 12, 618266 (3), Autosomal recessive	Autosomal recessive	y	y	[Death in infancy]	L3	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L3	L3	pre-infant-lethal
618267	EPIDERMODYSPLASIA VERRUCIFORMIS, SUSCEPTIBILITY TO, 3	Epidermodysplasia verruciformis 3, 618267 (3)	Epidermodysplasia verruciformis 3	n	-	-	-	CIB1	HGNC:16920	Epidermodysplasia verruciformis 3, 618267 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
618268	TRICHOHEPATONEURODEVELOPMENTAL SYNDROME	Trichohepatoneurodevelopmental syndrome, 618268 (3)	Trichohepatoneurodevelopmental syndrome	y	TRICHOHEPATONEURODEVELOPMENTAL SYNDROME; THNS	Clinical Synopsis	miscarriage|miscarriages	CCDC47	HGNC:24856	Trichohepatoneurodevelopmental syndrome, 618268 (3), Autosomal recessive	Autosomal recessive	y	y	[Multiple miscarriages in families of affected individuals]	L1	n	y	lethal	lethal	lethal	L1	L1	pre-infant-lethal
618273	MEGA-CORPUS-CALLOSUM SYNDROME WITH CEREBELLAR HYPOPLASIA AND CORTICAL MALFORMATIONS	Mega-corpus-callosum syndrome with cerebellar hypoplasia and cortical malformations, 618273 (3)	Mega-corpus-callosum syndrome with cerebellar hypoplasia and cortical malformations	n	-	-	-	MAST1	HGNC:19034	Mega-corpus-callosum syndrome with cerebellar hypoplasia and cortical malformations, 618273 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
618275	HYPOTRICHOSIS 14	Hypotrichosis 14, 618275 (3)	Hypotrichosis 14	n	-	-	-	LSS	HGNC:6708	Hypotrichosis 14, 618275 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
618276	NEURODEGENERATION, CHILDHOOD-ONSET, WITH CEREBELLAR ATROPHY	Neurodegeneration, childhood-onset, with cerebellar atrophy, 618276 (3)	Neurodegeneration, childhood-onset, with cerebellar atrophy	y	NEURODEGENERATION, CHILDHOOD-ONSET, WITH CEREBELLAR ATROPHY; CONDCA	Description|Clinical Features|Clinical Synopsis	death|deaths|died	AGTPBP1	HGNC:17258	Neurodegeneration, childhood-onset, with cerebellar atrophy, 618276 (3), Autosomal recessive	Autosomal recessive	y	y	[Shashi et al. (2018) reported 13 patients from 10 unrelated families, 5 of which were consanguineous, with a severe neurodevelopmental disorder apparent from infancy. Six of the patients died between 4 and 16 months of age, whereas the others were in the first or second decades of life]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
618278	FIBROSIS, NEURODEGENERATION, AND CEREBRAL ANGIOMATOSIS	FINCA syndrome, 618278 (3)	FINCA syndrome	y	FIBROSIS, NEURODEGENERATION, AND CEREBRAL ANGIOMATOSIS; FINCA	Description|Clinical Features|Clinical Synopsis	death|deaths|died	NHLRC2	HGNC:24731	FINCA syndrome, 618278 (3), Autosomal recessive	Autosomal recessive	y	y	[Rapp et al. (2021) reported 6 patients from 3 families of various ethnic origin with disease onset between 0 to 12 months of age. Two of the patients had an overall progressive disease course, 2 patients had a stable disease course, and 2 patients had an intermediate disease course. Four of the patients had exacerbations of respiratory disease, and chest CTs performed in 3 patients showed ground glass opacities with patchy consolidations in 2 and subpleural cyst formation in 1. Neurologic features included developmental delay in 5 patients, irritability in 5, axial hypotonia in 5, and dystonia in 6. Three patients had episodic diarrhea, 4 had feeding problems, and 3 had failure to thrive. One patient had hepatosplenomegaly and 2 patients had transient liver dysfunction. None of the patients had angiomatosis. Two patients died of respiratory distress, at ages 17 and 22 months]	L4	y	-	lethal	lethal	lethal	L4	L4	post-infant-lethal
618279	CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 1G	Charcot-Marie-Tooth disease, demyelinating, type 1G, 618279 (3)	Charcot-Marie-Tooth disease, demyelinating, type 1G	n	-	-	-	PMP2	HGNC:9117	Charcot-Marie-Tooth disease, demyelinating, type 1G, 618279 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
618280	CARDIAC-UROGENITAL SYNDROME	Cardiac-urogenital syndrome, 618280 (3)	Cardiac-urogenital syndrome	y	CARDIAC-UROGENITAL SYNDROME; CUGS	Clinical Features	died	MYRF	HGNC:1181	Cardiac-urogenital syndrome, 618280 (3), Autosomal dominant	Autosomal dominant	y	y	[Pinz et al. (2018) reported 2 unrelated male infants with partial anomalous pulmonary venous return in association with urogenital anomalies...The second patient was a male infant in whom postnatal echocardiogram showed near-interruption of the aortic arch with transverse arch hypoplasia and hypoplastic mitral valve, large ventricular septal defect, large patent ductus arteriosus, dextroposition and hypoplasia of the right pulmonary artery, and mild dilation with hypertrophy of the right ventricle. He also had narrowing of the mid and distal thoracic trachea, as well as right congenital diaphragmatic hernia (CDH), with extension of the hepatic dome into the right hemithorax. At repair of the diaphragmatic hernia, intestinal malrotation was discovered and repaired. Postoperatively he became anuric and died at day 10 of life]	L2	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L2	L2	pre-infant-lethal
618282	HYPER-IgE SYNDROME 3, AUTOSOMAL RECESSIVE, WITH RECURRENT INFECTIONS	Hyper-IgE syndrome 3, autosomal recessive, with recurrent infections, 618282 (3)	Hyper-IgE syndrome 3, autosomal recessive, with recurrent infections	y	HYPER-IgE SYNDROME 3, AUTOSOMAL RECESSIVE, WITH RECURRENT INFECTIONS; HIES3	Clinical Features	died	ZNF341	HGNC:15992	Hyper-IgE syndrome 3, autosomal recessive, with recurrent infections, 618282 (3), Autosomal recessive	Autosomal recessive	y	y	[1 patient died of sepsis at age 28.]	L6	y	-	lethal	lethal	lethal	L6	L6	post-infant-lethal
618284	MICROCEPHALY, CATARACTS, IMPAIRED INTELLECTUAL DEVELOPMENT, AND DYSTONIA WITH ABNORMAL STRIATUM	Microcephaly, cataracts, impaired intellectual development, and dystonia with abnormal striatum, 618284 (3)	Microcephaly, cataracts, impaired intellectual development, and dystonia with abnormal striatum	n	-	-	-	KCNA4	HGNC:6222	Microcephaly, cataracts, impaired intellectual development, and dystonia with abnormal striatum, 618284 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
618285	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 69	Developmental and epileptic encephalopathy 69, 618285 (3)	Developmental and epileptic encephalopathy 69	y	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 69; DEE69	Description|Clinical Features|Clinical Synopsis	death|deaths|died	CACNA1E	HGNC:1392	Developmental and epileptic encephalopathy 69, 618285 (3), Autosomal dominant	Autosomal dominant	y	y	[Helbig et al. (2018) reported 30 unrelated patients with a similar neurodevelopmental disorder characterized by early-onset intractable seizures, severe hypotonia, and severe or profound global developmental delay with absent or very poor speech and inability to sit or walk. Most of the patients were children in the first decade, although there were several teenagers and 1 patient who died at age 25 years. Six further patients died in the first years of life]	L4	y	-	lethal	lethal	lethal	L4	L4	post-infant-lethal
618286	MACROCEPHALY, ACQUIRED, WITH IMPAIRED INTELLECTUAL DEVELOPMENT	Macrocephaly, acquired, with impaired intellectual development, 618286 (3)	Macrocephaly, acquired, with impaired intellectual development	n	-	-	-	NFIB	HGNC:7785	Macrocephaly, acquired, with impaired intellectual development, 618286 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
618287	AUTOINFLAMMATORY DISEASE, FAMILIAL, BEHCET-LIKE 3	Autoinflammatory disease, familial, Behcet-like-3, 618287 (3)	Autoinflammatory disease, familial, Behcet-like-3	y	AUTOINFLAMMATORY DISEASE, FAMILIAL, BEHCET-LIKE 3; AIFBL3	Phenotype	death|deaths	RELA	HGNC:9955	Autoinflammatory disease, familial, Behcet-like-3, 618287 (3), Autosomal dominant	Autosomal dominant	y	n	-	-	-	-	ambiguous	ambiguous	ambiguous	-	-	-
618291	SPINAL MUSCULAR ATROPHY, LOWER EXTREMITY-PREDOMINANT, 2B, PRENATAL ONSET, AUTOSOMAL DOMINANT	Spinal muscular atrophy, lower extremity-predominant, 2B, autosomal dominant, 618291 (3)	Spinal muscular atrophy, lower extremity-predominant, 2B, autosomal dominant	y	SPINAL MUSCULAR ATROPHY, LOWER EXTREMITY-PREDOMINANT, 2B, PRENATAL ONSET, AUTOSOMAL DOMINANT; SMALED2B	Description|Clinical Features|Clinical Synopsis|Phenotype	die|death|deaths|died|lethal	BICD2	HGNC:17208	Spinal muscular atrophy, lower extremity-predominant, 2B, autosomal dominant, 618291 (3), Autosomal dominant	Autosomal dominant	y	y	[Storbeck et al. (2017) reported 3 unrelated patients of European descent with fetal hypokinesia, AMC, severe hypotonia, and respiratory insufficiency resulting in death in the first months of life]	L3	y	-	lethal	ambiguous|lethal	lethal	L3	L3	pre-infant-lethal
618292	NEURODEVELOPMENTAL DISORDER WITH IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND ATAXIA	Neurodevelopmental disorder with impaired intellectual development, hypotonia, and ataxia, 618292 (3)	Neurodevelopmental disorder with impaired intellectual development, hypotonia, and ataxia	n	-	-	-	DOCK3	HGNC:2989	Neurodevelopmental disorder with impaired intellectual development, hypotonia, and ataxia, 618292 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
618295	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 67	Intellectual developmental disorder, autosomal recessive 67, 618295 (3)	Intellectual developmental disorder, autosomal recessive 67	n	-	-	-	EIF3F	HGNC:3275	Intellectual developmental disorder, autosomal recessive 67, 618295 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
618298	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 70	Developmental and epileptic encephalopathy 70, 618298 (3)	Developmental and epileptic encephalopathy 70	n	-	-	-	PHACTR1	HGNC:20990	Developmental and epileptic encephalopathy 70, 618298 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
618300	CILIARY DYSKINESIA, PRIMARY, 40	Ciliary dyskinesia, primary, 40, 618300 (3)	Ciliary dyskinesia, primary, 40	y	CILIARY DYSKINESIA, PRIMARY, 40; CILD40	Clinical Features	died	DNAH9	HGNC:2953	Ciliary dyskinesia, primary, 40, 618300 (3), Autosomal recessive	Autosomal recessive	y	y	[Loges et al. (2018) reported 5 unrelated patients with CILD40 with situs inversus. They had only mild respiratory symptoms, such as recurrent cold-like infections. Nasal nitric oxide was mildly decreased compared to controls. One patient with severe congenital cardiac malformations died at age 8 days]	L2	y	-	lethal	lethal	lethal	L2	L2	pre-infant-lethal
618302	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 68	Intellectual developmental disorder, autosomal recessive 68, 618302 (3)	Intellectual developmental disorder, autosomal recessive 68	n	-	-	-	TRMT1	HGNC:25980	Intellectual developmental disorder, autosomal recessive 68, 618302 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
618314	HYPOMAGNESEMIA, SEIZURES, AND IMPAIRED INTELLECTUAL DEVELOPMENT 2	Hypomagnesemia, seizures, and impaired intellectual development 2, 618314 (3)	Hypomagnesemia, seizures, and impaired intellectual development 2	n	-	-	-	ATP1A1	HGNC:799	Hypomagnesemia, seizures, and impaired intellectual development 2, 618314 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
618316	INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC DEFECTS AND DYSMORPHIC FACIES	Intellectual developmental disorder with cardiac defects and dysmorphic facies, 618316 (3)	Intellectual developmental disorder with cardiac defects and dysmorphic facies	y	INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC DEFECTS AND DYSMORPHIC FACIES; IDDCDF	Clinical Features	died	TMEM94	HGNC:28983	Intellectual developmental disorder with cardiac defects and dysmorphic facies, 618316 (3), Autosomal recessive	Autosomal recessive	y	n	-	-	-	-	ambiguous	ambiguous	ambiguous	-	-	-
618317	BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 7, AUTOSOMAL RECESSIVE	Basal ganglia calcification, idiopathic, 7, autosomal recessive, 618317 (3)	Basal ganglia calcification, idiopathic, 7, autosomal recessive	n	-	-	-	MYORG	HGNC:19918	Basal ganglia calcification, idiopathic, 7, autosomal recessive, 618317 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
618321	ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 2	Encephalopathy, progressive, early-onset, with brain edema and/or leukoencephalopathy, 2, 618321 (3)	Encephalopathy, progressive, early-onset, with brain edema and/or leukoencephalopathy, 2	y	ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 2; PEBEL2	Description|Clinical Features|Clinical Synopsis|Phenotype	death|deaths|died	NAXD	HGNC:25576	Encephalopathy, progressive, early-onset, with brain edema and/or leukoencephalopathy, 2, 618321 (3), Autosomal recessive	Autosomal recessive	y	y	[Van Bergen et al. (2019) reported 6 unrelated children with a similar multisystem disorder resulting in early death in the first years of life]	L4	y	-	lethal	lethal	lethal	L4	L4	post-infant-lethal
618323	MYASTHENIC SYNDROME, CONGENITAL, 25, PRESYNAPTIC	Myasthenic syndrome, congenital, 25, 618323 (3)	Myasthenic syndrome, congenital, 25	y	MYASTHENIC SYNDROME, CONGENITAL, 25, PRESYNAPTIC; CMS25	Clinical Features|Clinical Synopsis	died|lethal|death|deaths	VAMP1	HGNC:12642	Myasthenic syndrome, congenital, 25, 618323 (3), Autosomal recessive	Autosomal recessive	y	y	[Early death may occur / Shen et al. (2017) reported a girl, born of consanguineous Brazilian parents, with a lethal muscle disorder...She died at age 14 years of respiratory failure associated with an infection]	L5	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L5	L5	post-infant-lethal
618324	CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 2	Congenital disorder of glycosylation with defective fucosylation 2, 618324 (3)	Congenital disorder of glycosylation with defective fucosylation 2	n	-	-	-	FCSK	HGNC:29500	Congenital disorder of glycosylation with defective fucosylation 2, 618324 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
618325	LISSENCEPHALY 9 WITH COMPLEX BRAINSTEM MALFORMATION	Lissencephaly 9 with complex brainstem malformation, 618325 (3)	Lissencephaly 9 with complex brainstem malformation	n	-	-	-	MACF1	HGNC:13664	Lissencephaly 9 with complex brainstem malformation, 618325 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
618328	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 71	Developmental and epileptic encephalopathy 71, 618328 (3)	Developmental and epileptic encephalopathy 71	y	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 71; DEE71	Description|Clinical Features|Clinical Synopsis	death|deaths|died	GLS	HGNC:4331	Developmental and epileptic encephalopathy 71, 618328 (3), Autosomal recessive	Autosomal recessive	y	y	[Death in first weeks of life]	L2	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L2	L2	pre-infant-lethal
618329	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 37	Combined oxidative phosphorylation deficiency 37, 618329 (3)	Combined oxidative phosphorylation deficiency 37	y	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 37; COXPD37	Description|Clinical Features|Clinical Synopsis	die|died|fatal|death|deaths	MICOS13	HGNC:33702	Combined oxidative phosphorylation deficiency 37, 618329 (3), Autosomal recessive	Autosomal recessive	y	y	[Zeharia et al. (2016) reported 2 sibs, born of consanguineous parents of Muslim origin, with a fatal multisystem disorder beginning in infancy. After normal development in the first months of life, the patients presented at age 3 and 7 months, respectively, with failure to thrive and hypotonia.... The patients became vegetative and died at 12 months and 5 years of age]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
618330	GLOBAL DEVELOPMENTAL DELAY WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT	Global developmental delay with or without impaired intellectual development, 618330 (3)	Global developmental delay with or without impaired intellectual development	n	-	-	-	CUX1	HGNC:2557	Global developmental delay with or without impaired intellectual development, 618330 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
618331	ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH EPISODIC RHABDOMYOLYSIS	Encephalopathy, progressive, early-onset, with episodic rhabdomyolysis, 618331 (3)	Encephalopathy, progressive, early-onset, with episodic rhabdomyolysis	n	-	-	-	TRAPPC2L	HGNC:30887	Encephalopathy, progressive, early-onset, with episodic rhabdomyolysis, 618331 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
618332	MENKE-HENNEKAM SYNDROME 1	Menke-Hennekam syndrome 1, 618332 (3)	Menke-Hennekam syndrome 1	n	-	-	-	CREBBP	HGNC:2348	Menke-Hennekam syndrome 1, 618332 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L2	L2	pre-infant-lethal
618333	MENKE-HENNEKAM SYNDROME 2	Menke-Hennekam syndrome 2, 618333 (3)	Menke-Hennekam syndrome 2	n	-	-	-	EP300	HGNC:3373	Menke-Hennekam syndrome 2, 618333 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L4	L4	post-infant-lethal
618336	INTRAUTERINE GROWTH RETARDATION, METAPHYSEAL DYSPLASIA, ADRENAL HYPOPLASIA CONGENITA, GENITAL ANOMALIES, AND IMMUNODEFICIENCY	IMAGE-I syndrome, 618336 (3)	IMAGE-I syndrome	y	INTRAUTERINE GROWTH RETARDATION, METAPHYSEAL DYSPLASIA, ADRENAL HYPOPLASIA CONGENITA, GENITAL ANOMALIES, AND IMMUNODEFICIENCY; IMAGEI	Clinical Features	died	POLE	HGNC:9177	IMAGE-I syndrome, 618336 (3), Autosomal recessive	Autosomal recessive	y	y	[Tan et al. (2006) described 2 Australian sisters with IUGR, AHC, and dysmorphic facial features, including frontal bossing and small low-set ears. Both girls had normal genitalia. The older girl died suddenly at age 3 months after developing a respiratory tract infection]	L3	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L3	L3	pre-infant-lethal
618341	SPERMATOGENIC FAILURE 35	Spermatogenic failure 35, 618341 (3)	Spermatogenic failure 35	n	-	-	-	QRICH2	HGNC:25326	Spermatogenic failure 35, 618341 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
618342	INTELLECTUAL DEVELOPMENTAL DISORDER WITH ABNORMAL BEHAVIOR, MICROCEPHALY, AND SHORT STATURE	Intellectual developmental disorder with abnormal behavior, microcephaly, and short stature, 618342 (3)	Intellectual developmental disorder with abnormal behavior, microcephaly, and short stature	n	-	-	-	PUS7	HGNC:26033	Intellectual developmental disorder with abnormal behavior, microcephaly, and short stature, 618342 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
618343	POLYMICROGYRIA WITH OR WITHOUT VASCULAR-TYPE EHLERS-DANLOS SYNDROME	Polymicrogyria with or without vascular-type EDS, 618343 (3)	Polymicrogyria with or without vascular-type EDS	y	POLYMICROGYRIA WITH OR WITHOUT VASCULAR-TYPE EHLERS-DANLOS SYNDROME; PMGEDSV	Description|Clinical Features|Clinical Synopsis	death|deaths|died	COL3A1	HGNC:2201	Polymicrogyria with or without vascular-type EDS, 618343 (3), Autosomal recessive	Autosomal recessive	n	y	[Early death due to vascular dissection may occur / Jorgensen et al. (2015) reported 2 sibs, born of unrelated parents, with a variant of vascular EDS. One died at age 15 years of vascular dissection, including dissection of the thoracic aorta and renal and femoral arteries]	L5	y	-	lethal	lethal	lethal	L5|L6	L5	post-infant-lethal
618346	MICROCEPHALY, GROWTH DEFICIENCY, SEIZURES, AND BRAIN MALFORMATIONS	Microcephaly, growth deficiency, seizures, and brain malformations, 618346 (3)	Microcephaly, growth deficiency, seizures, and brain malformations	y	MICROCEPHALY, GROWTH DEFICIENCY, SEIZURES, AND BRAIN MALFORMATIONS; MIGSB	Clinical Features	died	WDR4	HGNC:12756	Microcephaly, growth deficiency, seizures, and brain malformations, 618346 (3), Autosomal recessive	Autosomal recessive	n	y	[Shaheen et al. (2015) reported 2 unrelated patients (14DG1157 and 14DG1160), each born of consanguineous Egyptian parents, with microcephaly, poor overall growth, and lack of developmental progress.... The patients were unable to raise their heads, had no purposeful eye contact or speech, and made no developmental progress. In each family, a similarly affected sib had died in infancy]	L3	n	y	lethal	lethal|nonlethal	lethal|nonlethal	L3	L3	pre-infant-lethal
618347	GALLOWAY-MOWAT SYNDROME 6	Galloway-Mowat syndrome 6, 618347 (3)	Galloway-Mowat syndrome 6	n	-	-	-	WDR4	HGNC:12756	Galloway-Mowat syndrome 6, 618347 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L3	L3	pre-infant-lethal
618348	GALLOWAY-MOWAT SYNDROME 7	Galloway-Mowat syndrome 7, 618348 (3)	Galloway-Mowat syndrome 7	y	GALLOWAY-MOWAT SYNDROME 7; GAMOS7	Phenotype	lethality	NUP107	HGNC:29914	Galloway-Mowat syndrome 7, 618348 (3), Autosomal recessive	Autosomal recessive	y	n	-	-	-	-	ambiguous	ambiguous|nonlethal	ambiguous	-	-	-
618353	OOCYTE/ZYGOTE/EMBRYO MATURATION ARREST 6	Oocyte/zygote/embryo maturation arrest 6, 618353 (3)	Oocyte/zygote/embryo maturation arrest 6	n	-	-	-	ZP2	HGNC:13188	Oocyte/zygote/embryo maturation arrest 6, 618353 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
618354	HOUGE-JANSSENS SYNDROME 3	Houge-Janssens syndrome 3, 618354 (3)	Houge-Janssens syndrome 3	n	-	-	-	PPP2CA	HGNC:9299	Houge-Janssens syndrome 3, 618354 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
618356	NEURODEVELOPMENTAL DISORDER WITH CENTRAL AND PERIPHERAL MOTOR DYSFUNCTION	Neurodevelopmental disorder with central and peripheral motor dysfunction, 618356 (3)	Neurodevelopmental disorder with central and peripheral motor dysfunction	y	NEURODEVELOPMENTAL DISORDER WITH CENTRAL AND PERIPHERAL MOTOR DYSFUNCTION; NEDCPMD	Clinical Features	died	NFASC	HGNC:29866	Neurodevelopmental disorder with central and peripheral motor dysfunction, 618356 (3), Autosomal recessive	Autosomal recessive	y	y	[Anazi et al. (2017) reported a consanguineous family (14DG0056) in which several patients had a similar neurodevelopmental disorder. Two patients were described in detail. One girl presented in the neonatal period with generalized hypertonia, stridor, and poor feeding necessitating tube placement. She had global developmental delay, no purposeful movements, hyperreflexia, poor overall growth with small head circumference, and no social smile, but she could babble. The other patient, a boy, presented at birth with hypotonia and respiratory insufficiency necessitating mechanical ventilation. He also had dysmorphic features, including hypertelorism, high and broad nasal bridge, micrognathia, glossoptosis, cleft palate, long thin hyperextensible fingers, and 11 pairs of ribs. Brain imaging showed diffuse white matter T2 hyperintensities. Several members of both families had a similar phenotype; at least 1 died at 3 months of age]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
618358	CONE-ROD DYSTROPHY AND HEARING LOSS 2	Cone-rod dystrophy and hearing loss 2, 618358 (3)	Cone-rod dystrophy and hearing loss 2	n	-	-	-	CEP250	HGNC:1859	Cone-rod dystrophy and hearing loss 2, 618358 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
618360	BRAIN SMALL VESSEL DISEASE 3	Brain small vessel disease 3, 618360 (3)	Brain small vessel disease 3	y	BRAIN SMALL VESSEL DISEASE 3; BSVD3	Clinical Features	death|deaths	COLGALT1	HGNC:26182	Brain small vessel disease 3, 618360 (3), Autosomal recessive	Autosomal recessive	n	y	[Miyatake et al. (2018) reported 2 unrelated patients with small vessel disease with variable manifestations.... At age 9 years, he was infected with influenza virus and developed severe neurologic decompensation associated with multiple acute intracranial hemorrhages resulting in death]	L4	y	-	lethal	lethal	lethal	L4	L4	post-infant-lethal
618362	COFFIN-SIRIS SYNDROME 8	Coffin-Siris syndrome 8, 618362 (3)	Coffin-Siris syndrome 8	n	-	-	-	SMARCC2	HGNC:11105	Coffin-Siris syndrome 8, 618362 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
618363	SHORT STATURE, AMELOGENESIS IMPERFECTA, AND SKELETAL DYSPLASIA WITH SCOLIOSIS	Short stature, amelogenesis imperfecta, and skeletal dysplasia with scoliosis, 618363 (3)	Short stature, amelogenesis imperfecta, and skeletal dysplasia with scoliosis	y	SHORT STATURE, AMELOGENESIS IMPERFECTA, AND SKELETAL DYSPLASIA WITH SCOLIOSIS; SSASKS	Clinical Features	death|deaths|spontaneous_abortion|spontaneous_abortions	SLC10A7	HGNC:23088	Short stature, amelogenesis imperfecta, and skeletal dysplasia with scoliosis, 618363 (3), Autosomal recessive	Autosomal recessive	y	y	[The parents of the Iranian patient had a history of multiple pregnancies that resulted in spontaneous abortion and neonatal death due to respiratory distress accompanied by micromelia]	L1	n	y	lethal	lethal	lethal	L1	L1	pre-infant-lethal
618367	NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND HYPOMYELINATION	Neurodevelopmental disorder with microcephaly, epilepsy, and hypomyelination, 618367 (3)	Neurodevelopmental disorder with microcephaly, epilepsy, and hypomyelination	n	-	-	-	MTHFS	HGNC:7437	Neurodevelopmental disorder with microcephaly, epilepsy, and hypomyelination, 618367 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
618369	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 27	Spinocerebellar ataxia, autosomal recessive 27, 618369 (3)	Spinocerebellar ataxia, autosomal recessive 27	y	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 27; SCAR27	Clinical Features	died	GDAP2	HGNC:18010	Spinocerebellar ataxia, autosomal recessive 27, 618369 (3), Autosomal recessive	Autosomal recessive	n	n	-	-	-	-	ambiguous	ambiguous	ambiguous	-	-	-
618371	TURNPENNY-FRY SYNDROME	Turnpenny-Fry syndrome, 618371 (3)	Turnpenny-Fry syndrome	n	-	-	-	PCGF2	HGNC:12929	Turnpenny-Fry syndrome, 618371 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
618372	GASTROINTESTINAL ULCERATION, RECURRENT, WITH DYSFUNCTIONAL PLATELETS	Gastrointestinal ulceration, recurrent, with dysfunctional platelets, 618372 (3)	Gastrointestinal ulceration, recurrent, with dysfunctional platelets	n	-	-	-	PLA2G4A	HGNC:9035	Gastrointestinal ulceration, recurrent, with dysfunctional platelets, 618372 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
618374	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 72	Developmental and epileptic encephalopathy 72, 618374 (3)	Developmental and epileptic encephalopathy 72	n	-	-	-	NEUROD2	HGNC:7763	Developmental and epileptic encephalopathy 72, 618374 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
618379	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 73	Developmental and epileptic encephalopathy 73, 618379 (3)	Developmental and epileptic encephalopathy 73	y	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 73; DEE73	Clinical Features	died	RNF13	HGNC:10057	Developmental and epileptic encephalopathy 73, 618379 (3), Autosomal dominant	Autosomal dominant	y	y	[Edvardson et al. (2019) reported 3 unrelated children with a severe neurodevelopmental and neurodegenerative disorder. ...One patient died at 33 months, whereas the other 2 were alive at 21 months and 8 years]	L4	y	-	lethal	lethal	lethal	L4	L4	post-infant-lethal
618381	FACIAL DYSMORPHISM, HYPERTRICHOSIS, EPILEPSY, INTELLECTUAL/DEVELOPMENTAL DELAY, AND GINGIVAL OVERGROWTH SYNDROME	Facial dysmorphism, hypertrichosis, epilepsy, intellectual/developmental delay, and gingival overgrowth syndrome, 618381 (3)	Facial dysmorphism, hypertrichosis, epilepsy, intellectual/developmental delay, and gingival overgrowth syndrome	n	-	-	-	KCNK4	HGNC:6279	Facial dysmorphism, hypertrichosis, epilepsy, intellectual/developmental delay, and gingival overgrowth syndrome, 618381 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
618383	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 69	Intellectual developmental disorder, autosomal recessive 69, 618383 (3)	Intellectual developmental disorder, autosomal recessive 69	n	-	-	-	ZBTB11	HGNC:16740	Intellectual developmental disorder, autosomal recessive 69, 618383 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
618384	LEUKOENCEPHALOPATHY, ACUTE REVERSIBLE, WITH INCREASED URINARY ALPHA-KETOGLUTARATE	Leukoencephalopathy, acute reversible, with increased urinary alpha-ketoglutarate, 618384 (3)	Leukoencephalopathy, acute reversible, with increased urinary alpha-ketoglutarate	n	-	-	-	SLC13A3	HGNC:14430	Leukoencephalopathy, acute reversible, with increased urinary alpha-ketoglutarate, 618384 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
618386	AMELOGENESIS IMPERFECTA, TYPE IIIC	Amelogenesis imperfecta, type IIIC, 618386 (3)	Amelogenesis imperfecta, type IIIC	n	-	-	-	RELT	HGNC:13764	Amelogenesis imperfecta, type IIIC, 618386 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
618387	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE, WITH AXONAL NEUROPATHY 3	Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 3, 618387 (3)	Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 3	n	-	-	-	COA7	HGNC:25716	Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 3, 618387 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
618388	FETAL AKINESIA DEFORMATION SEQUENCE 2	Fetal akinesia deformation sequence 2, 618388 (3)	Fetal akinesia deformation sequence 2	y	FETAL AKINESIA DEFORMATION SEQUENCE 2; FADS2	Description|Clinical Features	lethal|death|deaths	RAPSN	HGNC:9863	Fetal akinesia deformation sequence 2, 618388 (3), Autosomal recessive	Autosomal recessive	y	y	[Michalk et al. (2008) described 2 sibs in a Pakistani family with fetal akinesia syndrome with congenital contractures. Respiratory distress resulted in the death of 1 sib at age 10 months]	L3	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L3	L3	pre-infant-lethal
618389	FETAL AKINESIA DEFORMATION SEQUENCE 3	Fetal akinesia deformation sequence 3, 618389 (3)	Fetal akinesia deformation sequence 3	y	FETAL AKINESIA DEFORMATION SEQUENCE 3; FADS3	Description|Clinical Features|Clinical Synopsis|Phenotype	lethal|demise|stillborn|death|deaths	DOK7	HGNC:26594	Fetal akinesia deformation sequence 3, 618389 (3), Autosomal recessive	Autosomal recessive	y	y	[Lethal in utero]	L1	y	-	lethal	ambiguous|lethal	lethal	L1	L1	pre-infant-lethal
618393	FETAL AKINESIA DEFORMATION SEQUENCE 4	Fetal akinesia deformation sequence 4, 618393 (3)	Fetal akinesia deformation sequence 4	y	FETAL AKINESIA DEFORMATION SEQUENCE 4; FADS4	Description|Clinical Features|Clinical Synopsis	death|deaths|died|lethal|miscarriage|miscarriages	NUP88	HGNC:8067	Fetal akinesia deformation sequence 4, 618393 (3), Autosomal recessive	Autosomal recessive	y	y	[Death in utero or soon after birth]	L1	y	-	lethal	lethal	lethal	L1	L1	pre-infant-lethal
618394	IMMUNODEFICIENCY 60 AND AUTOIMMUNITY	Immunodeficiency 60 and autoimmunity, 618394 (3)	Immunodeficiency 60 and autoimmunity	n	-	-	-	BACH2	HGNC:14078	Immunodeficiency 60 and autoimmunity, 618394 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
618395	SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY, TYPE 3	Spondyloepimetaphyseal dysplasia with joint laxity, type 3, 618395 (3)	Spondyloepimetaphyseal dysplasia with joint laxity, type 3	n	-	-	-	EXOC6B	HGNC:17085	Spondyloepimetaphyseal dysplasia with joint laxity, type 3, 618395 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
618396	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 74	Developmental and epileptic encephalopathy 74, 618396 (3)	Developmental and epileptic encephalopathy 74	n	-	-	-	GABRG2	HGNC:4087	Developmental and epileptic encephalopathy 74, 618396 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
618397	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 39	Combined oxidative phosphorylation deficiency 39, 618397 (3)	Combined oxidative phosphorylation deficiency 39	y	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 39; COXPD39	Clinical Features	death|deaths|died	GFM2	HGNC:29682	Combined oxidative phosphorylation deficiency 39, 618397 (3), Autosomal recessive	Autosomal recessive	n	y	[Fukumura et al. (2015) reported 2 Japanese sisters with a severe neurodevelopmental disorder. Both patients were born with arthrogryposis multiplex congenita and showed severe hypotonia. The older sib had enlarged lateral ventricles and hypoplasia of the corpus callosum, but no cortical malformations. She developed refractory seizures with hypsarrhythmia at age 3 months, and died at age 13 months after showing no developmental progress]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
618398	T-CELL LYMPHOMA, SUBCUTANEOUS PANNICULITIS-LIKE	T-cell lymphoma, subcutaneous panniculitis-like, 618398 (3)	T-cell lymphoma, subcutaneous panniculitis-like	n	-	-	-	HAVCR2	HGNC:18437	T-cell lymphoma, subcutaneous panniculitis-like, 618398 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
618400	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2EE	Charcot-Marie-Tooth disease, axonal, type 2EE, 618400 (3)	Charcot-Marie-Tooth disease, axonal, type 2EE	y	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2EE; CMT2EE	Clinical Features	fatal	MPV17	HGNC:7224	Charcot-Marie-Tooth disease, axonal, type 2EE, 618400 (3), Autosomal recessive	Autosomal recessive	n	n	-	-	-	-	ambiguous	ambiguous|lethal	lethal	L1	L1	pre-infant-lethal
618402	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 70	Intellectual developmental disorder, autosomal recessive 70, 618402 (3)	Intellectual developmental disorder, autosomal recessive 70	n	-	-	-	RSRC1	HGNC:24152	Intellectual developmental disorder, autosomal recessive 70, 618402 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
618404	LEUKODYSTROPHY, HYPOMYELINATING, 18	Leukodystrophy, hypomyelinating, 18, 618404 (3)	Leukodystrophy, hypomyelinating, 18	y	LEUKODYSTROPHY, HYPOMYELINATING, 18; HLD18	Clinical Features|Clinical Synopsis	died|death|deaths	DEGS1	HGNC:13709	Leukodystrophy, hypomyelinating, 18, 618404 (3), Autosomal recessive	Autosomal recessive	y	n	-	-	-	-	ambiguous	ambiguous	ambiguous	-	-	-
618406	BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 20	Obesity (BMIQ20), 618406 (3)	Obesity (BMIQ20)	n	-	-	-	MC4R	HGNC:6932	Obesity (BMIQ20), 618406 (3), Autosomal dominant, Autosomal recessive	Autosomal dominant, Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
618410	DEAFNESS, AUTOSOMAL RECESSIVE 113	Deafness, autosomal recessive 113, 618410 (3)	Deafness, autosomal recessive 113	n	-	-	-	CEACAM16	HGNC:31948	Deafness, autosomal recessive 113, 618410 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
618412	GLOBAL DEVELOPMENTAL DELAY, PROGRESSIVE ATAXIA, AND ELEVATED GLUTAMINE	Global developmental delay, progressive ataxia, and elevated glutamine, 618412 (3)	Global developmental delay, progressive ataxia, and elevated glutamine	n	-	-	-	GLS	HGNC:4331	Global developmental delay, progressive ataxia, and elevated glutamine, 618412 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L2	L2	pre-infant-lethal
618414	CONGENITAL MYOPATHY 14	Congenital myopathy 14, 618414 (3)	Congenital myopathy 14	y	CONGENITAL MYOPATHY 14; CMYP14	Clinical Features|Clinical Synopsis	died|death|deaths	MYL1	HGNC:7582	Congenital myopathy 14, 618414 (3), Autosomal recessive	Autosomal recessive	y	y	[died from respiratory failure at 7 months of age]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
618415	CATARACT 48	Cataract 48, 618415 (3)	Cataract 48	n	-	-	-	DNMBP	HGNC:30373	Cataract 48, 618415 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
618416	METABOLIC CRISES, RECURRENT, WITH VARIABLE ENCEPHALOMYOPATHIC FEATURES AND NEUROLOGIC REGRESSION	Metabolic crises, recurrent, with variable encephalomyopathic features and neurologic regression, 618416 (3)	Metabolic crises, recurrent, with variable encephalomyopathic features and neurologic regression	n	-	-	-	SLC25A42	HGNC:28380	Metabolic crises, recurrent, with variable encephalomyopathic features and neurologic regression, 618416 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
618418	SPASTIC PARAPLEGIA 80, AUTOSOMAL DOMINANT	Spastic paraplegia 80, autosomal dominant, 618418 (3)	Spastic paraplegia 80, autosomal dominant	n	-	-	-	UBAP1	HGNC:12461	Spastic paraplegia 80, autosomal dominant, 618418 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
618419	MYOECTODERMAL GONADAL DYSGENESIS SYNDROME	Myoectodermal gonadal dysgenesis syndrome, 618419 (3)	Myoectodermal gonadal dysgenesis syndrome	n	-	-	-	PPP2R3C	HGNC:17485	Myoectodermal gonadal dysgenesis syndrome, 618419 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
618420	SPERMATOGENIC FAILURE 36	Spermatogenic failure 36, 618420 (3)	Spermatogenic failure 36	n	-	-	-	PPP2R3C	HGNC:17485	Spermatogenic failure 36, 618420 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
618422	DEAFNESS, AUTOSOMAL RECESSIVE 100	Deafness, autosomal recessive 100, 618422 (3)	Deafness, autosomal recessive 100	n	-	-	-	PPIP5K2	HGNC:29035	Deafness, autosomal recessive 100, 618422 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
618425	NEURODEVELOPMENTAL DISORDER WITH IMPAIRED SPEECH AND HYPERKINETIC MOVEMENTS	Neurodevelopmental disorder with impaired speech and hyperkinetic movements, 618425 (3)	Neurodevelopmental disorder with impaired speech and hyperkinetic movements	y	NEURODEVELOPMENTAL DISORDER WITH IMPAIRED SPEECH AND HYPERKINETIC MOVEMENTS; NEDISHM	Clinical Features	died	ZNF142	HGNC:12927	Neurodevelopmental disorder with impaired speech and hyperkinetic movements, 618425 (3), Autosomal recessive	Autosomal recessive	y	y	[Khan et al. (2019) reported 7 patients from 4 unrelated families with NEDISHM. The patients ranged in age from 10 to 35 years... In family C, a presumably affected sib had died of seizures at age 9 years]	L4	n	y	lethal	lethal	lethal	L4	L4	post-infant-lethal
618429	SPERMATOGENIC FAILURE 37	Spermatogenic failure 37, 618429 (3)	Spermatogenic failure 37	n	-	-	-	TTC21A	HGNC:30761	Spermatogenic failure 37, 618429 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
618430	DEVELOPMENTAL DELAY WITH VARIABLE INTELLECTUAL IMPAIRMENT AND BEHAVIORAL ABNORMALITIES	Developmental delay with variable intellectual impairment and behavioral abnormalities, 618430 (3)	Developmental delay with variable intellectual impairment and behavioral abnormalities	n	-	-	-	TCF20	HGNC:11631	Developmental delay with variable intellectual impairment and behavioral abnormalities, 618430 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
618431	HYDATIDIFORM MOLE, RECURRENT, 3	Hydatidiform mole, recurrent, 3, 618431 (3)	Hydatidiform mole, recurrent, 3	y	HYDATIDIFORM MOLE, RECURRENT, 3; HYDM3	Clinical Features|Phenotype	miscarriage|miscarriages	MEI1	HGNC:28613	Hydatidiform mole, recurrent, 3, 618431 (3), Autosomal recessive	Autosomal recessive	y	n	-	-	-	-	ambiguous	ambiguous	ambiguous	-	-	-
618432	HYDATIDIFORM MOLE, RECURRENT, 4	Hydatidiform mole, recurrent, 4, 618432 (3)	Hydatidiform mole, recurrent, 4	y	HYDATIDIFORM MOLE, RECURRENT, 4; HYDM4	Clinical Features|Clinical Synopsis|Phenotype	miscarriage|miscarriages|spontaneous_abortion|spontaneous_abortions	TOP6BL	HGNC:26197	Hydatidiform mole, recurrent, 4, 618432 (3), Autosomal recessive	Autosomal recessive	y	n	-	-	-	-	ambiguous	ambiguous	ambiguous	-	-	-
618433	SPERMATOGENIC FAILURE 38	Spermatogenic failure 38, 618433 (3)	Spermatogenic failure 38	n	-	-	-	ARMC2	HGNC:23045	Spermatogenic failure 38, 618433 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
618435	ARTHROGRYPOSIS, DISTAL, TYPE 2B2	Arthrogryposis, distal, type 2B2, 618435 (3)	Arthrogryposis, distal, type 2B2	n	-	-	-	TNNT3	HGNC:11950	Arthrogryposis, distal, type 2B2, 618435 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
618436	ARTHROGRYPOSIS, DISTAL, TYPE 2B3	Arthrogryposis, distal, type 2B3 (Sheldon-Hall), 618436 (3)	Arthrogryposis, distal, type 2B3 (Sheldon-Hall)	n	-	-	-	MYH3	HGNC:7573	Arthrogryposis, distal, type 2B3 (Sheldon-Hall), 618436 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
618437	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 75	Developmental and epileptic encephalopathy 75, 618437 (3)	Developmental and epileptic encephalopathy 75	y	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 75; DEE75	Description|Clinical Features|Clinical Synopsis	death|deaths|died	PARS2	HGNC:30563	Developmental and epileptic encephalopathy 75, 618437 (3), Autosomal recessive	Autosomal recessive	y	y	[Yin et al. (2018) reported 2 Chinese sisters with DEE75 who showed delayed psychomotor development from infancy with inability to control the head until 3 to 6 months of age and poor feeding. Both developed intractable frequent seizures associated with hypsarrhythmia within the first year of life, and thereafter had essentially no development. The phenotype was consistent with West syndrome. They had hypotonia, dystonia, and progressive microcephaly. Brain imaging showed T2-weighted hyperintensities in the subcortical white matter and cerebellum, atrophy of the frontal lobes, generalized cortical atrophy, and delayed myelination. Both had increased serum lactate. Neither had other organ involvement. One sib died of pneumonia at 4 months of age]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
618440	OCULOSKELETODENTAL SYNDROME	Oculoskeletodental syndrome, 618440 (3)	Oculoskeletodental syndrome	n	-	-	-	PIK3C2A	HGNC:8971	Oculoskeletodental syndrome, 618440 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
618443	NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT VARIABLE BRAIN ABNORMALITIES	Neurodevelopmental disorder with or without variable brain abnormalities, 618443 (3)	Neurodevelopmental disorder with or without variable brain abnormalities	n	-	-	-	MAPK8IP3	HGNC:6884	Neurodevelopmental disorder with or without variable brain abnormalities, 618443 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
618447	LONG QT SYNDROME 8	Long QT syndrome 8, 618447 (3)	Long QT syndrome 8	y	LONG QT SYNDROME 8; LQT8	Description|Clinical Features|Clinical Synopsis	death|deaths|died	CACNA1C	HGNC:1390	Long QT syndrome 8, 618447 (3), Autosomal dominant	Autosomal dominant	n	y	[Congenital long QT syndrome is electrocardiographically characterized by a prolonged QT interval and polymorphic ventricular arrhythmias (torsade de pointes). ... In the second family, the proband was a 15-year-old boy who was diagnosed with LQT8 (Qtc of 514 ms) after the sudden unexplained death of his 12-year-old sister during sleep. His mother, maternal grandmother, maternal great uncle, and maternal great aunt all had a history of syncopal events during childhood]	L5	n	y	lethal	lethal|nonlethal	lethal|nonlethal	L4|L5	L4	post-infant-lethal
618451	NEURODEGENERATION, EARLY-ONSET, WITH CHOREOATHETOID MOVEMENTS AND MICROCYTIC ANEMIA	Neurodegeneration, early-onset, with choreoathetoid movements and microcytic anemia, 618451 (3)	Neurodegeneration, early-onset, with choreoathetoid movements and microcytic anemia	y	NEURODEGENERATION, EARLY-ONSET, WITH CHOREOATHETOID MOVEMENTS AND MICROCYTIC ANEMIA; NDCAMA	Clinical Features	death|deaths	IREB2	HGNC:6115	Neurodegeneration, early-onset, with choreoathetoid movements and microcytic anemia, 618451 (3), Autosomal recessive	Autosomal recessive	n	y	[Cooper et al. (2019) reported a boy, born of unrelated Australian parents, with a severe neurodegenerative disorder resulting in death at 10 years of age]	L5	y	-	lethal	lethal	lethal	L5	L5	post-infant-lethal
618454	DEVELOPMENTAL DELAY WITH OR WITHOUT DYSMORPHIC FACIES AND AUTISM	Developmental delay with or without dysmorphic facies and autism, 618454 (3)	Developmental delay with or without dysmorphic facies and autism	y	DEVELOPMENTAL DELAY WITH OR WITHOUT DYSMORPHIC FACIES AND AUTISM; DEDDFA	Clinical Features	died	TRRAP	HGNC:12347	Developmental delay with or without dysmorphic facies and autism, 618454 (3), Autosomal dominant	Autosomal dominant	y	y	[Cogne et al. (2019) reported 13 unrelated patients (patients 4-16) with global developmental delay and variably impaired intellectual development associated with de novo heterozygous mutations affecting residues 1031-1159 of TRRAP... One patient died at age 12 years with multiple congenital anomalies affecting the cardiac, renal, and endocrine system]	L5	y	-	lethal	lethal	lethal	L5	L5	post-infant-lethal
618456	DEAFNESS, AUTOSOMAL RECESSIVE 114	Deafness, autosomal recessive 114, 618456 (3)	Deafness, autosomal recessive 114	n	-	-	-	GRAP	HGNC:4562	Deafness, autosomal recessive 114, 618456 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
618460	KHAN-KHAN-KATSANIS SYNDROME	Khan-Khan-Katsanis syndrome, 618460 (3)	Khan-Khan-Katsanis syndrome	y	KHAN-KHAN-KATSANIS SYNDROME; 3KS	Clinical Features|Phenotype	died|death|deaths	NCAPG2	HGNC:21904	Khan-Khan-Katsanis syndrome, 618460 (3), Autosomal recessive	Autosomal recessive	n	y	[Khan et al. (2019) reported 2 unrelated girls with a complex syndromic neurodevelopmental disorder. The phenotypes were somewhat different, but the patients shared several core features, including poor overall growth with microcephaly, renal and skeletal abnormalities, and developmental delay. Both pregnancies were complicated by advanced maternal age (37 and 39 years). Patient 1, of European American origin, was 11 years old, whereas patient 2, of Mexican origin, had died of unknown causes at 4 months of age]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
618463	HYPOALPHALIPOPROTEINEMIA, PRIMARY, 2	Hypoalphalipoproteinemia, primary, 2, 618463 (3)	Hypoalphalipoproteinemia, primary, 2	y	HYPOALPHALIPOPROTEINEMIA, PRIMARY, 2	Clinical Features	died	APOA1	HGNC:600	Hypoalphalipoproteinemia, primary, 2, 618463 (3), Autosomal recessive	Autosomal recessive	y	n	-	-	-	-	ambiguous	ambiguous|lethal|nonlethal	lethal|nonlethal	LU	LU	post-infant-lethal
618464	PHEOCHROMOCYTOMA/PARAGANGLIOMA SYNDROME 6	Pheochromocytoma/paraganglioma syndrome 6, 618464 (3)	Pheochromocytoma/paraganglioma syndrome 6	n	-	-	-	SLC25A11	HGNC:10981	Pheochromocytoma/paraganglioma syndrome 6, 618464 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
618468	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 76	Developmental and epileptic encephalopathy 76, 618468 (3)	Developmental and epileptic encephalopathy 76	y	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 76; DEE76	Description|Clinical Features|Clinical Synopsis|Phenotype	death|deaths|died	ACTL6B	HGNC:160	Developmental and epileptic encephalopathy 76, 618468 (3), Autosomal recessive	Autosomal recessive	y	y	[Maddirevula et al. (2019) reported a 13-month-old girl (patient 17-1447), born of consanguineous parents, with a neurodevelopmental disorder. Clinical details were limited, but the patient reportedly presented with hyperekplexia and global developmental delay. Brain imaging showed agenesis of the corpus callosum, mild dilatation of the ventricles, mild atrophic changes, a simplified gyral pattern with prominent sulci, and mild posterior colpocephaly. Family history revealed that a similarly affected brother had died at 2 months of age / Bell et al. (2019) reported 11 children from 10 unrelated families (R1-R10) with a similar phenotype consistent with DEE76. The patients ranged from 5 months to 8 years of age; 3 died between 2 and 5 years of age]	L3	y	y	lethal	lethal|nonlethal	lethal|nonlethal	L3	L3	pre-infant-lethal
618469	CONTRACTURES, PTERYGIA, AND SPONDYLOCARPOTARSAL FUSION SYNDROME 1B	Contractures, pterygia, and spondylocarpotarsal fusion syndrome 1B, 618469 (3)	Contractures, pterygia, and spondylocarpotarsal fusion syndrome 1B	n	-	-	-	MYH3	HGNC:7573	Contractures, pterygia, and spondylocarpotarsal fusion syndrome 1B, 618469 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
618470	INTELLECTUAL DEVELOPMENTAL DISORDER WITH SEVERE SPEECH AND AMBULATION DEFECTS	Intellectual developmental disorder with severe speech and ambulation defects, 618470 (3)	Intellectual developmental disorder with severe speech and ambulation defects	n	-	-	-	ACTL6B	HGNC:160	Intellectual developmental disorder with severe speech and ambulation defects, 618470 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L3	L3	pre-infant-lethal
618475	PHEOCHROMOCYTOMA/PARAGANGLIOMA SYNDROME 7	Pheochromocytoma/paraganglioma syndrome 7, 618475 (3)	Pheochromocytoma/paraganglioma syndrome 7	n	-	-	-	DLST	HGNC:2911	Pheochromocytoma/paraganglioma syndrome 7, 618475 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
618476	BRAIN ABNORMALITIES, NEURODEGENERATION, AND DYSOSTEOSCLEROSIS	Brain abnormalities, neurodegeneration, and dysosteosclerosis, 618476 (3)	Brain abnormalities, neurodegeneration, and dysosteosclerosis	y	BRAIN ABNORMALITIES, NEURODEGENERATION, AND DYSOSTEOSCLEROSIS; BANDDOS	Clinical Features|Phenotype	died|lethal	CSF1R	HGNC:2433	Brain abnormalities, neurodegeneration, and dysosteosclerosis, 618476 (3), Autosomal recessive	Autosomal recessive	n	y	[Oosterhof et al. (2019) reported 2 unrelated patients with highly variable phenotypic expression of BANDDOS. The first patient, born of consanguineous Native Alaskan parents, presented at birth with multiple congenital brain anomalies first detected in prenatal ultrasound and associated with increased alpha-fetoprotein (104150). He had macrocephaly (+5 SD) and dysmorphic features, including cranial asymmetry, flattened midface, depressed nasal bridge, and bony prominences in the parietal skull. Skeletal survey showed a dense skeleton with irregular metaphyses. He also had hearing loss, respiratory difficulties, feeding difficulties, intractable seizures, and persistent hypocalcemia. He died of bacteremia at age 10 months]	L3	y	-	lethal	lethal	lethal	L3|L6	L3	pre-infant-lethal
618479	CEREBELLAR, OCULAR, CRANIOFACIAL, AND GENITAL SYNDROME	Cerebellar, ocular, craniofacial, and genital syndrome, 618479 (3)	Cerebellar, ocular, craniofacial, and genital syndrome	n	-	-	-	MAB21L1	HGNC:6757	Cerebellar, ocular, craniofacial, and genital syndrome, 618479 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
618480	NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND SPEECH AND WALKING IMPAIRMENT	Neurodevelopmental disorder with seizures and speech and walking impairment, 618480 (3)	Neurodevelopmental disorder with seizures and speech and walking impairment	n	-	-	-	DHPS	HGNC:2869	Neurodevelopmental disorder with seizures and speech and walking impairment, 618480 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
618481	DEAFNESS, AUTOSOMAL RECESSIVE 99	Deafness, autosomal recessive 99, 618481 (3)	Deafness, autosomal recessive 99	n	-	-	-	TMEM132E	HGNC:26991	Deafness, autosomal recessive 99, 618481 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
618482	GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 10	Generalized epilepsy with febrile seizures plus, type 10, 618482 (3)	Generalized epilepsy with febrile seizures plus, type 10	n	-	-	-	HCN1	HGNC:4845	Generalized epilepsy with febrile seizures plus, type 10, 618482 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L3	L3	pre-infant-lethal
618484	ARTHROGRYPOSIS MULTIPLEX CONGENITA 3, MYOGENIC TYPE	Arthrogryposis multiplex congenita 3, myogenic type, 618484 (3)	Arthrogryposis multiplex congenita 3, myogenic type	y	ARTHROGRYPOSIS MULTIPLEX CONGENITA 3, MYOGENIC TYPE; AMC3	Clinical Features	died	SYNE1	HGNC:17089	Arthrogryposis multiplex congenita 3, myogenic type, 618484 (3), Autosomal recessive	Autosomal recessive	y	y	[Baumann et al. (2017) reported an 8-year-old boy, born of consanguineous Turkish parents, with AMC3... Family history revealed that an older brother had presented with severe muscular hypotonia at birth and died at the age of 4 months from respiratory failure]	L3	n	y	lethal	lethal|nonlethal	lethal|nonlethal	L3|L6	L3	pre-infant-lethal
618492	NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY AND STRUCTURAL BRAIN ANOMALIES	Neurodevelopmental disorder with microcephaly and structural brain anomalies, 618492 (3)	Neurodevelopmental disorder with microcephaly and structural brain anomalies	n	-	-	-	DYNC1I2	HGNC:2964	Neurodevelopmental disorder with microcephaly and structural brain anomalies, 618492 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
618493	HYPOTONIA, HYPOVENTILATION, IMPAIRED INTELLECTUAL DEVELOPMENT, DYSAUTONOMIA, EPILEPSY, AND EYE ABNORMALITIES	Hypotonia, hypoventilation, impaired intellectual development, dysautonomia, epilepsy, and eye abnormalities, 618493 (3)	Hypotonia, hypoventilation, impaired intellectual development, dysautonomia, epilepsy, and eye abnormalities	y	HYPOTONIA, HYPOVENTILATION, IMPAIRED INTELLECTUAL DEVELOPMENT, DYSAUTONOMIA, EPILEPSY, AND EYE ABNORMALITIES; HIDEA	Description|Clinical Features|Clinical Synopsis	death|deaths|died	P4HTM	HGNC:28858	Hypotonia, hypoventilation, impaired intellectual development, dysautonomia, epilepsy, and eye abnormalities, 618493 (3), Autosomal recessive	Autosomal recessive	n	y	[Rahikkala et al. (2019) reported 7 patients from 4 unrelated families with HIDEA syndrome and reviewed the large Finnish family reported by Kaasinen et al. (2014). The families were Finnish, American, Turkish, and Syrian. Four patients died between 7 months and 8 years of age, whereas 3 were alive between 3 and 18 years of age]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
618494	CONGENITAL HYPOTONIA, EPILEPSY, DEVELOPMENTAL DELAY, AND DIGITAL ANOMALIES	Congenital hypotonia, epilepsy, developmental delay, and digital anomalies, 618494 (3)	Congenital hypotonia, epilepsy, developmental delay, and digital anomalies	y	CONGENITAL HYPOTONIA, EPILEPSY, DEVELOPMENTAL DELAY, AND DIGITAL ANOMALIES; CHEDDA	Clinical Features	died	ATN1	HGNC:3033	Congenital hypotonia, epilepsy, developmental delay, and digital anomalies, 618494 (3), Autosomal dominant	Autosomal dominant	y	y	[Palmer et al. (2019) reported 8 unrelated patients, ranging in age from 2 months to 9 years, with a similar neurodevelopmental disorder. One of the patients (patient 8), who died at 2 months of age, had previously been reported by Mosca et al. (2007) as having a multiple congenital anomaly syndrome with dysmorphic facial features, cleft palate, axial hypotonia, peripheral hypertonia, polymicrogyria, and cerebellar vermis hypoplasia]	L3	y	-	lethal	lethal	lethal	L3|L6	L3	pre-infant-lethal
618495	IMMUNODEFICIENCY 63 WITH LYMPHOPROLIFERATION AND AUTOIMMUNITY	Immunodeficiency 63 with lymphoproliferation and autoimmunity, 618495 (3)	Immunodeficiency 63 with lymphoproliferation and autoimmunity	y	IMMUNODEFICIENCY 63 WITH LYMPHOPROLIFERATION AND AUTOIMMUNITY; IMD63	Description|Clinical Features|Clinical Synopsis|Phenotype	die|died|fatal|death|deaths	IL2RB	HGNC:6009	Immunodeficiency 63 with lymphoproliferation and autoimmunity, 618495 (3), Autosomal recessive	Autosomal recessive	n	y	[Zhang et al. (2019) reported 8 patients from 4 consanguineous families, of South Asian, Middle Eastern, and Eastern European descent, with IMD63. Five patients from 3 families (families A, B, and C) presented in infancy or early childhood with features of autoimmunity and immune deficiency.... . Three of these patients died in the first years of life; 1 was alive after hematopoietic stem cell transplant and 1 was alive at 5 years of age on rituximab therapy. In the fourth family (family D), 3 sibs had onset of symptoms in utero, including intrauterine growth retardation, reduced fetal movements, and skin-like floating membranes in amniotic fluid, consistent with autoimmune desquamative dermatitis. One of these patients was delivered prematurely and died 2 hours after birth; the other 2 affected pregnancies were terminated]	L2	y	-	lethal	lethal	lethal	L2	L2	pre-infant-lethal
618496	AORTIC VALVE DISEASE 3	Aortic valve disease 3, 618496 (3)	Aortic valve disease 3	n	-	-	-	ROBO4	HGNC:17985	Aortic valve disease 3, 618496 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
618497	NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND NONEPILEPTIC HYPERKINETIC MOVEMENTS	Neurodevelopmental disorder with seizures and nonepileptic hyperkinetic movements, 618497 (3)	Neurodevelopmental disorder with seizures and nonepileptic hyperkinetic movements	y	NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND NONEPILEPTIC HYPERKINETIC MOVEMENTS; NEDNEH	Description|Clinical Features|Clinical Synopsis	die|died|death|deaths	CACNA1B	HGNC:1389	Neurodevelopmental disorder with seizures and nonepileptic hyperkinetic movements, 618497 (3), Autosomal recessive	Autosomal recessive	n	y	[Gorman et al. (2019) reported 6 patients from 3 unrelated families with a similar neurodevelopmental disorder. A consanguineous family from Pakistan contained 3 affected sibs, a nonconsanguineous European family contained 2 affected sibs, and a single patient, of Bulgarian descent, was adopted with unknown family history. All patients died between 3 and 17 years of age, mainly from respiratory failure, except the adopted girl who was alive at 6 years of age]	L4	y	-	lethal	lethal	lethal	L4	L4	post-infant-lethal
618498	POLYDACTYLY, POSTAXIAL, TYPE A10	Polydactyly, postaxial, type A10, 618498 (3)	Polydactyly, postaxial, type A10	n	-	-	-	KIAA0825	HGNC:28532	Polydactyly, postaxial, type A10, 618498 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
618499	NOONAN SYNDROME 11	Noonan syndrome 11, 618499 (3)	Noonan syndrome 11	n	-	-	-	MRAS	HGNC:7227	Noonan syndrome 11, 618499 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
618500	HOLOPROSENCEPHALY 12 WITH OR WITHOUT PANCREATIC AGENESIS	Holoprosencephaly 12, with or without pancreatic agenesis, 618500 (3)	Holoprosencephaly 12, with or without pancreatic agenesis	y	HOLOPROSENCEPHALY 12 WITH OR WITHOUT PANCREATIC AGENESIS; HPE12	Clinical Features|Clinical Synopsis	died|death|deaths	CNOT1	HGNC:7877	Holoprosencephaly 12, with or without pancreatic agenesis, 618500 (3), Autosomal dominant	Autosomal dominant	y	y	[De Franco et al. (2019) reported 3 unrelated patients with variable features suggestive of holoprosencephaly who were brought to attention due to congenital pancreatic agenesis... One (patient P01) had muscle weakness, low-set ears, onset of complex focal seizures at age 3, and mild learning difficulties at age 9 years. The second patient (P02), previously reported by Hilbrands et al. (2017), died at age 12 week]	L3	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L3	L3	pre-infant-lethal
618501	CEREBELLAR ATROPHY WITH SEIZURES AND VARIABLE DEVELOPMENTAL DELAY	Cerebellar atrophy with seizures and variable developmental delay, 618501 (3)	Cerebellar atrophy with seizures and variable developmental delay	n	-	-	-	CACNA2D2	HGNC:1400	Cerebellar atrophy with seizures and variable developmental delay, 618501 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
618504	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 71	Intellectual developmental disorder, autosomal recessive 71, 618504 (3)	Intellectual developmental disorder, autosomal recessive 71	n	-	-	-	ALKBH8	HGNC:25189	Intellectual developmental disorder, autosomal recessive 71, 618504 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
618505	NEURODEVELOPMENTAL DISORDER WITH COARSE FACIES AND MILD DISTAL SKELETAL ABNORMALITIES	Neurodevelopmental disorder with coarse facies and mild distal skeletal abnormalities, 618505 (3)	Neurodevelopmental disorder with coarse facies and mild distal skeletal abnormalities	n	-	-	-	KDM6B	HGNC:29012	Neurodevelopmental disorder with coarse facies and mild distal skeletal abnormalities, 618505 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
618506	INTELLECTUAL DEVELOPMENTAL DISORDER WITH SPEECH DELAY AND DYSMORPHIC FACIES	Coffin-Siris syndrome 10, 618506 (3)	Coffin-Siris syndrome 10	n	-	-	-	SOX4	HGNC:11200	Coffin-Siris syndrome 10, 618506 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
618511	NEUROPATHY, HEREDITARY MOTOR AND SENSORY, TYPE VIC, WITH OPTIC ATROPHY	Neuropathy, hereditary motor and sensory, type VIC, with optic atrophy, 618511 (3)	Neuropathy, hereditary motor and sensory, type VIC, with optic atrophy	y	NEUROPATHY, HEREDITARY MOTOR AND SENSORY, TYPE VIC, WITH OPTIC ATROPHY; HMSN6C	Clinical Features	died	PDXK	HGNC:8819	Neuropathy, hereditary motor and sensory, type VIC, with optic atrophy, 618511 (3), Autosomal recessive	Autosomal recessive	n	n	-	-	-	-	ambiguous	ambiguous	ambiguous	-	-	-
618512	O'DONNELL-LURIA-RODAN SYNDROME	O'Donnell-Luria-Rodan syndrome, 618512 (3)	O'Donnell-Luria-Rodan syndrome	n	-	-	-	KMT2E	HGNC:18541	O'Donnell-Luria-Rodan syndrome, 618512 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
618522	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 59	Intellectual developmental disorder, autosomal dominant 59, 618522 (3)	Intellectual developmental disorder, autosomal dominant 59	n	-	-	-	CAMK2G	HGNC:1463	Intellectual developmental disorder, autosomal dominant 59, 618522 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
618523	HYPER-IgE SYNDROME 4B, AUTOSOMAL RECESSIVE, WITH RECURRENT INFECTIONS	Hyper-IgE syndrome 4B, autosomal recessive, with recurrent infections, 618523 (3)	Hyper-IgE syndrome 4B, autosomal recessive, with recurrent infections	y	HYPER-IgE SYNDROME 4B, AUTOSOMAL RECESSIVE, WITH RECURRENT INFECTIONS; HIES4B	Clinical Features	death|deaths	IL6ST	HGNC:6021	Hyper-IgE syndrome 4B, autosomal recessive, with recurrent infections, 618523 (3), Autosomal recessive	Autosomal recessive	y	y	[Family history revealed early death of 3 sibs who were likely affected.]	LU	-	y	lethal	lethal	lethal	L1|L6|LU	L1	pre-infant-lethal
618524	CONGENITAL MYOPATHY 16	Congenital myopathy 16, 618524 (3)	Congenital myopathy 16	n	-	-	-	MYBPC1	HGNC:7549	Congenital myopathy 16, 618524 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L2	L2	pre-infant-lethal
618527	ICHTHYOTIC KERATODERMA, SPASTICITY, HYPOMYELINATION, AND DYSMORPHIC FACIAL FEATURES	Ichthyotic keratoderma, spasticity, hypomyelination, and dysmorphic facies, 618527 (3)	Ichthyotic keratoderma, spasticity, hypomyelination, and dysmorphic facies	n	-	-	-	ELOVL1	HGNC:14418	Ichthyotic keratoderma, spasticity, hypomyelination, and dysmorphic facies, 618527 (3), Autosomal dominant, Autosomal recessive	Autosomal dominant, Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
618529	ROBINOW SYNDROME, AUTOSOMAL RECESSIVE 2	Robinow syndrome, autosomal recessive 2, 618529 (3)	Robinow syndrome, autosomal recessive 2	n	-	-	-	NXN	HGNC:18008	Robinow syndrome, autosomal recessive 2, 618529 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
618531	ERYTHROKERATODERMIA VARIABILIS ET PROGRESSIVA 6	Erythrokeratodermia variabilis et progressiva 6, 618531 (3)	Erythrokeratodermia variabilis et progressiva 6	n	-	-	-	TRPM4	HGNC:17993	Erythrokeratodermia variabilis et progressiva 6, 618531 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L5	L5	post-infant-lethal
618533	DEAFNESS, AUTOSOMAL DOMINANT 37	Deafness, autosomal dominant 37, 618533 (3)	Deafness, autosomal dominant 37	n	-	-	-	COL11A1	HGNC:2186	Deafness, autosomal dominant 37, 618533 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L1	L1	pre-infant-lethal
618534	IMMUNODEFICIENCY 64 WITH LYMPHOPROLIFERATION	Immunodeficiency 64, 618534 (3)	Immunodeficiency 64	y	IMMUNODEFICIENCY 64 WITH LYMPHOPROLIFERATION; IMD64	Clinical Features|Phenotype	died	RASGRP1	HGNC:9878	Immunodeficiency 64, 618534 (3), Autosomal recessive	Autosomal recessive	y	y	[Platt et al. (2017) reported a girl, born of consanguineous Iraqi parents, with IMD64. She presented in early childhood with recurrent respiratory, dermal, and gastrointestinal infections. She also had warts consistent with epidermodysplasia verruciformis. At age 10 years, she presented with splenomegaly and lymphadenopathy; biopsy showed EBV-positive lymphoproliferative disease and a B-cell lymphoma. Immunologic workup showed CD4+ T-cell lymphopenia, increased CD8+ T cells, decreased numbers of naive T cells, low B cells, and transient hypogammaglobulinemia. She had poor T-cell proliferation responses and impaired NK cell cytolytic activity. Despite treatment, she died of complications of lymphoma]	L5	y	-	lethal	lethal	lethal	L5	L5	post-infant-lethal
618541	HYPOPIGMENTATION, ORGANOMEGALY, AND DELAYED MYELINATION AND DEVELOPMENT	Hypopigmentation, organomegaly, and delayed myelination and development, 618541 (3)	Hypopigmentation, organomegaly, and delayed myelination and development	n	-	-	-	CLCN7	HGNC:2025	Hypopigmentation, organomegaly, and delayed myelination and development, 618541 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	ambiguous|lethal|nonlethal	lethal|nonlethal	L3	L3	pre-infant-lethal
618546	TRICHOTHIODYSTROPHY 7, NONPHOTOSENSITIVE	Trichothiodystrophy 7, nonphotosensitive, 618546 (3)	Trichothiodystrophy 7, nonphotosensitive	n	-	-	-	TARS1	HGNC:11572	Trichothiodystrophy 7, nonphotosensitive, 618546 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
618547	NEURODEVELOPMENTAL DISORDER WITH VISUAL DEFECTS AND BRAIN ANOMALIES	Neurodevelopmental disorder with visual defects and brain anomalies, 618547 (3)	Neurodevelopmental disorder with visual defects and brain anomalies	y	NEURODEVELOPMENTAL DISORDER WITH VISUAL DEFECTS AND BRAIN ANOMALIES; NEDVIBA	Clinical Features	died	HK1	HGNC:4922	Neurodevelopmental disorder with visual defects and brain anomalies, 618547 (3), Autosomal dominant	Autosomal dominant	y	y	[Okur et al. (2019) reported 7 patients from 6 unrelated families with a similar neurodevelopmental disorder. The patients had global developmental delay apparent in infancy or early childhood, speech delay, and impaired intellectual development. Two sibs died of respiratory infections at 1 year of age]	L3	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L3	L3	pre-infant-lethal
618548	MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 4	Multiple congenital anomalies-hypotonia-seizures syndrome 4, 618548 (3)	Multiple congenital anomalies-hypotonia-seizures syndrome 4	y	MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 4; MCAHS4	Clinical Features|Clinical Synopsis	death|deaths|died	PIGQ	HGNC:14135	Multiple congenital anomalies-hypotonia-seizures syndrome 4, 618548 (3), Autosomal recessive	Autosomal recessive	y	y	[Johnstone et al. (2020) reported 7 patients from 6 families with PIGQ mutations. Four of the patients had died, 1 at 2 days of life secondary to cardiac and renal failure and 3 between 9 months and 5 years of age.]	L2	y	-	lethal	lethal	lethal	L2	L2	pre-infant-lethal
618550	OOCYTE/ZYGOTE/EMBRYO MATURATION ARREST 7	Oocyte/zygote/embryo maturation arrest 7, 618550 (3)	Oocyte/zygote/embryo maturation arrest 7	y	OOCYTE/ZYGOTE/EMBRYO MATURATION ARREST 7; OZEMA7	Description|Clinical Features|Clinical Synopsis	death|deaths|died	PANX1	HGNC:8599	Oocyte/zygote/embryo maturation arrest 7, 618550 (3), Autosomal dominant	Autosomal dominant	y	n	-	-	-	-	ambiguous	ambiguous	ambiguous	-	-	-
618555	NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE1I	Night blindness, congenital stationary, type 1I, 618555 (3)	Night blindness, congenital stationary, type 1I	n	-	-	-	GUCY2D	HGNC:4689	Night blindness, congenital stationary, type 1I, 618555 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	ambiguous|nonlethal	ambiguous	-	-	-
618557	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 78	Developmental and epileptic encephalopathy 78, 618557 (3)	Developmental and epileptic encephalopathy 78	n	-	-	-	GABRA2	HGNC:4076	Developmental and epileptic encephalopathy 78, 618557 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
618559	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 79	Developmental and epileptic encephalopathy 79, 618559 (3)	Developmental and epileptic encephalopathy 79	n	-	-	-	GABRA5	HGNC:4079	Developmental and epileptic encephalopathy 79, 618559 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
618564	MICROANGIOPATHY AND LEUKOENCEPHALOPATHY, PONTINE, AUTOSOMAL DOMINANT	Microangiopathy and leukoencephalopathy, pontine, autosomal dominant, 618564 (3)	Microangiopathy and leukoencephalopathy, pontine, autosomal dominant	y	MICROANGIOPATHY AND LEUKOENCEPHALOPATHY, PONTINE, AUTOSOMAL DOMINANT; PADMAL	Clinical Features	death|deaths	COL4A1	HGNC:2202	Microangiopathy and leukoencephalopathy, pontine, autosomal dominant, 618564 (3), Autosomal dominant	Autosomal dominant	y	y	[Verdura et al. (2016) reported a large French family (F1) in which 4 individuals presented with recurrent ischemic strokes associated with cSVD between 37 and 43 years of age. Initial features included sudden onset of anesthesia of the limbs, facial palsy, diplopia, or loss of balance, followed by subtle cognitive decline, mood disturbances, and progressive motor impairment with gait instability. Cognitive dysfunction included symptoms of dementia and dysexecutive function. The mother of the proband had a history of recurrent ischemic strokes leading to a bedridden state and death at 67 years of age]	L6	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L1|L6	L1	pre-infant-lethal
618569	NEURODEVELOPMENTAL DISORDER WITH ATAXIA, HYPOTONIA, AND MICROCEPHALY	Neurodevelopmental disorder with ataxia, hypotonia, and microcephaly, 618569 (3)	Neurodevelopmental disorder with ataxia, hypotonia, and microcephaly	n	-	-	-	SVBP	HGNC:29204	Neurodevelopmental disorder with ataxia, hypotonia, and microcephaly, 618569 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
618571	NEURODEVELOPMENTAL DISORDER WITH CATARACTS, POOR GROWTH, AND DYSMORPHIC FACIES	Neurodevelopmental disorder with cataracts, poor growth, and dysmorphic facies, 618571 (3)	Neurodevelopmental disorder with cataracts, poor growth, and dysmorphic facies	n	-	-	-	INTS1	HGNC:24555	Neurodevelopmental disorder with cataracts, poor growth, and dysmorphic facies, 618571 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
618573	HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 7	Hypothyroidism, congenital, nongoitrous, 7, 618573 (3)	Hypothyroidism, congenital, nongoitrous, 7	n	-	-	-	TRHR	HGNC:12299	Hypothyroidism, congenital, nongoitrous, 7, 618573 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
618577	NEURODEVELOPMENTAL DISORDER WITH STRUCTURAL BRAIN ANOMALIES AND DYSMORPHIC FACIES	Neurodevelopmental disorder with structural brain anomalies and dysmorphic facies, 618577 (3)	Neurodevelopmental disorder with structural brain anomalies and dysmorphic facies	n	-	-	-	RAC3	HGNC:9803	Neurodevelopmental disorder with structural brain anomalies and dysmorphic facies, 618577 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
618578	CONGENITAL MYOPATHY 19	Congenital myopathy 19, 618578 (3)	Congenital myopathy 19	y	CONGENITAL MYOPATHY 19; CMYP19	Clinical Features	died	PAX7	HGNC:8621	Congenital myopathy 19, 618578 (3), Autosomal recessive	Autosomal recessive	y	y	[died at 7 years of age and had 3 deceased sibs who were reportedly similarly affected]	L4	y	y	lethal	lethal	lethal	L4	L4	post-infant-lethal
618580	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 80	Developmental and epileptic encephalopathy 80, 618580 (3)	Developmental and epileptic encephalopathy 80	y	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 80; DEE80	Clinical Features|Clinical Synopsis	died|death|deaths	PIGB	HGNC:8959	Developmental and epileptic encephalopathy 80, 618580 (3), Autosomal recessive	Autosomal recessive	y	y	[Murakami et al. (2019) reported 16 patients from 10 unrelated families with a developmental disorder associated with early-onset epilepsy. Several of the families were consanguineous, and the severity of the disorder was somewhat variable. Eight of the 16 patients died in the first months or years of life]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
618587	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 60, WITH SEIZURES	Intellectual developmental disorder 60 with seizures, 618587 (3)	Intellectual developmental disorder 60 with seizures	n	-	-	-	AP2M1	HGNC:564	Intellectual developmental disorder 60 with seizures, 618587 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
618590	NEURODEVELOPMENTAL DISORDER WITH BRAIN ANOMALIES, SEIZURES, AND SCOLIOSIS	Neurodevelopmental disorder with brain anomalies, seizures, and scoliosis, 618590 (3)	Neurodevelopmental disorder with brain anomalies, seizures, and scoliosis	n	-	-	-	PIGU	HGNC:15791	Neurodevelopmental disorder with brain anomalies, seizures, and scoliosis, 618590 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
618594	NEPHROTIC SYNDROME, TYPE 21	Nephrotic syndrome, type 21, 618594 (3)	Nephrotic syndrome, type 21	n	-	-	-	AVIL	HGNC:14188	Nephrotic syndrome, type 21, 618594 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
618598	SPASTIC TETRAPLEGIA AND AXIAL HYPOTONIA, PROGRESSIVE	Spastic tetraplegia and axial hypotonia, progressive, 618598 (3)	Spastic tetraplegia and axial hypotonia, progressive	y	SPASTIC TETRAPLEGIA AND AXIAL HYPOTONIA, PROGRESSIVE; STAHP	Clinical Features	died	SOD1	HGNC:11179	Spastic tetraplegia and axial hypotonia, progressive, 618598 (3), Autosomal recessive	Autosomal recessive	y	y	[Andersen et al. (2019) reported a 3-year-old girl, born of consanguineous Afghan parents, with a severe and progressive motor neuron disease.. A sib with similar symptoms had died at age 6 years and reportedly had normal cognitive development]	L4	n	y	lethal	lethal	lethal	L4|L6	L4	post-infant-lethal
618603	NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA AND VARIABLE INTELLECTUAL AND BEHAVIORAL ABNORMALITIES	Neurodevelopmental disorder with hypotonia and variable intellectual and behavioral abnormalities, 618603 (3)	Neurodevelopmental disorder with hypotonia and variable intellectual and behavioral abnormalities	n	-	-	-	POLR2A	HGNC:9187	Neurodevelopmental disorder with hypotonia and variable intellectual and behavioral abnormalities, 618603 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
618604	SNIJDERS BLOK-FISHER SYNDROME	Snijders Blok-Fisher syndrome, 618604 (3)	Snijders Blok-Fisher syndrome	n	-	-	-	POU3F3	HGNC:9216	Snijders Blok-Fisher syndrome, 618604 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
618606	PONTOCEREBELLAR HYPOPLASIA, TYPE 13	Pontocerebellar hypoplasia, type 13, 618606 (3)	Pontocerebellar hypoplasia, type 13	n	-	-	-	VPS51	HGNC:1172	Pontocerebellar hypoplasia, type 13, 618606 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
618608	INTELLECTUAL DEVELOPMENTAL DISORDER WITH NASAL SPEECH, DYSMORPHIC FACIES, AND VARIABLE SKELETAL ANOMALIES	Intellectual developmental disorder with nasal speech, dysmorphic facies, and variable skeletal anomalies, 618608 (3)	Intellectual developmental disorder with nasal speech, dysmorphic facies, and variable skeletal anomalies	n	-	-	-	CNOT2	HGNC:7878	Intellectual developmental disorder with nasal speech, dysmorphic facies, and variable skeletal anomalies, 618608 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
618612	LOWER URINARY TRACT OBSTRUCTION, CONGENITAL	Lower urinary tract obstruction, congenital, 618612 (3)	Lower urinary tract obstruction, congenital	n	-	-	-	BNC2	HGNC:30988	Lower urinary tract obstruction, congenital, 618612 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
618613	RETINITIS PIGMENTOSA 86	Retinitis pigmentosa 86, 618613 (3)	Retinitis pigmentosa 86	n	-	-	-	KIAA1549	HGNC:22219	Retinitis pigmentosa 86, 618613 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
618619	WEISS-KRUSZKA SYNDROME	Weiss-Kruszka syndrome, 618619 (3)	Weiss-Kruszka syndrome	n	-	-	-	ZNF462	HGNC:21684	Weiss-Kruszka syndrome, 618619 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
618620	ABDOMINAL OBESITY-METABOLIC SYNDROME 4	Abdominal obesity-metabolic syndrome 4, 618620 (3)	Abdominal obesity-metabolic syndrome 4	y	ABDOMINAL OBESITY-METABOLIC SYNDROME 4; AOMS4	Clinical Features	death|deaths|died	CELA2A	HGNC:24609	Abdominal obesity-metabolic syndrome 4, 618620 (3), Autosomal dominant	Autosomal dominant	y	y	[Esteghamat et al. (2019) studied 11 affected members of a large 4-generation family with CELA2A-associated early-onset atherosclerosis and coronary artery disease (CAD). The proband, whose CAD risk factors included hypertension, type 2 diabetes, hypertriglyceridemia, and obesity, had her first ST-elevation myocardial infarction at age 28 years. Coronary artery angiography resulted in percutaneous intervention in 2 major coronary arteries. Among 53 extended blood relatives with a common ancestor, 25 were diagnosed with early-onset CAD at a median age of 43 years, and 11 had died from CAD (median age at death, 52 years)]	L6	y	-	lethal	lethal	lethal	L6	L6	post-infant-lethal
618622	NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, ARTHROGRYPOSIS, AND STRUCTURAL BRAIN ANOMALIES	Neurodevelopmental disorder with microcephaly, arthrogryposis, and structural brain anomalies, 618622 (3)	Neurodevelopmental disorder with microcephaly, arthrogryposis, and structural brain anomalies	y	NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, ARTHROGRYPOSIS, AND STRUCTURAL BRAIN ANOMALIES; NEDMABA	Description|Clinical Features|Clinical Synopsis|Phenotype	death|deaths|miscarriage|miscarriages	SMPD4	HGNC:32949	Neurodevelopmental disorder with microcephaly, arthrogryposis, and structural brain anomalies, 618622 (3), Autosomal recessive	Autosomal recessive	n	y	[Magini et al. (2019) reported at least 23 affected individuals from 12 unrelated families with a severe congenital neurodevelopmental disorder resulting in death before 12 months of age in about 33% of patients. Several families had single or recurrent miscarriages of possibly affected fetuses who did not undergo genetic testing, raising the number of likely affected to 32]	L1	y	y	lethal	lethal	lethal	L1	L1	pre-infant-lethal
618624	NOONAN SYNDROME 12	Noonan syndrome 12, 618624 (3)	Noonan syndrome 12	y	NOONAN SYNDROME 12; NS12	Clinical Features|Phenotype	died	RRAS2	HGNC:17271	Noonan syndrome 12, 618624 (3), Autosomal dominant	Autosomal dominant	y	y	[Capri et al. (2019) reported 9 patients from 6 families with Noonan syndrome and mutations in the RRAS2 gene. Most patients exhibited the characteristic facial gestalt, although it was less apparent in adulthood. There was considerable variability in severity, with some members of 1 family (family 3) having relatively mild disease whereas another patient (subject 4) died at 2 weeks of life with severe failure to thrive]	L2	y	-	lethal	lethal	lethal	L2	L2	pre-infant-lethal
618625	ROTHMUND-THOMSON SYNDROME, TYPE 1	Rothmund-Thomson syndrome, type 1, 618625 (3)	Rothmund-Thomson syndrome, type 1	n	-	-	-	ANAPC1	HGNC:19988	Rothmund-Thomson syndrome, type 1, 618625 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
618635	SIDDIQI SYNDROME	Siddiqi syndrome, 618635 (3)	Siddiqi syndrome	n	-	-	-	FITM2	HGNC:16135	Siddiqi syndrome, 618635 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
618641	INFANTILE LIVER FAILURE SYNDROME 3	Infantile liver failure syndrome 3, 618641 (3)	Infantile liver failure syndrome 3	y	INFANTILE LIVER FAILURE SYNDROME 3; ILFS3	Clinical Features	died	RINT1	HGNC:21876	Infantile liver failure syndrome 3, 618641 (3), Autosomal recessive	Autosomal recessive	n	y	[Cousin et al. (2019) reported 3 unrelated children with early-onset recurrent acute liver failure syndrome. Two patients had onset at 8 and 10 months of age, respectively, whereas the third patient had her first episode at 3 years of age. Only 1 (patient 1), who was born prematurely at 34 weeks' gestation, had neonatal jaundice and perinatal complications: this patient died of respiratory failure at 3 years of age]	L4	y	-	lethal	lethal	lethal	L4	L4	post-infant-lethal
618643	SPERMATOGENIC FAILURE 39	Spermatogenic failure 39, 618643 (3)	Spermatogenic failure 39	n	-	-	-	DNAH17	HGNC:2946	Spermatogenic failure 39, 618643 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
618644	OSTEOGENESIS IMPERFECTA, TYPE XX	Osteogenesis imperfecta, type XX, 618644 (3)	Osteogenesis imperfecta, type XX	y	OSTEOGENESIS IMPERFECTA, TYPE XX; OI20	Description|Clinical Features|Clinical Synopsis|Phenotype	died|stillbirth|stillbirths|stillborn|death|deaths|lethal	MESD	HGNC:13520	Osteogenesis imperfecta, type XX, 618644 (3), Autosomal recessive	Autosomal recessive	y	y	[Moosa et al. (2019) reported 5 probands from consanguineous families who were clinically diagnosed with a progressive deforming type of osteogenesis imperfecta. Fractures were observed prenatally in 2 patients, and all had a fracture within the first 2 years of life. Treatment with bisphosphonates, undertaken in 4 of the patients, was unsuccessful. Three patients died of respiratory failure, 2 before 18 months of age and 1 at age 17 years]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
618646	DIENCEPHALIC-MESENCEPHALIC JUNCTION DYSPLASIA SYNDROME 2	Diencephalic-mesencephalic junction dysplasia syndrome 2, 618646 (3)	Diencephalic-mesencephalic junction dysplasia syndrome 2	n	-	-	-	GSX2	HGNC:24959	Diencephalic-mesencephalic junction dysplasia syndrome 2, 618646 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
618648	IMMUNODEFICIENCY 65, SUSCEPTIBILITY TO VIRAL INFECTIONS	Immunodeficiency 65, susceptibility to viral infections, 618648 (3)	Immunodeficiency 65, susceptibility to viral infections	y	IMMUNODEFICIENCY 65, SUSCEPTIBILITY TO VIRAL INFECTIONS; IMD65	Clinical Features	died|miscarriage|miscarriages	IRF9	HGNC:6131	Immunodeficiency 65, susceptibility to viral infections, 618648 (3), Autosomal recessive	Autosomal recessive	n	y	[Bravo Garcia-Morato et al. (2019) reported 2 sibs, born of consanguineous parents of Portuguese origin, with severe and recurrent DNA and RNA viral infections beginning in infancy ... Family history revealed that an older sib had early-onset severe viral infections, including sepsis and meningoencephalitis associated with HSV infection. She died at 14 months of age due to enterohemorrhagic fever after vaccination for yellow fever virus]	L3	n	y	lethal	lethal	lethal	L3	L3	pre-infant-lethal
618652	NEUROOCULOCARDIOGENITOURINARY SYNDROME	Neurooculocardiogenitourinary syndrome, 618652 (3)	Neurooculocardiogenitourinary syndrome	y	NEUROOCULOCARDIOGENITOURINARY SYNDROME; NOCGUS	Description|Clinical Features	lethality|died	WDR37	HGNC:31406	Neurooculocardiogenitourinary syndrome, 618652 (3), Autosomal dominant	Autosomal dominant	y	y	[Reis et al. (2019) reported 4 unrelated patients with mutations in the WDR37 gene and overlapping multisystem phenotypes consisting of severe complex ocular anomalies, dysmorphic craniofacial features, hearing loss with recurrent otitis media, excess nuchal skin or cystic hygroma, structural brain anomalies with severe neurologic impairment, congenital heart defects, genitourinary anomalies, feeding disorders with postnatal growth deficiency, structural gastrointestinal anomalies, and skeletal anomalies, including scoliosis, hip dysplasia, syndactyly, and contractures. The 2 patients who were alive at age 30 years and 8 years were nonverbal with limited to no ambulation; another patient died at age 22 months from respiratory failure due to pneumonia and cardiac anomalies]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
618653	INTELLECTUAL DEVELOPMENTAL DISORDER WITH IMPAIRED LANGUAGE AND DYSMORPHIC FACIES	Intellectual developmental disorder with impaired language and dysmorphic facies, 618653 (3)	Intellectual developmental disorder with impaired language and dysmorphic facies	n	-	-	-	DDX6	HGNC:2747	Intellectual developmental disorder with impaired language and dysmorphic facies, 618653 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
618654	CONGENITAL MYOPATHY 8	Congenital myopathy 8, 618654 (3)	Congenital myopathy 8	n	-	-	-	ACTN2	HGNC:164	Congenital myopathy 8, 618654 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L4	L4	post-infant-lethal
618655	MYOPATHY, DISTAL, 6, ADULT-ONSET, AUTOSOMAL DOMINANT	Myopathy, distal, 6, adult onset, 618655 (3)	Myopathy, distal, 6, adult onset	n	-	-	-	ACTN2	HGNC:164	Myopathy, distal, 6, adult onset, 618655 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L4	L4	post-infant-lethal
618658	ZIMMERMANN-LABAND SYNDROME 3	Zimmermann-Laband syndrome 3, 618658 (3)	Zimmermann-Laband syndrome 3	n	-	-	-	KCNN3	HGNC:6292	Zimmermann-Laband syndrome 3, 618658 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
618659	NEURODEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND DISTAL SKELETAL ANOMALIES	Neurodevelopmental disorder with dysmorphic facies and distal skeletal anomalies, 618659 (3)	Neurodevelopmental disorder with dysmorphic facies and distal skeletal anomalies	n	-	-	-	ZMIZ1	HGNC:16493	Neurodevelopmental disorder with dysmorphic facies and distal skeletal anomalies, 618659 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
618660	HEMOLYTIC ANEMIA DUE TO GLUTATHIONE REDUCTASE DEFICIENCY	Hemolytic anemia due to glutathione reductase deficiency, 618660 (3)	Hemolytic anemia due to glutathione reductase deficiency	n	-	-	-	GSR	HGNC:4623	Hemolytic anemia due to glutathione reductase deficiency, 618660 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
618662	DIARRHEA 11, MALABSORPTIVE, CONGENITAL	Diarrhea 11, malabsorptive, congenital, 618662 (3)	Diarrhea 11, malabsorptive, congenital	y	DIARRHEA 11, MALABSORPTIVE, CONGENITAL; DIAR11	Clinical Features	died	PERCC1	HGNC:52293	Diarrhea 11, malabsorptive, congenital, 618662 (3), Autosomal recessive	Autosomal recessive	y	y	[Straussberg et al. (1997) reported a cluster of cases with Jewish Iraqi ancestry who showed no evidence of antienterocyte antibodies, did not respond to an elemental diet or to steroid or immunosuppression therapy, and were dependent on total parenteral nutrition for years. Their 5 Iraqi Jewish patients with intractable diarrhea beginning during the first days of life belonged to 4 families. The parents were consanguineous in 3 families. Two of the patients were brothers (patients 4 and 5), and another (patient 3) had a brother who died at an early age from protracted diarrhea]	LU	y	-	lethal	lethal	lethal	LU	LU	post-infant-lethal
618663	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 81	Developmental and epileptic encephalopathy 81, 618663 (3)	Developmental and epileptic encephalopathy 81	y	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 81; DEE81	Clinical Features|Clinical Synopsis	died|death|deaths	DMXL2	HGNC:2938	Developmental and epileptic encephalopathy 81, 618663 (3), Autosomal recessive	Autosomal recessive	y	n	-	-	-	-	ambiguous	ambiguous	ambiguous	-	-	-
618664	SPERMATOGENIC FAILURE 40	Spermatogenic failure 40, 618664 (3)	Spermatogenic failure 40	n	-	-	-	CFAP65	HGNC:25325	Spermatogenic failure 40, 618664 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
618665	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 72	Intellectual developmental disorder, autosomal recessive 72, 618665 (3)	Intellectual developmental disorder, autosomal recessive 72	n	-	-	-	METTL5	HGNC:25006	Intellectual developmental disorder, autosomal recessive 72, 618665 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
618666	SITOSTEROLEMIA 2	Sitosterolemia 2, 618666 (3)	Sitosterolemia 2	n	-	-	-	ABCG5	HGNC:13886	Sitosterolemia 2, 618666 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
618667	HYDROCEPHALUS, CONGENITAL, 4	Hydrocephalus, congenital, 4, 618667 (3)	Hydrocephalus, congenital, 4	n	-	-	-	TRIM71	HGNC:32669	Hydrocephalus, congenital, 4, 618667 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
618672	INTELLECTUAL DEVELOPMENTAL DISORDER WITH SPEECH DELAY, AUTISM, AND DYSMORPHIC FACIES	Intellectual developmental disorder with speech delay, autism, and dysmorphic facies, 618672 (3)	Intellectual developmental disorder with speech delay, autism, and dysmorphic facies	n	-	-	-	CNOT3	HGNC:7879	Intellectual developmental disorder with speech delay, autism, and dysmorphic facies, 618672 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
618677	CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 10	Cortical dysplasia, complex, with other brain malformations 10, 618677 (3)	Cortical dysplasia, complex, with other brain malformations 10	n	-	-	-	APC2	HGNC:24036	Cortical dysplasia, complex, with other brain malformations 10, 618677 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
618683	MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 6	Mitochondrial complex V (ATP synthase) deficiency, nuclear type 6, 618683 (3)	Mitochondrial complex V (ATP synthase) deficiency, nuclear type 6	y	MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 6; MC5DN6	Clinical Features|Clinical Synopsis	died|death|deaths	ATP5MK	HGNC:30889	Mitochondrial complex V (ATP synthase) deficiency, nuclear type 6, 618683 (3), Autosomal recessive	Autosomal recessive	n	y	[Death in childhood may occur]	L4	n	-	lethal	lethal	lethal	L4	L4	post-infant-lethal
618687	INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE AND BEHAVIORAL ABNORMALITIES	Intellectual developmental disorder with short stature and behavioral abnormalities, 618687 (3)	Intellectual developmental disorder with short stature and behavioral abnormalities	y	INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE AND BEHAVIORAL ABNORMALITIES; IDDSSBA	Clinical Features|Phenotype	died|lethal	IQSEC1	HGNC:29112	Intellectual developmental disorder with short stature and behavioral abnormalities, 618687 (3), Autosomal recessive	Autosomal recessive	n	y	[Ansar et al. (2019) reported 5 living patients from 2 unrelated consanguineous families with a similar developmental disorder... Two other similarly affected sibs had died]	LU	n	y	lethal	lethal	lethal	LU	LU	post-infant-lethal
618688	LEUKODYSTROPHY, HYPOMYELINATING, 19, TRANSIENT INFANTILE	Leukodystrophy, hypomyelinating, 19, transient infantile, 618688 (3)	Leukodystrophy, hypomyelinating, 19, transient infantile	n	-	-	-	TMEM63A	HGNC:29118	Leukodystrophy, hypomyelinating, 19, transient infantile, 618688 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
618695	CILIARY DYSKINESIA, PRIMARY, 42	Ciliary dyskinesia, primary, 42, 618695 (3)	Ciliary dyskinesia, primary, 42	y	CILIARY DYSKINESIA, PRIMARY, 42; CILD42	Clinical Features|Clinical Synopsis	died|death|deaths	MCIDAS	HGNC:40050	Ciliary dyskinesia, primary, 42, 618695 (3), Autosomal recessive	Autosomal recessive	n	y	[Death from respiratory insufficiency (in some patients) / Boon et al. (2014) reported 9 patients from 4 unrelated families with CILD42... Two died of respiratory insufficiency at 27 and 19 years of age, respectively, including a patient who had undergone a lung transplant]	L6	y	-	lethal	lethal	lethal	L6	L6	post-infant-lethal
618697	RETINITIS PIGMENTOSA 87 WITH CHOROIDAL INVOLVEMENT	Retinitis pigmentosa 87 with choroidal involvement, 618697 (3)	Retinitis pigmentosa 87 with choroidal involvement	y	RETINITIS PIGMENTOSA 87 WITH CHOROIDAL INVOLVEMENT; RP87	Phenotype	died	RPE65	HGNC:10294	Retinitis pigmentosa 87 with choroidal involvement, 618697 (3), Autosomal dominant	Autosomal dominant	y	n	-	-	-	-	ambiguous	ambiguous|nonlethal	ambiguous	-	-	-
618699	CILIARY DYSKINESIA, PRIMARY, 43	Ciliary dyskinesia, primary, 43, 618699 (3)	Ciliary dyskinesia, primary, 43	n	-	-	-	FOXJ1	HGNC:3816	Ciliary dyskinesia, primary, 43, 618699 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
618707	NEURODEVELOPMENTAL DISORDER WITH ABSENT LANGUAGE AND VARIABLE SEIZURES	Neurodevelopmental disorder with absent language and variable seizures, 618707 (3)	Neurodevelopmental disorder with absent language and variable seizures	n	-	-	-	WASF1	HGNC:12732	Neurodevelopmental disorder with absent language and variable seizures, 618707 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
618709	NEURODEVELOPMENTAL DISORDER WITH NONSPECIFIC BRAIN ABNORMALITIES AND WITH OR WITHOUT SEIZURES	Neurodevelopmental disorder with nonspecific brain abnormalities and with or without seizures, 618709 (3)	Neurodevelopmental disorder with nonspecific brain abnormalities and with or without seizures	n	-	-	-	DLL1	HGNC:2908	Neurodevelopmental disorder with nonspecific brain abnormalities and with or without seizures, 618709 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
618718	NEURODEVELOPMENTAL DISORDER WITH BEHAVIORAL ABNORMALITIES, ABSENT SPEECH, AND HYPOTONIA	Neurodevelopmental disorder with behavioral abnormalities, absent speech, and hypotonia, 618718 (3)	Neurodevelopmental disorder with behavioral abnormalities, absent speech, and hypotonia	n	-	-	-	NTNG2	HGNC:14288	Neurodevelopmental disorder with behavioral abnormalities, absent speech, and hypotonia, 618718 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
618719	MEGABLADDER, CONGENITAL	Megabladder, congenital, 618719 (3)	Megabladder, congenital	y	MEGABLADDER, CONGENITAL; MGBL	Clinical Features|Clinical Synopsis	died|die	MYOCD	HGNC:16067	Megabladder, congenital, 618719 (3), Autosomal dominant	Autosomal dominant	y	y	[Affected males frequently die in utero]	L1	y	-	lethal	lethal	lethal	L1	L1	pre-infant-lethal
618721	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 82	Developmental and epileptic encephalopathy 82, 618721 (3)	Developmental and epileptic encephalopathy 82	y	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 82; DEE82	Clinical Features|Clinical Synopsis	died|death|deaths	GOT2	HGNC:4433	Developmental and epileptic encephalopathy 82, 618721 (3), Autosomal recessive	Autosomal recessive	y	y	[Early death may occur / Van Karnebeek et al. (2019) reported 4 children, ranging in age from 4 to 10 years, from 3 unrelated families with DEE82... Each family had another affected fetus or child who died of the disorder]	L4	n	y	lethal	lethal	lethal	L4	L4	post-infant-lethal
618724	HEYN-SPROUL-JACKSON SYNDROME	Heyn-Sproul-Jackson syndrome, 618724 (3)	Heyn-Sproul-Jackson syndrome	n	-	-	-	DNMT3A	HGNC:2978	Heyn-Sproul-Jackson syndrome, 618724 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
618725	INTELLECTUAL DEVELOPMENTAL DISORDER WITH BEHAVIORAL ABNORMALITIES AND CRANIOFACIAL DYSMORPHISM WITH OR WITHOUT SEIZURES	Intellectual developmental disorder with behavioral abnormalities and craniofacial dysmorphism with or without seizures, 618725 (3)	Intellectual developmental disorder with behavioral abnormalities and craniofacial dysmorphism with or without seizures	n	-	-	-	PHF21A	HGNC:24156	Intellectual developmental disorder with behavioral abnormalities and craniofacial dysmorphism with or without seizures, 618725 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
618728	SPONDYLOEPIMETAPHYSEAL DYSPLASIA, ISIDOR-TOUTAIN TYPE	Spondyloepimetaphyseal dysplasia, Isidor-Toutain type, 618728 (3)	Spondyloepimetaphyseal dysplasia, Isidor-Toutain type	n	-	-	-	RPL13	HGNC:10303	Spondyloepimetaphyseal dysplasia, Isidor-Toutain type, 618728 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
618729	LIANG-WANG SYNDROME	Liang-Wang syndrome, 618729 (3)	Liang-Wang syndrome	n	-	-	-	KCNMA1	HGNC:6284	Liang-Wang syndrome, 618729 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
618730	NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, CORTICAL MALFORMATIONS, AND SPASTICITY	Neurodevelopmental disorder with microcephaly, cortical malformations, and spasticity, 618730 (3)	Neurodevelopmental disorder with microcephaly, cortical malformations, and spasticity	y	NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, CORTICAL MALFORMATIONS, AND SPASTICITY; NEDMCMS	Clinical Features|Clinical Synopsis	died|death|deaths	TMX2	HGNC:30739	Neurodevelopmental disorder with microcephaly, cortical malformations, and spasticity, 618730 (3), Autosomal recessive	Autosomal recessive	y	y	[Early death (in some patients) / Three patients in the report of Vandervore et al. (2019) had died: 2 in the first weeks of life and the third at age 6 years]	L2	y	-	lethal	lethal	lethal	L2	L2	pre-infant-lethal
618731	NEURODEVELOPMENTAL DISORDER WITH BRAIN ANOMALIES AND WITH OR WITHOUT VERTEBRAL OR CARDIAC ANOMALIES	Neurodevelopmental disorder with brain anomalies and with or without vertebral or cardiac anomalies, 618731 (3)	Neurodevelopmental disorder with brain anomalies and with or without vertebral or cardiac anomalies	n	-	-	-	DHX37	HGNC:17210	Neurodevelopmental disorder with brain anomalies and with or without vertebral or cardiac anomalies, 618731 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
618732	POIRIER-BIENVENU NEURODEVELOPMENTAL SYNDROME	Poirier-Bienvenu neurodevelopmental syndrome, 618732 (3)	Poirier-Bienvenu neurodevelopmental syndrome	n	-	-	-	CSNK2B	HGNC:2460	Poirier-Bienvenu neurodevelopmental syndrome, 618732 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
618733	NEUROMUSCULAR OCULOAUDITORY SYNDROME	Neuromuscular disease and ocular or auditory anomalies with or without seizures, 618733 (3)	Neuromuscular disease and ocular or auditory anomalies with or without seizures	y	NEUROMUSCULAR OCULOAUDITORY SYNDROME; NMOAS	Clinical Features	died	DHX16	HGNC:2739	Neuromuscular disease and ocular or auditory anomalies with or without seizures, 618733 (3), Autosomal dominant	Autosomal dominant	y	y	[Paine et al. (2019) reported 4 patients with a neuromuscular syndrome. The first patient (individual 6) presented at age 10 weeks with infantile spasms following an uneventful birth.. She died 16 days after birth]	L2	y	-	lethal	lethal	lethal	L2	L2	pre-infant-lethal
618736	STRUCTURAL BRAIN ANOMALIES WITH IMPAIRED INTELLECTUAL DEVELOPMENT AND CRANIOSYNOSTOSIS	Structural brain anomalies with impaired intellectual development and craniosynostosis, 618736 (3)	Structural brain anomalies with impaired intellectual development and craniosynostosis	n	-	-	-	ZIC1	HGNC:12872	Structural brain anomalies with impaired intellectual development and craniosynostosis, 618736 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
618737	CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 15	Pachygyria, microcephaly, developmental delay, and dysmorphic facies, with or without seizures, 618737 (3)	Pachygyria, microcephaly, developmental delay, and dysmorphic facies, with or without seizures	y	CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 15; CDCBM15	Clinical Features|Clinical Synopsis	died|death|deaths	TUBGCP2	HGNC:18599	Pachygyria, microcephaly, developmental delay, and dysmorphic facies, with or without seizures, 618737 (3), Autosomal recessive	Autosomal recessive	y	y	[Mitani et al. (2019) reported 5 children, ranging in age from 3 to 7 years, from 4 unrelated families with PAMDDFS. Two of the families, of Turkish (family 1) and Iranian (family 3) descent, were consanguineous; the other 2 families, of Indian (family 2) and Polish (family 4) descent, were not consanguineous. Two individuals from families 2 and 3 were born prematurely at 31 and 27 weeks' gestation, respectively, and died around 3 years of age]	L4	y	-	lethal	lethal	lethal	L4	L4	post-infant-lethal
618741	NEURODEVELOPMENTAL DISORDER WITH EPILEPSY, SPASTICITY, AND BRAIN ATROPHY	Neurodevelopmental disorder with epilepsy, spasticity, and brain atrophy, 618741 (3)	Neurodevelopmental disorder with epilepsy, spasticity, and brain atrophy	y	NEURODEVELOPMENTAL DISORDER WITH EPILEPSY, SPASTICITY, AND BRAIN ATROPHY; NEDESBA	Description|Clinical Features|Clinical Synopsis	death|deaths|died	TRAPPC4	HGNC:19943	Neurodevelopmental disorder with epilepsy, spasticity, and brain atrophy, 618741 (3), Autosomal recessive	Autosomal recessive	y	y	[Van Bergen et al. (2020) reported 8 children from 3 unrelated families of Caucasian, Turkish, and French-Canadian descent with a similar syndromic neurodevelopmental disorder. Four of the patients died in the first years of life]	L4	y	-	lethal	lethal	lethal	L4	L4	post-infant-lethal
618744	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 83	Developmental and epileptic encephalopathy 83, 618744 (3)	Developmental and epileptic encephalopathy 83	y	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 83; DEE83	Description|Clinical Features|Clinical Synopsis|Phenotype	die|died|death|deaths|lethal	UGP2	HGNC:12527	Developmental and epileptic encephalopathy 83, 618744 (3), Autosomal recessive	Autosomal recessive	y	y	[Perenthaler et al. (2020) reported 20 children from 13 unrelated families with DEE83. Most children were under age 3.5 years, although 4 patients ranged in age from 6 to 13 years. Of the 20 children, 11 died between 2 months and 13 years of age]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
618745	SPERMATOGENIC FAILURE 42	Spermatogenic failure 42, 618745 (3)	Spermatogenic failure 42	n	-	-	-	TTC29	HGNC:29936	Spermatogenic failure 42, 618745 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
618748	INTELLECTUAL DEVELOPMENTAL DISORDER WITH HYPOTONIA AND BEHAVIORAL ABNORMALITIES	Intellectual developmental disorder with hypotonia and behavioral abnormalities, 618748 (3)	Intellectual developmental disorder with hypotonia and behavioral abnormalities	n	-	-	-	CDK8	HGNC:1779	Intellectual developmental disorder with hypotonia and behavioral abnormalities, 618748 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
618751	SPERMATOGENIC FAILURE 43	Spermatogenic failure 43, 618751 (3)	Spermatogenic failure 43	n	-	-	-	SPEF2	HGNC:26293	Spermatogenic failure 43, 618751 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
618752	NEUTROPENIA, SEVERE CONGENITAL, 8, AUTOSOMAL DOMINANT	Neutropenia, severe congenital, 8, autosomal dominant, 618752 (3)	Neutropenia, severe congenital, 8, autosomal dominant	y	NEUTROPENIA, SEVERE CONGENITAL, 8, AUTOSOMAL DOMINANT; SCN8	Clinical Features	died	SRP54	HGNC:11301	Neutropenia, severe congenital, 8, autosomal dominant, 618752 (3), Autosomal dominant	Autosomal dominant	y	y	[Carapito et al. (2017) reported 3 unrelated patients with SCN8. All 3 presented in early infancy with severe neutropenia that was not responsive to treatment with GCSF in 2 of the 3 patients. The patients had poor overall growth with short stature. The patient from family A was a 6-year-old boy who presented in the neonatal period with respiratory distress and hypotonia, as well as neutropenia; other hematologic parameters were normal. Hematologic stem cell transplantation was successful with reconstitution. However, this patient also had significant additional systemic abnormalities, including delayed psychomotor development with autistic features, congenital cardiac septal defects requiring surgery, and dysmorphic features, such as low-set asymmetric ears, thin hair, microretrognathia, high-arched palate, small teeth, and pectus carinatum. The affected girl from family B had otherwise normal hematologic parameters and underwent unrelated cord blood transplantation, but died at 16 months of age]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
618760	NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA AND AUTISTIC FEATURES WITH OR WITHOUT HYPERKINETIC MOVEMENTS	Neurodevelopmental disorder with hypotonia and autistic features with or without hyperkinetic movements, 618760 (3)	Neurodevelopmental disorder with hypotonia and autistic features with or without hyperkinetic movements	n	-	-	-	VAMP2	HGNC:12643	Neurodevelopmental disorder with hypotonia and autistic features with or without hyperkinetic movements, 618760 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
618761	CATIFA SYNDROME	CATIFA syndrome, 618761 (3)	CATIFA syndrome	n	-	-	-	RIC1	HGNC:17686	CATIFA syndrome, 618761 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
618763	JOUBERT SYNDROME 36	Joubert syndrome 36, 618763 (3)	Joubert syndrome 36	n	-	-	-	FAM149B1	HGNC:29162	Joubert syndrome 36, 618763 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
618766	ARTHROGRYPOSIS MULTIPLEX CONGENITA 4, NEUROGENIC, WITH AGENESIS OF THE CORPUS CALLOSUM	Arthrogryposis multiplex congenita 4, neurogenic, with agenesis of the corpus callosum, 618766 (3)	Arthrogryposis multiplex congenita 4, neurogenic, with agenesis of the corpus callosum	y	ARTHROGRYPOSIS MULTIPLEX CONGENITA 4, NEUROGENIC, WITH AGENESIS OF THE CORPUS CALLOSUM; AMC4	Description|Clinical Features|Clinical Synopsis	die|died|death|deaths	SCYL2	HGNC:19286	Arthrogryposis multiplex congenita 4, neurogenic, with agenesis of the corpus callosum, 618766 (3), Autosomal recessive	Autosomal recessive	y	y	[Seidahmed et al. (2020) reported 2 unrelated highly consanguineous families of Saudi Arabian and Omani origin in which at least 8 individuals had AMC4. Six of the 8 patients died in infancy or early childhood; clinical details were available for 6 patients]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
618767	CORNEAL DYSTROPHY, MEESMANN, 2	Meesmann corneal dystrophy 2, 618767 (3)	Meesmann corneal dystrophy 2	n	-	-	-	KRT3	HGNC:6440	Meesmann corneal dystrophy 2, 618767 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
618768	SPASTIC PARAPLEGIA 81, AUTOSOMAL RECESSIVE	Spastic paraplegia 81, autosomal recessive, 618768 (3)	Spastic paraplegia 81, autosomal recessive	n	-	-	-	SELENOI	HGNC:29361	Spastic paraplegia 81, autosomal recessive, 618768 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
618770	SPASTIC PARAPLEGIA 82, AUTOSOMAL RECESSIVE	Spastic paraplegia 82, autosomal recessive, 618770 (3)	Spastic paraplegia 82, autosomal recessive	n	-	-	-	PCYT2	HGNC:8756	Spastic paraplegia 82, autosomal recessive, 618770 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
618774	CEBALID SYNDROME	CEBALID syndrome, 618774 (3)	CEBALID syndrome	n	-	-	-	MN1	HGNC:7180	CEBALID syndrome, 618774 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	ambiguous|nonlethal	ambiguous	-	-	-
618775	MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 10	Mitochondrial complex III deficiency, nuclear type 10, 618775 (3)	Mitochondrial complex III deficiency, nuclear type 10	y	MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 10; MC3DN10	Clinical Features	death|deaths	UQCRFS1	HGNC:12587	Mitochondrial complex III deficiency, nuclear type 10, 618775 (3), Autosomal recessive	Autosomal recessive	y	y	[Gusic et al. (2020) reported 2 children, a 3.5-month-old boy (patient 1), born of consanguineous Afghan parents, and a 9-year-old boy (patient 2), born of unrelated German parents, with MC3DN10. The patients presented with fetal bradycardia necessitating birth via cesarean section. After birth, both had hypertrophic cardiomyopathy, thrombocytopenia, poor feeding, hypotonia, and increased serum lactate and alanine. Patient 1 also had hearing impairment and severe obstruction of the left ventricular outflow tract, resulting in death at 3.5 months of age]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
618776	MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 34	Mitochondrial complex I deficiency, nuclear type 34, 618776 (3)	Mitochondrial complex I deficiency, nuclear type 34	y	MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 34; MC1DN34	Clinical Features|Clinical Synopsis	death|deaths|died	NDUFAF8	HGNC:33551	Mitochondrial complex I deficiency, nuclear type 34, 618776 (3), Autosomal recessive	Autosomal recessive	y	y	[Alston et al. (2020) reported 3 unrelated boys with MC1DN34. The presentations and phenotypes were slightly different, consistent with a mitochondrial disorder... He had metabolic acidosis with normal serum lactate, normochromic anemia, recurrent hypertensive crises, and required tube feeding. He died at 18 months of age]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
618779	COFFIN-SIRIS SYNDROME 11	Coffin-Siris syndrome 11, 618779 (3)	Coffin-Siris syndrome 11	n	-	-	-	SMARCD1	HGNC:11106	Coffin-Siris syndrome 11, 618779 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
618780	CONGENITAL HEART DEFECTS, MULTIPLE TYPES, 7	Congenital heart defects, multiple types, 7, 618780 (3)	Congenital heart defects, multiple types, 7	n	-	-	-	FLT4	HGNC:3767	Congenital heart defects, multiple types, 7, 618780 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
618781	CILIARY DYSKINESIA, PRIMARY, 44	Ciliary dyskinesia, primary, 44, 618781 (3)	Ciliary dyskinesia, primary, 44	n	-	-	-	NEK10	HGNC:18592	Ciliary dyskinesia, primary, 44, 618781 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
618782	LONG QT SYNDROME 16	Long QT syndrome 16, 618782 (3)	Long QT syndrome 16	y	LONG QT SYNDROME 16; LQT16	Description|Clinical Features|Clinical Synopsis|Phenotype	death|deaths|died|miscarriage|miscarriages	CALM3	HGNC:1449	Long QT syndrome 16, 618782 (3), Autosomal dominant	Autosomal dominant	y	y	[Wren et al. (2019) studied 4 patients from 3 families with long QT syndrome and mutations in the CALM3 gene. In family A, the proband was a Spanish girl with fetal sinus bradycardia at 16 weeks' gestation in whom ECG at birth showed profound bradycardia at 61 bpm and 2:1 AV block with markedly prolonged QTc intervals of 725 ms, as well as transient episodes of T-wave alternans. At day 23 of life, the patient experienced cardiac arrest; ECG at time of resuscitation showed ventricular fibrillation (VF). An epicardial cardioverter defibrillator (ICD) was implanted, and she experienced 2 appropriate ICD discharges at age 3 years while on propanolol. At age 4, she developed symptomatic hypoglycemia, and the propanolol dose was reduced; however, at age 5, she had hypoglycemic coma and died. Her mother had 3 spontaneous miscarriages and terminated 2 other pregnancies, 1 due to fetal bradycardia and 1 due to spina bifida. In family B, the proband was a 21-month-old boy, born of unrelated Saudi Arabian parents, who had bradycardia (45 to 60 bpm) at 12 hours of life. ECG showed bradycardia and prolonged QTc (660 ms). Treatment with propanolol did not change the QTc duration, and several months later a pacemaker was implanted because of syncope and recurrent 2:1 AV block. At age 21 months, he was doing well without syncope. His parents and nonidentical twin sister were asymptomatic and had normal ECGs with normal QTc intervals. In family D, 5 of 6 sibs experienced sudden death in childhood: the first child had seizures and died at age 6 years; the second at 45 days; the third was asymptomatic at age 13 years; the fourth had fetal bradycardia and exhibited LQTS with 2:1 AV block, and died suddenly at 10 days of life after implantation of an ICD; and the fifth child also had LQTS with 2:1 AV block and died suddenly at age 45 days]	L1	y	y	lethal	lethal	lethal	L1	L1	pre-infant-lethal
618786	IMAGAWA-MATSUMOTO SYNDROME	Imagawa-Matsumoto syndrome, 618786 (3)	Imagawa-Matsumoto syndrome	n	-	-	-	SUZ12	HGNC:17101	Imagawa-Matsumoto syndrome, 618786 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
618787	DEAFNESS, AUTOSOMAL DOMINANT 76	Deafness, autosomal dominant 76, 618787 (3)	Deafness, autosomal dominant 76	n	-	-	-	PLS1	HGNC:9090	Deafness, autosomal dominant 76, 618787 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
618792	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 84	Developmental and epileptic encephalopathy 84, 618792 (3)	Developmental and epileptic encephalopathy 84	y	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 84; DEE84	Clinical Features|Clinical Synopsis	died|death|deaths	UGDH	HGNC:12525	Developmental and epileptic encephalopathy 84, 618792 (3), Autosomal recessive	Autosomal recessive	y	y	[Death in childhood (in some patients)]	L4	y	-	lethal	lethal	lethal	L4	L4	post-infant-lethal
618793	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 62	Intellectual developmental disorder, autosomal dominant 62, 618793 (3)	Intellectual developmental disorder, autosomal dominant 62	n	-	-	-	DLG4	HGNC:2903	Intellectual developmental disorder, autosomal dominant 62, 618793 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
618795	JUVENILE ARTHRITIS	Juvenile arthritis, 618795 (3)	Juvenile arthritis	n	-	-	-	LACC1	HGNC:26789	Juvenile arthritis, 618795 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
618797	NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, NEONATAL RESPIRATORY INSUFFICIENCY, AND THERMODYSREGULATION	Neurodevelopmental disorder with hypotonia, neonatal respiratory insufficiency, and thermodysregulation, 618797 (3)	Neurodevelopmental disorder with hypotonia, neonatal respiratory insufficiency, and thermodysregulation	y	NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, NEONATAL RESPIRATORY INSUFFICIENCY, AND THERMODYSREGULATION; NEDHRIT	Clinical Features	miscarriage|miscarriages	RALGAPA1	HGNC:17770	Neurodevelopmental disorder with hypotonia, neonatal respiratory insufficiency, and thermodysregulation, 618797 (3), Autosomal recessive	Autosomal recessive	y	y	[Wagner et al. (2020) reported 4 unrelated children, ranging in age from 8 months to 4.5 years, with a similar neurodevelopmental disorder apparent from birth ... Family history revealed 3 miscarriages in family A]	L1	n	y	lethal	lethal	lethal	L1	L1	pre-infant-lethal
618798	BECK-FAHRNER SYNDROME	Beck-Fahrner syndrome, 618798 (3)	Beck-Fahrner syndrome	n	-	-	-	TET3	HGNC:28313	Beck-Fahrner syndrome, 618798 (3), Autosomal dominant, Autosomal recessive	Autosomal dominant, Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
618800	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 28	Spinocerebellar ataxia, autosomal recessive 28, 618800 (3)	Spinocerebellar ataxia, autosomal recessive 28	n	-	-	-	THG1L	HGNC:26053	Spinocerebellar ataxia, autosomal recessive 28, 618800 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
618801	CILIARY DYSKINESIA, PRIMARY, 45	Ciliary dyskinesia, primary, 45, 618801 (3)	Ciliary dyskinesia, primary, 45	y	CILIARY DYSKINESIA, PRIMARY, 45; CILD45	Phenotype	death|deaths	TTC12	HGNC:23700	Ciliary dyskinesia, primary, 45, 618801 (3), Autosomal recessive	Autosomal recessive	y	n	-	-	-	-	ambiguous	ambiguous	ambiguous	-	-	-
618804	SANDESTIG-STEFANOVA SYNDROME	Sandestig-Stefanova syndrome, 618804 (3)	Sandestig-Stefanova syndrome	y	SANDESTIG-STEFANOVA SYNDROME; SANDSTEF	Clinical Features|Clinical Synopsis|Phenotype	died|die	NUP188	HGNC:17859	Sandestig-Stefanova syndrome, 618804 (3), Autosomal recessive	Autosomal recessive	y	y	[Sandestig et al. (2019) reported 2 unrelated female infants from consanguineous families with strikingly similar phenotypes, who both had mutations in the NUP188 gene... Both infants were lethargic and hypotonic, requiring oxygen supplementation and tube feedings, and ultimately died due to central respiratory failure at 67 days and 140 days of life, respectively]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
618805	TRIOKINASE AND FMN CYCLASE DEFICIENCY SYNDROME	Triokinase and FMN cyclase deficiency syndrome, 618805 (3)	Triokinase and FMN cyclase deficiency syndrome	y	TRIOKINASE AND FMN CYCLASE DEFICIENCY SYNDROME; TKFCD	Description|Clinical Features	fatal|died	TKFC	HGNC:24552	Triokinase and FMN cyclase deficiency syndrome, 618805 (3), Autosomal recessive	Autosomal recessive	y	y	[Wortmann et al. (2020) reported 2 sib pairs from 2 unrelated consanguineous families with variable cataract, developmental delay, and other multisystem features, and mutations in the TKFC gene. In family 1, 2 affected sisters were born of first-cousin parents of Gujarati ancestry. The first sister had cataract, microphthalmia, and developmental delay, with speech delay and wide-based gait. Brain MRI showed cerebellar hypoplasia and mild delay of myelin maturation. Electro- and echocardiograms were normal. Her younger sister had cataracts and failure to thrive, and after immunizations at age 8 weeks, she developed vomiting and diarrhea. Evaluation revealed hypotension, tachypnea, severe lactic acidosis, and dilated cardiomyopathy with poor systolic function, as well as abnormal liver function. Brain MRI was normal. She required ventilatory and inotropic support; later attempts at extubation resulted in deterioration of cardiac function and recurrence of lactic acidosis. She died at 11 weeks of age]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
618806	T-CELL LYMPHOPENIA, INFANTILE, WITH OR WITHOUT NAIL DYSTROPHY, AUTOSOMAL DOMINANT	T-cell lymphopenia, infantile, with or without nail dystrophy, autosomal dominant, 618806 (3)	T-cell lymphopenia, infantile, with or without nail dystrophy, autosomal dominant	y	T-CELL LYMPHOPENIA, INFANTILE, WITH OR WITHOUT NAIL DYSTROPHY, AUTOSOMAL DOMINANT; TLIND	Clinical Features	died	FOXN1	HGNC:12765	T-cell lymphopenia, infantile, with or without nail dystrophy, autosomal dominant, 618806 (3), Autosomal dominant	Autosomal dominant	y	y	[Bosticardo et al. (2019) reported 21 newborns with low levels of T-cell receptor excision circles (TRECs) and T-cell lymphopenia identified through newborn screening for SCID... Three patients underwent hematopoietic stem cell transplantation; 1 died 2 years later at age 5 and the other 2 remained T-cell lymphopenic after transplantation]	L4	y	-	lethal	lethal	lethal	L3|L4	L3	pre-infant-lethal
618808	INTELLECTUAL DEVELOPMENTAL DISORDER WITH POOR GROWTH AND WITH OR WITHOUT SEIZURES OR ATAXIA	Intellectual developmental disorder with poor growth and with or without seizures or ataxia, 618808 (3)	Intellectual developmental disorder with poor growth and with or without seizures or ataxia	n	-	-	-	ABCA2	HGNC:32	Intellectual developmental disorder with poor growth and with or without seizures or ataxia, 618808 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
618810	PONTOCEREBELLAR HYPOPLASIA, HYPOTONIA, AND RESPIRATORY INSUFFICIENCY SYNDROME, NEONATAL LETHAL	Pontocerebellar hypoplasia, hypotonia, and respiratory insufficiency syndrome, neonatal lethal, 618810 (3)	Pontocerebellar hypoplasia, hypotonia, and respiratory insufficiency syndrome, neonatal lethal	y	PONTOCEREBELLAR HYPOPLASIA, HYPOTONIA, AND RESPIRATORY INSUFFICIENCY SYNDROME, NEONATAL LETHAL; PHRINL	Description|Clinical Features|Clinical Synopsis|Phenotype	death|deaths|lethal|died|fatal	ATAD3A	HGNC:25567	Pontocerebellar hypoplasia, hypotonia, and respiratory insufficiency syndrome, neonatal lethal, 618810 (3), Autosomal recessive	Autosomal recessive	y	y	[Death in the neonatal period / Desai et al. (2017) reported 5 patients from 4 unrelated families, 3 of which were consanguineous, with fatal chromosome 1p36.33 deletion syndrome. Symptoms such as decreased fetal movements and polyhydramnios were apparent prenatally late in gestation (after 33 weeks'). One infant died during a lengthy labor, 2 died in the first days of life after cesarean section at 33 weeks' gestation, and the 2 others died at 5 days and 7 months of age]	L2	y	-	lethal	ambiguous|lethal	lethal	L2	L2	pre-infant-lethal
618820	GENITOURINARY AND/OR BRAIN MALFORMATION SYNDROME	Genitourinary and/or/brain malformation syndrome, 618820 (3)	Genitourinary and/or/brain malformation syndrome	n	-	-	-	PPP1R12A	HGNC:7618	Genitourinary and/or/brain malformation syndrome, 618820 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
618821	RHIZOMELIC LIMB SHORTENING WITH DYSMORPHIC FEATURES	Rhizomelic limb shortening with dysmorphic features, 618821 (3)	Rhizomelic limb shortening with dysmorphic features	n	-	-	-	PKDCC	HGNC:25123	Rhizomelic limb shortening with dysmorphic features, 618821 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
618823	CONGENITAL MYOPATHY 9B, PROXIMAL, WITH MINICORE LESIONS	Congenital myopathy 9B, proximal, with minicore lesions, 618823 (3)	Congenital myopathy 9B, proximal, with minicore lesions	y	CONGENITAL MYOPATHY 9B, PROXIMAL, WITH MINICORE LESIONS; CMYP9B	Clinical Features	death|deaths|miscarriage|miscarriages	FXR1	HGNC:4023	Congenital myopathy 9B, proximal, with minicore lesions, 618823 (3), Autosomal recessive	Autosomal recessive	y	y	[death at age 17 years/ family history revealed 2 spontaneous miscarriages]	L5	y	y	lethal	lethal	lethal	L5	L5	post-infant-lethal
618824	BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 8, AUTOSOMAL RECESSIVE	Basal ganglia calcification, idiopathic, 8, autosomal recessive, 618824 (3)	Basal ganglia calcification, idiopathic, 8, autosomal recessive	y	BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 8, AUTOSOMAL RECESSIVE; IBGC8	Clinical Features	died	JAM2	HGNC:14686	Basal ganglia calcification, idiopathic, 8, autosomal recessive, 618824 (3), Autosomal recessive	Autosomal recessive	y	y	[Schottlaender et al. (2020) reported 7 patients from 4 unrelated families with IBGC8... The proband in family 2 died in his late forties]	L6	y	-	lethal	lethal	lethal	L6	L6	post-infant-lethal
618825	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 63, WITH MACROCEPHALY	Intellectual developmental disorder, autosomal dominant 63, with macrocephaly, 618825 (3)	Intellectual developmental disorder, autosomal dominant 63, with macrocephaly	n	-	-	-	TRIO	HGNC:12303	Intellectual developmental disorder, autosomal dominant 63, with macrocephaly, 618825 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
618826	RETINITIS PIGMENTOSA 88	Retinitis pigmentosa 88, 618826 (3)	Retinitis pigmentosa 88	n	-	-	-	RP1L1	HGNC:15946	Retinitis pigmentosa 88, 618826 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
618827	MYOPIA 27, AUTOSOMAL DOMINANT	Myopia 27, 618827 (3)	Myopia 27	n	-	-	-	CPSF1	HGNC:2324	Myopia 27, 618827 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
618828	NABAIS SA-DE VRIES SYNDROME, TYPE 1	Nabais Sa-de Vries syndrome, type 1, 618828 (3)	Nabais Sa-de Vries syndrome, type 1	n	-	-	-	SPOP	HGNC:11254	Nabais Sa-de Vries syndrome, type 1, 618828 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
618829	NABAIS SA-DE VRIES SYNDROME, TYPE 2	Nabais Sa-de Vries syndrome, type 2, 618829 (3)	Nabais Sa-de Vries syndrome, type 2	n	-	-	-	SPOP	HGNC:11254	Nabais Sa-de Vries syndrome, type 2, 618829 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
618832	EPILEPSY, EARLY-ONSET, 2, WITH OR WITHOUT DEVELOPMENTAL DELAY	Epilepsy, early-onset, 2, with or without developmental delay, 618832 (3)	Epilepsy, early-onset, 2, with or without developmental delay	y	EPILEPSY, EARLY-ONSET, 2, WITH OR WITHOUT DEVELOPMENTAL DELAY; EPEO2	Clinical Features	died	SETD1A	HGNC:29010	Epilepsy, early-onset, 2, with or without developmental delay, 618832 (3), Autosomal dominant	Autosomal dominant	y	y	[An older brother reportedly had neonatal seizures and died at around 1 month of age]	L2	-	y	lethal	lethal	lethal	L2|L4	L2	pre-infant-lethal
618835	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 40	Combined oxidative phosphorylation deficiency 40, 618835 (3)	Combined oxidative phosphorylation deficiency 40	y	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 40; COXPD40	Description|Clinical Features|Clinical Synopsis	lethal|death|deaths|demise|died	QRSL1	HGNC:21020	Combined oxidative phosphorylation deficiency 40, 618835 (3), Autosomal recessive	Autosomal recessive	y	y	[Kamps et al. (2018) reported 2 sibs, born of consanguineous Turkish parents (family 1), with infantile lethal COXPD40. The proband was diagnosed prenatally with hypertrophic cardiomyopathy and showed encephalopathy, failure to thrive, and lactic acidosis at birth. Brain MRI showed diffuse cerebral atrophy and T2-weighed abnormalities in the globus pallidus and putamen, as well as in infratentorial regions, consistent with Leigh syndrome. MRI spectroscopy of the white matter showed high lactic acid peak and an abnormal choline/creatine ratio, consistent with demyelination. She died at the age of 6 months. Her similarly affected brother died in utero with cardiomyopathy and evidence of growth delay and head lag / Friederich et al. (2018) reported 2 patients and an affected fetus with COXPD40 from 2 unrelated families (families 2 and 3)..... She died of heart failure on the first day of life]	L1	y	y	lethal	lethal	lethal	L1	L1	pre-infant-lethal
618839	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 42	Combined oxidative phosphorylation deficiency 42, 618839 (3)	Combined oxidative phosphorylation deficiency 42	y	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 42; COXPD42	Description|Clinical Features|Clinical Synopsis	died|lethal|death|deaths	GATC	HGNC:25068	Combined oxidative phosphorylation deficiency 42, 618839 (3), Autosomal recessive	Autosomal recessive	y	y	[Friederich et al. (2018) reported 6 patients from 2 consanguineous families (families 4 and 5) of Druze origin with infantile lethal COXPD42. The families were reportedly unrelated, but resided in adjacent villages. Three sibs in family 4 had normal early development, but presented at 2 to 3 months of age with failure to thrive, respiratory insufficiency, and cardiac dysfunction due to hypertrophic or dilated cardiomyopathy. Laboratory studies showed lactic acidosis, increased serum creatine kinase and alanine, anemia, and abnormal liver enzymes. All died in the first months of life]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
618840	ALOPECIA-INTELLECTUAL DISABILITY SYNDROME 4	Alopecia-intellectual disability syndrome 4, 618840 (3)	Alopecia-intellectual disability syndrome 4	n	-	-	-	LSS	HGNC:6708	Alopecia-intellectual disability syndrome 4, 618840 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
618841	HYPOGONADOTROPIC HYPOGONADISM 25 WITH ANOSMIA	Hypogonadotropic hypogonadism 25 with anosmia, 618841 (3)	Hypogonadotropic hypogonadism 25 with anosmia	n	-	-	-	NDNF	HGNC:26256	Hypogonadotropic hypogonadism 25 with anosmia, 618841 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
618845	VERTEBRAL, CARDIAC, RENAL, AND LIMB DEFECTS SYNDROME 3	Vertebral, cardiac, renal, and limb defects syndrome 3, 618845 (3)	Vertebral, cardiac, renal, and limb defects syndrome 3	y	VERTEBRAL, CARDIAC, RENAL, AND LIMB DEFECTS SYNDROME 3; VCRL3	Description|Clinical Features|Clinical Synopsis	lethal|died|death|deaths	NADSYN1	HGNC:29832	Vertebral, cardiac, renal, and limb defects syndrome 3, 618845 (3), Autosomal recessive	Autosomal recessive	y	y	[Szot et al. (2020) studied 5 patients from 4 unrelated families with multiple overlapping congenital anomalies and biallelic mutations in the NADSYN1 gene. All 5 individuals exhibited renal abnormalities, ranging from a mild hyperechoic renal cortex to the complete absence of both kidneys. Limb involvement, including short proximal long bones or micromelia, was observed in 4 patients. Cardiac and vertebral abnormalities were present in 3 patients. Vertebral defects included scoliosis with multiple malformed vertebrae and ribs, and segmentation defects of the thoracic, lumbar, and sacral spine. The heart was either hypoplastic due to underdevelopment of the left ventricle or compromised by malformation of the aorta and pulmonary artery. Various other abnormalities were also noted, including sacral dimples in 2 patients, and dysmorphic facial features, pulmonary hypoplasia, echogenic bowel, and polysplenia in 1 patient. Of the 5 pregnancies, 2 were terminated at 16 weeks of gestation and 1 at 23 weeks due to the severity of their phenotypes, and the other 2 patients died within 3 months of birth]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
618846	DIETS-JONGMANS SYNDROME	Diets-Jongmans syndrome, 618846 (3)	Diets-Jongmans syndrome	n	-	-	-	KDM3B	HGNC:1337	Diets-Jongmans syndrome, 618846 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
618848	MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 26	Muscular dystrophy, limb-girdle, autosomal recessive 26, 618848 (3)	Muscular dystrophy, limb-girdle, autosomal recessive 26	n	-	-	-	POPDC3	HGNC:17649	Muscular dystrophy, limb-girdle, autosomal recessive 26, 618848 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
618852	AUTOINFLAMMATION WITH EPISODIC FEVER AND LYMPHADENOPATHY	Autoinflammation with episodic fever and lymphadenopathy, 618852 (3)	Autoinflammation with episodic fever and lymphadenopathy	y	AUTOINFLAMMATION WITH EPISODIC FEVER AND LYMPHADENOPATHY; AIEFL	Phenotype	death|deaths	RIPK1	HGNC:10019	Autoinflammation with episodic fever and lymphadenopathy, 618852 (3), Autosomal dominant	Autosomal dominant	y	n	-	-	-	-	ambiguous	ambiguous|lethal	lethal	L3	L3	pre-infant-lethal
618853	ANAUXETIC DYSPLASIA 3	Anauxetic dysplasia 3, 618853 (3)	Anauxetic dysplasia 3	n	-	-	-	NEPRO	HGNC:24496	Anauxetic dysplasia 3, 618853 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
618855	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 44	Combined oxidative phosphorylation deficiency 44, 618855 (3)	Combined oxidative phosphorylation deficiency 44	n	-	-	-	FASTKD2	HGNC:29160	Combined oxidative phosphorylation deficiency 44, 618855 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
618856	DIABETES MELLITUS, PERMANENT NEONATAL, 2	Diabetes, permanent neonatal 2, with or without neurologic features, 618856 (3)	Diabetes, permanent neonatal 2, with or without neurologic features	y	DIABETES MELLITUS, PERMANENT NEONATAL, 2; PNDM2	Clinical Features	died	KCNJ11	HGNC:6257	Diabetes, permanent neonatal 2, with or without neurologic features, 618856 (3), Autosomal dominant	Autosomal dominant	y	y	[Gloyn et al. (2006) reported 4 unrelated patients with developmental delay, epilepsy, and neonatal diabetes (DEND) associated with mutations in the KCNJ11 gene. All had infantile-onset of diabetes without pancreatic autoantibodies (diagnosed from day 1 of life to 3 months) with hyperglycemia, polydipsia, polyuria, and ketoacidosis in some. The most severely affected child had seizures with hypsarrhythmia, neurologic deterioration with social withdrawal, and mild dysmorphic features, including prominent metopic suture, downturned mouth, and bilateral ptosis. She died from aspiration pneumonia at age 6 months; genetic analysis revealed a novel mutation in the KCNJ11 gene (C166F; 600937.0015)]	L3	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L3	L3	pre-infant-lethal
618857	DIABETES MELLITUS, PERMANENT NEONATAL, 3	Diabetes mellitus, permanent neonatal 3, with or without neurologic features, 618857 (3)	Diabetes mellitus, permanent neonatal 3, with or without neurologic features	n	-	-	-	ABCC8	HGNC:59	Diabetes mellitus, permanent neonatal 3, with or without neurologic features, 618857 (3), Autosomal dominant, Autosomal recessive	Autosomal dominant, Autosomal recessive	-	-	-	-	-	-	nonlethal	ambiguous|nonlethal	ambiguous	-	-	-
618858	DIABETES MELLITUS, PERMANENT NEONATAL, 4	Diabetes mellitus, permanent neonatal 4, 618858 (3)	Diabetes mellitus, permanent neonatal 4	n	-	-	-	INS	HGNC:6081	Diabetes mellitus, permanent neonatal 4, 618858 (3), Autosomal dominant, Autosomal recessive	Autosomal dominant, Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
618859	NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT AUTISTIC FEATURES AND/OR STRUCTURAL BRAIN ABNORMALITIES	Neurodevelopmental disorder with or without autistic features and/or structural brain abnormalities, 618859 (3)	Neurodevelopmental disorder with or without autistic features and/or structural brain abnormalities	n	-	-	-	NOVA2	HGNC:7887	Neurodevelopmental disorder with or without autistic features and/or structural brain abnormalities, 618859 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
618862	NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, MICROCEPHALY, AND SEIZURES	Neurodevelopmental disorder with hypotonia, microcephaly, and seizures, 618862 (3)	Neurodevelopmental disorder with hypotonia, microcephaly, and seizures	y	NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, MICROCEPHALY, AND SEIZURES; NEDHYMS	Clinical Features	died|spontaneous_abortion|spontaneous_abortions	ADARB1	HGNC:226	Neurodevelopmental disorder with hypotonia, microcephaly, and seizures, 618862 (3), Autosomal recessive	Autosomal recessive	y	y	[Patient 2 died of epilepsy at 2 years of age. Patient 3 had a family history, including 5 first trimester spontaneous abortions in the mother and several relatives with intellectual disability, although detailed genetic testing was not available]	L1	n	y	lethal	lethal	lethal	L1	L1	pre-infant-lethal
618863	RETINAL DYSTROPHY WITH LEUKODYSTROPHY	Retinal dystrophy with leukodystrophy, 618863 (3)	Retinal dystrophy with leukodystrophy	n	-	-	-	ACBD5	HGNC:23338	Retinal dystrophy with leukodystrophy, 618863 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
618866	TREMOR, HEREDITARY ESSENTIAL, 6	Tremor, hereditary essential, 6, 618866 (3)	Tremor, hereditary essential, 6	n	-	-	-	NOTCH2NLC	HGNC:53924	Tremor, hereditary essential, 6, 618866 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L6|LU	L6	post-infant-lethal
618868	NEURODEGENERATION, CHILDHOOD-ONSET, WITH ATAXIA, TREMOR, OPTIC ATROPHY, AND COGNITIVE DECLINE	Neurodegeneration, childhood-onset, with ataxia, tremor, optic atrophy, and cognitive decline, 618868 (3)	Neurodegeneration, childhood-onset, with ataxia, tremor, optic atrophy, and cognitive decline	n	-	-	-	SLC44A1	HGNC:18798	Neurodegeneration, childhood-onset, with ataxia, tremor, optic atrophy, and cognitive decline, 618868 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
618870	SKELETAL DYSPLASIA, MILD, WITH JOINT LAXITY AND ADVANCED BONE AGE	Skeletal dysplasia, mild, with joint laxity and advanced bone age, 618870 (3)	Skeletal dysplasia, mild, with joint laxity and advanced bone age	n	-	-	-	CSGALNACT1	HGNC:24290	Skeletal dysplasia, mild, with joint laxity and advanced bone age, 618870 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
618872	NIZON-ISIDOR SYNDROME	Nizon-Isidor syndrome, 618872 (3)	Nizon-Isidor syndrome	n	-	-	-	MED12L	HGNC:16050	Nizon-Isidor syndrome, 618872 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
618873	LISSENCEPHALY 10	Lissencephaly 10, 618873 (3)	Lissencephaly 10	n	-	-	-	CEP85L	HGNC:21638	Lissencephaly 10, 618873 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
618875	SEIZURES, EARLY-ONSET, WITH NEURODEGENERATION AND BRAIN CALCIFICATIONS	Seizures, early-onset, with neurodegeneration and brain calcification, 618875 (3)	Seizures, early-onset, with neurodegeneration and brain calcification	y	SEIZURES, EARLY-ONSET, WITH NEURODEGENERATION AND BRAIN CALCIFICATIONS; SENEBAC	Description|Clinical Features|Clinical Synopsis|Phenotype	death|deaths|died	NRROS	HGNC:24613	Seizures, early-onset, with neurodegeneration and brain calcification, 618875 (3), Autosomal recessive	Autosomal recessive	y	y	[Smith et al. (2020) reported 3 children from 2 unrelated families with a similar neurodegenerative disorder. After normal early development, all patients developed refractory seizures between 14 and 18 months, and thereafter showed regression of motor skills ultimately resulting in death by age 3 years]	L4	y	-	lethal	lethal	lethal	L4	L4	post-infant-lethal
618876	EPILEPSY, PROGRESSIVE MYOCLONIC, 11	Epilepsy, progressive myoclonic, 11, 618876 (3)	Epilepsy, progressive myoclonic, 11	n	-	-	-	SEMA6B	HGNC:10739	Epilepsy, progressive myoclonic, 11, 618876 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
618877	LEUKOENCEPHALOPATHY, DEVELOPMENTAL DELAY, AND EPISODIC NEUROLOGIC REGRESSION SYNDROME	Leukoencephalopathy, developmental delay, and episodic neurologic regression syndrome, 618877 (3)	Leukoencephalopathy, developmental delay, and episodic neurologic regression syndrome	n	-	-	-	EIF2AK2	HGNC:9437	Leukoencephalopathy, developmental delay, and episodic neurologic regression syndrome, 618877 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
618879	NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA AND CEREBELLAR ATROPHY, WITH OR WITHOUT SEIZURES	Neurodevelopmental disorder with hypotonia and cerebellar atrophy, with or without seizures, 618879 (3)	Neurodevelopmental disorder with hypotonia and cerebellar atrophy, with or without seizures	y	NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA AND CEREBELLAR ATROPHY, WITH OR WITHOUT SEIZURES; NEDHCAS	Clinical Features|Phenotype	died|lethal	PIGK	HGNC:8965	Neurodevelopmental disorder with hypotonia and cerebellar atrophy, with or without seizures, 618879 (3), Autosomal recessive	Autosomal recessive	y	y	[Chen et al. (2021) described 2 Chinese sibs with NEDHCAS. The older sib (patient 1) had recurrent seizures starting at 4 months of age, and severe hypotonia, lack of head control, strabismus, and nystagmus. At age 14 months, he was found to have microcephaly. Brain MRI at age 2 years and 8 months demonstrated progressive global brain atrophy and delayed myelination. Physical examination demonstrated dysmorphic facial features, including high-arched eyebrows, epicanthus, short anteverted nose, high-arched palate, tented lip, and retrognathia. He died at the age of 3 years and 4 months due to respiratory complications. The younger sib (patient 2) had a similar clinical course, including acquired microcephaly, hypotonia, dysmorphic features, and similar brain MRI findings. He died at age 1 year due to respiratory complications]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
618880	GLAUCOMA, PRIMARY CLOSED-ANGLE	Glaucoma, primary closed-angle, 618880 (3)	Glaucoma, primary closed-angle	y	GLAUCOMA, PRIMARY CLOSED-ANGLE; GLCC	Clinical Features	death|deaths	COL18A1	HGNC:2195	Glaucoma, primary closed-angle, 618880 (3), Autosomal dominant	Autosomal dominant	y	n	-	-	-	-	ambiguous	ambiguous|nonlethal	ambiguous	-	-	-
618881	GALACTOSEMIA IV	Galactosemia IV, 618881 (3)	Galactosemia IV	n	-	-	-	GALM	HGNC:24063	Galactosemia IV, 618881 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
618882	IMERSLUND-GRASBECK SYNDROME 2	Imerslund-Grasbeck syndrome 2, 618882 (3)	Imerslund-Grasbeck syndrome 2	n	-	-	-	AMN	HGNC:14604	Imerslund-Grasbeck syndrome 2, 618882 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
618883	HYPOPARATHYROIDISM, FAMILIAL ISOLATED, 2	Hypoparathyroidism, familial isolated 2, 618883 (3)	Hypoparathyroidism, familial isolated 2	n	-	-	-	GCM2	HGNC:4198	Hypoparathyroidism, familial isolated 2, 618883 (3), Autosomal dominant, Autosomal recessive	Autosomal dominant, Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
618885	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIt	Congenital disorder of glycosylation, type IIt, 618885 (3)	Congenital disorder of glycosylation, type IIt	n	-	-	-	GALNT2	HGNC:4124	Congenital disorder of glycosylation, type IIt, 618885 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
618886	PSEUDO-TORCH SYNDROME 3	Pseudo-TORCH syndrome 3, 618886 (3)	Pseudo-TORCH syndrome 3	y	PSEUDO-TORCH SYNDROME 3; PTORCH3	Description|Clinical Features|Clinical Synopsis	death|deaths|died	STAT2	HGNC:11363	Pseudo-TORCH syndrome 3, 618886 (3), Autosomal recessive	Autosomal recessive	y	y	[Duncan et al. (2019) reported 2 brothers, born of consanguineous Pakistani parents, with onset of a severe multisystemic inflammatory disorder soon after birth. Both infants were born prematurely, at 32 and 34 weeks' gestation, due to premature rupture of membranes. The first brother had transient neonatal thrombocytopenia without evidence of infection, and was later noted to have neurodevelopmental delay, poor growth, and thyroid dysfunction around 6 months. At 8 months, he presented with the first of 3 episodes of marked systemic and neuroinflammatory disease manifest as generalized tonic-clonic seizures, lethargy, and developmental regression. He was found to be septic with pneumococcal blood infection and multiorgan dysfunction, including fever, hepatosplenomegaly, increased D-dimers, thrombocytopenia, raised ferritin and LDH, elevated liver enzymes, and acute kidney injury with hypertension and nephrotic range proteinuria. He recovered from this episode and showed mild developmental progress, but had additional similar episodes with seizures, developmental regression, and multisystem involvement without evidence of infection; autoantibody screening was normal. He met the diagnostic criteria for hemophagocytic lymphohistiocytosis (HLH) and had features of renal thrombotic microangiopathy (TMA). Brain imaging showed progressive diffuse intracranial calcification, white matter disease, and intracranial hemorrhage. He died of infection during hematopoietic stem cell transplantation at age 20 months. His younger brother had similar disease course characterized by abnormal neurodevelopment apparent from early infancy. At about 3 weeks of age, he developed apneic episodes, anemia, coagulation anomalies, and proteinuria associated with brain imaging anomalies, such as intracranial parenchymal calcifications and hemorrhage, abnormal cerebral white matter, and brainstem and cerebellar atrophy. There was no evidence of infection. He continued to have neurologic regression and showed dystonia and EEG abnormalities, consistent with severe neurologic damage. He died at 14 weeks of age]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
618889	LIBERFARB SYNDROME	Liberfarb syndrome, 618889 (3)	Liberfarb syndrome	y	LIBERFARB SYNDROME; LIBF	Clinical Features	died	PISD	HGNC:8999	Liberfarb syndrome, 618889 (3), Autosomal recessive	Autosomal recessive	y	y	[Peter et al. (2019) followed up on the patient of Liberfarb et al. (1986), noting that she had died at age 35 years of cardiac arrest and anoxic encephalopathy. They also noted that the parents were consanguineous]	L6	y	-	lethal	lethal	lethal	L6	L6	post-infant-lethal
618890	NEURODEVELOPMENTAL DISORDER AND STRUCTURAL BRAIN ANOMALIES WITH OR WITHOUT SEIZURES AND SPASTICITY	Neurodevelopmental disorder and structural brain anomalies with or without seizures and spasticity, 618890 (3)	Neurodevelopmental disorder and structural brain anomalies with or without seizures and spasticity	y	NEURODEVELOPMENTAL DISORDER AND STRUCTURAL BRAIN ANOMALIES WITH OR WITHOUT SEIZURES AND SPASTICITY; NEDBASS	Description|Clinical Features|Clinical Synopsis|Phenotype	death|deaths|died|lethal	PTPN23	HGNC:14406	Neurodevelopmental disorder and structural brain anomalies with or without seizures and spasticity, 618890 (3), Autosomal recessive	Autosomal recessive	y	y	[Death in childhood (in some patients)]	L4	y	-	lethal	lethal	lethal	L4	L4	post-infant-lethal
618891	MICROCEPHALY, DEVELOPMENTAL DELAY, AND BRITTLE HAIR SYNDROME	Microcephaly, developmental delay, and brittle hair syndrome, 618891 (3)	Microcephaly, developmental delay, and brittle hair syndrome	n	-	-	-	CARS1	HGNC:1493	Microcephaly, developmental delay, and brittle hair syndrome, 618891 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
618892	HARDEROPORPHYRIA	Harderoporphyria, 618892 (3)	Harderoporphyria	y	HARDEROPORPHYRIA; HARPO	Clinical Features	died	CPOX	HGNC:2321	Harderoporphyria, 618892 (3), Autosomal recessive	Autosomal recessive	y	y	[Hasanoglu et al. (2011) reported a Turkish male infant, born of consanguineous parents, with harderoporphyria. He presented with neonatal jaundice, hemolytic anemia, and severe cutaneous photosensitivity. At age 1.5 months, he had an acute porphyric attack characterized by hepatosplenomegaly, elevated liver enzymes, red urine, metabolic acidosis, and severe Coombs-negative hemolytic anemia. The child died at age 5 months]	L3	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L3	L3	pre-infant-lethal
618901	46,XX SEX REVERSAL 5	46XX sex reversal 5, 618901 (3)	46XX sex reversal 5	y	46,XX SEX REVERSAL 5; SRXX5	Clinical Features	died	NR2F2	HGNC:7976	46XX sex reversal 5, 618901 (3), Autosomal dominant	Autosomal dominant	y	y	[died shortly after birth]	L2	y	-	lethal	lethal	lethal	L2|L6	L2	pre-infant-lethal
618906	INTELLECTUAL DEVELOPMENTAL DISORDER WITH AUTISTIC FEATURES AND LANGUAGE DELAY, WITH OR WITHOUT SEIZURES	Intellectual developmental disorder with autistic features and language delay, with or without seizures, 618906 (3)	Intellectual developmental disorder with autistic features and language delay, with or without seizures	n	-	-	-	TANC2	HGNC:30212	Intellectual developmental disorder with autistic features and language delay, with or without seizures, 618906 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
618907	SILVER-RUSSELL SYNDROME 4	Silver-Russell syndrome 4, 618907 (3)	Silver-Russell syndrome 4	n	-	-	-	PLAG1	HGNC:9045	Silver-Russell syndrome 4, 618907 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
618908	SILVER-RUSSELL SYNDROME 5	Silver-Russell syndrome 5, 618908 (3)	Silver-Russell syndrome 5	n	-	-	-	HMGA2	HGNC:5009	Silver-Russell syndrome 5, 618908 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
618912	NEURONOPATHY, DISTAL HEREDITARY MOTOR, AUTOSOMAL RECESSIVE 8	Neuronopathy, distal hereditary motor, autosomal recessive 8, 618912 (3)	Neuronopathy, distal hereditary motor, autosomal recessive 8	n	-	-	-	SORD	HGNC:11184	Neuronopathy, distal hereditary motor, autosomal recessive 8, 618912 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
618913	FANCONI RENOTUBULAR SYNDROME 5	Fanconi renotubular syndrome 5, 618913 (3)	Fanconi renotubular syndrome 5	y	FANCONI RENOTUBULAR SYNDROME 5; FRTS5	Clinical Features	fatal	NDUFAF6	HGNC:28625	Fanconi renotubular syndrome 5, 618913 (3), Autosomal recessive	Autosomal recessive	y	y	[Wornell et al. (2007) described 19 Acadian individuals, including one sib pair, with FRTS5. Most patients came to medical attention because of genu valgum due to hypophosphatemic rickets, with a mean age of presentation of 8.5 years. Average follow-up of patients was 8.4 years. Treatment with alkali and phosphate replacement and vitamin D resulted in improvement of rickets. Hypokalemia was not observed in any patient. Renal biopsy in 1 patient showed mild chronic interstitial fibrosis. Chronic kidney disease developed in half of the patients by age 13 years. Proteinuria was present in almost all patients by age 15 years. Hypertension developed in 7 patients. One patient developed pulmonary interstitial emphysema, and 2 patients developed fatal pulmonary fibrosis following renal transplantation]	LU	y	-	lethal	lethal|nonlethal	lethal|nonlethal	LU	LU	post-infant-lethal
618914	NEURODEVELOPMENTAL, JAW, EYE, AND DIGITAL SYNDROME	Neurodevelopmental, jaw, eye, and digital syndrome, 618914 (3)	Neurodevelopmental, jaw, eye, and digital syndrome	n	-	-	-	FBXW11	HGNC:13607	Neurodevelopmental, jaw, eye, and digital syndrome, 618914 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
618916	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 87	Developmental and epileptic encephalopathy 87, 618916 (3)	Developmental and epileptic encephalopathy 87	n	-	-	-	CDK19	HGNC:19338	Developmental and epileptic encephalopathy 87, 618916 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
618917	NEURODEVELOPMENTAL DISORDER WITH LANGUAGE IMPAIRMENT AND BEHAVIORAL ABNORMALITIES	Neurodevelopmental disorder with language impairment and behavioral abnormalities, 618917 (3)	Neurodevelopmental disorder with language impairment and behavioral abnormalities	y	NEURODEVELOPMENTAL DISORDER WITH LANGUAGE IMPAIRMENT AND BEHAVIORAL ABNORMALITIES; NEDLIB	Clinical Features|Phenotype	died	GRIA2	HGNC:4572	Neurodevelopmental disorder with language impairment and behavioral abnormalities, 618917 (3), Autosomal dominant	Autosomal dominant	y	y	[Salpietro et al. (2019) reported 25 unrelated patients, ranging from 3 months to 31 years of age, with a neurodevelopmental disorder... Two patients died in infancy]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
618918	PERIVENTRICULAR NODULAR HETEROTOPIA 9	Periventricular nodular heterotopia 9, 618918 (3)	Periventricular nodular heterotopia 9	n	-	-	-	MAP1B	HGNC:6836	Periventricular nodular heterotopia 9, 618918 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
618920	ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 14	Arrhythmogenic right ventricular dysplasia 14, 618920 (3)	Arrhythmogenic right ventricular dysplasia 14	y	ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 14; ARVD14	Description|Clinical Features|Clinical Synopsis	death|deaths|died	CDH2	HGNC:1759	Arrhythmogenic right ventricular dysplasia 14, 618920 (3), Autosomal dominant	Autosomal dominant	y	y	[He died suddenly at age 22 despite treatment with various antiarrhythmic drugs.]	L6	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L6	L6	post-infant-lethal
618922	NEURODEVELOPMENTAL DISORDER WITH SEIZURES, HYPOTONIA, AND BRAIN IMAGING ABNORMALITIES	Neurodevelopmental disorder with seizures, hypotonia, and brain abnormalities, 618922 (3)	Neurodevelopmental disorder with seizures, hypotonia, and brain abnormalities	y	NEURODEVELOPMENTAL DISORDER WITH SEIZURES, HYPOTONIA, AND BRAIN IMAGING ABNORMALITIES; NEDSHBA	Description|Clinical Features|Clinical Synopsis	death|deaths|died	GRM7	HGNC:4599	Neurodevelopmental disorder with seizures, hypotonia, and brain abnormalities, 618922 (3), Autosomal recessive	Autosomal recessive	y	y	[Marafi et al. (2020) reported 5 patients from 3 additional consanguineous families (families 4, 5, and 6) with NEDSHBA. They also reviewed the clinical features of the patients previously reported by Charng et al. (2016) and Reuter et al. (2017). Five of the 6 families were consanguineous and from the Middle East; family 2 was nonconsanguineous and from the United States. The patients ranged in age from 2 to 15 years; 5 had died between 45 days and 13 years of age, most commonly of respiratory failure]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
618924	EPISODIC ATAXIA, TYPE 9	Episodic ataxia, type 9, 618924 (3)	Episodic ataxia, type 9	y	EPISODIC ATAXIA, TYPE 9; EA9	Clinical Features	died	SCN2A	HGNC:10588	Episodic ataxia, type 9, 618924 (3), Autosomal dominant	Autosomal dominant	y	y	[Touma et al. (2013) reported a pair of monozygotic twin boys who carried the same de novo heterozygous A263V mutation identified in the patient reported by Liao et al. (2010). On the first day of life, both boys developed refractory seizures (up to 60 per day) associated with a burst-suppression pattern on EEG. One twin died on day 19 from iatrogenic cardiopulmonary arrest]	L2	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L2	L2	pre-infant-lethal
618929	AGENESIS OF CORPUS CALLOSUM, CARDIAC, OCULAR, AND GENITAL SYNDROME	Agenesis of corpus callosum, cardiac, ocular, and genital syndrome, 618929 (3)	Agenesis of corpus callosum, cardiac, ocular, and genital syndrome	n	-	-	-	CDH2	HGNC:1759	Agenesis of corpus callosum, cardiac, ocular, and genital syndrome, 618929 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L6	L6	post-infant-lethal
618935	GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, 5	Chronic granulomatous disease 5, autosomal recessive, 618935 (3)	Chronic granulomatous disease 5, autosomal recessive	y	GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, 5; CGD5	Clinical Features	died	CYBC1	HGNC:28672	Chronic granulomatous disease 5, autosomal recessive, 618935 (3), Autosomal recessive	Autosomal recessive	y	y	[Arnadottir et al. (2018) reported 2 Icelandic brothers with CGD5... Both patients underwent hematopoietic stem cell transplantation at 17 and 18 years of age. The older brother died of complications, whereas the younger brother had a successful transplant and remained symptom-free]	L5	y	-	lethal	lethal	lethal	L5	L5	post-infant-lethal
618939	TREACHER COLLINS SYNDROME 4	Treacher-Collins syndrome 4, 618939 (3)	Treacher-Collins syndrome 4	n	-	-	-	POLR1B	HGNC:20454	Treacher-Collins syndrome 4, 618939 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
618940	OCULOPHARYNGODISTAL MYOPATHY 2	Oculopharyngodistal myopathy 2, 618940 (3)	Oculopharyngodistal myopathy 2	n	-	-	-	GIPC1	HGNC:1226	Oculopharyngodistal myopathy 2, 618940 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
618944	HYPER-IgE SYNDROME 5, AUTOSOMAL RECESSIVE, WITH RECURRENT INFECTIONS	Hyper-IgE syndrome 5, autosomal recessive, with recurrent infections, 618944 (3)	Hyper-IgE syndrome 5, autosomal recessive, with recurrent infections	n	-	-	-	IL6R	HGNC:6019	Hyper-IgE syndrome 5, autosomal recessive, with recurrent infections, 618944 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
618947	ARTHROGRYPOSIS MULTIPLEX CONGENITA 5	Arthrogryposis multiplex congenita 5, 618947 (3)	Arthrogryposis multiplex congenita 5	y	ARTHROGRYPOSIS MULTIPLEX CONGENITA 5; AMC5	Clinical Features|Clinical Synopsis	died|death|deaths	TOR1A	HGNC:3098	Arthrogryposis multiplex congenita 5, 618947 (3), Autosomal recessive	Autosomal recessive	y	y	[Isik et al. (2019) reported a 4.5-month-old boy with AMC5. The pregnancy was complicated by decreased fetal movements and polyhydramnios. At birth, he showed severe arthrogryposis with hip dislocation, joint contractures, adducted thumbs, camptodactyly, pes valgus, rocker-bottom feet, and hammertoes. He also had increased muscle tone. Soon after birth, he developed bradycardia necessitating resuscitation and apneic episodes and respiratory failure requiring mechanical ventilation. The infant had poor overall growth with microcephaly and dysmorphic features, including prominent occiput, round face with full cheeks, broad nasal bridge, anteverted nares, long philtrum, micrognathia, large ears, short neck, kyphoscoliosis, and umbilical and inguinal hernia. He did not have strabismus, but retinal examination showed pale optic discs. At 4 months of age, he had severe hypotonia with inability to lift his head or swallow. He had daily dystonic movements associated with apnea, and he died at 4.5 months of age during one of these episodes.]	L3	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L3	L3	pre-infant-lethal
618948	HETEROTAXY, VISCERAL, 9, AUTOSOMAL, WITH MALE INFERTILITY	Heterotaxy, visceral, 9, autosomal, with male infertility, 618948 (3)	Heterotaxy, visceral, 9, autosomal, with male infertility	y	HETEROTAXY, VISCERAL, 9, AUTOSOMAL, WITH MALE INFERTILITY; HTX9	Clinical Features	died	MNS1	HGNC:29636	Heterotaxy, visceral, 9, autosomal, with male infertility, 618948 (3), Autosomal recessive	Autosomal recessive	y	n	-	-	-	-	ambiguous	ambiguous	ambiguous	-	-	-
618950	SULEIMAN-EL-HATTAB SYNDROME	Suleiman-El-Hattab syndrome, 618950 (3)	Suleiman-El-Hattab syndrome	n	-	-	-	TASP1	HGNC:15859	Suleiman-El-Hattab syndrome, 618950 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
618955	RETINITIS PIGMENTOSA 89	Retinitis pigmentosa 89, 618955 (3)	Retinitis pigmentosa 89	n	-	-	-	KIF3B	HGNC:6320	Retinitis pigmentosa 89, 618955 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
618960	MITCHELL SYNDROME	Mitchell syndrome, 618960 (3)	Mitchell syndrome	y	MITCHELL SYNDROME; MITCH	Clinical Features	died	ACOX1	HGNC:119	Mitchell syndrome, 618960 (3), Autosomal dominant	Autosomal dominant	y	y	[Chung et al. (2020) reported 3 unrelated patients with a progressive disorder including episodic demyelination, sensorimotor polyneuropathy, and hearing loss....At age 19, he developed respiratory muscle weakness, dysphagia, and altered mental status. A brain MRI showed development of central lesions. The patient died following removal of life support]	L6	y	-	lethal	lethal	lethal	L1|L6	L1	pre-infant-lethal
618961	SPONDYLOMETAPHYSEAL DYSPLASIA WITH CORNEAL DYSTROPHY	Spondylometaphyseal dysplasia with corneal dystrophy, 618961 (3)	Spondylometaphyseal dysplasia with corneal dystrophy	y	SPONDYLOMETAPHYSEAL DYSPLASIA WITH CORNEAL DYSTROPHY; SMDCD	Clinical Features	died	PLCB3	HGNC:9056	Spondylometaphyseal dysplasia with corneal dystrophy, 618961 (3), Autosomal recessive	Autosomal recessive	y	y	[Ben-Salem et al. (2018) reported 2 male cousins from a consanguineous Emirati family with spondylometaphyseal dysplasia and corneal dystrophy. Both were floppy at birth with a narrow chest and short ribs, and required intubation and ventilation... His cousin, who had chronic lung disease with pulmonary hypertension and was also oxygen-dependent, died of septic shock at 8 months of age]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
618969	IMMUNODEFICIENCY 70	Immunodeficiency 70, 618969 (3)	Immunodeficiency 70	n	-	-	-	IVNS1ABP	HGNC:16951	Immunodeficiency 70, 618969 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
618970	CONE-ROD SYNAPTIC DISORDER SYNDROME, CONGENITAL NONPROGRESSIVE	Cone-rod synaptic disorder syndrome, congenital nonprogressive, 618970 (3)	Cone-rod synaptic disorder syndrome, congenital nonprogressive	n	-	-	-	RIMS2	HGNC:17283	Cone-rod synaptic disorder syndrome, congenital nonprogressive, 618970 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
618971	TOLCHIN-LE CAIGNEC SYNDROME	Tolchin-Le Caignec syndrome, 618971 (3)	Tolchin-Le Caignec syndrome	n	-	-	-	SOX6	HGNC:16421	Tolchin-Le Caignec syndrome, 618971 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
618973	SODIUM-DEPENDENT MULTIVITAMIN TRANSPORTER DEFICIENCY	Sodium-dependent multivitamin transporter deficiency, 618973 (3)	Sodium-dependent multivitamin transporter deficiency	y	SODIUM-DEPENDENT MULTIVITAMIN TRANSPORTER DEFICIENCY; SMVTD	Clinical Features	died	SLC5A6	HGNC:11041	Sodium-dependent multivitamin transporter deficiency, 618973 (3), Autosomal recessive	Autosomal recessive	y	y	[died at 2.7 years of age]	L4	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L4	L4	post-infant-lethal
618974	LI-GHORBANI-WEISZ-HUBSHMAN SYNDROME	Li-Ghorgani-Weisz-Hubshman syndrome, 618974 (3)	Li-Ghorgani-Weisz-Hubshman syndrome	n	-	-	-	KAT8	HGNC:17933	Li-Ghorgani-Weisz-Hubshman syndrome, 618974 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
618975	CONGENITAL MYOPATHY 17	Congenital myopathy 17, 618975 (3)	Congenital myopathy 17	y	CONGENITAL MYOPATHY 17; CMYP17	Description|Clinical Features|Clinical Synopsis|Phenotype	death|deaths|died|lethal	MYOD1	HGNC:7611	Congenital myopathy 17, 618975 (3), Autosomal recessive	Autosomal recessive	y	y	[died on day 2]	L2	y	-	lethal	lethal	lethal	L2	L2	pre-infant-lethal
618977	OPTIC ATROPHY 12	Optic atrophy 12, 618977 (3)	Optic atrophy 12	n	-	-	-	AFG3L2	HGNC:315	Optic atrophy 12, 618977 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L5	L5	post-infant-lethal
618982	IMMUNODEFICIENCY 72 WITH AUTOINFLAMMATION AND LYMPHOPROLIFERATION	Immunodeficiency 72 with autoinflammation, 618982 (3)	Immunodeficiency 72 with autoinflammation	y	IMMUNODEFICIENCY 72 WITH AUTOINFLAMMATION AND LYMPHOPROLIFERATION; IMD72	Clinical Features	died	NCKAP1L	HGNC:4862	Immunodeficiency 72 with autoinflammation, 618982 (3), Autosomal recessive	Autosomal recessive	y	y	[Cook et al. (2020) reported 5 patients from 4 unrelated families with IMD72. The patients, who ranged in age from 2.5 to 17 years, had onset of symptoms in the first year of life. They presented with recurrent ear infections, recurrent pneumonia often leading to bronchiectasis, septic arthritis or bacteremia, and skin infections. Organisms included pneumococcus, Staphylococcus aureus, and Pseudomonas. One patient had HSV-1 encephalitis and molluscum contagiosum, and another had chronic EBV. In addition to immunodeficiency, all patients demonstrated features of an overactive immune system, including asthma, atopy, food allergies, hepatosplenomegaly, and variable lymphadenopathy. Several patients had symptoms consistent with a syndromic lymphoproliferative disease similar to autoimmune lymphoproliferative syndrome or hemophagocytic lymphohistiocytosis. Other severe autoimmune manifestations included immune complex glomerulonephritis with lupus-like features and idiopathic thrombocytopenia purpura after MMR vaccination. Immunologic laboratory studies were somewhat variable among the patients; findings included hyper-IgG (3 patients), poor antibody production (3 patients), increased B cells (3 patients), abnormal levels of memory or activated T cells (4 patients), decreased NK cells with impaired cytotoxicity (3 patients), and defective T-cell activation with impaired cytokine production. Two families had additional affected children who had died]	LU	n	y	lethal	lethal	lethal	LU	LU	post-infant-lethal
618985	GROWTH HORMONE INSENSITIVITY SYNDROME WITH IMMUNE DYSREGULATION 2, AUTOSOMAL DOMINANT	Growth hormone insensitivity with immune dysregulation 2, autosomal dominant, 618985 (3)	Growth hormone insensitivity with immune dysregulation 2, autosomal dominant	n	-	-	-	STAT5B	HGNC:11367	Growth hormone insensitivity with immune dysregulation 2, autosomal dominant, 618985 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
618986	IMMUNODEFICIENCY 73B WITH DEFECTIVE NEUTROPHIL CHEMOTAXIS AND LYMPHOPENIA	Immunodeficiency 73B with defective neutrophil chemotaxis and lymphopenia, 618986 (3)	Immunodeficiency 73B with defective neutrophil chemotaxis and lymphopenia	y	IMMUNODEFICIENCY 73B WITH DEFECTIVE NEUTROPHIL CHEMOTAXIS AND LYMPHOPENIA; IMD73B	Clinical Features	died	RAC2	HGNC:9802	Immunodeficiency 73B with defective neutrophil chemotaxis and lymphopenia, 618986 (3), Autosomal dominant	Autosomal dominant	y	y	[Sharapova et al. (2019) reported a 10-year-old girl with combined immunodeficiency presenting as recurrent chest infections, chronic lung disease, lymphadenopathy, hepatosplenomegaly, and severe viral infections with herpes and varicella. Immunologic studies showed decreased TRECs, decreased memory B cells, and low IgG. Patient neutrophils showed absence of a chemotactic response to fMLF as well as the presence of abnormal macropinocytic vesicles. The patient underwent 2 hematopoietic stem cell transplantations but died due to overwhelming adenoviral infection]	L5	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L5	L5	post-infant-lethal
618999	AUTOINFLAMMATION, IMMUNE DYSREGULATION, AND EOSINOPHILIA	Autoinflammation, immune dysregulation, and eosinophilia, 618999 (3)	Autoinflammation, immune dysregulation, and eosinophilia	y	AUTOINFLAMMATION, IMMUNE DYSREGULATION, AND EOSINOPHILIA; AIIDE	Clinical Features	died	JAK1	HGNC:6190	Autoinflammation, immune dysregulation, and eosinophilia, 618999 (3), Autosomal dominant	Autosomal dominant	y	n	-	-	-	-	ambiguous	ambiguous	ambiguous	-	-	-
619000	INTELLECTUAL DEVELOPMENTAL DISORDER WITH SEIZURES AND LANGUAGE DELAY	Intellectual developmental disorder with seizures and language delay, 619000 (3)	Intellectual developmental disorder with seizures and language delay	n	-	-	-	SETD1B	HGNC:29187	Intellectual developmental disorder with seizures and language delay, 619000 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
619004	DEEAH SYNDROME	DEEAH syndrome, 619004 (3)	DEEAH syndrome	y	DEEAH SYNDROME; DEEAH	Description|Clinical Features|Clinical Synopsis|Phenotype	death|deaths|died	MADD	HGNC:6766	DEEAH syndrome, 619004 (3), Autosomal recessive	Autosomal recessive	y	y	[Anazi et al. (2017) reported a female infant, born of consanguineous Saudi parents, with a severe multisystemic disorder resulting in death at 14 months of age]	L3	y	-	lethal	ambiguous|lethal	lethal	L3	L3	pre-infant-lethal
619005	NEURODEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES, IMPAIRED SPEECH, AND HYPOTONIA	Neurodevelopmental disorder with dysmorphic facies, impaired speech and hypotonia, 619005 (3)	Neurodevelopmental disorder with dysmorphic facies, impaired speech and hypotonia	y	NEURODEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES, IMPAIRED SPEECH, AND HYPOTONIA; NEDDISH	Clinical Synopsis	death|deaths	MADD	HGNC:6766	Neurodevelopmental disorder with dysmorphic facies, impaired speech and hypotonia, 619005 (3), Autosomal recessive	Autosomal recessive	y	n	-	-	-	-	ambiguous	ambiguous|lethal	lethal	L3	L3	pre-infant-lethal
619007	RETINITIS PIGMENTOSA 90	Retinitis pigmentosa 90, 619007 (3)	Retinitis pigmentosa 90	n	-	-	-	IDH3A	HGNC:5384	Retinitis pigmentosa 90, 619007 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
619009	OOCYTE/ZYGOTE/EMBRYO MATURATION ARREST 8	Oocyte/zygote/embryo maturation arrest 8, 619009 (3)	Oocyte/zygote/embryo maturation arrest 8	n	-	-	-	BTG4	HGNC:13862	Oocyte/zygote/embryo maturation arrest 8, 619009 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
619011	OOCYTE/ZYGOTE/EMBRYO MATURATION ARREST 9	Oocyte/zygote/embryo maturation arrest 9, 619011 (3)	Oocyte/zygote/embryo maturation arrest 9	n	-	-	-	TRIP13	HGNC:12307	Oocyte/zygote/embryo maturation arrest 9, 619011 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L4	L4	post-infant-lethal
619012	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 48	Combined oxidative phosphorylation deficiency 48, 619012 (3)	Combined oxidative phosphorylation deficiency 48	y	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 48; COXPD48	Clinical Features	died	NSUN3	HGNC:26208	Combined oxidative phosphorylation deficiency 48, 619012 (3), Autosomal recessive	Autosomal recessive	y	y	[Paramasivam et al. (2020) reported an 8-month-old boy, born of consanguineous parents of East Asian origin, with a complex encephalomyopathic disorder....The patient's older sister, who died, had lactic acidosis]	LU	n	y	lethal	lethal	lethal	LU	LU	post-infant-lethal
619016	IFAP SYNDROME 2	Ichthyosis, follicular, with atrichia and photophobia syndrome 2, 619016 (3)	Ichthyosis, follicular, with atrichia and photophobia syndrome 2	n	-	-	-	SREBF1	HGNC:11289	Ichthyosis, follicular, with atrichia and photophobia syndrome 2, 619016 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	ambiguous|nonlethal	ambiguous	-	-	-
619026	NEURODEVELOPMENTAL DISORDER WITH PROGRESSIVE SPASTICITY AND BRAIN WHITE MATTER ABNORMALITIES	Neurodevelopmental disorder with progressive spasticity and brain white matter abnormalities, 619026 (3)	Neurodevelopmental disorder with progressive spasticity and brain white matter abnormalities	y	NEURODEVELOPMENTAL DISORDER WITH PROGRESSIVE SPASTICITY AND BRAIN WHITE MATTER ABNORMALITIES; NEDSWMA	Clinical Features	died	HPDL	HGNC:28242	Neurodevelopmental disorder with progressive spasticity and brain white matter abnormalities, 619026 (3), Autosomal recessive	Autosomal recessive	y	y	[Ghosh et al. (2021) reported 16 patients with NEDSWMA from 7 unrelated consanguineous families from Egypt, Pakistan, and Iran. The patients, who ranged from 1 month to 14 years of age, had global developmental delay with variably impaired intellectual development, poor or absent speech, poor social skills, and delayed or absent acquisition of gross and fine motor skills. Eight patients died between 2 months and 13 years of age, most commonly from epilepsy]	L3	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L3	L3	pre-infant-lethal
619027	SPASTIC PARAPLEGIA 83, AUTOSOMAL RECESSIVE	Spastic paraplegia 83, autosomal recessive, 619027 (3)	Spastic paraplegia 83, autosomal recessive	n	-	-	-	HPDL	HGNC:28242	Spastic paraplegia 83, autosomal recessive, 619027 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L3	L3	pre-infant-lethal
619031	INTELLECTUAL DEVELOPMENTAL DISORDER WITH EPILEPSY, BEHAVIORAL ABNORMALITIES, AND COARSE FACIES	Intellectual developmental disorder with epilepsy, behavioral abnormalities, and coarse facies, 619031 (3)	Intellectual developmental disorder with epilepsy, behavioral abnormalities, and coarse facies	n	-	-	-	ALG14	HGNC:28287	Intellectual developmental disorder with epilepsy, behavioral abnormalities, and coarse facies, 619031 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L3	L3	pre-infant-lethal
619033	VISSERS-BODMER SYNDROME	Vissers-Bodmer syndrome, 619033 (3)	Vissers-Bodmer syndrome	n	-	-	-	CNOT1	HGNC:7877	Vissers-Bodmer syndrome, 619033 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L3	L3	pre-infant-lethal
619036	MYOPATHY, EPILEPSY, AND PROGRESSIVE CEREBRAL ATROPHY	Myopathy, epilepsy, and progressive cerebral atrophy, 619036 (3)	Myopathy, epilepsy, and progressive cerebral atrophy	y	MYOPATHY, EPILEPSY, AND PROGRESSIVE CEREBRAL ATROPHY; MEPCA	Description|Clinical Features|Clinical Synopsis|Phenotype	died|death|deaths	ALG14	HGNC:28287	Myopathy, epilepsy, and progressive cerebral atrophy, 619036 (3), Autosomal recessive	Autosomal recessive	y	y	[Schorling et al. (2017) reported 5 infants from 3 unrelated families with a neurodegenerative disorder resulting in death in the first year of life]	L3	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L3	L3	pre-infant-lethal
619040	MYOFIBRILLAR MYOPATHY 10	Myofibrillar myopathy 10, 619040 (3)	Myofibrillar myopathy 10	n	-	-	-	SVIL	HGNC:11480	Myofibrillar myopathy 10, 619040 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
619041	MONOSOMY 7 MYELODYSPLASIA AND LEUKEMIA SYNDROME 2	Monosomy 7 myelodysplasia and leukemia syndrome 2, 619041 (3)	Monosomy 7 myelodysplasia and leukemia syndrome 2	y	MONOSOMY 7 MYELODYSPLASIA AND LEUKEMIA SYNDROME 2; M7MLS2	Clinical Features	died	SAMD9	HGNC:1348	Monosomy 7 myelodysplasia and leukemia syndrome 2, 619041 (3), Autosomal dominant	Autosomal dominant	y	y	[Wong et al. (2018) reported 2 brothers (family 2) with AML and MDS, respectively, associated with monosomy 7 in bone marrow cells. The proband presented at age 4 years and the younger brother at age 2.5 years. Both had somatic loss of the paternal chromosome 7. One underwent successful hematopoietic stem cell transplantation and was alive at 33 years of age, whereas the other brother died in childhood during induction]	L4	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L3|L4	L3	pre-infant-lethal
619042	SPINAL MUSCULAR ATROPHY, INFANTILE, JAMES TYPE	Spinal muscular atrophy, infantile, James type, 619042 (3)	Spinal muscular atrophy, infantile, James type	n	-	-	-	GARS1	HGNC:4162	Spinal muscular atrophy, infantile, James type, 619042 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
619044	SPERMATOGENIC FAILURE 44	Spermatogenic failure 44, 619044 (3)	Spermatogenic failure 44	n	-	-	-	CEP112	HGNC:28514	Spermatogenic failure 44, 619044 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
619046	MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 3	Mitochondrial complex IV deficiency, nuclear type 3, 619046 (3)	Mitochondrial complex IV deficiency, nuclear type 3	y	MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 3; MC4DN3	Description|Clinical Features|Clinical Synopsis	die|died|death|deaths	COX10	HGNC:2260	Mitochondrial complex IV deficiency, nuclear type 3, 619046 (3), Autosomal recessive	Autosomal recessive	y	y	[Antonicka et al. (2003) reported 2 unrelated patients with COX deficiency caused by mutations in the COX10 gene... The second patient (patient S) presented at 6 weeks of age with hypotrophy, anemia, hypotonia, and lactic acidosis. Brain imaging showed symmetric basal ganglia lesions consistent with Leigh syndrome (see 256000). She died at age 4 months]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
619048	MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 4	Mitochondrial complex IV deficiency, nuclear type 4, 619048 (3)	Mitochondrial complex IV deficiency, nuclear type 4	y	MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 4; MC4DN4	Description|Clinical Features|Clinical Synopsis	death|deaths|died	SCO1	HGNC:10603	Mitochondrial complex IV deficiency, nuclear type 4, 619048 (3), Autosomal recessive	Autosomal recessive	y	y	[Valnot et al. (2000) described 4 male sibs with mitochondrial cytochrome c oxidase deficiency due to mutation in the SCO1 gene. The patients presented with a severe neurologic disorder from birth and metabolic acidosis. One patient died at age 2 months; a second at the age of 5 days]	L2	y	-	lethal	lethal	lethal	L2	L2	pre-infant-lethal
619051	MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 7	Mitochondrial complex IV deficiency, nuclear type 7, 619051 (3)	Mitochondrial complex IV deficiency, nuclear type 7	y	MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 7; MC4DN7	Description|Clinical Features|Clinical Synopsis	death|deaths|died	COX6B1	HGNC:2280	Mitochondrial complex IV deficiency, nuclear type 7, 619051 (3), Autosomal recessive	Autosomal recessive	y	y	[Abdulhag et al. (2015) reported a male infant, born of consanguineous Palestinian parents, who presented in the neonatal period with lactic acidosis and left ventricular hypertrophy. He developed encephalomyopathy with hydrocephalus, cortical blindness, and hypertrophic obstructive cardiomyopathy; he died at age 30 months]	L4	y	-	lethal	lethal	lethal	L4	L4	post-infant-lethal
619052	MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 8	Mitochondrial complex IV deficiency, nuclear type 8, 619052 (3)	Mitochondrial complex IV deficiency, nuclear type 8	n	-	-	-	TACO1	HGNC:24316	Mitochondrial complex IV deficiency, nuclear type 8, 619052 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
619054	MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 11	Mitochondrial complex IV deficiency, nuclear type 11, 619054 (3)	Mitochondrial complex IV deficiency, nuclear type 11	n	-	-	-	COX20	HGNC:26970	Mitochondrial complex IV deficiency, nuclear type 11, 619054 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
619055	MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 12	Mitochondrial complex IV deficiency, nuclear type 12, 619055 (3)	Mitochondrial complex IV deficiency, nuclear type 12	y	MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 12; MC4DN12	Description|Clinical Features|Clinical Synopsis	die|died|death|deaths	PET100	HGNC:40038	Mitochondrial complex IV deficiency, nuclear type 12, 619055 (3), Autosomal recessive	Autosomal recessive	y	y	[Olahova et al. (2015) reported a newborn girl, born of consanguineous British Pakistani parents, with MC4DN12. The patient had intrauterine growth retardation and was delivered by cesarean section at 34 weeks' gestation. She had severe lactic and metabolic acidosis, hypoglycemia, coagulopathy, increased serum creatine kinase, and intraventricular cysts on brain ultrasound. She developed seizures at 48 hours of age and died at 55 hours of age]	L2	y	-	lethal	lethal	lethal	L2	L2	pre-infant-lethal
619056	NEURODEVELOPMENTAL DISORDER WITH SPEECH IMPAIRMENT AND DYSMORPHIC FACIES	Neurodevelopmental disorder with speech impairment and dysmorphic facies, 619056 (3)	Neurodevelopmental disorder with speech impairment and dysmorphic facies	y	NEURODEVELOPMENTAL DISORDER WITH SPEECH IMPAIRMENT AND DYSMORPHIC FACIES; NEDSID	Clinical Features	died	SETD1A	HGNC:29010	Neurodevelopmental disorder with speech impairment and dysmorphic facies, 619056 (3), Autosomal dominant	Autosomal dominant	y	y	[Kummeling et al. (2021) reported 15 unrelated patients with a similar neurodevelopmental disorder who were ascertained from several different clinical or research centers through the GeneMatcher program. Twelve patients were between 34 months and 10 years of age, 2 were in their teens, and 1 was 23 years old. One boy (patient 5) died at 4 years of age]	L4	y	-	lethal	lethal	lethal	L2|L4	L2	pre-infant-lethal
619060	MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 16	Mitochondrial complex IV deficiency, nuclear type 16, 619060 (3)	Mitochondrial complex IV deficiency, nuclear type 16	n	-	-	-	COX4I1	HGNC:2265	Mitochondrial complex IV deficiency, nuclear type 16, 619060 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
619061	MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 17	Mitochondrial complex IV deficiency, nuclear type 17, 619061 (3)	Mitochondrial complex IV deficiency, nuclear type 17	n	-	-	-	COA8	HGNC:20492	Mitochondrial complex IV deficiency, nuclear type 17, 619061 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
619062	MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 18	Mitochondrial complex IV deficiency, nuclear type 18, 619062 (3)	Mitochondrial complex IV deficiency, nuclear type 18	y	MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 18; MC4DN18	Description|Clinical Features|Clinical Synopsis	death|deaths|died	COX6A2	HGNC:2279	Mitochondrial complex IV deficiency, nuclear type 18, 619062 (3), Autosomal recessive	Autosomal recessive	y	y	[Inoue et al. (2019) reported 2 unrelated Japanese patients with mitochondrial complex IV deficiency. The patients presented in early infancy with a muscle-specific phenotype, including early-onset hypotonia with limb and facial muscle weakness and high-arched palate. One patient (P1) had a more severe phenotype with respiratory insufficiency at birth and cardiomyopathy; he died of infection at 7 weeks of age]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
619072	NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND BRAIN ATROPHY	Neurodevelopmental disorder with seizures and brain atrophy, 619072 (3)	Neurodevelopmental disorder with seizures and brain atrophy	y	NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND BRAIN ATROPHY; NEDSEBA	Description|Clinical Features|Clinical Synopsis	spontaneous_abortion|spontaneous_abortions|died|death|deaths	EXOC7	HGNC:23214	Neurodevelopmental disorder with seizures and brain atrophy, 619072 (3), Autosomal recessive	Autosomal recessive	y	y	[Neurodevelopmental disorder with seizures and brain atrophy (NEDSEBA) is an autosomal recessive disorder with highly variable manifestations and severity of these core features. The most severely affected individuals develop symptoms in utero, which may lead to spontaneous abortion or planned termination]	L1	y	-	lethal	lethal	lethal	L1	L1	pre-infant-lethal
619073	VITAMIN D-DEPENDENT RICKETS, TYPE 3	Vitamin D-dependent rickets, type 3, 619073 (3)	Vitamin D-dependent rickets, type 3	n	-	-	-	CYP3A4	HGNC:2637	Vitamin D-dependent rickets, type 3, 619073 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
619074	CLEFT PALATE, PROLIFERATIVE RETINOPATHY, AND DEVELOPMENTAL DELAY	Cleft palate, proliferative retinopathy, and developmental delay, 619074 (3)	Cleft palate, proliferative retinopathy, and developmental delay	n	-	-	-	LRRC32	HGNC:4161	Cleft palate, proliferative retinopathy, and developmental delay, 619074 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
619075	BACHMANN-BUPP SYNDROME	Bachmann-Bupp syndrome, 619075 (3)	Bachmann-Bupp syndrome	y	BACHMANN-BUPP SYNDROME; BABS	Clinical Features	stillborn	ODC1	HGNC:8109	Bachmann-Bupp syndrome, 619075 (3), Autosomal dominant	Autosomal dominant	y	y	[Rodan et al. (2018) described 4 unrelated patients with a similar neurometabolic disorder. Patient 1 was a 7-year-old boy whose prenatal history was significant for polyhydramnios and decreased fetal movement. He was noted to be hypotonic at birth and had global developmental delay. He had behavioral issues including attention deficit-hyperactivity disorder (ADHD) and episodic aggression. Dysmorphic features included relative macrocephaly, bilateral ptosis, hypertelorism, deep-set eyes, retrognathia, large ears, bulbous nasal tip, and fifth finger clinodactyly. He had absent eyebrows and sparse hair. An EEG showed electrical status epilepticus during sleep. Brain MRI at 6 years of age showed bilateral germinolytic cysts, peritrigonal white matter volume loss, and a mildly dysmorphic cerebellar vermis. Patient 2 was a 16-year-old girl whose prenatal history was significant for polyhydramnios and macrosomia. She had global developmental delay since birth and behavioral issues including ADHD and aggression. On examination at age 16 years, she had dysmorphic features including macrocephaly, a broad forehead, hypertelorism, deep-set eyes, and blepharophimosis. Scalp and extremity hair was sparse. Brain MRI at 8 years of age showed a thick and short corpus callosum and dilated perivascular spaces. Patient 3 was an 8-year-old boy with global developmental delay since birth. There were no behavioral concerns. Dysmorphic features included high forehead, hypertelorism, ptosis, downslanting palpebral fissures, large ears, and bulbous nasal tip. He had sparse eyebrows and scalp hair as well as hypoplastic nails. Brain MRI at 4 years of age showed periventricular cysts, prominent perivascular spaces and multifocal white matter hyperintensities. Patient 4 was a male who was stillborn at 34 weeks' gestation]	L1	y	-	lethal	lethal	lethal	L1	L1	pre-infant-lethal
619080	KILQUIST SYNDROME	Kilquist syndrome, 619080 (3)	Kilquist syndrome	y	KILQUIST SYNDROME; KILQS	Clinical Features|Clinical Synopsis	died|death|deaths	SLC12A2	HGNC:10911	Kilquist syndrome, 619080 (3), Autosomal recessive	Autosomal recessive	y	y	[Early death (in some patients) / Stodberg et al. (2020) reported an 8-year-old girl, born of unrelated Swedish parents, with a syndromic neurodevelopmental disorder... Family history was notable for an older sib with overlapping symptoms who died at 22 days of age]	L2	n	y	lethal	lethal|nonlethal	lethal|nonlethal	L2	L2	pre-infant-lethal
619081	DEAFNESS, AUTOSOMAL DOMINANT 78	Deafness, autosomal dominant 78, 619081 (3)	Deafness, autosomal dominant 78	n	-	-	-	SLC12A2	HGNC:10911	Deafness, autosomal dominant 78, 619081 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L2	L2	pre-infant-lethal
619083	DELPIRE-MCNEILL SYNDROME	Delpire-McNeill syndrome, 619083 (3)	Delpire-McNeill syndrome	n	-	-	-	SLC12A2	HGNC:10911	Delpire-McNeill syndrome, 619083 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L2	L2	pre-infant-lethal
619087	NOONAN SYNDROME 13	Noonan syndrome 13, 619087 (3)	Noonan syndrome 13	n	-	-	-	MAPK1	HGNC:6871	Noonan syndrome 13, 619087 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
619090	DEVELOPMENTAL DELAY, IMPAIRED GROWTH, DYSMORPHIC FACIES, AND AXONAL NEUROPATHY	Developmental delay, impaired growth, dysmorphic facies, and axonal neuropathy, 619090 (3)	Developmental delay, impaired growth, dysmorphic facies, and axonal neuropathy	n	-	-	-	MORC2	HGNC:23573	Developmental delay, impaired growth, dysmorphic facies, and axonal neuropathy, 619090 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
619091	NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, IMPAIRED LANGUAGE, AND GAIT ABNORMALITIES	Neurodevelopmental disorder with microcephaly, impaired language, and gait abnormalities, autosomal recessive, 619091 (3)	Neurodevelopmental disorder with microcephaly, impaired language, and gait abnormalities, autosomal recessive	y	NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, IMPAIRED LANGUAGE, AND GAIT ABNORMALITIES; NEDMILG	Clinical Features	died	NARS1	HGNC:7643	Neurodevelopmental disorder with microcephaly, impaired language, and gait abnormalities, autosomal recessive, 619091 (3), Autosomal recessive	Autosomal recessive	y	y	[Manole et al. (2020) reported 24 patients from 13 unrelated families (families 9-21) with a neurodevelopmental disorder associated with biallelic mutations in the NARS1 gene. The patients were ascertained through an international collaborative network of research and diagnostic gene sequencing laboratories. Eight families were consanguineous and of various origins, including Pakistani, Indian, and Libyan. The patients, who ranged in age from 2 to 33 years, presented in infancy with global developmental delay, delayed walking, moderately to severely impaired intellectual development, and poor or absent language development. They had a small head circumference, with most having frank microcephaly (range -2.0 to -8.7 SD). More than half had onset of partial or generalized seizures in the first months or years of life. More variable features included hypotonia, reduced muscle power, broad-based or ataxic gait, spasticity, scoliosis, and clinodactyly. Five patients had a demyelinating or axonal sensorimotor peripheral neuropathy manifest as pes cavus, distal muscle weakness and atrophy, impaired sensation, and decreased or absent reflexes. Brain imaging, when performed, was often normal, although some patients had nonspecific abnormalities, including cerebral atrophy, delayed myelination, thin corpus callosum, and decreased white matter volume. Several patients or their similarly affected sibs died in childhood]	L4	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L4	L4	post-infant-lethal
619092	NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, IMPAIRED LANGUAGE, EPILEPSY, AND GAIT ABNORMALITIES	Neurodevelopmental disorder with microcephaly, impaired language, epilepsy, and gait abnormalities, autosomal dominant, 619092 (3)	Neurodevelopmental disorder with microcephaly, impaired language, epilepsy, and gait abnormalities, autosomal dominant	n	-	-	-	NARS1	HGNC:7643	Neurodevelopmental disorder with microcephaly, impaired language, epilepsy, and gait abnormalities, autosomal dominant, 619092 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L4	L4	post-infant-lethal
619094	SPERMATOGENIC FAILURE 45	Spermatogenic failure 45, 619094 (3)	Spermatogenic failure 45	n	-	-	-	DNAH2	HGNC:2948	Spermatogenic failure 45, 619094 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
619095	SPERMATOGENIC FAILURE 46	Spermatogenic failure 46, 619095 (3)	Spermatogenic failure 46	n	-	-	-	DNAH8	HGNC:2952	Spermatogenic failure 46, 619095 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
619096	MISMATCH REPAIR CANCER SYNDROME 2	Mismatch repair cancer syndrome 2, 619096 (3)	Mismatch repair cancer syndrome 2	y	MISMATCH REPAIR CANCER SYNDROME 2; MMRCS2	Clinical Features|Phenotype	death|deaths|died	MSH2	HGNC:7325	Mismatch repair cancer syndrome 2, 619096 (3), Autosomal recessive	Autosomal recessive	y	y	[Bougeard et al. (2003) described 2 sibs, a female who died of mediastinal T-cell lymphoma at the age of 15 months and her brother who died at age 4 years from a temporal glioblastoma]	L3	y	-	lethal	ambiguous|lethal|nonlethal	lethal|nonlethal	L3	L3	pre-infant-lethal
619097	MISMATCH REPAIR CANCER SYNDROME 3	Mismatch repair cancer syndrome 3, 619097 (3)	Mismatch repair cancer syndrome 3	y	MISMATCH REPAIR CANCER SYNDROME 3; MMRCS3	Clinical Features|Phenotype	death|deaths|died|fatal	MSH6	HGNC:7329	Mismatch repair cancer syndrome 3, 619097 (3), Autosomal recessive	Autosomal recessive	y	y	[Hegde et al. (2005) studied 2 sibs from a Pakistani family, a boy with lymphoma and colorectal cancer diagnosed at ages 5 and 8 years, respectively, and his sister who developed glioblastoma multiforme at age 8 years. Both children had cafe-au-lait spots and axillary freckling. The boy died at age 9 years and the girl at age 10 years]	L4	y	-	lethal	lethal	lethal	L4|L6	L4	post-infant-lethal
619099	INTELLECTUAL DEVELOPMENTAL DISORDER WITH SPEECH DELAY AND AXONAL PERIPHERAL NEUROPATHY	Intellectual developmental disorder with speech delay and axonal peripheral neuropathy, 619099 (3)	Intellectual developmental disorder with speech delay and axonal peripheral neuropathy	n	-	-	-	NEMF	HGNC:10663	Intellectual developmental disorder with speech delay and axonal peripheral neuropathy, 619099 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
619101	MISMATCH REPAIR CANCER SYNDROME 4	Mismatch repair cancer syndrome 4, 619101 (3)	Mismatch repair cancer syndrome 4	y	MISMATCH REPAIR CANCER SYNDROME 4; MMRCS4	Clinical Features|Phenotype	died	PMS2	HGNC:9122	Mismatch repair cancer syndrome 4, 619101 (3), Autosomal recessive	Autosomal recessive	y	y	[Baas et al. (2013) reported 2 unrelated children with MMRCS4 and structural brain anomalies. A boy (patient 1), born of consanguineous parents, developed a B-cell non-Hodgkin lymphoma (NHL) at age 9 years. At age 11, he developed a mucoepidermoid carcinoma of the parotid gland, and 6 months later, he was diagnosed with a T-cell NHL. Brain MRI showed agenesis of the corpus callosum, an interhemispheric cyst, and several periventricular gray matter heterotopias. He also had multiple cafe-au-lait spots. Another patient (patient 3) was a boy who was noted to have dilation of the lateral ventricles on prenatal ultrasound and agenesis of the corpus callosum after birth. He developed an anaplastic astrocytoma of the spinal cord at age 2 years, 10 months. At age 5 years, he developed a T-lymphoblastic lymphoma, and died of sepsis during treatment 9 months later]	L4	y	-	lethal	lethal	lethal	L4|L6	L4	post-infant-lethal
619102	SPERMATOGENIC FAILURE 47	Spermatogenic failure 47, 619102 (3)	Spermatogenic failure 47	n	-	-	-	DZIP1	HGNC:20908	Spermatogenic failure 47, 619102 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
619103	NEURODEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES, SLEEP DISTURBANCE, AND BRAIN ABNORMALITIES	Neurodevelopmental disorder with dysmorphic facies, sleep disturbance, and brain abnormalities, 619103 (3)	Neurodevelopmental disorder with dysmorphic facies, sleep disturbance, and brain abnormalities	n	-	-	-	KAT5	HGNC:5275	Neurodevelopmental disorder with dysmorphic facies, sleep disturbance, and brain abnormalities, 619103 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
619108	SPERMATOGENIC FAILURE 48	Spermatogenic failure 48, 619108 (3)	Spermatogenic failure 48	n	-	-	-	M1AP	HGNC:25183	Spermatogenic failure 48, 619108 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
619110	ARTHROGRYPOSIS, DISTAL, TYPE 1C	Arthrogryposis, distal, type 1C, 619110 (3)	Arthrogryposis, distal, type 1C	n	-	-	-	MYL11	HGNC:29824	Arthrogryposis, distal, type 1C, 619110 (3), Autosomal dominant, Autosomal recessive	Autosomal dominant, Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
619111	COACH SYNDROME 2	COACH syndrome 2, 619111 (3)	COACH syndrome 2	n	-	-	-	CC2D2A	HGNC:29253	COACH syndrome 2, 619111 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L1	L1	pre-infant-lethal
619112	NEURONOPATHY, DISTAL HEREDITARY MOTOR, AUTOSOMAL DOMINANT 13	Neuronopathy, distal hereditary motor, autosomal dominant 13, 619112 (3)	Neuronopathy, distal hereditary motor, autosomal dominant 13	y	NEURONOPATHY, DISTAL HEREDITARY MOTOR, AUTOSOMAL DOMINANT 13; HMND13	Phenotype	death|deaths	BSCL2	HGNC:15832	Neuronopathy, distal hereditary motor, autosomal dominant 13, 619112 (3), Autosomal dominant	Autosomal dominant	y	n	-	-	-	-	ambiguous	ambiguous|lethal|nonlethal	lethal|nonlethal	L3|L4	L3	pre-infant-lethal
619115	COMBINED OSTEOGENESIS IMPERFECTA AND EHLERS-DANLOS SYNDROME 1	Combined osteogenesis imperfecta and Ehlers-Danlos syndrome 1, 619115 (3)	Combined osteogenesis imperfecta and Ehlers-Danlos syndrome 1	n	-	-	-	COL1A1	HGNC:2197	Combined osteogenesis imperfecta and Ehlers-Danlos syndrome 1, 619115 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	ambiguous|lethal|nonlethal	lethal|nonlethal	L2|L5|LU	L2	pre-infant-lethal
619120	COMBINED OSTEOGENESIS IMPERFECTA AND EHLERS-DANLOS SYNDROME 2	Combined osteogenesis imperfecta and Ehlers-Danlos syndrome 2, 619120 (3)	Combined osteogenesis imperfecta and Ehlers-Danlos syndrome 2	n	-	-	-	COL1A2	HGNC:2198	Combined osteogenesis imperfecta and Ehlers-Danlos syndrome 2, 619120 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	ambiguous|lethal|nonlethal	lethal|nonlethal	L2|L4|L5	L2	pre-infant-lethal
619121	NEURODEVELOPMENTAL DISORDER WITH CARDIOMYOPATHY, SPASTICITY, AND BRAIN ABNORMALITIES	Neurodevelopmental disorder with cardiomyopathy, spasticity, and brain abnormalities, 619121 (3)	Neurodevelopmental disorder with cardiomyopathy, spasticity, and brain abnormalities	n	-	-	-	SHMT2	HGNC:10852	Neurodevelopmental disorder with cardiomyopathy, spasticity, and brain abnormalities, 619121 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
619123	CARDIOFACIONEURODEVELOPMENTAL SYNDROME	Cardiofacioneurodevelopmental syndrome, 619123 (3)	Cardiofacioneurodevelopmental syndrome	y	CARDIOFACIONEURODEVELOPMENTAL SYNDROME; CFNDS	Clinical Features	died	CCDC32	HGNC:28295	Cardiofacioneurodevelopmental syndrome, 619123 (3), Autosomal recessive	Autosomal recessive	y	y	[a brother with a similar phenotype with cleft lip and palate who died in the early neonatal period]	L2	n	y	lethal	lethal	lethal	L2	L2	pre-infant-lethal
619124	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 89	Developmental and epileptic encephalopathy 89, 619124 (3)	Developmental and epileptic encephalopathy 89	y	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 89; DEE89	Description|Clinical Features|Clinical Synopsis	die|died|death|deaths	GAD1	HGNC:4092	Developmental and epileptic encephalopathy 89, 619124 (3), Autosomal recessive	Autosomal recessive	y	y	[Chatron et al. (2020) reported 11 patients from 6 unrelated consanguineous families with a similar neurodevelopmental disorder. The patients, who were of Algerian (family A), Egyptian (family B), Turkish (families C and E), Iranian (family D), and Brazilian (family F) origin, were identified through the GeneMatcher program after whole-exome or whole-genome sequencing identified biallelic mutations in the GAD1 gene. Four of the patients died in infancy or early childhood]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
619125	KAYA-BARAKAT-MASSON SYNDROME	Kaya-Barakat-Masson syndrome, 619125 (3)	Kaya-Barakat-Masson syndrome	y	KAYA-BARAKAT-MASSON SYNDROME; KABAMAS	Description|Clinical Features|Clinical Synopsis	die|died|death|deaths	YIF1B	HGNC:30511	Kaya-Barakat-Masson syndrome, 619125 (3), Autosomal recessive	Autosomal recessive	y	y	[Diaz et al. (2020) reported 10 patients from 6 unrelated families with a similar neurodevelopmental disorder associated with YIF1B mutations identified through the GeneMatcher program. Four patients in 2 families (families 1 and 2) died between 7 and 15 months of age]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
619126	IMMUNODEFICIENCY 75 WITH LYMPHOPROLIFERATION	Immunodeficiency 75, 619126 (3)	Immunodeficiency 75	y	IMMUNODEFICIENCY 75 WITH LYMPHOPROLIFERATION; IMD75	Description|Clinical Features|Clinical Synopsis	die|died|death|deaths	TET2	HGNC:25941	Immunodeficiency 75, 619126 (3), Autosomal recessive	Autosomal recessive	y	y	[Death in childhood may occur]	L4	y	-	lethal	lethal	lethal	L4	L4	post-infant-lethal
619127	MANDIBULOACRAL DYSPLASIA PROGEROID SYNDROME	Mandibuloacral dysplasia progeroid syndrome, 619127 (3)	Mandibuloacral dysplasia progeroid syndrome	y	MANDIBULOACRAL DYSPLASIA PROGEROID SYNDROME; MDPS	Clinical Features|Phenotype	died|death|deaths	MTX2	HGNC:7506	Mandibuloacral dysplasia progeroid syndrome, 619127 (3), Autosomal recessive	Autosomal recessive	y	y	[Elouej et al. (2020) described 7 patients from 5 families with mandibuloacral dysplasia progeroid syndrome.. Three patients from a consanguineous Egyptian family included 2 brothers (patients 4-1 and 4-2) and their a 9-month-old first cousin (patient 4-3). Patient 4-1 had hyperthermia, diarrhea, hair loss, progeroid-like appearance, nail dystrophy, and hypodontia. He died at 2 years and 2 months of age]	L4	y	-	lethal	lethal	lethal	L4	L4	post-infant-lethal
619130	THROMBOCYTOPENIA 7	Thrombocytopenia, autosomal dominant, 7, 619130 (3)	Thrombocytopenia, autosomal dominant, 7	n	-	-	-	IKZF5	HGNC:14283	Thrombocytopenia, autosomal dominant, 7, 619130 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
619131	OSTEOGENESIS IMPERFECTA, TYPE XXI	Osteogenesis imperfecta, type XXI, 619131 (3)	Osteogenesis imperfecta, type XXI	n	-	-	-	KDELR2	HGNC:6305	Osteogenesis imperfecta, type XXI, 619131 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
619133	AMYOTROPHIC LATERAL SCLEROSIS 26 WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA	Amyotrophic lateral sclerosis 26 with or without frontotemporal dementia, 619133 (3)	Amyotrophic lateral sclerosis 26 with or without frontotemporal dementia	y	AMYOTROPHIC LATERAL SCLEROSIS 26 WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA; ALS26	Clinical Features|Clinical Synopsis	died|death|deaths	TIA1	HGNC:11802	Amyotrophic lateral sclerosis 26 with or without frontotemporal dementia, 619133 (3), Autosomal dominant	Autosomal dominant	y	y	[Mackenzie et al. (2017) reported a 3-generation family of European ancestry in which 4 individuals had ALS with or without FTD. The patients had onset between 28 and 55 years of age, and 4 had died between 30 and 60 years]	L6	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L6	L6	post-infant-lethal
619135	RITSCHER-SCHINZEL SYNDROME 3	Ritscher-Schinzel syndrome 3, 619135 (3)	Ritscher-Schinzel syndrome 3	y	RITSCHER-SCHINZEL SYNDROME 3; RTSC3	Clinical Features|Clinical Synopsis	died	VPS35L	HGNC:24641	Ritscher-Schinzel syndrome 3, 619135 (3), Autosomal recessive	Autosomal recessive	y	y	[died at 28 days of life]	L2	y	-	lethal	lethal	lethal	L2	L2	pre-infant-lethal
619141	FRONTOTEMPORAL DEMENTIA AND/OR AMYOTROPHIC LATERAL SCLEROSIS 5	Frontotemporal dementia and/or amyotrophic lateral sclerosis 5, 619141 (3)	Frontotemporal dementia and/or amyotrophic lateral sclerosis 5	y	FRONTOTEMPORAL DEMENTIA AND/OR AMYOTROPHIC LATERAL SCLEROSIS 5; FTDALS5	Description	death|deaths	CCNF	HGNC:1591	Frontotemporal dementia and/or amyotrophic lateral sclerosis 5, 619141 (3), Autosomal dominant	Autosomal dominant	y	y	[Frontotemporal dementia and/or amyotrophic lateral sclerosis-5 (FTDALS5) is an autosomal dominant neurodegenerative disorder characterized by onset of ALS or FTD symptoms in adulthood. The disease is progressive, and some patients may develop both diseases, although ALS seems to be more prevalent than FTD. The disorder usually results in premature death (summary by Williams et al., 2016)]	LU	y	-	lethal	lethal	lethal	LU	LU	post-infant-lethal
619142	CARDIOACROFACIAL DYSPLASIA 1	Cardioacrofacial dysplasia 1, 619142 (3)	Cardioacrofacial dysplasia 1	y	CARDIOACROFACIAL DYSPLASIA 1; CAFD1	Clinical Synopsis	death|deaths	PRKACA	HGNC:9380	Cardioacrofacial dysplasia 1, 619142 (3), Autosomal dominant	Autosomal dominant	y	y	[Death may occur in neonatal period or infancy due to respiratory failure]	L2	y	-	lethal	lethal	lethal	L2	L2	pre-infant-lethal
619144	SPERMATOGENIC FAILURE 49	Spermatogenic failure 49, 619144 (3)	Spermatogenic failure 49	n	-	-	-	CFAP58	HGNC:26676	Spermatogenic failure 49, 619144 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
619145	SPERMATOGENIC FAILURE 50	Spermatogenic failure 50, 619145 (3)	Spermatogenic failure 50	n	-	-	-	XRCC2	HGNC:12829	Spermatogenic failure 50, 619145 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
619147	LEUKOENCEPHALOPATHY, PROGRESSIVE, INFANTILE-ONSET, WITH OR WITHOUT DEAFNESS	Leukoencephalopathy, progressive, infantile-onset, with or without deafness, 619147 (3)	Leukoencephalopathy, progressive, infantile-onset, with or without deafness	y	LEUKOENCEPHALOPATHY, PROGRESSIVE, INFANTILE-ONSET, WITH OR WITHOUT DEAFNESS; LEPID	Description|Clinical Features|Clinical Synopsis	death|deaths|died	KARS1	HGNC:6215	Leukoencephalopathy, progressive, infantile-onset, with or without deafness, 619147 (3), Autosomal recessive	Autosomal recessive	y	y	[Ruzzenente et al. (2018) reported a French girl who presented in infancy with failure to thrive and congenital sensorineural deafness. She had developmental delay, disorganized movements, dysmorphic features, hypothyroidism, and increased serum lactate. Brain imaging showed hyperintensities in the deep white matter. She died at 20 months of age during an acute infection]	L3	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L3|L6	L3	pre-infant-lethal
619149	LESSEL-KREIENKAMP SYNDROME	Lessel-Kreienkamp syndrome, 619149 (3)	Lessel-Kreienkamp syndrome	n	-	-	-	AGO2	HGNC:3263	Lessel-Kreienkamp syndrome, 619149 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
619150	INTELLECTUAL DEVELOPMENTAL DISORDER WITH PAROXYSMAL DYSKINESIA OR SEIZURES	Intellectual developmental disorder with paroxysmal dyskinesia or seizures, 619150 (3)	Intellectual developmental disorder with paroxysmal dyskinesia or seizures	n	-	-	-	PDE2A	HGNC:8777	Intellectual developmental disorder with paroxysmal dyskinesia or seizures, 619150 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
619155	NEPHROTIC SYNDROME, TYPE 22	Nephrotic syndrome, type 22, 619155 (3)	Nephrotic syndrome, type 22	n	-	-	-	NOS1AP	HGNC:16859	Nephrotic syndrome, type 22, 619155 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
619157	NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT EARLY-ONSET GENERALIZED EPILEPSY	Neurodevelopmental disorder with or without early-onset generalized epilepsy, 619157 (3)	Neurodevelopmental disorder with or without early-onset generalized epilepsy	n	-	-	-	NBEA	HGNC:7648	Neurodevelopmental disorder with or without early-onset generalized epilepsy, 619157 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
619161	CARPAL TUNNEL SYNDROME 2	Carpal tunnel syndrome 2, 619161 (3)	Carpal tunnel syndrome 2	n	-	-	-	COMP	HGNC:2227	Carpal tunnel syndrome 2, 619161 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
619164	IMMUNODEFICIENCY 76	Immunodeficiency 76, 619164 (3)	Immunodeficiency 76	y	IMMUNODEFICIENCY 76; IMD76	Description|Clinical Features|Clinical Synopsis	die|died|death|deaths	FCHO1	HGNC:29002	Immunodeficiency 76, 619164 (3), Autosomal recessive	Autosomal recessive	y	y	[Calzoni et al. (2019) reported 5 unrelated children with onset of recurrent infections associated with T-cell lymphopenia in the first months or years of life... She died of respiratory failure. In addition to recurrent infections, including disseminated BCG, P4 experienced neuromotor regression associated with ataxia and tremor in early childhood; she died of respiratory failure at 4 years of age]	L4	y	-	lethal	lethal	lethal	L4	L4	post-infant-lethal
619165	OCULOCUTANEOUS ALBINISM, TYPE VIII	Oculocutaneous albinism, type VIII, 619165 (3)	Oculocutaneous albinism, type VIII	n	-	-	-	DCT	HGNC:2709	Oculocutaneous albinism, type VIII, 619165 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
619166	MITOCHONDRIAL COMPLEX II DEFICIENCY, NUCLEAR TYPE 2	Mitochondrial complex II deficiency, nuclear type 2, 619166 (3)	Mitochondrial complex II deficiency, nuclear type 2	y	MITOCHONDRIAL COMPLEX II DEFICIENCY, NUCLEAR TYPE 2; MC2DN2	Description|Clinical Features|Clinical Synopsis	die|died|death|deaths	SDHAF1	HGNC:33867	Mitochondrial complex II deficiency, nuclear type 2, 619166 (3), Autosomal recessive	Autosomal recessive	y	y	[Ohlenbusch et al. (2012) reported 5 patients with MC2DN2 from 3 families, including 2 additional members of the large Turkish pedigree reported by Ghezzi et al. (2009), the Norwegian boy reported by Brockmann et al. (2002), and 2 Palestinian sisters. All 5 patients had bilateral leukoencephalopathy on brain MRI and succinate peaks on MR spectroscopy. Mitochondrial complex II activity was found to be reduced in muscle, fibroblasts, or lymphocytes in all 5 patients. Motor regression was reported in 3 patients, spasticity in 3, and clumsiness in 1. Four of the patients died between the ages of 18 months and 11 years]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
619167	MITOCHONDRIAL COMPLEX II DEFICIENCY, NUCLEAR TYPE 3	Mitochondrial complex II deficiency, nuclear type 3, 619167 (3)	Mitochondrial complex II deficiency, nuclear type 3	y	MITOCHONDRIAL COMPLEX II DEFICIENCY, NUCLEAR TYPE 3; MC2DN3	Description|Clinical Features|Clinical Synopsis	fatal|died|death|deaths	SDHD	HGNC:10683	Mitochondrial complex II deficiency, nuclear type 3, 619167 (3), Autosomal recessive	Autosomal recessive	y	y	[Alston et al. (2015) reported an infant, born of unrelated Irish parents, with fatal cardiomyopathy associated with mitochondrial complex II deficiency. The patient was noted prenatally to have dilated cardiomyopathy with mitral regurgitation and left ventricular systolic dysfunction. He died on the first day of life / Death in infancy or childhood]	L2	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L2|L6	L2	pre-infant-lethal
619170	MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 36	Mitochondrial complex I deficiency, nuclear type 36, 619170 (3)	Mitochondrial complex I deficiency, nuclear type 36	y	MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 36; MC1DN36	Description|Clinical Features|Clinical Synopsis	death|deaths|died	NDUFC2	HGNC:7706	Mitochondrial complex I deficiency, nuclear type 36, 619170 (3), Autosomal recessive	Autosomal recessive	y	y	[Alahmad et al. (2020) reported 3 children from 2 unrelated consanguineous families with a complex mitochondrial disorder.... Brain imaging was consistent with Leigh syndrome. He died at 8 months of age]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
619172	HERMANSKY-PUDLAK SYNDROME 11	Hermansky-Pudlak syndrome 11, 619172 (3)	Hermansky-Pudlak syndrome 11	n	-	-	-	BLOC1S5	HGNC:18561	Hermansky-Pudlak syndrome 11, 619172 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
619173	NEURODEGENERATION, CHILDHOOD-ONSET, WITH HYPOTONIA, RESPIRATORY INSUFFICIENCY, AND BRAIN IMAGING ABNORMALITIES	Neurodegeneration, childhood-onset, hypotonia, respiratory insufficiency and brain imaging abnormalities, 619173 (3)	Neurodegeneration, childhood-onset, hypotonia, respiratory insufficiency and brain imaging abnormalities	y	NEURODEGENERATION, CHILDHOOD-ONSET, WITH HYPOTONIA, RESPIRATORY INSUFFICIENCY, AND BRAIN IMAGING ABNORMALITIES; CONRIBA	Description|Clinical Features	death|deaths|died	CLCN6	HGNC:2024	Neurodegeneration, childhood-onset, hypotonia, respiratory insufficiency and brain imaging abnormalities, 619173 (3), Autosomal dominant	Autosomal dominant	y	y	[Polovitskaya et al. (2020) reported 3 unrelated children, ranging from 18 months to 6 years of age, with a similar neurodegenerative disorder associated with a de novo mutation in the CLCN6 gene. The patients, who underwent exome sequencing for undiagnosed diseases, were identified through the GeneMatcher program. One patient (P2) died at 23 months of age]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
619175	PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 5	Proteasome-associated autoinflammatory syndrome 5, 619175 (3)	Proteasome-associated autoinflammatory syndrome 5	n	-	-	-	PSMB10	HGNC:9538	Proteasome-associated autoinflammatory syndrome 5, 619175 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
619176	OOCYTE/ZYGOTE/EMBRYO MATURATION ARREST 10	Oocyte/zygote/embryo maturation arrest 10, 619176 (3)	Oocyte/zygote/embryo maturation arrest 10	y	OOCYTE/ZYGOTE/EMBRYO MATURATION ARREST 10; OZEMA10	Clinical Features|Clinical Synopsis	miscarriage|miscarriages	REC114	HGNC:25065	Oocyte/zygote/embryo maturation arrest 10, 619176 (3), Autosomal recessive	Autosomal recessive	y	n	-	-	-	-	ambiguous	ambiguous	ambiguous	-	-	-
619177	SPERMATOGENIC FAILURE 51	Spermatogenic failure 51, 619177 (3)	Spermatogenic failure 51	n	-	-	-	CFAP91	HGNC:24010	Spermatogenic failure 51, 619177 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
619178	MYOFIBRILLAR MYOPATHY 11	Myofibrillar myopathy 11, 619178 (3)	Myofibrillar myopathy 11	y	MYOFIBRILLAR MYOPATHY 11; MFM11	Phenotype	lethal	UNC45B	HGNC:14304	Myofibrillar myopathy 11, 619178 (3), Autosomal recessive	Autosomal recessive	y	n	-	-	-	-	ambiguous	ambiguous	ambiguous	-	-	-
619179	MICROCEPHALY 26, PRIMARY, AUTOSOMAL DOMINANT	Microcephaly 26, primary, autosomal dominant, 619179 (3)	Microcephaly 26, primary, autosomal dominant	y	MICROCEPHALY 26, PRIMARY, AUTOSOMAL DOMINANT; MCPH26	Phenotype	death|deaths	LMNB1	HGNC:6637	Microcephaly 26, primary, autosomal dominant, 619179 (3), Autosomal dominant	Autosomal dominant	y	n	-	-	-	-	ambiguous	ambiguous|lethal	lethal	L6	L6	post-infant-lethal
619180	MICROCEPHALY 27, PRIMARY, AUTOSOMAL DOMINANT	Microcephaly 27, primary, autosomal dominant, 619180 (3)	Microcephaly 27, primary, autosomal dominant	y	MICROCEPHALY 27, PRIMARY, AUTOSOMAL DOMINANT; MCPH27	Phenotype	death|deaths	LMNB2	HGNC:6638	Microcephaly 27, primary, autosomal dominant, 619180 (3), Autosomal dominant	Autosomal dominant	y	n	-	-	-	-	ambiguous	ambiguous	ambiguous	-	-	-
619182	GASTRIC ADENOCARCINOMA AND PROXIMAL POLYPOSIS OF THE STOMACH	Gastric adenocarcinoma and proximal polyposis of the stomach, 619182 (3)	Gastric adenocarcinoma and proximal polyposis of the stomach	y	GASTRIC ADENOCARCINOMA AND PROXIMAL POLYPOSIS OF THE STOMACH; GAPPS	Clinical Features	died	APC	HGNC:583	Gastric adenocarcinoma and proximal polyposis of the stomach, 619182 (3), Autosomal dominant	Autosomal dominant	y	y	[Foretova et al. (2019) studied 8 Czech families with GAPPS and a mutation in the APC promoter 1B. Of the 24 carriers of the mutation, 20 had massive gastric polyposis, with more than 100 fundic glandular polyps diagnosed between the ages of 25 years and 65 years. Five had already died of adenocarcinoma of the stomach at ages 29, 40, 59, 60, and 64 years, and 1 who underwent gastrectomy at age 29 was found to have tubulopapillary adenocarcinoma with 2 positive lymph nodes]	L6	y	-	lethal	lethal	lethal	L4|L6	L4	post-infant-lethal
619184	SHORT STATURE, FACIAL DYSMORPHISM, AND SKELETAL ANOMALIES WITH OR WITHOUT CARDIAC ANOMALIES 2	Short stature, facial dysmorphism, and skeletal anomalies with or without cardiac anomalies, 619184 (3)	Short stature, facial dysmorphism, and skeletal anomalies with or without cardiac anomalies	n	-	-	-	SCUBE3	HGNC:13655	Short stature, facial dysmorphism, and skeletal anomalies with or without cardiac anomalies, 619184 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
619185	JOUBERT SYNDROME 37	Joubert syndrome 37, 619185 (3)	Joubert syndrome 37	y	JOUBERT SYNDROME 37; JBTS37	Clinical Synopsis	death|deaths	TOGARAM1	HGNC:19959	Joubert syndrome 37, 619185 (3), Autosomal recessive	Autosomal recessive	y	y	[Death in utero (in some patients)]	L1	y	-	lethal	lethal	lethal	L1	L1	pre-infant-lethal
619188	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 64	Intellectual developmental disorder, autosomal dominant 64, 619188 (3)	Intellectual developmental disorder, autosomal dominant 64	n	-	-	-	ZNF292	HGNC:18410	Intellectual developmental disorder, autosomal dominant 64, 619188 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
619189	LI-CAMPEAU SYNDROME	Li-Campeau syndrome, 619189 (3)	Li-Campeau syndrome	n	-	-	-	UBR7	HGNC:20344	Li-Campeau syndrome, 619189 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
619191	EPILEPSY, PROGRESSIVE MYOCLONIC, 12	Epilepsy, progressive myoclonic, 12, 619191 (3)	Epilepsy, progressive myoclonic, 12	n	-	-	-	SLC7A6OS	HGNC:25807	Epilepsy, progressive myoclonic, 12, 619191 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
619194	NEUROFACIOSKELETAL SYNDROME WITH OR WITHOUT RENAL AGENESIS	Neurofacioskeletal syndrome with or without renal agenesis, 619194 (3)	Neurofacioskeletal syndrome with or without renal agenesis	n	-	-	-	HS2ST1	HGNC:5193	Neurofacioskeletal syndrome with or without renal agenesis, 619194 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
619196	DEAFNESS, CONGENITAL, AND ADULT-ONSET PROGRESSIVE LEUKOENCEPHALOPATHY	Deafness, congenital, and adult-onset progressive leukoencephalopathy, 619196 (3)	Deafness, congenital, and adult-onset progressive leukoencephalopathy	y	DEAFNESS, CONGENITAL, AND ADULT-ONSET PROGRESSIVE LEUKOENCEPHALOPATHY; DEAPLE	Description|Clinical Features|Clinical Synopsis	death|deaths|died	KARS1	HGNC:6215	Deafness, congenital, and adult-onset progressive leukoencephalopathy, 619196 (3), Autosomal recessive	Autosomal recessive	y	y	[Premature death (in some patients) / Scheidecker et al. (2019) reported a 33-year-old French woman who was diagnosed with congenital deafness in childhood when she began attending a normal school... She had progressive cognitive decline and died at 33 years of age]	L6	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L3|L6	L3	pre-infant-lethal
619201	NEPHROTIC SYNDROME, TYPE 23	Nephrotic syndrome, type 23, 619201 (3)	Nephrotic syndrome, type 23	n	-	-	-	KIRREL1	HGNC:15734	Nephrotic syndrome, type 23, 619201 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
619202	SPERMATOGENIC FAILURE 52	Spermatogenic failure 52, 619202 (3)	Spermatogenic failure 52	n	-	-	-	C14orf39	HGNC:19849	Spermatogenic failure 52, 619202 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
619208	OLMSTED SYNDROME 2	Olmsted syndrome 2, 619208 (3)	Olmsted syndrome 2	n	-	-	-	PERP	HGNC:17637	Olmsted syndrome 2, 619208 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
619209	ERYTHROKERATODERMIA VARIABILIS ET PROGRESSIVA 7	Erythrokeratodermia variabilis et progressiva 7, 619209 (3)	Erythrokeratodermia variabilis et progressiva 7	n	-	-	-	PERP	HGNC:17637	Erythrokeratodermia variabilis et progressiva 7, 619209 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
619216	NEURONOPATHY, DISTAL HEREDITARY MOTOR, AUTOSOMAL RECESSIVE 7	Neuronopathy, distal hereditary motor, autosomal recessive 7, 619216 (3)	Neuronopathy, distal hereditary motor, autosomal recessive 7	n	-	-	-	VWA1	HGNC:30910	Neuronopathy, distal hereditary motor, autosomal recessive 7, 619216 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
619220	IMMUNODEFICIENCY 78 WITH AUTOIMMUNITY AND DEVELOPMENTAL DELAY	Immunodeficiency 78 with autoimmunity and developmental delay, 619220 (3)	Immunodeficiency 78 with autoimmunity and developmental delay	y	IMMUNODEFICIENCY 78 WITH AUTOIMMUNITY AND DEVELOPMENTAL DELAY; IMD78	Description|Clinical Features|Phenotype	die|died|death|deaths	TPP2	HGNC:12016	Immunodeficiency 78 with autoimmunity and developmental delay, 619220 (3), Autosomal recessive	Autosomal recessive	y	y	[Lu et al. (2014) reported 4 children from 2 unrelated families with a complex syndromic immune disorder... P2 underwent successful hematopoietic stem cell transplant, whereas P3 and P4 died at 3 and 11 years of age from complications of hematopoietic stem cell and liver transplantation, respectively]	L4	y	-	lethal	lethal	lethal	L4	L4	post-infant-lethal
619221	SULFIDE:QUINONE OXIDOREDUCTASE DEFICIENCY	Sulfide:quinone oxidoreductase deficiency, 619221 (3)	Sulfide:quinone oxidoreductase deficiency	y	SULFIDE:QUINONE OXIDOREDUCTASE DEFICIENCY; SQORD	Description|Clinical Features	die|died	SQOR	HGNC:20390	Sulfide:quinone oxidoreductase deficiency, 619221 (3), Autosomal recessive	Autosomal recessive	y	y	[Friederich et al. (2020) reported 2 sisters, born to consanguineous Lehrerleut Hutterite parents (family A), and an unrelated Turkish male (family B), born to consanguineous Turkish parents, with sulfide:quinone oxidoreductase deficiency and homozygous mutations in the SQOR gene. One sister (patient A.II-3) presented at age 4 years with an episode of fatigue and emesis, and rapid development of encephalopathy with tonic seizures. Laboratory studies showed lactic acidosis and an elevated anion gap. She developed respiratory distress and multiorgan failure, including liver failure. Brain MRI on the fourth day of hospitalization showed diffuse restriction of the caudate, putamen, and globus pallidi, as well as diffusion restriction in the posterior hippocampi, medial left temporal lobe, posterior inferior thalamus, and mamillary bodies. MR spectroscopy showed a large lactate peak and a depressed N-acetylaspartate peak. Muscle and liver biopsy showed normal histology. With supportive care, the multiorgan failure resolved, but she remained comatose and developed neurostorming episodes. She died shortly after discharge from the hospital]	L4	y	-	lethal	lethal	lethal	L4	L4	post-infant-lethal
619223	IMMUNODEFICIENCY 77	Immunodeficiency 77, 619223 (3)	Immunodeficiency 77	n	-	-	-	MPEG1	HGNC:29619	Immunodeficiency 77, 619223 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
619224	MITOCHONDRIAL COMPLEX II DEFICIENCY, NUCLEAR TYPE 4	Mitochondrial complex II deficiency, nuclear type 4, 619224 (3)	Mitochondrial complex II deficiency, nuclear type 4	y	MITOCHONDRIAL COMPLEX II DEFICIENCY, NUCLEAR TYPE 4; MC2DN4	Clinical Features	died	SDHB	HGNC:10681	Mitochondrial complex II deficiency, nuclear type 4, 619224 (3), Autosomal recessive	Autosomal recessive	y	y	[Helman et al. (2016) reported clinical and radiologic features in 5 patients, 4 of whom were living (patients 10, 11, 16 and 19) with an age range of 19 months to 9 years, and one of whom died at 1 year of age from respiratory failure (patient 15)]	L3	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L3|L5	L3	pre-infant-lethal
619226	BLISTERING, ACANTHOLYTIC, OF ORAL AND LARYNGEAL MUCOSA	Blistering, acantholytic, of oral and laryngeal mucosa, 619226 (3)	Blistering, acantholytic, of oral and laryngeal mucosa	n	-	-	-	DSG3	HGNC:3050	Blistering, acantholytic, of oral and laryngeal mucosa, 619226 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
619227	VERTEBRAL, CARDIAC, TRACHEOESOPHAGEAL, RENAL, AND LIMB DEFECTS	Vertebral, cardiac, tracheoesophageal, renal, and limb defects, 619227 (3)	Vertebral, cardiac, tracheoesophageal, renal, and limb defects	n	-	-	-	WBP11	HGNC:16461	Vertebral, cardiac, tracheoesophageal, renal, and limb defects, 619227 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
619228	DEVELOPMENTAL DELAY WITH DYSMORPHIC FACIES AND DENTAL ANOMALIES	Developmental delay with dysmorphic facies and dental anomalies, 619228 (3)	Developmental delay with dysmorphic facies and dental anomalies	n	-	-	-	SATB1	HGNC:10541	Developmental delay with dysmorphic facies and dental anomalies, 619228 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	LU	LU	post-infant-lethal
619229	DEN HOED-DE BOER-VOISIN SYNDROME	den Hoed-de Boer-Voisin syndrome, 619229 (3)	den Hoed-de Boer-Voisin syndrome	y	DEN HOED-DE BOER-VOISIN SYNDROME; DHDBV	Clinical Features	died	SATB1	HGNC:10541	den Hoed-de Boer-Voisin syndrome, 619229 (3), Autosomal dominant	Autosomal dominant	y	y	[Four patients died prematurely of various causes]	LU	y	-	lethal	lethal|nonlethal	lethal|nonlethal	LU	LU	post-infant-lethal
619232	BILE ACID CONJUGATION DEFECT 1	Bile acid conjugation defect 1, 619232 (3)	Bile acid conjugation defect 1	n	-	-	-	BAAT	HGNC:932	Bile acid conjugation defect 1, 619232 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
619234	SHORT STATURE, OLIGODONTIA, DYSMORPHIC FACIES, AND MOTOR DELAY	Short stature, oligodontia, dysmorphic facies, and motor delay, 619234 (3)	Short stature, oligodontia, dysmorphic facies, and motor delay	n	-	-	-	POLR3GL	HGNC:28466	Short stature, oligodontia, dysmorphic facies, and motor delay, 619234 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
619238	IMMUNODEFICIENCY 79	Immunodeficiency 79, 619238 (3)	Immunodeficiency 79	n	-	-	-	CD4	HGNC:1678	Immunodeficiency 79, 619238 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
619239	NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT AUTISM OR SEIZURES	Neurodevelopmental disorder with or without autism or seizures, 619239 (3)	Neurodevelopmental disorder with or without autism or seizures	n	-	-	-	CUL3	HGNC:2553	Neurodevelopmental disorder with or without autism or seizures, 619239 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
619243	GLOBAL DEVELOPMENTAL DELAY WITH SPEECH AND BEHAVIORAL ABNORMALITIES	Global developmental delay with speech and behavioral abnormalities, 619243 (3)	Global developmental delay with speech and behavioral abnormalities	n	-	-	-	TNRC6B	HGNC:29190	Global developmental delay with speech and behavioral abnormalities, 619243 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
619244	NEURODEVELOPMENTAL DISORDER WITH CEREBRAL ATROPHY AND VARIABLE FACIAL DYSMORPHISM	Neurodevelopmental disorder with cerebral atrophy and variable facial dysmorphism, 619244 (3)	Neurodevelopmental disorder with cerebral atrophy and variable facial dysmorphism	n	-	-	-	TTC5	HGNC:19274	Neurodevelopmental disorder with cerebral atrophy and variable facial dysmorphism, 619244 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
619245	PREMATURE OVARIAN FAILURE 19	Premature ovarian failure 19, 619245 (3)	Premature ovarian failure 19	n	-	-	-	HSF2BP	HGNC:5226	Premature ovarian failure 19, 619245 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
619255	BARALLE-MACKEN SYNDROME	Baralle-Macken syndrome, 619255 (3)	Baralle-Macken syndrome	y	BARALLE-MACKEN SYNDROME; BARMACS	Clinical Features	died	COPB1	HGNC:2231	Baralle-Macken syndrome, 619255 (3), Autosomal recessive	Autosomal recessive	y	y	[Macken et al. (2021) reported 6 girls, ranging in age from 11 to 18 years, from 2 unrelated consanguineous families of Roma Polish (family 1) and Saudi (family 2) origin who had a syndromic neurodevelopmental disorder. The patients presented in infancy with hypotonia and global developmental delay manifest as delayed walking with an unsteady gait (family 1) or inability to walk (family 2). They also had severely impaired intellectual development with poor or absent speech; 1 child was deaf due to a mutation in the GJB2 gene (121011). The sisters in family 1 developed cataracts at 13 and 7 years of age, whereas the patients in family 2 had earlier onset of cataracts. Despite these phenotypic similarities, each family had additional unique features. The sisters in family 1 had metabolic abnormalities with insulin resistance, axillary acanthosis, increased BMI, facial hirsutism, skin striae, and early menarche. These sisters also had dysmorphic features, including upslanting palpebral fissures, high narrow palate, tapering fingers, kyphosis, and foot deformities. One had focal seizures that could be controlled. Family history revealed that 3 cousins of the patients in family 1 had microcephaly and developmental delay and died in early childhood]	L4	n	y	lethal	lethal	lethal	L4	L4	post-infant-lethal
619256	HYPERCHOLANEMIA, FAMILIAL, 2	Hypercholanemia, familial 2, 619256 (3)	Hypercholanemia, familial 2	n	-	-	-	SLC10A1	HGNC:10905	Hypercholanemia, familial 2, 619256 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
619258	SPERMATOGENIC FAILURE 53	Spermatogenic failure 53, 619258 (3)	Spermatogenic failure 53	n	-	-	-	ACTL9	HGNC:28494	Spermatogenic failure 53, 619258 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
619259	NEURODEGENERATION WITH ATAXIA AND LATE-ONSET OPTIC ATROPHY	Neurodegeneration with ataxia and late-onset optic atrophy, 619259 (3)	Neurodegeneration with ataxia and late-onset optic atrophy	y	NEURODEGENERATION WITH ATAXIA AND LATE-ONSET OPTIC ATROPHY; NDAXOA	Clinical Features|Phenotype	died	SDHA	HGNC:10680	Neurodegeneration with ataxia and late-onset optic atrophy, 619259 (3), Autosomal dominant	Autosomal dominant	y	y	[Courage et al. (2017) reported a family in which a father and his 2 children had isolated complex II deficiency with variable manifestations. The proband was a 60-year-old man with neurologic symptoms since early childhood, when he presented with clumsiness, nystagmus in one eye, cramps in the feet, and speech impediment. At age 15 years, he had worsening ocular paresis, pyramidal signs, and ataxia. He was also found to have cardiomegaly and cardiomyopathy. At age 47, a myocardial biopsy showed increased mitochondria; he was also diagnosed with optic atrophy at this time. The cardiac and neurologic abnormalities were progressive. The patient also had recurrent depression with suicide attempts. Brain imaging was normal. The proband's affected son was a 30-year-old man diagnosed with cardiomyopathy in early childhood. As an adult, he presented with stable cardiomyopathy and developed progressive optic atrophy. Another child of the proband died at 7 months of age due to cardiac insufficiency associated with increased serum lactate and methylglutaconic aciduria; postmortem examination of cardiac muscle showed abnormal mitochondrial accumulation]	L3	n	y	lethal	lethal|nonlethal	lethal|nonlethal	L3	L3	pre-infant-lethal
619260	SPONDYLOEPIPHYSEAL DYSPLASIA, SENSORINEURAL HEARING LOSS, IMPAIRED INTELLECTUAL DEVELOPMENT, AND LEBER CONGENITAL AMAUROSIS	Spondyloepiphyseal dysplasia, sensorineural hearing loss, intellectual developmental disorder, and Leber congenital amaurosis, 619260 (3)	Spondyloepiphyseal dysplasia, sensorineural hearing loss, intellectual developmental disorder, and Leber congenital amaurosis	n	-	-	-	NMNAT1	HGNC:17877	Spondyloepiphyseal dysplasia, sensorineural hearing loss, intellectual developmental disorder, and Leber congenital amaurosis, 619260 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
619263	NEPHROTIC SYNDROME, TYPE 24	Nephrotic syndrome, type 24, 619263 (3)	Nephrotic syndrome, type 24	n	-	-	-	DAAM2	HGNC:18143	Nephrotic syndrome, type 24, 619263 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
619264	NEURODEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND VARIABLE SEIZURES	Neurodevelopmental disorder with dysmorphic facies and variable seizures, 619264 (3)	Neurodevelopmental disorder with dysmorphic facies and variable seizures	n	-	-	-	EMC10	HGNC:27609	Neurodevelopmental disorder with dysmorphic facies and variable seizures, 619264 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
619267	GLANZMANN THROMBASTHENIA 2	Glanzmann thrombasthenia 2, 619267 (3)	Glanzmann thrombasthenia 2	n	-	-	-	ITGB3	HGNC:6156	Glanzmann thrombasthenia 2, 619267 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
619268	ALZAHRANI-KUWAHARA SYNDROME	Alzahrani-Kuwahara syndrome, 619268 (3)	Alzahrani-Kuwahara syndrome	n	-	-	-	SMG8	HGNC:25551	Alzahrani-Kuwahara syndrome, 619268 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
619271	BLEEDING DISORDER, PLATELET-TYPE, 24	Bleeding disorder, platelet-type, 24, autosomal dominant, 619271 (3)	Bleeding disorder, platelet-type, 24, autosomal dominant	n	-	-	-	ITGB3	HGNC:6156	Bleeding disorder, platelet-type, 24, autosomal dominant, 619271 (3)	-	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
619272	MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 37	Mitochondrial complex I deficiency, nuclear type 37, 619272 (3)	Mitochondrial complex I deficiency, nuclear type 37	n	-	-	-	NDUFA8	HGNC:7692	Mitochondrial complex I deficiency, nuclear type 37, 619272 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
619273	CIMDAG SYNDROME	CIMDAG syndrome, 619273 (3)	CIMDAG syndrome	y	CIMDAG SYNDROME; CIMDAG	Clinical Features	died	VPS4A	HGNC:13488	CIMDAG syndrome, 619273 (3), Autosomal dominant	Autosomal dominant	y	y	[Rodger et al. (2020) reported 6 unrelated Caucasian patients, ranging from 2 to 29 years of age, with a neurodevelopmental disorder that they named CIMDAG (cerebellar hypoplasia, cataracts, impaired intellectual development, congenital microcephaly, dystonia, dyserythropoietic anemia, and growth retardation). The patients were ascertained through the GeneMatcher database or other repositories linked to diagnostic genetic testing. Two patients had died at 26 months and 29 years of age]	L4	y	-	lethal	lethal	lethal	L4	L4	post-infant-lethal
619274	DEAFNESS, AUTOSOMAL DOMINANT 80	Deafness, autosomal dominant 80, 619274 (3)	Deafness, autosomal dominant 80	n	-	-	-	GREB1L	HGNC:31042	Deafness, autosomal dominant 80, 619274 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L1	L1	pre-infant-lethal
619278	MICROCEPHALY, EPILEPSY, AND DIABETES SYNDROME 2	Microcephaly, epilepsy, and diabetes syndrome 2, 619278 (3)	Microcephaly, epilepsy, and diabetes syndrome 2	y	MICROCEPHALY, EPILEPSY, AND DIABETES SYNDROME 2; MEDS2	Clinical Features|Phenotype	died	YIPF5	HGNC:24877	Microcephaly, epilepsy, and diabetes syndrome 2, 619278 (3), Autosomal recessive	Autosomal recessive	y	y	[De Franco et al. (2020) reported 6 patients from 5 consanguineous families who had microcephaly, epilepsy, and diabetes syndrome (MEDS). All had severe microcephaly, with a median standard deviation of -6.2; epilepsy diagnosed at ages ranging from 1 to 7 months; and neonatal/early-onset diabetes, with age at diagnosis ranging from 4 weeks to 20 months, that was treated with a full replacement dose of insulin. For all 6 patients, birth weight was low, consistent with reduced insulin secretion in utero. The proband from family II died at the age of 1.3 years, and he had 2 sisters and 2 brothers who were also diagnosed with MEDS and died in infancy]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
619279	PARKINSONISM WITH POLYNEUROPATHY	Parkinsonism with polyneuropathy, 619279 (3)	Parkinsonism with polyneuropathy	n	-	-	-	UQCRC1	HGNC:12585	Parkinsonism with polyneuropathy, 619279 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
619281	IMMUNODEFICIENCY 14B, AUTOSOMAL RECESSIVE	Immunodeficiency 14B, autosomal recessive, 619281 (3)	Immunodeficiency 14B, autosomal recessive	y	IMMUNODEFICIENCY 14B, AUTOSOMAL RECESSIVE; IMD14B	Clinical Features	died	PIK3CD	HGNC:8977	Immunodeficiency 14B, autosomal recessive, 619281 (3), Autosomal recessive	Autosomal recessive	y	y	[Cohen et al. (2019) reported a boy, born of consanguineous Pakistani parents, with IMD14B. He tolerated vaccination in early childhood and was well until age 6 years when he presented with chronic diarrhea associated with colitis and polyarticular arthritis. He later developed features of inflammatory bowel disease. Laboratory studies showed leukocytosis, neutrophilia, monocytosis, and thrombocytosis. Serum IgG and IgA were decreased. Calcium flux in response to anti-CD3 crosslinking on patient T cells was decreased, although T-cell proliferative response was normal. The patient died at age 14 years of severe pneumonia and sepsis. Family history revealed a similarly affected brother who died of sepsis at 6 months of age]	L3	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L3	L3	pre-infant-lethal
619286	NEURODEVELOPMENTAL DISORDER WITH SPASTICITY, CATARACTS, AND CEREBELLAR HYPOPLASIA	Neurodevelopmental disorder with spasticity, cataracts, and cerebellar hypoplasia, 619286 (3)	Neurodevelopmental disorder with spasticity, cataracts, and cerebellar hypoplasia	y	NEURODEVELOPMENTAL DISORDER WITH SPASTICITY, CATARACTS, AND CEREBELLAR HYPOPLASIA; NEDSCAC	Clinical Features	died	MED27	HGNC:2377	Neurodevelopmental disorder with spasticity, cataracts, and cerebellar hypoplasia, 619286 (3), Autosomal recessive	Autosomal recessive	y	y	[Meng et al. (2021) reported 16 patients from 11 unrelated families with a similar neurodevelopmental disorder. The patients, who were ascertained through the GeneMatcher program, were of various ethic origins, including Algerian, Turkish, Pakistani, Kuwaiti, Hispanic, Finnish, and European. There were 13 pediatric patients, ranging from 10 months to 13 years of age, and 3 adults ranging from 26 to 42 years of age. Two sibs from family 3 died in childhood, and 1 affected sib in family 10 died in infancy; this latter patient also had a homozygous mutation in the COG6 gene (606977) and was excluded from the overall clinical analys]	L4	y	-	lethal	lethal	lethal	L4	L4	post-infant-lethal
619290	MAHVASH DISEASE	Mahvash disease, 619290 (3)	Mahvash disease	n	-	-	-	GCGR	HGNC:4192	Mahvash disease, 619290 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
619291	DYSTONIA 30	Dystonia 30, 619291 (3)	Dystonia 30	n	-	-	-	VPS16	HGNC:14584	Dystonia 30, 619291 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
619293	BLEPHAROPHIMOSIS-IMPAIRED INTELLECTUAL DEVELOPMENT SYNDROME	Blepharophimosis-impaired intellectual development syndrome, 619293 (3)	Blepharophimosis-impaired intellectual development syndrome	n	-	-	-	SMARCA2	HGNC:11098	Blepharophimosis-impaired intellectual development syndrome, 619293 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
619297	KINSSHIP SYNDROME	KINSSHIP syndrome, 619297 (3)	KINSSHIP syndrome	y	KINSSHIP SYNDROME; KINS	Clinical Features	died	AFF3	HGNC:6473	KINSSHIP syndrome, 619297 (3), Autosomal dominant	Autosomal dominant	y	y	[Steichen-Gersdorf et al. (2008) reported a female infant with mesomelic dysplasia characterized by bilateral fibular agenesis and short, dysplastic, triangulated tibiae. The femurs were of normal size. The forearms were slightly short, and the radial heads were subluxed. The feet were in a marked equinovalgus position with postaxial reduction on the left and abnormally spaced toes on the right. Head MRI demonstrated cortical and subcortical brain atrophy and dilatation of the ventricular system. The infant developed apneic spells and myoclonic jerks, and she died at age 4 months following a prolonged hypoxic episode]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
619301	PONTOCEREBELLAR HYPOPLASIA, TYPE 14	Pontocerebellar hypoplasia, type 14, 619301 (3)	Pontocerebellar hypoplasia, type 14	y	PONTOCEREBELLAR HYPOPLASIA, TYPE 14; PCH14	Description|Clinical Features|Clinical Synopsis	death|deaths|died	PPIL1	HGNC:9260	Pontocerebellar hypoplasia, type 14, 619301 (3), Autosomal recessive	Autosomal recessive	y	y	[Chai et al. (2021) reported 17 patients from 9 unrelated families with PCH14. The patients, who ranged from 2 months to 13 years of age, were ascertained through exome sequencing; several were identified through the GeneMatcher program. Five families were consanguineous, of Egyptian, Pakistani, or Mexican descent. The patients presented at birth with severe microcephaly (-2 to -6 SD), which progressed postnatally (-4 to -8 SD). Most showed essentially no developmental progress, with absent motor skills, no language, severe intellectual disability, and no social skills. Four patients died between 2 and 8 months of age]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
619303	PONTOCEREBELLAR HYPOPLASIA, TYPE 1E	Pontocerebellar hypoplasia, type 1E, 619303 (3)	Pontocerebellar hypoplasia, type 1E	y	PONTOCEREBELLAR HYPOPLASIA, TYPE 1E; PCH1E	Description|Clinical Features|Clinical Synopsis	die|died|lethal|death|deaths	SLC25A46	HGNC:25198	Pontocerebellar hypoplasia, type 1E, 619303 (3), Autosomal recessive	Autosomal recessive	y	y	[Death in the first days or weeks of life]	L2	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L2	L2	pre-infant-lethal
619306	NEURODEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND CEREBELLAR HYPOPLASIA	Neurodevelopmental disorder with dysmorphic facies and cerebellar hypoplasia, 619306 (3)	Neurodevelopmental disorder with dysmorphic facies and cerebellar hypoplasia	y	NEURODEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND CEREBELLAR HYPOPLASIA; NEDFACH	Clinical Features	died	EXOC2	HGNC:24968	Neurodevelopmental disorder with dysmorphic facies and cerebellar hypoplasia, 619306 (3), Autosomal recessive	Autosomal recessive	y	y	[Van Bergen et al. (2020) reported 2 patients from a large consanguineous Lebanese family with a severe neurodevelopmental disorder. The patients presented soon after birth with progressive microcephaly, global developmental delay, and dysmorphic features. One died at 10 years of age]	L5	y	-	lethal	lethal	lethal	L5	L5	post-infant-lethal
619310	LEUKODYSTROPHY, HYPOMYELINATING, 21	Leukodystrophy, hypomyelinating, 21, 619310 (3)	Leukodystrophy, hypomyelinating, 21	y	LEUKODYSTROPHY, HYPOMYELINATING, 21; HLD21	Description|Clinical Features	death|deaths|died	POLR3K	HGNC:14121	Leukodystrophy, hypomyelinating, 21, 619310 (3), Autosomal recessive	Autosomal recessive	y	y	[The disorder is progressive and may lead to premature death / Dorboz et al. (2018) reported 2 unrelated boys, each born of consanguineous parents of Berber origin from Algeria, with a severe neurodegenerative disorder beginning in infancy... Patient 2 died suddenly at age 18 years]	L5	y	-	lethal	lethal	lethal	L5	L5	post-infant-lethal
619311	HIATT-NEU-COOPER NEURODEVELOPMENTAL SYNDROME	Hiatt-Neu-Cooper neurodevelopmental syndrome, 619311 (3)	Hiatt-Neu-Cooper neurodevelopmental syndrome	n	-	-	-	RALA	HGNC:9839	Hiatt-Neu-Cooper neurodevelopmental syndrome, 619311 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
619312	RADIO-TARTAGLIA SYNDROME	Radio-Tartaglia syndrome, 619312 (3)	Radio-Tartaglia syndrome	n	-	-	-	SPEN	HGNC:17575	Radio-Tartaglia syndrome, 619312 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
619313	IMMUNODEFICIENCY 80 WITH OR WITHOUT CONGENITAL CARDIOMYOPATHY	Immunodeficiency 80 with or without cardiomyopathy, 619313 (3)	Immunodeficiency 80 with or without cardiomyopathy	y	IMMUNODEFICIENCY 80 WITH OR WITHOUT CONGENITAL CARDIOMYOPATHY; IMD80	Clinical Features|Clinical Synopsis|Phenotype	died|death|deaths|lethal	MCM10	HGNC:18043	Immunodeficiency 80 with or without cardiomyopathy, 619313 (3), Autosomal recessive	Autosomal recessive	y	y	[Mace et al. (2020) reported a boy, born of unrelated parents, who presented at 16 months of age with fever, organomegaly, diarrhea, and CMV infection. Laboratory studies showed mildly decreased B and T cells, reduced effector and memory T cells, and severe NK deficiency. Further analysis showed a preponderance of CD56(bright) NK cells, which produce cytokines, compared to CD56(dim) NK cells, which mediate target cell lysis. The patient underwent bone marrow transplantation for a suspected primary immunodeficiency, but he died at age 24 months from overwhelming CMV]	L4	y	-	lethal	lethal	lethal	L4	L4	post-infant-lethal
619314	BURATTI-HAREL SYNDROME	Buratti-Harel syndrome, 619314 (3)	Buratti-Harel syndrome	n	-	-	-	SIAH1	HGNC:10857	Buratti-Harel syndrome, 619314 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
619317	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 6B	Developmental and epileptic encephalopathy 6B, non-Dravet, 619317 (3)	Developmental and epileptic encephalopathy 6B, non-Dravet	y	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 6B; DEE6B	Clinical Features	died	SCN1A	HGNC:10585	Developmental and epileptic encephalopathy 6B, non-Dravet, 619317 (3), Autosomal dominant	Autosomal dominant	y	y	[Sadleir et al. (2017) reported 9 unrelated children, ranging from 3 to 12 years of age, with a severe epileptic encephalopathy... A few patients had nonspecific dysmorphic features, such as microcephaly, hypertelorism, and scoliosis. One patient died at age 10 years]	L5	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L3|L5	L3	pre-infant-lethal
619318	OCULOGASTROINTESTINAL NEURODEVELOPMENTAL SYNDROME	Oculogastrointestinal neurodevelopmental syndrome, 619318 (3)	Oculogastrointestinal neurodevelopmental syndrome	y	OCULOGASTROINTESTINAL NEURODEVELOPMENTAL SYNDROME; OGIN	Clinical Features	died|miscarriage|miscarriages|stillbirth|stillbirths	CAPN15	HGNC:11182	Oculogastrointestinal neurodevelopmental syndrome, 619318 (3), Autosomal recessive	Autosomal recessive	y	y	[Zha et al. (2020) reported 5 patients from 4 families with microphthalmia and/or coloboma as well as additional anomalies including hearing loss and delayed growth and development.... Her mother had experienced multiple miscarriages and stillbirth / The proband died at age 5 years of respiratory infection... the extended family history included a male cousin who died 2 hours after birth with abdominal distension, pelvic kidneys, lower limb deformity, and triangular face, as well as a female infant who died at 2 weeks of age with congenital malformations that included imperforate anus]	L2	n	y	lethal	lethal	lethal	L2	L2	pre-infant-lethal
619319	LYMPHATIC MALFORMATION 9	Lymphatic malformation 9, 619319 (3)	Lymphatic malformation 9	n	-	-	-	CELSR1	HGNC:1850	Lymphatic malformation 9, 619319 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
619320	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 65	Intellectual developmental disorder, autosomal dominant 65, 619320 (3)	Intellectual developmental disorder, autosomal dominant 65	n	-	-	-	KDM4B	HGNC:29136	Intellectual developmental disorder, autosomal dominant 65, 619320 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
619322	MARBACH-RUSTAD PROGEROID SYNDROME	Marbach-Rustad progeroid syndrome, 619322 (3)	Marbach-Rustad progeroid syndrome	n	-	-	-	LEMD2	HGNC:21244	Marbach-Rustad progeroid syndrome, 619322 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L6	L6	post-infant-lethal
619323	NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND GINGIVAL OVERGROWTH	Neurodevelopmental disorder with seizures and gingival overgrowth, 619323 (3)	Neurodevelopmental disorder with seizures and gingival overgrowth	y	NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND GINGIVAL OVERGROWTH; NEDSGO	Clinical Features|Phenotype	died|death|deaths	TBC1D2B	HGNC:29183	Neurodevelopmental disorder with seizures and gingival overgrowth, 619323 (3), Autosomal recessive	Autosomal recessive	y	y	[Harms et al. (2020) reported 4 patients from 3 unrelated families with NEDSGO. Two adult sibs in family 1 (patient 1 and 2) presented around age 5 years with gingival hypertrophy in the absence of medication exposure after normal early development... Patient 2 died at age 25 years]	L6	y	-	lethal	lethal	lethal	L6	L6	post-infant-lethal
619324	HYPERTRIGLYCERIDEMIA 2	Hypertriglyceridemia 2, 619324 (3)	Hypertriglyceridemia 2	n	-	-	-	CREB3L3	HGNC:18855	Hypertriglyceridemia 2, 619324 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
619325	COFFIN-SIRIS SYNDROME 12	Coffin-Siris syndrome 12, 619325 (3)	Coffin-Siris syndrome 12	n	-	-	-	BICRA	HGNC:4332	Coffin-Siris syndrome 12, 619325 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
619326	BDV SYNDROME	BDV syndrome, 619326 (3)	BDV syndrome	n	-	-	-	CPE	HGNC:2303	BDV syndrome, 619326 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
619328	LEUKODYSTROPHY, HYPOMYELINATING, 22	Leukodystrophy, hypomyelinating, 22, 619328 (3)	Leukodystrophy, hypomyelinating, 22	n	-	-	-	CLDN11	HGNC:8514	Leukodystrophy, hypomyelinating, 22, 619328 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
619329	FIBROMUSCULAR DYSPLASIA, MULTIFOCAL	Fibromuscular dysplasia, multifocal, 619329 (3)	Fibromuscular dysplasia, multifocal	n	-	-	-	COL5A1	HGNC:2209	Fibromuscular dysplasia, multifocal, 619329 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	LU	LU	post-infant-lethal
619333	NEURODEVELOPMENTAL DISORDER WITH CEREBELLAR ATROPHY AND MOTOR DYSFUNCTION	Neurodevelopmental disorder with cerebellar atrophy and motor dysfunction, 619333 (3)	Neurodevelopmental disorder with cerebellar atrophy and motor dysfunction	y	NEURODEVELOPMENTAL DISORDER WITH CEREBELLAR ATROPHY AND MOTOR DYSFUNCTION; NEDCAM	Clinical Features	died	GEMIN5	HGNC:20043	Neurodevelopmental disorder with cerebellar atrophy and motor dysfunction, 619333 (3), Autosomal recessive	Autosomal recessive	y	n	-	-	-	-	ambiguous	ambiguous	ambiguous	-	-	-
619334	ARTHROGRYPOSIS MULTIPLEX CONGENITA 6	Arthrogryposis multiplex congenita 6, 619334 (3)	Arthrogryposis multiplex congenita 6	y	ARTHROGRYPOSIS MULTIPLEX CONGENITA 6; AMC6	Description|Clinical Features|Clinical Synopsis|Phenotype	death|deaths|demise|died|lethal|miscarriage|miscarriages|stillborn	NEB	HGNC:7720	Arthrogryposis multiplex congenita 6, 619334 (3), Autosomal recessive	Autosomal recessive	y	y	[Death in utero or soon after birth]	L1	y	-	lethal	lethal	lethal	L1|L2	L1	pre-infant-lethal
619338	CATARACTS, SPASTIC PARAPARESIS, AND SPEECH DELAY	Cataracts, spastic paraparesis, and speech delay, 619338 (3)	Cataracts, spastic paraparesis, and speech delay	n	-	-	-	FAR1	HGNC:26222	Cataracts, spastic paraparesis, and speech delay, 619338 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
619340	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 96	Developmental and epileptic encephalopathy 96, 619340 (3)	Developmental and epileptic encephalopathy 96	y	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 96; DEE96	Description|Clinical Features|Phenotype	death|deaths|died|lethal	NSF	HGNC:8016	Developmental and epileptic encephalopathy 96, 619340 (3), Autosomal dominant	Autosomal dominant	y	y	[Suzuki et al. (2019) reported 2 unrelated Japanese infant girls with early infantile epileptic encephalopathy (EIEE). The first patient presented after birth with continuous vomiting and tonic seizures associated with a continuous burst-suppression pattern on EEG. She died of respiratory failure on day 36 of life]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
619345	DYSOSTOSIS MULTIPLEX, AIN-NAZ TYPE	Dysostosis multiplex, Ain-Naz type, 619345 (3)	Dysostosis multiplex, Ain-Naz type	y	DYSOSTOSIS MULTIPLEX, AIN-NAZ TYPE; DMAN	Description|Clinical Features|Clinical Synopsis	death|deaths|died	LYSET	HGNC:20218	Dysostosis multiplex, Ain-Naz type, 619345 (3), Autosomal recessive	Autosomal recessive	y	y	[Ain et al. (2021) reported 5 Pakistani sibs (family NMD02) and an Iranian girl (family ID01) with extreme short stature, severe skeletal dysplasia, and coarse facial features... The Iranian girl had upper airway difficulties and died of respiratory failure at age 5 years]	L4	y	-	lethal	lethal	lethal	L4	L4	post-infant-lethal
619350	VISCERAL MYOPATHY 2	Visceral myopathy 2, 619350 (3)	Visceral myopathy 2	n	-	-	-	MYH11	HGNC:7569	Visceral myopathy 2, 619350 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L3|L6	L3	pre-infant-lethal
619351	MEGACYSTIS-MICROCOLON-INTESTINAL HYPOPERISTALSIS SYNDROME 2	Megacystis-microcolon-intestinal hypoperistalsis syndrome 2, 619351 (3)	Megacystis-microcolon-intestinal hypoperistalsis syndrome 2	y	MEGACYSTIS-MICROCOLON-INTESTINAL HYPOPERISTALSIS SYNDROME 2; MMIHS2	Description|Clinical Features|Clinical Synopsis|Phenotype	fatal|died|die|demise|spontaneous_abortion|spontaneous_abortions	MYH11	HGNC:7569	Megacystis-microcolon-intestinal hypoperistalsis syndrome 2, 619351 (3), Autosomal recessive	Autosomal recessive	y	y	[Patients may die in infancy or early childhood of multiple organ failure / Gauthier et al. (2015) reported an Algerian boy who had megacystis and severe oligohydramnios observed on prenatal ultrasound. A classic prune belly phenotype (see 100100) was noted at birth, and he was anuric; ultrasound confirmed megacystis with normal wall thickness. He also had severe lung hypoplasia requiring assisted ventilation. The infant never passed meconium, and at 3 weeks, transit studies showed lack of opacification of the bowel distal to the duodenum; barium enema showed filiform opacification of the distal colon with no opacification of the cecum, consistent with microcolon. Echocardiogram was normal, and the ductus arteriosus closed spontaneously. The infant died following hemodynamic deterioration and multiorgan failure]	L3	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L3|L6	L3	pre-infant-lethal
619352	ATAXIA, INTENTION TREMOR, AND HYPOTONIA SYNDROME, CHILDHOOD-ONSET	Ataxia, intention tremor, and hypotonia syndrome, childhood-onset, 619352 (3)	Ataxia, intention tremor, and hypotonia syndrome, childhood-onset	n	-	-	-	POU4F1	HGNC:9218	Ataxia, intention tremor, and hypotonia syndrome, childhood-onset, 619352 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
619355	MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 22	Mitochondrial complex IV deficiency, nuclear type 22, 619355 (3)	Mitochondrial complex IV deficiency, nuclear type 22	y	MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 22; MC4DN22	Description|Clinical Features|Clinical Synopsis	fatal|died|death|deaths	COX16	HGNC:20213	Mitochondrial complex IV deficiency, nuclear type 22, 619355 (3), Autosomal recessive	Autosomal recessive	y	y	[Death in infancy /Wintjes et al. (2021) reported 2 unrelated patients with mitochondrial complex IV deficiency....Her heart function deteriorated after 5 months of age, and she died at almost 7 months of age]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
619356	ONYCHODYSTROPHY, OSTEODYSTROPHY, IMPAIRED INTELLECTUAL DEVELOPMENT, AND SEIZURES SYNDROME	Onychodystrophy, osteodystrophy, impaired intellectual development, and seizures syndrome, 619356 (3)	Onychodystrophy, osteodystrophy, impaired intellectual development, and seizures syndrome	y	ONYCHODYSTROPHY, OSTEODYSTROPHY, IMPAIRED INTELLECTUAL DEVELOPMENT, AND SEIZURES SYNDROME; OORS	Clinical Features	died	PIGF	HGNC:8962	Onychodystrophy, osteodystrophy, impaired intellectual development, and seizures syndrome, 619356 (3), Autosomal recessive	Autosomal recessive	y	y	[Salian et al. (2021) reported 2 unrelated children, each born of consanguineous Indian parents, with a similar syndromic neurodevelopmental disorder... She had tonic posturing without overt seizures. Neither patient had deafness, and brain imaging was normal. Patient 1 had a similarly affected brother who died before 2 years of age]	L3	n	y	lethal	lethal	lethal	L3	L3	pre-infant-lethal
619360	ANGIOEDEMA, HEREDITARY, 4	Angioedema, hereditary, 4, 619360 (3)	Angioedema, hereditary, 4	y	ANGIOEDEMA, HEREDITARY, 4; HAE4	Description|Clinical Features	death|deaths|died	PLG	HGNC:9071	Angioedema, hereditary, 4, 619360 (3), Autosomal dominant	Autosomal dominant	y	y	[Hereditary angioedema-4 (HAE4) is an autosomal dominant disorder characterized by episodic subcutaneous or submucosal edema with onset usually in adulthood. Swelling most commonly involves the face and tongue, sometimes resulting in occlusion of the airway, which can cause death / Bork et al. (2018) reported 18 affected individuals from 4 unrelated multigenerational families (families A-D) with hereditary angioedema with normal C1INH levels... Two women died of asphyxiation due to tongue swelling with upper airway obstruction at ages 36 and 47 years, respectively]	L6	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L6	L6	post-infant-lethal
619363	ANGIOEDEMA, HEREDITARY, 6	Angioedema, hereditary, 6, 619363 (3)	Angioedema, hereditary, 6	n	-	-	-	KNG1	HGNC:6383	Angioedema, hereditary, 6, 619363 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
619369	LYMPHATIC MALFORMATION 10	Lymphatic malformation 10, 619369 (3)	Lymphatic malformation 10	n	-	-	-	ANGPT2	HGNC:485	Lymphatic malformation 10, 619369 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
619371	CARDIOMYOPATHY, DILATED, 2D	Cardiomyopathy, dilated, 2D, 619371 (3)	Cardiomyopathy, dilated, 2D	y	CARDIOMYOPATHY, DILATED, 2D; CMD2D	Description|Clinical Features|Clinical Synopsis|Phenotype	death|deaths|died	RPL3L	HGNC:10351	Cardiomyopathy, dilated, 2D, 619371 (3), Autosomal recessive	Autosomal recessive	y	y	[Ganapathi et al. (2020) reported 6 patients from 3 unrelated families, from Germany, Colombia, and Spain, who presented with severe neonatal CMD within the first day to 2.5 months of life. Echocardiography showed dilated right atria and ventricles, progressing to biventricular dilation with reduced systolic function reflected in markedly low ejection fractions. Valvular insufficiency was present in 4 patients, involving the tricuspid and mitral valves. None of the children exhibited hypotonia. Of the 6 patients, 4 experienced cardiac decompensation and died of cardiogenic shock by 2 months of age; the 2 surviving patients underwent cardiac transplantation at 5 months of age and were alive at 9 years and 10 years, respectively]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
619373	NEURODEVELOPMENTAL DISORDER WITH INFANTILE EPILEPTIC SPASMS	Neurodevelopmental disorder with infantile epileptic spasms, 619373 (3)	Neurodevelopmental disorder with infantile epileptic spasms	n	-	-	-	NCDN	HGNC:17597	Neurodevelopmental disorder with infantile epileptic spasms, 619373 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
619375	AUTOINFLAMMATORY SYNDROME, FAMILIAL, WITH OR WITHOUT IMMUNODEFICIENCY	Autoinflammatory syndrome, familial, with or without immunodeficiency, 619375 (3)	Autoinflammatory syndrome, familial, with or without immunodeficiency	n	-	-	-	SOCS1	HGNC:19383	Autoinflammatory syndrome, familial, with or without immunodeficiency, 619375 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
619376	FAUNDES-BANKA SYNDROME	Faundes-Banka syndrome, 619376 (3)	Faundes-Banka syndrome	n	-	-	-	EIF5A	HGNC:3300	Faundes-Banka syndrome, 619376 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
619377	OSTEOOTOHEPATOENTERIC SYNDROME	Osteootohepatoenteric syndrome, 619377 (3)	Osteootohepatoenteric syndrome	n	-	-	-	UNC45A	HGNC:30594	Osteootohepatoenteric syndrome, 619377 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
619381	IMMUNODEFICIENCY 82 WITH SYSTEMIC INFLAMMATION	Immunodeficiency 82 with systemic inflammation, 619381 (3)	Immunodeficiency 82 with systemic inflammation	n	-	-	-	SYK	HGNC:11491	Immunodeficiency 82 with systemic inflammation, 619381 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
619382	LEBER HEREDITARY OPTIC NEUROPATHY, AUTOSOMAL RECESSIVE 1	Leber hereditary optic neuropathy, autosomal recessive 1, 619382 (3)	Leber hereditary optic neuropathy, autosomal recessive 1	n	-	-	-	DNAJC30	HGNC:16410	Leber hereditary optic neuropathy, autosomal recessive 1, 619382 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
619383	NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, FACIAL DYSMORPHISM, AND BRAIN ABNORMALITIES	Neurodevelopmental disorder with hypotonia, facial dysmorphism, and brain abnormalities, 619383 (3)	Neurodevelopmental disorder with hypotonia, facial dysmorphism, and brain abnormalities	y	NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, FACIAL DYSMORPHISM, AND BRAIN ABNORMALITIES; NEDHFBA	Clinical Features	died	PPP1R21	HGNC:30595	Neurodevelopmental disorder with hypotonia, facial dysmorphism, and brain abnormalities, 619383 (3), Autosomal recessive	Autosomal recessive	y	y	[Rehman et al. (2019) reported 6 children from 4 unrelated consanguineous families of Middle Eastern origin with a similar neurodevelopmental disorder. Two sibs from family 1 died within the first year of life]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
619386	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 52	Combined oxidative phosphorylation deficiency 52, 619386 (3)	Combined oxidative phosphorylation deficiency 52	y	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 52; COXPD52	Clinical Features	died	NFS1	HGNC:15910	Combined oxidative phosphorylation deficiency 52, 619386 (3), Autosomal recessive	Autosomal recessive	y	y	[Hershkovitz et al. (2021) reported 3 sibs from a consanguineous Arab Christian family with COXPD. All 3 sibs presented with lethargy and hypotonia. Two sibs, who died at age 43 days and 7 months, had hypoglycemia, respiratory failure, cardiac failure, renal failure, and disseminated intravascular coagulation]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
619389	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 29	Spinocerebellar ataxia, autosomal recessive 29, 619389 (3)	Spinocerebellar ataxia, autosomal recessive 29	n	-	-	-	VPS41	HGNC:12713	Spinocerebellar ataxia, autosomal recessive 29, 619389 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
619401	LYMPHATIC MALFORMATION 11	Lymphatic malformation 11, 619401 (3)	Lymphatic malformation 11	n	-	-	-	TIE1	HGNC:11809	Lymphatic malformation 11, 619401 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
619402	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 28	Cardiomyopathy, familial hypertrophic, 28, 619402 (3)	Cardiomyopathy, familial hypertrophic, 28	y	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 28; CMH28	Description|Clinical Features|Clinical Synopsis	death|deaths|died	FHOD3	HGNC:26178	Cardiomyopathy, familial hypertrophic, 28, 619402 (3), Autosomal dominant	Autosomal dominant	y	y	[Sudden death (in some patients) / Ochoa et al. (2018) summarized the clinical characteristics of 70 patients with hypertrophic cardiomyopathy (CMH) and mutations in the FHOD3 gene... Of 13 deaths in the families, 11 were sudden cardiac deaths, including 7 in relatives for whom genetic testing was unavailable. In addition, 2 patients died of heart failure: 1 was a 58-year-old woman with a concomitant diagnosis of severe rheumatic mitral stenosis and the other was a 37-year-old man with a restrictive filling pattern]	L6	y	-	lethal	lethal	lethal	L6	L6	post-infant-lethal
619405	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 30	Spinocerebellar ataxia, autosomal recessive 30, 619405 (3)	Spinocerebellar ataxia, autosomal recessive 30	n	-	-	-	PITRM1	HGNC:17663	Spinocerebellar ataxia, autosomal recessive 30, 619405 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
619406	HYPOKALEMIC TUBULOPATHY AND DEAFNESS	Hypokalemic tubulopathy and deafness, 619406 (3)	Hypokalemic tubulopathy and deafness	n	-	-	-	KCNJ16	HGNC:6262	Hypokalemic tubulopathy and deafness, 619406 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
619418	NEUROLOGIC, ENDOCRINE, AND PANCREATIC DISEASE, MULTISYSTEM, INFANTILE-ONSET 2	Infantile-onset multisystem neurologic, endocrine, and pancreatic disease 2, 619418 (3)	Infantile-onset multisystem neurologic, endocrine, and pancreatic disease 2	y	NEUROLOGIC, ENDOCRINE, AND PANCREATIC DISEASE, MULTISYSTEM, INFANTILE-ONSET 2; IMNEPD2	Description|Clinical Features|Clinical Synopsis	death|deaths|died	YARS1	HGNC:12840	Infantile-onset multisystem neurologic, endocrine, and pancreatic disease 2, 619418 (3), Autosomal recessive	Autosomal recessive	y	y	[Williams et al. (2019) reported 7 children from a large highly consanguineous Amish kindred with a severe multisystemic disorder apparent from birth. About half the patients were born prematurely, and many births were associated with intrauterine growth retardation or placental abnormalities. Four children died between 10 and 25 months due to end-stage liver disease or infection]	L3	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L3	L3	pre-infant-lethal
619420	MARTSOLF SYNDROME 2	Martsolf syndrome 2, 619420 (3)	Martsolf syndrome 2	n	-	-	-	RAB3GAP1	HGNC:17063	Martsolf syndrome 2, 619420 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	ambiguous|nonlethal	ambiguous	-	-	-
619422	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 31	Spinocerebellar ataxia, autosomal recessive 31, 619422 (3)	Spinocerebellar ataxia, autosomal recessive 31	n	-	-	-	ATG7	HGNC:16935	Spinocerebellar ataxia, autosomal recessive 31, 619422 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
619423	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 53	Combined oxidative phosphorylation deficiency 53, 619423 (3)	Combined oxidative phosphorylation deficiency 53	y	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 53; COXPD53	Clinical Features|Clinical Synopsis	died|death|deaths	C2orf69	HGNC:26799	Combined oxidative phosphorylation deficiency 53, 619423 (3), Autosomal recessive	Autosomal recessive	y	y	[Wong et al. (2021) described clinical features in 12 patients from 8 families with disease onset between birth and 3 months of age. All 12 patients had developmental delay, 9 of 10 patients had secondary microcephaly, 7 of 9 patients had dysgenesis of the corpus callosum, 6 of 7 patients had CNS hypomyelination, 7 of 7 patients had cerebral atrophy, and 11 of 11 patients had seizures. Immune anomalies included recurrent fevers in 8 patients, inflammatory arthritis in 3, septic arthritis in 2, aseptic osteomyelitis in 2, and hypochromic microcytic anemia in 4. Other features included hypotonia in 9 patients, muscle wasting in 8, abdominal distention in 4, spasticity in 4, and hepatomegaly in 2. Ten of 12 patients died between the ages of 9 and 32 months, and the 2 living patients were in critical condition]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
619424	MYOPATHY, MYOFIBRILLAR, 12, INFANTILE-ONSET, WITH CARDIOMYOPATHY	Myopathy, myofibrillar, 12, infantile-onset, with cardiomyopathy, 619424 (3)	Myopathy, myofibrillar, 12, infantile-onset, with cardiomyopathy	y	MYOPATHY, MYOFIBRILLAR, 12, INFANTILE-ONSET, WITH CARDIOMYOPATHY; MFM12	Description|Clinical Features|Clinical Synopsis|Phenotype	death|deaths|died|fatal|lethality	MYL2	HGNC:7583	Myopathy, myofibrillar, 12, infantile-onset, with cardiomyopathy, 619424 (3), Autosomal recessive	Autosomal recessive	y	y	[Infantile-onset myofibrillar myopathy-12 with cardiomyopathy (MFM12) is a severe autosomal recessive disorder affecting both skeletal and cardiac muscle tissue that is apparent in the first weeks of life. Affected infants show tremor or clonus at birth, followed by onset of rapidly progressive generalized muscle weakness and dilated cardiomyopathy and cardiac failure, usually resulting in death by 6 months of age]	L3	y	-	lethal	lethal	lethal	L3|L6	L3	pre-infant-lethal
619426	WHITE-KERNOHAN SYNDROME	White-Kernohan syndrome, 619426 (3)	White-Kernohan syndrome	n	-	-	-	DDB1	HGNC:2717	White-Kernohan syndrome, 619426 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
619428	FOCAL SEGMENTAL GLOMERULOSCLEROSIS AND NEURODEVELOPMENTAL SYNDROME	Focal segmental glomerulosclerosis and neurodevelopmental syndrome, 619428 (3)	Focal segmental glomerulosclerosis and neurodevelopmental syndrome	n	-	-	-	TRIM8	HGNC:15579	Focal segmental glomerulosclerosis and neurodevelopmental syndrome, 619428 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
619431	MEGACYSTIS-MICROCOLON-INTESTINAL HYPOPERISTALSIS SYNDROME 5	Megacystis-microcolon-intestinal hypoperistalsis syndrome 5, 619431 (3)	Megacystis-microcolon-intestinal hypoperistalsis syndrome 5	y	MEGACYSTIS-MICROCOLON-INTESTINAL HYPOPERISTALSIS SYNDROME 5; MMIHS5	Clinical Features|Clinical Synopsis|Phenotype	died|fatal|death|deaths	ACTG2	HGNC:145	Megacystis-microcolon-intestinal hypoperistalsis syndrome 5, 619431 (3), Autosomal dominant	Autosomal dominant	y	y	[Disorder is fatal without intensive supportive treatment / Halim et al. (2016) reported 8 sporadic patients with 'typical' MMIHS and mutations in the ACTG2 gene...Two others (S3 and S4) died at age 5 days and 5 months, respectively, upon discontinuation of treatment]	L2	y	-	lethal	lethal	lethal	L2|L3	L2	pre-infant-lethal
619435	RITSCHER-SCHINZEL SYNDROME 4	Ritscher-Schinzel syndrome 4, 619435 (3)	Ritscher-Schinzel syndrome 4	y	RITSCHER-SCHINZEL SYNDROME 4; RTSC4	Clinical Features	died|spontaneous_abortion|spontaneous_abortions	DPYSL5	HGNC:20637	Ritscher-Schinzel syndrome 4, 619435 (3), Autosomal dominant	Autosomal dominant	y	y	[She died at age 3.5 years after cardiac surgery. The younger sister had a successful heart operation on a cleft mitral valve and septum primum defect. Family history revealed a boy who died of asphyxia and multiple congenital anomalies soon after birth, as well as a spontaneous abortion during the third gestational month]	L2	y	y	lethal	lethal	lethal	L2	L2	pre-infant-lethal
619445	DIARRHEA 12, WITH MICROVILLUS ATROPHY	Diarrhea 12, with microvillus atrophy, 619445 (3)	Diarrhea 12, with microvillus atrophy	y	DIARRHEA 12, WITH MICROVILLUS ATROPHY; DIAR12	Clinical Features	death|deaths	STX3	HGNC:11438	Diarrhea 12, with microvillus atrophy, 619445 (3), Autosomal recessive	Autosomal recessive	y	y	[Alsaleem et al. (2017) reported a Saudi male infant who had onset of severe vomiting, mild diarrhea, and metabolic acidosis on day 3 of life.. Family history was remarkable for early neonatal death due to undiagnosed metabolic acidosis in a sib and cousins]	L2	n	y	lethal	lethal|nonlethal	lethal|nonlethal	L2	L2	pre-infant-lethal
619446	RETINAL DYSTROPHY AND MICROVILLUS INCLUSION DISEASE	Retinal dystrophy and microvillus inclusion disease, 619446 (3)	Retinal dystrophy and microvillus inclusion disease	n	-	-	-	STX3	HGNC:11438	Retinal dystrophy and microvillus inclusion disease, 619446 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L2	L2	pre-infant-lethal
619451	CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIE	Cutis laxa, autosomal recessive, type IIE, 619451 (3)	Cutis laxa, autosomal recessive, type IIE	n	-	-	-	LTBP1	HGNC:6714	Cutis laxa, autosomal recessive, type IIE, 619451 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
619460	LUO-SCHOCH-YAMAMOTO SYNDROME	Luo-Schoch-Yamamoto syndrome, 619460 (3)	Luo-Schoch-Yamamoto syndrome	y	LUO-SCHOCH-YAMAMOTO SYNDROME; LUSYAM	Phenotype	lethality	RNF2	HGNC:10061	Luo-Schoch-Yamamoto syndrome, 619460 (3), Autosomal dominant	Autosomal dominant	y	n	-	-	-	-	ambiguous	ambiguous	ambiguous	-	-	-
619461	MYASTHENIC SYNDROME, CONGENITAL, 7B, PRESYNAPTIC, AUTOSOMAL RECESSIVE	Myasthenic syndrome, congenital, 7B, presynaptic, autosomal recessive, 619461 (3)	Myasthenic syndrome, congenital, 7B, presynaptic, autosomal recessive	n	-	-	-	SYT2	HGNC:11510	Myasthenic syndrome, congenital, 7B, presynaptic, autosomal recessive, 619461 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
619463	PORTAL HYPERTENSION, NONCIRRHOTIC, 2	Portal hypertension, noncirrhotic, 2, 619463 (3)	Portal hypertension, noncirrhotic, 2	y	PORTAL HYPERTENSION, NONCIRRHOTIC, 2; NCPH2	Clinical Features|Clinical Synopsis	died|death|deaths	GIMAP5	HGNC:18005	Portal hypertension, noncirrhotic, 2, 619463 (3), Autosomal recessive	Autosomal recessive	y	y	[Early death (in some patients) / Patterson et al. (2018) as having an immunodeficiency with lymphopenia, neutropenia, and low NK cells... Three of the patients died between 17 and 44 years of age of infection or liver failure]	L5	y	-	lethal	lethal	lethal	L5	L5	post-infant-lethal
619466	CILIARY DYSKINESIA, PRIMARY, 47, AND LISSENCEPHALY	Ciliary dyskinesia, primary, 47, and lissencephaly, 619466 (3)	Ciliary dyskinesia, primary, 47, and lissencephaly	y	CILIARY DYSKINESIA, PRIMARY, 47, AND LISSENCEPHALY; CILD47	Clinical Features|Clinical Synopsis	died|death|deaths	TP73	HGNC:12003	Ciliary dyskinesia, primary, 47, and lissencephaly, 619466 (3), Autosomal recessive	Autosomal recessive	y	y	[Wallmeier et al. (2021) reported 7 patients from 5 unrelated consanguineous families with CILD47. The patients had chronic disease of the upper and lower respiratory tract characterized by recurrent infections of the airways, productive cough, chronic rhinitis, and otitis media. Several patients presented in the neonatal period requiring ventilatory support; 1 died from respiratory failure at 2 months of age]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
619467	USMANI-RIAZUDDIN SYNDROME, AUTOSOMAL DOMINANT	Usmani-Riazuddin syndrome, autosomal dominant, 619467 (3)	Usmani-Riazuddin syndrome, autosomal dominant	y	USMANI-RIAZUDDIN SYNDROME, AUTOSOMAL DOMINANT; USRISD	Clinical Features|Phenotype	died|lethal|lethality	AP1G1	HGNC:555	Usmani-Riazuddin syndrome, autosomal dominant, 619467 (3), Autosomal dominant	Autosomal dominant	y	y	[Usmani et al. (2021) reported 9 unrelated patients (families 3-11), ranging in age from 22 days to 40 years, with a neurodevelopmental disorder. The patients were ascertained through the GeneMatcher Program after exome sequencing, and the phenotype was characterized retrospectively. Two patients had died at 22 days and 4 years]	L2	y	-	lethal	lethal	lethal	L2|L4	L2	pre-infant-lethal
619470	NEURODEVELOPMENTAL DISORDER WITH MOTOR AND SPEECH DELAY AND BEHAVIORAL ABNORMALITIES	Neurodevelopmental disorder with motor and speech delay and behavioral abnormalities, 619470 (3)	Neurodevelopmental disorder with motor and speech delay and behavioral abnormalities	n	-	-	-	TMEM222	HGNC:25363	Neurodevelopmental disorder with motor and speech delay and behavioral abnormalities, 619470 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
619471	BARDET-BIEDL SYNDROME 20	Bardet-Biedl syndrome 20, 619471 (3)	Bardet-Biedl syndrome 20	n	-	-	-	IFT172	HGNC:30391	Bardet-Biedl syndrome 20, 619471 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L2	L2	pre-infant-lethal
619472	VISS SYNDROME	VISS syndrome, 619472 (3)	VISS syndrome	n	-	-	-	IPO8	HGNC:9853	VISS syndrome, 619472 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
619473	OCULOPHARYNGODISTAL MYOPATHY 3	Oculopharyngodistal myopathy 3, 619473 (3)	Oculopharyngodistal myopathy 3	y	OCULOPHARYNGODISTAL MYOPATHY 3; OPDM3	Clinical Features|Phenotype	died|death|deaths	NOTCH2NLC	HGNC:53924	Oculopharyngodistal myopathy 3, 619473 (3), Autosomal dominant	Autosomal dominant	y	y	[Yu et al. (2021) reported 5 Chinese patients, included 2 sisters, with OPDM3. The mean age at onset was 23.8 years (range 18 to 31). Four patients presented with distal leg weakness and 1 with diplopia and exotropia. The disease was slowly progressive and all patients eventually developed ptosis, facial and bulbar muscle weakness, and distal limb muscle weakness and atrophy with steppage gait. External ophthalmoplegia was also observed. Reflexes were decreased, but sensation was normal. Two patients died of respiratory events]	LU	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L6|LU	L6	post-infant-lethal
619475	DEVELOPMENTAL DELAY, IMPAIRED SPEECH, AND BEHAVIORAL ABNORMALITIES	Developmental delay, impaired speech, and behavioral abnormalities, 619475 (3)	Developmental delay, impaired speech, and behavioral abnormalities	n	-	-	-	SPTBN1	HGNC:11275	Developmental delay, impaired speech, and behavioral abnormalities, 619475 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
619479	SHORT-RIB THORACIC DYSPLASIA 21 WITHOUT POLYDACTYLY	Short-rib thoracic dysplasia 21 without polydactyly, 619479 (3)	Short-rib thoracic dysplasia 21 without polydactyly	y	SHORT-RIB THORACIC DYSPLASIA 21 WITHOUT POLYDACTYLY; SRTD21	Clinical Features	died	KIAA0753	HGNC:29110	Short-rib thoracic dysplasia 21 without polydactyly, 619479 (3), Autosomal recessive	Autosomal recessive	y	y	[Hammarsjo et al. (2021) ascertained 3 families (families 14, 15, and 16) with mutations in the KIAA0753 gene...The boy died at age 2 days and the girl at 4 months of age]	L2	y	-	lethal	lethal	lethal	L2	L2	pre-infant-lethal
619480	NEURODEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND THIN CORPUS CALLOSUM	Neurodevelopmental disorder with dysmorphic facies and thin corpus callosum, 619480 (3)	Neurodevelopmental disorder with dysmorphic facies and thin corpus callosum	n	-	-	-	SUPT16H	HGNC:11465	Neurodevelopmental disorder with dysmorphic facies and thin corpus callosum, 619480 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
619488	DEGCAGS SYNDROME	DEGCAGS syndrome, 619488 (3)	DEGCAGS syndrome	y	DEGCAGS SYNDROME; DEGCAGS	Description|Clinical Features|Clinical Synopsis	death|deaths|died	ZNF699	HGNC:24750	DEGCAGS syndrome, 619488 (3), Autosomal recessive	Autosomal recessive	y	y	[Death in childhood (in some patients)]	L4	y	-	lethal	lethal	lethal	L4	L4	post-infant-lethal
619489	SHORT STATURE, DAUBER-ARGENTE TYPE	Short stature, Dauber-Argente type, 619489 (3)	Short stature, Dauber-Argente type	n	-	-	-	PAPPA2	HGNC:14615	Short stature, Dauber-Argente type, 619489 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
619492	CARDIOMYOPATHY, DILATED, 2E	Cardiomyopathy, dilated, 2E, 619492 (3)	Cardiomyopathy, dilated, 2E	y	CARDIOMYOPATHY, DILATED, 2E; CMD2E	Description|Clinical Features|Clinical Synopsis|Phenotype	death|deaths|died|spontaneous_abortion|spontaneous_abortions	JPH2	HGNC:14202	Cardiomyopathy, dilated, 2E, 619492 (3), Autosomal recessive	Autosomal recessive	y	y	[Jones et al. (2019) studied an Iranian family (family 1) in which 2 children died with CMD. The proband (IV-3) had severe left ventricular (LV) dilation with rapidly declining systolic function as an infant; cardiac imaging at 20 months of age confirmed the diagnosis of CMD. By 4.5 years of age, his LV systolic function was severely depressed with medically refractory heart failure, and electrocardiograms showed prolongation of the PR interval, conduction delay, and T-wave abnormalities. He died at age 5 while awaiting transplant. An older brother (IV-2) who died at 37 days of age had presented with sudden fever, poor feeding, jaundice, and hypotonia as a neonate and exhibited cardiomegaly and clinical features consistent with cardiomyopathy. The first-cousin parents also had a pregnancy that ended in spontaneous abortion at 8 weeks (IV-1), and a 3-month old healthy boy (IV-4). The authors studied another consanguineous Iranian family (family 2) in which 2 brothers died at ages 6 months and 2.5 years, respectively, of cardiac arrest. The older brother (V-1) presented with fever, restlessness, and poor feeding at age 6 months, and his clinical status declined until in-hospital cardiac arrest 3 days later. The proband (V-2) was diagnosed prenatally with Ebstein anomaly, and did well until 2 years of age, when he underwent tricuspid valve annuloplasty and atrial septal defect closure. Postoperatively he had episodes of respiratory distress and developed generalized edema and progressive ventricular failure, and died of cardiac arrest at 2.5 years of age]	L1	y	y	lethal	lethal	lethal	L1|L4	L1	pre-infant-lethal
619493	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE 2v	Congenital disorder of glycosylation, type IIv, 619493 (3)	Congenital disorder of glycosylation, type IIv	n	-	-	-	EDEM3	HGNC:16787	Congenital disorder of glycosylation, type IIv, 619493 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
619501	VENTRICULOMEGALY AND ARTHROGRYPOSIS	Ventriculomegaly and arthrogryposis, 619501 (3)	Ventriculomegaly and arthrogryposis	y	VENTRICULOMEGALY AND ARTHROGRYPOSIS; VENARG	Clinical Features|Clinical Synopsis	death|deaths|miscarriage|miscarriages	KIDINS220	HGNC:29508	Ventriculomegaly and arthrogryposis, 619501 (3), Autosomal recessive	Autosomal recessive	y	y	[Mero et al. (2017) reported a consanguineous family in which 4 fetuses had VENARG resulting in intrauterine death or termination of the pregnancy / El-Dessouky et al. (2020) reported a consanguineous Egyptian family in which several fetuses were affected with VENARG... Obstetric history of the mother included 8 repeated spontaneous miscarriages at 8-12 weeks' gestation]	L1	y	y	lethal	lethal|nonlethal	lethal|nonlethal	L1	L1	pre-infant-lethal
619503	NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA AND DYSMORPHIC FACIES	Neurodevelopmental disorder with hypotonia and dysmorphic facies, 619503 (3)	Neurodevelopmental disorder with hypotonia and dysmorphic facies	n	-	-	-	GNB2	HGNC:4398	Neurodevelopmental disorder with hypotonia and dysmorphic facies, 619503 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
619504	CHOPRA-AMIEL-GORDON SYNDROME	Chopra-Amiel-Gordon syndrome, 619504 (3)	Chopra-Amiel-Gordon syndrome	n	-	-	-	ANKRD17	HGNC:23575	Chopra-Amiel-Gordon syndrome, 619504 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
619512	NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA AND BRAIN ABNORMALITIES	Neurodevelopmental disorder with hypotonia and brain abnormalities, 619512 (3)	Neurodevelopmental disorder with hypotonia and brain abnormalities	y	NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA AND BRAIN ABNORMALITIES; NEDHYBA	Clinical Features|Phenotype	died	CLCN3	HGNC:2021	Neurodevelopmental disorder with hypotonia and brain abnormalities, 619512 (3), Autosomal dominant	Autosomal dominant	y	y	[Duncan et al. (2021) reported 9 unrelated patients, ranging from 5 to 17 years of age, with a variable neurodevelopmental disorder. One of the patients died at 23 days of age]	L2	y	-	lethal	lethal	lethal	L2|L3	L2	pre-infant-lethal
619515	SPERMATOGENIC FAILURE 56	Spermatogenic failure 56, 619515 (3)	Spermatogenic failure 56	n	-	-	-	DNAH10	HGNC:2941	Spermatogenic failure 56, 619515 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
619517	NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND BRAIN ABNORMALITIES	Neurodevelopmental disorder with seizures and brain abnormalities, 619517 (3)	Neurodevelopmental disorder with seizures and brain abnormalities	y	NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND BRAIN ABNORMALITIES; NEDSBA	Clinical Features|Clinical Synopsis	died|death|deaths	CLCN3	HGNC:2021	Neurodevelopmental disorder with seizures and brain abnormalities, 619517 (3), Autosomal recessive	Autosomal recessive	y	y	[Duncan et al. (2021) reported 2 brothers (family 10) with a severe neurodevelopmental disorder. One was 18 months of age, whereas the other had died at age 14 months]	L3	y	-	lethal	lethal	lethal	L2|L3	L2	pre-infant-lethal
619518	MUSCULAR DYSTROPHY, CONGENITAL HEARING LOSS, AND OVARIAN INSUFFICIENCY SYNDROME	Muscular dystrophy, congenital hearing loss, and ovarian insufficiency syndrome, 619518 (3)	Muscular dystrophy, congenital hearing loss, and ovarian insufficiency syndrome	y	MUSCULAR DYSTROPHY, CONGENITAL HEARING LOSS, AND OVARIAN INSUFFICIENCY SYNDROME; MDHLO	Clinical Features	died	GGPS1	HGNC:4249	Muscular dystrophy, congenital hearing loss, and ovarian insufficiency syndrome, 619518 (3), Autosomal recessive	Autosomal recessive	y	y	[2 patients had died at the age of 11 months and 30 years ]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
619519	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2FF	Charcot-Marie-Tooth disease, axonal, type 2FF, 619519 (3)	Charcot-Marie-Tooth disease, axonal, type 2FF	n	-	-	-	CADM3	HGNC:17601	Charcot-Marie-Tooth disease, axonal, type 2FF, 619519 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
619522	NEURODEVELOPMENTAL-CRANIOFACIAL SYNDROME WITH VARIABLE RENAL AND CARDIAC ABNORMALITIES	Neurodevelopmental-craniofacial syndrome with variable renal and cardiac abnormalities, 619522 (3)	Neurodevelopmental-craniofacial syndrome with variable renal and cardiac abnormalities	n	-	-	-	ZMYM2	HGNC:12989	Neurodevelopmental-craniofacial syndrome with variable renal and cardiac abnormalities, 619522 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
619525	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIw	Congenital disorder of glycosylation, type IIw, 619525 (3)	Congenital disorder of glycosylation, type IIw	n	-	-	-	SLC37A4	HGNC:4061	Congenital disorder of glycosylation, type IIw, 619525 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
619527	PONTOCEREBELLAR HYPOPLASIA, TYPE 16	Pontocerebellar hypoplasia, type 16, 619527 (3)	Pontocerebellar hypoplasia, type 16	y	PONTOCEREBELLAR HYPOPLASIA, TYPE 16; PCH16	Clinical Features	died	MINPP1	HGNC:7102	Pontocerebellar hypoplasia, type 16, 619527 (3), Autosomal recessive	Autosomal recessive	y	y	[Ucuncu et al. (2020) reported 8 children from 6 unrelated families with PCH16. The patients, who ranged in age from 18 months to 12 years, presented in the perinatal period with axial hypotonia, distal hypertonia, and spastic tetraplegia, often with extrapyramidal signs and progressive microcephaly (down to -5 SD). Psychomotor development was essentially absent: none of the patients learned to walk or talk, and they had poor social skills. Ophthalmologic findings included nystagmus, abnormal ocular movement, ptosis, and cataracts. Four had optic atrophy and 1 was blind. All but 1 patient had seizures, with onset between 1 day and 7 years of age. Brain imaging showed cerebellar hypoplasia, pontine atrophy, enlarged ventricles, atrophy of the cerebral cortex, thin corpus callosum, hypoplasia of the basal ganglia and thalami, and nonspecific white matter abnormalities. Other features included dysphagia, muscle wasting, joint stiffness, scoliosis, and mild nonspecific facial features, including micrognathia, prominent nose, and low-set ears. Four of the patients (including 2 sibs of probands) died in childhood]	L4	y	-	lethal	lethal	lethal	L4	L4	post-infant-lethal
619528	SPERMATOGENIC FAILURE 57	Spermatogenic failure 57, 619528 (3)	Spermatogenic failure 57	n	-	-	-	PNLDC1	HGNC:21185	Spermatogenic failure 57, 619528 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
619531	CONE-ROD DYSTROPHY 22	Cone-rod dystrophy 22, 619531 (3)	Cone-rod dystrophy 22	n	-	-	-	TLCD3B	HGNC:25295	Cone-rod dystrophy 22, 619531 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
619534	BILIARY, RENAL, NEUROLOGIC, AND SKELETAL SYNDROME	Biliary, renal, neurologic, and skeletal syndrome, 619534 (3)	Biliary, renal, neurologic, and skeletal syndrome	y	BILIARY, RENAL, NEUROLOGIC, AND SKELETAL SYNDROME; BRENS	Clinical Features	died	IFT56	HGNC:21882	Biliary, renal, neurologic, and skeletal syndrome, 619534 (3), Autosomal recessive	Autosomal recessive	y	y	[Shaheen et al. (2020) reported 7 unrelated children, ranging from 13 days to 11 years of age, with BRENS. Some of the pregnancies were complicated by polyhydramnios. The 13-day-old patient had multiple congenital anomalies, including significant congenital cardiac defects, and died with edema, metabolic acidosis, and renal failure]	L2	y	-	lethal	lethal	lethal	L2	L2	pre-infant-lethal
619539	NEUROOCULAR SYNDROME	Neuroocular syndrome, 619539 (3)	Neuroocular syndrome	n	-	-	-	PRR12	HGNC:29217	Neuroocular syndrome, 619539 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
619542	KING-DENBOROUGH SYNDROME	King-Denborough syndrome, 619542 (3)	King-Denborough syndrome	y	KING-DENBOROUGH SYNDROME; KDS	Clinical Features	died	RYR1	HGNC:10483	King-Denborough syndrome, 619542 (3), Autosomal dominant	Autosomal dominant	y	y	[Denborough (1973) described 4 unrelated boys with a slowly progressive myopathy, as well as ptosis, short stature, low-set ears, malar hypoplasia, skeletal deformities, and cryptorchidism. All had been identified following episodes of malignant hyperthermia in which 3 of the boys died]	LU	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L1|LU	L1	pre-infant-lethal
619543	BOUDIN-MORTIER SYNDROME	Boudin-Mortier syndrome, 619543 (3)	Boudin-Mortier syndrome	n	-	-	-	NPR3	HGNC:7945	Boudin-Mortier syndrome, 619543 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
619548	USMANI-RIAZUDDIN SYNDROME, AUTOSOMAL RECESSIVE	Usmani-Riazuddin syndrome, autosomal recessive, 619548 (3)	Usmani-Riazuddin syndrome, autosomal recessive	y	USMANI-RIAZUDDIN SYNDROME, AUTOSOMAL RECESSIVE; USRISR	Clinical Features|Phenotype	died|lethality	AP1G1	HGNC:555	Usmani-Riazuddin syndrome, autosomal recessive, 619548 (3), Autosomal recessive	Autosomal recessive	y	y	[Usmani et al. (2021) reported 2 consanguineous families of Italian (family CPBO) and Pakistani (family PKMR328) descent in which 4 individuals were affected with a neurodevelopmental disorder. Two patients had died at ages 2 and 21 years]	L4	y	-	lethal	lethal	lethal	L2|L4	L2	pre-infant-lethal
619549	IMMUNODEFICIENCY 86	Immunodeficiency 86, mycobacteriosis, 619549 (3)	Immunodeficiency 86, mycobacteriosis	n	-	-	-	SPPL2A	HGNC:30227	Immunodeficiency 86, mycobacteriosis, 619549 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
619555	EPIDERMOLYSIS BULLOSA SIMPLEX 2A, GENERALIZED SEVERE	Epidermolysis bullosa simplex 2A, generalized severe, 619555 (3)	Epidermolysis bullosa simplex 2A, generalized severe	y	EPIDERMOLYSIS BULLOSA SIMPLEX 2A, GENERALIZED SEVERE; EBS2A	Clinical Features|Clinical Synopsis|Phenotype	death|deaths|died|fatal|lethal	KRT5	HGNC:6442	Epidermolysis bullosa simplex 2A, generalized severe, 619555 (3), Autosomal dominant	Autosomal dominant	y	n	-	-	-	-	ambiguous	ambiguous|lethal|nonlethal	lethal|nonlethal	L2	L2	pre-infant-lethal
619556	INTELLECTUAL DEVELOPMENTAL DISORDER WITH HYPOTONIA, IMPAIRED SPEECH, AND DYSMORPHIC FACIES	Intellectual developmental disorder with hypotonia, impaired speech, and dysmorphic facies, 619556 (3)	Intellectual developmental disorder with hypotonia, impaired speech, and dysmorphic facies	n	-	-	-	TNPO2	HGNC:19998	Intellectual developmental disorder with hypotonia, impaired speech, and dysmorphic facies, 619556 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
619557	SHORT STATURE, IMPAIRED INTELLECTUAL DEVELOPMENT, MICROCEPHALY, HYPOTONIA, AND OCULAR ANOMALIES	SIMHA syndrome, 619557 (3)	SIMHA syndrome	n	-	-	-	ZNF407	HGNC:19904	SIMHA syndrome, 619557 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
619561	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 97	Developmental and epileptic encephalopathy 97, 619561 (3)	Developmental and epileptic encephalopathy 97	n	-	-	-	CELF2	HGNC:2550	Developmental and epileptic encephalopathy 97, 619561 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
619562	JOUBERT SYNDROME 39	Joubert syndrome 39, 619562 (3)	Joubert syndrome 39	n	-	-	-	TMEM218	HGNC:27344	Joubert syndrome 39, 619562 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
619565	DYSTONIA 31	Dystonia 31, 619565 (3)	Dystonia 31	n	-	-	-	AOPEP	HGNC:1361	Dystonia 31, 619565 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
619566	MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 27	Muscular dystrophy, limb-girdle, autosomal recessive 27, 619566 (3)	Muscular dystrophy, limb-girdle, autosomal recessive 27	n	-	-	-	JAG2	HGNC:6189	Muscular dystrophy, limb-girdle, autosomal recessive 27, 619566 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
619573	IMMUNODEFICIENCY 87 AND AUTOIMMUNITY	Immunodeficiency 87 and autoimmunity, 619573 (3)	Immunodeficiency 87 and autoimmunity	y	IMMUNODEFICIENCY 87 AND AUTOIMMUNITY; IMD87	Clinical Features	died	DEF6	HGNC:2760	Immunodeficiency 87 and autoimmunity, 619573 (3), Autosomal recessive	Autosomal recessive	y	n	-	-	-	-	ambiguous	ambiguous	ambiguous	-	-	-
619574	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2HH	Charcot-Marie-Tooth disease, axonal, type 2HH, 619574 (3)	Charcot-Marie-Tooth disease, axonal, type 2HH	y	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2HH; CMT2HH	Phenotype	lethal	JAG1	HGNC:6188	Charcot-Marie-Tooth disease, axonal, type 2HH, 619574 (3), Autosomal dominant	Autosomal dominant	y	n	-	-	-	-	ambiguous	ambiguous|lethal|nonlethal	lethal|nonlethal	L4	L4	post-infant-lethal
619575	DEVELOPMENTAL DELAY WITH OR WITHOUT INTELLECTUAL IMPAIRMENT OR BEHAVIORAL ABNORMALITIES	Developmental delay with or without intellectual impairment or behavioral abnormalities, 619575 (3)	Developmental delay with or without intellectual impairment or behavioral abnormalities	n	-	-	-	TAOK1	HGNC:29259	Developmental delay with or without intellectual impairment or behavioral abnormalities, 619575 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
619576	CEREBELLAR ATAXIA, BRAIN ABNORMALITIES, AND CARDIAC CONDUCTION DEFECTS	Cerebellar ataxia, brain abnormalities, and cardiac conduction defects, 619576 (3)	Cerebellar ataxia, brain abnormalities, and cardiac conduction defects	y	CEREBELLAR ATAXIA, BRAIN ABNORMALITIES, AND CARDIAC CONDUCTION DEFECTS; CABAC	Clinical Features	died	EXOSC5	HGNC:24662	Cerebellar ataxia, brain abnormalities, and cardiac conduction defects, 619576 (3), Autosomal recessive	Autosomal recessive	y	n	-	-	-	-	ambiguous	ambiguous	ambiguous	-	-	-
619580	NEURODEVELOPMENTAL DISORDER WITH IMPAIRED LANGUAGE AND ATAXIA AND WITH OR WITHOUT SEIZURES	Neurodevelopmental disorder with impaired language and ataxia and with or without seizures, 619580 (3)	Neurodevelopmental disorder with impaired language and ataxia and with or without seizures	n	-	-	-	GRIK2	HGNC:4580	Neurodevelopmental disorder with impaired language and ataxia and with or without seizures, 619580 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
619582	JOUBERT SYNDROME 40	Joubert syndrome 40, 619582 (3)	Joubert syndrome 40	n	-	-	-	IFT74	HGNC:21424	Joubert syndrome 40, 619582 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
619585	SPERMATOGENIC FAILURE 58	Spermatogenic failure 58, 619585 (3)	Spermatogenic failure 58	n	-	-	-	IFT74	HGNC:21424	Spermatogenic failure 58, 619585 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
619588	EPIDERMOLYSIS BULLOSA SIMPLEX 2B, GENERALIZED INTERMEDIATE	Epidermolysis bullosa simplex 2B, generalized intermediate, 619588 (3)	Epidermolysis bullosa simplex 2B, generalized intermediate	n	-	-	-	KRT5	HGNC:6442	Epidermolysis bullosa simplex 2B, generalized intermediate, 619588 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	ambiguous|lethal|nonlethal	lethal|nonlethal	L2	L2	pre-infant-lethal
619594	EPIDERMOLYSIS BULLOSA SIMPLEX 2C, LOCALIZED	Epidermolysis bullosa simplex 2C, localized, 619594 (3)	Epidermolysis bullosa simplex 2C, localized	n	-	-	-	KRT5	HGNC:6442	Epidermolysis bullosa simplex 2C, localized, 619594 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	ambiguous|lethal|nonlethal	lethal|nonlethal	L2	L2	pre-infant-lethal
619595	DEVELOPMENTAL DELAY, HYPOTONIA, MUSCULOSKELETAL DEFECTS, AND BEHAVIORAL ABNORMALITIES	Developmental delay, hypotonia, musculoskeletal defects, and behavioral abnormalities, 619595 (3)	Developmental delay, hypotonia, musculoskeletal defects, and behavioral abnormalities	n	-	-	-	SRCAP	HGNC:16974	Developmental delay, hypotonia, musculoskeletal defects, and behavioral abnormalities, 619595 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
619599	EPIDERMOLYSIS BULLOSA SIMPLEX 2D, GENERALIZED, INTERMEDIATE OR SEVERE, AUTOSOMAL RECESSIVE	Epidermolysis bullosa simplex 2D, generalized, intermediate or severe, autosomal recessive, 619599 (3)	Epidermolysis bullosa simplex 2D, generalized, intermediate or severe, autosomal recessive	y	EPIDERMOLYSIS BULLOSA SIMPLEX 2D, GENERALIZED, INTERMEDIATE OR SEVERE, AUTOSOMAL RECESSIVE; EBS2D	Clinical Features|Clinical Synopsis	died|death|deaths	KRT5	HGNC:6442	Epidermolysis bullosa simplex 2D, generalized, intermediate or severe, autosomal recessive, 619599 (3), Autosomal recessive	Autosomal recessive	y	y	[Vahidnezhad et al. (2019) described 2 patients with EBS and homozygous mutations in the KRT5 gene....She died at 4 weeks of age]	L2	y	-	lethal	ambiguous|lethal|nonlethal	lethal|nonlethal	L2	L2	pre-infant-lethal
619602	FETAL AKINESIA, RESPIRATORY INSUFFICIENCY, MICROCEPHALY, POLYMICROGYRIA, AND DYSMORPHIC FACIES	Fetal akinesia, respiratory insufficiency, microcephaly, polymicrogyria, and dysmorphic facies, 619602 (3)	Fetal akinesia, respiratory insufficiency, microcephaly, polymicrogyria, and dysmorphic facies	y	FETAL AKINESIA, RESPIRATORY INSUFFICIENCY, MICROCEPHALY, POLYMICROGYRIA, AND DYSMORPHIC FACIES; FARIMPD	Description|Clinical Features|Clinical Synopsis|Phenotype	death|deaths|died|lethal	ATP1A2	HGNC:800	Fetal akinesia, respiratory insufficiency, microcephaly, polymicrogyria, and dysmorphic facies, 619602 (3), Autosomal recessive	Autosomal recessive	y	n	-	-	-	-	ambiguous	ambiguous|nonlethal	ambiguous	-	-	-
619603	GALLOWAY-MOWAT SYNDROME 9	Galloway-Mowat syndrome 9, 619603 (3)	Galloway-Mowat syndrome 9	y	GALLOWAY-MOWAT SYNDROME 9; GAMOS9	Description|Clinical Features|Clinical Synopsis	death|deaths|died	GON7	HGNC:20356	Galloway-Mowat syndrome 9, 619603 (3), Autosomal recessive	Autosomal recessive	y	y	[Early death may occur / Arrondel et al. (2019) reported 13 individuals from 5 unrelated consanguineous families, including 4 of Algerian descent and 1 of Arab descent, with GAMOS9... Five patients died between 3 and 33 years]	L4	y	-	lethal	lethal	lethal	L4	L4	post-infant-lethal
619605	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 98	Developmental and epileptic encephalopathy 98, 619605 (3)	Developmental and epileptic encephalopathy 98	y	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 98; DEE98	Description|Clinical Features	die|died	ATP1A2	HGNC:800	Developmental and epileptic encephalopathy 98, 619605 (3), Autosomal dominant	Autosomal dominant	y	n	-	-	-	-	ambiguous	ambiguous|nonlethal	ambiguous	-	-	-
619606	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 99	Developmental and epileptic encephalopathy 99, 619606 (3)	Developmental and epileptic encephalopathy 99	y	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 99; DEE99	Description|Clinical Features	die|died	ATP1A3	HGNC:801	Developmental and epileptic encephalopathy 99, 619606 (3), Autosomal dominant	Autosomal dominant	y	n	-	-	-	-	ambiguous	ambiguous|nonlethal	ambiguous	-	-	-
619607	HETEROTAXY, VISCERAL, 10, AUTOSOMAL, WITH MALE INFERTILITY	Heterotaxy, visceral, 10, autosomal, with male infertility, 619607 (3)	Heterotaxy, visceral, 10, autosomal, with male infertility	n	-	-	-	CFAP52	HGNC:16053	Heterotaxy, visceral, 10, autosomal, with male infertility, 619607 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
619608	HETEROTAXY, VISCERAL, 11, AUTOSOMAL, WITH MALE INFERTILITY	Heterotaxy, visceral, 11, autosomal, with male infertility, 619608 (3)	Heterotaxy, visceral, 11, autosomal, with male infertility	n	-	-	-	CFAP45	HGNC:17229	Heterotaxy, visceral, 11, autosomal, with male infertility, 619608 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
619609	GALLOWAY-MOWAT SYNDROME 10	Galloway-Mowat syndrome 10, 619609 (3)	Galloway-Mowat syndrome 10	y	GALLOWAY-MOWAT SYNDROME 10; GAMOS10	Description|Clinical Features|Clinical Synopsis	died|death|deaths|miscarriage|miscarriages	YRDC	HGNC:28905	Galloway-Mowat syndrome 10, 619609 (3), Autosomal recessive	Autosomal recessive	y	n	-	-	-	-	ambiguous	ambiguous	ambiguous	-	-	-
619611	INTERSTITIAL LUNG DISEASE 1	Interstitial lung disease 1, 619611 (3)	Interstitial lung disease 1	y	INTERSTITIAL LUNG DISEASE 1; ILD1	Clinical Features	died	SFTPA1	HGNC:10798	Interstitial lung disease 1, 619611 (3), Autosomal dominant, Autosomal recessive	Autosomal dominant, Autosomal recessive	y	n	-	-	-	-	ambiguous	ambiguous	ambiguous	-	-	-
619613	DELAYED PUBERTY, SELF-LIMITED	Delayed puberty, self-limited, 619613 (3)	Delayed puberty, self-limited	n	-	-	-	LGR4	HGNC:13299	Delayed puberty, self-limited, 619613 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
619614	RETINITIS PIGMENTOSA 92	Retinitis pigmentosa 92, 619614 (3)	Retinitis pigmentosa 92	n	-	-	-	HKDC1	HGNC:23302	Retinitis pigmentosa 92, 619614 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
619615	DEAFNESS, AUTOSOMAL RECESSIVE 119	Deafness, autosomal recessive 119, 619615 (3)	Deafness, autosomal recessive 119	n	-	-	-	AFG2B	HGNC:28762	Deafness, autosomal recessive 119, 619615 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
619616	NEURODEVELOPMENTAL DISORDER WITH HEARING LOSS AND SPASTICITY	Neurodevelopmental disorder with hearing loss and spasticity, 619616 (3)	Neurodevelopmental disorder with hearing loss and spasticity	n	-	-	-	AFG2B	HGNC:28762	Neurodevelopmental disorder with hearing loss and spasticity, 619616 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
619621	SPASTIC PARAPLEGIA 84, AUTOSOMAL RECESSIVE	Spastic paraplegia 84, autosomal recessive, 619621 (3)	Spastic paraplegia 84, autosomal recessive	n	-	-	-	PI4KA	HGNC:8983	Spastic paraplegia 84, autosomal recessive, 619621 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L1|L3	L1	pre-infant-lethal
619636	ACROMESOMELIC DYSPLASIA 4	Acromesomelic dysplasia 4, 619636 (3)	Acromesomelic dysplasia 4	n	-	-	-	PRKG2	HGNC:9416	Acromesomelic dysplasia 4, 619636 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
619638	SPONDYLOMETAPHYSEAL DYSPLASIA, PAGNAMENTA TYPE	Spondylometaphyseal dysplasia, Pagnamenta type, 619638 (3)	Spondylometaphyseal dysplasia, Pagnamenta type	n	-	-	-	PRKG2	HGNC:9416	Spondylometaphyseal dysplasia, Pagnamenta type, 619638 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
619639	NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA AND GROSS MOTOR AND SPEECH DELAY	Neurodevelopmental disorder with hypotonia and gross motor and speech delay, 619639 (3)	Neurodevelopmental disorder with hypotonia and gross motor and speech delay	n	-	-	-	UBE4A	HGNC:12499	Neurodevelopmental disorder with hypotonia and gross motor and speech delay, 619639 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
619641	HENGEL-MAROOFIAN-SCHOLS SYNDROME	Hengel-Maroofian-Schols syndrome, 619641 (3)	Hengel-Maroofian-Schols syndrome	n	-	-	-	BCAS3	HGNC:14347	Hengel-Maroofian-Schols syndrome, 619641 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
619644	IMMUNODEFICIENCY 91 AND HYPERINFLAMMATION	Immunodeficiency 91 and hyperinflammation, 619644 (3)	Immunodeficiency 91 and hyperinflammation	y	IMMUNODEFICIENCY 91 AND HYPERINFLAMMATION; IMD91	Description|Clinical Features|Clinical Synopsis	death|deaths|died	ZNFX1	HGNC:29271	Immunodeficiency 91 and hyperinflammation, 619644 (3), Autosomal recessive	Autosomal recessive	y	n	-	-	-	-	ambiguous	ambiguous	ambiguous	-	-	-
619646	SPERMATOGENIC FAILURE 60	Spermatogenic failure 60, 619646 (3)	Spermatogenic failure 60	n	-	-	-	TERB1	HGNC:26675	Spermatogenic failure 60, 619646 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
619647	DYSKINESIA WITH OROFACIAL INVOLVEMENT, AUTOSOMAL RECESSIVE	Dyskinesia with orofacial involvement, autosomal recessive, 619647 (3)	Dyskinesia with orofacial involvement, autosomal recessive	n	-	-	-	ADCY5	HGNC:236	Dyskinesia with orofacial involvement, autosomal recessive, 619647 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	ambiguous|nonlethal	ambiguous	-	-	-
619648	ZAKI SYNDROME	Zaki syndrome, 619648 (3)	Zaki syndrome	n	-	-	-	WLS	HGNC:30238	Zaki syndrome, 619648 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
619651	NEURODEVELOPMENTAL DISORDER WITH HYPERKINETIC MOVEMENTS AND DYSKINESIA	Neurodevelopmental disorder with hyperkinetic movements and dyskinesia, 619651 (3)	Neurodevelopmental disorder with hyperkinetic movements and dyskinesia	y	NEURODEVELOPMENTAL DISORDER WITH HYPERKINETIC MOVEMENTS AND DYSKINESIA; NEDHYD	Clinical Features	died	ADCY5	HGNC:236	Neurodevelopmental disorder with hyperkinetic movements and dyskinesia, 619651 (3), Autosomal recessive	Autosomal recessive	y	n	-	-	-	-	ambiguous	ambiguous|nonlethal	ambiguous	-	-	-
619652	IMMUNODEFICIENCY 92	Immunodeficiency 92, 619652 (3)	Immunodeficiency 92	n	-	-	-	REL	HGNC:9954	Immunodeficiency 92, 619652 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
619653	NEURODEVELOPMENTAL DISORDER, NONPROGRESSIVE, WITH SPASTICITY AND TRANSIENT OPISTHOTONUS	Neurodevelopmental disorder, nonprogressive, with spasticity and transient opisthotonus, 619653 (3)	Neurodevelopmental disorder, nonprogressive, with spasticity and transient opisthotonus	n	-	-	-	TNR	HGNC:11953	Neurodevelopmental disorder, nonprogressive, with spasticity and transient opisthotonus, 619653 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
619656	LOEYS-DIETZ SYNDROME 6	Loeys-Dietz syndrome 6, 619656 (3)	Loeys-Dietz syndrome 6	y	LOEYS-DIETZ SYNDROME 6; LDS6	Clinical Features|Phenotype	died	SMAD2	HGNC:6768	Loeys-Dietz syndrome 6, 619656 (3), Autosomal dominant	Autosomal dominant	y	n	-	-	-	-	ambiguous	ambiguous|nonlethal	ambiguous	-	-	-
619657	CONGENITAL HEART DEFECTS, MULTIPLE TYPES, 8, WITH OR WITHOUT HETEROTAXY	Congenital heart defects, multiple types, 8, with or without heterotaxy, 619657 (3)	Congenital heart defects, multiple types, 8, with or without heterotaxy	n	-	-	-	SMAD2	HGNC:6768	Congenital heart defects, multiple types, 8, with or without heterotaxy, 619657 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	ambiguous|nonlethal	ambiguous	-	-	-
619658	CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC, 7, WITH OR WITHOUT HEARING LOSS	Cholestasis, progressive familial intrahepatic, 7, with or without hearing loss, 619658 (3)	Cholestasis, progressive familial intrahepatic, 7, with or without hearing loss	n	-	-	-	USP53	HGNC:29255	Cholestasis, progressive familial intrahepatic, 7, with or without hearing loss, 619658 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
619662	CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC, 8	Cholestasis, progressive familial intrahepatic, 8, 619662 (3)	Cholestasis, progressive familial intrahepatic, 8	n	-	-	-	KIF12	HGNC:21495	Cholestasis, progressive familial intrahepatic, 8, 619662 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
619665	OVARIAN DYSGENESIS 9	Ovarian dysgenesis 9, 619665 (3)	Ovarian dysgenesis 9	n	-	-	-	SPIDR	HGNC:28971	Ovarian dysgenesis 9, 619665 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
619672	SPERMATOGENIC FAILURE 61	Spermatogenic failure 61, 619672 (3)	Spermatogenic failure 61	n	-	-	-	STAG3	HGNC:11356	Spermatogenic failure 61, 619672 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
619680	MARBACH-SCHAAF NEURODEVELOPMENTAL SYNDROME	Marbach-Schaaf neurodevelopmental syndrome, 619680 (3)	Marbach-Schaaf neurodevelopmental syndrome	n	-	-	-	PRKAR1B	HGNC:9390	Marbach-Schaaf neurodevelopmental syndrome, 619680 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
619681	DYSTONIA, EARLY-ONSET, AND/OR SPASTIC PARAPLEGIA	Dystonia, early-onset, and/or spastic paraplegia, 619681 (3)	Dystonia, early-onset, and/or spastic paraplegia	n	-	-	-	ATP5MC3	HGNC:843	Dystonia, early-onset, and/or spastic paraplegia, 619681 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
619685	NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, SEIZURES, AND NEONATAL CHOLESTASIS	Neurodevelopmental disorder with microcephaly, seizures, and neonatal cholestasis, 619685 (3)	Neurodevelopmental disorder with microcephaly, seizures, and neonatal cholestasis	y	NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, SEIZURES, AND NEONATAL CHOLESTASIS; NEDMSC	Description|Clinical Features|Clinical Synopsis	death|deaths|died	VPS50	HGNC:25956	Neurodevelopmental disorder with microcephaly, seizures, and neonatal cholestasis, 619685 (3), Autosomal recessive	Autosomal recessive	y	n	-	-	-	-	ambiguous	ambiguous	ambiguous	-	-	-
619686	SPASTIC PARAPLEGIA 85, AUTOSOMAL RECESSIVE	Spastic paraplegia 85, autosomal recessive, 619686 (3)	Spastic paraplegia 85, autosomal recessive	n	-	-	-	RNF170	HGNC:25358	Spastic paraplegia 85, autosomal recessive, 619686 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	ambiguous|nonlethal	ambiguous	-	-	-
619687	DYSTONIA 33	Dystonia 33, 619687 (3)	Dystonia 33	n	-	-	-	EIF2AK2	HGNC:9437	Dystonia 33, 619687 (3), Autosomal dominant, Autosomal recessive	Autosomal dominant, Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
619688	LEUKODYSTROPHY, HYPOMYELINATING, 23, WITH ATAXIA, DEAFNESS, LIVER DYSFUNCTION, AND DILATED CARDIOMYOPATHY	Leukodystrophy, hypomyelinating, 23, with ataxia, deafness, liver dysfunction, and dilated cardiomyopathy, 619688 (3)	Leukodystrophy, hypomyelinating, 23, with ataxia, deafness, liver dysfunction, and dilated cardiomyopathy	y	LEUKODYSTROPHY, HYPOMYELINATING, 23, WITH ATAXIA, DEAFNESS, LIVER DYSFUNCTION, AND DILATED CARDIOMYOPATHY; HLD23	Description|Clinical Features|Clinical Synopsis|Phenotype	death|deaths|died|spontaneous_abortion|spontaneous_abortions	RNF220	HGNC:25552	Leukodystrophy, hypomyelinating, 23, with ataxia, deafness, liver dysfunction, and dilated cardiomyopathy, 619688 (3), Autosomal recessive	Autosomal recessive	y	n	-	-	-	-	ambiguous	ambiguous	ambiguous	-	-	-
619690	BRUNET-WAGNER NEURODEVELOPMENTAL SYNDROME	Brunet-Wagner neurodevelopmental syndrome, 619690 (3)	Brunet-Wagner neurodevelopmental syndrome	n	-	-	-	RBL2	HGNC:9894	Brunet-Wagner neurodevelopmental syndrome, 619690 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
619691	TRICHOTHIODYSTROPHY 8, NONPHOTOSENSITIVE	Trichothiodystrophy 8, nonphotosensitive, 619691 (3)	Trichothiodystrophy 8, nonphotosensitive	y	TRICHOTHIODYSTROPHY 8, NONPHOTOSENSITIVE; TTD8	Clinical Features	died	AARS1	HGNC:20	Trichothiodystrophy 8, nonphotosensitive, 619691 (3), Autosomal recessive	Autosomal recessive	y	n	-	-	-	-	ambiguous	ambiguous|nonlethal	ambiguous	-	-	-
619693	AGAMMAGLOBULINEMIA 9, AUTOSOMAL RECESSIVE	Agammaglobulinemia 9, autosomal recessive, 619693 (3)	Agammaglobulinemia 9, autosomal recessive	n	-	-	-	SLC39A7	HGNC:4927	Agammaglobulinemia 9, autosomal recessive, 619693 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
619694	DEVELOPMENTAL DELAY WITH VARIABLE NEUROLOGIC AND BRAIN ABNORMALITIES	Developmental delay with variable neurologic and brain abnormalities, 619694 (3)	Developmental delay with variable neurologic and brain abnormalities	n	-	-	-	LMBRD2	HGNC:25287	Developmental delay with variable neurologic and brain abnormalities, 619694 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
619695	RAUCH-STEINDL SYNDROME	Rauch-Steindl syndrome, 619695 (3)	Rauch-Steindl syndrome	n	-	-	-	NSD2	HGNC:12766	Rauch-Steindl syndrome, 619695 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
619696	SPERMATOGENIC FAILURE 64	Spermatogenic failure 64, 619696 (3)	Spermatogenic failure 64	y	SPERMATOGENIC FAILURE 64; SPGF64	Clinical Features	miscarriage|miscarriages	FBXO43	HGNC:28521	Spermatogenic failure 64, 619696 (3), Autosomal recessive	Autosomal recessive	y	n	-	-	-	-	ambiguous	ambiguous|nonlethal	ambiguous	-	-	-
619697	OOCYTE/ZYGOTE/EMBRYO MATURATION ARREST 12	Oocyte/zygote/embryo maturation arrest 12, 619697 (3)	Oocyte/zygote/embryo maturation arrest 12	n	-	-	-	FBXO43	HGNC:28521	Oocyte/zygote/embryo maturation arrest 12, 619697 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	ambiguous|nonlethal	ambiguous	-	-	-
619698	MUCOPOLYSACCHARIDOSIS, TYPE X	Mucopolysaccharidosis, type X, 619698 (3)	Mucopolysaccharidosis, type X	n	-	-	-	ARSK	HGNC:25239	Mucopolysaccharidosis, type X, 619698 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
619699	FERGUSON-BONNI NEURODEVELOPMENTAL SYNDROME	Ferguson-Bonni neurodevelopmental syndrome, 619699 (3)	Ferguson-Bonni neurodevelopmental syndrome	n	-	-	-	ANAPC7	HGNC:17380	Ferguson-Bonni neurodevelopmental syndrome, 619699 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
619701	YOON-BELLEN NEURODEVELOPMENTAL SYNDROME	Yoon-Bellen neurodevelopmental syndrome, 619701 (3)	Yoon-Bellen neurodevelopmental syndrome	y	YOON-BELLEN NEURODEVELOPMENTAL SYNDROME; YOBELN	Clinical Features|Phenotype	died|lethality	OGDHL	HGNC:25590	Yoon-Bellen neurodevelopmental syndrome, 619701 (3), Autosomal recessive	Autosomal recessive	y	n	-	-	-	-	ambiguous	ambiguous	ambiguous	-	-	-
619702	HETEROTAXY, VISCERAL, 12, AUTOSOMAL	Heterotaxy, visceral, 12, autosomal, 619702 (3)	Heterotaxy, visceral, 12, autosomal	y	HETEROTAXY, VISCERAL, 12, AUTOSOMAL; HTX12	Description|Clinical Features|Clinical Synopsis	death|deaths|died	CIROP	HGNC:53647	Heterotaxy, visceral, 12, autosomal, 619702 (3), Autosomal recessive	Autosomal recessive	y	y	[died by 10 years of age]	L4	y	-	lethal	lethal	lethal	L4	L4	post-infant-lethal
619705	IMMUNODEFICIENCY 93 AND HYPERTROPHIC CARDIOMYOPATHY	Immunodeficiency 93 and hypertrophic cardiomyopathy, 619705 (3)	Immunodeficiency 93 and hypertrophic cardiomyopathy	y	IMMUNODEFICIENCY 93 AND HYPERTROPHIC CARDIOMYOPATHY; IMD93	Clinical Features|Clinical Synopsis	died|death|deaths	FNIP1	HGNC:29418	Immunodeficiency 93 and hypertrophic cardiomyopathy, 619705 (3), Autosomal recessive	Autosomal recessive	y	y	[died of pneumonia age 9 year]	L4	y	-	lethal	lethal	lethal	L4	L4	post-infant-lethal
619707	AGAMMAGLOBULINEMIA 10, AUTOSOMAL DOMINANT	Agammaglobulinemia 10, autosomal dominant, 619707 (3)	Agammaglobulinemia 10, autosomal dominant	n	-	-	-	SPI1	HGNC:11241	Agammaglobulinemia 10, autosomal dominant, 619707 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
619708	GASTROINTESTINAL DEFECTS AND IMMUNODEFICIENCY SYNDROME 2	Gastrointestinal defects and immunodeficiency syndrome 2, 619708 (3)	Gastrointestinal defects and immunodeficiency syndrome 2	y	GASTROINTESTINAL DEFECTS AND IMMUNODEFICIENCY SYNDROME 2; GIDID2	Description|Clinical Features|Clinical Synopsis	death|deaths	PI4KA	HGNC:8983	Gastrointestinal defects and immunodeficiency syndrome 2, 619708 (3), Autosomal recessive	Autosomal recessive	y	y	[Death occurs in the first weeks of life]	L3	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L1|L3	L1	pre-infant-lethal
619712	SPERMATOGENIC FAILURE 65	Spermatogenic failure 65, 619712 (3)	Spermatogenic failure 65	n	-	-	-	DNHD1	HGNC:26532	Spermatogenic failure 65, 619712 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
619714	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Iw, AUTOSOMAL DOMINANT	Congenital disorder of glycosylation, type Iw, autosomal dominant, 619714 (3)	Congenital disorder of glycosylation, type Iw, autosomal dominant	n	-	-	-	STT3A	HGNC:6172	Congenital disorder of glycosylation, type Iw, autosomal dominant, 619714 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
619717	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 73	Intellectual developmental disorder, autosomal recessive 73, 619717 (3)	Intellectual developmental disorder, autosomal recessive 73	n	-	-	-	NAA20	HGNC:15908	Intellectual developmental disorder, autosomal recessive 73, 619717 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
619718	HYPOGONADOTROPIC HYPOGONADISM 26 WITH OR WITHOUT ANOSMIA	Hypogonadotropic hypogonadism 26 with or without anosmia, 619718 (3)	Hypogonadotropic hypogonadism 26 with or without anosmia	n	-	-	-	TCF12	HGNC:11623	Hypogonadotropic hypogonadism 26 with or without anosmia, 619718 (3), Autosomal dominant, Autosomal recessive	Autosomal dominant, Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
619719	INTELLECTUAL DISABILITY AND MYOPATHY SYNDROME	Intellectual disability and myopathy syndrome, 619719 (3)	Intellectual disability and myopathy syndrome	n	-	-	-	ABCC9	HGNC:60	Intellectual disability and myopathy syndrome, 619719 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L6	L6	post-infant-lethal
619720	BRYANT-LI-BHOJ NEURODEVELOPMENTAL SYNDROME 1	Bryant-Li-Bhoj neurodevelopmental syndrome 1, 619720 (3)	Bryant-Li-Bhoj neurodevelopmental syndrome 1	y	BRYANT-LI-BHOJ NEURODEVELOPMENTAL SYNDROME 1; BRYLIB1	Clinical Features	died	H3-3A	HGNC:4764	Bryant-Li-Bhoj neurodevelopmental syndrome 1, 619720 (3), Autosomal dominant	Autosomal dominant	y	y	[died in the first years of life]	L4	y	-	lethal	lethal	lethal	L4	L4	post-infant-lethal
619721	BRYANT-LI-BHOJ NEURODEVELOPMENTAL SYNDROME 2	Bryant-Li-Bhoj neurodevelopmental syndrome 2, 619721 (3)	Bryant-Li-Bhoj neurodevelopmental syndrome 2	n	-	-	-	H3-3B	HGNC:4765	Bryant-Li-Bhoj neurodevelopmental syndrome 2, 619721 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
619725	NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT VARIABLE MOVEMENT OR BEHAVIORAL ABNORMALITIES	Neurodevelopmental disorder with or without variable movement or behavioral abnormalities, 619725 (3)	Neurodevelopmental disorder with or without variable movement or behavioral abnormalities	n	-	-	-	KCNN2	HGNC:6291	Neurodevelopmental disorder with or without variable movement or behavioral abnormalities, 619725 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
619727	CRANIOTUBULAR DYSPLASIA, IKEGAWA TYPE	Craniotubular dysplasia, Ikegawa type, 619727 (3)	Craniotubular dysplasia, Ikegawa type	n	-	-	-	TMEM53	HGNC:26186	Craniotubular dysplasia, Ikegawa type, 619727 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
619733	INCLUSION BODY MYOPATHY AND BRAIN WHITE MATTER ABNORMALITIES	Inclusion body myopathy and brain white matter abnormalities, 619733 (3)	Inclusion body myopathy and brain white matter abnormalities	n	-	-	-	ANXA11	HGNC:535	Inclusion body myopathy and brain white matter abnormalities, 619733 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
619735	SPASTIC PARAPLEGIA 86, AUTOSOMAL RECESSIVE	Spastic paraplegia 86, autosomal recessive, 619735 (3)	Spastic paraplegia 86, autosomal recessive	n	-	-	-	ABHD16A	HGNC:13921	Spastic paraplegia 86, autosomal recessive, 619735 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
619736	TEEBI HYPERTELORISM SYNDROME 2	Teebi hypertelorism syndrome 2, 619736 (3)	Teebi hypertelorism syndrome 2	n	-	-	-	CDH11	HGNC:1750	Teebi hypertelorism syndrome 2, 619736 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L2	L2	pre-infant-lethal
619737	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 54	Combined oxidative phosphorylation deficiency 54, 619737 (3)	Combined oxidative phosphorylation deficiency 54	n	-	-	-	PRORP	HGNC:19958	Combined oxidative phosphorylation deficiency 54, 619737 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
619738	PARKINSONISM-DYSTONIA 3, CHILDHOOD-ONSET	Parkinsonism-dystonia 3, childhood-onset, 619738 (3)	Parkinsonism-dystonia 3, childhood-onset	n	-	-	-	WARS2	HGNC:12730	Parkinsonism-dystonia 3, childhood-onset, 619738 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L2	L2	pre-infant-lethal
619742	CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 1I	Charcot-Marie-Tooth disease, demyelinating, type 1I, 619742 (3)	Charcot-Marie-Tooth disease, demyelinating, type 1I	n	-	-	-	POLR3B	HGNC:30348	Charcot-Marie-Tooth disease, demyelinating, type 1I, 619742 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
619743	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 55	Combined oxidative phosphorylation deficiency 55, 619743 (3)	Combined oxidative phosphorylation deficiency 55	n	-	-	-	POLRMT	HGNC:9200	Combined oxidative phosphorylation deficiency 55, 619743 (3), Autosomal dominant, Autosomal recessive	Autosomal dominant, Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
619745	NOONAN SYNDROME 14	Noonan syndrome 14, 619745 (3)	Noonan syndrome 14	n	-	-	-	SPRED2	HGNC:17722	Noonan syndrome 14, 619745 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
619747	CARDIOMYOPATHY, DILATED, 2F	Cardiomyopathy, dilated, 2F, 619747 (3)	Cardiomyopathy, dilated, 2F	n	-	-	-	BAG5	HGNC:941	Cardiomyopathy, dilated, 2F, 619747 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
619751	STUVE-WIEDEMANN SYNDROME 2	Stuve-Wiedemann syndrome 2, 619751 (3)	Stuve-Wiedemann syndrome 2	y	STUVE-WIEDEMANN SYNDROME 2; STWS2	Description|Clinical Features|Clinical Synopsis|Phenotype	lethal|died|miscarriage|miscarriages	IL6ST	HGNC:6021	Stuve-Wiedemann syndrome 2, 619751 (3), Autosomal recessive	Autosomal recessive	y	y	[Lethal in utero or soon after birth]	L1	y	-	lethal	lethal	lethal	L1|L6|LU	L1	pre-infant-lethal
619752	HYPER-IgE SYNDROME 4A, AUTOSOMAL DOMINANT, WITH RECURRENT INFECTIONS	Hyper-IgE syndrome 4A, autosomal dominant, with recurrent infections, 619752 (3)	Hyper-IgE syndrome 4A, autosomal dominant, with recurrent infections	y	HYPER-IgE SYNDROME 4A, AUTOSOMAL DOMINANT, WITH RECURRENT INFECTIONS; HIES4A	Clinical Features	died	IL6ST	HGNC:6021	Hyper-IgE syndrome 4A, autosomal dominant, with recurrent infections, 619752 (3), Autosomal dominant	Autosomal dominant	y	y	[Two probands and the father of another proband died in their twenties from complications of the disease.]	L6	y	y	lethal	lethal	lethal	L1|L6|LU	L1	pre-infant-lethal
619758	TESSADORI-BICKNELL-VAN HAAFTEN NEURODEVELOPMENTAL SYNDROME 1	Tessadori-Bicknell-van Haaften neurodevelopmental syndrome 1, 619758 (3)	Tessadori-Bicknell-van Haaften neurodevelopmental syndrome 1	y	TESSADORI-BICKNELL-VAN HAAFTEN NEURODEVELOPMENTAL SYNDROME 1; TEBIVANED1	Clinical Features	died	H4C3	HGNC:4787	Tessadori-Bicknell-van Haaften neurodevelopmental syndrome 1, 619758 (3), Autosomal dominant	Autosomal dominant	y	y	[ This patient had an older sister with similar features who died in early infancy]	L3	n	y	lethal	lethal	lethal	L3	L3	pre-infant-lethal
619761	CEREBELLAR DYSFUNCTION, IMPAIRED INTELLECTUAL DEVELOPMENT, AND HYPOGONADOTROPIC HYPOGONADISM	Cerebellar dysfunction, impaired intellectual development, and hypogonadotropic hypogonadism, 619761 (3)	Cerebellar dysfunction, impaired intellectual development, and hypogonadotropic hypogonadism	n	-	-	-	PRDM13	HGNC:13998	Cerebellar dysfunction, impaired intellectual development, and hypogonadotropic hypogonadism, 619761 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L2	L2	pre-infant-lethal
619762	KURY-ISIDOR SYNDROME	Kury-Isidor syndrome, 619762 (3)	Kury-Isidor syndrome	n	-	-	-	BAP1	HGNC:950	Kury-Isidor syndrome, 619762 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
619764	CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 1H	Charcot-Marie-Tooth disease, demyelinating, type 1H, 619764 (3)	Charcot-Marie-Tooth disease, demyelinating, type 1H	n	-	-	-	FBLN5	HGNC:3602	Charcot-Marie-Tooth disease, demyelinating, type 1H, 619764 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L3	L3	pre-infant-lethal
619767	PULMONARY FIBROSIS AND/OR BONE MARROW FAILURE SYNDROME, TELOMERE-RELATED, 6	Pulmonary fibrosis and/or bone marrow failure syndrome, telomere-related, 6, 619767 (3)	Pulmonary fibrosis and/or bone marrow failure syndrome, telomere-related, 6	y	PULMONARY FIBROSIS AND/OR BONE MARROW FAILURE SYNDROME, TELOMERE-RELATED, 6; PFBMFT6	Clinical Features	died	RPA1	HGNC:10289	Pulmonary fibrosis and/or bone marrow failure syndrome, telomere-related, 6, 619767 (3), Autosomal dominant	Autosomal dominant	y	y	[died of the disease]	LU	y	y	lethal	lethal	lethal	LU	LU	post-infant-lethal
619769	MACROCEPHALY, NEURODEVELOPMENTAL DELAY, LYMPHOID HYPERPLASIA, AND PERSISTENT FETAL HEMOGLOBIN	Macrocephaly, neurodevelopmental delay, lymphoid hyperplasia, and persistent fetal hemoglobin, 619769 (3)	Macrocephaly, neurodevelopmental delay, lymphoid hyperplasia, and persistent fetal hemoglobin	n	-	-	-	ZBTB7A	HGNC:18078	Macrocephaly, neurodevelopmental delay, lymphoid hyperplasia, and persistent fetal hemoglobin, 619769 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
619773	IMMUNODEFICIENCY 95	Immunodeficiency 95, 619773 (3)	Immunodeficiency 95	n	-	-	-	IFIH1	HGNC:18873	Immunodeficiency 95, 619773 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L3|L4	L3	pre-infant-lethal
619774	IMMUNODEFICIENCY 96	Immunodeficiency 96, 619774 (3)	Immunodeficiency 96	y	IMMUNODEFICIENCY 96; IMD96	Clinical Features	died	LIG1	HGNC:6598	Immunodeficiency 96, 619774 (3), Autosomal recessive	Autosomal recessive	y	y	[died of pneumonia at age 19]	L6	y	-	lethal	lethal	lethal	L6	L6	post-infant-lethal
619775	CONGENITAL DISORDER OF DEGLYCOSYLATION 2	Congenital disorder of deglycosylation 2, 619775 (3)	Congenital disorder of deglycosylation 2	n	-	-	-	MAN2C1	HGNC:6827	Congenital disorder of deglycosylation 2, 619775 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
619777	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 100	Developmental and epileptic encephalopathy 100, 619777 (3)	Developmental and epileptic encephalopathy 100	y	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 100; DEE100	Clinical Features	died	FBXO28	HGNC:29046	Developmental and epileptic encephalopathy 100, 619777 (3), Autosomal dominant	Autosomal dominant	y	y	[2 died at 25 years]	L6	y	-	lethal	lethal	lethal	L6	L6	post-infant-lethal
619780	MITOCHONDRIAL DNA DEPLETION SYNDROME 20 (MNGIE TYPE)	Mitochondrial DNA depletion syndrome 20 (MNGIE type), 619780 (3)	Mitochondrial DNA depletion syndrome 20 (MNGIE type)	y	MITOCHONDRIAL DNA DEPLETION SYNDROME 20 (MNGIE TYPE); MTDPS20	Clinical Features|Clinical Synopsis	death|deaths|died|fatal	LIG3	HGNC:6600	Mitochondrial DNA depletion syndrome 20 (MNGIE type), 619780 (3), Autosomal recessive	Autosomal recessive	y	y	[death within hours]	L2	y	-	lethal	lethal	lethal	L2	L2	pre-infant-lethal
619781	MYOPIA 28, AUTOSOMAL RECESSIVE	Myopia 28, autosomal recessive, 619781 (3)	Myopia 28, autosomal recessive	n	-	-	-	LOXL3	HGNC:13869	Myopia 28, autosomal recessive, 619781 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
619783	EPIDERMOLYSIS BULLOSA, JUNCTIONAL 2A, INTERMEDIATE	Epidermolysis bullosa, junctional 2A, intermediate, 619783 (3)	Epidermolysis bullosa, junctional 2A, intermediate	n	-	-	-	LAMA3	HGNC:6483	Epidermolysis bullosa, junctional 2A, intermediate, 619783 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L3|L4	L3	pre-infant-lethal
619784	EPIDERMOLYSIS BULLOSA, JUNCTIONAL 2B, SEVERE	Epidermolysis bullosa, junctional 2B, severe, 619784 (3)	Epidermolysis bullosa, junctional 2B, severe	y	EPIDERMOLYSIS BULLOSA, JUNCTIONAL 2B, SEVERE; JEB2B	Description|Clinical Features|Clinical Synopsis|Phenotype	die|died|death|deaths|lethal	LAMA3	HGNC:6483	Epidermolysis bullosa, junctional 2B, severe, 619784 (3), Autosomal recessive	Autosomal recessive	y	y	[died before 5 months of age]	L3	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L3|L4	L3	pre-infant-lethal
619785	EPIDERMOLYSIS BULLOSA, JUNCTIONAL 3A, INTERMEDIATE	Epidermolysis bullosa, junctional 3A, intermediate, 619785 (3)	Epidermolysis bullosa, junctional 3A, intermediate	n	-	-	-	LAMC2	HGNC:6493	Epidermolysis bullosa, junctional 3A, intermediate, 619785 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L3	L3	pre-infant-lethal
619786	EPIDERMOLYSIS BULLOSA, JUNCTIONAL 3B, SEVERE	Epidermolysis bullosa, junctional 3B, severe, 619786 (3)	Epidermolysis bullosa, junctional 3B, severe	y	EPIDERMOLYSIS BULLOSA, JUNCTIONAL 3B, SEVERE; JEB3B	Description|Clinical Features|Clinical Synopsis|Phenotype	die|died|death|deaths	LAMC2	HGNC:6493	Epidermolysis bullosa, junctional 3B, severe, 619786 (3), Autosomal recessive	Autosomal recessive	y	y	[died at 4 months of age]	L3	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L3	L3	pre-infant-lethal
619787	EPIDERMOLYSIS BULLOSA, JUNCTIONAL 4, INTERMEDIATE	Epidermolysis bullosa, junctional 4, intermediate, 619787 (3)	Epidermolysis bullosa, junctional 4, intermediate	n	-	-	-	COL17A1	HGNC:2194	Epidermolysis bullosa, junctional 4, intermediate, 619787 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
619789	ANEMIA, CONGENITAL DYSERYTHROPOIETIC, TYPE IIIb, AUTOSOMAL RECESSIVE	Anemia, congenital dyserythropoietic, type IIIb, autosomal recessive, 619789 (3)	Anemia, congenital dyserythropoietic, type IIIb, autosomal recessive	n	-	-	-	RACGAP1	HGNC:9804	Anemia, congenital dyserythropoietic, type IIIb, autosomal recessive, 619789 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
619790	OCULOPHARYNGODISTAL MYOPATHY 4	Oculopharyngodistal myopathy 4, 619790 (3)	Oculopharyngodistal myopathy 4	n	-	-	-	RILPL1	HGNC:26814	Oculopharyngodistal myopathy 4, 619790 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
619793	RESTRICTIVE DERMOPATHY 2	Restrictive dermopathy 2, 619793 (3)	Restrictive dermopathy 2	y	RESTRICTIVE DERMOPATHY 2; RSDM2	Description|Clinical Features	die|lethal|died	LMNA	HGNC:6636	Restrictive dermopathy 2, 619793 (3)	-	y	y	[Liveborn children usually die within the first week of life]	L2	y	-	lethal	ambiguous|lethal|nonlethal	lethal|nonlethal	L1|L2|L6	L1	pre-infant-lethal
619795	OSTEOGENESIS IMPERFECTA, TYPE XXII	Osteogenesis imperfecta, type XXII, 619795 (3)	Osteogenesis imperfecta, type XXII	n	-	-	-	CCDC134	HGNC:26185	Osteogenesis imperfecta, type XXII, 619795 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
619797	NEURODEVELOPMENTAL DISORDER WITH CENTRAL HYPOTONIA AND DYSMORPHIC FACIES	Neurodevelopmental disorder with central hypotonia and dysmorphic facies, 619797 (3)	Neurodevelopmental disorder with central hypotonia and dysmorphic facies	n	-	-	-	HDAC4	HGNC:14063	Neurodevelopmental disorder with central hypotonia and dysmorphic facies, 619797 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
619802	IMMUNODEFICIENCY 97 WITH AUTOINFLAMMATION	Immunodeficiency 97 with autoinflammation, 619802 (3)	Immunodeficiency 97 with autoinflammation	n	-	-	-	PIK3CG	HGNC:8978	Immunodeficiency 97 with autoinflammation, 619802 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
619804	DEAFNESS, AUTOSOMAL DOMINANT 82	Deafness, autosomal dominant 82, 619804 (3)	Deafness, autosomal dominant 82	n	-	-	-	ATP2B2	HGNC:815	Deafness, autosomal dominant 82, 619804 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
619806	SPINOCEREBELLAR ATAXIA 49	Spinocerebellar ataxia 49, 619806 (3)	Spinocerebellar ataxia 49	n	-	-	-	SAMD9L	HGNC:1349	Spinocerebellar ataxia 49, 619806 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L4|LU	L4	post-infant-lethal
619810	DEAFNESS, AUTOSOMAL DOMINANT 84	Deafness, autosomal dominant 84, 619810 (3)	Deafness, autosomal dominant 84	n	-	-	-	ATP11A	HGNC:13552	Deafness, autosomal dominant 84, 619810 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
619813	NEUTROPENIA, SEVERE CONGENITAL, 9, AUTOSOMAL DOMINANT	Neutropenia, severe congenital, 9, autosomal dominant, 619813 (3)	Neutropenia, severe congenital, 9, autosomal dominant	y	NEUTROPENIA, SEVERE CONGENITAL, 9, AUTOSOMAL DOMINANT; SCN9	Clinical Features	died	CLPB	HGNC:30664	Neutropenia, severe congenital, 9, autosomal dominant, 619813 (3), Autosomal dominant	Autosomal dominant	y	n	-	-	-	-	ambiguous	ambiguous|lethal	lethal	L2|L3	L2	pre-infant-lethal
619814	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 101	Developmental and epileptic encephalopathy 101, 619814 (3)	Developmental and epileptic encephalopathy 101	y	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 101; DEE101	Clinical Features|Clinical Synopsis	died|death|deaths	GRIN1	HGNC:4584	Developmental and epileptic encephalopathy 101, 619814 (3), Autosomal recessive	Autosomal recessive	y	y	[All developed intractable seizures on the first day of life and died between 5 days and 5 months of age. ]	L2	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L2	L2	pre-infant-lethal
619816	EPIDERMOLYSIS BULLOSA, JUNCTIONAL 5A, INTERMEDIATE	Epidermolysis bullosa, junctional 5A, intermediate, 619816 (3)	Epidermolysis bullosa, junctional 5A, intermediate	n	-	-	-	ITGB4	HGNC:6158	Epidermolysis bullosa, junctional 5A, intermediate, 619816 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L2	L2	pre-infant-lethal
619817	EPIDERMOLYSIS BULLOSA, JUNCTIONAL 6, WITH PYLORIC ATRESIA	Epidermolysis bullosa, junctional 6, with pyloric atresia, 619817 (3)	Epidermolysis bullosa, junctional 6, with pyloric atresia	y	EPIDERMOLYSIS BULLOSA, JUNCTIONAL 6, WITH PYLORIC ATRESIA; JEB6	Description|Clinical Features|Clinical Synopsis|Phenotype	lethal|death|deaths|died	ITGA6	HGNC:6142	Epidermolysis bullosa, junctional 6, with pyloric atresia, 619817 (3), Autosomal recessive	Autosomal recessive	y	y	[JEB5B is usually lethal within the first few weeks of life despite surgical correction of pyloric atresia ]	L2	y	-	lethal	lethal	lethal	L2	L2	pre-infant-lethal
619824	AGAMMAGLOBULINEMIA 8B, AUTOSOMAL RECESSIVE	Agammaglobulinemia 8B, autosomal recessive, 619824 (3)	Agammaglobulinemia 8B, autosomal recessive	y	AGAMMAGLOBULINEMIA 8B, AUTOSOMAL RECESSIVE; AGM8B	Clinical Features	died	TCF3	HGNC:11633	Agammaglobulinemia 8B, autosomal recessive, 619824 (3), Autosomal recessive	Autosomal recessive	y	y	[he had a relapse and died of the disease at 10 years of age]	L4	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L4	L4	post-infant-lethal
619825	AORTIC ANEURYSM, FAMILIAL THORACIC 12	Aortic aneurysm, familial thoracic 12, 619825 (3)	Aortic aneurysm, familial thoracic 12	n	-	-	-	THSD4	HGNC:25835	Aortic aneurysm, familial thoracic 12, 619825 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
619826	SPERMATOGENIC FAILURE 69	Spermatogenic failure 69, 619826 (3)	Spermatogenic failure 69	n	-	-	-	GGN	HGNC:18869	Spermatogenic failure 69, 619826 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
619827	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 75, WITH NEUROPSYCHIATRIC FEATURES AND VARIANT LISSENCEPHALY	Intellectual developmental disorder, autosomal recessive 75, with neuropsychiatric features and variant lissencephaly, 619827 (3)	Intellectual developmental disorder, autosomal recessive 75, with neuropsychiatric features and variant lissencephaly	y	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 75, WITH NEUROPSYCHIATRIC FEATURES AND VARIANT LISSENCEPHALY; MRT75	Clinical Synopsis|Phenotype	death|deaths	PIDD1	HGNC:16491	Intellectual developmental disorder, autosomal recessive 75, with neuropsychiatric features and variant lissencephaly, 619827 (3), Autosomal recessive	Autosomal recessive	y	n	-	-	-	-	ambiguous	ambiguous	ambiguous	-	-	-
619828	SPERMATOGENIC FAILURE 70	Spermatogenic failure 70, 619828 (3)	Spermatogenic failure 70	n	-	-	-	PDHA2	HGNC:8807	Spermatogenic failure 70, 619828 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
619831	SPERMATOGENIC FAILURE 71	Spermatogenic failure 71, 619831 (3)	Spermatogenic failure 71	n	-	-	-	ZSWIM7	HGNC:26993	Spermatogenic failure 71, 619831 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
619832	AUDITORY NEUROPATHY, AUTOSOMAL DOMINANT 3	Auditory neuropathy, autosomal dominant 3, 619832 (3)	Auditory neuropathy, autosomal dominant 3	n	-	-	-	TMEM43	HGNC:28472	Auditory neuropathy, autosomal dominant 3, 619832 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L6|LU	L6	post-infant-lethal
619833	NEURODEVELOPMENTAL DISORDER WITH NEUROMUSCULAR AND SKELETAL ABNORMALITIES	Neurodevelopmental disorder with neuromuscular and skeletal abnormalities, 619833 (3)	Neurodevelopmental disorder with neuromuscular and skeletal abnormalities	y	NEURODEVELOPMENTAL DISORDER WITH NEUROMUSCULAR AND SKELETAL ABNORMALITIES; NEDNMS	Clinical Features	died	NRCAM	HGNC:7994	Neurodevelopmental disorder with neuromuscular and skeletal abnormalities, 619833 (3), Autosomal recessive	Autosomal recessive	y	y	[she died at age 21 months]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
619835	3-METHYLGLUTACONIC ACIDURIA, TYPE VIIA	3-methylglutaconic aciduria, type VIIA, autosomal dominant, 619835 (3)	3-methylglutaconic aciduria, type VIIA, autosomal dominant	y	3-METHYLGLUTACONIC ACIDURIA, TYPE VIIA; MGCA7A	Clinical Features	died	CLPB	HGNC:30664	3-methylglutaconic aciduria, type VIIA, autosomal dominant, 619835 (3), Autosomal dominant	Autosomal dominant	y	y	[The least affected individual (P6) had mild speech delay and no seizures, whereas the most severely affected individual (P2) had early-onset seizures and essentially no development and died of respiratory failure at age 19 months]	L3	y	-	lethal	ambiguous|lethal	lethal	L2|L3	L2	pre-infant-lethal
619836	HYPOALPHALIPOPROTEINEMIA, PRIMARY, 2, INTERMEDIATE	Hypoalphalipoproteinemia, primary, 2, intermediate, 619836 (3)	Hypoalphalipoproteinemia, primary, 2, intermediate	n	-	-	-	APOA1	HGNC:600	Hypoalphalipoproteinemia, primary, 2, intermediate, 619836 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	ambiguous|lethal|nonlethal	lethal|nonlethal	LU	LU	post-infant-lethal
619840	MACROTHROMBOCYTOPENIA, ISOLATED, 2, AUTOSOMAL DOMINANT	Macrothrombocytopenia, isolated, 2, autosomal dominant, 619840 (3)	Macrothrombocytopenia, isolated, 2, autosomal dominant	n	-	-	-	TUBA8	HGNC:12410	Macrothrombocytopenia, isolated, 2, autosomal dominant, 619840 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
619841	CHILTON-OKUR-CHUNG NEURODEVELOPMENTAL SYNDROME	Chilton-Okur-Chung neurodevelopmental syndrome, 619841 (3)	Chilton-Okur-Chung neurodevelopmental syndrome	n	-	-	-	CDC42BPB	HGNC:1738	Chilton-Okur-Chung neurodevelopmental syndrome, 619841 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
619844	INTELLECTUAL DEVELOPMENTAL DISORDER WITH OR WITHOUT PERIPHERAL NEUROPATHY	Intellectual developmental disorder with or without peripheral neuropathy, 619844 (3)	Intellectual developmental disorder with or without peripheral neuropathy	n	-	-	-	NUDT2	HGNC:8049	Intellectual developmental disorder with or without peripheral neuropathy, 619844 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
619845	RETINITIS PIGMENTOSA 93	Retinitis pigmentosa 93, 619845 (3)	Retinitis pigmentosa 93	n	-	-	-	CC2D2A	HGNC:29253	Retinitis pigmentosa 93, 619845 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L1	L1	pre-infant-lethal
619847	NEURODEGENERATION, CHILDHOOD-ONSET, WITH PROGRESSIVE MICROCEPHALY	Neurodegeneration, childhood-onset, with progressive microcephaly, 619847 (3)	Neurodegeneration, childhood-onset, with progressive microcephaly	y	NEURODEGENERATION, CHILDHOOD-ONSET, WITH PROGRESSIVE MICROCEPHALY; CONPM	Description|Clinical Features|Clinical Synopsis	death|deaths	DTYMK	HGNC:3061	Neurodegeneration, childhood-onset, with progressive microcephaly, 619847 (3), Autosomal recessive	Autosomal recessive	y	y	[resulting in death at 18 and 32 months, respectively]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
619849	CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC, 9	Cholestasis, progressive familial intrahepatic, 9, 619849 (3)	Cholestasis, progressive familial intrahepatic, 9	n	-	-	-	ZFYVE19	HGNC:20758	Cholestasis, progressive familial intrahepatic, 9, 619849 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
619854	NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, IMPAIRED SPEECH, AND BEHAVIORAL ABNORMALITIES	Neurodevelopmental disorder with hypotonia, impaired speech, and behavioral abnormalities, 619854 (3)	Neurodevelopmental disorder with hypotonia, impaired speech, and behavioral abnormalities	n	-	-	-	GNAI1	HGNC:4384	Neurodevelopmental disorder with hypotonia, impaired speech, and behavioral abnormalities, 619854 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
619855	THYROID HORMONE METABOLISM, ABNORMAL, 2	Thyroid hormone metabolism, abnormal, 2, 619855 (3)	Thyroid hormone metabolism, abnormal, 2	n	-	-	-	DIO1	HGNC:2883	Thyroid hormone metabolism, abnormal, 2, 619855 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
619858	AUTOINFLAMMATORY-PANCYTOPENIA SYNDROME	Autoinflammatory-pancytopenia syndrome, 619858 (3)	Autoinflammatory-pancytopenia syndrome	y	AUTOINFLAMMATORY-PANCYTOPENIA SYNDROME; AIPCS	Phenotype	lethal	DNASE2	HGNC:2960	Autoinflammatory-pancytopenia syndrome, 619858 (3), Autosomal recessive	Autosomal recessive	y	n	-	-	-	-	ambiguous	ambiguous	ambiguous	-	-	-
619862	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 32	Spinocerebellar ataxia, autosomal recessive 32, 619862 (3)	Spinocerebellar ataxia, autosomal recessive 32	n	-	-	-	PRDX3	HGNC:9354	Spinocerebellar ataxia, autosomal recessive 32, 619862 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
619868	CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC, 10	Cholestasis, progressive familial intrahepatic, 10, 619868 (3)	Cholestasis, progressive familial intrahepatic, 10	y	CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC, 10; PFIC10	Clinical Features	died	MYO5B	HGNC:7603	Cholestasis, progressive familial intrahepatic, 10, 619868 (3), Autosomal recessive	Autosomal recessive	y	y	[One patient (P3) died of the disease while listed for liver transplant.]	LU	y	-	lethal	lethal	lethal	L3|LU	L3	pre-infant-lethal
619869	NEUROCARDIOFACIODIGITAL SYNDROME	Neurocardiofaciodigital syndrome, 619869 (3)	Neurocardiofaciodigital syndrome	n	-	-	-	MAPKAPK5	HGNC:6889	Neurocardiofaciodigital syndrome, 619869 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
619871	CORNEAL DYSTROPHY, PUNCTIFORM AND POLYCHROMATIC PRE-DESCEMET	Corneal dystrophy, punctiform and polychromatic pre-Descemet, 619871 (3)	Corneal dystrophy, punctiform and polychromatic pre-Descemet	n	-	-	-	PRDX3	HGNC:9354	Corneal dystrophy, punctiform and polychromatic pre-Descemet, 619871 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
619873	PARENTI-MIGNOT NEURODEVELOPMENTAL SYNDROME	Parenti-Mignot neurodevelopmental syndrome, 619873 (3)	Parenti-Mignot neurodevelopmental syndrome	n	-	-	-	CHD5	HGNC:16816	Parenti-Mignot neurodevelopmental syndrome, 619873 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
619876	NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, HYPOTONIA, NYSTAGMUS, AND SEIZURES	Neurodevelopmental disorder with microcephaly, hypotonia, nystagmus, and seizures, 619876 (3)	Neurodevelopmental disorder with microcephaly, hypotonia, nystagmus, and seizures	y	NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, HYPOTONIA, NYSTAGMUS, AND SEIZURES; NEDMHS	Description|Clinical Features|Clinical Synopsis	death|deaths|died	CPSF3	HGNC:2326	Neurodevelopmental disorder with microcephaly, hypotonia, nystagmus, and seizures, 619876 (3), Autosomal recessive	Autosomal recessive	y	y	[5 died of pneumonia or respiratory failure between 1 and 7 years of age. ]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
619877	DENTICI-NOVELLI NEURODEVELOPMENTAL SYNDROME	Dentici-Novelli neurodevelopmental syndrome, 619877 (3)	Dentici-Novelli neurodevelopmental syndrome	y	DENTICI-NOVELLI NEURODEVELOPMENTAL SYNDROME; DENNED	Clinical Features	died	ZNF526	HGNC:29415	Dentici-Novelli neurodevelopmental syndrome, 619877 (3), Autosomal recessive	Autosomal recessive	y	y	[One patient died at 5 years of age]	L4	y	-	lethal	lethal	lethal	L4	L4	post-infant-lethal
619879	MECKEL SYNDROME 14	Meckel syndrome 14, 619879 (3)	Meckel syndrome 14	y	MECKEL SYNDROME 14; MKS14	Description|Clinical Features|Clinical Synopsis	death|deaths|lethal|stillbirth|stillbirths|died|pregnancy_loss|pregnancy_losses|stillborn	TXNDC15	HGNC:20652	Meckel syndrome 14, 619879 (3), Autosomal recessive	Autosomal recessive	y	y	[was a stillborn male infant  a history of 2 pregnancy losses]	L1	y	y	lethal	lethal	lethal	L1	L1	pre-infant-lethal
619881	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 102	Developmental and epileptic encephalopathy 102, 619881 (3)	Developmental and epileptic encephalopathy 102	n	-	-	-	SLC38A3	HGNC:18044	Developmental and epileptic encephalopathy 102, 619881 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
619884	OSTEOPOROSIS, CHILDHOOD- OR JUVENILE-ONSET, WITH DEVELOPMENTAL DELAY	Osteoporosis, childhood- or juvenile-onset, with developmental delay, 619884 (3)	Osteoporosis, childhood- or juvenile-onset, with developmental delay	n	-	-	-	COPB2	HGNC:2232	Osteoporosis, childhood- or juvenile-onset, with developmental delay, 619884 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
619887	RENAL HYPODYSPLASIA/APLASIA 4	Renal hypodysplasia/aplasia 4, 619887 (3)	Renal hypodysplasia/aplasia 4	y	RENAL HYPODYSPLASIA/APLASIA 4; RHDA4	Clinical Features|Clinical Synopsis|Phenotype	died|miscarriage|miscarriages|death|deaths	GFRA1	HGNC:4243	Renal hypodysplasia/aplasia 4, 619887 (3), Autosomal recessive	Autosomal recessive	y	y	[died soon after birth .. miscarriages of their first and fourth pregnancies and terminated the second and third pregnancies due to BRA]	L1	y	y	lethal	lethal	lethal	L1	L1	pre-infant-lethal
619895	HOLOPROSENCEPHALY 14	Holoprosencephaly 14, 619895 (3)	Holoprosencephaly 14	y	HOLOPROSENCEPHALY 14; HPE14	Clinical Features|Clinical Synopsis|Phenotype	died|death|deaths	PLCH1	HGNC:29185	Holoprosencephaly 14, 619895 (3), Autosomal recessive	Autosomal recessive	y	y	[died shortly after birth]	L2	y	-	lethal	lethal	lethal	L2	L2	pre-infant-lethal
619897	CARDIOMYOPATHY, DILATED, 2G	Cardiomyopathy, dilated, 2G, 619897 (3)	Cardiomyopathy, dilated, 2G	y	CARDIOMYOPATHY, DILATED, 2G; CMD2G	Clinical Features|Clinical Synopsis|Phenotype	died|lethal|death|deaths	LMOD2	HGNC:6648	Cardiomyopathy, dilated, 2G, 619897 (3), Autosomal recessive	Autosomal recessive	y	y	[died at 24 days of life  died 12 hours after withdrawal of support at age 31 days .. died at 17 hours of life. .. Family history included a paternal uncle in a consanguineous marriage who had 4 infants who died in the first 6 months of life of unknown causes.]	L2	y	y	lethal	lethal	lethal	L2	L2	pre-infant-lethal
619902	HEPATORENOCARDIAC DEGENERATIVE FIBROSIS	Hepatorenocardiac degenerative fibrosis, 619902 (3)	Hepatorenocardiac degenerative fibrosis	n	-	-	-	TULP3	HGNC:12425	Hepatorenocardiac degenerative fibrosis, 619902 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
619903	PERIPHERAL MOTOR NEUROPATHY, CHILDHOOD-ONSET, BIOTIN-RESPONSIVE	Peripheral motor neuropathy, childhood-onset, biotin-responsive, 619903 (3)	Peripheral motor neuropathy, childhood-onset, biotin-responsive	n	-	-	-	SLC5A6	HGNC:11041	Peripheral motor neuropathy, childhood-onset, biotin-responsive, 619903 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L4	L4	post-infant-lethal
619908	NEURODEVELOPMENTAL DISORDER WITH LANGUAGE DELAY AND SEIZURES	Neurodevelopmental disorder with language delay and seizures, 619908 (3)	Neurodevelopmental disorder with language delay and seizures	n	-	-	-	TIAM1	HGNC:11805	Neurodevelopmental disorder with language delay and seizures, 619908 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
619909	PONTOCEREBELLAR HYPOPLASIA, TYPE 17	Pontocerebellar hypoplasia, type 17, 619909 (3)	Pontocerebellar hypoplasia, type 17	y	PONTOCEREBELLAR HYPOPLASIA, TYPE 17; PCH17	Description|Clinical Features|Clinical Synopsis|Phenotype	die|died|death|deaths	PRDM13	HGNC:13998	Pontocerebellar hypoplasia, type 17, 619909 (3), Autosomal recessive	Autosomal recessive	y	y	[Four children died between 22 days and 25 months of age]	L2	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L2	L2	pre-infant-lethal
619910	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 66	Intellectual developmental disorder, autosomal dominant 66, 619910 (3)	Intellectual developmental disorder, autosomal dominant 66	n	-	-	-	ATP2B1	HGNC:814	Intellectual developmental disorder, autosomal dominant 66, 619910 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
619911	INTELLECTUAL DEVELOPMENTAL DISORDER WITH LANGUAGE IMPAIRMENT AND EARLY-ONSET DOPA-RESPONSIVE DYSTONIA-PARKINSONISM	Intellectual developmental disorder with language impairment and early-onset DOPA-responsive dystonia-parkinsonism, 619911 (3)	Intellectual developmental disorder with language impairment and early-onset DOPA-responsive dystonia-parkinsonism	n	-	-	-	NR4A2	HGNC:7981	Intellectual developmental disorder with language impairment and early-onset DOPA-responsive dystonia-parkinsonism, 619911 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
619913	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 103	Developmental and epileptic encephalopathy 103, 619913 (3)	Developmental and epileptic encephalopathy 103	n	-	-	-	KCNC2	HGNC:6234	Developmental and epileptic encephalopathy 103, 619913 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
619922	NEURODEVELOPMENTAL DISORDER WITH DYSTONIA AND SEIZURES	Neurodevelopmental disorder with dystonia and seizures, 619922 (3)	Neurodevelopmental disorder with dystonia and seizures	y	NEURODEVELOPMENTAL DISORDER WITH DYSTONIA AND SEIZURES; NEDDS	Clinical Features|Clinical Synopsis	death|deaths|died	SHQ1	HGNC:25543	Neurodevelopmental disorder with dystonia and seizures, 619922 (3), Autosomal recessive	Autosomal recessive	y	y	[One of the sisters developed seizures at age 10 years, resulting in sudden death.]	L4	y	-	lethal	lethal	lethal	L4	L4	post-infant-lethal
619924	IMMUNODEFICIENCY 105	Immunodeficiency 105, severe combined, 619924 (3)	Immunodeficiency 105, severe combined	y	IMMUNODEFICIENCY 105; IMD105	Clinical Features|Clinical Synopsis	died|death|deaths	PTPRC	HGNC:9666	Immunodeficiency 105, severe combined, 619924 (3), Autosomal recessive	Autosomal recessive	y	y	[patient underwent bone marrow transplant at age 8 months, but died 55 days later]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
619927	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 67	Intellectual developmental disorder, autosomal dominant 67, 619927 (3)	Intellectual developmental disorder, autosomal dominant 67	n	-	-	-	GRIA1	HGNC:4571	Intellectual developmental disorder, autosomal dominant 67, 619927 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
619934	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 68	Intellectual developmental disorder, autosomal dominant 68, 619934 (3)	Intellectual developmental disorder, autosomal dominant 68	n	-	-	-	KMT2B	HGNC:15840	Intellectual developmental disorder, autosomal dominant 68, 619934 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
619935	IMMUNODEFICIENCY 106, SUSCEPTIBILITY TO VIRAL INFECTIONS	Immunodeficiency 106, susceptibility to viral infections, 619935 (3)	Immunodeficiency 106, susceptibility to viral infections	y	IMMUNODEFICIENCY 106, SUSCEPTIBILITY TO VIRAL INFECTIONS; IMD106	Clinical Features|Clinical Synopsis|Phenotype	death|deaths|died|fatal	IFNAR1	HGNC:5432	Immunodeficiency 106, susceptibility to viral infections, 619935 (3), Autosomal recessive	Autosomal recessive	y	y	[resulting in death around 20 months of age .. first cousin of the patient (P3) died at age 12 months following a severe adverse reaction to MMR vaccination]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
619937	SPERMATOGENIC FAILURE 74	Spermatogenic failure 74, 619937 (3)	Spermatogenic failure 74	n	-	-	-	MSH5	HGNC:7328	Spermatogenic failure 74, 619937 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
619938	PREMATURE OVARIAN FAILURE 20	Premature ovarian failure 20, 619938 (3)	Premature ovarian failure 20	y	PREMATURE OVARIAN FAILURE 20; POF20	Clinical Features	spontaneous_abortion|spontaneous_abortions	MSH4	HGNC:7327	Premature ovarian failure 20, 619938 (3), Autosomal recessive	Autosomal recessive	y	n	-	-	-	-	ambiguous	ambiguous|nonlethal	ambiguous	-	-	-
619947	WAARDENBURG SYNDROME, TYPE 2F	Waardenburg syndrome, type 2F, 619947 (3)	Waardenburg syndrome, type 2F	y	WAARDENBURG SYNDROME, TYPE 2F; WS2F	Clinical Features	death|deaths	KITLG	HGNC:6343	Waardenburg syndrome, type 2F, 619947 (3), Autosomal recessive	Autosomal recessive	y	n	-	-	-	-	ambiguous	ambiguous|nonlethal	ambiguous	-	-	-
619949	SPERMATOGENIC FAILURE 75	Spermatogenic failure 75, 619949 (3)	Spermatogenic failure 75	n	-	-	-	SHOC1	HGNC:26535	Spermatogenic failure 75, 619949 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
619950	TESSADORI-BICKNELL-VAN HAAFTEN NEURODEVELOPMENTAL SYNDROME 3	Tessadori-Bicknell-van Haaften neurodevelopmental syndrome 3, 619950 (3)	Tessadori-Bicknell-van Haaften neurodevelopmental syndrome 3	n	-	-	-	H4C5	HGNC:4790	Tessadori-Bicknell-van Haaften neurodevelopmental syndrome 3, 619950 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
619951	TESSADORI-BICKNELL-VAN HAAFTEN NEURODEVELOPMENTAL SYNDROME 4	Tessadori-Bicknell-van Haaften neurodevelopmental syndrome 4, 619951 (3)	Tessadori-Bicknell-van Haaften neurodevelopmental syndrome 4	y	TESSADORI-BICKNELL-VAN HAAFTEN NEURODEVELOPMENTAL SYNDROME 4; TEBIVANED4	Clinical Features	died	H4C9	HGNC:4793	Tessadori-Bicknell-van Haaften neurodevelopmental syndrome 4, 619951 (3), Autosomal dominant	Autosomal dominant	y	n	-	-	-	-	ambiguous	ambiguous	ambiguous	-	-	-
619955	DWORSCHAK-PUNETHA NEURODEVELOPMENTAL SYNDROME	Dworschak-Punetha neurodevelopmental syndrome, 619955 (3)	Dworschak-Punetha neurodevelopmental syndrome	n	-	-	-	PLXNA1	HGNC:9099	Dworschak-Punetha neurodevelopmental syndrome, 619955 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
619959	ACCES SYNDROME	ACCES syndrome, 619959 (3)	ACCES syndrome	n	-	-	-	UBA2	HGNC:30661	ACCES syndrome, 619959 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
619964	DEVELOPMENTAL DELAY, IMPAIRED SPEECH, AND BEHAVIORAL ABNORMALITIES, WITH OR WITHOUT SEIZURES	Developmental delay, impaired speech, and behavioral abnormalities, with or without seizures, 619964 (3)	Developmental delay, impaired speech, and behavioral abnormalities, with or without seizures	n	-	-	-	ARFGEF1	HGNC:15772	Developmental delay, impaired speech, and behavioral abnormalities, with or without seizures, 619964 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
619966	SPASTIC PARAPLEGIA 87, AUTOSOMAL RECESSIVE	Spastic paraplegia 87, autosomal recessive, 619966 (3)	Spastic paraplegia 87, autosomal recessive	n	-	-	-	TMEM63C	HGNC:23787	Spastic paraplegia 87, autosomal recessive, 619966 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
619967	CONGENITAL MYOPATHY 11	Congenital myopathy 11, 619967 (3)	Congenital myopathy 11	n	-	-	-	HACD1	HGNC:9639	Congenital myopathy 11, 619967 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
619970	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 104	Developmental and epileptic encephalopathy 104, 619970 (3)	Developmental and epileptic encephalopathy 104	y	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 104; DEE104	Clinical Features|Phenotype	stillborn|lethality	ATP6V0A1	HGNC:865	Developmental and epileptic encephalopathy 104, 619970 (3), Autosomal dominant	Autosomal dominant	y	n	-	-	-	-	ambiguous	ambiguous|nonlethal	ambiguous	-	-	-
619971	NEURODEVELOPMENTAL DISORDER WITH EPILEPSY AND BRAIN ATROPHY	Neurodevelopmental disorder with epilepsy and brain atrophy, 619971 (3)	Neurodevelopmental disorder with epilepsy and brain atrophy	n	-	-	-	ATP6V0A1	HGNC:865	Neurodevelopmental disorder with epilepsy and brain atrophy, 619971 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	ambiguous|nonlethal	ambiguous	-	-	-
619972	NEURODEVELOPMENTAL DISORDER WITH SEVERE MOTOR IMPAIRMENT, ABSENT LANGUAGE, CEREBRAL HYPOMYELINATION, AND BRAIN ATROPHY	Neurodevelopmental disorder with severe motor impairment, absent language, cerebral hypomyelination, and brain atrophy, 619972 (3)	Neurodevelopmental disorder with severe motor impairment, absent language, cerebral hypomyelination, and brain atrophy	y	NEURODEVELOPMENTAL DISORDER WITH SEVERE MOTOR IMPAIRMENT, ABSENT LANGUAGE, CEREBRAL HYPOMYELINATION, AND BRAIN ATROPHY; NEDMLHB	Phenotype	death|deaths	TAF8	HGNC:17300	Neurodevelopmental disorder with severe motor impairment, absent language, cerebral hypomyelination, and brain atrophy, 619972 (3), Autosomal recessive	Autosomal recessive	y	n	-	-	-	-	ambiguous	ambiguous	ambiguous	-	-	-
619975	TUMOR PREDISPOSITION SYNDROME 2	Tumor predisposition syndrome 2, 619975 (3)	Tumor predisposition syndrome 2	y	TUMOR PREDISPOSITION SYNDROME 2; TPDS2	Clinical Features	died	MBD4	HGNC:6919	Tumor predisposition syndrome 2, 619975 (3), Autosomal recessive	Autosomal recessive	y	y	[who developed AML in their early thirties. The disease was refractory to treatment in patient EMC-AML-1, and he died of relapsed AML several years later ]	L6	y	-	lethal	lethal	lethal	L6	L6	post-infant-lethal
619977	MACULAR DYSTROPHY, RETINAL, 4	Macular dystrophy, retinal, 4, 619977 (3)	Macular dystrophy, retinal, 4	n	-	-	-	CLEC3B	HGNC:11891	Macular dystrophy, retinal, 4, 619977 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
619983	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 105 WITH HYPOPITUITARISM	Developmental and epileptic encephalopathy 105 with hypopituitarism, 619983 (3)	Developmental and epileptic encephalopathy 105 with hypopituitarism	y	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 105 WITH HYPOPITUITARISM; DEE105	Clinical Features|Clinical Synopsis	died|death|deaths	HID1	HGNC:15736	Developmental and epileptic encephalopathy 105 with hypopituitarism, 619983 (3), Autosomal recessive	Autosomal recessive	y	y	[Two sibs from family 1 died within the first years of life due to respiratory complications or intractable seizures. Patient 4 (family 3) died at the age of 2 years (Weber, 2022). ]	L4	y	y	lethal	lethal	lethal	L4	L4	post-infant-lethal
619988	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 77	Intellectual developmental disorder, autosomal recessive 77, 619988 (3)	Intellectual developmental disorder, autosomal recessive 77	n	-	-	-	CEP104	HGNC:24866	Intellectual developmental disorder, autosomal recessive 77, 619988 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
619989	NEURODEVELOPMENTAL DISORDER WITH SPEECH DELAY AND VARIABLE OCULAR ANOMALIES	Neurodevelopmental disorder with speech delay and variable ocular anomalies, 619989 (3)	Neurodevelopmental disorder with speech delay and variable ocular anomalies	n	-	-	-	THUMPD1	HGNC:23807	Neurodevelopmental disorder with speech delay and variable ocular anomalies, 619989 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
619991	LIVER DISEASE, SEVERE CONGENITAL	Liver disease, severe congenital, 619991 (3)	Liver disease, severe congenital	y	LIVER DISEASE, SEVERE CONGENITAL; SCOLIV	Description|Clinical Features|Clinical Synopsis	die|died|death|deaths	FOCAD	HGNC:23377	Liver disease, severe congenital, 619991 (3), Autosomal recessive	Autosomal recessive	y	y	[6 died due to hepatic or multiorgan failure, 5 of them before 1 year of age]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
619995	NEURODEVELOPMENTAL DISORDER WITH INTENTION TREMOR, PYRAMIDAL SIGNS, DYSPRAXIA, AND OCULAR ANOMALIES	Neurodevelopmental disorder with intention tremor, pyramidal signs, dyspraxia, and ocular anomalies, 619995 (3)	Neurodevelopmental disorder with intention tremor, pyramidal signs, dyspraxia, and ocular anomalies	n	-	-	-	SMG9	HGNC:25763	Neurodevelopmental disorder with intention tremor, pyramidal signs, dyspraxia, and ocular anomalies, 619995 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L1	L1	pre-infant-lethal
620001	NEURODEVELOPMENTAL DISORDER WITH SPASTICITY, SEIZURES, AND BRAIN ABNORMALITIES	Neurodevelopmental disorder with spasticity, seizures, and brain abnormalities, 620001 (3)	Neurodevelopmental disorder with spasticity, seizures, and brain abnormalities	y	NEURODEVELOPMENTAL DISORDER WITH SPASTICITY, SEIZURES, AND BRAIN ABNORMALITIES; NEDSSBA	Description|Clinical Features|Clinical Synopsis|Phenotype	death|deaths|died	NSRP1	HGNC:25305	Neurodevelopmental disorder with spasticity, seizures, and brain abnormalities, 620001 (3), Autosomal recessive	Autosomal recessive	y	y	[Two patients died at 2 and 4 years of age;]	L4	y	-	lethal	lethal	lethal	L4	L4	post-infant-lethal
620005	PRIMORDIAL DWARFISM-IMMUNODEFICIENCY-LIPODYSTROPHY SYNDROME	Primordial dwarfism-immunodeficiency-lipodystrophy syndrome, 620005 (3)	Primordial dwarfism-immunodeficiency-lipodystrophy syndrome	y	PRIMORDIAL DWARFISM-IMMUNODEFICIENCY-LIPODYSTROPHY SYNDROME; PDIL	Clinical Features|Clinical Synopsis|Phenotype	died|death|deaths	PRIM1	HGNC:9369	Primordial dwarfism-immunodeficiency-lipodystrophy syndrome, 620005 (3), Autosomal recessive	Autosomal recessive	y	y	[4 died at or before age 2 years]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
620007	INTELLECTUAL DEVELOPMENTAL DISORDER WITH MUSCLE TONE ABNORMALITIES AND DISTAL SKELETAL DEFECTS	Intellectual developmental disorder with muscle tone abnormalities and distal skeletal defects, 620007 (3)	Intellectual developmental disorder with muscle tone abnormalities and distal skeletal defects	n	-	-	-	LGI3	HGNC:18711	Intellectual developmental disorder with muscle tone abnormalities and distal skeletal defects, 620007 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
620009	KERATODERMA-ICHTHYOSIS-DEAFNESS SYNDROME, AUTOSOMAL RECESSIVE	Keratoderma-ichthyosis-deafness syndrome, autosomal recessive, 620009 (3)	Keratoderma-ichthyosis-deafness syndrome, autosomal recessive	y	KERATODERMA-ICHTHYOSIS-DEAFNESS SYNDROME, AUTOSOMAL RECESSIVE; KDIDAR	Clinical Features	died	VPS33B	HGNC:12712	Keratoderma-ichthyosis-deafness syndrome, autosomal recessive, 620009 (3), Autosomal recessive	Autosomal recessive	y	n	-	-	-	-	ambiguous	ambiguous|lethal|nonlethal	lethal|nonlethal	L3	L3	pre-infant-lethal
620010	CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC, 12	Cholestasis, progressive familial intrahepatic, 12, 620010 (3)	Cholestasis, progressive familial intrahepatic, 12	n	-	-	-	VPS33B	HGNC:12712	Cholestasis, progressive familial intrahepatic, 12, 620010 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	ambiguous|lethal|nonlethal	lethal|nonlethal	L3	L3	pre-infant-lethal
620011	NEURONOPATHY, DISTAL HEREDITARY MOTOR, AUTOSOMAL RECESSIVE 6	Neuronopathy, distal hereditary motor, autosomal recessive 6, 620011 (3)	Neuronopathy, distal hereditary motor, autosomal recessive 6	n	-	-	-	REEP1	HGNC:25786	Neuronopathy, distal hereditary motor, autosomal recessive 6, 620011 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
620012	DEVELOPMENTAL DELAY, HYPOTONIA, AND IMPAIRED LANGUAGE	Developmental delay, hypotonia, and impaired language, 620012 (3)	Developmental delay, hypotonia, and impaired language	y	DEVELOPMENTAL DELAY, HYPOTONIA, AND IMPAIRED LANGUAGE; DEDHIL	Phenotype	lethal	FBXW7	HGNC:16712	Developmental delay, hypotonia, and impaired language, 620012 (3), Autosomal dominant	Autosomal dominant	y	n	-	-	-	-	ambiguous	ambiguous	ambiguous	-	-	-
620014	LYMPHATIC MALFORMATION 12	Lymphatic malformation 12, 620014 (3)	Lymphatic malformation 12	y	LYMPHATIC MALFORMATION 12; LMPHM12	Description|Clinical Features|Clinical Synopsis|Phenotype	stillbirth|stillbirths|died|stillborn	MDFIC	HGNC:28870	Lymphatic malformation 12, 620014 (3), Autosomal recessive	Autosomal recessive	y	y	[Two patients did not survive the neonatal period: in family LE-452, of Chinese ancestry, a male infant who was delivered at 26 weeks could not be resuscitated after birth; and in the European family CHOP-1, an older brother of the proband was stillborn with hydrops fetalis at 23 weeks' gestation.]	L1	y	y	lethal	lethal	lethal	L1	L1	pre-infant-lethal
620021	INTELLECTUAL DEVELOPMENTAL DISORDER WITH AUTISM AND DYSMORPHIC FACIES	Intellectual developmental disorder with autism and dysmorphic facies, 620021 (3)	Intellectual developmental disorder with autism and dysmorphic facies	n	-	-	-	PDZD8	HGNC:26974	Intellectual developmental disorder with autism and dysmorphic facies, 620021 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
620022	STICKLER SYNDROME, TYPE VI	Stickler syndrome, type VI, 620022 (3)	Stickler syndrome, type VI	n	-	-	-	COL9A3	HGNC:2219	Stickler syndrome, type VI, 620022 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
620023	NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, MOVEMENT ABNORMALITIES, AND SEIZURES	Neurodevelopmental disorder with microcephaly, movement abnormalities, and seizures, 620023 (3)	Neurodevelopmental disorder with microcephaly, movement abnormalities, and seizures	y	NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, MOVEMENT ABNORMALITIES, AND SEIZURES; NEDMIMS	Clinical Features	died|spontaneous_abortion|spontaneous_abortions	CHKA	HGNC:1937	Neurodevelopmental disorder with microcephaly, movement abnormalities, and seizures, 620023 (3), Autosomal recessive	Autosomal recessive	y	y	[The proband in family 2 had a significant family history of 3 similarly affected sibs with seizures and lack of speech who died between 18 months and 17 years; there was also a spontaneous abortion in this family. ]	L3	n	y	lethal	lethal	lethal	L3	L3	pre-infant-lethal
620024	NEURODEVELOPMENTAL DISORDER WITH SEIZURES, MICROCEPHALY, AND BRAIN ABNORMALITIES	Neurodevelopmental disorder with seizures, microcephaly, and brain abnormalities, 620024 (3)	Neurodevelopmental disorder with seizures, microcephaly, and brain abnormalities	y	NEURODEVELOPMENTAL DISORDER WITH SEIZURES, MICROCEPHALY, AND BRAIN ABNORMALITIES; NEDSMBA	Clinical Features	died	PPFIBP1	HGNC:9249	Neurodevelopmental disorder with seizures, microcephaly, and brain abnormalities, 620024 (3), Autosomal recessive	Autosomal recessive	y	y	[One sib died at 6 days of age]	L2	n	y	lethal	lethal	lethal	L2	L2	pre-infant-lethal
620025	DIAPHRAGMATIC HERNIA 4, WITH CARDIOVASCULAR DEFECTS	Diaphragmatic hernia 4, with cardiovascular defects, 620025 (3)	Diaphragmatic hernia 4, with cardiovascular defects	y	DIAPHRAGMATIC HERNIA 4, WITH CARDIOVASCULAR DEFECTS; DIH4	Description|Clinical Features|Clinical Synopsis	death|deaths|died	ALDH1A2	HGNC:15472	Diaphragmatic hernia 4, with cardiovascular defects, 620025 (3), Autosomal recessive	Autosomal recessive	y	y	[died soon after birth .. died of respiratory failure at 3 months of age]	L2	y	y	lethal	lethal	lethal	L2	L2	pre-infant-lethal
620027	NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, SHORT STATURE, AND SPEECH DELAY	Neurodevelopmental disorder with microcephaly, short stature, and speech delay, 620027 (3)	Neurodevelopmental disorder with microcephaly, short stature, and speech delay	n	-	-	-	TRAPPC10	HGNC:11868	Neurodevelopmental disorder with microcephaly, short stature, and speech delay, 620027 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
620028	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 106	Developmental and epileptic encephalopathy 106, 620028 (3)	Developmental and epileptic encephalopathy 106	n	-	-	-	UFSP2	HGNC:25640	Developmental and epileptic encephalopathy 106, 620028 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
620029	NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, LANGUAGE DELAY, AND SKELETAL DEFECTS WITH OR WITHOUT SEIZURES	Neurodevelopmental disorder with hypotonia, language delay, and skeletal defects with or without seizures, 620029 (3)	Neurodevelopmental disorder with hypotonia, language delay, and skeletal defects with or without seizures	n	-	-	-	CACNA1C	HGNC:1390	Neurodevelopmental disorder with hypotonia, language delay, and skeletal defects with or without seizures, 620029 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L4|L5	L4	post-infant-lethal
620032	CILIARY DYSKINESIA, PRIMARY, 48, WITHOUT SITUS INVERSUS	Ciliary dyskinesia, primary, 48, without situs inversus, 620032 (3)	Ciliary dyskinesia, primary, 48, without situs inversus	n	-	-	-	NME5	HGNC:7853	Ciliary dyskinesia, primary, 48, without situs inversus, 620032 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
620033	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 107	Developmental and epileptic encephalopathy 107, 620033 (3)	Developmental and epileptic encephalopathy 107	n	-	-	-	NAPB	HGNC:15751	Developmental and epileptic encephalopathy 107, 620033 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
620044	BONE MARROW FAILURE AND DIABETES MELLITUS SYNDROME	Bone marrow failure and diabetes mellitus syndrome, 620044 (3)	Bone marrow failure and diabetes mellitus syndrome	y	BONE MARROW FAILURE AND DIABETES MELLITUS SYNDROME; BMFDMS	Clinical Features|Phenotype	died|death|deaths	DUT	HGNC:3078	Bone marrow failure and diabetes mellitus syndrome, 620044 (3), Autosomal recessive	Autosomal recessive	y	y	[Patient 2 (family 1) died at age 11 years from a brain hemorrhage due to thrombocytopenia, and patient 3 (family 2) died at age 21 years from graft-versus-host disease]	L5	y	-	lethal	lethal	lethal	L5	L5	post-infant-lethal
620049	NEPHROTIC SYNDROME, TYPE 26	Nephrotic syndrome, type 26, 620049 (3)	Nephrotic syndrome, type 26	y	NEPHROTIC SYNDROME, TYPE 26; NPHS26	Clinical Features	died	LAMA5	HGNC:6485	Nephrotic syndrome, type 26, 620049 (3), Autosomal recessive	Autosomal recessive	y	y	[1 progressed to ESRD and died at age 6 years. ]	L4	y	-	lethal	lethal	lethal	L4	L4	post-infant-lethal
620056	POLYCYSTIC KIDNEY DISEASE 7	Polycystic kidney disease 7, 620056 (3)	Polycystic kidney disease 7	n	-	-	-	ALG5	HGNC:20266	Polycystic kidney disease 7, 620056 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
620062	DEVELOPMENTAL DELAY WITH SHORT STATURE, DYSMORPHIC FACIAL FEATURES, AND SPARSE HAIR 2	Developmental delay with short stature, dysmorphic facial features, and sparse hair 2, 620062 (3)	Developmental delay with short stature, dysmorphic facial features, and sparse hair 2	n	-	-	-	DPH2	HGNC:3004	Developmental delay with short stature, dysmorphic facial features, and sparse hair 2, 620062 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
620065	DEVELOPMENTAL DELAY, BEHAVIORAL ABNORMALITIES, AND NEUROPSYCHIATRIC DISORDERS	Developmental delay, behavioral abnormalities, and neuropsychiatric disorders, 620065 (3)	Developmental delay, behavioral abnormalities, and neuropsychiatric disorders	n	-	-	-	ADGRL1	HGNC:20973	Developmental delay, behavioral abnormalities, and neuropsychiatric disorders, 620065 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
620066	NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, CEREBRAL ATROPHY, AND VISUAL IMPAIRMENT	Neurodevelopmental disorder with microcephaly, cerebral atrophy, and visual impairment, 620066 (3)	Neurodevelopmental disorder with microcephaly, cerebral atrophy, and visual impairment	n	-	-	-	DOHH	HGNC:28662	Neurodevelopmental disorder with microcephaly, cerebral atrophy, and visual impairment, 620066 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
620067	CARDIAC VALVULAR DYSPLASIA 2	Cardiac valvular dysplasia 2, 620067 (3)	Cardiac valvular dysplasia 2	n	-	-	-	ADAMTS19	HGNC:17111	Cardiac valvular dysplasia 2, 620067 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
620068	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2II	Charcot-Marie-Tooth disease, axonal, type 2II, 620068 (3)	Charcot-Marie-Tooth disease, axonal, type 2II	n	-	-	-	SLC12A6	HGNC:10914	Charcot-Marie-Tooth disease, axonal, type 2II, 620068 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L6	L6	post-infant-lethal
620070	NEURODEVELOPMENTAL DISORDER WITH SHORT STATURE, PROMINENT FOREHEAD, AND FEEDING DIFFICULTIES	Neurodevelopmental disorder with short stature, prominent forehead, and feeding difficulties, 620070 (3)	Neurodevelopmental disorder with short stature, prominent forehead, and feeding difficulties	y	NEURODEVELOPMENTAL DISORDER WITH SHORT STATURE, PROMINENT FOREHEAD, AND FEEDING DIFFICULTIES; NEDSFF	Description|Clinical Features	death|deaths|died	DPH5	HGNC:24270	Neurodevelopmental disorder with short stature, prominent forehead, and feeding difficulties, 620070 (3), Autosomal recessive	Autosomal recessive	y	y	[characterized by distinct craniofacial features, multisystem dysfunction, profound neurodevelopmental delays, and neonatal death]	L2	y	-	lethal	lethal	lethal	L2	L2	pre-infant-lethal
620072	DIAMOND-BLACKFAN ANEMIA 21	Diamond-Blackfan anemia 21, 620072 (3)	Diamond-Blackfan anemia 21	y	DIAMOND-BLACKFAN ANEMIA 21; DBA21	Clinical Features	died	HEATR3	HGNC:26087	Diamond-Blackfan anemia 21, 620072 (3), Autosomal recessive	Autosomal recessive	y	y	[One patient died at age 20 years of osteosarcoma]	L6	y	-	lethal	lethal	lethal	L6	L6	post-infant-lethal
620073	NEURODEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND SKELETAL AND BRAIN ABNORMALITIES	Neurodevelopmental disorder with dysmorphic facies and skeletal and brain abnormalities, 620073 (3)	Neurodevelopmental disorder with dysmorphic facies and skeletal and brain abnormalities	n	-	-	-	HNRNPR	HGNC:5047	Neurodevelopmental disorder with dysmorphic facies and skeletal and brain abnormalities, 620073 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
620075	NEURODEVELOPMENTAL DISORDER WITH FACIAL DYSMORPHISM, ABSENT LANGUAGE, AND PSEUDO-PELGER-HUET ANOMALY	Neurodevelopmental disorder with facial dysmorphism, absent language, and pseudo-Pelger-Huet anomaly, 620075 (3)	Neurodevelopmental disorder with facial dysmorphism, absent language, and pseudo-Pelger-Huet anomaly	n	-	-	-	TMEM147	HGNC:30414	Neurodevelopmental disorder with facial dysmorphism, absent language, and pseudo-Pelger-Huet anomaly, 620075 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
620080	NEURONOPATHY, DISTAL HEREDITARY MOTOR, AUTOSOMAL DOMINANT 10	Neuronopathy, distal hereditary motor, autosomal dominant 10, 620080 (3)	Neuronopathy, distal hereditary motor, autosomal dominant 10	n	-	-	-	EMILIN1	HGNC:19880	Neuronopathy, distal hereditary motor, autosomal dominant 10, 620080 (3)	-	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
620083	NEURODEVELOPMENTAL DISORDER WITH CRANIOFACIAL DYSMORPHISM AND SKELETAL DEFECTS	Neurodevelopmental disorder with craniofacial dysmorphism and skeletal defects, 620083 (3)	Neurodevelopmental disorder with craniofacial dysmorphism and skeletal defects	y	NEURODEVELOPMENTAL DISORDER WITH CRANIOFACIAL DYSMORPHISM AND SKELETAL DEFECTS; NEDCDS	Clinical Features	died	HNRNPH1	HGNC:5041	Neurodevelopmental disorder with craniofacial dysmorphism and skeletal defects, 620083 (3), Autosomal dominant	Autosomal dominant	y	y	[died at 10.5 months]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
620084	SPERMATOGENIC FAILURE 76	Spermatogenic failure 76, 620084 (3)	Spermatogenic failure 76	n	-	-	-	CCDC34	HGNC:25079	Spermatogenic failure 76, 620084 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
620086	INTELLECTUAL DEVELOPMENTAL DISORDER WITH OCULAR ANOMALIES AND DISTINCTIVE FACIAL FEATURES	Intellectual developmental disorder with ocular anomalies and distinctive facial features, 620086 (3)	Intellectual developmental disorder with ocular anomalies and distinctive facial features	n	-	-	-	MTSS2	HGNC:25094	Intellectual developmental disorder with ocular anomalies and distinctive facial features, 620086 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
620089	NEURODEGENERATION, CHILDHOOD-ONSET, WITH MULTISYSTEM INVOLVEMENT DUE TO MITOCHONDRIAL DYSFUNCTION	Neurodegeneration, childhood-onset, with multisystem involvement due to mitochondrial dysfunction, 620089 (3)	Neurodegeneration, childhood-onset, with multisystem involvement due to mitochondrial dysfunction	y	NEURODEGENERATION, CHILDHOOD-ONSET, WITH MULTISYSTEM INVOLVEMENT DUE TO MITOCHONDRIAL DYSFUNCTION; CONDMIM	Description|Clinical Features|Clinical Synopsis	death|deaths|died	LETM1	HGNC:6556	Neurodegeneration, childhood-onset, with multisystem involvement due to mitochondrial dysfunction, 620089 (3), Autosomal recessive	Autosomal recessive	y	y	[Death in childhood may occur/ Nine patients from 4 families died of various causes between infancy and 8 years of age, and 9 patients, ranging in age from 1 to 39 years]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
620094	NEURODEVELOPMENTAL DISORDER WITH EYE MOVEMENT ABNORMALITIES AND ATAXIA	Neurodevelopmental disorder with eye movement abnormalities and ataxia, 620094 (3)	Neurodevelopmental disorder with eye movement abnormalities and ataxia	n	-	-	-	FRMD5	HGNC:28214	Neurodevelopmental disorder with eye movement abnormalities and ataxia, 620094 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
620098	DEVELOPMENTAL DELAY WITH VARIABLE INTELLECTUAL DISABILITY AND DYSMORPHIC FACIES	Developmental delay with variable intellectual disability and dysmorphic facies, 620098 (3)	Developmental delay with variable intellectual disability and dysmorphic facies	n	-	-	-	JARID2	HGNC:6196	Developmental delay with variable intellectual disability and dysmorphic facies, 620098 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
620099	CLEIDOCRANIAL DYSPLASIA 2	Cleidocranial dysplasia 2, 620099 (3)	Cleidocranial dysplasia 2	n	-	-	-	CBFB	HGNC:1539	Cleidocranial dysplasia 2, 620099 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
620102	RETINITIS PIGMENTOSA 95	Retinitis pigmentosa 95, 620102 (3)	Retinitis pigmentosa 95	n	-	-	-	RAX2	HGNC:18286	Retinitis pigmentosa 95, 620102 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
620103	SPERMATOGENIC FAILURE 77	Spermatogenic failure 77, 620103 (3)	Spermatogenic failure 77	n	-	-	-	FKBP6	HGNC:3722	Spermatogenic failure 77, 620103 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
620104	AMELOGENESIS IMPERFECTA, TYPE IK	Amelogenesis imperfecta, type IK, 620104 (3)	Amelogenesis imperfecta, type IK	n	-	-	-	SP6	HGNC:14530	Amelogenesis imperfecta, type IK, 620104 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
620106	SPASTIC PARAPLEGIA 88, AUTOSOMAL DOMINANT	Spastic paraplegia 88, autosomal dominant, 620106 (3)	Spastic paraplegia 88, autosomal dominant	n	-	-	-	KPNA3	HGNC:6396	Spastic paraplegia 88, autosomal dominant, 620106 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
620107	OROFACIODIGITAL SYNDROME XIX	Orofaciodigital syndrome XIX, 620107 (3)	Orofaciodigital syndrome XIX	n	-	-	-	SCNM1	HGNC:23136	Orofaciodigital syndrome XIX, 620107 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
620111	CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 1J	Charcot-Marie-Tooth disease, demyelinating, type 1J, 620111 (3)	Charcot-Marie-Tooth disease, demyelinating, type 1J	n	-	-	-	ITPR3	HGNC:6182	Charcot-Marie-Tooth disease, demyelinating, type 1J, 620111 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
620113	NEURODEVELOPMENTAL DISORDER WITH GROWTH RETARDATION, DYSMORPHIC FACIES, AND CORPUS CALLOSUM ABNORMALITIES	Neurodevelopmental disorder with growth retardation, dysmorphic facies, and corpus callosum abnormalities, 620113 (3)	Neurodevelopmental disorder with growth retardation, dysmorphic facies, and corpus callosum abnormalities	y	NEURODEVELOPMENTAL DISORDER WITH GROWTH RETARDATION, DYSMORPHIC FACIES, AND CORPUS CALLOSUM ABNORMALITIES; NEDGFC	Clinical Features	died	FRA10AC1	HGNC:1162	Neurodevelopmental disorder with growth retardation, dysmorphic facies, and corpus callosum abnormalities, 620113 (3), Autosomal recessive	Autosomal recessive	y	y	[she died of septic and hypovolemic shock at 6 years of age]	L4	y	-	lethal	lethal	lethal	L4	L4	post-infant-lethal
620114	NEURODEVELOPMENTAL DISORDER WITH SPEECH IMPAIRMENT AND WITH OR WITHOUT SEIZURES	Neurodevelopmental disorder with speech impairment and with or without seizures, 620114 (3)	Neurodevelopmental disorder with speech impairment and with or without seizures	n	-	-	-	CACNA1I	HGNC:1396	Neurodevelopmental disorder with speech impairment and with or without seizures, 620114 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
620115	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 108	Developmental and epileptic encephalopathy 108, 620115 (3)	Developmental and epileptic encephalopathy 108	n	-	-	-	MAST3	HGNC:19036	Developmental and epileptic encephalopathy 108, 620115 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
620125	PSEUDOHYPOALDOSTERONISM, TYPE IB2, AUTOSOMAL RECESSIVE	Pseudohypoaldosteronism, type IB2, autosomal recessive, 620125 (3)	Pseudohypoaldosteronism, type IB2, autosomal recessive	y	PSEUDOHYPOALDOSTERONISM, TYPE IB2, AUTOSOMAL RECESSIVE; PHA1B2	Clinical Features	died	SCNN1B	HGNC:10600	Pseudohypoaldosteronism, type IB2, autosomal recessive, 620125 (3), Autosomal recessive	Autosomal recessive	y	y	[The patient died of sudden cardiac arrest at age 6.5 years]	L4	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L4|L6	L4	post-infant-lethal
620126	PSEUDOHYPOALDOSTERONISM, TYPE IB3, AUTOSOMAL RECESSIVE	Pseudohypoaldosteronism, type IB3, autosomal recessive, 620126 (3)	Pseudohypoaldosteronism, type IB3, autosomal recessive	n	-	-	-	SCNN1G	HGNC:10602	Pseudohypoaldosteronism, type IB3, autosomal recessive, 620126 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
620133	DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 8	Dyskeratosis congenita, autosomal recessive 8, 620133 (3)	Dyskeratosis congenita, autosomal recessive 8	n	-	-	-	DCLRE1B	HGNC:17641	Dyskeratosis congenita, autosomal recessive 8, 620133 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
620138	MYOPATHY WITH MYALGIA, INCREASED SERUM CREATINE KINASE, AND WITH OR WITHOUT EPISODIC RHABDOMYOLYSIS	Myopathy with myalgia, increased serum creatine kinase, and with or without episodic rhabdomyolysis, 620138 (3)	Myopathy with myalgia, increased serum creatine kinase, and with or without episodic rhabdomyolysis	n	-	-	-	MLIP	HGNC:21355	Myopathy with myalgia, increased serum creatine kinase, and with or without episodic rhabdomyolysis, 620138 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
620139	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 56	Combined oxidative phosphorylation deficiency 56, 620139 (3)	Combined oxidative phosphorylation deficiency 56	y	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 56; COXPD56	Clinical Features	died	TAMM41	HGNC:25187	Combined oxidative phosphorylation deficiency 56, 620139 (3)	-	y	y	[She died from respiratory failure at 3 months of age.]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
620141	DEVELOPMENTAL DELAY, LANGUAGE IMPAIRMENT, AND OCULAR ABNORMALITIES	Developmental delay, language impairment, and ocular abnormalities, 620141 (3)	Developmental delay, language impairment, and ocular abnormalities	n	-	-	-	ARPC4	HGNC:707	Developmental delay, language impairment, and ocular abnormalities, 620141 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
620145	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 109	Developmental and epileptic encephalopathy 109, 620145 (3)	Developmental and epileptic encephalopathy 109	n	-	-	-	FZR1	HGNC:24824	Developmental and epileptic encephalopathy 109, 620145 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
620148	ICHTHYOSIS, ANNULAR EPIDERMOLYTIC, 2	Ichthyosis, annular epidermolytic 2, 620148 (3)	Ichthyosis, annular epidermolytic 2	n	-	-	-	KRT1	HGNC:6412	Ichthyosis, annular epidermolytic 2, 620148 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L2	L2	pre-infant-lethal
620149	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 110	Developmental and epileptic encephalopathy 110, 620149 (3)	Developmental and epileptic encephalopathy 110	n	-	-	-	CACNA2D1	HGNC:1399	Developmental and epileptic encephalopathy 110, 620149 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
620150	EPIDERMOLYTIC HYPERKERATOSIS 2	Epidermolytic hyperkeratosis 2, 620150 (3)	Epidermolytic hyperkeratosis 2	y	EPIDERMOLYTIC HYPERKERATOSIS 2; EHK2	Clinical Features|Phenotype	died|lethal	KRT10	HGNC:6413	Epidermolytic hyperkeratosis 2, 620150 (3)	-	y	y	[the patient died at 3 days of age]	L2	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L2|L6	L2	pre-infant-lethal
620151	WOLMAN DISEASE	Wolman disease, 620151 (3)	Wolman disease	y	WOLMAN DISEASE; WOLD	Description|Clinical Features|Clinical Synopsis|Phenotype	death|deaths|died	LIPA	HGNC:6617	Wolman disease, 620151 (3), Autosomal recessive	Autosomal recessive	y	y	[death by nutritional failure by 2 to 4 months of age]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
620152	HYPOMAGNESEMIA 7, RENAL, WITH OR WITHOUT DILATED CARDIOMYOPATHY	Hypomagnesemia 7, renal, with or without dilated cardiomyopathy, 620152 (3)	Hypomagnesemia 7, renal, with or without dilated cardiomyopathy	y	HYPOMAGNESEMIA 7, RENAL, WITH OR WITHOUT DILATED CARDIOMYOPATHY; HOMG7	Clinical Features|Phenotype	died	RRAGD	HGNC:19903	Hypomagnesemia 7, renal, with or without dilated cardiomyopathy, 620152 (3), Autosomal dominant	Autosomal dominant	y	y	[The proband in family 7 had a similarly affected sister who died in infancy of dilated cardiomyopathy]	L3	n	y	lethal	lethal	lethal	L3	L3	pre-infant-lethal
620154	OOCYTE/ZYGOTE/EMBRYO MATURATION ARREST 13	Oocyte/zygote/embryo maturation arrest 13, 620154 (3)	Oocyte/zygote/embryo maturation arrest 13	n	-	-	-	ZFP36L2	HGNC:1108	Oocyte/zygote/embryo maturation arrest 13, 620154 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
620155	RABIN-PAPPAS SYNDROME	Rabin-Pappas syndrome, 620155 (3)	Rabin-Pappas syndrome	n	-	-	-	SETD2	HGNC:18420	Rabin-Pappas syndrome, 620155 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
620156	CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 11	Cortical dysplasia, complex, with other brain malformations 11, 620156 (3)	Cortical dysplasia, complex, with other brain malformations 11	y	CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 11; CDCBM11	Clinical Features	died	KIF26A	HGNC:20226	Cortical dysplasia, complex, with other brain malformations 11, 620156 (3), Autosomal recessive	Autosomal recessive	y	y	[Several other sibs of the patient had similar clinical features and died in infancy but did not undergo genetic testing]	L3	n	y	lethal	lethal	lethal	L3	L3	pre-infant-lethal
620157	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 70	Intellectual developmental disorder, autosomal dominant 70, 620157 (3)	Intellectual developmental disorder, autosomal dominant 70	n	-	-	-	SETD2	HGNC:18420	Intellectual developmental disorder, autosomal dominant 70, 620157 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
620158	SPINOCEREBELLAR ATAXIA 50	Spinocerebellar ataxia 50, 620158 (3)	Spinocerebellar ataxia 50	y	SPINOCEREBELLAR ATAXIA 50; SCA50	Phenotype	death|deaths	NPTX1	HGNC:7952	Spinocerebellar ataxia 50, 620158 (3), Autosomal dominant	Autosomal dominant	y	n	-	-	-	-	ambiguous	ambiguous	ambiguous	-	-	-
620161	CONGENITAL MYOPATHY 15	Congenital myopathy 15, 620161 (3)	Congenital myopathy 15	n	-	-	-	TNNC2	HGNC:11944	Congenital myopathy 15, 620161 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
620166	MUSCULAR DYSTROPHY, CONGENITAL, WITH OR WITHOUT SEIZURES	Muscular dystrophy, congenital, with or without seizures, 620166 (3)	Muscular dystrophy, congenital, with or without seizures	y	MUSCULAR DYSTROPHY, CONGENITAL, WITH OR WITHOUT SEIZURES; MYOS	Clinical Features	died	GOSR2	HGNC:4431	Muscular dystrophy, congenital, with or without seizures, 620166 (3), Autosomal recessive	Autosomal recessive	y	y	[died of respiratory failure at age 5]	L4	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L4	L4	post-infant-lethal
620167	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 57	Combined oxidative phosphorylation deficiency 57, 620167 (3)	Combined oxidative phosphorylation deficiency 57	y	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 57; COXPD57	Description|Clinical Features|Clinical Synopsis	death|deaths|died	CRLS1	HGNC:16148	Combined oxidative phosphorylation deficiency 57, 620167 (3), Autosomal recessive	Autosomal recessive	y	y	[died at 3.5 months of age]	L3	y	y	lethal	lethal	lethal	L3	L3	pre-infant-lethal
620170	SPERMATOGENIC FAILURE 78	Spermatogenic failure 78, 620170 (3)	Spermatogenic failure 78	n	-	-	-	IQCN	HGNC:29350	Spermatogenic failure 78, 620170 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
620173	TOOTH AGENESIS, SELECTIVE, 10	Tooth agenesis, selective, 10, 620173 (3)	Tooth agenesis, selective, 10	n	-	-	-	TSPEAR	HGNC:1268	Tooth agenesis, selective, 10, 620173 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
620174	SPINOCEREBELLAR ATAXIA 27B, LATE-ONSET	Spinocerebellar ataxia 27B, late-onset, 620174 (3)	Spinocerebellar ataxia 27B, late-onset	n	-	-	-	FGF14	HGNC:3671	Spinocerebellar ataxia 27B, late-onset, 620174 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
620177	HYPOTRICHOSIS 15	Hypotrichosis 15, 620177 (3)	Hypotrichosis 15	n	-	-	-	C3orf52	HGNC:26255	Hypotrichosis 15, 620177 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
620183	MICROCEPHALY 30, PRIMARY, AUTOSOMAL RECESSIVE	Microcephaly 30, primary, autosomal recessive, 620183 (3)	Microcephaly 30, primary, autosomal recessive	n	-	-	-	BUB1	HGNC:1148	Microcephaly 30, primary, autosomal recessive, 620183 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
620184	ATELIS SYNDROME 1	Atelis syndrome 1, 620184 (3)	Atelis syndrome 1	y	ATELIS SYNDROME 1; ATELS1	Clinical Features|Clinical Synopsis|Phenotype	died|death|deaths	SLF2	HGNC:17814	Atelis syndrome 1, 620184 (3), Autosomal recessive	Autosomal recessive	y	y	[died between 2 months and 12 years of age]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
620185	ATELIS SYNDROME 2	Atelis syndrome 2, 620185 (3)	Atelis syndrome 2	y	ATELIS SYNDROME 2; ATELS2	Clinical Features|Clinical Synopsis|Phenotype	died|death|deaths	SMC5	HGNC:20465	Atelis syndrome 2, 620185 (3), Autosomal recessive	Autosomal recessive	y	y	[One patient died at 10 years of age]	L4	y	-	lethal	lethal	lethal	L4	L4	post-infant-lethal
620186	BRANCHIAL ARCH ABNORMALITIES, CHOANAL ATRESIA, ATHELIA, HEARING LOSS, AND HYPOTHYROIDISM SYNDROME	Branchial arch abnormalities, choanal atresia, athelia, hearing loss, and hypothyroidism syndrome, 620186 (3)	Branchial arch abnormalities, choanal atresia, athelia, hearing loss, and hypothyroidism syndrome	y	BRANCHIAL ARCH ABNORMALITIES, CHOANAL ATRESIA, ATHELIA, HEARING LOSS, AND HYPOTHYROIDISM SYNDROME; BCAHH	Clinical Features	died	KMT2D	HGNC:7133	Branchial arch abnormalities, choanal atresia, athelia, hearing loss, and hypothyroidism syndrome, 620186 (3), Autosomal dominant	Autosomal dominant	y	y	[The sister died at 4 months of age]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
620189	MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 7 WITH INFLAMMATION AND TUMOR PREDISPOSITION	Mosaic variegated aneuploidy syndrome 7 with inflammation and tumor predisposition, 620189 (3)	Mosaic variegated aneuploidy syndrome 7 with inflammation and tumor predisposition	y	MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 7 WITH INFLAMMATION AND TUMOR PREDISPOSITION; MVA7	Clinical Features	spontaneous_abortion|spontaneous_abortions	MAD1L1	HGNC:6762	Mosaic variegated aneuploidy syndrome 7 with inflammation and tumor predisposition, 620189 (3), Autosomal recessive	Autosomal recessive	y	n	-	-	-	-	ambiguous	ambiguous	ambiguous	-	-	-
620191	NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, DYSMORPHIC FACIES, AND SKIN ABNORMALITIES	Neurodevelopmental disorder with hypotonia, dysmorphic facies, and skin abnormalities, 620191 (3)	Neurodevelopmental disorder with hypotonia, dysmorphic facies, and skin abnormalities	n	-	-	-	PGM2L1	HGNC:20898	Neurodevelopmental disorder with hypotonia, dysmorphic facies, and skin abnormalities, 620191 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
620192	LACRIMOAURICULODENTODIGITAL SYNDROME 2	LADD syndrome 2, 620192 (3)	LADD syndrome 2	n	-	-	-	FGFR3	HGNC:3690	LADD syndrome 2, 620192 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L2|L3	L2	pre-infant-lethal
620193	LACRIMOAURICULODENTODIGITAL SYNDROME 3	LADD syndrome 3, 620193 (3)	LADD syndrome 3	n	-	-	-	FGF10	HGNC:3666	LADD syndrome 3, 620193 (3)	-	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
620194	NEURODEVELOPMENTAL DISORDER WITH POOR GROWTH, LARGE EARS, AND DYSMORPHIC FACIES	Neurodevelopmental disorder with poor growth, large ears, and dysmorphic facies, 620194 (3)	Neurodevelopmental disorder with poor growth, large ears, and dysmorphic facies	y	NEURODEVELOPMENTAL DISORDER WITH POOR GROWTH, LARGE EARS, AND DYSMORPHIC FACIES; NEDGEF	Description|Clinical Features|Clinical Synopsis	death|deaths|died	ZNF668	HGNC:25821	Neurodevelopmental disorder with poor growth, large ears, and dysmorphic facies, 620194 (3), Autosomal recessive	Autosomal recessive	y	y	[Patient 1 died at 13 months of age; he had a similarly affected sib who died at age 3 weeks]	L2	y	y	lethal	lethal	lethal	L2	L2	pre-infant-lethal
620196	SPERMATOGENIC FAILURE 79	Spermatogenic failure 79, 620196 (3)	Spermatogenic failure 79	n	-	-	-	KCNU1	HGNC:18867	Spermatogenic failure 79, 620196 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
620197	CILIARY DYSKINESIA, PRIMARY, 49, WITHOUT SITUS INVERSUS	Ciliary dyskinesia, primary, 49, without situs inversus, 620197 (3)	Ciliary dyskinesia, primary, 49, without situs inversus	n	-	-	-	CFAP74	HGNC:29368	Ciliary dyskinesia, primary, 49, without situs inversus, 620197 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
620199	INFLAMMATORY POIKILODERMA WITH HAIR ABNORMALITIES AND ACRAL KERATOSES	Inflammatory poikiloderma with hair abnormalities and acral keratoses, 620199 (3)	Inflammatory poikiloderma with hair abnormalities and acral keratoses	n	-	-	-	LTV1	HGNC:21173	Inflammatory poikiloderma with hair abnormalities and acral keratoses, 620199 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
620210	NEURODEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND ISCHIOPUBIC HYPOPLASIA	Neurodevelopmental disorder with dysmorphic facies and ischiopubic hypoplasia, 620210 (3)	Neurodevelopmental disorder with dysmorphic facies and ischiopubic hypoplasia	y	NEURODEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND ISCHIOPUBIC HYPOPLASIA; NEDFIH	Phenotype	death|deaths	NAE1	HGNC:621	Neurodevelopmental disorder with dysmorphic facies and ischiopubic hypoplasia, 620210 (3), Autosomal recessive	Autosomal recessive	y	n	-	-	-	-	ambiguous	ambiguous	ambiguous	-	-	-
620211	HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 8	Hyperinsulinemic hypoglycemia, familial, 8, 620211 (3)	Hyperinsulinemic hypoglycemia, familial, 8	n	-	-	-	SLC25A36	HGNC:25554	Hyperinsulinemic hypoglycemia, familial, 8, 620211 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
620221	SPASTIC PARAPLEGIA 79A, AUTOSOMAL DOMINANT, WITH ATAXIA	Spastic paraplegia 79A, autosomal dominant, 620221 (3)	Spastic paraplegia 79A, autosomal dominant	n	-	-	-	UCHL1	HGNC:12513	Spastic paraplegia 79A, autosomal dominant, 620221 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
620222	SPERMATOGENIC FAILURE 80	Spermatogenic failure 80, 620222 (3)	Spermatogenic failure 80	n	-	-	-	DRC1	HGNC:24245	Spermatogenic failure 80, 620222 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
620224	NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, DYSMORPHIC FACIES, AND SKELETAL ANOMALIES, WITH OR WITHOUT SEIZURES	Neurodevelopmental disorder with hypotonia, dysmorphic facies, and skeletal anomalies, with or without seizures, 620224 (3)	Neurodevelopmental disorder with hypotonia, dysmorphic facies, and skeletal anomalies, with or without seizures	n	-	-	-	TRPM3	HGNC:17992	Neurodevelopmental disorder with hypotonia, dysmorphic facies, and skeletal anomalies, with or without seizures, 620224 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
620227	DEAFNESS, AUTOSOMAL DOMINANT 85	Deafness, autosomal dominant 85, 620227 (3)	Deafness, autosomal dominant 85	n	-	-	-	USP48	HGNC:18533	Deafness, autosomal dominant 85, 620227 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
620228	RETINITIS PIGMENTOSA 96	Retinitis pigmentosa 96, autosomal dominant, 620228 (3)	Retinitis pigmentosa 96, autosomal dominant	y	RETINITIS PIGMENTOSA 96; RP96	Clinical Features	died	SAG	HGNC:10521	Retinitis pigmentosa 96, autosomal dominant, 620228 (3), Autosomal dominant	Autosomal dominant	y	n	-	-	-	-	ambiguous	ambiguous|nonlethal	ambiguous	-	-	-
620231	SHORT QT SYNDROME 7	Short QT syndrome 7, 620231 (3)	Short QT syndrome 7	y	SHORT QT SYNDROME 7; SQT7	Description|Clinical Features|Clinical Synopsis	death|deaths|died	SLC4A3	HGNC:11029	Short QT syndrome 7, 620231 (3), Autosomal dominant	Autosomal dominant	y	y	[died suddenly and unexpectedly while at rest at age 22 years.]	L6	y	y	lethal	lethal	lethal	L6	L6	post-infant-lethal
620233	RESPIRATORY INFECTIONS, RECURRENT, AND FAILURE TO THRIVE WITH OR WITHOUT DIARRHEA	Respiratory infections, recurrent, and failure to thrive with or without diarrhea, 620233 (3)	Respiratory infections, recurrent, and failure to thrive with or without diarrhea	n	-	-	-	AGR2	HGNC:328	Respiratory infections, recurrent, and failure to thrive with or without diarrhea, 620233 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
620236	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 29, WITH POLYGLUCOSAN BODIES	Cardiomyopathy, familial hypertrophic, 29, with polyglucosan bodies, 620236 (3)	Cardiomyopathy, familial hypertrophic, 29, with polyglucosan bodies	y	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 29, WITH POLYGLUCOSAN BODIES; CMH29	Description|Clinical Features|Clinical Synopsis	lethal|died|death|deaths	KLHL24	HGNC:25947	Cardiomyopathy, familial hypertrophic, 29, with polyglucosan bodies, 620236 (3), Autosomal recessive	Autosomal recessive	y	y	[Of 11 affected young adults in the 2 families, 3 died suddenly]	L6	y	y	lethal	lethal	lethal	L2|L6	L2	pre-infant-lethal
620237	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 78	Intellectual developmental disorder, autosomal recessive 78, 620237 (3)	Intellectual developmental disorder, autosomal recessive 78	n	-	-	-	WDR11	HGNC:13831	Intellectual developmental disorder, autosomal recessive 78, 620237 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
620238	DEAFNESS, AUTOSOMAL RECESSIVE 120	Deafness, autosomal recessive 120, 620238 (3)	Deafness, autosomal recessive 120	n	-	-	-	MINAR2	HGNC:33914	Deafness, autosomal recessive 120, 620238 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
620240	DEVELOPMENTAL DELAY WITH HYPOTONIA, MYOPATHY, AND BRAIN ABNORMALITIES	Developmental delay with hypotonia, myopathy, and brain abnormalities, 620240 (3)	Developmental delay with hypotonia, myopathy, and brain abnormalities	y	DEVELOPMENTAL DELAY WITH HYPOTONIA, MYOPATHY, AND BRAIN ABNORMALITIES; DEDHMB	Clinical Features	miscarriage|miscarriages	GOLGA2	HGNC:4425	Developmental delay with hypotonia, myopathy, and brain abnormalities, 620240 (3), Autosomal recessive	Autosomal recessive	y	y	[The parents of the proband had had 2 first trimester miscarriage]	L1	n	y	lethal	lethal	lethal	L1	L1	pre-infant-lethal
620242	NEURODEVELOPMENTAL DISORDER WITH POOR GROWTH AND BEHAVIORAL ABNORMALITIES	Neurodevelopmental disorder with poor growth and behavioral abnormalities, 620242 (3)	Neurodevelopmental disorder with poor growth and behavioral abnormalities	n	-	-	-	ATP9A	HGNC:13540	Neurodevelopmental disorder with poor growth and behavioral abnormalities, 620242 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
620243	LEUKODYSTROPHY, HYPOMYELINATING, 25	Leukodystrophy, hypomyelinating, 25, 620243 (3)	Leukodystrophy, hypomyelinating, 25	y	LEUKODYSTROPHY, HYPOMYELINATING, 25; HLD25	Phenotype	death|deaths	TMEM163	HGNC:25380	Leukodystrophy, hypomyelinating, 25, 620243 (3), Autosomal dominant	Autosomal dominant	y	n	-	-	-	-	ambiguous	ambiguous	ambiguous	-	-	-
620244	LYMPHATIC MALFORMATION 13	Lymphatic malformation 13, 620244 (3)	Lymphatic malformation 13	y	LYMPHATIC MALFORMATION 13; LMPHM13	Clinical Features|Phenotype	died|lethal	THSD1	HGNC:17754	Lymphatic malformation 13, 620244 (3), Autosomal recessive	Autosomal recessive	y	y	[died at 1 hour of life ]	L2	y	y	lethal	lethal	lethal	L2	L2	pre-infant-lethal
620245	EPISODIC KINESIGENIC DYSKINESIA 3	Episodic kinesigenic dyskinesia 3, 620245 (3)	Episodic kinesigenic dyskinesia 3	n	-	-	-	TMEM151A	HGNC:28497	Episodic kinesigenic dyskinesia 3, 620245 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
620246	CONGENITAL MYOPATHY 18	Congenital myopathy 18 due to dihydropyridine receptor defect, 620246 (3)	Congenital myopathy 18 due to dihydropyridine receptor defect	y	CONGENITAL MYOPATHY 18; CMYP18	Description|Clinical Features|Clinical Synopsis|Phenotype	death|deaths|died	CACNA1S	HGNC:1397	Congenital myopathy 18 due to dihydropyridine receptor defect, 620246 (3), Autosomal dominant, Autosomal recessive	Autosomal dominant, Autosomal recessive	y	y	[died at 10 days of age]	L2	y	y	lethal	lethal|nonlethal	lethal|nonlethal	L2	L2	pre-infant-lethal
620249	CONGENITAL MYOPATHY 10B, MILD VARIANT	Congenital myopathy 10B, mild variant, 620249 (3)	Congenital myopathy 10B, mild variant	y	CONGENITAL MYOPATHY 10B, MILD VARIANT; CMYP10B	Clinical Features	died	MEGF10	HGNC:29634	Congenital myopathy 10B, mild variant, 620249 (3), Autosomal recessive	Autosomal recessive	y	y	[She died suddenly at 13 years of age]	L5	y	-	lethal	lethal	lethal	L4|L5	L4	post-infant-lethal
620250	NEURODEVELOPMENTAL DISORDER WITH SEIZURES, SPASTICITY, AND COMPLETE OR PARTIAL AGENESIS OF THE CORPUS CALLOSUM	Neurodevelopmental disorder with seizures, spasticity, and complete or partial agenesis of the corpus callosum, 620250 (3)	Neurodevelopmental disorder with seizures, spasticity, and complete or partial agenesis of the corpus callosum	n	-	-	-	HECTD4	HGNC:26611	Neurodevelopmental disorder with seizures, spasticity, and complete or partial agenesis of the corpus callosum, 620250 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
620265	CONGENITAL MYOPATHY 2B, SEVERE INFANTILE, AUTOSOMAL RECESSIVE	Congenital myopathy 2B, severe infantile, autosomal recessive, 620265 (3)	Congenital myopathy 2B, severe infantile, autosomal recessive	y	CONGENITAL MYOPATHY 2B, SEVERE INFANTILE, AUTOSOMAL RECESSIVE; CMYP2B	Description|Clinical Features|Clinical Synopsis|Phenotype	death|deaths|died|lethal	ACTA1	HGNC:129	Congenital myopathy 2B, severe infantile, autosomal recessive, 620265 (3), Autosomal recessive	Autosomal recessive	y	y	[died at 2 months of age]	L3	y	-	lethal	lethal	lethal	L2|L3	L2	pre-infant-lethal
620269	LEUKODYSTROPHY, HYPOMYELINATING, 26, WITH CHONDRODYSPLASIA	Leukodystrophy, hypomyelinating, 26, with chondrodysplasia, 620269 (3)	Leukodystrophy, hypomyelinating, 26, with chondrodysplasia	n	-	-	-	SLC35B2	HGNC:16872	Leukodystrophy, hypomyelinating, 26, with chondrodysplasia, 620269 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
620270	NEURODEVELOPMENTAL DISORDER WITH ABSENT SPEECH AND MOVEMENT AND BEHAVIORAL ABNORMALITIES	Neurodevelopmental disorder with absent speech and movement and behavioral abnormalities, 620270 (3)	Neurodevelopmental disorder with absent speech and movement and behavioral abnormalities	n	-	-	-	UBE3C	HGNC:16803	Neurodevelopmental disorder with absent speech and movement and behavioral abnormalities, 620270 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
620275	MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 23	Mitochondrial complex IV deficiency, nuclear type 23, 620275 (3)	Mitochondrial complex IV deficiency, nuclear type 23	y	MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 23; MC4DN23	Clinical Features|Clinical Synopsis	died|death|deaths	COX11	HGNC:2261	Mitochondrial complex IV deficiency, nuclear type 23, 620275 (3), Autosomal recessive	Autosomal recessive	y	y	[died at 9 months of age]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
620276	OOCYTE/ZYGOTE/EMBRYO MATURATION ARREST 14	Oocyte/zygote/embryo maturation arrest 14, 620276 (3)	Oocyte/zygote/embryo maturation arrest 14	y	OOCYTE/ZYGOTE/EMBRYO MATURATION ARREST 14; OZEMA14	Clinical Features	miscarriage|miscarriages	CDC20	HGNC:1723	Oocyte/zygote/embryo maturation arrest 14, 620276 (3), Autosomal recessive	Autosomal recessive	y	n	-	-	-	-	ambiguous	ambiguous	ambiguous	-	-	-
620277	SPERMATOGENIC FAILURE 81	Spermatogenic failure 81, 620277 (3)	Spermatogenic failure 81	n	-	-	-	TEKT3	HGNC:14293	Spermatogenic failure 81, 620277 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
620278	CONGENITAL MYOPATHY 2C, SEVERE INFANTILE, AUTOSOMAL DOMINANT	Congenital myopathy 2C, severe infantile, autosomal dominant, 620278 (3)	Congenital myopathy 2C, severe infantile, autosomal dominant	y	CONGENITAL MYOPATHY 2C, SEVERE INFANTILE, AUTOSOMAL DOMINANT; CMYP2C	Description|Clinical Features|Clinical Synopsis|Phenotype	death|deaths|died	ACTA1	HGNC:129	Congenital myopathy 2C, severe infantile, autosomal dominant, 620278 (3), Autosomal dominant	Autosomal dominant	y	y	[death at 6 days of age]	L2	y	y	lethal	lethal	lethal	L2|L3	L2	pre-infant-lethal
620281	DEAFNESS, AUTOSOMAL DOMINANT 87	Deafness, autosomal dominant 87, 620281 (3)	Deafness, autosomal dominant 87	n	-	-	-	PI4KB	HGNC:8984	Deafness, autosomal dominant 87, 620281 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
620282	IMMUNODEFICIENCY 109 WITH LYMPHOPROLIFERATION	Immunodeficiency 109 with lymphoproliferation, 620282 (3)	Immunodeficiency 109 with lymphoproliferation	n	-	-	-	TNFRSF9	HGNC:11924	Immunodeficiency 109 with lymphoproliferation, 620282 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
620285	AMYOTROPHIC LATERAL SCLEROSIS 27, JUVENILE	Amyotrophic lateral sclerosis 27, juvenile, 620285 (3)	Amyotrophic lateral sclerosis 27, juvenile	n	-	-	-	SPTLC1	HGNC:11277	Amyotrophic lateral sclerosis 27, juvenile, 620285 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
620286	MYOPATHY, SARCOPLASMIC BODY	Myopathy, sarcoplasmic body, 620286 (3)	Myopathy, sarcoplasmic body	y	MYOPATHY, SARCOPLASMIC BODY; MYOSB	Clinical Features	died	MB	HGNC:6915	Myopathy, sarcoplasmic body, 620286 (3), Autosomal dominant	Autosomal dominant	y	y	[Six patients died of respiratory and/or cardiac failure between 18 and 30 years after disease onset]	LU	y	-	lethal	lethal	lethal	LU	LU	post-infant-lethal
620292	NEURODEVELOPMENTAL DISORDER WITH LANGUAGE DELAY AND BEHAVIORAL ABNORMALITIES, WITH OR WITHOUT SEIZURES	Neurodevelopmental disorder with language delay and behavioral abnormalities, with or without seizures, 620292 (3)	Neurodevelopmental disorder with language delay and behavioral abnormalities, with or without seizures	n	-	-	-	AGO1	HGNC:3262	Neurodevelopmental disorder with language delay and behavioral abnormalities, with or without seizures, 620292 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
620294	CONGENITAL HEART DEFECTS, MULTIPLE TYPES, 9	Congenital heart defects, multiple types, 9, 620294 (3)	Congenital heart defects, multiple types, 9	n	-	-	-	PLXND1	HGNC:9107	Congenital heart defects, multiple types, 9, 620294 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
620296	AUTOINFLAMMATION WITH PULMONARY AND CUTANEOUS VASCULITIS	Autoinflammation with pulmonary and cutaneous vasculitis, 620296 (3)	Autoinflammation with pulmonary and cutaneous vasculitis	y	AUTOINFLAMMATION WITH PULMONARY AND CUTANEOUS VASCULITIS; AIPCV	Clinical Features|Clinical Synopsis	death|deaths	HCK	HGNC:4840	Autoinflammation with pulmonary and cutaneous vasculitis, 620296 (3), Autosomal dominant	Autosomal dominant	y	y	[death at 17 years of age]	L5	y	-	lethal	lethal	lethal	L5	L5	post-infant-lethal
620300	MITOCHONDRIAL TRIFUNCTIONAL PROTEIN DEFICIENCY 2	Mitochondrial trifunctional protein deficiency 2, 620300 (3)	Mitochondrial trifunctional protein deficiency 2	y	MITOCHONDRIAL TRIFUNCTIONAL PROTEIN DEFICIENCY 2; MTPD2	Description|Clinical Features	death|deaths|lethal|died	HADHB	HGNC:4803	Mitochondrial trifunctional protein deficiency 2, 620300 (3)	-	y	y	[ died of cardiac arrest at ages 8 days and 3 month]	L2	y	-	lethal	lethal	lethal	L2	L2	pre-infant-lethal
620303	PITUITARY HORMONE DEFICIENCY, COMBINED OR ISOLATED, 8	Pituitary hormone deficiency, combined or isolated, 8, 620303 (3)	Pituitary hormone deficiency, combined or isolated, 8	n	-	-	-	ROBO1	HGNC:10249	Pituitary hormone deficiency, combined or isolated, 8, 620303 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
620305	NEUROOCULORENAL SYNDROME	Neurooculorenal syndrome, 620305 (3)	Neurooculorenal syndrome	n	-	-	-	ROBO1	HGNC:10249	Neurooculorenal syndrome, 620305 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
620306	NEURODEGENERATION AND SEIZURES DUE TO COPPER TRANSPORT DEFECT	Neurodegeneration and seizures due to copper transport defect, 620306 (3)	Neurodegeneration and seizures due to copper transport defect	y	NEURODEGENERATION AND SEIZURES DUE TO COPPER TRANSPORT DEFECT; NSCT	Clinical Synopsis	death|deaths	SLC31A1	HGNC:11016	Neurodegeneration and seizures due to copper transport defect, 620306 (3), Autosomal recessive	Autosomal recessive	y	y	[Death in infancy may occur]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
620310	CONGENITAL MYOPATHY 20	Congenital myopathy 20, 620310 (3)	Congenital myopathy 20	n	-	-	-	RYR3	HGNC:10485	Congenital myopathy 20, 620310 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
620311	PREMATURE OVARIAN FAILURE 21	Premature ovarian failure 21, 620311 (3)	Premature ovarian failure 21	n	-	-	-	TP63	HGNC:15979	Premature ovarian failure 21, 620311 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L2	L2	pre-infant-lethal
620312	LEUKOENCEPHALOPATHY WITH VANISHING WHITE MATTER 2	Leukoencephalopathy with vanishing white matter 2, with or without ovarian failure, 620312 (3)	Leukoencephalopathy with vanishing white matter 2, with or without ovarian failure	y	LEUKOENCEPHALOPATHY WITH VANISHING WHITE MATTER 2; VWM2	Description|Clinical Features|Phenotype	death|deaths|died	EIF2B2	HGNC:3258	Leukoencephalopathy with vanishing white matter 2, with or without ovarian failure, 620312 (3)	-	y	y	[Patient 1 died at the age of 8 months, and her similarly affected sisters died at 4.5 and 5 months of age.]	L3	y	y	lethal	lethal	lethal	L3	L3	pre-infant-lethal
620313	LEUKOENCEPHALOPATHY WITH VANISHING WHITE MATTER 3	Leukoencephalopathy with vanishing white matter 3, with or without ovarian failure, 620313 (3)	Leukoencephalopathy with vanishing white matter 3, with or without ovarian failure	n	-	-	-	EIF2B3	HGNC:3259	Leukoencephalopathy with vanishing white matter 3, with or without ovarian failure, 620313 (3)	-	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
620314	LEUKOENCEPHALOPATHY WITH VANISHING WHITE MATTER 4	Leukoencephalopathy with vanishing white matter 4, with or without ovarian failure, 620314 (3)	Leukoencephalopathy with vanishing white matter 4, with or without ovarian failure	n	-	-	-	EIF2B4	HGNC:3260	Leukoencephalopathy with vanishing white matter 4, with or without ovarian failure, 620314 (3)	-	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
620315	LEUKOENCEPHALOPATHY WITH VANISHING WHITE MATTER 5	Leukoencephalopathy with vanishing white matter 5, with or without ovarian failure, 620315 (3)	Leukoencephalopathy with vanishing white matter 5, with or without ovarian failure	y	LEUKOENCEPHALOPATHY WITH VANISHING WHITE MATTER 5; VWM5	Description|Clinical Features|Phenotype	death|deaths|died|fatal|demise	EIF2B5	HGNC:3261	Leukoencephalopathy with vanishing white matter 5, with or without ovarian failure, 620315 (3)	-	y	y	[death in 100% by 21 months of age]	L3	y	y	lethal	lethal	lethal	L3	L3	pre-infant-lethal
620316	CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 12	Cortical dysplasia, complex, with other brain malformations 12, 620316 (3)	Cortical dysplasia, complex, with other brain malformations 12	y	CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 12; CDCBM12	Clinical Features	died	CAMSAP1	HGNC:19946	Cortical dysplasia, complex, with other brain malformations 12, 620316 (3), Autosomal recessive	Autosomal recessive	y	y	[died at 5.5 years of age]	L4	y	-	lethal	lethal	lethal	L4	L4	post-infant-lethal
620317	NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY AND SPEECH DELAY, WITH OR WITHOUT BRAIN ABNORMALITIES	Neurodevelopmental disorder with microcephaly and speech delay, with or without brain abnormalities, 620317 (3)	Neurodevelopmental disorder with microcephaly and speech delay, with or without brain abnormalities	y	NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY AND SPEECH DELAY, WITH OR WITHOUT BRAIN ABNORMALITIES; NEDMSBA	Clinical Features	died	WARS1	HGNC:12729	Neurodevelopmental disorder with microcephaly and speech delay, with or without brain abnormalities, 620317 (3), Autosomal recessive	Autosomal recessive	y	y	[died at age 13 years]	L5	y	-	lethal	ambiguous|lethal	lethal	L5	L5	post-infant-lethal
620319	OOCYTE/ZYGOTE/EMBRYO MATURATION ARREST 17	Oocyte/zygote/embryo maturation arrest 17, 620319 (3)	Oocyte/zygote/embryo maturation arrest 17	n	-	-	-	KPNA7	HGNC:21839	Oocyte/zygote/embryo maturation arrest 17, 620319 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
620320	HEMATURIA, BENIGN FAMILIAL, 2	Hematuria, benign familial, 2, 620320 (3)	Hematuria, benign familial, 2	n	-	-	-	COL4A3	HGNC:2204	Hematuria, benign familial, 2, 620320 (3)	-	-	-	-	-	-	-	nonlethal	ambiguous|nonlethal	ambiguous	-	-	-
620321	C1q DEFICIENCY 2	C1q deficiency 2, 620321 (3)	C1q deficiency 2	n	-	-	-	C1QB	HGNC:1242	C1q deficiency 2, 620321 (3)	-	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
620322	C1q DEFICIENCY 3	C1q deficiency 3, 620322 (3)	C1q deficiency 3	n	-	-	-	C1QC	HGNC:1245	C1q deficiency 3, 620322 (3)	-	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
620323	SPASTIC PARAPLEGIA 70, AUTOSOMAL RECESSIVE	Spastic paraplegia 70, autosomal recessive, 620323 (3)	Spastic paraplegia 70, autosomal recessive	n	-	-	-	MARS1	HGNC:6898	Spastic paraplegia 70, autosomal recessive, 620323 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L4	L4	post-infant-lethal
620326	CONGENITAL MYOPATHY 21 WITH EARLY RESPIRATORY FAILURE	Congenital myopathy 21 with early respiratory failure, 620326 (3)	Congenital myopathy 21 with early respiratory failure	y	CONGENITAL MYOPATHY 21 WITH EARLY RESPIRATORY FAILURE; CMYP21	Description|Clinical Features|Clinical Synopsis	death|deaths	DNAJB4	HGNC:14886	Congenital myopathy 21 with early respiratory failure, 620326 (3), Autosomal recessive	Autosomal recessive	y	y	[death in the 11-year-old girl]	L5	y	-	lethal	lethal	lethal	L5	L5	post-infant-lethal
620327	NEURODEGENERATION WITH DEVELOPMENTAL DELAY, EARLY RESPIRATORY FAILURE, MYOCLONIC SEIZURES, AND BRAIN ABNORMALITIES	Neurodegeneration with developmental delay, early respiratory failure, myoclonic seizures, and brain abnormalities, 620327 (3)	Neurodegeneration with developmental delay, early respiratory failure, myoclonic seizures, and brain abnormalities	y	NEURODEGENERATION WITH DEVELOPMENTAL DELAY, EARLY RESPIRATORY FAILURE, MYOCLONIC SEIZURES, AND BRAIN ABNORMALITIES; NDDRSB	Description|Clinical Features|Clinical Synopsis	die|died|death|deaths	MED11	HGNC:32687	Neurodegeneration with developmental delay, early respiratory failure, myoclonic seizures, and brain abnormalities, 620327 (3), Autosomal recessive	Autosomal recessive	y	y	[died within hours or days after birth]	L2	y	-	lethal	lethal	lethal	L2	L2	pre-infant-lethal
620330	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 71, WITH BEHAVIORAL ABNORMALITIES	Intellectual developmental disorder, autosomal dominant 71, with behavioral abnormalities, 620330 (3)	Intellectual developmental disorder, autosomal dominant 71, with behavioral abnormalities	n	-	-	-	RFX7	HGNC:25777	Intellectual developmental disorder, autosomal dominant 71, with behavioral abnormalities, 620330 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
620331	HATIPOGLU IMMUNODEFICIENCY SYNDROME	Hatipoglu immunodeficiency syndrome, 620331 (3)	Hatipoglu immunodeficiency syndrome	n	-	-	-	DPP9	HGNC:18648	Hatipoglu immunodeficiency syndrome, 620331 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
620332	OOCYTE/ZYGOTE/EMBRYO MATURATION ARREST 18	Oocyte/zygote/embryo maturation arrest 18, 620332 (3)	Oocyte/zygote/embryo maturation arrest 18	n	-	-	-	NLRP2	HGNC:22948	Oocyte/zygote/embryo maturation arrest 18, 620332 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
620333	OOCYTE/ZYGOTE/EMBRYO MATURATION ARREST 19	Oocyte/zygote/embryo maturation arrest 19, 620333 (3)	Oocyte/zygote/embryo maturation arrest 19	y	OOCYTE/ZYGOTE/EMBRYO MATURATION ARREST 19; OZEMA19	Clinical Features	spontaneous_abortion|spontaneous_abortions	NLRP5	HGNC:21269	Oocyte/zygote/embryo maturation arrest 19, 620333 (3), Autosomal recessive	Autosomal recessive	y	n	-	-	-	-	ambiguous	ambiguous	ambiguous	-	-	-
620342	CONE-ROD DYSTROPHY 24	Cone-rod dystrophy 24, 620342 (3)	Cone-rod dystrophy 24	n	-	-	-	UNC119	HGNC:12565	Cone-rod dystrophy 24, 620342 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
620343	BASAL CELL NEVUS SYNDROME 2	Basal cell nevus syndrome 2, 620343 (3)	Basal cell nevus syndrome 2	n	-	-	-	SUFU	HGNC:16466	Basal cell nevus syndrome 2, 620343 (3)	-	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
620344	PROLONGED ELECTRORETINAL RESPONSE SUPPRESSION 2	Bradyopsia 2, 620344 (3)	Bradyopsia 2	n	-	-	-	RGS9BP	HGNC:30304	Bradyopsia 2, 620344 (3)	-	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
620351	CONGENITAL MYOPATHY 22A, CLASSIC	Congenital myopathy 22A, classic, 620351 (3)	Congenital myopathy 22A, classic	y	CONGENITAL MYOPATHY 22A, CLASSIC; CMYP22A	Clinical Features	died	SCN4A	HGNC:10591	Congenital myopathy 22A, classic, 620351 (3), Autosomal recessive	Autosomal recessive	y	y	[and died 5 hours post-delivery]	L2	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L1|L2|L3	L1	pre-infant-lethal
620352	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 31B	Developmental and epileptic encephalopathy 31B, autosomal recessive, 620352 (3)	Developmental and epileptic encephalopathy 31B, autosomal recessive	n	-	-	-	DNM1	HGNC:2972	Developmental and epileptic encephalopathy 31B, autosomal recessive, 620352 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
620353	SPERMATOGENIC FAILURE 82	Spermatogenic failure 82, 620353 (3)	Spermatogenic failure 82	n	-	-	-	AKAP3	HGNC:373	Spermatogenic failure 82, 620353 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
620356	CILIARY DYSKINESIA, PRIMARY, 50	Ciliary dyskinesia, primary, 50, 620356 (3)	Ciliary dyskinesia, primary, 50	n	-	-	-	DNAH7	HGNC:18661	Ciliary dyskinesia, primary, 50, 620356 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
620358	MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 4A	Mitochondrial complex V (ATP synthase) deficiency, nuclear type 4A, 620358 (3)	Mitochondrial complex V (ATP synthase) deficiency, nuclear type 4A	n	-	-	-	ATP5F1A	HGNC:823	Mitochondrial complex V (ATP synthase) deficiency, nuclear type 4A, 620358 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
620359	MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 7	Mitochondrial complex V (ATP synthase) deficiency, nuclear type 7, 620359 (3)	Mitochondrial complex V (ATP synthase) deficiency, nuclear type 7	y	MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 7; MC5DN7	Description|Clinical Features|Clinical Synopsis	die|death|deaths|died	ATP5PO	HGNC:850	Mitochondrial complex V (ATP synthase) deficiency, nuclear type 7, 620359 (3), Autosomal recessive	Autosomal recessive	y	y	[died at 4 and 6 month]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
620364	COMBINED LOW LDL AND FIBRINOGEN	Combined low LDL and fibrinogen, 620364 (3)	Combined low LDL and fibrinogen	n	-	-	-	B4GALT1	HGNC:924	Combined low LDL and fibrinogen, 620364 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
620365	PULMONARY FIBROSIS AND/OR BONE MARROW FAILURE SYNDROME, TELOMERE-RELATED, 7	Pulmonary fibrosis and/or bone marrow failure syndrome, telomere-related, 7, 620365 (3)	Pulmonary fibrosis and/or bone marrow failure syndrome, telomere-related, 7	y	PULMONARY FIBROSIS AND/OR BONE MARROW FAILURE SYNDROME, TELOMERE-RELATED, 7; PFBMFT7	Clinical Features	died	NAF1	HGNC:25126	Pulmonary fibrosis and/or bone marrow failure syndrome, telomere-related, 7, 620365 (3), Autosomal dominant	Autosomal dominant	y	y	[died at 54 years of age]	L6	y	-	lethal	lethal	lethal	L6	L6	post-infant-lethal
620369	CONGENITAL MYOPATHY 22B, SEVERE FETAL	Congenital myopathy 22B, severe fetal, 620369 (3)	Congenital myopathy 22B, severe fetal	y	CONGENITAL MYOPATHY 22B, SEVERE FETAL; CMYP22B	Description|Clinical Features|Clinical Synopsis	death|deaths|lethal	SCN4A	HGNC:10591	Congenital myopathy 22B, severe fetal, 620369 (3), Autosomal recessive	Autosomal recessive	y	y	[death in utero or shortly after birth]	L1	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L1|L2|L3	L1	pre-infant-lethal
620370	RECON PROGEROID SYNDROME	RECON progeroid syndrome, 620370 (3)	RECON progeroid syndrome	n	-	-	-	RECQL	HGNC:9948	RECON progeroid syndrome, 620370 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
620371	NEURODEVELOPMENTAL DISORDER WITH INTRACRANIAL HEMORRHAGE, SEIZURES, AND SPASTICITY	Neurodevelopmental disorder with intracranial hemorrhage, seizures, and spasticity, 620371 (3)	Neurodevelopmental disorder with intracranial hemorrhage, seizures, and spasticity	y	NEURODEVELOPMENTAL DISORDER WITH INTRACRANIAL HEMORRHAGE, SEIZURES, AND SPASTICITY; NEDIHSS	Description|Clinical Features|Clinical Synopsis	die|died|stillborn|death|deaths	ESAM	HGNC:17474	Neurodevelopmental disorder with intracranial hemorrhage, seizures, and spasticity, 620371 (3), Autosomal recessive	Autosomal recessive	y	y	[stillborn 31-week-old fetus]	L1	y	-	lethal	lethal	lethal	L1	L1	pre-infant-lethal
620374	NEPHROLITHIASIS, CALCIUM OXALATE, 2, WITH OR WITHOUT NEPHROCALCINOSIS	Nephrolithiasis, calcium oxalate, 2, with nephrocalcinosis, 620374 (3)	Nephrolithiasis, calcium oxalate, 2, with nephrocalcinosis	n	-	-	-	OXGR1	HGNC:4531	Nephrolithiasis, calcium oxalate, 2, with nephrocalcinosis, 620374 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
620375	MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 28	Muscular dystrophy, limb-girdle, autosomal recessive 28, 620375 (3)	Muscular dystrophy, limb-girdle, autosomal recessive 28	y	MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 28; LGMDR28	Clinical Features	died	HMGCR	HGNC:5006	Muscular dystrophy, limb-girdle, autosomal recessive 28, 620375 (3), Autosomal recessive	Autosomal recessive	y	y	[2 sibs in family 4 died at 10 and 8 years of age.]	L4	y	-	lethal	lethal	lethal	L4	L4	post-infant-lethal
620376	AUTOINFLAMMATORY DISEASE, SYSTEMIC, WITH VASCULITIS	Autoinflammatory disease, systemic, with vasculitis, 620376 (3)	Autoinflammatory disease, systemic, with vasculitis	n	-	-	-	LYN	HGNC:6735	Autoinflammatory disease, systemic, with vasculitis, 620376 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
620379	SPASTIC PARAPLEGIA 89, AUTOSOMAL RECESSIVE	Spastic paraplegia 89, autosomal recessive, 620379 (3)	Spastic paraplegia 89, autosomal recessive	n	-	-	-	AMFR	HGNC:463	Spastic paraplegia 89, autosomal recessive, 620379 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
620383	OOCYTE/ZYGOTE/EMBRYO MATURATION ARREST 20	Oocyte/zygote/embryo maturation arrest 20, 620383 (3)	Oocyte/zygote/embryo maturation arrest 20	n	-	-	-	MOS	HGNC:7199	Oocyte/zygote/embryo maturation arrest 20, 620383 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
620386	NEMALINE MYOPATHY 5B, AUTOSOMAL RECESSIVE, CHILDHOOD-ONSET	Nemaline myopathy 5B, autosomal recessive, childhood-onset, 620386 (3)	Nemaline myopathy 5B, autosomal recessive, childhood-onset	n	-	-	-	TNNT1	HGNC:11948	Nemaline myopathy 5B, autosomal recessive, childhood-onset, 620386 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L3|L6 	L3	pre-infant-lethal
620389	NEMALINE MYOPATHY 5C, AUTOSOMAL DOMINANT	Nemaline myopathy 5C, autosomal dominant, 620389 (3)	Nemaline myopathy 5C, autosomal dominant	y	NEMALINE MYOPATHY 5C, AUTOSOMAL DOMINANT; NEM5C	Clinical Features	death|deaths|died	TNNT1	HGNC:11948	Nemaline myopathy 5C, autosomal dominant, 620389 (3), Autosomal dominant	Autosomal dominant	y	y	[Two obligate carriers died at 55 and 40 years of age without significant muscle symptoms.]	L6 	-	y	lethal	lethal|nonlethal	lethal|nonlethal	L3|L6 	L3	pre-infant-lethal
620398	GLYCINE ENCEPHALOPATHY 2	Glycine encephalopathy 2, 620398 (3)	Glycine encephalopathy 2	y	GLYCINE ENCEPHALOPATHY 2; GCE2	Description|Clinical Features	die|died	AMT	HGNC:473	Glycine encephalopathy 2, 620398 (3)	-	y	y	[he died on the twentieth day.]	L2	y	-	lethal	lethal	lethal	L2	L2	pre-infant-lethal
620402	NEURONOPATHY, DISTAL HEREDITARY MOTOR, AUTOSOMAL RECESSIVE 9	Neuronopathy, distal hereditary motor, autosomal recessive 9, 620402 (3)	Neuronopathy, distal hereditary motor, autosomal recessive 9	n	-	-	-	COQ7	HGNC:2244	Neuronopathy, distal hereditary motor, autosomal recessive 9, 620402 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L3	L3	pre-infant-lethal
620409	SPERMATOGENIC FAILURE 84	Spermatogenic failure 84, 620409 (3)	Spermatogenic failure 84	n	-	-	-	CFAP61	HGNC:15872	Spermatogenic failure 84, 620409 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
620411	PALMOPLANTAR KERATODERMA, EPIDERMOLYTIC, 2	Palmoplantar keratoderma, epidermolytic, 2, 620411 (3)	Palmoplantar keratoderma, epidermolytic, 2	n	-	-	-	KRT1	HGNC:6412	Palmoplantar keratoderma, epidermolytic, 2, 620411 (3)	-	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L2	L2	pre-infant-lethal
620415	WOOLLY HAIR-SKIN FRAGILITY SYNDROME	Woolly hair-skin fragility syndrome, 620415 (3)	Woolly hair-skin fragility syndrome	n	-	-	-	TUFT1	HGNC:12422	Woolly hair-skin fragility syndrome, 620415 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
620416	SPASTIC PARAPLEGIA 90A, AUTOSOMAL DOMINANT	Spastic paraplegia 90A, autosomal dominant, 620416 (3)	Spastic paraplegia 90A, autosomal dominant	n	-	-	-	SPTSSA	HGNC:20361	Spastic paraplegia 90A, autosomal dominant, 620416 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
620423	MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 7	Multiple mitochondrial dysfunctions syndrome 7, 620423 (3)	Multiple mitochondrial dysfunctions syndrome 7	y	MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 7; MMDS7	Description|Clinical Features|Clinical Synopsis	fatal|died|lethal|death|deaths	GCSH	HGNC:4208	Multiple mitochondrial dysfunctions syndrome 7, 620423 (3), Autosomal recessive	Autosomal recessive	y	y	[He died on day 7 of life]	L2	y	-	lethal	lethal	lethal	L2	L2	pre-infant-lethal
620427	DYSTONIA 37, EARLY-ONSET, WITH STRIATAL LESIONS	Dystonia 37, early-onset, with striatal lesions, 620427 (3)	Dystonia 37, early-onset, with striatal lesions	n	-	-	-	NUP54	HGNC:17359	Dystonia 37, early-onset, with striatal lesions, 620427 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
620428	NEURODEVELOPMENTAL DISORDER WITH MOTOR AND LANGUAGE DELAY, OCULAR DEFECTS, AND BRAIN ABNORMALITIES	Neurodevelopmental disorder with motor and language delay, ocular defects, and brain abnormalities, 620428 (3)	Neurodevelopmental disorder with motor and language delay, ocular defects, and brain abnormalities	y	NEURODEVELOPMENTAL DISORDER WITH MOTOR AND LANGUAGE DELAY, OCULAR DEFECTS, AND BRAIN ABNORMALITIES; NEDMLOB	Clinical Features|Clinical Synopsis|Phenotype	death|deaths|died|die|lethality	INTS11	HGNC:26052	Neurodevelopmental disorder with motor and language delay, ocular defects, and brain abnormalities, 620428 (3), Autosomal recessive	Autosomal recessive	y	y	[Five female patients from 2 unrelated families died between 6 and 18]	L4	y	-	lethal	lethal	lethal	L4	L4	post-infant-lethal
620430	AUTOIMMUNE DISEASE, MULTISYSTEM, INFANTILE-ONSET, 3	Autoimmune disease, multisystem, infantile-onset, 3, 620430 (3)	Autoimmune disease, multisystem, infantile-onset, 3	n	-	-	-	CBLB	HGNC:1542	Autoimmune disease, multisystem, infantile-onset, 3, 620430 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
620438	CILIARY DYSKINESIA, PRIMARY, 51	Ciliary dyskinesia, primary, 51, 620438 (3)	Ciliary dyskinesia, primary, 51	n	-	-	-	BRWD1	HGNC:12760	Ciliary dyskinesia, primary, 51, 620438 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
620439	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 72	Intellectual developmental disorder, autosomal dominant 72, 620439 (3)	Intellectual developmental disorder, autosomal dominant 72	n	-	-	-	SRRM2	HGNC:16639	Intellectual developmental disorder, autosomal dominant 72, 620439 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
620443	DISABLING PANSCLEROTIC MORPHEA OF CHILDHOOD	Disabling pansclerotic morphea of childhood, 620443 (3)	Disabling pansclerotic morphea of childhood	y	DISABLING PANSCLEROTIC MORPHEA OF CHILDHOOD; DPMC	Clinical Features	died	STAT4	HGNC:11365	Disabling pansclerotic morphea of childhood, 620443 (3), Autosomal dominant	Autosomal dominant	y	y	[patient 3 died of infection at age 31 years]	L6	y	-	lethal	lethal	lethal	L6	L6	post-infant-lethal
620444	CRANIOFACIAL MICROSOMIA 2	Craniofacial microsomia 2, 620444 (3)	Craniofacial microsomia 2	n	-	-	-	FOXI3	HGNC:35123	Craniofacial microsomia 2, 620444 (3), Autosomal dominant, Autosomal recessive	Autosomal dominant, Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
620445	NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY AND MOVEMENT ABNORMALITIES	Neurodevelopmental disorder with microcephaly and movement abnormalities, 620445 (3)	Neurodevelopmental disorder with microcephaly and movement abnormalities	n	-	-	-	TTI1	HGNC:29029	Neurodevelopmental disorder with microcephaly and movement abnormalities, 620445 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
620447	MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 3	Megalencephalic leukoencephalopathy with subcortical cysts 3, 620447 (3)	Megalencephalic leukoencephalopathy with subcortical cysts 3	n	-	-	-	GPRC5B	HGNC:13308	Megalencephalic leukoencephalopathy with subcortical cysts 3, 620447 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
620449	IMMUNODEFICIENCY 112	Immunodeficiency 112, 620449 (3)	Immunodeficiency 112	y	IMMUNODEFICIENCY 112; IMD112	Clinical Features	died	MAP3K14	HGNC:6853	Immunodeficiency 112, 620449 (3), Autosomal recessive	Autosomal recessive	y	y	[She had a younger brother who died at age 2 years from suspected combined immunodeficiency.]	L4	-	y	lethal	lethal	lethal	L4	L4	post-infant-lethal
620450	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 73	Intellectual developmental disorder, autosomal dominant 73, 620450 (3)	Intellectual developmental disorder, autosomal dominant 73	n	-	-	-	TAF4	HGNC:11537	Intellectual developmental disorder, autosomal dominant 73, 620450 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
620451	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 58	Combined oxidative phosphorylation deficiency 58, 620451 (3)	Combined oxidative phosphorylation deficiency 58	y	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 58; COXPD58	Clinical Features	died	TEFM	HGNC:26223	Combined oxidative phosphorylation deficiency 58, 620451 (3), Autosomal recessive	Autosomal recessive	y	y	[died at 1 month of age of liver failure.]	L2 	y	-	lethal	lethal	lethal	L2 	L2	pre-infant-lethal
620452	AMYOTROPHIC LATERAL SCLEROSIS 28	Amyotrophic lateral sclerosis 28, 620452 (3)	Amyotrophic lateral sclerosis 28	n	-	-	-	LRP12	HGNC:31708	Amyotrophic lateral sclerosis 28, 620452 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L6	L6	post-infant-lethal
620453	DYSTONIA 22, JUVENILE-ONSET	Dystonia 22, juvenile-onset, 620453 (3)	Dystonia 22, juvenile-onset	n	-	-	-	TSPOAP1	HGNC:16831	Dystonia 22, juvenile-onset, 620453 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
620455	NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA AND SPEECH DELAY, WITH OR WITHOUT SEIZURES	Neurodevelopmental disorder with hypotonia and speech delay, with or without seizures, 620455 (3)	Neurodevelopmental disorder with hypotonia and speech delay, with or without seizures	y	NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA AND SPEECH DELAY, WITH OR WITHOUT SEIZURES; NEDHSS	Phenotype	lethality	EIF4A2	HGNC:3284	Neurodevelopmental disorder with hypotonia and speech delay, with or without seizures, 620455 (3), Autosomal dominant, Autosomal recessive	Autosomal dominant, Autosomal recessive	y	n	-	-	-	-	ambiguous	ambiguous	ambiguous	-	-	-
620458	AURICULOCONDYLAR SYNDROME 2B	Auriculocondylar syndrome 2B, 620458 (3)	Auriculocondylar syndrome 2B	n	-	-	-	PLCB4	HGNC:9059	Auriculocondylar syndrome 2B, 620458 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
620460	OCULOPHARYNGEAL MUSCULAR DYSTROPHY 2	Oculopharyngeal muscular dystrophy 2, 620460 (3)	Oculopharyngeal muscular dystrophy 2	y	OCULOPHARYNGEAL MUSCULAR DYSTROPHY 2; OPMD2	Phenotype	death|deaths	HNRNPA2B1	HGNC:5033	Oculopharyngeal muscular dystrophy 2, 620460 (3), Autosomal dominant	Autosomal dominant	y	n	-	-	-	-	ambiguous	ambiguous	ambiguous	-	-	-
620462	CARDIOMYOPATHY, DILATED, 2I	Cardiomyopathy, dilated, 2I, 620462 (3)	Cardiomyopathy, dilated, 2I	y	CARDIOMYOPATHY, DILATED, 2I; CMD2I	Clinical Features|Phenotype	died	CAP2	HGNC:20039	Cardiomyopathy, dilated, 2I, 620462 (3), Autosomal recessive	Autosomal recessive	y	y	[a 12-year-old Bedouin boy who died of congestive heart failure]	L5	y	-	lethal	lethal	lethal	L5	L5	post-infant-lethal
620465	EPILEPSY, EARLY-ONSET, 3, WITH OR WITHOUT DEVELOPMENTAL DELAY	Epilepsy, early-onset, 3, with or without developmental delay, 620465 (3)	Epilepsy, early-onset, 3, with or without developmental delay	n	-	-	-	ATP6V0C	HGNC:855	Epilepsy, early-onset, 3, with or without developmental delay, 620465 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
620469	CRANIAL DYSINNERVATION DISORDER, CONGENITAL, WITH ABSENT CORNEAL REFLEX AND DEVELOPMENTAL DELAY	Cranial dysinnervation disorder, congenital, with absent corneal reflex and developmental delay, 620469 (3)	Cranial dysinnervation disorder, congenital, with absent corneal reflex and developmental delay	n	-	-	-	NEUROG1	HGNC:7764	Cranial dysinnervation disorder, congenital, with absent corneal reflex and developmental delay, 620469 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
620475	THROMBOCYTOPENIA 8, WITH DYSMORPHIC FEATURES AND DEVELOPMENTAL DELAY	Thrombocytopenia 8, with dysmorphic features and developmental delay, 620475 (3)	Thrombocytopenia 8, with dysmorphic features and developmental delay	y	THROMBOCYTOPENIA 8, WITH DYSMORPHIC FEATURES AND DEVELOPMENTAL DELAY; THC8	Clinical Features	died	ACTB	HGNC:132	Thrombocytopenia 8, with dysmorphic features and developmental delay, 620475 (3), Autosomal dominant	Autosomal dominant	y	y	[she died of sepsis at age 15.]	L5	y	-	lethal	lethal	lethal	L1|L5|L6	L1	pre-infant-lethal
620478	THROMBOCYTOPENIA 9	Thrombocytopenia 9, 620478 (3)	Thrombocytopenia 9	n	-	-	-	THPO	HGNC:11795	Thrombocytopenia 9, 620478 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L4	L4	post-infant-lethal
620481	AMEGAKARYOCYTIC THROMBOCYTOPENIA, CONGENITAL, 2	Amegakaryocytic thrombocytopenia, congenital, 2, 620481 (3)	Amegakaryocytic thrombocytopenia, congenital, 2	y	AMEGAKARYOCYTIC THROMBOCYTOPENIA, CONGENITAL, 2; CAMT2	Clinical Features	died	THPO	HGNC:11795	Amegakaryocytic thrombocytopenia, congenital, 2, 620481 (3), Autosomal recessive	Autosomal recessive	y	y	[2 older brothers had died of aplastic anemia at 9 and 18 years of age,]	L4	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L4	L4	post-infant-lethal
620482	PARKINSON DISEASE 25, AUTOSOMAL RECESSIVE EARLY-ONSET, WITH IMPAIRED INTELLECTUAL DEVELOPMENT	Parkinson disease 25, autosomal recessive early-onset, with impaired intellectual development, 620482 (3)	Parkinson disease 25, autosomal recessive early-onset, with impaired intellectual development	n	-	-	-	PTPA	HGNC:9308	Parkinson disease 25, autosomal recessive early-onset, with impaired intellectual development, 620482 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
620483	VARIEGATE PORPHYRIA, CHILDHOOD-ONSET	Variegate porphyria, childhood-onset, 620483 (3)	Variegate porphyria, childhood-onset	y	VARIEGATE PORPHYRIA, CHILDHOOD-ONSET; VPCO	Clinical Features	death|deaths	PPOX	HGNC:9280	Variegate porphyria, childhood-onset, 620483 (3), Autosomal recessive	Autosomal recessive	y	y	[commenced about the age of 12 years and death occurred about 18 months later.]	L5	y	-	lethal	lethal|nonlethal	lethal|nonlethal	L5	L5	post-infant-lethal
620484	THROMBOCYTOPENIA 10	Thrombocytopenia 10, 620484 (3)	Thrombocytopenia 10	n	-	-	-	PTPRJ	HGNC:9673	Thrombocytopenia 10, 620484 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
620486	BLEEDING DISORDER, PLATELET-TYPE, 25	Bleeding disorder, platelet-type, 25, 620486 (3)	Bleeding disorder, platelet-type, 25	n	-	-	-	TPM4	HGNC:12013	Bleeding disorder, platelet-type, 25, 620486 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
620489	NEURODEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND BEHAVIORAL ABNORMALITIES	Neurodevelopmental disorder with dysmorphic facies and behavioral abnormalities, 620489 (3)	Neurodevelopmental disorder with dysmorphic facies and behavioral abnormalities	n	-	-	-	SRSF1	HGNC:10780	Neurodevelopmental disorder with dysmorphic facies and behavioral abnormalities, 620489 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
620494	NEURODEVELOPMENTAL DISORDER WITH IMPAIRED LANGUAGE, BEHAVIORAL ABNORMALITIES, AND DYSMORPHIC FACIES	Neurodevelopmental disorder with impaired language, behavioral abnormalities, and dysmorphic facies, 620494 (3)	Neurodevelopmental disorder with impaired language, behavioral abnormalities, and dysmorphic facies	n	-	-	-	UBAP2L	HGNC:29877	Neurodevelopmental disorder with impaired language, behavioral abnormalities, and dysmorphic facies, 620494 (3)	-	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
620499	SPERMATOGENIC FAILURE 86	Spermatogenic failure 86, 620499 (3)	Spermatogenic failure 86	n	-	-	-	ACTL7A	HGNC:161	Spermatogenic failure 86, 620499 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
620501	ZIEGLER-HUANG SYNDROME	Ziegler-Huang syndrome, 620501 (3)	Ziegler-Huang syndrome	n	-	-	-	SLC30A7	HGNC:19306	Ziegler-Huang syndrome, 620501 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
620502	NEURODEVELOPMENTAL DISORDER WITH LANGUAGE DELAY AND VARIABLE COGNITIVE ABNORMALITIES	Neurodevelopmental disorder with language delay and variable cognitive abnormalities, 620502 (3)	Neurodevelopmental disorder with language delay and variable cognitive abnormalities	n	-	-	-	GABBR1	HGNC:4070	Neurodevelopmental disorder with language delay and variable cognitive abnormalities, 620502 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
620504	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 111	Developmental and epileptic encephalopathy 111, 620504 (3)	Developmental and epileptic encephalopathy 111	y	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 111; DEE111	Description|Clinical Features|Clinical Synopsis	death|deaths|died	DEPDC5	HGNC:18423	Developmental and epileptic encephalopathy 111, 620504 (3), Autosomal recessive	Autosomal recessive	y	y	[P1, P4, and P5 died between 15 and 37 months of age]	L3	y	-	lethal	lethal	lethal	L3|L6	L3	pre-infant-lethal
620507	ICHTHYOSIS WITH ERYTHROKERATODERMA	Ichthyosis with erythrokeratoderma, 620507 (3)	Ichthyosis with erythrokeratoderma	n	-	-	-	KLK11	HGNC:6359	Ichthyosis with erythrokeratoderma, 620507 (3)	-	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
620510	XEROSIS AND GROWTH FAILURE WITH IMMUNE AND PULMONARY DYSFUNCTION SYNDROME	Xerosis and growth failure with immune and pulmonary dysfunction syndrome, 620510 (3)	Xerosis and growth failure with immune and pulmonary dysfunction syndrome	y	XEROSIS AND GROWTH FAILURE WITH IMMUNE AND PULMONARY DYSFUNCTION SYNDROME; XGIP	Description|Clinical Features	die|died	DBR1	HGNC:15594	Xerosis and growth failure with immune and pulmonary dysfunction syndrome, 620510 (3)	-	y	y	[proband B died at age 4 months]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
620511	FLIEDNER-ZWEIER SYNDROME	Fliedner-Zweier syndrome, 620511 (3)	Fliedner-Zweier syndrome	n	-	-	-	SCAF4	HGNC:19304	Fliedner-Zweier syndrome, 620511 (3)	-	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
620512	SPASTIC PARAPLEGIA 18A, AUTOSOMAL DOMINANT	Spastic paraplegia 18A, autosomal dominant, 620512 (3)	Spastic paraplegia 18A, autosomal dominant	n	-	-	-	ERLIN2	HGNC:1356	Spastic paraplegia 18A, autosomal dominant, 620512 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
620515	NEURODEVELOPMENTAL DISORDER WITH MOTOR REGRESSION, PROGRESSIVE SPASTIC PARAPLEGIA, AND OROMOTOR DYSFUNCTION	Neurodevelopmental disorder with motor regression, progressive spastic paraplegia, and oromotor dysfunction, 620515 (3)	Neurodevelopmental disorder with motor regression, progressive spastic paraplegia, and oromotor dysfunction	n	-	-	-	SNAPC4	HGNC:11137	Neurodevelopmental disorder with motor regression, progressive spastic paraplegia, and oromotor dysfunction, 620515 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
620519	ARRHYTHMOGENIC CARDIOMYOPATHY WITH VARIABLE ECTODERMAL ABNORMALITIES	Arrhythmogenic cardiomyopathy with variable ectodermal abnormalities, 620519 (3)	Arrhythmogenic cardiomyopathy with variable ectodermal abnormalities	y	ARRHYTHMOGENIC CARDIOMYOPATHY WITH VARIABLE ECTODERMAL ABNORMALITIES; ARCME	Description|Clinical Features|Clinical Synopsis	death|deaths|died|fatal	PPP1R13L	HGNC:18838	Arrhythmogenic cardiomyopathy with variable ectodermal abnormalities, 620519 (3), Autosomal recessive	Autosomal recessive	y	y	[all died before 3 years of age. In 1 of the sibships, 4 fetuses were aborted between 21 and 31 weeks of gestation due to midline brain, eye, and facial defects.]	L4	y	-	lethal	lethal	lethal	L4	L4	post-infant-lethal
620528	NEURONOPATHY, DISTAL HEREDITARY MOTOR, AUTOSOMAL DOMINANT 11	Neuronopathy, distal hereditary motor, autosomal dominant 11, 620528 (3)	Neuronopathy, distal hereditary motor, autosomal dominant 11	n	-	-	-	SPTAN1	HGNC:11273	Neuronopathy, distal hereditary motor, autosomal dominant 11, 620528 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L4	L4	post-infant-lethal
620532	HYPER-IgE SYNDROME 6, AUTOSOMAL DOMINANT, WITH RECURRENT INFECTIONS	Hyper-IgE syndrome 6, autosomal dominant, with recurrent infections, 620532 (3)	Hyper-IgE syndrome 6, autosomal dominant, with recurrent infections	y	HYPER-IgE SYNDROME 6, AUTOSOMAL DOMINANT, WITH RECURRENT INFECTIONS; HIES6	Clinical Features	died|fatal	STAT6	HGNC:11368	Hyper-IgE syndrome 6, autosomal dominant, with recurrent infections, 620532 (3), Autosomal dominant	Autosomal dominant	y	y	[P9 who died of anaphylaxis at 20 years of age]	L6	y	-	lethal	lethal	lethal	L6	L6	post-infant-lethal
620535	DEVELOPMENTAL DELAY, DYSMORPHIC FACIES, AND BRAIN ANOMALIES	Developmental delay, dysmorphic facies, and brain anomalies, 620535 (3)	Developmental delay, dysmorphic facies, and brain anomalies	n	-	-	-	U2AF2	HGNC:23156	Developmental delay, dysmorphic facies, and brain anomalies, 620535 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
620536	ALPORT SYNDROME 3B, AUTOSOMAL RECESSIVE	Alport syndrome 3B, autosomal recessive, 620536 (3)	Alport syndrome 3B, autosomal recessive	n	-	-	-	COL4A3	HGNC:2204	Alport syndrome 3B, autosomal recessive, 620536 (3)	-	-	-	-	-	-	-	nonlethal	ambiguous|nonlethal	ambiguous	-	-	-
620537	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 112	Developmental and epileptic encephalopathy 112, 620537 (3)	Developmental and epileptic encephalopathy 112	y	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 112; DEE112	Clinical Features	died	KCNH5	HGNC:6254	Developmental and epileptic encephalopathy 112, 620537 (3)	-	y	y	[patients died at age 14 months and 9 years]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
620538	SPASTIC PARAPLEGIA 91, AUTOSOMAL DOMINANT, WITH OR WITHOUT CEREBELLAR ATAXIA	Spastic paraplegia 91, autosomal dominant, with or without cerebellar ataxia, 620538 (3)	Spastic paraplegia 91, autosomal dominant, with or without cerebellar ataxia	n	-	-	-	SPTAN1	HGNC:11273	Spastic paraplegia 91, autosomal dominant, with or without cerebellar ataxia, 620538 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L4	L4	post-infant-lethal
620540	DEVELOPMENTAL DELAY WITH OR WITHOUT EPILEPSY	Developmental delay with or without epilepsy, 620540 (3)	Developmental delay with or without epilepsy	n	-	-	-	SPTAN1	HGNC:11273	Developmental delay with or without epilepsy, 620540 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L4	L4	post-infant-lethal
620542	NEURONOPATHY, DISTAL HEREDITARY MOTOR, AUTOSOMAL RECESSIVE 10	Neuronopathy, distal hereditary motor, autosomal recessive 10, 620542 (3)	Neuronopathy, distal hereditary motor, autosomal recessive 10	n	-	-	-	VRK1	HGNC:12718	Neuronopathy, distal hereditary motor, autosomal recessive 10, 620542 (3)	-	-	-	-	-	-	-	nonlethal	lethal|nonlethal	lethal|nonlethal	L4	L4	post-infant-lethal
620545	ARTHROGRYPOSIS, DISTAL, TYPE 12	Arthrogryposis, distal, type 12, 620545 (3)	Arthrogryposis, distal, type 12	n	-	-	-	ADAMTS15	HGNC:16305	Arthrogryposis, distal, type 12, 620545 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
620546	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIbb	Congenital disorder of glycosylation, type IIbb, 620546 (3)	Congenital disorder of glycosylation, type IIbb	n	-	-	-	COG3	HGNC:18619	Congenital disorder of glycosylation, type IIbb, 620546 (3)	-	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
620547	SPERMATOGENIC FAILURE 88	Spermatogenic failure 88, 620547 (3)	Spermatogenic failure 88	y	SPERMATOGENIC FAILURE 88; SPGF88	Clinical Features	miscarriage|miscarriages	KASH5	HGNC:26520	Spermatogenic failure 88, 620547 (3), Autosomal recessive	Autosomal recessive	y	y	[The proband's sisters, 3 of whom experienced recurrent miscarriages and 1 of whom had never achieved pregnancy, were diagnosed with diminished ovarian reserve based on hormone and ultrasound studies.]	L1	-	y	lethal	lethal	lethal	L1	L1	pre-infant-lethal
620548	PREMATURE OVARIAN FAILURE 22	Premature ovarian failure 22, 620548 (3)	Premature ovarian failure 22	y	PREMATURE OVARIAN FAILURE 22; POF22	Clinical Features|Phenotype	miscarriage|miscarriages|pregnancy_loss|pregnancy_losses	KASH5	HGNC:26520	Premature ovarian failure 22, 620548 (3)	-	y	y	[3 sisters experienced recurrent miscarriages within the third month of gestation, and 1 sister had never achieved pregnancy]	L1	-	y	lethal	lethal	lethal	L1	L1	pre-infant-lethal
620550	OPTIC ATROPHY 14	Optic atrophy 14, 620550 (3)	Optic atrophy 14	n	-	-	-	MIEF1	HGNC:25979	Optic atrophy 14, 620550 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
620551	DEAFNESS, AUTOSOMAL RECESSIVE 121	Deafness, autosomal recessive 121, 620551 (3)	Deafness, autosomal recessive 121	n	-	-	-	GPR156	HGNC:20844	Deafness, autosomal recessive 121, 620551 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
620558	CRANIOMETADIAPHYSEAL OSTEOSCLEROSIS WITH HIP DYSPLASIA	Craniometadiaphyseal osteosclerosis with hip dysplasia, 620558 (3)	Craniometadiaphyseal osteosclerosis with hip dysplasia	n	-	-	-	AXIN1	HGNC:903	Craniometadiaphyseal osteosclerosis with hip dysplasia, 620558 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
620565	IMMUNODEFICIENCY 113 WITH AUTOIMMUNITY AND AUTOINFLAMMATION	Immunodeficiency 133 with autoimmunity and autoinflammation, 620565 (3)	Immunodeficiency 133 with autoimmunity and autoinflammation	y	IMMUNODEFICIENCY 113 WITH AUTOIMMUNITY AND AUTOINFLAMMATION; IMD113	Clinical Features|Clinical Synopsis	died|death|deaths	ARPC5	HGNC:708	Immunodeficiency 133 with autoimmunity and autoinflammation, 620565 (3)	-	y	y	[She died at 6 months of age]	L3	y	-	lethal	lethal	lethal	L3	L3	pre-infant-lethal
620570	CILIARY DYSKINESIA, PRIMARY, 52	Ciliary dyskinesia, primary, 52, 620570 (3)	Ciliary dyskinesia, primary, 52	n	-	-	-	DAW1	HGNC:26383	Ciliary dyskinesia, primary, 52, 620570 (3)	-	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
620576	OTOSCLEROSIS 11	Otosclerosis 11, 620576 (3)	Otosclerosis 11	n	-	-	-	FOXL1	HGNC:3817	Otosclerosis 11, 620576 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
620583	OPTIC ATROPHY 15	Optic atrophy 15, 620583 (3)	Optic atrophy 15	n	-	-	-	MCAT	HGNC:29622	Optic atrophy 15, 620583 (3), Autosomal recessive	Autosomal recessive	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
620601	GARG-MISHRA PROGEROID SYNDROME	Garg-Mishra progeroid syndrome, 620601 (3)	Garg-Mishra progeroid syndrome	y	GARG-MISHRA PROGEROID SYNDROME; GMPGS	Clinical Features|Phenotype	died	TOMM7	HGNC:21648	Garg-Mishra progeroid syndrome, 620601 (3), Autosomal recessive	Autosomal recessive	y	y	[The proband died at 2.5 years of age]	L4	y	-	lethal	lethal	lethal	L4	L4	post-infant-lethal
620602	LYMPHATIC MALFORMATION 14	Lymphatic malformation 14, 620602 (3)	Lymphatic malformation 14	n	-	-	-	ERG	HGNC:3446	Lymphatic malformation 14, 620602 (3), Autosomal dominant	Autosomal dominant	-	-	-	-	-	-	nonlethal	nonlethal	nonlethal	-	-	-
620609	LONG-OLSEN SYNDROME	Long-Olsen syndrome, 620609 (3)	Long-Olsen syndrome	y	LONG-OLSEN SYNDROME; LNGOS	Description|Clinical Features|Clinical Synopsis	lethal|died|death|deaths	RRAGC	HGNC:19902	Long-Olsen syndrome, 620609 (3)	-	y	y	[He died on the fourth day of life from cardiovascular failure]	L2	y	-	lethal	lethal	lethal	L2	L2	pre-infant-lethal
